Citrus Sinensis ID: 026160

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240--
Protein Sequence
MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSLALPKKSAIQSSRTSSSAGIEEVMGEMY
Secondary Structure (PSIPRED)
ccccccHHHccccccccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEcccccccccccccccccccccccccccccccEEEEccccccccccHHHHHHcccccccccccccHHHHHHHHHHccccccccccccccccccHHHHHHHHHccccccccccccHHHHHHHHHHHHHEEEcccccccccccHHHHHHHHcccccccccccccccccccccccccccccccccHHHHHHccc
Secondary Structure Prediction (SSPRO)
cccccHHHHHcccccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEcccccHHHEEEcccccEEEccccccEEcccccccccccEEEEEcccccHHHHHcccccEEEcccHEHHHEEEEEEEcccccccccccccccccHHHHHHHHHHcccccccccccccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHccccccccccccccEEEEcccccccccccccccccccccEEcc
Coil and Loop (DISEMBL)
mpngsldqftydqessngnrtleWRTVYQIAGGIARGLEYLHrgcnvrivhfdikphnilldedfcpkisdfglakqsqdkkSTISMLHargtigyiapevfcrsfggashksdvySYGMMILEMAVGrknadvkasrssdiyfpnsiykhiepgndfqldgvVTEEEKELVKKMILVSLWCiqtnpsdrpsMHEVLEMLESSteilqippkpslalpkksaiqssrtsssaGIEEVMGEMY
Flexible Loop (DISEMBL)
mpngsldqftydqessngnrtlewRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGlakqsqdkkSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKpslalpkksaiqssrtsssagieevmgemy
Low Complexity Region (SEG)
MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGvvteeekelvkkMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIppkpslalpkksaiqssrtsssAGIEEVMGEMY
Disordered region (IsUnstruct)
********************TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLA********TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQT*********************************************************
Disordered Region (DISOPRED)
*PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKN*******S**IYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSL*********************V***M*
Disordered Region (DISEMBL)
***************SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGL*********TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSL*****************GIEEVMGEMY
Disordered Region (DISPRO)
**NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSLALPK***********************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSLALPKKSAIQSSRTSSSAGIEEVMGEMY
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	242	2.2.26 [Sep-21-2011]
Q9FID6	813	Probable receptor-like pr	no	no	0.929	0.276	0.534	2e-66
Q9FID5	806	Probable receptor-like pr	no	no	0.954	0.286	0.545	2e-66
Q3ECH2	892	Probable receptor-like pr	no	no	0.917	0.248	0.512	2e-64
Q9FLV4	872	G-type lectin S-receptor-	no	no	0.855	0.237	0.434	6e-44
Q9XID3	829	G-type lectin S-receptor-	no	no	0.826	0.241	0.433	7e-39
Q8RWZ5	821	G-type lectin S-receptor-	no	no	0.859	0.253	0.407	9e-39
C0LGH3	1033	Probable LRR receptor-lik	no	no	0.847	0.198	0.425	5e-37
C0LGH2	1032	Probable LRR receptor-lik	no	no	0.838	0.196	0.435	5e-37
Q9FHG4	681	Probable L-type lectin-do	no	no	0.867	0.308	0.394	2e-36
Q9LDT0	700	Putative cysteine-rich re	no	no	0.880	0.304	0.368	2e-35

>sp|Q9FID6|Y5392_ARATH Probable receptor-like protein kinase At5g39020 OS=Arabidopsis thaliana GN=At5g39020 PE=2 SV=1

 Score =  252 bits (643), Expect = 2e-66,   Method: Compositional matrix adjust.
 Identities = 123/230 (53%), Positives = 162/230 (70%), Gaps = 5/230 (2%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           + +GSLDQF    +S   N T    T+Y IA GIARGLEYLH GC  RIVHFDIKP NIL
Sbjct: 571 LEHGSLDQFISRNKSLTPNVT----TLYGIALGIARGLEYLHYGCKTRIVHFDIKPQNIL 626

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           LD++FCPK++DFGLAK  + ++S +S++  RGTIGYIAPEV  R +GG SHKSDVYSYGM
Sbjct: 627 LDDNFCPKVADFGLAKLCEKRESILSLIDTRGTIGYIAPEVVSRMYGGISHKSDVYSYGM 686

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDG-VVTEEEKELVKKMILVS 179
           ++L+M   R   +      S  YFP+ IYK +E G+   + G  + EE+ ++VKKMILVS
Sbjct: 687 LVLDMIGARNKVETTTCNGSTAYFPDWIYKDLENGDQTWIIGDEINEEDNKIVKKMILVS 746

Query: 180 LWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSLALPKKSAIQSSRTS 229
           LWCI+  PSDRP M++V+EM+E S + L++PPKPS  +  +  ++SS  S
Sbjct: 747 LWCIRPCPSDRPPMNKVVEMIEGSLDALELPPKPSRHISTELVLESSSLS 796

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q9FID5|Y5393_ARATH Probable receptor-like protein kinase At5g39030 OS=Arabidopsis thaliana GN=At5g39030 PE=2 SV=1

 Score =  252 bits (643), Expect = 2e-66,   Method: Compositional matrix adjust.
 Identities = 131/240 (54%), Positives = 168/240 (70%), Gaps = 9/240 (3%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           + NGSLDQF     S N + T +  T+Y IA GIARGLEYLH GC  RIVHFDIKP NIL
Sbjct: 573 LENGSLDQFM----SRNKSLTQDVTTLYGIALGIARGLEYLHYGCKTRIVHFDIKPQNIL 628

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           LD + CPK+SDFGLAK  + ++S +S++  RGTIGYIAPEVF R +G  SHKSDVYS+GM
Sbjct: 629 LDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGTIGYIAPEVFSRMYGRVSHKSDVYSFGM 688

Query: 121 MILEMAVGRKNADVKA--SRSSDIYFPNSIYKHIEPGNDFQLDG-VVTEEEKELVKKMIL 177
           ++++M   R    V+   S +S  YFP+ IYK +E G    + G  +T+EEKE+ KKMI+
Sbjct: 689 LVIDMIGARSKEIVETVDSAASSTYFPDWIYKDLEDGEQTWIFGDEITKEEKEIAKKMIV 748

Query: 178 VSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSLALPKKSAIQSSRTSSSAGIEEV 237
           V LWCIQ  PSDRPSM+ V+EM+E S + L+IPPKPS+ +  +   +SS  S S G E+V
Sbjct: 749 VGLWCIQPCPSDRPSMNRVVEMMEGSLDALEIPPKPSMHISTEVITESS--SLSDGGEDV 806

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q3ECH2|Y1670_ARATH Probable receptor-like protein kinase At1g67000 OS=Arabidopsis thaliana GN=At1g67000 PE=2 SV=2

 Score =  245 bits (626), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 122/238 (51%), Positives = 163/238 (68%), Gaps = 16/238 (6%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           + NGSLD+F  D+ S N    L+ +T+Y IA G+ARGLEYLH GC  RIVHFDIKP N+L
Sbjct: 632 LGNGSLDKFISDKSSVN----LDLKTLYGIALGVARGLEYLHYGCKTRIVHFDIKPQNVL 687

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           LD++ CPK+SDFGLAK  + K+S +S+L  RGTIGYIAPE+  R +G  SHKSDVYSYGM
Sbjct: 688 LDDNLCPKVSDFGLAKLCEKKESILSLLDTRGTIGYIAPEMISRLYGSVSHKSDVYSYGM 747

Query: 121 MILEMAVGRKNADVKASRSSD---IYFPNSIYKHIEPGN--DFQ-------LDGVVTEEE 168
           ++LEM   RK      +  SD   IYFP  IYK +E  N  D +       ++  ++ EE
Sbjct: 748 LVLEMIGARKKERFDQNSRSDGSSIYFPEWIYKDLEKANIKDIEKTENGGLIENGISSEE 807

Query: 169 KELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSLALPKKSAIQSS 226
           +E+ +KM LV LWCIQ++PSDRP M++V+EM+E S + L++PP+P L     S++  S
Sbjct: 808 EEIARKMTLVGLWCIQSSPSDRPPMNKVVEMMEGSLDALEVPPRPVLQQISASSVSDS 865

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1

 Score =  177 bits (449), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 97/223 (43%), Positives = 138/223 (61%), Gaps = 16/223 (7%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NGSLD++ +  E +     L+WRT ++IA   A+G+ Y H  C  RI+H DIKP NIL
Sbjct: 606 MINGSLDKWIFSSEQTAN--LLDWRTRFEIAVATAQGIAYFHEQCRNRIIHCDIKPENIL 663

Query: 61  LDEDFCPKISDFGLAK-QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           LD++FCPK+SDFGLAK   ++    ++M+  RGT GY+APE    S    + K+DVYSYG
Sbjct: 664 LDDNFCPKVSDFGLAKMMGREHSHVVTMI--RGTRGYLAPEWV--SNRPITVKADVYSYG 719

Query: 120 MMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN-----DFQLDGVVTEEEKELVKK 174
           M++LE+  GR+N D+    + D ++P   YK +  G      D +L GV  EEE   V K
Sbjct: 720 MLLLEIVGGRRNLDMSYD-AEDFFYPGWAYKELTNGTSLKAVDKRLQGVAEEEE---VVK 775

Query: 175 MILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSLAL 217
            + V+ WCIQ   S RPSM EV+++LE +++ + +PP P   L
Sbjct: 776 ALKVAFWCIQDEVSMRPSMGEVVKLLEGTSDEINLPPMPQTIL 818

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1

 Score =  160 bits (405), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 91/210 (43%), Positives = 126/210 (60%), Gaps = 10/210 (4%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NGSLD F +  +S+   + L W   + IA G A+G+ YLH  C   IVH DIKP NIL
Sbjct: 559 MRNGSLDNFLFTTDSA---KFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENIL 615

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           +D++F  K+SDFGLAK    K +  +M   RGT GY+APE         + KSDVYSYGM
Sbjct: 616 VDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANL--PITSKSDVYSYGM 673

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ-LDGVVTEEEK---ELVKKMI 176
           ++LE+  G++N DV + +++   F    Y+  E GN    LD  ++E++    E V +M+
Sbjct: 674 VLLELVSGKRNFDV-SEKTNHKKFSIWAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMV 732

Query: 177 LVSLWCIQTNPSDRPSMHEVLEMLESSTEI 206
             S WCIQ  P  RP+M +V++MLE  TEI
Sbjct: 733 KTSFWCIQEQPLQRPTMGKVVQMLEGITEI 762

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1

 Score =  160 bits (404), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 90/221 (40%), Positives = 134/221 (60%), Gaps = 13/221 (5%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +  GSL+++ + ++  +G+  L+W T + IA G A+GL YLH  C+ RIVH DIKP NIL
Sbjct: 568 LSKGSLERWIFRKK--DGDVLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENIL 625

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           LD++F  K+SDFGLAK    ++S +     RGT GY+APE         S KSDVYSYGM
Sbjct: 626 LDDNFNAKVSDFGLAKLMTREQSHV-FTTMRGTRGYLAPEWITNY--AISEKSDVYSYGM 682

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN-----DFQLDGVVTEEEKELVKKM 175
           ++LE+  GRKN D  +  S   +FP+  +K +E G      D ++  V   +E+  V++ 
Sbjct: 683 VLLELIGGRKNYD-PSETSEKCHFPSFAFKKMEEGKLMDIVDGKMKNVDVTDER--VQRA 739

Query: 176 ILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSLA 216
           +  +LWCIQ +   RPSM +V++MLE    ++Q P   ++ 
Sbjct: 740 MKTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPPSSSTMG 780

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2

 Score =  154 bits (389), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 91/214 (42%), Positives = 126/214 (58%), Gaps = 9/214 (4%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +PNGSLDQ  + +++ +    L+W T Y+I  G+ARGL YLH    +RIVH D+K  NIL
Sbjct: 769 LPNGSLDQALFGEKTLH----LDWSTRYEICLGVARGLVYLHEEARLRIVHRDVKASNIL 824

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           LD    PK+SDFGLAK   DKK+ IS   A GTIGY+APE   R  G  + K+DVY++G+
Sbjct: 825 LDSKLVPKVSDFGLAKLYDDKKTHISTRVA-GTIGYLAPEYAMR--GHLTEKTDVYAFGV 881

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL-DGVVTEEEKELVKKMILVS 179
           + LE+  GR N+D +       Y     +   E G + +L D  +TE   E  K+MI ++
Sbjct: 882 VALELVSGRPNSD-ENLEDEKRYLLEWAWNLHEKGREVELIDHQLTEFNMEEGKRMIGIA 940

Query: 180 LWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKP 213
           L C QT+ + RP M  V+ ML    E+  +  KP
Sbjct: 941 LLCTQTSHALRPPMSRVVAMLSGDVEVSDVTSKP 974

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2

 Score =  154 bits (389), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 94/216 (43%), Positives = 125/216 (57%), Gaps = 13/216 (6%)

Query: 1   MPNGSLDQFTYDQESSNGNRTL--EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHN 58
           +PNGSLDQ  +      G++TL  +W T Y+I  G+ARGL YLH   +VRIVH D+K  N
Sbjct: 770 LPNGSLDQALF------GDKTLHLDWSTRYEICLGVARGLVYLHEEASVRIVHRDVKASN 823

Query: 59  ILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSY 118
           ILLD    P+ISDFGLAK   DKK+ IS   A GTIGY+APE   R  G  + K+DVY++
Sbjct: 824 ILLDSRLVPQISDFGLAKLYDDKKTHISTRVA-GTIGYLAPEYAMR--GHLTEKTDVYAF 880

Query: 119 GMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL-DGVVTEEEKELVKKMIL 177
           G++ LE+  GR N+D         Y     +   E   D +L D  +T+   E  K+MI 
Sbjct: 881 GVVALELVSGRPNSDENLEEEKK-YLLEWAWNLHEKSRDIELIDDKLTDFNMEEAKRMIG 939

Query: 178 VSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKP 213
           ++L C QT+ + RP M  V+ ML    EI  +  KP
Sbjct: 940 IALLCTQTSHALRPPMSRVVAMLSGDVEIGDVTSKP 975

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FHG4|LRKS7_ARATH Probable L-type lectin-domain containing receptor kinase S.7 OS=Arabidopsis thaliana GN=LECRKS7 PE=2 SV=1

 Score =  152 bits (384), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 88/223 (39%), Positives = 133/223 (59%), Gaps = 13/223 (5%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           MPNGSLD+  Y QES  G   L+W     IA G+A  L YLH  C  ++VH DIK  NI+
Sbjct: 442 MPNGSLDKILY-QESQTGAVALDWSHRLNIAIGLASALSYLHHECEQQVVHRDIKTSNIM 500

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           LD +F  ++ DFGLA+ ++  KS +S L A GT+GY+APE     +G A+ K+D +SYG+
Sbjct: 501 LDINFNARLGDFGLARLTEHDKSPVSTLTA-GTMGYLAPEYL--QYGTATEKTDAFSYGV 557

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN-----DFQLDGVVTEEEKELVKKM 175
           +ILE+A GR+  D +      +   + +++    G      D +L G   E ++E++KK+
Sbjct: 558 VILEVACGRRPIDKEPESQKTVNLVDWVWRLHSEGRVLEAVDERLKG---EFDEEMMKKL 614

Query: 176 ILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPP-KPSLAL 217
           +LV L C   + ++RPSM  VL++L +  E   +P  KP+L+ 
Sbjct: 615 LLVGLKCAHPDSNERPSMRRVLQILNNEIEPSPVPKMKPTLSF 657

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LDT0|CRK30_ARATH Putative cysteine-rich receptor-like protein kinase 30 OS=Arabidopsis thaliana GN=CRK30 PE=3 SV=1

 Score =  149 bits (375), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 80/217 (36%), Positives = 118/217 (54%), Gaps = 4/217 (1%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +PN SLD F +   +      L+W   Y I GGI RGL YLH+   + I+H DIK  NIL
Sbjct: 422 VPNKSLDYFLFGSTNPTKKGQLDWTRRYNIIGGITRGLLYLHQDSRLTIIHRDIKASNIL 481

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           LD D  PKI+DFG+A+  +D ++  S     GT GY+ PE    + G  S KSDVYS+G+
Sbjct: 482 LDADMNPKIADFGMARNFRDHQTEDSTGRVVGTFGYMPPEYV--AHGQFSTKSDVYSFGV 539

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL--DGVVTEEEKELVKKMILV 178
           +ILE+  GRKN+       S       +++     +  +L    +    EK+ V + I +
Sbjct: 540 LILEIVSGRKNSSFYQMDGSVCNLVTYVWRLWNTDSSLELVDPAISGSYEKDEVTRCIHI 599

Query: 179 SLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSL 215
            L C+Q NP +RP++  + +ML +S+  L +P  P  
Sbjct: 600 GLLCVQENPVNRPALSTIFQMLTNSSITLNVPQPPGF 636

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	242
225452094	858	PREDICTED: probable receptor-like protei	0.946	0.266	0.660	7e-88
224111934	661	predicted protein [Populus trichocarpa]	0.954	0.349	0.645	2e-83
224095678	365	predicted protein [Populus trichocarpa]	0.954	0.632	0.645	2e-83
255551426	638	serine/threonine kinase, putative [Ricin	0.954	0.362	0.650	2e-83
145839451	627	receptor-like protein kinase [Capsicum a	0.929	0.358	0.641	8e-82
224103523	319	predicted protein [Populus trichocarpa]	0.892	0.677	0.662	2e-80
356522799	542	PREDICTED: probable receptor-like protei	0.929	0.415	0.623	3e-79
147812634	917	hypothetical protein VITISV_036944 [Viti	0.797	0.210	0.699	3e-79
224108429	365	predicted protein [Populus trichocarpa]	0.946	0.627	0.624	4e-79
224127698	580	predicted protein [Populus trichocarpa]	0.876	0.365	0.637	1e-78

>gi|225452094|ref|XP_002280747.1| PREDICTED: probable receptor-like protein kinase At1g67000-like [Vitis vinifera]

 Score =  329 bits (843), Expect = 7e-88,   Method: Compositional matrix adjust.
 Identities = 152/230 (66%), Positives = 178/230 (77%), Gaps = 1/230 (0%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           MPNGSLD+  Y + S N N  LEW+T+YQIA GIARGLEYL+RGCN RI+HFDIKPHNIL
Sbjct: 630 MPNGSLDKLIYQKGSPNANLKLEWKTMYQIAVGIARGLEYLYRGCNTRILHFDIKPHNIL 689

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           LDEDFCPKISDFGLAK  Q K+S +SM HARGT GYIAPEVFCR+FGG SHKSDVYSYGM
Sbjct: 690 LDEDFCPKISDFGLAKLCQRKESMVSMAHARGTAGYIAPEVFCRNFGGVSHKSDVYSYGM 749

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSL 180
           ++ EM  GRKN D + S +S IYFP  IYK ++PG D  L  +  EEE+E  +KM+LVSL
Sbjct: 750 LVFEMIGGRKNIDAQVSHTSQIYFPTWIYKQLQPGEDLILHSITNEEEEETARKMVLVSL 809

Query: 181 WCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSLALPKKSAIQSSRTSS 230
           WCIQ NPSDRPS+ +V+EMLE S + L+IPP P    P ++A Q   TSS
Sbjct: 810 WCIQLNPSDRPSIDKVVEMLEGSLQSLEIPPNP-FMFPTQNATQDPSTSS 858

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224111934|ref|XP_002332866.1| predicted protein [Populus trichocarpa] gi|222833668|gb|EEE72145.1| predicted protein [Populus trichocarpa]

 Score =  314 bits (805), Expect = 2e-83,   Method: Compositional matrix adjust.
 Identities = 149/231 (64%), Positives = 180/231 (77%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           MPNGSLD F  ++ S + N  LEW+ +Y+IA GIARGLEYLHRGCN RIVHFDIKPHNIL
Sbjct: 410 MPNGSLDSFISNKGSPHTNCRLEWKKLYEIAVGIARGLEYLHRGCNTRIVHFDIKPHNIL 469

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           LDEDFCPKISDFGLAK  + K S ISM+ ARGT GYIAPEVFCRSFGG ++KSDVYSYGM
Sbjct: 470 LDEDFCPKISDFGLAKLCKSKVSKISMIGARGTAGYIAPEVFCRSFGGVTYKSDVYSYGM 529

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSL 180
           M+LEM    K+ D+ +  ++++YFP+  Y +++PG      G +TEEEKE+VKKMILV L
Sbjct: 530 MVLEMVGKSKDFDMGSLETNELYFPDWFYMYLDPGEISTFHGGITEEEKEIVKKMILVGL 589

Query: 181 WCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSLALPKKSAIQSSRTSSS 231
           WCIQT PS RPSM +V+EM E S + LQIPP+PSL+ P++SA   S T SS
Sbjct: 590 WCIQTIPSHRPSMTKVVEMFEGSLQSLQIPPRPSLSSPRRSAQVHSSTVSS 640

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224095678|ref|XP_002334738.1| predicted protein [Populus trichocarpa] gi|222874466|gb|EEF11597.1| predicted protein [Populus trichocarpa]

 Score =  314 bits (804), Expect = 2e-83,   Method: Compositional matrix adjust.
 Identities = 149/231 (64%), Positives = 180/231 (77%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           MPNGSLD F  D+ S + N  LEW+ +Y+IA  IARGLEYLHRGCN RIVHFDIKPHNIL
Sbjct: 114 MPNGSLDSFISDKGSPHTNCRLEWKKLYEIAVSIARGLEYLHRGCNTRIVHFDIKPHNIL 173

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           LD++FCPKISDFGLAK  Q K S ISM+ ARGT+GYIAPEVFCRSFGG ++KSDVYSYGM
Sbjct: 174 LDDEFCPKISDFGLAKLCQSKVSKISMIGARGTVGYIAPEVFCRSFGGVTYKSDVYSYGM 233

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSL 180
           M+LEM    K+ D+ +  ++++YFP+  Y ++EPG    L G  TEEEKE+VKKMILV L
Sbjct: 234 MVLEMVGQSKDFDMGSLETNEMYFPDWFYMYLEPGKISTLHGGTTEEEKEIVKKMILVGL 293

Query: 181 WCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSLALPKKSAIQSSRTSSS 231
           WCIQT PS RPSM +V+EM E S + LQIPP+PS + P++SA + S T SS
Sbjct: 294 WCIQTIPSHRPSMTKVVEMFEGSLQSLQIPPRPSFSSPRRSAQEQSCTVSS 344

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255551426|ref|XP_002516759.1| serine/threonine kinase, putative [Ricinus communis] gi|223544132|gb|EEF45657.1| serine/threonine kinase, putative [Ricinus communis]

 Score =  314 bits (804), Expect = 2e-83,   Method: Compositional matrix adjust.
 Identities = 151/232 (65%), Positives = 179/232 (77%), Gaps = 1/232 (0%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           MPNGSLD+F YDQ S   N+ L+W+T+Y I  GIARGLEYLHRGCN RIVHFDIKPHNIL
Sbjct: 402 MPNGSLDKFIYDQGSQGVNKHLDWKTLYDITVGIARGLEYLHRGCNTRIVHFDIKPHNIL 461

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           LD+DFCPK+SDFGLAK  + K+S I+ML ARGTIGYIAPE+F R+FGG S+KSDVYSYGM
Sbjct: 462 LDKDFCPKVSDFGLAKLCKGKESIITMLGARGTIGYIAPEIFIRNFGGVSYKSDVYSYGM 521

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSL 180
           MILE+  GR  +DV  S S ++YFP  IYK+IE      L   +T+EE E+V+++ +V L
Sbjct: 522 MILEICGGRNKSDVGVSHSGEVYFPECIYKYIESEQVSTLHEKITDEEGEMVRRLTIVGL 581

Query: 181 WCIQTNPSDRPSMHEVLEMLE-SSTEILQIPPKPSLALPKKSAIQSSRTSSS 231
           WCIQTNPSDRPSM +V+EMLE SS E LQIPPKPSL  P      SS  SS+
Sbjct: 582 WCIQTNPSDRPSMTKVVEMLEGSSLESLQIPPKPSLFAPTTPQHYSSTLSSA 633

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|145839451|gb|ABP96804.1| receptor-like protein kinase [Capsicum annuum]

 Score =  309 bits (791), Expect = 8e-82,   Method: Compositional matrix adjust.
 Identities = 145/226 (64%), Positives = 174/226 (76%), Gaps = 1/226 (0%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           MPNGSL++F Y +E S+  R L W T+Y+IA GIARGLEYLHRGC  RI+HFDIKPHNIL
Sbjct: 391 MPNGSLEKFIY-EERSDTVRQLGWPTLYKIALGIARGLEYLHRGCTTRILHFDIKPHNIL 449

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           LDEDFCPKISDFGLAK     +S +SML ARGTIGYIAPE+ CR+ GG SHKSD YSYGM
Sbjct: 450 LDEDFCPKISDFGLAKLCMKNESIVSMLGARGTIGYIAPEIVCRNLGGVSHKSDAYSYGM 509

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSL 180
           M+LEM  GRKN D  A R+S+IYFP+ +Y+ IE   D QL G++ EEE E  +KM++ SL
Sbjct: 510 MVLEMIGGRKNVDAGADRTSEIYFPHWLYQRIELDEDLQLVGIMNEEENECARKMVIASL 569

Query: 181 WCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSLALPKKSAIQSS 226
           WCIQT+PS+RPSM +V+EMLE   + LQIPPKP L  P +  + SS
Sbjct: 570 WCIQTDPSNRPSMSKVVEMLEGKLDSLQIPPKPYLYSPSRIEVDSS 615

Source: Capsicum annuum

Species: Capsicum annuum

Genus: Capsicum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224103523|ref|XP_002334042.1| predicted protein [Populus trichocarpa] gi|222839651|gb|EEE77974.1| predicted protein [Populus trichocarpa]

 Score =  304 bits (779), Expect = 2e-80,   Method: Compositional matrix adjust.
 Identities = 143/216 (66%), Positives = 170/216 (78%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           MPNGSLD F   + S + N  LEW+ +Y+IA GIARGLEYLHRGCN RIVHFDIKPHNIL
Sbjct: 103 MPNGSLDSFISHKGSPHTNCRLEWKKLYEIAVGIARGLEYLHRGCNTRIVHFDIKPHNIL 162

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           LDEDFCPKISDFGLAK  Q K S ISM+ ARGT+GYIAPEVFCRSFGG ++KSDVYSYGM
Sbjct: 163 LDEDFCPKISDFGLAKLCQSKVSKISMIGARGTVGYIAPEVFCRSFGGVTYKSDVYSYGM 222

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSL 180
           M+LEM    K+ D+ +  ++++YFP+  Y +++PG      G  TEEEKE+VKKMILV L
Sbjct: 223 MVLEMVGQSKDFDMGSLETNELYFPDWFYMYLDPGEISIFHGGTTEEEKEIVKKMILVGL 282

Query: 181 WCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSLA 216
           WCIQT PS RPSM +V+EM E S + LQIPP+PSL+
Sbjct: 283 WCIQTMPSHRPSMTKVVEMFEGSLQSLQIPPRPSLS 318

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356522799|ref|XP_003530032.1| PREDICTED: probable receptor-like protein kinase At1g67000-like [Glycine max]

 Score =  300 bits (769), Expect = 3e-79,   Method: Compositional matrix adjust.
 Identities = 141/226 (62%), Positives = 174/226 (76%), Gaps = 1/226 (0%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NGSLD+F Y++       +L W+ +YQI+ GIARGLEYLHRGCN RI+HFDIKPHNIL
Sbjct: 317 MANGSLDKFIYNRGPET-IASLRWQNLYQISIGIARGLEYLHRGCNTRILHFDIKPHNIL 375

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           LDE+FCPKISDFGLAK    K+S ISM + RGT+GY+APE++ R FGG SHKSDVYSYGM
Sbjct: 376 LDENFCPKISDFGLAKLCPRKESIISMSNTRGTLGYVAPEMWNRHFGGVSHKSDVYSYGM 435

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSL 180
           M+LEM  GRKN D +ASR+S+IYFP+  YK +E  ND + D V+T EE E+ K+M +V L
Sbjct: 436 MLLEMVGGRKNIDAEASRTSEIYFPHLAYKRLELDNDLRPDEVMTTEENEIAKRMTIVGL 495

Query: 181 WCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSLALPKKSAIQSS 226
           WCIQT P+DRP M  V+EMLE S   L++PPKP L+ P +SA +SS
Sbjct: 496 WCIQTFPNDRPIMSRVIEMLEGSMNSLEMPPKPMLSSPTRSATESS 541

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147812634|emb|CAN75059.1| hypothetical protein VITISV_036944 [Vitis vinifera]

 Score =  300 bits (769), Expect = 3e-79,   Method: Compositional matrix adjust.
 Identities = 135/193 (69%), Positives = 155/193 (80%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           MPNGSLD+  Y + S N N  LEW+T+YQIA GIARGLEYL+RGCN RI+HFDIKPHNIL
Sbjct: 664 MPNGSLDKLIYQKGSPNANLKLEWKTMYQIAVGIARGLEYLYRGCNTRILHFDIKPHNIL 723

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           LDEDFCPKISDFGLAK  Q K+S +SM HARGT GYIAPEVFCR+FGG SHKSDVYSYGM
Sbjct: 724 LDEDFCPKISDFGLAKLCQRKESMVSMAHARGTAGYIAPEVFCRNFGGVSHKSDVYSYGM 783

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSL 180
           ++ EM  GRKN D + S +S IYFP  IYK ++PG D  L  +  EEE+E  +KM+LVSL
Sbjct: 784 LVFEMIGGRKNIDAQVSHTSQIYFPTWIYKQLQPGEDLILHSITNEEEEETARKMVLVSL 843

Query: 181 WCIQTNPSDRPSM 193
           WCIQ NPSDRPS+
Sbjct: 844 WCIQLNPSDRPSI 856

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224108429|ref|XP_002314844.1| predicted protein [Populus trichocarpa] gi|222863884|gb|EEF01015.1| predicted protein [Populus trichocarpa]

 Score =  300 bits (767), Expect = 4e-79,   Method: Compositional matrix adjust.
 Identities = 143/229 (62%), Positives = 172/229 (75%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NGSLD+  Y++  S  +  L W T+YQIA GIARGLEYLHRGCN RI+HFDIKPHNIL
Sbjct: 137 MSNGSLDKHIYEENLSKAHPKLGWETLYQIAVGIARGLEYLHRGCNTRILHFDIKPHNIL 196

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           LDE+FCPKISDFGLAK    K+S +SML ARGT GYIAPEVFCR+FGG SHKSDVYSYGM
Sbjct: 197 LDENFCPKISDFGLAKICPSKESIVSMLGARGTAGYIAPEVFCRNFGGVSHKSDVYSYGM 256

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSL 180
           ++LEM  GRKN  V    +S+IYFP+ IY+ +E G + QL G   E E++  +KMIL SL
Sbjct: 257 LVLEMIGGRKNFRVGVDNTSEIYFPHWIYRRLEIGEELQLRGAGNEVEEQNARKMILASL 316

Query: 181 WCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSLALPKKSAIQSSRTS 229
           WCIQT+PS+RP M  V++ML+ S E L IPPKP L+ P +S   S+  S
Sbjct: 317 WCIQTDPSNRPPMSRVVDMLQGSLESLPIPPKPYLSSPPRSPHGSNSNS 365

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224127698|ref|XP_002329342.1| predicted protein [Populus trichocarpa] gi|222870796|gb|EEF07927.1| predicted protein [Populus trichocarpa]

 Score =  298 bits (764), Expect = 1e-78,   Method: Compositional matrix adjust.
 Identities = 137/215 (63%), Positives = 168/215 (78%), Gaps = 3/215 (1%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           MPNGSLD+F Y Q S +G   L+W  +Y+IA GI RGLEYLHRGCN RIVHFDIKPHNIL
Sbjct: 369 MPNGSLDKFIYRQTSLHGKYNLQWEKLYEIAVGIGRGLEYLHRGCNTRIVHFDIKPHNIL 428

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           LD DFCPKISDFGLAK  + ++S +SM  ARGT GYIAPEVFC++FGG S+KSDVYSYGM
Sbjct: 429 LDTDFCPKISDFGLAKLCKREESMVSMTGARGTAGYIAPEVFCKNFGGVSYKSDVYSYGM 488

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSL 180
           M+LEM  G++N D+  S+SS+I+ PN +Y+  E  +   L GV+T+E +E +KKM+ V L
Sbjct: 489 MVLEMVGGKRNIDIGESQSSEIFLPNCMYESEEVSS---LHGVITDETEETIKKMVTVGL 545

Query: 181 WCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSL 215
           WC+QTNP DRPSM +V+EMLE S + LQ PPKP L
Sbjct: 546 WCVQTNPLDRPSMTKVVEMLEGSLQFLQTPPKPFL 580

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	242
TAIR|locus:2020583	799	AT1G70250 [Arabidopsis thalian	0.842	0.255	0.579	4.5e-59
TAIR|locus:2176737	665	PR5K "PR5-like receptor kinase	0.842	0.306	0.539	7.5e-57
TAIR|locus:2141862	853	AT4G18250 [Arabidopsis thalian	0.847	0.240	0.558	1e-56
TAIR|locus:2176717	638	AT5G38260 [Arabidopsis thalian	0.842	0.319	0.530	8.6e-56
TAIR|locus:2177142	813	AT5G39020 [Arabidopsis thalian	0.847	0.252	0.523	2.2e-52
TAIR|locus:2019713	892	AT1G67000 [Arabidopsis thalian	0.838	0.227	0.520	4.6e-52
TAIR|locus:2177152	806	AT5G39030 [Arabidopsis thalian	0.847	0.254	0.528	7.5e-52
TAIR|locus:2204480	666	AT1G66910 [Arabidopsis thalian	0.842	0.306	0.497	9.2e-52
TAIR|locus:2019688	674	AT1G66930 [Arabidopsis thalian	0.847	0.304	0.481	5.2e-49
TAIR|locus:2176707	579	AT5G38250 [Arabidopsis thalian	0.809	0.338	0.526	5.2e-49

TAIR|locus:2020583 AT1G70250 [Arabidopsis thaliana (taxid:3702)]

 Score = 606 (218.4 bits), Expect = 4.5e-59, P = 4.5e-59
 Identities = 124/214 (57%), Positives = 149/214 (69%)

Query:     1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
             MPNGSLD+F     S N +  +EW+T+Y IA G++ GLEYLH  C  RIVHFDIKP NIL
Sbjct:   535 MPNGSLDKFI----SKNMSAKMEWKTLYNIAVGVSHGLEYLHSHCVSRIVHFDIKPQNIL 590

Query:    61 LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
             +D D CPKISDFGLAK  ++ +S ISMLHARGTIGYIAPEVF ++FGG SHKSDVYSYGM
Sbjct:   591 IDGDLCPKISDFGLAKLCKNNESIISMLHARGTIGYIAPEVFSQNFGGVSHKSDVYSYGM 650

Query:   121 MILEMAVGRKN---ADVKASRSSDIYFPNSIYKHIEPGN--DFQLDGXXXXXXXXXXXXM 175
             ++LEM +G +N   A    S ++ +YFP+ IYK +E G    F  D             M
Sbjct:   651 VVLEM-IGARNIGRAQNAGSSNTSMYFPDWIYKDLEKGEIMSFLADQITEEEDEKIVKKM 709

Query:   176 ILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQI 209
             +LV LWCIQTNP DRP M +V+EMLE S E LQI
Sbjct:   710 VLVGLWCIQTNPYDRPPMSKVVEMLEGSLEALQI 743

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2176737 PR5K "PR5-like receptor kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 585 (211.0 bits), Expect = 7.5e-57, P = 7.5e-57
 Identities = 115/213 (53%), Positives = 147/213 (69%)

Query:     1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
             MPNGSLD++     S+N +  +EW  +Y +A GI+RGLEYLH  C  RIVHFDIKP NIL
Sbjct:   407 MPNGSLDKYI----SANMSTKMEWERLYDVAVGISRGLEYLHNRCVTRIVHFDIKPQNIL 462

Query:    61 LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
             +DE+ CPKISDFGLAK  ++K+S ISMLH RGT GYIAPE+F ++FG  SHKSDVYSYGM
Sbjct:   463 MDENLCPKISDFGLAKLCKNKESIISMLHMRGTFGYIAPEMFSKNFGAVSHKSDVYSYGM 522

Query:   121 MILEMAVGRKN---ADVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXX-MI 176
             ++LEM +G KN    +   S +  +YFP  +YK  E G   ++ G             ++
Sbjct:   523 VVLEM-IGAKNIEKVEYSGSNNGSMYFPEWVYKDFEKGEITRIFGDSITDEEEKIAKKLV 581

Query:   177 LVSLWCIQTNPSDRPSMHEVLEMLESSTEILQI 209
             LV+LWCIQ NPSDRP M +V+EMLE + E LQ+
Sbjct:   582 LVALWCIQMNPSDRPPMIKVIEMLEGNLEALQV 614

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0009691 "cytokinin biosynthetic process" evidence=RCA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0009620 "response to fungus" evidence=ISS

TAIR|locus:2141862 AT4G18250 [Arabidopsis thaliana (taxid:3702)]

 Score = 586 (211.3 bits), Expect = 1.0e-56, P = 1.0e-56
 Identities = 120/215 (55%), Positives = 149/215 (69%)

Query:     1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
             MPNGSLD+F     S N +  +EW+T+Y IA G+ARGLEYLH  C  +IVHFDIKP NIL
Sbjct:   596 MPNGSLDKFI----SENMSTKIEWKTLYNIAVGVARGLEYLHNSCVSKIVHFDIKPQNIL 651

Query:    61 LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
             +DED CPKISDFGLAK  + K+S ISML ARGT+GYIAPE+F +++GG SHKSDVYSYGM
Sbjct:   652 IDEDLCPKISDFGLAKLCKKKESIISMLDARGTVGYIAPEMFSKNYGGVSHKSDVYSYGM 711

Query:   121 MILEM--AVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL--DGXXXXXXXXXXXX-M 175
             ++LEM  A  R+  +  A+  S +YFP+ +Y+ +E     +L  D              M
Sbjct:   712 VVLEMIGATKREEVETSATDKSSMYFPDWVYEDLERKETMRLLEDHIIEEEEEEKIVKRM 771

Query:   176 ILVSLWCIQTNPSDRPSMHEVLEMLESST-EILQI 209
              LV LWCIQTNPSDRP M +V+EMLE S  E LQ+
Sbjct:   772 TLVGLWCIQTNPSDRPPMRKVVEMLEGSRLEALQV 806

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2176717 AT5G38260 [Arabidopsis thaliana (taxid:3702)]

 Score = 575 (207.5 bits), Expect = 8.6e-56, P = 8.6e-56
 Identities = 113/213 (53%), Positives = 151/213 (70%)

Query:     1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
             + NGSLDQF  +++S N    L+  T+Y+IA G+ARGL+YLH GC  RIVHFDIKP NIL
Sbjct:   396 LENGSLDQFLSEKKSLN----LDVSTLYRIALGVARGLDYLHHGCKTRIVHFDIKPQNIL 451

Query:    61 LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
             LD+ FCPK+SDFGLAK  + ++S +S+L ARGTIGYIAPEVF   +G  SHKSDVYSYGM
Sbjct:   452 LDDTFCPKVSDFGLAKLCEKRESILSLLDARGTIGYIAPEVFSGMYGRVSHKSDVYSYGM 511

Query:   121 MILEMAVGRKNADVK---ASRSSDIYFPNSIYKHIEPGND-FQLDGXXXXXXXXXXXXMI 176
             ++LEM +G KN +++   AS SS  YFP+ IYK++E G D ++               M 
Sbjct:   512 LVLEM-IGAKNKEIEETAASNSSSAYFPDWIYKNLENGEDTWKFGDEISREDKEVAKKMT 570

Query:   177 LVSLWCIQTNPSDRPSMHEVLEMLESSTEILQI 209
             LV LWCIQ +P +RP M+ ++EM+E S ++L++
Sbjct:   571 LVGLWCIQPSPLNRPPMNRIVEMMEGSLDVLEV 603

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2177142 AT5G39020 [Arabidopsis thaliana (taxid:3702)]

 Score = 546 (197.3 bits), Expect = 2.2e-52, P = 2.2e-52
 Identities = 110/210 (52%), Positives = 141/210 (67%)

Query:     1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
             + +GSLDQF    +S   N T    T+Y IA GIARGLEYLH GC  RIVHFDIKP NIL
Sbjct:   571 LEHGSLDQFISRNKSLTPNVT----TLYGIALGIARGLEYLHYGCKTRIVHFDIKPQNIL 626

Query:    61 LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
             LD++FCPK++DFGLAK  + ++S +S++  RGTIGYIAPEV  R +GG SHKSDVYSYGM
Sbjct:   627 LDDNFCPKVADFGLAKLCEKRESILSLIDTRGTIGYIAPEVVSRMYGGISHKSDVYSYGM 686

Query:   121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXX-MILVS 179
             ++L+M   R   +      S  YFP+ IYK +E G+   + G             MILVS
Sbjct:   687 LVLDMIGARNKVETTTCNGSTAYFPDWIYKDLENGDQTWIIGDEINEEDNKIVKKMILVS 746

Query:   180 LWCIQTNPSDRPSMHEVLEMLESSTEILQI 209
             LWCI+  PSDRP M++V+EM+E S + L++
Sbjct:   747 LWCIRPCPSDRPPMNKVVEMIEGSLDALEL 776

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009625 "response to insect" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

TAIR|locus:2019713 AT1G67000 [Arabidopsis thaliana (taxid:3702)]

 Score = 546 (197.3 bits), Expect = 4.6e-52, P = 4.6e-52
 Identities = 114/219 (52%), Positives = 146/219 (66%)

Query:     3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD 62
             NGSLD+F  D+ S N    L+ +T+Y IA G+ARGLEYLH GC  RIVHFDIKP N+LLD
Sbjct:   634 NGSLDKFISDKSSVN----LDLKTLYGIALGVARGLEYLHYGCKTRIVHFDIKPQNVLLD 689

Query:    63 EDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMI 122
             ++ CPK+SDFGLAK  + K+S +S+L  RGTIGYIAPE+  R +G  SHKSDVYSYGM++
Sbjct:   690 DNLCPKVSDFGLAKLCEKKESILSLLDTRGTIGYIAPEMISRLYGSVSHKSDVYSYGMLV 749

Query:   123 LEMAVGRKNADV-KASRS--SDIYFPNSIYKHIEPGN--DFQ-------LDGXXXXXXXX 170
             LEM   RK     + SRS  S IYFP  IYK +E  N  D +       ++         
Sbjct:   750 LEMIGARKKERFDQNSRSDGSSIYFPEWIYKDLEKANIKDIEKTENGGLIENGISSEEEE 809

Query:   171 XXXXMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQI 209
                 M LV LWCIQ++PSDRP M++V+EM+E S + L++
Sbjct:   810 IARKMTLVGLWCIQSSPSDRPPMNKVVEMMEGSLDALEV 848

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2177152 AT5G39030 [Arabidopsis thaliana (taxid:3702)]

 Score = 541 (195.5 bits), Expect = 7.5e-52, P = 7.5e-52
 Identities = 112/212 (52%), Positives = 141/212 (66%)

Query:     1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
             + NGSLDQF     S N + T +  T+Y IA GIARGLEYLH GC  RIVHFDIKP NIL
Sbjct:   573 LENGSLDQFM----SRNKSLTQDVTTLYGIALGIARGLEYLHYGCKTRIVHFDIKPQNIL 628

Query:    61 LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
             LD + CPK+SDFGLAK  + ++S +S++  RGTIGYIAPEVF R +G  SHKSDVYS+GM
Sbjct:   629 LDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGTIGYIAPEVFSRMYGRVSHKSDVYSFGM 688

Query:   121 MILEMAVGRKNADVKA--SRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXX-MIL 177
             ++++M   R    V+   S +S  YFP+ IYK +E G    + G             MI+
Sbjct:   689 LVIDMIGARSKEIVETVDSAASSTYFPDWIYKDLEDGEQTWIFGDEITKEEKEIAKKMIV 748

Query:   178 VSLWCIQTNPSDRPSMHEVLEMLESSTEILQI 209
             V LWCIQ  PSDRPSM+ V+EM+E S + L+I
Sbjct:   749 VGLWCIQPCPSDRPSMNRVVEMMEGSLDALEI 780

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2204480 AT1G66910 [Arabidopsis thaliana (taxid:3702)]

 Score = 537 (194.1 bits), Expect = 9.2e-52, P = 9.2e-52
 Identities = 106/213 (49%), Positives = 144/213 (67%)

Query:     1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
             M NGSLD+F   ++SS    T++WR +Y IA G+ARGLEYLH GC  RIVHFDIKP N+L
Sbjct:   423 MENGSLDKFISSKKSS----TMDWRELYGIALGVARGLEYLHHGCRTRIVHFDIKPQNVL 478

Query:    61 LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
             LD++  PK+SDFGLAK  + K+S +S++  RGTIGYIAPEVF R +G  SHKSDVYSYGM
Sbjct:   479 LDDNLSPKVSDFGLAKLCERKESILSLMDTRGTIGYIAPEVFSRVYGRVSHKSDVYSYGM 538

Query:   121 MILEMAVGRKN---ADVKASRSSDIYFPNSIYKHIEPG-NDFQLDGXXXXXXXXXXXXMI 176
             ++L++ +G +N    +   S +S +YFP  IY+ +E   N   ++             M 
Sbjct:   539 LVLDI-IGARNKTSTEDTTSSTSSMYFPEWIYRDLEKAHNGKSIETAISNEEDEIAKKMT 597

Query:   177 LVSLWCIQTNPSDRPSMHEVLEMLESSTEILQI 209
             LV LWCIQ  P DRP+M+ V+EM+E + + L++
Sbjct:   598 LVGLWCIQPWPLDRPAMNRVVEMMEGNLDALEV 630

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019688 AT1G66930 [Arabidopsis thaliana (taxid:3702)]

 Score = 511 (184.9 bits), Expect = 5.2e-49, P = 5.2e-49
 Identities = 103/214 (48%), Positives = 139/214 (64%)

Query:     1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
             + NGSLD+F  ++ S      L+   +Y IA G+ARGLEYLH GC  RIVHFDIKP N+L
Sbjct:   422 LENGSLDKFISEKTSV----ILDLTALYGIALGVARGLEYLHYGCKTRIVHFDIKPQNVL 477

Query:    61 LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
             LD++  PK+SDFGLAK  + K+S +S++  RGTIGYIAPE+  R +G  SHKSDVYSYGM
Sbjct:   478 LDDNLSPKVSDFGLAKLCEKKESVMSLMDTRGTIGYIAPEMISRVYGSVSHKSDVYSYGM 537

Query:   121 MILEMAVGRKNADV--KASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXX---XXXM 175
             ++ EM   RK       ++  S +YFP  IYK +E  ++  L+                M
Sbjct:   538 LVFEMIGARKKERFGQNSANGSSMYFPEWIYKDLEKADNGDLEHIEIGISSEEEEIAKKM 597

Query:   176 ILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQI 209
              LV LWCIQ++PSDRP M++V+EM+E S + L++
Sbjct:   598 TLVGLWCIQSSPSDRPPMNKVVEMMEGSLDALEV 631

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2176707 AT5G38250 [Arabidopsis thaliana (taxid:3702)]

 Score = 511 (184.9 bits), Expect = 5.2e-49, P = 5.2e-49
 Identities = 111/211 (52%), Positives = 144/211 (68%)

Query:     1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
             + NGSLDQ      S N    L+  T+Y IA G+ARGLEYLH GC  RIVHFDIKP N+L
Sbjct:   348 LENGSLDQ------SLN----LDVSTLYGIALGVARGLEYLHYGCKTRIVHFDIKPQNVL 397

Query:    61 LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
             LDE+  PK++DFGLAK  + ++S +S+L  RGTIGYIAPE+F R +G  SHKSDVYSYGM
Sbjct:   398 LDENLRPKVADFGLAKLCEKQESILSLLDTRGTIGYIAPELFSRMYGSVSHKSDVYSYGM 457

Query:   121 MILEMAVGRKNAD-VKAS--RSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXX-MI 176
             ++LEM +G +N + V+ +   +S  YFP+ IYK +E  ++ +L G             MI
Sbjct:   458 LVLEM-IGARNKERVQNADPNNSSAYFPDWIYKDLENFDNTRLLGDGLTREEEKNAKKMI 516

Query:   177 LVSLWCIQTNPSDRPSMHEVLEMLESSTEIL 207
             LV LWCIQ  PSDRPSM++V+EM+E S + L
Sbjct:   517 LVGLWCIQFRPSDRPSMNKVVEMMEGSLDSL 547

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	242
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-33
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-32
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	8e-32
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-29
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-29
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-26
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	8e-26
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-24
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-24
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-23
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-21
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-20
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-20
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-20
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-19
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	7e-19
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-18
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-18
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-17
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-17
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-16
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-15
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-14
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-14
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-14
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-14
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-14
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-14
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-14
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	8e-14
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-13
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-13
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-13
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-13
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-13
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-13
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-13
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	6e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	9e-13
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-12
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-12
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-12
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-12
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-12
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-12
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-12
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-12
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-12
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-12
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-12
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-12
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-12
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-12
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	6e-12
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	7e-12
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	8e-12
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	8e-12
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	9e-12
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-11
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-11
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-11
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-11
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-11
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-11
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-11
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	7e-11
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	7e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	7e-11
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	7e-11
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	9e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-10
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-10
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-10
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-10
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-10
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-10
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-10
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-10
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-10
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-10
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-10
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-10
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-10
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-10
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-10
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-10
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-10
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-10
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-10
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-10
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	6e-10
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	7e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	7e-10
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	9e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-09
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-09
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-09
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-09
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-09
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-09
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-09
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-09
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-09
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-09
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-09
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-09
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-09
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-09
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-09
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-09
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-09
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-09
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-09
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-09
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	5e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-09
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-09
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-09
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	6e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	6e-09
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	7e-09
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	8e-09
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	9e-09
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	9e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-08
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-08
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-08
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-08
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-08
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-08
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-08
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-08
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-08
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-08
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-08
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-08
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-08
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-08
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	6e-08
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-08
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	6e-08
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-08
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-08
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-08
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	8e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	9e-08
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	9e-08
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-07
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-07
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-07
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-07
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-07
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-07
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-07
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-07
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-07
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-07
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-07
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-07
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-07
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-07
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-07
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-07
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-07
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-07
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-07
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	5e-07
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-07
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	7e-07
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	7e-07
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	9e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	9e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	9e-07
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	9e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-06
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-06
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-06
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-06
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-06
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-06
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-06
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-06
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-06
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-06
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-06
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-06
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	5e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	5e-06
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	6e-06
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	6e-06
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	8e-06
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	8e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-05
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-05
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-05
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-05
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-05
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-05
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-05
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-05
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-05
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-05
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-05
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-05
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-05
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-05
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-05
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-05
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-05
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-05
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-05
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	5e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	6e-05
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-05
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	8e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	8e-05
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	9e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-04
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-04
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-04
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-04
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-04
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-04
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-04
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	4e-04
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	6e-04
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	0.002
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	0.002
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	0.004

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  121 bits (306), Expect = 1e-33
 Identities = 65/203 (32%), Positives = 89/203 (43%), Gaps = 31/203 (15%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
              G L  F Y          L      +IA  I RGLEYLH      I+H D+KP NIL
Sbjct: 80  CEGGDL--FDYLSR----GGPLSEDEAKKIALQILRGLEYLHS---NGIIHRDLKPENIL 130

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           LDE+   KI+DFGLAK+     S  S+    GT  Y+APEV      G   K DV+S G+
Sbjct: 131 LDENGVVKIADFGLAKKLLKSSS--SLTTFVGTPWYMAPEV-LLGGNGYGPKVDVWSLGV 187

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYK-----HIEPGNDFQLDGVVTEEEKELVKKM 175
           ++ E+  G+          S     + +             D       +EE K+L+K  
Sbjct: 188 ILYELLTGK-------PPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIK-- 238

Query: 176 ILVSLWCIQTNPSDRPSMHEVLE 198
                 C+  +PS RP+  E+L+
Sbjct: 239 -----KCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  117 bits (296), Expect = 1e-32
 Identities = 59/201 (29%), Positives = 81/201 (40%), Gaps = 59/201 (29%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
              GSL               L    + +I   I  GLEYLH   +  I+H D+KP NIL
Sbjct: 73  CEGGSLKDL-----LKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENIL 124

Query: 61  LDED-FCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           LD D    K++DFGL+K     KS   +    GT  Y+APEV     G  S KSD++S G
Sbjct: 125 LDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVL-LGKGYYSEKSDIWSLG 181

Query: 120 MMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVS 179
           +++ E+                                         E K+L++K     
Sbjct: 182 VILYEL----------------------------------------PELKDLIRK----- 196

Query: 180 LWCIQTNPSDRPSMHEVLEML 200
              +Q +P  RPS  E+LE L
Sbjct: 197 --MLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  116 bits (293), Expect = 8e-32
 Identities = 51/173 (29%), Positives = 78/173 (45%), Gaps = 34/173 (19%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I   LEYLH      IVH D+KP NILLDED   K++DFGLA+Q    +   + +   GT
Sbjct: 106 ILSALEYLHS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV---GT 159

Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNS-----I 148
             Y+APEV      G     D++S G+++ E+  G+              FP       +
Sbjct: 160 PEYMAPEVLLGK--GYGKAVDIWSLGVILYELLTGK------------PPFPGDDQLLEL 205

Query: 149 YKHI--EPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM 199
           +K I          +  ++ E K+L++K        +  +P  R +  E L+ 
Sbjct: 206 FKKIGKPKPPFPPPEWDISPEAKDLIRK-------LLVKDPEKRLTAEEALQH 251

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  111 bits (279), Expect = 1e-29
 Identities = 53/208 (25%), Positives = 88/208 (42%), Gaps = 40/208 (19%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           MP G L  +       N  + L    +   A  IARG+EYL        +H D+   N L
Sbjct: 83  MPGGDLLDYL----RKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCL 135

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRS-FGGASHKSDVYSYG 119
           + E+   KISDFGL++   D      +   +  I ++APE      F   + KSDV+S+G
Sbjct: 136 VGENLVVKISDFGLSRDLYDDD-YYKVKGGKLPIRWMAPESLKEGKF---TSKSDVWSFG 191

Query: 120 MMILEMA-------VGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELV 172
           +++ E+         G  NA+V               ++++ G           +     
Sbjct: 192 VLLWEIFTLGEEPYPGMSNAEV--------------LEYLKKGY-------RLPKPPNCP 230

Query: 173 KKMILVSLWCIQTNPSDRPSMHEVLEML 200
            ++  + L C   +P DRP+  E++E+L
Sbjct: 231 PELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  109 bits (275), Expect = 5e-29
 Identities = 50/208 (24%), Positives = 83/208 (39%), Gaps = 41/208 (19%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  G L  +            L    +   A  IARG+EYL        +H D+   N L
Sbjct: 83  MEGGDLLSYLRKNRP-----KLSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCL 134

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRS-FGGASHKSDVYSYG 119
           + E+   KISDFGL++   D          +  I ++APE      F   + KSDV+S+G
Sbjct: 135 VGENLVVKISDFGLSRDLYDDD-YYRKRGGKLPIRWMAPESLKEGKF---TSKSDVWSFG 190

Query: 120 MMILEMA-------VGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELV 172
           +++ E+         G  N +V               ++++ G           +     
Sbjct: 191 VLLWEIFTLGEQPYPGMSNEEV--------------LEYLKNGY-------RLPQPPNCP 229

Query: 173 KKMILVSLWCIQTNPSDRPSMHEVLEML 200
            ++  + L C   +P DRP+  E++E+L
Sbjct: 230 PELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  101 bits (255), Expect = 4e-26
 Identities = 43/129 (33%), Positives = 60/129 (46%), Gaps = 11/129 (8%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +  GSL               L    + +    I  GL YLH      IVH DIK  NIL
Sbjct: 83  VSGGSLSSL------LKKFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANIL 133

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           +D D   K++DFG AK+  D ++       RGT  ++APEV  R        +D++S G 
Sbjct: 134 VDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV-IRG-EEYGRAADIWSLGC 191

Query: 121 MILEMAVGR 129
            ++EMA G+
Sbjct: 192 TVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  101 bits (253), Expect = 8e-26
 Identities = 58/217 (26%), Positives = 88/217 (40%), Gaps = 48/217 (22%)

Query: 1   MPNGSLDQF---TYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPH 57
           M  G L  +   +     S    TL  + +   A  IA+G+EYL    + + VH D+   
Sbjct: 78  MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAAR 134

Query: 58  NILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYS 117
           N L+ ED   KISDFGL++   D          +  I ++APE      G  + KSDV+S
Sbjct: 135 NCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL--KDGIFTSKSDVWS 192

Query: 118 YGMMILEMAV-------GRKNADVKASRSSD------IYFPNSIYKHIEPGNDFQLDGVV 164
           +G+++ E+         G  N +V              Y P+ +Y               
Sbjct: 193 FGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY--------------- 237

Query: 165 TEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE 201
                EL+         C Q +P DRP+  E++E LE
Sbjct: 238 -----ELMLS-------CWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 97.6 bits (244), Expect = 1e-24
 Identities = 58/209 (27%), Positives = 88/209 (42%), Gaps = 42/209 (20%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           MP G L  F            L  + + Q+A  IA+G+EYL        VH D+   N L
Sbjct: 83  MPGGDLLDFLRKH-----GEKLTLKDLLQMALQIAKGMEYLES---KNFVHRDLAARNCL 134

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + E+   KISDFGL++   +          +  I ++APE      G  + KSDV+S+G+
Sbjct: 135 VTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL--KDGKFTSKSDVWSFGV 192

Query: 121 MILEMA-------VGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEE--KEL 171
           ++ E+         G  N +V               + +E G   +L      E    EL
Sbjct: 193 LLWEIFTLGEQPYPGMSNEEV--------------LELLEDGY--RLP---RPENCPDEL 233

Query: 172 VKKMILVSLWCIQTNPSDRPSMHEVLEML 200
            + M    L C   +P DRP+  E++E L
Sbjct: 234 YELM----LQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 96.1 bits (240), Expect = 5e-24
 Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 51/186 (27%)

Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK---QSQDKKSTIS 86
           IA  I +GL+YLH      I+H DIKP N+L++     KI+DFG++K    + D+ +T  
Sbjct: 104 IARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT-- 159

Query: 87  MLHARGTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP 145
                GT+ Y++PE     S+   S+ +D++S G+ +LE A+G+              FP
Sbjct: 160 ---FVGTVTYMSPERIQGESY---SYAADIWSLGLTLLECALGK--------------FP 199

Query: 146 NSIYKHIEPGNDFQL-------------DGVVTEEEKELVKKMILVSLWCIQTNPSDRPS 192
              +      + F+L                 + E ++ +         C+Q +P  RPS
Sbjct: 200 ---FLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISA-------CLQKDPKKRPS 249

Query: 193 MHEVLE 198
             E+L+
Sbjct: 250 AAELLQ 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 94.6 bits (236), Expect = 2e-23
 Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 42/206 (20%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
              GSL          + N+TL    +  +   + +GLEYLH   +  I+H DIK  NIL
Sbjct: 79  CSGGSLKDL-----LKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANIL 130

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEV-FCRSFGGASHKSDVYSYG 119
           L  D   K+ DFGL+ Q  D K+  +M+   GT  ++APEV   + +     K+D++S G
Sbjct: 131 LTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVINGKPYDY---KADIWSLG 184

Query: 120 MMILEMAVG----RKNADVKAS-RSSDIYFPN--SIYKHIEPGNDFQLDGVVTEEEKELV 172
           +  +E+A G     +   +KA  + +    P   +  K  +   DF             +
Sbjct: 185 ITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDF-------------L 231

Query: 173 KKMILVSLWCIQTNPSDRPSMHEVLE 198
           KK       C+Q NP  RP+  ++L+
Sbjct: 232 KK-------CLQKNPEKRPTAEQLLK 250

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 89.0 bits (221), Expect = 3e-21
 Identities = 53/165 (32%), Positives = 83/165 (50%), Gaps = 21/165 (12%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I  GLEYLH   +   VH DIK  NIL+D +   K++DFG+AKQ  +     S    +G+
Sbjct: 111 ILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF---KGS 164

Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIE 153
             ++APEV     GG    +D++S G  +LEMA G+          S +    +++K   
Sbjct: 165 PYWMAPEV-IAQQGGYGLAADIWSLGCTVLEMATGKPPW-------SQLEGVAAVFKIGR 216

Query: 154 PGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
                 +   +++E K+ + K       C+Q +PS RP+  E+LE
Sbjct: 217 SKELPPIPDHLSDEAKDFILK-------CLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 88.3 bits (217), Expect = 3e-20
 Identities = 67/253 (26%), Positives = 101/253 (39%), Gaps = 20/253 (7%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +  GSL+      +       L       I   I   LEYLH      I+H DIKP NIL
Sbjct: 80  VDGGSLEDL---LKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENIL 133

Query: 61  LDED-FCPKISDFGLAKQSQDKKSTISMLHAR----GTIGYIAPEVF-CRSFGGASHKSD 114
           LD D    K+ DFGLAK   D  ST S+        GT GY+APEV    S   AS  SD
Sbjct: 134 LDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSD 193

Query: 115 VYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKK 174
           ++S G+ + E+  G    + + + S+       I +   P     L     E   +    
Sbjct: 194 IWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASD 253

Query: 175 MILVSLWCIQTNPSDRPSM-----HEVLEMLESSTEILQIPPKPSLALPKKSAIQSSRTS 229
           ++      +  +P +R S      H++L  L+     L    KP  + P + ++  S  +
Sbjct: 254 LLKK---LLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEA 310

Query: 230 SSAGIEEVMGEMY 242
             + +  +     
Sbjct: 311 LISSLNSLAISGS 323

Length = 384

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 85.8 bits (213), Expect = 3e-20
 Identities = 42/110 (38%), Positives = 53/110 (48%), Gaps = 8/110 (7%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I   LEYLH   +  I+H DIKP NILLDE     I+DF +A +      T S     GT
Sbjct: 109 IVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST---SGT 162

Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIY 143
            GY+APEV CR   G S   D +S G+   E   G++     +    D  
Sbjct: 163 PGYMAPEVLCRQ--GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI 210

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 85.6 bits (213), Expect = 4e-20
 Identities = 48/165 (29%), Positives = 72/165 (43%), Gaps = 39/165 (23%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ-SQDKKSTISMLHARG 92
           I   LEYLH    + I++ D+KP NILLD D   K++DFGLAK+ S +   T +     G
Sbjct: 102 IVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC---G 155

Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR---KNADVKAS----RSSDIYFP 145
           T  Y+APEV      G     D +S G+++ EM  G+      D K          + FP
Sbjct: 156 TPEYLAPEVLLG--KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP 213

Query: 146 NSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDR 190
                             ++ E ++L+          +Q +P+ R
Sbjct: 214 EF----------------LSPEARDLISG-------LLQKDPTKR 235

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 83.5 bits (207), Expect = 2e-19
 Identities = 58/185 (31%), Positives = 95/185 (51%), Gaps = 30/185 (16%)

Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS 78
           N+TL    +  I     +GLEYLH   + + +H DIK  NILL+E+   K++DFG++ Q 
Sbjct: 93  NKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL 149

Query: 79  QD---KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR-KNADV 134
            D   K++T+      GT  ++APEV      G ++K+D++S G+  +EMA G+   +D+
Sbjct: 150 TDTMAKRNTVI-----GTPFWMAPEVIQEI--GYNNKADIWSLGITAIEMAEGKPPYSDI 202

Query: 135 KASRSSDIY-FPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSM 193
              R+  I+  PN       P          + E  + VKK       C+  +P +RPS 
Sbjct: 203 HPMRA--IFMIPNK------PPPTLSDPEKWSPEFNDFVKK-------CLVKDPEERPSA 247

Query: 194 HEVLE 198
            ++L+
Sbjct: 248 IQLLQ 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 82.7 bits (205), Expect = 7e-19
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 42/209 (20%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSLD+   + +     R L      +IA  + +GL YLH     +I+H D+KP NIL
Sbjct: 81  MDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHE--KHKIIHRDVKPSNIL 133

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGA-SHKSDVYSYG 119
           ++     K+ DFG++ Q  +   +++     GT  Y+APE   R  G   S KSD++S G
Sbjct: 134 VNSRGQIKLCDFGVSGQLVN---SLAKTFV-GTSSYMAPE---RIQGNDYSVKSDIWSLG 186

Query: 120 MMILEMAVGRKNADVKASRSSDIYFPNSIYK--HIEPGNDF-QLDGVVTEEEKELVKKMI 176
           + ++E+A GR              FP   Y   +  P   F  L  +V E    L     
Sbjct: 187 LSLIELATGR--------------FP---YPPENDPPDGIFELLQYIVNEPPPRLPSGKF 229

Query: 177 ------LVSLWCIQTNPSDRPSMHEVLEM 199
                  V+L C+  +P +RPS  E+LE 
Sbjct: 230 SPDFQDFVNL-CLIKDPRERPSYKELLEH 257

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 82.2 bits (203), Expect = 1e-18
 Identities = 38/97 (39%), Positives = 58/97 (59%), Gaps = 3/97 (3%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +  GL YLH   +  I+H D+K  N+L+D D   KISDFG++K+S D       +  +G+
Sbjct: 117 VLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGS 173

Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRK 130
           + ++APEV      G S K D++S G ++LEM  GR+
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 80.6 bits (200), Expect = 3e-18
 Identities = 43/171 (25%), Positives = 80/171 (46%), Gaps = 32/171 (18%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ---SQDKKSTISMLHA 90
           +   L+YLH     +I+H DIKP NI L  +   K+ DFG++K    + D   T+     
Sbjct: 112 LCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV---- 164

Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRK--NADVKASRSSDIYFPNSI 148
            GT  Y++PE+ C++    ++KSD++S G ++ E+   +     +     +  I     +
Sbjct: 165 -GTPYYLSPEL-CQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI-----L 216

Query: 149 YKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM 199
                P     +    + E + LV  +       +Q +P +RPS+ ++L+ 
Sbjct: 217 KGQYPP-----IPSQYSSELRNLVSSL-------LQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 77.9 bits (192), Expect = 4e-17
 Identities = 49/133 (36%), Positives = 67/133 (50%), Gaps = 19/133 (14%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
              GSLD   Y +    G R  E + + +IA  + +GL YLH   + +I+H DIKP NIL
Sbjct: 83  CEGGSLDS-IYKKVKKRGGRIGE-KVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNIL 137

Query: 61  LDEDFCPKISDFGLAKQ---SQDKKSTISMLHARGTIGYIAPEVFCRSFGGA-SHKSDVY 116
           L      K+ DFG++ +   S     T       GT  Y+APE   R  G   S  SDV+
Sbjct: 138 LTRKGQVKLCDFGVSGELVNSLAGTFT-------GTSFYMAPE---RIQGKPYSITSDVW 187

Query: 117 SYGMMILEMAVGR 129
           S G+ +LE+A  R
Sbjct: 188 SLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 76.6 bits (189), Expect = 9e-17
 Identities = 39/103 (37%), Positives = 56/103 (54%), Gaps = 12/103 (11%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTI--SMLHAR 91
           +  GL YLH      IVH DIKP NI LD +   K+ DFG A + ++  +T+   +    
Sbjct: 108 LLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA 164

Query: 92  GTIGYIAPEVFCRS----FGGASHKSDVYSYGMMILEMAVGRK 130
           GT  Y+APEV         G A   +D++S G ++LEMA G++
Sbjct: 165 GTPAYMAPEVITGGKGKGHGRA---ADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 77.2 bits (190), Expect = 1e-16
 Identities = 39/96 (40%), Positives = 62/96 (64%), Gaps = 9/96 (9%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD-KKSTISMLHARG 92
           +A  L++LH   ++ I++ D+KP NILLDE+   K++DFGL+K+S D +K   S     G
Sbjct: 107 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC---G 160

Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T+ Y+APEV  R   G +  +D +S+G+++ EM  G
Sbjct: 161 TVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 72.8 bits (179), Expect = 3e-15
 Identities = 56/168 (33%), Positives = 82/168 (48%), Gaps = 24/168 (14%)

Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGL-AKQSQDKKSTISMLHA-RGTI 94
           GLEYLH   N +I H DIK  NILL ED   KI+DFG+ A  +     T  +     GT 
Sbjct: 114 GLEYLHS--NGQI-HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTP 170

Query: 95  GYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEP 154
            ++APEV      G   K+D++S+G+  +E+A G       A  S   Y P  +      
Sbjct: 171 CWMAPEVM-EQVHGYDFKADIWSFGITAIELATGA------APYSK--YPPMKVLMLTLQ 221

Query: 155 GNDFQLDGVVTEEEKE----LVKKMILVSLWCIQTNPSDRPSMHEVLE 198
            +   L+   T  + +      +KMI +   C+Q +PS RP+  E+L+
Sbjct: 222 NDPPSLE---TGADYKKYSKSFRKMISL---CLQKDPSKRPTAEELLK 263

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 73.0 bits (179), Expect = 9e-15
 Identities = 56/187 (29%), Positives = 93/187 (49%), Gaps = 13/187 (6%)

Query: 20  RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ 79
           R L W    +IA GIA+ L +LH  C+  +V  ++ P  I++D    P +          
Sbjct: 775 RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCT 834

Query: 80  DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKAS-R 138
           D K  IS         Y+APE   R     + KSD+Y +G++++E+  G+  AD +    
Sbjct: 835 DTKCFISS-------AYVAPET--RETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH 885

Query: 139 SSDIYFPNSIYK--HIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEV 196
            S + +    Y   H++   D  + G V+  + E+V+ M L +L C  T+P+ RP  ++V
Sbjct: 886 GSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNL-ALHCTATDPTARPCANDV 944

Query: 197 LEMLESS 203
           L+ LES+
Sbjct: 945 LKTLESA 951

Length = 968

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 71.3 bits (175), Expect = 1e-14
 Identities = 53/212 (25%), Positives = 87/212 (41%), Gaps = 31/212 (14%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +P+GSL  +          + L        +  I +G++YL    + R +H D+   NIL
Sbjct: 90  LPSGSLRDYLQRHRDQINLKRL-----LLFSSQICKGMDYLG---SQRYIHRDLAARNIL 141

Query: 61  LDEDFCPKISDFGLAK-QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           ++ +   KISDFGLAK   +DK            I + APE  C      S  SDV+S+G
Sbjct: 142 VESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE--CLRTSKFSSASDVWSFG 199

Query: 120 MMILEM-AVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEK--------- 169
           + + E+   G  +    A     I                +L  ++ E E+         
Sbjct: 200 VTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIV------TRLLELLKEGERLPRPPSCPD 253

Query: 170 ELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE 201
           E+   M L    C +  P DRPS  +++ +++
Sbjct: 254 EVYDLMKL----CWEAEPQDRPSFADLILIVD 281

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 71.4 bits (176), Expect = 1e-14
 Identities = 37/96 (38%), Positives = 56/96 (58%), Gaps = 12/96 (12%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +   LEYLH   ++ IV+ D+KP N+LLD D   KI+DFG AK+ + +  T+      GT
Sbjct: 110 VVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC-----GT 161

Query: 94  IGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVG 128
             Y+APE+   + +G A    D ++ G++I EM  G
Sbjct: 162 PEYLAPEIILSKGYGKA---VDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 71.1 bits (175), Expect = 1e-14
 Identities = 54/169 (31%), Positives = 85/169 (50%), Gaps = 31/169 (18%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ---SQDKKSTISMLHA 90
           +  GLEYLH       +H DIK  NILL E+   K++DFG++ Q   +  K++T      
Sbjct: 107 VLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV---- 159

Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRK-NADVKASRSSDIYFPNSIY 149
            GT  ++APEV  +S  G   K+D++S G+  +E+A G    +D+   R   + F   I 
Sbjct: 160 -GTPFWMAPEVIKQS--GYDEKADIWSLGITAIELAKGEPPLSDLHPMR---VLF--LIP 211

Query: 150 KHIEPGNDFQLDGVV-TEEEKELVKKMILVSLWCIQTNPSDRPSMHEVL 197
           K+  P     L+G   ++  K+ V         C+  +P +RPS  E+L
Sbjct: 212 KNNPP----SLEGNKFSKPFKDFVSL-------CLNKDPKERPSAKELL 249

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 71.0 bits (174), Expect = 1e-14
 Identities = 39/100 (39%), Positives = 51/100 (51%), Gaps = 10/100 (10%)

Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I  GLE+LH     RIV+ D+KP N+LLD+    +ISD GLA + +  K        
Sbjct: 101 AAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI----KG 153

Query: 91  R-GTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           R GT GY+APEV            D ++ G  + EM  GR
Sbjct: 154 RAGTPGYMAPEVLQG--EVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 70.4 bits (173), Expect = 2e-14
 Identities = 51/174 (29%), Positives = 79/174 (45%), Gaps = 31/174 (17%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK----QSQDKKSTISMLH 89
           I   LEYLH   +  I+H D+KP NIL+D +   K++DFGL+K    + Q   +      
Sbjct: 102 IVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158

Query: 90  AR--GTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRK--NADVKASRSSDIYFP 145
            R  GT  YIAPEV      G S   D +S G ++ E  VG    + +           P
Sbjct: 159 KRIVGTPDYIAPEVILGQ--GHSKTVDWWSLGCILYEFLVGIPPFHGET----------P 206

Query: 146 NSIYKHIEPGN-DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
             I+++I  G  ++  D  V++E  +L+ K+       +  +P  R     + E
Sbjct: 207 EEIFQNILNGKIEWPEDVEVSDEAIDLISKL-------LVPDPEKRLGAKSIEE 253

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 70.1 bits (172), Expect = 2e-14
 Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 32/204 (15%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSL     D   S G   +        A  +  G+EYL        VH D+   N+L
Sbjct: 82  MAKGSL----VDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVL 134

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + ED   K+SDFGLAK++   + +      +  + + APE         S KSDV+S+G+
Sbjct: 135 VSEDLVAKVSDFGLAKEASQGQDS-----GKLPVKWTAPEAL--REKKFSTKSDVWSFGI 187

Query: 121 MILEM-AVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL-DGVVTEEEKELVKKMILV 178
           ++ E+ + GR    V   R         +  H+E G   +  +G       E+ K M   
Sbjct: 188 LLWEIYSFGR----VPYPRIP----LKDVVPHVEKGYRMEAPEGC----PPEVYKVM--- 232

Query: 179 SLWCIQTNPSDRPSMHEVLEMLES 202
              C + +P+ RP+  ++ E L  
Sbjct: 233 -KDCWELDPAKRPTFKQLREQLAL 255

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 70.3 bits (173), Expect = 2e-14
 Identities = 50/194 (25%), Positives = 80/194 (41%), Gaps = 53/194 (27%)

Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK------------- 76
            A  I   LEYLH   +  I+H D+KP NILLD+D   KI+DFG AK             
Sbjct: 107 YAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKG 163

Query: 77  QSQDKKSTISMLHAR-----GTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR-- 129
            + +  S I     R     GT  Y++PE+   +   A   SD+++ G +I +M  G+  
Sbjct: 164 DATNIDSQIEKNRRRFASFVGTAEYVSPELL--NEKPAGKSSDLWALGCIIYQMLTGKPP 221

Query: 130 ---KNADV--KASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQ 184
               N  +  +     +  FP +                     K+L++K+       + 
Sbjct: 222 FRGSNEYLTFQKILKLEYSFPPNFPPDA----------------KDLIEKL-------LV 258

Query: 185 TNPSDRPSMHEVLE 198
            +P DR  ++E  +
Sbjct: 259 LDPQDRLGVNEGYD 272

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 69.3 bits (170), Expect = 4e-14
 Identities = 43/134 (32%), Positives = 74/134 (55%), Gaps = 17/134 (12%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAG---GIARGLEYLHRGCNVRIVHFDIKPH 57
           M NGSLD+F  + +           TV Q+ G   GIA G++YL     +  VH D+   
Sbjct: 87  MENGSLDKFLREND--------GKFTVGQLVGMLRGIASGMKYL---SEMNYVHRDLAAR 135

Query: 58  NILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYS 117
           NIL++ +   K+SDFGL+++ +D ++T +    +  I + APE    ++   +  SDV+S
Sbjct: 136 NILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAI--AYRKFTSASDVWS 193

Query: 118 YGMMILE-MAVGRK 130
           +G+++ E M+ G +
Sbjct: 194 FGIVMWEVMSYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 69.1 bits (169), Expect = 5e-14
 Identities = 53/178 (29%), Positives = 82/178 (46%), Gaps = 41/178 (23%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLD---EDFCPKISDFGLAKQSQDKKSTISMLHA 90
           + RGL YLH     +I+H D+K  N+L+D   +    +I+DFG A +   K +       
Sbjct: 112 LLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQG 166

Query: 91  R--GTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRK--NADVKASRSSDIY--- 143
           +  GTI ++APEV      G S   DV+S G +I+EMA  +   NA+  ++  + I+   
Sbjct: 167 QLLGTIAFMAPEVLRGEQYGRS--CDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA 224

Query: 144 ---FPNSIYKHIEPG-NDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVL 197
                 SI +H+ PG  D                     +L C++  P DRP   E+L
Sbjct: 225 SATTAPSIPEHLSPGLRDV--------------------TLRCLELQPEDRPPSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 68.6 bits (168), Expect = 8e-14
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 34/203 (16%)

Query: 5   SLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDED 64
           SLD+F Y +    G    E   + +IA  I + LEYLH    + ++H D+KP N+L++ +
Sbjct: 85  SLDKF-YKKVYDKGLTIPE-DILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRN 140

Query: 65  FCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVF--CRSFGGASHKSDVYSYGMMI 122
              K+ DFG++    D   +++     G   Y+APE      +  G   KSDV+S G+ +
Sbjct: 141 GQVKLCDFGISGYLVD---SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITM 197

Query: 123 LEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDF-QLDGVVTEEEKELVKKMILVSLW 181
           +E+A GR              FP   +K       F QL  VV E   +L  +       
Sbjct: 198 IELATGR--------------FPYDSWK-----TPFQQLKQVVEEPSPQLPAEKFSPEFQ 238

Query: 182 -----CIQTNPSDRPSMHEVLEM 199
                C++ N  +RP+  E+L+ 
Sbjct: 239 DFVNKCLKKNYKERPNYPELLQH 261

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 68.4 bits (168), Expect = 1e-13
 Identities = 42/106 (39%), Positives = 60/106 (56%), Gaps = 16/106 (15%)

Query: 29  QIA---GGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ---SQDKK 82
           QIA     + +GLEYLH      ++H DIK  NILL +D   K++DFG A Q    + K+
Sbjct: 117 QIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR 173

Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           +++      GT  ++APEV  R   G   K D++S G+M +EMA G
Sbjct: 174 NSVV-----GTPYWMAPEVIKRKDYG--PKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 68.2 bits (167), Expect = 1e-13
 Identities = 53/153 (34%), Positives = 77/153 (50%), Gaps = 35/153 (22%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I   LEYLH   +  IV+ D+KP NILLD++   K++DFG AK+ +D+  T+      GT
Sbjct: 110 IVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC-----GT 161

Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR-----KNADVKASRSSDIYFPNSI 148
             Y+APEV      G +   D ++ G++I EM VG       N             P  I
Sbjct: 162 PEYLAPEVIQSK--GHNKAVDWWALGILIYEMLVGYPPFFDDN-------------PFGI 206

Query: 149 YKHIEPGN-DF--QLDGVVTEEEKELVKKMILV 178
           Y+ I  G  +F   LD       K+L+KK+++V
Sbjct: 207 YEKILAGKLEFPRHLDLYA----KDLIKKLLVV 235

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 67.6 bits (166), Expect = 1e-13
 Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 23/169 (13%)

Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK 82
           E+   + IA  +    EYLH   N  I++ D+KP N+LLD +   K+ DFG AK+ +  +
Sbjct: 92  EYTARFYIAC-VVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ 147

Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDI 142
            T +     GT  Y+APE+      G     D +S G+++ E+  GR           D 
Sbjct: 148 KTWTFC---GTPEYVAPEIILNK--GYDFSVDYWSLGILLYELLTGR------PPFGEDD 196

Query: 143 YFPNSIYKHIEPGNDF-QLDGVVTEEEKELVKKMILVSLWCIQTNPSDR 190
             P  IY  I  GN   +    + +  K+L+K++       ++ NP +R
Sbjct: 197 EDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQL-------LRRNPEER 238

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 67.7 bits (166), Expect = 2e-13
 Identities = 49/192 (25%), Positives = 82/192 (42%), Gaps = 39/192 (20%)

Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNV--RIVHFDIKPHNILLDEDFCPKISDFGLAK 76
            + +E   +++I   +   L   H   +    ++H D+KP NI LD +   K+ DFGLAK
Sbjct: 99  RKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK 158

Query: 77  ----QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR--- 129
                S   K+ +      GT  Y++PE           KSD++S G +I E+       
Sbjct: 159 ILGHDSSFAKTYV------GTPYYMSPEQLNHM--SYDEKSDIWSLGCLIYELCALSPPF 210

Query: 130 --KNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNP 187
             +N    AS+             I+ G   ++    + E  E++K M+ V       +P
Sbjct: 211 TARNQLQLASK-------------IKEGKFRRIPYRYSSELNEVIKSMLNV-------DP 250

Query: 188 SDRPSMHEVLEM 199
             RPS  E+L++
Sbjct: 251 DKRPSTEELLQL 262

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 67.9 bits (167), Expect = 2e-13
 Identities = 37/99 (37%), Positives = 52/99 (52%), Gaps = 16/99 (16%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK--QSQDKKSTISMLHARGT 93
           RGL Y H     RI+H D+KP NIL++ D   K++DFGLA+      +  T    H   T
Sbjct: 109 RGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT----HEVVT 161

Query: 94  IGYIAPEVFCRSFGGASHKS---DVYSYGMMILEMAVGR 129
           + Y APE+      G+ H S   D++S G +  EM  G+
Sbjct: 162 LWYRAPEILL----GSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 66.7 bits (163), Expect = 3e-13
 Identities = 48/176 (27%), Positives = 74/176 (42%), Gaps = 32/176 (18%)

Query: 24  WRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK--QSQDK 81
           WR   Q+     RGL+ LH     +I+H D+K  NILL  +   KI D G++K  +    
Sbjct: 106 WRIFIQLL----RGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA 158

Query: 82  KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSD 141
           K+ I      GT  Y+APEV+       S+KSD++S G ++ EMA      + ++ +   
Sbjct: 159 KTQI------GTPHYMAPEVWKGR--PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR 210

Query: 142 IYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVL 197
                  Y  I P     L   +                  +Q  P  RP+  ++L
Sbjct: 211 YKVQRGKYPPIPPIYSQDLQNFIR---------------SMLQVKPKLRPNCDKIL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 66.8 bits (163), Expect = 4e-13
 Identities = 50/177 (28%), Positives = 82/177 (46%), Gaps = 25/177 (14%)

Query: 24  WRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS 83
           W    Q+       L YLH+    RIVH D+ P+NI+L ED    I+DFGLAKQ Q +  
Sbjct: 116 WNIFVQMV----LALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK 169

Query: 84  TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIY 143
             S++   GTI Y  PE+      G   K+DV+++G ++ +M   +         S    
Sbjct: 170 LTSVV---GTILYSCPEIVKNEPYG--EKADVWAFGCILYQMCTLQPPFYSTNMLSLATK 224

Query: 144 FPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML 200
              ++Y   EP      +G+ +E+  +++         C+  +   RP + +V  M+
Sbjct: 225 IVEAVY---EPLP----EGMYSEDVTDVIT-------SCLTPDAEARPDIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 66.2 bits (162), Expect = 6e-13
 Identities = 41/125 (32%), Positives = 63/125 (50%), Gaps = 10/125 (8%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSL  F    E       L    +  +A  IA G+ YL        +H D+   NIL
Sbjct: 83  MSKGSLLDFLKSGEGKK----LRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNIL 135

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + E+   KI+DFGLA+  +D + T     A+  I + APE    ++G  + KSDV+S+G+
Sbjct: 136 VGENLVCKIADFGLARLIEDDEYTARE-GAKFPIKWTAPEAA--NYGRFTIKSDVWSFGI 192

Query: 121 MILEM 125
           ++ E+
Sbjct: 193 LLTEI 197

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 66.2 bits (162), Expect = 6e-13
 Identities = 50/186 (26%), Positives = 79/186 (42%), Gaps = 41/186 (22%)

Query: 28  YQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ--SQD--KKS 83
            Q+A  IA G+ YL      + VH D+   N ++ ED   KI DFG+ +     D  +K 
Sbjct: 122 IQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKG 178

Query: 84  TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-------GRKNADVKA 136
              +L  R    ++APE      G  + KSDV+S+G+++ EMA        G  N +V  
Sbjct: 179 GKGLLPVR----WMAPESL--KDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL- 231

Query: 137 SRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEV 196
                                F +DG   +  +    K++ +   C Q NP  RP+  E+
Sbjct: 232 --------------------KFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEI 271

Query: 197 LEMLES 202
           +  L+ 
Sbjct: 272 VSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 65.8 bits (161), Expect = 9e-13
 Identities = 41/126 (32%), Positives = 65/126 (51%), Gaps = 7/126 (5%)

Query: 5   SLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDED 64
           SLD+F Y          +    + +IA    + L YL     ++I+H D+KP NILLD +
Sbjct: 88  SLDKF-YKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRN 144

Query: 65  FCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMIL 123
              K+ DFG++ Q  D   +I+     G   Y+APE +   +  G   +SDV+S G+ + 
Sbjct: 145 GNIKLCDFGISGQLVD---SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLY 201

Query: 124 EMAVGR 129
           E+A G+
Sbjct: 202 EVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 65.4 bits (160), Expect = 1e-12
 Identities = 36/96 (37%), Positives = 51/96 (53%), Gaps = 14/96 (14%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ----SQDKKSTISMLHAR 91
           +GL YLH       +H DIK  NILL ED   K++DFG++ Q       +KS I      
Sbjct: 112 KGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI------ 162

Query: 92  GTIGYIAPEVFC-RSFGGASHKSDVYSYGMMILEMA 126
           GT  ++APEV      GG   K D+++ G+  +E+A
Sbjct: 163 GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELA 198

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 65.2 bits (159), Expect = 1e-12
 Identities = 60/201 (29%), Positives = 90/201 (44%), Gaps = 32/201 (15%)

Query: 1   MPNGSLDQFTYDQESSNG--NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHN 58
           MP GS+     DQ  + G    T+  +   QI      G+EYLH      IVH DIK  N
Sbjct: 86  MPGGSVK----DQLKAYGALTETVTRKYTRQIL----EGVEYLHSN---MIVHRDIKGAN 134

Query: 59  ILLDEDFCPKISDFGLAKQSQDKKSTIS-MLHARGTIGYIAPEVFCRSFGGASHKSDVYS 117
           IL D     K+ DFG +K+ Q   S+ + M    GT  +++PEV   S  G   K+DV+S
Sbjct: 135 ILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI--SGEGYGRKADVWS 192

Query: 118 YGMMILEMAVGRKN-ADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMI 176
            G  ++EM   +   A+ +A          +I+K      + QL   V+ + +  +++  
Sbjct: 193 VGCTVVEMLTEKPPWAEFEAMA--------AIFKIATQPTNPQLPSHVSPDARNFLRR-- 242

Query: 177 LVSLWCIQTNPSDRPSMHEVL 197
                    N   RPS  E+L
Sbjct: 243 -----TFVENAKKRPSAEELL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 65.8 bits (160), Expect = 1e-12
 Identities = 55/226 (24%), Positives = 103/226 (45%), Gaps = 30/226 (13%)

Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS 78
              L ++ +   A  +ARG+EYL    + + +H D+   N+L+ ED   KI+DFGLA+  
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV 184

Query: 79  QDKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKAS 137
            +        + R  + ++APE +F R +   +H+SDV+S+G+++ E             
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRVY---THQSDVWSFGVLLWE------------- 228

Query: 138 RSSDIYFPN-SIYKHIEPGNDFQL--DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMH 194
               I+    S Y  I     F+L  +G   ++      ++ ++   C    PS RP+  
Sbjct: 229 ----IFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFK 284

Query: 195 EVLEMLESSTEILQIPPKPSLALPKKS---AIQSSRTSSSAGIEEV 237
           +++E L+    +        L++P +        S +S S+G + V
Sbjct: 285 QLVEDLDRVLTVTSTDEYLDLSVPFEQYSPGCPDSPSSCSSGDDSV 330

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 65.5 bits (159), Expect = 1e-12
 Identities = 53/168 (31%), Positives = 86/168 (51%), Gaps = 28/168 (16%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ---SQDKKSTISMLHA 90
           I +GL+YLH   + + +H DIK  N+LL E    K++DFG+A Q   +Q K++T      
Sbjct: 110 ILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV---- 162

Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYK 150
            GT  ++APEV  +S      K+D++S G+  +E+A G          +SD++ P  +  
Sbjct: 163 -GTPFWMAPEVIQQS--AYDSKADIWSLGITAIELAKGE-------PPNSDMH-PMRVLF 211

Query: 151 HIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
            I   N   L G  ++  KE +         C+  +PS RP+  E+L+
Sbjct: 212 LIPKNNPPTLTGEFSKPFKEFIDA-------CLNKDPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 1e-12
 Identities = 38/104 (36%), Positives = 56/104 (53%), Gaps = 13/104 (12%)

Query: 27  VYQIAGGIARGLEYLHR-GCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTI 85
           VYQ+     +GL YLH  G    ++H DIK  NIL  +D   K++DFG+A +  D     
Sbjct: 105 VYQVL----QGLAYLHEQG----VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD 156

Query: 86  SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           + +   GT  ++APEV      GAS  SD++S G  ++E+  G 
Sbjct: 157 ASV--VGTPYWMAPEVI--EMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 64.9 bits (158), Expect = 1e-12
 Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 38/208 (18%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NGSL  F    E       L    +  +A  IA G+ ++ R      +H D++  NIL
Sbjct: 82  MENGSLVDFLKTPEGIK----LTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANIL 134

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + E  C KI+DFGLA+  +D + T +   A+  I + APE    ++G  + KSDV+S+G+
Sbjct: 135 VSETLCCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGI 191

Query: 121 MILEMAV-------GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVK 173
           ++ E+         G  N +V       I      Y+   P N         EE  EL++
Sbjct: 192 LLTEIVTYGRIPYPGMTNPEV-------IQNLERGYRMPRPDN-------CPEELYELMR 237

Query: 174 KMILVSLWCIQTNPSDRPSMHEVLEMLE 201
                   C +  P +RP+   +  +LE
Sbjct: 238 L-------CWKEKPEERPTFEYLRSVLE 258

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 64.5 bits (157), Expect = 2e-12
 Identities = 50/204 (24%), Positives = 90/204 (44%), Gaps = 28/204 (13%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  G+L  +  +       + +    +  +A  I+  +EYL +      +H D+   N L
Sbjct: 84  MTYGNLLDYLRE----CNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCL 136

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + E+   K++DFGL++       T +   A+  I + APE    ++   S KSDV+++G+
Sbjct: 137 VGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESL--AYNKFSIKSDVWAFGV 193

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL--DGVVTEEEKELVKKMILV 178
           ++ E+A                 +  S Y  I+    ++L   G   E  +    K+  +
Sbjct: 194 LLWEIAT----------------YGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYEL 237

Query: 179 SLWCIQTNPSDRPSMHEVLEMLES 202
              C Q NPSDRPS  E+ +  E+
Sbjct: 238 MRACWQWNPSDRPSFAEIHQAFET 261

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 64.6 bits (158), Expect = 2e-12
 Identities = 40/102 (39%), Positives = 55/102 (53%), Gaps = 16/102 (15%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
             RGL YLH     +++H DIK  NILL ++   K+ DFG++ Q        S L  R T
Sbjct: 122 TLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD------STLGRRNT 172

Query: 94  -IG---YIAPEVF-CRSFGGAS--HKSDVYSYGMMILEMAVG 128
            IG   ++APEV  C     AS   +SDV+S G+  +E+A G
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 64.6 bits (158), Expect = 3e-12
 Identities = 28/92 (30%), Positives = 46/92 (50%), Gaps = 9/92 (9%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIG 95
           +G+ Y+H      I+H D+KP N+L+  D   KI+DFGLA+    ++      H   T  
Sbjct: 110 KGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLAR-LFSEEEPRLYSHQVATRW 165

Query: 96  YIAPEVF--CRSFGGASHKSDVYSYGMMILEM 125
           Y APE+    R +       D+++ G +  E+
Sbjct: 166 YRAPELLYGARKYDPG---VDLWAVGCIFAEL 194

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 64.4 bits (157), Expect = 3e-12
 Identities = 56/215 (26%), Positives = 87/215 (40%), Gaps = 30/215 (13%)

Query: 1   MPNGSLDQFTYDQESSNGNRT-LEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP G L  +  + + + G++  L W         IA+G+ YL      R+VH D+   N+
Sbjct: 90  MPLGCLLDYVRNHKDNIGSQYLLNWCV------QIAKGMSYLE---EKRLVHRDLAARNV 140

Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L+      KI+DFGLAK     +        +  I ++A E         +HKSDV+SYG
Sbjct: 141 LVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE--SILHRIYTHKSDVWSYG 198

Query: 120 MMILE-MAVGRK-NADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMIL 177
           + + E M  G K    + A    D          +E G       + T     +   M+L
Sbjct: 199 VTVWELMTFGAKPYEGIPAVEIPD---------LLEKGERLPQPPICT-----IDVYMVL 244

Query: 178 VSLWCIQTN--PSDRPSMHEVLEMLESSTEILQIP 210
           V  W I     P+ +  ++E  +M       L I 
Sbjct: 245 VKCWMIDAESRPTFKELINEFSKMARDPQRYLVIQ 279

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 64.0 bits (156), Expect = 3e-12
 Identities = 50/200 (25%), Positives = 85/200 (42%), Gaps = 25/200 (12%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NG L  +  +++   G   L       +   +   +EYL        +H D+   N L
Sbjct: 81  MANGCLLNYLRERKGKLGTEWL-----LDMCSDVCEAMEYLESNG---FIHRDLAARNCL 132

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + ED   K+SDFGLA+   D + T S    +  + +  PEVF   +   S KSDV+S+G+
Sbjct: 133 VGEDNVVKVSDFGLARYVLDDQYTSSQ-GTKFPVKWAPPEVF--DYSRFSSKSDVWSFGV 189

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSL 180
           ++ E+    K    + S S        + + +  G  ++L        K    ++  +  
Sbjct: 190 LMWEVFSEGKMPYERFSNS-------EVVESVSAG--YRLY-----RPKLAPTEVYTIMY 235

Query: 181 WCIQTNPSDRPSMHEVLEML 200
            C    P DRP+  ++L  L
Sbjct: 236 SCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 64.0 bits (156), Expect = 3e-12
 Identities = 48/178 (26%), Positives = 81/178 (45%), Gaps = 36/178 (20%)

Query: 28  YQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISM 87
           +QI   ++    Y+H+     I+H DIK  NI L +    K+ DFG++K    + S    
Sbjct: 108 FQIVSAVS----YIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS---- 156

Query: 88  LHAR---GTIGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVGRKNADVKASRSSDI 142
             A    GT  Y++PE+ C+   G  +  KSD+++ G ++ E+   ++  D  A+     
Sbjct: 157 -MAETVVGTPYYMSPEL-CQ---GVKYNFKSDIWALGCVLYELLTLKRTFD--ATN---- 205

Query: 143 YFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML 200
             P ++   I  GN   +  V + E   LV          +Q +P  RP+  EVL+  
Sbjct: 206 --PLNLVVKIVQGNYTPVVSVYSSELISLVHS-------LLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 64.1 bits (156), Expect = 4e-12
 Identities = 50/166 (30%), Positives = 80/166 (48%), Gaps = 19/166 (11%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDE-DFCPKISDFGLAKQSQDKKSTISMLHARG 92
           I  GL+YLH   + +IVH DIK  N+L++      KISDFG +K+              G
Sbjct: 117 ILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF--TG 171

Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHI 152
           T+ Y+APEV  +   G    +D++S G  I+EMA G K   ++        F   ++K I
Sbjct: 172 TLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATG-KPPFIELGEPQAAMFKVGMFK-I 229

Query: 153 EPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
            P    ++   ++ E K  + +       C + +P  R S H++L+
Sbjct: 230 HP----EIPESLSAEAKNFILR-------CFEPDPDKRASAHDLLQ 264

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 4e-12
 Identities = 35/119 (29%), Positives = 50/119 (42%), Gaps = 34/119 (28%)

Query: 38  LEYLHR-GCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHAR----- 91
           L+ +H+ G     +H DIKP NIL+D D   K++DFGL K+    K     L+       
Sbjct: 114 LDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169

Query: 92  ----------------------GTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
                                 GT  YIAPEV   +      + D +S G+++ EM  G
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 63.6 bits (155), Expect = 4e-12
 Identities = 53/189 (28%), Positives = 86/189 (45%), Gaps = 33/189 (17%)

Query: 17  NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK 76
              R +  RT+++    +   LE++H     RI+H DIKP N+ +      K+ D GL +
Sbjct: 98  KQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGR 154

Query: 77  QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKA 136
               K  T +     GT  Y++PE    +  G + KSD++S G ++ EMA         A
Sbjct: 155 FFSSK--TTAAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMA---------A 201

Query: 137 SRSS------DIYFPNSIYKHIEPGNDFQLDG-VVTEEEKELVKKMILVSLWCIQTNPSD 189
            +S       ++Y   S+ K IE  +   L     +EE ++LV +       CI  +P  
Sbjct: 202 LQSPFYGDKMNLY---SLCKKIEKCDYPPLPADHYSEELRDLVSR-------CINPDPEK 251

Query: 190 RPSMHEVLE 198
           RP +  VL+
Sbjct: 252 RPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 63.5 bits (154), Expect = 6e-12
 Identities = 44/136 (32%), Positives = 73/136 (53%), Gaps = 20/136 (14%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAG---GIARGLEYLHRGCNVRIVHFDIKPH 57
           M NG+LD++  D +           + YQ+ G   GIA G++YL    ++  VH D+   
Sbjct: 88  MENGALDKYLRDHDGE--------FSSYQLVGMLRGIAAGMKYL---SDMNYVHRDLAAR 136

Query: 58  NILLDEDFCPKISDFGLAKQSQD-KKSTISMLHARGTIGYIAPEVFC-RSFGGASHKSDV 115
           NIL++ +   K+SDFGL++  +D  + T +    +  I + APE    R F  A   SDV
Sbjct: 137 NILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSA---SDV 193

Query: 116 YSYGMMILE-MAVGRK 130
           +S+G+++ E M+ G +
Sbjct: 194 WSFGIVMWEVMSFGER 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 63.4 bits (155), Expect = 7e-12
 Identities = 36/93 (38%), Positives = 51/93 (54%), Gaps = 14/93 (15%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ--SQDKKSTISMLHARGT 93
           RGLEYLH      I+H D+KP+N+L+  D   K++DFGLA+   S ++K    M H   T
Sbjct: 113 RGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK----MTHQVVT 165

Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILE 124
             Y APE+    R +G      D++S G +  E
Sbjct: 166 RWYRAPELLFGARHYGVG---VDMWSVGCIFAE 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 63.5 bits (155), Expect = 7e-12
 Identities = 35/106 (33%), Positives = 55/106 (51%), Gaps = 13/106 (12%)

Query: 28  YQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK---QSQDKKST 84
           YQ+     RGL+Y+H      ++H D+KP N+L++ED   +I DFG+A+    S  +   
Sbjct: 114 YQLL----RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY 166

Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRK 130
             M     T  Y APE+   S    +   D++S G +  EM +GR+
Sbjct: 167 F-MTEYVATRWYRAPELLL-SLPEYTTAIDMWSVGCIFAEM-LGRR 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 62.9 bits (153), Expect = 8e-12
 Identities = 37/100 (37%), Positives = 59/100 (59%), Gaps = 9/100 (9%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHAR-- 91
           I +GL YLH   N  I+H DIK  NIL+D     KISDFG++K+ +    +     AR  
Sbjct: 115 ILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS 171

Query: 92  --GTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             G++ ++APEV  ++    + K+D++S G +++EM  G+
Sbjct: 172 LQGSVFWMAPEVVKQTS--YTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 63.2 bits (154), Expect = 8e-12
 Identities = 55/196 (28%), Positives = 89/196 (45%), Gaps = 45/196 (22%)

Query: 29  QIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISML 88
           +I+  + RGL YL      +I+H D+KP NIL++     K+ DFG++ Q  D     SM 
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-----SMA 155

Query: 89  HA-RGTIGYIAPEVFCRSFGGASH---KSDVYSYGMMILEMAVGRKNADVKASRSSDIYF 144
           ++  GT  Y++PE   R  G  +H   +SD++S G+ ++EMA+GR              +
Sbjct: 156 NSFVGTRSYMSPE---RLQG--THYTVQSDIWSLGLSLVEMAIGR--------------Y 196

Query: 145 PNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESST 204
           P      I P +  +L+ +      E   K     +     +P D P    + E+L+   
Sbjct: 197 P------IPPPDAKELEAMFGRPVSEGEAKESHRPV---SGHPPDSPRPMAIFELLDYIV 247

Query: 205 EILQIPPKPSLALPKK 220
              + PPK    LP  
Sbjct: 248 N--EPPPK----LPSG 257

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 63.0 bits (153), Expect = 9e-12
 Identities = 53/159 (33%), Positives = 76/159 (47%), Gaps = 28/159 (17%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAG---GIARGLEYLHRGCNVRIVHFDIKPH 57
           M NG+LD F    +           TV Q+ G   GIA G++YL     +  VH D+   
Sbjct: 87  MENGALDSFLRQNDGQ--------FTVIQLVGMLRGIAAGMKYL---SEMNYVHRDLAAR 135

Query: 58  NILLDEDFCPKISDFGLAKQSQDKKST---ISMLHARGTIGYIAPEVFC-RSFGGASHKS 113
           NIL++ +   K+SDFGL++  +D  S     S L  +  I + APE    R F  A   S
Sbjct: 136 NILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSA---S 192

Query: 114 DVYSYGMMILE-MAVGRK------NADVKASRSSDIYFP 145
           DV+SYG+++ E M+ G +      N DV  +   D   P
Sbjct: 193 DVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLP 231

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 63.2 bits (154), Expect = 1e-11
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 14/106 (13%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
           +YQI     RGL+YLH   +  I+H DIKP N+L++ +   KI DFGLA+  ++   +  
Sbjct: 109 LYQIL----RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKH 160

Query: 87  MLHARGTIGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGRK 130
           M     T  Y APE+    R +  A    D++S G +  E+ +GR+
Sbjct: 161 MTQEVVTQYYRAPEILMGSRHYTSA---VDIWSVGCIFAEL-LGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 62.3 bits (151), Expect = 1e-11
 Identities = 46/152 (30%), Positives = 75/152 (49%), Gaps = 17/152 (11%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSL  F    E   G + L  + +   +  IA G+ Y+ R      +H D++  N+L
Sbjct: 83  MAKGSLLDFLKSDE---GGKVLLPKLI-DFSAQIAEGMAYIERK---NYIHRDLRAANVL 135

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + E    KI+DFGLA+  +D + T +   A+  I + APE    +FG  + KSDV+S+G+
Sbjct: 136 VSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAI--NFGSFTIKSDVWSFGI 192

Query: 121 MILEMAV-------GRKNADVKASRSSDIYFP 145
           ++ E+         G  N+DV ++       P
Sbjct: 193 LLYEIVTYGKIPYPGMSNSDVMSALQRGYRMP 224

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 61.9 bits (150), Expect = 2e-11
 Identities = 50/178 (28%), Positives = 84/178 (47%), Gaps = 34/178 (19%)

Query: 29  QIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISML 88
           Q +  +A G+EYL    + ++VH D+   NIL+ ED   K+SDFGLA+            
Sbjct: 104 QFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN---- 156

Query: 89  HARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM-AVGRKNADVKASRSSDIYFP-- 145
            ++  + + APE         S KSDV+SYG+++ E+ + GR              +P  
Sbjct: 157 -SKLPVKWTAPEAL--KHKKFSSKSDVWSYGVLLWEVFSYGRAP------------YPKM 201

Query: 146 --NSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE 201
               + + +E G  ++++     E       +++ S W  +T P  RPS H++ E LE
Sbjct: 202 SLKEVKECVEKG--YRME---PPEGCPADVYVLMTSCW--ETEPKKRPSFHKLREKLE 252

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 61.9 bits (150), Expect = 2e-11
 Identities = 40/112 (35%), Positives = 59/112 (52%), Gaps = 8/112 (7%)

Query: 18  GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ 77
           G R LE   V   +  I  G+ +LH   ++ IV+ D+KP N+LLD+    ++SD GLA +
Sbjct: 88  GERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVE 144

Query: 78  SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
            +D K+        GT GY+APE+        S+  D ++ G  I EM  GR
Sbjct: 145 LKDGKTIT---QRAGTNGYMAPEILKEE--PYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 61.6 bits (150), Expect = 2e-11
 Identities = 32/93 (34%), Positives = 45/93 (48%), Gaps = 6/93 (6%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ-SQDKKSTISMLHARG 92
           IA G+ YL      R +H D+   NILL  D   KI DFGL +   Q++   +   H + 
Sbjct: 106 IANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV 162

Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
              + APE         SH SDV+ +G+ + EM
Sbjct: 163 PFAWCAPE--SLRTRTFSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 61.2 bits (149), Expect = 3e-11
 Identities = 38/128 (29%), Positives = 59/128 (46%), Gaps = 18/128 (14%)

Query: 2   PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL 61
           P G L ++   +     +   E       A  +A G+ YL    +   VH D+   N+LL
Sbjct: 78  PLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLE---SKHFVHRDLAARNVLL 128

Query: 62  DEDFCPKISDFGLAKQ----SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYS 117
                 KISDFG+++     S   ++T      R  + + APE  C ++G  S KSDV+S
Sbjct: 129 VNRHQAKISDFGMSRALGAGSDYYRATT---AGRWPLKWYAPE--CINYGKFSSKSDVWS 183

Query: 118 YGMMILEM 125
           YG+ + E 
Sbjct: 184 YGVTLWEA 191

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 61.6 bits (149), Expect = 3e-11
 Identities = 56/180 (31%), Positives = 91/180 (50%), Gaps = 28/180 (15%)

Query: 22  LEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ---S 78
           LE   +  I   I +GL+YLH   + R +H DIK  N+LL E    K++DFG+A Q   +
Sbjct: 98  LEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154

Query: 79  QDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASR 138
           Q K++T       GT  ++APEV  +S      K+D++S G+  +E+A G          
Sbjct: 155 QIKRNTFV-----GTPFWMAPEVIKQS--AYDFKADIWSLGITAIELAKGE-------PP 200

Query: 139 SSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
           +SD++ P  +   I   +   L+G  ++  KE V+        C+  +P  RP+  E+L+
Sbjct: 201 NSDLH-PMRVLFLIPKNSPPTLEGQYSKPFKEFVEA-------CLNKDPRFRPTAKELLK 252

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 61.9 bits (150), Expect = 3e-11
 Identities = 48/148 (32%), Positives = 77/148 (52%), Gaps = 14/148 (9%)

Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ--SQDKKSTISML 88
           +G I   LE+LH+   + IV+ DIK  NILLD +    ++DFGL+K+  S++K+ T S  
Sbjct: 111 SGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC 167

Query: 89  HARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSI 148
              GTI Y+APE+  R  GG     D +S G++I E+  G     ++  R++       I
Sbjct: 168 ---GTIEYMAPEII-RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI 223

Query: 149 YKHIEPGNDFQLDGVVTEEEKELVKKMI 176
            K   P         +  E ++L+ K++
Sbjct: 224 LKCDPP-----FPSFIGPEAQDLLHKLL 246

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 61.2 bits (148), Expect = 3e-11
 Identities = 41/125 (32%), Positives = 68/125 (54%), Gaps = 10/125 (8%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSL  F  D E     R L+   +  +A  +A G+ Y+ R   +  +H D++  NIL
Sbjct: 82  MSKGSLLDFLKDGEG----RALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANIL 134

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + +    KI+DFGLA+  +D + T +   A+  I + APE     +G  + KSDV+S+G+
Sbjct: 135 VGDGLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGI 191

Query: 121 MILEM 125
           ++ E+
Sbjct: 192 LLTEL 196

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 61.0 bits (148), Expect = 5e-11
 Identities = 44/108 (40%), Positives = 59/108 (54%), Gaps = 11/108 (10%)

Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK 82
           E R V+  A  I  GLE LHR    RIV+ D+KP NILLD+    +ISD GLA +  + +
Sbjct: 101 EERAVF-YAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156

Query: 83  STISMLHAR-GTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           +    +  R GT+GY+APEV        S   D +  G +I EM  G+
Sbjct: 157 T----IRGRVGTVGYMAPEVVKNERYTFS--PDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 60.9 bits (147), Expect = 5e-11
 Identities = 52/165 (31%), Positives = 83/165 (50%), Gaps = 22/165 (13%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I +GL+YLH   + + +H DIK  N+LL E    K++DFG+A Q  D  + I      GT
Sbjct: 110 ILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGT 164

Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIE 153
             ++APEV  +S      K+D++S G+  +E+A G           S+++ P  +   I 
Sbjct: 165 PFWMAPEVIKQS--AYDSKADIWSLGITAIELAKGE-------PPHSELH-PMKVLFLIP 214

Query: 154 PGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
             N   L+G  ++  KE V+        C+   PS RP+  E+L+
Sbjct: 215 KNNPPTLEGNYSKPLKEFVEA-------CLNKEPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 60.8 bits (148), Expect = 7e-11
 Identities = 37/104 (35%), Positives = 55/104 (52%), Gaps = 9/104 (8%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK-QSQDKKSTI 85
           +YQI     RGL+Y+H   NV  +H D+KP N+LL+ +   KI DFGLA+    +   T 
Sbjct: 112 LYQIL----RGLKYIH-SANV--LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTG 164

Query: 86  SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
            +     T  Y APE+   +  G +   D++S G ++ EM   R
Sbjct: 165 FLTEYVATRWYRAPEIML-NSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 60.5 bits (147), Expect = 7e-11
 Identities = 51/188 (27%), Positives = 93/188 (49%), Gaps = 33/188 (17%)

Query: 21  TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK--QS 78
           TL  + +   A  +ARG+E+L    + + +H D+   N+L+ ED   KI+DFGLA+    
Sbjct: 128 TLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHH 184

Query: 79  QD--KKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK 135
            D  +K+T    + R  + ++APE +F R +   +H+SDV+S+G+++ E+          
Sbjct: 185 IDYYRKTT----NGRLPVKWMAPEALFDRVY---THQSDVWSFGVLLWEI---------- 227

Query: 136 ASRSSDIYFPNSIYKHIEPGNDFQL--DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSM 193
                      S Y  I     F+L  +G   E+ +   +++  +   C    PS RP+ 
Sbjct: 228 ------FTLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTF 281

Query: 194 HEVLEMLE 201
            +++E L+
Sbjct: 282 KQLVEDLD 289

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 60.8 bits (148), Expect = 7e-11
 Identities = 37/104 (35%), Positives = 55/104 (52%), Gaps = 15/104 (14%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
           VYQI     RGL+Y+H   +  I+H D+KP NI ++ED   KI DFGLA+ + D+     
Sbjct: 124 VYQIL----RGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE----- 171

Query: 87  MLHARGTIGYIAPEV-FCRSFGGASHKSDVYSYGMMILEMAVGR 129
           M     T  Y APE+         +   D++S G ++ E+  G+
Sbjct: 172 MTGYVATRWYRAPEIMLNW--MHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 60.1 bits (145), Expect = 7e-11
 Identities = 42/130 (32%), Positives = 69/130 (53%), Gaps = 11/130 (8%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSL  F   +      + L    +  +A  IA G+ Y+ R   +  VH D++  NIL
Sbjct: 82  MSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANIL 134

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + E+   K++DFGLA+  +D + T +   A+  I + APE     +G  + KSDV+S+G+
Sbjct: 135 VGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGI 191

Query: 121 MILEMAV-GR 129
           ++ E+   GR
Sbjct: 192 LLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 60.2 bits (146), Expect = 9e-11
 Identities = 44/155 (28%), Positives = 69/155 (44%), Gaps = 32/155 (20%)

Query: 39  EYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIA 98
           EYLH   +  I++ D+KP N+LLD     K++DFG AK+  D+  T+      GT  Y+A
Sbjct: 132 EYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC-----GTPEYLA 183

Query: 99  PEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYF---PNSIYKHIEPG 155
           PEV      G     D ++ G+++ E   G              +F   P  IY+ I  G
Sbjct: 184 PEVIQSK--GHGKAVDWWTMGVLLYEFIAGYPP-----------FFDDTPFRIYEKILAG 230

Query: 156 NDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDR 190
              +         ++LVK +       +QT+ + R
Sbjct: 231 R-LKFPNWFDGRARDLVKGL-------LQTDHTKR 257

Length = 329

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 59.9 bits (145), Expect = 1e-10
 Identities = 40/98 (40%), Positives = 54/98 (55%), Gaps = 8/98 (8%)

Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I  GLE++H   N  +V+ D+KP NILLDE    +ISD GLA     KK   S+   
Sbjct: 103 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 156

Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT GY+APEV  +     S  +D +S G M+ ++  G
Sbjct: 157 -GTHGYMAPEVLQKGVAYDS-SADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 59.9 bits (146), Expect = 1e-10
 Identities = 31/98 (31%), Positives = 53/98 (54%), Gaps = 9/98 (9%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +  GL+YLH      I+H DIK  NIL++ D   K++DFGLA+    K+++    +   T
Sbjct: 109 LLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLAR-PYTKRNSADYTNRVIT 164

Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y  PE+      +G      D++S G ++ E+ +G+
Sbjct: 165 LWYRPPELLLGATRYGPE---VDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 59.5 bits (144), Expect = 1e-10
 Identities = 50/199 (25%), Positives = 90/199 (45%), Gaps = 32/199 (16%)

Query: 2   PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL 61
           P G+L ++   +     N  L+  T+      I   L ++H      I+H D+K  NILL
Sbjct: 82  PGGTLAEYIQKR----CNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILL 134

Query: 62  DE-DFCPKISDFGLAKQ--SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSY 118
           D+     KI DFG++K   S+ K  T+      GT  YI+PE+ C      + KSD+++ 
Sbjct: 135 DKHKMVVKIGDFGISKILSSKSKAYTVV-----GTPCYISPEL-CEG-KPYNQKSDIWAL 187

Query: 119 GMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILV 178
           G ++ E+A  ++  +           P  + K I  G    +    + + ++L+  M   
Sbjct: 188 GCVLYELASLKRAFEAAN-------LPALVLK-IMSGTFAPISDRYSPDLRQLILSM--- 236

Query: 179 SLWCIQTNPSDRPSMHEVL 197
               +  +PS RP + +++
Sbjct: 237 ----LNLDPSKRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 59.9 bits (145), Expect = 1e-10
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 33/206 (16%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSLD+              E   + +I   + +GL++L    N  I+H D+KP N+L
Sbjct: 81  MDAGSLDKLY--AGGVATEGIPE-DVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVL 135

Query: 61  LDEDFCPKISDFGLAKQ--SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASH------K 112
           ++ +   K+ DFG++    +   K+ I      G   Y+APE      GG +       +
Sbjct: 136 VNGNGQVKLCDFGVSGNLVASLAKTNI------GCQSYMAPERI--KSGGPNQNPTYTVQ 187

Query: 113 SDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELV 172
           SDV+S G+ ILEMA+GR          ++I+   +    I  G+   L    +++ ++ V
Sbjct: 188 SDVWSLGLSILEMALGR--YPYPPETYANIF---AQLSAIVDGDPPTLPSGYSDDAQDFV 242

Query: 173 KKMILVSLWCIQTNPSDRPSMHEVLE 198
            K       C+   P+ RP+  ++LE
Sbjct: 243 AK-------CLNKIPNRRPTYAQLLE 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 60.2 bits (146), Expect = 1e-10
 Identities = 43/125 (34%), Positives = 65/125 (52%), Gaps = 16/125 (12%)

Query: 12  DQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISD 71
           D  S  G    + + +  +A  I  G+ YLHR     IVH DIKP N+L++     KI+D
Sbjct: 155 DGGSLEGTHIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIAD 211

Query: 72  FGLAK---QSQDK-KSTISMLHARGTIGYIAPEVFCRSFG-GA--SHKSDVYSYGMMILE 124
           FG+++   Q+ D   S++      GTI Y++PE        GA   +  D++S G+ ILE
Sbjct: 212 FGVSRILAQTMDPCNSSV------GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265

Query: 125 MAVGR 129
             +GR
Sbjct: 266 FYLGR 270

Length = 353

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 59.6 bits (144), Expect = 1e-10
 Identities = 42/112 (37%), Positives = 55/112 (49%), Gaps = 8/112 (7%)

Query: 18  GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ 77
           GN   E       A  I  GLE LHR      V+ D+KP NILLD+    +ISD GLA +
Sbjct: 95  GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVK 151

Query: 78  SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             + +S    +   GT+GY+APEV        S   D +  G +I EM  G+
Sbjct: 152 IPEGESIRGRV---GTVGYMAPEVLNNQRYTLS--PDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 59.6 bits (144), Expect = 2e-10
 Identities = 49/166 (29%), Positives = 75/166 (45%), Gaps = 25/166 (15%)

Query: 38  LEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYI 97
           LE+LH+     IV+ D+KP NILLD      + DFGL+K +     T +     GT  Y+
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC--GTTEYL 163

Query: 98  APEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNS--IYKHIEPG 155
           APEV     G   H  D +S G+++ EM  G           S  Y  ++  +Y++I  G
Sbjct: 164 APEVLLDEKGYTKH-VDFWSLGVLVFEMCCGW----------SPFYAEDTQQMYRNIAFG 212

Query: 156 NDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE 201
                  V+++E ++ VK +       +  NP  R   H     L+
Sbjct: 213 KVRFPKNVLSDEGRQFVKGL-------LNRNPQHRLGAHRDAVELK 251

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 59.0 bits (143), Expect = 2e-10
 Identities = 39/125 (31%), Positives = 69/125 (55%), Gaps = 12/125 (9%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLH-RGCNVRIVHFDIKPHNI 59
           +P GSL   T+ ++  N    L  + + Q++   A G+EYL  + C    +H D+   N 
Sbjct: 74  VPGGSL--LTFLRKKKNR---LTVKKLLQMSLDAAAGMEYLESKNC----IHRDLAARNC 124

Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L+ E+   KISDFG++++ +    T+S    +  I + APE    ++G  + +SDV+SYG
Sbjct: 125 LVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEAL--NYGRYTSESDVWSYG 182

Query: 120 MMILE 124
           +++ E
Sbjct: 183 ILLWE 187

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 59.5 bits (144), Expect = 2e-10
 Identities = 49/173 (28%), Positives = 86/173 (49%), Gaps = 30/173 (17%)

Query: 34  IARGLEYL-HRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           +ARG+E+L  R C    +H D+   NILL E+   KI DFGLA+        +    AR 
Sbjct: 182 VARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237

Query: 93  TIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEM-AVGRKNADVKASRSSDIYFPNSIYK 150
            + ++APE +F + +   + +SDV+S+G+++ E+ ++G                  S Y 
Sbjct: 238 PLKWMAPESIFDKVY---TTQSDVWSFGVLLWEIFSLG-----------------ASPYP 277

Query: 151 HIEPGNDF--QL-DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML 200
            ++   +F  +L +G      +    ++  + L C   NP DRP+  E++E+L
Sbjct: 278 GVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 59.3 bits (144), Expect = 2e-10
 Identities = 29/96 (30%), Positives = 46/96 (47%), Gaps = 6/96 (6%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H      I+H D+KP N+L++ +   K++DFGLA+            H   T
Sbjct: 107 LLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP--YTHYVVT 161

Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+      G S   D++S G +  E+   R
Sbjct: 162 RWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 59.0 bits (143), Expect = 2e-10
 Identities = 43/132 (32%), Positives = 61/132 (46%), Gaps = 25/132 (18%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSL  F    E     + L   ++  +A  +A G+ YL        +H D+   NIL
Sbjct: 84  MEKGSLLAFLRSPEG----QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNIL 136

Query: 61  LDEDFCPKISDFGLAK-------QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKS 113
           + ED   K++DFGLA+        S DKK             + APE    S G  S KS
Sbjct: 137 VGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK---------WTAPEAA--SHGTFSTKS 185

Query: 114 DVYSYGMMILEM 125
           DV+S+G+++ EM
Sbjct: 186 DVWSFGILLYEM 197

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 59.1 bits (143), Expect = 2e-10
 Identities = 46/136 (33%), Positives = 71/136 (52%), Gaps = 20/136 (14%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAG---GIARGLEYLHRGCNVRIVHFDIKPH 57
           M NGSLD F    +           TV Q+ G   GIA G++YL    ++  VH D+   
Sbjct: 87  MENGSLDAFLRKHDGQ--------FTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAAR 135

Query: 58  NILLDEDFCPKISDFGLAKQSQDK-KSTISMLHARGTIGYIAPEVFC-RSFGGASHKSDV 115
           NIL++ +   K+SDFGL++  +D  ++  +    +  I + APE    R F  A   SDV
Sbjct: 136 NILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSA---SDV 192

Query: 116 YSYGMMILE-MAVGRK 130
           +SYG+++ E M+ G +
Sbjct: 193 WSYGIVMWEVMSYGER 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 58.7 bits (142), Expect = 2e-10
 Identities = 48/199 (24%), Positives = 77/199 (38%), Gaps = 32/199 (16%)

Query: 2   PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL 61
            NG L +    Q          WR   QI      GL +LH     +I+H DIK  N+ L
Sbjct: 82  ENGDLHKLLKMQRGRPLPEDQVWRFFIQIL----LGLAHLHSK---KILHRDIKSLNLFL 134

Query: 62  DEDFCPKISDFGLAKQSQDKKSTISMLHAR---GTIGYIAPEVFCRSFGGASHKSDVYSY 118
           D     KI D G+AK   D     +   A    GT  Y++PE+ C      + KSDV++ 
Sbjct: 135 DAYDNVKIGDLGVAKLLSD-----NTNFANTIVGTPYYLSPEL-CED-KPYNEKSDVWAL 187

Query: 119 GMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILV 178
           G+++ E   G+   D     +  +     ++  +      QL  ++ +            
Sbjct: 188 GVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQ------------ 235

Query: 179 SLWCIQTNPSDRPSMHEVL 197
              C+  +   RP   ++L
Sbjct: 236 ---CLTKDYRQRPDTFQLL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 59.3 bits (144), Expect = 2e-10
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 15/103 (14%)

Query: 31  AGGIARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS---QDKKSTIS 86
           A  I  GL++LH RG    I++ D+K  N+LLD +   KI+DFG+ K+        ST  
Sbjct: 102 AAEIVLGLQFLHERG----IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC 157

Query: 87  MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
                GT  YIAPE+   S+       D ++ G+++ EM  G+
Sbjct: 158 -----GTPDYIAPEIL--SYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 59.1 bits (143), Expect = 2e-10
 Identities = 38/96 (39%), Positives = 53/96 (55%), Gaps = 13/96 (13%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ---SQDKKSTISMLHARG 92
           + LE+LH     +++H DIK  NILL  D   K++DFG   Q    Q K+ST+      G
Sbjct: 126 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----G 177

Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T  ++APEV  R   G   K D++S G+M +EM  G
Sbjct: 178 TPYWMAPEVVTRKAYGP--KVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 58.6 bits (142), Expect = 2e-10
 Identities = 38/112 (33%), Positives = 54/112 (48%), Gaps = 15/112 (13%)

Query: 18  GNRTLEWRTVYQIAGGIARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK 76
           G    +W    Q    +  G+E LH RG    I+H DIKP N+L+D+    K++DFGL++
Sbjct: 92  GGLPEDW--AKQYIAEVVLGVEDLHQRG----IIHRDIKPENLLIDQTGHLKLTDFGLSR 145

Query: 77  QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
              + K  +      GT  Y+APE       G    SD +S G +I E   G
Sbjct: 146 NGLENKKFV------GTPDYLAPETILGV--GDDKMSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 58.8 bits (142), Expect = 3e-10
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 11/101 (10%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ-----SQDKKSTISML 88
           I  G+ YLH  C   +VH DIK +N++L  +   K+ DFG A++          S + + 
Sbjct: 111 ILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNM-LK 166

Query: 89  HARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
              GT  ++APEV   S  G   KSD++S G  + EMA G+
Sbjct: 167 SMHGTPYWMAPEVINES--GYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 58.8 bits (142), Expect = 3e-10
 Identities = 38/104 (36%), Positives = 63/104 (60%), Gaps = 19/104 (18%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD----KK 82
            YQ+A    RG+EYL    + R +H D+   N+L+ ED   KI+DFGLA+   D    KK
Sbjct: 140 AYQVA----RGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192

Query: 83  STISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEM 125
           ++    + R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 193 TS----NGRLPVKWMAPEALFDRVY---THQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 58.5 bits (141), Expect = 3e-10
 Identities = 40/107 (37%), Positives = 58/107 (54%), Gaps = 9/107 (8%)

Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK 82
           E R V+  A  I  GLE LH+    RIV+ D+KP NILLD+    +ISD GLA    + +
Sbjct: 101 EGRAVF-YAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156

Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           +    +   GT+GY+APEV        +   D ++ G ++ EM  G+
Sbjct: 157 TIKGRV---GTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 58.4 bits (141), Expect = 4e-10
 Identities = 47/190 (24%), Positives = 83/190 (43%), Gaps = 31/190 (16%)

Query: 18  GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ 77
             R L    +   A  I+RG++YL     +++VH D+   N+L+ E    KISDFGL++ 
Sbjct: 120 DERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176

Query: 78  SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASH----KSDVYSYGMMILEMAVGRKNAD 133
             ++ S +     R  + ++A E          H    +SDV+S+G+++ E+        
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESL------FDHIYTTQSDVWSFGVLLWEI-------- 222

Query: 134 VKASRSSDIYFPNSIYKHIEPGNDFQL--DGVVTEEEKELVKKMILVSLWCIQTNPSDRP 191
                   +    + Y  I P   F L   G   E  +   ++M  + L C +  P  RP
Sbjct: 223 --------VTLGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRP 274

Query: 192 SMHEVLEMLE 201
           +  ++ + LE
Sbjct: 275 TFADISKELE 284

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 58.3 bits (142), Expect = 4e-10
 Identities = 47/230 (20%), Positives = 82/230 (35%), Gaps = 65/230 (28%)

Query: 6   LDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHR-GCNVRIVHFDIKPHNILLDED 64
           ++   Y        +      +  I   I +GL ++H+ G      H D+KP N+L+   
Sbjct: 80  MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG----FFHRDLKPENLLVSGP 135

Query: 65  FCPKISDFGLAKQSQDKK---STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMM 121
              KI+DFGLA++ + +      +S      T  Y APE+  RS    S   D+++ G +
Sbjct: 136 EVVKIADFGLAREIRSRPPYTDYVS------TRWYRAPEILLRS-TSYSSPVDIWALGCI 188

Query: 122 ILEMAVGRKNADVKASRSSDIYFPNS-----IYKHIE----PGNDFQLDGVVTEEEKELV 172
           + E+   R              FP S     +YK       P      +G       +L 
Sbjct: 189 MAELYTLRP------------LFPGSSEIDQLYKICSVLGTPTKQDWPEG------YKLA 230

Query: 173 KKM-----------------------ILVSLWCIQTNPSDRPSMHEVLEM 199
            K+                       I +    ++ +P  RP+  + L+ 
Sbjct: 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 57.7 bits (139), Expect = 5e-10
 Identities = 49/200 (24%), Positives = 84/200 (42%), Gaps = 25/200 (12%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M +G L  +   Q       TL       +   +  G+ YL       ++H D+   N L
Sbjct: 81  MEHGCLSDYLRAQRGKFSQETL-----LGMCLDVCEGMAYLESSN---VIHRDLAARNCL 132

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + E+   K+SDFG+ +   D + T S    +  + + +PEVF  SF   S KSDV+S+G+
Sbjct: 133 VGENQVVKVSDFGMTRFVLDDQYT-SSTGTKFPVKWSSPEVF--SFSKYSSKSDVWSFGV 189

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSL 180
           ++ E+    K      S S  +   N+ ++  +P              +   + +  +  
Sbjct: 190 LMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP--------------RLASQSVYELMQ 235

Query: 181 WCIQTNPSDRPSMHEVLEML 200
            C +  P DRPS   +L  L
Sbjct: 236 HCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 57.7 bits (139), Expect = 5e-10
 Identities = 51/206 (24%), Positives = 93/206 (45%), Gaps = 34/206 (16%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSL  F    +S  G++      +   +  IA G+ ++ +      +H D++  NIL
Sbjct: 82  MAKGSLLDFL---KSDEGSK-QPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANIL 134

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           +      KI+DFGLA+  +D + T +   A+  I + APE    +FG  + KSDV+S+G+
Sbjct: 135 VSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAI--NFGSFTIKSDVWSFGI 191

Query: 121 MILEM-AVGRKNADVKASRSSDIYFPN----SIYKHIEPGNDFQLDGVVTEEEKELVKKM 175
           +++E+   GR            I +P      + + +E G          EE       +
Sbjct: 192 LLMEIVTYGR------------IPYPGMSNPEVIRALERGYRMPRPENCPEE-------L 232

Query: 176 ILVSLWCIQTNPSDRPSMHEVLEMLE 201
             + + C +  P +RP+   +  +L+
Sbjct: 233 YNIMMRCWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 57.7 bits (139), Expect = 5e-10
 Identities = 48/164 (29%), Positives = 76/164 (46%), Gaps = 22/164 (13%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           IA  L+YLH      I+H D+K  N+ L      K+ D G+A+  +++    S L   GT
Sbjct: 111 IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTL--IGT 165

Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIE 153
             Y++PE+F  S    ++KSDV++ G  + EMA  +      A  + D+   NS+   I 
Sbjct: 166 PYYMSPELF--SNKPYNYKSDVWALGCCVYEMATLK-----HAFNAKDM---NSLVYRII 215

Query: 154 PGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVL 197
            G    +    + E  EL+  M       +   P  RPS+  +L
Sbjct: 216 EGKLPPMPKDYSPELGELIATM-------LSKRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 57.8 bits (139), Expect = 6e-10
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 26/202 (12%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSL  F  + +     + L+   +  +A  IA G+ Y+ R   +  +H D++  NIL
Sbjct: 82  MGKGSLLDFLKEGDG----KYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANIL 134

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + ++   KI+DFGLA+  +D + T +   A+  I + APE     +G  + KSDV+S+G+
Sbjct: 135 VGDNLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGI 191

Query: 121 MILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVS 179
           ++ E+   GR       +R         + + +E G          E   EL+K      
Sbjct: 192 LLTELVTKGRVPYPGMVNR--------EVLEQVERGYRMPCPQGCPESLHELMKL----- 238

Query: 180 LWCIQTNPSDRPSMHEVLEMLE 201
             C + +P +RP+   +   LE
Sbjct: 239 --CWKKDPDERPTFEYIQSFLE 258

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 57.9 bits (140), Expect = 6e-10
 Identities = 37/96 (38%), Positives = 55/96 (57%), Gaps = 9/96 (9%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHAR-G 92
           I+  LE+LH+     I++ D+KP NILLD     K++DFGL K+S  +    ++ H   G
Sbjct: 109 ISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG---TVTHTFCG 162

Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           TI Y+APE+  RS  G     D +S G ++ +M  G
Sbjct: 163 TIEYMAPEILMRS--GHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 57.8 bits (140), Expect = 6e-10
 Identities = 34/94 (36%), Positives = 52/94 (55%), Gaps = 9/94 (9%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ-SQDKKSTISMLHARGTI 94
           + L +LH      ++H DIK  +ILL  D   K+SDFG   Q S++     S++   GT 
Sbjct: 126 KALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV---GTP 179

Query: 95  GYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            ++APEV  R   G   + D++S G+M++EM  G
Sbjct: 180 YWMAPEVISRLPYGT--EVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 57.9 bits (141), Expect = 7e-10
 Identities = 35/110 (31%), Positives = 52/110 (47%), Gaps = 21/110 (19%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
           +YQI     RGL+YLH   N  ++H D+KP NIL++ +   KI DFGLA+     +    
Sbjct: 109 LYQIL----RGLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG 161

Query: 87  MLHARGTIG-----YIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
            L    T       Y APE+      +  A    D++S G +  E+   +
Sbjct: 162 FL----TEYVVTRWYRAPELLLSSSRYTKA---IDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 57.7 bits (139), Expect = 7e-10
 Identities = 41/100 (41%), Positives = 56/100 (56%), Gaps = 12/100 (12%)

Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I  GLE++H   N  +V+ D+KP NILLDE    +ISD GLA     KK   S+   
Sbjct: 103 ATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 156

Query: 91  RGTIGYIAPEVFCRSFGGASHKS--DVYSYGMMILEMAVG 128
            GT GY+APEV  +   G ++ S  D +S G M+ ++  G
Sbjct: 157 -GTHGYMAPEVLQK---GTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 57.5 bits (139), Expect = 7e-10
 Identities = 38/107 (35%), Positives = 56/107 (52%), Gaps = 8/107 (7%)

Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK 82
           E R  +  A  I  GLE+LH+    RI++ D+KP N+LLD D   +ISD GLA + +D +
Sbjct: 96  EPRACFYTAQ-IISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ 151

Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           S        GT G++APE+            D ++ G+ + EM   R
Sbjct: 152 SKTKGY--AGTPGFMAPELLQGE--EYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 57.3 bits (139), Expect = 9e-10
 Identities = 37/106 (34%), Positives = 60/106 (56%), Gaps = 12/106 (11%)

Query: 22  LEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDK 81
           L   T+  +   + RG+++LH   + RIVH D+KP NIL+  D   KI+DFGLA+    +
Sbjct: 104 LPPETIKDLMRQLLRGVDFLH--SH-RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160

Query: 82  KSTISMLHARGTIGYIAPEVFCRSFGGASHKS--DVYSYGMMILEM 125
            +  S++    T+ Y APEV  +S    S+ +  D++S G +  E+
Sbjct: 161 MALTSVV---VTLWYRAPEVLLQS----SYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 57.1 bits (138), Expect = 1e-09
 Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 8/99 (8%)

Query: 32  GGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ--SQDKKSTISMLH 89
             I   L++LH+   + I++ DIK  NILLD +    ++DFGL+K+  +++++   S   
Sbjct: 112 AEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC- 167

Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
             GTI Y+APEV     GG     D +S G++  E+  G
Sbjct: 168 --GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 56.9 bits (137), Expect = 1e-09
 Identities = 40/107 (37%), Positives = 57/107 (53%), Gaps = 9/107 (8%)

Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK 82
           E R ++  A  +  GLE L R    RIV+ D+KP NILLD+    +ISD GLA Q  + +
Sbjct: 101 EQRAIF-YAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156

Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           +    +   GT+GY+APEV        +   D +  G +I EM  G+
Sbjct: 157 TVRGRV---GTVGYMAPEVINNE--KYTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 56.7 bits (137), Expect = 1e-09
 Identities = 42/103 (40%), Positives = 63/103 (61%), Gaps = 12/103 (11%)

Query: 29  QIAGGIARGLEYLHRGCNV-RIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISM 87
           +IA  +  GL YL+   NV RI+H DIKP NIL++     K+ DFG+   S +  ++I+ 
Sbjct: 107 KIAVAVVEGLTYLY---NVHRIMHRDIKPSNILVNSRGQIKLCDFGV---SGELINSIAD 160

Query: 88  LHARGTIGYIAPEVFCRSFGGA-SHKSDVYSYGMMILEMAVGR 129
               GT  Y++PE   R  GG  + KSDV+S G+ I+E+A+G+
Sbjct: 161 TFV-GTSTYMSPE---RIQGGKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 56.7 bits (137), Expect = 1e-09
 Identities = 50/209 (23%), Positives = 94/209 (44%), Gaps = 29/209 (13%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M +G L  F            L  +T+ +    IA G+EYL    N   +H D+   N +
Sbjct: 89  MKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL---SNRNFIHRDLAARNCM 145

Query: 61  LDEDFCPKISDFGLAKQ--SQD--KKSTISMLHARG-TIGYIAPEVFCRSFGGASHKSDV 115
           L ED    ++DFGL+K+  S D  ++  I+ +  +   I  +A  V+       + KSDV
Sbjct: 146 LREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-------TSKSDV 198

Query: 116 YSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKM 175
           +++G+ + E+A  R         + +IY             D+   G   ++ ++ + ++
Sbjct: 199 WAFGVTMWEIAT-RGQTPYPGVENHEIY-------------DYLRHGNRLKQPEDCLDEL 244

Query: 176 ILVSLWCIQTNPSDRPSMHEVLEMLESST 204
             +   C + +P DRP+  ++ E+LE+  
Sbjct: 245 YDLMYSCWRADPKDRPTFTKLREVLENIL 273

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 56.9 bits (137), Expect = 1e-09
 Identities = 48/197 (24%), Positives = 92/197 (46%), Gaps = 26/197 (13%)

Query: 8   QFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP 67
           ++ Y+  +      L ++ +   A  +ARG+EYL    + + +H D+   N+L+ ED   
Sbjct: 124 EYCYN-PTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVM 179

Query: 68  KISDFGLAKQSQDKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEMA 126
           KI+DFGLA+            + R  + ++APE +F R +   +H+SDV+S+G+++ E+ 
Sbjct: 180 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEIF 236

Query: 127 V--GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQ 184
              G     V             ++K ++ G+        T E   +++        C  
Sbjct: 237 TLGGSPYPGVPVEE---------LFKLLKEGHRMDKPSNCTNELYMMMRD-------CWH 280

Query: 185 TNPSDRPSMHEVLEMLE 201
             PS RP+  +++E L+
Sbjct: 281 AVPSQRPTFKQLVEDLD 297

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 56.9 bits (137), Expect = 1e-09
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 22/169 (13%)

Query: 34  IARGLEYL-HRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           +ARG+E+L  R C    +H D+   NILL E+   KI DFGLA+        +    AR 
Sbjct: 183 VARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 93  TIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKH 151
            + ++APE +F + +   + +SDV+S+G+++ E+        + AS    +       + 
Sbjct: 239 PLKWMAPESIFDKVY---TTQSDVWSFGVLLWEI------FSLGASPYPGVQINEEFCQR 289

Query: 152 IEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML 200
           ++ G   +     T E   ++       L C Q +P +RP+   ++E+L
Sbjct: 290 LKDGTRMRAPENATPEIYRIM-------LACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 56.6 bits (136), Expect = 1e-09
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 31/209 (14%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M +G L  F       +  + L  + + +    IA G+EYL    +   +H D+   N +
Sbjct: 88  MKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCM 144

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFC-RSFGGASHKSDVYSYG 119
           L+E+    ++DFGL+K+  +         A+  + +IA E    R +   + KSDV+S+G
Sbjct: 145 LNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVY---TTKSDVWSFG 201

Query: 120 MMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ-----LDGVVTEEEKELVKK 174
           + + E+A  R         +S+      IY ++  GN  +     LDG+ +         
Sbjct: 202 VTMWEIAT-RGQTPYPGVENSE------IYDYLRQGNRLKQPPDCLDGLYS--------- 245

Query: 175 MILVSLWCIQTNPSDRPSMHEVLEMLESS 203
            ++ S W    NP DRPS   +   LE +
Sbjct: 246 -LMSSCW--LLNPKDRPSFETLRCELEKA 271

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 56.6 bits (136), Expect = 1e-09
 Identities = 56/201 (27%), Positives = 89/201 (44%), Gaps = 30/201 (14%)

Query: 1   MPNGSLDQFTYDQESSNGNR-TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP G L  +  + +   G++  L W         IA+G+ YL     VR+VH D+   N+
Sbjct: 90  MPYGCLLDYVRENKDRIGSQDLLNWCV------QIAKGMSYLE---EVRLVHRDLAARNV 140

Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSY 118
           L+      KI+DFGLA+     ++       +  I ++A E +  R F   +H+SDV+SY
Sbjct: 141 LVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF---THQSDVWSY 197

Query: 119 GMMILE-MAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMIL 177
           G+ + E M  G K  D   +R         I   +E G       + T +       MI+
Sbjct: 198 GVTVWELMTFGAKPYDGIPAR--------EIPDLLEKGERLPQPPICTID-----VYMIM 244

Query: 178 VSLWCIQTNPSDRPSMHEVLE 198
           V  W I  +   RP   E+++
Sbjct: 245 VKCWMI--DSECRPRFRELVD 263

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 56.7 bits (137), Expect = 1e-09
 Identities = 42/127 (33%), Positives = 61/127 (48%), Gaps = 13/127 (10%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +P GSL  +            L+ R +   A  I +G+EYL    + R VH D+   NIL
Sbjct: 89  LPYGSLRDYL-----QKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNIL 140

Query: 61  LDEDFCPKISDFGLAK-QSQDKKSTISMLHARGTIGYIAPEVFCRS-FGGASHKSDVYSY 118
           ++ +   KI DFGL K   QDK+           I + APE    S F   S  SDV+S+
Sbjct: 141 VESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKF---SVASDVWSF 197

Query: 119 GMMILEM 125
           G+++ E+
Sbjct: 198 GVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 56.5 bits (136), Expect = 2e-09
 Identities = 44/128 (34%), Positives = 63/128 (49%), Gaps = 16/128 (12%)

Query: 1   MPNGSL-DQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
            P GSL D     ++S +  R L W         IA+G+ YL       +VH ++   NI
Sbjct: 90  SPLGSLLDHVRQHRDSLDPQRLLNWCV------QIAKGMYYLEEHR---MVHRNLAARNI 140

Query: 60  LLDEDFCPKISDFGLAK--QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYS 117
           LL  D   +I+DFG+A      DKK   S    +  I ++A E     FG  +H+SDV+S
Sbjct: 141 LLKSDSIVQIADFGVADLLYPDDKKYFYS--EHKTPIKWMALESI--LFGRYTHQSDVWS 196

Query: 118 YGMMILEM 125
           YG+ + EM
Sbjct: 197 YGVTVWEM 204

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 56.8 bits (137), Expect = 2e-09
 Identities = 39/110 (35%), Positives = 59/110 (53%), Gaps = 9/110 (8%)

Query: 20  RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ 79
           R LE + +      I RGL+Y+H   +  +VH D+KP NIL++E+   KI DFGLA+  Q
Sbjct: 103 RPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR-IQ 158

Query: 80  DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           D +    M     T  Y APE+   ++     + D++S G +  EM  G+
Sbjct: 159 DPQ----MTGYVSTRYYRAPEIML-TWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 56.4 bits (136), Expect = 2e-09
 Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 48/209 (22%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSLD +          R +    + +IA  + +GL YL    +++I+H D+KP N+L
Sbjct: 81  MDGGSLDVY----------RKIPEHVLGRIAVAVVKGLTYL---WSLKILHRDVKPSNML 127

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGA-SHKSDVYSYG 119
           ++     K+ DFG++ Q  +  +   +    GT  Y+APE   R  G      SDV+S G
Sbjct: 128 VNTRGQVKLCDFGVSTQLVNSIAKTYV----GTNAYMAPE---RISGEQYGIHSDVWSLG 180

Query: 120 MMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDF----QLDGVVTEEEK------ 169
           +  +E+A+GR              FP   Y  I+         QL   + +E+       
Sbjct: 181 ISFMELALGR--------------FP---YPQIQKNQGSLMPLQLLQCIVDEDPPVLPVG 223

Query: 170 ELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
           +  +K +     C++  P +RP+   +++
Sbjct: 224 QFSEKFVHFITQCMRKQPKERPAPENLMD 252

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 56.5 bits (136), Expect = 2e-09
 Identities = 36/98 (36%), Positives = 52/98 (53%), Gaps = 10/98 (10%)

Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYL    ++ IV+ D+KP N+LLD+D   K++DFG AK    +  T+     
Sbjct: 137 AAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC---- 189

Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  YIAPE+      G    +D ++ G+ I E+ VG
Sbjct: 190 -GTPEYIAPEILLNV--GHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 56.6 bits (136), Expect = 2e-09
 Identities = 48/169 (28%), Positives = 79/169 (46%), Gaps = 22/169 (13%)

Query: 34  IARGLEYL-HRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           +A+G+E+L  R C    +H D+   NILL E+   KI DFGLA+        +    AR 
Sbjct: 188 VAKGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243

Query: 93  TIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKH 151
            + ++APE +F R +   + +SDV+S+G+++ E+        + AS    +       + 
Sbjct: 244 PLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI------FSLGASPYPGVKIDEEFCRR 294

Query: 152 IEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML 200
           ++ G   +     T E       M    L C    PS RP+  E++E L
Sbjct: 295 LKEGTRMRAPDYTTPE-------MYQTMLDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 56.3 bits (136), Expect = 2e-09
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 14/99 (14%)

Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLA---KQSQDKKSTISMLHARGT 93
            L +LH     +++H D+K  NILL  D   K++DFG++   K +  K+ T       GT
Sbjct: 115 ALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-----GT 166

Query: 94  IGYIAPEVF-CRSFGGA--SHKSDVYSYGMMILEMAVGR 129
             ++APEV  C +F      +K+D++S G+ ++E+A   
Sbjct: 167 PYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 56.5 bits (136), Expect = 2e-09
 Identities = 69/251 (27%), Positives = 104/251 (41%), Gaps = 45/251 (17%)

Query: 1   MPNGSL-DQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP G L D     +++      L W         IA+G+ YL      R+VH D+   N+
Sbjct: 90  MPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLE---ERRLVHRDLAARNV 140

Query: 60  LLDEDFCPKISDFGLAK-QSQDKKSTISMLHARG---TIGYIAPE-VFCRSFGGASHKSD 114
           L+      KI+DFGLAK    D+K      HA G    I ++A E +  R +   +H+SD
Sbjct: 141 LVKTPQHVKITDFGLAKLLGADEKE----YHAEGGKVPIKWMALESILHRIY---THQSD 193

Query: 115 VYSYGMMILE-MAVGRKNAD-VKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELV 172
           V+SYG+ + E M  G K  D + AS  S I         +E G       + T +     
Sbjct: 194 VWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPICTID----- 239

Query: 173 KKMILVSLWCIQTNPSDRPSMHEVL----EMLESSTEILQIPPKPSLALPKKSAIQSSRT 228
             MI+V  W I  +   RP   E++    +M       L I     + LP  +     R 
Sbjct: 240 VYMIMVKCWMI--DADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRA 297

Query: 229 S-SSAGIEEVM 238
                 +++V+
Sbjct: 298 LMDEEDMDDVV 308

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 55.8 bits (134), Expect = 2e-09
 Identities = 30/103 (29%), Positives = 55/103 (53%), Gaps = 5/103 (4%)

Query: 22  LEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDK 81
           L+ + + Q+    A G+EYL        +H D+   N L+ E    KISDFG++++ +D 
Sbjct: 91  LKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDG 147

Query: 82  KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILE 124
               +    +  + + APE    ++G  S +SDV+S+G+++ E
Sbjct: 148 VYASTGGMKQIPVKWTAPEAL--NYGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 55.9 bits (135), Expect = 2e-09
 Identities = 42/131 (32%), Positives = 69/131 (52%), Gaps = 20/131 (15%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAG---GIARGLEYLHRGCNVRIVHFDIKPH 57
           M +G L  F    E+ N        TV  + G    +A+G+EYL    + + VH D+   
Sbjct: 79  MKHGDLRNFIRS-ETHN-------PTVKDLIGFGLQVAKGMEYL---ASKKFVHRDLAAR 127

Query: 58  NILLDEDFCPKISDFGLAKQSQDKK--STISMLHARGTIGYIAPEVF-CRSFGGASHKSD 114
           N +LDE F  K++DFGLA+   DK+  S  +   A+  + ++A E    + F   + KSD
Sbjct: 128 NCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKF---TTKSD 184

Query: 115 VYSYGMMILEM 125
           V+S+G+++ E+
Sbjct: 185 VWSFGVLLWEL 195

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 55.9 bits (135), Expect = 2e-09
 Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 32/168 (19%)

Query: 38  LEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLA---KQSQDKKSTISMLHARGTI 94
           L+Y+H+   V ++H DIK  NIL+      K+ DFG+A    Q+  K+ST       GT 
Sbjct: 114 LKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-----GTP 165

Query: 95  GYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVGR-KNADVKASRSSDIYFPNSIYKH 151
            ++APEV      G  +  K+D++S G+ I EMA G    +DV A R+  +  P S    
Sbjct: 166 YWMAPEVI---TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML-IPKSKPPR 221

Query: 152 IEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM 199
           +   N +      ++  +E V         C+   P +R S  E+L+ 
Sbjct: 222 L-EDNGY------SKLLREFVA-------ACLDEEPKERLSAEELLKS 255

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 55.9 bits (135), Expect = 3e-09
 Identities = 36/101 (35%), Positives = 58/101 (57%), Gaps = 11/101 (10%)

Query: 31  AGGIARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ-DKKSTISML 88
           A  IA GL +LH +G    I++ D+K  N++LD +   KI+DFG+ K++    K+T +  
Sbjct: 107 AAEIAIGLFFLHSKG----IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC 162

Query: 89  HARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
              GT  YIAPE+      G S   D +++G+++ EM  G+
Sbjct: 163 ---GTPDYIAPEIIAYQPYGKS--VDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 55.7 bits (134), Expect = 3e-09
 Identities = 38/104 (36%), Positives = 57/104 (54%), Gaps = 17/104 (16%)

Query: 31  AGGIARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS---QDKKSTIS 86
           A  I  GL++LH +G    IV+ D+K  NILLD D   KI+DFG+ K++     K  T  
Sbjct: 102 AAEIICGLQFLHSKG----IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC 157

Query: 87  MLHARGTIGYIAPEVFC-RSFGGASHKSDVYSYGMMILEMAVGR 129
                GT  YIAPE+   + +       D +S+G+++ EM +G+
Sbjct: 158 -----GTPDYIAPEILLGQKYN---TSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 55.8 bits (135), Expect = 3e-09
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 15/106 (14%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
           +YQ+     RGL+Y+H   +  ++H D+KP N+LL+ +   KI DFGLA+ + +K     
Sbjct: 114 LYQLL----RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDF-- 164

Query: 87  MLHARGTIGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGRK 130
           M     T  Y APE+   C  +  A    DV+S G +  E+ +GRK
Sbjct: 165 MTEYVVTRWYRAPELLLNCSEYTTA---IDVWSVGCIFAEL-LGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 55.4 bits (133), Expect = 4e-09
 Identities = 31/93 (33%), Positives = 57/93 (61%), Gaps = 7/93 (7%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +ARG+EYL    + + +H D+   N+L+ E+   KI+DFGLA+   +        + R  
Sbjct: 146 VARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLP 202

Query: 94  IGYIAPE-VFCRSFGGASHKSDVYSYGMMILEM 125
           + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 203 VKWMAPEALFDRVY---THQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 55.5 bits (134), Expect = 5e-09
 Identities = 39/106 (36%), Positives = 57/106 (53%), Gaps = 11/106 (10%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK--QSQDKKST 84
           +YQI      GL+Y+H   NV  +H D+KP N+L++ D   KI DFGLA+       ++ 
Sbjct: 111 IYQIL----CGLKYIHSA-NV--LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENA 163

Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRK 130
             M     T  Y APE+   SF   +   DV+S G ++ E+ +GRK
Sbjct: 164 GFMTEYVATRWYRAPEIML-SFQSYTKAIDVWSVGCILAEL-LGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 55.5 bits (133), Expect = 5e-09
 Identities = 43/140 (30%), Positives = 71/140 (50%), Gaps = 13/140 (9%)

Query: 1   MPNGSLDQFTYDQESSNGNRTL-EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP+G L  + ++ + + G++ L  W         IA+G+ YL      R+VH D+   N+
Sbjct: 90  MPHGCLLDYVHEHKDNIGSQLLLNWCV------QIAKGMMYLEER---RLVHRDLAARNV 140

Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L+      KI+DFGLA+  +  +   +    +  I ++A E  C  +   +H+SDV+SYG
Sbjct: 141 LVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE--CIHYRKFTHQSDVWSYG 198

Query: 120 MMILE-MAVGRKNADVKASR 138
           + I E M  G K  D   +R
Sbjct: 199 VTIWELMTFGGKPYDGIPTR 218

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 55.1 bits (132), Expect = 5e-09
 Identities = 37/96 (38%), Positives = 53/96 (55%), Gaps = 13/96 (13%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ---SQDKKSTISMLHARG 92
           + L++LH     +++H DIK  NILL  D   K++DFG   Q    Q K+ST+      G
Sbjct: 126 QALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----G 177

Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T  ++APEV  R   G   K D++S G+M +EM  G
Sbjct: 178 TPYWMAPEVVTRKAYGP--KVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 55.2 bits (133), Expect = 5e-09
 Identities = 30/71 (42%), Positives = 40/71 (56%), Gaps = 5/71 (7%)

Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  IA  L YLH   ++ I++ D+KP NILLD      ++DFGL K+  +   T S    
Sbjct: 102 AAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC- 157

Query: 91  RGTIGYIAPEV 101
            GT  Y+APEV
Sbjct: 158 -GTPEYLAPEV 167

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 55.2 bits (133), Expect = 5e-09
 Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 9/97 (9%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I   L YLH      +V+ D+K  N++LD+D   KI+DFGL K+     +T+      GT
Sbjct: 104 IVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC--GT 158

Query: 94  IGYIAPEVFCRS-FGGASHKSDVYSYGMMILEMAVGR 129
             Y+APEV   + +G A    D +  G+++ EM  GR
Sbjct: 159 PEYLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 55.1 bits (133), Expect = 5e-09
 Identities = 38/96 (39%), Positives = 53/96 (55%), Gaps = 15/96 (15%)

Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ---DKKSTISMLHARGT 93
           GL+YLH     +IV+ D+K  N+LLD +   KI+DFGL K+     D+ ST       GT
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC-----GT 164

Query: 94  IGYIAPEVFC-RSFGGASHKSDVYSYGMMILEMAVG 128
             ++APEV    S+  A    D +  G++I EM VG
Sbjct: 165 PEFLAPEVLTETSYTRA---VDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 54.6 bits (131), Expect = 6e-09
 Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 48/211 (22%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSL     D   S G   L    + + +  +   +EYL        VH D+   N+L
Sbjct: 82  MAKGSL----VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVL 134

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFC-RSFGGASHKSDVYSYG 119
           + ED   K+SDFGL K++   + T      +  + + APE    + F   S KSDV+S+G
Sbjct: 135 VSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREKKF---STKSDVWSFG 186

Query: 120 MMILEM-AVGRKNADVKASRSSDIYFPNSIYKHIEPG--NDFQLDG------VVTEEEKE 170
           +++ E+ + GR            + +P    K + P     +++D       VV +  K+
Sbjct: 187 ILLWEIYSFGR------------VPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQ 234

Query: 171 LVKKMILVSLWCIQTNPSDRPSMHEVLEMLE 201
                      C   + + RPS  ++ E LE
Sbjct: 235 -----------CWHLDAATRPSFLQLREQLE 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 54.8 bits (132), Expect = 6e-09
 Identities = 34/99 (34%), Positives = 57/99 (57%), Gaps = 7/99 (7%)

Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I  GL++LH+     I++ D+K  N+LLD+D   KI+DFG+ K++ + +   S    
Sbjct: 102 AAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC- 157

Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
            GT  YIAPE+        +   D +S+G+++ EM +G+
Sbjct: 158 -GTPDYIAPEILKGQ--KYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 55.0 bits (132), Expect = 6e-09
 Identities = 36/103 (34%), Positives = 56/103 (54%), Gaps = 13/103 (12%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
           VYQ+     +GL+Y+H      I+H D+KP N+ ++ED   KI DFGLA+Q+  +     
Sbjct: 124 VYQML----KGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE----- 171

Query: 87  MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           M     T  Y APEV   ++   +   D++S G ++ EM  G+
Sbjct: 172 MTGYVVTRWYRAPEVIL-NWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 54.6 bits (131), Expect = 7e-09
 Identities = 52/169 (30%), Positives = 77/169 (45%), Gaps = 24/169 (14%)

Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           I  G  +GL YLH      ++H DIK  NILL E    K++DFG A +S    S +    
Sbjct: 126 ITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV---- 178

Query: 90  ARGTIGYIAPEV-FCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSI 148
             GT  ++APEV      G    K DV+S G+  +E+A  RK      +  S +Y     
Sbjct: 179 --GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA-ERKPPLFNMNAMSALY----- 230

Query: 149 YKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVL 197
             HI   +   L    + E  +  +  +    +C+Q  P +RP+  E+L
Sbjct: 231 --HIAQNDSPTLQ---SNEWTDSFRGFV---DYCLQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 54.7 bits (132), Expect = 8e-09
 Identities = 49/188 (26%), Positives = 77/188 (40%), Gaps = 47/188 (25%)

Query: 29  QIAGGIA----RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST 84
            I G +     + L YL     V  +H D+KP NILLD     K+ DFG++ +  D    
Sbjct: 114 DILGKMTVAIVKALHYLKEKHGV--IHRDVKPSNILLDASGNVKLCDFGISGRLVD---- 167

Query: 85  ISMLHAR--GTIGYIAPEVFCR-----SFGGASHKSDVYSYGMMILEMAVGRKNADVKAS 137
            S    R  G   Y+APE   R            ++DV+S G+ ++E+A G+        
Sbjct: 168 -SKAKTRSAGCAAYMAPE---RIDPPDPNPKYDIRADVWSLGISLVELATGQ-------- 215

Query: 138 RSSDIYFPNSIYKHIEPGNDFQ-LDGVVTEEEKELVKKMILVSLW------CIQTNPSDR 190
                 FP   YK+ +   +F+ L  ++ EE   L         +      C+  +   R
Sbjct: 216 ------FP---YKNCK--TEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKR 264

Query: 191 PSMHEVLE 198
           P   E+L+
Sbjct: 265 PKYRELLQ 272

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 54.7 bits (131), Expect = 9e-09
 Identities = 39/129 (30%), Positives = 68/129 (52%), Gaps = 14/129 (10%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSLDQ   +       + +    + +++  + RGL YL      +I+H D+KP NIL
Sbjct: 85  MDGGSLDQVLKEA------KRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNIL 136

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           ++     K+ DFG++ Q  D  +   +    GT  Y++PE    +    S +SD++S G+
Sbjct: 137 VNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTH--YSVQSDIWSMGL 190

Query: 121 MILEMAVGR 129
            ++E+A+GR
Sbjct: 191 SLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 54.4 bits (131), Expect = 9e-09
 Identities = 35/133 (26%), Positives = 54/133 (40%), Gaps = 46/133 (34%)

Query: 38  LEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGL----------------------- 74
           +E +H    +  +H DIKP NIL+D D   K++DFGL                       
Sbjct: 114 IESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170

Query: 75  -------AKQSQDKKSTISMLHAR-----------GTIGYIAPEVFCRSFGGASHKSDVY 116
                  ++  + +   +     R           GT  YIAPEV  R+  G +   D +
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWW 228

Query: 117 SYGMMILEMAVGR 129
           S G+++ EM VG+
Sbjct: 229 SVGVILYEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 54.7 bits (131), Expect = 1e-08
 Identities = 36/103 (34%), Positives = 57/103 (55%), Gaps = 13/103 (12%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
           +YQI     RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     
Sbjct: 126 IYQIL----RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----- 173

Query: 87  MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           M     T  Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 174 MTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 54.3 bits (130), Expect = 1e-08
 Identities = 36/93 (38%), Positives = 52/93 (55%), Gaps = 7/93 (7%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIG 95
           + LE+LH     +++H DIK  NILL  D   K++DFG   Q   ++S  S +   GT  
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPY 181

Query: 96  YIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           ++APEV  R   G   K D++S G+M +EM  G
Sbjct: 182 WMAPEVVTRKAYGP--KVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 54.1 bits (131), Expect = 1e-08
 Identities = 47/204 (23%), Positives = 87/204 (42%), Gaps = 54/204 (26%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK---QSQDKKS 83
           +YQ+     + L+Y+H G    ++H D+KP NILL+ D   K++DFGLA+   + ++   
Sbjct: 113 MYQLL----KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPE 165

Query: 84  TISMLHARGTIGYIAPEVFCRSFGGASHKS----DVYSYGMMILEMAVGR---------- 129
              +     T  Y APE+        S +     D++S G ++ EM +G+          
Sbjct: 166 NPVLTDYVATRWYRAPEILL-----GSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN 220

Query: 130 ------------KNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVT---EEEKELVKK 174
                          D+++ +S    F  ++   +       LD ++    ++  +L+KK
Sbjct: 221 QLEKIIEVIGPPSAEDIESIKSP---FAATMLDSLPSRPRKPLDELLPKASDDALDLLKK 277

Query: 175 MILVSLWCIQTNPSDRPSMHEVLE 198
                   +  NP+ R +  E LE
Sbjct: 278 -------LLVFNPNKRLTAEEALE 294

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 54.1 bits (130), Expect = 1e-08
 Identities = 40/125 (32%), Positives = 59/125 (47%), Gaps = 11/125 (8%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +P+ S D +TY    +  +R L       I   I  GL YLH     RI+H D+K  NI 
Sbjct: 136 LPHYSSDLYTY---LTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIF 189

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           +++     I D G A   Q      + L   GT+   APEV  R     + K+D++S G+
Sbjct: 190 INDVDQVCIGDLGAA---QFPVVAPAFLGLAGTVETNAPEVLARD--KYNSKADIWSAGI 244

Query: 121 MILEM 125
           ++ EM
Sbjct: 245 VLFEM 249

Length = 357

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 53.8 bits (129), Expect = 1e-08
 Identities = 49/209 (23%), Positives = 93/209 (44%), Gaps = 31/209 (14%)

Query: 1   MPNGSLDQFTY----DQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKP 56
           M +G L  +      + E++ G      + + Q+A  IA G+ YL+     + VH D+  
Sbjct: 91  MAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAA 147

Query: 57  HNILLDEDFCPKISDFGLAKQSQD----KKSTISMLHARGTIGYIAPEVFCRSFGGASHK 112
            N ++  DF  KI DFG+ +   +    +K    +L  R     +APE      G  +  
Sbjct: 148 RNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW----MAPESL--KDGVFTTS 201

Query: 113 SDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELV 172
           SD++S+G+++ E+           S +   Y   S  + ++    F +DG   ++     
Sbjct: 202 SDMWSFGVVLWEI----------TSLAEQPYQGLSNEQVLK----FVMDGGYLDQPDNCP 247

Query: 173 KKMILVSLWCIQTNPSDRPSMHEVLEMLE 201
           +++  +   C Q NP  RP+  E++ +L+
Sbjct: 248 ERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 54.0 bits (129), Expect = 1e-08
 Identities = 37/96 (38%), Positives = 53/96 (55%), Gaps = 13/96 (13%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ---SQDKKSTISMLHARG 92
           + LE+LH     +++H DIK  N+LL  D   K++DFG   Q    Q K+ST+      G
Sbjct: 126 QALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----G 177

Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T  ++APEV  R   G   K D++S G+M +EM  G
Sbjct: 178 TPYWMAPEVVTRKAYGP--KVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 53.8 bits (129), Expect = 1e-08
 Identities = 32/107 (29%), Positives = 57/107 (53%), Gaps = 6/107 (5%)

Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ- 77
           N+ +  + + ++   ++ G++YL        VH D+   N+LL      KISDFGL+K  
Sbjct: 89  NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 145

Query: 78  SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILE 124
             D+    +  H +  + + APE  C ++   S KSDV+S+G+++ E
Sbjct: 146 GADENYYKAKTHGKWPVKWYAPE--CMNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 53.5 bits (128), Expect = 2e-08
 Identities = 39/125 (31%), Positives = 61/125 (48%), Gaps = 8/125 (6%)

Query: 32  GGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ--SQDKKSTISMLH 89
           G I   LE+LH+   + I++ DIK  NILLD +    ++DFGL+K+    + +   S   
Sbjct: 112 GEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC- 167

Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIY 149
             GTI Y+AP++     GG     D +S G+++ E+  G     V   ++S       I 
Sbjct: 168 --GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRIL 225

Query: 150 KHIEP 154
           K   P
Sbjct: 226 KSEPP 230

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 53.6 bits (128), Expect = 2e-08
 Identities = 42/121 (34%), Positives = 69/121 (57%), Gaps = 15/121 (12%)

Query: 14  ESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFG 73
           +++ GN TL+   +  I   I RGL +LH+    +++H DIK  N+LL E+   K+ DFG
Sbjct: 101 KNTKGN-TLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 156

Query: 74  LAKQ---SQDKKSTISMLHARGTIGYIAPEVF-CRSFGGASH--KSDVYSYGMMILEMAV 127
           ++ Q   +  +++T       GT  ++APEV  C     A++  KSD++S G+  +EMA 
Sbjct: 157 VSAQLDRTVGRRNTFI-----GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 211

Query: 128 G 128
           G
Sbjct: 212 G 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 53.5 bits (128), Expect = 2e-08
 Identities = 36/96 (37%), Positives = 54/96 (56%), Gaps = 7/96 (7%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I   L+YLH G   +IV+ D+K  N++LD+D   KI+DFGL K+     +T+      GT
Sbjct: 104 IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC--GT 158

Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y+APEV   +  G +   D +  G+++ EM  GR
Sbjct: 159 PEYLAPEVLEDNDYGRA--VDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 52.7 bits (126), Expect = 3e-08
 Identities = 49/187 (26%), Positives = 85/187 (45%), Gaps = 33/187 (17%)

Query: 20  RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ 79
           R +  +TV++    +   LE++H   + R++H DIKP N+ +      K+ D GL +   
Sbjct: 101 RLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157

Query: 80  DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRS 139
            K +    L   GT  Y++PE    +  G + KSD++S G ++ EMA       +++   
Sbjct: 158 SKTTAAHSL--VGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAA------LQSPFY 207

Query: 140 SDIYFPNSIYKHIE-------PGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPS 192
            D     S+ K IE       P + +      +EE ++LV         CI  +P  RP 
Sbjct: 208 GDKMNLYSLCKKIEQCDYPPLPSDHY------SEELRQLVNM-------CINPDPEKRPD 254

Query: 193 MHEVLEM 199
           +  V ++
Sbjct: 255 ITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 52.9 bits (127), Expect = 3e-08
 Identities = 38/104 (36%), Positives = 52/104 (50%), Gaps = 18/104 (17%)

Query: 38  LEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK-----------QSQDKKSTIS 86
           LEYLH   N  IVH D+KP N+L+      K++DFGL+K           +   +K T  
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 87  MLHAR--GTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            L  +  GT  YIAPEV  R   G     D ++ G+++ E  VG
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 52.6 bits (126), Expect = 3e-08
 Identities = 34/125 (27%), Positives = 65/125 (52%), Gaps = 11/125 (8%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NG L    Y +E     +  +   + ++   +  G+ YL    + + +H D+   N L
Sbjct: 81  MSNGCL--LNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCL 132

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           +D+  C K+SDFGL++   D + T S+  ++  + +  PEV    +   S KSDV+++G+
Sbjct: 133 VDDQGCVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVL--LYSKFSSKSDVWAFGV 189

Query: 121 MILEM 125
           ++ E+
Sbjct: 190 LMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 52.7 bits (126), Expect = 3e-08
 Identities = 52/183 (28%), Positives = 84/183 (45%), Gaps = 37/183 (20%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIG 95
           RGL++LH   + R+VH D+KP NIL+      K++DFGLA+    + +  S++    T+ 
Sbjct: 121 RGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV---TLW 174

Query: 96  YIAPEVFCRSFGGASHKSDVYSYGMMILEM----AVGRKNADV--------------KAS 137
           Y APEV  +S    +   D++S G +  EM     + R ++DV              +  
Sbjct: 175 YRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232

Query: 138 RSSDIYFPNSIY--KHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHE 195
              D+  P   +  K  +P   F  D  + E  K+L+       L C+  NP+ R S + 
Sbjct: 233 WPRDVALPRQAFHSKSAQPIEKFVTD--IDELGKDLL-------LKCLTFNPAKRISAYS 283

Query: 196 VLE 198
            L 
Sbjct: 284 ALS 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 52.5 bits (126), Expect = 3e-08
 Identities = 46/180 (25%), Positives = 73/180 (40%), Gaps = 46/180 (25%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +  G+EYL R      +H D+   N L+      K+SDFG+ +   D + T S   A+  
Sbjct: 109 VCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSGAKFP 164

Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRK-------NADV--KASRSSDIYF 144
           + +  PEVF  +F   S KSDV+S+G+++ E+    K       N +V    SR   +Y 
Sbjct: 165 VKWSPPEVF--NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR 222

Query: 145 P----NSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML 200
           P     ++Y+                           V   C    P  RP+  E+L  +
Sbjct: 223 PKLASMTVYE---------------------------VMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 52.7 bits (126), Expect = 4e-08
 Identities = 34/106 (32%), Positives = 60/106 (56%), Gaps = 10/106 (9%)

Query: 21  TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK-QSQ 79
           TL  + +   A  +ARG++YL +    + +H D+   NIL+ E++  KI+DFGL++ Q  
Sbjct: 120 TLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEV 176

Query: 80  DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
             K T+  L  R    ++A E    ++   +  SDV+SYG+++ E+
Sbjct: 177 YVKKTMGRLPVR----WMAIESL--NYSVYTTNSDVWSYGVLLWEI 216

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 52.7 bits (126), Expect = 4e-08
 Identities = 37/97 (38%), Positives = 53/97 (54%), Gaps = 9/97 (9%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I   LEYLH   +  +V+ DIK  N++LD+D   KI+DFGL K+     +T+      GT
Sbjct: 104 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC--GT 158

Query: 94  IGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y+APEV     +G A    D +  G+++ EM  GR
Sbjct: 159 PEYLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 52.3 bits (125), Expect = 4e-08
 Identities = 45/194 (23%), Positives = 85/194 (43%), Gaps = 27/194 (13%)

Query: 12  DQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISD 71
           + E++        + + Q+AG IA G+ YL+     + VH D+   N ++ EDF  KI D
Sbjct: 106 EMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 162

Query: 72  FGLAKQSQD----KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV 127
           FG+ +   +    +K    +L  R    +++PE      G  +  SDV+S+G+++ E+A 
Sbjct: 163 FGMTRDIYETDYYRKGGKGLLPVR----WMSPESL--KDGVFTTYSDVWSFGVVLWEIAT 216

Query: 128 GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNP 187
             +      S    +               F ++G + ++       +  +   C Q NP
Sbjct: 217 LAEQPYQGMSNEQVL--------------RFVMEGGLLDKPDNCPDMLFELMRMCWQYNP 262

Query: 188 SDRPSMHEVLEMLE 201
             RPS  E++  ++
Sbjct: 263 KMRPSFLEIISSIK 276

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 52.3 bits (125), Expect = 5e-08
 Identities = 35/96 (36%), Positives = 52/96 (54%), Gaps = 6/96 (6%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL Y HR    +++H D+KP N+L++E    K++DFGLA+       T S  +   T
Sbjct: 113 ILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYS--NEVVT 167

Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y  P+V   S    S + D++  G +  EMA GR
Sbjct: 168 LWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 52.3 bits (126), Expect = 5e-08
 Identities = 49/191 (25%), Positives = 73/191 (38%), Gaps = 66/191 (34%)

Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHAR----- 91
            LEYLH    + IV+ D+KP NILL E     +SDF L+KQS  +   +S    R     
Sbjct: 115 ALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSK-ALRKGSRR 170

Query: 92  -----------------------GTIGYIAPEVFCRSFGGASHKSDV--YSYGMMILEMA 126
                                  GT  YIAPEV      G  H S V  ++ G+++ EM 
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEV----ISGDGHGSAVDWWTLGILLYEML 226

Query: 127 VGR-------KNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVS 179
            G        ++         ++ FP S                V+   ++L++K+    
Sbjct: 227 YGTTPFKGSNRDETFSNILKKEVTFPGSP--------------PVSSSARDLIRKL---- 268

Query: 180 LWCIQTNPSDR 190
              +  +PS R
Sbjct: 269 ---LVKDPSKR 276

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 52.0 bits (124), Expect = 5e-08
 Identities = 58/199 (29%), Positives = 85/199 (42%), Gaps = 29/199 (14%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           MP GS+     DQ  + G   L      +    I  G+ YLH      IVH DIK  NIL
Sbjct: 88  MPGGSVK----DQLKAYG--ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANIL 138

Query: 61  LDEDFCPKISDFGLAKQSQDK-KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
            D     K+ DFG +K+ Q    S   +    GT  +++PEV   S  G   K+DV+S G
Sbjct: 139 RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI--SGEGYGRKADVWSLG 196

Query: 120 MMILEMAVGRKN-ADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILV 178
             ++EM   +   A+ +A          +I+K      + QL   ++E  ++ +      
Sbjct: 197 CTVVEMLTEKPPWAEYEAMA--------AIFKIATQPTNPQLPSHISEHARDFLG----- 243

Query: 179 SLWCIQTNPSDRPSMHEVL 197
              CI      RPS  E+L
Sbjct: 244 ---CIFVEARHRPSAEELL 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 51.9 bits (125), Expect = 5e-08
 Identities = 34/116 (29%), Positives = 49/116 (42%), Gaps = 31/116 (26%)

Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST 84
             ++Q+   IA    Y H      I+H DIKP NIL+ E    K+ DFG A+        
Sbjct: 104 SYIWQLLQAIA----YCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARA------- 149

Query: 85  ISMLHARG---------TIGYIAPEVFC--RSFGGASHKSDVYSYGMMILEMAVGR 129
              L AR          T  Y APE+     ++G      DV++ G ++ E+  G 
Sbjct: 150 ---LRARPASPLTDYVATRWYRAPELLVGDTNYGKP---VDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 51.9 bits (124), Expect = 6e-08
 Identities = 44/134 (32%), Positives = 64/134 (47%), Gaps = 23/134 (17%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIG 95
           RGL Y H+    +I+H D+KP N+L++E    K++DFGLA+       T S  +   T+ 
Sbjct: 114 RGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYS--NEVVTLW 168

Query: 96  YIAPEVFCRSFGGASHKS--DVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIE 153
           Y  P+V     G   + +  D++  G ++ EMA GR              FP S  K  E
Sbjct: 169 YRPPDVL---LGSTEYSTPIDMWGVGCILYEMATGRP------------MFPGSTVKE-E 212

Query: 154 PGNDFQLDGVVTEE 167
               F+L G  TEE
Sbjct: 213 LHLIFRLLGTPTEE 226

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 51.6 bits (123), Expect = 6e-08
 Identities = 45/126 (35%), Positives = 59/126 (46%), Gaps = 12/126 (9%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           MP GS+     DQ  S G   L      +    I  G+ YLH      IVH DIK  NIL
Sbjct: 88  MPGGSIK----DQLKSYG--ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANIL 138

Query: 61  LDEDFCPKISDFGLAKQSQDK-KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
            D     K+ DFG +K+ Q    S   M    GT  +++PEV   S  G   K+D++S G
Sbjct: 139 RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI--SGEGYGRKADIWSVG 196

Query: 120 MMILEM 125
             ++EM
Sbjct: 197 CTVVEM 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 51.9 bits (124), Expect = 6e-08
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 7/103 (6%)

Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I+ GL +LHR     I++ D+K  N++LD +   KI+DFG+ K+      T      
Sbjct: 107 AAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC- 162

Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNAD 133
            GT  YIAPE+      G S   D ++YG+++ EM  G+   D
Sbjct: 163 -GTPDYIAPEIIAYQPYGKS--VDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 52.0 bits (124), Expect = 7e-08
 Identities = 43/130 (33%), Positives = 70/130 (53%), Gaps = 16/130 (12%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSLDQ           R  E + + +++  + +GL YL      +I+H D+KP NIL
Sbjct: 85  MDGGSLDQVL-----KKAGRIPE-QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNIL 136

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHA-RGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           ++     K+ DFG++ Q  D     SM ++  GT  Y++PE    +    S +SD++S G
Sbjct: 137 VNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPERLQGTH--YSVQSDIWSMG 189

Query: 120 MMILEMAVGR 129
           + ++EMA+GR
Sbjct: 190 LSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 52.1 bits (125), Expect = 7e-08
 Identities = 32/95 (33%), Positives = 47/95 (49%), Gaps = 4/95 (4%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS-QDKKSTISMLHARGTI 94
           R L+Y+H      + H D+KP NIL + D   KI DFGLA+ +  D  + I       T 
Sbjct: 114 RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 95  GYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
            Y APE+    F   +   D++S G +  E+  G+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 51.6 bits (123), Expect = 7e-08
 Identities = 50/180 (27%), Positives = 83/180 (46%), Gaps = 19/180 (10%)

Query: 20  RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ 79
           R +  RTV++    +   +E++H   + R++H DIKP N+ +      K+ D GL +   
Sbjct: 101 RLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157

Query: 80  DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRS 139
            K +    L   GT  Y++PE    +  G + KSD++S G ++ EMA       +++   
Sbjct: 158 SKTTAAHSL--VGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAA------LQSPFY 207

Query: 140 SDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM 199
            D     S+ + IE     Q D      E    K   LVS+ CI  +P  RP +  V ++
Sbjct: 208 GDKMNLFSLCQKIE-----QCDYPPLPTEHYSEKLRELVSM-CIYPDPDQRPDIGYVHQI 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 51.6 bits (124), Expect = 8e-08
 Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 67/210 (31%)

Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST 84
           + ++QI     RG+E+ H   +  I+H DIKP NIL+ +    K+ DFG A+        
Sbjct: 104 KYLFQIL----RGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFAR-------- 148

Query: 85  ISMLHARG--------TIGYIAPEVFCR--SFGGASHKSDVYSYGMMILEMAVGRK---- 130
              L A G        T  Y APE+      +G A    D+++ G ++ EM  G      
Sbjct: 149 --TLAAPGEVYTDYVATRWYRAPELLVGDTKYGRA---VDIWAVGCLVTEMLTGEPLFPG 203

Query: 131 NADVK------------ASRSSDIYFPNSIY--------KHIEPGNDF--QLDGVVTEEE 168
           ++D+               R  +I+  N ++        K IEP      +L G+V    
Sbjct: 204 DSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVL--- 260

Query: 169 KELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
            +L K+       C++ +P DRPS  ++L 
Sbjct: 261 -DLAKQ-------CLRIDPDDRPSSSQLLH 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 51.6 bits (124), Expect = 8e-08
 Identities = 39/127 (30%), Positives = 51/127 (40%), Gaps = 47/127 (37%)

Query: 38  LEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK-----------------QSQD 80
           L Y+HR         DIKP N+LLD     K+SDFGL                      +
Sbjct: 120 LGYIHR---------DIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170

Query: 81  KKSTIS--MLHAR-----------------GTIGYIAPEVFCRSFGGASHKSDVYSYGMM 121
               IS  M   R                 GT  YIAPEVF ++  G + + D +S G++
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT--GYNKECDWWSLGVI 228

Query: 122 ILEMAVG 128
           + EM VG
Sbjct: 229 MYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 51.6 bits (123), Expect = 8e-08
 Identities = 36/98 (36%), Positives = 50/98 (51%), Gaps = 7/98 (7%)

Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  IA  L YLH   ++ IV+ D+KP NILLD      ++DFGL K++ +   T S    
Sbjct: 102 AAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC- 157

Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APEV  +         D +  G ++ EM  G
Sbjct: 158 -GTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 51.6 bits (123), Expect = 9e-08
 Identities = 34/103 (33%), Positives = 58/103 (56%), Gaps = 13/103 (12%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
           +YQ+     RGL+Y+H   +  I+H D+KP N+ ++ED   +I DFGLA+Q+ D+     
Sbjct: 124 IYQLL----RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----- 171

Query: 87  MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           M     T  Y APE+   ++   +   D++S G ++ E+  G+
Sbjct: 172 MTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 51.3 bits (123), Expect = 9e-08
 Identities = 54/172 (31%), Positives = 74/172 (43%), Gaps = 30/172 (17%)

Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           I  G  +GL YLH   +   +H DIK  NILL E    K++DFG A       S +    
Sbjct: 120 ICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV---- 172

Query: 90  ARGTIGYIAPEV-FCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSI 148
             GT  ++APEV      G    K DV+S G+  +E+A  RK      +  S +Y     
Sbjct: 173 --GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA-ERKPPLFNMNAMSALY----- 224

Query: 149 YKHIEPGND---FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVL 197
             HI   ND      +   ++  +  V         C+Q  P DRPS  E+L
Sbjct: 225 --HIAQ-NDSPTLSSND-WSDYFRNFVDS-------CLQKIPQDRPSSEELL 265

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 51.2 bits (123), Expect = 1e-07
 Identities = 32/98 (32%), Positives = 53/98 (54%), Gaps = 14/98 (14%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK--QSQDKKSTISMLHARGT 93
           RGL+YLH      I+H D+K  N+LL +  C KI+DFGLA+      K  T  ++    T
Sbjct: 119 RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV----T 171

Query: 94  IGYIAPEVFCRSFGGASHKS--DVYSYGMMILEMAVGR 129
           + Y APE+     G  ++ +  D+++ G ++ E+   +
Sbjct: 172 LWYRAPELL---LGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 51.3 bits (123), Expect = 1e-07
 Identities = 40/174 (22%), Positives = 85/174 (48%), Gaps = 28/174 (16%)

Query: 34  IARGLEYL-HRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           +A+G+ +L  + C    +H D+   N+LL      KI DFGLA+   +  + +   +AR 
Sbjct: 150 VAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL 205

Query: 93  TIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEM-AVGRKNADVKASRSSDIYFPNSIYK 150
            + ++APE +F       + +SDV+SYG+++ E+ ++G       ++    +   +  YK
Sbjct: 206 PVKWMAPESIF---NCVYTFESDVWSYGILLWEIFSLG-------SNPYPGMPVDSKFYK 255

Query: 151 HIEPGNDFQLDGVV--TEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES 202
            I+ G  +++        E  +++K        C   +P  RP+  ++++++  
Sbjct: 256 LIKEG--YRMAQPEHAPAEIYDIMKT-------CWDADPLKRPTFKQIVQLIGK 300

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 51.2 bits (122), Expect = 1e-07
 Identities = 37/99 (37%), Positives = 55/99 (55%), Gaps = 15/99 (15%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFG----LAKQSQDKKSTISMLH 89
           + R L YLH   N  ++H DIK  +ILL  D   K+SDFG    ++K+   +KS +    
Sbjct: 127 VLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV---- 179

Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
             GT  ++APEV  R   G   + D++S G+M++EM  G
Sbjct: 180 --GTPYWMAPEVISRLPYGT--EVDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 51.0 bits (122), Expect = 1e-07
 Identities = 37/112 (33%), Positives = 55/112 (49%), Gaps = 25/112 (22%)

Query: 28  YQIAGGIARGLEYLH-RGCNVRIVHFDIKPHNILLDED-FCPKISDFGLAKQSQD--KKS 83
           YQ+  G+A    + H  G    ++H D+KP N+L+D+     KI+D GL +      K  
Sbjct: 117 YQLLKGVA----HCHKHG----VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY 168

Query: 84  TISMLHARGTIGYIAPEVFCRSFGGASHKS---DVYSYGMMILEMAVGRKNA 132
           T    H   T+ Y APEV      G++H S   D++S G +  EM+  RK  
Sbjct: 169 T----HEIVTLWYRAPEVLL----GSTHYSTPVDIWSVGCIFAEMS--RKQP 210

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 51.1 bits (122), Expect = 1e-07
 Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 13/102 (12%)

Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS---QDKKSTISM 87
           A  I  GL++LH   +  I++ D+K  N++LD D   KI+DFG+ K++    ++ ST   
Sbjct: 102 AAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC- 157

Query: 88  LHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
               GT  YIAPE+        +   D +S+G+++ EM +G+
Sbjct: 158 ----GTPDYIAPEILQGL--KYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 50.9 bits (122), Expect = 1e-07
 Identities = 54/220 (24%), Positives = 96/220 (43%), Gaps = 49/220 (22%)

Query: 1   MPNGSLDQF----------TYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIV 50
           M +G L++F              +S  G  TL    + QIA  IA G+ YL    +   V
Sbjct: 90  MEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS--QLLQIAVQIASGMVYL---ASQHFV 144

Query: 51  HFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST-------ISMLHARGTIGYIAPE-VF 102
           H D+   N L+  D   KI DFG+   S+D  +T        +ML  R    ++ PE + 
Sbjct: 145 HRDLATRNCLVGYDLVVKIGDFGM---SRDVYTTDYYRVGGHTMLPIR----WMPPESIM 197

Query: 103 CRSFGGASHKSDVYSYGMMILEM-AVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLD 161
            R F   + +SDV+S+G+++ E+   G++            ++  S  + IE        
Sbjct: 198 YRKF---TTESDVWSFGVVLWEIFTYGKQP-----------WYGLSNEEVIE----CITQ 239

Query: 162 GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE 201
           G + +  +    ++  + L C + +P  R ++ ++ E L+
Sbjct: 240 GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 51.2 bits (122), Expect = 1e-07
 Identities = 41/131 (31%), Positives = 65/131 (49%), Gaps = 15/131 (11%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           MP G L         SN +   +W   Y     +   L+ +H   ++ ++H D+KP N+L
Sbjct: 125 MPGGDLVNLM-----SNYDVPEKWAKFY--TAEVVLALDAIH---SMGLIHRDVKPDNML 174

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASH---KSDVYS 117
           LD+    K++DFG   +  D+   +    A GT  YI+PEV  +S GG  +   + D +S
Sbjct: 175 LDKHGHLKLADFGTCMK-MDETGMVRCDTAVGTPDYISPEVL-KSQGGDGYYGRECDWWS 232

Query: 118 YGMMILEMAVG 128
            G+ + EM VG
Sbjct: 233 VGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.4 bits (123), Expect = 1e-07
 Identities = 46/197 (23%), Positives = 99/197 (50%), Gaps = 26/197 (13%)

Query: 9   FTYDQESSNGNRTLEWRTVYQIAGGIARGLEYL-HRGCNVRIVHFDIKPHNILLDEDFCP 67
            + D+E +  +  L+   + + +  +A+G+++L  + C    +H D+   N+LL +    
Sbjct: 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVA 251

Query: 68  KISDFGLAKQSQDKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEM- 125
           KI DFGLA+   +  + +   +AR  + ++APE +F   +   + +SDV+SYG+++ E+ 
Sbjct: 252 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVY---TVQSDVWSYGILLWEIF 308

Query: 126 AVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLD-GVVTEEEKELVKKMILVSLWCIQ 184
           ++G+       S    I   +  YK ++ G  +Q+        E   + KM      C  
Sbjct: 309 SLGK-------SPYPGILVNSKFYKMVKRG--YQMSRPDFAPPEIYSIMKM------CWN 353

Query: 185 TNPSDRPSMHEVLEMLE 201
             P++RP+  ++ ++++
Sbjct: 354 LEPTERPTFSQISQLIQ 370

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 50.8 bits (122), Expect = 1e-07
 Identities = 36/106 (33%), Positives = 55/106 (51%), Gaps = 16/106 (15%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
           +YQ+  GIA    Y H   + R++H D+KP N+L+D +   K++DFGLA+       T +
Sbjct: 105 LYQLLQGIA----YCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYT 157

Query: 87  MLHARGTIGYIAPEVFCRSFGGASHKS---DVYSYGMMILEMAVGR 129
             H   T+ Y APE+      G+   S   D++S G +  EM   R
Sbjct: 158 --HEVVTLWYRAPEILL----GSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 50.8 bits (121), Expect = 1e-07
 Identities = 36/96 (37%), Positives = 55/96 (57%), Gaps = 9/96 (9%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ-SQDKKSTISMLHARG 92
           + + L YLH   +  ++H DIK  +ILL  D   K+SDFG   Q S+D     S++   G
Sbjct: 126 VLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV---G 179

Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T  ++APEV  R+  G   + D++S G+M++EM  G
Sbjct: 180 TPYWMAPEVISRTPYGT--EVDIWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 50.8 bits (121), Expect = 1e-07
 Identities = 40/132 (30%), Positives = 68/132 (51%), Gaps = 21/132 (15%)

Query: 2   PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL 61
           P G++D    + +     R L    +  I   +   L+YLH   +++I+H D+K  N+LL
Sbjct: 92  PGGAVDAIMLELD-----RGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLL 143

Query: 62  DEDFCPKISDFGLA----KQSQDKKSTISMLHARGTIGYIAPE-VFCRSFGGA--SHKSD 114
             D   K++DFG++    K  Q + S I      GT  ++APE V C +       +K+D
Sbjct: 144 TLDGDIKLADFGVSAKNVKTLQRRDSFI------GTPYWMAPEVVMCETMKDTPYDYKAD 197

Query: 115 VYSYGMMILEMA 126
           ++S G+ ++EMA
Sbjct: 198 IWSLGITLIEMA 209

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 50.1 bits (120), Expect = 2e-07
 Identities = 37/125 (29%), Positives = 62/125 (49%), Gaps = 10/125 (8%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSL    Y Q      R L+   +  +A  +A G+ YL        +H D+   N+L
Sbjct: 83  MKYGSL--LEYLQ--GGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVL 135

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + E+   K++DFGLA+  ++     +   A+  I + APE     +   S KSDV+S+G+
Sbjct: 136 VGENNICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPEAA--LYNRFSIKSDVWSFGI 192

Query: 121 MILEM 125
           ++ E+
Sbjct: 193 LLTEI 197

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 50.4 bits (120), Expect = 2e-07
 Identities = 37/97 (38%), Positives = 53/97 (54%), Gaps = 8/97 (8%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I   L+YLH   NV  V+ D+K  N++LD+D   KI+DFGL K+     +T+      GT
Sbjct: 104 IVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC--GT 159

Query: 94  IGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y+APEV     +G A    D +  G+++ EM  GR
Sbjct: 160 PEYLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 50.4 bits (120), Expect = 2e-07
 Identities = 37/105 (35%), Positives = 55/105 (52%), Gaps = 9/105 (8%)

Query: 34  IARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           I+  L YLH RG    I++ D+K  N+LLD +   K++D+G+ K+      T S     G
Sbjct: 105 ISLALNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC--G 158

Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKAS 137
           T  YIAPE+      G S   D ++ G+++ EM  GR   D+  S
Sbjct: 159 TPNYIAPEILRGEDYGFS--VDWWALGVLMFEMMAGRSPFDIVGS 201

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 50.3 bits (120), Expect = 2e-07
 Identities = 42/170 (24%), Positives = 83/170 (48%), Gaps = 22/170 (12%)

Query: 34  IARGLEYL-HRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           +A+G+ +L  + C    +H D+   NILL      KI DFGLA+  ++  + +   +AR 
Sbjct: 223 VAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278

Query: 93  TIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKH 151
            + ++APE +F   +   + +SDV+SYG+++ E+        + +S    +   +  YK 
Sbjct: 279 PVKWMAPESIFNCVY---TFESDVWSYGILLWEI------FSLGSSPYPGMPVDSKFYKM 329

Query: 152 IEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE 201
           I+ G           E  +++K        C   +P  RP+  ++++++E
Sbjct: 330 IKEGYRMLSPECAPSEMYDIMKS-------CWDADPLKRPTFKQIVQLIE 372

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 50.4 bits (120), Expect = 2e-07
 Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 6/94 (6%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIG 95
           RGL Y HR    +++H D+KP N+L++E    K++DFGLA+       T S  +   T+ 
Sbjct: 115 RGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYS--NEVVTLW 169

Query: 96  YIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           Y  P++   S    S + D++  G +  EM+ GR
Sbjct: 170 YRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 50.2 bits (120), Expect = 2e-07
 Identities = 32/105 (30%), Positives = 55/105 (52%), Gaps = 14/105 (13%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
           ++Q+  G+A    + H     R++H D+KP N+L++ +   K++DFGLA+       T +
Sbjct: 106 LFQLLQGLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 158

Query: 87  MLHARGTIGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
             H   T+ Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 159 --HEVVTLWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 50.4 bits (120), Expect = 3e-07
 Identities = 41/131 (31%), Positives = 65/131 (49%), Gaps = 15/131 (11%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           MP G L         SN +   +W   Y     +   L+ +H   ++  +H D+KP N+L
Sbjct: 125 MPGGDLVNLM-----SNYDVPEKWARFY--TAEVVLALDAIH---SMGFIHRDVKPDNML 174

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASH---KSDVYS 117
           LD+    K++DFG   +  +K+  +    A GT  YI+PEV  +S GG  +   + D +S
Sbjct: 175 LDKSGHLKLADFGTCMK-MNKEGMVRCDTAVGTPDYISPEVL-KSQGGDGYYGRECDWWS 232

Query: 118 YGMMILEMAVG 128
            G+ + EM VG
Sbjct: 233 VGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 49.8 bits (119), Expect = 3e-07
 Identities = 52/176 (29%), Positives = 85/176 (48%), Gaps = 44/176 (25%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I   L+++H   + +I+H DIK  NI L +D   K+ DFG+A+      ST+ +  AR  
Sbjct: 110 ICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN---STVEL--ARTC 161

Query: 94  IG---YIAPEVFCRSFGGASHKSDVYSYGMMILEM--------AVGRKNADVKASRSSDI 142
           IG   Y++PE+ C +    ++KSD+++ G ++ EM        A   KN  +K  R S  
Sbjct: 162 IGTPYYLSPEI-CEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS-- 217

Query: 143 YFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
                 Y  +     + L  +V+    +L K+           NP DRPS++ +LE
Sbjct: 218 ------YPPVSSHYSYDLRNLVS----QLFKR-----------NPRDRPSVNSILE 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 50.0 bits (119), Expect = 3e-07
 Identities = 37/105 (35%), Positives = 54/105 (51%), Gaps = 9/105 (8%)

Query: 31  AGGIARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           A  I   L +LH RG    I++ D+K  N+LLD D   K++D+G+ K+      T S   
Sbjct: 102 AAEICIALNFLHERG----IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC 157

Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADV 134
             GT  YIAPE+      G S   D ++ G+++ EM  GR   D+
Sbjct: 158 --GTPNYIAPEILRGEEYGFS--VDWWALGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 50.2 bits (120), Expect = 3e-07
 Identities = 35/105 (33%), Positives = 55/105 (52%), Gaps = 9/105 (8%)

Query: 31  AGGIARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +  I+  L +LH RG    I++ D+K  N+LLD +   K++D+G+ K+      T S   
Sbjct: 102 SAEISLALNFLHERG----IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC 157

Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADV 134
             GT  YIAPE+      G S   D ++ G+++ EM  GR   D+
Sbjct: 158 --GTPNYIAPEILRGEDYGFS--VDWWALGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 50.2 bits (120), Expect = 3e-07
 Identities = 41/135 (30%), Positives = 57/135 (42%), Gaps = 21/135 (15%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLH-RGCNVRIVHFDIKPHNI 59
           MP    D FTY   S      L       I   +   L YLH RG    I+H D+K  NI
Sbjct: 165 MPKYKCDLFTYVDRSG----PLPLEQAITIQRRLLEALAYLHGRG----IIHRDVKTENI 216

Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEV-----FCRSFGGASHKSD 114
            LDE     + DFG A +      T       GT+   +PE+     +C        K+D
Sbjct: 217 FLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCA-------KTD 269

Query: 115 VYSYGMMILEMAVGR 129
           ++S G+++ EM+V  
Sbjct: 270 IWSAGLVLFEMSVKN 284

Length = 392

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 49.6 bits (118), Expect = 3e-07
 Identities = 40/121 (33%), Positives = 67/121 (55%), Gaps = 15/121 (12%)

Query: 14  ESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFG 73
           +++ GN  L+   +  I   I RGL +LH     +++H DIK  N+LL E+   K+ DFG
Sbjct: 111 KNTKGN-ALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFG 166

Query: 74  LAKQ---SQDKKSTISMLHARGTIGYIAPEVF-CRSFGGAS--HKSDVYSYGMMILEMAV 127
           ++ Q   +  +++T       GT  ++APEV  C     A+  ++SD++S G+  +EMA 
Sbjct: 167 VSAQLDRTVGRRNTFI-----GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAE 221

Query: 128 G 128
           G
Sbjct: 222 G 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 49.8 bits (119), Expect = 3e-07
 Identities = 41/139 (29%), Positives = 69/139 (49%), Gaps = 23/139 (16%)

Query: 1   MPNGSLDQF------TYDQESSNGNRT----LEWRTVYQIAGGIARGLEYLHRGCNVRIV 50
           + +G L +F        D  + +G+ T    L+      IA  IA G+EYL    +   V
Sbjct: 90  LAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFV 146

Query: 51  HFDIKPHNILLDEDFCPKISDFGLAKQ--SQD--KKSTISMLHARGTIGYIAPEVFCRSF 106
           H D+   N L+ E    KISDFGL++   S D  +  + S+L  R    ++ PE     +
Sbjct: 147 HRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVR----WMPPEAIL--Y 200

Query: 107 GGASHKSDVYSYGMMILEM 125
           G  + +SD++S+G+++ E+
Sbjct: 201 GKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 49.7 bits (119), Expect = 3e-07
 Identities = 36/104 (34%), Positives = 52/104 (50%), Gaps = 14/104 (13%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
           +YQ+  GI    ++LH   +  I+H D+KP NI++  D   KI DFGLA+      ++  
Sbjct: 124 LYQMLCGI----KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFM 173

Query: 87  MLHARGTIGYIAPEVFCRSFG-GASHKSDVYSYGMMILEMAVGR 129
           M     T  Y APEV     G G     D++S G ++ EM  G 
Sbjct: 174 MTPYVVTRYYRAPEVI---LGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 49.7 bits (118), Expect = 4e-07
 Identities = 52/172 (30%), Positives = 77/172 (44%), Gaps = 24/172 (13%)

Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           I  G  +GL YLH   +  ++H DIK  NILL E    K++DFG A  +    S +    
Sbjct: 130 ITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV---- 182

Query: 90  ARGTIGYIAPEV-FCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSI 148
             GT  ++APEV      G    K DV+S G+  +E+A  RK      +  S +Y     
Sbjct: 183 --GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA-ERKPPLFNMNAMSALY----- 234

Query: 149 YKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML 200
             HI       L    + E  +  +  +     C+Q  P DRP+  E+L+ +
Sbjct: 235 --HIAQNESPTLQ---SNEWSDYFRNFVDS---CLQKIPQDRPTSEELLKHM 278

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 49.8 bits (119), Expect = 4e-07
 Identities = 32/99 (32%), Positives = 51/99 (51%), Gaps = 7/99 (7%)

Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  +   L +LHR     +++ D+K  NILLD +   K++DFG+ K+      T +    
Sbjct: 102 AAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC- 157

Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
            GT  YIAPE+      G S   D ++ G+++ EM  G+
Sbjct: 158 -GTPDYIAPEILQELEYGPS--VDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 49.6 bits (118), Expect = 4e-07
 Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 8/90 (8%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIG 95
           RGL++LH  C   IVH D+KP NIL+      K++DFGLA+        +++     T+ 
Sbjct: 119 RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVTLW 172

Query: 96  YIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
           Y APEV  +S    +   D++S G +  EM
Sbjct: 173 YRAPEVLLQS--TYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 49.3 bits (118), Expect = 4e-07
 Identities = 34/97 (35%), Positives = 51/97 (52%), Gaps = 12/97 (12%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIG 95
           RGL Y H+    R++H D+KP N+L+ E    K++DFGLA+       T S  +   T+ 
Sbjct: 114 RGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYS--NEVVTLW 168

Query: 96  YIAPEVFCRSFGGASHKS---DVYSYGMMILEMAVGR 129
           Y  P+V      G++  S   D++  G +  EMA GR
Sbjct: 169 YRPPDVLL----GSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 49.3 bits (118), Expect = 4e-07
 Identities = 35/105 (33%), Positives = 51/105 (48%), Gaps = 16/105 (15%)

Query: 28  YQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISM 87
           YQI  GI     + H     R++H D+KP N+L+D     K++DFGLA+         + 
Sbjct: 108 YQILQGIL----FCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT- 159

Query: 88  LHARGTIGYIAPEVFCRSFGGASHKS---DVYSYGMMILEMAVGR 129
            H   T+ Y APEV      G+   S   D++S G +  EMA  +
Sbjct: 160 -HEVVTLWYRAPEVLL----GSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 49.8 bits (119), Expect = 4e-07
 Identities = 39/131 (29%), Positives = 62/131 (47%), Gaps = 15/131 (11%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           MP G L     + +        +W   Y     +   L+ +H   ++  +H D+KP N+L
Sbjct: 125 MPGGDLVNLMSNYDIPE-----KWARFY--TAEVVLALDAIH---SMGFIHRDVKPDNML 174

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASH---KSDVYS 117
           LD+    K++DFG   +  D    +    A GT  YI+PEV  +S GG  +   + D +S
Sbjct: 175 LDKSGHLKLADFGTCMK-MDANGMVRCDTAVGTPDYISPEVL-KSQGGDGYYGRECDWWS 232

Query: 118 YGMMILEMAVG 128
            G+ + EM VG
Sbjct: 233 VGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 49.2 bits (117), Expect = 5e-07
 Identities = 28/72 (38%), Positives = 41/72 (56%), Gaps = 5/72 (6%)

Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  +A  + YLH   ++ I++ D+KP NILLD      ++DFGL K+  + + T S    
Sbjct: 102 AAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC- 157

Query: 91  RGTIGYIAPEVF 102
            GT  Y+APEV 
Sbjct: 158 -GTPEYLAPEVL 168

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 49.2 bits (117), Expect = 5e-07
 Identities = 38/135 (28%), Positives = 63/135 (46%), Gaps = 20/135 (14%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAG---GIARGLEYLHRGCNVRIVHFDIKPH 57
           M NG+LD F    E              Q+ G   G+A G++YL     +  VH  +  H
Sbjct: 88  MSNGALDSFLRKHEGQ--------LVAGQLMGMLPGLASGMKYL---SEMGYVHKGLAAH 136

Query: 58  NILLDEDFCPKISDFGLAKQSQDKKSTI-SMLHARGTIGYIAPEVFCRSFGGASHKSDVY 116
            +L++ D   KIS F   +  +DK   I + +  +  + + APE     +   S  SDV+
Sbjct: 137 KVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAI--QYHHFSSASDVW 192

Query: 117 SYGMMILE-MAVGRK 130
           S+G+++ E M+ G +
Sbjct: 193 SFGIVMWEVMSYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 48.9 bits (117), Expect = 7e-07
 Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 10/93 (10%)

Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ-SQDKKSTISMLHAR-GTI 94
           GL Y+HR    +I+H D+K  NIL+ +D   K++DFGLA+  S  K S  +    R  T+
Sbjct: 131 GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187

Query: 95  GYIAPEVF--CRSFGGASHKSDVYSYGMMILEM 125
            Y  PE+    R +G      D++  G ++ EM
Sbjct: 188 WYRPPELLLGERDYGPP---IDMWGAGCIMAEM 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 48.9 bits (117), Expect = 7e-07
 Identities = 28/89 (31%), Positives = 42/89 (47%), Gaps = 12/89 (13%)

Query: 41  LHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH-ARGTIGYIAP 99
           LH    +  +H D+KP N L+D     K++DFGL+      K  ++  +   G+  Y+AP
Sbjct: 117 LHE---LGYIHRDLKPENFLIDASGHIKLTDFGLS------KGIVTYANSVVGSPDYMAP 167

Query: 100 EVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           EV      G     D +S G M+ E   G
Sbjct: 168 EVLRGK--GYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 48.5 bits (115), Expect = 7e-07
 Identities = 35/104 (33%), Positives = 58/104 (55%), Gaps = 8/104 (7%)

Query: 22  LEWRTVYQIAGGIARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD 80
           L+ + + + A   A G+ YL  + C    +H D+   N L+ E+   KISDFG+++Q  D
Sbjct: 90  LKTKQLVKFALDAAAGMAYLESKNC----IHRDLAARNCLVGENNVLKISDFGMSRQEDD 145

Query: 81  KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILE 124
              + S L  +  I + APE    ++G  S +SDV+SYG+++ E
Sbjct: 146 GIYSSSGLK-QIPIKWTAPEAL--NYGRYSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 48.5 bits (115), Expect = 9e-07
 Identities = 43/126 (34%), Positives = 59/126 (46%), Gaps = 12/126 (9%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           MP GS+     DQ  + G   L      +    I +G+ YLH      IVH DIK  NIL
Sbjct: 88  MPGGSIK----DQLKAYG--ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANIL 138

Query: 61  LDEDFCPKISDFGLAKQSQD-KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
            D     K+ DFG +K+ Q    S   +    GT  +++PEV   S  G   K+DV+S  
Sbjct: 139 RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI--SGEGYGRKADVWSVA 196

Query: 120 MMILEM 125
             ++EM
Sbjct: 197 CTVVEM 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 48.7 bits (116), Expect = 9e-07
 Identities = 33/84 (39%), Positives = 44/84 (52%), Gaps = 5/84 (5%)

Query: 50  VHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFC--RSFG 107
           VH DIKP N+L+D     K++DFG A +    K   S L   GT  YIAPEV       G
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEVLTTMNGDG 182

Query: 108 GASH--KSDVYSYGMMILEMAVGR 129
             ++  + D +S G++  EM  GR
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 48.9 bits (116), Expect = 9e-07
 Identities = 46/189 (24%), Positives = 84/189 (44%), Gaps = 20/189 (10%)

Query: 15  SSNGNRTLEWRTVYQIAGGIARGLEYL-HRGCNVRIVHFDIKPHNILLDEDFCPKISDFG 73
           S +G+  L    +      +ARG+E+L  + C    VH D+   N+LL +    KI DFG
Sbjct: 227 SDDGSEGLTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFG 282

Query: 74  LAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNAD 133
           LA+      + +S       + ++APE    +    +  SDV+SYG+++ E+        
Sbjct: 283 LARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL--YTTLSDVWSYGILLWEI------FS 334

Query: 134 VKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSM 193
           +  +    +   ++ Y  I+ G         T+E  +++ K       C  + P  RPS 
Sbjct: 335 LGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVK-------CWNSEPEKRPSF 387

Query: 194 HEVLEMLES 202
             + +++ES
Sbjct: 388 LHLSDIVES 396

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 48.2 bits (115), Expect = 9e-07
 Identities = 36/117 (30%), Positives = 63/117 (53%), Gaps = 11/117 (9%)

Query: 16  SNGNR-TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGL 74
           ++G R  L+  TV      + +G+ + H     R++H D+KP N+L+++    K++DFGL
Sbjct: 90  THGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGL 146

Query: 75  AKQSQDKKSTISMLHARGTIGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           A+      +T S  +   T+ Y AP+V    R++   S   D++S G ++ EM  GR
Sbjct: 147 ARAFGIPVNTFS--NEVVTLWYRAPDVLLGSRTY---STSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 48.5 bits (115), Expect = 1e-06
 Identities = 35/102 (34%), Positives = 50/102 (49%), Gaps = 10/102 (9%)

Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE--DFCPKISDFGLAKQSQDKKSTISM 87
           I   + R ++YLH     RI+H DIK  NI ++   D C  + DFG A    D  +    
Sbjct: 187 IERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVC--LGDFGAACFPVDINANKYY 241

Query: 88  LHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             A GTI   APE+  R   G +   D++S G+++ EMA   
Sbjct: 242 GWA-GTIATNAPELLARDPYGPA--VDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 48.3 bits (115), Expect = 1e-06
 Identities = 37/103 (35%), Positives = 54/103 (52%), Gaps = 17/103 (16%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-KISDFGLAKQSQDKKSTI 85
           +YQI  GIA    Y H   + R++H D+KP N+L+D      K++DFGLA+       T 
Sbjct: 108 LYQILRGIA----YCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160

Query: 86  SMLHARGTIGYIAPEVFCRSFGGASHKS---DVYSYGMMILEM 125
           +  H   T+ Y APE+      G+ H S   D++S G +  EM
Sbjct: 161 T--HEVVTLWYRAPEILL----GSRHYSTPVDIWSVGCIFAEM 197

Length = 294

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 48.0 bits (114), Expect = 1e-06
 Identities = 41/169 (24%), Positives = 80/169 (47%), Gaps = 29/169 (17%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDED-FCPKISDFGLAKQSQDKKSTISMLHARG 92
           I+ GL+++H   + +I+H DIK  NI L ++    K+ DFG+A+Q  D     SM  A  
Sbjct: 110 ISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND-----SMELAYT 161

Query: 93  TIG---YIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIY 149
            +G   Y++PE+ C++    ++K+D++S G ++ E+   +   +        +      +
Sbjct: 162 CVGTPYYLSPEI-CQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF 219

Query: 150 KHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
             I P     L  ++++                 + +P DRPS+  +L+
Sbjct: 220 APISPNFSRDLRSLISQ---------------LFKVSPRDRPSITSILK 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 48.1 bits (114), Expect = 1e-06
 Identities = 32/106 (30%), Positives = 59/106 (55%), Gaps = 10/106 (9%)

Query: 21  TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD 80
           TL  + + Q A  +A G++YL      + +H D+   N+L+ E+   KI+DFGL++  + 
Sbjct: 115 TLTSQQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEV 171

Query: 81  K-KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
             K T+  L  R    ++A E    ++   + KSDV+S+G+++ E+
Sbjct: 172 YVKKTMGRLPVR----WMAIESL--NYSVYTTKSDVWSFGVLLWEI 211

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 48.1 bits (114), Expect = 1e-06
 Identities = 35/98 (35%), Positives = 50/98 (51%), Gaps = 7/98 (7%)

Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  IA  L YLH   ++ IV+ D+KP NILLD      ++DFGL K+   +  T +    
Sbjct: 102 AAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC- 157

Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APEV  +      +  D +  G ++ EM  G
Sbjct: 158 -GTPEYLAPEVIRKQ--PYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 48.1 bits (114), Expect = 1e-06
 Identities = 39/117 (33%), Positives = 64/117 (54%), Gaps = 15/117 (12%)

Query: 18  GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ 77
           G R  E    Y + G +  GL++LH   N RI+H D+K +NILL  +   K+ DFG++ Q
Sbjct: 122 GQRLDEAMISYILYGALL-GLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177

Query: 78  ---SQDKKSTISMLHARGTIGYIAPEVF-CRSFGGASH--KSDVYSYGMMILEMAVG 128
              ++ +++T     + GT  ++APEV  C      S+  + DV+S G+  +E+  G
Sbjct: 178 LTSTRLRRNT-----SVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 47.8 bits (113), Expect = 1e-06
 Identities = 33/106 (31%), Positives = 60/106 (56%), Gaps = 10/106 (9%)

Query: 21  TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD 80
           TL  + +   A  +ARG++YL +    + +H D+   NIL+ E++  KI+DFGL++  + 
Sbjct: 108 TLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEV 164

Query: 81  K-KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
             K T+  L  R    ++A E    ++   +  SDV+SYG+++ E+
Sbjct: 165 YVKKTMGRLPVR----WMAIESL--NYSVYTTNSDVWSYGVLLWEI 204

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 48.0 bits (114), Expect = 1e-06
 Identities = 36/103 (34%), Positives = 57/103 (55%), Gaps = 13/103 (12%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
           VYQ+      GL+Y+H      I+H D+KP N+ ++ED   KI DFGLA+ + D + T  
Sbjct: 123 VYQML----CGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHA-DAEMTGY 174

Query: 87  MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           ++    T  Y APEV   ++   +   D++S G ++ EM  G+
Sbjct: 175 VV----TRWYRAPEVIL-NWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 47.9 bits (114), Expect = 2e-06
 Identities = 42/142 (29%), Positives = 65/142 (45%), Gaps = 17/142 (11%)

Query: 41  LHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPE 100
           +H+   +  VH DIKP N+LLD++   +++DFG   +      T+    A GT  YI+PE
Sbjct: 118 VHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLR-LLADGTVQSNVAVGTPDYISPE 173

Query: 101 VFCRSFGGASH---KSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND 157
           +      G      + D +S G+ + EM  G       A    + Y    I  H      
Sbjct: 174 ILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE--TPFYAESLVETY--GKIMNH---KEH 226

Query: 158 FQLDGVVT---EEEKELVKKMI 176
           FQ    VT   EE K+L++++I
Sbjct: 227 FQFPPDVTDVSEEAKDLIRRLI 248

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 47.7 bits (114), Expect = 2e-06
 Identities = 48/205 (23%), Positives = 80/205 (39%), Gaps = 65/205 (31%)

Query: 27  VYQIAGGIARGLEYLHR-GCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK---QSQDKK 82
           +YQ+     + L+++HR G    I H DIKP NIL+ +D   K++DFG  +         
Sbjct: 106 MYQLL----KSLDHMHRNG----IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYT 156

Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMA---------------- 126
             IS      T  Y APE      G    K D+++ G +  E+                 
Sbjct: 157 EYIS------TRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIA 209

Query: 127 -----VGRKNADV----KASRSSDIYFPNS----IYKHIEPGNDFQLDGVVTEEEKELVK 173
                +G  +A+V    + SR  +  FP+     + K +   +   LD         L+K
Sbjct: 210 KIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLD---------LLK 260

Query: 174 KMILVSLWCIQTNPSDRPSMHEVLE 198
           K+       +  +P +R +  + L 
Sbjct: 261 KL-------LAYDPDERITAKQALR 278

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 47.2 bits (112), Expect = 3e-06
 Identities = 37/114 (32%), Positives = 58/114 (50%), Gaps = 11/114 (9%)

Query: 31  AGGIARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           A  I   L +LH +G    I++ D+K  N+LLD +   K++DFG+ K+      T S   
Sbjct: 102 AAEITSALMFLHDKG----IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC 157

Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIY 143
             GT  YIAPE+      G S   D ++ G+++ EM  G  +A  +A    D++
Sbjct: 158 --GTPDYIAPEILQEMLYGPS--VDWWAMGVLLYEMLCG--HAPFEAENEDDLF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 46.9 bits (111), Expect = 3e-06
 Identities = 30/84 (35%), Positives = 48/84 (57%), Gaps = 12/84 (14%)

Query: 49  IVHFDIKPHNILLDEDFCPKISDFG----LAKQSQDKKSTISMLHARGTIGYIAPEVFCR 104
           ++H DIK  +ILL  D   K+SDFG    ++K+   +KS +      GT  ++APE+  R
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV------GTPYWMAPELISR 190

Query: 105 SFGGASHKSDVYSYGMMILEMAVG 128
              G   + D++S G+M++EM  G
Sbjct: 191 LPYGP--EVDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 46.9 bits (111), Expect = 3e-06
 Identities = 35/100 (35%), Positives = 57/100 (57%), Gaps = 9/100 (9%)

Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ-DKKSTISMLH 89
           A  IA GL +LH   +  I++ D+K  N++LD +   KI+DFG+ K++  D  +T +   
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC- 162

Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             GT  YIAPE+      G S   D +++G+++ EM  G+
Sbjct: 163 --GTPDYIAPEIIAYQPYGKS--VDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 46.8 bits (111), Expect = 3e-06
 Identities = 50/212 (23%), Positives = 89/212 (41%), Gaps = 41/212 (19%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M +G L  F           TL  +T+ +    IA G+EYL    +   +H D+   N +
Sbjct: 89  MKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCM 145

Query: 61  LDEDFCPKISDFGLAKQ--SQD--KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVY 116
           L+E+    ++DFGL+K+  S D  ++   S L     + ++A E    +    +  SDV+
Sbjct: 146 LNENMTVCVADFGLSKKIYSGDYYRQGCASKL----PVKWLALESLADNV--YTTHSDVW 199

Query: 117 SYGMMILEMAV-------GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEK 169
           ++G+ + E+         G +N++              IY ++  GN  +      E+  
Sbjct: 200 AFGVTMWEIMTRGQTPYAGVENSE--------------IYNYLIKGNRLKQPPDCLEDVY 245

Query: 170 ELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE 201
           EL+ +       C    P  RPS   + + LE
Sbjct: 246 ELMCQ-------CWSPEPKCRPSFQHLRDQLE 270

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 46.6 bits (110), Expect = 3e-06
 Identities = 32/105 (30%), Positives = 54/105 (51%), Gaps = 5/105 (4%)

Query: 21  TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD 80
           TLE      I   IA G+E+L    +  +VH D+   N+L+ +    KISD GL ++   
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176

Query: 81  KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
                 M ++   I +++PE     +G  S  SD++SYG+++ E+
Sbjct: 177 ADYYKLMGNSLLPIRWMSPEAI--MYGKFSIDSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 46.2 bits (109), Expect = 5e-06
 Identities = 34/94 (36%), Positives = 53/94 (56%), Gaps = 10/94 (10%)

Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGL-AKQSQDKKSTISMLHARGTIG 95
            L YLH     +I+H D+K  NIL   D   K++DFG+ AK ++  +   S +   GT  
Sbjct: 115 ALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI---GTPY 168

Query: 96  YIAPE-VFCRSFGGASH--KSDVYSYGMMILEMA 126
           ++APE V C +     +  K+DV+S G+ ++EMA
Sbjct: 169 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 202

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 46.2 bits (110), Expect = 5e-06
 Identities = 26/106 (24%), Positives = 48/106 (45%), Gaps = 10/106 (9%)

Query: 29  QIAGGIARGLEYLHR-GCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ--SQDKKSTI 85
            I   +   L+Y+H  G     +H  +K  +ILL  D    +S    +       K+  +
Sbjct: 105 FILKDVLNALDYIHSKGF----IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160

Query: 86  SMLHARGTIG---YIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
                + ++    +++PEV  ++  G + KSD+YS G+   E+A G
Sbjct: 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 46.4 bits (110), Expect = 5e-06
 Identities = 41/130 (31%), Positives = 60/130 (46%), Gaps = 14/130 (10%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +P    D +TY        R L    V  +A  +   ++Y+H      I+H DIK  N+L
Sbjct: 239 LPKYRSDLYTY---LGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVL 292

Query: 61  LD--EDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKS-DVYS 117
           ++  ED C  + DFG A  ++   ST       GT+   APEV     G     S D++S
Sbjct: 293 VNGPEDIC--LGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLA---GDPYTPSVDIWS 347

Query: 118 YGMMILEMAV 127
            G++I E AV
Sbjct: 348 AGLVIFEAAV 357

Length = 461

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 46.2 bits (109), Expect = 5e-06
 Identities = 45/143 (31%), Positives = 67/143 (46%), Gaps = 16/143 (11%)

Query: 41  LHRGCNVRIVHFDIKPHNILLDEDFCPKISDFG-LAKQSQDKKSTISMLHARGTIGYIAP 99
           +H    +  VH DIKP N+LLD +   +++DFG   K +QD   T+    A GT  YI+P
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD--GTVQSSVAVGTPDYISP 172

Query: 100 EVFCR---SFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN 156
           E+        G    + D +S G+ + EM  G       A    + Y    I  H E   
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFYAESLVETY--GKIMNHEE--- 225

Query: 157 DFQLD---GVVTEEEKELVKKMI 176
            FQ       V+EE K+L++++I
Sbjct: 226 RFQFPSHITDVSEEAKDLIQRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 45.7 bits (108), Expect = 6e-06
 Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 14/92 (15%)

Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK---QSQDKKSTISMLHARGT 93
           G+ Y+H+    RI+H D+K  NI L  +   KI DFG+++    S D  +T +     GT
Sbjct: 118 GVHYMHQR---RILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTFT-----GT 168

Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
             Y++PE       G   KSD++S G ++ EM
Sbjct: 169 PYYMSPEAL--KHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 46.7 bits (111), Expect = 6e-06
 Identities = 32/110 (29%), Positives = 52/110 (47%), Gaps = 25/110 (22%)

Query: 34  IARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK---QSQDKKSTIS--- 86
           I   +EY+H +G    ++H D+KP NILL       I D+G A      ++    I    
Sbjct: 122 ICATIEYVHSKG----VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177

Query: 87  --MLHAR--------GTIGYIAPEVFCRSFGG-ASHKSDVYSYGMMILEM 125
             + ++         GT  Y+APE   R  G  AS  +D+Y+ G+++ +M
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPE---RLLGVPASESTDIYALGVILYQM 224

Length = 932

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 46.2 bits (109), Expect = 6e-06
 Identities = 37/125 (29%), Positives = 50/125 (40%), Gaps = 47/125 (37%)

Query: 50  VHFDIKPHNILLDEDFCPKISDFGLA---KQSQDKKSTISMLHAR--------------- 91
           +H DIKP NIL+D D   K++DFGL    + + D K   S  H R               
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 92  ---------------------------GTIGYIAPEVFCRSFGGASHKSDVYSYGMMILE 124
                                      GT  YIAPEV  R+  G +   D +S G+++ E
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVGVILYE 240

Query: 125 MAVGR 129
           M VG+
Sbjct: 241 MLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 45.8 bits (108), Expect = 6e-06
 Identities = 34/108 (31%), Positives = 51/108 (47%), Gaps = 10/108 (9%)

Query: 20  RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ 79
           + L+   +  +  G  +GL YLH   +  ++H D+K  NILL E    K+ DFG A    
Sbjct: 110 KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166

Query: 80  DKKSTISMLHARGTIGYIAPEV-FCRSFGGASHKSDVYSYGMMILEMA 126
                +      GT  ++APEV      G    K DV+S G+  +E+A
Sbjct: 167 PANXFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 208

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 45.5 bits (108), Expect = 8e-06
 Identities = 46/184 (25%), Positives = 78/184 (42%), Gaps = 38/184 (20%)

Query: 29  QIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP------KISDFGLAKQ----S 78
             A  +A+G +YL        +H DI   N LL    C       KI+DFG+A+     S
Sbjct: 120 FCARDVAKGCKYLEEN---HFIHRDIAARNCLLT---CKGPGRVAKIADFGMARDIYRAS 173

Query: 79  QDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILE-MAVGRKNADVKAS 137
             +K   +ML     I ++ PE F    G  + K+DV+S+G+++ E  ++G         
Sbjct: 174 YYRKGGRAML----PIKWMPPEAFLD--GIFTSKTDVWSFGVLLWEIFSLGY-------- 219

Query: 138 RSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVL 197
               + +P    +  +   +F   G   +  K     +  +   C Q  P DRP+   +L
Sbjct: 220 ----MPYPG---RTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATIL 272

Query: 198 EMLE 201
           E ++
Sbjct: 273 ERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 45.7 bits (108), Expect = 8e-06
 Identities = 33/105 (31%), Positives = 47/105 (44%), Gaps = 24/105 (22%)

Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ----------SQD 80
           A  I  G+ YLH   +   +H D+   N+LLD D   KI DFGLAK            +D
Sbjct: 113 AQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 169

Query: 81  KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
             S +          + A E  C      S+ SDV+S+G+ + E+
Sbjct: 170 GDSPVF---------WYAVE--CLKENKFSYASDVWSFGVTLYEL 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 45.4 bits (107), Expect = 1e-05
 Identities = 36/119 (30%), Positives = 59/119 (49%), Gaps = 8/119 (6%)

Query: 11  YDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDED-FCPKI 69
           Y +  +  N  L    V   +  + R L Y+H   +  I H D+KP N+L+D +    K+
Sbjct: 156 YMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKL 212

Query: 70  SDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            DFG AK     + ++S + +R    Y APE+   +    +H  D++S G +I EM +G
Sbjct: 213 CDFGSAKNLLAGQRSVSYICSR---FYRAPELMLGATNYTTH-IDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 45.0 bits (106), Expect = 1e-05
 Identities = 31/96 (32%), Positives = 47/96 (48%), Gaps = 10/96 (10%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIG 95
           RGL Y+H      I+H D+KP N+L+      K++DFGLA+       T S      T+ 
Sbjct: 114 RGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLW 168

Query: 96  YIAPEVFCRSFGGASHKS--DVYSYGMMILEMAVGR 129
           Y  P+V     G   + S  D++  G + +EM  G+
Sbjct: 169 YRPPDVL---LGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 44.9 bits (106), Expect = 1e-05
 Identities = 56/211 (26%), Positives = 88/211 (41%), Gaps = 41/211 (19%)

Query: 2   PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL 61
           P G L  +      +    T +  T+ ++A  IA GL +LH+      +H D+   N LL
Sbjct: 78  PLGDLKGYLRSCRKAE-LMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLL 133

Query: 62  DEDFCPKISDFGLA--KQSQDKKSTISMLHARGTIGYIAPEVFCRSFGG-----ASHKSD 114
             D   KI D+GL+  K  +D   T   L     + +IAPE+     G       + +S+
Sbjct: 134 TADLTVKIGDYGLSHNKYKEDYYVTPDQLWV--PLRWIAPELVDEVHGNLLVVDQTKESN 191

Query: 115 VYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ-LDGVVTEEEKELVK 173
           V+S G+ I E+                    +  Y+H+   +D Q L   V E++ +L K
Sbjct: 192 VWSLGVTIWEL----------------FELGSQPYRHL---SDEQVLTYTVREQQLKLPK 232

Query: 174 KMILVSL---W--CIQT---NPSDRPSMHEV 196
             + + L   W   +Q     P  RPS  EV
Sbjct: 233 PRLKLPLSDRWYEVMQFCWLQPEQRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 45.0 bits (106), Expect = 1e-05
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 12/95 (12%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIG 95
           +GL YLH    +   H DIK  NILL ++   K++DFG+A      K T ++   +  IG
Sbjct: 117 QGLAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVA-----AKITATIAKRKSFIG 168

Query: 96  ---YIAPEVFC-RSFGGASHKSDVYSYGMMILEMA 126
              ++APEV      GG +   D+++ G+  +E+A
Sbjct: 169 TPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELA 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 45.6 bits (108), Expect = 1e-05
 Identities = 32/117 (27%), Positives = 52/117 (44%), Gaps = 23/117 (19%)

Query: 49  IVHFDIKPHNILL---DEDFCPKISDFGL--------AKQSQDKKSTISMLHARGTIGYI 97
           IVH D+KP NI++         K+ DFG+                 T  +L   GT  Y 
Sbjct: 100 IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVL---GTPTYC 156

Query: 98  APEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEP 154
           APE   R     +  SD+Y++G++ LE   G++   V+ +  ++I      Y+ + P
Sbjct: 157 APEQL-RG-EPVTPNSDLYAWGLIFLECLTGQRV--VQGASVAEIL-----YQQLSP 204

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 44.9 bits (106), Expect = 1e-05
 Identities = 38/138 (27%), Positives = 65/138 (47%), Gaps = 18/138 (13%)

Query: 1   MPNGSLDQF----TYDQESSNGNR---------TLEWRTVYQIAGGIARGLEYLHRGCNV 47
           M NG L+QF      D +  NGN           + + ++  +A  IA G++YL    ++
Sbjct: 101 MENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSL 157

Query: 48  RIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFG 107
             VH D+   N L+ E+   KI+DFG+++             A   I ++A E  C   G
Sbjct: 158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWE--CILMG 215

Query: 108 GASHKSDVYSYGMMILEM 125
             +  SDV+++G+ + E+
Sbjct: 216 KFTTASDVWAFGVTLWEI 233

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 44.9 bits (107), Expect = 1e-05
 Identities = 29/92 (31%), Positives = 44/92 (47%), Gaps = 10/92 (10%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIG 95
            G+ +LH      I+H D+K  N+LL+     KI DFGLA++        + L    T+ 
Sbjct: 117 SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV--TLW 171

Query: 96  YIAPEVFCRSFGGA--SHKSDVYSYGMMILEM 125
           Y APE+     G    S   D++S G +  E+
Sbjct: 172 YRAPELL---LGAKEYSTAIDMWSVGCIFAEL 200

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 45.0 bits (106), Expect = 1e-05
 Identities = 35/131 (26%), Positives = 61/131 (46%), Gaps = 11/131 (8%)

Query: 1   MPNGSLDQFTYDQE------SSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDI 54
           M NG L+QF   +E       +N   ++    +  +A  IA G++YL    ++  VH D+
Sbjct: 99  MENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDL 155

Query: 55  KPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSD 114
              N L+   +  KI+DFG+++             A   I ++A E      G  +  SD
Sbjct: 156 ATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESIL--LGKFTTASD 213

Query: 115 VYSYGMMILEM 125
           V+++G+ + EM
Sbjct: 214 VWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 44.8 bits (106), Expect = 1e-05
 Identities = 34/127 (26%), Positives = 56/127 (44%), Gaps = 13/127 (10%)

Query: 4   GSLDQF---TYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           G L QF   T  ++       L  +    +   IA G+++L    N R VH D+   N L
Sbjct: 93  GDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCL 149

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLH--ARGTIGYIAPEVFCRSFGGASHKSDVYSY 118
           +      K+S   L+K   D  ++       A   + ++APE         S KSDV+S+
Sbjct: 150 VSSQREVKVSLLSLSK---DVYNSEYYKLRNALIPLRWLAPE--AVQEDDFSTKSDVWSF 204

Query: 119 GMMILEM 125
           G+++ E+
Sbjct: 205 GVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 44.6 bits (105), Expect = 1e-05
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 6/92 (6%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ-SQDKKSTISMLHARG 92
           ++ G++YL  G N   VH D+   N+LL      KISDFGL+K    D     +    + 
Sbjct: 104 VSMGMKYLE-GKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW 160

Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILE 124
            + + APE  C +F   S +SDV+SYG+ + E
Sbjct: 161 PLKWYAPE--CINFRKFSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 44.5 bits (105), Expect = 1e-05
 Identities = 50/218 (22%), Positives = 86/218 (39%), Gaps = 47/218 (21%)

Query: 1   MPNGSLDQFTYD-QESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           M  G L  +  D +    G   L  + +  I   +A+G  YL +   +  +H D+   N 
Sbjct: 81  MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNC 137

Query: 60  LLDED--FCP---KISDFGLAKQ--SQD--KKSTISMLHARGTIGYIAPEVFCRSFGGAS 110
           L+ E         KI DFGLA+     D  +K    +L  R    ++APE      G  +
Sbjct: 138 LVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR----WMAPESLLD--GKFT 191

Query: 111 HKSDVYSYGMMILEMAV-------GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGV 163
            +SDV+S+G+++ E+            N +V                H+  G   Q    
Sbjct: 192 TQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQ--------------HVTAGGRLQKPEN 237

Query: 164 VTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE 201
             ++  +L+         C   +PS+RP+   + E+L+
Sbjct: 238 CPDKIYQLMTN-------CWAQDPSERPTFDRIQEILQ 268

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 44.6 bits (106), Expect = 2e-05
 Identities = 42/163 (25%), Positives = 68/163 (41%), Gaps = 37/163 (22%)

Query: 28  YQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL----DEDFCPKISDFGLAKQSQDKKS 83
           +QI  G+     YLH      ++H D+KP NIL+     E    KI D GLA+       
Sbjct: 115 WQILNGVH----YLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN--AP 165

Query: 84  TISMLHARG---TIGYIAPEVFCRSFGGASHKS---DVYSYGMMILEMAVGR-----KNA 132
              +        TI Y APE+      GA H +   D+++ G +  E+         + A
Sbjct: 166 LKPLADLDPVVVTIWYRAPELLL----GARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221

Query: 133 DVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKM 175
            +K S         + ++  +    F++ G  TE++   +KKM
Sbjct: 222 KIKKS---------NPFQRDQLERIFEVLGTPTEKDWPDIKKM 255

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 44.5 bits (105), Expect = 2e-05
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 13/94 (13%)

Query: 38  LEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK---QSQDKKSTISMLHARGTI 94
           LE LH+     +++ D+KP NILLD      + DFGL K   +  DK +T       GT 
Sbjct: 106 LENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-----GTP 157

Query: 95  GYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            Y+APE+      G +   D ++ G+++ EM  G
Sbjct: 158 EYLAPELL--LGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 43.9 bits (104), Expect = 2e-05
 Identities = 32/117 (27%), Positives = 55/117 (47%), Gaps = 15/117 (12%)

Query: 15  SSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGL 74
            +N  + L  + +  +A  IA G+ YLH+     ++H DI   N ++DE+   KI+D  L
Sbjct: 107 EANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNAL 163

Query: 75  AKQSQDKKSTISMLHARGT-----IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMA 126
              S+D        H  G      + ++A E         S  SDV+S+G+++ E+ 
Sbjct: 164 ---SRDLFP--MDYHCLGDNENRPVKWMALESLVNKE--YSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 44.5 bits (105), Expect = 2e-05
 Identities = 29/83 (34%), Positives = 44/83 (53%), Gaps = 12/83 (14%)

Query: 48  RIVHFDIKPHNILLDEDFCPKISDFGLAKQ-----SQDKKSTISMLHARGTIGYIAPEVF 102
            ++H DIK  NILL  +   K+ DFG +K      S D   T       GT  Y+APE++
Sbjct: 163 HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC-----GTPYYVAPEIW 217

Query: 103 CRSFGGASHKSDVYSYGMMILEM 125
            R     S K+D++S G+++ E+
Sbjct: 218 RRK--PYSKKADMFSLGVLLYEL 238

Length = 496

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 43.8 bits (104), Expect = 3e-05
 Identities = 21/40 (52%), Positives = 26/40 (65%), Gaps = 3/40 (7%)

Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK 76
           G+ YLH   N  I+H DIK  NIL+D     KI+DFGLA+
Sbjct: 127 GINYLH--EN-HILHRDIKAANILIDNQGILKIADFGLAR 163

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 43.8 bits (103), Expect = 3e-05
 Identities = 36/127 (28%), Positives = 66/127 (51%), Gaps = 13/127 (10%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +P+GSL ++       N N+ +  +   + A  I +G++YL    + + VH D+   N+L
Sbjct: 90  LPSGSLKEYL----PRNKNK-INLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVL 141

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGT-IGYIAPEVFCRS-FGGASHKSDVYSY 118
           ++ +   KI DFGL K  +  K   ++     + + + APE   +S F  A   SDV+S+
Sbjct: 142 VESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIA---SDVWSF 198

Query: 119 GMMILEM 125
           G+ + E+
Sbjct: 199 GVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 43.8 bits (103), Expect = 3e-05
 Identities = 49/211 (23%), Positives = 85/211 (40%), Gaps = 31/211 (14%)

Query: 1   MPNGSLDQFT----------YDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIV 50
           M +G L++F            D +       L    +  IA  IA G+ YL    +   V
Sbjct: 89  MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFV 145

Query: 51  HFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPE-VFCRSFGGA 109
           H D+   N L+  +   KI DFG+++            H    I ++ PE +  R F   
Sbjct: 146 HRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF--- 202

Query: 110 SHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEK 169
           + +SDV+S+G+++ E+    K    + S          + + I  G        V E  +
Sbjct: 203 TTESDVWSFGVILWEIFTYGKQPWFQLS-------NTEVIECITQGR-------VLERPR 248

Query: 170 ELVKKMILVSLWCIQTNPSDRPSMHEVLEML 200
              K++  + L C Q  P  R ++ E+ ++L
Sbjct: 249 VCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 44.1 bits (104), Expect = 3e-05
 Identities = 49/184 (26%), Positives = 82/184 (44%), Gaps = 41/184 (22%)

Query: 29  QIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ--SQD--KKST 84
            IA  +A G+ YL      + VH D+   N L+ E+   KI+DFGL++   S D  K S 
Sbjct: 134 CIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASE 190

Query: 85  ISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIY 143
              +  R    ++ PE +F   +   + +SDV++YG+++ E+           S     Y
Sbjct: 191 NDAIPIR----WMPPESIFYNRY---TTESDVWAYGVVLWEI----------FSYGMQPY 233

Query: 144 FPNS---IYKHIEPGNDFQLDGVVTEEEK---ELVKKMILVSLWCIQTNPSDRPSMHEVL 197
           +  +   +  ++  GN      V++  +    EL   M L    C    PSDRPS   + 
Sbjct: 234 YGMAHEEVIYYVRDGN------VLSCPDNCPLELYNLMRL----CWSKLPSDRPSFASIN 283

Query: 198 EMLE 201
            +L+
Sbjct: 284 RILQ 287

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 43.9 bits (103), Expect = 4e-05
 Identities = 27/78 (34%), Positives = 43/78 (55%), Gaps = 2/78 (2%)

Query: 48  RIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFG 107
           +++H D+K  NI L      K+ DFG +KQ  D  S        GT  Y+APE++ R   
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERK-- 246

Query: 108 GASHKSDVYSYGMMILEM 125
             S K+D++S G+++ E+
Sbjct: 247 RYSKKADMWSLGVILYEL 264

Length = 478

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 43.2 bits (102), Expect = 4e-05
 Identities = 36/112 (32%), Positives = 57/112 (50%), Gaps = 21/112 (18%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDK---KSTISMLHA 90
           ++  L YL    + R VH DI   N+L+    C K+ DFGL++  +D+   K++   L  
Sbjct: 116 LSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL-- 170

Query: 91  RGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEMAV-------GRKNADV 134
              I ++APE +  R F  A   SDV+ +G+ + E+ +       G KN DV
Sbjct: 171 --PIKWMAPESINFRRFTSA---SDVWMFGVCMWEILMLGVKPFQGVKNNDV 217

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 43.5 bits (102), Expect = 5e-05
 Identities = 32/93 (34%), Positives = 48/93 (51%), Gaps = 8/93 (8%)

Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH   +  I+H D+KP NI++  D   KI DFGLA+ +    ++  M     T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191

Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
            APEV      G     D++S G ++ EM  G 
Sbjct: 192 RAPEVILGM--GYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 43.2 bits (102), Expect = 5e-05
 Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 10/98 (10%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLD-EDFCPKISDFGLAK---QSQDKKSTISMLHAR 91
           RGL+Y+H   +  ++H D+KP N+ ++ ED   KI DFGLA+        K  +S     
Sbjct: 125 RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE--GL 179

Query: 92  GTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
            T  Y +P +   S    +   D+++ G +  EM  G+
Sbjct: 180 VTKWYRSPRLLL-SPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 43.1 bits (101), Expect = 6e-05
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 16/104 (15%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
           +YQ+  GI    ++LH   +  I+H D+KP NI++  D   KI DFGLA+ +    +   
Sbjct: 129 LYQMLCGI----KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFM 178

Query: 87  MLHARGTIGYIAPEVFCRSFGGASHKS--DVYSYGMMILEMAVG 128
           M     T  Y APEV      G  +K   D++S G ++ E+  G
Sbjct: 179 MTPYVVTRYYRAPEVIL----GMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 43.1 bits (101), Expect = 6e-05
 Identities = 33/105 (31%), Positives = 54/105 (51%), Gaps = 21/105 (20%)

Query: 29  QIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST---- 84
            IA  IA G+ YL    ++  VH D+   N L+ +    KI DFG+   S+D  ST    
Sbjct: 126 AIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGM---SRDIYSTDYYR 179

Query: 85  ---ISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEM 125
               +ML  R    ++ PE +  R F   + +SD++S+G+++ E+
Sbjct: 180 VGGRTMLPIR----WMPPESILYRKF---TTESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 42.6 bits (100), Expect = 8e-05
 Identities = 25/81 (30%), Positives = 43/81 (53%), Gaps = 8/81 (9%)

Query: 1   MPNGSLDQFTYDQESSNG-----NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIK 55
           M NG L+QF    E           T+ + T+  +A  IA G++YL    ++  VH D+ 
Sbjct: 101 MENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLA 157

Query: 56  PHNILLDEDFCPKISDFGLAK 76
             N L+ +++  KI+DFG+++
Sbjct: 158 TRNCLVGKNYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 42.8 bits (100), Expect = 8e-05
 Identities = 31/89 (34%), Positives = 47/89 (52%), Gaps = 8/89 (8%)

Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH   +  I+H D+KP NI++  D   KI DFGLA+ +    ++  M     T  Y
Sbjct: 131 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 184

Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEM 125
            APEV      G     D++S G ++ EM
Sbjct: 185 RAPEVILGM--GYKENVDIWSVGCIMGEM 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 42.3 bits (99), Expect = 9e-05
 Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 14/96 (14%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ----DKKSTISMLHAR 91
           +GL YLH   +   +H DIK  NILL ++   K++DFG++ Q       +KS I      
Sbjct: 117 QGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI------ 167

Query: 92  GTIGYIAPEVFC-RSFGGASHKSDVYSYGMMILEMA 126
           GT  ++APEV      GG +   D+++ G+  +E+A
Sbjct: 168 GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELA 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 42.7 bits (100), Expect = 1e-04
 Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 7/93 (7%)

Query: 34  IARGLEYL-HRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           +A G+E+L  + C    VH D+   N+L+ E    KI DFGLA+      + IS      
Sbjct: 248 VANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303

Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
            + ++APE    +    +  SDV+S+G+++ E+
Sbjct: 304 PLKWMAPESIFNNL--YTTLSDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 42.4 bits (99), Expect = 1e-04
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 10/97 (10%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + RGL Y+H+     I+H D+KP N+L+ +    K++DFGLA+       T S  +   T
Sbjct: 112 LLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS--NEVVT 166

Query: 94  IGYIAPEVFCRSFGGASHKS--DVYSYGMMILEMAVG 128
           + Y  P+V     G   + +  D++  G + +EM  G
Sbjct: 167 LWYRPPDVL---LGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 42.4 bits (99), Expect = 1e-04
 Identities = 41/133 (30%), Positives = 63/133 (47%), Gaps = 14/133 (10%)

Query: 50  VHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGA 109
           VH DIKP NIL+D +   +++DFG   +  +  +  S + A GT  YI+PE+      G 
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGTPDYISPEILQAMEDGK 182

Query: 110 SH---KSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVT- 165
                + D +S G+ + EM  G       A    + Y    I  H E    FQ    VT 
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGE--TPFYAESLVETY--GKIMNHKE---RFQFPAQVTD 235

Query: 166 --EEEKELVKKMI 176
             E+ K+L++++I
Sbjct: 236 VSEDAKDLIRRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 42.5 bits (100), Expect = 1e-04
 Identities = 43/180 (23%), Positives = 70/180 (38%), Gaps = 66/180 (36%)

Query: 50  VHFDIKPHNILLDEDFCPKISDFGL---------------------AKQSQDKKSTISM- 87
           +H DIKP NIL+D     K+SDFGL                      K   D ++++++ 
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182

Query: 88  --------------------LHARGTIG---YIAPEVFCRSFGGASHKSDVYSYGMMILE 124
                               L A  T+G   YIAPE+F +   G   + D +S G ++ E
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ--GYGQECDWWSLGAIMFE 240

Query: 125 MAVG-------------RKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKEL 171
             +G             RK  + + +    +YFP+ I  H+    +  +  ++T  E  L
Sbjct: 241 CLIGWPPFCSENSHETYRKIINWRET----LYFPDDI--HLSVEAEDLIRRLITNAENRL 294

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 42.3 bits (99), Expect = 1e-04
 Identities = 35/101 (34%), Positives = 54/101 (53%), Gaps = 13/101 (12%)

Query: 29  QIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ--SQD--KKST 84
            IA  IA G+EYL    +   VH D+   NIL+ E    KISD GL+++  S D  +   
Sbjct: 128 HIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184

Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
            S+L  R    ++ PE     +G  S  SD++S+G+++ E+
Sbjct: 185 KSLLPIR----WMPPEAIM--YGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 41.9 bits (98), Expect = 1e-04
 Identities = 31/103 (30%), Positives = 50/103 (48%), Gaps = 10/103 (9%)

Query: 33  GIARGLEYLHR-GCNVRIVHFDIKPHNILLDEDFCPKISD----FGLAKQSQDKKSTISM 87
           G  RGL YLH+ G     +H +IK  +IL+  D    +S     + L +  Q  K     
Sbjct: 109 GALRGLNYLHQNGY----IHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDF 164

Query: 88  LH-ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
              +   + +++PE+  +   G + KSD+YS G+   E+A GR
Sbjct: 165 PQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 41.9 bits (98), Expect = 2e-04
 Identities = 37/138 (26%), Positives = 55/138 (39%), Gaps = 50/138 (36%)

Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLA--------------------- 75
            +E +H+   +  +H DIKP NIL+D D   K++DFGL                      
Sbjct: 113 AIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQD 169

Query: 76  -----------------------KQSQDKKSTISMLHAR-GTIGYIAPEVFCRSFGGASH 111
                                  +Q   K+    + H+  GT  YIAPEV  R   G + 
Sbjct: 170 SMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK--GYTQ 227

Query: 112 KSDVYSYGMMILEMAVGR 129
             D +S G+++ EM VG+
Sbjct: 228 LCDWWSVGVILFEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 41.6 bits (97), Expect = 2e-04
 Identities = 46/182 (25%), Positives = 77/182 (42%), Gaps = 24/182 (13%)

Query: 29  QIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISML 88
            IA  IA G+ YL    +   VH D+   N L+ E+   KI DFG+++            
Sbjct: 124 HIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG 180

Query: 89  HARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNS 147
           H    I ++ PE +  R F   + +SDV+S G+++ E+    K    + S        N 
Sbjct: 181 HTMLPIRWMPPESIMYRKF---TTESDVWSLGVVLWEIFTYGKQPWYQLSN-------NE 230

Query: 148 IYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPS---MHEVLEMLESST 204
           + + I  G   Q      +E  +L+       L C Q  P  R +   +H +L+ L  ++
Sbjct: 231 VIECITQGRVLQRPRTCPKEVYDLM-------LGCWQREPHMRLNIKEIHSLLQNLAKAS 283

Query: 205 EI 206
            +
Sbjct: 284 PV 285

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 41.3 bits (97), Expect = 2e-04
 Identities = 31/110 (28%), Positives = 49/110 (44%), Gaps = 20/110 (18%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ----------SQDK-- 81
           I  GL  LH       +H D+ P NI ++     KI+DFGLA++          S+D+  
Sbjct: 128 ILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184

Query: 82  KSTISMLHARGTIGYIAPEVFCRSFGGASHKS--DVYSYGMMILEMAVGR 129
           +    M     T+ Y APE+     G   +    D++S G +  E+  G+
Sbjct: 185 QRREEMTSKVVTLWYRAPELL---MGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 41.2 bits (96), Expect = 2e-04
 Identities = 34/112 (30%), Positives = 49/112 (43%), Gaps = 35/112 (31%)

Query: 50  VHFDIKPHNILLDEDFCPKISDFGLA--------------------------------KQ 77
           +H DIKP N+LLD     K+SDFGL                                 K 
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182

Query: 78  SQDKKSTISMLHAR-GTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
              KK+   + ++  GT  YIAPEVF ++  G +   D +S G+++ EM +G
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 41.0 bits (96), Expect = 2e-04
 Identities = 43/182 (23%), Positives = 77/182 (42%), Gaps = 20/182 (10%)

Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST 84
             + ++A  +A GL +LH+      +H D+   N  L  D   KI D+GLA +   +   
Sbjct: 100 DVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156

Query: 85  ISMLHARGTIGYIAPEVFCRSFGG------ASHKSDVYSYGMMILEMAVGRKNADVKASR 138
           I+       + ++APE+     G        + KS+++S G+ + E+      AD     
Sbjct: 157 ITKDCHAVPLRWLAPELV-EIRGQDLLPKDQTKKSNIWSLGVTMWELF---TAADQPYPD 212

Query: 139 SSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
            SD      + K +    D +L     + + +   +   V  +C   +P  RP+  EV E
Sbjct: 213 LSDE----QVLKQVVREQDIKLPK--PQLDLKYSDRWYEVMQFC-WLDPETRPTAEEVHE 265

Query: 199 ML 200
           +L
Sbjct: 266 LL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 40.8 bits (95), Expect = 3e-04
 Identities = 30/98 (30%), Positives = 56/98 (57%), Gaps = 14/98 (14%)

Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ---SQDKKSTISMLHARGT 93
           GL++LH     + +H D+K +NILL  +   K+ DFG++ Q   ++ +++T     + GT
Sbjct: 136 GLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT-----SVGT 187

Query: 94  IGYIAPEVF-CRSFGGASH--KSDVYSYGMMILEMAVG 128
             ++APEV  C     +++  + DV+S G+  +E+  G
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 40.4 bits (95), Expect = 4e-04
 Identities = 36/132 (27%), Positives = 66/132 (50%), Gaps = 14/132 (10%)

Query: 1   MPNGSLDQFTY-----DQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIK 55
           M NG L+QF           +  +++L + T+  +A  IA G+ YL    ++  VH D+ 
Sbjct: 101 MENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLA 157

Query: 56  PHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT--IGYIAPEVFCRSFGGASHKS 113
             N L+ +++  KI+DFG+++      S    +  R    I ++A E      G  + KS
Sbjct: 158 TRNCLVGKNYTIKIADFGMSRNLY--SSDYYRVQGRAPLPIRWMAWESVLL--GKFTTKS 213

Query: 114 DVYSYGMMILEM 125
           DV+++G+ + E+
Sbjct: 214 DVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 40.8 bits (95), Expect = 4e-04
 Identities = 33/112 (29%), Positives = 48/112 (42%), Gaps = 35/112 (31%)

Query: 50  VHFDIKPHNILLDEDFCPKISDFGLA---------------KQSQDKKSTISMLHAR--- 91
           +H DIKP N+LLD     K+SDFGL                  S     T   ++++   
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182

Query: 92  ---------------GTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
                          GT  YIAPEVF ++  G +   D +S G+++ EM +G
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 40.5 bits (95), Expect = 4e-04
 Identities = 27/93 (29%), Positives = 48/93 (51%), Gaps = 10/93 (10%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIG 95
           +GL + H      ++H D+KP N+L++++   K++DFGLA+         S      T+ 
Sbjct: 110 KGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS--AEVVTLW 164

Query: 96  YIAPEVFCRSFGGASHKS--DVYSYGMMILEMA 126
           Y  P+V    FG   + +  D++S G +  E+A
Sbjct: 165 YRPPDVL---FGAKLYSTSIDMWSAGCIFAELA 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 40.6 bits (95), Expect = 5e-04
 Identities = 19/43 (44%), Positives = 29/43 (67%), Gaps = 3/43 (6%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK 76
           +A  L+YLHR     I+H D+KP N+L+  +   K++DFGL+K
Sbjct: 113 VALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 40.4 bits (94), Expect = 6e-04
 Identities = 33/120 (27%), Positives = 58/120 (48%), Gaps = 7/120 (5%)

Query: 6   LDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF 65
           L  F YD+     +R L  +T   I   +   +EY+H   + +++H DIK  NI L+ D 
Sbjct: 249 LYSFMYDEAFDWKDRPLLKQT-RAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDG 304

Query: 66  CPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
              + DFG A   + ++         GT+   +PE+      G    +D++S G+++L+M
Sbjct: 305 KIVLGDFGTAMPFEKEREAFDYGWV-GTVATNSPEILAGD--GYCEITDIWSCGLILLDM 361

Length = 501

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 38.0 bits (88), Expect = 0.002
 Identities = 41/161 (25%), Positives = 73/161 (45%), Gaps = 22/161 (13%)

Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G++++H     R++H DIK  NI L ++   K+ DFG A+      +        GT  Y
Sbjct: 112 GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY--VGTPYY 166

Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN 156
           + PE++       ++KSD++S G ++ E+   +      +       + N I K +  G+
Sbjct: 167 VPPEIWENM--PYNNKSDIWSLGCILYELCTLKHPFQANS-------WKNLILK-VCQGS 216

Query: 157 DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVL 197
              L    + E + L+K+M        + NP  RPS   +L
Sbjct: 217 YKPLPSHYSYELRSLIKQM-------FKRNPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 39.0 bits (90), Expect = 0.002
 Identities = 37/130 (28%), Positives = 54/130 (41%), Gaps = 26/130 (20%)

Query: 22  LEWRTVYQIAGGIARGLEYLHR---GCN-VRIVHFDIKPHNILLDEDF------------ 65
           +E   +  I   +   L Y H    G N  R++H D+KP NI L                
Sbjct: 115 IEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174

Query: 66  -----CPKISDFGLAKQSQDKKSTISMLHA-RGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
                  KI DFGL+K    +    SM H+  GT  Y +PE+          KSD+++ G
Sbjct: 175 LNGRPIAKIGDFGLSKNIGIE----SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALG 230

Query: 120 MMILEMAVGR 129
            +I E+  G+
Sbjct: 231 CIIYELCSGK 240

Length = 1021

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 37.4 bits (87), Expect = 0.004
 Identities = 43/201 (21%), Positives = 81/201 (40%), Gaps = 41/201 (20%)

Query: 11  YDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPH------NILLDED 64
           Y +E  +  + L ++T   +A    +GL  L++        +  KP+      + L+ E+
Sbjct: 108 YLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYK--------YTNKPYKNLTSVSFLVTEN 159

Query: 65  FCPKISDFGLAK-QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMIL 123
           +  KI   GL K  S      ++ +       Y + ++    F   + K D+YS G+++ 
Sbjct: 160 YKLKIICHGLEKILSSPPFKNVNFM------VYFSYKMLNDIFSEYTIKDDIYSLGVVLW 213

Query: 124 EMAVGR---KNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSL 180
           E+  G+   +N   K     +IY  + I       N  +L      E K +V+       
Sbjct: 214 EIFTGKIPFENLTTK-----EIY--DLIINKN---NSLKLPLDCPLEIKCIVEA------ 257

Query: 181 WCIQTNPSDRPSMHEVLEMLE 201
            C   +   RP++ E+L  L 
Sbjct: 258 -CTSHDSIKRPNIKEILYNLS 277

Length = 283

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	242
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	99.98
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.98
PHA02988	283	hypothetical protein; Provisional	99.98
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.98
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.97
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.97
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.97
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.97
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.97
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.97
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.97
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.97
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.97
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.97
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.97
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.97
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.97
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.97
PTZ00283	496	serine/threonine protein kinase; Provisional	99.97
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.97
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.97
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.97
KOG0595	429	consensus Serine/threonine-protein kinase involved	99.97
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.97
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.97
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.97
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.97
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.97
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.97
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.97
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.97
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.97
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.97
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.97
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.97
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.97
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.97
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.97
PTZ00267	478	NIMA-related protein kinase; Provisional	99.97
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.97
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.97
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.97
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.97
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.97
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.97
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.97
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.97
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.97
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.97
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.97
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.97
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.97
KOG0589	426	consensus Serine/threonine protein kinase [General	99.97
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.96
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.96
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.96
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.96
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.96
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.96
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.96
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.96
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.96
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.96
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.96
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.96
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.96
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.96
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.96
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.96
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.96
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.96
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.96
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.96
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.96
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.96
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.96
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.96
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.96
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.96
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.96
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.96
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.96
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.96
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.96
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.96
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.96
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.96
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.96
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.96
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.96
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.96
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.96
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.96
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.96
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.96
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.96
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.96
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.96
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.96
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.96
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.96
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.96
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.96
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.96
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.96
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.96
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.96
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.96
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.96
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.96
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.96
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.96
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.96
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.96
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.96
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.96
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.96
PHA03212	391	serine/threonine kinase US3; Provisional	99.96
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.96
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.96
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.96
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.96
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.96
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.96
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.96
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.96
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.96
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.96
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.96
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.96
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.96
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.96
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.96
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.96
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.96
PHA03211	461	serine/threonine kinase US3; Provisional	99.96
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.96
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.96
PTZ00284	467	protein kinase; Provisional	99.96
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.96
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.96
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.96
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.96
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.96
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.96
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.96
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.96
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.96
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.96
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.96
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.96
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.96
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.96
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.96
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.96
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.96
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.96
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.96
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.96
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.96
PTZ00036	440	glycogen synthase kinase; Provisional	99.96
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.96
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.96
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.96
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.96
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.95
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.95
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.95
PHA03207	392	serine/threonine kinase US3; Provisional	99.95
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.95
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.95
PHA02882	294	putative serine/threonine kinase; Provisional	99.95
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.95
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.95
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.95
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.95
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.95
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.95
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.95
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.95
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.95
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.95
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.95
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.95
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.95
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.95
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.95
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.95
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.95
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.95
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.95
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.95
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.95
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.95
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.95
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.95
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.95
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.95
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.95
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.95
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.95
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.95
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.95
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.95
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.95
PHA03209	357	serine/threonine kinase US3; Provisional	99.95
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.95
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.95
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.95
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.95
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.95
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.95
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.95
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.95
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.95
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.95
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.95
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.95
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.95
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.95
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.95
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.95
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.95
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.95
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.95
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.95
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.95
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.95
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.95
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.95
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.95
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.95
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.95
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.95
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.95
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.95
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.95
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.95
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.95
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.95
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.95
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.95
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.95
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.95
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.95
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.95
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.95
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.95
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.95
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.95
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.95
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.95
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.94
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.94
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.94
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.94
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.94
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.94
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.94
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.94
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.94
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.94
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.94
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.94
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.94
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.94
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.94
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.94
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.94
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.94
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.94
KOG0610	459	consensus Putative serine/threonine protein kinase	99.94
KOG0605	550	consensus NDR and related serine/threonine kinases	99.94
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.94
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.94
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.94
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.94
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.94
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.94
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.94
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.94
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.94
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.94
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.94
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.94
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.94
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.94
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.94
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.94
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.94
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.94
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.94
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.94
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.94
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.94
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.94
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.94
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.94
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.94
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.94
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.94
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.94
PHA03210	501	serine/threonine kinase US3; Provisional	99.94
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.94
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.94
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.94
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.94
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.94
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.94
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.94
KOG0584	632	consensus Serine/threonine protein kinase [General	99.94
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.94
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.94
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.94
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.93
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.93
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.93
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.93
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.93
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.93
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.93
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.93
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.93
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.93
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.93
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.93
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.93
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.93
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.93
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.93
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.93
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.93
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.93
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.93
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.93
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.93
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.93
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.93
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.93
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.93
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.93
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.93
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.93
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.93
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.93
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.93
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.93
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.92
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.92
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.92
KOG3653	534	consensus Transforming growth factor beta/activin	99.92
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.92
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.92
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.92
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.92
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.92
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.92
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.92
PLN00009	294	cyclin-dependent kinase A; Provisional	99.92
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.92
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.92
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.92
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.92
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.91
KOG0586	596	consensus Serine/threonine protein kinase [General	99.91
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.91
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.91
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.91
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.91
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.9
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.9
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.9
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.9
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.89
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.88
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.88
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.88
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.88
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.87
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.87
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.86
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.86
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.86
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.86
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.86
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.85
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.84
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.83
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.82
KOG1152	772	consensus Signal transduction serine/threonine kin	99.79
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.77
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.76
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.76
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.75
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.74
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.74
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.73
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.73
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.69
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.68
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.66
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.63
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.57
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.44
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.34
PRK09188	365	serine/threonine protein kinase; Provisional	99.31
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.28
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.27
PRK12274	218	serine/threonine protein kinase; Provisional	99.27
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.26
COG4248	637	Uncharacterized protein with protein kinase and he	99.24
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.23
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.09
smart00090	237	RIO RIO-like kinase.	99.03
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.0
PRK10345	210	hypothetical protein; Provisional	98.95
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	98.89
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	98.87
PRK14879	211	serine/threonine protein kinase; Provisional	98.82
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	98.8
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.77
PRK09605	535	bifunctional UGMP family protein/serine/threonine	98.76
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	98.6
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.51
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	98.48
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.39
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.34
KOG1243	690	consensus Protein kinase [General function predict	98.3
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.24
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.23
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.19
KOG3087	229	consensus Serine/threonine protein kinase [General	98.17
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.13
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.05
PRK09902	216	hypothetical protein; Provisional	98.02
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	97.81
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	97.66
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	97.59
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.4
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	97.24
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	96.87
COG0478	304	RIO-like serine/threonine protein kinase fused to	96.78
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	96.75
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	95.93
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	95.66
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	95.55
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	95.35
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.26
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.22
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	94.95
PF01636	239	APH: Phosphotransferase enzyme family This family	94.84
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	94.83
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	94.63
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	94.39
PRK05231	319	homoserine kinase; Provisional	94.37
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	93.96
COG0661	517	AarF Predicted unusual protein kinase [General fun	93.95
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	93.88
PRK10271	188	thiK thiamine kinase; Provisional	93.84
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	93.82
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	93.47
PLN02236	344	choline kinase	93.27
COG2334	331	Putative homoserine kinase type II (protein kinase	92.92
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	92.91
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	92.57
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	92.06
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	91.37
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	91.22
PRK06148	1013	hypothetical protein; Provisional	90.6
PHA03111	444	Ser/Thr kinase; Provisional	90.41
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	90.38
KOG1235	538	consensus Predicted unusual protein kinase [Genera	89.79
KOG2268	465	consensus Serine/threonine protein kinase [Signal	89.77
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	89.52
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	89.38
PRK11768	325	serine/threonine protein kinase; Provisional	89.12
PRK06149	972	hypothetical protein; Provisional	86.52
KOG1093	725	consensus Predicted protein kinase (contains TBC a	86.32
PRK09550	401	mtnK methylthioribose kinase; Reviewed	86.08
KOG0576	829	consensus Mitogen-activated protein kinase kinase	83.97
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	82.59
PTZ00296	442	choline kinase; Provisional	82.15
PRK12396	409	5-methylribose kinase; Reviewed	81.81
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	81.67
COG4499	434	Predicted membrane protein [Function unknown]	81.43
PF10140	359	YukC: WXG100 protein secretion system (Wss), prote	81.22

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-37  Score=244.69  Aligned_cols=174  Identities=31%  Similarity=0.439  Sum_probs=145.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhh-CCCCCeeecCCCCCceeeCCCCceEEcccccccccC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHR-GCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ   79 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~-~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~   79 (242)
                      |.+|||++++...      +++++...-+++.+|++||.|||. .   +|+||||||+|+|++.+|.|||||||.+....
T Consensus       160 MDgGSLd~~~k~~------g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv  230 (364)
T KOG0581|consen  160 MDGGSLDDILKRV------GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILV  230 (364)
T ss_pred             cCCCCHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence            7899999999876      569999999999999999999996 5   99999999999999999999999999998765


Q ss_pred             CCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           80 DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        80 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ...    .....||..|++||.+.+.  .++.++||||||+.++|+.+|+.||.........   .......+..+..+.
T Consensus       231 nS~----a~tfvGT~~YMsPERi~g~--~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~---~~~Ll~~Iv~~ppP~  301 (364)
T KOG0581|consen  231 NSI----ANTFVGTSAYMSPERISGE--SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD---IFELLCAIVDEPPPR  301 (364)
T ss_pred             hhh----cccccccccccChhhhcCC--cCCcccceecccHHHHHHhhCCCCCCCcCCCCCC---HHHHHHHHhcCCCCC
Confidence            551    2245699999999999775  7899999999999999999999999765221111   233344555666666


Q ss_pred             cccc-cchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          160 LDGV-VTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       160 ~~~~-~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ++.. ++++++.++..       ||++||.+|||+.|++++
T Consensus       302 lP~~~fS~ef~~FV~~-------CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  302 LPEGEFSPEFRSFVSC-------CLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             CCcccCCHHHHHHHHH-------HhcCCcccCCCHHHHhcC
Confidence            7765 88888888887       999999999999999965

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-35  Score=242.19  Aligned_cols=186  Identities=33%  Similarity=0.468  Sum_probs=146.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCC-eeecCCCCCceeeCCCC-ceEEccccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVR-IVHFDIKPHNILLDEDF-CPKISDFGLAKQS   78 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~-i~h~dlk~~nil~~~~~-~~~L~dfg~~~~~   78 (242)
                      |++|+|.++|...    ..+.+++..++.++.+|++|+.|||++   + |+|+|||+.|+|++.++ .+||+|||+++..
T Consensus       122 ~~~GsL~~~l~~~----~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~  194 (362)
T KOG0192|consen  122 MPGGSLSVLLHKK----RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREK  194 (362)
T ss_pred             CCCCcHHHHHhhc----ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence            6899999999874    226799999999999999999999999   7 99999999999999997 9999999999866


Q ss_pred             CCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           79 QDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        79 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      .....  ..+...||..|+|||++.+....++.++||||||+++||++||+.||......       .........+...
T Consensus       195 ~~~~~--~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-------~~~~~v~~~~~Rp  265 (362)
T KOG0192|consen  195 VISKT--SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-------QVASAVVVGGLRP  265 (362)
T ss_pred             ccccc--cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhcCCCC
Confidence            54321  11123599999999999743247899999999999999999999999755531       2222333344444


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccC
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQI  209 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~  209 (242)
                      .++..+++.+..++.       .||+.||++||++.+++..|+.+......
T Consensus       266 ~~p~~~~~~l~~l~~-------~CW~~dp~~RP~f~ei~~~l~~~~~~~~~  309 (362)
T KOG0192|consen  266 PIPKECPPHLSSLME-------RCWLVDPSRRPSFLEIVSRLESIMSHISS  309 (362)
T ss_pred             CCCccCCHHHHHHHH-------HhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence            444445555555444       49999999999999999999988775443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4e-35  Score=244.76  Aligned_cols=170  Identities=35%  Similarity=0.566  Sum_probs=142.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|..+++..      +.+++.++..+++||+.||.|||+.   +|+|||||..|+|++.+.+||++|||++.....
T Consensus       100 C~~~sL~el~Krr------k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen  100 CHRGSLMELLKRR------KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             cCCccHHHHHHhc------CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence            7899999999855      5799999999999999999999999   999999999999999999999999999997764


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ...  ...+.+||+.|.|||++...  ..++.+||||+||++|-|+.|++||....-        ......+.. ....+
T Consensus       171 ~~E--rk~TlCGTPNYIAPEVl~k~--gHsfEvDiWSlGcvmYtLL~G~PPFetk~v--------kety~~Ik~-~~Y~~  237 (592)
T KOG0575|consen  171 DGE--RKKTLCGTPNYIAPEVLNKS--GHSFEVDIWSLGCVMYTLLVGRPPFETKTV--------KETYNKIKL-NEYSM  237 (592)
T ss_pred             ccc--ccceecCCCcccChhHhccC--CCCCchhhhhhhhHHHhhhhCCCCcccchH--------HHHHHHHHh-cCccc
Confidence            322  12245799999999999754  789999999999999999999999986643        122222222 23345


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      |..++.++++++.+|+       +.||.+|||+++++.+
T Consensus       238 P~~ls~~A~dLI~~lL-------~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  238 PSHLSAEAKDLIRKLL-------RPNPSERPSLDEVLDH  269 (592)
T ss_pred             ccccCHHHHHHHHHHh-------cCCcccCCCHHHHhcC
Confidence            6678999999999976       9999999999999964

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5e-35  Score=224.10  Aligned_cols=183  Identities=28%  Similarity=0.400  Sum_probs=147.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCC--eeecCCCCCceeeCCCCceEEccccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVR--IVHFDIKPHNILLDEDFCPKISDFGLAKQS   78 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~--i~h~dlk~~nil~~~~~~~~L~dfg~~~~~   78 (242)
                      |.+|+|.+.|+..+  .+.+.+++..+|+++.|++.||+++|+.. ..  |.||||||.||+++.+|.+||+|||+++..
T Consensus       102 c~~GDLsqmIk~~K--~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen  102 CDAGDLSQMIKHFK--KQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             hcccCHHHHHHHHH--hccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            67899999987543  25578999999999999999999999942 24  999999999999999999999999999987


Q ss_pred             CCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           79 QDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        79 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      .......  ....||+.|++||.+.+.  ++++++||||+||++|||+.-.+||...+-        .....++.++..+
T Consensus       179 ~s~~tfA--~S~VGTPyYMSPE~i~~~--~Y~~kSDiWslGCllyEMcaL~~PF~g~n~--------~~L~~KI~qgd~~  246 (375)
T KOG0591|consen  179 SSKTTFA--HSLVGTPYYMSPERIHES--GYNFKSDIWSLGCLLYEMCALQSPFYGDNL--------LSLCKKIEQGDYP  246 (375)
T ss_pred             cchhHHH--HhhcCCCcccCHHHHhcC--CCCcchhHHHHHHHHHHHHhcCCCcccccH--------HHHHHHHHcCCCC
Confidence            7654432  234699999999999876  889999999999999999999999987642        4445566666655


Q ss_pred             ccc-cccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhh
Q 026160          159 QLD-GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTE  205 (242)
Q Consensus       159 ~~~-~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~  205 (242)
                      +++ ..++..+..++.-       |+..||++||+...++..+.+-.+
T Consensus       247 ~~p~~~YS~~l~~li~~-------ci~vd~~~RP~t~~~v~di~~~l~  287 (375)
T KOG0591|consen  247 PLPDEHYSTDLRELINM-------CIAVDPEQRPDTVPYVQDIQSELD  287 (375)
T ss_pred             CCcHHHhhhHHHHHHHH-------HccCCcccCCCcchHHHHHHHHhc
Confidence            555 4566666655555       789999999997667766666444

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=239.28  Aligned_cols=181  Identities=31%  Similarity=0.479  Sum_probs=148.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+.|||.+||...    ....++..+.+.++.||++|++||+++   ++|||||.++|||++.+..+|++|||+++...+
T Consensus       283 m~~GsLl~yLr~~----~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d  355 (468)
T KOG0197|consen  283 MPKGSLLDYLRTR----EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGD  355 (468)
T ss_pred             cccCcHHHHhhhc----CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCC
Confidence            7899999999873    337899999999999999999999999   999999999999999999999999999995443


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      .. .......+.++.|.|||.+...  .++.+|||||||+++||++| |+.|+.....        ......++.+....
T Consensus       356 ~~-Y~~~~~~kfPIkWtAPEa~~~~--~FS~kSDVWSFGVlL~E~fT~G~~py~~msn--------~ev~~~le~GyRlp  424 (468)
T KOG0197|consen  356 DE-YTASEGGKFPIKWTAPEALNYG--KFSSKSDVWSFGVLLWELFTYGRVPYPGMSN--------EEVLELLERGYRLP  424 (468)
T ss_pred             Cc-eeecCCCCCCceecCHHHHhhC--CcccccceeehhhhHHHHhccCCCCCCCCCH--------HHHHHHHhccCcCC
Confidence            32 2222334578899999998654  78999999999999999997 6666654432        34445677777777


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      .|..+|+++-+++.       .||+.+|++|||+..+...|+.+...
T Consensus       425 ~P~~CP~~vY~lM~-------~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  425 RPEGCPDEVYELMK-------SCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             CCCCCCHHHHHHHH-------HHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            77777777655544       49999999999999999999877653

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-35  Score=233.69  Aligned_cols=184  Identities=32%  Similarity=0.452  Sum_probs=144.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC-CCceEEcccccccccC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE-DFCPKISDFGLAKQSQ   79 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~-~~~~~L~dfg~~~~~~   79 (242)
                      +++|||.+++....     ..|++..+....+|+++||.|||++   +++|+|||++|||++. ++.+||+|||++....
T Consensus        98 ~~~GsL~~~~~~~g-----~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen   98 APGGSLSDLIKRYG-----GKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLE  169 (313)
T ss_pred             cCCCcHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence            68999999998752     1699999999999999999999999   9999999999999999 7999999999988766


Q ss_pred             CC-cccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           80 DK-KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        80 ~~-~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      .. ..........||+.|+|||++... .....++|||||||++.||+||+.||.....      ..............+
T Consensus       170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~------~~~~~~~ig~~~~~P  242 (313)
T KOG0198|consen  170 SKGTKSDSELSVQGTPNYMAPEVIRNG-EVARRESDIWSLGCTVVEMLTGKPPWSEFFE------EAEALLLIGREDSLP  242 (313)
T ss_pred             cccccccccccccCCccccCchhhcCC-CcCCccchhhhcCCEEEeccCCCCcchhhcc------hHHHHHHHhccCCCC
Confidence            41 111122235699999999998751 2334699999999999999999999986411      012222233333344


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      .++..++++.++++.+       |+.+||++||||.+++++.-.....
T Consensus       243 ~ip~~ls~~a~~Fl~~-------C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  243 EIPDSLSDEAKDFLRK-------CFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             CCCcccCHHHHHHHHH-------HhhcCcccCcCHHHHhhChhhhccc
Confidence            5666778888877777       8999999999999999987765543

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-33  Score=230.65  Aligned_cols=197  Identities=41%  Similarity=0.663  Sum_probs=148.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|||.++|......    .++|..+++|+.++++||+|||..+.+.|+|||||++|||+|.+.+.||+|||++.....
T Consensus       154 m~nGsL~d~L~~~~~~----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~  229 (361)
T KOG1187|consen  154 MPNGSLEDHLHGKKGE----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE  229 (361)
T ss_pred             cCCCCHHHHhCCCCCC----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence            7899999999875421    799999999999999999999998767899999999999999999999999999965543


Q ss_pred             -CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCC-Ccc
Q 026160           81 -KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPG-NDF  158 (242)
Q Consensus        81 -~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~  158 (242)
                       .......  ..||..|++||+...  +..+.++||||||+++.|+++|+.+.+........ .+..+.......+ ...
T Consensus       230 ~~~~~~~~--~~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~-~l~~w~~~~~~~~~~~e  304 (361)
T KOG1187|consen  230 GDTSVSTT--VMGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGEL-SLVEWAKPLLEEGKLRE  304 (361)
T ss_pred             cccceeee--cCCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCCCCCcccc-cHHHHHHHHHHCcchhh
Confidence             2221111  058999999999865  46799999999999999999999888765422221 1223322222222 122


Q ss_pred             ccccccc-hHHH--HHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          159 QLDGVVT-EEEK--ELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       159 ~~~~~~~-~~~~--~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      ..+..+. .+..  ..+.++..++.+|++.+|.+||++.++++.|+.+...
T Consensus       305 iiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  305 IVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             eeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            2222221 1111  5678899999999999999999999999999655543

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-33  Score=232.22  Aligned_cols=172  Identities=31%  Similarity=0.482  Sum_probs=141.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +|||+|-++|.+.      +.|++......+.+|+.||+|||++   |||||||||+|||+++++.++|.|||-+.....
T Consensus       156 A~nGdll~~i~K~------Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~  226 (604)
T KOG0592|consen  156 APNGDLLDLIKKY------GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSP  226 (604)
T ss_pred             cCCCcHHHHHHHh------CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence            5899999999887      5699999999999999999999999   999999999999999999999999999986653


Q ss_pred             Cccc---------ch--hcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhh
Q 026160           81 KKST---------IS--MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIY  149 (242)
Q Consensus        81 ~~~~---------~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~  149 (242)
                      ....         ..  ...++||-.|.+||.+...  ..+.++|||+|||++|+|+.|.+||...+..        .+.
T Consensus       227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~--~~~~~sDiWAlGCilyQmlaG~PPFra~Ney--------liF  296 (604)
T KOG0592|consen  227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS--PAGPSSDLWALGCILYQMLAGQPPFRAANEY--------LIF  296 (604)
T ss_pred             hhccccCccCcccccCcccceeeeecccCHHHhcCC--CCCcccchHHHHHHHHHHhcCCCCCccccHH--------HHH
Confidence            3211         11  1235799999999999775  6788999999999999999999999866531        222


Q ss_pred             hccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          150 KHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      +.+. .....++...++.+++++++++       ..||.+|+|+.++.++
T Consensus       297 qkI~-~l~y~fp~~fp~~a~dLv~KLL-------v~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  297 QKIQ-ALDYEFPEGFPEDARDLIKKLL-------VRDPSDRLTSQQIKAH  338 (604)
T ss_pred             HHHH-HhcccCCCCCCHHHHHHHHHHH-------ccCccccccHHHHhhC
Confidence            2222 1234566778899999999976       9999999999999865

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-33  Score=231.59  Aligned_cols=172  Identities=28%  Similarity=0.404  Sum_probs=141.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|-|.+...       .+++.++..|++.++.||+|||.+   +|+|+|||..|||+..+|.+||+|||++.....
T Consensus       352 m~ggsLTDvVt~~-------~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~  421 (550)
T KOG0578|consen  352 MEGGSLTDVVTKT-------RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE  421 (550)
T ss_pred             cCCCchhhhhhcc-------cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence            6899999999764       499999999999999999999999   999999999999999999999999999987765


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....||+.|+|||+....  .+.++.||||||++++||+-|++||.......      ....-..........
T Consensus       422 ~~~K--R~TmVGTPYWMAPEVvtrk--~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr------AlyLIa~ng~P~lk~  491 (550)
T KOG0578|consen  422 EQSK--RSTMVGTPYWMAPEVVTRK--PYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIATNGTPKLKN  491 (550)
T ss_pred             ccCc--cccccCCCCccchhhhhhc--ccCccccchhhhhHHHHHhcCCCCccCCChHH------HHHHHhhcCCCCcCC
Confidence            5432  2345799999999998664  67899999999999999999999998644322      111112222223444


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      +..+++++++++.+       ||..|+++|+++.+||++
T Consensus       492 ~~klS~~~kdFL~~-------cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  492 PEKLSPELKDFLDR-------CLVVDVEQRASAKELLEH  523 (550)
T ss_pred             ccccCHHHHHHHHH-------HhhcchhcCCCHHHHhcC
Confidence            66788888888888       889999999999999975

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.8e-32  Score=226.71  Aligned_cols=167  Identities=26%  Similarity=0.410  Sum_probs=124.8

Q ss_pred             ccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccccc
Q 026160           20 RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAP   99 (242)
Q Consensus        20 ~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~P   99 (242)
                      ..+++.++..++.|+++||.|||+.   +++|+||||+||+++.++.++|+|||++................++..|+||
T Consensus       169 ~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  245 (338)
T cd05102         169 SPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP  245 (338)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence            4588999999999999999999999   9999999999999999999999999999765432222111222356789999


Q ss_pred             hhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccccccccchHHHHHHHHHHHH
Q 026160          100 EVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILV  178 (242)
Q Consensus       100 E~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  178 (242)
                      |.+.+.  .++.++||||||+++|++++ |..||......       .........+.....+..+++.+.       .+
T Consensus       246 E~~~~~--~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~-------~l  309 (338)
T cd05102         246 ESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-------EEFCQRLKDGTRMRAPENATPEIY-------RI  309 (338)
T ss_pred             HHhhcC--CCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-------HHHHHHHhcCCCCCCCCCCCHHHH-------HH
Confidence            988653  57899999999999999997 99998643321       111112222222223334444444       45


Q ss_pred             HHHhccCCCCCCCCHHHHHHHhhchhh
Q 026160          179 SLWCIQTNPSDRPSMHEVLEMLESSTE  205 (242)
Q Consensus       179 ~~~cl~~dp~~Rps~~~ll~~l~~~~~  205 (242)
                      +.+||+.||++|||+.++++.|+.+..
T Consensus       310 i~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         310 MLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            555999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=1.8e-33  Score=225.29  Aligned_cols=174  Identities=29%  Similarity=0.369  Sum_probs=133.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCC---CceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDED---FCPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~---~~~~L~dfg~~~~   77 (242)
                      |+||.|.+++-.+      +.+.+.....++.|++.|+.|||++   ||+||||||+|||++.+   ..+|+.|||++..
T Consensus       258 v~GGeLfd~vv~n------k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~  328 (475)
T KOG0615|consen  258 VEGGELFDKVVAN------KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLAKV  328 (475)
T ss_pred             ecCccHHHHHHhc------cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchhhc
Confidence            6899999999877      4599999999999999999999999   99999999999999866   6799999999998


Q ss_pred             cCCCcccchhcccccccccccchhhhcccCCC-CCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCC
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCRSFGGA-SHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN  156 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~-~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  156 (242)
                      .+...-   ..+.+||+.|.|||++.+..... ..+.||||+||++|-+++|.+||.......       .....+..+.
T Consensus       329 ~g~~sf---m~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-------sl~eQI~~G~  398 (475)
T KOG0615|consen  329 SGEGSF---MKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-------SLKEQILKGR  398 (475)
T ss_pred             ccccee---hhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-------cHHHHHhcCc
Confidence            764322   23457999999999997653333 458899999999999999999997554322       1112222222


Q ss_pred             cc---ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 026160          157 DF---QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML  200 (242)
Q Consensus       157 ~~---~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l  200 (242)
                      ..   .....++++..+++..       +|..||++|||+.+++++=
T Consensus       399 y~f~p~~w~~Iseea~dlI~~-------mL~VdP~~R~s~~eaL~hp  438 (475)
T KOG0615|consen  399 YAFGPLQWDRISEEALDLINW-------MLVVDPENRPSADEALNHP  438 (475)
T ss_pred             ccccChhhhhhhHHHHHHHHH-------hhEeCcccCcCHHHHhcCh
Confidence            21   1223455566666666       5599999999999999653

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=3.4e-32  Score=219.89  Aligned_cols=184  Identities=26%  Similarity=0.413  Sum_probs=141.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |.+||+.+.++..-.    .++++..+..|++++++||.|||.+   |.+|||||+.|||++.+|.|+|+|||.+.....
T Consensus       106 Ma~GS~ldIik~~~~----~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  106 MAGGSLLDIIKTYYP----DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             hcCCcHHHHHHHHcc----ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            679999999987532    5699999999999999999999999   999999999999999999999999998865544


Q ss_pred             Cccc--chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           81 KKST--ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        81 ~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      ....  .......|+++|+|||++.....+++.|+||||||+...|+.+|..||.-....       ......+.+....
T Consensus       179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm-------kvLl~tLqn~pp~  251 (516)
T KOG0582|consen  179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM-------KVLLLTLQNDPPT  251 (516)
T ss_pred             cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH-------HHHHHHhcCCCCC
Confidence            3211  111344699999999998777789999999999999999999999999754432       2222222222221


Q ss_pred             cccccc-chHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 026160          159 QLDGVV-TEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE  198 (242)
Q Consensus       159 ~~~~~~-~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~  198 (242)
                      ...... .++.+.+-+.|..++..||++||.+|||+.++++
T Consensus       252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            111112 2233455567777777799999999999999984

>PHA02988 hypothetical protein; Provisional

Probab=99.98  E-value=6.6e-32  Score=218.14  Aligned_cols=177  Identities=20%  Similarity=0.243  Sum_probs=135.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.+.      +.+++..+..++.+++.|+.|||+.  .+++|+||||+||+++.++.++|+|||++.....
T Consensus       104 ~~~g~L~~~l~~~------~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~  175 (283)
T PHA02988        104 CTRGYLREVLDKE------KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS  175 (283)
T ss_pred             CCCCcHHHHHhhC------CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence            6899999999765      4589999999999999999999973  1788999999999999999999999999875443


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ...     ...++..|+|||.+.+....++.++||||||+++|++++|..||......       .........+.....
T Consensus       176 ~~~-----~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-------~~~~~i~~~~~~~~~  243 (283)
T PHA02988        176 PPF-----KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-------EIYDLIINKNNSLKL  243 (283)
T ss_pred             ccc-----cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhcCCCCCC
Confidence            221     12478899999998764457799999999999999999999999744321       111111112222333


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchh
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESST  204 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~  204 (242)
                      +..+++++.++       +.+||+.||++|||+.++++.|+.+.
T Consensus       244 ~~~~~~~l~~l-------i~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        244 PLDCPLEIKCI-------VEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             CCcCcHHHHHH-------HHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            33455555544       44599999999999999999998654

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.98  E-value=2.1e-32  Score=228.32  Aligned_cols=186  Identities=28%  Similarity=0.400  Sum_probs=141.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+|-||+.||+..+     ..|...+.+.|+.|+++|+.|||.+   +|+|+|||..|||+..++.|+++|||++..-..
T Consensus       469 CeGsSLY~hlHv~e-----tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~  540 (678)
T KOG0193|consen  469 CEGSSLYTHLHVQE-----TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR  540 (678)
T ss_pred             ccCchhhhhccchh-----hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeee
Confidence            78999999998764     5799999999999999999999999   999999999999999999999999999864322


Q ss_pred             Ccccchhcccccccccccchhhhccc-CCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSF-GGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      -..........+...|+|||+++... ..+++.+||||||||+|||++|..||.... .       +++.-.+..+... 
T Consensus       541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~-~-------dqIifmVGrG~l~-  611 (678)
T KOG0193|consen  541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN-R-------DQIIFMVGRGYLM-  611 (678)
T ss_pred             eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC-h-------hheEEEecccccC-
Confidence            11111122345889999999986432 356999999999999999999999998222 2       2222222222111 


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTE  205 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~  205 (242)
                        ........+..+.|-+|+..||.+++++||.+.+|+..|+.+..
T Consensus       612 --pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  612 --PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             --ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence              11223334445566667777999999999999999998887655

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.9e-32  Score=223.95  Aligned_cols=175  Identities=26%  Similarity=0.400  Sum_probs=139.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCC-CceEEcccccccccC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDED-FCPKISDFGLAKQSQ   79 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~-~~~~L~dfg~~~~~~   79 (242)
                      |+||+|.++|.+.      +++++.++..++.|++.|++|+|+.   +|+||||||+|+|++.+ +++||+|||++....
T Consensus       102 ~~gGdL~~~i~~~------g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen  102 CSGGDLFDYIVNK------GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             cCCccHHHHHHHc------CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence            5789999999874      5699999999999999999999999   99999999999999999 999999999998773


Q ss_pred             -CCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           80 -DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        80 -~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                       ...   .....+|++.|.|||++.+.......++||||+|+++|.|++|..||+....        ...... ......
T Consensus       173 ~~~~---~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~--------~~l~~k-i~~~~~  240 (370)
T KOG0583|consen  173 GEDG---LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV--------PNLYRK-IRKGEF  240 (370)
T ss_pred             CCCC---cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH--------HHHHHH-HhcCCc
Confidence             221   2334579999999999987633446899999999999999999999986221        111111 222234


Q ss_pred             cccccc-chHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchh
Q 026160          159 QLDGVV-TEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESST  204 (242)
Q Consensus       159 ~~~~~~-~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~  204 (242)
                      ..+..+ ++++..++.+       |+..||.+|+|+.+++ .-.-+.
T Consensus       241 ~~p~~~~S~~~~~Li~~-------mL~~~P~~R~t~~~i~-~h~w~~  279 (370)
T KOG0583|consen  241 KIPSYLLSPEARSLIEK-------MLVPDPSTRITLLEIL-EHPWFQ  279 (370)
T ss_pred             cCCCCcCCHHHHHHHHH-------HcCCCcccCCCHHHHh-hChhhc
Confidence            455556 8888888888       4599999999999999 444444

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.97  E-value=1.1e-32  Score=210.75  Aligned_cols=173  Identities=30%  Similarity=0.439  Sum_probs=138.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      ||.|.|.|||.+.      -.+|+++...|++|+.+|+.|||.+   +|+|+||||+|||++.+.+++++|||+++....
T Consensus       105 ~prGELFDyLts~------VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~~  175 (411)
T KOG0599|consen  105 MPRGELFDYLTSK------VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLEP  175 (411)
T ss_pred             cccchHHHHhhhh------eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccCC
Confidence            7899999999876      4699999999999999999999999   999999999999999999999999999998777


Q ss_pred             Ccccchhcccccccccccchhhh----cccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCC
Q 026160           81 KKSTISMLHARGTIGYIAPEVFC----RSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN  156 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~----~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  156 (242)
                      ......   .+||+.|+|||.+.    ...++++...|+|+.|+++|.++.|.+||.-...        ..+.+.+..+.
T Consensus       176 GekLre---lCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ--------mlMLR~ImeGk  244 (411)
T KOG0599|consen  176 GEKLRE---LCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ--------MLMLRMIMEGK  244 (411)
T ss_pred             chhHHH---hcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH--------HHHHHHHHhcc
Confidence            655443   46999999999873    3345778899999999999999999999863321        22223333332


Q ss_pred             cc---ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 026160          157 DF---QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML  200 (242)
Q Consensus       157 ~~---~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l  200 (242)
                      ..   .....++...++++.+       ||+.||.+|.|+.|++++=
T Consensus       245 yqF~speWadis~~~KdLIsr-------lLqVdp~~Ritake~LaHp  284 (411)
T KOG0599|consen  245 YQFRSPEWADISATVKDLISR-------LLQVDPTKRITAKEALAHP  284 (411)
T ss_pred             cccCCcchhhccccHHHHHHH-------HHeeCchhcccHHHHhcCh
Confidence            11   1122355566666666       7799999999999999753

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.97  E-value=4e-32  Score=215.14  Aligned_cols=163  Identities=29%  Similarity=0.431  Sum_probs=135.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      ++||.|.-+|.++      +.+++..+.-.+..|+.||.|||+.   +|+||||||+|||++.+|.++|+|||++.....
T Consensus       107 ~~GGeLf~hL~~e------g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  107 LNGGELFYHLQRE------GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             cCCccHHHHHHhc------CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            5799999999877      4599999999999999999999999   999999999999999999999999999985433


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      .....  .+.+||+.|+|||++.+.  .++..+|-||||+++|||++|.+||...+.        ..+...+..+.....
T Consensus       178 ~~~~t--~tfcGT~eYmAPEil~~~--gy~~~vDWWsLGillYeML~G~pPF~~~~~--------~~~~~~I~~~k~~~~  245 (357)
T KOG0598|consen  178 DGDAT--RTFCGTPEYMAPEILLGK--GYDKAVDWWSLGILLYEMLTGKPPFYAEDV--------KKMYDKILKGKLPLP  245 (357)
T ss_pred             CCCcc--ccccCCccccChHHHhcC--CCCcccchHhHHHHHHHHhhCCCCCcCccH--------HHHHHHHhcCcCCCC
Confidence            32211  125799999999999875  889999999999999999999999986664        233334444444445


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCC
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRP  191 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp  191 (242)
                      +..++.+.+++++.++       ..||++|.
T Consensus       246 p~~ls~~ardll~~LL-------~rdp~~RL  269 (357)
T KOG0598|consen  246 PGYLSEEARDLLKKLL-------KRDPRQRL  269 (357)
T ss_pred             CccCCHHHHHHHHHHh-------ccCHHHhc
Confidence            5568889999999976       99999995

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.4e-32  Score=218.28  Aligned_cols=171  Identities=31%  Similarity=0.424  Sum_probs=143.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |.||++.+.|...      +.+.+.++..++++++.|+.|||..   +.+|+|||++|||+..+|.++|+|||++.....
T Consensus        93 ~~gGsv~~lL~~~------~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~  163 (467)
T KOG0201|consen   93 CGGGSVLDLLKSG------NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTN  163 (467)
T ss_pred             hcCcchhhhhccC------CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeec
Confidence            5789999999765      3358999999999999999999999   999999999999999999999999999987665


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      .....  .+.+||+.|+|||++..  ..++.++||||||+..+||.+|.+|+......        .....+.....+.+
T Consensus       164 ~~~rr--~tfvGTPfwMAPEVI~~--~~Y~~KADIWSLGITaiEla~GePP~s~~hPm--------rvlflIpk~~PP~L  231 (467)
T KOG0201|consen  164 TVKRR--KTFVGTPFWMAPEVIKQ--SGYDTKADIWSLGITAIELAKGEPPHSKLHPM--------RVLFLIPKSAPPRL  231 (467)
T ss_pred             hhhcc--ccccccccccchhhhcc--ccccchhhhhhhhHHHHHHhcCCCCCcccCcc--------eEEEeccCCCCCcc
Confidence            54432  35679999999999975  37899999999999999999999999755442        22334555566667


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ...+++.+++++..       ||++||+.||||.+++++
T Consensus       232 ~~~~S~~~kEFV~~-------CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  232 DGDFSPPFKEFVEA-------CLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             ccccCHHHHHHHHH-------HhhcCcccCcCHHHHhhh
Confidence            77788888888777       999999999999999853

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.97  E-value=3.7e-31  Score=213.50  Aligned_cols=183  Identities=22%  Similarity=0.339  Sum_probs=135.2

Q ss_pred             CCCCCcchhccccCCC----------CCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEc
Q 026160            1 MPNGSLDQFTYDQESS----------NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKIS   70 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~   70 (242)
                      +++|+|.+++......          .....+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+
T Consensus        90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~L~  166 (283)
T cd05048          90 LAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKIS  166 (283)
T ss_pred             CCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcEEEC
Confidence            4789999999764221          1125689999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhh
Q 026160           71 DFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIY  149 (242)
Q Consensus        71 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~  149 (242)
                      |||++................++..|+|||.+...  ..+.++|+|||||++|++++ |..||......        ...
T Consensus       167 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--------~~~  236 (283)
T cd05048         167 DFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--------EVI  236 (283)
T ss_pred             CCcceeeccccccccccCCCcccccccCHHHhccC--cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--------HHH
Confidence            99998765433222112223467789999987653  56889999999999999998 98888643321        111


Q ss_pred             hccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          150 KHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                      ..+........+..++.++.+       ++.+||+.||++||++.++++.|+++
T Consensus       237 ~~i~~~~~~~~~~~~~~~~~~-------l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         237 EMIRSRQLLPCPEDCPARVYA-------LMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             HHHHcCCcCCCcccCCHHHHH-------HHHHHccCChhhCcCHHHHHHHHhcC
Confidence            122222222233344555444       44559999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.9e-32  Score=218.68  Aligned_cols=177  Identities=27%  Similarity=0.329  Sum_probs=133.1

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      .||+++++.+     ++.+++..+..|+.||++||+|+|.+   |+.|||+||+|||+..+..+||+|||+++.......
T Consensus        94 ~NLYqLmK~R-----~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP  165 (538)
T KOG0661|consen   94 CNLYQLMKDR-----NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP  165 (538)
T ss_pred             hhHHHHHhhc-----CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccCCC
Confidence            4677888765     37899999999999999999999999   999999999999999888999999999999888877


Q ss_pred             cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCC------------CCcCcch-hhh
Q 026160           84 TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSS------------DIYFPNS-IYK  150 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~------------~~~~~~~-~~~  150 (242)
                      +..+.   .|++|+|||++... ..++.+.||||+||+++|+.+-++-|-+.+..++            ...+... ...
T Consensus       166 YTeYV---STRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La  241 (538)
T KOG0661|consen  166 YTEYV---STRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA  241 (538)
T ss_pred             cchhh---hcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence            76665   89999999998766 5889999999999999999998877754443221            1111110 000


Q ss_pred             c-----cC---CCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          151 H-----IE---PGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       151 ~-----~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .     ..   ......+-...+.+       .++++..|+++||++||||.+++++
T Consensus       242 ~~mnf~~P~~~~~~l~~L~p~~s~~-------~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  242 SAMNFRFPQVKPSPLKDLLPNASSE-------AASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHhccCCCcCCCCChHHhCcccCHH-------HHHHHHHHhcCCCccCccHHHHhcC
Confidence            0     00   11111111223334       4445555779999999999999975

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.97  E-value=6.5e-31  Score=210.80  Aligned_cols=183  Identities=26%  Similarity=0.377  Sum_probs=135.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...........+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        88 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  164 (272)
T cd05075          88 MKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYN  164 (272)
T ss_pred             CCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcccccCc
Confidence            57899999886544434456799999999999999999999998   999999999999999999999999999886644


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ............+..|.+||.....  .++.++|+||||+++|++++ |..||......        ........+....
T Consensus       165 ~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~  234 (272)
T cd05075         165 GDYYRQGRIAKMPVKWIAIESLADR--VYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--------EIYDYLRQGNRLK  234 (272)
T ss_pred             ccceecCCcccCCcccCCHHHccCC--CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHcCCCCC
Confidence            3222111122356789999987653  57889999999999999999 78888542211        1111122222222


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                      .+..++..       +.+++.+||+.||++|||+.++++.|+.+
T Consensus       235 ~~~~~~~~-------~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         235 QPPDCLDG-------LYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCCCCCHH-------HHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            22233333       44556669999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.97  E-value=9.5e-31  Score=210.90  Aligned_cols=180  Identities=24%  Similarity=0.371  Sum_probs=135.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....     +.+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        90 ~~~gsL~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          90 SPLGSLLDHVRQHR-----DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             CCCCcHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            57999999997543     4589999999999999999999998   999999999999999999999999999976543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ...........++..|++||.+...  .++.++|+||||+++||+++ |..||.....        .........+....
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~  231 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFG--RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--------HEVPDLLEKGERLA  231 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccC--CcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHCCCcCC
Confidence            3222222223466789999988643  57899999999999999998 9888864322        11111122222222


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTE  205 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~  205 (242)
                      .+..++..       +..++.+||..||++|||+.++++.|..+..
T Consensus       232 ~~~~~~~~-------~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         232 QPQICTID-------VYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             CCCCCCHH-------HHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            22223333       3445666999999999999999999988665

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.97  E-value=1.7e-30  Score=210.68  Aligned_cols=186  Identities=24%  Similarity=0.387  Sum_probs=136.7

Q ss_pred             CCCCCcchhccccCC----------CCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEc
Q 026160            1 MPNGSLDQFTYDQES----------SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKIS   70 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~   70 (242)
                      +++|+|.+++..+..          ......+++..++.++.|++.|+.|||++   +++|+||||+||+++.++.++|+
T Consensus        89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~  165 (291)
T cd05094          89 MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIG  165 (291)
T ss_pred             CCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEEC
Confidence            578999999975421          11224589999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhh
Q 026160           71 DFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIY  149 (242)
Q Consensus        71 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~  149 (242)
                      |||++................++..|+|||.+.+.  .++.++||||||+++|++++ |..||......        ...
T Consensus       166 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--------~~~  235 (291)
T cd05094         166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--------EVI  235 (291)
T ss_pred             CCCcccccCCCceeecCCCCCcceeecChHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------HHH
Confidence            99998765443222112223357789999988653  57889999999999999998 99998643321        111


Q ss_pred             hccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          150 KHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      .....+.........+..       +.+++.+||+.||++|||+.++++.|+.+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~-------~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         236 ECITQGRVLERPRVCPKE-------VYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             HHHhCCCCCCCCccCCHH-------HHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            111122211222223333       45566669999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.97  E-value=2.1e-31  Score=206.05  Aligned_cols=173  Identities=20%  Similarity=0.305  Sum_probs=128.0

Q ss_pred             CccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccC-CCcccchhcccccccccc
Q 026160           19 NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARGTIGYI   97 (242)
Q Consensus        19 ~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~-~~~~~~~~~~~~~~~~y~   97 (242)
                      ..+++...+.+++.|+++|+.|+|++   +++||||||+|||++.+|.+||||||+++... ....+..+   ..|++|+
T Consensus        95 p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDY---VATRWYR  168 (396)
T KOG0593|consen   95 PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDY---VATRWYR  168 (396)
T ss_pred             cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhh---hhhhhcc
Confidence            46799999999999999999999999   99999999999999999999999999999776 44444444   4899999


Q ss_pred             cchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcC--------c--chhhhccCCCCccccc-----c
Q 026160           98 APEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYF--------P--NSIYKHIEPGNDFQLD-----G  162 (242)
Q Consensus        98 ~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~--------~--~~~~~~~~~~~~~~~~-----~  162 (242)
                      |||.+.+. ..+....||||+||++.||++|.+.|-..+..++.+.+        +  ..++..-.-.....++     .
T Consensus       169 aPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~e  247 (396)
T KOG0593|consen  169 APELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPE  247 (396)
T ss_pred             Chhhhccc-CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCcc
Confidence            99999775 36788999999999999999999988665544321111        0  1111111111111111     1


Q ss_pred             ccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 026160          163 VVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE  198 (242)
Q Consensus       163 ~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~  198 (242)
                      .+....-.+..-.++++..||+.||++|++.+++++
T Consensus       248 pLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  248 PLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             chhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            112222334446788889999999999999999984

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.7e-30  Score=208.27  Aligned_cols=183  Identities=26%  Similarity=0.405  Sum_probs=135.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|..++...........+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        89 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  165 (273)
T cd05035          89 MKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYS  165 (273)
T ss_pred             cCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCccceeeccc
Confidence            47899999987655444456799999999999999999999998   999999999999999999999999999876544


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ............+..|.+||.+..  ...+.++|+||||+++||+++ |..||......        ........+....
T Consensus       166 ~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~  235 (273)
T cd05035         166 GDYYRQGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--------EIYDYLRHGNRLK  235 (273)
T ss_pred             cccccccccccCCccccCHhhccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCC
Confidence            322211111234568999998754  367889999999999999999 88887533211        1111112222222


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                      .+..++.+       +.+++.+||+.||++|||+.++++.|+.+
T Consensus       236 ~~~~~~~~-------~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         236 QPEDCLDE-------LYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCcCCCHH-------HHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            23334444       45555569999999999999999999865

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.97  E-value=1.9e-30  Score=210.00  Aligned_cols=186  Identities=25%  Similarity=0.369  Sum_probs=137.1

Q ss_pred             CCCCCcchhccccCC-------CCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccc
Q 026160            1 MPNGSLDQFTYDQES-------SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFG   73 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~-------~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg   73 (242)
                      +++|+|.+++..+..       ......+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||
T Consensus        89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg  165 (288)
T cd05093          89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFG  165 (288)
T ss_pred             CCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEeccCC
Confidence            578999999875431       12234599999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhcc
Q 026160           74 LAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHI  152 (242)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~  152 (242)
                      ++................++..|+|||.+.+.  ..+.++|+||||+++|+|++ |..||......        ......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--------~~~~~i  235 (288)
T cd05093         166 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--------EVIECI  235 (288)
T ss_pred             ccccccCCceeecCCCCCccccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHH
Confidence            98765433222222222356789999988653  67889999999999999998 88888543321        111111


Q ss_pred             CCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          153 EPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      ..+.....+...+.+       +.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       236 ~~~~~~~~~~~~~~~-------l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         236 TQGRVLQRPRTCPKE-------VYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HcCCcCCCCCCCCHH-------HHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            122222222334444       45556669999999999999999999987754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.97  E-value=1.3e-30  Score=218.31  Aligned_cols=166  Identities=23%  Similarity=0.440  Sum_probs=122.0

Q ss_pred             ccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccccc
Q 026160           20 RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAP   99 (242)
Q Consensus        20 ~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~P   99 (242)
                      ..+++.+++.++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++................++..|+||
T Consensus       207 ~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP  283 (374)
T cd05106         207 WPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAP  283 (374)
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCH
Confidence            4588999999999999999999999   9999999999999999999999999998765433222111122345679999


Q ss_pred             hhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccccccccchHHHHHHHHHHHH
Q 026160          100 EVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILV  178 (242)
Q Consensus       100 E~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  178 (242)
                      |.+...  .++.++|+||||+++|++++ |..||.......       ........+.....+...++++.       ++
T Consensus       284 E~~~~~--~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~-------~l  347 (374)
T cd05106         284 ESIFDC--VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-------KFYKMVKRGYQMSRPDFAPPEIY-------SI  347 (374)
T ss_pred             HHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccccccH-------HHHHHHHcccCccCCCCCCHHHH-------HH
Confidence            988653  57889999999999999997 999986433211       11111111112222223444444       44


Q ss_pred             HHHhccCCCCCCCCHHHHHHHhhchh
Q 026160          179 SLWCIQTNPSDRPSMHEVLEMLESST  204 (242)
Q Consensus       179 ~~~cl~~dp~~Rps~~~ll~~l~~~~  204 (242)
                      +.+||+.||++|||+.++++.|+.+.
T Consensus       348 i~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         348 MKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             HHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            55599999999999999999998753

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.97  E-value=1.6e-30  Score=213.25  Aligned_cols=181  Identities=25%  Similarity=0.400  Sum_probs=135.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++.+..     ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        90 ~~~g~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          90 MPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             CCCCCHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccC
Confidence            57899999997643     3588999999999999999999999   999999999999999999999999999986654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ............+..|++||.+...  .++.++||||||+++|++++ |..||......        .............
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~  231 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------EISSILEKGERLP  231 (316)
T ss_pred             CCcceeccCCccceeecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHhCCCCCC
Confidence            3222211122345689999988653  67889999999999999997 89998643211        1111112222222


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      .+..++.+       +..++.+||+.||++||++.+++..+..+...
T Consensus       232 ~~~~~~~~-------~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         232 QPPICTID-------VYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             CCCCCCHH-------HHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence            22333433       44566669999999999999999998877543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.97  E-value=7.5e-31  Score=226.67  Aligned_cols=177  Identities=26%  Similarity=0.333  Sum_probs=133.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.++|.....  ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++....
T Consensus       121 ~~~gsL~~~l~~~~~--~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~  195 (496)
T PTZ00283        121 ANAGDLRQEIKSRAK--TNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAA  195 (496)
T ss_pred             CCCCcHHHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecccCeeccc
Confidence            578999999975422  335799999999999999999999999   999999999999999999999999999876543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ...........|+..|+|||.+.+.  .++.++|||||||++|++++|+.||.....        .........+....+
T Consensus       196 ~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~k~DVwSlGvilyeLltG~~Pf~~~~~--------~~~~~~~~~~~~~~~  265 (496)
T PTZ00283        196 TVSDDVGRTFCGTPYYVAPEIWRRK--PYSKKADMFSLGVLLYELLTLKRPFDGENM--------EEVMHKTLAGRYDPL  265 (496)
T ss_pred             cccccccccccCCcceeCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHhcCCCCCC
Confidence            3222222234589999999998653  578999999999999999999999964322        111111112222233


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      +..+++++.+++.       +||+.||++||++.+++++
T Consensus       266 ~~~~~~~l~~li~-------~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        266 PPSISPEMQEIVT-------ALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CCCCCHHHHHHHH-------HHcccChhhCcCHHHHHhC
Confidence            4445555555544       4889999999999999864

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.97  E-value=1.9e-30  Score=208.99  Aligned_cols=180  Identities=25%  Similarity=0.412  Sum_probs=132.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....     ..+++.++..++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++.....
T Consensus        90 ~~~g~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          90 MPYGCLLDYVRENK-----DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             CCCCCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            57899999997532     4599999999999999999999999   999999999999999999999999999886643


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ...........++..|++||...+.  .++.++|||||||++||+++ |..||......        .............
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~  231 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHR--RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--------EIPDLLEKGERLP  231 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHCCCcCC
Confidence            3222111112345689999988543  57889999999999999998 88888643221        1111111111112


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTE  205 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~  205 (242)
                      .+..++.++       .+++.+||+.||++||++.++++.|+.+..
T Consensus       232 ~~~~~~~~~-------~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         232 QPPICTIDV-------YMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             CCccCCHHH-------HHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            222344444       445556999999999999999999876643

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.97  E-value=3.1e-30  Score=207.67  Aligned_cols=182  Identities=25%  Similarity=0.368  Sum_probs=133.9

Q ss_pred             CCCCCcchhccccCC--------CCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEccc
Q 026160            1 MPNGSLDQFTYDQES--------SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDF   72 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~--------~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~df   72 (242)
                      +++|+|.++|.....        ......+++.++..++.|++.|+.|||+.   +++|+||||.||+++.++.++|+||
T Consensus        90 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~kl~d~  166 (280)
T cd05049          90 MEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDF  166 (280)
T ss_pred             CCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeEEECCc
Confidence            578999999976432        22345689999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhc
Q 026160           73 GLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKH  151 (242)
Q Consensus        73 g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~  151 (242)
                      |++................++..|+|||.+.+.  .++.++||||||+++|++++ |..||......        .....
T Consensus       167 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--------~~~~~  236 (280)
T cd05049         167 GMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--------EVIEC  236 (280)
T ss_pred             ccceecccCcceecCCCCcccceecChhhhccC--CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHH
Confidence            998754332221111222356789999988653  57889999999999999998 99998643321        11111


Q ss_pred             cCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 026160          152 IEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES  202 (242)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~  202 (242)
                      ...+.....+..++..+.       +++.+||+.||++||++.++++.|++
T Consensus       237 ~~~~~~~~~~~~~~~~~~-------~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         237 ITQGRLLQRPRTCPSEVY-------DIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             HHcCCcCCCCCCCCHHHH-------HHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            112222222233444444       45555999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=7.2e-31  Score=221.12  Aligned_cols=172  Identities=27%  Similarity=0.434  Sum_probs=144.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|-|+|||-.+      +++++.++++++.||+.|+.|+|..   +|+||||||+|+|++..+++|++|||.+.....
T Consensus        94 v~gGELFdylv~k------G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~  164 (786)
T KOG0588|consen   94 VPGGELFDYLVRK------GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP  164 (786)
T ss_pred             cCCchhHHHHHhh------CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC
Confidence            6899999999877      6799999999999999999999999   999999999999999998999999999987555


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....   .+.+|.+.|.+||++.+. .....++||||.|+++|.|++|+.||+..+.        .....++..+ .+.+
T Consensus       165 gklL---eTSCGSPHYA~PEIV~G~-pYdG~~sDVWSCGVILfALLtG~LPFdDdNi--------r~LLlKV~~G-~f~M  231 (786)
T KOG0588|consen  165 GKLL---ETSCGSPHYAAPEIVSGR-PYDGRPSDVWSCGVILFALLTGKLPFDDDNI--------RVLLLKVQRG-VFEM  231 (786)
T ss_pred             Cccc---cccCCCcccCCchhhcCC-CCCCCccccchhHHHHHHHHhCCCCCCCccH--------HHHHHHHHcC-cccC
Confidence            4333   345699999999999876 4557899999999999999999999983332        2222333333 3456


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      +..++.++.+++.+|+       ..||++|.|+++++++-.
T Consensus       232 Ps~Is~eaQdLLr~ml-------~VDp~~RiT~~eI~kHP~  265 (786)
T KOG0588|consen  232 PSNISSEAQDLLRRML-------DVDPSTRITTEEILKHPF  265 (786)
T ss_pred             CCcCCHHHHHHHHHHh-------ccCccccccHHHHhhCch
Confidence            7789999999999977       889999999999998754

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=9.4e-31  Score=209.55  Aligned_cols=122  Identities=30%  Similarity=0.457  Sum_probs=107.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCC------CceEEccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDED------FCPKISDFGL   74 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~------~~~~L~dfg~   74 (242)
                      |.||+|.+||..+      +.++++.+..++.||+.|+++||++   +|+||||||.|||++..      -.+|++|||+
T Consensus        91 C~gGDLs~yi~~~------~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf  161 (429)
T KOG0595|consen   91 CNGGDLSDYIRRR------GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF  161 (429)
T ss_pred             CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence            7899999999887      4699999999999999999999999   99999999999999864      3589999999


Q ss_pred             ccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccc
Q 026160           75 AKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKA  136 (242)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  136 (242)
                      ++.........   +.+|++.|+|||++...  .++.|+|+||+|+++|++++|+.||+...
T Consensus       162 AR~L~~~~~a~---tlcGSplYMAPEV~~~~--~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t  218 (429)
T KOG0595|consen  162 ARFLQPGSMAE---TLCGSPLYMAPEVIMSQ--QYDAKADLWSIGTILYQCLTGKPPFDAET  218 (429)
T ss_pred             hhhCCchhHHH---HhhCCccccCHHHHHhc--cccchhhHHHHHHHHHHHHhCCCCccccC
Confidence            99877544332   34699999999999753  78999999999999999999999998544

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.97  E-value=3.5e-30  Score=212.94  Aligned_cols=166  Identities=27%  Similarity=0.444  Sum_probs=123.9

Q ss_pred             cccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccccch
Q 026160           21 TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPE  100 (242)
Q Consensus        21 ~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE  100 (242)
                      .+++..+..++.|++.||.|||++   +|+|+||||.||+++.++.++|+|||++................++..|+|||
T Consensus       169 ~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE  245 (337)
T cd05054         169 PLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE  245 (337)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence            689999999999999999999999   99999999999999999999999999997654332222222223567899999


Q ss_pred             hhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccccccccchHHHHHHHHHHHHH
Q 026160          101 VFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVS  179 (242)
Q Consensus       101 ~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  179 (242)
                      .+.+.  .++.++|||||||++|++++ |..||......       ...............+...++       .+.+++
T Consensus       246 ~~~~~--~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~-------~~~~l~  309 (337)
T cd05054         246 SIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-------EEFCRRLKEGTRMRAPEYATP-------EIYSIM  309 (337)
T ss_pred             HhcCC--CCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-------HHHHHHHhccCCCCCCccCCH-------HHHHHH
Confidence            88654  67889999999999999997 99998643221       111111112111122222333       355566


Q ss_pred             HHhccCCCCCCCCHHHHHHHhhchhh
Q 026160          180 LWCIQTNPSDRPSMHEVLEMLESSTE  205 (242)
Q Consensus       180 ~~cl~~dp~~Rps~~~ll~~l~~~~~  205 (242)
                      .+||+.+|++||++.+++++|+.+.+
T Consensus       310 ~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         310 LDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHccCChhhCcCHHHHHHHHHHHHh
Confidence            66999999999999999999997654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.97  E-value=3.1e-30  Score=216.17  Aligned_cols=164  Identities=24%  Similarity=0.436  Sum_probs=120.7

Q ss_pred             ccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccccc
Q 026160           20 RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAP   99 (242)
Q Consensus        20 ~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~P   99 (242)
                      ..+++..+..++.|++.||.|||+.   +++|+||||.||+++.++.++|+|||++................++..|+||
T Consensus       209 ~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  285 (375)
T cd05104         209 LALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAP  285 (375)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeCh
Confidence            3588999999999999999999998   9999999999999999999999999998765443322211122345679999


Q ss_pred             hhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccccccccchHHHHHHHHHHHH
Q 026160          100 EVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILV  178 (242)
Q Consensus       100 E~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  178 (242)
                      |.+.+.  .++.++|+||||+++|++++ |..||......       .........+.....+...+.       .+.++
T Consensus       286 E~~~~~--~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~-------~l~~l  349 (375)
T cd05104         286 ESIFNC--VYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-------SKFYKMIKEGYRMLSPECAPS-------EMYDI  349 (375)
T ss_pred             hHhcCC--CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-------HHHHHHHHhCccCCCCCCCCH-------HHHHH
Confidence            998653  67889999999999999998 78887543221       111111112111112222333       34556


Q ss_pred             HHHhccCCCCCCCCHHHHHHHhhc
Q 026160          179 SLWCIQTNPSDRPSMHEVLEMLES  202 (242)
Q Consensus       179 ~~~cl~~dp~~Rps~~~ll~~l~~  202 (242)
                      +.+||+.||++|||+.++++.|+.
T Consensus       350 i~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         350 MKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             HHHHccCChhHCcCHHHHHHHHHh
Confidence            666999999999999999999985

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.97  E-value=6.4e-31  Score=209.75  Aligned_cols=176  Identities=31%  Similarity=0.507  Sum_probs=128.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.++|....    ...+++.+++.++.|+++||.|||+.   +++|++|+++||+++.++.+||+|||++.....
T Consensus        83 ~~~g~L~~~L~~~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~  155 (259)
T PF07714_consen   83 CPGGSLDDYLKSKN----KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE  155 (259)
T ss_dssp             -TTEBHHHHHHHTC----TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred             cccccccccccccc----cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence            57899999998762    25699999999999999999999999   999999999999999999999999999987633


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ...............|.|||.+...  .++.++||||||+++||+++ |+.||.....        .........+....
T Consensus       156 ~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--------~~~~~~~~~~~~~~  225 (259)
T PF07714_consen  156 KSKYKNDSSQQLPLRYLAPEVLKDG--EYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--------EEIIEKLKQGQRLP  225 (259)
T ss_dssp             SSSEEESTTSESGGGGS-HHHHHHS--EESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--------HHHHHHHHTTEETT
T ss_pred             ccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccc--------ccccccccccccce
Confidence            2222222223467789999998664  47899999999999999999 6778653321        11112222333333


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML  200 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l  200 (242)
                      .+..++..+.++       +..||+.||++|||+.++++.|
T Consensus       226 ~~~~~~~~~~~l-------i~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  226 IPDNCPKDIYSL-------IQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             SBTTSBHHHHHH-------HHHHT-SSGGGS--HHHHHHHH
T ss_pred             eccchhHHHHHH-------HHHHcCCChhhCcCHHHHHhcC
Confidence            334455555444       4459999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.97  E-value=3.5e-30  Score=208.83  Aligned_cols=184  Identities=26%  Similarity=0.433  Sum_probs=134.0

Q ss_pred             CCCCCcchhccccC----------CCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEc
Q 026160            1 MPNGSLDQFTYDQE----------SSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKIS   70 (242)
Q Consensus         1 ~~~GsL~~~l~~~~----------~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~   70 (242)
                      +++|+|.+++....          .......+++..++.++.|++.|+.|||+.   +++|+||||+||+++.++.++|+
T Consensus        98 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~~~kL~  174 (293)
T cd05053          98 AAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIA  174 (293)
T ss_pred             CCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCCeEEeC
Confidence            47899999986532          112345799999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhh
Q 026160           71 DFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIY  149 (242)
Q Consensus        71 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~  149 (242)
                      |||++................++..|+|||.+.+.  .++.++|||||||++|++++ |..||......        ...
T Consensus       175 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~~~  244 (293)
T cd05053         175 DFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--------ELF  244 (293)
T ss_pred             ccccccccccccceeccCCCCCCccccCHHHhccC--CcCcccceeehhhHHHHHhcCCCCCCCCCCHH--------HHH
Confidence            99999865543222111122345679999987553  67889999999999999997 88887533211        111


Q ss_pred             hccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchh
Q 026160          150 KHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESST  204 (242)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~  204 (242)
                      ...........+...+..       +.+++.+||..||++|||+.++++.|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~-------~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         245 KLLKEGYRMEKPQNCTQE-------LYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHHHcCCcCCCCCCCCHH-------HHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            111111111222233333       445666699999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.97  E-value=2e-30  Score=209.64  Aligned_cols=175  Identities=29%  Similarity=0.433  Sum_probs=130.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....    ...+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 ~~~g~L~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05631          82 MNGGDLKFHIYNMG----NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPE  154 (285)
T ss_pred             cCCCcHHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence            57899998886532    24689999999999999999999999   999999999999999999999999999876543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....   ....++..|+|||.+.+.  .++.++|||||||++|++++|..||........    .......... .....
T Consensus       155 ~~~~---~~~~g~~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~----~~~~~~~~~~-~~~~~  224 (285)
T cd05631         155 GETV---RGRVGTVGYMAPEVINNE--KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK----REEVDRRVKE-DQEEY  224 (285)
T ss_pred             CCee---cCCCCCCCccCHhhhcCC--CCCcccCchhHHHHHHHHHhCCCCCCCCCcchh----HHHHHHHhhc-ccccC
Confidence            2221   123589999999998653  678899999999999999999999975443211    0111111111 11122


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPS-----MHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps-----~~~ll~~  199 (242)
                      +..+++++.+++.       +||+.||++||+     +++++++
T Consensus       225 ~~~~s~~~~~li~-------~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         225 SEKFSEDAKSICR-------MLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             CccCCHHHHHHHH-------HHhhcCHHHhcCCCCCCHHHHhcC
Confidence            3334555555544       488999999997     7888864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.97  E-value=4.9e-30  Score=204.27  Aligned_cols=177  Identities=25%  Similarity=0.393  Sum_probs=133.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++...      +.+++..+..++.|++.|+.|||+.   +++|+||||.||+++.++.++|+|||++.....
T Consensus        77 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~  147 (257)
T cd05116          77 AELGPLNKFLQKN------KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGA  147 (257)
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCC
Confidence            4689999999654      3589999999999999999999998   999999999999999999999999999876544


Q ss_pred             Ccccc-hhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           81 KKSTI-SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        81 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      ..... ......++..|+|||.+..  ...+.++|+||||+++||+++ |..||......        .....+..+...
T Consensus       148 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~i~~~~~~  217 (257)
T cd05116         148 DENYYKAKTHGKWPVKWYAPECMNY--YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--------EVTQMIESGERM  217 (257)
T ss_pred             CCCeeeecCCCCCCccccCHhHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHCCCCC
Confidence            32211 1111123578999998754  356789999999999999998 89998744321        111222222233


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                      ..+..+++++.+++.+       ||+.||++||++.++.+.|+..
T Consensus       218 ~~~~~~~~~l~~li~~-------~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         218 ECPQRCPPEMYDLMKL-------CWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCCHHHHHHHHH-------HhccCchhCcCHHHHHHHHhcc
Confidence            3444556655555544       9999999999999999999753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-30  Score=225.14  Aligned_cols=183  Identities=22%  Similarity=0.256  Sum_probs=137.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|-||+.++..    .+|++.++++|+.++++|+.+||.. .+.+||||||.+|||++.+|.+||||||.++....
T Consensus       124 C~gg~Lvd~mn~Rlq----~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~  198 (738)
T KOG1989|consen  124 CKGGSLVDFMNTRLQ----TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKIL  198 (738)
T ss_pred             ccCCcHHHHHHHHHh----ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccC
Confidence            789999999987654    4599999999999999999999997 45799999999999999999999999998874332


Q ss_pred             Ccc---c----chhcccccccccccchhhhcc-cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhcc
Q 026160           81 KKS---T----ISMLHARGTIGYIAPEVFCRS-FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHI  152 (242)
Q Consensus        81 ~~~---~----~~~~~~~~~~~y~~PE~~~~~-~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  152 (242)
                      ...   .    .......-|+.|++||.+.-- ....+.|+|||+|||++|.|+....||+.....           .-+
T Consensus       199 ~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-----------aIl  267 (738)
T KOG1989|consen  199 SPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-----------AIL  267 (738)
T ss_pred             CCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----------eEE
Confidence            210   0    000122368999999987332 235699999999999999999999999844321           111


Q ss_pred             CCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          153 EPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      ......+-...++..++++|+.       ||+.||++||++.++++.+..+...
T Consensus       268 ng~Y~~P~~p~ys~~l~~LI~~-------mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  268 NGNYSFPPFPNYSDRLKDLIRT-------MLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             eccccCCCCccHHHHHHHHHHH-------HhccCcccCCCHHHHHHHHHHHhcC
Confidence            1111111123456666666665       7799999999999999998877653

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.97  E-value=1.2e-30  Score=214.70  Aligned_cols=170  Identities=26%  Similarity=0.384  Sum_probs=129.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      +.+++.++..++.||+.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        77 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  147 (323)
T cd05571          77 ANGGELFFHLSRE------RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS  147 (323)
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCccccc
Confidence            5789999998764      4589999999999999999999999   999999999999999999999999999875322


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....|++.|+|||.+.+.  .++.++|+|||||++|+|++|..||......        ........ ....+
T Consensus       148 ~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--------~~~~~~~~-~~~~~  214 (323)
T cd05571         148 DGAT--MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILM-EEIRF  214 (323)
T ss_pred             CCCc--ccceecCccccChhhhcCC--CCCccccCcccchhhhhhhcCCCCCCCCCHH--------HHHHHHHc-CCCCC
Confidence            2111  1123589999999998654  5688999999999999999999999643211        11111111 11223


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRP-----SMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp-----s~~~ll~~  199 (242)
                      +..+++++.+++.+       ||+.||++||     ++.+++++
T Consensus       215 p~~~~~~~~~li~~-------~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         215 PRTLSPEAKSLLAG-------LLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCCCHHHHHHHHH-------HccCCHHHcCCCCCCCHHHHHcC
Confidence            44566666665555       7799999999     79998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.97  E-value=5.7e-30  Score=206.03  Aligned_cols=182  Identities=23%  Similarity=0.390  Sum_probs=130.9

Q ss_pred             CCCCCcchhccccCCCC----CCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEccccccc
Q 026160            1 MPNGSLDQFTYDQESSN----GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK   76 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~----~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~   76 (242)
                      +++|+|.+++.+.....    ....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.
T Consensus        91 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~dfg~~~  167 (277)
T cd05062          91 MTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR  167 (277)
T ss_pred             CCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECCCCCcc
Confidence            57899999997542211    123468889999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCC
Q 026160           77 QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPG  155 (242)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  155 (242)
                      ...............++..|+|||.+.+.  ..+.++|+||||+++|++++ |..||.....        ..........
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--------~~~~~~~~~~  237 (277)
T cd05062         168 DIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--------EQVLRFVMEG  237 (277)
T ss_pred             ccCCcceeecCCCCccCHhhcChhHhhcC--CcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHcC
Confidence            65433222211122356789999998653  57889999999999999998 6778753321        1111111111


Q ss_pred             CccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 026160          156 NDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES  202 (242)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~  202 (242)
                      .....+...+..       +.+++.+||+.||++|||+.++++.|+.
T Consensus       238 ~~~~~~~~~~~~-------~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         238 GLLDKPDNCPDM-------LFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             CcCCCCCCCCHH-------HHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            112223334444       4445556999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.97  E-value=3.9e-30  Score=193.89  Aligned_cols=187  Identities=27%  Similarity=0.348  Sum_probs=137.2

Q ss_pred             CCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCC
Q 026160            2 PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDK   81 (242)
Q Consensus         2 ~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~   81 (242)
                      ..|||.|+|...+.  .+..+++.++++++.+|++||.+||... +.++|+||||.|||++.++.+.+.|||.++...-.
T Consensus       106 ~~Gsl~d~i~~~k~--kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~  182 (302)
T KOG2345|consen  106 KRGSLLDEIERLKI--KGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQ  182 (302)
T ss_pred             ccccHHHHHHHHhh--cCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccccceE
Confidence            46899999976544  3457999999999999999999999982 24999999999999999999999999988754322


Q ss_pred             cc-------cchhcccccccccccchhhhc-ccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccC
Q 026160           82 KS-------TISMLHARGTIGYIAPEVFCR-SFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIE  153 (242)
Q Consensus        82 ~~-------~~~~~~~~~~~~y~~PE~~~~-~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  153 (242)
                      ..       .........|..|+|||.+.- .....+.+.|||||||++|.++.|..||+..-..-....+      .+.
T Consensus       183 i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL------Av~  256 (302)
T KOG2345|consen  183 IEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL------AVQ  256 (302)
T ss_pred             eechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE------eee
Confidence            11       111223358899999998743 3346699999999999999999999999754432222211      111


Q ss_pred             C-CCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchh
Q 026160          154 P-GNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESST  204 (242)
Q Consensus       154 ~-~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~  204 (242)
                      + ....+....+++.+.++++.       |++.||.+||++.+++..+..+.
T Consensus       257 n~q~s~P~~~~yse~l~~lik~-------mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  257 NAQISIPNSSRYSEALHQLIKS-------MLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ccccccCCCCCccHHHHHHHHH-------HhcCCcccCCCHHHHHHHHHhhc
Confidence            1 11111122355556666665       66999999999999999988653

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.97  E-value=4e-30  Score=209.70  Aligned_cols=186  Identities=21%  Similarity=0.298  Sum_probs=129.2

Q ss_pred             CCCCCcchhccccCCC-------------CCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCce
Q 026160            1 MPNGSLDQFTYDQESS-------------NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP   67 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~-------------~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~   67 (242)
                      |++|+|.+++......             .....+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.+
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~dlkp~Nill~~~~~~  177 (304)
T cd05096         101 MENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTI  177 (304)
T ss_pred             CCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---CccccCcchhheEEcCCccE
Confidence            5789999998654221             1224578899999999999999999999   99999999999999999999


Q ss_pred             EEcccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh--cCCCccccccCCCCCcCc
Q 026160           68 KISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV--GRKNADVKASRSSDIYFP  145 (242)
Q Consensus        68 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~--g~~p~~~~~~~~~~~~~~  145 (242)
                      +|+|||++................++..|+|||.+...  .++.++|+||||+++|++++  +..||.......  . ..
T Consensus       178 kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~--~-~~  252 (304)
T cd05096         178 KIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG--KFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQ--V-IE  252 (304)
T ss_pred             EECCCccceecccCceeEecCcCCCCccccCHHHHhcC--CCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHH--H-HH
Confidence            99999998765443322222223357789999987653  57889999999999999987  455665332110  0 00


Q ss_pred             chhh--hccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          146 NSIY--KHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       146 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      ....  ...........+..++..       +.+++.+||+.||++|||+.++.+.|+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~-------~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         253 NAGEFFRDQGRQVYLFRPPPCPQG-------LYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             HHHHHhhhccccccccCCCCCCHH-------HHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            0000  000000011112233433       455566699999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.3e-30  Score=228.53  Aligned_cols=190  Identities=26%  Similarity=0.386  Sum_probs=148.0

Q ss_pred             CCCCCcchhcccc-CCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccC
Q 026160            1 MPNGSLDQFTYDQ-ESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ   79 (242)
Q Consensus         1 ~~~GsL~~~l~~~-~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~   79 (242)
                      |+||+|..||.+. ....++..|+..+.+.++.+|++|+.||+++   ++|||||..+|+|++....+|++|||+++...
T Consensus       777 M~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy  853 (1025)
T KOG1095|consen  777 MEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLARDIY  853 (1025)
T ss_pred             cccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchhHhhh
Confidence            7899999999875 2233356799999999999999999999999   99999999999999999999999999999554


Q ss_pred             CCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           80 DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        80 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      ....+.......-+..|+|||.+.+  +.++.++||||||+++||+++ |..||...+.        .........+.+.
T Consensus       854 ~~~yyr~~~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n--------~~v~~~~~~ggRL  923 (1025)
T KOG1095|consen  854 DKDYYRKHGEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN--------FEVLLDVLEGGRL  923 (1025)
T ss_pred             hchheeccCccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcch--------HHHHHHHHhCCcc
Confidence            4443333333345689999999976  488999999999999999998 6777765443        2222222233344


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccCC
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIP  210 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~  210 (242)
                      ..+..++..+       +++|..||+.+|++||++..+++.+..+.......
T Consensus       924 ~~P~~CP~~l-------y~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~  968 (1025)
T KOG1095|consen  924 DPPSYCPEKL-------YQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT  968 (1025)
T ss_pred             CCCCCCChHH-------HHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence            5555565544       45666699999999999999999998887664433

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.97  E-value=1.2e-29  Score=202.61  Aligned_cols=178  Identities=28%  Similarity=0.429  Sum_probs=132.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....    ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        84 ~~~~~L~~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          84 MTYGNLLDYLRECN----RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             CCCCcHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence            47899999996542    24689999999999999999999998   999999999999999999999999999876544


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ..... ......+..|.+||.+.+.  ..+.++|+||||+++|++++ |..||.....        ..............
T Consensus       157 ~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~  225 (263)
T cd05052         157 DTYTA-HAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVYELLEKGYRME  225 (263)
T ss_pred             ceeec-cCCCCCccccCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHCCCCCC
Confidence            32211 1111245679999987553  56889999999999999998 8888753321        11111122222222


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                      .+..++.++.+++.       +||+.||++|||+.++++.|+.+
T Consensus       226 ~~~~~~~~~~~li~-------~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         226 RPEGCPPKVYELMR-------ACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCHHHHHHHH-------HHccCCcccCCCHHHHHHHHHhh
Confidence            33345555555544       49999999999999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-30  Score=215.62  Aligned_cols=177  Identities=30%  Similarity=0.473  Sum_probs=146.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+.|-|...|+..      ++++......|..+|+.|+.|||..   .|||||||.-||||+.+..||++|||-++...+
T Consensus       194 Ca~GqL~~VLka~------~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~  264 (904)
T KOG4721|consen  194 CAQGQLYEVLKAG------RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSD  264 (904)
T ss_pred             cccccHHHHHhcc------CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence            7889999999876      5699999999999999999999999   999999999999999999999999999886655


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....   ..+.||..|+|||++...  ..+.|.||||||+|+|||+||.-||......       ..++....+......
T Consensus       265 ~STk---MSFaGTVaWMAPEvIrne--PcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-------AIIwGVGsNsL~Lpv  332 (904)
T KOG4721|consen  265 KSTK---MSFAGTVAWMAPEVIRNE--PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-------AIIWGVGSNSLHLPV  332 (904)
T ss_pred             hhhh---hhhhhhHhhhCHHHhhcC--CcccccceehhHHHHHHHHhcCCCccccchh-------eeEEeccCCcccccC
Confidence            4322   234599999999999774  7799999999999999999999998633321       333344444445556


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhh
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTE  205 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~  205 (242)
                      +..+++-++-++++       ||+-.|.+||++++++.+|+-...
T Consensus       333 PstcP~GfklL~Kq-------cw~sKpRNRPSFrqil~HldIa~p  370 (904)
T KOG4721|consen  333 PSTCPDGFKLLLKQ-------CWNSKPRNRPSFRQILLHLDIASP  370 (904)
T ss_pred             cccCchHHHHHHHH-------HHhcCCCCCccHHHHHHHHhhcCH
Confidence            67777777777776       999999999999999999986553

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.97  E-value=9.8e-30  Score=202.36  Aligned_cols=174  Identities=26%  Similarity=0.417  Sum_probs=130.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++.+...    ..+++..+..++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 ~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          82 MAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             CCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccc
Confidence            578999999876432    4589999999999999999999998   999999999999999999999999999875433


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ...     ....+..|+|||.+...  ..+.++|+|||||++|++++ |+.||.....        ..............
T Consensus       155 ~~~-----~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~  219 (256)
T cd05082         155 TQD-----TGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPRVEKGYKMD  219 (256)
T ss_pred             cCC-----CCccceeecCHHHHccC--CCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHhcCCCCC
Confidence            221     11245679999988653  57889999999999999997 8888753321        11111111222222


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                      ....+++.+.+       ++.+||+.||++|||+.++++.|+.+
T Consensus       220 ~~~~~~~~~~~-------li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         220 APDGCPPVVYD-------VMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             CCCCCCHHHHH-------HHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            23334554444       44559999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=3.8e-30  Score=221.82  Aligned_cols=176  Identities=24%  Similarity=0.285  Sum_probs=131.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.++|....  .....+++.++..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++.....
T Consensus       147 ~~gg~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        147 GSGGDLNKQIKQRL--KEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             CCCCCHHHHHHHHH--hccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            58999999986532  1235689999999999999999999999   999999999999999999999999999986654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ...........|+..|+|||.+.+.  .++.++|||||||++|+|++|..||.....        .........+.....
T Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--------~~~~~~~~~~~~~~~  291 (478)
T PTZ00267        222 SVSLDVASSFCGTPYYLAPELWERK--RYSKKADMWSLGVILYELLTLHRPFKGPSQ--------REIMQQVLYGKYDPF  291 (478)
T ss_pred             ccccccccccCCCccccCHhHhCCC--CCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCC
Confidence            3222222234589999999988653  678899999999999999999999864322        111111111112222


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE  198 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~  198 (242)
                      +..++.++.++       +.+||+.||++||++.++++
T Consensus       292 ~~~~s~~~~~l-------i~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        292 PCPVSSGMKAL-------LDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CccCCHHHHHH-------HHHHhccChhhCcCHHHHHh
Confidence            33445554444       44588999999999999874

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=9.9e-30  Score=202.46  Aligned_cols=178  Identities=26%  Similarity=0.405  Sum_probs=132.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.++|...      +.+++..+..++.|++.|+.|||..   +++|+||||+||+++.++.++|+|||++.....
T Consensus        77 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~  147 (257)
T cd05060          77 APLGPLLKYLKKR------REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGA  147 (257)
T ss_pred             CCCCcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeec
Confidence            4789999999765      3589999999999999999999998   999999999999999999999999999876543


Q ss_pred             Ccccch-hcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           81 KKSTIS-MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        81 ~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      ...... .....++..|.|||.+...  ..+.++|+||||+++|++++ |..||......        ............
T Consensus       148 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~--------~~~~~~~~~~~~  217 (257)
T cd05060         148 GSDYYRATTAGRWPLKWYAPECINYG--KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA--------EVIAMLESGERL  217 (257)
T ss_pred             CCcccccccCccccccccCHHHhcCC--CCCccchHHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHHcCCcC
Confidence            332211 1111234579999988553  57889999999999999997 99998644321        111111111111


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchh
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESST  204 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~  204 (242)
                      ..+..++..       +.+++.+||..||++|||+.++++.|+++.
T Consensus       218 ~~~~~~~~~-------l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         218 PRPEECPQE-------IYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CCCCCCCHH-------HHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            222234443       445555699999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.97  E-value=9.9e-30  Score=205.05  Aligned_cols=182  Identities=21%  Similarity=0.347  Sum_probs=131.9

Q ss_pred             CCCCCcchhccccCC---------CCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcc
Q 026160            1 MPNGSLDQFTYDQES---------SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISD   71 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~---------~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~d   71 (242)
                      +++|+|.+++.....         ......+++.++..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|
T Consensus        89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~d  165 (280)
T cd05092          89 MRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGD  165 (280)
T ss_pred             CCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEECC
Confidence            478999999876431         11224589999999999999999999998   999999999999999999999999


Q ss_pred             cccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhh
Q 026160           72 FGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYK  150 (242)
Q Consensus        72 fg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~  150 (242)
                      ||++................++..|.|||.+.+.  .++.++|+|||||++|++++ |..||.......        ...
T Consensus       166 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------~~~  235 (280)
T cd05092         166 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--------AIE  235 (280)
T ss_pred             CCceeEcCCCceeecCCCccccccccCHHHhccC--CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--------HHH
Confidence            9998755433221111122346789999987653  57889999999999999998 888885332211        111


Q ss_pred             ccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 026160          151 HIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES  202 (242)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~  202 (242)
                      ....+.....+..+++.+.+++       .+||+.||++||++.++++.|++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~li-------~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         236 CITQGRELERPRTCPPEVYAIM-------QGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HHHcCccCCCCCCCCHHHHHHH-------HHHccCChhhCCCHHHHHHHHhC
Confidence            1111112222334455554444       44999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.97  E-value=3e-30  Score=223.01  Aligned_cols=186  Identities=26%  Similarity=0.397  Sum_probs=149.6

Q ss_pred             CCCCCcchhccccCC--------CCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEccc
Q 026160            1 MPNGSLDQFTYDQES--------SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDF   72 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~--------~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~df   72 (242)
                      |.+|+|..||..+.-        .+....|+..+.+.|+.||+.|+.||-+.   .+|||||-.+|+||.++..||++||
T Consensus       571 m~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKIsDf  647 (774)
T KOG1026|consen  571 MDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKISDF  647 (774)
T ss_pred             cccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEeccc
Confidence            678999999985421        11134599999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhc
Q 026160           73 GLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKH  151 (242)
Q Consensus        73 g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~  151 (242)
                      |+++.......+....+..-+++|+|||.+.-  ++++.+|||||||+++||+++ |+.||.....        +.....
T Consensus       648 GLsRdiYssDYYk~~~~t~lPIRWMppEsIly--~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn--------~EVIe~  717 (774)
T KOG1026|consen  648 GLSRDIYSSDYYKVRGNTLLPIRWMPPESILY--GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN--------QEVIEC  717 (774)
T ss_pred             ccchhhhhhhhhcccCCceeeeecCCHHHhhc--CcccchhhhhhhhhhhhhhhccccCcccccch--------HHHHHH
Confidence            99998777666555444556789999998854  489999999999999999996 8889876654        333344


Q ss_pred             cCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          152 IEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      +..+....-+..+|       .+++.||+.||+.+|++||++.|+...|++..+.
T Consensus       718 i~~g~lL~~Pe~CP-------~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  718 IRAGQLLSCPENCP-------TEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             HHcCCcccCCCCCC-------HHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            44544444444444       4566677779999999999999999999987764

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.97  E-value=9.9e-30  Score=206.01  Aligned_cols=185  Identities=26%  Similarity=0.422  Sum_probs=134.8

Q ss_pred             CCCCCcchhccccCCC------------------CCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeC
Q 026160            1 MPNGSLDQFTYDQESS------------------NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD   62 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~   62 (242)
                      +++|+|.+++......                  .....+++.+++.++.|++.||.|||+.   +++|+||||+||+++
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nill~  161 (290)
T cd05045          85 AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVA  161 (290)
T ss_pred             cCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEEEc
Confidence            4789999998754221                  1234689999999999999999999998   999999999999999


Q ss_pred             CCCceEEcccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCC
Q 026160           63 EDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSD  141 (242)
Q Consensus        63 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~  141 (242)
                      .++.++|+|||++................++..|++||.+.+.  .++.++||||||+++|++++ |..||.....    
T Consensus       162 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----  235 (290)
T cd05045         162 EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP----  235 (290)
T ss_pred             CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC--CcchHhHHHHHHHHHHHHHhcCCCCCCCCCH----
Confidence            9999999999998755433222111122356789999987553  57889999999999999998 8888854321    


Q ss_pred             CcCcchhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhh
Q 026160          142 IYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTE  205 (242)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~  205 (242)
                          ...............+..++.+       +..++..||+.||++||++.++++.|+++..
T Consensus       236 ----~~~~~~~~~~~~~~~~~~~~~~-------~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         236 ----ERLFNLLKTGYRMERPENCSEE-------MYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             ----HHHHHHHhCCCCCCCCCCCCHH-------HHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence                1111122221122222334444       4455566999999999999999999998653

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.97  E-value=3.4e-30  Score=212.63  Aligned_cols=176  Identities=28%  Similarity=0.428  Sum_probs=130.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      +.+++.++..++.||+.||.|||+.   +++|+||||+|||++.++.++|+|||++.....
T Consensus        87 ~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~  157 (332)
T cd05614          87 VSGGEMFTHLYQR------DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS  157 (332)
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence            5789999999765      4599999999999999999999999   999999999999999999999999999876433


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ..... .....|+..|+|||.+.+. ...+.++|||||||++|+|++|..||.........    ......... .....
T Consensus       158 ~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----~~~~~~~~~-~~~~~  230 (332)
T cd05614         158 EEKER-TYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ----SEVSRRILK-CDPPF  230 (332)
T ss_pred             cCCCc-cccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH----HHHHHHHhc-CCCCC
Confidence            22111 1123589999999998653 24578999999999999999999999644322111    111111111 11223


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRP-----SMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp-----s~~~ll~~  199 (242)
                      +..+++.+.+++.+       ||+.||++||     ++.+++++
T Consensus       231 ~~~~~~~~~~li~~-------~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         231 PSFIGPEAQDLLHK-------LLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             CCCCCHHHHHHHHH-------HcCCCHHHcCCCCCCCHHHHHcC
Confidence            34456666555555       8899999999     77888765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.97  E-value=1.6e-29  Score=207.05  Aligned_cols=187  Identities=26%  Similarity=0.439  Sum_probs=135.2

Q ss_pred             CCCCCcchhccccCCC----------CCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEc
Q 026160            1 MPNGSLDQFTYDQESS----------NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKIS   70 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~   70 (242)
                      +++|+|.+++......          .....+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+
T Consensus       100 ~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~~kL~  176 (314)
T cd05099         100 AAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIA  176 (314)
T ss_pred             CCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEcCCCcEEEc
Confidence            5789999999764311          1234689999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhh
Q 026160           71 DFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIY  149 (242)
Q Consensus        71 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~  149 (242)
                      |||++................++..|++||.+.+.  .++.++|+||||+++|++++ |..||......        ...
T Consensus       177 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--------~~~  246 (314)
T cd05099         177 DFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR--VYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--------ELF  246 (314)
T ss_pred             cccccccccccccccccccCCCCccccCHHHHccC--CcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--------HHH
Confidence            99999765432221111111244679999988653  57889999999999999998 78887533211        111


Q ss_pred             hccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhc
Q 026160          150 KHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEIL  207 (242)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~  207 (242)
                      ...........+..++.++.+       ++.+||+.||++|||+.++++.|+++....
T Consensus       247 ~~~~~~~~~~~~~~~~~~l~~-------li~~cl~~~p~~Rps~~~ll~~l~~~~~~~  297 (314)
T cd05099         247 KLLREGHRMDKPSNCTHELYM-------LMRECWHAVPTQRPTFKQLVEALDKVLAAV  297 (314)
T ss_pred             HHHHcCCCCCCCCCCCHHHHH-------HHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence            111111111223334444444       455599999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.97  E-value=1.3e-29  Score=201.95  Aligned_cols=178  Identities=26%  Similarity=0.399  Sum_probs=132.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....     ..+++.++..++.|++.|+.|||++   +++|+||||.||+++.++.++|+|||++.....
T Consensus        76 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  147 (257)
T cd05115          76 ASGGPLNKFLSGKK-----DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGA  147 (257)
T ss_pred             CCCCCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccC
Confidence            47899999986532     4689999999999999999999999   999999999999999999999999999875543


Q ss_pred             Ccccch-hcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           81 KKSTIS-MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        81 ~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      ...... .....++..|+|||.+...  ..+.++|+||||+++|++++ |..||......        ........+...
T Consensus       148 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~  217 (257)
T cd05115         148 DDSYYKARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--------EVMSFIEQGKRL  217 (257)
T ss_pred             CccceeccCCCCCCcccCCHHHHccC--CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHHCCCCC
Confidence            322111 1111235689999987643  56889999999999999996 99998643321        111222222223


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                      ..+...++++.+++.+       ||..||++||++.++.+.|+.+
T Consensus       218 ~~~~~~~~~l~~li~~-------c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         218 DCPAECPPEMYALMKD-------CWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCHHHHHHHHH-------HcCCChhhCcCHHHHHHHHhhh
Confidence            3344455555555544       9999999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.97  E-value=6.1e-30  Score=207.14  Aligned_cols=121  Identities=28%  Similarity=0.369  Sum_probs=100.8

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      .|+|.+++....    ...+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        92 ~~~l~~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  164 (290)
T cd07862          92 DQDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM  164 (290)
T ss_pred             CCCHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceEeccCCc
Confidence            367778876532    24589999999999999999999999   99999999999999999999999999987654332


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      ..   ....++..|+|||.+.+.  .++.++|+|||||++|++++|..||...
T Consensus       165 ~~---~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~~f~~~  212 (290)
T cd07862         165 AL---TSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGS  212 (290)
T ss_pred             cc---ccccccccccChHHHhCC--CCCCccchHHHHHHHHHHHcCCCCcCCC
Confidence            11   123478999999998653  5688999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.97  E-value=5.1e-30  Score=211.39  Aligned_cols=178  Identities=22%  Similarity=0.356  Sum_probs=129.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.+.      +.+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        78 ~~~g~L~~~~~~~------~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  148 (329)
T cd05588          78 VSGGDLMFHMQRQ------RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR  148 (329)
T ss_pred             CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccccc
Confidence            6899999988654      4599999999999999999999999   999999999999999999999999999864221


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCC-cCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDI-YFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  159 (242)
                      ....  .....|+..|+|||.+.+.  .++.++|+|||||++|++++|..||.......... ............ ....
T Consensus       149 ~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~  223 (329)
T cd05588         149 PGDT--TSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE-KQIR  223 (329)
T ss_pred             CCCc--cccccCCccccCHHHHcCC--CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc-CCCC
Confidence            1111  1123588999999998653  56889999999999999999999997443222110 001111111111 1223


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCC------HHHHHHH
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPS------MHEVLEM  199 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps------~~~ll~~  199 (242)
                      .+..++.++.+++.+       ||+.||.+|++      +.+++++
T Consensus       224 ~p~~~~~~~~~li~~-------~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         224 IPRSLSVKASSVLKG-------FLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             CCCCCCHHHHHHHHH-------HhccCHHHcCCCCCCCCHHHHhcC
Confidence            344556666666555       77999999997      6777654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.97  E-value=1.2e-29  Score=206.32  Aligned_cols=184  Identities=24%  Similarity=0.398  Sum_probs=133.3

Q ss_pred             CCCCCcchhccccCCCC----------CCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEc
Q 026160            1 MPNGSLDQFTYDQESSN----------GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKIS   70 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~   70 (242)
                      +++|+|.+++.+.....          ....+++.+++.++.|++.|+.|||+.   +++|+||||+||+++.++.++|+
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~  161 (297)
T cd05089          85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIA  161 (297)
T ss_pred             cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEEC
Confidence            47899999997543211          124689999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhh
Q 026160           71 DFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIY  149 (242)
Q Consensus        71 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~  149 (242)
                      |||++.........   .....+..|++||.....  .++.++||||||+++|+|++ |..||......        ...
T Consensus       162 dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~--------~~~  228 (297)
T cd05089         162 DFGLSRGEEVYVKK---TMGRLPVRWMAIESLNYS--VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA--------ELY  228 (297)
T ss_pred             CcCCCccccceecc---CCCCcCccccCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--------HHH
Confidence            99998643221111   111234579999987543  56889999999999999997 98998643321        111


Q ss_pred             hccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhc
Q 026160          150 KHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEIL  207 (242)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~  207 (242)
                      ...........+..++..+.+       ++.+||+.||.+|||+.++++.|+.+.+..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~-------li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         229 EKLPQGYRMEKPRNCDDEVYE-------LMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             HHHhcCCCCCCCCCCCHHHHH-------HHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            112222222223334444444       455599999999999999999998877643

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.97  E-value=1.6e-29  Score=206.09  Aligned_cols=186  Identities=23%  Similarity=0.445  Sum_probs=135.2

Q ss_pred             CCCCCcchhccccCCCC----------CCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEc
Q 026160            1 MPNGSLDQFTYDQESSN----------GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKIS   70 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~   70 (242)
                      +++|+|.++|.......          ....+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+
T Consensus       103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili~~~~~~kl~  179 (304)
T cd05101         103 ASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIA  179 (304)
T ss_pred             CCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEEcCCCcEEEC
Confidence            47899999997643211          124688999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhh
Q 026160           71 DFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIY  149 (242)
Q Consensus        71 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~  149 (242)
                      |||++................++..|+|||.+.+.  .++.++||||||+++|++++ |..||.....        ....
T Consensus       180 D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~  249 (304)
T cd05101         180 DFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--------EELF  249 (304)
T ss_pred             CCccceecccccccccccCCCCCceeeCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCcccCCH--------HHHH
Confidence            99998866543222111122355789999988653  57889999999999999998 6777743321        1111


Q ss_pred             hccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          150 KHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      ...........+..++..       +..++.+||+.+|++|||+.++++.|+.+...
T Consensus       250 ~~~~~~~~~~~~~~~~~~-------~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         250 KLLKEGHRMDKPANCTNE-------LYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             HHHHcCCcCCCCCCCCHH-------HHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence            111122222222234444       44455559999999999999999999987764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.97  E-value=1.3e-29  Score=204.26  Aligned_cols=186  Identities=23%  Similarity=0.334  Sum_probs=136.1

Q ss_pred             CCCCCcchhccccCCC--CCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEccccccccc
Q 026160            1 MPNGSLDQFTYDQESS--NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS   78 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~--~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~   78 (242)
                      +++|+|.+++......  .....+++.+++.++.+++.||.|||+.   +++|+||+|.||+++.++.++++|||+++..
T Consensus        91 ~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g~~~~~  167 (280)
T cd05043          91 MNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDL  167 (280)
T ss_pred             CCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCCCCcccc
Confidence            4689999999764321  1225699999999999999999999998   9999999999999999999999999999765


Q ss_pred             CCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           79 QDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        79 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      .............++..|+|||.+.+.  .++.++||||||+++|++++ |+.||......        ...........
T Consensus       168 ~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~  237 (280)
T cd05043         168 FPMDYHCLGDNENRPVKWMALESLVNK--EYSSASDVWSFGVLLWELMTLGQTPYVEIDPF--------EMAAYLKDGYR  237 (280)
T ss_pred             cCCceEEeCCCCCcchhccCHHHHhcC--CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH--------HHHHHHHcCCC
Confidence            433222111122356679999988653  57889999999999999998 99998643221        11111111111


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      ......++++       +.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus       238 ~~~~~~~~~~-------~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         238 LAQPINCPDE-------LFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             CCCCCcCCHH-------HHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            1122223433       45566669999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.97  E-value=1.2e-29  Score=204.76  Aligned_cols=182  Identities=23%  Similarity=0.305  Sum_probs=130.7

Q ss_pred             CCCCCcchhccccC----------CCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEc
Q 026160            1 MPNGSLDQFTYDQE----------SSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKIS   70 (242)
Q Consensus         1 ~~~GsL~~~l~~~~----------~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~   70 (242)
                      +++|+|.+++....          .......+++..+..++.|++.||.|||+.   +++|+||||.||+++.++.++|+
T Consensus        90 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~kl~  166 (283)
T cd05091          90 CSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKIS  166 (283)
T ss_pred             CCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCceEec
Confidence            46788888875321          011124588999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhh
Q 026160           71 DFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIY  149 (242)
Q Consensus        71 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~  149 (242)
                      |||++................++..|+|||.+...  .++.++|+||||+++||+++ |..||.....        ....
T Consensus       167 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~~  236 (283)
T cd05091         167 DLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--------QDVI  236 (283)
T ss_pred             ccccccccccchheeeccCccCCccccCHHHHhcC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--------HHHH
Confidence            99998765433222111222356789999987543  57889999999999999998 7777754321        1112


Q ss_pred             hccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 026160          150 KHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES  202 (242)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~  202 (242)
                      ...........+..++..+.       .++..||+.+|++||++++++..|+.
T Consensus       237 ~~i~~~~~~~~~~~~~~~~~-------~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         237 EMIRNRQVLPCPDDCPAWVY-------TLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHcCCcCCCCCCCCHHHH-------HHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            22222222223334454444       45555999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=2.1e-30  Score=213.02  Aligned_cols=173  Identities=29%  Similarity=0.405  Sum_probs=147.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.+.|.+++.    ..++++.+..++.|++.|+.|||++   .|+|||||..|||++.++.|+|+|||+++..+.
T Consensus        86 ~eGg~l~~~i~~~k~----~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   86 CEGGDLAQLIKEQKG----VLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             cCCCCHHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            789999999998763    6799999999999999999999988   999999999999999999999999999998877


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....||+.|+.||.+.+.  .+..++|||||||++||+++-+++|...+.        ......+.......+
T Consensus       159 ~~~~--a~tvvGTp~YmcPEil~d~--pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m--------~~Li~ki~~~~~~Pl  226 (426)
T KOG0589|consen  159 EDSL--ASTVVGTPYYMCPEILSDI--PYNEKSDIWSLGCCLYEMCTLKPAFKASNM--------SELILKINRGLYSPL  226 (426)
T ss_pred             chhh--hheecCCCcccCHHHhCCC--CCCccCcchhhcchHHHHHhcccccCccch--------HHHHHHHhhccCCCC
Confidence            6422  1234699999999999775  778999999999999999999999986654        222334444446777


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      +..++.+++.+++.|       +..+|..||++.+++..
T Consensus       227 p~~ys~el~~lv~~~-------l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  227 PSMYSSELRSLVKSM-------LRKNPEHRPSALELLRR  258 (426)
T ss_pred             CccccHHHHHHHHHH-------hhcCCccCCCHHHHhhC
Confidence            888899999999984       49999999999999976

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.96  E-value=5.8e-30  Score=211.04  Aligned_cols=178  Identities=23%  Similarity=0.358  Sum_probs=128.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      +.+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        78 ~~~~~L~~~~~~~------~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~  148 (329)
T cd05618          78 VNGGDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  148 (329)
T ss_pred             CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccC
Confidence            5789999888654      4599999999999999999999999   999999999999999999999999999865322


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCc-CcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIY-FPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  159 (242)
                      ....  .....|+..|+|||.+.+.  .++.++|+|||||++|+|++|..||........... .......... .....
T Consensus       149 ~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~-~~~~~  223 (329)
T cd05618         149 PGDT--TSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-EKQIR  223 (329)
T ss_pred             CCCc--cccccCCccccCHHHHcCC--CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh-cCCCC
Confidence            1111  1123589999999998654  568899999999999999999999964332211110 0111111111 11223


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSM------HEVLEM  199 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~------~~ll~~  199 (242)
                      ++..++..+.+++.+       ||+.||++||++      .+++++
T Consensus       224 ~p~~~~~~~~~ll~~-------~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         224 IPRSLSVKAASVLKS-------FLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             CCCCCCHHHHHHHHH-------HhcCCHHHcCCCCCCCCHHHHhcC
Confidence            344455555555555       889999999984      566544

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.96  E-value=1.8e-29  Score=201.96  Aligned_cols=178  Identities=26%  Similarity=0.460  Sum_probs=132.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....     ..+++.++..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        87 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          87 MENGSLDKFLREND-----GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             CCCCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            57899999997642     3689999999999999999999998   999999999999999999999999999987652


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ...........++..|++||.+...  .++.++|+||||+++|++++ |..||.....        ..............
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~--~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~  228 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSYGERPYWDMSN--------QDVIKAVEDGYRLP  228 (266)
T ss_pred             cccceeccCCCCCccccChhhhccC--CCccccchHHHHHHHHHHHccCCCCCCCCCH--------HHHHHHHHcCCCCC
Confidence            2211111112345689999987653  57889999999999999997 8888853221        11111111111111


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                      .+..++..       +.+++.+||+.+|++||++.++++.|+++
T Consensus       229 ~~~~~~~~-------l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         229 PPMDCPSA-------LYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CCCCCCHH-------HHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            22233443       44566669999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.96  E-value=3.6e-30  Score=198.59  Aligned_cols=158  Identities=30%  Similarity=0.464  Sum_probs=133.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      ++||.|..+|++.      +++++..+...+.+|+.|++|||+.   +|++|||||+|||++++|.+|+.|||++.+...
T Consensus       126 v~GGElFS~Lrk~------~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  126 VPGGELFSYLRKS------GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             cCCccHHHHHHhc------CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            5899999999876      4699999999999999999999999   999999999999999999999999999998776


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ..-     +.+||+.|+|||++...  .+..++|-||||+++|||+.|.+||...+.        ..+...+..+ ...+
T Consensus       197 rT~-----TlCGTPeYLAPEii~sk--~ynkavDWWalGVLIYEMlaG~pPF~~~~~--------~~iY~KI~~~-~v~f  260 (355)
T KOG0616|consen  197 RTW-----TLCGTPEYLAPEIIQSK--GYNKAVDWWALGVLIYEMLAGYPPFYDDNP--------IQIYEKILEG-KVKF  260 (355)
T ss_pred             cEE-----EecCCccccChHHhhcC--CCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------HHHHHHHHhC-cccC
Confidence            522     23599999999999765  678899999999999999999999986664        2333333322 3456


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCC
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDR  190 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~R  190 (242)
                      |..+++.++++++.++       +.|-.+|
T Consensus       261 P~~fs~~~kdLl~~LL-------~vD~t~R  283 (355)
T KOG0616|consen  261 PSYFSSDAKDLLKKLL-------QVDLTKR  283 (355)
T ss_pred             CcccCHHHHHHHHHHH-------hhhhHhh
Confidence            7788999999999977       6666666

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.96  E-value=1.5e-29  Score=203.38  Aligned_cols=182  Identities=25%  Similarity=0.418  Sum_probs=132.7

Q ss_pred             CCCCCcchhccccCCC----CCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEccccccc
Q 026160            1 MPNGSLDQFTYDQESS----NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK   76 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~----~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~   76 (242)
                      +++|+|.+++......    .....+++..++.++.|++.||.|||+.   +++|+||+|.||+++.++.++|+|||+++
T Consensus        91 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~dfg~~~  167 (277)
T cd05032          91 MAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTR  167 (277)
T ss_pred             CCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECCcccch
Confidence            4689999999754321    1123578999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCC
Q 026160           77 QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPG  155 (242)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  155 (242)
                      ...............++..|.|||.+...  ..+.++|+||||+++|++++ |..||.....        .........+
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~--------~~~~~~~~~~  237 (277)
T cd05032         168 DIYETDYYRKGGKGLLPVRWMAPESLKDG--VFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--------EEVLKFVIDG  237 (277)
T ss_pred             hhccCcccccCCCCCccccccCHHHHhcC--CCCcccchHHHHHHHHHhhccCCCCCccCCH--------HHHHHHHhcC
Confidence            65433222111222356789999987543  57889999999999999998 8888853322        1111122222


Q ss_pred             CccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 026160          156 NDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES  202 (242)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~  202 (242)
                      .....+..++.+       +.+++.+||+.+|++|||+.++++.|+.
T Consensus       238 ~~~~~~~~~~~~-------~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         238 GHLDLPENCPDK-------LLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             CCCCCCCCCCHH-------HHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            222233334444       4455556999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.96  E-value=1.8e-29  Score=201.24  Aligned_cols=177  Identities=29%  Similarity=0.454  Sum_probs=132.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++.+..    ...+++.++..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        84 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          84 MEKGSLLAFLRSPE----GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             cccCCHHHHHhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence            57899999997643    25689999999999999999999998   999999999999999999999999999876543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      .....  ....++..|++||.+...  .++.++|+||||+++|++++ |..||.....        ..............
T Consensus       157 ~~~~~--~~~~~~~~~~~PE~~~~~--~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~  224 (261)
T cd05148         157 DVYLS--SDKKIPYKWTAPEAASHG--TFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--------HEVYDQITAGYRMP  224 (261)
T ss_pred             ccccc--cCCCCceEecCHHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHHHhCCcCC
Confidence            22111  122356789999987553  56889999999999999998 7888864331        11111111222222


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                      .+..+++.+       .+++.+||+.||++|||+.++++.|+.+
T Consensus       225 ~~~~~~~~~-------~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         225 CPAKCPQEI-------YKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             CCCCCCHHH-------HHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            233344444       4455569999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.96  E-value=1.8e-29  Score=202.50  Aligned_cols=181  Identities=25%  Similarity=0.433  Sum_probs=130.8

Q ss_pred             CCCCCcchhccccCC----------CCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEc
Q 026160            1 MPNGSLDQFTYDQES----------SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKIS   70 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~   70 (242)
                      +++|+|.+++.....          ......+++.++..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+
T Consensus        78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~  154 (270)
T cd05047          78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA  154 (270)
T ss_pred             CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEEC
Confidence            478999999976431          11234689999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhh
Q 026160           71 DFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIY  149 (242)
Q Consensus        71 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~  149 (242)
                      |||++.........   .....+..|.|||.+...  .++.++|+||||+++|++++ |..||......        ...
T Consensus       155 dfgl~~~~~~~~~~---~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--------~~~  221 (270)
T cd05047         155 DFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------ELY  221 (270)
T ss_pred             CCCCccccchhhhc---cCCCCccccCChHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCccccCHH--------HHH
Confidence            99998533221111   111235679999987543  57889999999999999996 99998543211        111


Q ss_pred             hccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchh
Q 026160          150 KHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESST  204 (242)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~  204 (242)
                      ...........+..++.       .+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       222 ~~~~~~~~~~~~~~~~~-------~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         222 EKLPQGYRLEKPLNCDD-------EVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             HHHhCCCCCCCCCcCCH-------HHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            11111111112222333       3455666699999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=5.1e-30  Score=207.93  Aligned_cols=168  Identities=32%  Similarity=0.441  Sum_probs=129.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      +.+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        83 ~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          83 VPGGELFSYLRNS------GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            5789999999765      4589999999999999999999999   999999999999999999999999999876543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ...     ...+++.|+|||.+.+.  ..+.++|||||||++|+|++|..||......        .....+... ...+
T Consensus       154 ~~~-----~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~--------~~~~~i~~~-~~~~  217 (291)
T cd05612         154 RTW-----TLCGTPEYLAPEVIQSK--GHNKAVDWWALGILIYEMLVGYPPFFDDNPF--------GIYEKILAG-KLEF  217 (291)
T ss_pred             Ccc-----cccCChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhC-CcCC
Confidence            221     23488999999998654  5688999999999999999999999643321        111111111 1123


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHHh
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPS-----MHEVLEML  200 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps-----~~~ll~~l  200 (242)
                      +..+++.+.+++++       ||+.||.+||+     +.+++++-
T Consensus       218 ~~~~~~~~~~li~~-------~l~~dp~~R~~~~~~~~~~~l~h~  255 (291)
T cd05612         218 PRHLDLYAKDLIKK-------LLVVDRTRRLGNMKNGADDVKNHR  255 (291)
T ss_pred             CccCCHHHHHHHHH-------HcCCCHHHccCCccCCHHHHhcCc
Confidence            33455566665555       77999999995     88888763

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=4.7e-30  Score=210.10  Aligned_cols=170  Identities=22%  Similarity=0.347  Sum_probs=127.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      +.+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        75 ~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~  145 (312)
T cd05585          75 INGGELFHHLQRE------GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMK  145 (312)
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCcc
Confidence            5799999999764      4599999999999999999999999   999999999999999999999999999875332


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....|+..|+|||.+.+.  .++.++|+|||||++|+|++|..||......        ........ ....+
T Consensus       146 ~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~tg~~pf~~~~~~--------~~~~~~~~-~~~~~  212 (312)
T cd05585         146 DDDK--TNTFCGTPEYLAPELLLGH--GYTKAVDWWTLGVLLYEMLTGLPPFYDENVN--------EMYRKILQ-EPLRF  212 (312)
T ss_pred             CCCc--cccccCCcccCCHHHHcCC--CCCCccceechhHHHHHHHhCCCCcCCCCHH--------HHHHHHHc-CCCCC
Confidence            2211  1123489999999998654  6788999999999999999999999643221        11111111 11223


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCC---HHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPS---MHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps---~~~ll~~  199 (242)
                      +..+++++.+++.+       ||+.||++||+   +.+++.+
T Consensus       213 ~~~~~~~~~~li~~-------~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         213 PDGFDRDAKDLLIG-------LLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             CCcCCHHHHHHHHH-------HcCCCHHHcCCCCCHHHHHcC
Confidence            34456666555555       88999999985   5666543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.96  E-value=1.7e-29  Score=202.27  Aligned_cols=177  Identities=24%  Similarity=0.386  Sum_probs=130.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|++++....     ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++++|||.+.....
T Consensus        88 ~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          88 MSNGALDSFLRKHE-----GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             CCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            57899999997642     4689999999999999999999999   999999999999999999999999998765432


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ..... .....++..|+|||.+...  .++.++|||||||++|++++ |..||......        ........+....
T Consensus       160 ~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--------~~~~~~~~~~~~~  228 (266)
T cd05064         160 EAIYT-TMSGKSPVLWAAPEAIQYH--HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--------DVIKAVEDGFRLP  228 (266)
T ss_pred             cchhc-ccCCCCceeecCHHHHhhC--CccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHHCCCCCC
Confidence            21111 1112245789999987653  67889999999999999875 99998644321        1111222222222


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                      .+..++..+.+       ++..||+.+|++||++.++++.|.++
T Consensus       229 ~~~~~~~~~~~-------li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         229 APRNCPNLLHQ-------LMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CCCCCCHHHHH-------HHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            33344444444       44559999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.96  E-value=2.1e-29  Score=200.39  Aligned_cols=181  Identities=29%  Similarity=0.441  Sum_probs=135.2

Q ss_pred             CCCCCcchhccccCCC---CCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESS---NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~---~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~   77 (242)
                      +++|+|.+++......   .....+++.+++.++.|++.||.|||+.   +++|+||+|.||+++.++.++|+|||.+..
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~  154 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRD  154 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccc
Confidence            4789999999764210   0125699999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCC
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGN  156 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  156 (242)
                      ..............++..|+|||.+...  .++.++|+||||+++|++++ |..||.....        .........+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~  224 (262)
T cd00192         155 VYDDDYYRKKTGGKLPIRWMAPESLKDG--IFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--------EEVLEYLRKGY  224 (262)
T ss_pred             cccccccccccCCCcCccccCHHHhccC--CcchhhccHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCC
Confidence            6654322222223467889999988654  67889999999999999998 5888865421        11222222222


Q ss_pred             ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          157 DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      ....+..++.++.       +++.+||..||++|||+.++++.|+
T Consensus       225 ~~~~~~~~~~~~~-------~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 RLPKPEYCPDELY-------ELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CCCCCccCChHHH-------HHHHHHccCCcccCcCHHHHHHhhC
Confidence            2233334444444       4555599999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.96  E-value=1.6e-29  Score=206.53  Aligned_cols=186  Identities=25%  Similarity=0.438  Sum_probs=134.5

Q ss_pred             CCCCCcchhccccCCCC----------CCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEc
Q 026160            1 MPNGSLDQFTYDQESSN----------GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKIS   70 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~   70 (242)
                      +++|+|.++|..+....          ....+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+
T Consensus       106 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~~kL~  182 (307)
T cd05098         106 ASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIA  182 (307)
T ss_pred             CCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEcCCCcEEEC
Confidence            57899999997643211          123589999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhh
Q 026160           71 DFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIY  149 (242)
Q Consensus        71 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~  149 (242)
                      |||++................++..|+|||.+.+.  .++.++|+||||+++|+|++ |..||.....        ....
T Consensus       183 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~~~g~~p~~~~~~--------~~~~  252 (307)
T cd05098         183 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--------EELF  252 (307)
T ss_pred             CCcccccccccchhhccccCCCccceeChHHhccC--CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--------HHHH
Confidence            99998765432211111111234689999988653  56889999999999999998 7788753221        1111


Q ss_pred             hccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          150 KHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      ...........+...+.++.       +++.+||+.+|++|||+.++++.|+.+...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~-------~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         253 KLLKEGHRMDKPSNCTNELY-------MMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             HHHHcCCCCCCCCcCCHHHH-------HHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence            11112222222333444444       455559999999999999999999987765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.96  E-value=2.2e-29  Score=202.69  Aligned_cols=181  Identities=24%  Similarity=0.386  Sum_probs=130.4

Q ss_pred             CCCCCcchhccccCC-CCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCC---ceEEccccccc
Q 026160            1 MPNGSLDQFTYDQES-SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF---CPKISDFGLAK   76 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~-~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~---~~~L~dfg~~~   76 (242)
                      +++|+|.+++..... ......+++.++..++.|++.|+.|||+.   +++|+||+|+||+++.++   .++|+|||++.
T Consensus        91 ~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~  167 (277)
T cd05036          91 MAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR  167 (277)
T ss_pred             CCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCcccc
Confidence            478999999976532 12223699999999999999999999999   999999999999998654   58999999988


Q ss_pred             ccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCC
Q 026160           77 QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPG  155 (242)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  155 (242)
                      ................+..|+|||.+.+.  .++.++|||||||++|++++ |..||......        .........
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--------~~~~~~~~~  237 (277)
T cd05036         168 DIYRASYYRKGGRAMLPIKWMPPEAFLDG--IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--------EVMEFVTGG  237 (277)
T ss_pred             ccCCccceecCCCCCccHhhCCHHHHhcC--CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHcC
Confidence            65433222111112235679999998653  57899999999999999996 88888643321        111111111


Q ss_pred             CccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          156 NDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      .....+..++.       .+.+++.+||+.||++|||+.+++++|.
T Consensus       238 ~~~~~~~~~~~-------~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         238 GRLDPPKGCPG-------PVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             CcCCCCCCCCH-------HHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            11122233343       3455666699999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.96  E-value=2.1e-29  Score=201.00  Aligned_cols=177  Identities=25%  Similarity=0.421  Sum_probs=131.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....    ...+++.++..++.+++.|++|||+.   +++|+||+|.||+++.++.++|+|||++.....
T Consensus        83 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05072          83 MAKGSLLDFLKSDE----GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIED  155 (261)
T ss_pred             CCCCcHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCC
Confidence            57899999997642    25689999999999999999999998   999999999999999999999999999986544


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ..... .....++..|+|||.+...  ..+.++|+||||+++|++++ |..||......        .............
T Consensus       156 ~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~~~~~~~~~  224 (261)
T cd05072         156 NEYTA-REGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--------DVMSALQRGYRMP  224 (261)
T ss_pred             Cceec-cCCCccceecCCHHHhccC--CCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--------HHHHHHHcCCCCC
Confidence            32111 1112356689999987543  56789999999999999998 88888543211        1111111111111


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES  202 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~  202 (242)
                      ....++.+       +.+++.+||+.+|++||+++++.+.|+.
T Consensus       225 ~~~~~~~~-------~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         225 RMENCPDE-------LYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCCCCCHH-------HHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            22233444       4445556999999999999999999985

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.96  E-value=8.9e-30  Score=209.85  Aligned_cols=170  Identities=27%  Similarity=0.410  Sum_probs=129.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      +.+++.++..++.||+.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        77 ~~~g~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~  147 (328)
T cd05593          77 VNGGELFFHLSRE------RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT  147 (328)
T ss_pred             CCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCC
Confidence            5789999988664      4599999999999999999999999   999999999999999999999999999875322


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....++..|+|||.+.+.  .++.++|||||||++|++++|..||......        ....... .....+
T Consensus       148 ~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~Pf~~~~~~--------~~~~~~~-~~~~~~  214 (328)
T cd05593         148 DAAT--MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELIL-MEDIKF  214 (328)
T ss_pred             cccc--cccccCCcCccChhhhcCC--CCCccCCccccchHHHHHhhCCCCCCCCCHH--------HHHHHhc-cCCccC
Confidence            2111  1123488999999998653  5688999999999999999999999643221        1111111 111223


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRP-----SMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp-----s~~~ll~~  199 (242)
                      +..+++++.+++.+       ||+.||++|+     ++.+++++
T Consensus       215 p~~~~~~~~~li~~-------~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         215 PRTLSADAKSLLSG-------LLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCCHHHHHHHHH-------HcCCCHHHcCCCCCCCHHHHhcC
Confidence            44456666665555       7799999997     89999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.96  E-value=5.9e-30  Score=197.82  Aligned_cols=180  Identities=26%  Similarity=0.377  Sum_probs=138.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC---CCceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE---DFCPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~---~~~~~L~dfg~~~~   77 (242)
                      |+||.|...|.++..    ..+++.++.+|+.||..|+.|||+.   +|.||||||+|+|...   +..+||+|||++..
T Consensus       141 meGGeLfsriq~~g~----~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~  213 (400)
T KOG0604|consen  141 MEGGELFSRIQDRGD----QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE  213 (400)
T ss_pred             ccchHHHHHHHHccc----ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccc
Confidence            789999999988754    7899999999999999999999999   9999999999999964   55799999999987


Q ss_pred             cCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      .....   .....+.|+.|.|||++...  ++....|+||+|+++|-|++|.+||........    ...+...+..+..
T Consensus       214 t~~~~---~L~TPc~TPyYvaPevlg~e--KydkscdmwSlgVimYIlLCGyPPFYS~hg~ai----spgMk~rI~~gqy  284 (400)
T KOG0604|consen  214 TQEPG---DLMTPCFTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----SPGMKRRIRTGQY  284 (400)
T ss_pred             cCCCc---cccCCcccccccCHHHhCch--hcCCCCCccchhHHHHHhhcCCCcccccCCccC----ChhHHhHhhccCc
Confidence            65432   23345689999999998654  688899999999999999999999975544221    1222222222221


Q ss_pred             ---cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          158 ---FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       158 ---~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                         ......+++..+++++.       +|..+|.+|.|+.++.++=.-.
T Consensus       285 ~FP~pEWs~VSe~aKdlIR~-------LLkt~PteRlTI~~~m~hpwi~  326 (400)
T KOG0604|consen  285 EFPEPEWSCVSEAAKDLIRK-------LLKTEPTERLTIEEVMDHPWIN  326 (400)
T ss_pred             cCCChhHhHHHHHHHHHHHH-------HhcCCchhheeHHHhhcCchhc
Confidence               11223455566666666       4499999999999999775543

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.96  E-value=3.3e-29  Score=202.23  Aligned_cols=185  Identities=23%  Similarity=0.376  Sum_probs=130.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++...       .+++.+++.++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        90 ~~~~~l~~~~~~~-------~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          90 VPLGSLRDYLPKH-------KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             CCCCCHHHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCC
Confidence            4789999998653       499999999999999999999999   999999999999999999999999999876543


Q ss_pred             Ccccch-hcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCc-------chhhhcc
Q 026160           81 KKSTIS-MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP-------NSIYKHI  152 (242)
Q Consensus        81 ~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~-------~~~~~~~  152 (242)
                      ...... .....++..|++||.+.+.  ..+.++|+||||+++|++++|..||.............       .......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKEN--KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL  237 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhccc--CCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence            322111 1112345679999987653  56889999999999999999999875432211000000       0000001


Q ss_pred             CCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchh
Q 026160          153 EPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESST  204 (242)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~  204 (242)
                      ........+..++.       .+..++..||+.||++|||+.++++.|+.+.
T Consensus       238 ~~~~~~~~~~~~~~-------~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         238 ERGMRLPCPKNCPQ-------EVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hcCCCCCCCCCCCH-------HHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            11111111222333       4455556699999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.2e-30  Score=215.56  Aligned_cols=184  Identities=26%  Similarity=0.378  Sum_probs=144.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|++||.+..     ..++..++..++.+.+.||+|||+.   +++||||-.+|+|++.++.+|++|||+++....
T Consensus       243 ~~gGsL~~~L~k~~-----~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~  314 (474)
T KOG0194|consen  243 CNGGSLDDYLKKNK-----KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ  314 (474)
T ss_pred             cCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence            78999999998763     2699999999999999999999999   999999999999999999999999999876542


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhcc-CCCCcc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHI-EPGNDF  158 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~  158 (242)
                      ......  ..+-+..|+|||.+...  .++.++||||||+++||+++ |..||......        .....+ .++...
T Consensus       315 ~~~~~~--~~klPirWLAPEtl~~~--~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--------~v~~kI~~~~~r~  382 (474)
T KOG0194|consen  315 YVMKKF--LKKLPIRWLAPETLNTG--IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--------EVKAKIVKNGYRM  382 (474)
T ss_pred             eeeccc--cccCcceecChhhhccC--ccccccchhheeeeEEeeeccCCCCCCCCCHH--------HHHHHHHhcCccC
Confidence            222211  12467899999998654  88999999999999999998 67787655432        222333 444444


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccCCC
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPP  211 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~  211 (242)
                      ..+...+.+...+       +..||..||++|||+.++.+.|+.+......+.
T Consensus       383 ~~~~~~p~~~~~~-------~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~~  428 (474)
T KOG0194|consen  383 PIPSKTPKELAKV-------MKQCWKKDPEDRPTMSTIKKKLEALEKKKEAFD  428 (474)
T ss_pred             CCCCCCHHHHHHH-------HHHhccCChhhccCHHHHHHHHHHHHhcccccc
Confidence            4444444444444       445999999999999999999999988766543

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.96  E-value=4.8e-29  Score=205.96  Aligned_cols=186  Identities=25%  Similarity=0.455  Sum_probs=134.3

Q ss_pred             CCCCCcchhccccCCC----------CCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEc
Q 026160            1 MPNGSLDQFTYDQESS----------NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKIS   70 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~   70 (242)
                      +++|+|.++|......          .....+++.++..++.|++.||.|||..   +++|+||||.||+++.++.++|+
T Consensus       100 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~~~~~~kL~  176 (334)
T cd05100         100 ASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIA  176 (334)
T ss_pred             CCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEEC
Confidence            4789999999764211          1234588999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhh
Q 026160           71 DFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIY  149 (242)
Q Consensus        71 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~  149 (242)
                      |||+++...............++..|+|||.+.+.  .++.++||||||+++|+|++ |..||.....        ....
T Consensus       177 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~  246 (334)
T cd05100         177 DFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--------EELF  246 (334)
T ss_pred             CcccceecccccccccccCCCcCceEcCHHHhccC--CcCchhhhHHHHHHHHHHHhcCCCCCCCCCH--------HHHH
Confidence            99998765433221111112245679999988653  56889999999999999998 7788753321        1111


Q ss_pred             hccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          150 KHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      ...........+..++.+       +..++.+||+.+|++|||+.++++.|+.+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~-------l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~  296 (334)
T cd05100         247 KLLKEGHRMDKPANCTHE-------LYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV  296 (334)
T ss_pred             HHHHcCCCCCCCCCCCHH-------HHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence            111111111222233333       44555569999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.2e-29  Score=207.99  Aligned_cols=175  Identities=22%  Similarity=0.287  Sum_probs=133.6

Q ss_pred             ccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccccc
Q 026160           20 RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAP   99 (242)
Q Consensus        20 ~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~P   99 (242)
                      -.|++.++..++.||+.||.|+|++   +|+|||||.+||||+.+|.+||+|||+++++...... .++..+.|.+|.||
T Consensus       213 vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~-~~T~rVvTLWYRpP  288 (560)
T KOG0600|consen  213 VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA-PYTSRVVTLWYRPP  288 (560)
T ss_pred             cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCCCc-ccccceEEeeccCh
Confidence            4799999999999999999999999   9999999999999999999999999999977654422 24556789999999


Q ss_pred             hhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCC------------CCCcCcchhhhccCCCC-ccccccccch
Q 026160          100 EVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRS------------SDIYFPNSIYKHIEPGN-DFQLDGVVTE  166 (242)
Q Consensus       100 E~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~------------~~~~~~~~~~~~~~~~~-~~~~~~~~~~  166 (242)
                      |.+.+. ..++.+.|+||.|||+.||++|++.+......+            ...+|+........... .......+.+
T Consensus       289 ELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E  367 (560)
T KOG0600|consen  289 ELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRE  367 (560)
T ss_pred             HHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHH
Confidence            999886 578999999999999999999999886554322            22222211111111111 1111223444


Q ss_pred             HHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          167 EEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       167 ~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .++.+....++++..+|..||++|.|+.++++.
T Consensus       368 ~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  368 TFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             HhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            456666777888888889999999999998853

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.96  E-value=2.4e-29  Score=205.11  Aligned_cols=184  Identities=26%  Similarity=0.422  Sum_probs=133.4

Q ss_pred             CCCCCcchhccccCCC----------CCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEc
Q 026160            1 MPNGSLDQFTYDQESS----------NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKIS   70 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~   70 (242)
                      +++|+|.+++......          .....+++.+++.++.|++.|+.|||+.   +++|+||||+||+++.++.++|+
T Consensus        90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl~  166 (303)
T cd05088          90 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA  166 (303)
T ss_pred             CCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEEeC
Confidence            5789999999764321          1234689999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhh
Q 026160           71 DFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIY  149 (242)
Q Consensus        71 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~  149 (242)
                      |||++.........   .....+..|++||.+...  ..+.++|+||||+++|++++ |..||......        ...
T Consensus       167 dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~~  233 (303)
T cd05088         167 DFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------ELY  233 (303)
T ss_pred             ccccCcccchhhhc---ccCCCcccccCHHHHhcc--CCcccccchhhhhHHHHHHhcCCCCcccCChH--------HHH
Confidence            99998643211111   111235679999987553  56889999999999999998 99998643321        111


Q ss_pred             hccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhc
Q 026160          150 KHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEIL  207 (242)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~  207 (242)
                      ...........+...+++       +.+++.+||+.+|++||++.+++..|+.+.+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~-------~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~  284 (303)
T cd05088         234 EKLPQGYRLEKPLNCDDE-------VYDLMRQCWREKPYERPSFAQILVSLNRMLEER  284 (303)
T ss_pred             HHHhcCCcCCCCCCCCHH-------HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            111111111122223333       455666699999999999999999998876654

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.96  E-value=3.1e-29  Score=200.72  Aligned_cols=181  Identities=24%  Similarity=0.425  Sum_probs=131.8

Q ss_pred             CCCCCcchhccccCCCC-CCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCC-----ceEEccccc
Q 026160            1 MPNGSLDQFTYDQESSN-GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF-----CPKISDFGL   74 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~-----~~~L~dfg~   74 (242)
                      +++|+|.+++.+..... ....+++.++..++.|++.|+.|||+.   +++|+||+|+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            47899999997643222 335689999999999999999999998   999999999999998877     899999999


Q ss_pred             ccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccC
Q 026160           75 AKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIE  153 (242)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~  153 (242)
                      +.................+..|+|||.+.+.  ..+.++|+||||+++|++++ |..||......        .......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--------~~~~~~~  227 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDG--KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--------EVLQHVT  227 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccC--CcccchhHHHHHHHHHHHHHcCCCCCcccCHH--------HHHHHHh
Confidence            8755432221111122356789999988653  57899999999999999998 89888633221        1111111


Q ss_pred             CCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          154 PGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      .......+..++.       .+.+++.+||..+|++||++.++++.|+
T Consensus       228 ~~~~~~~~~~~~~-------~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         228 AGGRLQKPENCPD-------KIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             cCCccCCcccchH-------HHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            2222222223333       3455666699999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.96  E-value=8.2e-30  Score=210.15  Aligned_cols=167  Identities=26%  Similarity=0.390  Sum_probs=128.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.+.      +.+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       100 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263        100 VVGGELFTHLRKA------GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             CCCChHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            5789999999765      4589999999999999999999999   999999999999999999999999999986544


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ...     ...+++.|+|||.+.+.  ..+.++|+|||||++|+|++|..||.....        ......+..+ ...+
T Consensus       171 ~~~-----~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~~-~~~~  234 (329)
T PTZ00263        171 RTF-----TLCGTPEYLAPEVIQSK--GHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--------FRIYEKILAG-RLKF  234 (329)
T ss_pred             Ccc-----eecCChhhcCHHHHcCC--CCCCcceeechHHHHHHHHcCCCCCCCCCH--------HHHHHHHhcC-CcCC
Confidence            322     23488999999998654  568899999999999999999999964321        1111111111 1223


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPS-----MHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps-----~~~ll~~  199 (242)
                      +..++..+.+++.+       ||+.||.+|++     +.+++.+
T Consensus       235 p~~~~~~~~~li~~-------~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        235 PNWFDGRARDLVKG-------LLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             CCCCCHHHHHHHHH-------HhhcCHHHcCCCCCCCHHHHhcC
Confidence            33455555555555       88999999996     6888755

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.96  E-value=2.8e-29  Score=204.64  Aligned_cols=180  Identities=23%  Similarity=0.393  Sum_probs=131.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++.....    ..+++.++..++.+++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       121 ~~~~~L~~~i~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  193 (302)
T cd05055         121 CCYGDLLNFLRRKRE----SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMN  193 (302)
T ss_pred             CCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccccC
Confidence            478999999975422    3489999999999999999999998   999999999999999999999999999875543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ...........++..|+|||.+.+.  ..+.++||||||+++|++++ |..||......       .........+....
T Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~~  264 (302)
T cd05055         194 DSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-------SKFYKLIKEGYRMA  264 (302)
T ss_pred             CCceeecCCCCcccccCCHhhhccC--CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-------HHHHHHHHcCCcCC
Confidence            3221111122356789999988654  56889999999999999998 88888643321       11111111111111


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                      .+...+++       +.+++.+||+.+|++|||+.++++.|++.
T Consensus       265 ~~~~~~~~-------~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         265 QPEHAPAE-------IYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             CCCCCCHH-------HHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            22223444       44555559999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.96  E-value=1.7e-29  Score=207.16  Aligned_cols=169  Identities=24%  Similarity=0.406  Sum_probs=127.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        78 ~~gg~L~~~~~~~------~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~  148 (316)
T cd05592          78 LNGGDLMFHIQSS------GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN  148 (316)
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCC
Confidence            5799999998754      4599999999999999999999998   999999999999999999999999999875432


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....|+..|+|||.+.+.  .++.++|+|||||++|+|++|..||......        .....+.. .....
T Consensus       149 ~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~-~~~~~  215 (316)
T cd05592         149 GEGK--ASTFCGTPDYIAPEILKGQ--KYNESVDWWSFGVLLYEMLIGQSPFHGEDED--------ELFDSILN-DRPHF  215 (316)
T ss_pred             CCCc--cccccCCccccCHHHHcCC--CCCCcccchhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHc-CCCCC
Confidence            2211  1123589999999998654  5688999999999999999999999744321        11111111 11223


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHH-HHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMH-EVLE  198 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~-~ll~  198 (242)
                      +..++.++.+++.+       ||+.||++||++. ++++
T Consensus       216 ~~~~~~~~~~ll~~-------~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         216 PRWISKEAKDCLSK-------LFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCCCCHHHHHHHHH-------HccCCHHHcCCChHHHHc
Confidence            33455555555554       8899999999875 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.96  E-value=1.1e-29  Score=208.70  Aligned_cols=164  Identities=23%  Similarity=0.341  Sum_probs=125.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.+.      +.+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        78 ~~~g~L~~~i~~~------~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~  148 (320)
T cd05590          78 VNGGDLMFHIQKS------RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF  148 (320)
T ss_pred             CCCchHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc
Confidence            5789999998765      4599999999999999999999999   999999999999999999999999999875332


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....|++.|+|||.+.+.  .++.++|+|||||++|+|++|..||......        .....+... ....
T Consensus       149 ~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--------~~~~~i~~~-~~~~  215 (320)
T cd05590         149 NGKT--TSTFCGTPDYIAPEILQEM--LYGPSVDWWAMGVLLYEMLCGHAPFEAENED--------DLFEAILND-EVVY  215 (320)
T ss_pred             CCCc--ccccccCccccCHHHHcCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCHH--------HHHHHHhcC-CCCC
Confidence            2111  1123489999999998653  5688999999999999999999999744321        111111111 1123


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSM  193 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~  193 (242)
                      +..++.++.+++.+       ||+.||++||++
T Consensus       216 ~~~~~~~~~~li~~-------~L~~dP~~R~~~  241 (320)
T cd05590         216 PTWLSQDAVDILKA-------FMTKNPTMRLGS  241 (320)
T ss_pred             CCCCCHHHHHHHHH-------HcccCHHHCCCC
Confidence            33456666665555       779999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.96  E-value=3.6e-29  Score=202.01  Aligned_cols=182  Identities=24%  Similarity=0.340  Sum_probs=131.9

Q ss_pred             CCCCCcchhccccCC-----------CCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEE
Q 026160            1 MPNGSLDQFTYDQES-----------SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKI   69 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~-----------~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L   69 (242)
                      +++|+|.+++.....           ......+++.++..++.|++.||.|||++   +++|+||||+||+++.++.++|
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~kl  165 (283)
T cd05090          89 LNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKI  165 (283)
T ss_pred             CCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcEEe
Confidence            468899999854321           01124588999999999999999999999   9999999999999999999999


Q ss_pred             cccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchh
Q 026160           70 SDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSI  148 (242)
Q Consensus        70 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~  148 (242)
                      +|||++................++..|.+||.+.+.  ..+.++|+||||+++|++++ |..||.....        ...
T Consensus       166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--------~~~  235 (283)
T cd05090         166 SDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG--KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--------QEV  235 (283)
T ss_pred             ccccccccccCCcceecccCCCccceecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHH
Confidence            999999765433222112222356679999988653  57889999999999999998 8888854321        111


Q ss_pred             hhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 026160          149 YKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES  202 (242)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~  202 (242)
                      ............+..+++.+.+       ++.+||+.||++||++.++++.|++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~-------li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         236 IEMVRKRQLLPCSEDCPPRMYS-------LMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHcCCcCCCCCCCCHHHHH-------HHHHHcccCcccCcCHHHHHHHhhc
Confidence            1111122222233344554444       4455999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.96  E-value=1e-29  Score=209.10  Aligned_cols=170  Identities=28%  Similarity=0.373  Sum_probs=128.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      +.+++..+..++.||+.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        77 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  147 (323)
T cd05595          77 ANGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  147 (323)
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccC
Confidence            5789999888654      4589999999999999999999999   999999999999999999999999998865322


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....++..|+|||.+.+.  .++.++|+|||||++|++++|..||......       ........  ....+
T Consensus       148 ~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------~~~~~~~~--~~~~~  214 (323)
T cd05595         148 DGAT--MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFELILM--EEIRF  214 (323)
T ss_pred             CCCc--cccccCCcCcCCcccccCC--CCCchhchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHhc--CCCCC
Confidence            2111  1123488999999998653  5688999999999999999999999643321       01111111  11123


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRP-----SMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp-----s~~~ll~~  199 (242)
                      +..+++++.+++.+       ||+.||++|+     ++.+++++
T Consensus       215 p~~~~~~~~~li~~-------~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         215 PRTLSPEAKSLLAG-------LLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCCCHHHHHHHHH-------HccCCHHHhCCCCCCCHHHHHcC
Confidence            34456666665555       8899999998     88888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.96  E-value=2.7e-29  Score=207.24  Aligned_cols=120  Identities=33%  Similarity=0.494  Sum_probs=102.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      +.+++..+..++.|++.||.|||+.+  +++|+||||+||+++.++.++|+|||++.....
T Consensus        85 ~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  156 (331)
T cd06649          85 MDGGSLDQVLKEA------KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (331)
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence            5789999999765      35899999999999999999999851  699999999999999999999999999875543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADV  134 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~  134 (242)
                      ...    ....++..|+|||.+.+.  .++.++|+|||||++|++++|+.||..
T Consensus       157 ~~~----~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         157 SMA----NSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             ccc----ccCCCCcCcCCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            221    122488999999998654  578899999999999999999999964

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.96  E-value=3.3e-29  Score=198.83  Aligned_cols=176  Identities=24%  Similarity=0.375  Sum_probs=127.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....     ..+++.+++.++.|++.||.|||+.   +++|+||+|.||+++.++.++|+|||++.....
T Consensus        75 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  146 (252)
T cd05084          75 VQGGDFLTFLRTEG-----PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEED  146 (252)
T ss_pred             ccCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccc
Confidence            47899999986432     3589999999999999999999999   999999999999999999999999999875433


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ............+..|+|||.+.+.  ..+.++|+||||+++|++++ |..||......        .............
T Consensus       147 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--------~~~~~~~~~~~~~  216 (252)
T cd05084         147 GVYASTGGMKQIPVKWTAPEALNYG--RYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--------QTREAIEQGVRLP  216 (252)
T ss_pred             ccccccCCCCCCceeecCchhhcCC--CCChHHHHHHHHHHHHHHHhCCCCCccccCHH--------HHHHHHHcCCCCC
Confidence            2111111111234569999987553  56889999999999999997 88888643221        1111111111122


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      .+..++..       +.+++.+||+.||++|||+.++++.|+
T Consensus       217 ~~~~~~~~-------~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         217 CPELCPDA-------VYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CcccCCHH-------HHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            22333444       444555699999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.96  E-value=2e-29  Score=203.08  Aligned_cols=179  Identities=28%  Similarity=0.382  Sum_probs=129.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....    ...+++..+..++.|++.||.|||+.   +++|+||||.||+++.++.++|+|||++.....
T Consensus        75 ~~g~~L~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~  147 (277)
T cd05607          75 MNGGDLKYHIYNVG----ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD  147 (277)
T ss_pred             CCCCCHHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence            57899998886542    24589999999999999999999998   999999999999999999999999999876554


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....   ....++..|+|||.+.+.  .++.++|+|||||++|++++|..||.........    ...............
T Consensus       148 ~~~~---~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~  218 (277)
T cd05607         148 GKTI---TQRAGTNGYMAPEILKEE--PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK----EELKRRTLEDEVKFE  218 (277)
T ss_pred             Ccee---eccCCCCCccCHHHHccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH----HHHHHHhhccccccc
Confidence            3222   123488899999998654  4788999999999999999999998643321110    111111111111111


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES  202 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~  202 (242)
                      ...++.++.+++.+       ||+.||++||++.++++.+..
T Consensus       219 ~~~~~~~~~~li~~-------~L~~~P~~R~~~~~~~~~~~~  253 (277)
T cd05607         219 HQNFTEESKDICRL-------FLAKKPEDRLGSREKNDDPRK  253 (277)
T ss_pred             cccCCHHHHHHHHH-------HhccCHhhCCCCccchhhhhc
Confidence            12345555555554       889999999999776654443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.96  E-value=3.7e-29  Score=203.96  Aligned_cols=180  Identities=26%  Similarity=0.423  Sum_probs=132.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....     ..+++..+..++.|++.||.|||++   +++|+||||.||+++.++.++|+|||++.....
T Consensus        90 ~~~g~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          90 MPHGCLLDYVHEHK-----DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             cCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccC
Confidence            57899999987642     3589999999999999999999999   999999999999999999999999999986543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ...........++..|++||.+.+.  ..+.++||||||+++|++++ |..||......        ........+....
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~  231 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYR--KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--------EIPDLLEKGERLP  231 (303)
T ss_pred             cccccccCCCccccccCCHHHhccC--CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHCCCCCC
Confidence            3222111122356789999987543  57889999999999999997 88888643211        1111111111111


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTE  205 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~  205 (242)
                      .+..++.       .+..++..||..+|++||++.++++.|+.+.+
T Consensus       232 ~~~~~~~-------~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         232 QPPICTI-------DVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             CCCCCCH-------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            2222333       34455666999999999999999999998654

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=7.4e-30  Score=210.75  Aligned_cols=172  Identities=20%  Similarity=0.242  Sum_probs=128.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      +.+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        83 ~~g~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          83 VPGGDFRTLLNNL------GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            5799999999764      4589999999999999999999999   999999999999999999999999999876544


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ..     ....++..|+|||.+.+.  .++.++|||||||++|+|++|..||.........    ...............
T Consensus       154 ~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~  222 (333)
T cd05600         154 YA-----NSVVGSPDYMAPEVLRGK--GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW----ENLKYWKETLQRPVY  222 (333)
T ss_pred             cc-----CCcccCccccChhHhcCC--CCCCccceecchHHHhhhhhCCCCCCCCCHHHHH----HHHHhccccccCCCC
Confidence            11     123588999999998664  6788999999999999999999999654321100    000000000000000


Q ss_pred             ---ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 ---DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ---~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                         ...+++++.+       ++.+||..+|++||++.+++++
T Consensus       223 ~~~~~~~s~~~~~-------li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         223 DDPRFNLSDEAWD-------LITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CccccccCHHHHH-------HHHHHhhChhhhcCCHHHHHhC
Confidence               0123444444       4445889999999999999976

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.96  E-value=7.9e-30  Score=209.92  Aligned_cols=170  Identities=26%  Similarity=0.389  Sum_probs=128.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhh-CCCCCeeecCCCCCceeeCCCCceEEcccccccccC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHR-GCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ   79 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~-~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~   79 (242)
                      |++|+|.+++...      +.+++.++..++.||+.||.|||+ .   +++|+||||+||+++.++.++|+|||++....
T Consensus        77 ~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~  147 (325)
T cd05594          77 ANGGELFFHLSRE------RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  147 (325)
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence            5789999988654      459999999999999999999997 6   99999999999999999999999999986533


Q ss_pred             CCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           80 DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        80 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      .....  .....++..|+|||.+.+.  .++.++|||||||++|+|++|..||......        ....... .....
T Consensus       148 ~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--------~~~~~i~-~~~~~  214 (325)
T cd05594         148 KDGAT--MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELIL-MEEIR  214 (325)
T ss_pred             CCCcc--cccccCCcccCCHHHHccC--CCCCccccccccceeeeeccCCCCCCCCCHH--------HHHHHHh-cCCCC
Confidence            22111  1123489999999998653  5688999999999999999999999643321        1111111 11122


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRP-----SMHEVLEM  199 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp-----s~~~ll~~  199 (242)
                      ++..+++++.+++.+       ||+.||++|+     ++.+++++
T Consensus       215 ~p~~~~~~~~~li~~-------~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         215 FPRTLSPEAKSLLSG-------LLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCCCHHHHHHHHH-------HhhcCHHHhCCCCCCCHHHHhcC
Confidence            334456666665555       7799999996     89999865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.96  E-value=4.3e-30  Score=212.37  Aligned_cols=188  Identities=22%  Similarity=0.224  Sum_probs=126.5

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      +|+|.+++...      ..+++..+..++.|+++||.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        87 ~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  157 (338)
T cd07859          87 ESDLHQVIKAN------DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDT  157 (338)
T ss_pred             CCCHHHHHHhc------ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence            46777777654      4599999999999999999999999   99999999999999999999999999987543221


Q ss_pred             c-cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCC-------cCcchhhhccCC
Q 026160           83 S-TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDI-------YFPNSIYKHIEP  154 (242)
Q Consensus        83 ~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~-------~~~~~~~~~~~~  154 (242)
                      . ........++..|+|||.+.+....++.++|||||||++|+|++|+.||..........       ..+......+..
T Consensus       158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  237 (338)
T cd07859         158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN  237 (338)
T ss_pred             CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            1 11112235889999999886533467889999999999999999999986433210000       000000000000


Q ss_pred             C--------CccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          155 G--------NDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       155 ~--------~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .        .....+...+.........+.+++.+||+.||++|||+.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            0        00000000011111122344566777999999999999999975

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.96  E-value=2.1e-29  Score=206.66  Aligned_cols=168  Identities=25%  Similarity=0.399  Sum_probs=126.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        78 ~~~g~L~~~i~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~  148 (316)
T cd05620          78 LNGGDLMFHIQDK------GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF  148 (316)
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeeccc
Confidence            5789999998764      4589999999999999999999999   999999999999999999999999998864321


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....++..|+|||.+.+.  .++.++|+|||||++|+|++|..||......        ........ .....
T Consensus       149 ~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--------~~~~~~~~-~~~~~  215 (316)
T cd05620         149 GDNR--ASTFCGTPDYIAPEILQGL--KYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--------ELFESIRV-DTPHY  215 (316)
T ss_pred             CCCc--eeccCCCcCccCHHHHcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHh-CCCCC
Confidence            1111  1123589999999998654  5788999999999999999999999643321        11111111 11222


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHH-HHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMH-EVL  197 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~-~ll  197 (242)
                      +..++.++.+++.+       ||+.||++||++. +++
T Consensus       216 ~~~~~~~~~~li~~-------~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         216 PRWITKESKDILEK-------LFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCCHHHHHHHHH-------HccCCHHHcCCChHHHH
Confidence            33455566655555       8899999999985 555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.96  E-value=7.5e-29  Score=199.73  Aligned_cols=180  Identities=26%  Similarity=0.400  Sum_probs=134.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....     ..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        90 ~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          90 MPLGCLLDYVRNHK-----DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             CCCCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            47899999997643     3489999999999999999999998   999999999999999999999999999986654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ...........++..|++||.+..  ...+.++|+||||+++|++++ |..||.....        .........+....
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~~~  231 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILH--RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--------VEIPDLLEKGERLP  231 (279)
T ss_pred             cccceecCCCcccccccCHHHhhc--CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHhCCCCCC
Confidence            332221111223567999998754  356889999999999999998 9999865432        11122222222222


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTE  205 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~  205 (242)
                      .+...+..+       ..++.+||..||++||++.++++.|+.+..
T Consensus       232 ~~~~~~~~~-------~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         232 QPPICTIDV-------YMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             CCCCCCHHH-------HHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            233344443       445556999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.96  E-value=3.6e-29  Score=201.82  Aligned_cols=178  Identities=25%  Similarity=0.384  Sum_probs=130.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....  ..+..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        75 ~~~g~L~~~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  149 (280)
T cd05608          75 MNGGDLRYHIYNVD--EENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKD  149 (280)
T ss_pred             CCCCCHHHHHHhcc--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence            57999998885432  2345799999999999999999999999   999999999999999999999999999876543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      .....  ....++..|+|||.+.+.  .++.++|+||||+++|++++|+.||.........    ......... .....
T Consensus       150 ~~~~~--~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~----~~~~~~~~~-~~~~~  220 (280)
T cd05608         150 GQSKT--KGYAGTPGFMAPELLQGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN----KELKQRILN-DSVTY  220 (280)
T ss_pred             CCccc--cccCCCcCccCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH----HHHHHhhcc-cCCCC
Confidence            32211  122478899999998654  6678999999999999999999999754322111    111111111 11122


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRP-----SMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp-----s~~~ll~~  199 (242)
                      +..+++.+.+++.+       ||+.||++||     ++++++++
T Consensus       221 ~~~~~~~~~~li~~-------~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         221 PDKFSPASKSFCEA-------LLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             cccCCHHHHHHHHH-------HhcCCHHHhcCCCCCCHHHHhcC
Confidence            33455555555555       8899999999     67777764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.96  E-value=2e-29  Score=209.24  Aligned_cols=180  Identities=27%  Similarity=0.418  Sum_probs=139.3

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      |+|+.+|...      +.++++.+..++.+++.||+|||+.   +|+|+|+||.|||+++.|.+|+||||+++.+.....
T Consensus        85 g~L~~il~~d------~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~  155 (808)
T KOG0597|consen   85 GDLFTILEQD------GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS  155 (808)
T ss_pred             hhHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCce
Confidence            6889998776      5699999999999999999999999   999999999999999999999999999998776433


Q ss_pred             cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccccccc
Q 026160           84 TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGV  163 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (242)
                      -  ....+||+.|+|||...+  ..++..+|+||+||++||++.|++||.......       .. ..+ ...+...+..
T Consensus       156 v--ltsikGtPlYmAPElv~e--~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~-------Lv-~~I-~~d~v~~p~~  222 (808)
T KOG0597|consen  156 V--LTSIKGTPLYMAPELVEE--QPYDHTSDLWSLGCILYELYVGQPPFYARSITQ-------LV-KSI-LKDPVKPPST  222 (808)
T ss_pred             e--eeeccCcccccCHHHHcC--CCccchhhHHHHHHHHHHHhcCCCCchHHHHHH-------HH-HHH-hcCCCCCccc
Confidence            2  334579999999999875  478999999999999999999999997544211       11 111 1112223335


Q ss_pred             cchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HhhchhhhccCCCC
Q 026160          164 VTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE--MLESSTEILQIPPK  212 (242)
Q Consensus       164 ~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~--~l~~~~~~~~~~~~  212 (242)
                      .+..+..+++.       .|.+||.+|.|+.+++.  +.++.....+.+..
T Consensus       223 ~S~~f~nfl~g-------LL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~  266 (808)
T KOG0597|consen  223 ASSSFVNFLQG-------LLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQ  266 (808)
T ss_pred             ccHHHHHHHHH-------HhhcChhhcccHHHHhcChHHhhhhhhhccccc
Confidence            66666666666       45999999999999985  34444444444433

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.96  E-value=7.9e-29  Score=197.59  Aligned_cols=177  Identities=29%  Similarity=0.477  Sum_probs=130.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++.+..    ...+++.++..++.+++.|+.|||+.   +++|+||+|.||+++.++.++|+|||++.....
T Consensus        82 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05070          82 MSKGSLLDFLKDGE----GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIED  154 (260)
T ss_pred             cCCCcHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence            46899999997542    25689999999999999999999999   999999999999999999999999999976543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ..... .....++..|+|||.....  ..+.++|+||||+++|++++ |..||......        .............
T Consensus       155 ~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~  223 (260)
T cd05070         155 NEYTA-RQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--------EVLEQVERGYRMP  223 (260)
T ss_pred             ccccc-ccCCCCCccccChHHHhcC--CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCCCC
Confidence            32111 1111245679999987543  57889999999999999999 88888543211        1111111221222


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES  202 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~  202 (242)
                      .+...+..       +.+++.+||..||++|||+.++.+.|+.
T Consensus       224 ~~~~~~~~-------~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         224 CPQDCPIS-------LHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCcCCHH-------HHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            22334444       4445555999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=8.9e-29  Score=197.38  Aligned_cols=177  Identities=27%  Similarity=0.421  Sum_probs=130.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....    ...+++.++..++.+++.|+.+||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        83 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          83 MKYGSLLEYLQGGA----GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE  155 (261)
T ss_pred             ccCCcHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence            36899999997643    24689999999999999999999998   999999999999999999999999999886653


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ..... ......+..|++||.+...  ..+.++|+||||+++|++++ |..||.....        ..............
T Consensus       156 ~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~  224 (261)
T cd05068         156 DIYEA-REGAKFPIKWTAPEAALYN--RFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--------AEVLQQVDQGYRMP  224 (261)
T ss_pred             Ccccc-cCCCcCceeccCccccccC--CCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCC
Confidence            22111 1111234579999987653  67889999999999999999 8888864321        11111111111111


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES  202 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~  202 (242)
                      .+...+..       +.+++.+||+.||++||++.++++.|+.
T Consensus       225 ~~~~~~~~-------~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         225 CPPGCPKE-------LYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCCcCCHH-------HHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            22233333       4455566999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.96  E-value=7.4e-29  Score=198.98  Aligned_cols=183  Identities=23%  Similarity=0.354  Sum_probs=131.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++...........++...+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||+++....
T Consensus        89 ~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~  165 (273)
T cd05074          89 MKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYS  165 (273)
T ss_pred             CCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccccccccC
Confidence            35788888876443322334689999999999999999999998   999999999999999999999999999886543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ...........++..|++||.+...  ..+.++|+||||+++|++++ |..||......        .............
T Consensus       166 ~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~  235 (273)
T cd05074         166 GDYYRQGCASKLPVKWLALESLADN--VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--------EIYNYLIKGNRLK  235 (273)
T ss_pred             CcceecCCCccCchhhcCHhHHhcC--ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--------HHHHHHHcCCcCC
Confidence            3221111122345689999987653  56789999999999999998 77887533211        1111111111111


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                      .....+       ..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       236 ~~~~~~-------~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         236 QPPDCL-------EDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCCCCC-------HHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            112222       3455566669999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.96  E-value=1.8e-29  Score=207.38  Aligned_cols=170  Identities=24%  Similarity=0.335  Sum_probs=128.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      +.+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        78 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~  148 (321)
T cd05591          78 VNGGDLMFQIQRS------RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL  148 (321)
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceeccc
Confidence            5789999998765      4589999999999999999999999   999999999999999999999999999875332


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....++..|+|||.+.+.  .++.++|+|||||++|+|++|+.||......        .....+... ....
T Consensus       149 ~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--------~~~~~i~~~-~~~~  215 (321)
T cd05591         149 NGVT--TTTFCGTPDYIAPEILQEL--EYGPSVDWWALGVLMYEMMAGQPPFEADNED--------DLFESILHD-DVLY  215 (321)
T ss_pred             CCcc--ccccccCccccCHHHHcCC--CCCCccceechhHHHHHHhcCCCCCCCCCHH--------HHHHHHHcC-CCCC
Confidence            2111  1123488999999988653  5688999999999999999999999754321        111111111 1122


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCC-------CHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRP-------SMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp-------s~~~ll~~  199 (242)
                      +..++.++.+++.+       ||+.||++|+       ++.+++++
T Consensus       216 p~~~~~~~~~ll~~-------~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         216 PVWLSKEAVSILKA-------FMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCHHHHHHHHH-------HhccCHHHcCCCCCCCCCHHHHhcC
Confidence            33345555555555       7799999999       88888755

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.96  E-value=5.3e-29  Score=198.18  Aligned_cols=175  Identities=26%  Similarity=0.445  Sum_probs=129.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....     ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        81 ~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~  152 (256)
T cd05059          81 MANGCLLNYLRERK-----GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD  152 (256)
T ss_pred             CCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccc
Confidence            47899999997542     3689999999999999999999999   999999999999999999999999999876543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ..... .....++..|.|||.+.+.  .++.++|+||||+++|++++ |..||......        .............
T Consensus       153 ~~~~~-~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~  221 (256)
T cd05059         153 DQYTS-SQGTKFPVKWAPPEVFDYS--RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--------EVVESVSAGYRLY  221 (256)
T ss_pred             ccccc-cCCCCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--------HHHHHHHcCCcCC
Confidence            22111 1111234579999988653  56789999999999999998 78888643321        1111112222222


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      .+..++.+       +.+++.+||+.+|++|||+.++++.|.
T Consensus       222 ~~~~~~~~-------~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         222 RPKLAPTE-------VYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             CCCCCCHH-------HHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            23334444       445555599999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.96  E-value=2.2e-29  Score=206.67  Aligned_cols=170  Identities=24%  Similarity=0.353  Sum_probs=128.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.+.      ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        78 ~~~~~L~~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  148 (318)
T cd05570          78 VNGGDLMFHIQRS------GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL  148 (318)
T ss_pred             CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCc
Confidence            5789999988764      3599999999999999999999999   999999999999999999999999998864322


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....++..|+|||.+.+.  .++.++|+|||||++|++++|..||......        .....+... ....
T Consensus       149 ~~~~--~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--------~~~~~i~~~-~~~~  215 (318)
T cd05570         149 GGVT--TSTFCGTPDYIAPEILSYQ--PYGPAVDWWALGVLLYEMLAGQSPFEGDDED--------ELFQSILED-EVRY  215 (318)
T ss_pred             CCCc--ccceecCccccCHHHhcCC--CCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--------HHHHHHHcC-CCCC
Confidence            1111  1123478999999998654  6788999999999999999999999643321        111111111 1122


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSM-----HEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~-----~~ll~~  199 (242)
                      +..++.++.+++.       +||+.||++|||+     .+++++
T Consensus       216 ~~~~~~~~~~li~-------~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         216 PRWLSKEAKSILK-------SFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CCcCCHHHHHHHH-------HHccCCHHHcCCCCCCCHHHHhcC
Confidence            3345555555554       4889999999999     888764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.96  E-value=8.9e-29  Score=197.32  Aligned_cols=177  Identities=28%  Similarity=0.476  Sum_probs=130.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....    ...+++..+..++.+++.||.|||+.   +++|+||+|.||+++.++.++|+|||++.....
T Consensus        82 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05069          82 MGKGSLLDFLKEGD----GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIED  154 (260)
T ss_pred             CCCCCHHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence            46889999997542    24589999999999999999999998   999999999999999999999999999876543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      .... ......++..|++||...+.  ..+.++|+||||+++|++++ |..||......        .............
T Consensus       155 ~~~~-~~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~  223 (260)
T cd05069         155 NEYT-ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--------EVLEQVERGYRMP  223 (260)
T ss_pred             Cccc-ccCCCccchhhCCHHHhccC--CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCC
Confidence            3211 11112356679999987543  57889999999999999999 88888643211        1111111111111


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES  202 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~  202 (242)
                      .+...+..       +.+++.+||+.||++||+++++++.|+.
T Consensus       224 ~~~~~~~~-------~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         224 CPQGCPES-------LHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCcccCHH-------HHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            22223334       4445555999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.96  E-value=7.7e-29  Score=197.35  Aligned_cols=175  Identities=23%  Similarity=0.449  Sum_probs=129.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....     ..+++.+++.++.|++.|+.|||+.   +++|+||+|.||+++.++.++|+|||.+.....
T Consensus        81 ~~~~~l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05113          81 MSNGCLLNYLREHG-----KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD  152 (256)
T ss_pred             CCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCC
Confidence            46899999986532     3589999999999999999999999   999999999999999999999999999876543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ..... .....++..|.+||.+...  .++.++|+||||+++|++++ |..||......        ........+....
T Consensus       153 ~~~~~-~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~  221 (256)
T cd05113         153 DEYTS-SVGSKFPVRWSPPEVLLYS--KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--------ETVEKVSQGLRLY  221 (256)
T ss_pred             Cceee-cCCCccChhhCCHHHHhcC--cccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHhcCCCCC
Confidence            32111 1112355679999988653  56789999999999999998 88888643321        1111112222222


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      .+...+       ..+.+++.+||+.||++||++.++++.|+
T Consensus       222 ~~~~~~-------~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         222 RPHLAS-------EKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCC-------HHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            222233       34455666699999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.96  E-value=2.6e-29  Score=207.00  Aligned_cols=177  Identities=23%  Similarity=0.357  Sum_probs=130.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      +.+++.++..++.||+.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        78 ~~~~~L~~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~  148 (327)
T cd05617          78 VNGGDLMFHMQRQ------RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG  148 (327)
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccC
Confidence            5799999988654      4599999999999999999999999   999999999999999999999999999875322


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....|+..|+|||.+.+.  .++.++|+||||+++|+|++|..||........... .......... .....
T Consensus       149 ~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~-~~~~~~~~~~-~~~~~  222 (327)
T cd05617         149 PGDT--TSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNT-EDYLFQVILE-KPIRI  222 (327)
T ss_pred             CCCc--eecccCCcccCCHHHHCCC--CCCchheeehhHHHHHHHHhCCCCCCccCCCccccc-HHHHHHHHHh-CCCCC
Confidence            1111  1123488999999998653  568899999999999999999999965433221111 1111111111 12234


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSM------HEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~------~~ll~~  199 (242)
                      +..++..+.+++.+       ||+.||++|+++      .+++++
T Consensus       223 p~~~~~~~~~li~~-------~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         223 PRFLSVKASHVLKG-------FLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             CCCCCHHHHHHHHH-------HhccCHHHcCCCCCCCCHHHHHcC
Confidence            44566666666666       779999999984      566554

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.96  E-value=4.7e-29  Score=210.21  Aligned_cols=167  Identities=25%  Similarity=0.385  Sum_probs=122.8

Q ss_pred             ccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccccc
Q 026160           20 RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAP   99 (242)
Q Consensus        20 ~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~P   99 (242)
                      ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++................++..|+||
T Consensus       232 ~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP  308 (400)
T cd05105         232 EGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAP  308 (400)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceECh
Confidence            4588999999999999999999998   9999999999999999999999999998765433222111222356789999


Q ss_pred             hhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccccccccchHHHHHHHHHHHH
Q 026160          100 EVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILV  178 (242)
Q Consensus       100 E~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  178 (242)
                      |.+.+.  .++.++||||||+++|++++ |..||......       ...............+..++.       .+.++
T Consensus       309 E~~~~~--~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~-------~l~~l  372 (400)
T cd05105         309 ESIFDN--LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD-------STFYNKIKSGYRMAKPDHATQ-------EVYDI  372 (400)
T ss_pred             hhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCcccchh-------HHHHHHHhcCCCCCCCccCCH-------HHHHH
Confidence            988653  56889999999999999997 88888643221       111111112212222223333       34555


Q ss_pred             HHHhccCCCCCCCCHHHHHHHhhchhh
Q 026160          179 SLWCIQTNPSDRPSMHEVLEMLESSTE  205 (242)
Q Consensus       179 ~~~cl~~dp~~Rps~~~ll~~l~~~~~  205 (242)
                      +.+||+.||++|||+.++.+.|+.+..
T Consensus       373 i~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         373 MVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             HHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            666999999999999999999997643

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.96  E-value=7.9e-29  Score=197.66  Aligned_cols=179  Identities=26%  Similarity=0.390  Sum_probs=128.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....     ..+++..+..++.|+++|+.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        79 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~  150 (262)
T cd05058          79 MKHGDLRNFIRSET-----HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYD  150 (262)
T ss_pred             CCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccC
Confidence            46899999996532     3467888899999999999999998   999999999999999999999999999875433


Q ss_pred             Cccc--chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcC-CCccccccCCCCCcCcchhhhccCCCCc
Q 026160           81 KKST--ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR-KNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        81 ~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      ....  .......++..|+|||.+...  ..+.++||||||+++|++++|. +||.....        .........+..
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--------~~~~~~~~~~~~  220 (262)
T cd05058         151 KEYYSVHNHTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--------FDITVYLLQGRR  220 (262)
T ss_pred             CcceeecccccCcCCccccChhHhccC--ccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHhcCCC
Confidence            2111  111122356789999987653  5788999999999999999964 45532211        111111111111


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchh
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESST  204 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~  204 (242)
                      ...+...+.       .+.+++..||+.+|++||++.++++.|+.+.
T Consensus       221 ~~~~~~~~~-------~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         221 LLQPEYCPD-------PLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             CCCCCcCCH-------HHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            112222333       4555666699999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.96  E-value=2.2e-29  Score=208.32  Aligned_cols=167  Identities=29%  Similarity=0.381  Sum_probs=130.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      +.+++..+..++.|++.||.|||+.   +++|+||||+|||++.++.++|+|||++.....
T Consensus       113 ~~~g~L~~~i~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        113 VIGGEFFTFLRRN------KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            5799999999765      4599999999999999999999999   999999999999999999999999999876543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ...     ...|++.|+|||.+.+.  .++.++|+|||||++|+|++|..||.....        ......+... ....
T Consensus       184 ~~~-----~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--------~~~~~~i~~~-~~~~  247 (340)
T PTZ00426        184 RTY-----TLCGTPEYIAPEILLNV--GHGKAADWWTLGIFIYEILVGCPPFYANEP--------LLIYQKILEG-IIYF  247 (340)
T ss_pred             Ccc-----eecCChhhcCHHHHhCC--CCCccccccchhhHHHHHhcCCCCCCCCCH--------HHHHHHHhcC-CCCC
Confidence            221     23488999999998653  568899999999999999999999974332        1111111111 1123


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRP-----SMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp-----s~~~ll~~  199 (242)
                      +..+++.+.+++++       ||+.||++|+     ++.+++++
T Consensus       248 p~~~~~~~~~li~~-------~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        248 PKFLDNNCKHLMKK-------LLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             CCCCCHHHHHHHHH-------HcccCHHHcCCCCCCCHHHHHcC
Confidence            34456666666555       7799999995     89998876

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=7.4e-30  Score=210.48  Aligned_cols=172  Identities=28%  Similarity=0.394  Sum_probs=126.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      +.+++..+..++.||+.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        78 ~~~g~L~~~l~~~------~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~  148 (330)
T cd05586          78 MSGGELFWHLQKE------GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLT  148 (330)
T ss_pred             CCCChHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCC
Confidence            5789999988654      4599999999999999999999999   999999999999999999999999999875432


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....|+..|+|||.+.+. ..++.++|||||||++|+|++|..||.....        ......+..+.....
T Consensus       149 ~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~--------~~~~~~i~~~~~~~~  217 (330)
T cd05586         149 DNKT--TNTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT--------QQMYRNIAFGKVRFP  217 (330)
T ss_pred             CCCC--ccCccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCH--------HHHHHHHHcCCCCCC
Confidence            2211  1123488999999988643 3468899999999999999999999864332        111111111111111


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCC----CHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRP----SMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp----s~~~ll~~  199 (242)
                      ...++++..+++.+       ||+.||++||    ++.+++++
T Consensus       218 ~~~~~~~~~~li~~-------~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         218 KNVLSDEGRQFVKG-------LLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             CccCCHHHHHHHHH-------HcCCCHHHCCCCCCCHHHHhcC
Confidence            12345555555555       7799999998    56777653

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.96  E-value=6.7e-29  Score=200.97  Aligned_cols=184  Identities=22%  Similarity=0.389  Sum_probs=131.8

Q ss_pred             CCCCCcchhccccCCC----CCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEccccccc
Q 026160            1 MPNGSLDQFTYDQESS----NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK   76 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~----~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~   76 (242)
                      +++|+|.+++.+....    .....++...+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.
T Consensus        91 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~Dfg~~~  167 (288)
T cd05061          91 MAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR  167 (288)
T ss_pred             CCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEECcCCccc
Confidence            5789999999754221    1124567788999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCC
Q 026160           77 QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPG  155 (242)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  155 (242)
                      ...............++..|++||.+.+.  ..+.++|+|||||++|++++ |..||......        ........+
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--------~~~~~~~~~  237 (288)
T cd05061         168 DIYETDYYRKGGKGLLPVRWMAPESLKDG--VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--------QVLKFVMDG  237 (288)
T ss_pred             cccccccccccCCCcccccccCHHHhccC--CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcC
Confidence            55433222212222346789999987653  56889999999999999998 67787532211        111111111


Q ss_pred             CccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchh
Q 026160          156 NDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESST  204 (242)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~  204 (242)
                      .....+...++.       +.+++.+||+.||++|||+.++++.|++..
T Consensus       238 ~~~~~~~~~~~~-------~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         238 GYLDQPDNCPER-------VTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             CCCCCCCCCCHH-------HHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            111222233444       444555599999999999999999998754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.96  E-value=3.8e-29  Score=203.01  Aligned_cols=186  Identities=23%  Similarity=0.322  Sum_probs=129.9

Q ss_pred             CCCCCcchhccccCC-----CCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccc
Q 026160            1 MPNGSLDQFTYDQES-----SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLA   75 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~-----~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~   75 (242)
                      +++|+|.++|.....     ......+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~  177 (296)
T cd05051         101 MENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMS  177 (296)
T ss_pred             CCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---CccccccchhceeecCCCceEEccccce
Confidence            468899999876431     11224689999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh--cCCCccccccCCCCCcCcchhhh--c
Q 026160           76 KQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV--GRKNADVKASRSSDIYFPNSIYK--H  151 (242)
Q Consensus        76 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~--g~~p~~~~~~~~~~~~~~~~~~~--~  151 (242)
                      ................++..|+|||.+...  ..+.++||||||+++|++++  +..||.......   .+......  .
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~---~~~~~~~~~~~  252 (296)
T cd05051         178 RNLYSSDYYRVQGRAPLPIRWMAWESVLLG--KFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ---VIENAGHFFRD  252 (296)
T ss_pred             eecccCcceeecCcCCCCceecCHHHhhcC--CCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH---HHHHHHhcccc
Confidence            765433222222223456789999987653  57899999999999999998  666765332110   00000000  0


Q ss_pred             cCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          152 IEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      .........+..++.       .+.+++.+||+.||++|||+.++++.|+
T Consensus       253 ~~~~~~~~~~~~~~~-------~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         253 DGRQIYLPRPPNCPK-------DIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             ccccccCCCccCCCH-------HHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            000000111122233       3555666699999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.96  E-value=1.1e-28  Score=197.07  Aligned_cols=178  Identities=28%  Similarity=0.436  Sum_probs=131.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++.+..    ...+++..+..++.+++.||.|||+.   +++|+||+|.||+++.++.++|+|||.+.....
T Consensus        82 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~  154 (262)
T cd05071          82 MSKGSLLDFLKGEM----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED  154 (262)
T ss_pred             CCCCcHHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence            57899999997542    24689999999999999999999998   999999999999999999999999999876543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ..... .....++..|++||.....  ..+.++|+||||+++|++++ |..||.....        ..............
T Consensus       155 ~~~~~-~~~~~~~~~y~~PE~~~~~--~~~~~~DvwslG~~l~ellt~g~~p~~~~~~--------~~~~~~~~~~~~~~  223 (262)
T cd05071         155 NEYTA-RQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERGYRMP  223 (262)
T ss_pred             ccccc-ccCCcccceecCHhHhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCh--------HHHHHHHhcCCCCC
Confidence            32211 1112356679999987543  57889999999999999999 7778753321        11111111111111


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                      ....++       ..+.+++.+||+.||++||++.++++.|+..
T Consensus       224 ~~~~~~-------~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         224 CPPECP-------ESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CccccC-------HHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            122233       3455666779999999999999999998853

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.96  E-value=9.9e-29  Score=196.58  Aligned_cols=175  Identities=27%  Similarity=0.437  Sum_probs=129.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....     ..+++..+..++.+++.||.|||+.   +++|+||+|.||+++.++.++|+|||.+.....
T Consensus        81 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05114          81 MENGCLLNYLRQRQ-----GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD  152 (256)
T ss_pred             CCCCcHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence            47899999987532     3589999999999999999999999   999999999999999999999999998876543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      .... ......++..|+|||.+...  .++.++|+||||+++|++++ |+.||......        ........+....
T Consensus       153 ~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--------~~~~~i~~~~~~~  221 (256)
T cd05114         153 DEYT-SSSGAKFPVKWSPPEVFNFS--KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--------EVVEMISRGFRLY  221 (256)
T ss_pred             Ccee-ccCCCCCchhhCChhhcccC--ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHCCCCCC
Confidence            2211 11112245679999988643  56889999999999999999 88888643321        1111111111111


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      .+...+.       .+.+++.+||+.||++|||+.++++.|.
T Consensus       222 ~~~~~~~-------~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         222 RPKLASM-------TVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             CCCCCCH-------HHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            2222232       4566667799999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.96  E-value=3.9e-29  Score=210.03  Aligned_cols=178  Identities=24%  Similarity=0.336  Sum_probs=133.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      +.+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++.....
T Consensus        83 ~~gg~L~~~l~~~------~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~  153 (381)
T cd05626          83 IPGGDMMSLLIRM------EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW  153 (381)
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence            5899999999765      4589999999999999999999998   999999999999999999999999998753211


Q ss_pred             Cccc---------------------------------------------chhcccccccccccchhhhcccCCCCCCccc
Q 026160           81 KKST---------------------------------------------ISMLHARGTIGYIAPEVFCRSFGGASHKSDV  115 (242)
Q Consensus        81 ~~~~---------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di  115 (242)
                      ....                                             .......||..|+|||.+.+.  .++.++||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~Di  231 (381)
T cd05626         154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK--GYTQLCDW  231 (381)
T ss_pred             ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC--CCCCccce
Confidence            0000                                             000123589999999998653  57889999


Q ss_pred             hhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 026160          116 YSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHE  195 (242)
Q Consensus       116 ~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~  195 (242)
                      |||||++|||++|..||.........    ..+ ..............+++++.+++.+|+     |+..++..|+++.+
T Consensus       232 wSlG~il~elltG~~Pf~~~~~~~~~----~~i-~~~~~~~~~~~~~~~s~~~~dli~~ll-----~~~~~~~~R~~~~~  301 (381)
T cd05626         232 WSVGVILFEMLVGQPPFLAPTPTETQ----LKV-INWENTLHIPPQVKLSPEAVDLITKLC-----CSAEERLGRNGADD  301 (381)
T ss_pred             eehhhHHHHHHhCCCCCcCCCHHHHH----HHH-HccccccCCCCCCCCCHHHHHHHHHHc-----cCcccccCCCCHHH
Confidence            99999999999999999754321100    000 000111111122346788899998887     88888888999999


Q ss_pred             HHHH
Q 026160          196 VLEM  199 (242)
Q Consensus       196 ll~~  199 (242)
                      ++++
T Consensus       302 ~l~h  305 (381)
T cd05626         302 IKAH  305 (381)
T ss_pred             HhcC
Confidence            9975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.96  E-value=1e-28  Score=199.84  Aligned_cols=182  Identities=25%  Similarity=0.374  Sum_probs=130.5

Q ss_pred             CCCCCcchhccccCC----------------CCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCC
Q 026160            1 MPNGSLDQFTYDQES----------------SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDED   64 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~----------------~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~   64 (242)
                      +++|+|.+++.....                ......+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.+
T Consensus        90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~~~~  166 (288)
T cd05050          90 MAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGEN  166 (288)
T ss_pred             CCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheEecCC
Confidence            478999999875321                12234588999999999999999999998   99999999999999999


Q ss_pred             CceEEcccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCc
Q 026160           65 FCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIY  143 (242)
Q Consensus        65 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~  143 (242)
                      +.++|+|||++.................+..|+|||.+...  .++.++|+||||+++|+|++ |..||......     
T Consensus       167 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~-----  239 (288)
T cd05050         167 MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE-----  239 (288)
T ss_pred             CceEECccccceecccCccccccCCCccChhhcCHHHHhcC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-----
Confidence            99999999998754433221111112245679999987553  67889999999999999997 77787533211     


Q ss_pred             CcchhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 026160          144 FPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES  202 (242)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~  202 (242)
                         ..............+..++.+       +..++.+||+.||++|||+.|+++.|+.
T Consensus       240 ---~~~~~~~~~~~~~~~~~~~~~-------l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 ---EVIYYVRDGNVLSCPDNCPLE-------LYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ---HHHHHHhcCCCCCCCCCCCHH-------HHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence               111122222222222233333       4556666999999999999999999873

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.96  E-value=3.2e-29  Score=206.13  Aligned_cols=170  Identities=32%  Similarity=0.450  Sum_probs=128.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      +.+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 ~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  152 (323)
T cd05584          82 LSGGELFMHLERE------GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIH  152 (323)
T ss_pred             CCCchHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence            5789999998764      4588999999999999999999999   999999999999999999999999999865332


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....++..|+|||.+.+.  ..+.++||||||+++|+|++|..||......       ... ...... ...+
T Consensus       153 ~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~pf~~~~~~-------~~~-~~~~~~-~~~~  219 (323)
T cd05584         153 EGTV--THTFCGTIEYMAPEILMRS--GHGKAVDWWSLGALMYDMLTGAPPFTAENRK-------KTI-DKILKG-KLNL  219 (323)
T ss_pred             CCCc--ccccCCCccccChhhccCC--CCCCcceecccHHHHHHHhcCCCCCCCCCHH-------HHH-HHHHcC-CCCC
Confidence            2211  1123488999999998654  5678999999999999999999999643321       111 111111 1223


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRP-----SMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp-----s~~~ll~~  199 (242)
                      +..+++.+.+++.+       ||+.||++||     ++.+++++
T Consensus       220 ~~~~~~~~~~li~~-------~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         220 PPYLTPEARDLLKK-------LLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             CCCCCHHHHHHHHH-------HcccCHhHcCCCCCCCHHHHhcC
Confidence            34455555555555       8899999999     88888764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.96  E-value=1.2e-28  Score=200.24  Aligned_cols=188  Identities=22%  Similarity=0.317  Sum_probs=130.0

Q ss_pred             CCCCCcchhccccCCC-----CCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccc
Q 026160            1 MPNGSLDQFTYDQESS-----NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLA   75 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~-----~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~   75 (242)
                      +++|+|.+++......     .....+++.++..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~  177 (296)
T cd05095         101 MENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMS  177 (296)
T ss_pred             CCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEEEcCCCCEEeccCccc
Confidence            4689999999764321     1124588899999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh--cCCCccccccCCCCCcCcchhhhccC
Q 026160           76 KQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV--GRKNADVKASRSSDIYFPNSIYKHIE  153 (242)
Q Consensus        76 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~--g~~p~~~~~~~~~~~~~~~~~~~~~~  153 (242)
                      .................+..|++||.....  .++.++|+|||||++|++++  |..||........... .........
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~-~~~~~~~~~  254 (296)
T cd05095         178 RNLYSGDYYRIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIEN-TGEFFRDQG  254 (296)
T ss_pred             ccccCCcceeccCcCcCccccCCHHHHhcC--CccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHH-HHHHHhhcc
Confidence            765433221111122345789999977543  57889999999999999998  6677754322110000 000000000


Q ss_pred             CCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          154 PGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      .......+..++       ..+.+++.+||+.||++||++.++++.|+
T Consensus       255 ~~~~~~~~~~~~-------~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         255 RQVYLPKPALCP-------DSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             ccccCCCCCCCC-------HHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            000111112233       34555666799999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.7e-29  Score=199.62  Aligned_cols=178  Identities=26%  Similarity=0.290  Sum_probs=128.4

Q ss_pred             CcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCccc
Q 026160            5 SLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST   84 (242)
Q Consensus         5 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~   84 (242)
                      +|.+.|+.+      ..|+...+--++.|++.||.|+|+-   +|+||||||.|++++.+..+|++|||+++........
T Consensus       111 DL~~iik~~------~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~  181 (359)
T KOG0660|consen  111 DLHQIIKSQ------QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED  181 (359)
T ss_pred             HHHHHHHcC------ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence            344555443      4599999999999999999999998   9999999999999999999999999999977542111


Q ss_pred             chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcC-------cchhh--------
Q 026160           85 ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYF-------PNSIY--------  149 (242)
Q Consensus        85 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~-------~~~~~--------  149 (242)
                      ...+.-..|.+|.|||.+... ..++.+.||||+||++.||++|++-|-+.+...+-...       .....        
T Consensus       182 ~~mTeYVaTRWYRAPElll~~-~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~a  260 (359)
T KOG0660|consen  182 GFMTEYVATRWYRAPELLLNS-SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKA  260 (359)
T ss_pred             cchhcceeeeeecCHHHHhcc-ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHH
Confidence            122233589999999998554 68899999999999999999999988655432210000       00000        


Q ss_pred             ----hccCCCC---ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          150 ----KHIEPGN---DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       150 ----~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                          .......   -...-...++.+.+++.+|+       .+||.+|+|++|++++
T Consensus       261 r~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL-------~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  261 RPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKML-------VFDPKKRITAEEALAH  310 (359)
T ss_pred             HHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHh-------ccCccccCCHHHHhcC
Confidence                0011111   11122345666677777755       9999999999999875

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.96  E-value=1.1e-28  Score=196.40  Aligned_cols=178  Identities=29%  Similarity=0.397  Sum_probs=131.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++.+...    ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        77 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~  149 (257)
T cd05040          77 APLGSLLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQ  149 (257)
T ss_pred             cCCCcHHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccc
Confidence            468999999976431    4689999999999999999999999   999999999999999999999999999887654


Q ss_pred             Ccccchh-cccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           81 KKSTISM-LHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        81 ~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      ....... ....++..|+|||.+...  .++.++|+||||+++|+|++ |..||.......       ............
T Consensus       150 ~~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~  220 (257)
T cd05040         150 NEDHYVMEEHLKVPFAWCAPESLRTR--TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-------ILKKIDKEGERL  220 (257)
T ss_pred             cccceecccCCCCCceecCHHHhccc--CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHhcCCcC
Confidence            3221111 122366789999987653  57889999999999999998 999986332211       000001011111


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      ..+...+.       .+.+++.+||+.+|++|||+.++++.|.
T Consensus       221 ~~~~~~~~-------~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         221 ERPEACPQ-------DIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCCccCCH-------HHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            11222333       4455666699999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.96  E-value=5.1e-29  Score=197.08  Aligned_cols=191  Identities=23%  Similarity=0.263  Sum_probs=131.4

Q ss_pred             CcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCccc
Q 026160            5 SLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST   84 (242)
Q Consensus         5 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~   84 (242)
                      +|.+|+.......  ..++...+..++.||+.||.|||++   +|+||||||.|++++.+|.+||+|||+++...-... 
T Consensus       102 DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~-  175 (323)
T KOG0594|consen  102 DLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMR-  175 (323)
T ss_pred             cHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHHHhcCCcc-
Confidence            4666776653211  4677789999999999999999999   999999999999999999999999999986552222 


Q ss_pred             chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccccc------------CCCCCcCcchhhh-c
Q 026160           85 ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKAS------------RSSDIYFPNSIYK-H  151 (242)
Q Consensus        85 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~------------~~~~~~~~~~~~~-~  151 (242)
                       .++..++|.+|.|||++.++. .++...||||+||++.||+++++-|.....            .+....|+..... .
T Consensus       176 -~yt~evvTlWYRaPEvLlGs~-~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~  253 (323)
T KOG0594|consen  176 -TYTPEVVTLWYRAPEVLLGST-SYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPD  253 (323)
T ss_pred             -cccccEEEeeccCHHHhcCCC-cCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcccccc
Confidence             233456899999999998874 589999999999999999999887754432            1111111111100 0


Q ss_pred             cC-CCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--hhch
Q 026160          152 IE-PGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM--LESS  203 (242)
Q Consensus       152 ~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~--l~~~  203 (242)
                      .. ......-+..+............+++.+|++++|.+|.|+..++.+  +...
T Consensus       254 ~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  254 YKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             ccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence            00 0000000111222222222345556666779999999999999987  5443

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.96  E-value=1.1e-28  Score=195.95  Aligned_cols=173  Identities=27%  Similarity=0.361  Sum_probs=130.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....    ...++..+++.++.+++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~~~~~L~~~l~~~~----~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~  153 (256)
T cd08529          81 AENGDLHKLLKMQR----GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD  153 (256)
T ss_pred             CCCCcHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccC
Confidence            47899999997642    25699999999999999999999998   999999999999999999999999998876554


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      .....  ....++..|.|||.+.+.  ..+.++|+||||+++|++++|..||.....        ...............
T Consensus       154 ~~~~~--~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~  221 (256)
T cd08529         154 NTNFA--NTIVGTPYYLSPELCEDK--PYNEKSDVWALGVVLYECCTGKHPFDANNQ--------GALILKIIRGVFPPV  221 (256)
T ss_pred             ccchh--hccccCccccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCCCCC
Confidence            32221  122477899999988654  567899999999999999999999864431        111111111212222


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ...++.       .+.+++.+||+.+|++||++.++++.
T Consensus       222 ~~~~~~-------~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         222 SQMYSQ-------QLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ccccCH-------HHHHHHHHHccCCcccCcCHHHHhhC
Confidence            223333       44555566999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.96  E-value=3.7e-29  Score=205.13  Aligned_cols=169  Identities=26%  Similarity=0.381  Sum_probs=126.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.+.      ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        78 ~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~  148 (316)
T cd05619          78 LNGGDLMFHIQSC------HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENML  148 (316)
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCC
Confidence            5799999999764      4589999999999999999999999   999999999999999999999999999875322


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....++..|+|||.+.+.  .++.++|+|||||++|++++|..||......        ......... ....
T Consensus       149 ~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~~--------~~~~~i~~~-~~~~  215 (316)
T cd05619         149 GDAK--TCTFCGTPDYIAPEILLGQ--KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--------ELFQSIRMD-NPCY  215 (316)
T ss_pred             CCCc--eeeecCCccccCHHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhC-CCCC
Confidence            2111  1123488999999998654  5788999999999999999999999643321        111111111 1112


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHH-HHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMH-EVLE  198 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~-~ll~  198 (242)
                      +..++.++.+++.+       ||+.||++||++. ++++
T Consensus       216 ~~~~~~~~~~li~~-------~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         216 PRWLTREAKDILVK-------LFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CccCCHHHHHHHHH-------HhccCHhhcCCChHHHHc
Confidence            33355555555555       7899999999997 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=4.4e-29  Score=210.04  Aligned_cols=185  Identities=23%  Similarity=0.282  Sum_probs=127.1

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      +|+|..++...      +.+++.++..++.||+.||.|||+.   +|+|+||||+||+++.++.++|+|||++.......
T Consensus       166 ~~~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~  236 (391)
T PHA03212        166 KTDLYCYLAAK------RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN  236 (391)
T ss_pred             CCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence            46777777554      4589999999999999999999999   99999999999999999999999999986533221


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhh---h---------
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIY---K---------  150 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~---~---------  150 (242)
                      .. ......||+.|+|||.+.+.  .++.++|||||||++|++++|..||.................   .         
T Consensus       237 ~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~  313 (391)
T PHA03212        237 AN-KYYGWAGTIATNAPELLARD--PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF  313 (391)
T ss_pred             cc-ccccccCccCCCChhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence            11 11123589999999998653  578899999999999999999988754332111100000000   0         


Q ss_pred             --------------ccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          151 --------------HIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       151 --------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                                    ....................+...+..++.+||++||++|||+.+++++
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence                          0000000000000111222344566778888999999999999999964

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.96  E-value=6.6e-29  Score=198.99  Aligned_cols=186  Identities=22%  Similarity=0.304  Sum_probs=124.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++..... ......++.....++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        77 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~  152 (269)
T cd05042          77 CPLGDLKNYLRSNRG-MVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYP  152 (269)
T ss_pred             CCCCcHHHHHHhccc-cccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEecccccccccc
Confidence            578999999976532 1123456788899999999999999999   999999999999999999999999999865433


Q ss_pred             Ccccchhcccccccccccchhhhcc-----cCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCC
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRS-----FGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEP  154 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  154 (242)
                      ...........++..|+|||.+...     ....+.++|+|||||++|++++ |..||.......   ............
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~~~~~~~~~  229 (269)
T cd05042         153 EDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---VLKQVVREQDIK  229 (269)
T ss_pred             chheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHHHhhccCcc
Confidence            2211111122356679999987532     1245789999999999999998 677775332110   000000000001


Q ss_pred             CCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          155 GNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      ......+..++...       ..++..|| .||++|||+.+|++.|.
T Consensus       230 ~~~~~~~~~~~~~~-------~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         230 LPKPQLDLKYSDRW-------YEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCCcccccCCHHH-------HHHHHHHh-cCcccccCHHHHHHHhc
Confidence            11111222233333       33444588 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.96  E-value=1.5e-28  Score=203.80  Aligned_cols=167  Identities=26%  Similarity=0.415  Sum_probs=122.5

Q ss_pred             ccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccccc
Q 026160           20 RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAP   99 (242)
Q Consensus        20 ~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~P   99 (242)
                      ..+++.++..++.|+++||.|||+.   +++|+||||.||+++.++.++|+|||++................++..|++|
T Consensus       174 ~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  250 (343)
T cd05103         174 KVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  250 (343)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECc
Confidence            3578899999999999999999999   9999999999999999999999999998765333222111122355679999


Q ss_pred             hhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccccccccchHHHHHHHHHHHH
Q 026160          100 EVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILV  178 (242)
Q Consensus       100 E~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  178 (242)
                      |.+.+.  .++.++|+||||+++|++++ |..||......       .........+.....+...++       .+.++
T Consensus       251 E~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~-------~~~~~  314 (343)
T cd05103         251 ETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------EEFCRRLKEGTRMRAPDYTTP-------EMYQT  314 (343)
T ss_pred             HHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-------HHHHHHHhccCCCCCCCCCCH-------HHHHH
Confidence            987553  57889999999999999997 88888543211       111111112211222222233       35566


Q ss_pred             HHHhccCCCCCCCCHHHHHHHhhchhh
Q 026160          179 SLWCIQTNPSDRPSMHEVLEMLESSTE  205 (242)
Q Consensus       179 ~~~cl~~dp~~Rps~~~ll~~l~~~~~  205 (242)
                      +..||+.||++|||+.+++++|+.+.+
T Consensus       315 ~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         315 MLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            677999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.96  E-value=4.2e-29  Score=205.52  Aligned_cols=170  Identities=24%  Similarity=0.352  Sum_probs=126.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        83 ~~~g~L~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          83 VNGGDLMYHIQQV------GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            5789999998764      4589999999999999999999999   999999999999999999999999999864322


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....|+..|+|||.+.+.  .++.++|+|||||++|+|++|+.||......        .....+... ....
T Consensus       154 ~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~~--------~~~~~i~~~-~~~~  220 (324)
T cd05587         154 GGKT--TRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--------ELFQSIMEH-NVSY  220 (324)
T ss_pred             CCCc--eeeecCCccccChhhhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcC-CCCC
Confidence            1111  1123589999999998653  5688999999999999999999999643321        111111111 1122


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSM-----HEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~-----~~ll~~  199 (242)
                      +..++.++.+++.+       ||+.||++|++.     .+++++
T Consensus       221 ~~~~~~~~~~li~~-------~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         221 PKSLSKEAVSICKG-------LLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             CCCCCHHHHHHHHH-------HhhcCHHHcCCCCCCCHHHHhcC
Confidence            33455555555544       889999999976     566543

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.96  E-value=1.6e-28  Score=195.79  Aligned_cols=177  Identities=30%  Similarity=0.489  Sum_probs=131.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....    +..+++.++..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 ~~~~~L~~~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05067          82 MENGSLVDFLKTPE----GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED  154 (260)
T ss_pred             CCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence            47899999986542    25689999999999999999999998   999999999999999999999999999876542


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ..... .....++..|++||.+...  ..+.++|+||||+++|++++ |..||......        .............
T Consensus       155 ~~~~~-~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~  223 (260)
T cd05067         155 NEYTA-REGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--------EVIQNLERGYRMP  223 (260)
T ss_pred             CCccc-ccCCcccccccCHHHhccC--CcCcccchHHHHHHHHHHHhCCCCCCCCCChH--------HHHHHHHcCCCCC
Confidence            22111 1112356789999987643  56889999999999999998 99998643321        1111111111112


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES  202 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~  202 (242)
                      .+...+.+       +.+++.+||+.+|++|||+++++..|+.
T Consensus       224 ~~~~~~~~-------~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         224 RPDNCPEE-------LYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCHH-------HHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            22233444       4555556999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.96  E-value=4.9e-29  Score=208.20  Aligned_cols=175  Identities=26%  Similarity=0.414  Sum_probs=130.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.+.      +.+++.++..++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||++.....
T Consensus        83 ~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~  153 (363)
T cd05628          83 LPGGDMMTLLMKK------DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK  153 (363)
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence            6899999999765      4599999999999999999999999   999999999999999999999999999875432


Q ss_pred             Cccc---------------------------------chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh
Q 026160           81 KKST---------------------------------ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV  127 (242)
Q Consensus        81 ~~~~---------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~  127 (242)
                      ....                                 .......||..|+|||.+.+.  .++.++|+|||||++|+|++
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DvwSlGvil~ell~  231 (363)
T cd05628         154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLI  231 (363)
T ss_pred             cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC--CCCCchhhhhhHHHHHHHHh
Confidence            1100                                 000123589999999998654  67889999999999999999


Q ss_pred             cCCCccccccCCCCCcCcchhhhccCC-CCccccc--cccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          128 GRKNADVKASRSSDIYFPNSIYKHIEP-GNDFQLD--GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       128 g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      |..||......        .....+.. .....++  ..+++++++++.+|+     |...++..||++.+++++
T Consensus       232 G~~Pf~~~~~~--------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-----~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         232 GYPPFCSETPQ--------ETYKKVMNWKETLIFPPEVPISEKAKDLILRFC-----CEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCCCCCHH--------HHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHc-----CChhhcCCCCCHHHHhCC
Confidence            99999643321        11111111 0011111  235778888887765     655566678999999986

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.96  E-value=4.2e-29  Score=205.45  Aligned_cols=169  Identities=24%  Similarity=0.346  Sum_probs=126.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      +.+++.++..++.|++.||.|||+.   +++|+||||+|||++.++.++|+|||++.....
T Consensus        83 ~~~g~L~~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          83 VNGGDLMYQIQQV------GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            5789999998765      4589999999999999999999998   999999999999999999999999999875332


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....|++.|+|||.+...  .++.++|+|||||++|+|++|..||......        .....+... ....
T Consensus       154 ~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--------~~~~~i~~~-~~~~  220 (323)
T cd05616         154 DGVT--TKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQSIMEH-NVAY  220 (323)
T ss_pred             CCCc--cccCCCChhhcCHHHhcCC--CCCCccchhchhHHHHHHHhCCCCCCCCCHH--------HHHHHHHhC-CCCC
Confidence            2111  1123488999999998653  5789999999999999999999999744321        111111111 1122


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSM-----HEVLE  198 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~-----~~ll~  198 (242)
                      +..++.++.+++.+       ||+.||++|++.     .++++
T Consensus       221 p~~~s~~~~~li~~-------~l~~~p~~R~~~~~~~~~~i~~  256 (323)
T cd05616         221 PKSMSKEAVAICKG-------LMTKHPGKRLGCGPEGERDIKE  256 (323)
T ss_pred             CCcCCHHHHHHHHH-------HcccCHHhcCCCCCCCHHHHhc
Confidence            33455555555555       779999999984     56654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=8.4e-29  Score=197.55  Aligned_cols=174  Identities=30%  Similarity=0.387  Sum_probs=129.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++...      +.++...+..++.|++.|+.|||+.   +++|+||+|.||+++.++.++|+|||++.....
T Consensus        86 ~~~~~l~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          86 MPGGSVKDQLKAY------GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             CCCCcHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            4789999999765      3589999999999999999999999   999999999999999999999999999875443


Q ss_pred             Ccccch-hcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTIS-MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ...... .....++..|+|||.+.+.  ..+.++|+||||+++|++++|+.||......       ..............
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~  227 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGE--GYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-------AAIFKIATQPTNPQ  227 (263)
T ss_pred             cccccccccCCCcCccccCcceeccC--CCCchhhhHHHHHHHHHHHhCCCCccccchH-------HHHHHHhccCCCCC
Confidence            221111 0122367889999998764  4788999999999999999999998643221       11111111111222


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .+..++..+.+++       .+||..+|++|||+.+++++
T Consensus       228 ~~~~~~~~~~~li-------~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         228 LPSHVSPDARNFL-------RRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             CCccCCHHHHHHH-------HHHhhcCcccCCCHHHHhhC
Confidence            3334455555544       45889999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.96  E-value=5.1e-29  Score=189.61  Aligned_cols=181  Identities=22%  Similarity=0.208  Sum_probs=128.0

Q ss_pred             CcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCccc
Q 026160            5 SLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST   84 (242)
Q Consensus         5 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~   84 (242)
                      +|...|+..     +..|+..++..++.++++|++|||++   .|+||||||.|+|++.+|.+|++|||+++.+......
T Consensus        86 dLe~vIkd~-----~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   86 DLEVVIKDK-----NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             cHHHHhccc-----ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            344445443     46799999999999999999999999   9999999999999999999999999999988765443


Q ss_pred             chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCC------------CCCcCcchhhh--
Q 026160           85 ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRS------------SDIYFPNSIYK--  150 (242)
Q Consensus        85 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~------------~~~~~~~~~~~--  150 (242)
                      ...  ...|.+|.|||.+.+. ..+....||||.||++.||+-|.+-|-+.+.-+            ....|++....  
T Consensus       158 ~~~--~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd  234 (318)
T KOG0659|consen  158 QTH--QVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD  234 (318)
T ss_pred             ccc--ceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence            322  2589999999999887 577899999999999999999876654333211            11111111110  


Q ss_pred             --ccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 026160          151 --HIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML  200 (242)
Q Consensus       151 --~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l  200 (242)
                        ............    -+.......++++..+|.+||.+|+|+.|++++=
T Consensus       235 Y~~~~~~P~~~~~~----lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~  282 (318)
T KOG0659|consen  235 YVKIQQFPKPPLNN----LFPAASSDALDLLSKMLTYNPKKRITASQALKHP  282 (318)
T ss_pred             HHHHhcCCCCcccc----ccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence              000000000000    1122233345566667799999999999999764

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.96  E-value=7.9e-29  Score=197.19  Aligned_cols=170  Identities=22%  Similarity=0.325  Sum_probs=127.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCC-------ceEEcccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF-------CPKISDFG   73 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~-------~~~L~dfg   73 (242)
                      +++|+|++++....     ..+++..+..++.|++.||.|||++   +++|+||||+||+++.++       .++|+|||
T Consensus        82 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          82 VKFGPLDVFLHREK-----NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             CCCCcHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            57899999997653     2689999999999999999999998   999999999999998877       79999999


Q ss_pred             cccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhcc
Q 026160           74 LAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHI  152 (242)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~  152 (242)
                      ++.......      ...++..|.+||.+.......+.++|+||||+++|++++ |..||.........    ... .  
T Consensus       154 ~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~----~~~-~--  220 (259)
T cd05037         154 IPITVLSRE------ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE----RFY-Q--  220 (259)
T ss_pred             ccccccccc------ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH----HHH-h--
Confidence            987654421      123567899999986543467889999999999999999 46666544321110    000 0  


Q ss_pred             CCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          153 EPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                       ....  .+....       ..+.+++.+||..+|++|||+.++++.|+
T Consensus       221 -~~~~--~~~~~~-------~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 -DQHR--LPMPDC-------AELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             -cCCC--CCCCCc-------hHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence             0000  110011       45666777799999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.96  E-value=1.5e-28  Score=197.03  Aligned_cols=186  Identities=24%  Similarity=0.295  Sum_probs=126.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++..... .....+++..+..++.|++.|+.|||+.   +++|+||||.||+++.++.++|+|||++.....
T Consensus        77 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~  152 (269)
T cd05087          77 CPLGDLKGYLRSCRK-AELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYK  152 (269)
T ss_pred             CCCCcHHHHHHHhhh-cccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccC
Confidence            578999999976432 1224567788889999999999999999   999999999999999999999999999865443


Q ss_pred             Ccccchhcccccccccccchhhhccc-----CCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCC
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSF-----GGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEP  154 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~-----~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  154 (242)
                      ...........++..|+|||.+....     ...+.++|+||||+++|++++ |..||..........   .........
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~---~~~~~~~~~  229 (269)
T cd05087         153 EDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT---YTVREQQLK  229 (269)
T ss_pred             cceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH---HHhhcccCC
Confidence            32221112223667899999875321     134789999999999999996 999996433211000   000000001


Q ss_pred             CCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          155 GNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      ..........+..+       ..++..|| .+|++|||+.+|++.|+
T Consensus       230 ~~~~~~~~~~~~~~-------~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         230 LPKPRLKLPLSDRW-------YEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCCccCCCCChHH-------HHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            11111111223333       33455598 58999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.96  E-value=2.3e-29  Score=203.23  Aligned_cols=186  Identities=22%  Similarity=0.364  Sum_probs=129.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++.+..     ..+++.++..++.|++.||.|||++   +++|+||||.||+++.++.++|+|||++.....
T Consensus        90 ~~g~~L~~~l~~~~-----~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          90 LPSGSLKEYLPRNK-----NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             cCCCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            47899999986542     3589999999999999999999999   999999999999999999999999999886544


Q ss_pred             Ccccc-hhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCC-------cCcchhhhcc
Q 026160           81 KKSTI-SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDI-------YFPNSIYKHI  152 (242)
Q Consensus        81 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~-------~~~~~~~~~~  152 (242)
                      ..... ......++..|.|||.+.+.  .++.++||||||+++|+++++..|...........       ..........
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQS--KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL  239 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccC--CCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence            32211 11122366789999987653  56789999999999999999776542211100000       0000000011


Q ss_pred             CCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          153 EPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                      ..+.....+..++.       .+.+++.+||+.||++|||+.++++.|+.+
T Consensus       240 ~~~~~~~~~~~~~~-------~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         240 EEGKRLPRPPNCPE-------EVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HcCccCCCCCCCCH-------HHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            11111112222333       455566669999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.96  E-value=1.7e-28  Score=196.25  Aligned_cols=181  Identities=26%  Similarity=0.380  Sum_probs=132.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....  .....+++.+++.++.++++|+.|||+.   +++|+||+|.||+++.++.++|+|||++.....
T Consensus        84 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          84 ADAGDLSRMIKHFK--KQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             cCCCCHHHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            46889999886422  1235689999999999999999999999   999999999999999999999999998876543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      .....  ....++..|+|||.+.+.  ..+.++|+||||+++|++++|..||........      ..............
T Consensus       159 ~~~~~--~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~  228 (267)
T cd08229         159 KTTAA--HSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY------SLCKKIEQCDYPPL  228 (267)
T ss_pred             CCccc--ccccCCcCccCHHHhcCC--CccchhhHHHHHHHHHHHHhCCCCcccccchHH------HHhhhhhcCCCCCC
Confidence            32211  122478899999988653  567899999999999999999999864322110      11111111111111


Q ss_pred             -ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          161 -DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       161 -~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                       ....+++       +.+++.+||+.||++|||+.++++.++++
T Consensus       229 ~~~~~~~~-------~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         229 PSDHYSEE-------LRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CcccccHH-------HHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence             1123333       44555569999999999999999998865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.96  E-value=9.7e-29  Score=199.86  Aligned_cols=120  Identities=29%  Similarity=0.350  Sum_probs=99.3

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      |+|.+++....    ...+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        91 ~~l~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~  163 (288)
T cd07863          91 QDLRTYLDKVP----PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA  163 (288)
T ss_pred             cCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccccccCccc
Confidence            56777775432    24589999999999999999999999   999999999999999999999999999876543322


Q ss_pred             cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           84 TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      .   ....++..|+|||.+.+.  .++.++|||||||++|+|++|.+||...
T Consensus       164 ~---~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~~f~~~  210 (288)
T cd07863         164 L---TPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGN  210 (288)
T ss_pred             C---CCccccccccCchHhhCC--CCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence            1   123478899999988653  5788999999999999999999988543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.96  E-value=2.6e-28  Score=195.06  Aligned_cols=181  Identities=27%  Similarity=0.385  Sum_probs=132.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....  .....++..++..++.++++|+.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        84 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          84 ADAGDLSRMIKHFK--KQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             CCCCCHHHHHHHhc--ccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            57899999986532  2235689999999999999999999999   999999999999999999999999999875443


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      .....  ....++..|.|||.+.+.  .++.++|+||||+++|++++|..||.......      .........+.....
T Consensus       159 ~~~~~--~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~  228 (267)
T cd08224         159 KTTAA--HSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL------YSLCKKIEKCDYPPL  228 (267)
T ss_pred             CCccc--ceecCCccccCHHHhccC--CCCchhcHHHHHHHHHHHHHCCCCcccCCccH------HHHHhhhhcCCCCCC
Confidence            22111  122477889999988653  57889999999999999999999985433110      001111111111111


Q ss_pred             cc-ccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          161 DG-VVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       161 ~~-~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                      +. ..+..       +.+++.+||..+|++|||+.++++.|+.+
T Consensus       229 ~~~~~~~~-------~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         229 PADHYSEE-------LRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             ChhhcCHH-------HHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            11 23333       44555569999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.96  E-value=4.2e-29  Score=205.42  Aligned_cols=165  Identities=26%  Similarity=0.362  Sum_probs=124.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      +.+++..+..++.||+.||.|||+.   +++|+||||.||+++.++.++|+|||++.....
T Consensus        78 ~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~  148 (323)
T cd05575          78 VNGGELFFHLQRE------RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE  148 (323)
T ss_pred             CCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCccccc
Confidence            5789999998764      4589999999999999999999999   999999999999999999999999999864322


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....++..|+|||.+.+.  .++.++|+|||||++|+|++|..||......        .....+... ....
T Consensus       149 ~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~--------~~~~~i~~~-~~~~  215 (323)
T cd05575         149 HSKT--TSTFCGTPEYLAPEVLRKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA--------EMYDNILNK-PLRL  215 (323)
T ss_pred             CCCc--cccccCChhhcChhhhcCC--CCCccccccccchhhhhhhcCCCCCCCCCHH--------HHHHHHHcC-CCCC
Confidence            2111  1123488999999998653  5788999999999999999999999643321        111111111 1123


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMH  194 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~  194 (242)
                      ...++..+.+++.+       ||+.||++||++.
T Consensus       216 ~~~~~~~~~~li~~-------~l~~~p~~R~~~~  242 (323)
T cd05575         216 KPNISVSARHLLEG-------LLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCHHHHHHHHH-------HhhcCHHhCCCCC
Confidence            33456666666665       7799999999884

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.96  E-value=2.2e-28  Score=196.08  Aligned_cols=179  Identities=23%  Similarity=0.372  Sum_probs=132.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....     ..+++..+..++.+++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        88 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          88 APLGELRSYLQVNK-----YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             CCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccc
Confidence            57899999996532     3589999999999999999999998   999999999999999999999999999876544


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ..... .....++..|+|||.+...  .++.++|+||||+++|++++ |..||.......        ............
T Consensus       160 ~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--------~~~~~~~~~~~~  228 (270)
T cd05056         160 ESYYK-ASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--------VIGRIENGERLP  228 (270)
T ss_pred             cccee-cCCCCccccccChhhhccC--CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHHcCCcCC
Confidence            32211 1111234679999987543  57889999999999999986 999986443211        111111222222


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTE  205 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~  205 (242)
                      .+..++..+.+       ++.+||..+|++|||+.++++.|+.+..
T Consensus       229 ~~~~~~~~~~~-------li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         229 MPPNCPPTLYS-------LMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             CCCCCCHHHHH-------HHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            33344554444       4455889999999999999999998654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.96  E-value=2.2e-28  Score=197.50  Aligned_cols=186  Identities=25%  Similarity=0.380  Sum_probs=129.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....     ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        89 ~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          89 LPYGSLRDYLQKHR-----ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             cCCCCHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            47899999996532     3589999999999999999999999   999999999999999999999999999886543


Q ss_pred             Ccccchh-cccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCC-----C---cCcchhhhc
Q 026160           81 KKSTISM-LHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSD-----I---YFPNSIYKH  151 (242)
Q Consensus        81 ~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~-----~---~~~~~~~~~  151 (242)
                      ....... ....++..|.|||.+.+.  .++.++|+||||+++|++++|..++.........     .   .........
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL  238 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccC--CcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence            3221111 111234569999988653  5688999999999999999987665322111000     0   000000001


Q ss_pred             cCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          152 IEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                      .........+..++.       .+.+++.+||+.+|++|||+.++++.|+++
T Consensus       239 ~~~~~~~~~~~~~~~-------~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         239 LKNNGRLPAPPGCPA-------EIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HhcCCcCCCCCCCCH-------HHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            111111111222333       355556669999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=1.4e-28  Score=210.02  Aligned_cols=187  Identities=22%  Similarity=0.251  Sum_probs=126.8

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      .|+|.+++....     +.+++.++..++.|++.||.|||+.   +|+|+||||+|||++.++.++|+|||+++......
T Consensus       243 ~~~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        243 RSDLYTYLGARL-----RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence            467888875432     3699999999999999999999999   99999999999999999999999999987654322


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc--ccc
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND--FQL  160 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  160 (242)
                      .........|+..|++||.+.+.  .++.++|||||||++||+++|..++...................+.....  ..+
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~~~--~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~  392 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLAGD--PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF  392 (461)
T ss_pred             ccccccccCCCcCCcCHHHHcCC--CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence            21111123589999999998654  57889999999999999999887654333221111111111111100000  000


Q ss_pred             cc---------------------cc---chHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DG---------------------VV---TEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~---------------------~~---~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      +.                     ..   .......-..+..++.+||++||.+|||+.|++++
T Consensus       393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            00                     00   00011112245567777999999999999999976

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.96  E-value=1.4e-28  Score=196.83  Aligned_cols=182  Identities=25%  Similarity=0.355  Sum_probs=133.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++.....  ....++..++..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        84 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          84 ADAGDLSQMIKYFKK--QKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             cCCCcHHHHHHHhhh--ccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            468899988864321  224589999999999999999999998   999999999999999999999999999876544


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....++..|+|||.+.+.  ..+.++|+||||+++|++++|..||.......      ...............
T Consensus       159 ~~~~--~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~  228 (267)
T cd08228         159 KTTA--AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL------FSLCQKIEQCDYPPL  228 (267)
T ss_pred             hhHH--HhcCCCCccccChhhhccC--CCCchhhHHHHHHHHHHHhcCCCCCccccccH------HHHHHHHhcCCCCCC
Confidence            3221  1123477899999988653  56789999999999999999999985432211      111111111111111


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                      .      .......+.+++.+||+.+|++||++.++++.++.+
T Consensus       229 ~------~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         229 P------TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             C------hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            1      112234455666679999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=1.8e-28  Score=194.98  Aligned_cols=174  Identities=28%  Similarity=0.456  Sum_probs=130.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++.....    ..+++..+..++.|++.|+.|||+.   +++|+||+|.||+++.++.++|+|||.+.....
T Consensus        82 ~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~  154 (256)
T cd05039          82 MAKGSLVDYLRSRGR----AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ  154 (256)
T ss_pred             cCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccc
Confidence            578999999976532    3699999999999999999999999   999999999999999999999999999876643


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ...     ....+..|.+||.+...  ..+.++|+||||+++|++++ |..||......        .............
T Consensus       155 ~~~-----~~~~~~~~~ape~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~  219 (256)
T cd05039         155 GQD-----SGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------DVVPHVEKGYRME  219 (256)
T ss_pred             ccc-----cCCCcccccCchhhcCC--cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHhcCCCCC
Confidence            222     12245679999987543  56789999999999999997 88888543221        1111111111111


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                      .+..+++.+       .+++.+||..+|++|||+.++++.|+.+
T Consensus       220 ~~~~~~~~~-------~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         220 APEGCPPEV-------YKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             CccCCCHHH-------HHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            222334444       4455558899999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>PTZ00284 protein kinase; Provisional

Probab=99.96  E-value=4.1e-29  Score=215.11  Aligned_cols=118  Identities=25%  Similarity=0.364  Sum_probs=98.1

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhh-CCCCCeeecCCCCCceeeCCCC----------------
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHR-GCNVRIVHFDIKPHNILLDEDF----------------   65 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~-~~~~~i~h~dlk~~nil~~~~~----------------   65 (242)
                      +|+|.+++.+.      +.+++.++..++.||+.||.|||+ .   +|+|+||||+|||++.++                
T Consensus       215 g~~l~~~l~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~  285 (467)
T PTZ00284        215 GPCLLDWIMKH------GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVTNRALPPDPC  285 (467)
T ss_pred             CCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence            67788888654      459999999999999999999997 5   999999999999998655                


Q ss_pred             ceEEcccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccc
Q 026160           66 CPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKA  136 (242)
Q Consensus        66 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  136 (242)
                      .+||+|||.+.......     ....++..|+|||++.+.  .++.++|||||||++|||++|+.||....
T Consensus       286 ~vkl~DfG~~~~~~~~~-----~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        286 RVRICDLGGCCDERHSR-----TAIVSTRHYRSPEVVLGL--GWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             eEEECCCCccccCcccc-----ccccCCccccCcHHhhcC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            48999999876433221     123589999999998764  67889999999999999999999997543

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.96  E-value=2.3e-28  Score=194.21  Aligned_cols=173  Identities=29%  Similarity=0.468  Sum_probs=129.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....    ...+++.++..++.|++.|+.|||+.   +++|+||+|.||+++.++.++|+|||++.....
T Consensus        80 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~  152 (254)
T cd05083          80 MSKGNLVNFLRTRG----RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSM  152 (254)
T ss_pred             CCCCCHHHHHHhcC----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccc
Confidence            57899999997642    24689999999999999999999998   999999999999999999999999999875433


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ...     ....+..|.|||.+...  .++.++|+||||+++|++++ |..||.......        .......+....
T Consensus       153 ~~~-----~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~  217 (254)
T cd05083         153 GVD-----NSKLPVKWTAPEALKHK--KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--------VKECVEKGYRME  217 (254)
T ss_pred             cCC-----CCCCCceecCHHHhccC--CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--------HHHHHhCCCCCC
Confidence            211     11245679999987543  56889999999999999997 888886433211        111111111111


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES  202 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~  202 (242)
                      .+..+++.+       .+++.+||+.+|++||++.++++.|+.
T Consensus       218 ~~~~~~~~~-------~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         218 PPEGCPADV-------YVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCcCCHHH-------HHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            222344444       445555999999999999999999874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.96  E-value=1.8e-28  Score=201.72  Aligned_cols=169  Identities=25%  Similarity=0.385  Sum_probs=125.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|..++..       ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        84 ~~~~~L~~~~~~-------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          84 AAGGDLMMHIHT-------DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             CCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            578999888754       3599999999999999999999999   999999999999999999999999998864322


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....++..|+|||.+.+.  .++.++|+|||||++|+|++|..||......        ......... ....
T Consensus       154 ~~~~--~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~G~~pf~~~~~~--------~~~~~i~~~-~~~~  220 (324)
T cd05589         154 FGDR--TSTFCGTPEFLAPEVLTET--SYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--------EVFDSIVND-EVRY  220 (324)
T ss_pred             CCCc--ccccccCccccCHhHhcCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhC-CCCC
Confidence            2111  1123488999999998653  5688999999999999999999999643321        111111111 1123


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRP-----SMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp-----s~~~ll~~  199 (242)
                      +..++..+.+++.+       ||+.||++||     ++.+++++
T Consensus       221 p~~~~~~~~~li~~-------~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         221 PRFLSREAISIMRR-------LLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             CCCCCHHHHHHHHH-------HhhcCHhHcCCCCCCCHHHHhhC
Confidence            33455555555554       8899999999     57777764

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.96  E-value=4.1e-29  Score=205.68  Aligned_cols=168  Identities=27%  Similarity=0.368  Sum_probs=126.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      +.+++..+..++.||++||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        78 ~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~  148 (325)
T cd05602          78 INGGELFYHLQRE------RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  148 (325)
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCccccc
Confidence            5789999999764      4588999999999999999999999   999999999999999999999999999875332


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....|+..|+|||.+.+.  .++.++|||||||++|+|++|..||.......        ....+... ....
T Consensus       149 ~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------~~~~i~~~-~~~~  215 (325)
T cd05602         149 HNGT--TSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--------MYDNILNK-PLQL  215 (325)
T ss_pred             CCCC--cccccCCccccCHHHHcCC--CCCCccccccccHHHHHHhcCCCCCCCCCHHH--------HHHHHHhC-CcCC
Confidence            2111  1123589999999998653  57889999999999999999999996433211        11111111 1122


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVL  197 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll  197 (242)
                      ...++..+.+++.+       ||+.||.+|+++.+.+
T Consensus       216 ~~~~~~~~~~li~~-------~l~~~p~~R~~~~~~~  245 (325)
T cd05602         216 KPNITNSARHLLEG-------LLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCCCCHHHHHHHHH-------HcccCHHHCCCCCCCH
Confidence            33456666666666       7799999999887433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=4.4e-29  Score=207.35  Aligned_cols=175  Identities=28%  Similarity=0.391  Sum_probs=130.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.+.      ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        83 ~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          83 MPGGDLMNLLIRK------DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            5789999999765      4699999999999999999999998   999999999999999999999999999876544


Q ss_pred             Cc---------------------------ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcc
Q 026160           81 KK---------------------------STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNAD  133 (242)
Q Consensus        81 ~~---------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~  133 (242)
                      ..                           .........++..|+|||.+.+.  .++.++|||||||++|+|++|..||.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~Pf~  231 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEMLYGFPPFY  231 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC--CCCCceeeEecchhhhhhccCCCCCC
Confidence            32                           00111123588999999998764  67899999999999999999999997


Q ss_pred             ccccCCCCCcCcchhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHH
Q 026160          134 VKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPS-MHEVLEM  199 (242)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps-~~~ll~~  199 (242)
                      ........    ..+.. ............+++++.+++.+       ||. ||.+||+ +.+++++
T Consensus       232 ~~~~~~~~----~~i~~-~~~~~~~p~~~~~~~~~~~li~~-------ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         232 SDTLQETY----NKIIN-WKESLRFPPDPPVSPEAIDLICR-------LLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCCHHHHH----HHHhc-cCCcccCCCCCCCCHHHHHHHHH-------Hcc-ChhhcCCCHHHHhcC
Confidence            54421100    00000 00111111112245666665555       777 9999999 9999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.96  E-value=1.3e-28  Score=197.49  Aligned_cols=176  Identities=25%  Similarity=0.309  Sum_probs=128.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....    ...+++..+..++.|++.|+.|||+.   +++|+||+|.||+++.++.++|+|||++.....
T Consensus        91 ~~~~~L~~~l~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~  163 (272)
T cd06637          91 CGAGSVTDLIKNTK----GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR  163 (272)
T ss_pred             CCCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence            57889999987642    24689999999999999999999999   999999999999999999999999999875433


Q ss_pred             Ccccchhcccccccccccchhhhcc---cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRS---FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      ....  .....++..|+|||.+...   ...++.++|+||||+++|++++|..||........       ..........
T Consensus       164 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~-------~~~~~~~~~~  234 (272)
T cd06637         164 TVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-------LFLIPRNPAP  234 (272)
T ss_pred             cccc--CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH-------HHHHhcCCCC
Confidence            2211  1123478899999987532   23467899999999999999999999863322110       0000111111


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ......++..       +.+++.+||..||.+|||+.+++++
T Consensus       235 ~~~~~~~~~~-------~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         235 RLKSKKWSKK-------FQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             CCCCCCcCHH-------HHHHHHHHcCCChhhCCCHHHHhhC
Confidence            1111223333       4455666999999999999999863

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.96  E-value=1.5e-28  Score=204.57  Aligned_cols=162  Identities=28%  Similarity=0.380  Sum_probs=115.9

Q ss_pred             ccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccccchh
Q 026160           22 LEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEV  101 (242)
Q Consensus        22 l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~  101 (242)
                      +++..+..++.||+.||.|||+.   +++|+|||++||+++.++.++|+|||++.........  .....++..|++||.
T Consensus       165 ~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~--~~~~~gt~~y~aPE~  239 (353)
T PLN00034        165 ADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--CNSSVGTIAYMSPER  239 (353)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccccc--ccccccCccccCccc
Confidence            56778889999999999999999   9999999999999999999999999998765432211  112358899999998


Q ss_pred             hhcc---cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccccccccchHHHHHHHHHHHH
Q 026160          102 FCRS---FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILV  178 (242)
Q Consensus       102 ~~~~---~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  178 (242)
                      +...   ....+.++|||||||++|++++|+.||........     ...............+..++.++.+       +
T Consensus       240 ~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~-------l  307 (353)
T PLN00034        240 INTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW-----ASLMCAICMSQPPEAPATASREFRH-------F  307 (353)
T ss_pred             cccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH-----HHHHHHHhccCCCCCCCccCHHHHH-------H
Confidence            7432   12345689999999999999999999973222110     0011111111112222334444444       4


Q ss_pred             HHHhccCCCCCCCCHHHHHHHh
Q 026160          179 SLWCIQTNPSDRPSMHEVLEML  200 (242)
Q Consensus       179 ~~~cl~~dp~~Rps~~~ll~~l  200 (242)
                      +.+||+.||++|||+.+++++=
T Consensus       308 i~~~l~~~P~~Rpt~~ell~hp  329 (353)
T PLN00034        308 ISCCLQREPAKRWSAMQLLQHP  329 (353)
T ss_pred             HHHHccCChhhCcCHHHHhcCc
Confidence            4559999999999999999863

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=2.3e-28  Score=183.92  Aligned_cols=169  Identities=20%  Similarity=0.190  Sum_probs=124.0

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      |||.+++.+.+     +.+++.+++.++.|++.||.|||+.   +      ||+||+++.++.+++  ||++........
T Consensus         1 GsL~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~~   64 (176)
T smart00750        1 VSLADILEVRG-----RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQS   64 (176)
T ss_pred             CcHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccccC
Confidence            89999997642     4699999999999999999999998   5      999999999999998  998876544221


Q ss_pred             cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccccccc
Q 026160           84 TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGV  163 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (242)
                             .++..|+|||.+.+.  .++.++|||||||++|++++|..||.........  . ...........    +. 
T Consensus        65 -------~g~~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~--~-~~~~~~~~~~~----~~-  127 (176)
T smart00750       65 -------RVDPYFMAPEVIQGQ--SYTEKADIYSLGITLYEALDYELPYNEERELSAI--L-EILLNGMPADD----PR-  127 (176)
T ss_pred             -------CCcccccChHHhcCC--CCcchhhHHHHHHHHHHHHhCCCCccccchhcHH--H-HHHHHHhccCC----cc-
Confidence                   478999999998664  5688999999999999999999998643321110  0 00111111100    00 


Q ss_pred             cchHHHHHHH--HHHHHHHHhccCCCCCCCCHHHHHHHhhchhh
Q 026160          164 VTEEEKELVK--KMILVSLWCIQTNPSDRPSMHEVLEMLESSTE  205 (242)
Q Consensus       164 ~~~~~~~~~~--~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~  205 (242)
                      ..........  .+.+++.+||+.||++||++.++++++.....
T Consensus       128 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      128 DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            0011122222  57778888999999999999999999887643

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.96  E-value=1.7e-28  Score=195.18  Aligned_cols=173  Identities=26%  Similarity=0.357  Sum_probs=128.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....    ...+++.++..++.+++.|+.+||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 ~~~~~l~~~l~~~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~  154 (257)
T cd08223          82 CEGGDLYHKLKEQK----GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN  154 (257)
T ss_pred             cCCCcHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence            57899999997642    24689999999999999999999999   999999999999999999999999999876543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....++..|+|||.+.+.  ..+.++|+||||++++++++|..||......       .... ....+.....
T Consensus       155 ~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-------~~~~-~~~~~~~~~~  222 (257)
T cd08223         155 QCDM--ASTLIGTPYYMSPELFSNK--PYNYKSDVWALGCCVYEMATLKHAFNAKDMN-------SLVY-RIIEGKLPPM  222 (257)
T ss_pred             cCCc--cccccCCcCccChhHhcCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-------HHHH-HHHhcCCCCC
Confidence            2221  1123478899999988653  5678999999999999999999998643211       1111 1111111122


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      +...++.       +.+++.+||+.||++|||+.+++++
T Consensus       223 ~~~~~~~-------~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         223 PKDYSPE-------LGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ccccCHH-------HHHHHHHHhccCcccCCCHHHHhcC
Confidence            2234444       4455555889999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.96  E-value=3.8e-28  Score=193.69  Aligned_cols=177  Identities=25%  Similarity=0.457  Sum_probs=130.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++.+..    ...+++.++..++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        82 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  154 (260)
T cd05073          82 MAKGSLLDFLKSDE----GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED  154 (260)
T ss_pred             CCCCcHHHHHHhCC----ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence            47899999997642    25688999999999999999999998   999999999999999999999999999876543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      .... ......++..|++||.+...  ..+.++|+||||+++|++++ |..||......        .............
T Consensus       155 ~~~~-~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~~~~~~~~~  223 (260)
T cd05073         155 NEYT-AREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--------EVIRALERGYRMP  223 (260)
T ss_pred             CCcc-cccCCcccccccCHhHhccC--CcCccccchHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHhCCCCCC
Confidence            2211 11112345679999988643  56889999999999999998 88888643211        1111111111111


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES  202 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~  202 (242)
                      .....+.       .+.+++.+||+.||++||++.++.+.|+.
T Consensus       224 ~~~~~~~-------~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         224 RPENCPE-------ELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CcccCCH-------HHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            2222333       34555566999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.96  E-value=3.1e-28  Score=194.90  Aligned_cols=178  Identities=25%  Similarity=0.421  Sum_probs=130.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|++++....     ..+++.++..++.+++.|+.|||+.   +++|+||||+||+++.++.++++|||++.....
T Consensus        88 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          88 MENGALDKYLRDHD-----GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             CCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            57899999986532     4589999999999999999999999   999999999999999999999999999876543


Q ss_pred             Ccccchh-cccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           81 KKSTISM-LHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        81 ~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      ....... .....+..|++||.+...  .++.++|+||||+++|++++ |..||.....        ......+......
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--------~~~~~~i~~~~~~  229 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSFGERPYWDMSN--------HEVMKAINDGFRL  229 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcC--CcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--------HHHHHHHhcCCCC
Confidence            2211110 111134579999987653  56889999999999999997 9999864332        1111111111111


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                      .....++       ..+.+++.+||+.+|++||++.++++.|+++
T Consensus       230 ~~~~~~~-------~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         230 PAPMDCP-------SAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CCCCCCC-------HHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1112233       3455666669999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.1e-28  Score=199.52  Aligned_cols=175  Identities=28%  Similarity=0.403  Sum_probs=129.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  154 (285)
T cd05605          82 MNGGDLKFHIYNMG----NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPE  154 (285)
T ss_pred             cCCCcHHHHHHhcC----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            57899999886542    24699999999999999999999999   999999999999999999999999999876543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....   ....++..|+|||.+.+.  .++.++|+||||+++|++++|..||........    .......... .....
T Consensus       155 ~~~~---~~~~~~~~y~aPE~~~~~--~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~----~~~~~~~~~~-~~~~~  224 (285)
T cd05605         155 GETI---RGRVGTVGYMAPEVVKNE--RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK----REEVERRVKE-DQEEY  224 (285)
T ss_pred             CCcc---ccccCCCCccCcHHhcCC--CCCccccchhHHHHHHHHHHCCCCCCCCchhhH----HHHHHHHhhh-ccccc
Confidence            3221   122478899999998653  578899999999999999999999975332110    0111111111 11112


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRP-----SMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp-----s~~~ll~~  199 (242)
                      +..++..+.+       ++.+||+.||++||     ++.+++++
T Consensus       225 ~~~~~~~~~~-------li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         225 SEKFSEAARS-------ICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             CcccCHHHHH-------HHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            2234444444       45558999999999     88888765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.96  E-value=2.1e-28  Score=206.18  Aligned_cols=166  Identities=23%  Similarity=0.346  Sum_probs=121.3

Q ss_pred             ccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccccc
Q 026160           20 RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAP   99 (242)
Q Consensus        20 ~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~P   99 (242)
                      ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++................++..|++|
T Consensus       234 ~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP  310 (401)
T cd05107         234 PALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAP  310 (401)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeCh
Confidence            4578889999999999999999998   9999999999999999999999999998764332221111122356789999


Q ss_pred             hhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccccccccchHHHHHHHHHHHH
Q 026160          100 EVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILV  178 (242)
Q Consensus       100 E~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  178 (242)
                      |.+...  .++.++|+||||+++||+++ |..||......       .........+.....+..++.++.+       +
T Consensus       311 E~~~~~--~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~-------~~~~~~~~~~~~~~~p~~~~~~l~~-------l  374 (401)
T cd05107         311 ESIFNN--LYTTLSDVWSFGILLWEIFTLGGTPYPELPMN-------EQFYNAIKRGYRMAKPAHASDEIYE-------I  374 (401)
T ss_pred             HHhcCC--CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch-------HHHHHHHHcCCCCCCCCCCCHHHHH-------H
Confidence            988653  56889999999999999998 78887543211       1111111111112223334444444       4


Q ss_pred             HHHhccCCCCCCCCHHHHHHHhhchh
Q 026160          179 SLWCIQTNPSDRPSMHEVLEMLESST  204 (242)
Q Consensus       179 ~~~cl~~dp~~Rps~~~ll~~l~~~~  204 (242)
                      +.+||+.+|++||+++++++.|+.+.
T Consensus       375 i~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         375 MQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             HHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            45599999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.96  E-value=3.1e-28  Score=193.02  Aligned_cols=177  Identities=28%  Similarity=0.435  Sum_probs=128.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....     ..++...+..++.+++.++.|||++   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        74 ~~~~~l~~~l~~~~-----~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  145 (251)
T cd05041          74 VPGGSLLTFLRKKK-----NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEG  145 (251)
T ss_pred             CCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccC
Confidence            46889999986532     3588999999999999999999999   999999999999999999999999999875542


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ............+..|.|||.+.+.  .++.++|+||||+++|++++ |..||......        .............
T Consensus       146 ~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--------~~~~~~~~~~~~~  215 (251)
T cd05041         146 GIYTVSDGLKQIPIKWTAPEALNYG--RYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--------QTRERIESGYRMP  215 (251)
T ss_pred             CcceeccccCcceeccCChHhhccC--CCCcchhHHHHHHHHHHHHhccCCCCccCCHH--------HHHHHHhcCCCCC
Confidence            2211111111235579999987553  57889999999999999998 78887543321        1111111111111


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES  202 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~  202 (242)
                      .+...+.       .+.+++.+||..+|++|||+.++++.|++
T Consensus       216 ~~~~~~~-------~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         216 APQLCPE-------EIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             CCccCCH-------HHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            2222333       45556666999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=6.5e-29  Score=205.59  Aligned_cols=174  Identities=25%  Similarity=0.351  Sum_probs=126.7

Q ss_pred             CcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCccc
Q 026160            5 SLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST   84 (242)
Q Consensus         5 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~   84 (242)
                      +|.+.|.+...     -++.-.+..+..|++.++.+.|..   ||||.||||+|+|+- .|.+||+|||++.........
T Consensus       445 DL~kiL~k~~~-----~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTs  515 (677)
T KOG0596|consen  445 DLNKILKKKKS-----IDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTS  515 (677)
T ss_pred             cHHHHHHhccC-----CCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCccccc
Confidence            45566665432     233237788889999999999999   999999999999885 579999999999988777666


Q ss_pred             chhcccccccccccchhhhcc---------cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCC
Q 026160           85 ISMLHARGTIGYIAPEVFCRS---------FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPG  155 (242)
Q Consensus        85 ~~~~~~~~~~~y~~PE~~~~~---------~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  155 (242)
                      .......||..|++||.+...         .-+.+.++|||||||++|+|+.|+.||.......      .....-..++
T Consensus       516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~------aKl~aI~~P~  589 (677)
T KOG0596|consen  516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI------AKLHAITDPN  589 (677)
T ss_pred             eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH------HHHHhhcCCC
Confidence            666677899999999998432         1135789999999999999999999996443211      1112222232


Q ss_pred             CccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          156 NDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ....++..-+...      ++.+|..||+.||++|||+.+||++
T Consensus       590 ~~Iefp~~~~~~~------li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  590 HEIEFPDIPENDE------LIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             ccccccCCCCchH------HHHHHHHHHhcCcccCCCcHHHhcC
Confidence            3222222222221      5556666999999999999999864

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.6e-29  Score=225.90  Aligned_cols=177  Identities=29%  Similarity=0.417  Sum_probs=146.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+.+...+.      .++.-......|++.|+.|||+.   |||||||||+||+++.+|.+|++|||.+.....
T Consensus      1316 C~~GsLa~ll~~gri------~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGRI------EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             hccCcHHHHHHhcch------hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence            789999999976533      66666667789999999999999   999999999999999999999999999987765


Q ss_pred             Ccc--cchhcccccccccccchhhhccc-CCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           81 KKS--TISMLHARGTIGYIAPEVFCRSF-GGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        81 ~~~--~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      ...  ........||+.|+|||++.+.. .+.-.+.||||||||+.||+||+.||...+..       ..+..+..-+..
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aIMy~V~~gh~ 1459 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAIMYHVAAGHK 1459 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHHHhHHhccCC
Confidence            421  12222346999999999997654 45577899999999999999999999866654       345556777777


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML  200 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l  200 (242)
                      +.+|..++.+-++++..       ||..||+.|.++.|++++-
T Consensus      1460 Pq~P~~ls~~g~dFle~-------Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1460 PQIPERLSSEGRDFLEH-------CLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred             CCCchhhhHhHHHHHHH-------HHhcCchhhhHHHHHHHhh
Confidence            88888888888888887       9999999999999888763

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.96  E-value=1.9e-28  Score=192.01  Aligned_cols=169  Identities=22%  Similarity=0.253  Sum_probs=125.6

Q ss_pred             ccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccccc
Q 026160           20 RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAP   99 (242)
Q Consensus        20 ~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~P   99 (242)
                      .+++..++..++.|+++|++|||.+   .|+|||||++|+|++..|.+|++|||+++.++.....  ++....|.+|.||
T Consensus       172 q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~--~T~lVVTLWYRaP  246 (419)
T KOG0663|consen  172 QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP--YTPLVVTLWYRAP  246 (419)
T ss_pred             CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCccc--CcceEEEeeecCH
Confidence            5799999999999999999999999   9999999999999999999999999999988876433  3345689999999


Q ss_pred             hhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCC------------CCcCcchhhhc------cCCCCccc--
Q 026160          100 EVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSS------------DIYFPNSIYKH------IEPGNDFQ--  159 (242)
Q Consensus       100 E~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~------------~~~~~~~~~~~------~~~~~~~~--  159 (242)
                      |.+.+. ..++.+.|+||+||++.|++++++-|......++            +..|+......      ........  
T Consensus       247 ELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr  325 (419)
T KOG0663|consen  247 ELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLR  325 (419)
T ss_pred             HHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhh
Confidence            999886 5789999999999999999999988765543221            11111111111      00111111  


Q ss_pred             --cccc-cchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          160 --LDGV-VTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       160 --~~~~-~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                        +... +++...+++.       ..|.+||.+|.|+.+.+++=.
T Consensus       326 ~kF~~~~lse~g~~Lln-------~llt~dP~kR~tA~~~L~h~~  363 (419)
T KOG0663|consen  326 KKFGALSLSEQGFDLLN-------KLLTYDPGKRITAEDGLKHEY  363 (419)
T ss_pred             hhccccccchhHHHHHH-------HHhccCccccccHHHhhcccc
Confidence              1111 3344444444       466999999999999997644

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=3.5e-28  Score=193.81  Aligned_cols=177  Identities=30%  Similarity=0.476  Sum_probs=130.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++.+..    +..+++.++..++.+++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        83 ~~~~~L~~~i~~~~----~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  155 (261)
T cd05034          83 MSKGSLLDFLKSGE----GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED  155 (261)
T ss_pred             cCCCCHHHHHhccc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence            47899999997642    24689999999999999999999999   999999999999999999999999999876553


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      .... .......+..|.+||.+.+.  ..+.++|+||||+++|++++ |+.||.....        .........+....
T Consensus       156 ~~~~-~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--------~~~~~~~~~~~~~~  224 (261)
T cd05034         156 DEYT-AREGAKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--------REVLEQVERGYRMP  224 (261)
T ss_pred             hhhh-hhhccCCCccccCHHHhccC--CcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCC
Confidence            2111 11112245689999988653  57889999999999999998 8988853321        11111111111111


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES  202 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~  202 (242)
                      .+...+.+       +.+++.+||..+|++||++.++++.|+.
T Consensus       225 ~~~~~~~~-------~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         225 RPPNCPEE-------LYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCHH-------HHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            22223333       4555666899999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.96  E-value=1.9e-28  Score=198.17  Aligned_cols=123  Identities=21%  Similarity=0.315  Sum_probs=98.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|..+...      ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 ~~~~~l~~~~~~------~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  152 (287)
T cd07848          82 VEKNMLELLEEM------PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE  152 (287)
T ss_pred             CCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence            355655544322      24699999999999999999999998   999999999999999999999999999876543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      .... ......++..|+|||.+.+.  .++.++|+|||||++|++++|+.||...
T Consensus       153 ~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~pf~~~  204 (287)
T cd07848         153 GSNA-NYTEYVATRWYRSPELLLGA--PYGKAVDMWSVGCILGELSDGQPLFPGE  204 (287)
T ss_pred             cccc-cccccccccccCCcHHHcCC--CCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence            2211 11123478899999998654  5688999999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.96  E-value=3.8e-28  Score=194.58  Aligned_cols=178  Identities=26%  Similarity=0.409  Sum_probs=129.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....     +.+++.+++.++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        87 ~~~~~L~~~l~~~~-----~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          87 MENGALDSFLRQND-----GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             CCCCcHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence            47899999986532     4589999999999999999999998   999999999999999999999999998875543


Q ss_pred             Ccccchhcccc---cccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCC
Q 026160           81 KKSTISMLHAR---GTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGN  156 (242)
Q Consensus        81 ~~~~~~~~~~~---~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  156 (242)
                      ...........   .+..|++||.+...  ..+.++|+||||+++||+++ |..||......        ..........
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--------~~~~~i~~~~  228 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--------DVINAIEQDY  228 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccC--cccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--------HHHHHHHcCC
Confidence            22211111111   23479999988643  56889999999999999886 99888643321        1111111111


Q ss_pred             ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          157 DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                      ....+..++..       +..++.+||+.+|++||++.+++..|+++
T Consensus       229 ~~~~~~~~~~~-------~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 RLPPPMDCPTA-------LHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             cCCCcccCCHH-------HHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            11122233433       34555669999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.96  E-value=1.3e-28  Score=203.35  Aligned_cols=121  Identities=32%  Similarity=0.485  Sum_probs=101.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      +.+++..+..++.+++.|+.|||+.  .+++|+||||+||+++.++.++|+|||++.....
T Consensus        85 ~~~~~L~~~l~~~------~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          85 MDGGSLDQVLKKA------GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            5789999999764      4589999999999999999999974  1799999999999999999999999999875433


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      ....    ...++..|+|||.+.+.  .++.++|+|||||++|++++|+.||...
T Consensus       157 ~~~~----~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         157 SMAN----SFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             hccc----cCCCCccccCHHHhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            2111    12478899999998653  5788999999999999999999998643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.96  E-value=2.2e-28  Score=195.68  Aligned_cols=178  Identities=23%  Similarity=0.272  Sum_probs=127.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++...      ..+++.++..++.|++.|+.|||+.   +++|+||+|.||+++.++.++|+|||++.....
T Consensus        88 ~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06646          88 CGGGSLQDIYHVT------GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITA  158 (267)
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence            5789999998654      4589999999999999999999998   999999999999999999999999999876543


Q ss_pred             Ccccchhcccccccccccchhhhcc-cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRS-FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ....  .....++..|+|||.+... ....+.++|+||||+++|++++|..||...............   ... .....
T Consensus       159 ~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~-~~~~~  232 (267)
T cd06646         159 TIAK--RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS---NFQ-PPKLK  232 (267)
T ss_pred             cccc--cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC---CCC-CCCCc
Confidence            2211  1122477899999987432 234678999999999999999999998543322111100000   000 00001


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML  200 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l  200 (242)
                      ....++..       +.+++.+||+.||++|||+.++++.+
T Consensus       233 ~~~~~~~~-------~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         233 DKTKWSST-------FHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             cccccCHH-------HHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            11123344       44455569999999999999998765

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.96  E-value=9.4e-29  Score=200.20  Aligned_cols=121  Identities=30%  Similarity=0.423  Sum_probs=99.3

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      |+|.+++....     ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        87 ~~l~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          87 SDLKQYLDNCG-----NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             cCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            57888876432     3588999999999999999999999   999999999999999999999999999875433221


Q ss_pred             cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           84 TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      .  .....++..|+|||.+.+. ..++.++|+|||||++|++++|..||...
T Consensus       159 ~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~  207 (288)
T cd07871         159 T--YSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGS  207 (288)
T ss_pred             c--ccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            1  1123478899999987653 35688999999999999999999998643

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.96  E-value=2.7e-28  Score=198.13  Aligned_cols=188  Identities=21%  Similarity=0.304  Sum_probs=128.5

Q ss_pred             CCCCCcchhccccCCC------CCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEccccc
Q 026160            1 MPNGSLDQFTYDQESS------NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGL   74 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~------~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~   74 (242)
                      |++|+|.+++......      .....+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+
T Consensus        99 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nill~~~~~~kl~dfg~  175 (295)
T cd05097          99 MENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGM  175 (295)
T ss_pred             CCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEEEcCCCcEEeccccc
Confidence            5789999998653211      1123478999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh--cCCCccccccCCCCCcCcchhhhcc
Q 026160           75 AKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV--GRKNADVKASRSSDIYFPNSIYKHI  152 (242)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~--g~~p~~~~~~~~~~~~~~~~~~~~~  152 (242)
                      +................++..|+|||.+...  .++.++|+||||+++|++++  +..||............ .......
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~-~~~~~~~  252 (295)
T cd05097         176 SRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENT-GEFFRNQ  252 (295)
T ss_pred             ccccccCcceeccCcCcCceeecChhhhccC--CcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHH-HHhhhhc
Confidence            8765433222111222356789999987653  57899999999999999988  55676543221100000 0000000


Q ss_pred             CCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          153 EPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      ........+...++       .+.+++.+||+.||++|||++++++.|+
T Consensus       253 ~~~~~~~~~~~~~~-------~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         253 GRQIYLSQTPLCPS-------PVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             cccccCCCCCCCCH-------HHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            00000111222334       4555556699999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.96  E-value=1.5e-28  Score=209.88  Aligned_cols=187  Identities=23%  Similarity=0.295  Sum_probs=123.1

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCC-ceEEcccccccccCCCc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF-CPKISDFGLAKQSQDKK   82 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~-~~~L~dfg~~~~~~~~~   82 (242)
                      |+|.+++....  .....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++ .++|+|||++.......
T Consensus       151 ~~l~~~~~~~~--~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~  225 (440)
T PTZ00036        151 QTVHKYMKHYA--RNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ  225 (440)
T ss_pred             ccHHHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccchhccCCC
Confidence            45656554321  1235699999999999999999999999   999999999999998654 69999999998654332


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcC-------cchhhhccCC-
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYF-------PNSIYKHIEP-  154 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~-------~~~~~~~~~~-  154 (242)
                      ...   ...+++.|+|||.+.+. ..++.++|||||||++|+|++|.+||............       .......... 
T Consensus       226 ~~~---~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~  301 (440)
T PTZ00036        226 RSV---SYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPN  301 (440)
T ss_pred             Ccc---cCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchh
Confidence            221   22478899999987653 35788999999999999999999999654321100000       0000000000 


Q ss_pred             CCccccccccchHHHH-----HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          155 GNDFQLDGVVTEEEKE-----LVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       155 ~~~~~~~~~~~~~~~~-----~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .....++...+..+..     ....+.+++.+||.+||.+|||+.+++++
T Consensus       302 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        302 YADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             hhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            0000011101111111     11345556666999999999999999854

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.96  E-value=2.1e-28  Score=197.28  Aligned_cols=172  Identities=30%  Similarity=0.396  Sum_probs=129.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++..+      +.+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        79 ~~~~~L~~~i~~~------~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~  149 (279)
T cd05633          79 MNGGDLHYHLSQH------GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK  149 (279)
T ss_pred             CCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccc
Confidence            5789999998765      4599999999999999999999999   999999999999999999999999999875543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....    ...++..|+|||.+... ...+.++|+||||+++|++++|..||........     ... ..........+
T Consensus       150 ~~~~----~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~-~~~~~~~~~~~  218 (279)
T cd05633         150 KKPH----ASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEI-DRMTLTVNVEL  218 (279)
T ss_pred             cCcc----CcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-----HHH-HHHhhcCCcCC
Confidence            2211    22488999999987532 3567899999999999999999999975432211     111 11111111223


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRP-----SMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp-----s~~~ll~~  199 (242)
                      +..++.++.+++.+       ||+.||++||     |+.+++++
T Consensus       219 ~~~~~~~~~~li~~-------~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         219 PDSFSPELKSLLEG-------LLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ccccCHHHHHHHHH-------HhcCCHHHhcCCCCCCHHHHHhC
Confidence            33455556555555       7799999999     69999885

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.96  E-value=3.1e-29  Score=205.79  Aligned_cols=166  Identities=28%  Similarity=0.432  Sum_probs=124.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.+.      ..+++.++..++.||+.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        80 ~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  150 (318)
T cd05582          80 LRGGDLFTRLSKE------VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID  150 (318)
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence            5789999998654      4599999999999999999999999   999999999999999999999999999876543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      .....  ....++..|+|||.+.+.  ..+.++|+|||||++|+|++|+.||......       ... ..+... ....
T Consensus       151 ~~~~~--~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~-------~~~-~~i~~~-~~~~  217 (318)
T cd05582         151 HEKKA--YSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-------ETM-TMILKA-KLGM  217 (318)
T ss_pred             CCCce--ecccCChhhcCHHHHcCC--CCCCccceeccceEeeeeccCCCCCCCCCHH-------HHH-HHHHcC-CCCC
Confidence            32111  123488999999998653  5678999999999999999999999643321       111 111111 1122


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHE  195 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~  195 (242)
                      +..+++.+.+++.+       ||+.||++||++.+
T Consensus       218 p~~~~~~~~~li~~-------~l~~~P~~R~~a~~  245 (318)
T cd05582         218 PQFLSPEAQSLLRA-------LFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCHHHHHHHHH-------HhhcCHhHcCCCCC
Confidence            33455555555544       88999999999443

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.96  E-value=4.3e-29  Score=205.90  Aligned_cols=177  Identities=25%  Similarity=0.317  Sum_probs=129.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.+..     ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        83 ~~~~~L~~~l~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601          83 QPGGDLLSLLNRYE-----DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA  154 (330)
T ss_pred             CCCCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence            57999999997642     3599999999999999999999999   999999999999999999999999999976544


Q ss_pred             Ccccchhcccccccccccchhhhcc----cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCC
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRS----FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN  156 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~----~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  156 (242)
                      .... ......++..|+|||.+...    ...++.++|||||||++|+|++|..||........   + ..+. ......
T Consensus       155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~---~-~~i~-~~~~~~  228 (330)
T cd05601         155 NKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT---Y-NNIM-NFQRFL  228 (330)
T ss_pred             CCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH---H-HHHH-cCCCcc
Confidence            3222 11123588999999988532    23467899999999999999999999964332110   0 0000 001111


Q ss_pred             ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          157 DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .......++.++.+++..       ||. ||++|||+.+++.+
T Consensus       229 ~~~~~~~~~~~~~~li~~-------ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         229 KFPEDPKVSSDFLDLIQS-------LLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             CCCCCCCCCHHHHHHHHH-------Hcc-ChhhCCCHHHHhCC
Confidence            111122355566665555       667 99999999999864

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.96  E-value=2e-28  Score=194.69  Aligned_cols=173  Identities=24%  Similarity=0.307  Sum_probs=128.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....    ...++...+..++.|++.|+.|||+.   +++|+||+|.||+++.++.++++|||.+.....
T Consensus        80 ~~~~~l~~~~~~~~----~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  152 (255)
T cd08219          80 CDGGDLMQKIKLQR----GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS  152 (255)
T ss_pred             CCCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence            47899999886532    24689999999999999999999999   999999999999999999999999999876543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      .....  ....++..|+|||.+...  ..+.++|+||||+++|++++|..||......        ........+.....
T Consensus       153 ~~~~~--~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~  220 (255)
T cd08219         153 PGAYA--CTYVGTPYYVPPEIWENM--PYNNKSDIWSLGCILYELCTLKHPFQANSWK--------NLILKVCQGSYKPL  220 (255)
T ss_pred             ccccc--ccccCCccccCHHHHccC--CcCchhhhhhhchhheehhhccCCCCCCCHH--------HHHHHHhcCCCCCC
Confidence            32211  122478889999988553  5788999999999999999999999643211        11111112222223


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      +..++..+.       +++.+||+.||++|||+.+++..
T Consensus       221 ~~~~~~~~~-------~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         221 PSHYSYELR-------SLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CcccCHHHH-------HHHHHHHhCCcccCCCHHHHhhc
Confidence            333444444       44555889999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.95  E-value=5.9e-28  Score=191.35  Aligned_cols=176  Identities=25%  Similarity=0.385  Sum_probs=128.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....     ..+++.++..++.+++.++.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        74 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  145 (250)
T cd05085          74 VPGGDFLSFLRKKK-----DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDD  145 (250)
T ss_pred             CCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccc
Confidence            47899999986532     3588999999999999999999998   999999999999999999999999999875433


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ..... ......+..|+|||.+...  ..+.++|+||||+++|++++ |..||......        .............
T Consensus       146 ~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--------~~~~~~~~~~~~~  214 (250)
T cd05085         146 GIYSS-SGLKQIPIKWTAPEALNYG--RYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--------QAREQVEKGYRMS  214 (250)
T ss_pred             ccccc-CCCCCCcccccCHHHhccC--CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHHcCCCCC
Confidence            22111 1111245679999988543  57889999999999999998 88888543221        1111111111112


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES  202 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~  202 (242)
                      .+..++..       +.+++.+||+.+|++||++.++++.|.+
T Consensus       215 ~~~~~~~~-------~~~li~~~l~~~p~~Rp~~~~l~~~l~~  250 (250)
T cd05085         215 CPQKCPDD-------VYKVMQRCWDYKPENRPKFSELQKELAA  250 (250)
T ss_pred             CCCCCCHH-------HHHHHHHHcccCcccCCCHHHHHHHhcC
Confidence            22234444       4445555999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.95  E-value=1.9e-28  Score=198.08  Aligned_cols=175  Identities=27%  Similarity=0.401  Sum_probs=128.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....    ...+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 ~~g~~L~~~l~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  154 (285)
T cd05630          82 MNGGDLKFHIYHMG----EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  154 (285)
T ss_pred             cCCCcHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence            57899999986532    24599999999999999999999998   999999999999999999999999999875443


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      .....   ...++..|+|||.+.+.  .++.++|+||||+++|++++|..||.........    ... ...........
T Consensus       155 ~~~~~---~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~----~~~-~~~~~~~~~~~  224 (285)
T cd05630         155 GQTIK---GRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR----EEV-ERLVKEVQEEY  224 (285)
T ss_pred             Ccccc---CCCCCccccChHHHcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCccchH----HHH-Hhhhhhhhhhc
Confidence            22211   22488999999998653  5788999999999999999999999743221100    000 00000011112


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPS-----MHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps-----~~~ll~~  199 (242)
                      ...+++++.+++       ..||+.||++|||     +.+++++
T Consensus       225 ~~~~~~~~~~li-------~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         225 SEKFSPDARSLC-------KMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             CccCCHHHHHHH-------HHHhhcCHHHccCCCCCchHHHHcC
Confidence            233455554444       4488999999999     8888873

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.95  E-value=2.3e-28  Score=199.31  Aligned_cols=122  Identities=28%  Similarity=0.356  Sum_probs=99.3

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      .|+|.+++....     ..++...+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        86 ~~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          86 HTDLCQYMDKHP-----GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CcCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            467777775432     4589999999999999999999999   99999999999999999999999999987543222


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      ..  .....++..|+|||.+.+. ..++.++|+|||||++|+|++|..||...
T Consensus       158 ~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~  207 (303)
T cd07869         158 HT--YSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGM  207 (303)
T ss_pred             cc--CCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            11  1123478899999987653 34678899999999999999999999643

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=2e-28  Score=206.44  Aligned_cols=123  Identities=27%  Similarity=0.352  Sum_probs=102.5

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      +|+|.+++...      ..+++.++..++.||+.||.|||+.   +|+|+||||+||+++.++.++|+|||++.......
T Consensus       169 ~~~l~~~l~~~------~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        169 KCDLFTYVDRS------GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             CCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            46788888433      4699999999999999999999999   99999999999999999999999999987655433


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccc
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKA  136 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  136 (242)
                      .........++..|+|||.+...  .++.++|||||||++|+|++|..||....
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~  291 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLALD--PYCAKTDIWSAGLVLFEMSVKNVTLFGKQ  291 (392)
T ss_pred             ccccccccccccCccCHhHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence            22222233589999999998653  57889999999999999999999986544

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.95  E-value=7.8e-29  Score=209.02  Aligned_cols=117  Identities=28%  Similarity=0.321  Sum_probs=101.4

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCC--CceEEcccccccccCCC
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDED--FCPKISDFGLAKQSQDK   81 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~--~~~~L~dfg~~~~~~~~   81 (242)
                      -||++||+.++.    .+|+...+..++.||+.+|.+||..   +|||+||||+|||+...  ..|||+|||.++.....
T Consensus       272 ~NLYellK~n~f----~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~  344 (586)
T KOG0667|consen  272 TNLYELLKNNKF----RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR  344 (586)
T ss_pred             hhHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccccCCc
Confidence            378899987755    7899999999999999999999998   99999999999999653  46999999999987765


Q ss_pred             cccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccc
Q 026160           82 KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADV  134 (242)
Q Consensus        82 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~  134 (242)
                      ...     -+.++.|+|||++.+.  .++.+.|||||||++.||.+|.+.|-+
T Consensus       345 vyt-----YiQSRfYRAPEVILGl--pY~~~IDmWSLGCIlAEL~tG~PLfpG  390 (586)
T KOG0667|consen  345 VYT-----YIQSRFYRAPEVILGL--PYDTAIDMWSLGCILAELFTGEPLFPG  390 (586)
T ss_pred             cee-----eeeccccccchhhccC--CCCCccceeehhhhHHhHhcCccccCC
Confidence            442     2478999999999885  789999999999999999999765543

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.95  E-value=2.1e-28  Score=200.67  Aligned_cols=130  Identities=22%  Similarity=0.277  Sum_probs=99.8

Q ss_pred             CCCcchhccccCC---CCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceee----CCCCceEEcccccc
Q 026160            3 NGSLDQFTYDQES---SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL----DEDFCPKISDFGLA   75 (242)
Q Consensus         3 ~GsL~~~l~~~~~---~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~----~~~~~~~L~dfg~~   75 (242)
                      +++|.+++.....   ......+++..+..++.|++.||.|||+.   +++|+||||+||++    +.++.++|+|||++
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            4566666643221   11223589999999999999999999999   99999999999999    45678999999999


Q ss_pred             cccCCCccc-chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccc
Q 026160           76 KQSQDKKST-ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKA  136 (242)
Q Consensus        76 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  136 (242)
                      ......... .......++..|+|||.+.+. ..++.++|+|||||++|+|++|+.||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            865443221 111233578999999988653 346889999999999999999999996443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.95  E-value=2.2e-28  Score=198.61  Aligned_cols=166  Identities=20%  Similarity=0.218  Sum_probs=118.9

Q ss_pred             ccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccc-----hhccccccccc
Q 026160           22 LEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTI-----SMLHARGTIGY   96 (242)
Q Consensus        22 l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~-----~~~~~~~~~~y   96 (242)
                      .++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||+++.........     ......+|..|
T Consensus       123 ~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y  199 (294)
T PHA02882        123 KNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYY  199 (294)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccc
Confidence            56788899999999999999998   99999999999999999999999999987653221110     01112489999


Q ss_pred             ccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCc-chhhhccCCCCccccccccchHHHHHHHHH
Q 026160           97 IAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP-NSIYKHIEPGNDFQLDGVVTEEEKELVKKM  175 (242)
Q Consensus        97 ~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (242)
                      +|||.+.+.  .++.++|||||||++|++++|..||............. .........+..  .....+       ..+
T Consensus       200 ~ape~~~~~--~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~-------~~~  268 (294)
T PHA02882        200 AGLDAHNGA--CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKI--KIKNAN-------KFI  268 (294)
T ss_pred             cCHHHhCCC--CCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhh--ccCCCC-------HHH
Confidence            999988654  57899999999999999999999997553322111000 000111111110  011223       335


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          176 ILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       176 ~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      .+++..||..+|++||++.++++.|+
T Consensus       269 ~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        269 YDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            55666699999999999999998764

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.95  E-value=3.7e-28  Score=193.62  Aligned_cols=169  Identities=22%  Similarity=0.301  Sum_probs=123.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCc--------eEEccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFC--------PKISDF   72 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~--------~~L~df   72 (242)
                      |++|+|++++....     ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.        ++++||
T Consensus        81 ~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~  152 (258)
T cd05078          81 VKFGSLDTYLKKNK-----NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP  152 (258)
T ss_pred             CCCCcHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence            57899999997643     3689999999999999999999999   9999999999999977654        689999


Q ss_pred             ccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcC-CCccccccCCCCCcCcchhhhc
Q 026160           73 GLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR-KNADVKASRSSDIYFPNSIYKH  151 (242)
Q Consensus        73 g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~  151 (242)
                      |++........      ..++..|+|||.+.+. ...+.++|+||||+++|++++|. .|+.......        ....
T Consensus       153 g~~~~~~~~~~------~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--------~~~~  217 (258)
T cd05078         153 GISITVLPKEI------LLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--------KLQF  217 (258)
T ss_pred             ccccccCCchh------ccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--------HHHH
Confidence            98865443221      2367889999988653 34688999999999999999985 5544322110        0000


Q ss_pred             cCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          152 IEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      ...  ....+.....+       +.+++.+||+.||++|||++++++.|.
T Consensus       218 ~~~--~~~~~~~~~~~-------~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         218 YED--RHQLPAPKWTE-------LANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             HHc--cccCCCCCcHH-------HHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            000  11122223333       445555699999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.95  E-value=2.4e-28  Score=204.39  Aligned_cols=174  Identities=23%  Similarity=0.326  Sum_probs=129.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.+++...       .+++..+..++.|++.||.|||+.   +++|+||||+|||++.++.++|+|||++.....
T Consensus       125 ~~gg~L~~~l~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         125 MPGGDLVNLMSNY-------DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             CCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            5799999998642       488999999999999999999999   999999999999999999999999999876543


Q ss_pred             Ccccchhcccccccccccchhhhccc--CCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSF--GGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      .... ......|++.|+|||.+....  ..++.++|+|||||++|+|++|..||......       .............
T Consensus       195 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~i~~~~~~~  266 (370)
T cd05596         195 NGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------GTYSKIMDHKNSL  266 (370)
T ss_pred             CCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-------HHHHHHHcCCCcC
Confidence            2211 111235899999999886532  24688999999999999999999999754321       0111111111111


Q ss_pred             ccc--cccchHHHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 026160          159 QLD--GVVTEEEKELVKKMILVSLWCIQTNPSD--RPSMHEVLEM  199 (242)
Q Consensus       159 ~~~--~~~~~~~~~~~~~~~~l~~~cl~~dp~~--Rps~~~ll~~  199 (242)
                      ..+  ..++.++.+++.+       ||..+|++  |+|+.+++++
T Consensus       267 ~~~~~~~~s~~~~~li~~-------~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         267 TFPDDIEISKQAKDLICA-------FLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CCCCcCCCCHHHHHHHHH-------HccChhhccCCCCHHHHhcC
Confidence            111  2356677777666       66888987  9999999876

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.95  E-value=6.4e-28  Score=193.29  Aligned_cols=185  Identities=19%  Similarity=0.267  Sum_probs=123.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.+...  ....++...+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        77 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~  151 (268)
T cd05086          77 CELGDLKSYLSQEQW--HRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK  151 (268)
T ss_pred             CCCCcHHHHHHhhhc--ccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCc
Confidence            578999999976422  234577788899999999999999998   999999999999999999999999998764322


Q ss_pred             Ccccchhcccccccccccchhhhcc-----cCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCC
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRS-----FGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEP  154 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  154 (242)
                      ...........++..|+|||.+...     ....+.++|+||||+++|++++ +..||.......   ............
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~~~~~~~~~  228 (268)
T cd05086         152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE---VLNHVIKDQQVK  228 (268)
T ss_pred             chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHhhcccc
Confidence            2111111123467889999987431     1234778999999999999997 466764322110   000000000011


Q ss_pred             CCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          155 GNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      .........+++.       +..++..|| .+|++||++.++++.|.
T Consensus       229 ~~~~~~~~~~~~~-------~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         229 LFKPQLELPYSER-------WYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             cCCCccCCCCcHH-------HHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            1111122223333       334455598 68999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.95  E-value=4.2e-28  Score=193.81  Aligned_cols=168  Identities=24%  Similarity=0.327  Sum_probs=122.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCc-------eEEcccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFC-------PKISDFG   73 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~-------~~L~dfg   73 (242)
                      |++|+|+.++....     ..+++..++.++.|++.|+.|||+.   +++|+||||.||+++.++.       ++++|||
T Consensus        86 ~~~~~l~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          86 VEFGPLDLFMHRKS-----DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             ccCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            47889998886532     4589999999999999999999999   9999999999999976554       8999999


Q ss_pred             cccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHH-hcCCCccccccCCCCCcCcchhhhcc
Q 026160           74 LAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMA-VGRKNADVKASRSSDIYFPNSIYKHI  152 (242)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll-~g~~p~~~~~~~~~~~~~~~~~~~~~  152 (242)
                      ++........      ..++..|+|||.+... ..++.++||||||+++|+++ .|..||.......        .....
T Consensus       158 ~~~~~~~~~~------~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--------~~~~~  222 (262)
T cd05077         158 IPITVLSRQE------CVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--------KERFY  222 (262)
T ss_pred             CCccccCccc------ccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--------HHHHH
Confidence            8865543221      2367889999987532 35688999999999999998 5777765332111        00000


Q ss_pred             CCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 026160          153 EPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML  200 (242)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l  200 (242)
                      ...  ........       ..+.+++.+||+.||++||++.++++.+
T Consensus       223 ~~~--~~~~~~~~-------~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         223 EGQ--CMLVTPSC-------KELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             hcC--ccCCCCCh-------HHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            000  00111112       3355667779999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.95  E-value=2.7e-28  Score=200.66  Aligned_cols=164  Identities=25%  Similarity=0.355  Sum_probs=122.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        83 ~~~g~L~~~i~~~------~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          83 VNGGDLMYHIQQV------GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence            5789999998765      4599999999999999999999999   999999999999999999999999999875332


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....|+..|+|||.+.+.  .++.++|+||||+++|+|++|..||......        .....+... ....
T Consensus       154 ~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~~--------~~~~~i~~~-~~~~  220 (323)
T cd05615         154 DGVT--TRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--------ELFQSIMEH-NVSY  220 (323)
T ss_pred             CCcc--ccCccCCccccCHHHHcCC--CCCCccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhC-CCCC
Confidence            2111  1123488999999988653  5688999999999999999999999754321        111111111 1112


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSM  193 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~  193 (242)
                      +..++.++.+++       .+||+.||++|++.
T Consensus       221 p~~~~~~~~~li-------~~~l~~~p~~R~~~  246 (323)
T cd05615         221 PKSLSKEAVSIC-------KGLMTKHPSKRLGC  246 (323)
T ss_pred             CccCCHHHHHHH-------HHHcccCHhhCCCC
Confidence            333455554444       44889999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.95  E-value=4.7e-28  Score=193.73  Aligned_cols=173  Identities=27%  Similarity=0.433  Sum_probs=127.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++...      +.++...+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        88 ~~~~~L~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06628          88 VPGGSVAALLNNY------GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEA  158 (267)
T ss_pred             cCCCCHHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence            4788999999764      4589999999999999999999998   999999999999999999999999999876542


Q ss_pred             Ccccc----hhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCC
Q 026160           81 KKSTI----SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN  156 (242)
Q Consensus        81 ~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  156 (242)
                      .....    ......++..|++||.+.+.  ..+.++|+||||+++|++++|..||......       .... ......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~-~~~~~~  228 (267)
T cd06628         159 NSLSTKTNGARPSLQGSVFWMAPEVVKQT--SYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-------QAIF-KIGENA  228 (267)
T ss_pred             ccccCCccccccccCCCcCccChhHhccC--CCCchhhhHHHHHHHHHHhhCCCCCCCccHH-------HHHH-HHhccC
Confidence            21110    01112367889999988653  5678899999999999999999999643221       1111 111122


Q ss_pred             ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          157 DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ....+..++..+.++       +.+||+.||++||++.++++.
T Consensus       229 ~~~~~~~~~~~~~~l-------i~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         229 SPEIPSNISSEAIDF-------LEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             CCcCCcccCHHHHHH-------HHHHccCCchhCcCHHHHhhC
Confidence            222333344444444       445899999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.95  E-value=5.2e-28  Score=199.24  Aligned_cols=127  Identities=22%  Similarity=0.290  Sum_probs=100.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++..+..    ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+++.||+.......
T Consensus        81 ~~~~~l~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~  153 (327)
T cd08227          81 MAYGSAKDLICTHFM----DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIN  153 (327)
T ss_pred             cCCCcHHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccc
Confidence            578999999965432    4589999999999999999999998   999999999999999999999999976543221


Q ss_pred             Ccccc-----hhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccc
Q 026160           81 KKSTI-----SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADV  134 (242)
Q Consensus        81 ~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~  134 (242)
                      .....     ......++..|+|||.+.+....++.++|||||||++|++++|..||..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            11000     0011235677999999865434578899999999999999999999964

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.95  E-value=1.9e-28  Score=201.40  Aligned_cols=165  Identities=26%  Similarity=0.333  Sum_probs=123.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      +.+++.++..++.||+.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        78 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  148 (321)
T cd05603          78 VNGGELFFHLQRE------RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE  148 (321)
T ss_pred             CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCC
Confidence            5789998888654      4589999999999999999999998   999999999999999999999999999875322


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....+++.|+|||.+.+.  .++.++|+|||||++|+|++|..||......        .....+... ....
T Consensus       149 ~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~~~-~~~~  215 (321)
T cd05603         149 PEET--TSTFCGTPEYLAPEVLRKE--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS--------QMYDNILHK-PLQL  215 (321)
T ss_pred             CCCc--cccccCCcccCCHHHhcCC--CCCCcCcccccchhhhhhhcCCCCCCCCCHH--------HHHHHHhcC-CCCC
Confidence            2111  1123488999999998653  5788999999999999999999999644311        111111111 1223


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMH  194 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~  194 (242)
                      +...+..+.+++.+       ||+.||.+|+++.
T Consensus       216 ~~~~~~~~~~li~~-------~l~~~p~~R~~~~  242 (321)
T cd05603         216 PGGKTVAACDLLVG-------LLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCHHHHHHHHH-------HccCCHhhcCCCC
Confidence            33445555555555       7899999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.6e-28  Score=200.97  Aligned_cols=172  Identities=21%  Similarity=0.381  Sum_probs=140.0

Q ss_pred             CCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceee-CCCCceEEcccccccccCC
Q 026160            2 PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL-DEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         2 ~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~-~~~~~~~L~dfg~~~~~~~   80 (242)
                      .+|+|+|||-++.     .+++++.+.+.+.||+.|+.|+|+-   .||||||||+|+.+ .+-|.|||.|||++..+..
T Consensus       100 D~GDl~DyImKHe-----~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen  100 DGGDLFDYIMKHE-----EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             CCchHHHHHHhhh-----ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            4789999998876     5799999999999999999999998   99999999999766 5678999999999988776


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....   ...+|...|.|||++.+. ...-++.||||||+++|.+++|++||...+..+-...+         -......
T Consensus       172 G~kL---~TsCGSLAYSAPEILLGD-sYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI---------mDCKYtv  238 (864)
T KOG4717|consen  172 GKKL---TTSCGSLAYSAPEILLGD-SYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI---------MDCKYTV  238 (864)
T ss_pred             cchh---hcccchhhccCchhhhcC-ccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh---------hcccccC
Confidence            5543   345699999999999875 34467899999999999999999999866654322111         1122345


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      +..++.+.++++..|+       ..||.+|.|.+++...-+
T Consensus       239 PshvS~eCrdLI~sML-------vRdPkkRAslEeI~s~~W  272 (864)
T KOG4717|consen  239 PSHVSKECRDLIQSML-------VRDPKKRASLEEIVSTSW  272 (864)
T ss_pred             chhhhHHHHHHHHHHH-------hcCchhhccHHHHhcccc
Confidence            5668888999999876       999999999998876543

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.95  E-value=4.1e-28  Score=195.67  Aligned_cols=176  Identities=25%  Similarity=0.281  Sum_probs=126.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.....    ..+++..+..++.|++.|+.|||+.   +++|+||+|.||+++.++.++|+|||++.....
T Consensus       101 ~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~  173 (282)
T cd06636         101 CGAGSVTDLVKNTKG----NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR  173 (282)
T ss_pred             CCCCcHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence            578899999976432    4588889999999999999999999   999999999999999999999999999875432


Q ss_pred             Ccccchhcccccccccccchhhhcc---cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRS---FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      ....  .....++..|+|||.+...   ...++.++|+||||+++|++++|..||.........       .........
T Consensus       174 ~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~-------~~~~~~~~~  244 (282)
T cd06636         174 TVGR--RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL-------FLIPRNPPP  244 (282)
T ss_pred             cccC--CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-------hhHhhCCCC
Confidence            2111  1123478899999987421   235678899999999999999999999643321110       000000011


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ......++.+       +.+++.+||+.||.+|||+.+++++
T Consensus       245 ~~~~~~~~~~-------~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         245 KLKSKKWSKK-------FIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             CCcccccCHH-------HHHHHHHHhCCChhhCcCHHHHhcC
Confidence            1111223443       4555566999999999999999753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.95  E-value=6e-28  Score=196.23  Aligned_cols=172  Identities=25%  Similarity=0.342  Sum_probs=126.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++..       ..+++.++..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        99 ~~~~~L~~~~~~-------~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~  168 (296)
T cd06654          99 LAGGSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (296)
T ss_pred             cCCCCHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence            578999999854       2488999999999999999999999   999999999999999999999999998875433


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      .....  ....++..|+|||.+.+.  ..+.++|+||||+++|++++|+.||.........      .............
T Consensus       169 ~~~~~--~~~~~~~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~------~~~~~~~~~~~~~  238 (296)
T cd06654         169 EQSKR--STMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL------YLIATNGTPELQN  238 (296)
T ss_pred             ccccc--CcccCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH------HHHhcCCCCCCCC
Confidence            22111  112478899999988653  5678999999999999999999999644321100      0000000001111


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      +..++..       +.+++.+||..||++|||+.++++.
T Consensus       239 ~~~~~~~-------l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         239 PEKLSAI-------FRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             ccccCHH-------HHHHHHHHCcCCcccCcCHHHHhhC
Confidence            2223333       4445566999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.95  E-value=8.7e-28  Score=190.88  Aligned_cols=175  Identities=28%  Similarity=0.481  Sum_probs=129.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++.....    ..+++.++..++.|++.|+.+||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        83 ~~~~~l~~~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       83 MEGGDLLDYLRKNRP----KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             cCCCCHHHHHHhhhh----ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence            478999999876421    2289999999999999999999999   999999999999999999999999999876654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ....... ...++..|++||.+..  ...+.++|+||||+++|++++ |..||.....        ..............
T Consensus       156 ~~~~~~~-~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~  224 (258)
T smart00219      156 DDYYKKK-GGKLPIRWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--------EEVLEYLKKGYRLP  224 (258)
T ss_pred             ccccccc-cCCCcccccChHHhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHhcCCCCC
Confidence            4222111 1236678999998843  367899999999999999998 7777764221        11111122222222


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML  200 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l  200 (242)
                      .+...+.+       +.+++.+||..||++|||+.++++.|
T Consensus       225 ~~~~~~~~-------~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      225 KPENCPPE-------IYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCCcCCHH-------HHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            22233444       44455568999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.95  E-value=2.6e-28  Score=204.72  Aligned_cols=179  Identities=27%  Similarity=0.402  Sum_probs=150.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +|.|.|+.||...+     ..|+.......+.||..||.|||+.   .++||||..+|||++....|||+|||+++...+
T Consensus       472 ~~~GELr~yLq~nk-----~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  472 APLGELREYLQQNK-----DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLED  543 (974)
T ss_pred             ccchhHHHHHHhcc-----ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccc
Confidence            47899999998765     4699999999999999999999999   999999999999999999999999999998877


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ...+..- ..+-++.|++||.+.-  ..++.++|+|-||+.+||++. |..||......+        ....++++...+
T Consensus       544 ~~yYkaS-~~kLPIKWmaPESINf--RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD--------VI~~iEnGeRlP  612 (974)
T KOG4257|consen  544 DAYYKAS-RGKLPIKWMAPESINF--RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD--------VIGHIENGERLP  612 (974)
T ss_pred             cchhhcc-ccccceeecCccccch--hcccchhhHHHHHHHHHHHHHhcCCccccccccc--------eEEEecCCCCCC
Confidence            6654433 3456789999998743  378999999999999999975 899997655432        235678888888


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTE  205 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~  205 (242)
                      .++.+++.+-.+       |.+||++||.+||.+.++...|..+.+
T Consensus       613 ~P~nCPp~LYsl-------mskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  613 CPPNCPPALYSL-------MSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             CCCCCChHHHHH-------HHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            888888876554       445999999999999999998887765

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.95  E-value=3.7e-29  Score=214.02  Aligned_cols=181  Identities=27%  Similarity=0.425  Sum_probs=143.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|+.||.++.     +-++.-+..-+++.|+.|++||-+.   ++|||||..+|||++.+-..|++|||+++...+
T Consensus       712 MENGsLDsFLR~~D-----GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  712 MENGSLDSFLRQND-----GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             hhCCcHHHHHhhcC-----CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeeccc
Confidence            79999999998764     4499999999999999999999999   999999999999999999999999999986644


Q ss_pred             Ccc-cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           81 KKS-TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        81 ~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      ... .+.-.-.+-+++|.|||.+.-  .+++.++|+||||+++||.++ |..||.....        +.....++.+...
T Consensus       784 d~~~~ytt~GGKIPiRWTAPEAIa~--RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN--------QdVIkaIe~gyRL  853 (996)
T KOG0196|consen  784 DPEAAYTTLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--------QDVIKAIEQGYRL  853 (996)
T ss_pred             CCCccccccCCccceeecChhHhhh--cccCchhhccccceEEEEecccCCCcccccch--------HHHHHHHHhccCC
Confidence            331 111111234579999998854  378999999999999999884 8888764432        2233445555554


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      +-+..+       ...+.+||+.||++|..+||.+.+++..|.+++..
T Consensus       854 PpPmDC-------P~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  854 PPPMDC-------PAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             CCCCCC-------cHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence            444444       44566677779999999999999999999998864

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.95  E-value=5.6e-28  Score=194.80  Aligned_cols=186  Identities=23%  Similarity=0.404  Sum_probs=132.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|++++....     ..+++.++..++.|++.||.|||+.   +++|+||+|.||+++.++.++|+|||++.....
T Consensus        90 ~~~~~l~~~l~~~~-----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05038          90 LPSGSLRDYLQRHR-----DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPE  161 (284)
T ss_pred             CCCCCHHHHHHhCc-----cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence            47899999997643     3599999999999999999999998   999999999999999999999999999987653


Q ss_pred             Ccccch-hcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCc-------Ccchhhhcc
Q 026160           81 KKSTIS-MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIY-------FPNSIYKHI  152 (242)
Q Consensus        81 ~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~-------~~~~~~~~~  152 (242)
                      ...... .....++..|.+||.+.+.  ..+.++|+||||+++|++++|..|+...........       .........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTS--KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL  239 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccC--CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence            222111 1111245579999988654  678899999999999999999988754322111100       000011111


Q ss_pred             CCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          153 EPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                      ........+..++       ..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       240 ~~~~~~~~~~~~~-------~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         240 KEGERLPRPPSCP-------DEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HcCCcCCCCccCC-------HHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1111111122222       3456677779999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.95  E-value=1.1e-27  Score=191.82  Aligned_cols=178  Identities=27%  Similarity=0.429  Sum_probs=130.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....     ..+++.++..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        87 ~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          87 MENGSLDAFLRKHD-----GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             CCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            57899999997542     3589999999999999999999999   999999999999999999999999999886554


Q ss_pred             Ccccchh-cccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           81 KKSTISM-LHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        81 ~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      ....... .....+..|++||.+...  .++.++|+||||+++|++++ |..||.......        ...........
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--------~~~~~~~~~~~  228 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--------VIKAIEEGYRL  228 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccC--ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--------HHHHHhCCCcC
Confidence            3221111 111234679999988653  57889999999999999886 999986443211        11111111111


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                      .....+++.+       ..++.+||+.+|++||++.++++.|+++
T Consensus       229 ~~~~~~~~~~-------~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         229 PAPMDCPAAL-------HQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CCCCCCCHHH-------HHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            2222334444       4555569999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.95  E-value=1.3e-28  Score=202.67  Aligned_cols=166  Identities=26%  Similarity=0.326  Sum_probs=124.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      +.+++.++..++.||+.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        78 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~  148 (325)
T cd05604          78 VNGGELFFHLQRE------RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA  148 (325)
T ss_pred             CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCC
Confidence            5789999888654      4599999999999999999999999   999999999999999999999999999864322


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....++..|+|||.+.+.  .++.++|+|||||++|+|++|..||......        ......... ....
T Consensus       149 ~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~~--------~~~~~~~~~-~~~~  215 (325)
T cd05604         149 QSDT--TTTFCGTPEYLAPEVIRKQ--PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA--------EMYDNILHK-PLVL  215 (325)
T ss_pred             CCCC--cccccCChhhCCHHHHcCC--CCCCcCccccccceehhhhcCCCCCCCCCHH--------HHHHHHHcC-CccC
Confidence            2111  1123488999999998653  5678999999999999999999999644321        111111111 1112


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHE  195 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~  195 (242)
                      ....+..+.+++.+       |++.||.+||++.+
T Consensus       216 ~~~~~~~~~~ll~~-------ll~~~p~~R~~~~~  243 (325)
T cd05604         216 RPGASLTAWSILEE-------LLEKDRQRRLGAKE  243 (325)
T ss_pred             CCCCCHHHHHHHHH-------HhccCHHhcCCCCC
Confidence            22345555555555       77999999998863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.95  E-value=5.4e-28  Score=195.46  Aligned_cols=175  Identities=29%  Similarity=0.373  Sum_probs=127.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....    +..+++..+..++.|++.||.|||+.   +++|+||+|.||+++.++.++|+|||++.....
T Consensus        82 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05632          82 MNGGDLKFHIYNMG----NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPE  154 (285)
T ss_pred             ccCccHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCC
Confidence            57899999886542    24699999999999999999999998   999999999999999999999999999876543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....   ....++..|+|||.+.+.  .++.++|+||||+++|++++|..||.........    ........... ...
T Consensus       155 ~~~~---~~~~g~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~----~~~~~~~~~~~-~~~  224 (285)
T cd05632         155 GESI---RGRVGTVGYMAPEVLNNQ--RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR----EEVDRRVLETE-EVY  224 (285)
T ss_pred             CCcc---cCCCCCcCccChHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHHhhhccc-ccc
Confidence            2221   123488999999998653  5788999999999999999999999743321100    11111111111 111


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPS-----MHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps-----~~~ll~~  199 (242)
                      ...++.++       .+++..||+.||++||+     +.+++++
T Consensus       225 ~~~~~~~~-------~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         225 SAKFSEEA-------KSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             CccCCHHH-------HHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            22334444       44555589999999999     6677764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.95  E-value=8.4e-28  Score=190.95  Aligned_cols=174  Identities=29%  Similarity=0.385  Sum_probs=128.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++++|.+++....     ..+++..+..++.|++.|+.|||+.   +++|+||+|.||+++.++.++|+|||++.....
T Consensus        80 ~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~  151 (256)
T cd06612          80 CGAGSVSDIMKITN-----KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD  151 (256)
T ss_pred             CCCCcHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence            46889999986532     4689999999999999999999999   999999999999999999999999999876554


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....++..|.+||.+.+.  ..+.++|+||||+++|++++|..||...........    .  ..........
T Consensus       152 ~~~~--~~~~~~~~~y~~PE~~~~~--~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~----~--~~~~~~~~~~  221 (256)
T cd06612         152 TMAK--RNTVIGTPFWMAPEVIQEI--GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM----I--PNKPPPTLSD  221 (256)
T ss_pred             Cccc--cccccCCccccCHHHHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh----h--ccCCCCCCCc
Confidence            3211  1122367899999998654  678899999999999999999999874432211100    0  0000000111


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      +..++..       +.+++.+||+.||++|||+.+++++
T Consensus       222 ~~~~~~~-------~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         222 PEKWSPE-------FNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             hhhcCHH-------HHHHHHHHHhcChhhCcCHHHHhcC
Confidence            1123333       4455566999999999999999863

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.95  E-value=8.3e-28  Score=193.94  Aligned_cols=176  Identities=24%  Similarity=0.286  Sum_probs=126.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|..++.+..     ..+++..+..++.|+++||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        84 ~~~~~l~~~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  155 (282)
T cd06643          84 CAGGAVDAVMLELE-----RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  155 (282)
T ss_pred             cCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccc
Confidence            46888988876432     4699999999999999999999998   999999999999999999999999999876543


Q ss_pred             Ccccchhcccccccccccchhhhc---ccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhcc-CCCC
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCR---SFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHI-EPGN  156 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~  156 (242)
                      ....  .....++..|++||.+..   ....++.++|+||||+++|++++|..||.......       ...... ....
T Consensus       156 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-------~~~~~~~~~~~  226 (282)
T cd06643         156 TIQR--RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-------VLLKIAKSEPP  226 (282)
T ss_pred             cccc--cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-------HHHHHhhcCCC
Confidence            2221  112347889999998742   12345789999999999999999999986433211       000000 0011


Q ss_pred             ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 026160          157 DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML  200 (242)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l  200 (242)
                      ....+..++.++.+       ++.+||+.||++||++.+++++-
T Consensus       227 ~~~~~~~~~~~~~~-------li~~~l~~~p~~Rp~~~~il~~~  263 (282)
T cd06643         227 TLAQPSRWSSEFKD-------FLKKCLEKNVDARWTTTQLLQHP  263 (282)
T ss_pred             CCCCccccCHHHHH-------HHHHHccCChhhCcCHHHHhcCC
Confidence            11122234444444       44559999999999999987654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.95  E-value=1.7e-28  Score=194.32  Aligned_cols=178  Identities=27%  Similarity=0.328  Sum_probs=129.1

Q ss_pred             CcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCC-CceEEcccccccccCCCcc
Q 026160            5 SLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDED-FCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         5 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~-~~~~L~dfg~~~~~~~~~~   83 (242)
                      +|.++++..  ...+..++.-.+.-...||.+|+.|||+.   +|+||||||.|+|++.+ |.+||||||.+........
T Consensus       107 tL~~~~r~~--~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep  181 (364)
T KOG0658|consen  107 TLYRVIRHY--TRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP  181 (364)
T ss_pred             HHHHHHHHH--hhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence            455555431  12335688888888999999999999998   99999999999999975 8999999999998766655


Q ss_pred             cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcC----------------c--
Q 026160           84 TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYF----------------P--  145 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~----------------~--  145 (242)
                      ...+   ..++.|+|||.+.+. ..++.+.||||.|||+.||+.|++-|-+.+..++...+                +  
T Consensus       182 niSY---icSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y  257 (364)
T KOG0658|consen  182 NISY---ICSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY  257 (364)
T ss_pred             ceeE---EEeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence            4433   378999999999887 57899999999999999999999888665432211000                0  


Q ss_pred             -chhhhccCCCCccc-cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 026160          146 -NSIYKHIEPGNDFQ-LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE  198 (242)
Q Consensus       146 -~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~  198 (242)
                       ......+....... +....+++..+++.+       +|.++|.+|.++.+++.
T Consensus       258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~-------~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSK-------LLQYSPSKRLSALEALA  305 (364)
T ss_pred             ccccCcccccccceeecccCCCHHHHHHHHH-------HhccChhhcCCHHHHhc
Confidence             00001111111111 334456666666666       66999999999999884

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.95  E-value=7.6e-28  Score=192.57  Aligned_cols=172  Identities=30%  Similarity=0.415  Sum_probs=124.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++...      ..++...+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        88 ~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~  158 (266)
T cd06651          88 MPGGSVKDQLKAY------GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  158 (266)
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence            4688999998754      3489999999999999999999998   999999999999999999999999999875432


Q ss_pred             Cccc-chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKST-ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      .... .......++..|+|||.+.+.  ..+.++|+||||+++|++++|+.||......       ..............
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~~  229 (266)
T cd06651         159 ICMSGTGIRSVTGTPYWMSPEVISGE--GYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-------AAIFKIATQPTNPQ  229 (266)
T ss_pred             ccccCCccccCCccccccCHHHhCCC--CCCchhhhHHHHHHHHHHHHCCCCccccchH-------HHHHHHhcCCCCCC
Confidence            1111 111122477889999988653  5688999999999999999999998643211       11111111111122


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE  198 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~  198 (242)
                      ++..+++.+.+++        .||..+|++||++.++++
T Consensus       230 ~~~~~~~~~~~li--------~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         230 LPSHISEHARDFL--------GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CchhcCHHHHHHH--------HHhcCChhhCcCHHHHhc
Confidence            2222333333332        388899999999999976

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.95  E-value=9e-28  Score=200.28  Aligned_cols=107  Identities=29%  Similarity=0.366  Sum_probs=91.5

Q ss_pred             cccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccccch
Q 026160           21 TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPE  100 (242)
Q Consensus        21 ~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE  100 (242)
                      .++...+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.........   ....++..|+|||
T Consensus       119 ~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE  192 (359)
T cd07876         119 ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM---TPYVVTRYYRAPE  192 (359)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCccccccCccC---CCCcccCCCCCch
Confidence            478899999999999999999999   9999999999999999999999999998754332211   1234788999999


Q ss_pred             hhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160          101 VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus       101 ~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      .+.+.  .++.++|||||||++|+|++|..||...
T Consensus       193 ~~~~~--~~~~~~DiwSlG~il~el~tg~~pf~~~  225 (359)
T cd07876         193 VILGM--GYKENVDIWSVGCIMGELVKGSVIFQGT  225 (359)
T ss_pred             hccCC--CCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            98653  6788999999999999999999999744

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=3.6e-28  Score=203.94  Aligned_cols=175  Identities=26%  Similarity=0.403  Sum_probs=125.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      +.+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++....
T Consensus        83 ~~gg~L~~~l~~~------~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~  153 (377)
T cd05629          83 LPGGDLMTMLIKY------DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK  153 (377)
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence            5799999999764      4589999999999999999999999   999999999999999999999999999863321


Q ss_pred             Ccccc---------------------------------------------hhcccccccccccchhhhcccCCCCCCccc
Q 026160           81 KKSTI---------------------------------------------SMLHARGTIGYIAPEVFCRSFGGASHKSDV  115 (242)
Q Consensus        81 ~~~~~---------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di  115 (242)
                      .....                                             ......|++.|+|||.+.+.  .++.++||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di  231 (377)
T cd05629         154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ--GYGQECDW  231 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC--CCCCceee
Confidence            10000                                             00012488999999998654  57889999


Q ss_pred             hhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCC---CC
Q 026160          116 YSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDR---PS  192 (242)
Q Consensus       116 ~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~R---ps  192 (242)
                      |||||++|+|++|..||........   + ..+.. ............++.++.+++.+|       +. +|.+|   ++
T Consensus       232 wSlGvil~elltG~~Pf~~~~~~~~---~-~~i~~-~~~~~~~p~~~~~s~~~~dli~~l-------L~-~~~~r~~r~~  298 (377)
T cd05629         232 WSLGAIMFECLIGWPPFCSENSHET---Y-RKIIN-WRETLYFPDDIHLSVEAEDLIRRL-------IT-NAENRLGRGG  298 (377)
T ss_pred             EecchhhhhhhcCCCCCCCCCHHHH---H-HHHHc-cCCccCCCCCCCCCHHHHHHHHHH-------hc-CHhhcCCCCC
Confidence            9999999999999999964332110   0 00000 001111111123566777777774       46 56654   69


Q ss_pred             HHHHHHH
Q 026160          193 MHEVLEM  199 (242)
Q Consensus       193 ~~~ll~~  199 (242)
                      +.+++.+
T Consensus       299 ~~~~l~h  305 (377)
T cd05629         299 AHEIKSH  305 (377)
T ss_pred             HHHHhcC
Confidence            9999876

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.95  E-value=6.5e-28  Score=199.10  Aligned_cols=181  Identities=23%  Similarity=0.285  Sum_probs=130.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.+..     ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        83 ~~~g~L~~~l~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          83 YVGGDLLTLLSKFE-----DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             cCCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            57999999997632     3589999999999999999999998   999999999999999999999999999865432


Q ss_pred             Ccccchhcccccccccccchhhhcc---cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRS---FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      ..... .....|+..|+|||++...   ...++.++|+|||||++|+|++|+.||.........    ..+.........
T Consensus       155 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~----~~i~~~~~~~~~  229 (332)
T cd05623         155 DGTVQ-SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY----GKIMNHKERFQF  229 (332)
T ss_pred             CCcce-ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHH----HHHhCCCccccC
Confidence            22111 1123589999999988531   235688999999999999999999999644321100    001001011111


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ......+++++.+++.+|+     |...++..|+++.+++++
T Consensus       230 p~~~~~~s~~~~~li~~ll-----~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         230 PAQVTDVSEDAKDLIRRLI-----CSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CCccccCCHHHHHHHHHHc-----cChhhhcCCCCHHHHhCC
Confidence            1112346777888887766     555566668999999877

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.95  E-value=1.1e-27  Score=192.95  Aligned_cols=172  Identities=28%  Similarity=0.371  Sum_probs=130.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.+++...      +.+++.++..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        79 ~~g~~L~~~l~~~------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~  149 (278)
T cd05606          79 MNGGDLHYHLSQH------GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK  149 (278)
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCc
Confidence            5789999988654      4599999999999999999999998   999999999999999999999999999875543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....    ...++..|++||.+.+. ..++.++|+||+|+++|++++|..||.........     ... .........+
T Consensus       150 ~~~~----~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~-----~~~-~~~~~~~~~~  218 (278)
T cd05606         150 KKPH----ASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-----EID-RMTLTMAVEL  218 (278)
T ss_pred             cCCc----CcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH-----HHH-HHhhccCCCC
Confidence            2221    23488999999998643 24678899999999999999999999754322111     000 1111112223


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRP-----SMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp-----s~~~ll~~  199 (242)
                      +..++.++.+++.+       ||..||++||     ++.+++++
T Consensus       219 ~~~~s~~~~~li~~-------~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         219 PDSFSPELRSLLEG-------LLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             CCcCCHHHHHHHHH-------HhhcCHHhccCCCCCCHHHHHhC
Confidence            34456666666666       7799999999     99999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.95  E-value=9.6e-28  Score=193.38  Aligned_cols=173  Identities=27%  Similarity=0.415  Sum_probs=123.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|..+.          .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        81 ~~~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~  147 (279)
T cd06619          81 MDGGSLDVYR----------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN  147 (279)
T ss_pred             CCCCChHHhh----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence            4566665432          378889999999999999999999   999999999999999999999999999876543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....    ...++..|+|||.+.+.  ..+.++|+||||+++|++++|+.||............ ...............
T Consensus       148 ~~~~----~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~  220 (279)
T cd06619         148 SIAK----TYVGTNAYMAPERISGE--QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP-LQLLQCIVDEDPPVL  220 (279)
T ss_pred             cccc----CCCCChhhcCceeecCC--CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch-HHHHHHHhccCCCCC
Confidence            3211    22478899999988654  5788999999999999999999999754322211111 111111111111111


Q ss_pred             -ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 026160          161 -DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML  200 (242)
Q Consensus       161 -~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l  200 (242)
                       ....++++       .+++.+||+.||++||++.+++++-
T Consensus       221 ~~~~~~~~~-------~~li~~~l~~~P~~Rp~~~eil~~~  254 (279)
T cd06619         221 PVGQFSEKF-------VHFITQCMRKQPKERPAPENLMDHP  254 (279)
T ss_pred             CCCcCCHHH-------HHHHHHHhhCChhhCCCHHHHhcCc
Confidence             11233444       4455558899999999999998763

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.95  E-value=9.6e-28  Score=191.99  Aligned_cols=177  Identities=23%  Similarity=0.259  Sum_probs=126.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++...      +.+++.++..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        88 ~~~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06645          88 CGGGSLQDIYHVT------GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITA  158 (267)
T ss_pred             cCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence            5789999998654      4599999999999999999999999   999999999999999999999999999875543


Q ss_pred             Ccccchhcccccccccccchhhhc-ccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCR-SFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ....  .....++..|+|||.+.. ....++.++|+||||+++|++++|..||..........   ......... ....
T Consensus       159 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~---~~~~~~~~~-~~~~  232 (267)
T cd06645         159 TIAK--RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LMTKSNFQP-PKLK  232 (267)
T ss_pred             cccc--cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH---hhhccCCCC-Cccc
Confidence            2211  112347889999998742 12346789999999999999999999985433211000   000000000 0000


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ....++..+       .+++.+||+.||++|||+.+++++
T Consensus       233 ~~~~~~~~~-------~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         233 DKMKWSNSF-------HHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             ccCCCCHHH-------HHHHHHHccCCchhCcCHHHHhcC
Confidence            011233344       445555889999999999998864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.8e-28  Score=197.77  Aligned_cols=170  Identities=30%  Similarity=0.445  Sum_probs=135.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |.||+|.-+|+...    ++++++..+...+.+|+.||++||..   +||+|||||+|||+|..|.++++|+|+++.+..
T Consensus       267 MNGGDLkfHiyn~g----~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  267 MNGGDLKFHIYNHG----NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             ecCCceeEEeeccC----CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            78999999999874    38999999999999999999999999   999999999999999999999999999998877


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ......   ..||..|+|||++.+.  .++.+.|-|||||++|||+.|..||.........    ....+.+. ......
T Consensus       340 g~~~~~---rvGT~GYMAPEvl~ne--~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~----eEvdrr~~-~~~~ey  409 (591)
T KOG0986|consen  340 GKPIRG---RVGTVGYMAPEVLQNE--VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR----EEVDRRTL-EDPEEY  409 (591)
T ss_pred             CCcccc---ccCcccccCHHHHcCC--cccCCccHHHHHhHHHHHHcccCchhhhhhhhhH----HHHHHHHh-cchhhc
Confidence            655432   3599999999999775  5899999999999999999999999755543211    11111111 112223


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMH  194 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~  194 (242)
                      +...+++++++.+.++       ..||++|.-.+
T Consensus       410 ~~kFS~eakslc~~LL-------~Kdp~~RLGcr  436 (591)
T KOG0986|consen  410 SDKFSEEAKSLCEGLL-------TKDPEKRLGCR  436 (591)
T ss_pred             ccccCHHHHHHHHHHH-------ccCHHHhccCC
Confidence            3556777777666644       99999996433

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.95  E-value=3.6e-28  Score=201.42  Aligned_cols=116  Identities=29%  Similarity=0.424  Sum_probs=98.5

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      +++|.+++..       ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus       103 ~~~l~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  172 (343)
T cd07878         103 GADLNNIVKC-------QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM  172 (343)
T ss_pred             CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccceecCCCc
Confidence            5677776643       3599999999999999999999999   99999999999999999999999999988654432


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccc
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADV  134 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~  134 (242)
                      .     ...++..|+|||.+.+. ..++.++|||||||++|+|++|..||..
T Consensus       173 ~-----~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~  218 (343)
T cd07878         173 T-----GYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPG  218 (343)
T ss_pred             C-----CccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            1     22478999999988653 3568899999999999999999999864

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.95  E-value=1.3e-27  Score=215.09  Aligned_cols=178  Identities=23%  Similarity=0.332  Sum_probs=127.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCC----CCeeecCCCCCceeeCC-------------
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCN----VRIVHFDIKPHNILLDE-------------   63 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~----~~i~h~dlk~~nil~~~-------------   63 (242)
                      |++|+|.++|.....  ....+++..++.++.||+.||.|||+...    .+|+|+||||.|||++.             
T Consensus        96 ~~gGSL~~lL~k~~~--~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~  173 (1021)
T PTZ00266         96 CDAGDLSRNIQKCYK--MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQAN  173 (1021)
T ss_pred             CCCCcHHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccc
Confidence            578999999975321  22469999999999999999999998521    25999999999999953             


Q ss_pred             ----CCceEEcccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCC
Q 026160           64 ----DFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRS  139 (242)
Q Consensus        64 ----~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~  139 (242)
                          ...++|+|||++.........   ....+++.|+|||++......++.++|||||||++|+|++|..||...... 
T Consensus       174 n~ng~~iVKLsDFGlAr~l~~~s~~---~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~-  249 (1021)
T PTZ00266        174 NLNGRPIAKIGDFGLSKNIGIESMA---HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF-  249 (1021)
T ss_pred             ccCCCCceEEccCCccccccccccc---cccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH-
Confidence                234899999998765433221   123589999999998665456788999999999999999999999643221 


Q ss_pred             CCCcCcchhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 026160          140 SDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE  198 (242)
Q Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~  198 (242)
                            ......+........ ...+.++.       +|+..||+.+|.+||++.+++.
T Consensus       250 ------~qli~~lk~~p~lpi-~~~S~eL~-------dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        250 ------SQLISELKRGPDLPI-KGKSKELN-------ILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             ------HHHHHHHhcCCCCCc-CCCCHHHH-------HHHHHHhcCChhHCcCHHHHhc
Confidence                  111111111111111 12344444       4555588999999999999985

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.95  E-value=1.4e-27  Score=189.84  Aligned_cols=174  Identities=27%  Similarity=0.354  Sum_probs=129.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.+..    ...+++.++..++.|++.++.|||+.   +++|+||+|.||+++.++.++|+|||++.....
T Consensus        81 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~  153 (256)
T cd08221          81 ANGGTLYDKIVRQK----GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGS  153 (256)
T ss_pred             cCCCcHHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccc
Confidence            57899999997642    25689999999999999999999998   999999999999999999999999999876544


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ...  ......++..|.+||.+.+.  ..+.++|+||||+++|++++|..||......       ... .....+.....
T Consensus       154 ~~~--~~~~~~~~~~y~ape~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-------~~~-~~~~~~~~~~~  221 (256)
T cd08221         154 EYS--MAETVVGTPYYMSPELCQGV--KYNFKSDIWALGCVLYELLTLKRTFDATNPL-------NLV-VKIVQGNYTPV  221 (256)
T ss_pred             ccc--cccccCCCccccCHhhcCCC--CCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-------HHH-HHHHcCCCCCC
Confidence            331  11223478899999987654  4678899999999999999999998643321       111 11111111111


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML  200 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l  200 (242)
                      ...++.+       +.+++.+||+.+|++|||+.++++.+
T Consensus       222 ~~~~~~~-------~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         222 VSVYSSE-------LISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ccccCHH-------HHHHHHHHcccCcccCCCHHHHhhCc
Confidence            1223333       44555569999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.95  E-value=1.3e-27  Score=193.14  Aligned_cols=178  Identities=21%  Similarity=0.299  Sum_probs=128.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....  .....+++..+..++.|+++|+.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus       102 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  176 (286)
T cd06638         102 CNGGSVTDLVKGFL--KRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS  176 (286)
T ss_pred             cCCCCHHHHHHHhh--ccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeeccc
Confidence            57899999886432  1235689999999999999999999998   999999999999999999999999999876543


Q ss_pred             Ccccchhcccccccccccchhhhcc---cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCC-
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRS---FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN-  156 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  156 (242)
                      ....  .....++..|+|||.+...   ...++.++|+||||+++|++++|+.||........       .. ...... 
T Consensus       177 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-------~~-~~~~~~~  246 (286)
T cd06638         177 TRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-------LF-KIPRNPP  246 (286)
T ss_pred             CCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-------Hh-hccccCC
Confidence            2211  1123488899999987432   23468899999999999999999999864332110       00 000010 


Q ss_pred             -ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 026160          157 -DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML  200 (242)
Q Consensus       157 -~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l  200 (242)
                       ....+..++..       +..++.+||+.||++|||+.+++++.
T Consensus       247 ~~~~~~~~~~~~-------~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         247 PTLHQPELWSNE-------FNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             CcccCCCCcCHH-------HHHHHHHHccCCcccCCCHHHHhhcc
Confidence             01111223333       44555669999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=2.4e-28  Score=203.58  Aligned_cols=117  Identities=29%  Similarity=0.420  Sum_probs=96.6

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      .|+|.+++...     .+.+++.++..++.||+.||.|||+.   +|+|+||||+||+++.++.++|+|||++.......
T Consensus       140 ~~~l~~~l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  211 (357)
T PHA03209        140 SSDLYTYLTKR-----SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP  211 (357)
T ss_pred             CCcHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence            46788887543     25699999999999999999999999   99999999999999999999999999987533222


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCc
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNA  132 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~  132 (242)
                      ...   ...++..|+|||.+.+.  .++.++|+|||||++|+++++..++
T Consensus       212 ~~~---~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        212 AFL---GLAGTVETNAPEVLARD--KYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ccc---cccccccccCCeecCCC--CCCchhhHHHHHHHHHHHHHcCCcc
Confidence            111   23488999999998653  5788999999999999999866554

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=3.6e-28  Score=203.03  Aligned_cols=175  Identities=26%  Similarity=0.369  Sum_probs=126.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      +.+++..+..++.|++.||.|||+.   +++|+||||+|||++.++.++|+|||++.....
T Consensus        83 ~~~g~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          83 LPGGDMMTLLMKK------DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             CCCcHHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            5799999999764      4599999999999999999999999   999999999999999999999999999865432


Q ss_pred             Ccccc------------------------------------hhcccccccccccchhhhcccCCCCCCccchhHHHHHHH
Q 026160           81 KKSTI------------------------------------SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILE  124 (242)
Q Consensus        81 ~~~~~------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~  124 (242)
                      .....                                    ......||+.|+|||++...  .++.++|||||||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~e  231 (364)
T cd05599         154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT--GYNKECDWWSLGVIMYE  231 (364)
T ss_pred             cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC--CCCCeeeeecchhHHHH
Confidence            11000                                    00112489999999988653  67889999999999999


Q ss_pred             HHhcCCCccccccCCCCCcCcchhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCC---HHHHHHH
Q 026160          125 MAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPS---MHEVLEM  199 (242)
Q Consensus       125 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps---~~~ll~~  199 (242)
                      |++|..||.........    ..+ ..............+++++.+++.+       |+. +|.+|++   +.+++++
T Consensus       232 l~~G~~Pf~~~~~~~~~----~~i-~~~~~~~~~~~~~~~s~~~~~li~~-------ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         232 MLVGYPPFCSDNPQETY----RKI-INWKETLQFPDEVPLSPEAKDLIKR-------LCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             hhcCCCCCCCCCHHHHH----HHH-HcCCCccCCCCCCCCCHHHHHHHHH-------Hcc-CHhhcCCCCCHHHHhcC
Confidence            99999999644321100    000 0001111111112356666666666       555 8999998   9888874

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.95  E-value=5.3e-28  Score=185.09  Aligned_cols=161  Identities=26%  Similarity=0.412  Sum_probs=124.7

Q ss_pred             ccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccccc
Q 026160           20 RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAP   99 (242)
Q Consensus        20 ~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~P   99 (242)
                      +++++..+=++...+++||.||-.++  +|+|||+||+|||++..|++||||||++.+..+.....   +..|-+.|++|
T Consensus       186 ~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAht---rsAGC~~YMaP  260 (391)
T KOG0983|consen  186 GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHT---RSAGCAAYMAP  260 (391)
T ss_pred             CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccccc---cccCCccccCc
Confidence            56888888899999999999999885  99999999999999999999999999998776655443   23477899999


Q ss_pred             hhhhcc-cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccccc--ccchHHHHHHHHHH
Q 026160          100 EVFCRS-FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDG--VVTEEEKELVKKMI  176 (242)
Q Consensus       100 E~~~~~-~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  176 (242)
                      |.+... ...+..++|+||||+.++|+.||+.||.......       .....+.+...+.++.  ..++.+.+++..  
T Consensus       261 ERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF-------e~ltkvln~ePP~L~~~~gFSp~F~~fv~~--  331 (391)
T KOG0983|consen  261 ERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF-------EVLTKVLNEEPPLLPGHMGFSPDFQSFVKD--  331 (391)
T ss_pred             cccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH-------HHHHHHHhcCCCCCCcccCcCHHHHHHHHH--
Confidence            998544 4578899999999999999999999997654422       1112222222233322  245555555554  


Q ss_pred             HHHHHhccCCCCCCCCHHHHHHH
Q 026160          177 LVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       177 ~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                           ||.+|+.+||...+++++
T Consensus       332 -----CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  332 -----CLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             -----HhhcCcccCcchHHHhcC
Confidence                 999999999999999875

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.95  E-value=9.4e-28  Score=200.51  Aligned_cols=107  Identities=30%  Similarity=0.362  Sum_probs=92.1

Q ss_pred             cccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccccch
Q 026160           21 TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPE  100 (242)
Q Consensus        21 ~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE  100 (242)
                      .++...+..++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++.........   ....++..|+|||
T Consensus       122 ~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~---~~~~~t~~y~aPE  195 (364)
T cd07875         122 ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPE  195 (364)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccccCCCCcc---cCCcccCCcCCHH
Confidence            378889999999999999999999   9999999999999999999999999999765443221   1234789999999


Q ss_pred             hhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160          101 VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus       101 ~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      .+.+.  .++.++|||||||++|+|++|+.||...
T Consensus       196 ~~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~  228 (364)
T cd07875         196 VILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGT  228 (364)
T ss_pred             HHhCC--CCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence            98654  6788999999999999999999999643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.95  E-value=6.4e-29  Score=197.72  Aligned_cols=178  Identities=30%  Similarity=0.408  Sum_probs=127.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.++|...      +.+++.++..++.|+++||.+||+.   +++|+||||+||+++.++.++|+|||.+.....
T Consensus        80 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~  150 (260)
T PF00069_consen   80 CPGGSLQDYLQKN------KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE  150 (260)
T ss_dssp             ETTEBHHHHHHHH------SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS
T ss_pred             ccccccccccccc------ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence            4567999999843      4699999999999999999999999   999999999999999999999999999875421


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....++..|.|||.+.. ....+.++|+||||+++|+|++|..||.........    ...............
T Consensus       151 ~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~----~~~~~~~~~~~~~~~  223 (260)
T PF00069_consen  151 NNEN--FNPFVGTPEYMAPEVLQQ-GKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQL----EIIEKILKRPLPSSS  223 (260)
T ss_dssp             TTSE--BSSSSSSGGGSCHHHHTT-TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHH----HHHHHHHHTHHHHHT
T ss_pred             cccc--cccccccccccccccccc-cccccccccccccccccccccccccccccccchhhh----hhhhhcccccccccc
Confidence            1111  112347889999999861 136789999999999999999999998755111100    000000000000000


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .  .   .......+.+++.+||+.||++|||+.+++++
T Consensus       224 ~--~---~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  224 Q--Q---SREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             T--S---HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             c--c---cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0  0   00001566677777999999999999999863

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.95  E-value=1.4e-27  Score=189.70  Aligned_cols=172  Identities=26%  Similarity=0.423  Sum_probs=127.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCC-CceEEcccccccccC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDED-FCPKISDFGLAKQSQ   79 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~-~~~~L~dfg~~~~~~   79 (242)
                      +++|+|.+++.+..    ...+++..+..++.++++++.|||++   +++|+||+|.||+++.+ +.++|+|||++....
T Consensus        81 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~  153 (256)
T cd08220          81 APGGTLAEYIQKRC----NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILS  153 (256)
T ss_pred             CCCCCHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecC
Confidence            47899999997643    24589999999999999999999999   99999999999999864 457999999988665


Q ss_pred             CCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           80 DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        80 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ......   ...++..|+|||.+.+.  ..+.++|+||||+++|++++|..||......       ... ..........
T Consensus       154 ~~~~~~---~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-------~~~-~~~~~~~~~~  220 (256)
T cd08220         154 SKSKAY---TVVGTPCYISPELCEGK--PYNQKSDIWALGCVLYELASLKRAFEAANLP-------ALV-LKIMSGTFAP  220 (256)
T ss_pred             CCcccc---ccccCCcccCchhccCC--CCCcccchHHHHHHHHHHHhCCCCcccCchH-------HHH-HHHHhcCCCC
Confidence            433221   12478899999988653  5678999999999999999999998643321       111 1111111122


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .+..++..+.+++       .+||+.||++|||+.+++.+
T Consensus       221 ~~~~~~~~l~~li-------~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         221 ISDRYSPDLRQLI-------LSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             CCCCcCHHHHHHH-------HHHccCChhhCCCHHHHhhC
Confidence            2333455555444       44899999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.95  E-value=1.2e-27  Score=199.19  Aligned_cols=107  Identities=29%  Similarity=0.357  Sum_probs=92.2

Q ss_pred             cccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccccch
Q 026160           21 TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPE  100 (242)
Q Consensus        21 ~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE  100 (242)
                      .++..++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.........   ....++..|+|||
T Consensus       115 ~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE  188 (355)
T cd07874         115 ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPE  188 (355)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccCCCcccc---CCccccCCccCHH
Confidence            478899999999999999999999   9999999999999999999999999999765443221   1234789999999


Q ss_pred             hhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160          101 VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus       101 ~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      .+.+.  .++.++|+|||||++|+|++|+.||...
T Consensus       189 ~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~  221 (355)
T cd07874         189 VILGM--GYKENVDIWSVGCIMGEMVRHKILFPGR  221 (355)
T ss_pred             HHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            98654  5788999999999999999999999643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=7.4e-28  Score=198.67  Aligned_cols=181  Identities=24%  Similarity=0.283  Sum_probs=131.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.+..     ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        83 ~~g~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          83 YVGGDLLTLLSKFE-----DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             CCCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            57999999996532     4589999999999999999999999   999999999999999999999999999876543


Q ss_pred             Ccccchhcccccccccccchhhhcc---cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRS---FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      ..... .....++..|+|||.+...   ...++.++|+|||||++|+|++|..||........    ...+.........
T Consensus       155 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~----~~~i~~~~~~~~~  229 (331)
T cd05597         155 DGTVQ-SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET----YGKIMNHKEHFQF  229 (331)
T ss_pred             CCCcc-ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH----HHHHHcCCCcccC
Confidence            32211 1113489999999998632   23467899999999999999999999964332110    0001111111111


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ......+++.+.+++.+|+     |...++..|+++.+++++
T Consensus       230 ~~~~~~~~~~~~~li~~ll-----~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         230 PPDVTDVSEEAKDLIRRLI-----CSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             CCccCCCCHHHHHHHHHHc-----cCcccccCCCCHHHHhcC
Confidence            1122336777888888866     656666668999999987

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.95  E-value=1.8e-27  Score=189.23  Aligned_cols=175  Identities=25%  Similarity=0.447  Sum_probs=128.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....     ..++++.+..++.+++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  152 (256)
T cd05112          81 MEHGCLSDYLRAQR-----GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD  152 (256)
T ss_pred             CCCCcHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeeccc
Confidence            46899999986532     3588999999999999999999998   999999999999999999999999998875543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ..... .....++..|++||.+.+.  .++.++|+||||+++|++++ |..||......        ........+....
T Consensus       153 ~~~~~-~~~~~~~~~~~aPe~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~  221 (256)
T cd05112         153 DQYTS-STGTKFPVKWSSPEVFSFS--KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--------EVVETINAGFRLY  221 (256)
T ss_pred             Ccccc-cCCCccchhhcCHhHhccC--CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--------HHHHHHhCCCCCC
Confidence            22111 1112245689999987643  57789999999999999998 88888643211        1111111111111


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      .+...+       ..+.+++.+||+.+|++|||+.++++.|.
T Consensus       222 ~~~~~~-------~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         222 KPRLAS-------QSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             CCCCCC-------HHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            122223       34556677799999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.95  E-value=1.1e-27  Score=191.47  Aligned_cols=174  Identities=27%  Similarity=0.379  Sum_probs=127.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|++++.+.      ..+++..+..++.|++.|+.|||+.   +++|+||+|.||+++.++.++|+|||++.....
T Consensus        84 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          84 VPGGSISSILNRF------GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            5789999999764      3589999999999999999999998   999999999999999999999999998875432


Q ss_pred             Ccc----cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCC
Q 026160           81 KKS----TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN  156 (242)
Q Consensus        81 ~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  156 (242)
                      ...    ........++..|.|||.+.+.  ..+.++|+||||+++|++++|..||.......      ...........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~~~~~  226 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINES--GYGRKSDIWSIGCTVFEMATGKPPLASMDRLA------AMFYIGAHRGL  226 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCC--CCcchhhHHHHHHHHHHHHhCCCccccCChHH------HHHHhhhccCC
Confidence            111    0011122478899999988653  56789999999999999999999996433211      00000011111


Q ss_pred             ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 026160          157 DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE  198 (242)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~  198 (242)
                      ....+..++.++.+++       .+||+.+|++||++.++++
T Consensus       227 ~~~~~~~~~~~~~~~i-------~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         227 MPRLPDSFSAAAIDFV-------TSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCCCCCCCCHHHHHHH-------HHHhcCCcccCCCHHHHhc
Confidence            2223334455554444       4588999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.95  E-value=1.1e-27  Score=190.85  Aligned_cols=175  Identities=26%  Similarity=0.344  Sum_probs=132.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhh-----hCCCCCeeecCCCCCceeeCCCCceEEcccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLH-----RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLA   75 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH-----~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~   75 (242)
                      +++|+|.+++....  .....+++.+++.++.+++.|+.|||     +.   +++|+||+|+||+++.++.++|+|||++
T Consensus        83 ~~~~~L~~~l~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          83 CEGGDLAQLIQKCK--KERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             ccCCCHHHHHHHHh--hcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence            47899999987542  23457999999999999999999999     66   9999999999999999999999999998


Q ss_pred             cccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCC
Q 026160           76 KQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPG  155 (242)
Q Consensus        76 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  155 (242)
                      ..........  ....++..|.+||.+...  ..+.++|+||||+++|++++|..||.....        .........+
T Consensus       158 ~~~~~~~~~~--~~~~~~~~~~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~  225 (265)
T cd08217         158 KILGHDSSFA--KTYVGTPYYMSPEQLNHM--SYDEKSDIWSLGCLIYELCALSPPFTARNQ--------LQLASKIKEG  225 (265)
T ss_pred             ccccCCcccc--cccccCCCccChhhhcCC--CCCchhHHHHHHHHHHHHHHCCCcccCcCH--------HHHHHHHhcC
Confidence            8665443211  123478899999988653  468899999999999999999999875431        1112222222


Q ss_pred             CccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          156 NDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .....+...+..+.       +++.+||+.+|++||++.+++++
T Consensus       226 ~~~~~~~~~~~~~~-------~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         226 KFRRIPYRYSSELN-------EVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             CCCCCccccCHHHH-------HHHHHHccCCcccCCCHHHHhhC
Confidence            22233334444444       44555889999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=9.5e-28  Score=192.70  Aligned_cols=171  Identities=24%  Similarity=0.384  Sum_probs=137.8

Q ss_pred             CCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCC
Q 026160            2 PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDK   81 (242)
Q Consensus         2 ~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~   81 (242)
                      .+|.|+|||....      .|++.++..+++||+.|+.|+|.+   +|+|+|||.+|||++.++++|++|||++..+...
T Consensus       136 S~GeLYDYiSer~------~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  136 SGGELYDYISERG------SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             CCccHHHHHHHhc------cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            4899999999874      599999999999999999999999   9999999999999999999999999999877654


Q ss_pred             cccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccccc
Q 026160           82 KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLD  161 (242)
Q Consensus        82 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (242)
                      ..   ..+++|++.|.+||+..+. +.-....|.||||+++|.++.|.-||+..+.        ....+.+..+...  .
T Consensus       207 kf---LqTFCGSPLYASPEIvNG~-PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh--------k~lvrQIs~GaYr--E  272 (668)
T KOG0611|consen  207 KF---LQTFCGSPLYASPEIVNGT-PYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH--------KRLVRQISRGAYR--E  272 (668)
T ss_pred             cH---HHHhcCCcccCCccccCCC-CCCCCccchhhHHHHHHHHhhcccccCCchH--------HHHHHHhhccccc--C
Confidence            43   3356799999999999775 3446789999999999999999999987663        2222333333221  1


Q ss_pred             cccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 026160          162 GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES  202 (242)
Q Consensus       162 ~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~  202 (242)
                      +..+.....+++-       +|..||++|.|+.++..+.+-
T Consensus       273 P~~PSdA~gLIRw-------mLmVNP~RRATieDiAsHWWv  306 (668)
T KOG0611|consen  273 PETPSDASGLIRW-------MLMVNPERRATIEDIASHWWV  306 (668)
T ss_pred             CCCCchHHHHHHH-------HHhcCcccchhHHHHhhhhee
Confidence            2234455666665       448999999999999988764

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.95  E-value=1e-27  Score=194.83  Aligned_cols=172  Identities=25%  Similarity=0.361  Sum_probs=126.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++..       ..+++.++..++.+++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        98 ~~~~~L~~~~~~-------~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~  167 (296)
T cd06655          98 LAGGSLTDVVTE-------TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP  167 (296)
T ss_pred             cCCCcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence            478999998854       3589999999999999999999999   999999999999999999999999998875443


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      .....  ....++..|+|||.+.+.  ..+.++|+||||+++|++++|..||.........    ...  ..........
T Consensus       168 ~~~~~--~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~----~~~--~~~~~~~~~~  237 (296)
T cd06655         168 EQSKR--STMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL----YLI--ATNGTPELQN  237 (296)
T ss_pred             ccccC--CCcCCCccccCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHH--HhcCCcccCC
Confidence            22111  122477899999987653  5688999999999999999999999654321100    000  0001111112


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      +..+++.+.+       ++.+||..||++|||+.+++++
T Consensus       238 ~~~~~~~~~~-------li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         238 PEKLSPIFRD-------FLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             cccCCHHHHH-------HHHHHhhcChhhCCCHHHHhhC
Confidence            2234444444       4555999999999999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.95  E-value=1.6e-27  Score=191.22  Aligned_cols=176  Identities=29%  Similarity=0.434  Sum_probs=127.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++.+.      ..++...+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        90 ~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  160 (272)
T cd06629          90 VPGGSIGSCLRTY------GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDD  160 (272)
T ss_pred             CCCCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence            4789999998765      4689999999999999999999998   999999999999999999999999999876543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccc-
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ-  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  159 (242)
                      ...........++..|.+||.+......++.++|+||||+++|++++|..||.......       ............. 
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~  233 (272)
T cd06629         161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-------AMFKLGNKRSAPPI  233 (272)
T ss_pred             cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-------HHHHhhccccCCcC
Confidence            22211112234778999999886543346889999999999999999999985322210       0000000111111 


Q ss_pred             ---cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          160 ---LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       160 ---~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                         ....++.++.+       ++.+||+.||++|||+.+++++
T Consensus       234 ~~~~~~~~~~~~~~-------li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         234 PPDVSMNLSPVALD-------FLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             CccccccCCHHHHH-------HHHHHhcCChhhCCCHHHHhhC
Confidence               11123444444       4455889999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.95  E-value=9.2e-28  Score=200.82  Aligned_cols=174  Identities=23%  Similarity=0.337  Sum_probs=127.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...       .+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.++|+|||++.....
T Consensus       125 ~~gg~L~~~l~~~-------~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~  194 (370)
T cd05621         125 MPGGDLVNLMSNY-------DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE  194 (370)
T ss_pred             CCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence            5799999999643       488999999999999999999999   999999999999999999999999999986543


Q ss_pred             Ccccchhcccccccccccchhhhccc--CCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSF--GGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      .... ......|+..|+|||.+....  ..++.++|+|||||++|+|++|..||......       .............
T Consensus       195 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-------~~~~~i~~~~~~~  266 (370)
T cd05621         195 TGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-------GTYSKIMDHKNSL  266 (370)
T ss_pred             CCce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCccc
Confidence            3221 112345899999999986532  23678999999999999999999999744321       1111111111111


Q ss_pred             ccc--cccchHHHHHHHHHHHHHHHhccCCCC--CCCCHHHHHHH
Q 026160          159 QLD--GVVTEEEKELVKKMILVSLWCIQTNPS--DRPSMHEVLEM  199 (242)
Q Consensus       159 ~~~--~~~~~~~~~~~~~~~~l~~~cl~~dp~--~Rps~~~ll~~  199 (242)
                      ..+  ..++..+++++..       |+..++.  .|+++.+++++
T Consensus       267 ~~p~~~~~s~~~~~li~~-------~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         267 NFPEDVEISKHAKNLICA-------FLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CCCCcccCCHHHHHHHHH-------HccCchhccCCCCHHHHhcC
Confidence            111  2346666666666       4454443  48999999987

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.95  E-value=6.8e-28  Score=197.54  Aligned_cols=129  Identities=22%  Similarity=0.292  Sum_probs=98.7

Q ss_pred             CCCcchhccccCC---CCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceee----CCCCceEEcccccc
Q 026160            3 NGSLDQFTYDQES---SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL----DEDFCPKISDFGLA   75 (242)
Q Consensus         3 ~GsL~~~l~~~~~---~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~----~~~~~~~L~dfg~~   75 (242)
                      +|+|.+++.....   ......+++..+..++.|++.||.|||+.   +++|+||||+||++    +.++.++|+|||++
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            3566666543211   11234588999999999999999999999   99999999999999    45678999999999


Q ss_pred             cccCCCcccc-hhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           76 KQSQDKKSTI-SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        76 ~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      .......... ......++..|+|||.+.+. ..++.++|||||||++|++++|..||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            8654432211 11223478899999988653 34688999999999999999999998644

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.95  E-value=2.1e-27  Score=190.18  Aligned_cols=176  Identities=30%  Similarity=0.417  Sum_probs=126.0

Q ss_pred             CCCCCcchhccccCCCCCCccc--cHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC-CCceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTL--EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE-DFCPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l--~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~-~~~~~L~dfg~~~~   77 (242)
                      +++|+|.+++....     ..+  +...+..++.|++.|+.|||+.   +++|+||+|+||+++. ++.++|+|||++..
T Consensus        87 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~  158 (268)
T cd06624          87 VPGGSLSALLRSKW-----GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR  158 (268)
T ss_pred             CCCCCHHHHHHHhc-----ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence            47899999997542     234  7888999999999999999998   9999999999999976 67899999999875


Q ss_pred             cCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      .......  .....++..|.+||.+.......+.++|+||||+++|++++|..||..........      .........
T Consensus       159 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~------~~~~~~~~~  230 (268)
T cd06624         159 LAGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM------FKVGMFKIH  230 (268)
T ss_pred             cccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH------hhhhhhccC
Confidence            5332211  11123788999999986543456889999999999999999999986432211110      000000111


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ...+..+++++       ..++.+||+.+|++|||+.+++++
T Consensus       231 ~~~~~~~~~~~-------~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         231 PEIPESLSAEA-------KNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             CCCCcccCHHH-------HHHHHHHcCCCchhCCCHHHHHhC
Confidence            11222334444       445556999999999999999864

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.95  E-value=3e-27  Score=190.23  Aligned_cols=170  Identities=29%  Similarity=0.391  Sum_probs=127.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++..       ..+++..+..++.++++|+.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        84 ~~~~~L~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06642          84 LGGGSALDLLKP-------GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             cCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccC
Confidence            578999998854       3589999999999999999999998   999999999999999999999999999876544


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....++..|++||.+.+.  .++.++|+||||+++|++++|..|+.......        .............
T Consensus       154 ~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~~~~~~~~~~~  221 (277)
T cd06642         154 TQIK--RNTFVGTPFWMAPEVIKQS--AYDFKADIWSLGITAIELAKGEPPNSDLHPMR--------VLFLIPKNSPPTL  221 (277)
T ss_pred             cchh--hhcccCcccccCHHHhCcC--CCchhhhHHHHHHHHHHHHhCCCCCcccchhh--------HHhhhhcCCCCCC
Confidence            3221  1122477889999998654  56889999999999999999999986432211        1111111111222


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ...++.+       +.+++.+||+.+|++||++.+++++
T Consensus       222 ~~~~~~~-------~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         222 EGQYSKP-------FKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CcccCHH-------HHHHHHHHccCCcccCcCHHHHHHh
Confidence            2233333       4455566999999999999999985

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.95  E-value=3.3e-27  Score=193.30  Aligned_cols=193  Identities=20%  Similarity=0.248  Sum_probs=130.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.....    ..+++..+..++.|+++||.|||+.   +++|+||||+||+++.++.++++||+.+.....
T Consensus        81 ~~~~~l~~~l~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~  153 (314)
T cd08216          81 MAYGSCEDLLKTHFP----EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIK  153 (314)
T ss_pred             cCCCCHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecc
Confidence            578999999976422    4588999999999999999999999   999999999999999999999999998864432


Q ss_pred             Cccc-----chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCC--------------
Q 026160           81 KKST-----ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSD--------------  141 (242)
Q Consensus        81 ~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~--------------  141 (242)
                      ....     .......++..|++||.+......++.++|+||||+++|++++|..||.........              
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (314)
T cd08216         154 HGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDK  233 (314)
T ss_pred             ccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCcccccc
Confidence            2110     001112366789999998654345788999999999999999999999743211000              


Q ss_pred             CcCcchhhhccCC---CCcccc-ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 026160          142 IYFPNSIYKHIEP---GNDFQL-DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML  200 (242)
Q Consensus       142 ~~~~~~~~~~~~~---~~~~~~-~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l  200 (242)
                      ...+.........   ...... ...-......+...+.+++.+||+.||++|||+.+++++-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p  296 (314)
T cd08216         234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS  296 (314)
T ss_pred             CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence            0000000000000   000000 0000111122334566778889999999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.95  E-value=8.2e-28  Score=181.43  Aligned_cols=171  Identities=27%  Similarity=0.339  Sum_probs=131.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC---CCceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE---DFCPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~---~~~~~L~dfg~~~~   77 (242)
                      |.||+|..-|-++      -..++..+-..+.||++||.|+|.+   +|+|||+||+|+++..   ..-+||+|||++..
T Consensus        92 m~G~dl~~eIV~R------~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   92 VTGGELFEDIVAR------EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             ccchHHHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence            4667776665554      3588889999999999999999999   9999999999999953   34589999999988


Q ss_pred             cCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      ........   .+.|++.|++||++..  ..++..+|||+-|+++|-++.|.+||........    -+.+. ...-...
T Consensus       163 l~~g~~~~---G~~GtP~fmaPEvvrk--dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl----ye~I~-~g~yd~~  232 (355)
T KOG0033|consen  163 VNDGEAWH---GFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL----YEQIK-AGAYDYP  232 (355)
T ss_pred             eCCccccc---cccCCCcccCHHHhhc--CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH----HHHHh-ccccCCC
Confidence            77443332   3469999999999875  3788999999999999999999999986432110    01111 1111122


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVL  197 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll  197 (242)
                      .+....++++.++++++|+       ..||.+|.|+.|.+
T Consensus       233 ~~~w~~is~~Ak~LvrrML-------~~dP~kRIta~EAL  265 (355)
T KOG0033|consen  233 SPEWDTVTPEAKSLIRRML-------TVNPKKRITADEAL  265 (355)
T ss_pred             CcccCcCCHHHHHHHHHHh-------ccChhhhccHHHHh
Confidence            3344578999999999977       89999999999987

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.95  E-value=3.5e-28  Score=203.95  Aligned_cols=175  Identities=25%  Similarity=0.354  Sum_probs=126.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.+.      +.+++..+..++.||+.||.|||+.   +|+|+||||+||+++.++.++|+|||++..+..
T Consensus        83 ~~~g~L~~~i~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          83 IPGGDMMSLLIRL------GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence            5899999999765      4589999999999999999999999   999999999999999999999999998753210


Q ss_pred             Ccc-----------------------------------------cchhcccccccccccchhhhcccCCCCCCccchhHH
Q 026160           81 KKS-----------------------------------------TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG  119 (242)
Q Consensus        81 ~~~-----------------------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG  119 (242)
                      ...                                         ........|+..|+|||.+.+.  .++.++||||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG  231 (376)
T cd05598         154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVG  231 (376)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC--CCCcceeeeecc
Confidence            000                                         0000113588999999998654  568899999999


Q ss_pred             HHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCC---CHHHH
Q 026160          120 MMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRP---SMHEV  196 (242)
Q Consensus       120 ~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp---s~~~l  196 (242)
                      |++|+|++|..||.........    ..+ ..............+++++.+++.+|       + .+|.+|+   ++.++
T Consensus       232 vilyell~G~~Pf~~~~~~~~~----~~i-~~~~~~~~~~~~~~~s~~~~~li~~l-------~-~~p~~R~~~~t~~el  298 (376)
T cd05598         232 VILYEMLVGQPPFLADTPAETQ----LKV-INWETTLHIPSQAKLSREASDLILRL-------C-CGAEDRLGKNGADEI  298 (376)
T ss_pred             ceeeehhhCCCCCCCCCHHHHH----HHH-hccCccccCCCCCCCCHHHHHHHHHH-------h-cCHhhcCCCCCHHHH
Confidence            9999999999999754321100    000 01111111111224566666666653       2 3999999   89999


Q ss_pred             HHH
Q 026160          197 LEM  199 (242)
Q Consensus       197 l~~  199 (242)
                      +++
T Consensus       299 l~h  301 (376)
T cd05598         299 KAH  301 (376)
T ss_pred             hCC
Confidence            976

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.95  E-value=3.4e-28  Score=202.52  Aligned_cols=186  Identities=23%  Similarity=0.308  Sum_probs=141.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|++||.++..    ..+.-+....|+.||+.|++||.+.   +++||||.+.|+|+++++.+|++|||.++-...
T Consensus       617 mEnGDLnqFl~ahea----pt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys  689 (807)
T KOG1094|consen  617 MENGDLNQFLSAHEL----PTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS  689 (807)
T ss_pred             HhcCcHHHHHHhccC----cccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccccc
Confidence            689999999998855    2356667778999999999999999   999999999999999999999999999997777


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHH--hcCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMA--VGRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll--~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      ...+....+..-+++|+|||.+...  +++.++|+|+||+.+||++  +...||.......- ...............  
T Consensus       690 g~yy~vqgr~vlpiRwmawEsillg--kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v-ven~~~~~~~~~~~~--  764 (807)
T KOG1094|consen  690 GDYYRVQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV-VENAGEFFRDQGRQV--  764 (807)
T ss_pred             CCceeeecceeeeeeehhHHHHHhc--cccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH-HHhhhhhcCCCCcce--
Confidence            7666666667788999999987653  7899999999999999985  57888864432110 000011111111111  


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                           +......+...++++|.+||..|-++|||++++...|...
T Consensus       765 -----~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  765 -----VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             -----eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence                 2222233445667788889999999999999999988753

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.8e-27  Score=191.20  Aligned_cols=170  Identities=31%  Similarity=0.392  Sum_probs=128.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++...       .+++..+..++.|++.|+.|||+.   +++|+||+|.||+++.++.++|+|||++.....
T Consensus        81 ~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  150 (274)
T cd06609          81 CGGGSCLDLLKPG-------KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTS  150 (274)
T ss_pred             eCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence            4788999998653       589999999999999999999998   999999999999999999999999999876654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....++..|++||.+.+.  .++.++|+||||+++|++++|..||......        ..............
T Consensus       151 ~~~~--~~~~~~~~~y~~PE~~~~~--~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--------~~~~~~~~~~~~~~  218 (274)
T cd06609         151 TMSK--RNTFVGTPFWMAPEVIKQS--GYDEKADIWSLGITAIELAKGEPPLSDLHPM--------RVLFLIPKNNPPSL  218 (274)
T ss_pred             cccc--cccccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCcccCchH--------HHHHHhhhcCCCCC
Confidence            3211  1122477889999998664  4789999999999999999999999644321        11111111111112


Q ss_pred             ccc-cchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGV-VTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~-~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ... ++..+.       +++.+||..||++|||+.+++++
T Consensus       219 ~~~~~~~~~~-------~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         219 EGNKFSKPFK-------DFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             cccccCHHHH-------HHHHHHhhCChhhCcCHHHHhhC
Confidence            211 344444       44555899999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.95  E-value=8e-28  Score=202.19  Aligned_cols=175  Identities=25%  Similarity=0.359  Sum_probs=125.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.+.      +.+++..+..++.||+.||.|||+.   +|+|+||||+|||++.++.++|+|||++.....
T Consensus        83 ~~gg~L~~~l~~~------~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~  153 (382)
T cd05625          83 IPGGDMMSLLIRM------GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (382)
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence            6899999999764      3589999999999999999999999   999999999999999999999999998753211


Q ss_pred             Ccc---------------------------------------------cchhcccccccccccchhhhcccCCCCCCccc
Q 026160           81 KKS---------------------------------------------TISMLHARGTIGYIAPEVFCRSFGGASHKSDV  115 (242)
Q Consensus        81 ~~~---------------------------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di  115 (242)
                      ...                                             ........|++.|+|||++.+.  .++.++||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~Di  231 (382)
T cd05625         154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDW  231 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC--CCCCeeeE
Confidence            000                                             0000113588999999998654  57889999


Q ss_pred             hhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCC---
Q 026160          116 YSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPS---  192 (242)
Q Consensus       116 ~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps---  192 (242)
                      |||||++|+|++|..||.........    ..+ ..............++++..+++.+|+        .+|.+|++   
T Consensus       232 wSlGvil~elltG~~Pf~~~~~~~~~----~~i-~~~~~~~~~p~~~~~s~~~~~li~~l~--------~~p~~R~~~~~  298 (382)
T cd05625         232 WSVGVILYEMLVGQPPFLAQTPLETQ----MKV-INWQTSLHIPPQAKLSPEASDLIIKLC--------RGPEDRLGKNG  298 (382)
T ss_pred             EechHHHHHHHhCCCCCCCCCHHHHH----HHH-HccCCCcCCCCcccCCHHHHHHHHHHc--------cCHhHcCCCCC
Confidence            99999999999999999754321100    000 001111111112345677777776632        48999987   


Q ss_pred             HHHHHHH
Q 026160          193 MHEVLEM  199 (242)
Q Consensus       193 ~~~ll~~  199 (242)
                      +.+++++
T Consensus       299 ~~ei~~h  305 (382)
T cd05625         299 ADEIKAH  305 (382)
T ss_pred             HHHHhcC
Confidence            8887754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.95  E-value=2.1e-27  Score=190.30  Aligned_cols=169  Identities=21%  Similarity=0.335  Sum_probs=127.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCC-ceEEcccccccccC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF-CPKISDFGLAKQSQ   79 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~-~~~L~dfg~~~~~~   79 (242)
                      +++|+|.+++...      ..+++.++..++.|+++|+.|||+.   +++|+||+|+||+++.++ .++|+|||++....
T Consensus        91 ~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~  161 (267)
T PHA03390         91 IKDGDLFDLLKKE------GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG  161 (267)
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence            5799999999764      3699999999999999999999998   999999999999999888 99999999987654


Q ss_pred             CCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           80 DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        80 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ....      ..++..|+|||.+.+.  .++.++|+||||+++|++++|..||.......  ... .......  .....
T Consensus       162 ~~~~------~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~-~~~~~~~--~~~~~  228 (267)
T PHA03390        162 TPSC------YDGTLDYFSPEKIKGH--NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE--LDL-ESLLKRQ--QKKLP  228 (267)
T ss_pred             CCcc------CCCCCcccChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCcch--hhH-HHHHHhh--cccCC
Confidence            3322      2378899999998653  56789999999999999999999997332211  111 1111111  11112


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCC-HHHHHH
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPS-MHEVLE  198 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps-~~~ll~  198 (242)
                      .....++.+.+++.+       ||+.||.+||+ ++++++
T Consensus       229 ~~~~~~~~~~~li~~-------~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        229 FIKNVSKNANDFVQS-------MLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             cccccCHHHHHHHHH-------HhccChhhCCchHHHHhc
Confidence            223455666666655       77999999996 688875

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.95  E-value=1.5e-27  Score=191.79  Aligned_cols=169  Identities=23%  Similarity=0.351  Sum_probs=123.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCC-------ceEEcccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF-------CPKISDFG   73 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~-------~~~L~dfg   73 (242)
                      |++|+|++++....     +.+++..+..++.|++.||.|||+.   +++|+||||.||+++..+       .++++|||
T Consensus        98 ~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g  169 (274)
T cd05076          98 VEHGPLDVCLRKEK-----GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPG  169 (274)
T ss_pred             CCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcccCccceeeecCCc
Confidence            57999999986532     4689999999999999999999998   999999999999997543       37999999


Q ss_pred             cccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHH-hcCCCccccccCCCCCcCcchhhhcc
Q 026160           74 LAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMA-VGRKNADVKASRSSDIYFPNSIYKHI  152 (242)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll-~g~~p~~~~~~~~~~~~~~~~~~~~~  152 (242)
                      ++........      ..++..|++||.+.+. ...+.++|+||||+++|+++ +|..||........     .....  
T Consensus       170 ~~~~~~~~~~------~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-----~~~~~--  235 (274)
T cd05076         170 VSFTALSREE------RVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-----ERFYE--  235 (274)
T ss_pred             cccccccccc------cccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-----HHHHH--
Confidence            8764432211      2367789999987553 45688999999999999985 68888864432110     00000  


Q ss_pred             CCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          153 EPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                       .  ....+....+       .+..++.+||+.+|++|||+.++++.|.
T Consensus       236 -~--~~~~~~~~~~-------~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         236 -K--KHRLPEPSCK-------ELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             -h--ccCCCCCCCh-------HHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence             0  0011111222       3556667799999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.95  E-value=2.5e-27  Score=191.98  Aligned_cols=177  Identities=24%  Similarity=0.284  Sum_probs=127.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....  .....+++..+..++.|++.||.|||+.   +++|+||||.||+++.++.++|+|||++.....
T Consensus       106 ~~~~sL~~~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~  180 (291)
T cd06639         106 CNGGSVTELVKGLL--ICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS  180 (291)
T ss_pred             CCCCcHHHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhccc
Confidence            46899999886431  1235689999999999999999999998   999999999999999999999999999876543


Q ss_pred             Ccccchhcccccccccccchhhhccc---CCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSF---GGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~---~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      .....  ....++..|++||.+....   ...+.++|+||||+++|++++|+.||.......       .... ......
T Consensus       181 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-------~~~~-~~~~~~  250 (291)
T cd06639         181 TRLRR--NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-------TLFK-IPRNPP  250 (291)
T ss_pred             ccccc--cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-------HHHH-HhcCCC
Confidence            22111  1124788899999875321   135789999999999999999999986432210       0111 111100


Q ss_pred             c--ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          158 F--QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       158 ~--~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .  ..+....       ..+..++.+||+.||++||++.+++++
T Consensus       251 ~~~~~~~~~~-------~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         251 PTLLHPEKWC-------RSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             CCCCcccccC-------HHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            0  1111222       235556666999999999999999864

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.95  E-value=1.7e-27  Score=193.24  Aligned_cols=172  Identities=25%  Similarity=0.357  Sum_probs=124.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++..       ..+++.++..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus       101 ~~~~~L~~~~~~-------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (292)
T cd06658         101 LEGGALTDIVTH-------TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK  170 (292)
T ss_pred             CCCCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence            578899998854       3489999999999999999999999   999999999999999999999999998865433


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....++..|+|||.+.+.  ..+.++|+||||+++|++++|..||........    ..........  ....
T Consensus       171 ~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~----~~~~~~~~~~--~~~~  240 (292)
T cd06658         171 EVPK--RKSLVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA----MRRIRDNLPP--RVKD  240 (292)
T ss_pred             cccc--CceeecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhcCCC--cccc
Confidence            2211  1123478899999988543  567899999999999999999999864322100    0000000000  0011


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ....+..+.       .++.+||..||++|||+.+++++
T Consensus       241 ~~~~~~~~~-------~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         241 SHKVSSVLR-------GFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccccCHHHH-------HHHHHHccCChhHCcCHHHHhhC
Confidence            112333333       44555889999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.95  E-value=3.1e-27  Score=191.54  Aligned_cols=175  Identities=25%  Similarity=0.308  Sum_probs=125.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|..++.+..     ..+++.++..++.|++.++.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        91 ~~~~~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          91 CPGGAVDAIMLELD-----RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             CCCCcHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            47888888775432     3589999999999999999999998   999999999999999999999999998865433


Q ss_pred             Ccccchhcccccccccccchhhhcc---cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccC-CCC
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRS---FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIE-PGN  156 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~  156 (242)
                      ....  .....++..|++||.+...   ...++.++|+||||+++|++++|..||.......       ....... ...
T Consensus       163 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~~  233 (292)
T cd06644         163 TLQR--RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-------VLLKIAKSEPP  233 (292)
T ss_pred             cccc--cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-------HHHHHhcCCCc
Confidence            2111  1123477899999987432   1245778999999999999999999986433210       0000000 000


Q ss_pred             ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          157 DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ....+..++.++.       +++.+||+.||++||++.+++++
T Consensus       234 ~~~~~~~~~~~~~-------~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         234 TLSQPSKWSMEFR-------DFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             cCCCCcccCHHHH-------HHHHHHhcCCcccCcCHHHHhcC
Confidence            1111223344444       45555899999999999999764

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.95  E-value=4.1e-27  Score=189.14  Aligned_cols=182  Identities=23%  Similarity=0.317  Sum_probs=128.6

Q ss_pred             CCCCCcchhccccCCCC---CCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSN---GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~---~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~   77 (242)
                      +++|+|.+++.......   ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++++|||++..
T Consensus        90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~~  166 (275)
T cd05046          90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKD  166 (275)
T ss_pred             cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcccccccc
Confidence            47899999997653111   122689999999999999999999999   999999999999999999999999998864


Q ss_pred             cCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCC
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGN  156 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  156 (242)
                      ....... ......++..|++||.+.+.  ..+.++|+||||+++|++++ |..||......       ...........
T Consensus       167 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-------~~~~~~~~~~~  236 (275)
T cd05046         167 VYNSEYY-KLRNALIPLRWLAPEAVQED--DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-------EVLNRLQAGKL  236 (275)
T ss_pred             cCccccc-ccCCceeEEeecChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCccccchH-------HHHHHHHcCCc
Confidence            4322111 11122356779999987543  46788999999999999998 77787532211       11111110011


Q ss_pred             ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 026160          157 DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES  202 (242)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~  202 (242)
                      .......++..       +.+++.+||+.||++|||+.++++.|.+
T Consensus       237 ~~~~~~~~~~~-------l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         237 ELPVPEGCPSR-------LYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             CCCCCCCCCHH-------HHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            11112233443       4445556999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.95  E-value=2.9e-27  Score=188.04  Aligned_cols=173  Identities=24%  Similarity=0.330  Sum_probs=128.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++.....    ..+++.++..++.|++.|+.|||+.   +++|+||+|.||+++.++.++++|||++.....
T Consensus        81 ~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~  153 (256)
T cd08218          81 CEGGDLYKKINAQRG----VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS  153 (256)
T ss_pred             CCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence            468899998875421    3588999999999999999999998   999999999999999999999999999876544


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....++..|.|||.+.+.  ..+.++|+||||++++++++|..||......       .... ....+.....
T Consensus       154 ~~~~--~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-------~~~~-~~~~~~~~~~  221 (256)
T cd08218         154 TVEL--ARTCIGTPYYLSPEICENR--PYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-------NLVL-KIIRGSYPPV  221 (256)
T ss_pred             chhh--hhhccCCccccCHHHhCCC--CCCCccchhHHHHHHHHHHcCCCCccCCCHH-------HHHH-HHhcCCCCCC
Confidence            3221  1122477889999988653  5678999999999999999999998643221       1111 1111111122


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      +..++.+       +.+++.+||+.+|++||++.+++++
T Consensus       222 ~~~~~~~-------~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         222 SSHYSYD-------LRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             cccCCHH-------HHHHHHHHhhCChhhCcCHHHHhhC
Confidence            2233444       4445555889999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=2e-27  Score=190.49  Aligned_cols=179  Identities=27%  Similarity=0.353  Sum_probs=127.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....  ..+..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        91 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~  165 (275)
T cd06608          91 CGGGSVTDLVKGLR--KKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS  165 (275)
T ss_pred             CCCCcHHHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccceeccc
Confidence            46789988886532  1235689999999999999999999998   999999999999999999999999999876543


Q ss_pred             Ccccchhcccccccccccchhhhcc---cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRS---FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      ....  .....++..|+|||.+...   ...++.++|+||||+++|++++|..||.......       ... .......
T Consensus       166 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~-~~~~~~~  235 (275)
T cd06608         166 TLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-------ALF-KIPRNPP  235 (275)
T ss_pred             chhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-------HHH-HhhccCC
Confidence            3221  1123478899999987432   2345788999999999999999999996332111       111 1111111


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ....  .   .......+.+++.+||..||++|||+.+++++
T Consensus       236 ~~~~--~---~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         236 PTLK--S---PENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             CCCC--c---hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            1110  0   01122334455666999999999999999863

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.95  E-value=3e-27  Score=189.30  Aligned_cols=177  Identities=27%  Similarity=0.404  Sum_probs=129.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhh-CCCCCeeecCCCCCceeeCCCCceEEcccccccccC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHR-GCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ   79 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~-~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~   79 (242)
                      +++|+|.+++....  .....+++..++.++.|++.++.|||+ .   +++|+||+|+||+++.++.++|+|||++....
T Consensus        91 ~~~~~l~~~l~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  165 (269)
T cd08528          91 IEGAPLGEHFNSLK--EKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ  165 (269)
T ss_pred             CCCCcHHHHHHHHH--hccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEecccceeecc
Confidence            46889999885421  122469999999999999999999996 5   89999999999999999999999999987655


Q ss_pred             CCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           80 DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        80 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ...   ......++..|.+||.+.+.  .++.++|+||||+++|++++|..||.......       .............
T Consensus       166 ~~~---~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~  233 (269)
T cd08528         166 PES---KLTSVVGTILYSCPEIVKNE--PYGEKADVWAFGCILYQMCTLQPPFYSTNMLS-------LATKIVEAVYEPL  233 (269)
T ss_pred             ccc---ccccccCcccCcChhhhcCC--CCchHHHHHHHHHHHHHHHhCCCcccccCHHH-------HHHHHhhccCCcC
Confidence            443   11223478899999988653  56889999999999999999999985332110       0111111111111


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      ....+++.+       .+++.+||+.||++||++.++.++++
T Consensus       234 ~~~~~~~~l-------~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         234 PEGMYSEDV-------TDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             CcccCCHHH-------HHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            111234444       44555699999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.95  E-value=3.1e-27  Score=190.21  Aligned_cols=171  Identities=29%  Similarity=0.380  Sum_probs=128.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++..       ..+++.++..++.+++.|+.|||+.   +++|+||+|+||+++.++.++++|||++.....
T Consensus        84 ~~~~~L~~~i~~-------~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06640          84 LGGGSALDLLRA-------GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             CCCCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence            578999999864       2488999999999999999999998   999999999999999999999999999876543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      .....  ....++..|.|||.+.+.  ..+.++|+||||+++|++++|..||........        ............
T Consensus       154 ~~~~~--~~~~~~~~y~apE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--------~~~~~~~~~~~~  221 (277)
T cd06640         154 TQIKR--NTFVGTPFWMAPEVIQQS--AYDSKADIWSLGITAIELAKGEPPNSDMHPMRV--------LFLIPKNNPPTL  221 (277)
T ss_pred             Ccccc--ccccCcccccCHhHhccC--CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH--------hhhhhcCCCCCC
Confidence            32211  112467889999988653  568899999999999999999999864332110        001111111111


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML  200 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l  200 (242)
                      ..       .....+.+++.+||+.+|++||++.+++.+-
T Consensus       222 ~~-------~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  254 (277)
T cd06640         222 TG-------EFSKPFKEFIDACLNKDPSFRPTAKELLKHK  254 (277)
T ss_pred             ch-------hhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence            11       2334455667779999999999999998763

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.95  E-value=2.8e-27  Score=189.17  Aligned_cols=173  Identities=28%  Similarity=0.340  Sum_probs=124.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++...      ..+++..+..++.|++.||.|||+.   +++|+||+|.||+++.++.++|+|||++.....
T Consensus        88 ~~~~~L~~~l~~~------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~  158 (265)
T cd06652          88 MPGGSIKDQLKSY------GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQT  158 (265)
T ss_pred             cCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence            4789999999765      3488999999999999999999999   999999999999999999999999998875432


Q ss_pred             Cccc-chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKST-ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      .... .......++..|+|||.+.+.  ..+.++|+||||+++|++++|+.||......       ..............
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~  229 (265)
T cd06652         159 ICLSGTGMKSVTGTPYWMSPEVISGE--GYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-------AAIFKIATQPTNPV  229 (265)
T ss_pred             ccccccccccCCCCccccChhhhcCC--CCCcchhHHHHHHHHHHHhhCCCCCCccchH-------HHHHHHhcCCCCCC
Confidence            2111 011122477899999988653  5688999999999999999999998633211       11111111111111


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .+...+..+.+       ++.+||. +|++||++.+++++
T Consensus       230 ~~~~~~~~~~~-------~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         230 LPPHVSDHCRD-------FLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             CchhhCHHHHH-------HHHHHhc-ChhhCCCHHHHhcC
Confidence            22223333334       4444664 89999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.2e-28  Score=205.73  Aligned_cols=175  Identities=31%  Similarity=0.482  Sum_probs=134.8

Q ss_pred             CCCCCcchhccccCCCCCCccc--cHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC-CCceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTL--EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE-DFCPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l--~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~-~~~~~L~dfg~~~~   77 (242)
                      +|||||-++|...=     +++  ++.++-....||++||.|||.+   .|||||||..|+|++. +|.+|++|||-+++
T Consensus       654 VPGGSLSsLLrskW-----GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKR  725 (1226)
T KOG4279|consen  654 VPGGSLSSLLRSKW-----GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKR  725 (1226)
T ss_pred             CCCCcHHHHHHhcc-----CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchh
Confidence            69999999997642     445  7888888999999999999999   9999999999999975 89999999999887


Q ss_pred             cCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      .........  ++.||..|+|||++.....++..++|||||||.+.||.||++||-........      +.+..--...
T Consensus       726 LAginP~TE--TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA------MFkVGmyKvH  797 (1226)
T KOG4279|consen  726 LAGINPCTE--TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA------MFKVGMYKVH  797 (1226)
T ss_pred             hccCCcccc--ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh------hhhhcceecC
Confidence            654433322  34599999999999776678899999999999999999999999655443221      1111111222


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE  198 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~  198 (242)
                      +.++..++.+.+.++       .+|...||.+||++.++++
T Consensus       798 P~iPeelsaeak~Fi-------lrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  798 PPIPEELSAEAKNFI-------LRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             CCCcHHHHHHHHHHH-------HHHcCCCcccCccHHHhcc
Confidence            333444444444444       4499999999999999985

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.95  E-value=2.1e-27  Score=198.75  Aligned_cols=175  Identities=25%  Similarity=0.331  Sum_probs=127.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...       .++...+..++.||+.||.|||+.   +|+|+||||+||+++.++.++|+|||++.....
T Consensus       125 ~~gg~L~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~  194 (371)
T cd05622         125 MPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK  194 (371)
T ss_pred             CCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence            5799999998643       488999999999999999999999   999999999999999999999999999876543


Q ss_pred             Ccccchhcccccccccccchhhhccc--CCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCC--C
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSF--GGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPG--N  156 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~  156 (242)
                      .... ......|++.|+|||.+....  ..++.++|||||||++|+|++|..||.......       .........  .
T Consensus       195 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~~~  266 (371)
T cd05622         195 EGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-------TYSKIMNHKNSL  266 (371)
T ss_pred             CCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCcc
Confidence            2211 112235899999999986532  236889999999999999999999997443210       011111111  1


Q ss_pred             ccccccccchHHHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHHh
Q 026160          157 DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSD--RPSMHEVLEML  200 (242)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~--Rps~~~ll~~l  200 (242)
                      .......++.++++++..       |+..++.+  |+++.+++++.
T Consensus       267 ~~~~~~~~s~~~~~li~~-------~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         267 TFPDDNDISKEAKNLICA-------FLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             cCCCcCCCCHHHHHHHHH-------HcCChhhhcCCCCHHHHhcCc
Confidence            111122456667776666       55733332  78999998864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1.7e-27  Score=194.14  Aligned_cols=168  Identities=24%  Similarity=0.358  Sum_probs=127.6

Q ss_pred             ccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCC---cccchhccccccccccc
Q 026160           22 LEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDK---KSTISMLHARGTIGYIA   98 (242)
Q Consensus        22 l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~---~~~~~~~~~~~~~~y~~   98 (242)
                      +++.++++++++++.||+|||.+   +|+||||||+|+|++.+|++|++|||.+......   ..........||+.|+|
T Consensus       207 ls~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~A  283 (576)
T KOG0585|consen  207 LSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFA  283 (576)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccc
Confidence            99999999999999999999999   9999999999999999999999999999866222   11112223579999999


Q ss_pred             chhhhccc--CCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCC-CccccccccchHHHHHHHHH
Q 026160           99 PEVFCRSF--GGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPG-NDFQLDGVVTEEEKELVKKM  175 (242)
Q Consensus        99 PE~~~~~~--~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  175 (242)
                      ||.+.+..  .....+.||||+|+.+|-++.|+.||......        .....+.+. ......+...+.+++++.+|
T Consensus       284 PE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~--------~l~~KIvn~pL~fP~~pe~~e~~kDli~~l  355 (576)
T KOG0585|consen  284 PELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL--------ELFDKIVNDPLEFPENPEINEDLKDLIKRL  355 (576)
T ss_pred             hHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH--------HHHHHHhcCcccCCCcccccHHHHHHHHHH
Confidence            99886522  23477899999999999999999999744321        111111111 11112223566778888886


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHHHhhchhhhc
Q 026160          176 ILVSLWCIQTNPSDRPSMHEVLEMLESSTEIL  207 (242)
Q Consensus       176 ~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~  207 (242)
                      +       .+||++|.+..++..+..-.....
T Consensus       356 L-------~KdP~~Ri~l~~ik~Hpwvt~~g~  380 (576)
T KOG0585|consen  356 L-------EKDPEQRITLPDIKLHPWVTRDGD  380 (576)
T ss_pred             h-------hcChhheeehhhheecceeccCCC
Confidence            6       999999999999999888766543

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.95  E-value=2e-27  Score=194.21  Aligned_cols=121  Identities=31%  Similarity=0.441  Sum_probs=98.4

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      ++|.+++....     ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        88 ~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          88 KDLKQYMDDCG-----NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            46777765432     4588999999999999999999999   999999999999999999999999999875433221


Q ss_pred             cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           84 TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      .  .....++..|.|||.+.+. ..++.++|+||||+++|+|++|..||...
T Consensus       160 ~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~  208 (309)
T cd07872         160 T--YSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGS  208 (309)
T ss_pred             c--cccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            1  1122468899999987653 35688999999999999999999999644

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.95  E-value=1.1e-27  Score=193.28  Aligned_cols=187  Identities=19%  Similarity=0.246  Sum_probs=126.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++++|..++...      ..+++.++..++.|++.+|.|||+.   +++|+||+|.||+++.++.++|+|||++.....
T Consensus        82 ~~~~~l~~~~~~~------~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07847          82 CDHTVLNELEKNP------RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTG  152 (286)
T ss_pred             cCccHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCC
Confidence            4667777766443      3589999999999999999999998   999999999999999999999999999886554


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcC--------cchhhhcc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYF--------PNSIYKHI  152 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~--------~~~~~~~~  152 (242)
                      .....  ....++..|.+||.+.+. ..++.++|+||||+++|++++|..||......+.....        ........
T Consensus       153 ~~~~~--~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07847         153 PGDDY--TDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFS  229 (286)
T ss_pred             Ccccc--cCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcc
Confidence            33111  112367889999987543 35678999999999999999999999644321110000        00000000


Q ss_pred             C-------CCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          153 E-------PGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       153 ~-------~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .       .....................+.+++.+||+.||++|||+.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            0       0000000000001112233456677777999999999999998764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=3.8e-27  Score=189.88  Aligned_cols=174  Identities=24%  Similarity=0.335  Sum_probs=127.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++.+..     +.+++.++..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        84 ~~~~~L~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~  155 (280)
T cd06611          84 CDGGALDSIMLELE-----RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS  155 (280)
T ss_pred             cCCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence            57899999987642     4599999999999999999999999   999999999999999999999999998875443


Q ss_pred             Ccccchhcccccccccccchhhhcc---cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRS---FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      .....  ....++..|.+||.+...   ....+.++|+||||+++|++++|..||......        ...........
T Consensus       156 ~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~  225 (280)
T cd06611         156 TLQKR--DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--------RVLLKILKSEP  225 (280)
T ss_pred             ccccc--ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--------HHHHHHhcCCC
Confidence            22211  122478899999987422   234578999999999999999999998643221        11111111111


Q ss_pred             c--ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          158 F--QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       158 ~--~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .  ..+..++.++.+       ++..||+.||++||++.+++++
T Consensus       226 ~~~~~~~~~~~~~~~-------li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         226 PTLDQPSKWSSSFND-------FLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CCcCCcccCCHHHHH-------HHHHHhccChhhCcCHHHHhcC
Confidence            1  112234444444       4555889999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.95  E-value=3.1e-27  Score=192.15  Aligned_cols=172  Identities=25%  Similarity=0.339  Sum_probs=126.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++.+       ..+++.++..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        98 ~~~~~L~~~~~~-------~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656          98 LAGGSLTDVVTE-------TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             cCCCCHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence            478999999854       3488999999999999999999998   999999999999999999999999998875443


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      .....  ....++..|.+||.+.+.  ..+.++|+||||+++|++++|..||..........    ....  ........
T Consensus       168 ~~~~~--~~~~~~~~y~aPE~~~~~--~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~----~~~~--~~~~~~~~  237 (297)
T cd06656         168 EQSKR--STMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY----LIAT--NGTPELQN  237 (297)
T ss_pred             CccCc--CcccCCccccCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee----eecc--CCCCCCCC
Confidence            22111  112477899999988653  56789999999999999999999996443211110    0000  00001111


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      +..++..+       .+++.+||+.||++||++.+++++
T Consensus       238 ~~~~~~~~-------~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         238 PERLSAVF-------RDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             ccccCHHH-------HHHHHHHccCChhhCcCHHHHhcC
Confidence            22233333       345556999999999999999884

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.95  E-value=3e-27  Score=190.80  Aligned_cols=121  Identities=22%  Similarity=0.302  Sum_probs=98.1

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      .|+|.+++....     ..+++..+..++.||++||.|||+.   +++|+||+|.||+++.++.++|+|||++.......
T Consensus        82 ~~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          82 DQDLKKYFDSCN-----GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            357777765432     4599999999999999999999999   99999999999999999999999999987554322


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccc
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADV  134 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~  134 (242)
                      ..  .....++..|+|||.+.+. ..++.++|+||||+++|+|++|..|+..
T Consensus       154 ~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~  202 (284)
T cd07839         154 RC--YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFP  202 (284)
T ss_pred             CC--cCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence            11  1122467899999988653 3468899999999999999999988653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.95  E-value=2.9e-27  Score=190.91  Aligned_cols=123  Identities=28%  Similarity=0.352  Sum_probs=99.6

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      |+|.+++....   .+..+++.++..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        83 ~~l~~~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          83 MDLKKYLDSLP---KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CCHHHHHhcCC---CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            67888875432   235699999999999999999999998   999999999999999999999999999875543221


Q ss_pred             cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           84 TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      .  .....++..|+|||.+.+. ..++.++|+||||+++|++++|..||...
T Consensus       157 ~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~  205 (285)
T cd07861         157 V--YTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGD  205 (285)
T ss_pred             c--ccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            1  1122467889999987553 34678899999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.95  E-value=4.2e-27  Score=187.74  Aligned_cols=172  Identities=23%  Similarity=0.353  Sum_probs=127.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++.+.      ..++...+..++.|++.||.|||+.   +++|+||+|.||+++.++.++|+|||++.....
T Consensus        75 ~~~~~L~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~  145 (262)
T cd05572          75 CLGGELWTILRDR------GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS  145 (262)
T ss_pred             CCCCcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence            4789999999765      3489999999999999999999998   999999999999999999999999999886654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....   ....++..|++||.+...  .++.++|+||||+++|++++|..||........     ...............
T Consensus       146 ~~~~---~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~  215 (262)
T cd05572         146 GQKT---WTFCGTPEYVAPEIILNK--GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM-----EIYNDILKGNGKLEF  215 (262)
T ss_pred             cccc---ccccCCcCccChhHhcCC--CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH-----HHHHHHhccCCCCCC
Confidence            3211   112478899999987653  568899999999999999999999975542110     111111111111222


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPS-----MHEVLE  198 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps-----~~~ll~  198 (242)
                      +...+++       +..++.+||+.||++||+     +.++++
T Consensus       216 ~~~~~~~-------~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         216 PNYIDKA-------AKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CcccCHH-------HHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            2223344       444555599999999999     777776

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=7.7e-27  Score=187.72  Aligned_cols=172  Identities=25%  Similarity=0.331  Sum_probs=127.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++...       .+++..++.++.+++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        84 ~~~~~L~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          84 AEGGSVRTLMKAG-------PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             CCCCcHHHHHHcc-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            4688999988542       589999999999999999999999   999999999999999999999999999876654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      .....  ....++..|+|||.+.+. ..++.++|+||||+++|++++|..||........       . ..........+
T Consensus       154 ~~~~~--~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-------~-~~~~~~~~~~~  222 (277)
T cd06917         154 NSSKR--STFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA-------M-MLIPKSKPPRL  222 (277)
T ss_pred             Ccccc--ccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChhhh-------h-hccccCCCCCC
Confidence            33211  123478899999987542 3468899999999999999999999964332111       0 01111111111


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ...      .....+.+++.+||+.||++||++.+++++
T Consensus       223 ~~~------~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         223 EDN------GYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             Ccc------cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            111      022345566667999999999999999874

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.95  E-value=1e-27  Score=200.84  Aligned_cols=122  Identities=31%  Similarity=0.428  Sum_probs=98.5

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      ++|.+++...      ..+++..+..++.||+.||.|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        88 ~~l~~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~  158 (372)
T cd07853          88 SDLHKIIVSP------QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES  158 (372)
T ss_pred             cCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence            4555655433      4699999999999999999999999   999999999999999999999999999876543221


Q ss_pred             cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccc
Q 026160           84 TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKA  136 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  136 (242)
                      . ......++..|+|||.+.+. ..++.++|||||||++|+|++|+.||....
T Consensus       159 ~-~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~  209 (372)
T cd07853         159 K-HMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQS  209 (372)
T ss_pred             c-cCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence            1 11122468899999988653 346789999999999999999999996543

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.94  E-value=4.1e-27  Score=191.46  Aligned_cols=170  Identities=24%  Similarity=0.371  Sum_probs=125.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++..       ..+++.++..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus       100 ~~~~~L~~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~  169 (297)
T cd06659         100 LQGGALTDIVSQ-------TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK  169 (297)
T ss_pred             CCCCCHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence            478889887754       3589999999999999999999999   999999999999999999999999998865433


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCC--Ccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPG--NDF  158 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~  158 (242)
                      ....  .....++..|+|||.+.+.  ..+.++|+||||+++|++++|+.||.......        ........  ...
T Consensus       170 ~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~  237 (297)
T cd06659         170 DVPK--RKSLVGTPYWMAPEVISRT--PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--------AMKRLRDSPPPKL  237 (297)
T ss_pred             cccc--ccceecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhccCCCCc
Confidence            2211  1123478899999988653  56889999999999999999999986433211        00011100  011


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ......+..+.+       ++.+||+.+|++||++.+++++
T Consensus       238 ~~~~~~~~~l~~-------~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         238 KNAHKISPVLRD-------FLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             cccCCCCHHHHH-------HHHHHhcCCcccCcCHHHHhhC
Confidence            111223444444       4455889999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.94  E-value=4.4e-27  Score=191.12  Aligned_cols=186  Identities=22%  Similarity=0.263  Sum_probs=126.9

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      +|+|.+++....     ..+++.++..++.||++||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        85 ~~~L~~~i~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          85 ETDLEKVIKDKS-----IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             CCCHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            688999986542     2699999999999999999999999   99999999999999999999999999997665432


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCC------CcCc-chhhhc---c
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSD------IYFP-NSIYKH---I  152 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~------~~~~-~~~~~~---~  152 (242)
                      ...  ....++..|.|||.+.+. ..++.++|+|||||++|++++|.++|.........      ...+ ......   .
T Consensus       157 ~~~--~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (298)
T cd07841         157 RKM--THQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSL  233 (298)
T ss_pred             ccc--cccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccc
Confidence            211  122367789999987543 35688999999999999999997776533211000      0000 000000   0


Q ss_pred             CCCCcccc--ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          153 EPGNDFQL--DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       153 ~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ........  ..............+.+++.+||+.||++|||+.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            00000000  000000112223556677788999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.94  E-value=3.3e-27  Score=188.57  Aligned_cols=175  Identities=30%  Similarity=0.446  Sum_probs=128.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhh-CCCCCeeecCCCCCceeeCCCCceEEcccccccccC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHR-GCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ   79 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~-~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~   79 (242)
                      +++++|.+++....     ..+++..+..++.|++.|+.|||+ .   +++|+||+|.||+++.++.++|+|||.+....
T Consensus        81 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~  152 (265)
T cd06605          81 MDGGSLDKILKEVQ-----GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV  152 (265)
T ss_pred             cCCCcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence            46789999987642     468999999999999999999999 8   99999999999999999999999999886543


Q ss_pred             CCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           80 DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        80 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ......    ..++..|++||.+.+.  .++.++|+||||+++|++++|..||..........  .... ..........
T Consensus       153 ~~~~~~----~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~--~~~~-~~~~~~~~~~  223 (265)
T cd06605         153 NSLAKT----FVGTSSYMAPERIQGN--DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI--FELL-QYIVNEPPPR  223 (265)
T ss_pred             HHHhhc----ccCChhccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCccccccccH--HHHH-HHHhcCCCCC
Confidence            221111    3477899999988654  67889999999999999999999986543211111  0111 1111111111


Q ss_pred             cccc-cchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          160 LDGV-VTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       160 ~~~~-~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .+.. ++.+       +..++.+||..||++|||+.+++.+
T Consensus       224 ~~~~~~~~~-------~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         224 LPSGKFSPD-------FQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             CChhhcCHH-------HHHHHHHHcCCCchhCcCHHHHhhC
Confidence            1111 3344       4445555999999999999999854

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.94  E-value=5.7e-27  Score=191.53  Aligned_cols=121  Identities=33%  Similarity=0.478  Sum_probs=100.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++.+.      +.+++..+..++.|+++||.|||+.  .+++|+||+|.||+++.++.++|+|||++.....
T Consensus        81 ~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (308)
T cd06615          81 MDGGSLDQVLKKA------GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  152 (308)
T ss_pred             cCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence            4789999999765      4589999999999999999999973  1899999999999999999999999998865433


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      ...    ....++..|++||.+.+.  ..+.++|+||||+++|++++|..||...
T Consensus       153 ~~~----~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~  201 (308)
T cd06615         153 SMA----NSFVGTRSYMSPERLQGT--HYTVQSDIWSLGLSLVEMAIGRYPIPPP  201 (308)
T ss_pred             ccc----ccCCCCcCccChhHhcCC--CCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence            211    123478899999987543  5678999999999999999999998543

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.94  E-value=6.6e-27  Score=186.54  Aligned_cols=174  Identities=30%  Similarity=0.449  Sum_probs=131.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhh-CCCCCeeecCCCCCceeeCCCCceEEcccccccccC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHR-GCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ   79 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~-~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~   79 (242)
                      +++|+|.+++...      ..++...++.++.|+++|+.|||+ .   +++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~~~~~L~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~  151 (264)
T cd06623          81 MDGGSLADLLKKV------GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLE  151 (264)
T ss_pred             cCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            4789999999765      469999999999999999999999 8   99999999999999999999999999987654


Q ss_pred             CCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           80 DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        80 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ......  ....++..|.|||.+...  ..+.++|+||||+++|++++|..||.......     ...............
T Consensus       152 ~~~~~~--~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-----~~~~~~~~~~~~~~~  222 (264)
T cd06623         152 NTLDQC--NTFVGTVTYMSPERIQGE--SYSYAADIWSLGLTLLECALGKFPFLPPGQPS-----FFELMQAICDGPPPS  222 (264)
T ss_pred             cCCCcc--cceeecccccCHhhhCCC--CCCchhhHHHHHHHHHHHHhCCCCCccccccC-----HHHHHHHHhcCCCCC
Confidence            433221  122477899999987654  67889999999999999999999986554211     011111111222222


Q ss_pred             cccc-cchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          160 LDGV-VTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       160 ~~~~-~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .+.. ++..+.+++.+       ||+.+|++|||+.++++.
T Consensus       223 ~~~~~~~~~l~~li~~-------~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         223 LPAEEFSPEFRDFISA-------CLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCcccCCHHHHHHHHH-------HccCChhhCCCHHHHHhC
Confidence            2323 44445555544       889999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.94  E-value=5.7e-27  Score=186.29  Aligned_cols=172  Identities=31%  Similarity=0.456  Sum_probs=127.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++++|.+++.+.      ..+++..+..++.|++.|+.|||+.   +++|+||+|.||+++.++.++|+|||++.....
T Consensus        84 ~~~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          84 VPGGSLAKLLKKY------GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             cCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            4788999999754      3589999999999999999999999   999999999999999999999999998876543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ...   .....++..|++||.+.... ..+.++|+||||+++|++++|..||......       ...............
T Consensus       155 ~~~---~~~~~~~~~y~~pe~~~~~~-~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~  223 (258)
T cd06632         155 FSF---AKSFKGSPYWMAPEVIAQQG-GYGLAADIWSLGCTVLEMATGKPPWSQLEGV-------AAVFKIGRSKELPPI  223 (258)
T ss_pred             ccc---ccccCCCcceeCHHHhcCCC-CCCchhhhHHHHHHHHHHHhCCCCcccCcHH-------HHHHHHHhcccCCCc
Confidence            321   11234788899999875431 3788999999999999999999998644311       111111111111222


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      +..+++.+.+++       .+||+.+|++||++.+++.+
T Consensus       224 ~~~~~~~~~~li-------~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         224 PDHLSDEAKDFI-------LKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             CCCcCHHHHHHH-------HHHhhcCcccCcCHHHHhcC
Confidence            333445555444       45889999999999999863

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=5.5e-27  Score=192.17  Aligned_cols=176  Identities=27%  Similarity=0.325  Sum_probs=125.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....    ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        83 ~~~~~L~~~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          83 CPGGELFRLLQRQP----GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             cCCCCHHHHHHhCC----CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            46899999987542    25689999999999999999999998   999999999999999999999999998875432


Q ss_pred             Ccccc---------------------------hhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcc
Q 026160           81 KKSTI---------------------------SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNAD  133 (242)
Q Consensus        81 ~~~~~---------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~  133 (242)
                      .....                           ......++..|+|||.+.+.  ..+.++||||||+++|++++|..||.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~l~~g~~pf~  233 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD--GHGSAVDWWTLGILLYEMLYGTTPFK  233 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC--CCCchHHHHHHHHHHHHHhhCCCCCC
Confidence            21100                           00112467889999998654  56889999999999999999999986


Q ss_pred             ccccCCCCCcCcchhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCC----HHHHHHH
Q 026160          134 VKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPS----MHEVLEM  199 (242)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps----~~~ll~~  199 (242)
                      ......       ..................+..+.       +++.+||+.||++|||    +.+++.+
T Consensus       234 ~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~-------~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         234 GSNRDE-------TFSNILKKEVTFPGSPPVSSSAR-------DLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             CCchHH-------HHHHHhcCCccCCCccccCHHHH-------HHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            443211       11111111111111111344444       4455588999999999    6666663

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.94  E-value=6.3e-27  Score=189.24  Aligned_cols=170  Identities=24%  Similarity=0.327  Sum_probs=125.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++..       ..++..++..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        98 ~~~~~L~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~  167 (285)
T cd06648          98 LEGGALTDIVTH-------TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK  167 (285)
T ss_pred             cCCCCHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence            468999999865       2489999999999999999999999   999999999999999999999999998765433


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccc-
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ-  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  159 (242)
                      ....  .....++..|++||.+.+.  .++.++|+||||+++|++++|..||......        ............. 
T Consensus       168 ~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--------~~~~~~~~~~~~~~  235 (285)
T cd06648         168 EVPR--RKSLVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--------QAMKRIRDNLPPKL  235 (285)
T ss_pred             CCcc--cccccCCccccCHHHhcCC--CCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--------HHHHHHHhcCCCCC
Confidence            2211  1122478899999988653  5688999999999999999999998643211        0001111110000 


Q ss_pred             -cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          160 -LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       160 -~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                       ....++.       .+.+++.+||+.||++|||+.+++++
T Consensus       236 ~~~~~~~~-------~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         236 KNLHKVSP-------RLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             cccccCCH-------HHHHHHHHHcccChhhCcCHHHHccC
Confidence             1111333       34555666999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.7e-27  Score=199.19  Aligned_cols=151  Identities=26%  Similarity=0.370  Sum_probs=123.2

Q ss_pred             HHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceee-CCCCceEEcccccccccCCCcccchhcccccccccccchhhh
Q 026160           25 RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL-DEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFC  103 (242)
Q Consensus        25 ~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~-~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~  103 (242)
                      .++..|+++|+.|+.|||.+   ||+||||||.|||+ ...+.++|+|||.+......     +...+.|..|.|||++.
T Consensus       415 ~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~  486 (612)
T KOG0603|consen  415 SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLA  486 (612)
T ss_pred             HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhc
Confidence            78888999999999999998   99999999999999 58889999999999876654     22335788999999987


Q ss_pred             cccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccccccccchHHHHHHHHHHHHHHHhc
Q 026160          104 RSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCI  183 (242)
Q Consensus       104 ~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl  183 (242)
                      .  ..++.++|+||||+++|+|++|..||......       ..+...+..+   .+...+++++++++..       ||
T Consensus       487 ~--~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~ei~~~i~~~---~~s~~vS~~AKdLl~~-------LL  547 (612)
T KOG0603|consen  487 I--QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IEIHTRIQMP---KFSECVSDEAKDLLQQ-------LL  547 (612)
T ss_pred             c--CCCCcchhhHHHHHHHHHHHhCCCccccCCch-------HHHHHhhcCC---ccccccCHHHHHHHHH-------hc
Confidence            4  48899999999999999999999999765543       1222222222   1225688999999998       45


Q ss_pred             cCCCCCCCCHHHHHHHhhc
Q 026160          184 QTNPSDRPSMHEVLEMLES  202 (242)
Q Consensus       184 ~~dp~~Rps~~~ll~~l~~  202 (242)
                      +.||.+|+++.++..+=..
T Consensus       548 ~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  548 QVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             cCChhhCcChhhhccCcch
Confidence            9999999999999877665

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=3.9e-27  Score=187.72  Aligned_cols=171  Identities=25%  Similarity=0.334  Sum_probs=124.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      ..+++..+..++.|++.||.|||+.   +++|+||+|.||+++.++.++|+|||++.....
T Consensus        79 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  149 (260)
T cd05611          79 LNGGDCASLIKTL------GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE  149 (260)
T ss_pred             cCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc
Confidence            5789999999654      3589999999999999999999998   999999999999999999999999998875433


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ..      ...++..|.+||.+.+.  .++.++|+||||+++|++++|..||.......   .+ ... ...........
T Consensus       150 ~~------~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~-~~~-~~~~~~~~~~~  216 (260)
T cd05611         150 NK------KFVGTPDYLAPETILGV--GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA---VF-DNI-LSRRINWPEEV  216 (260)
T ss_pred             cc------cCCCCcCccChhhhcCC--CCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH---HH-HHH-HhcccCCCCcc
Confidence            11      12377889999998654  46889999999999999999999996432210   00 000 00000011111


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML  200 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l  200 (242)
                      ...++.++.       +++.+||+.||++||++.++.+.|
T Consensus       217 ~~~~~~~~~-------~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         217 KEFCSPEAV-------DLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             cccCCHHHH-------HHHHHHccCCHHHccCCCcHHHHH
Confidence            122344444       455558899999999776555443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.94  E-value=9.1e-27  Score=186.01  Aligned_cols=182  Identities=28%  Similarity=0.415  Sum_probs=130.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++.....   ...+++..+..++.|++.|+.+||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~  154 (267)
T cd06610          81 LSGGSLLDIMKSSYP---RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLAD  154 (267)
T ss_pred             cCCCcHHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence            578999999865321   24689999999999999999999998   999999999999999999999999999876554


Q ss_pred             Ccccc--hhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           81 KKSTI--SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        81 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      .....  ......++..|++||.+... ...+.++|+||||+++|++++|+.||.......       ........ ...
T Consensus       155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-------~~~~~~~~-~~~  225 (267)
T cd06610         155 GGDRTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMK-------VLMLTLQN-DPP  225 (267)
T ss_pred             CccccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhh-------hHHHHhcC-CCC
Confidence            32221  11223478899999987654 357889999999999999999999996443211       00000000 001


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .....  .....+...+.+++.+||+.||++|||+.+++++
T Consensus       226 ~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         226 SLETG--ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             CcCCc--cccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            11100  0011233445566666999999999999999864

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.94  E-value=8.5e-27  Score=186.46  Aligned_cols=177  Identities=27%  Similarity=0.420  Sum_probs=126.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCC-ceEEcccccccccC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF-CPKISDFGLAKQSQ   79 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~-~~~L~dfg~~~~~~   79 (242)
                      +++|+|.+++.+.      +.+++..+..++.|++.||.|||+.   +++|+||+|.||+++.++ .++|+|||.+....
T Consensus        85 ~~~~~L~~~l~~~------~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          85 MAGGSVSHLLSKY------GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             cCCCcHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            4789999999754      4589999999999999999999999   999999999999998765 58999999987655


Q ss_pred             CCcccc--hhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           80 DKKSTI--SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        80 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      ......  ......++..|.|||.+.+.  ..+.++|+||||+++|++++|..||.........    ............
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~  229 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGE--QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL----ALIFKIASATTA  229 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH----HHHHHHhccCCC
Confidence            432111  01122467899999988653  5688999999999999999999998643321110    111111111111


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ...+..+++++.       +++.+||..+|++|||+.+++++
T Consensus       230 ~~~~~~~~~~~~-------~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         230 PSIPEHLSPGLR-------DVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             CCCchhhCHHHH-------HHHHHHcCCCcccCcCHHHHhcC
Confidence            222223334444       45555889999999999999853

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.94  E-value=8.4e-27  Score=187.65  Aligned_cols=174  Identities=30%  Similarity=0.401  Sum_probs=127.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++.+...    ..+++.++..++.|++.|+.|||+.   +++|+||+|.||+++.++.++|+|||++.....
T Consensus        75 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~  147 (277)
T cd05577          75 MNGGDLKYHIYNVGE----PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG  147 (277)
T ss_pred             CCCCcHHHHHHHcCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc
Confidence            468999999976532    4689999999999999999999999   999999999999999999999999998875543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....   ....++..|.+||.+.+.  .++.++|+||||+++|++++|+.||........    ......... ......
T Consensus       148 ~~~~---~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~-~~~~~~  217 (277)
T cd05577         148 GKKI---KGRAGTPGYMAPEVLQGE--VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE----KEELKRRTL-EMAVEY  217 (277)
T ss_pred             CCcc---ccccCCCCcCCHHHhcCC--CCCchhhhHHHHHHHHHHhhCCCCCCCCccccc----HHHHHhccc-cccccC
Confidence            2211   122467889999998654  478899999999999999999999964433111    011111111 111222


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRP-----SMHEVLE  198 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp-----s~~~ll~  198 (242)
                      +...++.+.+++.+       ||+.||++||     ++.+++.
T Consensus       218 ~~~~~~~~~~li~~-------~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         218 PDKFSPEAKDLCEA-------LLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CccCCHHHHHHHHH-------HccCChhHccCCCcccHHHHHh
Confidence            33445556555555       8899999999     6666764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.94  E-value=1.5e-27  Score=198.98  Aligned_cols=172  Identities=26%  Similarity=0.417  Sum_probs=125.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.+.      +.+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        83 ~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~  153 (360)
T cd05627          83 LPGGDMMTLLMKK------DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK  153 (360)
T ss_pred             CCCccHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence            6899999999765      4599999999999999999999999   999999999999999999999999999864422


Q ss_pred             Cccc---------------------------------chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh
Q 026160           81 KKST---------------------------------ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV  127 (242)
Q Consensus        81 ~~~~---------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~  127 (242)
                      ....                                 .......|+..|+|||++.+.  .++.++|+|||||++|+|++
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyel~t  231 (360)
T cd05627         154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLI  231 (360)
T ss_pred             ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC--CCCCcceeccccceeeeccc
Confidence            1000                                 000123588999999998654  67889999999999999999


Q ss_pred             cCCCccccccCCCCCcCcchhhhccCC-CCccccc--cccchHHHHHHHHHHHHHHHhccCCCCCCCC---HHHHHHH
Q 026160          128 GRKNADVKASRSSDIYFPNSIYKHIEP-GNDFQLD--GVVTEEEKELVKKMILVSLWCIQTNPSDRPS---MHEVLEM  199 (242)
Q Consensus       128 g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps---~~~ll~~  199 (242)
                      |..||.......        ....+.. .....++  ..+++++++++.+|       + .||.+|++   +.+++++
T Consensus       232 G~~Pf~~~~~~~--------~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l-------~-~~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         232 GYPPFCSETPQE--------TYRKVMNWKETLVFPPEVPISEKAKDLILRF-------C-TDSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCCCCCCHHH--------HHHHHHcCCCceecCCCCCCCHHHHHHHHHh-------c-cChhhcCCCCCHHHHhcC
Confidence            999996443211        1111111 0111111  22566666666653       2 49999985   6777765

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.94  E-value=1.4e-26  Score=187.14  Aligned_cols=178  Identities=27%  Similarity=0.415  Sum_probs=127.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|..++....   ....+++..+..++.+++.|+.|||+.  .+++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  155 (286)
T cd06622          81 MDAGSLDKLYAGGV---ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA  155 (286)
T ss_pred             cCCCCHHHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence            57899988886531   124699999999999999999999963  1899999999999999999999999999875533


Q ss_pred             Ccccchhcccccccccccchhhhccc----CCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCC
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSF----GGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN  156 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~----~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  156 (242)
                      ....    ...++..|++||.+.+..    ..++.++|+|||||++|++++|..||.......  .   ...........
T Consensus       156 ~~~~----~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~---~~~~~~~~~~~  226 (286)
T cd06622         156 SLAK----TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--I---FAQLSAIVDGD  226 (286)
T ss_pred             Cccc----cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--H---HHHHHHHhhcC
Confidence            2221    123677899999875431    134789999999999999999999986432111  0   01111111222


Q ss_pred             ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          157 DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ....+..++.++.+++       .+||+.+|++||++.+++..
T Consensus       227 ~~~~~~~~~~~~~~li-------~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         227 PPTLPSGYSDDAQDFV-------AKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             CCCCCcccCHHHHHHH-------HHHcccCcccCCCHHHHhcC
Confidence            2223333455555444       45889999999999999974

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.94  E-value=1.4e-26  Score=184.76  Aligned_cols=175  Identities=30%  Similarity=0.488  Sum_probs=127.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++...      ..+++..+..++.+++.|+.|||+.   +++|+||++.||+++.++.++|+|||++.....
T Consensus        81 ~~~~~L~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~  151 (264)
T cd06626          81 CSGGTLEELLEHG------RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN  151 (264)
T ss_pred             CCCCcHHHHHhhc------CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence            4789999998754      3488999999999999999999999   999999999999999999999999999876654


Q ss_pred             Ccccchh--cccccccccccchhhhccc-CCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           81 KKSTISM--LHARGTIGYIAPEVFCRSF-GGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        81 ~~~~~~~--~~~~~~~~y~~PE~~~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      .......  ....++..|++||.+.... ...+.++|+||||+++|++++|..||......       ............
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~  224 (264)
T cd06626         152 NTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-------FQIMFHVGAGHK  224 (264)
T ss_pred             CCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-------HHHHHHHhcCCC
Confidence            3222111  1124678999999986542 23688999999999999999999999644311       111111111111


Q ss_pred             ccccc--ccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 026160          158 FQLDG--VVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE  198 (242)
Q Consensus       158 ~~~~~--~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~  198 (242)
                      ..++.  .++..+.       +++.+||+.||++|||+.+++.
T Consensus       225 ~~~~~~~~~~~~~~-------~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         225 PPIPDSLQLSPEGK-------DFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCCcccccCHHHH-------HHHHHHccCCcccCCCHHHHhc
Confidence            11221  1244444       4455599999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.94  E-value=1.2e-26  Score=184.16  Aligned_cols=175  Identities=30%  Similarity=0.423  Sum_probs=130.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++++|.+++.+.      ..+++.+++.++.+++.++.|||+.   +++|+||+|.||+++.++.++|+|||.+.....
T Consensus        83 ~~~~~L~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          83 VSGGSLSSLLKKF------GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             cCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            3688999998765      3699999999999999999999998   999999999999999999999999999887665


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ...........++..|.+||.+...  ..+.++|+||||++++++++|..||......      ................
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~  225 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRGE--EYGRAADIWSLGCTVIEMATGKPPWSELGNP------MAALYKIGSSGEPPEI  225 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCch------HHHHHhccccCCCcCC
Confidence            4331111123478899999988654  4789999999999999999999998755411      0111111111112222


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      +...+..       +.+++.+||+.||++||++.+++.+
T Consensus       226 ~~~~~~~-------l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         226 PEHLSEE-------AKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             CcccCHH-------HHHHHHHhCcCChhhCCCHHHHhhC
Confidence            3333444       4444555999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.94  E-value=6.9e-27  Score=190.73  Aligned_cols=177  Identities=24%  Similarity=0.302  Sum_probs=124.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      ++||+|.+++...      +.+++..+..++.|++.|+.|||+.   +++|+||+|.||+++.++.++|+|||++.....
T Consensus        83 ~~g~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~  153 (305)
T cd05609          83 VEGGDCATLLKNI------GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM  153 (305)
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence            5789999999654      4589999999999999999999998   999999999999999999999999998763211


Q ss_pred             Ccc-------------cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcch
Q 026160           81 KKS-------------TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNS  147 (242)
Q Consensus        81 ~~~-------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~  147 (242)
                      ...             ........++..|+|||.+...  ..+.++|+||||+++|++++|..||......       ..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-------~~  224 (305)
T cd05609         154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-------EL  224 (305)
T ss_pred             CccccccccccccchhhccccCCccCccccCchhccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HH
Confidence            100             0000112367789999987653  5688999999999999999999998633211       11


Q ss_pred             hhhccCCC-CccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 026160          148 IYKHIEPG-NDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES  202 (242)
Q Consensus       148 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~  202 (242)
                      ........ ........++.++.+++       .+||+.||++||++.++.+.|+.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~li-------~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         225 FGQVISDDIEWPEGDEALPADAQDLI-------SRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HHHHHhcccCCCCccccCCHHHHHHH-------HHHhccChhhccCccCHHHHHhC
Confidence            11111110 11111113444454444       45889999999996666555554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.94  E-value=4.5e-27  Score=193.98  Aligned_cols=181  Identities=23%  Similarity=0.278  Sum_probs=125.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.+++.+..     ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        83 ~~gg~L~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          83 YVGGDLLTLLSKFE-----DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             CCCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            57999999997632     3589999999999999999999999   999999999999999999999999999876543


Q ss_pred             Ccccchhcccccccccccchhhhccc---CCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSF---GGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~---~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      ..... .....|+..|+|||.+....   ..++.++|+||||+++|+|++|+.||........    ...+.........
T Consensus       155 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~----~~~i~~~~~~~~~  229 (331)
T cd05624         155 DGTVQ-SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET----YGKIMNHEERFQF  229 (331)
T ss_pred             CCcee-eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH----HHHHHcCCCcccC
Confidence            32211 11235899999999885421   2467899999999999999999999964332110    0000000000001


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ......+++++.+++.+|+     |...++..|+++++++++
T Consensus       230 p~~~~~~~~~~~~li~~ll-----~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         230 PSHITDVSEEAKDLIQRLI-----CSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             CCccccCCHHHHHHHHHHc-----cCchhhcCCCCHHHHhcC
Confidence            1111235666777776654     322233335788888865

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.94  E-value=1.3e-26  Score=186.22  Aligned_cols=175  Identities=27%  Similarity=0.395  Sum_probs=134.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      ||||+|..+++++.    ++.+++..+...+..++.||+|||..   |||+|||||+|||+-++|.+-|+||+++.....
T Consensus       159 CpGGdL~~LrqkQp----~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  159 CPGGDLHSLRQKQP----GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             CCCccHHHHHhhCC----CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            89999999998764    48999999999999999999999999   999999999999999999999999999864321


Q ss_pred             Cc-------------------------------ccch--------------h---------cccccccccccchhhhccc
Q 026160           81 KK-------------------------------STIS--------------M---------LHARGTIGYIAPEVFCRSF  106 (242)
Q Consensus        81 ~~-------------------------------~~~~--------------~---------~~~~~~~~y~~PE~~~~~~  106 (242)
                      ..                               ....              .         ..++||-.|+|||++.+. 
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~-  310 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE-  310 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC-
Confidence            00                               0000              0         013588999999999875 


Q ss_pred             CCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCC
Q 026160          107 GGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTN  186 (242)
Q Consensus       107 ~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~d  186 (242)
                       +...+.|-|+|||++|||+.|.-||-..+...       -...-+...........++..++++|++++       .+|
T Consensus       311 -GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~-------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LL-------vKd  375 (459)
T KOG0610|consen  311 -GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-------TLRNIVGQPLKFPEEPEVSSAAKDLIRKLL-------VKD  375 (459)
T ss_pred             -CCCchhhHHHHHHHHHHHHhCCCCcCCCCchh-------hHHHHhcCCCcCCCCCcchhHHHHHHHHHh-------ccC
Confidence             67889999999999999999999998666432       111111122222222346677888888855       999


Q ss_pred             CCCCCC----HHHHHH
Q 026160          187 PSDRPS----MHEVLE  198 (242)
Q Consensus       187 p~~Rps----~~~ll~  198 (242)
                      |.+|.-    +.|+.+
T Consensus       376 P~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  376 PSKRLGSKRGAAEIKR  391 (459)
T ss_pred             hhhhhccccchHHhhc
Confidence            999987    777764

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.94  E-value=3.6e-27  Score=194.75  Aligned_cols=171  Identities=27%  Similarity=0.418  Sum_probs=131.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +|||++..+|...      ..|++..+...+.+.+.|+..+|+.   |++||||||+|+||+..|.+||+|||++.-...
T Consensus       223 lPGGD~mTLL~~~------~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~  293 (550)
T KOG0605|consen  223 LPGGDMMTLLMRK------DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK  293 (550)
T ss_pred             cCCccHHHHHHhc------CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhh
Confidence            5899999999876      5699999999999999999999999   999999999999999999999999999852211


Q ss_pred             C---------------------cccc------hh------------------cccccccccccchhhhcccCCCCCCccc
Q 026160           81 K---------------------KSTI------SM------------------LHARGTIGYIAPEVFCRSFGGASHKSDV  115 (242)
Q Consensus        81 ~---------------------~~~~------~~------------------~~~~~~~~y~~PE~~~~~~~~~~~~~Di  115 (242)
                      .                     ....      ..                  ...+||+-|+|||++.+.  ++....|.
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k--gY~~~cDw  371 (550)
T KOG0605|consen  294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK--GYGKECDW  371 (550)
T ss_pred             hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC--CCCccccH
Confidence            0                     0000      00                  013599999999999886  68889999


Q ss_pred             hhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhcc---CCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCC-
Q 026160          116 YSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHI---EPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRP-  191 (242)
Q Consensus       116 ~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp-  191 (242)
                      ||||||+|||+.|.+||......        ...+++   ......+....+++++.+++.+++       . ||++|. 
T Consensus       372 WSLG~ImyEmLvGyPPF~s~tp~--------~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll-------~-d~~~RLG  435 (550)
T KOG0605|consen  372 WSLGCIMYEMLVGYPPFCSETPQ--------ETYRKIVNWRETLKFPEEVDLSDEAKDLITRLL-------C-DPENRLG  435 (550)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHHhhhccCCCcCcccHHHHHHHHHHh-------c-CHHHhcC
Confidence            99999999999999999765532        121111   111122233346788899999866       4 999996 


Q ss_pred             --CHHHHHH
Q 026160          192 --SMHEVLE  198 (242)
Q Consensus       192 --s~~~ll~  198 (242)
                        .+.||.+
T Consensus       436 ~~G~~EIK~  444 (550)
T KOG0605|consen  436 SKGAEEIKK  444 (550)
T ss_pred             cccHHHHhc
Confidence              4666654

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=5.7e-27  Score=186.77  Aligned_cols=177  Identities=24%  Similarity=0.304  Sum_probs=127.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....     ..++..++..++.|++.|+.|||+.   +++|+||+|.||+++.++.++|+|||++.....
T Consensus        82 ~~~~~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          82 CGGGSLQDIYQVTR-----GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             CCCCcHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhh
Confidence            46789999886642     4589999999999999999999998   999999999999999999999999999876543


Q ss_pred             Ccccchhcccccccccccchhhhcc-cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCC-CCcc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRS-FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEP-GNDF  158 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~  158 (242)
                      ....  .....++..|.+||.+... ....+.++|+||||+++|+|++|..||........       ....... ....
T Consensus       154 ~~~~--~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-------~~~~~~~~~~~~  224 (262)
T cd06613         154 TIAK--RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-------LFLISKSNFPPP  224 (262)
T ss_pred             hhhc--cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhccCCCc
Confidence            2211  1122477889999987542 12567899999999999999999999864332110       0000000 0000


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ..     .........+.+++.+||..||.+|||+.+++.+
T Consensus       225 ~~-----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         225 KL-----KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             cc-----cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00     0111223345667777999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.94  E-value=9.6e-27  Score=188.27  Aligned_cols=185  Identities=27%  Similarity=0.362  Sum_probs=130.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++.....  ....++...+..++.|++.||.|||+.   +++|+||++.||+++.++.++|+|||++.....
T Consensus        83 ~~~~~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          83 CEGGSLDSIYKKVKK--RGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             cCCCCHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            578999888764321  235689999999999999999999998   999999999999999999999999999865443


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....    ...++..|.+||.+.+.  .++.++|+||||+++|++++|..||.........   ...............+
T Consensus       158 ~~~~----~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~  228 (287)
T cd06621         158 SLAG----TFTGTSFYMAPERIQGK--PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG---PIELLSYIVNMPNPEL  228 (287)
T ss_pred             cccc----cccCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC---hHHHHHHHhcCCchhh
Confidence            2211    12367889999987553  5688999999999999999999999755321100   0111111111111111


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML  200 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l  200 (242)
                      ..... ........+.+++.+||+.||++|||+.+++++-
T Consensus       229 ~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~  267 (287)
T cd06621         229 KDEPG-NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP  267 (287)
T ss_pred             ccCCC-CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence            11111 0011234456677779999999999999999843

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.94  E-value=1.2e-26  Score=188.30  Aligned_cols=172  Identities=26%  Similarity=0.352  Sum_probs=126.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++.+.       .+++.++..++.|++.|+.|||++   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        98 ~~~~~L~~~~~~~-------~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~  167 (293)
T cd06647          98 LAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (293)
T ss_pred             CCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence            4789999998653       488999999999999999999999   999999999999999999999999998865443


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      .....  ....++..|++||.+...  ..+.++|+||||+++|++++|..||..........    ....  ........
T Consensus       168 ~~~~~--~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~----~~~~--~~~~~~~~  237 (293)
T cd06647         168 EQSKR--STMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY----LIAT--NGTPELQN  237 (293)
T ss_pred             ccccc--ccccCChhhcCchhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee----ehhc--CCCCCCCC
Confidence            32211  112477889999987553  56889999999999999999999997543321110    0000  00000111


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ...++..       +.+++.+||+.+|++||++.+++.+
T Consensus       238 ~~~~~~~-------l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         238 PEKLSAI-------FRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             ccccCHH-------HHHHHHHHccCChhhCcCHHHHhcC
Confidence            1122333       4455566999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.94  E-value=7.7e-27  Score=190.09  Aligned_cols=121  Identities=29%  Similarity=0.431  Sum_probs=98.7

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      |+|.+++....     ..+++..+..++.|+++||.|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        88 ~~l~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          88 KDLKQYLDDCG-----NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             cCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            57777776532     4588999999999999999999999   999999999999999999999999999875433221


Q ss_pred             cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           84 TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      ..  ....++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||...
T Consensus       160 ~~--~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~  208 (301)
T cd07873         160 TY--SNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGS  208 (301)
T ss_pred             cc--cccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            11  122367899999987653 35678999999999999999999998644

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.94  E-value=8.1e-27  Score=188.41  Aligned_cols=182  Identities=26%  Similarity=0.364  Sum_probs=129.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++.+.      +.+++..+..++.+++.++.|||+.  .+++|+||+|+||+++.++.++|+|||++.....
T Consensus        85 ~~~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~  156 (284)
T cd06620          85 MDCGSLDRIYKKG------GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN  156 (284)
T ss_pred             CCCCCHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence            5789999988664      3589999999999999999999973  1899999999999999999999999998765432


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcch---hhhccCCCCc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNS---IYKHIEPGND  157 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~  157 (242)
                      ....    ...++..|++||.+.+.  ..+.++|+|||||++|++++|..||...............   ..........
T Consensus       157 ~~~~----~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd06620         157 SIAD----TFVGTSTYMSPERIQGG--KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP  230 (284)
T ss_pred             hccC----ccccCcccCCHHHHccC--CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC
Confidence            2111    23478899999987543  6788999999999999999999999754432111000000   0011111111


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES  202 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~  202 (242)
                      ..++..      .....+.+++.+||+.||++|||+.+++++..-
T Consensus       231 ~~~~~~------~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~  269 (284)
T cd06620         231 PRLPSS------DFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF  269 (284)
T ss_pred             CCCCch------hcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence            111111      123345566667999999999999999987543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.3e-26  Score=187.71  Aligned_cols=193  Identities=22%  Similarity=0.269  Sum_probs=141.6

Q ss_pred             CCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhh-----CCCCCeeecCCCCCceeeCCCCceEEccccccc
Q 026160            2 PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHR-----GCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK   76 (242)
Q Consensus         2 ~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~-----~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~   76 (242)
                      |+|||+|||...       .++.+..++++..++.||+|||.     ++++.|.|||||.+|||+.+++..-++|+|++.
T Consensus       292 e~GSL~DyL~r~-------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv  364 (513)
T KOG2052|consen  292 EHGSLYDYLNRN-------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  364 (513)
T ss_pred             cCCcHHHHHhhc-------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence            789999999763       69999999999999999999996     457899999999999999999999999999998


Q ss_pred             ccCCCccc--chhcccccccccccchhhhcccCCC----CCCccchhHHHHHHHHHhc----------CCCccccccCCC
Q 026160           77 QSQDKKST--ISMLHARGTIGYIAPEVFCRSFGGA----SHKSDVYSYGMMILEMAVG----------RKNADVKASRSS  140 (242)
Q Consensus        77 ~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~----~~~~Di~slG~~~~~ll~g----------~~p~~~~~~~~~  140 (242)
                      +.......  .....+.||.+|+|||++.......    -..+||||||.|+||+..+          +.||...-..+.
T Consensus       365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP  444 (513)
T KOG2052|consen  365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP  444 (513)
T ss_pred             EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence            76654222  2223457999999999996543221    2457999999999999764          345543333322


Q ss_pred             CCcCcchhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhh
Q 026160          141 DIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTE  205 (242)
Q Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~  205 (242)
                      .+.  +....-......+..+...  .....++.|.++|..||..||.-|.|+--+.+.|.++.+
T Consensus       445 s~e--eMrkVVCv~~~RP~ipnrW--~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  445 SFE--EMRKVVCVQKLRPNIPNRW--KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CHH--HHhcceeecccCCCCCccc--ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            211  1111111111112222111  124567889999999999999999999999999998875

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.94  E-value=1.6e-26  Score=182.60  Aligned_cols=171  Identities=30%  Similarity=0.430  Sum_probs=127.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++++|.+++....     ..+++..+..++.+++.|+.+||..   +++|+||+|.||+++.++.++|+|||.+.....
T Consensus        79 ~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  150 (253)
T cd05122          79 CSGGSLKDLLKSTN-----QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSD  150 (253)
T ss_pred             CCCCcHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccccc
Confidence            46789999987642     4699999999999999999999998   999999999999999999999999999876655


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ...   .....++..|.+||.+...  ..+.++|+||||+++|++++|..||.......       ....... ......
T Consensus       151 ~~~---~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~-~~~~~~  217 (253)
T cd05122         151 TKA---RNTMVGTPYWMAPEVINGK--PYDYKADIWSLGITAIELAEGKPPYSELPPMK-------ALFKIAT-NGPPGL  217 (253)
T ss_pred             ccc---ccceecCCcccCHHHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCchHH-------HHHHHHh-cCCCCc
Confidence            432   1123478899999998654  47889999999999999999999986443211       1111110 111111


Q ss_pred             c--cccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 D--GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~--~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .  ..++..       +.+++.+||+.||++|||+.+++++
T Consensus       218 ~~~~~~~~~-------~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         218 RNPEKWSDE-------FKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             CcccccCHH-------HHHHHHHHccCChhhCCCHHHHhcC
Confidence            1  112333       4445555999999999999999864

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.94  E-value=1.3e-26  Score=187.76  Aligned_cols=167  Identities=28%  Similarity=0.424  Sum_probs=127.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++...      ..++...+..++.|+++||.|||+.   +++|+||+|.||+++.++.++|+|||++.....
T Consensus        83 ~~~~~L~~~~~~~------~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          83 VPGGELFSHLRKS------GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            4689999999765      4599999999999999999999998   999999999999999999999999999876554


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ..     ....++..|++||.+.+.  ..+.++|+||||+++|++++|..||.....        ......... ....+
T Consensus       154 ~~-----~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~-~~~~~  217 (290)
T cd05580         154 RT-----YTLCGTPEYLAPEIILSK--GYGKAVDWWALGILIYEMLAGYPPFFDDNP--------IQIYEKILE-GKVRF  217 (290)
T ss_pred             CC-----CCCCCCccccChhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhc-CCccC
Confidence            31     122478899999987543  567899999999999999999999864431        111111111 11223


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRP-----SMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp-----s~~~ll~~  199 (242)
                      +...+..+.+++.+       ||..||++|+     ++++++++
T Consensus       218 ~~~~~~~l~~li~~-------~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         218 PSFFSPDAKDLIRN-------LLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             CccCCHHHHHHHHH-------HccCCHHHccCcccCCHHHHHcC
Confidence            33445555555554       8899999999     77777744

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.94  E-value=2.8e-26  Score=185.13  Aligned_cols=184  Identities=24%  Similarity=0.246  Sum_probs=126.7

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      |+|.+++.....    ..+++.++..++.|+++||.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        90 ~~l~~~l~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~  162 (287)
T cd07838          90 QDLATYLSKCPK----PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA  162 (287)
T ss_pred             cCHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceeccCCcc
Confidence            567777755321    3589999999999999999999998   999999999999999999999999999876544322


Q ss_pred             cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCC------cCcchhh-hccC---
Q 026160           84 TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDI------YFPNSIY-KHIE---  153 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~------~~~~~~~-~~~~---  153 (242)
                      ..   ...++..|++||.+.+.  ..+.++|+||||+++|+|++|.+||..........      ....... ....   
T Consensus       163 ~~---~~~~~~~~~~PE~~~~~--~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07838         163 LT---SVVVTLWYRAPEVLLQS--SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP  237 (287)
T ss_pred             cc---cccccccccChHHhccC--CCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence            21   12367889999998654  56889999999999999999998886433211000      0000000 0000   


Q ss_pred             -CCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          154 -PGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       154 -~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                       .....................+.+++.+||+.||++||++.+++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         238 RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             hhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence             0000000011111122344566778888999999999999998853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.94  E-value=1.2e-26  Score=185.47  Aligned_cols=185  Identities=20%  Similarity=0.276  Sum_probs=148.7

Q ss_pred             CCCcchhcccc--CCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            3 NGSLDQFTYDQ--ESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         3 ~GsL~~~l~~~--~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      -|||+.||...  ........++..+...++.|++.|++|||+.   +|+|.||..+|++|+..-++||+|-.+++....
T Consensus       372 ~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP  448 (563)
T KOG1024|consen  372 VGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSRDLFP  448 (563)
T ss_pred             cchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhccccCc
Confidence            48999999832  2334556788899999999999999999999   999999999999999999999999999986654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ....--....-.+..|+++|.+...  .++.++|+||||+++||+++ |+.|+..-+        +......+.++.+..
T Consensus       449 ~DYhcLGDnEnRPvkWMslEal~n~--~yssasDvWsfGVllWELmtlg~~PyaeID--------PfEm~~ylkdGyRla  518 (563)
T KOG1024|consen  449 GDYHCLGDNENRPVKWMSLEALQNS--HYSSASDVWSFGVLLWELMTLGKLPYAEID--------PFEMEHYLKDGYRLA  518 (563)
T ss_pred             ccccccCCCCCCcccccCHHHHhhh--hhcchhhhHHHHHHHHHHHhcCCCCccccC--------HHHHHHHHhccceec
Confidence            4333222222356789999999765  78999999999999999997 777765333        466777888888888


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhc
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEIL  207 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~  207 (242)
                      .+-++++++...+.       -||+.+|++||++.|+...|..+-.++
T Consensus       519 QP~NCPDeLf~vMa-------cCWallpeeRPsf~Qlv~cLseF~~ql  559 (563)
T KOG1024|consen  519 QPFNCPDELFTVMA-------CCWALLPEERPSFSQLVICLSEFHTQL  559 (563)
T ss_pred             CCCCCcHHHHHHHH-------HHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence            88888887765544       499999999999999999998765543

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.94  E-value=1.4e-26  Score=184.42  Aligned_cols=170  Identities=29%  Similarity=0.376  Sum_probs=127.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++...      ..++..++..++.|+++||.|||+.   +++|+||+|.||+++.++.++|+|||++.....
T Consensus        82 ~~~~~L~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~  152 (258)
T cd05578          82 LLGGDLRYHLSQK------VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTP  152 (258)
T ss_pred             CCCCCHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence            5789999999764      4689999999999999999999998   999999999999999999999999999876554


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....   ....++..|.+||.+...  ..+.++|+||||+++|++++|..||.......     .......... .....
T Consensus       153 ~~~~---~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~-~~~~~  221 (258)
T cd05578         153 DTLT---TSTSGTPGYMAPEVLCRQ--GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-----RDQIRAKQET-ADVLY  221 (258)
T ss_pred             Cccc---cccCCChhhcCHHHHccc--CCCCcccchhhHHHHHHHHhCCCCCCCCCccH-----HHHHHHHhcc-ccccC
Confidence            3221   123477899999998654  47889999999999999999999987554321     1111111111 11222


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCH--HHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSM--HEVL  197 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~--~~ll  197 (242)
                      +...+       ..+.+++.+||+.||.+||++  .+++
T Consensus       222 ~~~~~-------~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         222 PATWS-------TEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             cccCc-------HHHHHHHHHHccCChhHcCCccHHHHh
Confidence            33334       344455556899999999999  6554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.94  E-value=2e-26  Score=182.89  Aligned_cols=175  Identities=24%  Similarity=0.334  Sum_probs=130.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++++|.+++.....  .+..+++.++..++.+++.|+.+||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  155 (258)
T cd08215          81 ADGGDLSQKIKKQKK--EGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS  155 (258)
T ss_pred             cCCCcHHHHHHHhhc--cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence            468899999976421  236799999999999999999999999   999999999999999999999999999876554


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....++..|.+||.+...  ..+.++|+||+|++++++++|..||......        .............+
T Consensus       156 ~~~~--~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~  223 (258)
T cd08215         156 TVDL--AKTVVGTPYYLSPELCQNK--PYNYKSDIWSLGCVLYELCTLKHPFEGENLL--------ELALKILKGQYPPI  223 (258)
T ss_pred             Ccce--ecceeeeecccChhHhccC--CCCccccHHHHHHHHHHHHcCCCCCCCCcHH--------HHHHHHhcCCCCCC
Confidence            4311  1123478889999987653  5688999999999999999999998644321        11111111112222


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      +..++..+       .+++.+||..+|++|||+.+++++
T Consensus       224 ~~~~~~~~-------~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         224 PSQYSSEL-------RNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             CCCCCHHH-------HHHHHHHcCCChhhCcCHHHHhcC
Confidence            33344444       445555999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.94  E-value=1.4e-26  Score=184.59  Aligned_cols=174  Identities=29%  Similarity=0.424  Sum_probs=125.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++.+.      +.+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        75 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~  145 (265)
T cd05579          75 LPGGDLASLLENV------GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV  145 (265)
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhccc
Confidence            4688999999764      3589999999999999999999998   999999999999999999999999998875443


Q ss_pred             Cccc------chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCC
Q 026160           81 KKST------ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEP  154 (242)
Q Consensus        81 ~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  154 (242)
                      ....      .......++..|++||.....  ..+.++|+||||+++|++++|..||......        ........
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~  215 (265)
T cd05579         146 RRQINLNDDEKEDKRIVGTPDYIAPEVILGQ--GHSKTVDWWSLGCILYEFLVGIPPFHGETPE--------EIFQNILN  215 (265)
T ss_pred             CcccccccccccccCcccCccccCHHHhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhc
Confidence            2110      011123467889999988654  4688999999999999999999998644321        11111111


Q ss_pred             CCccccccc--cchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          155 GNDFQLDGV--VTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       155 ~~~~~~~~~--~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      +. ...+..  .+..+       ..++.+||+.+|++|||+..+.+.|+
T Consensus       216 ~~-~~~~~~~~~~~~~-------~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         216 GK-IEWPEDVEVSDEA-------IDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             CC-cCCCccccCCHHH-------HHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            11 111111  23444       44555588999999999955555443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.94  E-value=1e-26  Score=183.14  Aligned_cols=157  Identities=25%  Similarity=0.316  Sum_probs=118.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++.+.      ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++++|||.+.....
T Consensus        67 ~~~~~L~~~l~~~------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~  137 (237)
T cd05576          67 AEGGKLWSHISKF------LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED  137 (237)
T ss_pred             CCCCCHHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccc
Confidence            5789999999764      3499999999999999999999998   999999999999999999999999998765543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ...     ...++..|++||.....  ..+.++|+||+|+++|++++|..|+........             .......
T Consensus       138 ~~~-----~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-------------~~~~~~~  197 (237)
T cd05576         138 SCD-----GEAVENMYCAPEVGGIS--EETEACDWWSLGAILFELLTGKTLVECHPSGIN-------------THTTLNI  197 (237)
T ss_pred             ccc-----cCCcCccccCCcccCCC--CCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-------------cccccCC
Confidence            221     12356679999987543  567899999999999999999987653221100             0001112


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSM  193 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~  193 (242)
                      +..+++.+.+++.+       ||+.||++||++
T Consensus       198 ~~~~~~~~~~li~~-------~l~~dp~~R~~~  223 (237)
T cd05576         198 PEWVSEEARSLLQQ-------LLQFNPTERLGA  223 (237)
T ss_pred             cccCCHHHHHHHHH-------HccCCHHHhcCC
Confidence            33345555555554       889999999996

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.94  E-value=1.4e-26  Score=207.57  Aligned_cols=188  Identities=21%  Similarity=0.208  Sum_probs=130.9

Q ss_pred             CCCCCcchhccccCC-----CCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccc
Q 026160            1 MPNGSLDQFTYDQES-----SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLA   75 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~-----~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~   75 (242)
                      |+||+|.+++.....     ......+++..++.++.|+++||.|||+.   +++||||||+||+++.++.++|+|||++
T Consensus        84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcc
Confidence            579999999864211     11124567788999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCcc----------------cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCC
Q 026160           76 KQSQDKKS----------------TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRS  139 (242)
Q Consensus        76 ~~~~~~~~----------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~  139 (242)
                      ........                ........|++.|+|||.+.+.  ..+.++|+|||||++|+|++|..||.......
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~--~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV--PASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC--CCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            76521100                0001123589999999988654  56889999999999999999999996533211


Q ss_pred             CCCcCcchhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHhhchhhh
Q 026160          140 SDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRP-SMHEVLEMLESSTEI  206 (242)
Q Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp-s~~~ll~~l~~~~~~  206 (242)
                      ..      ................+++.       +.+++.+||+.||++|+ +++++++.|+...+.
T Consensus       239 i~------~~~~i~~P~~~~p~~~iP~~-------L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        239 IS------YRDVILSPIEVAPYREIPPF-------LSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             hh------hhhhccChhhccccccCCHH-------HHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            00      00000000000001123333       44555669999999996 677788888776553

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.94  E-value=1.2e-26  Score=191.88  Aligned_cols=187  Identities=25%  Similarity=0.279  Sum_probs=127.5

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      |+|.+++...      +.+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        93 ~~L~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~  163 (337)
T cd07858          93 TDLHQIIRSS------QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD  163 (337)
T ss_pred             CCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCCCcc
Confidence            5677776543      4599999999999999999999999   999999999999999999999999999876544321


Q ss_pred             cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCC--------------CCC-cCcc-h
Q 026160           84 TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRS--------------SDI-YFPN-S  147 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~--------------~~~-~~~~-~  147 (242)
                      .  .....++..|+|||.+... ...+.++|+||||+++|++++|..||.......              ... .... .
T Consensus       164 ~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd07858         164 F--MTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK  240 (337)
T ss_pred             c--ccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence            1  1122467899999987543 247889999999999999999999986432100              000 0000 0


Q ss_pred             hhh---ccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--hhchhhh
Q 026160          148 IYK---HIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM--LESSTEI  206 (242)
Q Consensus       148 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~--l~~~~~~  206 (242)
                      ...   .........    .......+...+.+++.+||+.||++|||+.+++++  ++.+...
T Consensus       241 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~  300 (337)
T cd07858         241 ARRYIRSLPYTPRQS----FARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP  300 (337)
T ss_pred             hhHHHHhcCcccccC----HHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence            000   000000000    000011223445566666999999999999999988  6654433

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.94  E-value=1.3e-26  Score=188.00  Aligned_cols=189  Identities=21%  Similarity=0.240  Sum_probs=124.6

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC-CCceEEcccccccccCCCc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE-DFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~-~~~~~L~dfg~~~~~~~~~   82 (242)
                      |+|.+++..... .....+++..+..++.||++||.|||+.   +++|+||+|+||+++. ++.++|+|||++.......
T Consensus        90 ~~l~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~  165 (295)
T cd07837          90 SDLKKFMDSNGR-GPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV  165 (295)
T ss_pred             cCHHHHHHHhcc-cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccceecCCCc
Confidence            578888765432 1235689999999999999999999999   9999999999999998 8899999999987554322


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcC-------cchhhhccCCC
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYF-------PNSIYKHIEPG  155 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~-------~~~~~~~~~~~  155 (242)
                      ...  ....++..|.|||.+.+. ...+.++|+||||+++|+|++|..||............       ...........
T Consensus       166 ~~~--~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (295)
T cd07837         166 KSY--THEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKL  242 (295)
T ss_pred             ccc--CCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhc
Confidence            111  112357789999987543 34688999999999999999999998643211100000       00000000000


Q ss_pred             C----ccc-cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          156 N----DFQ-LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       156 ~----~~~-~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .    ... .+.........+...+.+++.+||+.||++||++.+++.+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         243 RDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             cchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0    000 0000000011233445566667999999999999998863

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=7.2e-27  Score=196.64  Aligned_cols=174  Identities=23%  Similarity=0.350  Sum_probs=133.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |.||-++..+-...     ++|++.++--+|.|+++||.|||++   +|+|||||..|||++.+|.++|+|||.+.....
T Consensus       111 C~GGAVDaimlEL~-----r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~  182 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELG-----RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS  182 (1187)
T ss_pred             cCCchHhHHHHHhc-----cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh
Confidence            78898888877664     5799999999999999999999999   999999999999999999999999999876544


Q ss_pred             Ccccchhcccccccccccchhhhc---ccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCR---SFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      ....  ...++||+.|+|||+..-   ....+.+++||||||+.+.||.-+.+|-...+.        ......+.....
T Consensus       183 t~qk--RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp--------MRVllKiaKSeP  252 (1187)
T KOG0579|consen  183 TRQK--RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSEP  252 (1187)
T ss_pred             HHhh--hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch--------HHHHHHHhhcCC
Confidence            3322  234579999999997632   223578999999999999999999887543222        111112222111


Q ss_pred             --cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          158 --FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       158 --~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                        .-.+..++..+.++++.       ||..||..||++.+++++
T Consensus       253 PTLlqPS~Ws~~F~DfLk~-------cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  253 PTLLQPSHWSRSFSDFLKR-------CLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             CcccCcchhhhHHHHHHHH-------HHhcCCccCCCHHHHhhC
Confidence              12245566677777766       999999999999999853

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=9e-27  Score=195.72  Aligned_cols=179  Identities=25%  Similarity=0.361  Sum_probs=139.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |.+|+|-|||.+...    .-++.-..+.++.||..|++||..+   ++|||||...|+|+.++..||++|||+++.+..
T Consensus       345 M~yGNLLdYLRecnr----~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg  417 (1157)
T KOG4278|consen  345 MCYGNLLDYLRECNR----SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTG  417 (1157)
T ss_pred             ccCccHHHHHHHhch----hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence            789999999987644    4466667788999999999999999   999999999999999999999999999997754


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ... ......+.++.|.|||.+.-  ..++.++|+|+||+++||+.| |..||-.-+.        .+....++++..-.
T Consensus       418 DTY-TAHAGAKFPIKWTAPEsLAy--NtFSiKSDVWAFGVLLWEIATYGMsPYPGidl--------SqVY~LLEkgyRM~  486 (1157)
T KOG4278|consen  418 DTY-TAHAGAKFPIKWTAPESLAY--NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVYGLLEKGYRMD  486 (1157)
T ss_pred             Cce-ecccCccCcccccCcccccc--cccccchhhHHHHHHHHHHHhcCCCCCCCccH--------HHHHHHHhcccccc
Confidence            322 22223457889999998743  367999999999999999986 6666643332        23334455555555


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESST  204 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~  204 (242)
                      -+..|++..       +.+|+.||+++|.+||++.++.+.++...
T Consensus       487 ~PeGCPpkV-------YeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  487 GPEGCPPKV-------YELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             CCCCCCHHH-------HHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence            555666654       45556699999999999999999988654

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.94  E-value=1.9e-26  Score=185.94  Aligned_cols=184  Identities=22%  Similarity=0.321  Sum_probs=128.5

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      +|+|.+++....    ...+++.++..++.|++.+|.|||++   +++|+||+|.||+++.++.++|+|||++.......
T Consensus        81 ~~~l~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (283)
T cd07830          81 EGNLYQLMKDRK----GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP  153 (283)
T ss_pred             CCCHHHHHHhcc----cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence            688888887653    24689999999999999999999999   99999999999999999999999999987655432


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCC------------CCcCcchhhh
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSS------------DIYFPNSIYK  150 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~------------~~~~~~~~~~  150 (242)
                      ...   ...++..|+|||.+... ...+.++|+||||+++|++++|..||........            ...+..... 
T Consensus       154 ~~~---~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  228 (283)
T cd07830         154 PYT---DYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK-  228 (283)
T ss_pred             CcC---CCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh-
Confidence            221   12377889999987543 3568899999999999999999998854332110            000000000 


Q ss_pred             ccCCCCccccccccchHHH----HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          151 HIEPGNDFQLDGVVTEEEK----ELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                       .........+...+....    .....+..++.+||+.||++|||+.+++.+
T Consensus       229 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         229 -LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             -hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence             000000011111111111    113456777888999999999999998764

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.94  E-value=1.9e-26  Score=185.75  Aligned_cols=184  Identities=19%  Similarity=0.206  Sum_probs=124.9

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      .|+|.+++....     ..+++.++..++.|++.||.|||+.   +++|+||+|.||+++. +.++|+|||++.......
T Consensus        83 ~~~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          83 DMNLYELIKGRK-----RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             CccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            367777775532     4689999999999999999999999   9999999999999999 999999999987654433


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCC-------CcCcchhhhccCCC
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSD-------IYFPNSIYKHIEPG  155 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~-------~~~~~~~~~~~~~~  155 (242)
                      ....   ..++..|.|||.+... ...+.++|+|||||++|++++|..||......+..       ..............
T Consensus       154 ~~~~---~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
T cd07831         154 PYTE---YISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS  229 (282)
T ss_pred             CcCC---CCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccc
Confidence            2221   2367899999976443 35678999999999999999999999643321100       00000000000000


Q ss_pred             C--cccccccc----chHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          156 N--DFQLDGVV----TEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       156 ~--~~~~~~~~----~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .  ....+...    ..........+.+++.+||+.||++||++.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            0  00011100    01111234556666677999999999999999864

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.94  E-value=8.8e-27  Score=188.46  Aligned_cols=161  Identities=29%  Similarity=0.416  Sum_probs=116.6

Q ss_pred             ccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccccc
Q 026160           20 RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAP   99 (242)
Q Consensus        20 ~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~P   99 (242)
                      ..+++..+..++.+++.|++|||+.  .+++|+||||+||+++.++.++|+|||++..........   ...++..|.+|
T Consensus       102 ~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~y~aP  176 (288)
T cd06616         102 SVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKT---RDAGCRPYMAP  176 (288)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCccc---cccCccCccCH
Confidence            5699999999999999999999973  289999999999999999999999999987554332211   12478889999


Q ss_pred             hhhhccc-CCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccccc----cccchHHHHHHHH
Q 026160          100 EVFCRSF-GGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLD----GVVTEEEKELVKK  174 (242)
Q Consensus       100 E~~~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~  174 (242)
                      |.+.... ..++.++|+||||+++|++++|+.||.......      ..... ........+.    ..++.+       
T Consensus       177 E~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~-~~~~~~~~~~~~~~~~~~~~-------  242 (288)
T cd06616         177 ERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF------DQLTQ-VVKGDPPILSNSEEREFSPS-------  242 (288)
T ss_pred             HHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHH------HHHhh-hcCCCCCcCCCcCCCccCHH-------
Confidence            9885431 256889999999999999999999986443100      11111 1111111111    123344       


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          175 MILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       175 ~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      +.+++.+||+.||++|||+.+++++
T Consensus       243 l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         243 FVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcC
Confidence            4455556999999999999999875

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.94  E-value=2.9e-26  Score=188.94  Aligned_cols=193  Identities=23%  Similarity=0.315  Sum_probs=127.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....    ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++++||+.+.....
T Consensus        81 ~~~~~l~~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~  153 (328)
T cd08226          81 MAYGSANSLLKTYF----PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVR  153 (328)
T ss_pred             ccCCCHHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhc
Confidence            46789999887642    24589999999999999999999998   999999999999999999999999975432221


Q ss_pred             Cccc--ch---hcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCC-------Cc-----
Q 026160           81 KKST--IS---MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSD-------IY-----  143 (242)
Q Consensus        81 ~~~~--~~---~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~-------~~-----  143 (242)
                      ....  ..   .....++..|++||.+.+....++.++|+|||||++|++++|..||.........       ..     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd08226         154 NGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDI  233 (328)
T ss_pred             cCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccc
Confidence            1100  00   0011245679999998664345688999999999999999999998643211000       00     


Q ss_pred             --Ccchhhh---------------ccCCCC-cccc-ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 026160          144 --FPNSIYK---------------HIEPGN-DFQL-DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML  200 (242)
Q Consensus       144 --~~~~~~~---------------~~~~~~-~~~~-~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l  200 (242)
                        .+.....               ....+. .... .....+........+.+++++||+.||++|||+.+++++-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~  309 (328)
T cd08226         234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA  309 (328)
T ss_pred             cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence              0000000               000000 0000 0001111233445677888889999999999999998543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.94  E-value=2.8e-26  Score=182.31  Aligned_cols=173  Identities=23%  Similarity=0.339  Sum_probs=126.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCC-ceEEcccccccccC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF-CPKISDFGLAKQSQ   79 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~-~~~L~dfg~~~~~~   79 (242)
                      +++++|.+++....    ...+++..+..++.+++.|+.|||+.   +++|+||+|.||+++.++ .++|+|||.+....
T Consensus        81 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~  153 (257)
T cd08225          81 CDGGDLMKRINRQR----GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN  153 (257)
T ss_pred             CCCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhcc
Confidence            47889999986542    23589999999999999999999999   999999999999998875 46999999887654


Q ss_pred             CCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           80 DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        80 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ......  ....++..|.|||.+...  ..+.++|+||||+++|++++|..||......       ....... ......
T Consensus       154 ~~~~~~--~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~-~~~~~~  221 (257)
T cd08225         154 DSMELA--YTCVGTPYYLSPEICQNR--PYNNKTDIWSLGCVLYELCTLKHPFEGNNLH-------QLVLKIC-QGYFAP  221 (257)
T ss_pred             CCcccc--cccCCCccccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHH-------HHHHHHh-cccCCC
Confidence            432211  123478889999987553  5788999999999999999999998643211       1111111 111111


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .....+..       +.+++.+||..+|++|||+.+++++
T Consensus       222 ~~~~~~~~-------~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         222 ISPNFSRD-------LRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             CCCCCCHH-------HHHHHHHHhccChhhCcCHHHHhhC
Confidence            22223333       4455556889999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.94  E-value=2.4e-26  Score=182.51  Aligned_cols=173  Identities=25%  Similarity=0.379  Sum_probs=129.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++++|.+++....  .....+++..++.++.+++.|+.|||+.   +++|+||+|.||+++.++.++|+|||++.....
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~  155 (256)
T cd08530          81 APFGDLSKAISKRK--KKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKK  155 (256)
T ss_pred             cCCCCHHHHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence            46889999986632  2235689999999999999999999998   999999999999999999999999999876654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....    ...++..|.+||.+.+.  ..+.++|+||||+++|++++|..||......        ..............
T Consensus       156 ~~~~----~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~  221 (256)
T cd08530         156 NMAK----TQIGTPHYMAPEVWKGR--PYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--------DLRYKVQRGKYPPI  221 (256)
T ss_pred             CCcc----cccCCccccCHHHHCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhcCCCCCC
Confidence            3111    12477899999998653  5678999999999999999999998644321        11111112222222


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      +...+       ..+..++.+||+.+|++|||+.++++.
T Consensus       222 ~~~~~-------~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         222 PPIYS-------QDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             chhhC-------HHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            22233       345556666999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.94  E-value=3.3e-26  Score=201.57  Aligned_cols=185  Identities=25%  Similarity=0.416  Sum_probs=142.6

Q ss_pred             CCCCCcchhccccC---CCCCC-------ccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEc
Q 026160            1 MPNGSLDQFTYDQE---SSNGN-------RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKIS   70 (242)
Q Consensus         1 ~~~GsL~~~l~~~~---~~~~~-------~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~   70 (242)
                      |++|+|.+||...+   ..+..       ..|+....+.++.||+.|++||++.   .++||||..+|||+..+..+|++
T Consensus       384 ~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~~~kIa  460 (609)
T KOG0200|consen  384 AEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNKVIKIA  460 (609)
T ss_pred             ccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCCEEEEc
Confidence            57899999998876   11111       2499999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCCcccchh-cccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchh
Q 026160           71 DFGLAKQSQDKKSTISM-LHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSI  148 (242)
Q Consensus        71 dfg~~~~~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~  148 (242)
                      |||+++.......+... ....-+..|+|||.+..  ..++.++|+||||+++||+++ |..||-...       .....
T Consensus       461 DFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~--~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~-------~~~~l  531 (609)
T KOG0200|consen  461 DFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD--RVFTSKSDVWSFGILLWEIFTLGGTPYPGIP-------PTEEL  531 (609)
T ss_pred             cccceeccCCCCceEecCCCCccceeecCHHHhcc--CcccccchhhHHHHHHHHHhhCCCCCCCCCC-------cHHHH
Confidence            99999865554443311 11113567999999976  388999999999999999987 666774311       01222


Q ss_pred             hhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchh
Q 026160          149 YKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESST  204 (242)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~  204 (242)
                      ...+..+.....+..++.       +++.+|+.||+.+|++||++.++.+.++...
T Consensus       532 ~~~l~~G~r~~~P~~c~~-------eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  532 LEFLKEGNRMEQPEHCSD-------EIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             HHHHhcCCCCCCCCCCCH-------HHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence            335666666555555544       4566677799999999999999999999953

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.94  E-value=2.1e-26  Score=186.25  Aligned_cols=180  Identities=25%  Similarity=0.347  Sum_probs=129.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++...      ..+++..+..++.|++++|.|||+.   +++|+||+|.||+++.++.++|+|||++.....
T Consensus        87 ~~~~~L~~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  157 (288)
T cd05583          87 VNGGELFTHLYQR------EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA  157 (288)
T ss_pred             CCCCcHHHHHhhc------CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence            4688999998654      3589999999999999999999998   999999999999999999999999998876443


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ...... ....++..|.+||.+.+.....+.++|+||||+++|++++|..||.........    .......... ....
T Consensus       158 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~----~~~~~~~~~~-~~~~  231 (288)
T cd05583         158 EEEERA-YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ----SEISRRILKS-KPPF  231 (288)
T ss_pred             cccccc-ccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH----HHHHHHHHcc-CCCC
Confidence            322111 112478899999987654334688999999999999999999998643221100    1111111111 1122


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES  202 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~  202 (242)
                      +..++..+.+       ++.+||+.||++|||+.++.+.|+.
T Consensus       232 ~~~~~~~l~~-------li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         232 PKTMSAEARD-------FIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             CcccCHHHHH-------HHHHHhcCCHhhccCcchHHHHhcC
Confidence            2334444444       4455889999999998877776654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.94  E-value=4.3e-26  Score=184.29  Aligned_cols=173  Identities=29%  Similarity=0.413  Sum_probs=126.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++++|.+++....     ..+++.++..++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        97 ~~~~~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  168 (286)
T cd06614          97 MDGGSLTDIITQNF-----VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK  168 (286)
T ss_pred             cCCCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence            46899999998753     3699999999999999999999998   999999999999999999999999998865443


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCC-ccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN-DFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  159 (242)
                      ....  .....++..|.+||.+.+.  ..+.++|+||||+++|++++|..||.......       .......... ...
T Consensus       169 ~~~~--~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~  237 (286)
T cd06614         169 EKSK--RNSVVGTPYWMAPEVIKRK--DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-------ALFLITTKGIPPLK  237 (286)
T ss_pred             chhh--hccccCCcccCCHhHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhcCCCCCc
Confidence            2211  1122367889999987653  56889999999999999999999986332210       0000000000 000


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ....++.       .+..++.+||+.+|.+|||+.++++.
T Consensus       238 ~~~~~~~-------~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         238 NPEKWSP-------EFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             chhhCCH-------HHHHHHHHHhccChhhCcCHHHHhhC
Confidence            1111333       34455666999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.94  E-value=2.2e-26  Score=185.71  Aligned_cols=187  Identities=23%  Similarity=0.284  Sum_probs=126.3

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      +|+|.+++....     +.+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 ~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          82 PSDLSEVLRDEE-----RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            788988886542     4699999999999999999999998   99999999999999999999999999987655432


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCc------Cc-chhhhccCC-
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIY------FP-NSIYKHIEP-  154 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~------~~-~~~~~~~~~-  154 (242)
                      . .......++..|+|||.+.+. ...+.++||||||+++|++++|.++|...........      .+ ......... 
T Consensus       154 ~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07832         154 P-RLYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL  231 (286)
T ss_pred             C-CccccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCc
Confidence            1 111223578899999987543 3457899999999999999999777753321100000      00 000000000 


Q ss_pred             --CCccccccc----cchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          155 --GNDFQLDGV----VTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       155 --~~~~~~~~~----~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                        ......+..    ......+....+.+++.+||+.||++|||+++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence              000000000    000011123555666777889999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.94  E-value=2.1e-26  Score=199.43  Aligned_cols=122  Identities=25%  Similarity=0.374  Sum_probs=94.6

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      ++|.+++..... .........++..++.||+.||.|||+.   +|+|+||||+|||++.++.++|+|||++........
T Consensus       247 ~~l~~~l~~~~~-~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  322 (501)
T PHA03210        247 FDLYSFMYDEAF-DWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE  322 (501)
T ss_pred             cCHHHHHhhccc-cccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEeCCCceecCcccc
Confidence            456666544321 1122345677889999999999999999   999999999999999999999999999986654322


Q ss_pred             cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCc
Q 026160           84 TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNA  132 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~  132 (242)
                      ... ....|+..|++||.+.+.  .++.++|||||||++|||++|..++
T Consensus       323 ~~~-~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~~~~~p  368 (501)
T PHA03210        323 AFD-YGWVGTVATNSPEILAGD--GYCEITDIWSCGLILLDMLSHDFCP  368 (501)
T ss_pred             ccc-ccccCCcCCCCchhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            111 123589999999998654  5788999999999999999987543

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.94  E-value=4.1e-26  Score=189.90  Aligned_cols=106  Identities=30%  Similarity=0.367  Sum_probs=91.3

Q ss_pred             ccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccccchh
Q 026160           22 LEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEV  101 (242)
Q Consensus        22 l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~  101 (242)
                      ++..++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.........   ....++..|+|||.
T Consensus       115 l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~  188 (353)
T cd07850         115 LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEV  188 (353)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCCC---CCCcccccccCHHH
Confidence            88899999999999999999999   9999999999999999999999999999865443221   12247788999999


Q ss_pred             hhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160          102 FCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus       102 ~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      +.+.  ..+.++|+|||||++|+|++|+.||...
T Consensus       189 ~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~  220 (353)
T cd07850         189 ILGM--GYKENVDIWSVGCIMGEMIRGTVLFPGT  220 (353)
T ss_pred             HhCC--CCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence            8653  5788999999999999999999998643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.94  E-value=1.9e-26  Score=191.30  Aligned_cols=174  Identities=24%  Similarity=0.289  Sum_probs=136.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC----CCceEEccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE----DFCPKISDFGLAK   76 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~----~~~~~L~dfg~~~   76 (242)
                      |.||.|.+.|.+.       .+++..+..++.|++.++.|||+.   +++|+||||+|+|+..    ++.++++|||++.
T Consensus       118 ~~GGeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  118 CEGGELFDRIVKK-------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             cCCchHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            5799999999765       299999999999999999999998   9999999999999963    3479999999999


Q ss_pred             ccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCC
Q 026160           77 QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN  156 (242)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  156 (242)
                      .......   ....+||+.|+|||++...  .++...||||+|+++|.|++|..||..........    .+....-...
T Consensus       188 ~~~~~~~---~~~~~Gtp~y~APEvl~~~--~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~----~i~~~~~~f~  258 (382)
T KOG0032|consen  188 FIKPGER---LHTIVGTPEYVAPEVLGGR--PYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL----AILRGDFDFT  258 (382)
T ss_pred             EccCCce---EeeecCCccccCchhhcCC--CCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH----HHHcCCCCCC
Confidence            8776322   2245699999999998753  67899999999999999999999998666322111    1111111111


Q ss_pred             ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          157 DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      . .....++..++++++.|+       ..||..|+|+.+++++-+
T Consensus       259 ~-~~w~~is~~akd~i~~ll-------~~dp~~R~ta~~~L~HpW  295 (382)
T KOG0032|consen  259 S-EPWDDISESAKDFIRKLL-------EFDPRKRLTAAQALQHPW  295 (382)
T ss_pred             C-CCccccCHHHHHHHHHhc-------ccCcccCCCHHHHhcCcc
Confidence            1 222346778888888855       999999999999999744

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.7e-26  Score=194.39  Aligned_cols=163  Identities=23%  Similarity=0.408  Sum_probs=125.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +.||++..+++.       ..+++..+..++..|+.||.|||++   +|++||||..|||+|.+|.+||+|||+++..-.
T Consensus       451 ~~Ggdm~~~~~~-------~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~  520 (694)
T KOG0694|consen  451 VAGGDLMHHIHT-------DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG  520 (694)
T ss_pred             cCCCcEEEEEec-------ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCC
Confidence            357886555543       4699999999999999999999999   999999999999999999999999999975332


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  -.+.+||+.|+|||++.+.  .++.+.|-||||+++|||+.|..||...+..        .....+. +.....
T Consensus       521 ~g~~--TsTfCGTpey~aPEil~e~--~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe--------e~FdsI~-~d~~~y  587 (694)
T KOG0694|consen  521 QGDR--TSTFCGTPEFLAPEVLTEQ--SYTRAVDWWGLGVLLYEMLVGESPFPGDDEE--------EVFDSIV-NDEVRY  587 (694)
T ss_pred             CCCc--cccccCChhhcChhhhccC--cccchhhHHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHh-cCCCCC
Confidence            2111  1245799999999999875  7899999999999999999999999765532        1111111 112334


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSM  193 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~  193 (242)
                      +..++.+...++++|+       ..||++|.-+
T Consensus       588 P~~ls~ea~~il~~ll-------~k~p~kRLG~  613 (694)
T KOG0694|consen  588 PRFLSKEAIAIMRRLL-------RKNPEKRLGS  613 (694)
T ss_pred             CCcccHHHHHHHHHHh-------ccCcccccCC
Confidence            4456777777777755       9999999744

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.94  E-value=3.4e-26  Score=184.42  Aligned_cols=176  Identities=28%  Similarity=0.403  Sum_probs=124.6

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      .|+|.+++.....  ....+++..++.++.|++.|+.|||++  .+++|+||||+||+++.++.++|+|||++.......
T Consensus        83 ~~~l~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (283)
T cd06617          83 DTSLDKFYKKVYD--KGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV  158 (283)
T ss_pred             cccHHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            3778888765321  235799999999999999999999984  289999999999999999999999999987654322


Q ss_pred             ccchhcccccccccccchhhhccc--CCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           83 STISMLHARGTIGYIAPEVFCRSF--GGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ..   ....++..|.+||.+.+..  ..++.++|+||||+++|++++|..||.......      ....... .......
T Consensus       159 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~-~~~~~~~  228 (283)
T cd06617         159 AK---TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF------QQLKQVV-EEPSPQL  228 (283)
T ss_pred             cc---ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH------HHHHHHH-hcCCCCC
Confidence            11   1124778899999875421  245789999999999999999999986322110      1111111 1111111


Q ss_pred             c-cccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 D-GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~-~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      + ..++.+       +.+++.+||..+|++||++.+++++
T Consensus       229 ~~~~~~~~-------l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         229 PAEKFSPE-------FQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             CccccCHH-------HHHHHHHHccCChhhCcCHHHHhcC
Confidence            1 123344       4455556999999999999999873

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.94  E-value=2.1e-26  Score=185.95  Aligned_cols=187  Identities=22%  Similarity=0.288  Sum_probs=124.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++++|+.+....      ..+++.++..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 ~~~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07846          82 VDHTVLDDLEKYP------NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  152 (286)
T ss_pred             CCccHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence            4567777766433      3489999999999999999999998   999999999999999999999999999876543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCC-------cCcchhhhccC
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDI-------YFPNSIYKHIE  153 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~-------~~~~~~~~~~~  153 (242)
                      ....  .....++..|++||.+.+. ...+.++|+||||+++|++++|.+||..........       .+.........
T Consensus       153 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07846         153 PGEV--YTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQ  229 (286)
T ss_pred             Cccc--cCcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhc
Confidence            3221  1123477899999987543 346788999999999999999998885332110000       00000000000


Q ss_pred             C------CCccccc--cccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          154 P------GNDFQLD--GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       154 ~------~~~~~~~--~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .      .......  .........+...+.+++.+||+.||++||++.++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            0      0000000  00000011223445667777999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=4.8e-26  Score=181.95  Aligned_cols=173  Identities=27%  Similarity=0.345  Sum_probs=127.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++...      +.+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        88 ~~~~~L~~~~~~~------~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  158 (264)
T cd06653          88 MPGGSIKDQLKAY------GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQT  158 (264)
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence            4688999998654      3588999999999999999999999   999999999999999999999999999876432


Q ss_pred             Ccc-cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKS-TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ... ........++..|.|||.+.+.  ..+.++|+||||+++|++++|..||......       ..............
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~  229 (264)
T cd06653         159 ICMSGTGIKSVTGTPYWMSPEVISGE--GYGRKADVWSVACTVVEMLTEKPPWAEYEAM-------AAIFKIATQPTKPM  229 (264)
T ss_pred             ccccCccccccCCcccccCHhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccCHH-------HHHHHHHcCCCCCC
Confidence            111 0111122478899999988653  5688999999999999999999998643211       11122222222233


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ++..+++.+.+++.+       ||. +|..||++.+++.+
T Consensus       230 ~p~~~~~~~~~~i~~-------~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         230 LPDGVSDACRDFLKQ-------IFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             CCcccCHHHHHHHHH-------Hhc-CcccCccHHHHhcC
Confidence            344455555555555       778 57999999988764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.94  E-value=2.2e-26  Score=188.37  Aligned_cols=129  Identities=23%  Similarity=0.248  Sum_probs=100.5

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC----CCceEEcccccccccC
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE----DFCPKISDFGLAKQSQ   79 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~----~~~~~L~dfg~~~~~~   79 (242)
                      ++|.+++..... .....++...+..++.|++.||.|||+.   +++|+||||+||+++.    ++.++|+|||++....
T Consensus        88 ~~l~~~~~~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~  163 (316)
T cd07842          88 HDLWQIIKFHRQ-AKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN  163 (316)
T ss_pred             cCHHHHHHhhcc-CCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCccccccC
Confidence            466666644322 1224789999999999999999999999   9999999999999998    8999999999988654


Q ss_pred             CCcc-cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccccc
Q 026160           80 DKKS-TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKAS  137 (242)
Q Consensus        80 ~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~  137 (242)
                      .... ........++..|+|||.+.+. ..++.++|+||||+++|++++|..||.....
T Consensus       164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~  221 (316)
T cd07842         164 APLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREA  221 (316)
T ss_pred             CCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence            4322 1111223467889999987543 3467899999999999999999999975443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.94  E-value=1.4e-26  Score=194.33  Aligned_cols=170  Identities=29%  Similarity=0.466  Sum_probs=140.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC-CCceEEcccccccccC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE-DFCPKISDFGLAKQSQ   79 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~-~~~~~L~dfg~~~~~~   79 (242)
                      |..|+|+.|+++++      .++.+.+..|++||++||.|||++ .+.|+|||||=.||+|++ -|.||++|+|++....
T Consensus       125 ~TSGtLr~Y~kk~~------~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r  197 (632)
T KOG0584|consen  125 FTSGTLREYRKKHR------RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR  197 (632)
T ss_pred             ccCCcHHHHHHHhc------cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence            57899999999884      599999999999999999999997 579999999999999987 4889999999998766


Q ss_pred             CCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           80 DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        80 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ......    .+||+.|+|||.+..   .+....||||||..+.||+|+..||.--..       +.++.+.+..+..+.
T Consensus       198 ~s~aks----vIGTPEFMAPEmYEE---~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-------~AQIYKKV~SGiKP~  263 (632)
T KOG0584|consen  198 KSHAKS----VIGTPEFMAPEMYEE---NYNELVDVYAFGMCMLEMVTSEYPYSECTN-------PAQIYKKVTSGIKPA  263 (632)
T ss_pred             ccccce----eccCccccChHHHhh---hcchhhhhhhhhHHHHHHHhccCChhhhCC-------HHHHHHHHHcCCCHH
Confidence            544332    369999999999864   578999999999999999999999974433       366666666665443


Q ss_pred             c-ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          160 L-DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       160 ~-~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      . ...-.++.++++.+       |+.. .++|+|+.|||+.
T Consensus       264 sl~kV~dPevr~fIek-------Cl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  264 ALSKVKDPEVREFIEK-------CLAT-KSERLSAKELLKD  296 (632)
T ss_pred             HhhccCCHHHHHHHHH-------HhcC-chhccCHHHHhhC
Confidence            3 33346667777776       8899 9999999999963

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.94  E-value=1.8e-26  Score=190.81  Aligned_cols=181  Identities=25%  Similarity=0.273  Sum_probs=121.0

Q ss_pred             ccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccc-hhccccccccccc
Q 026160           20 RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTI-SMLHARGTIGYIA   98 (242)
Q Consensus        20 ~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~-~~~~~~~~~~y~~   98 (242)
                      +.+++..+..++.|+++||.|||+.   +++|+||||+||+++.++.++|+|||++.......... ......++..|+|
T Consensus       101 ~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  177 (336)
T cd07849         101 QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA  177 (336)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccC
Confidence            3589999999999999999999999   99999999999999999999999999987654322211 1112347889999


Q ss_pred             chhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCC--------cCcchhhhccCCC--------Ccccccc
Q 026160           99 PEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDI--------YFPNSIYKHIEPG--------NDFQLDG  162 (242)
Q Consensus        99 PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~--------~~~~~~~~~~~~~--------~~~~~~~  162 (242)
                      ||.+.+. ..++.++|+||||+++|++++|+.||..........        ...... ..+...        .......
T Consensus       178 PE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  255 (336)
T cd07849         178 PEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL-NCIISLRARNYIKSLPFKPKV  255 (336)
T ss_pred             hHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH-HHhhchhhhhHHhhcCcCCcc
Confidence            9987543 356889999999999999999999985432110000        000000 000000        0000000


Q ss_pred             ccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--hhchhh
Q 026160          163 VVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM--LESSTE  205 (242)
Q Consensus       163 ~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~--l~~~~~  205 (242)
                      ............+.+++.+||+.||++|||+.+++++  ++....
T Consensus       256 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         256 PWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             cHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence            0000001123445667777999999999999999987  554443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.94  E-value=4e-26  Score=184.82  Aligned_cols=177  Identities=24%  Similarity=0.333  Sum_probs=126.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      ..++..++..++.|++.||.|||+.   +++|+||+|.||+++.++.++|+|||++.....
T Consensus        87 ~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  157 (290)
T cd05613          87 INGGELFTHLSQR------ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE  157 (290)
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence            5789999999764      3588999999999999999999998   999999999999999999999999999876543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ..... .....++..|++||.+.......+.++|+||||+++|++++|..||.........    .......... ....
T Consensus       158 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~----~~~~~~~~~~-~~~~  231 (290)
T cd05613         158 DEVER-AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ----AEISRRILKS-EPPY  231 (290)
T ss_pred             ccccc-cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH----HHHHHHhhcc-CCCC
Confidence            22111 1123478899999988654345678899999999999999999998643221110    1111111111 1112


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRP-----SMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp-----s~~~ll~~  199 (242)
                      +..+++.+       ..++.+||+.||++||     ++.+++++
T Consensus       232 ~~~~~~~~-------~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         232 PQEMSALA-------KDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             CccCCHHH-------HHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence            22334444       4455558899999997     67777664

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.94  E-value=8e-26  Score=185.49  Aligned_cols=176  Identities=28%  Similarity=0.338  Sum_probs=127.0

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      |+|.+++....     ..+++.++..++.+++.|+.|||+.   +++|+||+|.||+++.++.++|+|||++....... 
T Consensus       109 g~l~~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~-  179 (317)
T cd06635         109 GSASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN-  179 (317)
T ss_pred             CCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCcc-
Confidence            57777765432     4589999999999999999999999   99999999999999999999999999876544322 


Q ss_pred             cchhcccccccccccchhhhc-ccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccccc
Q 026160           84 TISMLHARGTIGYIAPEVFCR-SFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDG  162 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~-~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (242)
                           ...++..|++||.+.. .....+.++|+||||+++|++++|..||.......       ................
T Consensus       180 -----~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~  247 (317)
T cd06635         180 -----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQNESPTLQSN  247 (317)
T ss_pred             -----cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-------HHHHHHhccCCCCCCc
Confidence                 1247889999998743 22356889999999999999999999986432110       0111111111111111


Q ss_pred             ccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhc
Q 026160          163 VVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEIL  207 (242)
Q Consensus       163 ~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~  207 (242)
                      .++..       +.+++.+||+.+|.+||++.+++++........
T Consensus       248 ~~~~~-------l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  285 (317)
T cd06635         248 EWSDY-------FRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP  285 (317)
T ss_pred             cccHH-------HHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence            23333       444555699999999999999999877655443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.93  E-value=5.9e-26  Score=182.71  Aligned_cols=170  Identities=31%  Similarity=0.413  Sum_probs=127.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++..       ..+++..+..++.+++.++.+||+.   +++|+||+|.||+++.++.++++|||++.....
T Consensus        84 ~~~~~l~~~i~~-------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06641          84 LGGGSALDLLEP-------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  153 (277)
T ss_pred             CCCCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence            468899998854       3589999999999999999999998   999999999999999999999999998876543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....++..|.+||.+...  ..+.++|+||||+++|++++|..||......        ..............
T Consensus       154 ~~~~--~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~  221 (277)
T cd06641         154 TQIK--RNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELAKGEPPHSELHPM--------KVLFLIPKNNPPTL  221 (277)
T ss_pred             chhh--hccccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCccchH--------HHHHHHhcCCCCCC
Confidence            3211  1123477889999987543  5678899999999999999999998643211        11111111222223


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ...++.++.++       +.+||+.+|++||++.+++++
T Consensus       222 ~~~~~~~~~~~-------i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         222 EGNYSKPLKEF-------VEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CcccCHHHHHH-------HHHHccCChhhCcCHHHHHhC
Confidence            33345555444       455999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=5.1e-26  Score=180.29  Aligned_cols=170  Identities=30%  Similarity=0.427  Sum_probs=128.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++++|.+++...      ..+++..+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~~~~~L~~~~~~~------~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  151 (254)
T cd06627          81 AENGSLRQIIKKF------GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLND  151 (254)
T ss_pred             CCCCcHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCC
Confidence            4678999998664      4699999999999999999999998   999999999999999999999999999987654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....++..|.+||.....  ..+.++|+|+||+++|++++|..||......       ..... .........
T Consensus       152 ~~~~--~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-------~~~~~-~~~~~~~~~  219 (254)
T cd06627         152 VSKD--DASVVGTPYWMAPEVIEMS--GASTASDIWSLGCTVIELLTGNPPYYDLNPM-------AALFR-IVQDDHPPL  219 (254)
T ss_pred             Cccc--ccccccchhhcCHhhhcCC--CCCcchhHHHHHHHHHHHHhCCCCCCCccHH-------HHHHH-HhccCCCCC
Confidence            4332  1123478899999987654  4688999999999999999999998643321       10111 111122223


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE  198 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~  198 (242)
                      +..++..+.+++.       +||..+|++|||+.+++.
T Consensus       220 ~~~~~~~~~~~i~-------~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         220 PEGISPELKDFLM-------QCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCHHHHHHHH-------HHHhCChhhCcCHHHHhc
Confidence            3345555555554       488999999999999875

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.93  E-value=4.9e-26  Score=184.60  Aligned_cols=121  Identities=25%  Similarity=0.285  Sum_probs=99.3

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      |+|.+++....     ..+++.++..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        90 ~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  161 (293)
T cd07843          90 HDLKSLMETMK-----QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK  161 (293)
T ss_pred             cCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence            57777776532     3599999999999999999999999   999999999999999999999999999886654321


Q ss_pred             cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           84 TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      .  .....++..|+|||.+.+. ...+.++|+||||+++|++++|..||...
T Consensus       162 ~--~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~  210 (293)
T cd07843         162 P--YTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGK  210 (293)
T ss_pred             c--cccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            1  1122467889999987653 24578999999999999999999998643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.93  E-value=7.6e-26  Score=184.89  Aligned_cols=171  Identities=28%  Similarity=0.333  Sum_probs=123.6

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      .|+|.+++....     ..++..++..++.+++.|+.|||+.   +++|+||+|.||+++.++.++|+|||++.......
T Consensus        98 ~~~l~~~~~~~~-----~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  169 (308)
T cd06634          98 LGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN  169 (308)
T ss_pred             CCCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCcc
Confidence            367777665432     3589999999999999999999998   99999999999999999999999999887654322


Q ss_pred             ccchhcccccccccccchhhhc-ccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccc-c
Q 026160           83 STISMLHARGTIGYIAPEVFCR-SFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ-L  160 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  160 (242)
                      .      ..++..|+|||.+.. .....+.++||||||+++|++++|..||.......       .. .......... .
T Consensus       170 ~------~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~-~~~~~~~~~~~~  235 (308)
T cd06634         170 X------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------AL-YHIAQNESPALQ  235 (308)
T ss_pred             c------ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-------HH-HHHhhcCCCCcC
Confidence            1      237789999998753 12346789999999999999999999985432111       00 1111111111 1


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES  202 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~  202 (242)
                      ...++..+       ..++.+||+.+|++||++.++++.-.-
T Consensus       236 ~~~~~~~~-------~~li~~cl~~~P~~Rp~~~~ll~~~~~  270 (308)
T cd06634         236 SGHWSEYF-------RNFVDSCLQKIPQDRPTSEVLLKHRFV  270 (308)
T ss_pred             cccccHHH-------HHHHHHHhhCCcccCCCHHHHhhCccc
Confidence            11233334       445556999999999999999987553

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.93  E-value=2.8e-26  Score=194.64  Aligned_cols=176  Identities=28%  Similarity=0.397  Sum_probs=141.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      ++.|||-+.|.+...    ..|-......++.||+.|+.||.++   ++|||||...|+++.....||++|||+++....
T Consensus       192 aplGSLldrLrka~~----~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  192 APLGSLLDRLRKAKK----AILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             cccchHHHHHhhccc----cceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCC
Confidence            578999999987332    5688899999999999999999999   999999999999999888999999999998776


Q ss_pred             Ccccchhc-ccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           81 KKSTISML-HARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        81 ~~~~~~~~-~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      ....+... ..+..+.|.|||.+...  .++.++|+|+||+.+|||++ |+.||-....        ..+...++.+...
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsLrh~--kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--------~qIL~~iD~~erL  334 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESLRHR--KFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--------IQILKNIDAGERL  334 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHhccc--cccccchhhhhhhhHHhhhccCCCCCCCCCH--------HHHHHhccccccC
Confidence            65544332 34567789999998654  78999999999999999997 6778876553        4555555555444


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML  200 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l  200 (242)
                      ..+..+       .+.++++|..||..+|++|||+..+.+.+
T Consensus       335 pRPk~c-------sedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  335 PRPKYC-------SEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             CCCCCC-------hHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            444444       45566777779999999999999997443

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.93  E-value=6.9e-26  Score=185.00  Aligned_cols=169  Identities=31%  Similarity=0.371  Sum_probs=122.2

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      |+|.+++....     ..+++.++..++.|++.||.|||+.   +++|+||+|.||+++.++.++|+|||++........
T Consensus        99 g~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~  170 (307)
T cd06607          99 GSASDILEVHK-----KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS  170 (307)
T ss_pred             CCHHHHHHHcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCCCC
Confidence            56666664332     3589999999999999999999998   999999999999999999999999998875543321


Q ss_pred             cchhcccccccccccchhhhc-ccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccccc
Q 026160           84 TISMLHARGTIGYIAPEVFCR-SFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDG  162 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~-~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (242)
                            ..++..|+|||.+.. .....+.++|+||||+++|++++|..||.......        .............. 
T Consensus       171 ------~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~--------~~~~~~~~~~~~~~-  235 (307)
T cd06607         171 ------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNDSPTLS-  235 (307)
T ss_pred             ------ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH--------HHHHHhcCCCCCCC-
Confidence                  236788999998742 22356889999999999999999999986433211        00000001011110 


Q ss_pred             ccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 026160          163 VVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML  200 (242)
Q Consensus       163 ~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l  200 (242)
                           .......+.+++.+||+.||++||++.+++.+.
T Consensus       236 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         236 -----SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             -----chhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence                 011223455566679999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.93  E-value=5.4e-26  Score=184.66  Aligned_cols=173  Identities=23%  Similarity=0.353  Sum_probs=121.2

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhh-CCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHR-GCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~-~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      ++|.+++...     ...+++..+..++.+++.|+.|||+ .   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        98 ~~l~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          98 TCLDKLLKRI-----QGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             cCHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            4555555432     1368999999999999999999997 5   89999999999999999999999999987654332


Q ss_pred             ccchhcccccccccccchhhhccc--CCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCC-Cccc
Q 026160           83 STISMLHARGTIGYIAPEVFCRSF--GGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPG-NDFQ  159 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  159 (242)
                      ...   ...++..|+|||.+....  ...+.++|+||||+++|++++|+.||.......      .......... ....
T Consensus       170 ~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~  240 (296)
T cd06618         170 AKT---RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF------EVLTKILQEEPPSLP  240 (296)
T ss_pred             ccc---CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH------HHHHHHhcCCCCCCC
Confidence            221   123677899999885432  346789999999999999999999986432210      0010111111 0011


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML  200 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l  200 (242)
                      ....++.+       +.+++.+||+.||++||++.+++++-
T Consensus       241 ~~~~~~~~-------l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         241 PNEGFSPD-------FCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             CCCCCCHH-------HHHHHHHHccCChhhCCCHHHHhcCh
Confidence            11123344       44455569999999999999998664

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.93  E-value=5.5e-26  Score=211.30  Aligned_cols=184  Identities=25%  Similarity=0.436  Sum_probs=129.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.++++         .+++.++..++.++++|++|||..+..+++|+||||+||+++.++..++. |+.......
T Consensus       765 ~~~g~L~~~l~---------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~  834 (968)
T PLN00113        765 IEGKNLSEVLR---------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT  834 (968)
T ss_pred             CCCCcHHHHHh---------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence            68999999994         28899999999999999999995444499999999999999988777665 444332211


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCC-----C
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEP-----G  155 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----~  155 (242)
                      ..      ...++..|+|||.+.+.  .++.++|||||||++||+++|+.||+.........  ..+.......     .
T Consensus       835 ~~------~~~~t~~y~aPE~~~~~--~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~  904 (968)
T PLN00113        835 DT------KCFISSAYVAPETRETK--DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSI--VEWARYCYSDCHLDMW  904 (968)
T ss_pred             CC------CccccccccCcccccCC--CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcH--HHHHHHhcCccchhhe
Confidence            11      12478899999987653  67899999999999999999999985433221111  0111100000     0


Q ss_pred             CccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhh
Q 026160          156 NDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTE  205 (242)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~  205 (242)
                      .+......... .......+++++.+||+.||++|||+.++++.|+++..
T Consensus       905 ~~~~~~~~~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        905 IDPSIRGDVSV-NQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             eCccccCCCCc-cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            01111111111 12345568889999999999999999999999997655

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.93  E-value=2.9e-26  Score=184.99  Aligned_cols=121  Identities=26%  Similarity=0.353  Sum_probs=97.6

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      ++|.+++....    ...+++..+..++.|++.|+.|||+.   +++|+||+|.||+++.++.++|+|||++........
T Consensus        83 ~~l~~~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          83 QDLKKFMDASP----LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cCHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            56777765432    25689999999999999999999998   999999999999999999999999999875543221


Q ss_pred             cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccc
Q 026160           84 TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADV  134 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~  134 (242)
                      ..  ....++..|.|||.+.+. ...+.++|+||||+++|++++|+.||..
T Consensus       156 ~~--~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~  203 (284)
T cd07860         156 TY--THEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPG  203 (284)
T ss_pred             cc--ccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            11  112357789999987543 3457889999999999999999999854

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.93  E-value=4.9e-26  Score=183.62  Aligned_cols=183  Identities=21%  Similarity=0.243  Sum_probs=124.0

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      +++|.+++.....    ..+++..+..++.|+++||.|||+.   +++|+||+|.||+++.++.++|+|||++.......
T Consensus        81 ~~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~  153 (283)
T cd07835          81 DLDLKKYMDSSPL----TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV  153 (283)
T ss_pred             CcCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence            3678888865431    4689999999999999999999998   99999999999999999999999999987544322


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCc-------Ccchh-------
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIY-------FPNSI-------  148 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~-------~~~~~-------  148 (242)
                      ..  .....++..|+|||.+.+. ..++.++|+||||+++|++++|+.||...........       .....       
T Consensus       154 ~~--~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07835         154 RT--YTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL  230 (283)
T ss_pred             cc--cCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhc
Confidence            11  1112357889999987543 2457889999999999999999999864322100000       00000       


Q ss_pred             ---hhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          149 ---YKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       149 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                         ...........    ...........+.+++.+||+.||++|||+.+++++
T Consensus       231 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         231 PDYKPTFPKWARQD----LSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhhhhcccccccc----hhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence               00000000000    000011122345566677999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=1.8e-26  Score=209.93  Aligned_cols=171  Identities=21%  Similarity=0.301  Sum_probs=116.7

Q ss_pred             CCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCC-----------------
Q 026160            2 PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDED-----------------   64 (242)
Q Consensus         2 ~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~-----------------   64 (242)
                      .+++|.++|...     ...+++.++..++.||++||.|||++   +|+||||||+|||++..                 
T Consensus        62 ~~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~---gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~  133 (793)
T PLN00181         62 EDVSLRQWLDNP-----DRSVDAFECFHVFRQIVEIVNAAHSQ---GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSD  133 (793)
T ss_pred             CCccHHHHHhcc-----cccccHHHHHHHHHHHHHHHHHHHhC---CeeeccCCchhEEEcccCcEEEeeccccCccccc
Confidence            367899999643     24699999999999999999999999   99999999999999643                 


Q ss_pred             --CceEEcccccccccCCCcc--------------cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhc
Q 026160           65 --FCPKISDFGLAKQSQDKKS--------------TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG  128 (242)
Q Consensus        65 --~~~~L~dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g  128 (242)
                        +.++++|||+++.......              ........+|+.|+|||.+.+.  .++.++|||||||++|||++|
T Consensus       134 ~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~~~~sDVwSlGviL~ELl~~  211 (793)
T PLN00181        134 EDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGS--SSNCASDVYRLGVLLFELFCP  211 (793)
T ss_pred             ccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccC--CCCchhhhhhHHHHHHHHhhC
Confidence              4456666666653211000              0000112478889999998654  568999999999999999998


Q ss_pred             CCCccccccCCCCCcCcchhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          129 RKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       129 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ..|+.......      .......       .    ++...........++.+||+.||.+||++.+++++
T Consensus       212 ~~~~~~~~~~~------~~~~~~~-------~----~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        212 VSSREEKSRTM------SSLRHRV-------L----PPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             CCchhhHHHHH------HHHHHhh-------c----ChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence            87764221100      0000000       0    11111111223456677999999999999999864

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.93  E-value=6e-26  Score=185.34  Aligned_cols=174  Identities=22%  Similarity=0.245  Sum_probs=119.3

Q ss_pred             ccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccch---------hccc
Q 026160           20 RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS---------MLHA   90 (242)
Q Consensus        20 ~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~---------~~~~   90 (242)
                      ..+++.++..++.|+++||.|||+.   +++|+||+|.||+++.++.++|+|||++...........         ....
T Consensus       110 ~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (311)
T cd07866         110 VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL  186 (311)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccc
Confidence            4699999999999999999999999   999999999999999999999999999875543221111         1122


Q ss_pred             ccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCC------------CCcCcchhhhccCC----
Q 026160           91 RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSS------------DIYFPNSIYKHIEP----  154 (242)
Q Consensus        91 ~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~------------~~~~~~~~~~~~~~----  154 (242)
                      .++..|.|||.+.+. ..++.++|+||||+++|++++|..||........            ...++.+  .....    
T Consensus       187 ~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  263 (311)
T cd07866         187 VVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGW--RSLPGCEGV  263 (311)
T ss_pred             eeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhh--hhccccccc
Confidence            357789999987543 3467899999999999999999999864332110            0000000  00000    


Q ss_pred             CCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          155 GNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ......+.............+.+++.+||+.||++|||+.+++.+
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         264 HSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             ccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            000001111111122233556777888999999999999998753

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.93  E-value=5e-26  Score=185.71  Aligned_cols=123  Identities=24%  Similarity=0.341  Sum_probs=97.3

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      ++|.+++...     ...+++.++..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus       103 ~~l~~~l~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  174 (310)
T cd07865         103 HDLAGLLSNK-----NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKN  174 (310)
T ss_pred             cCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCcccccCCcc
Confidence            4666666442     13689999999999999999999999   999999999999999999999999999876543221


Q ss_pred             c--chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           84 T--ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        84 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      .  .......++..|+|||.+.+. ...+.++|+||||+++|++++|..||...
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~  227 (310)
T cd07865         175 SKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGN  227 (310)
T ss_pred             cCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            1  111122467889999987543 23578899999999999999999988643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.93  E-value=5.1e-26  Score=187.92  Aligned_cols=188  Identities=21%  Similarity=0.248  Sum_probs=125.8

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      +|+|.+++...      +.+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        91 ~~~l~~~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  161 (334)
T cd07855          91 ESDLHHIIHSD------QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP  161 (334)
T ss_pred             hhhHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence            36777777543      4599999999999999999999998   99999999999999999999999999987654322


Q ss_pred             cc--chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCC-------------CCc---C
Q 026160           83 ST--ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSS-------------DIY---F  144 (242)
Q Consensus        83 ~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~-------------~~~---~  144 (242)
                      ..  .......++..|.+||.+... ...+.++|+||||+++|++++|..||........             ...   .
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~  240 (334)
T cd07855         162 TEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG  240 (334)
T ss_pred             cCCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence            11  111123478899999987543 3468899999999999999999999954322100             000   0


Q ss_pred             cchhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          145 PNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      ............ .................+.+++.+||+.||++|||+.+++.+-.
T Consensus       241 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~  296 (334)
T cd07855         241 SDRVRKYIQNLP-RKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF  296 (334)
T ss_pred             hhhHHHHHhhcc-cCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChh
Confidence            000000000000 00000000011122344555666699999999999999887533

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.93  E-value=1e-25  Score=181.51  Aligned_cols=186  Identities=20%  Similarity=0.267  Sum_probs=127.4

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      .|+|.+++....     ..+++.++..++.++++||.|||+.   +++|+||+|.||+++.++.++|+|||.+.......
T Consensus        81 ~~~l~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~  152 (283)
T cd05118          81 DTDLYKLIKDRQ-----RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV  152 (283)
T ss_pred             CCCHHHHHHhhc-----ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence            357777775532     4689999999999999999999999   99999999999999999999999999987665443


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcC-------cchhhhccCC-
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYF-------PNSIYKHIEP-  154 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~-------~~~~~~~~~~-  154 (242)
                      ..  .....++..|.+||.+.+. ...+.++|+||||+++|++++|+.||............       .......... 
T Consensus       153 ~~--~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd05118         153 RP--YTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL  229 (283)
T ss_pred             cc--ccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhh
Confidence            11  1122467889999987653 35788999999999999999999988543321100000       0000000000 


Q ss_pred             --CCcccc----ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          155 --GNDFQL----DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       155 --~~~~~~----~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                        ......    ..........+...+.+++.+||+.||.+||++.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence              000000    000111122345566777788999999999999999863

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.93  E-value=5.1e-26  Score=183.82  Aligned_cols=123  Identities=24%  Similarity=0.324  Sum_probs=98.9

Q ss_pred             CCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCC
Q 026160            2 PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDK   81 (242)
Q Consensus         2 ~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~   81 (242)
                      ++++|..++.+.      ..++..++..++.+++.|+.|||+.   +++|+||+++||+++.++.++|+|||++......
T Consensus        83 ~~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          83 ERTLLELLEASP------GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            455555554332      4589999999999999999999999   9999999999999999999999999998766544


Q ss_pred             cccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           82 KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        82 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      .... .....++..|+|||.+.+. ..++.++|+||||+++|++++|..||...
T Consensus       154 ~~~~-~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~  205 (288)
T cd07833         154 PASP-LTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGD  205 (288)
T ss_pred             cccc-ccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            3211 1122467889999998653 25688999999999999999999988643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.93  E-value=7.7e-26  Score=183.20  Aligned_cols=121  Identities=31%  Similarity=0.413  Sum_probs=98.1

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      |+|.+++....     ..+++..+..++.|+++||.|||+.   +++|+||+|.||+++.++.++|+|||++........
T Consensus        87 ~~L~~~~~~~~-----~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          87 TDLKQYMDDCG-----GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            57888876542     3689999999999999999999998   999999999999999999999999999875432211


Q ss_pred             cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           84 TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      ..  ....++..|.|||.+.+. ...+.++|+||||+++|++++|..||...
T Consensus       159 ~~--~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~  207 (291)
T cd07844         159 TY--SNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGS  207 (291)
T ss_pred             cc--cccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            11  112357789999987643 34678999999999999999999998543

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.93  E-value=3.2e-26  Score=187.12  Aligned_cols=121  Identities=27%  Similarity=0.363  Sum_probs=98.5

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      |+|.+++....     ..+++.++..++.|+++||.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        92 ~~l~~~l~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~  163 (309)
T cd07845          92 QDLASLLDNMP-----TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK  163 (309)
T ss_pred             CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence            46667765432     4689999999999999999999999   999999999999999999999999999886654321


Q ss_pred             cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           84 TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      .  .....++..|.|||.+.+. ...+.++|+||||+++|++++|..||...
T Consensus       164 ~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~  212 (309)
T cd07845         164 P--MTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGK  212 (309)
T ss_pred             C--CCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            1  1122356789999987653 34678999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=3.6e-26  Score=171.70  Aligned_cols=171  Identities=26%  Similarity=0.420  Sum_probs=138.6

Q ss_pred             CCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCC
Q 026160            2 PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDK   81 (242)
Q Consensus         2 ~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~   81 (242)
                      ++|+|+..|...+.    +.+++...+....|++.|+.|+|..   +|+||||||+|+|++.++.++++|||-+......
T Consensus       105 ~~gel~k~L~~~~~----~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~  177 (281)
T KOG0580|consen  105 PRGELYKDLQEGRM----KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN  177 (281)
T ss_pred             CCchHHHHHHhccc----ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCCC
Confidence            57999999986543    6799999999999999999999999   9999999999999999999999999998765422


Q ss_pred             cccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccccc
Q 026160           82 KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLD  161 (242)
Q Consensus        82 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (242)
                      .    ..+.+||.-|.|||...+.  ..+...|+|++|++.||++.|.+||......        ...+.+ ...+..++
T Consensus       178 k----R~tlcgt~dyl~pEmv~~~--~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~--------etYkrI-~k~~~~~p  242 (281)
T KOG0580|consen  178 K----RKTLCGTLDYLPPEMVEGR--GHDKFVDLWSLGVLCYEFLVGLPPFESQSHS--------ETYKRI-RKVDLKFP  242 (281)
T ss_pred             C----ceeeecccccCCHhhcCCC--CccchhhHHHHHHHHHHHHhcCCchhhhhhH--------HHHHHH-HHccccCC
Confidence            2    2234699999999998664  6788999999999999999999999866521        111111 12233445


Q ss_pred             cccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          162 GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       162 ~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      ..++.++.+++.+       |+.++|.+|.+..+++++-.
T Consensus       243 ~~is~~a~dlI~~-------ll~~~p~~r~~l~~v~~hpw  275 (281)
T KOG0580|consen  243 STISGGAADLISR-------LLVKNPIERLALTEVMDHPW  275 (281)
T ss_pred             cccChhHHHHHHH-------HhccCccccccHHHHhhhHH
Confidence            6788888888888       66999999999999987643

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.93  E-value=1.1e-26  Score=184.87  Aligned_cols=120  Identities=26%  Similarity=0.364  Sum_probs=102.0

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeC--------------------
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD--------------------   62 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~--------------------   62 (242)
                      |-|++|||.++..    .+++...+..|+.||++++.+||+.   +++|-||||+|||+.                    
T Consensus       174 G~S~~dFlk~N~y----~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~  246 (415)
T KOG0671|consen  174 GLSTFDFLKENNY----IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPL  246 (415)
T ss_pred             ChhHHHHhccCCc----cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccceeccC
Confidence            3489999987544    7899999999999999999999999   999999999999982                    


Q ss_pred             CCCceEEcccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccc
Q 026160           63 EDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKA  136 (242)
Q Consensus        63 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  136 (242)
                      ++..++++|||.++.......     ..+.|..|.|||++.+-  +++..+|+||+||+++|+.+|...|....
T Consensus       247 ks~~I~vIDFGsAtf~~e~hs-----~iVsTRHYRAPEViLgL--GwS~pCDvWSiGCIL~ElytG~~LFqtHe  313 (415)
T KOG0671|consen  247 KSTAIKVIDFGSATFDHEHHS-----TIVSTRHYRAPEVILGL--GWSQPCDVWSIGCILVELYTGETLFQTHE  313 (415)
T ss_pred             CCcceEEEecCCcceeccCcc-----eeeeccccCCchheecc--CcCCccCceeeeeEEEEeeccceecccCC
Confidence            123489999999987665442     23589999999999875  78999999999999999999998876665

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.93  E-value=1e-25  Score=182.88  Aligned_cols=172  Identities=23%  Similarity=0.326  Sum_probs=123.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++..       ..+++..+..++.|++.++.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        99 ~~~~~L~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~  168 (292)
T cd06657          99 LEGGALTDIVTH-------TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  168 (292)
T ss_pred             CCCCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence            478899887743       3489999999999999999999999   999999999999999999999999998765543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....++..|++||.+...  ..+.++|+||||+++|++++|..||........    ..........  ....
T Consensus       169 ~~~~--~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~----~~~~~~~~~~--~~~~  238 (292)
T cd06657         169 EVPR--RKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA----MKMIRDNLPP--KLKN  238 (292)
T ss_pred             cccc--ccccccCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhhCCc--ccCC
Confidence            2211  1122477889999987543  567899999999999999999999864321100    0000000000  0001


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ...+++.+.       +++.+||+.||.+||++.+++++
T Consensus       239 ~~~~~~~l~-------~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         239 LHKVSPSLK-------GFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             cccCCHHHH-------HHHHHHHhCCcccCcCHHHHhcC
Confidence            112344444       44555889999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.93  E-value=8.5e-26  Score=181.62  Aligned_cols=171  Identities=30%  Similarity=0.455  Sum_probs=126.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++.+.      +.+++..+..++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        84 ~~~~~L~~~l~~~------~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          84 APNGELLQYIRKY------GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            4689999999765      3699999999999999999999998   999999999999999999999999999876543


Q ss_pred             Cccc------------------chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCC
Q 026160           81 KKST------------------ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDI  142 (242)
Q Consensus        81 ~~~~------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~  142 (242)
                      ....                  .......++..|.+||.....  ..+.++|+||||++++++++|..||......    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----  228 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK--PAGKSSDLWALGCIIYQMLTGKPPFRGSNEY----  228 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCC--CCChhhhHHHHHHHHHHHHhCCCCCCCccHH----
Confidence            3211                  111123467889999987653  5788999999999999999999998754411    


Q ss_pred             cCcchhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCH----HHHHH
Q 026160          143 YFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSM----HEVLE  198 (242)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~----~~ll~  198 (242)
                          ....... ......+..+++.+.+++.       +||+.||++|||+    .++++
T Consensus       229 ----~~~~~~~-~~~~~~~~~~~~~~~~li~-------~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         229 ----LTFQKIL-KLEYSFPPNFPPDAKDLIE-------KLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             ----HHHHHHH-hcCCCCCCccCHHHHHHHH-------HHhcCCHhhCCCcccCHHHHhc
Confidence                0001111 1111222334445544444       4889999999999    77664

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.93  E-value=1.1e-25  Score=185.81  Aligned_cols=123  Identities=28%  Similarity=0.355  Sum_probs=99.5

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      +++|.+++...      ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        89 ~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~  159 (332)
T cd07857          89 EADLHQIIRSG------QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENP  159 (332)
T ss_pred             cCCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence            46777777543      4699999999999999999999998   99999999999999999999999999987654322


Q ss_pred             ccc--hhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           83 STI--SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        83 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      ...  ......++..|++||.+.+. ...+.++|+||||+++|++++|..||...
T Consensus       160 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~  213 (332)
T cd07857         160 GENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGK  213 (332)
T ss_pred             ccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence            110  11123478899999987542 35688999999999999999999998643

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.93  E-value=7.5e-26  Score=182.58  Aligned_cols=186  Identities=23%  Similarity=0.267  Sum_probs=126.2

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      ++|.+++....     ..+++.++..++.|++.|+.|||+.   +++|+||+|.||+++.++.++|+|||++........
T Consensus        84 ~~l~~~~~~~~-----~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~  155 (287)
T cd07840          84 HDLTGLLDSPE-----VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS  155 (287)
T ss_pred             ccHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence            46777765431     4699999999999999999999998   999999999999999999999999999886654431


Q ss_pred             cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCC------------CCcCcchhhh-
Q 026160           84 TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSS------------DIYFPNSIYK-  150 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~------------~~~~~~~~~~-  150 (242)
                      . ......++..|+|||.+.+. ..++.++|+||||+++|++++|..||........            ...++..... 
T Consensus       156 ~-~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07840         156 A-DYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP  233 (287)
T ss_pred             c-cccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence            1 11122367789999977543 3567899999999999999999999864332100            0000000000 


Q ss_pred             ccCC-CCccccccccchHHHHH-HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          151 HIEP-GNDFQLDGVVTEEEKEL-VKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       151 ~~~~-~~~~~~~~~~~~~~~~~-~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .... ................. ...+.+++.+||..||++||++.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            0000 00000000111111221 4566778888999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.93  E-value=1.6e-25  Score=178.50  Aligned_cols=174  Identities=25%  Similarity=0.330  Sum_probs=125.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++++|.+++....  .....+++.++..++.|++.|+.|||+.   +++|+||+|+||+++. +.++|+|||++.....
T Consensus        84 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~  157 (260)
T cd08222          84 CEGRDLDCKLEELK--HTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG  157 (260)
T ss_pred             CCCCCHHHHHHHHh--hcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCC
Confidence            57889999886532  1335799999999999999999999998   9999999999999975 5699999998876543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....++..|.+||.+..  ...+.++|+||||+++|++++|..||......       ... .....+.....
T Consensus       158 ~~~~--~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-------~~~-~~~~~~~~~~~  225 (260)
T cd08222         158 SCDL--ATTFTGTPYYMSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL-------SVV-LRIVEGPTPSL  225 (260)
T ss_pred             Cccc--ccCCCCCcCccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-------HHH-HHHHcCCCCCC
Confidence            2211  112347788999998754  35678899999999999999999998533211       111 11111112222


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      +..++.+       +.+++.+||..||++||++.+++++
T Consensus       226 ~~~~~~~-------~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         226 PETYSRQ-------LNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             cchhcHH-------HHHHHHHHhcCChhhCcCHHHHhhC
Confidence            2233333       4455566889999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.93  E-value=1.3e-25  Score=182.67  Aligned_cols=186  Identities=20%  Similarity=0.194  Sum_probs=122.1

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      |+|.+++...     ...+++.++..++.|++.||.|||+.   +++|+||+|.||+++.++.++|+|||++........
T Consensus       100 ~~l~~~l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~  171 (302)
T cd07864         100 HDLMGLLESG-----LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES  171 (302)
T ss_pred             ccHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCcccccccccCCcc
Confidence            3555555432     24689999999999999999999999   999999999999999999999999999876544332


Q ss_pred             cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCc-------chhhhccCCCC
Q 026160           84 TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP-------NSIYKHIEPGN  156 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~  156 (242)
                      .. .....++..|++||.+.+. ...+.++|+||||+++|++++|+.||.............       ...........
T Consensus       172 ~~-~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (302)
T cd07864         172 RP-YTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLP  249 (302)
T ss_pred             cc-cccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccc
Confidence            11 1112356789999987543 345789999999999999999999986432110000000       00000000000


Q ss_pred             c-------cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          157 D-------FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       157 ~-------~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .       .............+...+.+++..||+.||++|||+.+++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         250 YFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             cccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0       000000001111123445666666999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.93  E-value=1e-25  Score=186.34  Aligned_cols=181  Identities=23%  Similarity=0.280  Sum_probs=122.5

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      |+|.+++...       .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        93 ~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~  162 (337)
T cd07852          93 TDLHAVIRAN-------ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE  162 (337)
T ss_pred             cCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence            4666666432       578889999999999999999998   999999999999999999999999999876543321


Q ss_pred             c---chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCC--------CcCcc------
Q 026160           84 T---ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSD--------IYFPN------  146 (242)
Q Consensus        84 ~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~--------~~~~~------  146 (242)
                      .   .......++..|++||.+... ...+.++|+||||+++|++++|+.||.........        .....      
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07852         163 NPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK  241 (337)
T ss_pred             cccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence            1   111123478899999987543 35678999999999999999999998533211100        00000      


Q ss_pred             -----hhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          147 -----SIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       147 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                           .............    ...........+.+++.+||+.||++|||+.+++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         242 SPFAATMLDSLPSRPRKP----LDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             hhhHHHhhhhcccccccc----hhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                 0000000000000    000111123445666777999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.93  E-value=1.2e-25  Score=200.40  Aligned_cols=172  Identities=28%  Similarity=0.431  Sum_probs=121.2

Q ss_pred             CCCCCcchhccccCCCCCCccc-cHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTL-EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ   79 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l-~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~   79 (242)
                      |+.-+|++++.....      . .-...|.++++|++||.|+|++   |++||||||.||+++.++.|||+|||+++...
T Consensus       678 CE~~ll~~iI~~N~~------~~~~d~~wrLFreIlEGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~  748 (1351)
T KOG1035|consen  678 CEKTLLRDIIRRNHF------NSQRDEAWRLFREILEGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLK  748 (1351)
T ss_pred             hhhhHHHHHHHhccc------chhhHHHHHHHHHHHHHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhh
Confidence            566677888876543      2 5779999999999999999999   99999999999999999999999999998621


Q ss_pred             ------CC----------cccchhcccccccccccchhhhcccC-CCCCCccchhHHHHHHHHHhcCCCccccccCCCCC
Q 026160           80 ------DK----------KSTISMLHARGTIGYIAPEVFCRSFG-GASHKSDVYSYGMMILEMAVGRKNADVKASRSSDI  142 (242)
Q Consensus        80 ------~~----------~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~  142 (242)
                            ..          ......+...||..|.|||.+.+... .++.|.||||||+|++||+.-   |...-..    
T Consensus       749 ~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yP---F~TsMER----  821 (1351)
T KOG1035|consen  749 ENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYP---FGTSMER----  821 (1351)
T ss_pred             hhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhcc---CCchHHH----
Confidence                  00          00112234579999999999866532 689999999999999999853   4322111    


Q ss_pred             cCcchhhhccCCCCcccc---ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 026160          143 YFPNSIYKHIEPGNDFQL---DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE  198 (242)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~  198 (242)
                         ..+...+..+..+..   ....-+....+++.       +++.||++||||.||+.
T Consensus       822 ---a~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~-------Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  822 ---ASILTNLRKGSIPEPADFFDPEHPEEASLIRW-------LLSHDPSKRPTATELLN  870 (1351)
T ss_pred             ---HHHHHhcccCCCCCCcccccccchHHHHHHHH-------HhcCCCccCCCHHHHhh
Confidence               122222222221111   11222333444444       55999999999999984

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.93  E-value=2.6e-25  Score=182.15  Aligned_cols=169  Identities=29%  Similarity=0.378  Sum_probs=121.6

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      .|+|.+++....     ..+++.++..++.|++.++.|||+.   +++|+||+|.||+++.++.++|+|||++.......
T Consensus       104 ~~~l~~~l~~~~-----~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~  175 (313)
T cd06633         104 LGSASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN  175 (313)
T ss_pred             CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCCC
Confidence            356777765432     4589999999999999999999998   99999999999999999999999999876433221


Q ss_pred             ccchhcccccccccccchhhhc-ccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccccc
Q 026160           83 STISMLHARGTIGYIAPEVFCR-SFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLD  161 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (242)
                            ...++..|++||.+.. .....+.++|+||||+++|++++|..||........       ..............
T Consensus       176 ------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~-------~~~~~~~~~~~~~~  242 (313)
T cd06633         176 ------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------LYHIAQNDSPTLQS  242 (313)
T ss_pred             ------CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-------HHHHHhcCCCCCCc
Confidence                  2247788999998743 123567899999999999999999999865432110       00000011111111


Q ss_pred             cccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          162 GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       162 ~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ..++..+.       .++.+||+.+|.+||++.+++.+
T Consensus       243 ~~~~~~l~-------~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         243 NEWTDSFR-------GFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             cccCHHHH-------HHHHHHccCChhhCcCHHHHhcC
Confidence            12333344       45555999999999999999865

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.93  E-value=2.8e-25  Score=175.82  Aligned_cols=169  Identities=30%  Similarity=0.439  Sum_probs=126.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++...      ..+++..+..++.|+++|+.|||+.   +++|+||+|.||+++.++.++|+|||++.....
T Consensus        75 ~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~  145 (250)
T cd05123          75 APGGELFSHLSKE------GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSS  145 (250)
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence            4689999999765      3589999999999999999999998   999999999999999999999999999876544


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....++..|.+||...+.  ..+.++|+||||+++|++++|..||.....        ......... .....
T Consensus       146 ~~~~--~~~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~-~~~~~  212 (250)
T cd05123         146 EGSR--TNTFCGTPEYLAPEVLLGK--GYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKILK-DPLRF  212 (250)
T ss_pred             CCCc--ccCCcCCccccChHHhCCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHhc-CCCCC
Confidence            3211  1122477889999988654  467899999999999999999999864432        111111111 12223


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCH---HHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSM---HEVLE  198 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~---~~ll~  198 (242)
                      +...+..+.+++.       +||..||++||++   .++++
T Consensus       213 ~~~~~~~l~~~i~-------~~l~~~p~~R~~~~~~~~l~~  246 (250)
T cd05123         213 PEFLSPEARDLIS-------GLLQKDPTKRLGSGGAEEIKA  246 (250)
T ss_pred             CCCCCHHHHHHHH-------HHhcCCHhhCCCcccHHHHHh
Confidence            3344555555444       4889999999999   55543

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.93  E-value=1.4e-25  Score=185.43  Aligned_cols=189  Identities=21%  Similarity=0.190  Sum_probs=125.1

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      .|+|.+++...      ..+++..+..++.|++.||.|||+.   +++|+||+++||+++.++.++|+|||.+.......
T Consensus       103 ~~~l~~~l~~~------~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~  173 (335)
T PTZ00024        103 ASDLKKVVDRK------IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPP  173 (335)
T ss_pred             ccCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCccceeeccccc
Confidence            36788887653      4589999999999999999999998   99999999999999999999999999987654110


Q ss_pred             c------------cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCC----------
Q 026160           83 S------------TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSS----------  140 (242)
Q Consensus        83 ~------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~----------  140 (242)
                      .            ........++..|.|||.+.+. ...+.++|+||||+++|++++|..||........          
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~  252 (335)
T PTZ00024        174 YSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGT  252 (335)
T ss_pred             ccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            0            0011112357789999988653 3468899999999999999999999864432110          


Q ss_pred             --CCcCcchhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          141 --DIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       141 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                        ...++...............+.............+.+++..||+.||++|||+.+++.+-.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~  315 (335)
T PTZ00024        253 PNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY  315 (335)
T ss_pred             CchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence              0000000000000000000000000111112334556666799999999999999997544

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.93  E-value=2.6e-25  Score=180.19  Aligned_cols=121  Identities=27%  Similarity=0.350  Sum_probs=96.2

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      |+|.+++...     ...+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        87 ~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          87 TDLAQYMIQH-----PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             CCHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            5666665432     13578888999999999999999999   999999999999999999999999998875433221


Q ss_pred             cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           84 TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      ..  ....++..|+|||.+.+. ...+.++|+||||+++|++++|..||...
T Consensus       159 ~~--~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~  207 (291)
T cd07870         159 TY--SSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGV  207 (291)
T ss_pred             CC--CCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence            11  122367899999987543 24677899999999999999999999643

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=8.4e-26  Score=176.98  Aligned_cols=168  Identities=27%  Similarity=0.369  Sum_probs=135.2

Q ss_pred             CCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCC
Q 026160            2 PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDK   81 (242)
Q Consensus         2 ~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~   81 (242)
                      .||.|+-+|...      +.+++.........|+.||.|||++   +|+.||||.+|++++++|.+|+.|||++...-..
T Consensus       251 nGGeLf~HLsre------r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  251 NGGELFFHLSRE------RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY  321 (516)
T ss_pred             cCceEeeehhhh------hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcccc
Confidence            589999999876      5699999999999999999999999   9999999999999999999999999998754332


Q ss_pred             cccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccccc
Q 026160           82 KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLD  161 (242)
Q Consensus        82 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (242)
                      ...  ....+||+.|+|||++.++  .+..+.|-|.+|+++|||++|+.||.......        . -.+.......++
T Consensus       322 g~t--~kTFCGTPEYLAPEVleDn--DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k--------L-FeLIl~ed~kFP  388 (516)
T KOG0690|consen  322 GDT--TKTFCGTPEYLAPEVLEDN--DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK--------L-FELILMEDLKFP  388 (516)
T ss_pred             cce--eccccCChhhcCchhhccc--cccceeehhhhhHHHHHHHhccCcccccchhH--------H-HHHHHhhhccCC
Confidence            221  2245799999999999875  67889999999999999999999997555321        1 111122244567


Q ss_pred             cccchHHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 026160          162 GVVTEEEKELVKKMILVSLWCIQTNPSDRP-----SMHEVLE  198 (242)
Q Consensus       162 ~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp-----s~~~ll~  198 (242)
                      ..++++++.++..++       .+||.+|.     .+.++.+
T Consensus       389 r~ls~eAktLLsGLL-------~kdP~kRLGgGpdDakEi~~  423 (516)
T KOG0690|consen  389 RTLSPEAKTLLSGLL-------KKDPKKRLGGGPDDAKEIMR  423 (516)
T ss_pred             ccCCHHHHHHHHHHh-------hcChHhhcCCCchhHHHHHh
Confidence            789999999988866       99999994     4555553

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.93  E-value=3.1e-25  Score=188.60  Aligned_cols=192  Identities=22%  Similarity=0.287  Sum_probs=137.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC--CC--ceEEccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE--DF--CPKISDFGLAK   76 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~--~~--~~~L~dfg~~~   76 (242)
                      |++|||+..|.+   +++..+|++.+.+.++.++..||.|||.+   +|+||||||.||++..  +|  ..||+|||+++
T Consensus        99 C~gGsL~~~L~~---PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar  172 (732)
T KOG4250|consen   99 CSGGSLRKVLNS---PENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR  172 (732)
T ss_pred             cCCCcHHHHhcC---cccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence            789999999976   45678999999999999999999999999   9999999999998842  24  36999999999


Q ss_pred             ccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhh------
Q 026160           77 QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYK------  150 (242)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~------  150 (242)
                      ...+......   ..||..|.+||.+... ..++...|.|||||++|+++||..||...............+..      
T Consensus       173 el~d~s~~~S---~vGT~~YLhPel~E~q-~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v  248 (732)
T KOG4250|consen  173 ELDDNSLFTS---LVGTEEYLHPELYERQ-KKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV  248 (732)
T ss_pred             cCCCCCeeee---ecCchhhcChHHHhhc-cCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence            8877765443   4599999999998642 47789999999999999999999999877765321111111110      


Q ss_pred             -----ccCCCC-----ccccccccchHHHHHHHHHHHHHHHhccCCCCCCC--CHHHHHHHhhchhh
Q 026160          151 -----HIEPGN-----DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRP--SMHEVLEMLESSTE  205 (242)
Q Consensus       151 -----~~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp--s~~~ll~~l~~~~~  205 (242)
                           ...++.     ..+.+..++..+.......+   ...|..+|.+|-  .+.+....+..+..
T Consensus       249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwL---a~~L~~~~~~~~~~~~~~~Fa~~~dIL~  312 (732)
T KOG4250|consen  249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWL---ASMLEWNPRKRGHEGFDRFFAEVDDILN  312 (732)
T ss_pred             eEeeecccCCceeeeccCCCcccccHHHHhhhhHHH---HHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence                 011111     11123333444444444444   445677788887  77767666665544

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.93  E-value=2.1e-25  Score=183.88  Aligned_cols=191  Identities=20%  Similarity=0.219  Sum_probs=128.3

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      ++|.+++...      ..+++..+..++.+++.||.|||+.   +++|+||||.||+++.++.++|+|||++........
T Consensus        88 ~~l~~~l~~~------~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          88 TDLHKVIKSP------QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED  158 (330)
T ss_pred             hhHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence            4677777543      3699999999999999999999999   999999999999999999999999999987654421


Q ss_pred             c-chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCC--------CCcCcch-------
Q 026160           84 T-ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSS--------DIYFPNS-------  147 (242)
Q Consensus        84 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~--------~~~~~~~-------  147 (242)
                      . .......++..|+|||.+.+. ...+.++|+||||+++|++++|..||........        .......       
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  237 (330)
T cd07834         159 EKGFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE  237 (330)
T ss_pred             ccccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence            0 011123478889999988654 2678899999999999999999999864432100        0000000       


Q ss_pred             -hhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--hhchhh
Q 026160          148 -IYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM--LESSTE  205 (242)
Q Consensus       148 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~--l~~~~~  205 (242)
                       ....... ...............+...+.+++.+||+.||++|||+.+++.+  ++....
T Consensus       238 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         238 KARNYLKS-LPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             chhhHHhh-cccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence             0000000 00000000000011123445566666999999999999999985  554443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.92  E-value=4.1e-25  Score=177.91  Aligned_cols=186  Identities=26%  Similarity=0.277  Sum_probs=126.1

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      .++|.+++....     ..+++.++..++.+++.||.+||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~  152 (282)
T cd07829          81 DMDLKKYLDKRP-----GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPL  152 (282)
T ss_pred             CcCHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence            368888887642     3599999999999999999999999   99999999999999999999999999987654432


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCc-------CcchhhhccCCC
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIY-------FPNSIYKHIEPG  155 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~-------~~~~~~~~~~~~  155 (242)
                      ...  .....+..|+|||.+... ...+.++|+||||+++|++++|..||...........       ............
T Consensus       153 ~~~--~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
T cd07829         153 RTY--THEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL  229 (282)
T ss_pred             ccc--CccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccc
Confidence            211  112356789999987543 3668899999999999999999998864331100000       000000000000


Q ss_pred             --Cccccc----cccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          156 --NDFQLD----GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       156 --~~~~~~----~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                        .....+    .............+.+++..||..||++||++.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence              000000    00001111223456667777999999999999998863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.92  E-value=2.5e-25  Score=179.53  Aligned_cols=187  Identities=24%  Similarity=0.282  Sum_probs=123.9

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      |+|.+++.....   ...+++.++..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        82 ~~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          82 KDLKKYMDTHGV---RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             ccHHHHHHhcCC---CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            578888765431   24689999999999999999999998   999999999999999999999999999875433211


Q ss_pred             cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcC-------cchhhhccCCCC
Q 026160           84 TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYF-------PNSIYKHIEPGN  156 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~-------~~~~~~~~~~~~  156 (242)
                      .  .....++..|++||.+.+. ..++.++|+||||+++|++++|..||............       ............
T Consensus       156 ~--~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07836         156 T--FSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP  232 (284)
T ss_pred             c--cccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc
Confidence            1  1112367789999987543 34678999999999999999999998644321100000       000000000000


Q ss_pred             --ccccccccchHH----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          157 --DFQLDGVVTEEE----KELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       157 --~~~~~~~~~~~~----~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                        ....+.......    ......+.+++.+||+.||++||++.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence              000000000000    1122344566667999999999999998853

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.92  E-value=1.3e-25  Score=186.25  Aligned_cols=181  Identities=23%  Similarity=0.251  Sum_probs=123.9

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      +++|.+++..       ..+++.++..++.|+++|+.|||+.   +++|+||+|.||+++.++.++|+|||++.......
T Consensus       103 ~~~L~~~~~~-------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~  172 (343)
T cd07851         103 GADLNNIVKC-------QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM  172 (343)
T ss_pred             CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccccccccccc
Confidence            5678777754       3589999999999999999999998   99999999999999999999999999987654321


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCc-------CcchhhhccCCC
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIY-------FPNSIYKHIEPG  155 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~-------~~~~~~~~~~~~  155 (242)
                      .     ...++..|.+||.+.+. ...+.++|+||||+++|++++|..||...........       ............
T Consensus       173 ~-----~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  246 (343)
T cd07851         173 T-----GYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE  246 (343)
T ss_pred             c-----CCcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccch
Confidence            1     12467889999987543 2567899999999999999999999853321100000       000000000000


Q ss_pred             --------CccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          156 --------NDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       156 --------~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                              ...................+.+++.+||+.||++|||+.+++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence                    00000000001111123455667777999999999999999864

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.92  E-value=5.2e-25  Score=179.53  Aligned_cols=196  Identities=24%  Similarity=0.330  Sum_probs=137.2

Q ss_pred             CCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhC------CCCCeeecCCCCCceeeCCCCceEEcccccc
Q 026160            2 PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRG------CNVRIVHFDIKPHNILLDEDFCPKISDFGLA   75 (242)
Q Consensus         2 ~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~------~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~   75 (242)
                      |+|||.+||+.+       .++|.+..+|+..+++||+|||..      +++.|+|||||.+|||+..++...|+|||++
T Consensus       291 ~kGsL~dyL~~n-------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA  363 (534)
T KOG3653|consen  291 PKGSLCDYLKAN-------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA  363 (534)
T ss_pred             cCCcHHHHHHhc-------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence            689999999875       699999999999999999999974      3578999999999999999999999999999


Q ss_pred             cccCCCcccchhcccccccccccchhhhcccCCC----CCCccchhHHHHHHHHHhcCCCccccccCCCCCcCc------
Q 026160           76 KQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGA----SHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP------  145 (242)
Q Consensus        76 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~----~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~------  145 (242)
                      .++.............||.+|+|||++.+.....    -.+.||||+|.|+||++++-...+.....+....+.      
T Consensus       364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h  443 (534)
T KOG3653|consen  364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH  443 (534)
T ss_pred             EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence            9877554433333457999999999997643221    246799999999999998755443311111111111      


Q ss_pred             ----chhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          146 ----NSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       146 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                          +..........++.++...-..  .-+.-+.+.+..||+.|++.|.|+.=+-+.+..+.-.
T Consensus       444 Pt~e~mq~~VV~kK~RP~~p~~W~~h--~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~  506 (534)
T KOG3653|consen  444 PTLEEMQELVVRKKQRPKIPDAWRKH--AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML  506 (534)
T ss_pred             CCHHHHHHHHHhhccCCCChhhhhcC--ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence                1111111222222222111111  2234444556669999999999999888888776654

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.92  E-value=4.4e-25  Score=183.15  Aligned_cols=116  Identities=31%  Similarity=0.436  Sum_probs=96.4

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      +|+|.+++..       ..+++..+..++.|++.|+.|||+.   +++|+||||.||+++.++.++|+|||++.......
T Consensus       105 ~~~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~~  174 (345)
T cd07877         105 GADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM  174 (345)
T ss_pred             ccCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEecccccccccccc
Confidence            5667666643       3489999999999999999999999   99999999999999999999999999987643322


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccc
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADV  134 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~  134 (242)
                      .     ...++..|+|||.+.+. ...+.++|+|||||++|++++|..||..
T Consensus       175 ~-----~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~  220 (345)
T cd07877         175 T-----GYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPG  220 (345)
T ss_pred             c-----ccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            1     12478889999987542 3467889999999999999999999853

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.92  E-value=5.6e-25  Score=182.34  Aligned_cols=176  Identities=23%  Similarity=0.250  Sum_probs=118.9

Q ss_pred             cccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccccch
Q 026160           21 TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPE  100 (242)
Q Consensus        21 ~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE  100 (242)
                      .+++..+..++.|++.||.|||+.   +++|+||+|.||+++.++.++|+|||++........     ...++..|+|||
T Consensus       113 ~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~~~-----~~~~~~~y~aPE  184 (342)
T cd07879         113 PLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMT-----GYVVTRWYRAPE  184 (342)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCCCC-----CceeeecccChh
Confidence            589999999999999999999999   999999999999999999999999999875433211     123678899999


Q ss_pred             hhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCc------Cc-chhhhccCCC--------Cccccccccc
Q 026160          101 VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIY------FP-NSIYKHIEPG--------NDFQLDGVVT  165 (242)
Q Consensus       101 ~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~------~~-~~~~~~~~~~--------~~~~~~~~~~  165 (242)
                      .+.+. ...+.++|+||||+++|++++|+.||...........      .+ ..........        ..........
T Consensus       185 ~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (342)
T cd07879         185 VILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFS  263 (342)
T ss_pred             hhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHH
Confidence            87542 2467899999999999999999999974331100000      00 0000000000        0000000000


Q ss_pred             hHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--hhchhh
Q 026160          166 EEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM--LESSTE  205 (242)
Q Consensus       166 ~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~--l~~~~~  205 (242)
                      .........+.+++.+||+.||++||++.+++.+  ++....
T Consensus       264 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         264 TLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            0000112345566677999999999999999955  766544

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.7e-25  Score=184.02  Aligned_cols=171  Identities=27%  Similarity=0.437  Sum_probs=138.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |=||.|-..|.+.      +.+.......++.-+++|++|||+.   +|++|||||+|++++.+|-+||.|||++.....
T Consensus       502 ClGGElWTiLrdR------g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~  572 (732)
T KOG0614|consen  502 CLGGELWTILRDR------GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS  572 (732)
T ss_pred             hcCchhhhhhhhc------CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence            4578887778766      5699999999999999999999999   999999999999999999999999999999887


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCC-Cccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPG-NDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  159 (242)
                      ....+.   ++||+.|.|||++...  ....+.|.||||+++||+++|.+||...+...        ....+..+ ....
T Consensus       573 g~KTwT---FcGTpEYVAPEIILnK--GHD~avDyWaLGIli~ELL~G~pPFs~~dpmk--------tYn~ILkGid~i~  639 (732)
T KOG0614|consen  573 GRKTWT---FCGTPEYVAPEIILNK--GHDRAVDYWALGILIYELLTGSPPFSGVDPMK--------TYNLILKGIDKIE  639 (732)
T ss_pred             CCceee---ecCCcccccchhhhcc--CcchhhHHHHHHHHHHHHHcCCCCCCCCchHH--------HHHHHHhhhhhhh
Confidence            766553   4699999999998775  67889999999999999999999998766432        22222222 1233


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHHh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPS-----MHEVLEML  200 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps-----~~~ll~~l  200 (242)
                      +|..++....++++++.       ..+|.+|.-     +.++.++.
T Consensus       640 ~Pr~I~k~a~~Lik~LC-------r~~P~ERLG~~~~gI~DIkkH~  678 (732)
T KOG0614|consen  640 FPRRITKTATDLIKKLC-------RDNPTERLGYQKGGINDIKKHR  678 (732)
T ss_pred             cccccchhHHHHHHHHH-------hcCcHhhhccccCChHHHHhhh
Confidence            45667778888888876       889999964     67777654

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.92  E-value=5.5e-25  Score=189.66  Aligned_cols=181  Identities=27%  Similarity=0.401  Sum_probs=146.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      ||+|+|.||++.++     ..|-.+..+.++.||++|+.|||.+   .++||||-.+|+|+..-..+|+.|||+++....
T Consensus       779 mP~G~LlDyvr~hr-----~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  779 MPLGCLLDYVREHR-----DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             cccchHHHHHHHhh-----ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence            79999999999876     4699999999999999999999998   999999999999999988999999999987765


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ....+.....+..+.|+|-|.+..  ..++.++|+||||+.+||++| |..|++....        ..+...++.+.+..
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~--~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~--------~eI~dlle~geRLs  920 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRI--RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA--------EEIPDLLEKGERLS  920 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhc--cCCCchhhhhhhhhhHHHHHhcCCCccCCCCH--------HHhhHHHhccccCC
Confidence            544443333456788999998765  378999999999999999987 8888876654        33334445555555


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      .++.++-++-       -+|.+||..|++.||+++++...+......
T Consensus       921 qPpiCtiDVy-------~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  921 QPPICTIDVY-------MVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             CCCCccHHHH-------HHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence            5555655443       445559999999999999999888876643

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.92  E-value=7.5e-26  Score=175.68  Aligned_cols=172  Identities=27%  Similarity=0.412  Sum_probs=134.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |-.||+-|.+..++     ++|++.++..+++.-++||+|||..   .-+|||||..|||+..+|..||+|||.+....+
T Consensus       110 CGAGSiSDI~R~R~-----K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD  181 (502)
T KOG0574|consen  110 CGAGSISDIMRARR-----KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD  181 (502)
T ss_pred             cCCCcHHHHHHHhc-----CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhh
Confidence            34578888876553     6899999999999999999999998   889999999999999999999999999987665


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCC--cc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN--DF  158 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~  158 (242)
                      .....+  +.+||++|+|||++...  .+..++||||||+...||..|++||..-.....-+        .+..+.  .+
T Consensus       182 TMAKRN--TVIGTPFWMAPEVI~EI--GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF--------MIPT~PPPTF  249 (502)
T KOG0574|consen  182 TMAKRN--TVIGTPFWMAPEVIEEI--GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF--------MIPTKPPPTF  249 (502)
T ss_pred             hHHhhC--ccccCcccccHHHHHHh--ccchhhhHhhhcchhhhhhcCCCCcccccccceeE--------eccCCCCCCC
Confidence            543322  34699999999999776  67889999999999999999999996443332211        122222  22


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ..+...+.++.+++++       ||-++|++|-|+.+++++
T Consensus       250 ~KPE~WS~~F~DFi~~-------CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  250 KKPEEWSSEFNDFIRS-------CLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CChHhhhhHHHHHHHH-------HhcCCHHHHHHHHHHhhh
Confidence            2334455555555555       999999999999999864

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.92  E-value=5.6e-25  Score=192.20  Aligned_cols=186  Identities=23%  Similarity=0.197  Sum_probs=115.6

Q ss_pred             CCCCCcchhccccCCCC--------------CCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC-CC
Q 026160            1 MPNGSLDQFTYDQESSN--------------GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE-DF   65 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~--------------~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~-~~   65 (242)
                      +++|+|.+++.......              .........+..++.|++.||.|||+.   +|+|+||||+|||++. ++
T Consensus       217 ~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NILl~~~~~  293 (566)
T PLN03225        217 EGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNIIFSEGSG  293 (566)
T ss_pred             cCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHEEEeCCCC
Confidence            46788888886542100              011122345678999999999999998   9999999999999986 57


Q ss_pred             ceEEcccccccccCCCcccchhcccccccccccchhhhcccC--------------------CCCCCccchhHHHHHHHH
Q 026160           66 CPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFG--------------------GASHKSDVYSYGMMILEM  125 (242)
Q Consensus        66 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~--------------------~~~~~~Di~slG~~~~~l  125 (242)
                      .++|+|||++......... ......+++.|+|||.+.....                    .++.++|||||||++|||
T Consensus       294 ~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el  372 (566)
T PLN03225        294 SFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM  372 (566)
T ss_pred             cEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHH
Confidence            8999999999754332211 1112357889999996633211                    123466999999999999


Q ss_pred             HhcCCCccccccC------CCCCcCcchhhhccCCCCccccccccchHHHHH-------HHHHHHHHHHhccCCCCCCCC
Q 026160          126 AVGRKNADVKASR------SSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKEL-------VKKMILVSLWCIQTNPSDRPS  192 (242)
Q Consensus       126 l~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~~cl~~dp~~Rps  192 (242)
                      +++..+++.....      ........+. .....        ..+++....       .....+++.+||++||++|||
T Consensus       373 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~-~~~~~--------~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t  443 (566)
T PLN03225        373 AFPNLRSDSNLIQFNRQLKRNDYDLVAWR-KLVEP--------RASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS  443 (566)
T ss_pred             HhCcCCCchHHHHHHHHHHhcCCcHHHHH-Hhhcc--------ccchhhhhhhhhccccchHHHHHHHHHccCCcccCCC
Confidence            9876654321100      0000000000 00000        011111110       112235666688999999999


Q ss_pred             HHHHHHH
Q 026160          193 MHEVLEM  199 (242)
Q Consensus       193 ~~~ll~~  199 (242)
                      +.+++++
T Consensus       444 a~e~L~H  450 (566)
T PLN03225        444 AKAALAH  450 (566)
T ss_pred             HHHHhCC
Confidence            9999986

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.92  E-value=3.3e-25  Score=183.71  Aligned_cols=183  Identities=21%  Similarity=0.263  Sum_probs=119.3

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC-CCceEEcccccccccCCCc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE-DFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~-~~~~~L~dfg~~~~~~~~~   82 (242)
                      ++|.+++..       ..+++..+..++.|+++||.|||+.   +++|+||||+||+++. ++.++|+|||++.......
T Consensus       100 ~~L~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~  169 (342)
T cd07854         100 TDLANVLEQ-------GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHY  169 (342)
T ss_pred             ccHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCcccceecCCcc
Confidence            456666532       3589999999999999999999998   9999999999999975 5578999999987654322


Q ss_pred             ccch-hcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCc--------Cc-------c
Q 026160           83 STIS-MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIY--------FP-------N  146 (242)
Q Consensus        83 ~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~--------~~-------~  146 (242)
                      .... .....++..|.|||.+... ...+.++|+|||||++|++++|..||...........        ..       .
T Consensus       170 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (342)
T cd07854         170 SHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLN  248 (342)
T ss_pred             ccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhh
Confidence            1111 1112367789999986542 3567899999999999999999999964432110000        00       0


Q ss_pred             hhhhccC-CCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          147 SIYKHIE-PGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       147 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ....... .......+  .......+...+.+++.+||+.||++|||+.+++++
T Consensus       249 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         249 VIPSFVRNDGGEPRRP--LRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             hhhhhhhhcccccCCC--HHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            0000000 00000000  000011122345566667999999999999999854

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.92  E-value=1.7e-24  Score=175.65  Aligned_cols=122  Identities=29%  Similarity=0.358  Sum_probs=95.2

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC-CCceEEcccccccccCCCc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE-DFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~-~~~~~L~dfg~~~~~~~~~   82 (242)
                      |+|.+++....    ...+++..+..++.||+.||.|||+.   +++|+||+|+||+++. ++.++|+|||++.......
T Consensus        85 ~~l~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         85 LDLKKHMDSSP----DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccHHHHHHhCC----CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            56666664332    23468888999999999999999999   9999999999999985 5579999999987654322


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      ..  .....++..|+|||.+.+. ...+.++|+||||+++|++++|..||...
T Consensus       158 ~~--~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~  207 (294)
T PLN00009        158 RT--FTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGD  207 (294)
T ss_pred             cc--cccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            11  1112367889999987553 35678999999999999999999998643

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.92  E-value=6.7e-25  Score=170.86  Aligned_cols=113  Identities=29%  Similarity=0.357  Sum_probs=98.0

Q ss_pred             ccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCC----CceEEcccccccccCCCcccc-hhccccccc
Q 026160           20 RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDED----FCPKISDFGLAKQSQDKKSTI-SMLHARGTI   94 (242)
Q Consensus        20 ~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~----~~~~L~dfg~~~~~~~~~~~~-~~~~~~~~~   94 (242)
                      +-++-..+..|+-||++|+.|||++   =|+||||||+||++..+    |+||++|||+++.+...-... .......|+
T Consensus       127 ~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTi  203 (438)
T KOG0666|consen  127 KQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTI  203 (438)
T ss_pred             ccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEE
Confidence            5688999999999999999999999   89999999999999877    899999999999877654443 344556899


Q ss_pred             ccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccc
Q 026160           95 GYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKA  136 (242)
Q Consensus        95 ~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  136 (242)
                      +|.|||.+.+. ..++.+.|+|++||++.||++-++-|....
T Consensus       204 WYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E  244 (438)
T KOG0666|consen  204 WYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGRE  244 (438)
T ss_pred             EecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchh
Confidence            99999999886 577999999999999999999888775443

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=9.2e-25  Score=177.44  Aligned_cols=179  Identities=28%  Similarity=0.409  Sum_probs=134.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeC---CCCceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD---EDFCPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~---~~~~~~L~dfg~~~~   77 (242)
                      |||-+|+-||+.+      +.++++++..|+.||+.||.||... ++.|+|-||||.|||+.   ..|.+|+.|||++..
T Consensus       550 ceGNDLDFYLKQh------klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI  622 (775)
T KOG1151|consen  550 CEGNDLDFYLKQH------KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI  622 (775)
T ss_pred             cCCCchhHHHHhh------hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence            7899999999887      4599999999999999999999986 56999999999999995   357799999999987


Q ss_pred             cCCCccc----chh-cccccccccccchhhhcc--cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhh
Q 026160           78 SQDKKST----ISM-LHARGTIGYIAPEVFCRS--FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYK  150 (242)
Q Consensus        78 ~~~~~~~----~~~-~~~~~~~~y~~PE~~~~~--~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~  150 (242)
                      +......    ... ....||.+|+|||.+.-.  .++.+.+.|+||+|+++|.++.|+.||.......+ +.    ...
T Consensus       623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd-IL----qeN  697 (775)
T KOG1151|consen  623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD-IL----QEN  697 (775)
T ss_pred             ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH-HH----hhh
Confidence            6543222    111 123599999999977432  45779999999999999999999999974433211 00    011


Q ss_pred             ccCC--CCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 026160          151 HIEP--GNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE  198 (242)
Q Consensus       151 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~  198 (242)
                      .+.+  ...++..+.++.+..+++++       ||++.-++|....++..
T Consensus       698 TIlkAtEVqFP~KPvVsseAkaFIRR-------CLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  698 TILKATEVQFPPKPVVSSEAKAFIRR-------CLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             chhcceeccCCCCCccCHHHHHHHHH-------HHHhhhhhhhhHHHHcc
Confidence            1111  12233345678888887777       88999999988877653

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.92  E-value=3.1e-24  Score=168.39  Aligned_cols=172  Identities=28%  Similarity=0.348  Sum_probs=126.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|..++....      .++...++.++.+++.++.+||+.   +++|+||+|.||+++.++.++++|||.+.....
T Consensus        69 ~~~~~L~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~  139 (244)
T smart00220       69 CDGGDLFDLLKKRG------RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDP  139 (244)
T ss_pred             CCCCCHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecc
Confidence            35679999886542      289999999999999999999999   999999999999999999999999999887655


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....   ....++..|.+||.+...  ..+.++|+|+||++++++++|..||......       ...............
T Consensus       140 ~~~~---~~~~~~~~~~~pE~~~~~--~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-------~~~~~~~~~~~~~~~  207 (244)
T smart00220      140 GGLL---TTFVGTPEYMAPEVLLGK--GYGKAVDVWSLGVILYELLTGKPPFPGDDQL-------LELFKKIGKPKPPFP  207 (244)
T ss_pred             cccc---ccccCCcCCCCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-------HHHHHHHhccCCCCc
Confidence            4211   123477899999988643  5677999999999999999999998653211       111111111111110


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE  198 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~  198 (242)
                      ...     ..+...+..++.+||..+|++||++.++++
T Consensus       208 ~~~-----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      208 PPE-----WKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             ccc-----ccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            000     002244555666799999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=3.5e-25  Score=169.48  Aligned_cols=176  Identities=16%  Similarity=0.225  Sum_probs=126.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC--CCceEEccccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE--DFCPKISDFGLAKQS   78 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~--~~~~~L~dfg~~~~~   78 (242)
                      +|.|+|...+..       .++-+.....++.|+++|+.|||+.   ++||||||.+||||..  ..++||||||..+..
T Consensus       104 aP~gdL~snv~~-------~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen  104 APRGDLRSNVEA-------AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             CccchhhhhcCc-------ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccccc
Confidence            588999888866       3588889999999999999999999   9999999999999953  347999999999887


Q ss_pred             CCCcccchhcccccccccccchhhhcc---cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCC
Q 026160           79 QDKKSTISMLHARGTIGYIAPEVFCRS---FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPG  155 (242)
Q Consensus        79 ~~~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  155 (242)
                      +.......     .+..|.+||.+...   .......+|+|.||+++|.+++|..||......+..+.....+.. ....
T Consensus       174 g~tV~~~~-----~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~-rk~~  247 (378)
T KOG1345|consen  174 GTTVKYLE-----YVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLK-RKNP  247 (378)
T ss_pred             Cceehhhh-----hhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhc-ccCc
Confidence            77655443     45678899976432   123477899999999999999999999855544433321111111 1111


Q ss_pred             CccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          156 NDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                             .++..++.+..+.+.+..+-+..++++|--..++.+.
T Consensus       248 -------~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  248 -------ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             -------cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence                   2344444444555555555779999999544444433

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=5.3e-25  Score=184.07  Aligned_cols=166  Identities=31%  Similarity=0.410  Sum_probs=130.7

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      ||--|.|.-++     +++.+-++..|+.+.+.||+|||+.   +.||||||..|||++..|.|||+|||.+.....-..
T Consensus       110 GSAsDlleVhk-----KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAns  181 (948)
T KOG0577|consen  110 GSASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANS  181 (948)
T ss_pred             ccHHHHHHHHh-----ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchhc
Confidence            66677777665     5799999999999999999999999   999999999999999999999999999877665443


Q ss_pred             cchhcccccccccccchhhhc-ccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccccc-
Q 026160           84 TISMLHARGTIGYIAPEVFCR-SFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLD-  161 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~-~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  161 (242)
                      +      +||+.|+|||++.. ..+.++-+.|||||||...|+...++|....+..+.        ..++..+..+.+. 
T Consensus       182 F------vGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA--------LYHIAQNesPtLqs  247 (948)
T KOG0577|consen  182 F------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--------LYHIAQNESPTLQS  247 (948)
T ss_pred             c------cCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH--------HHHHHhcCCCCCCC
Confidence            3      59999999998743 234678999999999999999999999887665432        2333333333332 


Q ss_pred             cccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 026160          162 GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE  198 (242)
Q Consensus       162 ~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~  198 (242)
                      ...+..++.++..       ||++-|.+|||..++++
T Consensus       248 ~eWS~~F~~Fvd~-------CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  248 NEWSDYFRNFVDS-------CLQKIPQERPTSEELLK  277 (948)
T ss_pred             chhHHHHHHHHHH-------HHhhCcccCCcHHHHhh
Confidence            2334444444444       99999999999999883

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.91  E-value=5.7e-25  Score=184.40  Aligned_cols=176  Identities=22%  Similarity=0.315  Sum_probs=143.0

Q ss_pred             CCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCC
Q 026160            2 PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDK   81 (242)
Q Consensus         2 ~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~   81 (242)
                      .+|.+++||.++      +.+.+..+..++.|++.|++|||++   .|+|+|||++|++++.+.+++++|||++..+...
T Consensus       138 ~~ge~~~yl~~~------gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~  208 (596)
T KOG0586|consen  138 SGGELFDYLVKH------GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYG  208 (596)
T ss_pred             cCchhHHHHHhc------ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeeccc
Confidence            579999999887      4588899999999999999999999   9999999999999999999999999999988755


Q ss_pred             cccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccccc
Q 026160           82 KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLD  161 (242)
Q Consensus        82 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (242)
                      ....   ..+|++.|.|||.+.+.. ...+..|+||+|+++|-++.|..||+........       .+.  .....+++
T Consensus       209 ~~lq---t~cgsppyAaPEl~~g~~-y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-------~rv--l~gk~rIp  275 (596)
T KOG0586|consen  209 LMLQ---TFCGSPPYAAPELFNGKK-YDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-------PRV--LRGKYRIP  275 (596)
T ss_pred             cccc---ccCCCCCccChHhhcCcc-cCCcceehhhhhhhheeeeecccccCCccccccc-------chh--eeeeeccc
Confidence            4332   346999999999998763 5688999999999999999999999865532211       111  11123344


Q ss_pred             cccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          162 GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       162 ~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      -.++-+.++++++|+       ..+|.+|++.+++.+.-+.....
T Consensus       276 ~~ms~dce~lLrk~l-------vl~Pskr~~~dqim~~~W~n~~~  313 (596)
T KOG0586|consen  276 FYMSCDCEDLLRKFL-------VLNPSKRGPCDQIMKDRWRNDLL  313 (596)
T ss_pred             ceeechhHHHHHHhh-------ccCccccCCHHHhhhhcccchhh
Confidence            456778888899877       89999999999999877665543

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=2.5e-24  Score=163.38  Aligned_cols=112  Identities=24%  Similarity=0.369  Sum_probs=96.2

Q ss_pred             ccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCC--cccchhcccccccccc
Q 026160           20 RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDK--KSTISMLHARGTIGYI   97 (242)
Q Consensus        20 ~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~--~~~~~~~~~~~~~~y~   97 (242)
                      .+++..++.+++.++.+||+|+|.+   .|+|||+|++|+||+++|.++|+|||+++.+...  .....++.+..|.+|.
T Consensus       119 vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYr  195 (376)
T KOG0669|consen  119 VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYR  195 (376)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecC
Confidence            4699999999999999999999999   9999999999999999999999999999755432  2233355667899999


Q ss_pred             cchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           98 APEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        98 ~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      +||.+.+. ..+..+.|||.-||++.+|+++.+-+...
T Consensus       196 ppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimqgn  232 (376)
T KOG0669|consen  196 PPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQGN  232 (376)
T ss_pred             CHHHhhcc-cccCCcchhHhHHHHHHHHHccCccccCC
Confidence            99998775 46788999999999999999998876543

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.91  E-value=3.9e-24  Score=177.37  Aligned_cols=117  Identities=29%  Similarity=0.406  Sum_probs=96.8

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      +++|.+++..       ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus       103 ~~~l~~~~~~-------~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  172 (343)
T cd07880         103 GTDLGKLMKH-------EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM  172 (343)
T ss_pred             CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccccccCc
Confidence            4566666543       3589999999999999999999998   99999999999999999999999999987654322


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      .     ...++..|++||.+.+. ...+.++|+||||+++|++++|..||...
T Consensus       173 ~-----~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~  219 (343)
T cd07880         173 T-----GYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGH  219 (343)
T ss_pred             c-----ccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            1     12367889999988543 24688999999999999999999998643

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.91  E-value=1.2e-24  Score=179.40  Aligned_cols=181  Identities=27%  Similarity=0.291  Sum_probs=121.5

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      +++|.+++..       ..++...+..++.|+++||.|||+.   +++|+||+|.||+++.++.++|+|||++.......
T Consensus        93 ~~~L~~~~~~-------~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~  162 (328)
T cd07856          93 GTDLHRLLTS-------RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQM  162 (328)
T ss_pred             ccCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCCc
Confidence            4677776643       3578888999999999999999999   99999999999999999999999999987543322


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCC-------cCcchhhhccCCC
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDI-------YFPNSIYKHIEPG  155 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~-------~~~~~~~~~~~~~  155 (242)
                      .     ...++..|++||.+.+. ..++.++|+||||+++|++++|..||..........       ..+..........
T Consensus       163 ~-----~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (328)
T cd07856         163 T-----GYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE  236 (328)
T ss_pred             C-----CCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccch
Confidence            1     12367789999986442 356889999999999999999999985432100000       0000000000000


Q ss_pred             C--------ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          156 N--------DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       156 ~--------~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .        ........+.........+.+++.+||+.+|++|||+.+++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0        0000000000111123455666677999999999999999876

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.91  E-value=5.6e-26  Score=173.30  Aligned_cols=166  Identities=27%  Similarity=0.352  Sum_probs=120.6

Q ss_pred             ccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccccc
Q 026160           20 RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAP   99 (242)
Q Consensus        20 ~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~P   99 (242)
                      ..+++.-.-.|..-.++||.||-..  ..|+|||+||+|||++..|.+||||||++..........   .-.|-..|+||
T Consensus       162 ~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT---~daGCrpYmAP  236 (361)
T KOG1006|consen  162 SRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKT---VDAGCRPYMAP  236 (361)
T ss_pred             ccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhh---hccCCccccCh
Confidence            4688888888888889999999987  489999999999999999999999999987654443322   22377899999


Q ss_pred             hhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccccccccchHHHHHHHHHHHHH
Q 026160          100 EVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVS  179 (242)
Q Consensus       100 E~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  179 (242)
                      |.+.....++..++|+||||+.+||+.||..|+.......      ++.. .+-.+..+.+.  .+.+.......|..++
T Consensus       237 ERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svf------eql~-~Vv~gdpp~l~--~~~~~~~~s~~~~~fi  307 (361)
T KOG1006|consen  237 ERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVF------EQLC-QVVIGDPPILL--FDKECVHYSFSMVRFI  307 (361)
T ss_pred             hccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHH------HHHH-HHHcCCCCeec--CcccccccCHHHHHHH
Confidence            9997766678999999999999999999999987554321      1111 11122222221  1111122233344444


Q ss_pred             HHhccCCCCCCCCHHHHHHH
Q 026160          180 LWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       180 ~~cl~~dp~~Rps~~~ll~~  199 (242)
                      -.|+-+|.+.||++.+++++
T Consensus       308 ntCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  308 NTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             HHHhhcccccCcchhhhhcC
Confidence            45999999999999998753

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.90  E-value=8.9e-24  Score=165.20  Aligned_cols=182  Identities=25%  Similarity=0.342  Sum_probs=134.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCC---ceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF---CPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~---~~~L~dfg~~~~   77 (242)
                      |.||+|-.+|.+++      .+++.++..+..+|+.||.|||.+   ||.|||+||+|||-..-.   -+|||||++..-
T Consensus       158 m~GGplLshI~~~~------~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg  228 (463)
T KOG0607|consen  158 MRGGPLLSHIQKRK------HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSG  228 (463)
T ss_pred             ccCchHHHHHHHhh------hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccc
Confidence            57999999999885      499999999999999999999999   999999999999986533   379999988753


Q ss_pred             cCCC-----cccchhcccccccccccchhh---hcccCCCCCCccchhHHHHHHHHHhcCCCccccccCC-------CCC
Q 026160           78 SQDK-----KSTISMLHARGTIGYIAPEVF---CRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRS-------SDI  142 (242)
Q Consensus        78 ~~~~-----~~~~~~~~~~~~~~y~~PE~~---~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~-------~~~  142 (242)
                      ....     ..........|+..|+|||+.   .+....+..+.|.||||+++|-|++|.+||...=..+       .--
T Consensus       229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr  308 (463)
T KOG0607|consen  229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR  308 (463)
T ss_pred             cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH
Confidence            3221     112233456788999999975   3444567899999999999999999999997543221       111


Q ss_pred             cCcchhhhccCCCCcccc---ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 026160          143 YFPNSIYKHIEPGNDFQL---DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE  198 (242)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~  198 (242)
                      ..++.....++++....-   ...++.+.++++..++       ..|+.+|.++.+++.
T Consensus       309 ~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLl-------vrda~~rlsa~~vln  360 (463)
T KOG0607|consen  309 VCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLL-------VRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHH-------hccHHhhhhhhhccC
Confidence            222333334444443221   2345667777777755       899999999998886

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.6e-23  Score=164.98  Aligned_cols=170  Identities=24%  Similarity=0.386  Sum_probs=132.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      ++||+|--++..+      ++|+++.+......|+.||.|||++   ||+.+|||..|+|++..|.+||.|||.+..-..
T Consensus       333 v~ggdlmfhmqrq------rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~  403 (593)
T KOG0695|consen  333 VNGGDLMFHMQRQ------RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG  403 (593)
T ss_pred             ecCcceeeehhhh------hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCC
Confidence            5789998888766      5699999999999999999999999   999999999999999999999999998864322


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  -.+.+||+.|.|||++++.  .+.++.|-|+||++++||+.|+.||+.......+..-.+...+.+. ....++
T Consensus       404 ~gd~--tstfcgtpnyiapeilrge--eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil-ekqiri  478 (593)
T KOG0695|consen  404 PGDT--TSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL-EKQIRI  478 (593)
T ss_pred             CCcc--cccccCCCcccchhhhccc--ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh-hhcccc
Confidence            2111  1245699999999999875  6778999999999999999999999876643333222222222221 223445


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCC
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRP  191 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp  191 (242)
                      +..++-.....++.++       ++||.+|.
T Consensus       479 prslsvkas~vlkgfl-------nkdp~erl  502 (593)
T KOG0695|consen  479 PRSLSVKASHVLKGFL-------NKDPKERL  502 (593)
T ss_pred             cceeehhhHHHHHHhh-------cCCcHHhc
Confidence            5566777777788866       99999994

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.8e-23  Score=185.44  Aligned_cols=176  Identities=27%  Similarity=0.349  Sum_probs=134.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      ||||+|-.++.+..      +++++-+...+..++.||.-+|+.   |+|||||||.|||++..|.++|+|||.+-....
T Consensus       157 ~pGGDlltLlSk~~------~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~  227 (1317)
T KOG0612|consen  157 MPGGDLLTLLSKFD------RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA  227 (1317)
T ss_pred             ccCchHHHHHhhcC------CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence            79999999998763      599999999999999999999999   999999999999999999999999998877764


Q ss_pred             Ccccchhcccccccccccchhhhccc---CCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSF---GGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~---~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      ...-. ....+|||-|.+||++....   +.+....|-||+|+++|||+.|.-||.......-.    ..+..+ .+...
T Consensus       228 dG~V~-s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY----~KIm~h-k~~l~  301 (1317)
T KOG0612|consen  228 DGTVR-SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETY----GKIMNH-KESLS  301 (1317)
T ss_pred             CCcEE-eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHH----HHHhch-hhhcC
Confidence            43322 23457999999999985432   45688899999999999999999999755432110    111111 11111


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCC---HHHHHHH
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPS---MHEVLEM  199 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps---~~~ll~~  199 (242)
                      ++-...++++.++++++++        -+|+.|..   +.++..+
T Consensus       302 FP~~~~VSeeakdLI~~ll--------~~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  302 FPDETDVSEEAKDLIEALL--------CDREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             CCcccccCHHHHHHHHHHh--------cChhhhcccccHHHHHhC
Confidence            1122458999999999987        36777766   7777653

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.90  E-value=2e-24  Score=186.43  Aligned_cols=184  Identities=30%  Similarity=0.456  Sum_probs=128.9

Q ss_pred             CCcchhcccc-CCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC---C--CceEEcccccccc
Q 026160            4 GSLDQFTYDQ-ESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE---D--FCPKISDFGLAKQ   77 (242)
Q Consensus         4 GsL~~~l~~~-~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~---~--~~~~L~dfg~~~~   77 (242)
                      .||.|+++.. ........   -..+.++.|+++||++||+.   +|+||||||.||||+.   +  .+++|+|||++.+
T Consensus       587 ~sL~dlie~~~~d~~~~~~---i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk  660 (903)
T KOG1027|consen  587 CSLQDLIESSGLDVEMQSD---IDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK  660 (903)
T ss_pred             hhHHHHHhccccchhhccc---ccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence            4788998874 11111111   35577889999999999998   9999999999999975   3  4589999999997


Q ss_pred             cCCCcccch-hcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhc-CCCccccccCCCCCcCcchhhhccCCC
Q 026160           78 SQDKKSTIS-MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG-RKNADVKASRSSDIYFPNSIYKHIEPG  155 (242)
Q Consensus        78 ~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~  155 (242)
                      ......... .....||..|.|||.+...  ..+.+.|||||||++|+.++| ..||.-.-..+..+.........+.. 
T Consensus       661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~--~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~-  737 (903)
T KOG1027|consen  661 LAGGKSSFSRLSGGSGTSGWQAPEQLRED--RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEP-  737 (903)
T ss_pred             cCCCcchhhcccCCCCcccccCHHHHhcc--ccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeecc-
Confidence            765433222 2344699999999999764  446689999999999999986 88987444433222111111111111 


Q ss_pred             CccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHH------------HHhhchhhhccCC
Q 026160          156 NDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVL------------EMLESSTEILQIP  210 (242)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll------------~~l~~~~~~~~~~  210 (242)
                             ....++.+++.+|+       ++||..||++.+|+            +.|+.+.+.....
T Consensus       738 -------~~d~eA~dLI~~ml-------~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSDRvE~e  790 (903)
T KOG1027|consen  738 -------LPDCEAKDLISRML-------NPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVSDRVEKE  790 (903)
T ss_pred             -------CchHHHHHHHHHhc-------CCCcccCCCHHHHhCCCccCChHHHHHHHHhhhhhhhhh
Confidence                   11117788888866       99999999999997            4566665554444

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.89  E-value=1.7e-22  Score=173.13  Aligned_cols=188  Identities=23%  Similarity=0.209  Sum_probs=122.3

Q ss_pred             CCCCCcchhccccCCC------------------CCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeC
Q 026160            1 MPNGSLDQFTYDQESS------------------NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD   62 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~   62 (242)
                      |++|+|.++|+.....                  .....+++..+..++.|++.+|.|||+.   +++|+||||.||+++
T Consensus       267 ~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~  343 (507)
T PLN03224        267 ESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVT  343 (507)
T ss_pred             CCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEEC
Confidence            5789999988643210                  0122456788999999999999999998   999999999999999


Q ss_pred             CCCceEEcccccccccCCCcccchhcccccccccccchhhhcccC--------------------CCCCCccchhHHHHH
Q 026160           63 EDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFG--------------------GASHKSDVYSYGMMI  122 (242)
Q Consensus        63 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~--------------------~~~~~~Di~slG~~~  122 (242)
                      .++.++|+|||++.......... ......++.|.+||.+.....                    ....+.|+||+||++
T Consensus       344 ~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil  422 (507)
T PLN03224        344 VDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLL  422 (507)
T ss_pred             CCCcEEEEeCcCccccccCCccC-ccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHH
Confidence            99999999999986543322111 111124789999998743210                    112357999999999


Q ss_pred             HHHHhcCC-CccccccCCCCC---cCc-chhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCC---CCCCCHH
Q 026160          123 LEMAVGRK-NADVKASRSSDI---YFP-NSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNP---SDRPSMH  194 (242)
Q Consensus       123 ~~ll~g~~-p~~~~~~~~~~~---~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp---~~Rps~~  194 (242)
                      ++|+++.. |+.....-....   ... ..+................++...+++.+|+       ..+|   .+|+|+.
T Consensus       423 ~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL-------~~~~~~~~~RlSa~  495 (507)
T PLN03224        423 MQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLI-------TKRDQANRGRLSVG  495 (507)
T ss_pred             HHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHh-------ccCCCCcccCCCHH
Confidence            99999875 554221110000   000 0001111111122223445677777877765       6554   7899999


Q ss_pred             HHHHH
Q 026160          195 EVLEM  199 (242)
Q Consensus       195 ~ll~~  199 (242)
                      |++++
T Consensus       496 eaL~H  500 (507)
T PLN03224        496 QALSH  500 (507)
T ss_pred             HHhCC
Confidence            99876

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.88  E-value=3.8e-23  Score=152.59  Aligned_cols=115  Identities=33%  Similarity=0.440  Sum_probs=96.4

Q ss_pred             CCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccc
Q 026160           18 GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYI   97 (242)
Q Consensus        18 ~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~   97 (242)
                      .++.+++.-.=+|+..++.||.|||++  ..++|||+||.|||++..|++|+||||++-...+.......   .|-..|+
T Consensus       141 ~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~d---aGCkpYm  215 (282)
T KOG0984|consen  141 KGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMD---AGCKPYM  215 (282)
T ss_pred             cCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHHh---cCCCccC
Confidence            346799999999999999999999998  59999999999999999999999999999866655433222   2567899


Q ss_pred             cchhhhcc--cCCCCCCccchhHHHHHHHHHhcCCCcccccc
Q 026160           98 APEVFCRS--FGGASHKSDVYSYGMMILEMAVGRKNADVKAS  137 (242)
Q Consensus        98 ~PE~~~~~--~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~  137 (242)
                      |||.+...  ...++.++||||||+.++||.+++.||.....
T Consensus       216 aPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  216 APERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             ChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            99988432  23679999999999999999999999875443

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.88  E-value=4.6e-23  Score=178.87  Aligned_cols=176  Identities=27%  Similarity=0.326  Sum_probs=134.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |-+||.-|+++..+    ...+.+..+.-|++.++.|+.+||.+   .++|+|+|-.|||++.++.|||+|||++.....
T Consensus       103 C~gGSVTDLVKn~~----g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQlds  175 (953)
T KOG0587|consen  103 CGGGSVTDLVKNTK----GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS  175 (953)
T ss_pred             cCCccHHHHHhhhc----ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence            77999999998875    47899999999999999999999999   999999999999999999999999999987766


Q ss_pred             Ccccchhcccccccccccchhhhc---ccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCR---SFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      .....  .+.+||+.|+|||++.-   ....++.++|+||||+...||.-|.+|+--......        .-.+..+..
T Consensus       176 T~grR--nT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra--------LF~IpRNPP  245 (953)
T KOG0587|consen  176 TVGRR--NTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA--------LFLIPRNPP  245 (953)
T ss_pred             ccccc--cCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh--------hccCCCCCC
Confidence            54432  23569999999998732   223457899999999999999999998753332211        111222222


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE  198 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~  198 (242)
                      +.+.     ....-.+++.+++..||.+|.++||+..++++
T Consensus       246 PkLk-----rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  246 PKLK-----RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             cccc-----chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            2211     11223344555555699999999999998874

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.88  E-value=7.1e-23  Score=159.91  Aligned_cols=106  Identities=33%  Similarity=0.426  Sum_probs=91.7

Q ss_pred             ccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccccchh
Q 026160           22 LEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEV  101 (242)
Q Consensus        22 l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~  101 (242)
                      +.-.++..++.|++.|++|||+.   +|+||||||+||++..++.+|++|||+++.....-   ..+.-..++.|.|||+
T Consensus       115 lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~---~mtpyVvtRyyrapev  188 (369)
T KOG0665|consen  115 LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDF---MMTPYVVTRYYRAPEV  188 (369)
T ss_pred             cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCccc---ccCchhheeeccCchh
Confidence            66678889999999999999999   99999999999999999999999999998766541   1223357899999999


Q ss_pred             hhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160          102 FCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus       102 ~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      +.+.  .+....||||+||++-||++|..-|.+.
T Consensus       189 il~~--~~ke~vdiwSvGci~gEli~~~Vlf~g~  220 (369)
T KOG0665|consen  189 ILGM--GYKENVDIWSVGCIMGELILGTVLFPGK  220 (369)
T ss_pred             eecc--CCcccchhhhhhhHHHHHhhceEEecCc
Confidence            9886  4889999999999999999998766533

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.88  E-value=1.7e-22  Score=180.39  Aligned_cols=67  Identities=30%  Similarity=0.501  Sum_probs=61.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK   76 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~   76 (242)
                      |++|+|.+++...      +.+++..++.++.||+.||.|||+.   +|+|+||||+|||++.++.++|+|||+++
T Consensus        86 ~~g~~L~~li~~~------~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          86 LIGGDVKSLLHIY------GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            5789999999754      3589999999999999999999998   99999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=4.6e-22  Score=167.80  Aligned_cols=160  Identities=26%  Similarity=0.374  Sum_probs=125.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      .|||++-.+|-+..      .+.+..+...+..|..|+++.|..   |+|||||||.|||||.+|.+||.|||+++-+..
T Consensus       711 IPGGDmMSLLIrmg------IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW  781 (1034)
T KOG0608|consen  711 IPGGDMMSLLIRMG------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  781 (1034)
T ss_pred             cCCccHHHHHHHhc------cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecccccccee
Confidence            48999999987764      499999999999999999999998   999999999999999999999999999863321


Q ss_pred             Ccccc-----------------hh-----------------------cccccccccccchhhhcccCCCCCCccchhHHH
Q 026160           81 KKSTI-----------------SM-----------------------LHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM  120 (242)
Q Consensus        81 ~~~~~-----------------~~-----------------------~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~  120 (242)
                      .....                 .+                       ....||..|+|||++...  +++...|-||.|+
T Consensus       782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~--g~~q~cdwws~gv  859 (1034)
T KOG0608|consen  782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART--GYTQLCDWWSVGV  859 (1034)
T ss_pred             ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc--CccccchhhHhhH
Confidence            10000                 00                       012599999999999764  7788999999999


Q ss_pred             HHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccccccccchHHHHHHHHHH
Q 026160          121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMI  176 (242)
Q Consensus       121 ~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (242)
                      ++|||+.|+.||-...........     .++.+.........++.+..+++.+++
T Consensus       860 il~em~~g~~pf~~~tp~~tq~kv-----~nw~~~l~~~~~~~ls~e~~~li~kLc  910 (1034)
T KOG0608|consen  860 ILYEMLVGQPPFLADTPGETQYKV-----INWRNFLHIPYQGNLSKEALDLIQKLC  910 (1034)
T ss_pred             HHHHHhhCCCCccCCCCCcceeee-----eehhhccccccccccCHHHHHHHHHHh
Confidence            999999999999765554433222     233444455566778999999998876

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.87  E-value=6.4e-23  Score=169.34  Aligned_cols=183  Identities=22%  Similarity=0.291  Sum_probs=134.4

Q ss_pred             CcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCC-CceEEcccccccccCCCcc
Q 026160            5 SLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDED-FCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         5 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~-~~~~L~dfg~~~~~~~~~~   83 (242)
                      ||...|++..   .+-+|.+..+...+.|+..||..|-.+   +|+|.||||.|||+..+ ..+||||||.+.....+..
T Consensus       519 NLRevLKKyG---~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~enei  592 (752)
T KOG0670|consen  519 NLREVLKKYG---RNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGSASFASENEI  592 (752)
T ss_pred             hHHHHHHHhC---cccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCccccccccccc
Confidence            5666776543   346799999999999999999999999   99999999999999875 4579999999988776654


Q ss_pred             cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCC-------CCcCcc-------hhh
Q 026160           84 TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSS-------DIYFPN-------SIY  149 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~-------~~~~~~-------~~~  149 (242)
                      ..+.    .+.+|.|||++.+.  .++...|+||+||.+||+.||+..|-+...+.-       .-.++.       ++.
T Consensus       593 tPYL----VSRFYRaPEIiLG~--~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~d  666 (752)
T KOG0670|consen  593 TPYL----VSRFYRAPEIILGL--PYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKD  666 (752)
T ss_pred             cHHH----HHHhccCcceeecC--cccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhh
Confidence            4433    57899999999886  678899999999999999999876643321110       000000       000


Q ss_pred             hc--------------------------cCCCC----ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          150 KH--------------------------IEPGN----DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       150 ~~--------------------------~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ++                          +.+..    .......++.+-...+.++..|+..|+..||++|.|..++|++
T Consensus       667 qHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  667 QHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH  746 (752)
T ss_pred             hhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence            00                          00000    0111223566677788899999999999999999999998864

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=7.3e-22  Score=159.38  Aligned_cols=162  Identities=25%  Similarity=0.378  Sum_probs=124.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |.||+|--+|.+-      +.+.+..+...+..|+-||-+||++   +|++||||..||+++.+|.+|+.|||++..--.
T Consensus       432 vnGGDLMyhiQQ~------GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  432 VNGGDLMYHIQQV------GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             ecCchhhhHHHHh------cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccccc
Confidence            4688888888765      5699999999999999999999999   999999999999999999999999999864222


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ...  .-.+.+||+.|+|||++.  +..+..+.|-||+|+++|||+.|++||+..+..        ...+.+.+.. ...
T Consensus       503 ~~~--TTkTFCGTPdYiAPEIi~--YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~--------elF~aI~ehn-vsy  569 (683)
T KOG0696|consen  503 DGV--TTKTFCGTPDYIAPEIIA--YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--------ELFQAIMEHN-VSY  569 (683)
T ss_pred             CCc--ceeeecCCCcccccceEE--ecccccchhHHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHHcc-CcC
Confidence            111  112456999999999874  346788999999999999999999999876642        2222221111 123


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCC
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRP  191 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp  191 (242)
                      +..++.++..+.+.++       -+.|.+|.
T Consensus       570 PKslSkEAv~ickg~l-------tK~P~kRL  593 (683)
T KOG0696|consen  570 PKSLSKEAVAICKGLL-------TKHPGKRL  593 (683)
T ss_pred             cccccHHHHHHHHHHh-------hcCCcccc
Confidence            4446666666666655       89999993

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.86  E-value=7.1e-22  Score=143.17  Aligned_cols=111  Identities=26%  Similarity=0.325  Sum_probs=95.2

Q ss_pred             CccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhccccccccccc
Q 026160           19 NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIA   98 (242)
Q Consensus        19 ~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~   98 (242)
                      ++.+..+.+..++.|+++|+.|+|+.   ++.|||+||.|.+|..+|.+||+|||+++.++-....  +.....|.+|.|
T Consensus        95 ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrc--ysaevvtlwyrp  169 (292)
T KOG0662|consen   95 NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC--YSAEVVTLWYRP  169 (292)
T ss_pred             CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEe--eeceeeeeeccC
Confidence            46789999999999999999999999   9999999999999999999999999999987754332  333458899999


Q ss_pred             chhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           99 PEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        99 PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      |.++.+. ..++.+.|+||-||++.|+.....|....
T Consensus       170 pdvlfga-kly~tsidmwsagcifaelanagrplfpg  205 (292)
T KOG0662|consen  170 PDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPG  205 (292)
T ss_pred             cceeeee-ehhccchHhhhcchHHHHHhhcCCCCCCC
Confidence            9999876 57799999999999999998765554433

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.86  E-value=5.8e-22  Score=148.63  Aligned_cols=166  Identities=19%  Similarity=0.246  Sum_probs=119.3

Q ss_pred             ccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCC-CceEEcccccccccCCCcccchhccccccccccc
Q 026160           20 RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDED-FCPKISDFGLAKQSQDKKSTISMLHARGTIGYIA   98 (242)
Q Consensus        20 ~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~-~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~   98 (242)
                      ..|+...+...+.++++||.|+|+.   ||.|||+||.|++|+.. ..++|+|+|++.++........   +..+..|.-
T Consensus       127 ~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnV---RVASRyfKG  200 (338)
T KOG0668|consen  127 PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKG  200 (338)
T ss_pred             hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCceeee---eeehhhcCC
Confidence            3577788888999999999999999   99999999999999964 5699999999998776554432   346778899


Q ss_pred             chhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCc---------------------CcchhhhccCCCCc
Q 026160           99 PEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIY---------------------FPNSIYKHIEPGND  157 (242)
Q Consensus        99 PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~  157 (242)
                      ||.+.+- ..+..+.|+|||||++..|+..+.||.-...+.+...                     +......-......
T Consensus       201 PELLVdy-~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~r  279 (338)
T KOG0668|consen  201 PELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSR  279 (338)
T ss_pred             chheeec-hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhcccc
Confidence            9988653 5678999999999999999999999875543332110                     00000000001111


Q ss_pred             --------cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          158 --------FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       158 --------~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                              ..-...+++++.+++.+       .|.+|..+|+|+.|+..+
T Consensus       280 k~w~~Fi~~~n~hl~~peaiDlldk-------lLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  280 KPWSRFINSENQHLVSPEAIDLLDK-------LLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             ccHHHhCCccccccCChHHHHHHHH-------HHhhccccccchHHHhcC
Confidence                    11112245666666666       459999999999998754

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=4.4e-22  Score=152.95  Aligned_cols=113  Identities=31%  Similarity=0.441  Sum_probs=94.8

Q ss_pred             CCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccc
Q 026160           18 GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYI   97 (242)
Q Consensus        18 ~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~   97 (242)
                      +...++.+.+.-++.||++||.|||+-   +|.||||||.|.|++.|..+|+||||+++...... ....+....|..|.
T Consensus       149 SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~-~~hMTqEVVTQYYR  224 (449)
T KOG0664|consen  149 SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD-RLNMTHEVVTQYYR  224 (449)
T ss_pred             cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhh-hhhhHHHHHHHHhc
Confidence            446799999999999999999999998   99999999999999999999999999998654322 22223345788999


Q ss_pred             cchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           98 APEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        98 ~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      +||++.+. ..++.+.||||.||++.|++..+..|...
T Consensus       225 APEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQAq  261 (449)
T KOG0664|consen  225 APELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQAA  261 (449)
T ss_pred             cHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhcc
Confidence            99999876 47799999999999999999877666533

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.86  E-value=1.3e-22  Score=168.06  Aligned_cols=169  Identities=26%  Similarity=0.347  Sum_probs=123.6

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCC---ceEEcccccccccC
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF---CPKISDFGLAKQSQ   79 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~---~~~L~dfg~~~~~~   79 (242)
                      +|+.-..|-+...    ++|++.....++.||+.||+|||-.   +|+|.||||+|||+....   ++||||||+++..+
T Consensus       646 ~GDMLEMILSsEk----gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg  718 (888)
T KOG4236|consen  646 HGDMLEMILSSEK----GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG  718 (888)
T ss_pred             cchHHHHHHHhhc----ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecc
Confidence            3555555544333    6799999999999999999999999   999999999999997643   58999999999887


Q ss_pred             CCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           80 DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        80 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ...-..   ...||+.|+|||++...  .+..+.|+||.|+++|--+.|..||.....-.+.+-...++       ....
T Consensus       719 EksFRr---sVVGTPAYLaPEVLrnk--GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFM-------yPp~  786 (888)
T KOG4236|consen  719 EKSFRR---SVVGTPAYLAPEVLRNK--GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFM-------YPPN  786 (888)
T ss_pred             hhhhhh---hhcCCccccCHHHHhhc--cccccccceeeeEEEEEEecccccCCCccchhHHhhccccc-------cCCC
Confidence            654332   33599999999999875  77889999999999999999999997544322211111111       1111


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVL  197 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll  197 (242)
                      -...+++++.+++..++       +..=.+|.|.+..+
T Consensus       787 PW~eis~~AidlIn~LL-------qVkm~kRysvdk~l  817 (888)
T KOG4236|consen  787 PWSEISPEAIDLINNLL-------QVKMRKRYSVDKSL  817 (888)
T ss_pred             chhhcCHHHHHHHHHHH-------HHHHHHhcchHhhc
Confidence            22346777888888876       44556676666544

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.85  E-value=6e-21  Score=146.26  Aligned_cols=141  Identities=39%  Similarity=0.575  Sum_probs=115.1

Q ss_pred             CCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC-CCceEEcccccccccCC
Q 026160            2 PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE-DFCPKISDFGLAKQSQD   80 (242)
Q Consensus         2 ~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~-~~~~~L~dfg~~~~~~~   80 (242)
                      ++++|.+++....     ..++...+..++.++++++.+||+.   +++|+||++.||+++. ++.++|+||+.+.....
T Consensus        74 ~~~~l~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~  145 (215)
T cd00180          74 EGGSLKDLLKENE-----GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTS  145 (215)
T ss_pred             CCCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccC
Confidence            5688999887542     3589999999999999999999999   9999999999999998 89999999999876654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ...  ......+...|.+||..... ...+.+.|+|++|++++++                                   
T Consensus       146 ~~~--~~~~~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l-----------------------------------  187 (215)
T cd00180         146 DKS--LLKTIVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL-----------------------------------  187 (215)
T ss_pred             Ccc--hhhcccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH-----------------------------------
Confidence            431  11122467889999987543 3567899999999999998                                   


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML  200 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l  200 (242)
                                  ..+..++..|++.||++||++.++++.+
T Consensus       188 ------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                        3455556668899999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=6.6e-21  Score=156.31  Aligned_cols=109  Identities=24%  Similarity=0.266  Sum_probs=72.1

Q ss_pred             ccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhh---------------------
Q 026160           91 RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIY---------------------  149 (242)
Q Consensus        91 ~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~---------------------  149 (242)
                      +.|..|++||++.+.  .+++.+||||++|++|||+||...|+.......... .+.+.                     
T Consensus       412 IQTRQYRapEVllGs--gY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rD-EDHiA~i~ELLG~iPr~ia~~Gk~SR  488 (590)
T KOG1290|consen  412 IQTRQYRAPEVLLGS--GYSTSADIWSTACMAFELATGDYLFEPHSGENYSRD-EDHIALIMELLGKIPRKIALGGKYSR  488 (590)
T ss_pred             hhhhhccCcceeecC--CCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCcc-HHHHHHHHHHHhhccHHHHhcCcchH
Confidence            478899999999886  789999999999999999999998887765442211 01111                     


Q ss_pred             ---------hccCCCCccccccccchH---HHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 026160          150 ---------KHIEPGNDFQLDGVVTEE---EKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES  202 (242)
Q Consensus       150 ---------~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~  202 (242)
                               +++.......+...+.+.   ..+...+|-+++..+|+++|++||||.+++++=.-
T Consensus       489 dFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwL  553 (590)
T KOG1290|consen  489 DFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWL  553 (590)
T ss_pred             hhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccc
Confidence                     011111111110000000   13346677888888999999999999999976553

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=6.1e-21  Score=166.82  Aligned_cols=181  Identities=22%  Similarity=0.245  Sum_probs=136.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      ||+ +|..++...      ..++..++..++.||+.|+.|||+.   |+.|+|+|++|+++..+|.++++|||.+..+..
T Consensus       403 ~~~-Dlf~~~~~~------~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~  472 (601)
T KOG0590|consen  403 CPY-DLFSLVMSN------GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY  472 (601)
T ss_pred             ccH-HHHHHHhcc------cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence            456 777777664      3599999999999999999999999   999999999999999999999999998865443


Q ss_pred             Cccc--chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           81 KKST--ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        81 ~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      ....  ......+|+..|.|||++.+. .......||||.|+++..|++|+.||......+..+.       ........
T Consensus       473 ~~e~~~~~~~g~~gS~pY~apE~~~~~-~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~-------~~~~~~~~  544 (601)
T KOG0590|consen  473 PWEKNIHESSGIVGSDPYLAPEVLTGK-EYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK-------TNNYSDQR  544 (601)
T ss_pred             CcchhhhhhcCcccCCcCcCccccccc-ccCcchhhhhhccceEEEEecCCCccccccccccchh-------hhcccccc
Confidence            3222  333445699999999998775 3446778999999999999999999987766554320       00001111


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ........-+..+......++.++|+.||.+|.|+.++++.
T Consensus       545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            11122333455666666777777889999999999999864

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.82  E-value=4.2e-20  Score=155.41  Aligned_cols=194  Identities=22%  Similarity=0.370  Sum_probs=139.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.|.+....     -.+++.-...+.+++++|+.|+|+.  +-..|+.++..|++++....+|+.|||+......
T Consensus        29 c~rGsl~D~i~~~~-----~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~  101 (484)
T KOG1023|consen   29 CSRGSLLDILSNED-----IKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEE  101 (484)
T ss_pred             ecCccHHhHHhccc-----cCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeeccccceeeeeEEEEechhhhcccccc
Confidence            68999999998754     4688899999999999999999998  2339999999999999999999999999876643


Q ss_pred             Ccccchhcccccccccccchhhhccc--CC---CCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCC
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSF--GG---ASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPG  155 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~--~~---~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  155 (242)
                      ...........-...|.|||.+....  ..   .+.+.|+||||++++|+++...||.........    ..+...+..+
T Consensus       102 ~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~----~eii~~~~~~  177 (484)
T KOG1023|consen  102 TAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDP----DEIILRVKKG  177 (484)
T ss_pred             cccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCCh----HHHHHHHHhc
Confidence            11111111222456899999986531  11   477899999999999999999999876554432    1111122221


Q ss_pred             CccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          156 NDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      ....+.+.+...- +....++.++..||..+|.+||++.++...++.+...
T Consensus       178 ~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  178 GSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             CCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            1111111121111 4444678888889999999999999999998876553

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.79  E-value=3.3e-20  Score=155.07  Aligned_cols=118  Identities=24%  Similarity=0.313  Sum_probs=101.1

Q ss_pred             CCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCC
Q 026160            2 PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDK   81 (242)
Q Consensus         2 ~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~   81 (242)
                      ++-+|+|||.-+      +.+++.++.-|+.|++.|+++||++   +|+|||||-+|+.++.+|.+||+|||.+......
T Consensus       653 ~gIDLFd~IE~k------p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa~~ksg  723 (772)
T KOG1152|consen  653 EGIDLFDFIEFK------PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSG  723 (772)
T ss_pred             CCcchhhhhhcc------CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchhhhcCC
Confidence            456899999876      5699999999999999999999999   9999999999999999999999999988754443


Q ss_pred             cccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcc
Q 026160           82 KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNAD  133 (242)
Q Consensus        82 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~  133 (242)
                      .    ....+||..|.|||++.+. .......|||++|+++|.++....||.
T Consensus       724 p----fd~f~gtv~~aapevl~g~-~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  724 P----FDVFVGTVDYAAPEVLGGE-KYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             C----cceeeeeccccchhhhCCC-ccCCCcchhhhhhheeeEEEeccCCCc
Confidence            2    1234699999999999876 344667899999999999998888764

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.77  E-value=1.7e-18  Score=134.50  Aligned_cols=124  Identities=31%  Similarity=0.419  Sum_probs=101.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++.....     .+++..+..++.+++.++.+||+.   +++|+|+++.||+++.++.++|+|||.+.....
T Consensus        79 ~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~  150 (225)
T smart00221       79 CEGGDLFDYLRKKGG-----KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHR  150 (225)
T ss_pred             cCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecC
Confidence            467799999876421     188999999999999999999999   999999999999999999999999998886654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADV  134 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~  134 (242)
                      .... ......+...|++||.+. .....+.++|+|+||++++++++|+.||..
T Consensus       151 ~~~~-~~~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      151 DLAA-LLKTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccc-cccceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            4200 111223677899999874 334667799999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.76  E-value=9.3e-19  Score=138.90  Aligned_cols=143  Identities=22%  Similarity=0.320  Sum_probs=97.6

Q ss_pred             ccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccccc
Q 026160           20 RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAP   99 (242)
Q Consensus        20 ~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~P   99 (242)
                      ..+....+..+..|+++.+++||+.   |++|+||+++|++++.+|.++|+||+.....+.....     ...+..|.||
T Consensus       140 ~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PP  211 (288)
T PF14531_consen  140 SPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPP  211 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-H
T ss_pred             chhHHHHHHHHHHHHHHHHHHHhhc---ceEecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCCh
Confidence            4466667778889999999999999   9999999999999999999999999988776654332     1255779999


Q ss_pred             hhhhcc------cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccccccccchHHHHHHH
Q 026160          100 EVFCRS------FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVK  173 (242)
Q Consensus       100 E~~~~~------~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (242)
                      |.....      .-..+.+.|.|+||+++|.|+++..||+.........    .         ....+..+++..+.++.
T Consensus       212 e~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~----~---------~f~~C~~~Pe~v~~LI~  278 (288)
T PF14531_consen  212 ELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPE----W---------DFSRCRDMPEPVQFLIR  278 (288)
T ss_dssp             HHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSG----G---------GGTTSS---HHHHHHHH
T ss_pred             hhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccccc----c---------cchhcCCcCHHHHHHHH
Confidence            976432      1245888999999999999999999998664432221    1         11222256777777777


Q ss_pred             HHHHHHHHhccCCCCCC
Q 026160          174 KMILVSLWCIQTNPSDR  190 (242)
Q Consensus       174 ~~~~l~~~cl~~dp~~R  190 (242)
                      .|+       +.||.+|
T Consensus       279 ~lL-------~~~~~~R  288 (288)
T PF14531_consen  279 GLL-------QRNPEDR  288 (288)
T ss_dssp             HHT--------SSGGGS
T ss_pred             HHc-------cCCcccC
Confidence            755       9999887

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.76  E-value=9.4e-19  Score=155.71  Aligned_cols=172  Identities=24%  Similarity=0.251  Sum_probs=121.4

Q ss_pred             CcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccC-CC--
Q 026160            5 SLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ-DK--   81 (242)
Q Consensus         5 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~-~~--   81 (242)
                      ||+|.|..+      +-+..-++..++.||+.|+.-+|..   +|+|||||.+|||++.=..+.|.||...+... ..  
T Consensus       106 nLyDRlSTR------PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  106 NLYDRLSTR------PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             hhhhhhccc------hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            677777765      4488999999999999999999999   99999999999999988889999997654221 11  


Q ss_pred             --cccchhcccccccccccchhhhccc--------C-CCCCCccchhHHHHHHHHHh-cCCCccccccCCCC---CcCcc
Q 026160           82 --KSTISMLHARGTIGYIAPEVFCRSF--------G-GASHKSDVYSYGMMILEMAV-GRKNADVKASRSSD---IYFPN  146 (242)
Q Consensus        82 --~~~~~~~~~~~~~~y~~PE~~~~~~--------~-~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~---~~~~~  146 (242)
                        .......+.+...+|.|||.+....        . ..+.+.||||+||++.|+++ |.++|...+.....   -+.++
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e  256 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPE  256 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHH
Confidence              1112222334556899999885422        1 14678899999999999987 57777644321111   11112


Q ss_pred             hhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          147 SIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                      +....+           .....+.++..|+       +.||++|.++++.++.-++.
T Consensus       257 ~~Le~I-----------ed~~~Rnlil~Mi-------~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  257 QLLEKI-----------EDVSLRNLILSMI-------QRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             HHHHhC-----------cCccHHHHHHHHH-------ccCchhccCHHHHHHhhhcc
Confidence            222222           2335677777766       99999999999999875543

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.75  E-value=2.5e-17  Score=135.42  Aligned_cols=200  Identities=20%  Similarity=0.205  Sum_probs=137.6

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCC-----CceEEcccccccc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDED-----FCPKISDFGLAKQ   77 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~-----~~~~L~dfg~~~~   77 (242)
                      |-||.++.....    ++.++..++..++.|++.+|++||+.   |++||||||.|+++...     ..+.|.|||++++
T Consensus       104 G~sL~dl~~~~~----~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~  176 (322)
T KOG1164|consen  104 GPSLEDLRKRNP----PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR  176 (322)
T ss_pred             CccHHHHHHhCC----CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence            556777654432    47899999999999999999999999   99999999999999754     3589999999983


Q ss_pred             cC--CCccc--c---h-hcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhh
Q 026160           78 SQ--DKKST--I---S-MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIY  149 (242)
Q Consensus        78 ~~--~~~~~--~---~-~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~  149 (242)
                      ..  .....  .   . ....+||..|.++....+.  ..+.+.|+||++.++.++..|..||..........    ...
T Consensus       177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~--e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~----~~~  250 (322)
T KOG1164|consen  177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI--EQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS----KFE  250 (322)
T ss_pred             ccccCCCCcccccCCCCccCCCCccccccHHHhCCC--ccCCchhhhhHHHHHHHHhcCCCCCccccccchHH----HHH
Confidence            22  22110  0   0 1123599999999988664  66889999999999999999999996544332211    111


Q ss_pred             hccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccCCCCCCCCCCcccc
Q 026160          150 KHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSLALPKKSA  222 (242)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~~~~~~~~~~  222 (242)
                      ...............+.++..+...       +-..+...+|....+...++............+.+|.....
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~~~~~  316 (322)
T KOG1164|consen  251 KDPRKLLTDRFGDLKPEEFAKILEY-------IDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWEVKLR  316 (322)
T ss_pred             HHhhhhccccccCCChHHHHHHHHH-------hhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCccccccc
Confidence            1111110000111223333333333       44689999999999999998888776566666666665443

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.74  E-value=1.5e-18  Score=140.26  Aligned_cols=111  Identities=28%  Similarity=0.391  Sum_probs=89.3

Q ss_pred             cccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC-CCceEEcccccccccCCC------------------
Q 026160           21 TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE-DFCPKISDFGLAKQSQDK------------------   81 (242)
Q Consensus        21 ~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~-~~~~~L~dfg~~~~~~~~------------------   81 (242)
                      .++..++...+..++.||.++|.+   ||+||||||.|+|++. -+.-.|+|||++......                  
T Consensus       128 ~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~  204 (418)
T KOG1167|consen  128 SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAM  204 (418)
T ss_pred             cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccc
Confidence            478899999999999999999999   9999999999999986 456789999998721100                  


Q ss_pred             ---------------cccch---------hcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           82 ---------------KSTIS---------MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        82 ---------------~~~~~---------~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                                     .....         .....||+.|.|||++... +..+.+.||||.|+++.-++++..||...
T Consensus       205 g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~QttaiDiws~GVI~Lslls~~~PFf~a  281 (418)
T KOG1167|consen  205 GKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQTTAIDIWSAGVILLSLLSRRYPFFKA  281 (418)
T ss_pred             cCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCcCCccceeeccceeehhhccccccccC
Confidence                           00000         0113499999999999775 56789999999999999999999998644

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.74  E-value=4.2e-18  Score=144.63  Aligned_cols=172  Identities=24%  Similarity=0.312  Sum_probs=125.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |-+|+|.|--+-.      +.+++.++..+++..++++.|||+.   +-+|||||..||+++..|.++|.|||.+..+..
T Consensus        94 cgggslQdiy~~T------gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   94 CGGGSLQDIYHVT------GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             cCCCcccceeeec------ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh
Confidence            5578888766544      5799999999999999999999998   889999999999999999999999999876654


Q ss_pred             Ccccchhcccccccccccchhh-hcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcc-
Q 026160           81 KKSTISMLHARGTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDF-  158 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-  158 (242)
                      ....  ...++||+.|++||+. .+..+.+...+|||++|+...|+-.-++|-.-....       .........+.++ 
T Consensus       165 ti~K--rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm-------r~l~LmTkS~~qpp  235 (829)
T KOG0576|consen  165 TIAK--RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM-------RALFLMTKSGFQPP  235 (829)
T ss_pred             hhhh--hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH-------HHHHHhhccCCCCC
Confidence            4332  1235799999999976 344467889999999999999987666553322111       1111111111111 


Q ss_pred             --ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 026160          159 --QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVL  197 (242)
Q Consensus       159 --~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll  197 (242)
                        .-+...++.+.++++.       |+-.+|++|||++-++
T Consensus       236 ~lkDk~kws~~fh~fvK~-------altknpKkRptaeklL  269 (829)
T KOG0576|consen  236 TLKDKTKWSEFFHNFVKG-------ALTKNPKKRPTAEKLL  269 (829)
T ss_pred             cccCCccchHHHHHHHHH-------HhcCCCccCCChhhhe
Confidence              1123455556666665       8899999999998776

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.73  E-value=8.9e-18  Score=129.38  Aligned_cols=176  Identities=20%  Similarity=0.322  Sum_probs=123.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEE--ccccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKI--SDFGLAKQS   78 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L--~dfg~~~~~   78 (242)
                      ||.|||+..|+.+..    -.++..++.+++.++++|+.|||+-. +-+....|+...++++++...++  +|--++...
T Consensus       269 mp~gslynvlhe~t~----vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfqe  343 (448)
T KOG0195|consen  269 MPFGSLYNVLHEQTS----VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE  343 (448)
T ss_pred             ccchHHHHHHhcCcc----EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeeec
Confidence            799999999987643    67888999999999999999999963 23444568888899988766544  453333221


Q ss_pred             CCCcccchhcccccccccccchhhhcccC-CCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           79 QDKKSTISMLHARGTIGYIAPEVFCRSFG-GASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        79 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      .         .+...+.|++||.+..... ..-.+.|+|||++++||+.|...||......+-..       +-..++..
T Consensus       344 ~---------gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm-------kialeglr  407 (448)
T KOG0195|consen  344 V---------GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM-------KIALEGLR  407 (448)
T ss_pred             c---------ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh-------hhhhcccc
Confidence            1         1125689999999865422 33567899999999999999999997665543222       11122333


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchh
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESST  204 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~  204 (242)
                      ..+++..+...       .++|.-|++.||.+||.++.++-.|++.+
T Consensus       408 v~ippgis~hm-------~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  408 VHIPPGISRHM-------NKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ccCCCCccHHH-------HHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            33333333333       33333399999999999999999998754

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.73  E-value=4.3e-17  Score=131.52  Aligned_cols=173  Identities=21%  Similarity=0.305  Sum_probs=123.9

Q ss_pred             CcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeC--CCC--ceEEcccccccccCC
Q 026160            5 SLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD--EDF--CPKISDFGLAKQSQD   80 (242)
Q Consensus         5 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~--~~~--~~~L~dfg~~~~~~~   80 (242)
                      +|..||..+       ..+.....-++.|+++|+.|||..   +|.|||+|..|||+.  .++  .+.++|||++-....
T Consensus       328 tLr~yl~~~-------~~s~r~~~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~  397 (598)
T KOG4158|consen  328 TLREYLWTR-------HRSYRTGRVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDN  397 (598)
T ss_pred             hHHHHHhcC-------CCchHHHHHHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccc
Confidence            566676553       478888999999999999999999   999999999999994  333  468899998865443


Q ss_pred             Ccccchh----cccccccccccchhhhcccCC----CCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhcc
Q 026160           81 KKSTISM----LHARGTIGYIAPEVFCRSFGG----ASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHI  152 (242)
Q Consensus        81 ~~~~~~~----~~~~~~~~y~~PE~~~~~~~~----~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  152 (242)
                      ......+    ...-|.-..++||+.....+.    .-.+.|.|+.|.+.||+++...||........+.       +.-
T Consensus       398 hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~-------r~Y  470 (598)
T KOG4158|consen  398 HGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT-------RTY  470 (598)
T ss_pred             cccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech-------hhh
Confidence            2111111    122367789999998654322    2468999999999999999999997633221111       112


Q ss_pred             CCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          153 EPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      .+...+.++..+++.+++++..++       +.||++|++.+-....|.
T Consensus       471 qe~qLPalp~~vpp~~rqlV~~lL-------~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  471 QESQLPALPSRVPPVARQLVFDLL-------KRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             hhhhCCCCcccCChHHHHHHHHHh-------cCCccccCCccHHHhHHH
Confidence            223345567788999999998866       999999999876554443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.69  E-value=2.1e-16  Score=124.75  Aligned_cols=200  Identities=17%  Similarity=0.188  Sum_probs=145.0

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC-----CCceEEcccccccc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE-----DFCPKISDFGLAKQ   77 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~-----~~~~~L~dfg~~~~   77 (242)
                      |-||.|+.+-..     +.++.+++..++.|++..++++|+.   .+|.|||||+|+||..     ...+.++|||++..
T Consensus       107 GPSLEDLFD~Cg-----R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  107 GPSLEDLFDLCG-----RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             CcCHHHHHHHhc-----CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            457777766443     5799999999999999999999999   9999999999999953     23589999999987


Q ss_pred             cCCCccc-----chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhcc
Q 026160           78 SQDKKST-----ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHI  152 (242)
Q Consensus        78 ~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  152 (242)
                      +.+....     .......||..|++-....+.  ..+.+.|+-|||.++.+.+-|..||...........    . ..+
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGr--EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k----Y-eKI  251 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK----Y-EKI  251 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccc--hhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH----H-HHh
Confidence            6543221     112233599999999887664  568899999999999999999999986655432211    1 111


Q ss_pred             CCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccCCCCCCCCCCcc
Q 026160          153 EPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSLALPKK  220 (242)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~~~~~~~~  220 (242)
                      ......   ..+..-...+..+|...+......+..+-|..+-+...+.++.+.+.....-..+|...
T Consensus       252 Ge~Kr~---T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~l  316 (449)
T KOG1165|consen  252 GETKRS---TPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGL  316 (449)
T ss_pred             cccccc---CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccccccccccc
Confidence            111110   01111223344455555555668999999999999999999999888877777776654

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.68  E-value=2.9e-17  Score=136.59  Aligned_cols=116  Identities=27%  Similarity=0.465  Sum_probs=95.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |.-++|.|||...+   .....++.....++.|++.|+.|   +   +.+|+|+||.||+...+..+++.|||+......
T Consensus       338 c~~~tledWl~rr~---~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~  408 (516)
T KOG1033|consen  338 CEKETLEDWLRRRR---TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDK  408 (516)
T ss_pred             hhhhhHHHHhhCCC---cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhheeeccc
Confidence            44578999996432   23567788899999999999999   5   999999999999999999999999999876554


Q ss_pred             Cc----ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh
Q 026160           81 KK----STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV  127 (242)
Q Consensus        81 ~~----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~  127 (242)
                      ..    .....+...+|..|++||.+.+.  .++.++||||||++++|++.
T Consensus       409 ~~~~~~~~a~~t~~~gt~~YmsPEQi~g~--~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  409 DETVAPAAASHTQQVGTLLYMSPEQIRGQ--QYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             CCcccchhhhhhhcccccccCCHHHHhhh--hhhhhcchhhHHHHHHHHHH
Confidence            43    12223344699999999999875  78999999999999999987

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.66  E-value=8.4e-17  Score=121.89  Aligned_cols=206  Identities=18%  Similarity=0.164  Sum_probs=145.6

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC---CCceEEcccccccccC
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE---DFCPKISDFGLAKQSQ   79 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~---~~~~~L~dfg~~~~~~   79 (242)
                      |-||.++..=     .++.++.++++.++-|++..++|+|.+   +++||||||.|+|+.-   ...+.|+|||++.++.
T Consensus        94 GPsLEdLfnf-----C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   94 GPSLEDLFNF-----CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             CccHHHHHHH-----HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            3466666532     235699999999999999999999999   9999999999999963   3468999999999776


Q ss_pred             CCcc-----cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCC
Q 026160           80 DKKS-----TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEP  154 (242)
Q Consensus        80 ~~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  154 (242)
                      +...     ........||..|.+-....+.  ..+.+.|+-|+|.++.+.--|..||............. .+......
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~--eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE-kI~EkK~s  242 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGI--EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE-KISEKKMS  242 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhh--hhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH-HHHHhhcC
Confidence            5422     1122233588999998877653  45788999999999999999999998766544332211 11122222


Q ss_pred             CCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccCCCCCCCCCCcccccCCC
Q 026160          155 GNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSLALPKKSAIQSS  226 (242)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (242)
                      .....++...|.++...+.-       |...-.++-|...-+.+.++.+...+--.-.-..+|.+..-....
T Consensus       243 ~~ie~LC~G~P~EF~myl~Y-------~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lkqk~~q  307 (341)
T KOG1163|consen  243 TPIEVLCKGFPAEFAMYLNY-------CRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLKQKSQQ  307 (341)
T ss_pred             CCHHHHhCCCcHHHHHHHHH-------HhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHHHHhhc
Confidence            23334455556666555544       888899999999988888887776655555556677776443333

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.63  E-value=4e-15  Score=121.19  Aligned_cols=190  Identities=31%  Similarity=0.330  Sum_probs=126.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCC-ceEEcccccccccC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF-CPKISDFGLAKQSQ   79 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~-~~~L~dfg~~~~~~   79 (242)
                      +.+++|.+++......   ..++......++.|++.++.|+|+.   +++|+|+||+|++++..+ .++++|||.+....
T Consensus        80 ~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~  153 (384)
T COG0515          80 VDGGSLEDLLKKIGRK---GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP  153 (384)
T ss_pred             CCCCcHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence            4577777666554211   3699999999999999999999999   999999999999999888 69999999987544


Q ss_pred             CCcccc----hhcccccccccccchhhhccc-CCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCC
Q 026160           80 DKKSTI----SMLHARGTIGYIAPEVFCRSF-GGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEP  154 (242)
Q Consensus        80 ~~~~~~----~~~~~~~~~~y~~PE~~~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  154 (242)
                      ......    ......++..|.+||.+.+.. .......|+|++|++++++++|..||......................
T Consensus       154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  233 (384)
T COG0515         154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP  233 (384)
T ss_pred             CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence            332211    123446899999999986632 366889999999999999999999965444210000000011111100


Q ss_pred             CCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          155 GNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ...........   ......+..++..|+..+|..|.+..+....
T Consensus       234 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 SLASPLSPSNP---ELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ccccccCcccc---chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            00000110111   1112334445555778899999998887765

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.57  E-value=2.2e-15  Score=127.85  Aligned_cols=152  Identities=24%  Similarity=0.316  Sum_probs=116.1

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      ||.|...+.+.      ..+.+.........++-++.++|+.   +++|+|+|++||+++.+|.+++.|||+++..-...
T Consensus        81 gg~lft~l~~~------~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~  151 (612)
T KOG0603|consen   81 GGDLFTRLSKE------VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK  151 (612)
T ss_pred             cchhhhccccC------CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence            45666666655      4488888888999999999999999   99999999999999999999999999987654433


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccccc
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDG  162 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (242)
                      ..      +|+..|++||+..+    ...+.|-||||++++++++|..||.....        .     .........+.
T Consensus       152 ~~------cgt~eymApEI~~g----h~~a~D~ws~gvl~felltg~~pf~~~~~--------~-----~Il~~~~~~p~  208 (612)
T KOG0603|consen  152 IA------CGTYEYRAPEIING----HLSAADWWSFGVLAFELLTGTLPFGGDTM--------K-----RILKAELEMPR  208 (612)
T ss_pred             hc------ccchhhhhhHhhhc----cCCcccchhhhhhHHHHhhCCCCCchHHH--------H-----HHhhhccCCch
Confidence            22      58999999999863    47889999999999999999999986110        1     11111223444


Q ss_pred             ccchHHHHHHHHHHHHHHHhccCCCCCCCCH
Q 026160          163 VVTEEEKELVKKMILVSLWCIQTNPSDRPSM  193 (242)
Q Consensus       163 ~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~  193 (242)
                      .+.....+++..+.       ..+|.+|.-.
T Consensus       209 ~l~~~a~~~~~~l~-------~r~p~nrLg~  232 (612)
T KOG0603|consen  209 ELSAEARSLFRQLF-------KRNPENRLGA  232 (612)
T ss_pred             hhhHHHHHHHHHHH-------hhCHHHHhcc
Confidence            55666666666655       7888888533

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.44  E-value=9.2e-14  Score=124.08  Aligned_cols=140  Identities=29%  Similarity=0.406  Sum_probs=99.7

Q ss_pred             HHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc-------------cchhcccccccccccch
Q 026160           34 IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS-------------TISMLHARGTIGYIAPE  100 (242)
Q Consensus        34 l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~-------------~~~~~~~~~~~~y~~PE  100 (242)
                      .+.+++|||+.   +|+|+|+|+.|.+|..-|.+|+.|||++........             ...-...++|+.|.|||
T Consensus       152 mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPe  228 (1205)
T KOG0606|consen  152 MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPE  228 (1205)
T ss_pred             hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChh
Confidence            37889999999   999999999999999999999999999874332111             00011236999999999


Q ss_pred             hhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccccccccchHHHHHHHHHHHHHH
Q 026160          101 VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSL  180 (242)
Q Consensus       101 ~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  180 (242)
                      ++...  +|....|-|++|+++|+.+-|..||+.......   +...+..   .......+..++++..+++.+++    
T Consensus       229 Vilrq--gygkpvdwwamGiIlyeFLVgcvpffGdtpeel---fg~visd---~i~wpE~dea~p~Ea~dli~~LL----  296 (1205)
T KOG0606|consen  229 VILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL---FGQVISD---DIEWPEEDEALPPEAQDLIEQLL----  296 (1205)
T ss_pred             hhhhh--ccCCCccHHHHHHHHHHHheeeeeccCCCHHHH---Hhhhhhh---hccccccCcCCCHHHHHHHHHHH----
Confidence            88654  677889999999999999999999986632110   0000000   00011113347888889888866    


Q ss_pred             HhccCCCCCCC
Q 026160          181 WCIQTNPSDRP  191 (242)
Q Consensus       181 ~cl~~dp~~Rp  191 (242)
                         +.+|..|-
T Consensus       297 ---~qnp~~Rl  304 (1205)
T KOG0606|consen  297 ---RQNPLCRL  304 (1205)
T ss_pred             ---HhChHhhc
Confidence               78888884

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.34  E-value=9.8e-12  Score=112.44  Aligned_cols=118  Identities=22%  Similarity=0.196  Sum_probs=96.0

Q ss_pred             CCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeC-------CCCceEEccccc
Q 026160            2 PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD-------EDFCPKISDFGL   74 (242)
Q Consensus         2 ~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~-------~~~~~~L~dfg~   74 (242)
                      +.|||-|++.      .++.+++..+..+..|++.-+++||..   +||||||||.|+++-       .+..++|+|||.
T Consensus       777 ~~Gtlld~~N------~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~  847 (974)
T KOG1166|consen  777 PYGTLLDLIN------TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR  847 (974)
T ss_pred             ccccHHHhhc------cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence            5799999996      447799999999999999999999999   999999999999992       344589999999


Q ss_pred             ccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCC
Q 026160           75 AKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRK  130 (242)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~  130 (242)
                      +-.+.-............+..+-.+|...+.  .++...|.|.|+.+++-|+.|+.
T Consensus       848 siDm~lfp~~~~F~~~~~td~f~C~EM~~gr--pWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGR--PWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ceeeeEcCCCcEEeeeeccccchhHHHhcCC--CCchhhhhHHHHHHHHHHHHHHH
Confidence            8644332222222234578888899988765  77999999999999999999864

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.31  E-value=4.2e-12  Score=105.12  Aligned_cols=74  Identities=27%  Similarity=0.308  Sum_probs=58.8

Q ss_pred             HHHHHHHHHHhHHhhhCCCCCeeecCC-CCCceeeCCCCceEEcccccccccCCCcccch------hcccccccccccch
Q 026160           28 YQIAGGIARGLEYLHRGCNVRIVHFDI-KPHNILLDEDFCPKISDFGLAKQSQDKKSTIS------MLHARGTIGYIAPE  100 (242)
Q Consensus        28 ~~i~~~l~~al~~LH~~~~~~i~h~dl-k~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~------~~~~~~~~~y~~PE  100 (242)
                      ..++.+++++|.|||+.   +|+|+|| ||+||+++.++.++|+|||++...........      .....++..|.+||
T Consensus       114 ~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe  190 (365)
T PRK09188        114 PAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPD  190 (365)
T ss_pred             HHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcc
Confidence            46788999999999999   9999999 99999999889999999999986654321111      12345777899999


Q ss_pred             hhhc
Q 026160          101 VFCR  104 (242)
Q Consensus       101 ~~~~  104 (242)
                      .+..
T Consensus       191 ~~~~  194 (365)
T PRK09188        191 ALTP  194 (365)
T ss_pred             cCCh
Confidence            8743

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.28  E-value=5.1e-12  Score=96.01  Aligned_cols=57  Identities=19%  Similarity=0.177  Sum_probs=50.9

Q ss_pred             ccccHHHHHHHHHHHHHHhHHh-hhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160           20 RTLEWRTVYQIAGGIARGLEYL-HRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus        20 ~~l~~~~~~~i~~~l~~al~~L-H~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      ..++..++..++.|++.+|.++ |+.   +++|+||||+||+++ ++.++|+|||++.....
T Consensus       112 ~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~~~v~LiDFG~a~~~~~  169 (190)
T cd05147         112 APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-DGKLYIIDVSQSVEHDH  169 (190)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-CCcEEEEEccccccCCC
Confidence            4688999999999999999999 688   999999999999998 47899999999875433

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.27  E-value=8.3e-12  Score=99.08  Aligned_cols=175  Identities=23%  Similarity=0.309  Sum_probs=110.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |.-|+|..||++.+.  ..+.+....-.+|+.||+.||.|||++ .+.++|++++-..|++..+|.+++..-.....-..
T Consensus       154 mssgs~~~fLkrt~~--~~~a~~~~~wkkw~tqIlsal~yLhs~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s  230 (458)
T KOG1266|consen  154 MSSGSLKQFLKRTKK--NQKALFQKAWKKWCTQILSALSYLHSC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPS  230 (458)
T ss_pred             ccchhHHHHHHHHHH--hhhhhhHHHHHHHHHHHHhhhhhhhcc-CCccccCCcchhheeecCCceEEecccCccccchh
Confidence            567999999987643  456788889999999999999999997 56899999999999999999888764221111100


Q ss_pred             Cccc--chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           81 KKST--ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        81 ~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      -...  .......+-+.|.+||.  +.....+..+|||+||....++..+..-.    ......+..........-+.  
T Consensus       231 ~~~~~~~Ek~~~~~~~g~~a~~s--g~~tn~~~a~dIy~fgmcAlemailEiq~----tnseS~~~~ee~ia~~i~~l--  302 (458)
T KOG1266|consen  231 VNSTREAEKSVNTSLPGFSAPES--GTTTNTTGASDIYKFGMCALEMAILEIQS----TNSESKVEVEENIANVIIGL--  302 (458)
T ss_pred             hhhhhHhhhhccccCCccccCCc--CcccccccchhhhhhhHHHHHHHHheecc----CCCcceeehhhhhhhheeec--
Confidence            0000  00011135577888885  23335578899999999999987764311    11111111111111110000  


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE  198 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~  198 (242)
                           -..--++.+..       |++-.|..||++++++.
T Consensus       303 -----en~lqr~~i~k-------cl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  303 -----ENGLQRGSITK-------CLEGEPNGRPDARLLLF  330 (458)
T ss_pred             -----cCccccCcCcc-------cccCCCCCCcchhhhhc
Confidence                 01111233344       99999999999998874

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.27  E-value=9.6e-12  Score=94.50  Aligned_cols=106  Identities=19%  Similarity=0.129  Sum_probs=76.4

Q ss_pred             HHHHHHHHHHhHHhhhCCCCCeeecCC-CCCceeeCCCCceEEcccccccccCCCcccc---h--------hcccccccc
Q 026160           28 YQIAGGIARGLEYLHRGCNVRIVHFDI-KPHNILLDEDFCPKISDFGLAKQSQDKKSTI---S--------MLHARGTIG   95 (242)
Q Consensus        28 ~~i~~~l~~al~~LH~~~~~~i~h~dl-k~~nil~~~~~~~~L~dfg~~~~~~~~~~~~---~--------~~~~~~~~~   95 (242)
                      ..++.+++.++.++|+.   ||+|+|| ||.||+++.++.++|+|||++..........   .        ......++.
T Consensus        94 ~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~  170 (218)
T PRK12274         94 LAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPA  170 (218)
T ss_pred             HHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCC
Confidence            35778999999999999   9999999 7999999999999999999998655433210   0        011235667


Q ss_pred             cccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccc
Q 026160           96 YIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKA  136 (242)
Q Consensus        96 y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  136 (242)
                      |+.|+...-.....-.+.+-++.|+.+|.++|+..+.....
T Consensus       171 ~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        171 ALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             CCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            77777543221111245566789999999999988765443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.26  E-value=1.7e-12  Score=114.16  Aligned_cols=181  Identities=25%  Similarity=0.292  Sum_probs=128.0

Q ss_pred             CCCCcchhcc-ccCCCCCCccccHHHHHHHHHHHHHHhHHhh-hCCCCCeeecCCCCCceeeCCCC-ceEEccccccccc
Q 026160            2 PNGSLDQFTY-DQESSNGNRTLEWRTVYQIAGGIARGLEYLH-RGCNVRIVHFDIKPHNILLDEDF-CPKISDFGLAKQS   78 (242)
Q Consensus         2 ~~GsL~~~l~-~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH-~~~~~~i~h~dlk~~nil~~~~~-~~~L~dfg~~~~~   78 (242)
                      .||++.+-+. ...     ...+...+-..+.|+..++.|+| ..   ++.|+|+||+|.+++.++ .++..|||++..+
T Consensus       104 ~g~~~f~~i~~~~~-----~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen  104 DGGSLFSKISHPDS-----TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             cccccccccccCCc-----cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccc
Confidence            4566666662 221     14666777788999999999999 77   999999999999999999 8999999999877


Q ss_pred             CC-Ccccchhccccc-ccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCC
Q 026160           79 QD-KKSTISMLHARG-TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN  156 (242)
Q Consensus        79 ~~-~~~~~~~~~~~~-~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  156 (242)
                      .. ...........| +..|.+||...+. .......|+||.|+++.-+++|..||+........+.  .++...  ...
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~--~~~~~~--~~~  250 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS--SWKSNK--GRF  250 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCccccccccccce--eecccc--ccc
Confidence            76 444333444567 9999999998664 2446778999999999999999999986665543321  111111  111


Q ss_pred             ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 026160          157 DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES  202 (242)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~  202 (242)
                      .............++..+       ++..+|+.|.+.+++...=..
T Consensus       251 ~~~~~~~~~~~~~~~l~k-------~l~~~~~~r~s~~~~~~d~~~  289 (601)
T KOG0590|consen  251 TQLPWNSISDQAHDLLHK-------ILKENPSNRLSIEELKLDNWL  289 (601)
T ss_pred             ccCccccCChhhhhcccc-------cccCCchhccccccccccccc
Confidence            112223344445555555       557999999999887654433

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.24  E-value=2.6e-10  Score=93.70  Aligned_cols=197  Identities=13%  Similarity=0.141  Sum_probs=130.2

Q ss_pred             CCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhccccccccc
Q 026160           17 NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY   96 (242)
Q Consensus        17 ~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y   96 (242)
                      ..-....|.-.+.+++.|+.+..-||..   |.+-+|++++|+|++.++.|.|.|-+..........+.+   ..+...|
T Consensus       109 qs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~~~~c---pVg~~ef  182 (637)
T COG4248         109 QSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGTLHLC---PVGVSEF  182 (637)
T ss_pred             ccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeeccCCceEec---ccCcccc
Confidence            3445688999999999999999999998   999999999999999999999998654443333333333   2488999


Q ss_pred             ccchhhh-cccC--CCCCCccchhHHHHHHHHHhc-CCCccccccCCCCC-----cCcchhhhccCCCCccccccccchH
Q 026160           97 IAPEVFC-RSFG--GASHKSDVYSYGMMILEMAVG-RKNADVKASRSSDI-----YFPNSIYKHIEPGNDFQLDGVVTEE  167 (242)
Q Consensus        97 ~~PE~~~-~~~~--~~~~~~Di~slG~~~~~ll~g-~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~  167 (242)
                      ++||... +...  ..+...|.|.||+++++++.| ..||..-......-     .+.........+......+...+..
T Consensus       183 tPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P  262 (637)
T COG4248         183 TPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIP  262 (637)
T ss_pred             CCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCC
Confidence            9999764 2211  336788999999999999887 88986443222111     0001111111111111112222233


Q ss_pred             HHHHHHHHHHHHHHhccC--CCCCCCCHHHHHHHhhchhhhccCCCCCCCC-CCc
Q 026160          168 EKELVKKMILVSLWCIQT--NPSDRPSMHEVLEMLESSTEILQIPPKPSLA-LPK  219 (242)
Q Consensus       168 ~~~~~~~~~~l~~~cl~~--dp~~Rps~~~ll~~l~~~~~~~~~~~~~~~~-~~~  219 (242)
                      +..+...+..+..+|...  ++.-|||++..+..|..+.+++......... |+.
T Consensus       263 ~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a~H~y~~  317 (637)
T COG4248         263 LSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSAMHVYPV  317 (637)
T ss_pred             hhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhcccccccC
Confidence            344444455555556653  3568999999999999999988777665554 444

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.23  E-value=1.8e-11  Score=93.08  Aligned_cols=57  Identities=25%  Similarity=0.236  Sum_probs=51.7

Q ss_pred             ccccHHHHHHHHHHHHHHhHHhhh-CCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160           20 RTLEWRTVYQIAGGIARGLEYLHR-GCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus        20 ~~l~~~~~~~i~~~l~~al~~LH~-~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      ..++..++..++.+++.++.++|+ .   +++|+||||+||+++ ++.++|+|||++.....
T Consensus       112 ~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         112 VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-CCCEEEEEcccceecCC
Confidence            357888999999999999999999 8   999999999999998 78999999999976554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.09  E-value=4e-11  Score=92.83  Aligned_cols=77  Identities=17%  Similarity=0.210  Sum_probs=57.4

Q ss_pred             HHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccccchhhhcccCCC
Q 026160           30 IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGA  109 (242)
Q Consensus        30 i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~  109 (242)
                      ...+++.++..+|..   +++|+|++|.|++++.+| ++|+|||............         .     .....  .+
T Consensus       140 ~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~d---------~-----~vler--~y  199 (232)
T PRK10359        140 VKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAKD---------R-----IDLER--HY  199 (232)
T ss_pred             HHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EEEEECCCcccccchhhHH---------H-----HHHHh--Hh
Confidence            456999999999999   999999999999999888 9999999876543221110         0     11111  23


Q ss_pred             CCCccchhHHHHHHHHH
Q 026160          110 SHKSDVYSYGMMILEMA  126 (242)
Q Consensus       110 ~~~~Di~slG~~~~~ll  126 (242)
                      ..+.|+|+||+.+....
T Consensus       200 ~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        200 GIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             cccccccceeEeehHHH
Confidence            36899999999877654

>smart00090 RIO RIO-like kinase

Probab=99.03  E-value=4.1e-10  Score=88.46  Aligned_cols=55  Identities=22%  Similarity=0.207  Sum_probs=48.8

Q ss_pred             cccHHHHHHHHHHHHHHhHHhhhCCCCC-eeecCCCCCceeeCCCCceEEcccccccccC
Q 026160           21 TLEWRTVYQIAGGIARGLEYLHRGCNVR-IVHFDIKPHNILLDEDFCPKISDFGLAKQSQ   79 (242)
Q Consensus        21 ~l~~~~~~~i~~~l~~al~~LH~~~~~~-i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~   79 (242)
                      .+...++..++.|++.++.+||+.   + ++|+||||.||+++ ++.++|+|||.+....
T Consensus       144 ~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      144 EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence            456667789999999999999999   8 99999999999999 7889999999886533

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.00  E-value=3.4e-10  Score=97.87  Aligned_cols=156  Identities=22%  Similarity=0.390  Sum_probs=106.1

Q ss_pred             HHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCccc--chhcc-----ccccccccc
Q 026160           26 TVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST--ISMLH-----ARGTIGYIA   98 (242)
Q Consensus        26 ~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~--~~~~~-----~~~~~~y~~   98 (242)
                      ....-+.++++|+.|+|..  .++||++|.|.+|.+++++..|++.|+++........+  ..+..     ......|.+
T Consensus       100 ~~f~nl~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~a  177 (700)
T KOG2137|consen  100 DGFANLGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLA  177 (700)
T ss_pred             HhhhhhhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCccccc
Confidence            4444566777899999998  59999999999999999999999999987654431111  11111     124568999


Q ss_pred             chhhhcccCCCCCCccchhHHHHHHHHHhcCCC-ccccccCCCCCcCcchhhhccCCCCccccccccchHHHHHHHHHHH
Q 026160           99 PEVFCRSFGGASHKSDVYSYGMMILEMAVGRKN-ADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMIL  177 (242)
Q Consensus        99 PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (242)
                      ||.+...  ..+.++|+||+|+++|.+..|..+ +....... .    ........+-........++.++++.+.+++ 
T Consensus       178 pE~~~~~--~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-~----~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l-  249 (700)
T KOG2137|consen  178 PEYLLGT--TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-S----YSFSRNLLNAGAFGYSNNLPSELRESLKKLL-  249 (700)
T ss_pred             chhhccc--cccccccceeeeeEEEEEecCCcchhhccCCcc-h----hhhhhcccccccccccccCcHHHHHHHHHHh-
Confidence            9998763  568899999999999999854443 33222111 0    1111122222222233568889999888866 


Q ss_pred             HHHHhccCCCCCCCCHHHHH
Q 026160          178 VSLWCIQTNPSDRPSMHEVL  197 (242)
Q Consensus       178 l~~~cl~~dp~~Rps~~~ll  197 (242)
                            ..+...||++.++.
T Consensus       250 ------~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  250 ------NGDSAVRPTLDLLL  263 (700)
T ss_pred             ------cCCcccCcchhhhh
Confidence                  99999999777665

>PRK10345 hypothetical protein; Provisional

Probab=98.95  E-value=8.8e-10  Score=84.78  Aligned_cols=61  Identities=28%  Similarity=0.403  Sum_probs=47.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHh-HHhhhCCCCCeeecCCCCCceeeCC----CCceEEcccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGL-EYLHRGCNVRIVHFDIKPHNILLDE----DFCPKISDFG   73 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al-~~LH~~~~~~i~h~dlk~~nil~~~----~~~~~L~dfg   73 (242)
                      +++|+|.+++.+.       .+++.  ..++.+++.++ +|||+.   +|+|+||||+||+++.    +..++|+|++
T Consensus        89 ~~~~tL~~~l~~~-------~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         89 KPSITLTEFAEQC-------RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             CcchhHHHHHHcc-------cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            3568999999552       25555  35577888777 899999   9999999999999974    3479999944

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=98.89  E-value=2.5e-09  Score=84.21  Aligned_cols=62  Identities=24%  Similarity=0.251  Sum_probs=49.7

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccC
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ   79 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~   79 (242)
                      ++|.+++...       .++..    .+.+++.++.+||+.   ||+|+||||.|||++.++.++|+|||.+....
T Consensus       132 ~~L~~~l~~~-------~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LIDfg~~~~~~  193 (239)
T PRK01723        132 RDLVALLQEA-------PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLIDFDRGELRT  193 (239)
T ss_pred             CCHHHHHhcC-------CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEECCCcccCC
Confidence            4677776432       24443    356899999999999   99999999999999988899999999886543

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=98.87  E-value=3.2e-09  Score=81.28  Aligned_cols=52  Identities=21%  Similarity=0.217  Sum_probs=46.7

Q ss_pred             HHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160           26 TVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus        26 ~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      ....++.+++.++.++|+.   +++|+||+|.||+++.++.++|+|||.+.....
T Consensus       126 ~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         126 DPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             cHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence            4567889999999999998   999999999999999999999999999865554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=98.82  E-value=4.9e-09  Score=80.93  Aligned_cols=63  Identities=24%  Similarity=0.331  Sum_probs=54.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~   77 (242)
                      ++|++|.+++...         .. ++..++.+++.++.++|+.   +++|+|++|.||+++ ++.++|+|||.+..
T Consensus        81 ~~G~~L~~~~~~~---------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN---------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc---------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            4678888887542         11 7889999999999999999   999999999999999 78899999998754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=98.80  E-value=4.9e-09  Score=80.17  Aligned_cols=60  Identities=28%  Similarity=0.368  Sum_probs=49.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~   77 (242)
                      |+|++|.+++....       .      .++.+++.+|.+||+.   +++|+|++|.||+++ ++.++++|||++..
T Consensus        79 ~~g~~l~~~~~~~~-------~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGN-------D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcH-------H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            35677776664321       0      7889999999999998   999999999999999 78999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.77  E-value=1.4e-08  Score=86.58  Aligned_cols=107  Identities=30%  Similarity=0.396  Sum_probs=87.1

Q ss_pred             cccHHHHHHHHHHHHH----HhHHhhhCCCCCeeecCCCCCceeeCCC-CceEEcccccccccCCCcccchh---ccccc
Q 026160           21 TLEWRTVYQIAGGIAR----GLEYLHRGCNVRIVHFDIKPHNILLDED-FCPKISDFGLAKQSQDKKSTISM---LHARG   92 (242)
Q Consensus        21 ~l~~~~~~~i~~~l~~----al~~LH~~~~~~i~h~dlk~~nil~~~~-~~~~L~dfg~~~~~~~~~~~~~~---~~~~~   92 (242)
                      -++....+..+.+...    |+.++|++   +++|.|+++.|+++..+ ...++.||++.............   .+..+
T Consensus       214 ~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~  290 (524)
T KOG0601|consen  214 FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEG  290 (524)
T ss_pred             cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCC
Confidence            4777888888888888    99999999   99999999999999998 77899999999877665422111   22247


Q ss_pred             ccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcc
Q 026160           93 TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNAD  133 (242)
Q Consensus        93 ~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~  133 (242)
                      ...|.+||...+   .++..+|+|++|.++.+..++.....
T Consensus       291 ~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~~  328 (524)
T KOG0601|consen  291 DCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLPS  328 (524)
T ss_pred             CceEeChhhhcc---ccchHhhhcchhhhhHhhHhhccccc
Confidence            788999998765   56889999999999999998866543

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=98.76  E-value=7.9e-09  Score=90.82  Aligned_cols=47  Identities=28%  Similarity=0.377  Sum_probs=43.1

Q ss_pred             HHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccc
Q 026160           27 VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ   77 (242)
Q Consensus        27 ~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~   77 (242)
                      ...++.+++.++.+||+.   +++|+||||+||++ .++.++|+|||++..
T Consensus       430 ~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        430 NPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             HHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            567899999999999999   99999999999999 577899999999865

>cd05119 RIO RIO kinase family, catalytic domain

Probab=98.60  E-value=4.8e-08  Score=73.87  Aligned_cols=52  Identities=27%  Similarity=0.206  Sum_probs=47.0

Q ss_pred             HHHHHHHHHHHHHhHHhhh-CCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160           25 RTVYQIAGGIARGLEYLHR-GCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus        25 ~~~~~i~~~l~~al~~LH~-~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      .++..++.+++.++.++|. .   +++|+||+|+||+++ ++.++|+|||.+.....
T Consensus       114 ~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         114 EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-CCcEEEEECcccccccC
Confidence            6778899999999999999 7   999999999999999 88999999999865443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.51  E-value=2e-07  Score=84.52  Aligned_cols=166  Identities=20%  Similarity=0.258  Sum_probs=112.5

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCC-
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDK-   81 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~-   81 (242)
                      ||+|...|+..      +..+.+-....+..+..++++||+.   .+.|+|+++.|.++..++...+.+|+........ 
T Consensus       888 ~~~~~Skl~~~------~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~  958 (1205)
T KOG0606|consen  888 GGDLPSKLHNS------GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP  958 (1205)
T ss_pred             cCCchhhhhcC------CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccccccc
Confidence            35555555443      2455555666777888999999997   7999999999999999999999998733211100 


Q ss_pred             ------------------------ccc----chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcc
Q 026160           82 ------------------------KST----ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNAD  133 (242)
Q Consensus        82 ------------------------~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~  133 (242)
                                              ...    .......+++.|.+||...+.  ......|.|++|+.+++.++|.+||.
T Consensus       959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~--~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen  959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR--RHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred             CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc--cCCCcchhhhhhhhhhhhhcCCCCCC
Confidence                                    000    111234589999999998764  45667889999999999999999987


Q ss_pred             ccccCCCCCcCcchhhhccCCCCcccc--ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHH
Q 026160          134 VKASRSSDIYFPNSIYKHIEPGNDFQL--DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMH  194 (242)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~  194 (242)
                      ....        ..+..++.+......  +...+++..+++..++       ..+|.+|..+.
T Consensus      1037 a~tp--------q~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll-------~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETP--------QQIFENILNRDIPWPEGPEEGSYEAQDLINRLL-------TEEPTQRLGAK 1084 (1205)
T ss_pred             Ccch--------hhhhhccccCCCCCCCCccccChhhhhhhhhhh-------ccCchhccCcc
Confidence            5443        233333333332221  2345666666666644       88999997766

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=98.48  E-value=3.6e-07  Score=66.04  Aligned_cols=55  Identities=29%  Similarity=0.254  Sum_probs=47.6

Q ss_pred             cHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccc
Q 026160           23 EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ   77 (242)
Q Consensus        23 ~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~   77 (242)
                      +......++.++++++.+||.....+++|+|+++.|++++..+.++++||+.+..
T Consensus        84 ~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          84 SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            4467778899999999999986334799999999999999888999999998764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.39  E-value=2.4e-07  Score=79.18  Aligned_cols=167  Identities=23%  Similarity=0.302  Sum_probs=104.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCC-CceEEcccccccccC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDED-FCPKISDFGLAKQSQ   79 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~-~~~~L~dfg~~~~~~   79 (242)
                      |.+|++...+...      ..+....++.+..|++.++.++|+.   ..+|+|+++.||++..+ +..++.||++.....
T Consensus       348 ~~~~s~~l~~~~~------~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~  418 (524)
T KOG0601|consen  348 CEGGSSSLRSVTS------QMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA  418 (524)
T ss_pred             hcCcchhhhhHHH------HhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccc
Confidence            3455555555222      3477889999999999999999998   99999999999999876 667899999886532


Q ss_pred             CCcccchhcccccccccc-cchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           80 DKKSTISMLHARGTIGYI-APEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        80 ~~~~~~~~~~~~~~~~y~-~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      ....-     .....++. ..|++... ..+..+.|+++||.-+.+.+++..--....           ....+..+...
T Consensus       419 ~~~~~-----~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-----------~~~~i~~~~~p  481 (524)
T KOG0601|consen  419 FSSGV-----FHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSPLSESGV-----------QSLTIRSGDTP  481 (524)
T ss_pred             eeccc-----ccccccccccchhhccc-cccccccccccccccccccccCcccCcccc-----------cceeeeccccc
Confidence            22111     11223333 25555443 355678899999999999998864322111           11122222222


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      ..+... ..+..+.+.       ....++..||++.++..+.+
T Consensus       482 ~~~~~~-~~~q~~~kv-------~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  482 NLPGLK-LQLQVLLKV-------MINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             CCCchH-Hhhhhhhhh-------hcCCccccchhhhhhcccch
Confidence            222111 233333333       44899999999888765544

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.34  E-value=8.2e-07  Score=67.39  Aligned_cols=55  Identities=16%  Similarity=0.105  Sum_probs=46.4

Q ss_pred             ccHHHHHHHHHHHHHHhHHh-hhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160           22 LEWRTVYQIAGGIARGLEYL-HRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus        22 l~~~~~~~i~~~l~~al~~L-H~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      ++..+...+..+++.++..| |..   +++|+||++.||++. ++.+.++|||.+.....
T Consensus       121 ~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         121 LNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSEYNMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence            45566778889999999988 887   999999999999997 46799999998876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.30  E-value=1.7e-06  Score=75.33  Aligned_cols=97  Identities=19%  Similarity=0.207  Sum_probs=70.1

Q ss_pred             HHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccccchhhh
Q 026160           24 WRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFC  103 (242)
Q Consensus        24 ~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~  103 (242)
                      ...+.--+.||+.||.|||..+  +++|++|....|+++..|..+|++|.++............  ....-.|..|+.+.
T Consensus       103 ~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~--~~~~~s~~~P~~~~  178 (690)
T KOG1243|consen  103 KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKS--LYLIESFDDPEEID  178 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccccc--chhhhcccChhhcC
Confidence            3455566899999999998653  9999999999999999999999999887654432210000  01223455665442


Q ss_pred             cccCCCCCCccchhHHHHHHHHHhc
Q 026160          104 RSFGGASHKSDVYSYGMMILEMAVG  128 (242)
Q Consensus       104 ~~~~~~~~~~Di~slG~~~~~ll~g  128 (242)
                      ..    .-..|.|.|||++++++.|
T Consensus       179 ~s----~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  179 PS----EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cc----ccchhhhhHHHHHHHHhCc
Confidence            22    2456999999999999998

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.24  E-value=1.8e-06  Score=68.94  Aligned_cols=66  Identities=21%  Similarity=0.185  Sum_probs=51.8

Q ss_pred             CcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC-------CCceEEcccccccc
Q 026160            5 SLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE-------DFCPKISDFGLAKQ   77 (242)
Q Consensus         5 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~-------~~~~~L~dfg~~~~   77 (242)
                      +|.+++....    ....+...+..++.+++..+.-||..   |++|+|+++.|||++.       +..+.|+||+.+..
T Consensus       122 sL~~~~~~~~----~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        122 SLEDYCADWA----TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             cHHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            5666653211    12355667888999999999999999   9999999999999974       45789999997753

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.23  E-value=1.7e-06  Score=64.18  Aligned_cols=46  Identities=30%  Similarity=0.403  Sum_probs=40.4

Q ss_pred             HHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccc
Q 026160           28 YQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ   77 (242)
Q Consensus        28 ~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~   77 (242)
                      ..++..+-..+.-||..   +|+|+||+++|+++...+ +.++|||++..
T Consensus        95 ~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          95 PDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             hHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            56778888889999999   999999999999998654 99999999864

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.19  E-value=2.1e-06  Score=66.09  Aligned_cols=53  Identities=28%  Similarity=0.317  Sum_probs=47.6

Q ss_pred             ccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCC---ceEEcccccccc
Q 026160           22 LEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF---CPKISDFGLAKQ   77 (242)
Q Consensus        22 l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~---~~~L~dfg~~~~   77 (242)
                      .+......++.+++..+.-||..   |++|+|+++.|||+..+.   .+.|+||+-+..
T Consensus       115 ~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  115 LDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             cchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            56667889999999999999999   999999999999998876   789999997764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.17  E-value=2.9e-06  Score=62.92  Aligned_cols=66  Identities=29%  Similarity=0.387  Sum_probs=50.3

Q ss_pred             CcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCC-c--eEEcccccccc
Q 026160            5 SLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF-C--PKISDFGLAKQ   77 (242)
Q Consensus         5 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~-~--~~L~dfg~~~~   77 (242)
                      ++.+|+.....    ..........++..+-+.+.-||.+   +++||||+.+||++..++ .  +.++|||++..
T Consensus        97 ~vk~~i~~~~~----~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   97 TVKDFILSTME----DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             HHHHHHHHHcc----CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence            67777766532    2222233378899999999999999   999999999999996544 2  48999999864

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.13  E-value=2.6e-06  Score=72.94  Aligned_cols=69  Identities=25%  Similarity=0.286  Sum_probs=50.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHH-HhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIAR-GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ   79 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~-al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~   79 (242)
                      ++|++|.+++.....     .+   ....++..++. .+..+|..   |++|+|++|.||++..++.++++|||++....
T Consensus       240 i~G~~L~~~~~~~~~-----~~---~~~~ia~~~~~~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       240 IDGIPLSDIAALDEA-----GL---DRKALAENLARSFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             ECCcccccHHHHHhc-----CC---CHHHHHHHHHHHHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            467777776543211     12   23446666665 46788988   99999999999999999999999999997765


Q ss_pred             C
Q 026160           80 D   80 (242)
Q Consensus        80 ~   80 (242)
                      .
T Consensus       309 ~  309 (437)
T TIGR01982       309 E  309 (437)
T ss_pred             H
Confidence            4

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.05  E-value=5.7e-06  Score=61.34  Aligned_cols=49  Identities=31%  Similarity=0.269  Sum_probs=39.9

Q ss_pred             HHHHHHHHHHhHHhhhCC--CCCeeecCCCCCceeeCCCCceEEcccccccc
Q 026160           28 YQIAGGIARGLEYLHRGC--NVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ   77 (242)
Q Consensus        28 ~~i~~~l~~al~~LH~~~--~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~   77 (242)
                      ...+.++++++..||+..  ..+++|+|+++.||+++ ++.++++||+.+..
T Consensus        86 ~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          86 PENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             HHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            345678999999999982  11359999999999998 66899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK09902 hypothetical protein; Provisional

Probab=98.02  E-value=9.6e-06  Score=61.94  Aligned_cols=66  Identities=9%  Similarity=0.040  Sum_probs=53.2

Q ss_pred             CcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCc--eEEcccccccc
Q 026160            5 SLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFC--PKISDFGLAKQ   77 (242)
Q Consensus         5 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~--~~L~dfg~~~~   77 (242)
                      +|.+++.+...    ...+..++..++.+++..++-||+.   |+.|+|+.+.||+++.++.  +.++||.-++.
T Consensus       112 ~L~~~l~~~~~----~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        112 SIADWYAQHAV----SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             cHHHHHhcCCc----CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            56666644321    2457778889999999999999999   9999999999999986666  89999986653

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.81  E-value=3.9e-05  Score=57.98  Aligned_cols=52  Identities=33%  Similarity=0.361  Sum_probs=39.5

Q ss_pred             HHHHHHHHHHHHHHhHH-hhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccC
Q 026160           24 WRTVYQIAGGIARGLEY-LHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ   79 (242)
Q Consensus        24 ~~~~~~i~~~l~~al~~-LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~   79 (242)
                      ......++.+++..+.. +|..   |++||||++.||+++.+ .+.++|||.+....
T Consensus       105 ~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  105 PEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             GSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred             chhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEEecCcceecC
Confidence            34567788888885555 5687   99999999999999877 89999999886544

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=97.66  E-value=3.6e-05  Score=67.26  Aligned_cols=33  Identities=27%  Similarity=0.377  Sum_probs=30.0

Q ss_pred             CeeecCCCCCceeeCCCC----ceEEcccccccccCC
Q 026160           48 RIVHFDIKPHNILLDEDF----CPKISDFGLAKQSQD   80 (242)
Q Consensus        48 ~i~h~dlk~~nil~~~~~----~~~L~dfg~~~~~~~   80 (242)
                      |++|+|++|.||+++.++    ++.++|||++.....
T Consensus       280 GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        280 GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            999999999999999887    899999999886654

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=97.59  E-value=0.00051  Score=58.79  Aligned_cols=90  Identities=17%  Similarity=0.292  Sum_probs=68.9

Q ss_pred             CCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhccccccccc
Q 026160           17 NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY   96 (242)
Q Consensus        17 ~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y   96 (242)
                      ..+.+++++..|.++.||..||.++|+.   |+.-+-|.+.+|+++++.++++..-|+........              
T Consensus       385 ~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~--------------  447 (655)
T KOG3741|consen  385 SQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP--------------  447 (655)
T ss_pred             cCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecCCC--------------
Confidence            4567899999999999999999999999   99989999999999998888887655443222111              


Q ss_pred             ccchhhhcccCCCCCCccchhHHHHHHHHHhcCC
Q 026160           97 IAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRK  130 (242)
Q Consensus        97 ~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~  130 (242)
                        -+.+..     ..+-|.-.||.++..|.+|..
T Consensus       448 --~~~le~-----~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  448 --TEPLES-----QQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             --CcchhH-----HhhhhHHHHHHHHHHHhhccc
Confidence              011111     245678889999999999853

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.40  E-value=0.0004  Score=64.63  Aligned_cols=151  Identities=21%  Similarity=0.277  Sum_probs=96.8

Q ss_pred             ccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCC---ceeeCCCCceEEc--ccccccccCCCcccchhccccccc
Q 026160           20 RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPH---NILLDEDFCPKIS--DFGLAKQSQDKKSTISMLHARGTI   94 (242)
Q Consensus        20 ~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~---nil~~~~~~~~L~--dfg~~~~~~~~~~~~~~~~~~~~~   94 (242)
                      ..++..+...+..++++|+.++|+.   ...|.-+...   +-.+++.+.+...  ||+.+............   ....
T Consensus       281 ~~i~~~~~r~~~~~~~~GL~~~h~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~---~~~~  354 (1351)
T KOG1035|consen  281 GSIPLETLRILHQKLLEGLAYLHSL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSD---LLAE  354 (1351)
T ss_pred             cccCHHHHHHHHHHHhhhHHHHHHh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhh---cCcc
Confidence            4688999999999999999999997   4444444443   3344455555555  88887766655433222   1445


Q ss_pred             ccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccccccccchHHHHHHHH
Q 026160           95 GYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKK  174 (242)
Q Consensus        95 ~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (242)
                      .+.++|.............|+|.+|.....+..|..+-.......       ..           ++ ....      ..
T Consensus       355 ~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~~-------~~-----------l~-~~~~------~~  409 (1351)
T KOG1035|consen  355 IRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVPV-------SL-----------LD-VLST------SE  409 (1351)
T ss_pred             ccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccchh-------hh-----------hc-cccc------hh
Confidence            667777765554455666799999999999987754322111100       00           00 0000      03


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          175 MILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       175 ~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      +.....+|+.-++++|+++.+++.+.-
T Consensus       410 ~~d~~~~~~~~~~~~Rl~~~~ll~~~f  436 (1351)
T KOG1035|consen  410 LLDALPKCLDEDSEERLSALELLTHPF  436 (1351)
T ss_pred             hhhhhhhhcchhhhhccchhhhhhchh
Confidence            455566699999999999999987654

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=97.24  E-value=0.00083  Score=51.84  Aligned_cols=31  Identities=26%  Similarity=0.295  Sum_probs=26.4

Q ss_pred             CCeeecCCCCCceeeCC--CCceEEcccccccc
Q 026160           47 VRIVHFDIKPHNILLDE--DFCPKISDFGLAKQ   77 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~--~~~~~L~dfg~~~~   77 (242)
                      ..++|+|+.+.||+++.  ++.+.++||+.+..
T Consensus       174 ~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         174 PGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence            47899999999999998  56689999987753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=96.87  E-value=0.0016  Score=50.27  Aligned_cols=43  Identities=26%  Similarity=0.346  Sum_probs=36.6

Q ss_pred             HHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEccccccc
Q 026160           30 IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK   76 (242)
Q Consensus        30 i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~   76 (242)
                      +...+++++.-+|..   |++|+|..|.|++++.+ .++++||+...
T Consensus       140 ~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i~iID~~~k~  182 (229)
T PF06176_consen  140 LAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GIRIIDTQGKR  182 (229)
T ss_pred             HHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cEEEEECcccc
Confidence            445677889999998   99999999999999865 49999997654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=96.78  E-value=0.0025  Score=50.49  Aligned_cols=51  Identities=27%  Similarity=0.200  Sum_probs=40.3

Q ss_pred             HHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccc
Q 026160           24 WRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ   77 (242)
Q Consensus        24 ~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~   77 (242)
                      .+....++..|+.-+..+-..   |++|+|++.-||+++.+|.+.++||--+..
T Consensus       201 ~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         201 VENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             ccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCCCEEEEeCccccc
Confidence            445556666666666655566   999999999999999999999999976543

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=96.75  E-value=0.0033  Score=47.63  Aligned_cols=58  Identities=22%  Similarity=0.171  Sum_probs=51.2

Q ss_pred             cccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEccccccccc
Q 026160           21 TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS   78 (242)
Q Consensus        21 ~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~   78 (242)
                      .-+|..+.+++.++++.+.+++......+...|++++|+.++.++.++++|.+.+...
T Consensus        55 ~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   55 QSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            3689999999999999999999955557899999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=95.93  E-value=0.016  Score=45.52  Aligned_cols=53  Identities=23%  Similarity=0.211  Sum_probs=43.6

Q ss_pred             HHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccC
Q 026160           24 WRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ   79 (242)
Q Consensus        24 ~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~   79 (242)
                      ..+...+..++++.+.-|-..  .++||+||+.-|||+. ++.+.++||+-+....
T Consensus       165 ~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         165 LEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             chhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-CCeEEEEECccccccC
Confidence            335777788888888877773  2999999999999999 7889999999887544

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=95.66  E-value=0.011  Score=47.51  Aligned_cols=52  Identities=21%  Similarity=0.234  Sum_probs=37.7

Q ss_pred             HHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEccccccccc
Q 026160           26 TVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS   78 (242)
Q Consensus        26 ~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~   78 (242)
                      ...+.+..+-.++.-.+... ..++|+|+.+.|++.+..+.++|+||..+..-
T Consensus       133 ~~~~~~~~l~~~l~~~~~~~-~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~~  184 (269)
T COG0510         133 LLRKKLKELRRALEEVPKDD-LVPCHNDLNPGNLLLTDKGGLFLIDWEYAGLN  184 (269)
T ss_pred             HHHHHHHHHHHHhhhcCCCc-eeeecCCCCccceEEcCCCcEEEEecccCCCc
Confidence            33444455555555555421 26999999999999999899999999988643

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=95.55  E-value=0.031  Score=45.51  Aligned_cols=31  Identities=32%  Similarity=0.300  Sum_probs=27.3

Q ss_pred             CCCeeecCCCCCceeeCCC----CceEEccccccc
Q 026160           46 NVRIVHFDIKPHNILLDED----FCPKISDFGLAK   76 (242)
Q Consensus        46 ~~~i~h~dlk~~nil~~~~----~~~~L~dfg~~~   76 (242)
                      ..+++|+|+.+.||+++.+    +.+.++||+++.
T Consensus       178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            3589999999999999874    789999998875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=95.35  E-value=0.028  Score=43.95  Aligned_cols=30  Identities=27%  Similarity=0.381  Sum_probs=26.5

Q ss_pred             CCeeecCCCCCceeeCC-CCceEEccccccc
Q 026160           47 VRIVHFDIKPHNILLDE-DFCPKISDFGLAK   76 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~-~~~~~L~dfg~~~   76 (242)
                      .+++|+|+.+.||+++. ++.+.++||.++.
T Consensus       170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            38999999999999997 5789999998774

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.26  E-value=0.048  Score=45.38  Aligned_cols=57  Identities=19%  Similarity=0.178  Sum_probs=48.1

Q ss_pred             ccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCC
Q 026160           22 LEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDK   81 (242)
Q Consensus        22 l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~   81 (242)
                      ..++++..++.+.+.-+.-+...  -..-|+++...||+|+ +|+|.|+||-+++....+
T Consensus       318 ~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfklsRl~~~q  374 (488)
T COG5072         318 DRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLSRLSYSQ  374 (488)
T ss_pred             ccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeeeecccCC
Confidence            45688888888888888888776  4889999999999999 999999999999854443

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.22  E-value=0.022  Score=43.82  Aligned_cols=30  Identities=37%  Similarity=0.526  Sum_probs=21.6

Q ss_pred             CCeeecCCCCCceee-CCCCceEEccccccc
Q 026160           47 VRIVHFDIKPHNILL-DEDFCPKISDFGLAK   76 (242)
Q Consensus        47 ~~i~h~dlk~~nil~-~~~~~~~L~dfg~~~   76 (242)
                      ..++|+|+.+.||++ ..++.++|+||.++.
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            389999999999999 778899999999875

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=94.95  E-value=0.009  Score=57.99  Aligned_cols=126  Identities=13%  Similarity=-0.020  Sum_probs=81.5

Q ss_pred             CCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCC--CCeeecCCCCCceeeCCCCceEEcccccccccC
Q 026160            2 PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCN--VRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ   79 (242)
Q Consensus         2 ~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~--~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~   79 (242)
                      .+|.+.+.|-+...  ....+...-+.....+.+.+..-.|+..+  .-.+|.++++.|.+|..+..+++.++|+.+...
T Consensus      1314 ~~g~~f~iIikg~e--e~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn 1391 (2724)
T KOG1826|consen 1314 EFGKLFSIIIKGLE--ESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN 1391 (2724)
T ss_pred             HHhHHHHHHHhccc--cCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccC
Confidence            35666666544321  12233333333333333555555554322  247899999999999999999999999988333


Q ss_pred             CCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcc
Q 026160           80 DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNAD  133 (242)
Q Consensus        80 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~  133 (242)
                      ......  ....+++.|+.++....-  .++.++|+|..|+.+|..-.|..+|.
T Consensus      1392 p~~sf~--Gl~l~sp~~v~qli~N~i--k~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1392 PVLSFF--GLELCSPIYVLQLIKNEI--KFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred             chHhhh--hhhhCCHHHHHHHHHHHH--hhhhHHHHHHHHHHHHHHhcccHHHH
Confidence            322221  123477788888877553  55777999999999999988887764

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=94.84  E-value=0.03  Score=43.31  Aligned_cols=30  Identities=40%  Similarity=0.442  Sum_probs=21.3

Q ss_pred             CCeeecCCCCCceeeC-CCCceEEccccccc
Q 026160           47 VRIVHFDIKPHNILLD-EDFCPKISDFGLAK   76 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~-~~~~~~L~dfg~~~   76 (242)
                      ..++|+|+.+.||+++ .++.+.++||+.+.
T Consensus       166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             EEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             cEEEEeccccccceeeeccceeEEEecccce
Confidence            3899999999999999 56667899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=94.83  E-value=0.043  Score=44.91  Aligned_cols=30  Identities=33%  Similarity=0.520  Sum_probs=26.7

Q ss_pred             CCeeecCCCCCceeeCCCCceEEccccccc
Q 026160           47 VRIVHFDIKPHNILLDEDFCPKISDFGLAK   76 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~~~~~~L~dfg~~~   76 (242)
                      .+++|+|+.+.|++++.++.+.++||+.+.
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            489999999999999988777899998774

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=94.63  E-value=0.042  Score=43.08  Aligned_cols=31  Identities=26%  Similarity=0.370  Sum_probs=26.0

Q ss_pred             CCeeecCCCCCceeeCCCCceEEcccccccc
Q 026160           47 VRIVHFDIKPHNILLDEDFCPKISDFGLAKQ   77 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~   77 (242)
                      .+++|+|+.+.|++++.++...++||+.+..
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            4799999999999998766567999997653

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=94.39  E-value=0.092  Score=42.90  Aligned_cols=29  Identities=31%  Similarity=0.353  Sum_probs=25.2

Q ss_pred             CCeeecCCCCCceeeCCCCceEEccccccc
Q 026160           47 VRIVHFDIKPHNILLDEDFCPKISDFGLAK   76 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~~~~~~L~dfg~~~   76 (242)
                      .+++|+|+.+.|++++. +.+.++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            48999999999999987 568999998654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK05231 homoserine kinase; Provisional

Probab=94.37  E-value=0.085  Score=43.33  Aligned_cols=31  Identities=26%  Similarity=0.366  Sum_probs=26.4

Q ss_pred             CCeeecCCCCCceeeCCCCceEEcccccccc
Q 026160           47 VRIVHFDIKPHNILLDEDFCPKISDFGLAKQ   77 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~   77 (242)
                      .+++|+|+.+.||+++.+....++||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            3899999999999998766568999997753

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=93.96  E-value=0.081  Score=42.92  Aligned_cols=31  Identities=29%  Similarity=0.395  Sum_probs=26.9

Q ss_pred             CCeeecCCCCCceeeCCCCceEEcccccccc
Q 026160           47 VRIVHFDIKPHNILLDEDFCPKISDFGLAKQ   77 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~   77 (242)
                      .+++|+|+.+.|++++.++.+.++||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            3799999999999999877778999987653

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=93.95  E-value=0.06  Score=47.21  Aligned_cols=34  Identities=32%  Similarity=0.421  Sum_probs=31.0

Q ss_pred             CeeecCCCCCceeeCCCCceEEcccccccccCCC
Q 026160           48 RIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDK   81 (242)
Q Consensus        48 ~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~   81 (242)
                      |+.|+|..|.||++..+|++.+.|||+.......
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            9999999999999999999999999998766543

>TIGR02721 ycfN_thiK thiamine kinase

Probab=93.88  E-value=0.043  Score=43.58  Aligned_cols=30  Identities=20%  Similarity=0.365  Sum_probs=26.1

Q ss_pred             CCeeecCCCCCceeeCCCCceEEcccccccc
Q 026160           47 VRIVHFDIKPHNILLDEDFCPKISDFGLAKQ   77 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~   77 (242)
                      ..++|+|+.+.||++++++ +.|+||+.+..
T Consensus       146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            3799999999999999876 78999998754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK10271 thiK thiamine kinase; Provisional

Probab=93.84  E-value=0.048  Score=41.15  Aligned_cols=29  Identities=17%  Similarity=0.311  Sum_probs=25.7

Q ss_pred             CeeecCCCCCceeeCCCCceEEcccccccc
Q 026160           48 RIVHFDIKPHNILLDEDFCPKISDFGLAKQ   77 (242)
Q Consensus        48 ~i~h~dlk~~nil~~~~~~~~L~dfg~~~~   77 (242)
                      ..+|+|+.|.|++++.++ ++|+||+++..
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            679999999999998776 88999998864

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=93.82  E-value=0.051  Score=42.44  Aligned_cols=29  Identities=17%  Similarity=0.082  Sum_probs=25.7

Q ss_pred             CCeeecCCCCCceeeCCCCceEEccccccc
Q 026160           47 VRIVHFDIKPHNILLDEDFCPKISDFGLAK   76 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~~~~~~L~dfg~~~   76 (242)
                      ..++|+|+.+.|++++.++ +.++||+.+.
T Consensus       153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       153 STCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            3679999999999999877 9999998775

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=93.47  E-value=0.053  Score=42.65  Aligned_cols=30  Identities=23%  Similarity=0.238  Sum_probs=26.5

Q ss_pred             CCeeecCCCCCceeeCCCCceEEccccccc
Q 026160           47 VRIVHFDIKPHNILLDEDFCPKISDFGLAK   76 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~~~~~~L~dfg~~~   76 (242)
                      ..++|+|+.+.|+++++++.+.|+||+.+.
T Consensus       163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            479999999999999987778899998764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02236 choline kinase

Probab=93.27  E-value=0.13  Score=42.82  Aligned_cols=31  Identities=29%  Similarity=0.420  Sum_probs=26.7

Q ss_pred             CCeeecCCCCCceeeCC-CCceEEcccccccc
Q 026160           47 VRIVHFDIKPHNILLDE-DFCPKISDFGLAKQ   77 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~-~~~~~L~dfg~~~~   77 (242)
                      ..++|+|+++.||+++. ++.+.++||.++..
T Consensus       200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             ceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            48999999999999976 46799999988753

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=92.92  E-value=0.27  Score=40.74  Aligned_cols=28  Identities=39%  Similarity=0.610  Sum_probs=25.0

Q ss_pred             eeecCCCCCceeeCCCCc-eEEccccccc
Q 026160           49 IVHFDIKPHNILLDEDFC-PKISDFGLAK   76 (242)
Q Consensus        49 i~h~dlk~~nil~~~~~~-~~L~dfg~~~   76 (242)
                      +||+|+.+.||+++.+.. +.++||+.+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            999999999999998774 8899999775

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=92.91  E-value=0.17  Score=41.40  Aligned_cols=31  Identities=23%  Similarity=0.184  Sum_probs=27.9

Q ss_pred             CCeeecCCCCCceeeCCCCceEEcccccccc
Q 026160           47 VRIVHFDIKPHNILLDEDFCPKISDFGLAKQ   77 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~   77 (242)
                      .+++|+|+.+.|+++++++.+.++||..++.
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            4899999999999999988999999987764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=92.57  E-value=0.27  Score=37.55  Aligned_cols=41  Identities=27%  Similarity=0.329  Sum_probs=28.9

Q ss_pred             HHHHHHhHHhhhCCCCCeeecCCCCCceeeCCC--C--ceEEcc-cccc
Q 026160           32 GGIARGLEYLHRGCNVRIVHFDIKPHNILLDED--F--CPKISD-FGLA   75 (242)
Q Consensus        32 ~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~--~--~~~L~d-fg~~   75 (242)
                      ..+-+-..+|-..   +|+.+|++|.||++...  +  .+.|+| ||..
T Consensus       125 ~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  125 QALDEFKRYLLDH---HIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             HHHHHHHHHHHHc---CCeecCCCcccEEEEecCCCceEEEEEeCCCCc
Confidence            3344455677777   89999999999999532  2  477887 5543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=92.06  E-value=0.26  Score=40.85  Aligned_cols=31  Identities=26%  Similarity=0.306  Sum_probs=26.5

Q ss_pred             CCeeecCCCCCceeeCC-CCceEEcccccccc
Q 026160           47 VRIVHFDIKPHNILLDE-DFCPKISDFGLAKQ   77 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~-~~~~~L~dfg~~~~   77 (242)
                      ...+|+|+.+.||+++. ++.++++||.++..
T Consensus       182 ~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        182 VVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             eEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            36899999999999974 57899999998753

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=91.37  E-value=0.5  Score=35.95  Aligned_cols=30  Identities=27%  Similarity=0.288  Sum_probs=24.9

Q ss_pred             CeeecCCCCCceeeCCCC-----ceEEcccccccc
Q 026160           48 RIVHFDIKPHNILLDEDF-----CPKISDFGLAKQ   77 (242)
Q Consensus        48 ~i~h~dlk~~nil~~~~~-----~~~L~dfg~~~~   77 (242)
                      .++|||+.+.|+++..++     .+.++||..+..
T Consensus       121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~  155 (196)
T smart00587      121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY  155 (196)
T ss_pred             EEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence            899999999999997543     588999987653

subfamily of choline kinases

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=91.22  E-value=0.17  Score=40.86  Aligned_cols=31  Identities=39%  Similarity=0.520  Sum_probs=25.7

Q ss_pred             CCeeecCCCCCceeeCCCCc-eEEcccccccc
Q 026160           47 VRIVHFDIKPHNILLDEDFC-PKISDFGLAKQ   77 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~~~~-~~L~dfg~~~~   77 (242)
                      ..++|+|+.+.|++++.++. .-++||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            37999999999999987555 56999997754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PRK06148 hypothetical protein; Provisional

Probab=90.60  E-value=0.38  Score=46.09  Aligned_cols=30  Identities=37%  Similarity=0.470  Sum_probs=25.6

Q ss_pred             CeeecCCCCCceeeCCCC--ce-EEcccccccc
Q 026160           48 RIVHFDIKPHNILLDEDF--CP-KISDFGLAKQ   77 (242)
Q Consensus        48 ~i~h~dlk~~nil~~~~~--~~-~L~dfg~~~~   77 (242)
                      ++||+|+++.||+++.++  ++ -|+|||-+..
T Consensus       204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        204 QVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             ceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            899999999999998775  45 4999998764

>PHA03111 Ser/Thr kinase; Provisional

Probab=90.41  E-value=0.41  Score=39.56  Aligned_cols=38  Identities=29%  Similarity=0.306  Sum_probs=23.3

Q ss_pred             HHHHHHHHHHHHhHHh-hhCCCCCeeecCCCCCceeeCC
Q 026160           26 TVYQIAGGIARGLEYL-HRGCNVRIVHFDIKPHNILLDE   63 (242)
Q Consensus        26 ~~~~i~~~l~~al~~L-H~~~~~~i~h~dlk~~nil~~~   63 (242)
                      -+..+..|++...-.. ...+-...+|.||||.|||+-.
T Consensus       280 YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFd  318 (444)
T PHA03111        280 YIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFD  318 (444)
T ss_pred             HHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEec
Confidence            3445566666544222 1111138999999999999943

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=90.38  E-value=0.32  Score=37.92  Aligned_cols=39  Identities=28%  Similarity=0.246  Sum_probs=32.9

Q ss_pred             HHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEccccc
Q 026160           35 ARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGL   74 (242)
Q Consensus        35 ~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~   74 (242)
                      +++|.-.|+. ..+.+|||..|.||+=++.|.+||.|-+.
T Consensus       151 i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  151 IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhh
Confidence            4567778864 35999999999999999999999999664

The function of this family is unknown.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=89.79  E-value=0.72  Score=40.69  Aligned_cols=33  Identities=30%  Similarity=0.300  Sum_probs=28.3

Q ss_pred             CeeecCCCCCceeeCC----CCceEEcccccccccCC
Q 026160           48 RIVHFDIKPHNILLDE----DFCPKISDFGLAKQSQD   80 (242)
Q Consensus        48 ~i~h~dlk~~nil~~~----~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|-.|.||++..    ++.+.+.|||+......
T Consensus       321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            8999999999999983    66799999999875544

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=89.77  E-value=0.7  Score=38.25  Aligned_cols=47  Identities=17%  Similarity=0.203  Sum_probs=35.7

Q ss_pred             HHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccC
Q 026160           30 IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ   79 (242)
Q Consensus        30 i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~   79 (242)
                      +...+..-+--|-..   |+||+|.+--||++..++.+.++||--.....
T Consensus       207 ly~~lm~~Iv~la~~---GlIHgDFNEFNimv~dd~~i~vIDFPQmvS~s  253 (465)
T KOG2268|consen  207 LYDDLMGLIVRLANH---GLIHGDFNEFNIMVKDDDKIVVIDFPQMVSTS  253 (465)
T ss_pred             HHHHHHHHHHHHHHc---CceecccchheeEEecCCCEEEeechHhhccC
Confidence            333444445556666   99999999999999999999999997655443

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=89.52  E-value=0.33  Score=39.91  Aligned_cols=34  Identities=26%  Similarity=0.385  Sum_probs=29.6

Q ss_pred             CCCeeecCCCCCceeeCCCCceEEcccccccccC
Q 026160           46 NVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ   79 (242)
Q Consensus        46 ~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~   79 (242)
                      ...++|||+.+.|++++.++.+-++||+.+..-.
T Consensus       197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             CceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            3589999999999999998889999999887543

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=89.38  E-value=0.48  Score=39.31  Aligned_cols=34  Identities=35%  Similarity=0.257  Sum_probs=21.6

Q ss_pred             HHHHHHHHHHHh---HHhhhCCCCCeeecCCCCCceeeC
Q 026160           27 VYQIAGGIARGL---EYLHRGCNVRIVHFDIKPHNILLD   62 (242)
Q Consensus        27 ~~~i~~~l~~al---~~LH~~~~~~i~h~dlk~~nil~~   62 (242)
                      +..+..|++...   ..|-.+  ...+|.||||.|||+-
T Consensus       277 vkfifLQiaLLyikIYelp~c--~nF~H~DLKPdNILiF  313 (434)
T PF05445_consen  277 VKFIFLQIALLYIKIYELPCC--TNFLHVDLKPDNILIF  313 (434)
T ss_pred             HHHHHHHHHHHHeeeecCCCc--ceeeecccCcCcEEEe
Confidence            334455555432   223323  3899999999999994

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>PRK11768 serine/threonine protein kinase; Provisional

Probab=89.12  E-value=0.82  Score=37.81  Aligned_cols=28  Identities=36%  Similarity=0.475  Sum_probs=23.8

Q ss_pred             CCeeecCCCCCceeeCCCCceEEccccccc
Q 026160           47 VRIVHFDIKPHNILLDEDFCPKISDFGLAK   76 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~~~~~~L~dfg~~~   76 (242)
                      .+++|+|+.+.||++. + .+.++||+.+.
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            3799999999999995 4 57899999775

>PRK06149 hypothetical protein; Provisional

Probab=86.52  E-value=1.1  Score=42.93  Aligned_cols=31  Identities=29%  Similarity=0.433  Sum_probs=25.0

Q ss_pred             CCeeecCCCCCceeeCCCC--c---eEEcccccccc
Q 026160           47 VRIVHFDIKPHNILLDEDF--C---PKISDFGLAKQ   77 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~~~--~---~~L~dfg~~~~   77 (242)
                      .++||+|+...||+++.+.  .   .-++|||.+..
T Consensus       208 ~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~~  243 (972)
T PRK06149        208 LQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLVR  243 (972)
T ss_pred             ccccCCCCCcccEEEcCCCCCCcceeEEEEcccchh
Confidence            3899999999999998652  2   37999997753

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=86.32  E-value=0.12  Score=45.04  Aligned_cols=78  Identities=23%  Similarity=0.184  Sum_probs=39.5

Q ss_pred             CCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccccc-ccchHHHHHHHHHHHHHHHhccCCCCC
Q 026160          111 HKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDG-VVTEEEKELVKKMILVSLWCIQTNPSD  189 (242)
Q Consensus       111 ~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~cl~~dp~~  189 (242)
                      .++|||++|.++.++.-|..-|.........    ..+....... ...... ........+-+..+++..+|+-..|..
T Consensus       110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l----~~i~k~~~~d-~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~i  184 (725)
T KOG1093|consen  110 PKSDVWSLGFIILELYLGISLEAELTESEYL----EILLKYYTDD-QELLSTAMEHLIQLLADKKRLPLLKKCLWLEPII  184 (725)
T ss_pred             cchhhhhHHHHHHHHHHhhHHHHHHHHHHHH----HHHHHhccCc-hhHHHHHHHHHHHHhhhHhHHHHhccCCcccccc
Confidence            5999999999999998875433211111000    0000000000 000000 001122344566677778899888888


Q ss_pred             CCCH
Q 026160          190 RPSM  193 (242)
Q Consensus       190 Rps~  193 (242)
                      ||..
T Consensus       185 r~l~  188 (725)
T KOG1093|consen  185 RPLP  188 (725)
T ss_pred             ccch
Confidence            8643

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=86.08  E-value=1.4  Score=37.63  Aligned_cols=30  Identities=23%  Similarity=0.288  Sum_probs=25.6

Q ss_pred             CCeeecCCCCCceeeCCCCceEEcccccccc
Q 026160           47 VRIVHFDIKPHNILLDEDFCPKISDFGLAKQ   77 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~   77 (242)
                      ..++|||+.+.||++..+ .++++||.++..
T Consensus       223 ~~l~HgDl~~gni~~~~~-~~~viD~E~a~~  252 (401)
T PRK09550        223 EALLHGDLHTGSIFVTEE-ETKVIDPEFAFY  252 (401)
T ss_pred             CceeeccCCcccEEeeCC-CcEEEecccccc
Confidence            489999999999999765 589999987653

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=83.97  E-value=0.62  Score=41.79  Aligned_cols=94  Identities=29%  Similarity=0.197  Sum_probs=65.8

Q ss_pred             HHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccccchhhhcc
Q 026160           26 TVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRS  105 (242)
Q Consensus        26 ~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~  105 (242)
                      +...+++.-.+++.++|+.   .-+|+|    ||+.+. +..++.+|+..........   .....+++.+++||+....
T Consensus       337 ~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~---~~t~~~~~~~~~pev~~~~  405 (829)
T KOG0576|consen  337 QFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMK---PRTAIGTPEPLAPEVIQEN  405 (829)
T ss_pred             hhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCcccc---cccCCCCCCCCCchhhccc
Confidence            3344455566788899986   557777    666544 6788999988766554431   2234588999999987654


Q ss_pred             cCCCCCCccchhHHHHHHHHHhcCCCc
Q 026160          106 FGGASHKSDVYSYGMMILEMAVGRKNA  132 (242)
Q Consensus       106 ~~~~~~~~Di~slG~~~~~ll~g~~p~  132 (242)
                        .+....|.|++|.-..++--|.+|-
T Consensus       406 --~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  406 --TIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             --ccccCCCccCCCcchhhcCCCCCCC
Confidence              5677889999998777777666654

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=82.59  E-value=2  Score=34.73  Aligned_cols=30  Identities=33%  Similarity=0.314  Sum_probs=24.3

Q ss_pred             CCeeecCCCCCceeeCCC--C---ceEEccccccc
Q 026160           47 VRIVHFDIKPHNILLDED--F---CPKISDFGLAK   76 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~~--~---~~~L~dfg~~~   76 (242)
                      ..++|||+...||++..+  |   .+.+.||-+++
T Consensus       215 ~vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~  249 (294)
T PF02958_consen  215 NVLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR  249 (294)
T ss_pred             eEEEcCccCHHhEeEccccccccccceeecccccc
Confidence            379999999999999654  3   58899997654

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PTZ00296 choline kinase; Provisional

Probab=82.15  E-value=3  Score=36.18  Aligned_cols=29  Identities=24%  Similarity=0.547  Sum_probs=24.7

Q ss_pred             CCeeecCCCCCceeeCCCCceEEccccccc
Q 026160           47 VRIVHFDIKPHNILLDEDFCPKISDFGLAK   76 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~~~~~~L~dfg~~~   76 (242)
                      ..++|+|+.+.||+.+.+ .++|+||.++.
T Consensus       284 ~VfCHNDl~~~NiL~~~~-~l~LIDfEYAg  312 (442)
T PTZ00296        284 IVFCHNDLQENNIINTNK-CLRLIDFEYSG  312 (442)
T ss_pred             eeEEeCCCCccceeecCC-CEEEEeecccc
Confidence            489999999999987654 49999998875

>PRK12396 5-methylribose kinase; Reviewed

Probab=81.81  E-value=2.4  Score=36.12  Aligned_cols=30  Identities=20%  Similarity=0.329  Sum_probs=25.4

Q ss_pred             CCeeecCCCCCceeeCCCCceEEcccccccc
Q 026160           47 VRIVHFDIKPHNILLDEDFCPKISDFGLAKQ   77 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~   77 (242)
                      ...+|||+.+.||+++.+ .++++|..++..
T Consensus       227 ~aLlHGDlHtGSI~v~~~-~~kvIDpEFAfy  256 (409)
T PRK12396        227 QALIHGDLHTGSVFVKND-STKVIDPEFAFY  256 (409)
T ss_pred             hhhccCcCCCCCEEecCC-ceEEEccccccc
Confidence            489999999999999875 589999777653

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=81.67  E-value=2.6  Score=35.45  Aligned_cols=30  Identities=23%  Similarity=0.276  Sum_probs=25.0

Q ss_pred             CCeeecCCCCCceeeCCCCceEEcccccccc
Q 026160           47 VRIVHFDIKPHNILLDEDFCPKISDFGLAKQ   77 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~   77 (242)
                      ..++|||+.+.||+++.+ .++++|+.++..
T Consensus       192 ~~llHGDl~~gNi~~~~~-~~~~iD~e~~~~  221 (370)
T TIGR01767       192 ETLLHGDLHSGSIFVSEH-ETKVIDPEFAFY  221 (370)
T ss_pred             ceeeeccCCcccEEEcCC-CCEEEcCccccc
Confidence            489999999999999765 477999986653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>COG4499 Predicted membrane protein [Function unknown]

Probab=81.43  E-value=5.1  Score=33.55  Aligned_cols=82  Identities=21%  Similarity=0.210  Sum_probs=55.9

Q ss_pred             ccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccccchh
Q 026160           22 LEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEV  101 (242)
Q Consensus        22 l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~  101 (242)
                      +.-...++++.+.+..|.-+..    .-.|.=+.|+||+++.++.+.+..+|+-...              +|.=+.||.
T Consensus        82 ~~k~~Klr~a~~~I~~l~e~~~----tr~~~~laPeNilf~~~l~p~~vH~Glk~~l--------------pPye~tee~  143 (434)
T COG4499          82 KEKTRKLRLALQNIATLSELNN----TRYTFFLAPENILFDGGLTPFFVHRGLKNSL--------------PPYEMTEER  143 (434)
T ss_pred             HHHHHHHHHHHHHHHHHHHhhc----cceeEEecchheEEcCCCceEEEecchhccC--------------CCCCCCHHH
Confidence            4556777878888887775554    3466678899999999999999988875432              223345554


Q ss_pred             hhcccCCCCCCccchhHHHHHHHHHhcCCCcc
Q 026160          102 FCRSFGGASHKSDVYSYGMMILEMAVGRKNAD  133 (242)
Q Consensus       102 ~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~  133 (242)
                      +..            .+-+++..++.|+.+|.
T Consensus       144 f~~------------~ykA~~~~~fn~k~~Fe  163 (434)
T COG4499         144 FLK------------EYKALAIYAFNGKFSFE  163 (434)
T ss_pred             HHH------------HHHHHHHHHHcCCccHH
Confidence            432            34556667777777775

>PF10140 YukC: WXG100 protein secretion system (Wss), protein YukC; InterPro: IPR018778 Members of this family are associated with type VII secretion of WXG100 family targets in the Firmicutes, but not in the Actinobacteria

Probab=81.22  E-value=1.7  Score=36.36  Aligned_cols=52  Identities=25%  Similarity=0.381  Sum_probs=33.6

Q ss_pred             ccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEccccccc
Q 026160           20 RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK   76 (242)
Q Consensus        20 ~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~   76 (242)
                      +.++..+++.++.+|..--.++++     -+|.-+.|.|++++.++.+++.-.|+-.
T Consensus        54 ~~~~~~eklr~~~ni~~l~~~~~~-----~~~f~l~P~Nl~fd~~~~p~i~hrGi~~  105 (359)
T PF10140_consen   54 KKLDKSEKLRLLINIAALKEHLNS-----RYTFILHPENLVFDKNLMPKILHRGIKE  105 (359)
T ss_dssp             GGS-HHHHHHHHHHGGGGGGGGGS-----SEE---SGGGEEE-TTS-EEES--EETT
T ss_pred             HhcCHHHHHHHHHHHHHHHHHhcC-----ceeEEEechheEEcCCCCEEEEEcCCcC
Confidence            357788999999995544444444     4888999999999999999999887654

This protein is designated YukC in Bacillus subtilis and EssB is Staphylococcus aureus. ; PDB: 4ANN_A.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	242
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-28
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		4e-28
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-21
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-21
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		8e-20
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-19
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-19
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-17
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-13
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		7e-12
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		8e-12
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		9e-12
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-11
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-11
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-11
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-11
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-11
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-11
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-11
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-11
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-11
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		8e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-10
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-10
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-10
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-10
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-10
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-10
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-10
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-10
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		8e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		8e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		8e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		8e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		9e-10
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-09
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-09
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-09
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-09
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-09
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-09
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-09
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-09
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-09
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-09
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-09
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-09
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-09
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-09
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-09
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-09
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-09
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-09
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-09
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-09
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-09
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-09
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-09
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-09
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-09
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-09
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-09
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-09
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-09
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-09
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-09
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-09
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-09
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-09
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-09
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-09
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		5e-09
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-09
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		5e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-09
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		6e-09
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		7e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		7e-09
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		7e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		7e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		7e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-09
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		7e-09
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		7e-09
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		7e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		7e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		7e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		7e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		7e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		7e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		7e-09
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		7e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		8e-09
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		8e-09
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		8e-09
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		8e-09
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-09
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		8e-09
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		9e-09
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		9e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		9e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		9e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-08
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-08
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-08
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-08
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-08
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-08
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-08
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-08
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-08
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-08
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-08
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-08
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-08
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-08
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-08
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-08
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-08
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-08
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-08
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-08
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-08
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-08
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-08
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-08
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-08
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-08
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-08
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-08
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-08
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-08
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-08
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-08
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-08
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-08
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-08
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-08
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-08
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-08
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-08
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-08
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-08
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-08
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-08
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-08
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-08
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-08
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-08
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-08
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-08
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-08
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-08
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		4e-08
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-08
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-08
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-08
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-08
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-08
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-08
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-08
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-08
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		5e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		5e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		5e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-08
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		6e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-08
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-08
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-08
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		6e-08
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		6e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-08
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-08
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-08
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		7e-08
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		7e-08
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		7e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-08
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-08
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-08
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		8e-08
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		8e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		8e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		8e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-08
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		8e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		8e-08
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		8e-08
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		8e-08
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		9e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		9e-08
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		9e-08
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		9e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		9e-08
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		9e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		9e-08
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-07
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-07
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-07
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-07
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-07
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-07
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-07
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-07
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-07
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-07
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-07
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-07
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-07
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-07
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-07
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-07
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-07
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-07
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-07
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-07
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-07
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-07
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-07
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-07
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-07
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-07
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-07
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-07
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-07
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-07
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-07
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-07
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-07
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-07
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-07
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-07
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-07
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-07
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-07
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-07
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-07
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-07
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-07
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-07
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-07
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-07
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-07
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-07
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-07
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-07
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-07
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-07
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-07
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-07
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-07
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-07
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-07
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-07
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-07
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-07
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-07
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-07
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		4e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-07
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-07
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-07
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-07
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-07
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-07
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-07
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-07
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-07
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-07
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-07
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-07
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-07
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-07
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-07
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		4e-07
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-07
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-07
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-07
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		5e-07
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-07
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		5e-07
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-07
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-07
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		5e-07
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-07
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		5e-07
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-07
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-07
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-07
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		5e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-07
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		6e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-07
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		6e-07
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		6e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		6e-07
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		6e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-07
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		6e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-07
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		6e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		6e-07
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		6e-07
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		6e-07
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		7e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-07
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		7e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		7e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		7e-07
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		7e-07
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		7e-07
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		7e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		7e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		7e-07
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		7e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		7e-07
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		7e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		7e-07
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		7e-07
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		7e-07
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		7e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		8e-07
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		8e-07
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-07
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		8e-07
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-07
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		9e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		9e-07
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-07
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-07
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		9e-07
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-07
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-07
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		9e-07
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		9e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-06
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-06
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-06
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-06
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-06
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-06
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-06
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-06
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-06
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-06
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-06
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-06
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-06
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-06
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-06
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-06
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-06
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-06
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-06
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-06
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-06
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-06
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-06
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-06
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-06
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-06
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-06
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-06
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-06
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-06
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-06
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-06
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-06
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-06
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-06
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-06
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-06
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-06
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-06
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-06
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-06
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-06
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-06
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-06
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-06
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-06
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-06
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-06
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-06
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-06
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-06
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-06
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-06
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-06
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-06
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-06
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-06
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-06
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-06
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-06
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-06
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-06
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-06
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-06
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-06
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-06
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-06
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-06
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		5e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		5e-06
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-06
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-06
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		5e-06
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-06
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-06
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		5e-06
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-06
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-06
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-06
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		5e-06
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-06
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-06
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		6e-06
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-06
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-06
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		6e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		7e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-06
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-06
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-06
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		9e-06
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-05
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-05
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-05
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-05
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-05
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-05
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-05
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-05
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-05
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-05
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-05
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-05
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-05
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-05
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-05
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-05
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-05
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-05
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-05
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-05
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-05
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-05
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-05
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-05
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-05
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-05
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-05
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-05
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-05
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-05
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-05
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-05
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-05
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-05
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-05
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-05
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-05
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-05
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-05
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-05
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-05
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-05
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-05
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-05
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-05
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-05
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-05
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-05
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-05
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-05
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-05
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-05
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-05
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-05
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-05
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-05
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-05
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-05
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-05
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-05
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-05
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-05
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-05
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-05
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-05
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-05
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-05
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-05
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-05
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		5e-05
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-05
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-05
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		5e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-05
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		6e-05
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		6e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		6e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-05
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		6e-05
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		6e-05
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		7e-05
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		7e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		7e-05
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		7e-05
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		7e-05
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		7e-05
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		7e-05
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		8e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		8e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		8e-05
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-05
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-05
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		9e-05
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		9e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		9e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		9e-05
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-04
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-04
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-04
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-04
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-04
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-04
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-04
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-04
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-04
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-04
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-04
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-04
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-04
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-04
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-04
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-04
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-04
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-04
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-04
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-04
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-04
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-04
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-04
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-04
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-04
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-04
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-04
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-04
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-04
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-04
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-04
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-04
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-04
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-04
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		3e-04
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-04
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-04
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-04
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-04
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-04
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-04
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-04
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-04
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		4e-04
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-04
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-04
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-04
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-04
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		5e-04
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		5e-04
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-04
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		5e-04
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-04
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		6e-04
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		7e-04
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-04
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-04
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		7e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		7e-04
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		7e-04
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		7e-04
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		7e-04
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		7e-04
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		7e-04
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		7e-04
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		7e-04
3kk8_A	284	Camkii Substrate Complex A Length = 284		8e-04
3kk9_A	282	Camkii Substrate Complex B Length = 282		8e-04
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		8e-04
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  123 bits (308), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/207 (38%), Positives = 111/207 (53%), Gaps = 14/207 (6%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NGS+      +E       L+W    +IA G ARGL YLH  C+ +I+H D+K  NIL
Sbjct: 117 MANGSVASCL--RERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANIL 174
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           LDE+F   + DFGLAK   D K        RGTIG+IAPE    S G +S K+DV+ YG+
Sbjct: 175 LDEEFEAVVGDFGLAK-LMDYKDXHVXXAVRGTIGHIAPEYL--STGKSSEKTDVFGYGV 231
Query: 121 MILEMAVGRKNADV-KASRSSDIYFPNSIY-----KHIEPGNDFQLDGXXXXXXXXXXXX 174
           M+LE+  G++  D+ + +   D+   + +      K +E   D  L G            
Sbjct: 232 MLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQG---NYKDEEVEQ 288
Query: 175 MILVSLWCIQTNPSDRPSMHEVLEMLE 201
           +I V+L C Q++P +RP M EV+ MLE
Sbjct: 289 LIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  121 bits (303), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 78/207 (37%), Positives = 110/207 (53%), Gaps = 14/207 (6%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NGS+      +E       L+W    +IA G ARGL YLH  C+ +I+H D+K  NIL
Sbjct: 109 MANGSVASCL--RERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANIL 166
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           LDE+F   + DFGLAK   D K        RG IG+IAPE    S G +S K+DV+ YG+
Sbjct: 167 LDEEFEAVVGDFGLAK-LMDYKDXHVXXAVRGXIGHIAPEYL--STGKSSEKTDVFGYGV 223
Query: 121 MILEMAVGRKNADV-KASRSSDIYFPNSIY-----KHIEPGNDFQLDGXXXXXXXXXXXX 174
           M+LE+  G++  D+ + +   D+   + +      K +E   D  L G            
Sbjct: 224 MLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQG---NYKDEEVEQ 280
Query: 175 MILVSLWCIQTNPSDRPSMHEVLEMLE 201
           +I V+L C Q++P +RP M EV+ MLE
Sbjct: 281 LIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 102/211 (48%), Gaps = 16/211 (7%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NG+L +  Y   S     ++ W    +I  G ARGL YLH      I+H D+K  NIL
Sbjct: 117 MENGNLKRHLYG--SDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINIL 171
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           LDE+F PKI+DFG++K+  +   T      +GT+GYI PE F +  G  + KSDVYS+G+
Sbjct: 172 LDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIK--GRLTEKSDVYSFGV 229
Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMIL--- 177
           ++ E+   R        R       N     +E  N+ QL+               L   
Sbjct: 230 VLFEVLCARSAIVQSLPRE----MVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKF 285
Query: 178 --VSLWCIQTNPSDRPSMHEVLEMLESSTEI 206
              ++ C+  +  DRPSM +VL  LE +  +
Sbjct: 286 GDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 102/211 (48%), Gaps = 16/211 (7%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NG+L +  Y   S     ++ W    +I  G ARGL YLH      I+H D+K  NIL
Sbjct: 117 MENGNLKRHLYG--SDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINIL 171
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           LDE+F PKI+DFG++K+  +   T      +GT+GYI PE F +  G  + KSDVYS+G+
Sbjct: 172 LDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIK--GRLTEKSDVYSFGV 229
Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMIL--- 177
           ++ E+   R        R       N     +E  N+ QL+               L   
Sbjct: 230 VLFEVLCARSAIVQSLPRE----MVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKF 285
Query: 178 --VSLWCIQTNPSDRPSMHEVLEMLESSTEI 206
              ++ C+  +  DRPSM +VL  LE +  +
Sbjct: 286 GDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 93.6 bits (231), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 97/205 (47%), Gaps = 12/205 (5%)
Query: 1   MPNGSLDQFTYDQESS-NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MPNGSL     D+ S  +G   L W    +IA G A G+ +LH   ++   H DIK  NI
Sbjct: 112 MPNGSL----LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI---HRDIKSANI 164
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           LLDE F  KISDFGLA+ S+    T+      GT  Y+APE      G  + KSD+YS+G
Sbjct: 165 LLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEAL---RGEITPKSDIYSFG 221
Query: 120 MMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVS 179
           +++LE+  G    D        +     I    +   D+ +D             M  V+
Sbjct: 222 VVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY-IDKKMNDADSTSVEAMYSVA 280
Query: 180 LWCIQTNPSDRPSMHEVLEMLESST 204
             C+    + RP + +V ++L+  T
Sbjct: 281 SQCLHEKKNKRPDIKKVQQLLQEMT 305

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 97/205 (47%), Gaps = 12/205 (5%)
Query: 1   MPNGSLDQFTYDQESS-NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MPNGSL     D+ S  +G   L W    +IA G A G+ +LH   ++   H DIK  NI
Sbjct: 112 MPNGSL----LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI---HRDIKSANI 164
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           LLDE F  KISDFGLA+ S+    T+      GT  Y+APE      G  + KSD+YS+G
Sbjct: 165 LLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEAL---RGEITPKSDIYSFG 221
Query: 120 MMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVS 179
           +++LE+  G    D        +     I    +   D+ +D             M  V+
Sbjct: 222 VVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY-IDKKMNDADSTSVEAMYSVA 280
Query: 180 LWCIQTNPSDRPSMHEVLEMLESST 204
             C+    + RP + +V ++L+  T
Sbjct: 281 SQCLHEKKNKRPDIKKVQQLLQEMT 305

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 91.3 bits (225), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 96/205 (46%), Gaps = 12/205 (5%)
Query: 1   MPNGSLDQFTYDQESS-NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MPNGSL     D+ S  +G   L W    +IA G A G+ +LH   ++   H DIK  NI
Sbjct: 106 MPNGSL----LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI---HRDIKSANI 158
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           LLDE F  KISDFGLA+ S+     +      GT  Y+APE      G  + KSD+YS+G
Sbjct: 159 LLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEAL---RGEITPKSDIYSFG 215
Query: 120 MMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVS 179
           +++LE+  G    D        +     I    +   D+ +D             M  V+
Sbjct: 216 VVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY-IDKKMNDADSTSVEAMYSVA 274
Query: 180 LWCIQTNPSDRPSMHEVLEMLESST 204
             C+    + RP + +V ++L+  T
Sbjct: 275 SQCLHEKKNKRPDIKKVQQLLQEMT 299

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 94/204 (46%), Gaps = 12/204 (5%)
Query: 2   PNGSLDQFTYDQESS-NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           PNGSL     D+ S  +G   L W    +IA G A G+ +LH   ++   H DIK  NIL
Sbjct: 104 PNGSL----LDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHHI---HRDIKSANIL 156
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           LDE F  KISDFGLA+ S+     +      GT  Y APE      G  + KSD+YS+G+
Sbjct: 157 LDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEAL---RGEITPKSDIYSFGV 213
Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSL 180
           ++LE+  G    D        +     I    +   D+ +D                V+ 
Sbjct: 214 VLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY-IDKKXNDADSTSVEAXYSVAS 272
Query: 181 WCIQTNPSDRPSMHEVLEMLESST 204
            C+    + RP + +V ++L+  T
Sbjct: 273 QCLHEKKNKRPDIKKVQQLLQEXT 296

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 42/96 (43%), Positives = 64/96 (66%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD-KKSTISMLHARG 92
           +A GL++LH   ++ I++ D+KP NILLDE+   K++DFGL+K++ D +K   S     G
Sbjct: 139 LALGLDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFC---G 192
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T+ Y+APEV  R   G SH +D +SYG+++ EM  G
Sbjct: 193 TVEYMAPEVVNRQ--GHSHSADWWSYGVLMFEMLTG 226

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/172 (31%), Positives = 84/172 (48%), Gaps = 39/172 (22%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ---DKKSTISMLHA 90
           I  G +YLHR    R++H D+K  N+ L+ED   KI DFGLA + +   ++K T+     
Sbjct: 130 IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC---- 182
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPN---S 147
            GT  YIAPEV  +   G S + DV+S G ++  + VG+   +    + + +       S
Sbjct: 183 -GTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS 239
Query: 148 IYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLW--CIQTNPSDRPSMHEVL 197
           I KHI P                     +  SL    +QT+P+ RP+++E+L
Sbjct: 240 IPKHINP---------------------VAASLIQKMLQTDPTARPTINELL 270

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/172 (31%), Positives = 84/172 (48%), Gaps = 39/172 (22%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ---DKKSTISMLHA 90
           I  G +YLHR    R++H D+K  N+ L+ED   KI DFGLA + +   ++K T+     
Sbjct: 126 IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC---- 178
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPN---S 147
            GT  YIAPEV  +   G S + DV+S G ++  + VG+   +    + + +       S
Sbjct: 179 -GTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS 235
Query: 148 IYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLW--CIQTNPSDRPSMHEVL 197
           I KHI P                     +  SL    +QT+P+ RP+++E+L
Sbjct: 236 IPKHINP---------------------VAASLIQKMLQTDPTARPTINELL 266

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/172 (31%), Positives = 84/172 (48%), Gaps = 39/172 (22%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ---DKKSTISMLHA 90
           I  G +YLHR    R++H D+K  N+ L+ED   KI DFGLA + +   ++K T+     
Sbjct: 126 IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC---- 178
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPN---S 147
            GT  YIAPEV  +   G S + DV+S G ++  + VG+   +    + + +       S
Sbjct: 179 -GTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS 235
Query: 148 IYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLW--CIQTNPSDRPSMHEVL 197
           I KHI P                     +  SL    +QT+P+ RP+++E+L
Sbjct: 236 IPKHINP---------------------VAASLIQKMLQTDPTARPTINELL 266

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 83/172 (48%), Gaps = 39/172 (22%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ---DKKSTISMLHA 90
           I  G +YLHR    R++H D+K  N+ L+ED   KI DFGLA + +   ++K  +     
Sbjct: 124 IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---- 176
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPN---S 147
            GT  YIAPEV  +   G S + DV+S G ++  + VG+   +    + + +       S
Sbjct: 177 -GTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS 233
Query: 148 IYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLW--CIQTNPSDRPSMHEVL 197
           I KHI P                     +  SL    +QT+P+ RP+++E+L
Sbjct: 234 IPKHINP---------------------VAASLIQKMLQTDPTARPTINELL 264

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 83/172 (48%), Gaps = 39/172 (22%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ---DKKSTISMLHA 90
           I  G +YLHR    R++H D+K  N+ L+ED   KI DFGLA + +   ++K  +     
Sbjct: 148 IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---- 200
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPN---S 147
            GT  YIAPEV  +   G S + DV+S G ++  + VG+   +    + + +       S
Sbjct: 201 -GTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS 257
Query: 148 IYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLW--CIQTNPSDRPSMHEVL 197
           I KHI P                     +  SL    +QT+P+ RP+++E+L
Sbjct: 258 IPKHINP---------------------VAASLIQKMLQTDPTARPTINELL 288

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 83/172 (48%), Gaps = 39/172 (22%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ---DKKSTISMLHA 90
           I  G +YLHR    R++H D+K  N+ L+ED   KI DFGLA + +   ++K  +     
Sbjct: 150 IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---- 202
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPN---S 147
            GT  YIAPEV  +   G S + DV+S G ++  + VG+   +    + + +       S
Sbjct: 203 -GTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS 259
Query: 148 IYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLW--CIQTNPSDRPSMHEVL 197
           I KHI P                     +  SL    +QT+P+ RP+++E+L
Sbjct: 260 IPKHINP---------------------VAASLIQKMLQTDPTARPTINELL 290

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/109 (35%), Positives = 60/109 (55%), Gaps = 4/109 (3%)
Query: 22  LEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDK 81
            E + +  IA   ARG++YLH      I+H D+K +NI L ED   KI DFGLA +    
Sbjct: 117 FEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173
Query: 82  KSTISMLHARGTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVGR 129
             +       G+I ++APEV   +     S +SDVY++G+++ E+  G+
Sbjct: 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/109 (35%), Positives = 60/109 (55%), Gaps = 4/109 (3%)
Query: 22  LEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDK 81
            E + +  IA   ARG++YLH      I+H D+K +NI L ED   KI DFGLA +    
Sbjct: 117 FEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173
Query: 82  KSTISMLHARGTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVGR 129
             +       G+I ++APEV   +     S +SDVY++G+++ E+  G+
Sbjct: 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 77/152 (50%), Gaps = 17/152 (11%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSL  F    +S  G + L  + +   +  IA G+ Y+ R      +H D++  N+L
Sbjct: 90  MAKGSLLDFL---KSDEGGKVLLPKLI-DFSAQIAEGMAYIERK---NYIHRDLRAANVL 142
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + E    KI+DFGLA+  +D + T +   A+  I + APE    +FG  + KSDV+S+G+
Sbjct: 143 VSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAI--NFGCFTIKSDVWSFGI 199
Query: 121 MILEMAV-------GRKNADVKASRSSDIYFP 145
           ++ E+         GR NADV  + S     P
Sbjct: 200 LLYEIVTYGKIPYPGRTNADVMTALSQGYRMP 231

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/108 (37%), Positives = 62/108 (57%), Gaps = 8/108 (7%)
Query: 22  LEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDK 81
           L   T       I  G+++ H   ++RIVH DIKP NIL+D +   KI DFG+AK +  +
Sbjct: 108 LSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAK-ALSE 163
Query: 82  KSTISMLHARGTIGYIAPEVFCRSFGGASHK-SDVYSYGMMILEMAVG 128
            S     H  GT+ Y +PE   ++ G A+ + +D+YS G+++ EM VG
Sbjct: 164 TSLTQTNHVLGTVQYFSPE---QAKGEATDECTDIYSIGIVLYEMLVG 208

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 69/125 (55%), Gaps = 16/125 (12%)
Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ---DKKSTISMLHARG 92
           +G++YLH   N R++H D+K  N+ L++D   KI DFGLA + +   ++K T+      G
Sbjct: 153 QGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLC-----G 204
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPN---SIY 149
           T  YIAPEV C+   G S + D++S G ++  + VG+   +    + + I       S+ 
Sbjct: 205 TPNYIAPEVLCKK--GHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVP 262
Query: 150 KHIEP 154
           +HI P
Sbjct: 263 RHINP 267

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 39/96 (40%), Positives = 62/96 (64%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD-KKSTISMLHARG 92
           +A  L++LH   ++ I++ D+KP NILLDE+   K++DFGL+K+S D +K   S     G
Sbjct: 135 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC---G 188
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T+ Y+APEV  R   G +  +D +S+G+++ EM  G
Sbjct: 189 TVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTG 222

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 39/96 (40%), Positives = 62/96 (64%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD-KKSTISMLHARG 92
           +A  L++LH   ++ I++ D+KP NILLDE+   K++DFGL+K+S D +K   S     G
Sbjct: 136 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC---G 189
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T+ Y+APEV  R   G +  +D +S+G+++ EM  G
Sbjct: 190 TVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTG 223

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 39/96 (40%), Positives = 62/96 (64%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD-KKSTISMLHARG 92
           +A  L++LH   ++ I++ D+KP NILLDE+   K++DFGL+K+S D +K   S     G
Sbjct: 135 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC---G 188
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T+ Y+APEV  R   G +  +D +S+G+++ EM  G
Sbjct: 189 TVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTG 222

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 17/152 (11%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSL  F    +S  G + L  + +   +  IA G+ Y+ R      +H D++  N+L
Sbjct: 89  MAKGSLLDFL---KSDEGGKVLLPKLI-DFSAQIAEGMAYIERK---NYIHRDLRAANVL 141
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + E    KI+DFGLA+  +D + T +   A+  I + APE    +FG  + KS+V+S+G+
Sbjct: 142 VSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAI--NFGCFTIKSNVWSFGI 198
Query: 121 MILEMAV-------GRKNADVKASRSSDIYFP 145
           ++ E+         GR NADV ++ S     P
Sbjct: 199 LLYEIVTYGKIPYPGRTNADVMSALSQGYRMP 230

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/113 (38%), Positives = 66/113 (58%), Gaps = 7/113 (6%)
Query: 16  SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLA 75
           S     L+ R    +A  +A+G+ YLH   N  IVH ++K  N+L+D+ +  K+ DFGL 
Sbjct: 128 SGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGL- 185
Query: 76  KQSQDKKST-ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV 127
             S+ K ST +S   A GT  ++APEV       ++ KSDVYS+G+++ E+A 
Sbjct: 186 --SRLKASTFLSSKSAAGTPEWMAPEVLRDE--PSNEKSDVYSFGVILWELAT 234

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/109 (35%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 22  LEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDK 81
            E + +  IA   ARG++YLH      I+H D+K +NI L ED   KI DFGLA      
Sbjct: 105 FEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRW 161
Query: 82  KSTISMLHARGTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVGR 129
             +       G+I ++APEV   +     S +SDVY++G+++ E+  G+
Sbjct: 162 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 57/101 (56%), Gaps = 4/101 (3%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           IA   A+G++YLH      I+H D+K +NI L ED   KI DFGLA +      +     
Sbjct: 137 IARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ 193
Query: 90  ARGTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVGR 129
             G+I ++APEV   +     S +SDVY++G+++ E+  G+
Sbjct: 194 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 57/101 (56%), Gaps = 4/101 (3%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           IA   A+G++YLH      I+H D+K +NI L ED   KI DFGLA +      +     
Sbjct: 109 IARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ 165
Query: 90  ARGTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVGR 129
             G+I ++APEV   +     S +SDVY++G+++ E+  G+
Sbjct: 166 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 57/101 (56%), Gaps = 4/101 (3%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           IA   A+G++YLH      I+H D+K +NI L ED   KI DFGLA +      +     
Sbjct: 129 IARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ 185
Query: 90  ARGTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVGR 129
             G+I ++APEV   +     S +SDVY++G+++ E+  G+
Sbjct: 186 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 62/112 (55%), Gaps = 5/112 (4%)
Query: 16  SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLA 75
           S     L+ R    +A  +A+G+ YLH   N  IVH D+K  N+L+D+ +  K+ DFGL+
Sbjct: 128 SGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLS 186
Query: 76  KQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV 127
           +        +    A GT  ++APEV       ++ KSDVYS+G+++ E+A 
Sbjct: 187 RLKAS--XFLXSKXAAGTPEWMAPEVLRDE--PSNEKSDVYSFGVILWELAT 234

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 68/125 (54%), Gaps = 16/125 (12%)
Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ---DKKSTISMLHARG 92
           +G++YLH   N R++H D+K  N+ L++D   KI DFGLA + +   ++K  +      G
Sbjct: 153 QGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLC-----G 204
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPN---SIY 149
           T  YIAPEV C+   G S + D++S G ++  + VG+   +    + + I       S+ 
Sbjct: 205 TPNYIAPEVLCKK--GHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVP 262
Query: 150 KHIEP 154
           +HI P
Sbjct: 263 RHINP 267

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 68/125 (54%), Gaps = 16/125 (12%)
Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ---DKKSTISMLHARG 92
           +G++YLH   N R++H D+K  N+ L++D   KI DFGLA + +   ++K  +      G
Sbjct: 137 QGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLC-----G 188
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPN---SIY 149
           T  YIAPEV C+   G S + D++S G ++  + VG+   +    + + I       S+ 
Sbjct: 189 TPNYIAPEVLCKK--GHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVP 246
Query: 150 KHIEP 154
           +HI P
Sbjct: 247 RHINP 251

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 68/125 (54%), Gaps = 16/125 (12%)
Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ---DKKSTISMLHARG 92
           +G++YLH   N R++H D+K  N+ L++D   KI DFGLA + +   ++K  +      G
Sbjct: 153 QGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLC-----G 204
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPN---SIY 149
           T  YIAPEV C+   G S + D++S G ++  + VG+   +    + + I       S+ 
Sbjct: 205 TPNYIAPEVLCKK--GHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVP 262
Query: 150 KHIEP 154
           +HI P
Sbjct: 263 RHINP 267

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 56/101 (55%), Gaps = 4/101 (3%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           IA   A+G++YLH      I+H D+K +NI L ED   KI DFGLA        +     
Sbjct: 114 IARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 170
Query: 90  ARGTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVGR 129
             G+I ++APEV   +     S +SDVY++G+++ E+  G+
Sbjct: 171 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 56/101 (55%), Gaps = 4/101 (3%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           IA   A+G++YLH      I+H D+K +NI L ED   KI DFGLA        +     
Sbjct: 109 IARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 165
Query: 90  ARGTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVGR 129
             G+I ++APEV   +     S +SDVY++G+++ E+  G+
Sbjct: 166 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 56/101 (55%), Gaps = 4/101 (3%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           IA   A+G++YLH      I+H D+K +NI L ED   KI DFGLA        +     
Sbjct: 109 IARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 165
Query: 90  ARGTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVGR 129
             G+I ++APEV   +     S +SDVY++G+++ E+  G+
Sbjct: 166 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 56/101 (55%), Gaps = 4/101 (3%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           IA   A+G++YLH      I+H D+K +NI L ED   KI DFGLA        +     
Sbjct: 114 IARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 170
Query: 90  ARGTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVGR 129
             G+I ++APEV   +     S +SDVY++G+++ E+  G+
Sbjct: 171 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 56/101 (55%), Gaps = 4/101 (3%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           IA   A+G++YLH      I+H D+K +NI L ED   KI DFGLA        +     
Sbjct: 136 IARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 192
Query: 90  ARGTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVGR 129
             G+I ++APEV   +     S +SDVY++G+++ E+  G+
Sbjct: 193 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 56/101 (55%), Gaps = 4/101 (3%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           IA   A+G++YLH      I+H D+K +NI L ED   KI DFGLA        +     
Sbjct: 137 IARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 193
Query: 90  ARGTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVGR 129
             G+I ++APEV   +     S +SDVY++G+++ E+  G+
Sbjct: 194 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 56/101 (55%), Gaps = 4/101 (3%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           IA   A+G++YLH      I+H D+K +NI L ED   KI DFGLA        +     
Sbjct: 111 IARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 167
Query: 90  ARGTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVGR 129
             G+I ++APEV   +     S +SDVY++G+++ E+  G+
Sbjct: 168 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 208

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 55/100 (55%), Gaps = 4/100 (4%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           IA   A+G++YLH      I+H D+K +NI L E    KI DFGLA        +  +  
Sbjct: 137 IARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQ 193
Query: 90  ARGTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVG 128
             G++ ++APEV   +     S +SDVYSYG+++ E+  G
Sbjct: 194 PTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTG 233

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/159 (33%), Positives = 77/159 (48%), Gaps = 28/159 (17%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAG---GIARGLEYLHRGCNVRIVHFDIKPH 57
           M NGSLD F    +           TV Q+ G   GIA G++YL    ++  VH D+   
Sbjct: 116 MENGSLDSFLRQNDGQ--------FTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAAR 164
Query: 58  NILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG---TIGYIAPEVF-CRSFGGASHKS 113
           NIL++ +   K+SDFGL++  +D  S  +   A G    I + APE    R F  A   S
Sbjct: 165 NILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSA---S 221
Query: 114 DVYSYGMMILE-MAVGRK------NADVKASRSSDIYFP 145
           DV+SYG+++ E M+ G +      N DV  +   D   P
Sbjct: 222 DVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP 260

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 67/119 (56%), Gaps = 8/119 (6%)
Query: 8   QFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP 67
           +F+++  S N    L  + +   A  +ARG+EYL    + + +H D+   N+L+ ED   
Sbjct: 134 EFSFNP-SHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVM 189
Query: 68  KISDFGLAKQSQDKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEM 125
           KI+DFGLA+            + R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 190 KIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 245

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 72/130 (55%), Gaps = 19/130 (14%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAG---GIARGLEYLHRGCNVRIVHFDIKPH 57
           M NG+LD+F  +++           +V Q+ G   GIA G++YL    N+  VH D+   
Sbjct: 128 MENGALDKFLREKDGEF--------SVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAAR 176
Query: 58  NILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARGTIGYIAPEVFC-RSFGGASHKSDV 115
           NIL++ +   K+SDFGL++  + D ++T +    +  I + APE    R F  A   SDV
Sbjct: 177 NILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSA---SDV 233
Query: 116 YSYGMMILEM 125
           +S+G+++ E+
Sbjct: 234 WSFGIVMWEV 243

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 59/116 (50%), Gaps = 7/116 (6%)
Query: 26  TVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTI 85
           TV      +   L+YL    N RI+H D+KP NILLDE     I+DF +A     +    
Sbjct: 116 TVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT 172
Query: 86  SMLHARGTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSS 140
           +M    GT  Y+APE+F  R   G S   D +S G+   E+  GR+   +++S SS
Sbjct: 173 TMA---GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS 225

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/127 (32%), Positives = 66/127 (51%), Gaps = 10/127 (7%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSL  F  D E     R L+   +  +A  +A G+ Y+ R   +  +H D++  NIL
Sbjct: 85  MNKGSLLDFLKDGEG----RALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANIL 137
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           +      KI+DFGLA+  +D + T     A+  I + APE     +G  + KSDV+S+G+
Sbjct: 138 VGNGLICKIADFGLARLIEDNEXTARQ-GAKFPIKWTAPEAAL--YGRFTIKSDVWSFGI 194
Query: 121 MILEMAV 127
           ++ E+  
Sbjct: 195 LLTELVT 201

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 76/160 (47%), Gaps = 26/160 (16%)
Query: 3   NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD 62
           NG+L    +  E+ N  R   WR   QI       L Y+H      I+H D+KP NI +D
Sbjct: 99  NGTLYDLIH-SENLNQQRDEYWRLFRQIL----EALSYIHSQG---IIHRDLKPMNIFID 150
Query: 63  EDFCPKISDFGLAKQ-----------SQD-KKSTISMLHARGTIGYIAPEVFCRSFGGAS 110
           E    KI DFGLAK            SQ+   S+ ++  A GT  Y+A EV   + G  +
Sbjct: 151 ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYN 209
Query: 111 HKSDVYSYGMMILEM----AVGRKNADV-KASRSSDIYFP 145
            K D+YS G++  EM    + G +  ++ K  RS  I FP
Sbjct: 210 EKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSIEFP 249

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 67/119 (56%), Gaps = 8/119 (6%)
Query: 8   QFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP 67
           +++Y+  S N    L  + +   A  +ARG+EYL    + + +H D+   N+L+ ED   
Sbjct: 123 EYSYNP-SHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVM 178
Query: 68  KISDFGLAKQSQDKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEM 125
           KI+DFGLA+            + R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 179 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 234

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 67/119 (56%), Gaps = 8/119 (6%)
Query: 8   QFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP 67
           +++Y+  S N    L  + +   A  +ARG+EYL    + + +H D+   N+L+ ED   
Sbjct: 126 EYSYNP-SHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVM 181
Query: 68  KISDFGLAKQSQDKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEM 125
           KI+DFGLA+            + R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 182 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 237

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 67/119 (56%), Gaps = 8/119 (6%)
Query: 8   QFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP 67
           +++Y+  S N    L  + +   A  +ARG+EYL    + + +H D+   N+L+ ED   
Sbjct: 134 EYSYNP-SHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVM 189
Query: 68  KISDFGLAKQSQDKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEM 125
           KI+DFGLA+            + R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 190 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 245

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 67/119 (56%), Gaps = 8/119 (6%)
Query: 8   QFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP 67
           +++Y+  S N    L  + +   A  +ARG+EYL    + + +H D+   N+L+ ED   
Sbjct: 134 EYSYNP-SHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVM 189
Query: 68  KISDFGLAKQSQDKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEM 125
           KI+DFGLA+            + R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 190 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 245

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 67/119 (56%), Gaps = 8/119 (6%)
Query: 8   QFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP 67
           +++Y+  S N    L  + +   A  +ARG+EYL    + + +H D+   N+L+ ED   
Sbjct: 127 EYSYNP-SHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVM 182
Query: 68  KISDFGLAKQSQDKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEM 125
           KI+DFGLA+            + R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 183 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 238

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 67/119 (56%), Gaps = 8/119 (6%)
Query: 8   QFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP 67
           +++Y+  S N    L  + +   A  +ARG+EYL    + + +H D+   N+L+ ED   
Sbjct: 175 EYSYNP-SHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVM 230
Query: 68  KISDFGLAKQSQDKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEM 125
           KI+DFGLA+            + R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 231 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 286

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/130 (33%), Positives = 69/130 (53%), Gaps = 19/130 (14%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAG---GIARGLEYLHRGCNVRIVHFDIKPH 57
           M NGSLD F    ++          TV Q+ G   GIA G++YL    ++  VH D+   
Sbjct: 128 MENGSLDSFLRKHDAQF--------TVIQLVGMLRGIASGMKYL---SDMGYVHRDLAAR 176
Query: 58  NILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARGTIGYIAPEVFC-RSFGGASHKSDV 115
           NIL++ +   K+SDFGLA+  + D ++  +    +  I + +PE    R F  A   SDV
Sbjct: 177 NILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA---SDV 233
Query: 116 YSYGMMILEM 125
           +SYG+++ E+
Sbjct: 234 WSYGIVLWEV 243

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/112 (32%), Positives = 62/112 (55%), Gaps = 7/112 (6%)
Query: 15  SSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGL 74
           S N    L  + +   A  +ARG+EYL    + + +H D+   N+L+ ED   KI+DFGL
Sbjct: 140 SHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGL 196
Query: 75  AKQSQDKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEM 125
           A+            + R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 197 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 245

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/112 (32%), Positives = 62/112 (55%), Gaps = 7/112 (6%)
Query: 15  SSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGL 74
           S N    L  + +   A  +ARG+EYL    + + +H D+   N+L+ ED   KI+DFGL
Sbjct: 125 SHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGL 181
Query: 75  AKQSQDKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEM 125
           A+            + R  + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 182 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 230

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 69/130 (53%), Gaps = 19/130 (14%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAG---GIARGLEYLHRGCNVRIVHFDIKPH 57
           M NGSLD F    ++          TV Q+ G   GIA G++YL    ++  VH D+   
Sbjct: 128 MENGSLDSFLRKHDAQF--------TVIQLVGMLRGIASGMKYL---SDMGFVHRDLAAR 176
Query: 58  NILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARGTIGYIAPEVFC-RSFGGASHKSDV 115
           NIL++ +   K+SDFGL++  + D ++  +    +  I + +PE    R F  A   SDV
Sbjct: 177 NILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA---SDV 233
Query: 116 YSYGMMILEM 125
           +SYG+++ E+
Sbjct: 234 WSYGIVLWEV 243

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/149 (34%), Positives = 71/149 (47%), Gaps = 25/149 (16%)
Query: 14  ESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFG 73
           E+ N  R   WR   QI       L Y+H      I+H D+KP NI +DE    KI DFG
Sbjct: 109 ENLNQQRDEYWRLFRQIL----EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFG 161
Query: 74  LAKQ-----------SQD-KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMM 121
           LAK            SQ+   S+ ++  A GT  Y+A EV   + G  + K D+YS G++
Sbjct: 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGII 220
Query: 122 ILEM----AVGRKNADV-KASRSSDIYFP 145
             EM    + G +  ++ K  RS  I FP
Sbjct: 221 FFEMIYPFSTGMERVNILKKLRSVSIEFP 249

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 59/109 (54%), Gaps = 6/109 (5%)
Query: 16  SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLA 75
           + G R L  +T+ Q+ G  A G+EYL   C    +H D+   N L+ E    KISDFG++
Sbjct: 205 TEGAR-LRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMS 260
Query: 76  KQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILE 124
           ++  D     S    +  + + APE    ++G  S +SDV+S+G+++ E
Sbjct: 261 REEADGVXAASGGLRQVPVKWTAPEAL--NYGRYSSESDVWSFGILLWE 307

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/127 (31%), Positives = 65/127 (51%), Gaps = 10/127 (7%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSL  F          + L    +  +A  IA G+ Y+ R   +  VH D++  NIL
Sbjct: 84  MSKGSLLDFL----KGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANIL 136
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + E+   K++DFGLA+  +D + T     A+  I + APE     +G  + KSDV+S+G+
Sbjct: 137 VGENLVCKVADFGLARLIEDNEXTARQ-GAKFPIKWTAPEAAL--YGRFTIKSDVWSFGI 193
Query: 121 MILEMAV 127
           ++ E+  
Sbjct: 194 LLTELTT 200

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/159 (33%), Positives = 76/159 (47%), Gaps = 28/159 (17%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAG---GIARGLEYLHRGCNVRIVHFDIKPH 57
           M NGSLD F    +           TV Q+ G   GIA G++YL    ++  VH  +   
Sbjct: 90  MENGSLDSFLRQNDGQ--------FTVIQLVGMLRGIAAGMKYL---ADMNYVHRALAAR 138
Query: 58  NILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG---TIGYIAPEVF-CRSFGGASHKS 113
           NIL++ +   K+SDFGL++  +D  S  +   A G    I + APE    R F  A   S
Sbjct: 139 NILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSA---S 195
Query: 114 DVYSYGMMILE-MAVGRK------NADVKASRSSDIYFP 145
           DV+SYG+++ E M+ G +      N DV  +   D   P
Sbjct: 196 DVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP 234

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 69/130 (53%), Gaps = 19/130 (14%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAG---GIARGLEYLHRGCNVRIVHFDIKPH 57
           M NGSLD F    ++          TV Q+ G   GIA G++YL    ++  VH D+   
Sbjct: 99  MENGSLDSFLRKHDAQF--------TVIQLVGMLRGIASGMKYLS---DMGYVHRDLAAR 147
Query: 58  NILLDEDFCPKISDFGLAKQSQDK-KSTISMLHARGTIGYIAPEVFC-RSFGGASHKSDV 115
           NIL++ +   K+SDFGL++  +D  ++  +    +  I + +PE    R F  A   SDV
Sbjct: 148 NILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA---SDV 204
Query: 116 YSYGMMILEM 125
           +SYG+++ E+
Sbjct: 205 WSYGIVLWEV 214

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 69/130 (53%), Gaps = 19/130 (14%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAG---GIARGLEYLHRGCNVRIVHFDIKPH 57
           M NGSLD F    ++          TV Q+ G   GIA G++YL    ++  VH D+   
Sbjct: 99  MENGSLDSFLRKHDAQF--------TVIQLVGMLRGIASGMKYLS---DMGYVHRDLAAR 147
Query: 58  NILLDEDFCPKISDFGLAKQSQDK-KSTISMLHARGTIGYIAPEVFC-RSFGGASHKSDV 115
           NIL++ +   K+SDFGL++  +D  ++  +    +  I + +PE    R F  A   SDV
Sbjct: 148 NILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA---SDV 204
Query: 116 YSYGMMILEM 125
           +SYG+++ E+
Sbjct: 205 WSYGIVLWEV 214

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 55/103 (53%), Gaps = 14/103 (13%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDF--------CPKISDFGLAKQSQDKKSTI 85
           IARG+ YLH    V I+H D+K  NIL+ +            KI+DFGLA++        
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH----RT 169
Query: 86  SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           + + A G   ++APEV   S    S  SDV+SYG+++ E+  G
Sbjct: 170 TKMSAAGAYAWMAPEVIRASM--FSKGSDVWSYGVLLWELLTG 210

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 69/130 (53%), Gaps = 19/130 (14%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAG---GIARGLEYLHRGCNVRIVHFDIKPH 57
           M NGSLD F    ++          TV Q+ G   GIA G++YL    ++  VH D+   
Sbjct: 116 MENGSLDSFLRKHDAQF--------TVIQLVGMLRGIASGMKYLS---DMGYVHRDLAAR 164
Query: 58  NILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARGTIGYIAPEVFC-RSFGGASHKSDV 115
           NIL++ +   K+SDFGL++  + D ++  +    +  I + +PE    R F  A   SDV
Sbjct: 165 NILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA---SDV 221
Query: 116 YSYGMMILEM 125
           +SYG+++ E+
Sbjct: 222 WSYGIVLWEV 231

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 69/130 (53%), Gaps = 19/130 (14%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAG---GIARGLEYLHRGCNVRIVHFDIKPH 57
           M NGSLD F    ++          TV Q+ G   GIA G++YL    ++  VH D+   
Sbjct: 128 MENGSLDSFLRKHDAQF--------TVIQLVGMLRGIASGMKYL---SDMGAVHRDLAAR 176
Query: 58  NILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARGTIGYIAPEVFC-RSFGGASHKSDV 115
           NIL++ +   K+SDFGL++  + D ++  +    +  I + +PE    R F  A   SDV
Sbjct: 177 NILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA---SDV 233
Query: 116 YSYGMMILEM 125
           +SYG+++ E+
Sbjct: 234 WSYGIVLWEV 243

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 52/96 (54%), Gaps = 7/96 (7%)
Query: 34  IARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           I   LEYLH +G    I+H D+KP NILL+ED   +I+DFG AK    +          G
Sbjct: 141 IVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 196
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T  Y++PE+       AS  SD+++ G +I ++  G
Sbjct: 197 TAQYVSPELLTEK--SASKSSDLWALGCIIYQLVAG 230

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 59/123 (47%), Gaps = 10/123 (8%)
Query: 21  TLEWRTVYQIAGGIARGLEYLHR-------GCNVRIVHFDIKPHNILLDEDFCPKISDFG 73
            + W  +  IA  +ARGL YLH        G    I H DIK  N+LL  +    I+DFG
Sbjct: 117 VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176
Query: 74  LAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFG---GASHKSDVYSYGMMILEMAVGRK 130
           LA + +  KS        GT  Y+APEV   +      A  + D+Y+ G+++ E+A    
Sbjct: 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCT 236
Query: 131 NAD 133
            AD
Sbjct: 237 AAD 239

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 57/98 (58%), Gaps = 6/98 (6%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  IA G+ Y+ R   +  VH D++  NIL+ E+   K++DFGLA+  +D + T     
Sbjct: 119 MAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQ-G 174
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV 127
           A+  I + APE     +G  + KSDV+S+G+++ E+  
Sbjct: 175 AKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTT 210

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 57/98 (58%), Gaps = 6/98 (6%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  IA G+ Y+ R   +  VH D++  NIL+ E+   K++DFGLA+  +D + T     
Sbjct: 285 MAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-G 340
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV 127
           A+  I + APE     +G  + KSDV+S+G+++ E+  
Sbjct: 341 AKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTT 376

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/122 (35%), Positives = 67/122 (54%), Gaps = 8/122 (6%)
Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS 78
           N+TL    +  I     +GLEYLH    +R +H DIK  NILL+ +   K++DFG+A Q 
Sbjct: 119 NKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175
Query: 79  QDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKN-ADVKAS 137
            D  +  + +   GT  ++APEV      G +  +D++S G+  +EMA G+   AD+   
Sbjct: 176 TDXMAKRNXVI--GTPFWMAPEVIQEI--GYNCVADIWSLGITAIEMAEGKPPYADIHPM 231
Query: 138 RS 139
           R+
Sbjct: 232 RA 233

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 30/211 (14%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M +G L QF     S   N T+  + +      +ARG+EYL      + VH D+   N +
Sbjct: 105 MCHGDLLQFI---RSPQRNPTV--KDLISFGLQVARGMEYL---AEQKFVHRDLAARNCM 156
Query: 61  LDEDFCPKISDFGLAKQSQDKK--STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSY 118
           LDE F  K++DFGLA+   D++  S     HAR  + + A E   +++   + KSDV+S+
Sbjct: 157 LDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL-QTYRFTT-KSDVWSF 214
Query: 119 GMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN--DFQLDGXXXXXXXXXXXXMI 176
           G+++ E+           +R +        Y+HI+P +   F   G            + 
Sbjct: 215 GVLLWEL----------LTRGA------PPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLY 258
Query: 177 LVSLWCIQTNPSDRPSMHEVLEMLESSTEIL 207
            V   C + +P+ RP+   ++  +E     L
Sbjct: 259 QVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 57/98 (58%), Gaps = 6/98 (6%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  IA G+ Y+ R   +  VH D++  NIL+ E+   K++DFGLA+  +D + T     
Sbjct: 285 MAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-G 340
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV 127
           A+  I + APE     +G  + KSDV+S+G+++ E+  
Sbjct: 341 AKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTT 376

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 57/98 (58%), Gaps = 6/98 (6%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  IA G+ Y+ R   +  VH D++  NIL+ E+   K++DFGLA+  +D + T     
Sbjct: 285 MAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-G 340
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV 127
           A+  I + APE     +G  + KSDV+S+G+++ E+  
Sbjct: 341 AKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTT 376

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 69/130 (53%), Gaps = 19/130 (14%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAG---GIARGLEYLHRGCNVRIVHFDIKPH 57
           M NGSLD F    ++          TV Q+ G   GIA G++YL    ++  VH D+   
Sbjct: 126 MENGSLDSFLRKHDAQF--------TVIQLVGMLRGIASGMKYL---SDMGYVHRDLAAR 174
Query: 58  NILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARGTIGYIAPEVFC-RSFGGASHKSDV 115
           NIL++ +   K+SDFGL++  + D ++  +    +  I + +PE    R F  A   SDV
Sbjct: 175 NILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA---SDV 231
Query: 116 YSYGMMILEM 125
           +SYG+++ E+
Sbjct: 232 WSYGIVLWEV 241

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 69/130 (53%), Gaps = 19/130 (14%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAG---GIARGLEYLHRGCNVRIVHFDIKPH 57
           M NGSLD F    ++          TV Q+ G   GIA G++YL    ++  VH D+   
Sbjct: 128 MENGSLDSFLRKHDAQF--------TVIQLVGMLRGIASGMKYL---SDMGYVHRDLAAR 176
Query: 58  NILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARGTIGYIAPEVFC-RSFGGASHKSDV 115
           NIL++ +   K+SDFGL++  + D ++  +    +  I + +PE    R F  A   SDV
Sbjct: 177 NILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA---SDV 233
Query: 116 YSYGMMILEM 125
           +SYG+++ E+
Sbjct: 234 WSYGIVLWEV 243

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 69/130 (53%), Gaps = 19/130 (14%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAG---GIARGLEYLHRGCNVRIVHFDIKPH 57
           M NGSLD F    ++          TV Q+ G   GIA G++YL    ++  VH D+   
Sbjct: 128 MENGSLDSFLRKHDAQF--------TVIQLVGMLRGIASGMKYL---SDMGYVHRDLAAR 176
Query: 58  NILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARGTIGYIAPEVFC-RSFGGASHKSDV 115
           NIL++ +   K+SDFGL++  + D ++  +    +  I + +PE    R F  A   SDV
Sbjct: 177 NILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA---SDV 233
Query: 116 YSYGMMILEM 125
           +SYG+++ E+
Sbjct: 234 WSYGIVLWEV 243

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 69/130 (53%), Gaps = 19/130 (14%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAG---GIARGLEYLHRGCNVRIVHFDIKPH 57
           M NGSLD F    ++          TV Q+ G   GIA G++YL    ++  VH D+   
Sbjct: 128 MENGSLDSFLRKHDAQF--------TVIQLVGMLRGIASGMKYL---SDMGYVHRDLAAR 176
Query: 58  NILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARGTIGYIAPEVFC-RSFGGASHKSDV 115
           NIL++ +   K+SDFGL++  + D ++  +    +  I + +PE    R F  A   SDV
Sbjct: 177 NILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA---SDV 233
Query: 116 YSYGMMILEM 125
           +SYG+++ E+
Sbjct: 234 WSYGIVLWEV 243

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 69/130 (53%), Gaps = 19/130 (14%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAG---GIARGLEYLHRGCNVRIVHFDIKPH 57
           M NGSLD F    ++          TV Q+ G   GIA G++YL    ++  VH D+   
Sbjct: 128 MENGSLDSFLRKHDAQF--------TVIQLVGMLRGIASGMKYL---SDMGYVHRDLAAR 176
Query: 58  NILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARGTIGYIAPEVFC-RSFGGASHKSDV 115
           NIL++ +   K+SDFGL++  + D ++  +    +  I + +PE    R F  A   SDV
Sbjct: 177 NILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA---SDV 233
Query: 116 YSYGMMILEM 125
           +SYG+++ E+
Sbjct: 234 WSYGIVLWEV 243

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 69/130 (53%), Gaps = 19/130 (14%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAG---GIARGLEYLHRGCNVRIVHFDIKPH 57
           M NGSLD F    ++          TV Q+ G   GIA G++YL    ++  VH D+   
Sbjct: 128 MENGSLDSFLRKHDAQF--------TVIQLVGMLRGIASGMKYL---SDMGYVHRDLAAR 176
Query: 58  NILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARGTIGYIAPEVFC-RSFGGASHKSDV 115
           NIL++ +   K+SDFGL++  + D ++  +    +  I + +PE    R F  A   SDV
Sbjct: 177 NILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA---SDV 233
Query: 116 YSYGMMILEM 125
           +SYG+++ E+
Sbjct: 234 WSYGIVLWEV 243

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/127 (31%), Positives = 65/127 (51%), Gaps = 10/127 (7%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSL  F          + L    +  +A  IA G+ Y+ R   +  VH D++  NIL
Sbjct: 87  MSKGSLLDFL----KGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANIL 139
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + E+   K++DFGLA+  +D + T     A+  I + APE     +G  + KSDV+S+G+
Sbjct: 140 VGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAAL--YGRFTIKSDVWSFGI 196
Query: 121 MILEMAV 127
           ++ E+  
Sbjct: 197 LLTELTT 203

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 59/109 (54%), Gaps = 6/109 (5%)
Query: 16  SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLA 75
           + G R L  +T+ Q+ G  A G+EYL   C    +H D+   N L+ E    KISDFG++
Sbjct: 205 TEGAR-LRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMS 260
Query: 76  KQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILE 124
           ++  D     S    +  + + APE    ++G  S +SDV+S+G+++ E
Sbjct: 261 REEADGVYAASGGLRQVPVKWTAPEAL--NYGRYSSESDVWSFGILLWE 307

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 84/182 (46%), Gaps = 32/182 (17%)
Query: 22  LEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDK 81
           LE   +  I   I +GL+YLH   + R +H DIK  N+LL E    K++DFG+A Q  D 
Sbjct: 113 LEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD- 168
Query: 82  KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR-KNADVKASRSS 140
            + I      GT  ++APEV  +S      K+D++S G+  +E+A G   N+D+   R  
Sbjct: 169 -TQIKRNXFVGTPFWMAPEVIKQS--AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL 225
Query: 141 DIYFPNSIY----KHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEV 196
            +   NS      +H +P  +F                       C+  +P  RP+  E+
Sbjct: 226 FLIPKNSPPTLEGQHSKPFKEFVEA--------------------CLNKDPRFRPTAKEL 265
Query: 197 LE 198
           L+
Sbjct: 266 LK 267

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 57/98 (58%), Gaps = 6/98 (6%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  IA G+ Y+ R   +  VH D++  NIL+ E+   K++DFGLA+  +D + T     
Sbjct: 108 MAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-G 163
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV 127
           A+  I + APE     +G  + KSDV+S+G+++ E+  
Sbjct: 164 AKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTT 199

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 57/98 (58%), Gaps = 6/98 (6%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  IA G+ Y+ R   +  VH D++  NIL+ E+   K++DFGLA+  +D + T     
Sbjct: 110 MAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-G 165
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV 127
           A+  I + APE     +G  + KSDV+S+G+++ E+  
Sbjct: 166 AKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTT 201

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 57/98 (58%), Gaps = 6/98 (6%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  IA G+ Y+ R   +  VH D++  NIL+ E+   K++DFGLA+  +D + T     
Sbjct: 119 MAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-G 174
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV 127
           A+  I + APE     +G  + KSDV+S+G+++ E+  
Sbjct: 175 AKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTT 210

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 57/98 (58%), Gaps = 6/98 (6%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  IA G+ Y+ R   +  VH D++  NIL+ E+   K++DFGLA+  +D + T     
Sbjct: 368 MAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-G 423
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV 127
           A+  I + APE     +G  + KSDV+S+G+++ E+  
Sbjct: 424 AKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTT 459

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 55/103 (53%), Gaps = 7/103 (6%)
Query: 29  QIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISML 88
           +I     + L +L    N++I+H DIKP NILLD     K+ DFG++ Q  D   +I+  
Sbjct: 129 KITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD---SIAKT 183
Query: 89  HARGTIGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
              G   Y+APE      S  G   +SDV+S G+ + E+A GR
Sbjct: 184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 57/98 (58%), Gaps = 6/98 (6%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  IA G+ Y+ R   +  VH D++  NIL+ E+   K++DFGLA+  +D + T     
Sbjct: 119 MAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-G 174
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV 127
           A+  I + APE     +G  + KSDV+S+G+++ E+  
Sbjct: 175 AKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTT 210

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 57/98 (58%), Gaps = 6/98 (6%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  IA G+ Y+ R   +  VH D++  NIL+ E+   K++DFGLA+  +D + T     
Sbjct: 119 MAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-G 174
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV 127
           A+  I + APE     +G  + KSDV+S+G+++ E+  
Sbjct: 175 AKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTT 210

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 57/98 (58%), Gaps = 6/98 (6%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  IA G+ Y+ R   +  VH D++  NIL+ E+   K++DFGLA+  +D + T     
Sbjct: 119 MAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-G 174
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV 127
           A+  I + APE     +G  + KSDV+S+G+++ E+  
Sbjct: 175 AKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTT 210

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 57/98 (58%), Gaps = 6/98 (6%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  IA G+ Y+ R   +  VH D++  NIL+ E+   K++DFGLA+  +D + T     
Sbjct: 119 MAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-G 174
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV 127
           A+  I + APE     +G  + KSDV+S+G+++ E+  
Sbjct: 175 AKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTT 210

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 68/130 (52%), Gaps = 19/130 (14%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAG---GIARGLEYLHRGCNVRIVHFDIKPH 57
           M NGSLD F    ++          TV Q+ G   GIA G++YL    ++  VH D+   
Sbjct: 128 MENGSLDSFLRKHDAQF--------TVIQLVGMLRGIASGMKYL---SDMGYVHRDLAAR 176
Query: 58  NILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARGTIGYIAPEVFC-RSFGGASHKSDV 115
           NIL++ +   K+SDFGL +  + D ++  +    +  I + +PE    R F  A   SDV
Sbjct: 177 NILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA---SDV 233
Query: 116 YSYGMMILEM 125
           +SYG+++ E+
Sbjct: 234 WSYGIVLWEV 243

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 57/98 (58%), Gaps = 6/98 (6%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  IA G+ Y+ R   +  VH D++  NIL+ E+   K++DFGLA+  +D + T     
Sbjct: 119 MAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-G 174
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV 127
           A+  I + APE     +G  + KSDV+S+G+++ E+  
Sbjct: 175 AKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTT 210

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/98 (39%), Positives = 53/98 (54%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  +   LEYLH   +  I++ D+KP NILLD++   KI+DFG AK   D    +     
Sbjct: 112 AAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLC---- 164
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  YIAPEV   S    +   D +S+G++I EM  G
Sbjct: 165 -GTPDYIAPEVV--STKPYNKSIDWWSFGILIYEMLAG 199

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/96 (39%), Positives = 53/96 (55%), Gaps = 13/96 (13%)
Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ---SQDKKSTISMLHARG 92
           + LE+LH     +++H DIK  NILL  D   K++DFG   Q    Q K+ST+      G
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----G 178
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T  ++APEV  R   G   K D++S G+M +EM  G
Sbjct: 179 TPYWMAPEVVTRKAYGP--KVDIWSLGIMAIEMIEG 212

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 76/172 (44%), Gaps = 28/172 (16%)
Query: 34  IARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           +ARG+E+L  R C    +H D+   NILL E+   KI DFGLA+        +     R 
Sbjct: 208 VARGMEFLSSRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRL 263
Query: 93  TIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKH 151
            + ++APE +F + +   S KSDV+SYG+++ E+                     S Y  
Sbjct: 264 PLKWMAPESIFDKIY---STKSDVWSYGVLLWEI----------------FSLGGSPYPG 304
Query: 152 IEPGNDF---QLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEML 200
           ++   DF     +G            +  + L C   +P +RP   E++E L
Sbjct: 305 VQMDEDFCSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 57/93 (61%), Gaps = 7/93 (7%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +ARG+EYL    + + +H D+   N+L+ E+   KI+DFGLA+   +        + R  
Sbjct: 166 LARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLP 222
Query: 94  IGYIAPE-VFCRSFGGASHKSDVYSYGMMILEM 125
           + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 223 VKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/98 (40%), Positives = 54/98 (55%), Gaps = 8/98 (8%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I  GLE++H   N  +V+ D+KP NILLDE    +ISD GLA     KK   S+   
Sbjct: 298 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 351
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT GY+APEV  +     S  +D +S G M+ ++  G
Sbjct: 352 -GTHGYMAPEVLQKGVAYDS-SADWFSLGCMLFKLLRG 387

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/98 (40%), Positives = 54/98 (55%), Gaps = 8/98 (8%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I  GLE++H   N  +V+ D+KP NILLDE    +ISD GLA     KK   S+   
Sbjct: 297 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 350
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT GY+APEV  +     S  +D +S G M+ ++  G
Sbjct: 351 -GTHGYMAPEVLQKGVAYDS-SADWFSLGCMLFKLLRG 386

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 57/93 (61%), Gaps = 7/93 (7%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +ARG+EYL    + + +H D+   N+L+ E+   KI+DFGLA+   +        + R  
Sbjct: 166 LARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLP 222
Query: 94  IGYIAPE-VFCRSFGGASHKSDVYSYGMMILEM 125
           + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 223 VKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 47/213 (22%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAG---GIARGLEYLHRGCNVRIVHFDIKPH 57
           M NGSLD F       N  R     TV Q+ G   GI  G++YL    ++  VH D+   
Sbjct: 97  MENGSLDAFL----RKNDGRF----TVIQLVGMLRGIGSGMKYLS---DMSYVHRDLAAR 145
Query: 58  NILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARGTIGYIAPEVFC-RSFGGASHKSDV 115
           NIL++ +   K+SDFG+++  + D ++  +    +  I + APE    R F  A   SDV
Sbjct: 146 NILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSA---SDV 202
Query: 116 YSYGMMILE-MAVGRK------NADVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXX 168
           +SYG+++ E M+ G +      N DV  +       P        P  D  +        
Sbjct: 203 WSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLP--------PPMDCPI-------- 246
Query: 169 XXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLE 201
                 +  + L C Q   SDRP   +++ ML+
Sbjct: 247 -----ALHQLMLDCWQKERSDRPKFGQIVNMLD 274

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 84/185 (45%), Gaps = 23/185 (12%)
Query: 21  TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFG----LAK 76
            L+  T+  I   +  GLEYLH+   +   H D+K  NILL ED   +I+DFG    LA 
Sbjct: 117 VLDESTIATILREVLEGLEYLHKNGQI---HRDVKAGNILLGEDGSVQIADFGVSAFLAT 173
Query: 77  QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG----RKNA 132
                ++ +      GT  ++APEV      G   K+D++S+G+  +E+A G     K  
Sbjct: 174 GGDITRNKVRKTFV-GTPCWMAPEVM-EQVRGYDFKADIWSFGITAIELATGAAPYHKYP 231
Query: 133 DVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPS 192
            +K    +    P S+   ++     +  G              ++SL C+Q +P  RP+
Sbjct: 232 PMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRK---------MISL-CLQKDPEKRPT 281
Query: 193 MHEVL 197
             E+L
Sbjct: 282 AAELL 286

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 85/177 (48%), Gaps = 31/177 (17%)
Query: 28  YQIA---GGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ---SQDK 81
           +QIA     I +GL+YLH   + + +H DIK  N+LL E    K++DFG+A Q   +Q K
Sbjct: 120 FQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 176
Query: 82  KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSD 141
           ++T       GT  ++APEV  +S      K+D++S G+  +E+A G          +SD
Sbjct: 177 RNTFV-----GTPFWMAPEVIQQS--AYDSKADIWSLGITAIELAKGE-------PPNSD 222
Query: 142 IYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
           ++ P  +   I   N   L G                   C+  +PS RP+  E+L+
Sbjct: 223 MH-PMRVLFLIPKNNPPTLVGDFTKSFKEFIDA-------CLNKDPSFRPTAKELLK 271

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 84/185 (45%), Gaps = 23/185 (12%)
Query: 21  TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFG----LAK 76
            L+  T+  I   +  GLEYLH+   +   H D+K  NILL ED   +I+DFG    LA 
Sbjct: 112 VLDESTIATILREVLEGLEYLHKNGQI---HRDVKAGNILLGEDGSVQIADFGVSAFLAT 168
Query: 77  QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG----RKNA 132
                ++ +      GT  ++APEV      G   K+D++S+G+  +E+A G     K  
Sbjct: 169 GGDITRNKVRKTFV-GTPCWMAPEVM-EQVRGYDFKADIWSFGITAIELATGAAPYHKYP 226
Query: 133 DVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPS 192
            +K    +    P S+   ++     +  G              ++SL C+Q +P  RP+
Sbjct: 227 PMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRK---------MISL-CLQKDPEKRPT 276
Query: 193 MHEVL 197
             E+L
Sbjct: 277 AAELL 281

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/98 (40%), Positives = 54/98 (55%), Gaps = 8/98 (8%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I  GLE++H   N  +V+ D+KP NILLDE    +ISD GLA     KK   S+   
Sbjct: 298 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 351
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT GY+APEV  +     S  +D +S G M+ ++  G
Sbjct: 352 -GTHGYMAPEVLQKGVAYDS-SADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/98 (40%), Positives = 54/98 (55%), Gaps = 8/98 (8%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I  GLE++H   N  +V+ D+KP NILLDE    +ISD GLA     KK   S+   
Sbjct: 298 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 351
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT GY+APEV  +     S  +D +S G M+ ++  G
Sbjct: 352 -GTHGYMAPEVLQKGVAYDS-SADWFSLGCMLFKLLRG 387

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 57/98 (58%), Gaps = 6/98 (6%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           ++  IA G+ Y+ R   +  VH D++  NIL+ E+   K++DFGLA+  +D + T     
Sbjct: 116 MSAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQ-G 171
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV 127
           A+  I + APE     +G  + KSDV+S+G+++ E+  
Sbjct: 172 AKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTT 207

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 47/213 (22%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAG---GIARGLEYLHRGCNVRIVHFDIKPH 57
           M NGSLD F       N  R     TV Q+ G   GI  G++YL    ++  VH D+   
Sbjct: 91  MENGSLDAFL----RKNDGRF----TVIQLVGMLRGIGSGMKYLS---DMSYVHRDLAAR 139
Query: 58  NILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARGTIGYIAPEVFC-RSFGGASHKSDV 115
           NIL++ +   K+SDFG+++  + D ++  +    +  I + APE    R F  A   SDV
Sbjct: 140 NILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSA---SDV 196
Query: 116 YSYGMMILE-MAVGRK------NADVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXX 168
           +SYG+++ E M+ G +      N DV  +       P        P  D  +        
Sbjct: 197 WSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLP--------PPMDCPI-------- 240
Query: 169 XXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLE 201
                 +  + L C Q   SDRP   +++ ML+
Sbjct: 241 -----ALHQLMLDCWQKERSDRPKFGQIVNMLD 268

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 47/213 (22%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAG---GIARGLEYLHRGCNVRIVHFDIKPH 57
           M NGSLD F       N  R     TV Q+ G   GI  G++YL    ++  VH D+   
Sbjct: 112 MENGSLDAFL----RKNDGRF----TVIQLVGMLRGIGSGMKYLS---DMSAVHRDLAAR 160
Query: 58  NILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARGTIGYIAPEVFC-RSFGGASHKSDV 115
           NIL++ +   K+SDFG+++  + D ++  +    +  I + APE    R F  A   SDV
Sbjct: 161 NILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSA---SDV 217
Query: 116 YSYGMMILE-MAVGRK------NADVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXX 168
           +SYG+++ E M+ G +      N DV  +       P        P  D  +        
Sbjct: 218 WSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLP--------PPMDCPI-------- 261
Query: 169 XXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLE 201
                 +  + L C Q   SDRP   +++ ML+
Sbjct: 262 -----ALHQLMLDCWQKERSDRPKFGQIVNMLD 289

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/130 (31%), Positives = 68/130 (52%), Gaps = 17/130 (13%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAG---GIARGLEYLHRGCNVRIVHFDIKPH 57
           M NGSLD F    +           TV Q+ G   GI+ G++YL    ++  VH D+   
Sbjct: 105 MENGSLDTFLKKNDGQF--------TVIQLVGMLRGISAGMKYLS---DMGYVHRDLAAR 153
Query: 58  NILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVY 116
           NIL++ +   K+SDFGL++  + D ++  +    +  I + APE    +F   +  SDV+
Sbjct: 154 NILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI--AFRKFTSASDVW 211
Query: 117 SYGMMILEMA 126
           SYG+++ E+ 
Sbjct: 212 SYGIVMWEVV 221

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 57/98 (58%), Gaps = 6/98 (6%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           ++  IA G+ Y+ R   +  VH D++  NIL+ E+   K++DFGLA+  +D + T     
Sbjct: 116 MSAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-G 171
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV 127
           A+  I + APE     +G  + KSDV+S+G+++ E+  
Sbjct: 172 AKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTT 207

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 74/158 (46%), Gaps = 26/158 (16%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAG---GIARGLEYLHRGCNVRIVHFDIKPH 57
           M NG+LD F    +           TV Q+ G   GIA G+ YL     +  VH D+   
Sbjct: 99  MENGALDSFLRLNDGQF--------TVIQLVGMLRGIASGMRYL---AEMSYVHRDLAAR 147
Query: 58  NILLDEDFCPKISDFGLAK---QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSD 114
           NIL++ +   K+SDFGL++   ++    +  S L  +  I + APE    +F   +  SD
Sbjct: 148 NILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAI--AFRKFTSASD 205
Query: 115 VYSYGMMILE-MAVGRK------NADVKASRSSDIYFP 145
            +SYG+++ E M+ G +      N DV  +   D   P
Sbjct: 206 AWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLP 243

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 7/96 (7%)
Query: 34  IARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           I   LEYLH +G    I+H D+KP NILL+ED   +I+DFG AK    +          G
Sbjct: 119 IVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 174
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T  Y++PE+       A   SD+++ G +I ++  G
Sbjct: 175 TAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAG 208

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 7/96 (7%)
Query: 34  IARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           I   LEYLH +G    I+H D+KP NILL+ED   +I+DFG AK    +          G
Sbjct: 141 IVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T  Y++PE+       A   SD+++ G +I ++  G
Sbjct: 197 TAQYVSPELLTEK--SAXKSSDLWALGCIIYQLVAG 230

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 7/96 (7%)
Query: 34  IARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           I   LEYLH +G    I+H D+KP NILL+ED   +I+DFG AK    +          G
Sbjct: 141 IVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T  Y++PE+       A   SD+++ G +I ++  G
Sbjct: 197 TAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAG 230

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 56/98 (57%), Gaps = 6/98 (6%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  IA G+ Y+ R   +  VH D+   NIL+ E+   K++DFGLA+  +D + T     
Sbjct: 119 MAAQIASGMAYVER---MNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQ-G 174
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV 127
           A+  I + APE     +G  + KSDV+S+G+++ E+  
Sbjct: 175 AKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTT 210

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 7/96 (7%)
Query: 34  IARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           I   LEYLH +G    I+H D+KP NILL+ED   +I+DFG AK    +          G
Sbjct: 139 IVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T  Y++PE+       A   SD+++ G +I ++  G
Sbjct: 195 TAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAG 228

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 7/96 (7%)
Query: 34  IARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           I   LEYLH +G    I+H D+KP NILL+ED   +I+DFG AK    +          G
Sbjct: 117 IVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 172
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T  Y++PE+       A   SD+++ G +I ++  G
Sbjct: 173 TAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAG 206

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 7/96 (7%)
Query: 34  IARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           I   LEYLH +G    I+H D+KP NILL+ED   +I+DFG AK    +          G
Sbjct: 138 IVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 193
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T  Y++PE+       A   SD+++ G +I ++  G
Sbjct: 194 TAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAG 227

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 7/96 (7%)
Query: 34  IARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           I   LEYLH +G    I+H D+KP NILL+ED   +I+DFG AK    +          G
Sbjct: 138 IVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 193
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T  Y++PE+       A   SD+++ G +I ++  G
Sbjct: 194 TAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAG 227

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 7/96 (7%)
Query: 34  IARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           I   LEYLH +G    I+H D+KP NILL+ED   +I+DFG AK    +          G
Sbjct: 116 IVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 171
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T  Y++PE+       A   SD+++ G +I ++  G
Sbjct: 172 TAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAG 205

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 6/98 (6%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  IA G+ Y+ R   +  VH D++  NIL+ E+   K++DFGL +  +D + T     
Sbjct: 286 MAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQ-G 341
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV 127
           A+  I + APE     +G  + KSDV+S+G+++ E+  
Sbjct: 342 AKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTT 377

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 7/96 (7%)
Query: 34  IARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           I   LEYLH +G    I+H D+KP NILL+ED   +I+DFG AK    +          G
Sbjct: 141 IVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T  Y++PE+       A   SD+++ G +I ++  G
Sbjct: 197 TAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAG 230

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 7/96 (7%)
Query: 34  IARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           I   LEYLH +G    I+H D+KP NILL+ED   +I+DFG AK    +          G
Sbjct: 142 IVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 197
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T  Y++PE+       A   SD+++ G +I ++  G
Sbjct: 198 TAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAG 231

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 7/96 (7%)
Query: 34  IARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           I   LEYLH +G    I+H D+KP NILL+ED   +I+DFG AK    +          G
Sbjct: 118 IVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 173
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T  Y++PE+       A   SD+++ G +I ++  G
Sbjct: 174 TAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAG 207

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 7/96 (7%)
Query: 34  IARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           I   LEYLH +G    I+H D+KP NILL+ED   +I+DFG AK    +          G
Sbjct: 139 IVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T  Y++PE+       A   SD+++ G +I ++  G
Sbjct: 195 TAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAG 228

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 7/96 (7%)
Query: 34  IARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           I   LEYLH +G    I+H D+KP NILL+ED   +I+DFG AK    +          G
Sbjct: 142 IVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 197
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T  Y++PE+       A   SD+++ G +I ++  G
Sbjct: 198 TAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAG 231

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 7/96 (7%)
Query: 34  IARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           I   LEYLH +G    I+H D+KP NILL+ED   +I+DFG AK    +          G
Sbjct: 144 IVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 199
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T  Y++PE+       A   SD+++ G +I ++  G
Sbjct: 200 TAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAG 233

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 7/96 (7%)
Query: 34  IARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           I   LEYLH +G    I+H D+KP NILL+ED   +I+DFG AK    +          G
Sbjct: 139 IVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T  Y++PE+       A   SD+++ G +I ++  G
Sbjct: 195 TAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAG 228

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 74/158 (46%), Gaps = 26/158 (16%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAG---GIARGLEYLHRGCNVRIVHFDIKPH 57
           M NG+LD F    +           TV Q+ G   GIA G+ YL     +  VH D+   
Sbjct: 97  MENGALDSFLRLNDGQF--------TVIQLVGMLRGIASGMRYL---AEMSYVHRDLAAR 145
Query: 58  NILLDEDFCPKISDFGLAKQSQDKKST---ISMLHARGTIGYIAPEVFCRSFGGASHKSD 114
           NIL++ +   K+SDFGL++  ++  S     S L  +  I + APE    +F   +  SD
Sbjct: 146 NILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAI--AFRKFTSASD 203
Query: 115 VYSYGMMILE-MAVGRK------NADVKASRSSDIYFP 145
            +SYG+++ E M+ G +      N DV  +   D   P
Sbjct: 204 AWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLP 241

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 7/96 (7%)
Query: 34  IARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           I   LEYLH +G    I+H D+KP NILL+ED   +I+DFG AK    +          G
Sbjct: 141 IVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T  Y++PE+       A   SD+++ G +I ++  G
Sbjct: 197 TAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAG 230

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 7/96 (7%)
Query: 34  IARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           I   LEYLH +G    I+H D+KP NILL+ED   +I+DFG AK    +          G
Sbjct: 141 IVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T  Y++PE+       A   SD+++ G +I ++  G
Sbjct: 197 TAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAG 230

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 7/96 (7%)
Query: 34  IARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           I   LEYLH +G    I+H D+KP NILL+ED   +I+DFG AK    +          G
Sbjct: 123 IVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 178
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T  Y++PE+       A   SD+++ G +I ++  G
Sbjct: 179 TAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAG 212

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 53/104 (50%), Gaps = 8/104 (7%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST 84
           R  +Q+  G+     YLH    + I H DIKP N+LLDE    KISDFGLA   +     
Sbjct: 109 RFFHQLMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
             +    GT+ Y+APE+  R    A    DV+S G+++  M  G
Sbjct: 162 RLLNKMXGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 7/96 (7%)
Query: 34  IARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           I   LEYLH +G    I+H D+KP NILL+ED   +I+DFG AK    +          G
Sbjct: 139 IVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVG 194
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T  Y++PE+       A   SD+++ G +I ++  G
Sbjct: 195 TAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAG 228

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 53/104 (50%), Gaps = 8/104 (7%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST 84
           R  +Q+  G+     YLH    + I H DIKP N+LLDE    KISDFGLA   +     
Sbjct: 108 RFFHQLMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
             +    GT+ Y+APE+  R    A    DV+S G+++  M  G
Sbjct: 161 RLLNKMXGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 53/104 (50%), Gaps = 8/104 (7%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST 84
           R  +Q+  G+     YLH    + I H DIKP N+LLDE    KISDFGLA   +     
Sbjct: 108 RFFHQLMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
             +    GT+ Y+APE+  R    A    DV+S G+++  M  G
Sbjct: 161 RLLNKMXGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 7/96 (7%)
Query: 34  IARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           I   LEYLH +G    I+H D+KP NILL+ED   +I+DFG AK    +          G
Sbjct: 146 IVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 201
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T  Y++PE+       A   SD+++ G +I ++  G
Sbjct: 202 TAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAG 235

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 53/104 (50%), Gaps = 8/104 (7%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST 84
           R  +Q+  G+     YLH    + I H DIKP N+LLDE    KISDFGLA   +     
Sbjct: 108 RFFHQLMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
             +    GT+ Y+APE+  R    A    DV+S G+++  M  G
Sbjct: 161 RLLNKMXGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 53/104 (50%), Gaps = 8/104 (7%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST 84
           R  +Q+  G+     YLH    + I H DIKP N+LLDE    KISDFGLA   +     
Sbjct: 108 RFFHQLMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
             +    GT+ Y+APE+  R    A    DV+S G+++  M  G
Sbjct: 161 RLLNKMXGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 78/181 (43%), Gaps = 38/181 (20%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +  G+ YL   C   ++H D+   N L+ E+   K+SDFG+ +   D + T S    +  
Sbjct: 113 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFP 168
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-------GRKNADVKASRSS--DIYF 144
           + + +PEVF  SF   S KSDV+S+G+++ E+          R N++V    S+   +Y 
Sbjct: 169 VKWASPEVF--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 226
Query: 145 PNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLESST 204
           P     H+     +Q+                     C +  P DRP+   +L  L    
Sbjct: 227 PRLASTHV-----YQIMNH------------------CWRERPEDRPAFSRLLRQLAEIA 263
Query: 205 E 205
           E
Sbjct: 264 E 264

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 72/141 (51%), Gaps = 13/141 (9%)
Query: 1   MPNGSLDQFTYDQESSNGNRTL-EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP+G L ++ ++ + + G++ L  W         IA+G+ YL      R+VH D+   N+
Sbjct: 98  MPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEER---RLVHRDLAARNV 148
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L+      KI+DFGLA+  +  +   +    +  I ++A E  C  +   +H+SDV+SYG
Sbjct: 149 LVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE--CIHYRKFTHQSDVWSYG 206
Query: 120 MMILE-MAVGRKNADVKASRS 139
           + I E M  G K  D   +R 
Sbjct: 207 VTIWELMTFGGKPYDGIPTRE 227

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 58/93 (62%), Gaps = 7/93 (7%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +ARG+EYL    + + +H D+   N+L+ E+   KI+DFGLA+   +     +  + R  
Sbjct: 166 LARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLP 222
Query: 94  IGYIAPE-VFCRSFGGASHKSDVYSYGMMILEM 125
           + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 223 VKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 41/107 (38%), Positives = 58/107 (54%), Gaps = 9/107 (8%)
Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK 82
           E R V+  A  I  GLE LHR    RIV+ D+KP NILLD+    +ISD GLA    + +
Sbjct: 285 EARAVF-YAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340
Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           +    +   GT+GY+APEV        +   D ++ G ++ EM  G+
Sbjct: 341 TIKGRV---GTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 52/93 (55%), Gaps = 7/93 (7%)
Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIG 95
           + LE+LH     +++H DIK  NILL  D   K++DFG   Q   ++S  S +   GT  
Sbjct: 128 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXM--VGTPY 182
Query: 96  YIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           ++APEV  R   G   K D++S G+M +EM  G
Sbjct: 183 WMAPEVVTRKAYGP--KVDIWSLGIMAIEMIEG 213

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 52/93 (55%), Gaps = 7/93 (7%)
Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIG 95
           + LE+LH     +++H DIK  NILL  D   K++DFG   Q   ++S  S +   GT  
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXM--VGTPY 181
Query: 96  YIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           ++APEV  R   G   K D++S G+M +EM  G
Sbjct: 182 WMAPEVVTRKAYGP--KVDIWSLGIMAIEMIEG 212

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 77/165 (46%), Gaps = 22/165 (13%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I +GL+YLH   + + +H DIK  N+LL E    K++DFG+A Q  D  + I      GT
Sbjct: 113 ILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNXFVGT 167
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIE 153
             ++APEV  +S      K+D++S G+  +E+A G           S+++ P  +   I 
Sbjct: 168 PFWMAPEVIKQS--AYDSKADIWSLGITAIELARGE-------PPHSELH-PMKVLFLIP 217
Query: 154 PGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
             N   L+G                   C+   PS RP+  E+L+
Sbjct: 218 KNNPPTLEGNYSKPLKEFVEA-------CLNKEPSFRPTAKELLK 255

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 89/195 (45%), Gaps = 38/195 (19%)
Query: 20  RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ 79
           + LE   + ++   +  G+ +L    + + +H D+   N L+D D C K+SDFG+ +   
Sbjct: 99  KGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL 155
Query: 80  DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM-AVGRKNAD----- 133
           D +  +S +  +  + + APEVF   +   S KSDV+++G+++ E+ ++G+   D     
Sbjct: 156 DDQ-YVSSVGTKFPVKWSAPEVF--HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS 212
Query: 134 ---VKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDR 190
              +K S+   +Y P     H+     +Q                I+ S W     P  R
Sbjct: 213 EVVLKVSQGHRLYRP-----HLASDTIYQ----------------IMYSCW--HELPEKR 249
Query: 191 PSMHEVLEMLESSTE 205
           P+  ++L  +E   E
Sbjct: 250 PTFQQLLSSIEPLRE 264

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 78/181 (43%), Gaps = 38/181 (20%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +  G+ YL   C   ++H D+   N L+ E+   K+SDFG+ +   D + T S    +  
Sbjct: 110 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFP 165
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-------GRKNADVKASRSS--DIYF 144
           + + +PEVF  SF   S KSDV+S+G+++ E+          R N++V    S+   +Y 
Sbjct: 166 VKWASPEVF--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 223
Query: 145 PNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLESST 204
           P     H+     +Q+                     C +  P DRP+   +L  L    
Sbjct: 224 PRLASTHV-----YQIMNH------------------CWKERPEDRPAFSRLLRQLAEIA 260
Query: 205 E 205
           E
Sbjct: 261 E 261

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 78/181 (43%), Gaps = 38/181 (20%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +  G+ YL   C   ++H D+   N L+ E+   K+SDFG+ +   D + T S    +  
Sbjct: 115 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFP 170
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-------GRKNADVKASRSS--DIYF 144
           + + +PEVF  SF   S KSDV+S+G+++ E+          R N++V    S+   +Y 
Sbjct: 171 VKWASPEVF--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 228
Query: 145 PNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLESST 204
           P     H+     +Q+                     C +  P DRP+   +L  L    
Sbjct: 229 PRLASTHV-----YQIMNH------------------CWRERPEDRPAFSRLLRQLAEIA 265
Query: 205 E 205
           E
Sbjct: 266 E 266

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 78/181 (43%), Gaps = 38/181 (20%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +  G+ YL   C   ++H D+   N L+ E+   K+SDFG+ +   D + T S    +  
Sbjct: 112 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFP 167
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-------GRKNADVKASRSS--DIYF 144
           + + +PEVF  SF   S KSDV+S+G+++ E+          R N++V    S+   +Y 
Sbjct: 168 VKWASPEVF--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 225
Query: 145 PNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLESST 204
           P     H+     +Q+                     C +  P DRP+   +L  L    
Sbjct: 226 PRLASTHV-----YQIMNH------------------CWKERPEDRPAFSRLLRQLAEIA 262
Query: 205 E 205
           E
Sbjct: 263 E 263

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 28/168 (16%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ---SQDKKSTISMLHA 90
           I +GL+YLH   + + +H DIK  N+LL E    K++DFG+A Q   +Q K++T      
Sbjct: 113 ILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV---- 165
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYK 150
            GT  ++APEV  +S      K+D++S G+  +E+A G           S+++ P  +  
Sbjct: 166 -GTPFWMAPEVIKQS--AYDSKADIWSLGITAIELARGE-------PPHSELH-PMKVLF 214
Query: 151 HIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
            I   N   L+G                   C+   PS RP+  E+L+
Sbjct: 215 LIPKNNPPTLEGNYSKPLKEFVEA-------CLNKEPSFRPTAKELLK 255

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 72/140 (51%), Gaps = 13/140 (9%)
Query: 1   MPNGSLDQFTYDQESSNGNRTL-EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP+G L ++ ++ + + G++ L  W         IA+G+ YL      R+VH D+   N+
Sbjct: 121 MPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEER---RLVHRDLAARNV 171
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L+      KI+DFGLA+  +  +   +    +  I ++A E  C  +   +H+SDV+SYG
Sbjct: 172 LVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE--CIHYRKFTHQSDVWSYG 229
Query: 120 MMILE-MAVGRKNADVKASR 138
           + I E M  G K  D   +R
Sbjct: 230 VTIWELMTFGGKPYDGIPTR 249

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 57/93 (61%), Gaps = 7/93 (7%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +ARG+EYL    + + +H D+   N+L+ E+   KI+DFGLA+   +        + R  
Sbjct: 166 LARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 94  IGYIAPE-VFCRSFGGASHKSDVYSYGMMILEM 125
           + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 223 VKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 57/93 (61%), Gaps = 7/93 (7%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +ARG+EYL    + + +H D+   N+L+ E+   KI+DFGLA+   +        + R  
Sbjct: 166 LARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 94  IGYIAPE-VFCRSFGGASHKSDVYSYGMMILEM 125
           + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 223 VKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 57/93 (61%), Gaps = 7/93 (7%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +ARG+EYL    + + +H D+   N+L+ E+   KI+DFGLA+   +        + R  
Sbjct: 166 LARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 94  IGYIAPE-VFCRSFGGASHKSDVYSYGMMILEM 125
           + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 223 VKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/107 (38%), Positives = 58/107 (54%), Gaps = 9/107 (8%)
Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK 82
           E R V+  A  I  GLE LHR    RIV+ D+KP NILLD+    +ISD GLA    + +
Sbjct: 285 EARAVF-YAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340
Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           +    +   GT+GY+APEV        +   D ++ G ++ EM  G+
Sbjct: 341 TIKGRV---GTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQ 382

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 57/93 (61%), Gaps = 7/93 (7%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +ARG+EYL    + + +H D+   N+L+ E+   KI+DFGLA+   +        + R  
Sbjct: 166 LARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 94  IGYIAPE-VFCRSFGGASHKSDVYSYGMMILEM 125
           + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 223 VKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 68/131 (51%), Gaps = 21/131 (16%)
Query: 1   MPNGSLDQF--TYDQESSNGNRTLEWRTVYQIAG---GIARGLEYLHRGCNVRIVHFDIK 55
           M NGSLD F  T+D +           T+ Q+ G   G+  G+ YL    ++  VH D+ 
Sbjct: 132 MENGSLDTFLRTHDGQF----------TIMQLVGMLRGVGAGMRYL---SDLGYVHRDLA 178
Query: 56  PHNILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSD 114
             N+L+D +   K+SDFGL++  + D  +  +    +  I + APE    +F   S  SD
Sbjct: 179 ARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAI--AFRTFSSASD 236
Query: 115 VYSYGMMILEM 125
           V+S+G+++ E+
Sbjct: 237 VWSFGVVMWEV 247

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 84/180 (46%), Gaps = 28/180 (15%)
Query: 22  LEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ---S 78
           L+   +  I   I +GL+YLH   + + +H DIK  N+LL E    K++DFG+A Q   +
Sbjct: 121 LDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 177
Query: 79  QDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASR 138
           Q K++T       GT  ++APEV  +S      K+D++S G+  +E+A G          
Sbjct: 178 QIKRNTFV-----GTPFWMAPEVIKQS--AYDSKADIWSLGITAIELARGE-------PP 223
Query: 139 SSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
            S+++ P  +   I   N   L+G                   C+   PS RP+  E+L+
Sbjct: 224 HSELH-PMKVLFLIPKNNPPTLEGNYSKPLKEFVEA-------CLNKEPSFRPTAKELLK 275

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 57/93 (61%), Gaps = 7/93 (7%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +ARG+EYL    + + +H D+   N+L+ E+   KI+DFGLA+   +        + R  
Sbjct: 166 LARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 94  IGYIAPE-VFCRSFGGASHKSDVYSYGMMILEM 125
           + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 223 VKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +  T+     
Sbjct: 133 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC---- 185
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 186 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 220

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 70/129 (54%), Gaps = 9/129 (6%)
Query: 3   NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD 62
           + SLD+F Y Q    G +T+    + +IA  I + LE+LH    + ++H D+KP N+L++
Sbjct: 133 DTSLDKF-YKQVIDKG-QTIPEDILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLIN 188
Query: 63  EDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFG--GASHKSDVYSYGM 120
                K+ DFG++    D   +++     G   Y+APE         G S KSD++S G+
Sbjct: 189 ALGQVKMCDFGISGYLVD---SVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGI 245
Query: 121 MILEMAVGR 129
            ++E+A+ R
Sbjct: 246 TMIELAILR 254

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NGSL  F    ++ +G + L    +  +A  IA G+ ++        +H D++  NIL
Sbjct: 89  MENGSLVDFL---KTPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANIL 141
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + +    KI+DFGLA+  +D + T +   A+  I + APE    ++G  + KSDV+S+G+
Sbjct: 142 VSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGI 198
Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSL 180
           ++ E+    +      +    I      Y+ + P N                  +  +  
Sbjct: 199 LLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN--------------CPEELYQLMR 244
Query: 181 WCIQTNPSDRPS---MHEVLEMLESSTE 205
            C +  P DRP+   +  VLE   ++TE
Sbjct: 245 LCWKERPEDRPTFDYLRSVLEDFFTATE 272

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 77/165 (46%), Gaps = 22/165 (13%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I +GL+YLH   + + +H DIK  N+LL E    K++DFG+A Q  D  + I      GT
Sbjct: 128 ILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNXFVGT 182
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIE 153
             ++APEV  +S      K+D++S G+  +E+A G           S+++ P  +   I 
Sbjct: 183 PFWMAPEVIKQS--AYDSKADIWSLGITAIELARGE-------PPHSELH-PMKVLFLIP 232
Query: 154 PGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
             N   L+G                   C+   PS RP+  E+L+
Sbjct: 233 KNNPPTLEGNYSKPLKEFVEA-------CLNKEPSFRPTAKELLK 270

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NGSL  F    ++ +G + L    +  +A  IA G+ ++        +H D++  NIL
Sbjct: 98  MENGSLVDFL---KTPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANIL 150
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + +    KI+DFGLA+  +D + T +   A+  I + APE    ++G  + KSDV+S+G+
Sbjct: 151 VSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGI 207
Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSL 180
           ++ E+    +      +    I      Y+ + P N                  +  +  
Sbjct: 208 LLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN--------------CPEELYQLMR 253
Query: 181 WCIQTNPSDRPS---MHEVLEMLESSTE 205
            C +  P DRP+   +  VLE   ++TE
Sbjct: 254 LCWKERPEDRPTFDYLRSVLEDFFTATE 281

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NGSL  F    ++ +G + L    +  +A  IA G+ ++        +H D++  NIL
Sbjct: 95  MENGSLVDFL---KTPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANIL 147
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + +    KI+DFGLA+  +D + T +   A+  I + APE    ++G  + KSDV+S+G+
Sbjct: 148 VSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGI 204
Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSL 180
           ++ E+    +      +    I      Y+ + P N                  +  +  
Sbjct: 205 LLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN--------------CPEELYQLMR 250
Query: 181 WCIQTNPSDRPS---MHEVLEMLESSTE 205
            C +  P DRP+   +  VLE   ++TE
Sbjct: 251 LCWKERPEDRPTFDYLRSVLEDFFTATE 278

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 57/93 (61%), Gaps = 7/93 (7%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +ARG+EYL    + + +H D+   N+L+ E+   KI+DFGLA+   +        + R  
Sbjct: 212 LARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 268
Query: 94  IGYIAPE-VFCRSFGGASHKSDVYSYGMMILEM 125
           + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 269 VKWMAPEALFDRVY---THQSDVWSFGVLMWEI 298

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 57/93 (61%), Gaps = 7/93 (7%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +ARG+EYL    + + +H D+   N+L+ E+   KI+DFGLA+   +        + R  
Sbjct: 155 LARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 211
Query: 94  IGYIAPE-VFCRSFGGASHKSDVYSYGMMILEM 125
           + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 212 VKWMAPEALFDRVY---THQSDVWSFGVLMWEI 241

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +  T+     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC---- 200
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 201 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 235

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NGSL  F    ++ +G + L    +  +A  IA G+ ++        +H D++  NIL
Sbjct: 97  MENGSLVDFL---KTPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANIL 149
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + +    KI+DFGLA+  +D + T +   A+  I + APE    ++G  + KSDV+S+G+
Sbjct: 150 VSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGI 206
Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSL 180
           ++ E+    +      +    I      Y+ + P N                  +  +  
Sbjct: 207 LLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN--------------CPEELYQLMR 252
Query: 181 WCIQTNPSDRPS---MHEVLEMLESSTE 205
            C +  P DRP+   +  VLE   ++TE
Sbjct: 253 LCWKERPEDRPTFDYLRSVLEDFFTATE 280

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 57/93 (61%), Gaps = 7/93 (7%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +ARG+EYL    + + +H D+   N+L+ E+   KI+DFGLA+   +        + R  
Sbjct: 158 LARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 214
Query: 94  IGYIAPE-VFCRSFGGASHKSDVYSYGMMILEM 125
           + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 215 VKWMAPEALFDRVY---THQSDVWSFGVLMWEI 244

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 57/93 (61%), Gaps = 7/93 (7%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +ARG+EYL    + + +H D+   N+L+ E+   KI+DFGLA+   +        + R  
Sbjct: 153 LARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 209
Query: 94  IGYIAPE-VFCRSFGGASHKSDVYSYGMMILEM 125
           + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 210 VKWMAPEALFDRVY---THQSDVWSFGVLMWEI 239

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NGSL  F    ++ +G + L    +  +A  IA G+ ++        +H D++  NIL
Sbjct: 89  MENGSLVDFL---KTPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANIL 141
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + +    KI+DFGLA+  +D + T +   A+  I + APE    ++G  + KSDV+S+G+
Sbjct: 142 VSDTLSCKIADFGLARLIEDAEXT-AREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGI 198
Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSL 180
           ++ E+    +      +    I      Y+ + P N                  +  +  
Sbjct: 199 LLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN--------------CPEELYQLMR 244
Query: 181 WCIQTNPSDRPS---MHEVLEMLESSTE 205
            C +  P DRP+   +  VLE   ++TE
Sbjct: 245 LCWKERPEDRPTFDYLRSVLEDFFTATE 272

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 68/131 (51%), Gaps = 21/131 (16%)
Query: 1   MPNGSLDQF--TYDQESSNGNRTLEWRTVYQIAG---GIARGLEYLHRGCNVRIVHFDIK 55
           M NGSLD F  T+D +           T+ Q+ G   G+  G+ YL    ++  VH D+ 
Sbjct: 132 MENGSLDTFLRTHDGQF----------TIMQLVGMLRGVGAGMRYL---SDLGYVHRDLA 178
Query: 56  PHNILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSD 114
             N+L+D +   K+SDFGL++  + D  +  +    +  I + APE    +F   S  SD
Sbjct: 179 ARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI--AFRTFSSASD 236
Query: 115 VYSYGMMILEM 125
           V+S+G+++ E+
Sbjct: 237 VWSFGVVMWEV 247

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 66/130 (50%), Gaps = 19/130 (14%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAG---GIARGLEYLHRGCNVRIVHFDIKPH 57
           M NG+LD F    +           TV Q+ G   GIA G+ YL    ++  VH D+   
Sbjct: 126 MENGALDAFLRKHDGQF--------TVIQLVGMLRGIAAGMRYL---ADMGYVHRDLAAR 174
Query: 58  NILLDEDFCPKISDFGLAKQSQDKKSTI-SMLHARGTIGYIAPEVF-CRSFGGASHKSDV 115
           NIL++ +   K+SDFGL++  +D    + +    +  + + APE    R F  A   SDV
Sbjct: 175 NILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSA---SDV 231
Query: 116 YSYGMMILEM 125
           +SYG+++ E+
Sbjct: 232 WSYGIVMWEV 241

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 76/167 (45%), Gaps = 21/167 (12%)
Query: 35  ARGLEYLHRGCNVRIVHFDIKPHNILLDE-DFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           ++G+ YLH      ++H D+KP N+LL       KI DFG A   Q       M + +G+
Sbjct: 113 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGS 167
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIE 153
             ++APEVF  S    S K DV+S+G+++ E+   RK  D     +  I +  +++    
Sbjct: 168 AAWMAPEVFEGS--NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW--AVHNGTR 223
Query: 154 PGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEML 200
           P     L                     C   +PS RPSM E+++++
Sbjct: 224 PPLIKNLPKPIESLMTR-----------CWSKDPSQRPSMEEIVKIM 259

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 53/96 (55%), Gaps = 13/96 (13%)
Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ---SQDKKSTISMLHARG 92
           + LE+LH     +++H +IK  NILL  D   K++DFG   Q    Q K+ST+      G
Sbjct: 128 QALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----G 179
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T  ++APEV  R   G   K D++S G+M +EM  G
Sbjct: 180 TPYWMAPEVVTRKAYGP--KVDIWSLGIMAIEMIEG 213

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 59/107 (55%), Gaps = 6/107 (5%)
Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS 78
           NR ++ + + ++   ++ G++YL        VH D+   N+LL      KISDFGL+K  
Sbjct: 105 NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 161
Query: 79  Q-DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILE 124
           + D+    +  H +  + + APE  C ++   S KSDV+S+G+++ E
Sbjct: 162 RADENXYKAQTHGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 206

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 78/181 (43%), Gaps = 38/181 (20%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +  G+ YL   C   ++H D+   N L+ E+   K+SDFG+ +   D + T S    +  
Sbjct: 132 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFP 187
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-------GRKNADVKASRSSD--IYF 144
           + + +PEVF  SF   S KSDV+S+G+++ E+          R N++V    S+   +Y 
Sbjct: 188 VKWASPEVF--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 245
Query: 145 PNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLESST 204
           P     H+     +Q+                     C +  P DRP+   +L  L    
Sbjct: 246 PRLASTHV-----YQIMNH------------------CWKERPEDRPAFSRLLRQLAEIA 282
Query: 205 E 205
           E
Sbjct: 283 E 283

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 76/167 (45%), Gaps = 21/167 (12%)
Query: 35  ARGLEYLHRGCNVRIVHFDIKPHNILLDE-DFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           ++G+ YLH      ++H D+KP N+LL       KI DFG A   Q       M + +G+
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGS 166
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIE 153
             ++APEVF  S    S K DV+S+G+++ E+   RK  D     +  I +  +++    
Sbjct: 167 AAWMAPEVFEGS--NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW--AVHNGTR 222
Query: 154 PGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEML 200
           P     L                     C   +PS RPSM E+++++
Sbjct: 223 PPLIKNLPKPIESLMTR-----------CWSKDPSQRPSMEEIVKIM 258

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 59/107 (55%), Gaps = 6/107 (5%)
Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS 78
           NR ++ + + ++   ++ G++YL        VH D+   N+LL      KISDFGL+K  
Sbjct: 121 NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 177
Query: 79  Q-DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILE 124
           + D+    +  H +  + + APE  C ++   S KSDV+S+G+++ E
Sbjct: 178 RADENYYKAQTHGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 59/107 (55%), Gaps = 6/107 (5%)
Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS 78
           NR ++ + + ++   ++ G++YL        VH D+   N+LL      KISDFGL+K  
Sbjct: 121 NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 177
Query: 79  Q-DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILE 124
           + D+    +  H +  + + APE  C ++   S KSDV+S+G+++ E
Sbjct: 178 RADENYYKAQTHGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 222

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 52/93 (55%), Gaps = 7/93 (7%)
Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIG 95
           + LE+LH     +++H DIK  NILL  D   K++DFG   Q   ++S  S +   GT  
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEM--VGTPY 181
Query: 96  YIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           ++APEV  R   G   K D++S G+M +EM  G
Sbjct: 182 WMAPEVVTRKAYGP--KVDIWSLGIMAIEMIEG 212

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 53/104 (50%), Gaps = 8/104 (7%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST 84
           R  +Q+  G+     YLH    + I H DIKP N+LLDE    KISDFGLA   +     
Sbjct: 108 RFFHQLMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
             +    GT+ Y+APE+  R    A    DV+S G+++  M  G
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 53/104 (50%), Gaps = 8/104 (7%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST 84
           R  +Q+  G+     YLH    + I H DIKP N+LLDE    KISDFGLA   +     
Sbjct: 108 RFFHQLMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
             +    GT+ Y+APE+  R    A    DV+S G+++  M  G
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 53/104 (50%), Gaps = 8/104 (7%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST 84
           R  +Q+  G+     YLH    + I H DIKP N+LLDE    KISDFGLA   +     
Sbjct: 109 RFFHQLMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
             +    GT+ Y+APE+  R    A    DV+S G+++  M  G
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+++D+    K++DFGLAK+ + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC---- 199
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 78/175 (44%), Gaps = 24/175 (13%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  I+  +EYL +      +H D+   N L+ E+   K++DFGL++       T +   
Sbjct: 114 MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXT-AHAG 169
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIY 149
           A+  I + APE    ++   S KSDV+++G+++ E+A                 +  S Y
Sbjct: 170 AKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIAT----------------YGMSPY 211
Query: 150 KHIEPGNDFQLDGXXXXXXXXXXXXMILVSLW--CIQTNPSDRPSMHEVLEMLES 202
             I+P   ++L                +  L   C Q NPSDRPS  E+ +  E+
Sbjct: 212 PGIDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 266

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NGSL  F    ++ +G + L    +  +A  IA G+ ++        +H D++  NIL
Sbjct: 94  MENGSLVDFL---KTPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANIL 146
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + +    KI+DFGLA+  +D + T +   A+  I + APE    ++G  + KSDV+S+G+
Sbjct: 147 VSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGI 203
Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSL 180
           ++ E+    +      +    I      Y+ + P N                  +  +  
Sbjct: 204 LLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN--------------CPEELYQLMR 249
Query: 181 WCIQTNPSDRPS---MHEVLEMLESSTE 205
            C +  P DRP+   +  VLE   ++TE
Sbjct: 250 LCWKERPEDRPTFDYLRSVLEDFFTATE 277

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 53/104 (50%), Gaps = 8/104 (7%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST 84
           R  +Q+  G+     YLH    + I H DIKP N+LLDE    KISDFGLA   +     
Sbjct: 108 RFFHQLMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
             +    GT+ Y+APE+  R    A    DV+S G+++  M  G
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 53/104 (50%), Gaps = 8/104 (7%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST 84
           R  +Q+  G+     YLH    + I H DIKP N+LLDE    KISDFGLA   +     
Sbjct: 108 RFFHQLMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
             +    GT+ Y+APE+  R    A    DV+S G+++  M  G
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 53/104 (50%), Gaps = 8/104 (7%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST 84
           R  +Q+  G+     YLH    + I H DIKP N+LLDE    KISDFGLA   +     
Sbjct: 107 RFFHQLMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
             +    GT+ Y+APE+  R    A    DV+S G+++  M  G
Sbjct: 160 RLLNKMCGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTAMLAG 202

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 78/175 (44%), Gaps = 24/175 (13%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  I+  +EYL +      +H D+   N L+ E+   K++DFGL++       T +   
Sbjct: 114 MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXT-AHAG 169
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIY 149
           A+  I + APE    ++   S KSDV+++G+++ E+A                 +  S Y
Sbjct: 170 AKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIAT----------------YGMSPY 211
Query: 150 KHIEPGNDFQLDGXXXXXXXXXXXXMILVSLW--CIQTNPSDRPSMHEVLEMLES 202
             I+P   ++L                +  L   C Q NPSDRPS  E+ +  E+
Sbjct: 212 PGIDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 266

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 53/104 (50%), Gaps = 8/104 (7%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST 84
           R  +Q+  G+     YLH    + I H DIKP N+LLDE    KISDFGLA   +     
Sbjct: 108 RFFHQLMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
             +    GT+ Y+APE+  R    A    DV+S G+++  M  G
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 59/107 (55%), Gaps = 6/107 (5%)
Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS 78
           NR ++ + + ++   ++ G++YL        VH D+   N+LL      KISDFGL+K  
Sbjct: 101 NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 157
Query: 79  Q-DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILE 124
           + D+    +  H +  + + APE  C ++   S KSDV+S+G+++ E
Sbjct: 158 RADENYYKAQTHGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 202

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 53/104 (50%), Gaps = 8/104 (7%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST 84
           R  +Q+  G+     YLH    + I H DIKP N+LLDE    KISDFGLA   +     
Sbjct: 109 RFFHQLMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
             +    GT+ Y+APE+  R    A    DV+S G+++  M  G
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 53/104 (50%), Gaps = 8/104 (7%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST 84
           R  +Q+  G+     YLH    + I H DIKP N+LLDE    KISDFGLA   +     
Sbjct: 109 RFFHQLMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
             +    GT+ Y+APE+  R    A    DV+S G+++  M  G
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHA-EPVDVWSCGIVLTAMLAG 204

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 53/104 (50%), Gaps = 8/104 (7%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST 84
           R  +Q+  G+     YLH    + I H DIKP N+LLDE    KISDFGLA   +     
Sbjct: 109 RFFHQLMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
             +    GT+ Y+APE+  R    A    DV+S G+++  M  G
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 53/104 (50%), Gaps = 8/104 (7%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST 84
           R  +Q+  G+     YLH    + I H DIKP N+LLDE    KISDFGLA   +     
Sbjct: 108 RFFHQLMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
             +    GT+ Y+APE+  R    A    DV+S G+++  M  G
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 53/104 (50%), Gaps = 8/104 (7%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST 84
           R  +Q+  G+     YLH    + I H DIKP N+LLDE    KISDFGLA   +     
Sbjct: 108 RFFHQLMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
             +    GT+ Y+APE+  R    A    DV+S G+++  M  G
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 53/104 (50%), Gaps = 8/104 (7%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST 84
           R  +Q+  G+     YLH    + I H DIKP N+LLDE    KISDFGLA   +     
Sbjct: 108 RFFHQLMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
             +    GT+ Y+APE+  R    A    DV+S G+++  M  G
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHA-EPVDVWSCGIVLTAMLAG 203

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 53/104 (50%), Gaps = 8/104 (7%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST 84
           R  +Q+  G+     YLH    + I H DIKP N+LLDE    KISDFGLA   +     
Sbjct: 109 RFFHQLMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
             +    GT+ Y+APE+  R    A    DV+S G+++  M  G
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHA-EPVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 53/104 (50%), Gaps = 8/104 (7%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST 84
           R  +Q+  G+     YLH    + I H DIKP N+LLDE    KISDFGLA   +     
Sbjct: 109 RFFHQLMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
             +    GT+ Y+APE+  R    A    DV+S G+++  M  G
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHA-EPVDVWSCGIVLTAMLAG 204

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 53/104 (50%), Gaps = 8/104 (7%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST 84
           R  +Q+  G+     YLH    + I H DIKP N+LLDE    KISDFGLA   +     
Sbjct: 109 RFFHQLMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
             +    GT+ Y+APE+  R    A    DV+S G+++  M  G
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHA-EPVDVWSCGIVLTAMLAG 204

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/188 (23%), Positives = 83/188 (44%), Gaps = 22/188 (11%)
Query: 20  RTLEWRTVYQIAGGIARGLEYL-HRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS 78
           R LE R +   +  +A+G+ +L  + C    +H D+   N+LL      KI DFGLA+  
Sbjct: 153 RPLELRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDI 208
Query: 79  QDKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKAS 137
            +  + I   +AR  + ++APE +F   +   + +SDV+SYG+++ E+        +  +
Sbjct: 209 MNDSNYIVKGNARLPVKWMAPESIFDCVY---TVQSDVWSYGILLWEI------FSLGLN 259
Query: 138 RSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVL 197
               I   +  YK ++       DG            +  +   C    P+ RP+  ++ 
Sbjct: 260 PYPGILVNSKFYKLVK-------DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQIC 312
Query: 198 EMLESSTE 205
             L+   +
Sbjct: 313 SFLQEQAQ 320

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 59/107 (55%), Gaps = 6/107 (5%)
Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS 78
           NR ++ + + ++   ++ G++YL        VH D+   N+LL      KISDFGL+K  
Sbjct: 119 NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 175
Query: 79  Q-DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILE 124
           + D+    +  H +  + + APE  C ++   S KSDV+S+G+++ E
Sbjct: 176 RADENYYKAQTHGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 220

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 59/107 (55%), Gaps = 6/107 (5%)
Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS 78
           NR ++ + + ++   ++ G++YL        VH D+   N+LL      KISDFGL+K  
Sbjct: 99  NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 155
Query: 79  Q-DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILE 124
           + D+    +  H +  + + APE  C ++   S KSDV+S+G+++ E
Sbjct: 156 RADENYYKAQTHGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 200

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 57/101 (56%), Gaps = 11/101 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ--DKKSTISML 88
           A  I  GL++LH      IV+ D+K  NILLD+D   KI+DFG+ K++   D K+     
Sbjct: 124 AAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFC- 179
Query: 89  HARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
              GT  YIAPE+        +H  D +S+G+++ EM +G+
Sbjct: 180 ---GTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVAT 185
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 186 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 59/107 (55%), Gaps = 6/107 (5%)
Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS 78
           NR ++ + + ++   ++ G++YL        VH D+   N+LL      KISDFGL+K  
Sbjct: 111 NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167
Query: 79  Q-DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILE 124
           + D+    +  H +  + + APE  C ++   S KSDV+S+G+++ E
Sbjct: 168 RADENYYKAQTHGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 212

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 57/103 (55%), Gaps = 13/103 (12%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
           +YQI     RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     
Sbjct: 131 IYQIL----RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----- 178
Query: 87  MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           M     T  Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 179 MTGXVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 53/97 (54%), Gaps = 6/97 (6%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDE-DFCPKISDFGLAKQSQDKKSTISMLHARG 92
           I  GL+YLH   + +IVH DIK  N+L++      KISDFG +K+              G
Sbjct: 131 ILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF--TG 185
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T+ Y+APE+  +   G    +D++S G  I+EMA G+
Sbjct: 186 TLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 139 ILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVAT 190
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 191 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 59/107 (55%), Gaps = 6/107 (5%)
Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS 78
           NR ++ + + ++   ++ G++YL        VH D+   N+LL      KISDFGL+K  
Sbjct: 105 NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 161
Query: 79  Q-DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILE 124
           + D+    +  H +  + + APE  C ++   S KSDV+S+G+++ E
Sbjct: 162 RADENYYKAQTHGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 206

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 139 ILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVAT 190
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 191 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 145 ILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVAT 196
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 197 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NGSL  F    ++ +G + L    +  +A  IA G+ ++        +H D++  NIL
Sbjct: 99  MENGSLVDFL---KTPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANIL 151
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + +    KI+DFGLA+  +D + T +   A+  I + APE    ++G  + KSDV+S+G+
Sbjct: 152 VSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGI 208
Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSL 180
           ++ E+    +      +    I      Y+ + P N                  +  +  
Sbjct: 209 LLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN--------------CPEELYQLMR 254
Query: 181 WCIQTNPSDRPS---MHEVLEMLESSTE 205
            C +  P DRP+   +  VLE   ++TE
Sbjct: 255 LCWKERPEDRPTFDYLRSVLEDFFTATE 282

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+DE    +++DFG AK+ + +   +     
Sbjct: 134 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC---- 186
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 187 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 221

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 64/127 (50%), Gaps = 10/127 (7%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSL  F    E S          +   +  IA G+ ++ +      +H D++  NIL
Sbjct: 91  MAKGSLLDFLKSDEGSKQPLP----KLIDFSAQIAEGMAFIEQR---NYIHRDLRAANIL 143
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           +      KI+DFGLA+  +D + T +   A+  I + APE    +FG  + KSDV+S+G+
Sbjct: 144 VSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAI--NFGSFTIKSDVWSFGI 200
Query: 121 MILEMAV 127
           +++E+  
Sbjct: 201 LLMEIVT 207

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 90/201 (44%), Gaps = 24/201 (11%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NGSL  F    ++ +G + L    +  +A  IA G+ ++        +H D++  NIL
Sbjct: 89  MENGSLVDFL---KTPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANIL 141
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + +    KI+DFGLA+  +D + T +   A+  I + APE    ++G  + KSDV+S+G+
Sbjct: 142 VSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGI 198
Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSL 180
           ++ E+    +      +    I      Y+ + P N                  +  +  
Sbjct: 199 LLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN--------------CPEELYQLMR 244
Query: 181 WCIQTNPSDRPSMHEVLEMLE 201
            C +  P DRP+   +  +LE
Sbjct: 245 LCWKERPEDRPTFDYLRSVLE 265

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/188 (23%), Positives = 83/188 (44%), Gaps = 22/188 (11%)
Query: 20  RTLEWRTVYQIAGGIARGLEYL-HRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS 78
           R LE R +   +  +A+G+ +L  + C    +H D+   N+LL      KI DFGLA+  
Sbjct: 147 RPLELRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDI 202
Query: 79  QDKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKAS 137
            +  + I   +AR  + ++APE +F   +   + +SDV+SYG+++ E+        +  +
Sbjct: 203 MNDSNYIVKGNARLPVKWMAPESIFDCVY---TVQSDVWSYGILLWEI------FSLGLN 253
Query: 138 RSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVL 197
               I   +  YK ++       DG            +  +   C    P+ RP+  ++ 
Sbjct: 254 PYPGILVNSKFYKLVK-------DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQIC 306
Query: 198 EMLESSTE 205
             L+   +
Sbjct: 307 SFLQEQAQ 314

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 154 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MXGXVAT 205
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 206 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 53/97 (54%), Gaps = 6/97 (6%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDE-DFCPKISDFGLAKQSQDKKSTISMLHARG 92
           I  GL+YLH   + +IVH DIK  N+L++      KISDFG +K+              G
Sbjct: 117 ILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF--TG 171
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T+ Y+APE+  +   G    +D++S G  I+EMA G+
Sbjct: 172 TLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 57/93 (61%), Gaps = 7/93 (7%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +ARG+EYL    + + +H D+   N+L+ E+   +I+DFGLA+   +        + R  
Sbjct: 166 LARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLP 222
Query: 94  IGYIAPE-VFCRSFGGASHKSDVYSYGMMILEM 125
           + ++APE +F R +   +H+SDV+S+G+++ E+
Sbjct: 223 VKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/188 (23%), Positives = 83/188 (44%), Gaps = 22/188 (11%)
Query: 20  RTLEWRTVYQIAGGIARGLEYL-HRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS 78
           R LE R +   +  +A+G+ +L  + C    +H D+   N+LL      KI DFGLA+  
Sbjct: 155 RPLELRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDI 210
Query: 79  QDKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKAS 137
            +  + I   +AR  + ++APE +F   +   + +SDV+SYG+++ E+        +  +
Sbjct: 211 MNDSNYIVKGNARLPVKWMAPESIFDCVY---TVQSDVWSYGILLWEI------FSLGLN 261
Query: 138 RSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVL 197
               I   +  YK ++       DG            +  +   C    P+ RP+  ++ 
Sbjct: 262 PYPGILVNSKFYKLVK-------DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQIC 314
Query: 198 EMLESSTE 205
             L+   +
Sbjct: 315 SFLQEQAQ 322

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 69/127 (54%), Gaps = 10/127 (7%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NGSL  F    ++ +G + L    +  +A  IA G+ ++        +H D++  NIL
Sbjct: 90  MENGSLVDFL---KTPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANIL 142
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + +    KI+DFGLA+  +D + T +   A+  I + APE    ++G  + KSDV+S+G+
Sbjct: 143 VSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGI 199
Query: 121 MILEMAV 127
           ++ E+  
Sbjct: 200 LLTEIVT 206

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 57/101 (56%), Gaps = 11/101 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ--DKKSTISML 88
           A  I  GL++LH      IV+ D+K  NILLD+D   KI+DFG+ K++   D K+     
Sbjct: 125 AAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN---- 177
Query: 89  HARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
              GT  YIAPE+        +H  D +S+G+++ EM +G+
Sbjct: 178 EFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 69/127 (54%), Gaps = 10/127 (7%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NGSL  F    ++ +G + L    +  +A  IA G+ ++        +H D++  NIL
Sbjct: 91  MENGSLVDFL---KTPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANIL 143
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + +    KI+DFGLA+  +D + T +   A+  I + APE    ++G  + KSDV+S+G+
Sbjct: 144 VSDTLSCKIADFGLARLIEDNEXT-AREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGI 200
Query: 121 MILEMAV 127
           ++ E+  
Sbjct: 201 LLTEIVT 207

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 69/149 (46%), Gaps = 25/149 (16%)
Query: 14  ESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFG 73
           E+ N  R   WR   QI       L Y+H      I+H ++KP NI +DE    KI DFG
Sbjct: 109 ENLNQQRDEYWRLFRQIL----EALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFG 161
Query: 74  LAKQ-----------SQD-KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMM 121
           LAK            SQ+   S+ ++  A GT  Y+A EV   + G  + K D YS G++
Sbjct: 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGT-GHYNEKIDXYSLGII 220
Query: 122 ILE----MAVGRKNADV-KASRSSDIYFP 145
             E     + G +  ++ K  RS  I FP
Sbjct: 221 FFEXIYPFSTGXERVNILKKLRSVSIEFP 249

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    K++DFG AK+ + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC---- 199
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    K++DFG AK+ + +   +     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC---- 200
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 201 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 235

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 85/179 (47%), Gaps = 32/179 (17%)
Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS-QDK 81
           E RT   I   +A  L Y H   + R++H DIKP N+LL      KI+DFG +  +   +
Sbjct: 108 EQRTATYITE-LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSR 163
Query: 82  KSTISMLHARGTIGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVGRKNADVKASRS 139
           ++T+S     GT+ Y+ PE+      G  H  K D++S G++  E  VG+     +A+  
Sbjct: 164 RTTLS-----GTLDYLPPEM----IEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTY 212
Query: 140 SDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
            + Y   S  +   P  DF  +G              L+S   ++ NPS RP + EVLE
Sbjct: 213 QETYKRISRVEFTFP--DFVTEGARD-----------LISR-LLKHNPSQRPMLREVLE 257

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 53/96 (55%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 185
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   +    +   D++S G ++ E+  GR
Sbjct: 186 RWYRAPEIMLNAM-HYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    K++DFG AK+ + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC---- 199
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 68/129 (52%), Gaps = 14/129 (10%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSLDQ   +       + +    + +++  + RGL YL      +I+H D+KP NIL
Sbjct: 96  MDGGSLDQVLKEA------KRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNIL 147
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           ++     K+ DFG++ Q  D  +   +    GT  Y+APE    +    S +SD++S G+
Sbjct: 148 VNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMAPERLQGTH--YSVQSDIWSMGL 201
Query: 121 MILEMAVGR 129
            ++E+AVGR
Sbjct: 202 SLVELAVGR 210

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/123 (30%), Positives = 57/123 (46%), Gaps = 11/123 (8%)
Query: 22  LEWRTVYQIAGGIARGLEYLHR--------GCNVRIVHFDIKPHNILLDEDFCPKISDFG 73
           + W  +  +A  ++RGL YLH         G    I H D K  N+LL  D    ++DFG
Sbjct: 109 ITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFG 168
Query: 74  LAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFG---GASHKSDVYSYGMMILEMAVGRK 130
           LA + +  K         GT  Y+APEV   +      A  + D+Y+ G+++ E+    K
Sbjct: 169 LAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCK 228
Query: 131 NAD 133
            AD
Sbjct: 229 AAD 231

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 55/98 (56%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   ++    
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLA---- 199
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 78/175 (44%), Gaps = 24/175 (13%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  I+  +EYL +      +H D+   N L+ E+   K++DFGL++       T +   
Sbjct: 114 MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFT-AHAG 169
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIY 149
           A+  I + APE    ++   S KSDV+++G+++ E+A                 +  S Y
Sbjct: 170 AKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIAT----------------YGMSPY 211
Query: 150 KHIEPGNDFQLDGXXXXXXXXXXXXMILVSLW--CIQTNPSDRPSMHEVLEMLES 202
             I+P   ++L                +  L   C Q NPSDRPS  E+ +  E+
Sbjct: 212 PGIDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 266

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 185
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 186 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 157 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MXGYVAT 208
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 209 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 185
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 186 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 185
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 186 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    K++DFG AK+ + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC---- 199
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 141 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 192
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 193 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 140 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 191
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 192 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 185
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 186 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 146 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 197
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 198 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 141 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVAT 192
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 193 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 146 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 197
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 198 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 139 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 190
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 191 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 133 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 184
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 185 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 136 ILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVAT 187
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 188 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 185
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 186 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 136 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 187
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 188 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 140 ILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVAT 191
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 192 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 185
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 186 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 141 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVAT 192
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 193 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 185
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 186 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 145 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 196
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 197 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 146 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 197
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 198 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 141 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVAT 192
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 193 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 136 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 187
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 188 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 80/178 (44%), Gaps = 30/178 (16%)
Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK 82
           E RT   I   +A  L Y H   + R++H DIKP N+LL      KI+DFG +  +   +
Sbjct: 112 EQRTATYITE-LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 167
Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVGRKNADVKASRSS 140
            T       GT+ Y+ PE       G  H  K D++S G++  E  VG+     +A+   
Sbjct: 168 RTTLC----GTLDYLPPE----XIEGRXHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQ 217
Query: 141 DIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
           + Y   S  +   P  DF  +G              L+S   ++ NPS RP + EVLE
Sbjct: 218 ETYKRISRVEFTFP--DFVTEGARD-----------LISR-LLKHNPSQRPXLREVLE 261

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 136 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 187
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 188 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 131 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 182
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 183 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 55/102 (53%), Gaps = 12/102 (11%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGLAKQSQDKKSTIS 86
           I   +  G+ YLH+     IVH D+KP N+LL   ++D   KI DFGL+   +++K    
Sbjct: 141 IIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---K 194
Query: 87  MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           M    GT  YIAPEV  + +     K DV+S G+++  +  G
Sbjct: 195 MKERLGTAYYIAPEVLRKKY---DEKCDVWSIGVILFILLAG 233

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 185
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 186 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/190 (23%), Positives = 83/190 (43%), Gaps = 22/190 (11%)
Query: 18  GNRTLEWRTVYQIAGGIARGLEYL-HRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK 76
            N TL  R +   +  +A+G+ +L  + C    +H D+   N+LL      KI DFGLA+
Sbjct: 157 ANSTLSTRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLAR 212
Query: 77  QSQDKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK 135
              +  + I   +AR  + ++APE +F   +   + +SDV+SYG+++ E+        + 
Sbjct: 213 DIMNDSNYIVKGNARLPVKWMAPESIFDCVY---TVQSDVWSYGILLWEI------FSLG 263
Query: 136 ASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHE 195
            +    I   +  YK ++       DG            +  +   C    P+ RP+  +
Sbjct: 264 LNPYPGILVNSKFYKLVK-------DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQ 316
Query: 196 VLEMLESSTE 205
           +   L+   +
Sbjct: 317 ICSFLQEQAQ 326

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 90/201 (44%), Gaps = 24/201 (11%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NGSL  F    ++ +G + L    +  +A  IA G+ ++        +H D++  NIL
Sbjct: 84  MENGSLVDFL---KTPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANIL 136
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + +    KI+DFGLA+  +D + T +   A+  I + APE    ++G  + KSDV+S+G+
Sbjct: 137 VSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGI 193
Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSL 180
           ++ E+    +      +    I      Y+ + P N                  +  +  
Sbjct: 194 LLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN--------------CPEELYQLMR 239
Query: 181 WCIQTNPSDRPSMHEVLEMLE 201
            C +  P DRP+   +  +LE
Sbjct: 240 LCWKERPEDRPTFDYLRSVLE 260

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 80/182 (43%), Gaps = 24/182 (13%)
Query: 21  TLEWRTVYQIAGGIARGLEYL-HRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ 79
           TLE    Y     +A+G+E+L  R C    +H D+   NILL E    KI DFGLA+   
Sbjct: 137 TLEHLICYSFQ--VAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIX 190
Query: 80  DKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASR 138
                +    AR  + ++APE +F R +   + +SDV+S+G+++ E+        + AS 
Sbjct: 191 KDPDXVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI------FSLGASP 241
Query: 139 SSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
              +       + ++       +G            M    L C    PS RP+  E++E
Sbjct: 242 YPGVKIDEEFCRRLK-------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 294
Query: 199 ML 200
            L
Sbjct: 295 HL 296

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 131 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 182
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 183 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 185
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 186 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 157 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 208
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 209 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 76/168 (45%), Gaps = 20/168 (11%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +A+G+E+L    + + +H D+   NILL E    KI DFGLA+        +    AR  
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 94  IGYIAPE-VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHI 152
           + ++APE +F R +   + +SDV+S+G+++ E+        + AS    +       + +
Sbjct: 214 LKWMAPETIFDRVY---TIQSDVWSFGVLLWEI------FSLGASPYPGVKIDEEFCRRL 264
Query: 153 EPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEML 200
           +       +G            M    L C    PS RP+  E++E L
Sbjct: 265 K-------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 80/182 (43%), Gaps = 24/182 (13%)
Query: 21  TLEWRTVYQIAGGIARGLEYL-HRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ 79
           TLE    Y     +A+G+E+L  R C    +H D+   NILL E    KI DFGLA+   
Sbjct: 137 TLEHLICYSFQ--VAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIX 190
Query: 80  DKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASR 138
                +    AR  + ++APE +F R +   + +SDV+S+G+++ E+        + AS 
Sbjct: 191 KDPDXVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI------FSLGASP 241
Query: 139 SSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
              +       + ++       +G            M    L C    PS RP+  E++E
Sbjct: 242 YPGVKIDEEFCRRLK-------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 294
Query: 199 ML 200
            L
Sbjct: 295 HL 296

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVAT 185
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 186 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 144 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 195
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 196 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 154 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 205
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 206 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ +    T+     
Sbjct: 168 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLC---- 220
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 221 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 255

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 132 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 183
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 184 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 130 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 181
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 182 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 139 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 190
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 191 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 153 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 204
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 205 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+ +         T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV-----AT 185
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 186 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 153 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 204
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 205 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 140 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 191
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 192 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 154 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 205
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 206 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 58/114 (50%), Gaps = 14/114 (12%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
            +EY HR    +IVH D+KP N+LLD++   KI+DFGL+    D     +   + G+  Y
Sbjct: 120 AIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT---SCGSPNY 173
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYK 150
            APEV       A  + DV+S G+++  M VGR   D       D + PN   K
Sbjct: 174 AAPEVINGKL-YAGPEVDVWSCGIVLYVMLVGRLPFD-------DEFIPNLFKK 219

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 69/127 (54%), Gaps = 10/127 (7%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NGSL  F    ++ +G + L    +  +A  IA G+ ++        +H D++  NIL
Sbjct: 95  MENGSLVDFL---KTPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANIL 147
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + +    KI+DFGLA+  +D + T +   A+  I + APE    ++G  + KSDV+S+G+
Sbjct: 148 VSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGI 204
Query: 121 MILEMAV 127
           ++ E+  
Sbjct: 205 LLTEIVT 211

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 90/201 (44%), Gaps = 24/201 (11%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NGSL  F    ++ +G + L    +  +A  IA G+ ++        +H D++  NIL
Sbjct: 89  MENGSLVDFL---KTPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANIL 141
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + +    KI+DFGLA+  +D + T +   A+  I + APE    ++G  + KSDV+S+G+
Sbjct: 142 VSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGI 198
Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSL 180
           ++ E+    +      +    I      Y+ + P N                  +  +  
Sbjct: 199 LLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN--------------CPEELYQLMR 244
Query: 181 WCIQTNPSDRPSMHEVLEMLE 201
            C +  P DRP+   +  +LE
Sbjct: 245 LCWKERPEDRPTFDYLRSVLE 265

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 22/181 (12%)
Query: 21  TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD 80
           TLE    Y     +A+G+E+L    + + +H D+   NILL E    KI DFGLA+    
Sbjct: 146 TLEHLICYSFQ--VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXK 200
Query: 81  KKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRS 139
               +    AR  + ++APE +F R +   + +SDV+S+G+++ E+        + AS  
Sbjct: 201 DPDXVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI------FSLGASPY 251
Query: 140 SDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEM 199
             +       + ++       +G            M    L C    PS RP+  E++E 
Sbjct: 252 PGVKIDEEFCRRLK-------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304
Query: 200 L 200
           L
Sbjct: 305 L 305

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 69/144 (47%), Gaps = 30/144 (20%)
Query: 2   PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLH----RGCNVR--IVHFDIK 55
           PNGSL ++           T +W +  ++A  + RGL YLH    RG + +  I H D+ 
Sbjct: 95  PNGSLXKYL-------SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLN 147
Query: 56  PHNILLDEDFCPKISDFGLA---------KQSQDKKSTISMLHARGTIGYIAPEVF---- 102
             N+L+  D    ISDFGL+         +  ++  + IS +   GTI Y+APEV     
Sbjct: 148 SRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV---GTIRYMAPEVLEGAV 204
Query: 103 -CRSFGGASHKSDVYSYGMMILEM 125
             R    A  + D+Y+ G++  E+
Sbjct: 205 NLRDXESALKQVDMYALGLIYWEI 228

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 130 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 181
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 182 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 80/182 (43%), Gaps = 24/182 (13%)
Query: 21  TLEWRTVYQIAGGIARGLEYL-HRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ 79
           TLE    Y     +A+G+E+L  R C    +H D+   NILL E    KI DFGLA+   
Sbjct: 146 TLEHLICYSFQ--VAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIX 199
Query: 80  DKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASR 138
                +    AR  + ++APE +F R +   + +SDV+S+G+++ E+        + AS 
Sbjct: 200 KDPDXVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI------FSLGASP 250
Query: 139 SSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
              +       + ++       +G            M    L C    PS RP+  E++E
Sbjct: 251 YPGVKIDEEFCRRLK-------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 303
Query: 199 ML 200
            L
Sbjct: 304 HL 305

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/121 (34%), Positives = 69/121 (57%), Gaps = 15/121 (12%)
Query: 14  ESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFG 73
           +++ GN TL+   +  I   I RGL +LH+    +++H DIK  N+LL E+   K+ DFG
Sbjct: 119 KNTKGN-TLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 174
Query: 74  LAKQ---SQDKKSTISMLHARGTIGYIAPEVF-CRSFGGASH--KSDVYSYGMMILEMAV 127
           ++ Q   +  +++T       GT  ++APEV  C     A++  KSD++S G+  +EMA 
Sbjct: 175 VSAQLDRTVGRRNTFI-----GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 229
Query: 128 G 128
           G
Sbjct: 230 G 230

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 130 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 181
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 182 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 140 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 191
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 192 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 81/178 (45%), Gaps = 30/178 (16%)
Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK 82
           E RT   I   +A  L Y H   + R++H DIKP N+LL      KI+DFG +  +   +
Sbjct: 124 EQRTATYITE-LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 179
Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVGRKNADVKASRSS 140
            T       GT+ Y+ PE+      G  H  K D++S G++  E  VG+     +A+   
Sbjct: 180 RTTLC----GTLDYLPPEM----IEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQ 229
Query: 141 DIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
           + Y   S  +   P  DF  +G              L+S   ++ NPS RP + EVLE
Sbjct: 230 ETYKRISRVEFTFP--DFVTEGARD-----------LISR-LLKHNPSQRPMLREVLE 273

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 64/127 (50%), Gaps = 10/127 (7%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSL  F    E S          +   +  IA G+ ++ +      +H D++  NIL
Sbjct: 264 MAKGSLLDFLKSDEGSKQPLP----KLIDFSAQIAEGMAFIEQR---NYIHRDLRAANIL 316
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           +      KI+DFGLA+  +D + T +   A+  I + APE    +FG  + KSDV+S+G+
Sbjct: 317 VSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAI--NFGSFTIKSDVWSFGI 373
Query: 121 MILEMAV 127
           +++E+  
Sbjct: 374 LLMEIVT 380

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 81/178 (45%), Gaps = 30/178 (16%)
Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK 82
           E RT   I   +A  L Y H   + R++H DIKP N+LL      KI+DFG +  +   +
Sbjct: 110 EQRTATYITE-LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 165
Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVGRKNADVKASRSS 140
            T       GT+ Y+ PE+      G  H  K D++S G++  E  VG+     +A+   
Sbjct: 166 RTTLC----GTLDYLPPEM----IEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQ 215
Query: 141 DIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
           + Y   S  +   P  DF  +G              L+S   ++ NPS RP + EVLE
Sbjct: 216 ETYKRISRVEFTFP--DFVTEGARD-----------LISR-LLKHNPSQRPMLREVLE 259

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 81/178 (45%), Gaps = 30/178 (16%)
Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK 82
           E RT   I   +A  L Y H   + R++H DIKP N+LL      KI+DFG +  +   +
Sbjct: 112 EQRTATYITE-LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 167
Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVGRKNADVKASRSS 140
            T       GT+ Y+ PE+      G  H  K D++S G++  E  VG+     +A+   
Sbjct: 168 RTTLC----GTLDYLPPEM----IEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQ 217
Query: 141 DIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
           + Y   S  +   P  DF  +G              L+S   ++ NPS RP + EVLE
Sbjct: 218 ETYKRISRVEFTFP--DFVTEGARD-----------LISR-LLKHNPSQRPMLREVLE 261

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 81/178 (45%), Gaps = 30/178 (16%)
Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK 82
           E RT   I   +A  L Y H   + R++H DIKP N+LL      KI+DFG +  +   +
Sbjct: 107 EQRTATYITE-LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 162
Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVGRKNADVKASRSS 140
            T       GT+ Y+ PE+      G  H  K D++S G++  E  VG+     +A+   
Sbjct: 163 RTTLC----GTLDYLPPEM----IEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQ 212
Query: 141 DIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
           + Y   S  +   P  DF  +G              L+S   ++ NPS RP + EVLE
Sbjct: 213 ETYKRISRVEFTFP--DFVTEGARD-----------LISR-LLKHNPSQRPMLREVLE 256

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+++D+    K++DFG AK+ + +   +     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---- 200
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 201 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 235

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+++D+    K++DFG AK+ + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---- 199
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 81/178 (45%), Gaps = 30/178 (16%)
Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK 82
           E RT   I   +A  L Y H   + R++H DIKP N+LL      KI+DFG +  +   +
Sbjct: 112 EQRTATYITE-LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 167
Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVGRKNADVKASRSS 140
            T       GT+ Y+ PE+      G  H  K D++S G++  E  VG+     +A+   
Sbjct: 168 RTTLC----GTLDYLPPEM----IEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQ 217
Query: 141 DIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
           + Y   S  +   P  DF  +G              L+S   ++ NPS RP + EVLE
Sbjct: 218 ETYKRISRVEFTFP--DFVTEGARD-----------LISR-LLKHNPSQRPMLREVLE 261

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+++D+    K++DFG AK+ + +   +     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---- 200
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 201 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 235

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+++D+    K++DFG AK+ + +   +     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---- 200
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 201 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 235

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 81/178 (45%), Gaps = 30/178 (16%)
Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK 82
           E RT   I   +A  L Y H   + R++H DIKP N+LL      KI+DFG +  +   +
Sbjct: 133 EQRTATYITE-LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 188
Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVGRKNADVKASRSS 140
            T       GT+ Y+ PE+      G  H  K D++S G++  E  VG+     +A+   
Sbjct: 189 RTTLC----GTLDYLPPEM----IEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQ 238
Query: 141 DIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
           + Y   S  +   P  DF  +G              L+S   ++ NPS RP + EVLE
Sbjct: 239 ETYKRISRVEFTFP--DFVTEGARD-----------LISR-LLKHNPSQRPMLREVLE 282

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 76/168 (45%), Gaps = 20/168 (11%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +A+G+E+L    + + +H D+   NILL E    KI DFGLA+        +    AR  
Sbjct: 153 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLP 209
Query: 94  IGYIAPE-VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHI 152
           + ++APE +F R +   + +SDV+S+G+++ E+        + AS    +       + +
Sbjct: 210 LKWMAPETIFDRVY---TIQSDVWSFGVLLWEI------FSLGASPYPGVKIDEEFXRRL 260
Query: 153 EPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEML 200
           +       +G            M    L C    PS RP+  E++E L
Sbjct: 261 K-------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+ +         T
Sbjct: 130 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV-----AT 181
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 182 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+++D+    K++DFG AK+ + +   +     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---- 200
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 201 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+++D+    K++DFG AK+ + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---- 199
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 55/98 (56%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+++D+    +++DFGLAK+ + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC---- 199
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 77/167 (46%), Gaps = 29/167 (17%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +A  L Y H   + R++H DIKP N+LL      KI+DFG +  +   + T       GT
Sbjct: 120 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GT 172
Query: 94  IGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKH 151
           + Y+ PE+      G  H  K D++S G++  E  VG+     +A+   + Y   S  + 
Sbjct: 173 LDYLPPEM----IEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRISRVEF 226
Query: 152 IEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
             P  DF  +G              L+S   ++ NPS RP + EVLE
Sbjct: 227 TFP--DFVTEGARD-----------LISR-LLKHNPSQRPMLREVLE 259

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLX---- 199
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 58/107 (54%), Gaps = 6/107 (5%)
Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ- 77
           NR ++ + + ++   ++ G++YL        VH D+   N+LL      KISDFGL+K  
Sbjct: 463 NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 519
Query: 78  SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILE 124
             D+    +  H +  + + APE  C ++   S KSDV+S+G+++ E
Sbjct: 520 RADENYYKAQTHGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 564

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 22/181 (12%)
Query: 21  TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD 80
           TLE    Y     +A+G+E+L    + + +H D+   NILL E    KI DFGLA+    
Sbjct: 198 TLEHLICYSFQ--VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 252
Query: 81  KKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRS 139
               +    AR  + ++APE +F R +   + +SDV+S+G+++ E+        + AS  
Sbjct: 253 DPDYVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI------FSLGASPY 303
Query: 140 SDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEM 199
             +       + ++       +G            M    L C    PS RP+  E++E 
Sbjct: 304 PGVKIDEEFCRRLK-------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 356
Query: 200 L 200
           L
Sbjct: 357 L 357

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 58/107 (54%), Gaps = 6/107 (5%)
Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ- 77
           NR ++ + + ++   ++ G++YL        VH D+   N+LL      KISDFGL+K  
Sbjct: 464 NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 520
Query: 78  SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILE 124
             D+    +  H +  + + APE  C ++   S KSDV+S+G+++ E
Sbjct: 521 RADENYYKAQTHGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWE 565

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 77/167 (46%), Gaps = 29/167 (17%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +A  L Y H   + R++H DIKP N+LL      KI+DFG +  +   + T       GT
Sbjct: 121 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GT 173
Query: 94  IGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKH 151
           + Y+ PE+      G  H  K D++S G++  E  VG+     +A+   + Y   S  + 
Sbjct: 174 LDYLPPEM----IEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRISRVEF 227
Query: 152 IEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
             P  DF  +G              L+S   ++ NPS RP + EVLE
Sbjct: 228 TFP--DFVTEGARD-----------LISR-LLKHNPSQRPMLREVLE 260

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 80/182 (43%), Gaps = 24/182 (13%)
Query: 21  TLEWRTVYQIAGGIARGLEYL-HRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ 79
           TLE    Y     +A+G+E+L  R C    +H D+   NILL E    KI DFGLA+   
Sbjct: 146 TLEHLICYSFQ--VAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 80  DKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASR 138
                +    AR  + ++APE +F R +   + +SDV+S+G+++ E+        + AS 
Sbjct: 200 KDPDXVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI------FSLGASP 250
Query: 139 SSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
              +       + ++       +G            M    L C    PS RP+  E++E
Sbjct: 251 YPGVKIDEEFCRRLK-------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 303
Query: 199 ML 200
            L
Sbjct: 304 HL 305

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 77/167 (46%), Gaps = 29/167 (17%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +A  L Y H   + R++H DIKP N+LL      KI+DFG +  +   + T       GT
Sbjct: 114 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GT 166
Query: 94  IGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKH 151
           + Y+ PE+      G  H  K D++S G++  E  VG+     +A+   + Y   S  + 
Sbjct: 167 LDYLPPEM----IEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRISRVEF 220
Query: 152 IEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
             P  DF  +G              L+S   ++ NPS RP + EVLE
Sbjct: 221 TFP--DFVTEGARD-----------LISR-LLKHNPSQRPMLREVLE 253

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 80/182 (43%), Gaps = 24/182 (13%)
Query: 21  TLEWRTVYQIAGGIARGLEYL-HRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ 79
           TLE    Y     +A+G+E+L  R C    +H D+   NILL E    KI DFGLA+   
Sbjct: 183 TLEHLICYSFQ--VAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIY 236
Query: 80  DKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASR 138
                +    AR  + ++APE +F R +   + +SDV+S+G+++ E+        + AS 
Sbjct: 237 KDPDYVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI------FSLGASP 287
Query: 139 SSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
              +       + ++       +G            M    L C    PS RP+  E++E
Sbjct: 288 YPGVKIDEEFCRRLK-------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 340
Query: 199 ML 200
            L
Sbjct: 341 HL 342

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ + D+     M     T
Sbjct: 163 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 214
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 215 RWYRAPEIML-NWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 56/110 (50%), Gaps = 13/110 (11%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ---SQDKKSTISMLHA 90
           I  G+ YLH      I+H D+   N+LL  +   KI+DFGLA Q     +K  T+     
Sbjct: 121 IITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---- 173
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSS 140
            GT  YI+PE+  RS  G   +SDV+S G M   + +GR   D    +++
Sbjct: 174 -GTPNYISPEIATRSAHGL--ESDVWSLGCMFYTLLIGRPPFDTDTVKNT 220

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 22/181 (12%)
Query: 21  TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD 80
           TLE    Y     +A+G+E+L    + + +H D+   NILL E    KI DFGLA+    
Sbjct: 196 TLEHLICYSFQ--VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 250
Query: 81  KKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRS 139
               +    AR  + ++APE +F R +   + +SDV+S+G+++ E+        + AS  
Sbjct: 251 DPDYVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI------FSLGASPY 301
Query: 140 SDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEM 199
             +       + ++       +G            M    L C    PS RP+  E++E 
Sbjct: 302 PGVKIDEEFCRRLK-------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 354
Query: 200 L 200
           L
Sbjct: 355 L 355

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 80/182 (43%), Gaps = 24/182 (13%)
Query: 21  TLEWRTVYQIAGGIARGLEYL-HRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ 79
           TLE    Y     +A+G+E+L  R C    +H D+   NILL E    KI DFGLA+   
Sbjct: 189 TLEHLICYSFQ--VAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIY 242
Query: 80  DKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASR 138
                +    AR  + ++APE +F R +   + +SDV+S+G+++ E+        + AS 
Sbjct: 243 KDPDYVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI------FSLGASP 293
Query: 139 SSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
              +       + ++ G   +               M    L C    PS RP+  E++E
Sbjct: 294 YPGVKIDEEFCRRLKEGTRMR-------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 346
Query: 199 ML 200
            L
Sbjct: 347 HL 348

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   +     
Sbjct: 142 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 194
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 195 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 229

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 77/167 (46%), Gaps = 29/167 (17%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +A  L Y H   + R++H DIKP N+LL      KI+DFG +  +   + T       GT
Sbjct: 116 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GT 168
Query: 94  IGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKH 151
           + Y+ PE+      G  H  K D++S G++  E  VG+     +A+   + Y   S  + 
Sbjct: 169 LDYLPPEM----IEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRISRVEF 222
Query: 152 IEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
             P  DF  +G              L+S   ++ NPS RP + EVLE
Sbjct: 223 TFP--DFVTEGARD-----------LISR-LLKHNPSQRPMLREVLE 255

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 80/182 (43%), Gaps = 24/182 (13%)
Query: 21  TLEWRTVYQIAGGIARGLEYL-HRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ 79
           TLE    Y     +A+G+E+L  R C    +H D+   NILL E    KI DFGLA+   
Sbjct: 191 TLEHLICYSFQ--VAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIY 244
Query: 80  DKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASR 138
                +    AR  + ++APE +F R +   + +SDV+S+G+++ E+        + AS 
Sbjct: 245 KDPDYVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI------FSLGASP 295
Query: 139 SSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
              +       + ++       +G            M    L C    PS RP+  E++E
Sbjct: 296 YPGVKIDEEFCRRLK-------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 348
Query: 199 ML 200
            L
Sbjct: 349 HL 350

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 68/129 (52%), Gaps = 14/129 (10%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSLDQ           R  E + + +++  + +GL YL      +I+H D+KP NIL
Sbjct: 89  MDGGSLDQVL-----KKAGRIPE-QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNIL 140
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           ++     K+ DFG++ Q  D+ +        GT  Y++PE    +    S +SD++S G+
Sbjct: 141 VNSRGEIKLCDFGVSGQLIDEMAN----EFVGTRSYMSPERLQGTH--YSVQSDIWSMGL 194
Query: 121 MILEMAVGR 129
            ++EMAVGR
Sbjct: 195 SLVEMAVGR 203

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 69/129 (53%), Gaps = 9/129 (6%)
Query: 3   NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD 62
           + SLD+F Y Q    G +T+    + +IA  I + LE+LH    + ++H D+KP N+L++
Sbjct: 89  DTSLDKF-YKQVIDKG-QTIPEDILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLIN 144
Query: 63  EDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFG--GASHKSDVYSYGM 120
                K+ DFG++    D    ++     G   Y+APE         G S KSD++S G+
Sbjct: 145 ALGQVKMCDFGISGYLVDD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGI 201
Query: 121 MILEMAVGR 129
            ++E+A+ R
Sbjct: 202 TMIELAILR 210

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   +     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 200
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 201 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 235

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 86/195 (44%), Gaps = 38/195 (19%)
Query: 24  WRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS 83
           W      A  IA G+ YLH   ++ I+H D+  HN L+ E+    ++DFGLA+   D+K+
Sbjct: 107 WSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163
Query: 84  TISMLHAR------------GTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVGRK 130
               L +             G   ++APE+   RS+     K DV+S+G+++ E+ +GR 
Sbjct: 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY---DEKVDVFSFGIVLCEI-IGRV 219
Query: 131 NADVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXX---XXXXXXMILVSLWCIQTNP 187
           NAD         Y P ++        DF L+                   +++ C   +P
Sbjct: 220 NADPD-------YLPRTM--------DFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDP 264
Query: 188 SDRPSMHEVLEMLES 202
             RPS  ++   LE+
Sbjct: 265 EKRPSFVKLEHWLET 279

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   +     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 200
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 201 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 235

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   +     
Sbjct: 140 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 192
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 193 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 227

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   +     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 200
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 201 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 235

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   +     
Sbjct: 140 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 192
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 193 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 227

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   +     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 200
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 201 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 235

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   +     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 200
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 201 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   +     
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 200
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 201 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 235

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 80/182 (43%), Gaps = 24/182 (13%)
Query: 21  TLEWRTVYQIAGGIARGLEYL-HRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ 79
           TLE    Y     +A+G+E+L  R C    +H D+   NILL E    KI DFGLA+   
Sbjct: 137 TLEHLICYSFQ--VAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIY 190
Query: 80  DKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASR 138
                +    AR  + ++APE +F R +   + +SDV+S+G+++ E+        + AS 
Sbjct: 191 KDPDYVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI------FSLGASP 241
Query: 139 SSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
              +       + ++       +G            M    L C    PS RP+  E++E
Sbjct: 242 YPGVKIDEEFCRRLK-------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 294
Query: 199 ML 200
            L
Sbjct: 295 HL 296

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 77/167 (46%), Gaps = 29/167 (17%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +A  L Y H   + R++H DIKP N+LL      KI+DFG +  +   + T       GT
Sbjct: 117 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLC----GT 169
Query: 94  IGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKH 151
           + Y+ PE+      G  H  K D++S G++  E  VG+     +A+   + Y   S  + 
Sbjct: 170 LDYLPPEM----IEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRISRVEF 223
Query: 152 IEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
             P  DF  +G              L+S   ++ NPS RP + EVLE
Sbjct: 224 TFP--DFVTEGARD-----------LISR-LLKHNPSQRPMLREVLE 256

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 22/181 (12%)
Query: 21  TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD 80
           TLE    Y     +A+G+E+L    + + +H D+   NILL E    KI DFGLA+    
Sbjct: 148 TLEHLICYSFQ--VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 202
Query: 81  KKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRS 139
               +    AR  + ++APE +F R +   + +SDV+S+G+++ E+        + AS  
Sbjct: 203 DPDYVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI------FSLGASPY 253
Query: 140 SDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEM 199
             +       + ++       +G            M    L C    PS RP+  E++E 
Sbjct: 254 PGVKIDEEFCRRLK-------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 306
Query: 200 L 200
           L
Sbjct: 307 L 307

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   +     
Sbjct: 168 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 220
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 221 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 255

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 80/182 (43%), Gaps = 24/182 (13%)
Query: 21  TLEWRTVYQIAGGIARGLEYL-HRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ 79
           TLE    Y     +A+G+E+L  R C    +H D+   NILL E    KI DFGLA+   
Sbjct: 137 TLEHLICYSFQ--VAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIY 190
Query: 80  DKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASR 138
                +    AR  + ++APE +F R +   + +SDV+S+G+++ E+        + AS 
Sbjct: 191 KDPDYVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI------FSLGASP 241
Query: 139 SSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
              +       + ++       +G            M    L C    PS RP+  E++E
Sbjct: 242 YPGVKIDEEFCRRLK-------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 294
Query: 199 ML 200
            L
Sbjct: 295 HL 296

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 68/129 (52%), Gaps = 14/129 (10%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSLDQ           R  E + + +++  + +GL YL      +I+H D+KP NIL
Sbjct: 113 MDGGSLDQVL-----KKAGRIPE-QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNIL 164
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           ++     K+ DFG++ Q  D  +   +    GT  Y++PE    +    S +SD++S G+
Sbjct: 165 VNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTH--YSVQSDIWSMGL 218
Query: 121 MILEMAVGR 129
            ++EMAVGR
Sbjct: 219 SLVEMAVGR 227

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   +     
Sbjct: 168 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 220
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 221 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 255

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 68/129 (52%), Gaps = 14/129 (10%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSLDQ           R  E + + +++  + +GL YL      +I+H D+KP NIL
Sbjct: 105 MDGGSLDQVL-----KKAGRIPE-QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNIL 156
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           ++     K+ DFG++ Q  D  +   +    GT  Y++PE    +    S +SD++S G+
Sbjct: 157 VNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTH--YSVQSDIWSMGL 210
Query: 121 MILEMAVGR 129
            ++EMAVGR
Sbjct: 211 SLVEMAVGR 219

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 80/182 (43%), Gaps = 24/182 (13%)
Query: 21  TLEWRTVYQIAGGIARGLEYL-HRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ 79
           TLE    Y     +A+G+E+L  R C    +H D+   NILL E    KI DFGLA+   
Sbjct: 146 TLEHLICYSFQ--VAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 80  DKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASR 138
                +    AR  + ++APE +F R +   + +SDV+S+G+++ E+        + AS 
Sbjct: 200 KDPDYVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI------FSLGASP 250
Query: 139 SSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
              +       + ++       +G            M    L C    PS RP+  E++E
Sbjct: 251 YPGVKIDEEFCRRLK-------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 303
Query: 199 ML 200
            L
Sbjct: 304 HL 305

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 68/129 (52%), Gaps = 14/129 (10%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSLDQ           R  E + + +++  + +GL YL      +I+H D+KP NIL
Sbjct: 86  MDGGSLDQVL-----KKAGRIPE-QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNIL 137
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           ++     K+ DFG++ Q  D  +   +    GT  Y++PE    +    S +SD++S G+
Sbjct: 138 VNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTH--YSVQSDIWSMGL 191
Query: 121 MILEMAVGR 129
            ++EMAVGR
Sbjct: 192 SLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 68/129 (52%), Gaps = 14/129 (10%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSLDQ           R  E + + +++  + +GL YL      +I+H D+KP NIL
Sbjct: 86  MDGGSLDQVL-----KKAGRIPE-QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNIL 137
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           ++     K+ DFG++ Q  D  +   +    GT  Y++PE    +    S +SD++S G+
Sbjct: 138 VNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTH--YSVQSDIWSMGL 191
Query: 121 MILEMAVGR 129
            ++EMAVGR
Sbjct: 192 SLVEMAVGR 200

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 22/181 (12%)
Query: 21  TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD 80
           TLE    Y     +A+G+E+L    + + +H D+   NILL E    KI DFGLA+    
Sbjct: 142 TLEHLICYSFQ--VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYK 196
Query: 81  KKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRS 139
               +    AR  + ++APE +F R +   + +SDV+S+G+++ E+        + AS  
Sbjct: 197 DPDYVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI------FSLGASPY 247
Query: 140 SDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEM 199
             +       + ++       +G            M    L C    PS RP+  E++E 
Sbjct: 248 PGVKIDEEFCRRLK-------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300
Query: 200 L 200
           L
Sbjct: 301 L 301

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI D+GLA+ + D+     M     T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDE-----MTGYVAT 185
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 186 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 81/178 (45%), Gaps = 30/178 (16%)
Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK 82
           E RT   I   +A  L Y H   + R++H DIKP N+LL      KI+DFG +  +   +
Sbjct: 107 EQRTATYITE-LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 162
Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVGRKNADVKASRSS 140
            T       GT+ Y+ PE+      G  H  K D++S G++  E  VG+     +A+   
Sbjct: 163 RT----ELCGTLDYLPPEM----IEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQ 212
Query: 141 DIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
           + Y   S  +   P  DF  +G              L+S   ++ NPS RP + EVLE
Sbjct: 213 ETYKRISRVEFTFP--DFVTEGARD-----------LISR-LLKHNPSQRPMLREVLE 256

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 68/129 (52%), Gaps = 14/129 (10%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSLDQ           R  E + + +++  + +GL YL      +I+H D+KP NIL
Sbjct: 86  MDGGSLDQVL-----KKAGRIPE-QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNIL 137
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           ++     K+ DFG++ Q  D  +   +    GT  Y++PE    +    S +SD++S G+
Sbjct: 138 VNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTH--YSVQSDIWSMGL 191
Query: 121 MILEMAVGR 129
            ++EMAVGR
Sbjct: 192 SLVEMAVGR 200

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/107 (38%), Positives = 59/107 (55%), Gaps = 15/107 (14%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL---LDEDFCPKISDFGLAKQSQDK 81
           R ++Q+   +    +YLH   ++ IVH D+KP N+L   LDED    ISDFGL+K  +D 
Sbjct: 120 RLIFQVLDAV----KYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDP 171
Query: 82  KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            S +S   A GT GY+APEV  +     S   D +S G++   +  G
Sbjct: 172 GSVLST--ACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCG 214

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 68/129 (52%), Gaps = 14/129 (10%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSLDQ           R  E + + +++  + +GL YL      +I+H D+KP NIL
Sbjct: 148 MDGGSLDQVL-----KKAGRIPE-QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNIL 199
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           ++     K+ DFG++ Q  D  +   +    GT  Y++PE    +    S +SD++S G+
Sbjct: 200 VNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTH--YSVQSDIWSMGL 253
Query: 121 MILEMAVGR 129
            ++EMAVGR
Sbjct: 254 SLVEMAVGR 262

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 68/129 (52%), Gaps = 14/129 (10%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSLDQ           R  E + + +++  + +GL YL      +I+H D+KP NIL
Sbjct: 86  MDGGSLDQVL-----KKAGRIPE-QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNIL 137
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           ++     K+ DFG++ Q  D  +   +    GT  Y++PE    +    S +SD++S G+
Sbjct: 138 VNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTH--YSVQSDIWSMGL 191
Query: 121 MILEMAVGR 129
            ++EMAVGR
Sbjct: 192 SLVEMAVGR 200

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARG 92
           I RGL+Y+H   +  ++H D+KP N+LL+     KI DFGLA+ +  D   T  +     
Sbjct: 133 ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVA 189
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T  Y APE+   S  G +   D++S G ++ EM   R
Sbjct: 190 TRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARG 92
           I RGL+Y+H   +  ++H D+KP N+LL+     KI DFGLA+ +  D   T  +     
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 193
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T  Y APE+   S  G +   D++S G ++ EM   R
Sbjct: 194 TRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARG 92
           I RGL+Y+H   +  ++H D+KP N+LL+     KI DFGLA+ +  D   T  +     
Sbjct: 138 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 194
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T  Y APE+   S  G +   D++S G ++ EM   R
Sbjct: 195 TRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNR 230

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/107 (38%), Positives = 59/107 (55%), Gaps = 15/107 (14%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL---LDEDFCPKISDFGLAKQSQDK 81
           R ++Q+   +    +YLH   ++ IVH D+KP N+L   LDED    ISDFGL+K  +D 
Sbjct: 120 RLIFQVLDAV----KYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDP 171
Query: 82  KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            S +S   A GT GY+APEV  +     S   D +S G++   +  G
Sbjct: 172 GSVLST--ACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCG 214

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 68/129 (52%), Gaps = 14/129 (10%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSLDQ           R  E + + +++  + +GL YL      +I+H D+KP NIL
Sbjct: 86  MDGGSLDQVL-----KKAGRIPE-QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNIL 137
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           ++     K+ DFG++ Q  D  +   +    GT  Y++PE    +    S +SD++S G+
Sbjct: 138 VNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTH--YSVQSDIWSMGL 191
Query: 121 MILEMAVGR 129
            ++EMAVGR
Sbjct: 192 SLVEMAVGR 200

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 61/125 (48%), Gaps = 14/125 (11%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSL     D   S G   L    + + +  +   +EYL  G N   VH D+   N+L
Sbjct: 88  MAKGSL----VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-GNN--FVHRDLAARNVL 140
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + ED   K+SDFGL K++   + T      +  + + APE    +    S KSDV+S+G+
Sbjct: 141 VSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREA--AFSTKSDVWSFGI 193
Query: 121 MILEM 125
           ++ E+
Sbjct: 194 LLWEI 198

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/107 (38%), Positives = 59/107 (55%), Gaps = 15/107 (14%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL---LDEDFCPKISDFGLAKQSQDK 81
           R ++Q+   +    +YLH   ++ IVH D+KP N+L   LDED    ISDFGL+K  +D 
Sbjct: 120 RLIFQVLDAV----KYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDP 171
Query: 82  KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            S +S   A GT GY+APEV  +     S   D +S G++   +  G
Sbjct: 172 GSVLST--ACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCG 214

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARG 92
           I RGL+Y+H   +  ++H D+KP N+LL+     KI DFGLA+ +  D   T  +     
Sbjct: 133 ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T  Y APE+   S  G +   D++S G ++ EM   R
Sbjct: 190 TRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARG 92
           I RGL+Y+H   +  ++H D+KP N+LL+     KI DFGLA+ +  D   T  +     
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T  Y APE+   S  G +   D++S G ++ EM   R
Sbjct: 194 TRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARG 92
           I RGL+Y+H   +  ++H D+KP N+LL+     KI DFGLA+ +  D   T  +     
Sbjct: 133 ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T  Y APE+   S  G +   D++S G ++ EM   R
Sbjct: 190 TRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 59/117 (50%), Gaps = 11/117 (9%)
Query: 22  LEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL---DED--FCPKISDFGLAK 76
           ++W    ++   IA G+EY+ +  N  IVH D++  NI L   DE+   C K++DFGL++
Sbjct: 119 IKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177
Query: 77  QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNAD 133
           QS    S +      G   ++APE         + K+D YS+ M++  +  G    D
Sbjct: 178 QSVHSVSGL-----LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARG 92
           I RGL+Y+H   +  ++H D+KP N+LL+     KI DFGLA+ +  D   T  +     
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T  Y APE+   S  G +   D++S G ++ EM   R
Sbjct: 194 TRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/107 (38%), Positives = 59/107 (55%), Gaps = 15/107 (14%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL---LDEDFCPKISDFGLAKQSQDK 81
           R ++Q+   +    +YLH   ++ IVH D+KP N+L   LDED    ISDFGL+K  +D 
Sbjct: 120 RLIFQVLDAV----KYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDP 171
Query: 82  KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            S +S   A GT GY+APEV  +     S   D +S G++   +  G
Sbjct: 172 GSVLST--ACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCG 214

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 81/178 (45%), Gaps = 30/178 (16%)
Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK 82
           E RT   I   +A  L Y H   + R++H DIKP N+LL      KI+DFG +  +   +
Sbjct: 107 EQRTATYITE-LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 162
Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVGRKNADVKASRSS 140
            T       GT+ Y+ PE+      G  H  K D++S G++  E  VG+     +A+   
Sbjct: 163 RTDLC----GTLDYLPPEM----IEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQ 212
Query: 141 DIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
           + Y   S  +   P  DF  +G              L+S   ++ NPS RP + EVLE
Sbjct: 213 ETYKRISRVEFTFP--DFVTEGARD-----------LISR-LLKHNPSQRPMLREVLE 256

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 81/178 (45%), Gaps = 30/178 (16%)
Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK 82
           E RT   I   +A  L Y H   + R++H DIKP N+LL      KI+DFG +  +   +
Sbjct: 112 EQRTATYITE-LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 167
Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVGRKNADVKASRSS 140
            T       GT+ Y+ PE+      G  H  K D++S G++  E  VG+     +A+   
Sbjct: 168 RTDLC----GTLDYLPPEM----IEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQ 217
Query: 141 DIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
           + Y   S  +   P  DF  +G              L+S   ++ NPS RP + EVLE
Sbjct: 218 ETYKRISRVEFTFP--DFVTEGARD-----------LISR-LLKHNPSQRPMLREVLE 261

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 88/200 (44%), Gaps = 23/200 (11%)
Query: 8   QFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYL-HRGCNVRIVHFDIKPHNILLDEDFC 66
           +++Y+  S N    L  R +   +  +A+G+ +L  + C    +H D+   N+LL     
Sbjct: 150 EYSYN-PSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHV 204
Query: 67  PKISDFGLAKQSQDKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEM 125
            KI DFGLA+   +  + I   +AR  + ++APE +F   +   + +SDV+SYG+++ E+
Sbjct: 205 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY---TVQSDVWSYGILLWEI 261
Query: 126 AVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQT 185
                   +  +    I   +  YK ++       DG            +  +   C   
Sbjct: 262 ------FSLGLNPYPGILVNSKFYKLVK-------DGYQMAQPAFAPKNIYSIMQACWAL 308
Query: 186 NPSDRPSMHEVLEMLESSTE 205
            P+ RP+  ++   L+   +
Sbjct: 309 EPTHRPTFQQICSFLQEQAQ 328

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGL + + D+     M     T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE-----MTGYVAT 185
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 186 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 81/178 (45%), Gaps = 30/178 (16%)
Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK 82
           E RT   I   +A  L Y H   + R++H DIKP N+LL      KI+DFG +  +   +
Sbjct: 108 EQRTATYITE-LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163
Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVGRKNADVKASRSS 140
            T       GT+ Y+ PE+      G  H  K D++S G++  E  VG+     +A+   
Sbjct: 164 RTDLC----GTLDYLPPEM----IEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQ 213
Query: 141 DIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
           + Y   S  +   P  DF  +G              L+S   ++ NPS RP + EVLE
Sbjct: 214 ETYKRISRVEFTFP--DFVTEGARD-----------LISR-LLKHNPSQRPMLREVLE 257

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 80/182 (43%), Gaps = 38/182 (20%)
Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK 82
           E R  +Q    I   +EY HR    +IVH D+KP N+LLDE    KI+DFGL+    D  
Sbjct: 104 EARRFFQ---QIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 157
Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDI 142
              +   + G+  Y APEV       A  + DV+S G+++  M   R   D     S  +
Sbjct: 158 FLKT---SCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYVMLCRRLPFD---DESIPV 210
Query: 143 YFPN------SIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEV 196
            F N      ++ K + PG                   M++V       NP +R S+HE+
Sbjct: 211 LFKNISNGVYTLPKFLSPG------------AAGLIKRMLIV-------NPLNRISIHEI 251
Query: 197 LE 198
           ++
Sbjct: 252 MQ 253

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARG 92
           I RGL+Y+H   +  ++H D+KP N+LL+     KI DFGLA+ +  D   T  +     
Sbjct: 135 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T  Y APE+   S  G +   D++S G ++ EM   R
Sbjct: 192 TRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 80/182 (43%), Gaps = 38/182 (20%)
Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK 82
           E R  +Q    I   +EY HR    +IVH D+KP N+LLDE    KI+DFGL+    D  
Sbjct: 114 EARRFFQ---QIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 167
Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDI 142
              +   + G+  Y APEV       A  + DV+S G+++  M   R   D     S  +
Sbjct: 168 FLKT---SCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYVMLCRRLPFD---DESIPV 220
Query: 143 YFPN------SIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEV 196
            F N      ++ K + PG                   M++V       NP +R S+HE+
Sbjct: 221 LFKNISNGVYTLPKFLSPG------------AAGLIKRMLIV-------NPLNRISIHEI 261
Query: 197 LE 198
           ++
Sbjct: 262 MQ 263

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 90/201 (44%), Gaps = 24/201 (11%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NGSL  F    ++ +G + L    +  +A  IA G+ ++        +H +++  NIL
Sbjct: 85  MENGSLVDFL---KTPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHRNLRAANIL 137
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + +    KI+DFGLA+  +D + T +   A+  I + APE    ++G  + KSDV+S+G+
Sbjct: 138 VSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGI 194
Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSL 180
           ++ E+    +      +    I      Y+ + P N                  +  +  
Sbjct: 195 LLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN--------------CPEELYQLMR 240
Query: 181 WCIQTNPSDRPSMHEVLEMLE 201
            C +  P DRP+   +  +LE
Sbjct: 241 LCWKERPEDRPTFDYLRSVLE 261

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARG 92
           I RGL+Y+H   +  ++H D+KP N+LL+     KI DFGLA+ +  D   T  +     
Sbjct: 153 ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T  Y APE+   S  G +   D++S G ++ EM   R
Sbjct: 210 TRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 81/178 (45%), Gaps = 30/178 (16%)
Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK 82
           E RT   I   +A  L Y H   + R++H DIKP N+LL      KI+DFG +  +   +
Sbjct: 107 EQRTATYITE-LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 162
Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVGRKNADVKASRSS 140
            T       GT+ Y+ PE+      G  H  K D++S G++  E  VG+     +A+   
Sbjct: 163 RTDLC----GTLDYLPPEM----IEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQ 212
Query: 141 DIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
           + Y   S  +   P  DF  +G              L+S   ++ NPS RP + EVLE
Sbjct: 213 ETYKRISRVEFTFP--DFVTEGARD-----------LISR-LLKHNPSQRPMLREVLE 256

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARG 92
           I RGL+Y+H   +  ++H D+KP N+LL+     KI DFGLA+ +  D   T  +     
Sbjct: 135 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T  Y APE+   S  G +   D++S G ++ EM   R
Sbjct: 192 TRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARG 92
           I RGL+Y+H   +  ++H D+KP N+LL+     KI DFGLA+ +  D   T  +     
Sbjct: 141 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 197
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T  Y APE+   S  G +   D++S G ++ EM   R
Sbjct: 198 TRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARG 92
           I RGL+Y+H   +  ++H D+KP N+LL+     KI DFGLA+ +  D   T  +     
Sbjct: 133 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T  Y APE+   S  G +   D++S G ++ EM   R
Sbjct: 190 TRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARG 92
           I RGL+Y+H   +  ++H D+KP N+LL+     KI DFGLA+ +  D   T  +     
Sbjct: 131 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T  Y APE+   S  G +   D++S G ++ EM   R
Sbjct: 188 TRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 80/182 (43%), Gaps = 38/182 (20%)
Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK 82
           E R  +Q    I   +EY HR    +IVH D+KP N+LLDE    KI+DFGL+    D  
Sbjct: 108 EARRFFQ---QIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 161
Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDI 142
              +   + G+  Y APEV       A  + DV+S G+++  M   R   D     S  +
Sbjct: 162 FLKT---SCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYVMLCRRLPFD---DESIPV 214
Query: 143 YFPN------SIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEV 196
            F N      ++ K + PG                   M++V       NP +R S+HE+
Sbjct: 215 LFKNISNGVYTLPKFLSPG------------AAGLIKRMLIV-------NPLNRISIHEI 255
Query: 197 LE 198
           ++
Sbjct: 256 MQ 257

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARG 92
           I RGL+Y+H   +  ++H D+KP N+LL+     KI DFGLA+ +  D   T  +     
Sbjct: 133 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T  Y APE+   S  G +   D++S G ++ EM   R
Sbjct: 190 TRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARG 92
           I RGL+Y+H   +  ++H D+KP N+LL+     KI DFGLA+ +  D   T  +     
Sbjct: 131 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T  Y APE+   S  G +   D++S G ++ EM   R
Sbjct: 188 TRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNR 223

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARG 92
           I RGL+Y+H   +  ++H D+KP N+LL+     KI DFGLA+ +  D   T  +     
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T  Y APE+   S  G +   D++S G ++ EM   R
Sbjct: 194 TRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARG 92
           I RGL+Y+H   +  ++H D+KP N+LL+     KI DFGLA+ +  D   T  +     
Sbjct: 138 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 194
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T  Y APE+   S  G +   D++S G ++ EM   R
Sbjct: 195 TRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARG 92
           I RGL+Y+H   +  ++H D+KP N+LL+     KI DFGLA+ +  D   T  +     
Sbjct: 139 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 195
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T  Y APE+   S  G +   D++S G ++ EM   R
Sbjct: 196 TRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARG 92
           I RGL+Y+H   +  ++H D+KP N+LL+     KI DFGLA+ +  D   T  +     
Sbjct: 130 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 186
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T  Y APE+   S  G +   D++S G ++ EM   R
Sbjct: 187 TRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARG 92
           I RGL+Y+H   +  ++H D+KP N+LL+     KI DFGLA+ +  D   T  +     
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T  Y APE+   S  G +   D++S G ++ EM   R
Sbjct: 194 TRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 80/182 (43%), Gaps = 38/182 (20%)
Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK 82
           E R  +Q    I   +EY HR    +IVH D+KP N+LLDE    KI+DFGL+    D  
Sbjct: 113 EARRFFQ---QIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166
Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDI 142
              +   + G+  Y APEV       A  + DV+S G+++  M   R   D     S  +
Sbjct: 167 FLKT---SCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYVMLCRRLPFD---DESIPV 219
Query: 143 YFPN------SIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEV 196
            F N      ++ K + PG                   M++V       NP +R S+HE+
Sbjct: 220 LFKNISNGVYTLPKFLSPG------------AAGLIKRMLIV-------NPLNRISIHEI 260
Query: 197 LE 198
           ++
Sbjct: 261 MQ 262

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+++D+    +++DFG AK+ + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARG 92
           I RGL+Y+H   +  ++H D+KP N+LL+     KI DFGLA+ +  D   T  +     
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T  Y APE+   S  G +   D++S G ++ EM   R
Sbjct: 194 TRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARG 92
           I RGL+Y+H   +  ++H D+KP N+LL+     KI DFGLA+ +  D   T  +     
Sbjct: 153 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T  Y APE+   S  G +   D++S G ++ EM   R
Sbjct: 210 TRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/190 (22%), Positives = 82/190 (43%), Gaps = 22/190 (11%)
Query: 18  GNRTLEWRTVYQIAGGIARGLEYL-HRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK 76
            N T   R +   +  +A+G+ +L  + C    +H D+   N+LL      KI DFGLA+
Sbjct: 157 ANSTASTRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLAR 212
Query: 77  QSQDKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK 135
              +  + I   +AR  + ++APE +F   +   + +SDV+SYG+++ E+        + 
Sbjct: 213 DIMNDSNYIVKGNARLPVKWMAPESIFDCVY---TVQSDVWSYGILLWEI------FSLG 263
Query: 136 ASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHE 195
            +    I   +  YK ++       DG            +  +   C    P+ RP+  +
Sbjct: 264 LNPYPGILVNSKFYKLVK-------DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQ 316
Query: 196 VLEMLESSTE 205
           +   L+   +
Sbjct: 317 ICSFLQEQAQ 326

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 81/173 (46%), Gaps = 20/173 (11%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  I+  +EYL +      +H D+   N L+ E+   K++DFGL++       T +   
Sbjct: 121 MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXT-AHAG 176
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIY 149
           A+  I + APE    ++   S KSDV+++G+++ E+A       +      D+   + +Y
Sbjct: 177 AKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDL---SQVY 227
Query: 150 KHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLES 202
           + +E   D++++                    C Q NPSDRPS  E+ +  E+
Sbjct: 228 ELLE--KDYRMERPEGCPEKVYELMRA-----CWQWNPSDRPSFAEIHQAFET 273

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ-DKKSTISMLHARG 92
           I RGL+Y+H   +  ++H D+KP N+LL+     KI DFGLA+ +  D   T  +     
Sbjct: 135 ILRGLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T  Y APE+   S  G +   D++S G ++ EM   R
Sbjct: 192 TRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+++D+    +++DFG AK+ + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I EMA G
Sbjct: 200 -GTPEYLAPEIIISK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APE+      G +   D ++ G++I +MA G
Sbjct: 200 -GTPEYLAPEIILSK--GYNKAVDWWALGVLIYQMAAG 234

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 81/173 (46%), Gaps = 20/173 (11%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  I+  +EYL +      +H D+   N L+ E+   K++DFGL++       T +   
Sbjct: 117 MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXT-AHAG 172
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIY 149
           A+  I + APE    ++   S KSDV+++G+++ E+A       +      D+   + +Y
Sbjct: 173 AKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDL---SQVY 223
Query: 150 KHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLES 202
           + +E   D++++                    C Q NPSDRPS  E+ +  E+
Sbjct: 224 ELLE--KDYRMERPEGCPEKVYELMRA-----CWQWNPSDRPSFAEIHQAFET 269

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 83/179 (46%), Gaps = 32/179 (17%)
Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS-QDK 81
           E RT   I   +A  L Y H   + R++H DIKP N+LL      KI+DFG +  +   +
Sbjct: 108 EQRTATYITE-LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163
Query: 82  KSTISMLHARGTIGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVGRKNADVKASRS 139
           + T+      GT+ Y+ PE+      G  H  K D++S G++  E  VG+     +A+  
Sbjct: 164 RDTLC-----GTLDYLPPEM----IEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTY 212
Query: 140 SDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
            + Y   S  +   P  DF  +G              L+S   ++ NPS RP + EVLE
Sbjct: 213 QETYKRISRVEFTFP--DFVTEGARD-----------LISR-LLKHNPSQRPMLREVLE 257

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 81/178 (45%), Gaps = 30/178 (16%)
Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK 82
           E RT   I   +A  L Y H   + R++H DIKP N+LL      KI++FG +  +   +
Sbjct: 109 EQRTATYITE-LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR 164
Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVGRKNADVKASRSS 140
            T       GT+ Y+ PE+      G  H  K D++S G++  E  VG+     +A+   
Sbjct: 165 RTTLC----GTLDYLPPEM----IEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQ 214
Query: 141 DIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
           + Y   S  +   P  DF  +G              L+S   ++ NPS RP + EVLE
Sbjct: 215 ETYKRISRVEFTFP--DFVTEGARD-----------LISR-LLKHNPSQRPMLREVLE 258

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 81/178 (45%), Gaps = 30/178 (16%)
Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK 82
           E RT   I   +A  L Y H   + R++H DIKP N+LL      KI++FG +  +   +
Sbjct: 110 EQRTATYITE-LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR 165
Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVGRKNADVKASRSS 140
            T       GT+ Y+ PE+      G  H  K D++S G++  E  VG+     +A+   
Sbjct: 166 RTTLC----GTLDYLPPEM----IEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQ 215
Query: 141 DIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
           + Y   S  +   P  DF  +G              L+S   ++ NPS RP + EVLE
Sbjct: 216 ETYKRISRVEFTFP--DFVTEGARD-----------LISR-LLKHNPSQRPMLREVLE 259

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 81/173 (46%), Gaps = 20/173 (11%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  I+  +EYL +      +H D+   N L+ E+   K++DFGL++       T +   
Sbjct: 121 MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAG 176
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIY 149
           A+  I + APE    ++   S KSDV+++G+++ E+A       +      D+   + +Y
Sbjct: 177 AKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDL---SQVY 227
Query: 150 KHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLES 202
           + +E   D++++                    C Q NPSDRPS  E+ +  E+
Sbjct: 228 ELLE--KDYRMERPEGCPEKVYELMRA-----CWQWNPSDRPSFAEIHQAFET 273

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 81/173 (46%), Gaps = 20/173 (11%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  I+  +EYL +      +H D+   N L+ E+   K++DFGL++       T +   
Sbjct: 116 MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAG 171
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIY 149
           A+  I + APE    ++   S KSDV+++G+++ E+A       +      D+   + +Y
Sbjct: 172 AKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDL---SQVY 222
Query: 150 KHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLES 202
           + +E   D++++                    C Q NPSDRPS  E+ +  E+
Sbjct: 223 ELLE--KDYRMERPEGCPEKVYELMRA-----CWQWNPSDRPSFAEIHQAFET 268

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 81/173 (46%), Gaps = 20/173 (11%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  I+  +EYL +      +H D+   N L+ E+   K++DFGL++       T +   
Sbjct: 116 MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAG 171
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIY 149
           A+  I + APE    ++   S KSDV+++G+++ E+A       +      D+   + +Y
Sbjct: 172 AKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDL---SQVY 222
Query: 150 KHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLES 202
           + +E   D++++                    C Q NPSDRPS  E+ +  E+
Sbjct: 223 ELLE--KDYRMERPEGCPEKVYELMRA-----CWQWNPSDRPSFAEIHQAFET 268

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 81/173 (46%), Gaps = 20/173 (11%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  I+  +EYL +      +H D+   N L+ E+   K++DFGL++       T +   
Sbjct: 121 MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAG 176
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIY 149
           A+  I + APE    ++   S KSDV+++G+++ E+A       +      D+   + +Y
Sbjct: 177 AKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDL---SQVY 227
Query: 150 KHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLES 202
           + +E   D++++                    C Q NPSDRPS  E+ +  E+
Sbjct: 228 ELLE--KDYRMERPEGCPEKVYELMRA-----CWQWNPSDRPSFAEIHQAFET 273

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 60/106 (56%), Gaps = 10/106 (9%)
Query: 21  TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK-QSQ 79
           TL  + +   A  +ARG++YL +    + +H D+   NIL+ E++  KI+DFGL++ Q  
Sbjct: 128 TLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEV 184
Query: 80  DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
             K T+  L  R    ++A E    ++   +  SDV+SYG+++ E+
Sbjct: 185 YVKKTMGRLPVR----WMAIESL--NYSVYTTNSDVWSYGVLLWEI 224

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 81/173 (46%), Gaps = 20/173 (11%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  I+  +EYL +      +H D+   N L+ E+   K++DFGL++       T +   
Sbjct: 129 MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAG 184
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIY 149
           A+  I + APE    ++   S KSDV+++G+++ E+A       +      D+   + +Y
Sbjct: 185 AKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDL---SQVY 235
Query: 150 KHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLES 202
           + +E   D++++                    C Q NPSDRPS  E+ +  E+
Sbjct: 236 ELLE--KDYRMERPEGCPEKVYELMRA-----CWQWNPSDRPSFAEIHQAFET 281

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 81/173 (46%), Gaps = 20/173 (11%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  I+  +EYL +      +H D+   N L+ E+   K++DFGL++       T +   
Sbjct: 116 MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAG 171
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIY 149
           A+  I + APE    ++   S KSDV+++G+++ E+A       +      D+   + +Y
Sbjct: 172 AKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDL---SQVY 222
Query: 150 KHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLES 202
           + +E   D++++                    C Q NPSDRPS  E+ +  E+
Sbjct: 223 ELLE--KDYRMERPEGCPEKVYELMRA-----CWQWNPSDRPSFAEIHQAFET 268

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 81/173 (46%), Gaps = 20/173 (11%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  I+  +EYL +      +H D+   N L+ E+   K++DFGL++       T +   
Sbjct: 116 MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAG 171
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIY 149
           A+  I + APE    ++   S KSDV+++G+++ E+A       +      D+   + +Y
Sbjct: 172 AKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDL---SQVY 222
Query: 150 KHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLES 202
           + +E   D++++                    C Q NPSDRPS  E+ +  E+
Sbjct: 223 ELLE--KDYRMERPEGCPEKVYELMRA-----CWQWNPSDRPSFAEIHQAFET 268

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 60/106 (56%), Gaps = 10/106 (9%)
Query: 21  TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK-QSQ 79
           TL  + +   A  +ARG++YL +    + +H D+   NIL+ E++  KI+DFGL++ Q  
Sbjct: 138 TLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEV 194
Query: 80  DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
             K T+  L  R    ++A E    ++   +  SDV+SYG+++ E+
Sbjct: 195 YVKKTMGRLPVR----WMAIESL--NYSVYTTNSDVWSYGVLLWEI 234

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 60/125 (48%), Gaps = 14/125 (11%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSL     D   S G   L    + + +  +   +EYL  G N   VH D+   N+L
Sbjct: 82  MAKGSL----VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-GNN--FVHRDLAARNVL 134
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + ED   K+SDFGL K++   + T      +  + + APE         S KSDV+S+G+
Sbjct: 135 VSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREK--KFSTKSDVWSFGI 187
Query: 121 MILEM 125
           ++ E+
Sbjct: 188 LLWEI 192

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 81/173 (46%), Gaps = 20/173 (11%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  I+  +EYL +      +H D+   N L+ E+   K++DFGL++       T +   
Sbjct: 120 MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAG 175
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIY 149
           A+  I + APE    ++   S KSDV+++G+++ E+A       +      D+   + +Y
Sbjct: 176 AKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDL---SQVY 226
Query: 150 KHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLES 202
           + +E   D++++                    C Q NPSDRPS  E+ +  E+
Sbjct: 227 ELLE--KDYRMERPEGCPEKVYELMRA-----CWQWNPSDRPSFAEIHQAFET 272

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 81/173 (46%), Gaps = 20/173 (11%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  I+  +EYL +      +H D+   N L+ E+   K++DFGL++       T +   
Sbjct: 116 MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAG 171
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIY 149
           A+  I + APE    ++   S KSDV+++G+++ E+A       +      D+   + +Y
Sbjct: 172 AKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDL---SQVY 222
Query: 150 KHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLES 202
           + +E   D++++                    C Q NPSDRPS  E+ +  E+
Sbjct: 223 ELLE--KDYRMERPEGCPEKVYELMRA-----CWQWNPSDRPSFAEIHQAFET 268

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 80/178 (44%), Gaps = 30/178 (16%)
Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK 82
           E RT   I   +A  L Y H   + R++H DIKP N+LL      KI+DFG +  +   +
Sbjct: 110 EQRTATYITE-LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 165
Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVGRKNADVKASRSS 140
                    GT+ Y+ PE+      G  H  K D++S G++  E  VG+     +A+   
Sbjct: 166 RAALC----GTLDYLPPEM----IEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQ 215
Query: 141 DIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
           + Y   S  +   P  DF  +G              L+S   ++ NPS RP + EVLE
Sbjct: 216 ETYKRISRVEFTFP--DFVTEGARD-----------LISR-LLKHNPSQRPMLREVLE 259

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 80/178 (44%), Gaps = 30/178 (16%)
Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK 82
           E RT   I   +A  L Y H   + R++H DIKP N+LL      KI+DFG +  +   +
Sbjct: 112 EQRTATYITE-LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 167
Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVGRKNADVKASRSS 140
                    GT+ Y+ PE+      G  H  K D++S G++  E  VG+     +A+   
Sbjct: 168 RXX----LXGTLDYLPPEM----IEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQ 217
Query: 141 DIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
           + Y   S  +   P  DF  +G              L+S   ++ NPS RP + EVLE
Sbjct: 218 ETYKRISRVEFTFP--DFVTEGARD-----------LISR-LLKHNPSQRPMLREVLE 261

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 81/173 (46%), Gaps = 20/173 (11%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  I+  +EYL +      +H D+   N L+ E+   K++DFGL++       T +   
Sbjct: 121 MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAG 176
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIY 149
           A+  I + APE    ++   S KSDV+++G+++ E+A       +      D+   + +Y
Sbjct: 177 AKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDL---SQVY 227
Query: 150 KHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLES 202
           + +E   D++++                    C Q NPSDRPS  E+ +  E+
Sbjct: 228 ELLE--KDYRMERPEGCPEKVYELMRA-----CWQWNPSDRPSFAEIHQAFET 273

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 81/173 (46%), Gaps = 20/173 (11%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  I+  +EYL +      +H D+   N L+ E+   K++DFGL++       T +   
Sbjct: 117 MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-APAG 172
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIY 149
           A+  I + APE    ++   S KSDV+++G+++ E+A       +      D+   + +Y
Sbjct: 173 AKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDL---SQVY 223
Query: 150 KHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLES 202
           + +E   D++++                    C Q NPSDRPS  E+ +  E+
Sbjct: 224 ELLE--KDYRMERPEGCPEKVYELMRA-----CWQWNPSDRPSFAEIHQAFET 269

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 81/173 (46%), Gaps = 20/173 (11%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  I+  +EYL +      +H D+   N L+ E+   K++DFGL++       T +   
Sbjct: 116 MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAG 171
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIY 149
           A+  I + APE    ++   S KSDV+++G+++ E+A       +      D+   + +Y
Sbjct: 172 AKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDL---SQVY 222
Query: 150 KHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLES 202
           + +E   D++++                    C Q NPSDRPS  E+ +  E+
Sbjct: 223 ELLE--KDYRMERPEGCPEKVYELMRA-----CWQWNPSDRPSFAEIHQAFET 268

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 81/173 (46%), Gaps = 20/173 (11%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  I+  +EYL +      +H D+   N L+ E+   K++DFGL++       T +   
Sbjct: 121 MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAG 176
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIY 149
           A+  I + APE    ++   S KSDV+++G+++ E+A       +      D+   + +Y
Sbjct: 177 AKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDL---SQVY 227
Query: 150 KHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLES 202
           + +E   D++++                    C Q NPSDRPS  E+ +  E+
Sbjct: 228 ELLE--KDYRMERPEGCPEKVYELMRA-----CWQWNPSDRPSFAEIHQAFET 273

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/126 (31%), Positives = 62/126 (49%), Gaps = 16/126 (12%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSL     D   S G   L    + + +  +   +EYL  G N   VH D+   N+L
Sbjct: 97  MAKGSL----VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-GNN--FVHRDLAARNVL 149
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFC-RSFGGASHKSDVYSYG 119
           + ED   K+SDFGL K++   + T      +  + + APE    + F   S KSDV+S+G
Sbjct: 150 VSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREKKF---STKSDVWSFG 201
Query: 120 MMILEM 125
           +++ E+
Sbjct: 202 ILLWEI 207

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  IA  L YLH   ++ IV+ D+KP NILLD      ++DFGL K++ +  ST S    
Sbjct: 145 AAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTF-- 199
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+APEV  +         D +  G ++ EM  G
Sbjct: 200 CGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYG 235

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 81/173 (46%), Gaps = 20/173 (11%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  I+  +EYL +      +H D+   N L+ E+   K++DFGL++       T +   
Sbjct: 118 MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAG 173
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIY 149
           A+  I + APE    ++   S KSDV+++G+++ E+A       +      D+   + +Y
Sbjct: 174 AKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDL---SQVY 224
Query: 150 KHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLES 202
           + +E   D++++                    C Q NPSDRPS  E+ +  E+
Sbjct: 225 ELLE--KDYRMERPEGCPEKVYELMRA-----CWQWNPSDRPSFAEIHQAFET 270

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 81/173 (46%), Gaps = 20/173 (11%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  I+  +EYL +      +H D+   N L+ E+   K++DFGL++       T +   
Sbjct: 118 MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAG 173
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIY 149
           A+  I + APE    ++   S KSDV+++G+++ E+A       +      D+   + +Y
Sbjct: 174 AKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDL---SQVY 224
Query: 150 KHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLES 202
           + +E   D++++                    C Q NPSDRPS  E+ +  E+
Sbjct: 225 ELLE--KDYRMERPEGCPEKVYELMRA-----CWQWNPSDRPSFAEIHQAFET 270

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 81/173 (46%), Gaps = 20/173 (11%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  I+  +EYL +      +H D+   N L+ E+   K++DFGL++       T +   
Sbjct: 118 MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-APAG 173
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIY 149
           A+  I + APE    ++   S KSDV+++G+++ E+A       +      D+   + +Y
Sbjct: 174 AKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDL---SQVY 224
Query: 150 KHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLES 202
           + +E   D++++                    C Q NPSDRPS  E+ +  E+
Sbjct: 225 ELLE--KDYRMERPEGCPEKVYELMRA-----CWQWNPSDRPSFAEIHQAFET 270

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 10/98 (10%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           I   +     Y+H   N  I H D+KP NIL+D++   K+SDFG ++   DKK    +  
Sbjct: 156 IIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK----IKG 209
Query: 90  ARGTIGYIAPEVFCR--SFGGASHKSDVYSYGMMILEM 125
           +RGT  ++ PE F    S+ GA  K D++S G+ +  M
Sbjct: 210 SRGTYEFMPPEFFSNESSYNGA--KVDIWSLGICLYVM 245

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 80/178 (44%), Gaps = 30/178 (16%)
Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK 82
           E RT   I   +A  L Y H   + +++H DIKP N+LL      KI+DFG +  +   +
Sbjct: 107 EQRTATYITE-LANALSYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 162
Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVGRKNADVKASRSS 140
                    GT+ Y+ PE+      G  H  K D++S G++  E  VG+     +A+   
Sbjct: 163 RAALC----GTLDYLPPEM----IEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQ 212
Query: 141 DIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
           D Y   S  +   P  DF  +G              L+S   ++ NPS RP + EVLE
Sbjct: 213 DTYKRISRVEFTFP--DFVTEGARD-----------LISR-LLKHNPSQRPMLREVLE 256

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 8/104 (7%)
Query: 22  LEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDK 81
           L   T+  +     RGL++LH  C   IVH D+KP NIL+      K++DFGLA+    +
Sbjct: 109 LPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ 165
Query: 82  KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
              +++     T+ Y APEV  +S    +   D++S G +  EM
Sbjct: 166 ---MALFPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEM 204

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 76/167 (45%), Gaps = 29/167 (17%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +A  L Y H   + R++H DIKP N+LL      KI+DFG +  +   +         GT
Sbjct: 117 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GT 169
Query: 94  IGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKH 151
           + Y+ PE+      G  H  K D++S G++  E  VG+     +A+   + Y   S  + 
Sbjct: 170 LDYLPPEM----IEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRISRVEF 223
Query: 152 IEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
             P  DF  +G              L+S   ++ NPS RP + EVLE
Sbjct: 224 TFP--DFVTEGARD-----------LISR-LLKHNPSQRPMLREVLE 256

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 77/178 (43%), Gaps = 38/178 (21%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +  G+ YL       ++H D+   N L+ E+   K+SDFG+ +   D + T S    +  
Sbjct: 112 VCEGMAYLEEA---SVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFP 167
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-------GRKNADVKASRSS--DIYF 144
           + + +PEVF  SF   S KSDV+S+G+++ E+          R N++V    S+   +Y 
Sbjct: 168 VKWASPEVF--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 225
Query: 145 PNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLES 202
           P     H+     +Q+                     C +  P DRP+   +L  L +
Sbjct: 226 PRLASTHV-----YQIMNH------------------CWKERPEDRPAFSRLLRQLAA 260

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 80/178 (44%), Gaps = 30/178 (16%)
Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK 82
           E RT   I   +A  L Y H   + R++H DIKP N+LL      KI+DFG +  +   +
Sbjct: 109 EQRTATYITE-LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 164
Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVGRKNADVKASRSS 140
                    GT+ Y+ PE+      G  H  K D++S G++  E  VG+     +A+   
Sbjct: 165 RXXLC----GTLDYLPPEM----IEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQ 214
Query: 141 DIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
           + Y   S  +   P  DF  +G              L+S   ++ NPS RP + EVLE
Sbjct: 215 ETYKRISRVEFTFP--DFVTEGARD-----------LISR-LLKHNPSQRPMLREVLE 258

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + R L YLH   N  ++H DIK  +ILL  D   K+SDFG   Q   +      L   GT
Sbjct: 150 VLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXL--VGT 204
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
             ++APEV  R   G   + D++S G+M++EM  G
Sbjct: 205 PYWMAPEVISRLPYGT--EVDIWSLGIMVIEMIDG 237

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI  FGLA+ + D+     M     T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDE-----MTGYVAT 185
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 186 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 8/104 (7%)
Query: 22  LEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDK 81
           L   T+  +     RGL++LH  C   IVH D+KP NIL+      K++DFGLA+    +
Sbjct: 117 LPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ 173
Query: 82  KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
            +   ++    T+ Y APEV  +S    +   D++S G +  EM
Sbjct: 174 MALTPVV---VTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEM 212

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I   L+YLH   NV  V+ D+K  N++LD+D   KI+DFGL K+     +T+      GT
Sbjct: 260 IVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC--GT 315
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y+APEV   +  G +   D +  G+++ EM  GR
Sbjct: 316 PEYLAPEVLEDNDYGRA--VDWWGLGVVMYEMMCGR 349

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 76/167 (45%), Gaps = 29/167 (17%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +A  L Y H   + R++H DIKP N+LL      KI+DFG +  +   +         GT
Sbjct: 120 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GT 172
Query: 94  IGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKH 151
           + Y+ PE+      G  H  K D++S G++  E  VG+     +A+   + Y   S  + 
Sbjct: 173 LDYLPPEM----IEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRISRVEF 226
Query: 152 IEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
             P  DF  +G              L+S   ++ NPS RP + EVLE
Sbjct: 227 TFP--DFVTEGARD-----------LISR-LLKHNPSQRPMLREVLE 259

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 60/125 (48%), Gaps = 14/125 (11%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSL     D   S G   L    + + +  +   +EYL  G N   VH D+   N+L
Sbjct: 269 MAKGSL----VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-GNN--FVHRDLAARNVL 321
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + ED   K+SDFGL K++   + T      +  + + APE         S KSDV+S+G+
Sbjct: 322 VSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREK--KFSTKSDVWSFGI 374
Query: 121 MILEM 125
           ++ E+
Sbjct: 375 LLWEI 379

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 57/103 (55%), Gaps = 13/103 (12%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
           VYQ+     RGL+Y+H      I+H D+KP N+ ++ED   +I DFGLA+Q+ ++     
Sbjct: 137 VYQLL----RGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEE----- 184
Query: 87  MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           M     T  Y APE+   ++   +   D++S G ++ E+  G+
Sbjct: 185 MTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI D GLA+ + D+     M     T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDE-----MTGYVAT 185
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 186 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 76/167 (45%), Gaps = 29/167 (17%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +A  L Y H   + R++H DIKP N+LL      KI+DFG +  +   +         GT
Sbjct: 117 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GT 169
Query: 94  IGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKH 151
           + Y+ PE+      G  H  K D++S G++  E  VG+     +A+   + Y   S  + 
Sbjct: 170 LDYLPPEM----IEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQETYKRISRVEF 223
Query: 152 IEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
             P  DF  +G              L+S   ++ NPS RP + EVLE
Sbjct: 224 TFP--DFVTEGARD-----------LISR-LLKHNPSQRPMLREVLE 256

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI DF LA+ + D+     M     T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDE-----MTGYVAT 185
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 186 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/107 (34%), Positives = 58/107 (54%), Gaps = 8/107 (7%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           IA+G+ YL    +VR+VH D+   N+L+      KI+DFGLA+     ++       +  
Sbjct: 128 IAKGMSYLE---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVP 184
Query: 94  IGYIAPE-VFCRSFGGASHKSDVYSYGMMILE-MAVGRKNADVKASR 138
           I ++A E +  R F   +H+SDV+SYG+ + E M  G K  D   +R
Sbjct: 185 IKWMALESILRRRF---THQSDVWSYGVTVWELMTFGAKPYDGIPAR 228

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I   L+YLH   NV  V+ D+K  N++LD+D   KI+DFGL K+     +T+      GT
Sbjct: 257 IVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC--GT 312
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y+APEV   +  G +   D +  G+++ EM  GR
Sbjct: 313 PEYLAPEVLEDNDYGRA--VDWWGLGVVMYEMMCGR 346

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 58/103 (56%), Gaps = 13/103 (12%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
           VYQ+     RGL+Y+H   +  I+H D+KP N+ ++ED   +I DFGLA+Q+ ++     
Sbjct: 137 VYQLL----RGLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE----- 184
Query: 87  MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           M     T  Y APE+   ++   +   D++S G ++ E+  G+
Sbjct: 185 MTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 53/98 (54%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT  Y+AP +      G +   D ++ G++I EMA G
Sbjct: 200 -GTPEYLAPAIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 70/145 (48%), Gaps = 14/145 (9%)
Query: 1   MPNGSLDQFTYDQESSNGNR-TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP G L  +  + + + G++  L W         IA+G+ YL    + R+VH D+   N+
Sbjct: 98  MPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNV 148
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L+      KI+DFGLAK    ++        +  I ++A E         +H+SDV+SYG
Sbjct: 149 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYG 206
Query: 120 MMILE-MAVGRKNAD-VKASRSSDI 142
           + + E M  G K  D + AS  S I
Sbjct: 207 VTVWELMTFGSKPYDGIPASEISSI 231

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 58/103 (56%), Gaps = 13/103 (12%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
           VYQ+     RGL+Y+H   +  I+H D+KP N+ ++ED   +I DFGLA+Q+ ++     
Sbjct: 129 VYQLL----RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEE----- 176
Query: 87  MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           M     T  Y APE+   ++   +   D++S G ++ E+  G+
Sbjct: 177 MTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 70/145 (48%), Gaps = 14/145 (9%)
Query: 1   MPNGSLDQFTYDQESSNGNR-TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP G L  +  + + + G++  L W         IA+G+ YL    + R+VH D+   N+
Sbjct: 98  MPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNV 148
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L+      KI+DFGLAK    ++        +  I ++A E         +H+SDV+SYG
Sbjct: 149 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYG 206
Query: 120 MMILE-MAVGRKNAD-VKASRSSDI 142
           + + E M  G K  D + AS  S I
Sbjct: 207 VTVWELMTFGSKPYDGIPASEISSI 231

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 70/145 (48%), Gaps = 14/145 (9%)
Query: 1   MPNGSLDQFTYDQESSNGNR-TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP G L  +  + + + G++  L W         IA+G+ YL    + R+VH D+   N+
Sbjct: 98  MPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNV 148
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L+      KI+DFGLAK    ++        +  I ++A E         +H+SDV+SYG
Sbjct: 149 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYG 206
Query: 120 MMILE-MAVGRKNAD-VKASRSSDI 142
           + + E M  G K  D + AS  S I
Sbjct: 207 VTVWELMTFGSKPYDGIPASEISSI 231

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 70/145 (48%), Gaps = 14/145 (9%)
Query: 1   MPNGSLDQFTYDQESSNGNR-TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP G L  +  + + + G++  L W         IA+G+ YL    + R+VH D+   N+
Sbjct: 102 MPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNV 152
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L+      KI+DFGLAK    ++        +  I ++A E         +H+SDV+SYG
Sbjct: 153 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYG 210
Query: 120 MMILE-MAVGRKNAD-VKASRSSDI 142
           + + E M  G K  D + AS  S I
Sbjct: 211 VTVWELMTFGSKPYDGIPASEISSI 235

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 8/104 (7%)
Query: 22  LEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDK 81
           L   T+  +     RGL++LH  C   IVH D+KP NIL+      K++DFGLA+    +
Sbjct: 109 LPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ 165
Query: 82  KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
            +   ++    T+ Y APEV  +S    +   D++S G +  EM
Sbjct: 166 MALAPVV---VTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEM 204

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 70/145 (48%), Gaps = 14/145 (9%)
Query: 1   MPNGSLDQFTYDQESSNGNR-TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP G L  +  + + + G++  L W         IA+G+ YL    + R+VH D+   N+
Sbjct: 92  MPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNV 142
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L+      KI+DFGLAK    ++        +  I ++A E         +H+SDV+SYG
Sbjct: 143 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYG 200
Query: 120 MMILE-MAVGRKNAD-VKASRSSDI 142
           + + E M  G K  D + AS  S I
Sbjct: 201 VTVWELMTFGSKPYDGIPASEISSI 225

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 70/145 (48%), Gaps = 14/145 (9%)
Query: 1   MPNGSLDQFTYDQESSNGNR-TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP G L  +  + + + G++  L W         IA+G+ YL    + R+VH D+   N+
Sbjct: 104 MPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNV 154
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L+      KI+DFGLAK    ++        +  I ++A E         +H+SDV+SYG
Sbjct: 155 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYG 212
Query: 120 MMILE-MAVGRKNAD-VKASRSSDI 142
           + + E M  G K  D + AS  S I
Sbjct: 213 VTVWELMTFGSKPYDGIPASEISSI 237

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 70/145 (48%), Gaps = 14/145 (9%)
Query: 1   MPNGSLDQFTYDQESSNGNR-TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP G L  +  + + + G++  L W         IA+G+ YL    + R+VH D+   N+
Sbjct: 99  MPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNV 149
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L+      KI+DFGLAK    ++        +  I ++A E         +H+SDV+SYG
Sbjct: 150 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYG 207
Query: 120 MMILE-MAVGRKNAD-VKASRSSDI 142
           + + E M  G K  D + AS  S I
Sbjct: 208 VTVWELMTFGSKPYDGIPASEISSI 232

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 70/145 (48%), Gaps = 14/145 (9%)
Query: 1   MPNGSLDQFTYDQESSNGNR-TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP G L  +  + + + G++  L W         IA+G+ YL    + R+VH D+   N+
Sbjct: 98  MPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNV 148
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L+      KI+DFGLAK    ++        +  I ++A E         +H+SDV+SYG
Sbjct: 149 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYG 206
Query: 120 MMILE-MAVGRKNAD-VKASRSSDI 142
           + + E M  G K  D + AS  S I
Sbjct: 207 VTVWELMTFGSKPYDGIPASEISSI 231

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 70/145 (48%), Gaps = 14/145 (9%)
Query: 1   MPNGSLDQFTYDQESSNGNR-TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP G L  +  + + + G++  L W         IA+G+ YL    + R+VH D+   N+
Sbjct: 100 MPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNV 150
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L+      KI+DFGLAK    ++        +  I ++A E         +H+SDV+SYG
Sbjct: 151 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYG 208
Query: 120 MMILE-MAVGRKNAD-VKASRSSDI 142
           + + E M  G K  D + AS  S I
Sbjct: 209 VTVWELMTFGSKPYDGIPASEISSI 233

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 53/97 (54%), Gaps = 7/97 (7%)
Query: 30  IAGGIARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISML 88
            A  +A+G+E+L  + C    VH D+   N+L+      KI DFGLA+      + +   
Sbjct: 177 FAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRG 232
Query: 89  HARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
           +AR  + ++APE      G  + KSDV+SYG+++ E+
Sbjct: 233 NARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEI 267

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 70/145 (48%), Gaps = 14/145 (9%)
Query: 1   MPNGSLDQFTYDQESSNGNR-TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP G L  +  + + + G++  L W         IA+G+ YL    + R+VH D+   N+
Sbjct: 101 MPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNV 151
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L+      KI+DFGLAK    ++        +  I ++A E         +H+SDV+SYG
Sbjct: 152 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYG 209
Query: 120 MMILE-MAVGRKNAD-VKASRSSDI 142
           + + E M  G K  D + AS  S I
Sbjct: 210 VTVWELMTFGSKPYDGIPASEISSI 234

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 70/145 (48%), Gaps = 14/145 (9%)
Query: 1   MPNGSLDQFTYDQESSNGNR-TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP G L  +  + + + G++  L W         IA+G+ YL    + R+VH D+   N+
Sbjct: 99  MPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNV 149
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L+      KI+DFGLAK    ++        +  I ++A E         +H+SDV+SYG
Sbjct: 150 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYG 207
Query: 120 MMILE-MAVGRKNAD-VKASRSSDI 142
           + + E M  G K  D + AS  S I
Sbjct: 208 VTVWELMTFGSKPYDGIPASEISSI 232

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 70/145 (48%), Gaps = 14/145 (9%)
Query: 1   MPNGSLDQFTYDQESSNGNR-TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP G L  +  + + + G++  L W         IA+G+ YL    + R+VH D+   N+
Sbjct: 101 MPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNV 151
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L+      KI+DFGLAK    ++        +  I ++A E         +H+SDV+SYG
Sbjct: 152 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYG 209
Query: 120 MMILE-MAVGRKNAD-VKASRSSDI 142
           + + E M  G K  D + AS  S I
Sbjct: 210 VTVWELMTFGSKPYDGIPASEISSI 234

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 70/145 (48%), Gaps = 14/145 (9%)
Query: 1   MPNGSLDQFTYDQESSNGNR-TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP G L  +  + + + G++  L W         IA+G+ YL    + R+VH D+   N+
Sbjct: 105 MPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNV 155
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L+      KI+DFGLAK    ++        +  I ++A E         +H+SDV+SYG
Sbjct: 156 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYG 213
Query: 120 MMILE-MAVGRKNAD-VKASRSSDI 142
           + + E M  G K  D + AS  S I
Sbjct: 214 VTVWELMTFGSKPYDGIPASEISSI 238

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI D GLA+ + D+     M     T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDE-----MTGYVAT 185
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 186 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 70/145 (48%), Gaps = 14/145 (9%)
Query: 1   MPNGSLDQFTYDQESSNGNR-TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP G L  +  + + + G++  L W         IA+G+ YL    + R+VH D+   N+
Sbjct: 101 MPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNV 151
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L+      KI+DFGLAK    ++        +  I ++A E         +H+SDV+SYG
Sbjct: 152 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYG 209
Query: 120 MMILE-MAVGRKNAD-VKASRSSDI 142
           + + E M  G K  D + AS  S I
Sbjct: 210 VTVWELMTFGSKPYDGIPASEISSI 234

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 70/145 (48%), Gaps = 14/145 (9%)
Query: 1   MPNGSLDQFTYDQESSNGNR-TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP G L  +  + + + G++  L W         IA+G+ YL    + R+VH D+   N+
Sbjct: 100 MPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNV 150
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L+      KI+DFGLAK    ++        +  I ++A E         +H+SDV+SYG
Sbjct: 151 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYG 208
Query: 120 MMILE-MAVGRKNAD-VKASRSSDI 142
           + + E M  G K  D + AS  S I
Sbjct: 209 VTVWELMTFGSKPYDGIPASEISSI 233

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 73/146 (50%), Gaps = 16/146 (10%)
Query: 1   MPNGSLDQFTYDQESSNGNR-TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP G L  +  + + + G++  L W         IA+G+ YL    + R+VH D+   N+
Sbjct: 101 MPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNV 151
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSY 118
           L+      KI+DFGLAK    ++        +  I ++A E +  R +   +H+SDV+SY
Sbjct: 152 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY---THQSDVWSY 208
Query: 119 GMMILE-MAVGRKNAD-VKASRSSDI 142
           G+ + E M  G K  D + AS  S I
Sbjct: 209 GVTVWELMTFGSKPYDGIPASEISSI 234

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/97 (38%), Positives = 53/97 (54%), Gaps = 12/97 (12%)
Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-KISDFGLAKQSQDKKSTISMLHARGTI 94
           R L Y+H   +  I H DIKP N+LLD D    K+ DFG AKQ    +  +S + +R   
Sbjct: 167 RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR--- 220
Query: 95  GYIAPEVFCRSFGGASHKS--DVYSYGMMILEMAVGR 129
            Y APE+    FG   + S  DV+S G ++ E+ +G+
Sbjct: 221 YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 70/145 (48%), Gaps = 14/145 (9%)
Query: 1   MPNGSLDQFTYDQESSNGNR-TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP G L  +  + + + G++  L W         IA+G+ YL    + R+VH D+   N+
Sbjct: 105 MPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNV 155
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L+      KI+DFGLAK    ++        +  I ++A E         +H+SDV+SYG
Sbjct: 156 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYG 213
Query: 120 MMILE-MAVGRKNAD-VKASRSSDI 142
           + + E M  G K  D + AS  S I
Sbjct: 214 VTVWELMTFGSKPYDGIPASEISSI 238

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 70/145 (48%), Gaps = 14/145 (9%)
Query: 1   MPNGSLDQFTYDQESSNGNR-TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP G L  +  + + + G++  L W         IA+G+ YL    + R+VH D+   N+
Sbjct: 123 MPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNV 173
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L+      KI+DFGLAK    ++        +  I ++A E         +H+SDV+SYG
Sbjct: 174 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYG 231
Query: 120 MMILE-MAVGRKNAD-VKASRSSDI 142
           + + E M  G K  D + AS  S I
Sbjct: 232 VTVWELMTFGSKPYDGIPASEISSI 256

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 70/145 (48%), Gaps = 14/145 (9%)
Query: 1   MPNGSLDQFTYDQESSNGNR-TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP G L  +  + + + G++  L W         IA+G+ YL    + R+VH D+   N+
Sbjct: 108 MPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNV 158
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L+      KI+DFGLAK    ++        +  I ++A E         +H+SDV+SYG
Sbjct: 159 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYG 216
Query: 120 MMILE-MAVGRKNAD-VKASRSSDI 142
           + + E M  G K  D + AS  S I
Sbjct: 217 VTVWELMTFGSKPYDGIPASEISSI 241

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 70/145 (48%), Gaps = 14/145 (9%)
Query: 1   MPNGSLDQFTYDQESSNGNR-TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP G L  +  + + + G++  L W         IA+G+ YL    + R+VH D+   N+
Sbjct: 105 MPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNV 155
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L+      KI+DFGLAK    ++        +  I ++A E         +H+SDV+SYG
Sbjct: 156 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYG 213
Query: 120 MMILE-MAVGRKNAD-VKASRSSDI 142
           + + E M  G K  D + AS  S I
Sbjct: 214 VTVWELMTFGSKPYDGIPASEISSI 238

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 70/145 (48%), Gaps = 14/145 (9%)
Query: 1   MPNGSLDQFTYDQESSNGNR-TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP G L  +  + + + G++  L W         IA+G+ YL    + R+VH D+   N+
Sbjct: 98  MPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNV 148
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L+      KI+DFGLAK    ++        +  I ++A E         +H+SDV+SYG
Sbjct: 149 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYG 206
Query: 120 MMILE-MAVGRKNAD-VKASRSSDI 142
           + + E M  G K  D + AS  S I
Sbjct: 207 VTVWELMTFGSKPYDGIPASEISSI 231

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 58/117 (49%), Gaps = 11/117 (9%)
Query: 22  LEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL---DED--FCPKISDFGLAK 76
           ++W    ++   IA G+EY+ +  N  IVH D++  NI L   DE+   C K++DFG ++
Sbjct: 119 IKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ 177
Query: 77  QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNAD 133
           QS    S +      G   ++APE         + K+D YS+ M++  +  G    D
Sbjct: 178 QSVHSVSGL-----LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 57/95 (60%), Gaps = 9/95 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK--STISMLHAR 91
           +A+G++YL    + + VH D+   N +LDE F  K++DFGLA+   DK+  S  +   A+
Sbjct: 141 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAK 197
Query: 92  GTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEM 125
             + ++A E    + F   + KSDV+S+G+++ E+
Sbjct: 198 LPVKWMALESLQTQKF---TTKSDVWSFGVLLWEL 229

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 70/145 (48%), Gaps = 14/145 (9%)
Query: 1   MPNGSLDQFTYDQESSNGNR-TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP G L  +  + + + G++  L W         IA+G+ YL    + R+VH D+   N+
Sbjct: 132 MPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNV 182
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L+      KI+DFGLAK    ++        +  I ++A E         +H+SDV+SYG
Sbjct: 183 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYG 240
Query: 120 MMILE-MAVGRKNAD-VKASRSSDI 142
           + + E M  G K  D + AS  S I
Sbjct: 241 VTVWELMTFGSKPYDGIPASEISSI 265

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 78/181 (43%), Gaps = 27/181 (14%)
Query: 29  QIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD----KKST 84
           Q+AG IA G+ YL+     + VH D+   N ++ EDF  KI DFG+ +   +    +K  
Sbjct: 127 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGG 183
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYF 144
             +L  R    +++PE      G  +  SDV+S+G+++ E+A   +      S    +  
Sbjct: 184 KGLLPVR----WMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR- 236
Query: 145 PNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLESST 204
                        F ++G            ++ +   C Q NP  RPS  E++  ++   
Sbjct: 237 -------------FVMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIKEEM 283
Query: 205 E 205
           E
Sbjct: 284 E 284

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 57/95 (60%), Gaps = 9/95 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK--STISMLHAR 91
           +A+G++YL    + + VH D+   N +LDE F  K++DFGLA+   DK+  S  +   A+
Sbjct: 142 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 198
Query: 92  GTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEM 125
             + ++A E    + F   + KSDV+S+G+++ E+
Sbjct: 199 LPVKWMALESLQTQKF---TTKSDVWSFGVLLWEL 230

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 57/95 (60%), Gaps = 9/95 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK--STISMLHAR 91
           +A+G++YL    + + VH D+   N +LDE F  K++DFGLA+   DK+  S  +   A+
Sbjct: 161 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 217
Query: 92  GTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEM 125
             + ++A E    + F   + KSDV+S+G+++ E+
Sbjct: 218 LPVKWMALESLQTQKF---TTKSDVWSFGVLLWEL 249

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 56/97 (57%), Gaps = 6/97 (6%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +G+EYLH     +I+H DIKP N+L+ ED   KI+DFG++ + +   + +S  +  GT
Sbjct: 146 LIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLS--NTVGT 200
Query: 94  IGYIAPEVFCRSFGGASHKS-DVYSYGMMILEMAVGR 129
             ++APE    +    S K+ DV++ G+ +     G+
Sbjct: 201 PAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/97 (38%), Positives = 53/97 (54%), Gaps = 12/97 (12%)
Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-KISDFGLAKQSQDKKSTISMLHARGTI 94
           R L Y+H   +  I H DIKP N+LLD D    K+ DFG AKQ    +  +S + +R   
Sbjct: 161 RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--- 214
Query: 95  GYIAPEVFCRSFGGASHKS--DVYSYGMMILEMAVGR 129
            Y APE+    FG   + S  DV+S G ++ E+ +G+
Sbjct: 215 YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/97 (38%), Positives = 53/97 (54%), Gaps = 12/97 (12%)
Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-KISDFGLAKQSQDKKSTISMLHARGTI 94
           R L Y+H   +  I H DIKP N+LLD D    K+ DFG AKQ    +  +S + +R   
Sbjct: 171 RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--- 224
Query: 95  GYIAPEVFCRSFGGASHKS--DVYSYGMMILEMAVGR 129
            Y APE+    FG   + S  DV+S G ++ E+ +G+
Sbjct: 225 YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 57/95 (60%), Gaps = 9/95 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK--STISMLHAR 91
           +A+G++YL    + + VH D+   N +LDE F  K++DFGLA+   DK+  S  +   A+
Sbjct: 134 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 190
Query: 92  GTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEM 125
             + ++A E    + F   + KSDV+S+G+++ E+
Sbjct: 191 LPVKWMALESLQTQKF---TTKSDVWSFGVLLWEL 222

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 57/95 (60%), Gaps = 9/95 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK--STISMLHAR 91
           +A+G++YL    + + VH D+   N +LDE F  K++DFGLA+   DK+  S  +   A+
Sbjct: 141 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 197
Query: 92  GTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEM 125
             + ++A E    + F   + KSDV+S+G+++ E+
Sbjct: 198 LPVKWMALESLQTQKF---TTKSDVWSFGVLLWEL 229

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 9/131 (6%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           + + SLD+F Y Q    G +T+    + +IA  I + LE+LH    + ++H D+KP N+L
Sbjct: 114 LXDTSLDKF-YKQVIDKG-QTIPEDILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVL 169
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFG--GASHKSDVYSY 118
           ++     K  DFG++    D    ++     G   Y APE         G S KSD++S 
Sbjct: 170 INALGQVKXCDFGISGYLVDD---VAKDIDAGCKPYXAPERINPELNQKGYSVKSDIWSL 226
Query: 119 GMMILEMAVGR 129
           G+  +E+A+ R
Sbjct: 227 GITXIELAILR 237

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 77/169 (45%), Gaps = 20/169 (11%)
Query: 34  IARGLEYL-HRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           +A+G+ +L  + C    +H D+   NILL      KI DFGLA+  ++  + +   +AR 
Sbjct: 177 VAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARL 232
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHI 152
            + ++APE         + +SDV+SYG+ + E+        + +S    +   +  YK I
Sbjct: 233 PVKWMAPESIFNCV--YTFESDVWSYGIFLWEL------FSLGSSPYPGMPVDSKFYKMI 284
Query: 153 EPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLE 201
           +       +G            M  +   C   +P  RP+  ++++++E
Sbjct: 285 K-------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 57/95 (60%), Gaps = 9/95 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK--STISMLHAR 91
           +A+G++YL    + + VH D+   N +LDE F  K++DFGLA+   DK+  S  +   A+
Sbjct: 160 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 216
Query: 92  GTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEM 125
             + ++A E    + F   + KSDV+S+G+++ E+
Sbjct: 217 LPVKWMALESLQTQKF---TTKSDVWSFGVLLWEL 248

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/97 (38%), Positives = 53/97 (54%), Gaps = 12/97 (12%)
Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-KISDFGLAKQSQDKKSTISMLHARGTI 94
           R L Y+H   +  I H DIKP N+LLD D    K+ DFG AKQ    +  +S + +R   
Sbjct: 138 RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--- 191
Query: 95  GYIAPEVFCRSFGGASHKS--DVYSYGMMILEMAVGR 129
            Y APE+    FG   + S  DV+S G ++ E+ +G+
Sbjct: 192 YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/97 (38%), Positives = 53/97 (54%), Gaps = 12/97 (12%)
Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-KISDFGLAKQSQDKKSTISMLHARGTI 94
           R L Y+H   +  I H DIKP N+LLD D    K+ DFG AKQ    +  +S + +R   
Sbjct: 167 RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--- 220
Query: 95  GYIAPEVFCRSFGGASHKS--DVYSYGMMILEMAVGR 129
            Y APE+    FG   + S  DV+S G ++ E+ +G+
Sbjct: 221 YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/97 (38%), Positives = 53/97 (54%), Gaps = 12/97 (12%)
Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-KISDFGLAKQSQDKKSTISMLHARGTI 94
           R L Y+H   +  I H DIKP N+LLD D    K+ DFG AKQ    +  +S + +R   
Sbjct: 212 RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--- 265
Query: 95  GYIAPEVFCRSFGGASHKS--DVYSYGMMILEMAVGR 129
            Y APE+    FG   + S  DV+S G ++ E+ +G+
Sbjct: 266 YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 57/95 (60%), Gaps = 9/95 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK--STISMLHAR 91
           +A+G++YL    + + VH D+   N +LDE F  K++DFGLA+   DK+  S  +   A+
Sbjct: 142 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 198
Query: 92  GTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEM 125
             + ++A E    + F   + KSDV+S+G+++ E+
Sbjct: 199 LPVKWMALESLQTQKF---TTKSDVWSFGVLLWEL 230

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS-QDKKSTISMLHARG 92
           I+  L +LH+     I++ D+KP NI+L+     K++DFGL K+S  D   T +     G
Sbjct: 130 ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC---G 183
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           TI Y+APE+  RS  G +   D +S G ++ +M  G
Sbjct: 184 TIEYMAPEILMRS--GHNRAVDWWSLGALMYDMLTG 217

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 65/131 (49%), Gaps = 15/131 (11%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           MP G L         SN +   +W   Y     +   L+ +H   ++ ++H D+KP N+L
Sbjct: 157 MPGGDLVNLM-----SNYDVPEKWAKFY--TAEVVLALDAIH---SMGLIHRDVKPDNML 206
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASH---KSDVYS 117
           LD+    K++DFG   +  D+   +    A GT  YI+PEV  +S GG  +   + D +S
Sbjct: 207 LDKHGHLKLADFGTCMK-MDETGMVHCDTAVGTPDYISPEVL-KSQGGDGYYGRECDWWS 264
Query: 118 YGMMILEMAVG 128
            G+ + EM VG
Sbjct: 265 VGVFLFEMLVG 275

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 57/95 (60%), Gaps = 9/95 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK--STISMLHAR 91
           +A+G++YL    + + VH D+   N +LDE F  K++DFGLA+   DK+  S  +   A+
Sbjct: 140 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 196
Query: 92  GTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEM 125
             + ++A E    + F   + KSDV+S+G+++ E+
Sbjct: 197 LPVKWMALESLQTQKF---TTKSDVWSFGVLLWEL 228

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 58/117 (49%), Gaps = 11/117 (9%)
Query: 22  LEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL---DED--FCPKISDFGLAK 76
           ++W    ++   IA G+EY+ +  N  IVH D++  NI L   DE+   C K++DF L++
Sbjct: 119 IKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ 177
Query: 77  QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNAD 133
           QS    S +      G   ++APE         + K+D YS+ M++  +  G    D
Sbjct: 178 QSVHSVSGL-----LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 56/109 (51%), Gaps = 7/109 (6%)
Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS 78
            R +  RTV++    +   LE++H   + R++H DIKP N+ +      K+ D GL +  
Sbjct: 130 KRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186
Query: 79  QDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV 127
             K +    L   GT  Y++PE    +  G + KSD++S G ++ EMA 
Sbjct: 187 SSKTTAAHSL--VGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAA 231

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/97 (38%), Positives = 53/97 (54%), Gaps = 12/97 (12%)
Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-KISDFGLAKQSQDKKSTISMLHARGTI 94
           R L Y+H   +  I H DIKP N+LLD D    K+ DFG AKQ    +  +S + +R   
Sbjct: 169 RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--- 222
Query: 95  GYIAPEVFCRSFGGASHKS--DVYSYGMMILEMAVGR 129
            Y APE+    FG   + S  DV+S G ++ E+ +G+
Sbjct: 223 YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/97 (38%), Positives = 53/97 (54%), Gaps = 12/97 (12%)
Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-KISDFGLAKQSQDKKSTISMLHARGTI 94
           R L Y+H   +  I H DIKP N+LLD D    K+ DFG AKQ    +  +S + +R   
Sbjct: 145 RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR--- 198
Query: 95  GYIAPEVFCRSFGGASHKS--DVYSYGMMILEMAVGR 129
            Y APE+    FG   + S  DV+S G ++ E+ +G+
Sbjct: 199 YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 51/97 (52%), Gaps = 5/97 (5%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISML-HARG 92
           I RGL+Y+H   +  ++H D+KP N+L++     KI DFGLA+ +  +      L     
Sbjct: 153 ILRGLKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVA 209
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T  Y APE+   S  G +   D++S G ++ EM   R
Sbjct: 210 TRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/97 (38%), Positives = 53/97 (54%), Gaps = 12/97 (12%)
Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-KISDFGLAKQSQDKKSTISMLHARGTI 94
           R L Y+H   +  I H DIKP N+LLD D    K+ DFG AKQ    +  +S + +R   
Sbjct: 152 RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR--- 205
Query: 95  GYIAPEVFCRSFGGASHKS--DVYSYGMMILEMAVGR 129
            Y APE+    FG   + S  DV+S G ++ E+ +G+
Sbjct: 206 YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 57/95 (60%), Gaps = 9/95 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK--STISMLHAR 91
           +A+G++YL    + + VH D+   N +LDE F  K++DFGLA+   DK+  S  +   A+
Sbjct: 139 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 195
Query: 92  GTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEM 125
             + ++A E    + F   + KSDV+S+G+++ E+
Sbjct: 196 LPVKWMALESLQTQKF---TTKSDVWSFGVLLWEL 227

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I RGL+Y+H   +  I+H D+KP N+ ++ED   KI D GLA+ + D+     M     T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDE-----MTGYVAT 185
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 186 RWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/97 (38%), Positives = 53/97 (54%), Gaps = 12/97 (12%)
Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-KISDFGLAKQSQDKKSTISMLHARGTI 94
           R L Y+H   +  I H DIKP N+LLD D    K+ DFG AKQ    +  +S + +R   
Sbjct: 141 RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR--- 194
Query: 95  GYIAPEVFCRSFGGASHKS--DVYSYGMMILEMAVGR 129
            Y APE+    FG   + S  DV+S G ++ E+ +G+
Sbjct: 195 YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 57/95 (60%), Gaps = 9/95 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK--STISMLHAR 91
           +A+G++YL    + + VH D+   N +LDE F  K++DFGLA+   DK+  S  +   A+
Sbjct: 137 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193
Query: 92  GTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEM 125
             + ++A E    + F   + KSDV+S+G+++ E+
Sbjct: 194 LPVKWMALESLQTQKF---TTKSDVWSFGVLLWEL 225

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 7/96 (7%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I   LEYLH   +  +V+ DIK  N++LD+D   KI+DFGL K+     +T+      GT
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC--GT 168
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y+APEV   +  G +   D +  G+++ EM  GR
Sbjct: 169 PEYLAPEVLEDNDYGRA--VDWWGLGVVMYEMMCGR 202

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/117 (35%), Positives = 59/117 (50%), Gaps = 12/117 (10%)
Query: 16  SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-KISDFGL 74
           S   +TL    V      + R L Y+H   +  I H DIKP N+LLD D    K+ DFG 
Sbjct: 113 SRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169
Query: 75  AKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKS--DVYSYGMMILEMAVGR 129
           AKQ    +  +S + +R    Y APE+    FG   + S  DV+S G ++ E+ +G+
Sbjct: 170 AKQLVRGEPNVSXICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 53/101 (52%), Gaps = 16/101 (15%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD---EDFCPKISDFGLAKQSQDK 81
           R + Q+  GI     Y+H+    +IVH D+KP N+LL+   +D   +I DFGL+   +  
Sbjct: 130 RIIRQVLSGIT----YMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182
Query: 82  KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMI 122
           K    M    GT  YIAPEV     G    K DV+S G+++
Sbjct: 183 K---KMKDKIGTAYYIAPEVL---HGTYDEKCDVWSTGVIL 217

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 61/119 (51%), Gaps = 11/119 (9%)
Query: 11  YDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKIS 70
           +D    NG   L+ +   ++   I  G++Y HR     +VH D+KP N+LLD     KI+
Sbjct: 104 FDYICKNGR--LDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIA 158
Query: 71  DFGLAKQSQDKKSTISMLHARGTIGYIAPEVFC-RSFGGASHKSDVYSYGMMILEMAVG 128
           DFGL+    D +    +  + G+  Y APEV   R + G   + D++S G+++  +  G
Sbjct: 159 DFGLSNMMSDGE---FLRXSCGSPNYAAPEVISGRLYAGP--EVDIWSSGVILYALLCG 212

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/117 (35%), Positives = 59/117 (50%), Gaps = 12/117 (10%)
Query: 16  SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-KISDFGL 74
           S   +TL    V      + R L Y+H   +  I H DIKP N+LLD D    K+ DFG 
Sbjct: 113 SRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169
Query: 75  AKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKS--DVYSYGMMILEMAVGR 129
           AKQ    +  +S + +R    Y APE+    FG   + S  DV+S G ++ E+ +G+
Sbjct: 170 AKQLVRGEPNVSXICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/117 (35%), Positives = 59/117 (50%), Gaps = 12/117 (10%)
Query: 16  SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-KISDFGL 74
           S   +TL    V      + R L Y+H   +  I H DIKP N+LLD D    K+ DFG 
Sbjct: 113 SRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169
Query: 75  AKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKS--DVYSYGMMILEMAVGR 129
           AKQ    +  +S + +R    Y APE+    FG   + S  DV+S G ++ E+ +G+
Sbjct: 170 AKQLVRGEPNVSXICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/97 (38%), Positives = 53/97 (54%), Gaps = 12/97 (12%)
Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-KISDFGLAKQSQDKKSTISMLHARGTI 94
           R L Y+H   +  I H DIKP N+LLD D    K+ DFG AKQ    +  +S + +R   
Sbjct: 145 RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR--- 198
Query: 95  GYIAPEVFCRSFGGASHKS--DVYSYGMMILEMAVGR 129
            Y APE+    FG   + S  DV+S G ++ E+ +G+
Sbjct: 199 YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I   L+YLH   NV  V+ D+K  N++LD+D   KI+DFGL K+     +T+      GT
Sbjct: 119 IVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFC--GT 174
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y+APEV   +  G +   D +  G+++ EM  GR
Sbjct: 175 PEYLAPEVLEDNDYGRA--VDWWGLGVVMYEMMCGR 208

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/117 (35%), Positives = 59/117 (50%), Gaps = 12/117 (10%)
Query: 16  SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-KISDFGL 74
           S   +TL    V      + R L Y+H   +  I H DIKP N+LLD D    K+ DFG 
Sbjct: 114 SRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 170
Query: 75  AKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKS--DVYSYGMMILEMAVGR 129
           AKQ    +  +S + +R    Y APE+    FG   + S  DV+S G ++ E+ +G+
Sbjct: 171 AKQLVRGEPNVSXICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 77/169 (45%), Gaps = 20/169 (11%)
Query: 34  IARGLEYL-HRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           +A+G+ +L  + C    +H D+   NILL      KI DFGLA+  ++  + +   +AR 
Sbjct: 177 VAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 232
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHI 152
            + ++APE         + +SDV+SYG+ + E+        + +S    +   +  YK I
Sbjct: 233 PVKWMAPESIFNCV--YTFESDVWSYGIFLWEL------FSLGSSPYPGMPVDSKFYKMI 284
Query: 153 EPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLE 201
           +       +G            M  +   C   +P  RP+  ++++++E
Sbjct: 285 K-------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I   L+YLH   NV  V+ D+K  N++LD+D   KI+DFGL K+     +T+      GT
Sbjct: 118 IVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFC--GT 173
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y+APEV   +  G +   D +  G+++ EM  GR
Sbjct: 174 PEYLAPEVLEDNDYGRA--VDWWGLGVVMYEMMCGR 207

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 7/96 (7%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I   LEYLH   +  +V+ DIK  N++LD+D   KI+DFGL K+     +T+      GT
Sbjct: 119 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC--GT 173
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y+APEV   +  G +   D +  G+++ EM  GR
Sbjct: 174 PEYLAPEVLEDNDYGRA--VDWWGLGVVMYEMMCGR 207

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I   L+YLH   NV  V+ D+K  N++LD+D   KI+DFGL K+     +T+      GT
Sbjct: 117 IVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFC--GT 172
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y+APEV   +  G +   D +  G+++ EM  GR
Sbjct: 173 PEYLAPEVLEDNDYGRA--VDWWGLGVVMYEMMCGR 206

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/117 (35%), Positives = 59/117 (50%), Gaps = 12/117 (10%)
Query: 16  SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-KISDFGL 74
           S   +TL    V      + R L Y+H   +  I H DIKP N+LLD D    K+ DFG 
Sbjct: 117 SRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 173
Query: 75  AKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKS--DVYSYGMMILEMAVGR 129
           AKQ    +  +S + +R    Y APE+    FG   + S  DV+S G ++ E+ +G+
Sbjct: 174 AKQLVRGEPNVSXICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/97 (38%), Positives = 53/97 (54%), Gaps = 12/97 (12%)
Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-KISDFGLAKQSQDKKSTISMLHARGTI 94
           R L Y+H   +  I H DIKP N+LLD D    K+ DFG AKQ    +  +S + +R   
Sbjct: 146 RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--- 199
Query: 95  GYIAPEVFCRSFGGASHKS--DVYSYGMMILEMAVGR 129
            Y APE+    FG   + S  DV+S G ++ E+ +G+
Sbjct: 200 YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 77/169 (45%), Gaps = 20/169 (11%)
Query: 34  IARGLEYL-HRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           +A+G+ +L  + C    +H D+   NILL      KI DFGLA+  ++  + +   +AR 
Sbjct: 170 VAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 225
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHI 152
            + ++APE         + +SDV+SYG+ + E+        + +S    +   +  YK I
Sbjct: 226 PVKWMAPESIFNCV--YTFESDVWSYGIFLWEL------FSLGSSPYPGMPVDSKFYKMI 277
Query: 153 EPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLE 201
           +       +G            M  +   C   +P  RP+  ++++++E
Sbjct: 278 K-------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 319

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/97 (38%), Positives = 53/97 (54%), Gaps = 12/97 (12%)
Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-KISDFGLAKQSQDKKSTISMLHARGTI 94
           R L Y+H   +  I H DIKP N+LLD D    K+ DFG AKQ    +  +S + +R   
Sbjct: 133 RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR--- 186
Query: 95  GYIAPEVFCRSFGGASHKS--DVYSYGMMILEMAVGR 129
            Y APE+    FG   + S  DV+S G ++ E+ +G+
Sbjct: 187 YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 77/185 (41%), Gaps = 23/185 (12%)
Query: 20  RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ 79
           R L    +   A  I++G++YL     +++VH D+   NIL+ E    KISDFGL++   
Sbjct: 145 RALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 80  DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRS 139
           ++ S +     R  + ++A E         + +SDV+S+G+++ E+     N        
Sbjct: 202 EEDSXVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTLGGNP------- 252
Query: 140 SDIYFPNSIYKHIEPGNDFQL--DGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVL 197
                    Y  I P   F L   G            M  + L C +  P  RP   ++ 
Sbjct: 253 ---------YPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADIS 303
Query: 198 EMLES 202
           + LE 
Sbjct: 304 KDLEK 308

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/117 (35%), Positives = 59/117 (50%), Gaps = 12/117 (10%)
Query: 16  SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-KISDFGL 74
           S   +TL    V      + R L Y+H   +  I H DIKP N+LLD D    K+ DFG 
Sbjct: 113 SRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169
Query: 75  AKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKS--DVYSYGMMILEMAVGR 129
           AKQ    +  +S + +R    Y APE+    FG   + S  DV+S G ++ E+ +G+
Sbjct: 170 AKQLVRGEPNVSYICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 55/103 (53%), Gaps = 13/103 (12%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
           VYQ+     +GL Y+H      I+H D+KP N+ ++ED   KI DFGLA+Q+  +     
Sbjct: 134 VYQML----KGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE----- 181
Query: 87  MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           M     T  Y APEV   ++   +   D++S G ++ EM  G+
Sbjct: 182 MXGXVVTRWYRAPEVIL-NWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/117 (35%), Positives = 59/117 (50%), Gaps = 12/117 (10%)
Query: 16  SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-KISDFGL 74
           S   +TL    V      + R L Y+H   +  I H DIKP N+LLD D    K+ DFG 
Sbjct: 113 SRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169
Query: 75  AKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKS--DVYSYGMMILEMAVGR 129
           AKQ    +  +S + +R    Y APE+    FG   + S  DV+S G ++ E+ +G+
Sbjct: 170 AKQLVRGEPNVSYICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 77/169 (45%), Gaps = 20/169 (11%)
Query: 34  IARGLEYL-HRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           +A+G+ +L  + C    +H D+   NILL      KI DFGLA+  ++  + +   +AR 
Sbjct: 172 VAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 227
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHI 152
            + ++APE         + +SDV+SYG+ + E+        + +S    +   +  YK I
Sbjct: 228 PVKWMAPESIFNCV--YTFESDVWSYGIFLWEL------FSLGSSPYPGMPVDSKFYKMI 279
Query: 153 EPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLE 201
           +       +G            M  +   C   +P  RP+  ++++++E
Sbjct: 280 K-------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 321

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 60/106 (56%), Gaps = 10/106 (9%)
Query: 21  TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK-QSQ 79
           TL  + +   A  +ARG++YL +    + +H ++   NIL+ E++  KI+DFGL++ Q  
Sbjct: 135 TLSSQQLLHFAADVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSRGQEV 191
Query: 80  DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
             K T+  L  R    ++A E    ++   +  SDV+SYG+++ E+
Sbjct: 192 YVKKTMGRLPVR----WMAIESL--NYSVYTTNSDVWSYGVLLWEI 231

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 9/100 (9%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ-SQDKKSTISML 88
           +   + + L YLH      ++H DIK  +ILL  D   K+SDFG   Q S+D      ++
Sbjct: 146 VCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLV 202
Query: 89  HARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
              GT  ++APEV  RS      + D++S G+M++EM  G
Sbjct: 203 ---GTPYWMAPEVISRSLYAT--EVDIWSLGIMVIEMVDG 237

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 56/100 (56%), Gaps = 8/100 (8%)
Query: 26  TVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTI 85
           T+  +   + RGL++LH   + R+VH D+KP NIL+      K++DFGLA+    + +  
Sbjct: 121 TIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 177
Query: 86  SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
           S++    T+ Y APEV  +S    +   D++S G +  EM
Sbjct: 178 SVV---VTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEM 212

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 7/96 (7%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I   LEYLH   +  +V+ DIK  N++LD+D   KI+DFGL K+     +T+      GT
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC--GT 168
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y+APEV   +  G +   D +  G+++ EM  GR
Sbjct: 169 PEYLAPEVLEDNDYGRA--VDWWGLGVVMYEMMCGR 202

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 77/169 (45%), Gaps = 20/169 (11%)
Query: 34  IARGLEYL-HRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           +A+G+ +L  + C    +H D+   NILL      KI DFGLA+  ++  + +   +AR 
Sbjct: 154 VAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 209
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHI 152
            + ++APE         + +SDV+SYG+ + E+        + +S    +   +  YK I
Sbjct: 210 PVKWMAPESIFNCV--YTFESDVWSYGIFLWEL------FSLGSSPYPGMPVDSKFYKMI 261
Query: 153 EPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLE 201
           +       +G            M  +   C   +P  RP+  ++++++E
Sbjct: 262 K-------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 80/178 (44%), Gaps = 30/178 (16%)
Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK 82
           E RT   I   +A  L Y H   + R++H DIKP N+LL      KI+DFG +  +   +
Sbjct: 133 EQRTATYITE-LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 188
Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVGRKNADVKASRSS 140
                    GT+ Y+ PE+      G  H  K D++S G++  E  VG+     +A+   
Sbjct: 189 RDDLC----GTLDYLPPEM----IEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQ 238
Query: 141 DIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
           + Y   S  +   P  DF  +G              L+S   ++ NPS RP + EVLE
Sbjct: 239 ETYKRISRVEFTFP--DFVTEGARD-----------LISR-LLKHNPSQRPMLREVLE 282

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 37/97 (38%), Positives = 53/97 (54%), Gaps = 12/97 (12%)
Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-KISDFGLAKQSQDKKSTISMLHARGTI 94
           R L Y+H   +  I H DIKP N+LLD D    K+ DFG AKQ    +  +S + +R   
Sbjct: 133 RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--- 186
Query: 95  GYIAPEVFCRSFGGASHKS--DVYSYGMMILEMAVGR 129
            Y APE+    FG   + S  DV+S G ++ E+ +G+
Sbjct: 187 YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 56/100 (56%), Gaps = 8/100 (8%)
Query: 26  TVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTI 85
           T+  +   + RGL++LH   + R+VH D+KP NIL+      K++DFGLA+    + +  
Sbjct: 121 TIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 177
Query: 86  SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
           S++    T+ Y APEV  +S    +   D++S G +  EM
Sbjct: 178 SVV---VTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEM 212

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 56/100 (56%), Gaps = 8/100 (8%)
Query: 26  TVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTI 85
           T+  +   + RGL++LH   + R+VH D+KP NIL+      K++DFGLA+    + +  
Sbjct: 121 TIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 177
Query: 86  SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
           S++    T+ Y APEV  +S    +   D++S G +  EM
Sbjct: 178 SVV---VTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEM 212

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 8/104 (7%)
Query: 22  LEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDK 81
           L   T+  +     RGL++LH  C   IVH D+KP NIL+      K++DFGLA+    +
Sbjct: 109 LPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ 165
Query: 82  KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
            +   ++    T+ Y APEV  +S    +   D++S G +  EM
Sbjct: 166 MALDPVV---VTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEM 204

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 7/96 (7%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I   LEYLH   +  +V+ DIK  N++LD+D   KI+DFGL K+     +T+      GT
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC--GT 168
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y+APEV   +  G +   D +  G+++ EM  GR
Sbjct: 169 PEYLAPEVLEDNDYGRA--VDWWGLGVVMYEMMCGR 202

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 37/105 (35%), Positives = 55/105 (52%), Gaps = 9/105 (8%)
Query: 34  IARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           I+  L YLH RG    I++ D+K  N+LLD +   K++D+G+ K+      T S     G
Sbjct: 162 ISLALNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC--G 215
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKAS 137
           T  YIAPE+      G S   D ++ G+++ EM  GR   D+  S
Sbjct: 216 TPNYIAPEILRGEDYGFS--VDWWALGVLMFEMMAGRSPFDIVGS 258

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 72/146 (49%), Gaps = 16/146 (10%)
Query: 1   MPNGSLDQFTYDQESSNGNR-TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP G L  +  + + + G++  L W         IA G+ YL    + R+VH D+   N+
Sbjct: 95  MPFGCLLDYVREHKDNIGSQYLLNW------CVQIAEGMNYLE---DRRLVHRDLAARNV 145
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSY 118
           L+      KI+DFGLAK    ++        +  I ++A E +  R +   +H+SDV+SY
Sbjct: 146 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY---THQSDVWSY 202
Query: 119 GMMILE-MAVGRKNAD-VKASRSSDI 142
           G+ + E M  G K  D + AS  S I
Sbjct: 203 GVTVWELMTFGSKPYDGIPASEISSI 228

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 53/101 (52%), Gaps = 16/101 (15%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD---EDFCPKISDFGLAKQSQDK 81
           R + Q+  GI     Y+H+    +IVH D+KP N+LL+   +D   +I DFGL+   +  
Sbjct: 153 RIIRQVLSGIT----YMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 205
Query: 82  KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMI 122
           K    M    GT  YIAPEV     G    K DV+S G+++
Sbjct: 206 K---KMKDKIGTAYYIAPEVL---HGTYDEKCDVWSTGVIL 240

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 7/96 (7%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I   LEYLH   +  +V+ DIK  N++LD+D   KI+DFGL K+     +T+      GT
Sbjct: 117 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC--GT 171
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y+APEV   +  G +   D +  G+++ EM  GR
Sbjct: 172 PEYLAPEVLEDNDYGRA--VDWWGLGVVMYEMMCGR 205

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 7/96 (7%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I   LEYLH   +  +V+ DIK  N++LD+D   KI+DFGL K+     +T+      GT
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC--GT 168
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y+APEV   +  G +   D +  G+++ EM  GR
Sbjct: 169 PEYLAPEVLEDNDYGRA--VDWWGLGVVMYEMMCGR 202

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 53/101 (52%), Gaps = 16/101 (15%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD---EDFCPKISDFGLAKQSQDK 81
           R + Q+  GI     Y+H+    +IVH D+KP N+LL+   +D   +I DFGL+   +  
Sbjct: 154 RIIRQVLSGIT----YMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 206
Query: 82  KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMI 122
           K    M    GT  YIAPEV     G    K DV+S G+++
Sbjct: 207 K---KMKDKIGTAYYIAPEVL---HGTYDEKCDVWSTGVIL 241

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 7/96 (7%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I   LEYLH   +  +V+ DIK  N++LD+D   KI+DFGL K+     +T+      GT
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC--GT 168
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y+APEV   +  G +   D +  G+++ EM  GR
Sbjct: 169 PEYLAPEVLEDNDYGRA--VDWWGLGVVMYEMMCGR 202

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 7/95 (7%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I+  L +LH+     I++ D+KP NI+L+     K++DFGL K+S    +        GT
Sbjct: 130 ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFC--GT 184
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           I Y+APE+  RS  G +   D +S G ++ +M  G
Sbjct: 185 IEYMAPEILMRS--GHNRAVDWWSLGALMYDMLTG 217

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 77/181 (42%), Gaps = 27/181 (14%)
Query: 29  QIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD----KKST 84
           Q+AG IA G+ YL+     + VH D+   N ++ EDF  KI DFG+ +   +    +K  
Sbjct: 136 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGG 192
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYF 144
             +L  R    +++PE      G  +  SDV+S+G+++ E+A   +      S    +  
Sbjct: 193 KGLLPVR----WMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL-- 244
Query: 145 PNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLESST 204
                        F ++G            +  +   C Q NP  RPS  E++  ++   
Sbjct: 245 ------------RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 292
Query: 205 E 205
           E
Sbjct: 293 E 293

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 53/98 (54%), Gaps = 10/98 (10%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +   +     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT   +APE+      G +   D ++ G++I EMA G
Sbjct: 200 -GTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAG 234

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 77/185 (41%), Gaps = 23/185 (12%)
Query: 20  RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ 79
           R L    +   A  I++G++YL     +++VH D+   NIL+ E    KISDFGL++   
Sbjct: 145 RALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 80  DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRS 139
           ++ S +     R  + ++A E         + +SDV+S+G+++ E+     N        
Sbjct: 202 EEDSYVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTLGGNP------- 252
Query: 140 SDIYFPNSIYKHIEPGNDFQL--DGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVL 197
                    Y  I P   F L   G            M  + L C +  P  RP   ++ 
Sbjct: 253 ---------YPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADIS 303
Query: 198 EMLES 202
           + LE 
Sbjct: 304 KDLEK 308

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 56/108 (51%), Gaps = 9/108 (8%)
Query: 31  AGGIARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +  I+  L YLH RG    I++ D+K  N+LLD +   K++D+G+ K+      T S   
Sbjct: 112 SAEISLALNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC 167
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKAS 137
             GT  YIAPE+      G S   D ++ G+++ EM  GR   D+  S
Sbjct: 168 --GTPNYIAPEILRGEDYGFS--VDWWALGVLMFEMMAGRSPFDIVGS 211

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 56/110 (50%), Gaps = 14/110 (12%)
Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLA---KQSQ 79
           E R ++  A  I  GLE+LH+     I++ D+KP N+LLD+D   +ISD GLA   K  Q
Sbjct: 288 EPRAIFYTAQ-IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343
Query: 80  DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
            K    +     GT G++APE+            D ++ G+ + EM   R
Sbjct: 344 TKTKGYA-----GTPGFMAPELLLGE--EYDFSVDYFALGVTLYEMIAAR 386

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 80/178 (44%), Gaps = 30/178 (16%)
Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK 82
           E RT   I   +A  L Y H   + R++H DIKP N+LL      KI+DFG +  +   +
Sbjct: 110 EQRTATYITE-LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 165
Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVGRKNADVKASRSS 140
                    GT+ Y+ PE+      G  H  K D++S G++  E  VG+     +A+   
Sbjct: 166 RDDLC----GTLDYLPPEM----IEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQ 215
Query: 141 DIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
           + Y   S  +   P  DF  +G              L+S   ++ NPS RP + EVLE
Sbjct: 216 ETYKRISRVEFTFP--DFVTEGARD-----------LISR-LLKHNPSQRPMLREVLE 259

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 56/110 (50%), Gaps = 14/110 (12%)
Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLA---KQSQ 79
           E R ++  A  I  GLE+LH+     I++ D+KP N+LLD+D   +ISD GLA   K  Q
Sbjct: 288 EPRAIFYTAQ-IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343
Query: 80  DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
            K    +     GT G++APE+            D ++ G+ + EM   R
Sbjct: 344 TKTKGYA-----GTPGFMAPELLLGE--EYDFSVDYFALGVTLYEMIAAR 386

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 56/110 (50%), Gaps = 14/110 (12%)
Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLA---KQSQ 79
           E R ++  A  I  GLE+LH+     I++ D+KP N+LLD+D   +ISD GLA   K  Q
Sbjct: 288 EPRAIFYTAQ-IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343
Query: 80  DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
            K    +     GT G++APE+            D ++ G+ + EM   R
Sbjct: 344 TKTKGYA-----GTPGFMAPELLLGE--EYDFSVDYFALGVTLYEMIAAR 386

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/107 (36%), Positives = 57/107 (53%), Gaps = 16/107 (14%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP----KISDFGLAKQ-SQDK 81
           V ++   +   L Y H   +  +VH D+KP NIL  +D  P    KI DFGLA+    D+
Sbjct: 126 VAELMKQMMNALAYFH---SQHVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDE 181
Query: 82  KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            ST    +A GT  Y+APEVF R     + K D++S G+++  +  G
Sbjct: 182 HST----NAAGTALYMAPEVFKRD---VTFKCDIWSAGVVMYFLLTG 221

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 37/105 (35%), Positives = 55/105 (52%), Gaps = 9/105 (8%)
Query: 34  IARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           I+  L YLH RG    I++ D+K  N+LLD +   K++D+G+ K+      T S     G
Sbjct: 130 ISLALNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC--G 183
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKAS 137
           T  YIAPE+      G S   D ++ G+++ EM  GR   D+  S
Sbjct: 184 TPNYIAPEILRGEDYGFS--VDWWALGVLMFEMMAGRSPFDIVGS 226

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 55/107 (51%), Gaps = 16/107 (14%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD---EDFCPKISDFGLAKQSQDK 81
           R + Q+  GI     Y+H+    +IVH D+KP N+LL+   +D   +I DFGL+   +  
Sbjct: 136 RIIRQVLSGIT----YMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 188
Query: 82  KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           K    M    GT  YIAPEV     G    K DV+S G+++  +  G
Sbjct: 189 K---KMKDKIGTAYYIAPEVL---HGTYDEKCDVWSTGVILYILLSG 229

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 77/181 (42%), Gaps = 27/181 (14%)
Query: 29  QIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD----KKST 84
           Q+AG IA G+ YL+     + VH D+   N ++ EDF  KI DFG+ +   +    +K  
Sbjct: 164 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 220
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYF 144
             +L  R    +++PE      G  +  SDV+S+G+++ E+A   +      S    +  
Sbjct: 221 KGLLPVR----WMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL-- 272
Query: 145 PNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLESST 204
                        F ++G            +  +   C Q NP  RPS  E++  ++   
Sbjct: 273 ------------RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 320
Query: 205 E 205
           E
Sbjct: 321 E 321

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 81/173 (46%), Gaps = 20/173 (11%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  I+  +EYL +      +H ++   N L+ E+   K++DFGL++       T +   
Sbjct: 323 MATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAG 378
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIY 149
           A+  I + APE    ++   S KSDV+++G+++ E+A       +      D+   + +Y
Sbjct: 379 AKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL---SQVY 429
Query: 150 KHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLES 202
           + +E   D++++                    C Q NPSDRPS  E+ +  E+
Sbjct: 430 ELLE--KDYRMERPEGCPEKVYELMRA-----CWQWNPSDRPSFAEIHQAFET 475

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 37/105 (35%), Positives = 55/105 (52%), Gaps = 9/105 (8%)
Query: 34  IARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARG 92
           I+  L YLH RG    I++ D+K  N+LLD +   K++D+G+ K+      T S     G
Sbjct: 119 ISLALNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC--G 172
Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKAS 137
           T  YIAPE+      G S   D ++ G+++ EM  GR   D+  S
Sbjct: 173 TPNYIAPEILRGEDYGFS--VDWWALGVLMFEMMAGRSPFDIVGS 215

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 53/99 (53%), Gaps = 11/99 (11%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNIL-LDEDF---CPKISDFGLAKQSQDKKSTISMLH 89
           I + +EYLH   +  +VH D+KP NIL +DE     C +I DFG AKQ + +     ++ 
Sbjct: 130 IGKTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGL--LMT 184
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
              T  ++APEV  R   G     D++S G+++  M  G
Sbjct: 185 PCYTANFVAPEVLKRQ--GYDEGCDIWSLGILLYTMLAG 221

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 77/181 (42%), Gaps = 27/181 (14%)
Query: 29  QIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD----KKST 84
           Q+AG IA G+ YL+     + VH D+   N ++ EDF  KI DFG+ +   +    +K  
Sbjct: 129 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 185
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYF 144
             +L  R    +++PE      G  +  SDV+S+G+++ E+A   +      S    +  
Sbjct: 186 KGLLPVR----WMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL-- 237
Query: 145 PNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLESST 204
                        F ++G            +  +   C Q NP  RPS  E++  ++   
Sbjct: 238 ------------RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 285
Query: 205 E 205
           E
Sbjct: 286 E 286

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 53/99 (53%), Gaps = 11/99 (11%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNIL-LDEDF---CPKISDFGLAKQSQDKKSTISMLH 89
           I + +EYLH   +  +VH D+KP NIL +DE     C +I DFG AKQ + +     ++ 
Sbjct: 130 IGKTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGL--LMT 184
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
              T  ++APEV  R   G     D++S G+++  M  G
Sbjct: 185 PCYTANFVAPEVLKRQ--GYDEGCDIWSLGILLYTMLAG 221

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 56/110 (50%), Gaps = 14/110 (12%)
Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLA---KQSQ 79
           E R ++  A  I  GLE+LH+     I++ D+KP N+LLD+D   +ISD GLA   K  Q
Sbjct: 288 EPRAIFYTAQ-IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343
Query: 80  DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
            K    +     GT G++APE+            D ++ G+ + EM   R
Sbjct: 344 TKTKGYA-----GTPGFMAPELLLGE--EYDFSVDYFALGVTLYEMIAAR 386

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 77/181 (42%), Gaps = 27/181 (14%)
Query: 29  QIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD----KKST 84
           Q+AG IA G+ YL+     + VH D+   N ++ EDF  KI DFG+ +   +    +K  
Sbjct: 135 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 191
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYF 144
             +L  R    +++PE      G  +  SDV+S+G+++ E+A   +      S    +  
Sbjct: 192 KGLLPVR----WMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL-- 243
Query: 145 PNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLESST 204
                        F ++G            +  +   C Q NP  RPS  E++  ++   
Sbjct: 244 ------------RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 291
Query: 205 E 205
           E
Sbjct: 292 E 292

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 77/181 (42%), Gaps = 27/181 (14%)
Query: 29  QIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD----KKST 84
           Q+AG IA G+ YL+     + VH D+   N ++ EDF  KI DFG+ +   +    +K  
Sbjct: 135 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 191
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYF 144
             +L  R    +++PE      G  +  SDV+S+G+++ E+A   +      S    +  
Sbjct: 192 KGLLPVR----WMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL-- 243
Query: 145 PNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLESST 204
                        F ++G            +  +   C Q NP  RPS  E++  ++   
Sbjct: 244 ------------RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 291
Query: 205 E 205
           E
Sbjct: 292 E 292

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 45/79 (56%), Gaps = 3/79 (3%)
Query: 50  VHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGA 109
            H D+KP NIL+  D    + DFG+A  + D+K T  + +  GT+ Y APE F  S   A
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLT-QLGNTVGTLYYXAPERFSESH--A 212
Query: 110 SHKSDVYSYGMMILEMAVG 128
           ++++D+Y+   ++ E   G
Sbjct: 213 TYRADIYALTCVLYECLTG 231

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 65/131 (49%), Gaps = 15/131 (11%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           MP G L         SN +   +W   Y     +   L+ +H   ++  +H D+KP N+L
Sbjct: 156 MPGGDLVNLM-----SNYDVPEKWARFY--TAEVVLALDAIH---SMGFIHRDVKPDNML 205
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASH---KSDVYS 117
           LD+    K++DFG   +  +K+  +    A GT  YI+PEV  +S GG  +   + D +S
Sbjct: 206 LDKSGHLKLADFGTCMK-MNKEGMVRCDTAVGTPDYISPEVL-KSQGGDGYYGRECDWWS 263
Query: 118 YGMMILEMAVG 128
            G+ + EM VG
Sbjct: 264 VGVFLYEMLVG 274

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 60/127 (47%), Gaps = 20/127 (15%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSL  F    E S          +   +  IA G+ ++ +      +H D++  NIL
Sbjct: 258 MAKGSLLDFLKSDEGSKQPLP----KLIDFSAQIAEGMAFIEQR---NYIHRDLRAANIL 310
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           +      KI+DFGLA+           + A+  I + APE    +FG  + KSDV+S+G+
Sbjct: 311 VSASLVCKIADFGLAR-----------VGAKFPIKWTAPEAI--NFGSFTIKSDVWSFGI 357
Query: 121 MILEMAV 127
           +++E+  
Sbjct: 358 LLMEIVT 364

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 65/131 (49%), Gaps = 15/131 (11%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           MP G L         SN +   +W   Y     +   L+ +H   ++  +H D+KP N+L
Sbjct: 151 MPGGDLVNLM-----SNYDVPEKWARFY--TAEVVLALDAIH---SMGFIHRDVKPDNML 200
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASH---KSDVYS 117
           LD+    K++DFG   +  +K+  +    A GT  YI+PEV  +S GG  +   + D +S
Sbjct: 201 LDKSGHLKLADFGTCMK-MNKEGMVRCDTAVGTPDYISPEVL-KSQGGDGYYGRECDWWS 258
Query: 118 YGMMILEMAVG 128
            G+ + EM VG
Sbjct: 259 VGVFLYEMLVG 269

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 77/181 (42%), Gaps = 27/181 (14%)
Query: 29  QIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD----KKST 84
           Q+AG IA G+ YL+     + VH D+   N ++ EDF  KI DFG+ +   +    +K  
Sbjct: 133 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 189
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYF 144
             +L  R    +++PE      G  +  SDV+S+G+++ E+A   +      S    +  
Sbjct: 190 KGLLPVR----WMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL-- 241
Query: 145 PNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLESST 204
                        F ++G            +  +   C Q NP  RPS  E++  ++   
Sbjct: 242 ------------RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 289
Query: 205 E 205
           E
Sbjct: 290 E 290

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 65/131 (49%), Gaps = 15/131 (11%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           MP G L         SN +   +W   Y     +   L+ +H   ++  +H D+KP N+L
Sbjct: 156 MPGGDLVNLM-----SNYDVPEKWARFY--TAEVVLALDAIH---SMGFIHRDVKPDNML 205
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASH---KSDVYS 117
           LD+    K++DFG   +  +K+  +    A GT  YI+PEV  +S GG  +   + D +S
Sbjct: 206 LDKSGHLKLADFGTCMK-MNKEGMVRCDTAVGTPDYISPEVL-KSQGGDGYYGRECDWWS 263
Query: 118 YGMMILEMAVG 128
            G+ + EM VG
Sbjct: 264 VGVFLYEMLVG 274

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 77/181 (42%), Gaps = 27/181 (14%)
Query: 29  QIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD----KKST 84
           Q+AG IA G+ YL+     + VH D+   N ++ EDF  KI DFG+ +   +    +K  
Sbjct: 136 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 192
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYF 144
             +L  R    +++PE      G  +  SDV+S+G+++ E+A   +      S    +  
Sbjct: 193 KGLLPVR----WMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL-- 244
Query: 145 PNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLESST 204
                        F ++G            +  +   C Q NP  RPS  E++  ++   
Sbjct: 245 ------------RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 292
Query: 205 E 205
           E
Sbjct: 293 E 293

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 77/181 (42%), Gaps = 27/181 (14%)
Query: 29  QIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD----KKST 84
           Q+AG IA G+ YL+     + VH D+   N ++ EDF  KI DFG+ +   +    +K  
Sbjct: 132 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 188
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYF 144
             +L  R    +++PE      G  +  SDV+S+G+++ E+A   +      S    +  
Sbjct: 189 KGLLPVR----WMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL-- 240
Query: 145 PNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLESST 204
                        F ++G            +  +   C Q NP  RPS  E++  ++   
Sbjct: 241 ------------RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 288
Query: 205 E 205
           E
Sbjct: 289 E 289

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 77/181 (42%), Gaps = 27/181 (14%)
Query: 29  QIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD----KKST 84
           Q+AG IA G+ YL+     + VH D+   N ++ EDF  KI DFG+ +   +    +K  
Sbjct: 142 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYF 144
             +L  R    +++PE      G  +  SDV+S+G+++ E+A   +      S    +  
Sbjct: 199 KGLLPVR----WMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL-- 250
Query: 145 PNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLESST 204
                        F ++G            +  +   C Q NP  RPS  E++  ++   
Sbjct: 251 ------------RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298
Query: 205 E 205
           E
Sbjct: 299 E 299

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 6/96 (6%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + RGL Y HR    +++H D+KP N+L++E    K++DFGLA+       T    +   T
Sbjct: 109 LLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD--NEVVT 163
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y  P++   S    S + D++  G +  EMA GR
Sbjct: 164 LWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGR 198

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 77/181 (42%), Gaps = 27/181 (14%)
Query: 29  QIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD----KKST 84
           Q+AG IA G+ YL+     + VH D+   N ++ EDF  KI DFG+ +   +    +K  
Sbjct: 142 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYF 144
             +L  R    +++PE      G  +  SDV+S+G+++ E+A   +      S    +  
Sbjct: 199 KGLLPVR----WMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL-- 250
Query: 145 PNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLESST 204
                        F ++G            +  +   C Q NP  RPS  E++  ++   
Sbjct: 251 ------------RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298
Query: 205 E 205
           E
Sbjct: 299 E 299

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 57/95 (60%), Gaps = 9/95 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK--STISMLHAR 91
           +A+G+++L    + + VH D+   N +LDE F  K++DFGLA+   DK+  S  +   A+
Sbjct: 142 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 198
Query: 92  GTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEM 125
             + ++A E    + F   + KSDV+S+G+++ E+
Sbjct: 199 LPVKWMALESLQTQKF---TTKSDVWSFGVLLWEL 230

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 57/95 (60%), Gaps = 9/95 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK--STISMLHAR 91
           +A+G+++L    + + VH D+   N +LDE F  K++DFGLA+   DK+  S  +   A+
Sbjct: 143 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAK 199
Query: 92  GTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEM 125
             + ++A E    + F   + KSDV+S+G+++ E+
Sbjct: 200 LPVKWMALESLQTQKF---TTKSDVWSFGVLLWEL 231

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 81/173 (46%), Gaps = 20/173 (11%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  I+  +EYL +      +H ++   N L+ E+   K++DFGL++       T +   
Sbjct: 362 MATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAG 417
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIY 149
           A+  I + APE    ++   S KSDV+++G+++ E+A       +      D+   + +Y
Sbjct: 418 AKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL---SQVY 468
Query: 150 KHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLES 202
           + +E   D++++                    C Q NPSDRPS  E+ +  E+
Sbjct: 469 ELLE--KDYRMERPEGCPEKVYELMRA-----CWQWNPSDRPSFAEIHQAFET 514

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 57/95 (60%), Gaps = 9/95 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK--STISMLHAR 91
           +A+G+++L    + + VH D+   N +LDE F  K++DFGLA+   DK+  S  +   A+
Sbjct: 143 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 199
Query: 92  GTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEM 125
             + ++A E    + F   + KSDV+S+G+++ E+
Sbjct: 200 LPVKWMALESLQTQKF---TTKSDVWSFGVLLWEL 231

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 40/127 (31%), Positives = 65/127 (51%), Gaps = 13/127 (10%)
Query: 1   MPNGSLDQFTYDQESS-NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           +P+G L  F     +  + +R L +      +  I +G+EYL    + R VH D+   NI
Sbjct: 92  LPSGCLRDFLQRHRARLDASRLLLY------SSQICKGMEYLG---SRRCVHRDLAARNI 142
Query: 60  LLDEDFCPKISDFGLAK-QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSY 118
           L++ +   KI+DFGLAK    DK   +     +  I + APE    S    S +SDV+S+
Sbjct: 143 LVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESL--SDNIFSRQSDVWSF 200
Query: 119 GMMILEM 125
           G+++ E+
Sbjct: 201 GVVLYEL 207

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 57/95 (60%), Gaps = 9/95 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK--STISMLHAR 91
           +A+G+++L    + + VH D+   N +LDE F  K++DFGLA+   DK+  S  +   A+
Sbjct: 201 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 257
Query: 92  GTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEM 125
             + ++A E    + F   + KSDV+S+G+++ E+
Sbjct: 258 LPVKWMALESLQTQKF---TTKSDVWSFGVLLWEL 289

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 6/96 (6%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + RG+ + H+    RI+H D+KP N+L++ D   K++DFGLA+         S  H   T
Sbjct: 128 LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF--GIPVRSYTHEVVT 182
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y AP+V   S    S   D++S G +  EM  G+
Sbjct: 183 LWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 57/95 (60%), Gaps = 9/95 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK--STISMLHAR 91
           +A+G+++L    + + VH D+   N +LDE F  K++DFGLA+   DK+  S  +   A+
Sbjct: 142 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 198
Query: 92  GTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEM 125
             + ++A E    + F   + KSDV+S+G+++ E+
Sbjct: 199 LPVKWMALESLQTQKF---TTKSDVWSFGVLLWEL 230

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 6/96 (6%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + RG+ + H+    RI+H D+KP N+L++ D   K++DFGLA+         S  H   T
Sbjct: 128 LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF--GIPVRSYTHEVVT 182
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y AP+V   S    S   D++S G +  EM  G+
Sbjct: 183 LWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGK 217

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 57/95 (60%), Gaps = 9/95 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK--STISMLHAR 91
           +A+G+++L    + + VH D+   N +LDE F  K++DFGLA+   DK+  S  +   A+
Sbjct: 140 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 196
Query: 92  GTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEM 125
             + ++A E    + F   + KSDV+S+G+++ E+
Sbjct: 197 LPVKWMALESLQTQKF---TTKSDVWSFGVLLWEL 228

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 57/95 (60%), Gaps = 9/95 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK--STISMLHAR 91
           +A+G+++L    + + VH D+   N +LDE F  K++DFGLA+   DK+  S  +   A+
Sbjct: 147 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 203
Query: 92  GTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEM 125
             + ++A E    + F   + KSDV+S+G+++ E+
Sbjct: 204 LPVKWMALESLQTQKF---TTKSDVWSFGVLLWEL 235

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 77/181 (42%), Gaps = 27/181 (14%)
Query: 29  QIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD----KKST 84
           Q+AG IA G+ YL+     + VH D+   N  + EDF  KI DFG+ +   +    +K  
Sbjct: 129 QMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGG 185
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYF 144
             +L  R    +++PE      G  +  SDV+S+G+++ E+A   +      S    +  
Sbjct: 186 KGLLPVR----WMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL-- 237
Query: 145 PNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLESST 204
                        F ++G            ++ +   C Q NP  RPS  E++  ++   
Sbjct: 238 ------------RFVMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIKEEM 285
Query: 205 E 205
           E
Sbjct: 286 E 286

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/112 (31%), Positives = 57/112 (50%), Gaps = 10/112 (8%)
Query: 21  TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD 80
           TL  +   +I   +   +  LH+   + IVH D+KP NILLD+D   K++DFG + Q   
Sbjct: 120 TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176
Query: 81  KKSTISMLHARGTIGYIAPEVFCRSFG----GASHKSDVYSYGMMILEMAVG 128
            +   S+    GT  Y+APE+   S      G   + D++S G+++  +  G
Sbjct: 177 GEKLRSVC---GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/124 (32%), Positives = 67/124 (54%), Gaps = 22/124 (17%)
Query: 17  NGNRTLEWR---TVYQIAGGIARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDF 72
           NG  T+E R       I   IA  +E+LH +G    ++H D+KP NI    D   K+ DF
Sbjct: 107 NGRCTIEERERSVCLHIFLQIAEAVEFLHSKG----LMHRDLKPSNIFFTMDDVVKVGDF 162
Query: 73  GLAK---QSQDKKSTISML--HAR-----GTIGYIAPEVFCRSFGGA-SHKSDVYSYGMM 121
           GL     Q +++++ ++ +  +AR     GT  Y++PE   +  G + SHK D++S G++
Sbjct: 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPE---QIHGNSYSHKVDIFSLGLI 219
Query: 122 ILEM 125
           + E+
Sbjct: 220 LFEL 223

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 60/124 (48%), Gaps = 4/124 (3%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
            G I   LE+LH+   + I++ DIK  NILLD +    ++DFGL+K+    ++  +    
Sbjct: 165 VGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 221
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYK 150
            GTI Y+AP++      G     D +S G+++ E+  G     V   ++S       I K
Sbjct: 222 -GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 280
Query: 151 HIEP 154
              P
Sbjct: 281 SEPP 284

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 66/125 (52%), Gaps = 16/125 (12%)
Query: 3   NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD 62
            G+L+Q+   +     ++ L      QI     +G++Y+H   + +++H D+KP NI L 
Sbjct: 118 KGTLEQWIEKRRGEKLDKVLALELFEQIT----KGVDYIH---SKKLIHRDLKPSNIFLV 170
Query: 63  EDFCPKISDFGLAKQ-SQDKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGM 120
           +    KI DFGL      D K T     ++GT+ Y++PE +  + +G    + D+Y+ G+
Sbjct: 171 DTKQVKIGDFGLVTSLKNDGKRT----RSKGTLRYMSPEQISSQDYG---KEVDLYALGL 223
Query: 121 MILEM 125
           ++ E+
Sbjct: 224 ILAEL 228

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 53/94 (56%), Gaps = 10/94 (10%)
Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIG 95
           +GLEYLH+     I+H D+KP+N+LLDE+   K++DFGLAK         +  H   T  
Sbjct: 123 QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYXHQVVTRW 177
Query: 96  YIAPEVF--CRSFGGASHKSDVYSYGMMILEMAV 127
           Y APE+    R +G      D+++ G ++ E+ +
Sbjct: 178 YRAPELLFGARMYGVG---VDMWAVGCILAELLL 208

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/107 (37%), Positives = 53/107 (49%), Gaps = 16/107 (14%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGLAKQSQDK 81
           R + Q+  GI     Y+H+     IVH D+KP NILL   ++D   KI DFGL+   Q  
Sbjct: 125 RIIKQVFSGIT----YMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-- 175
Query: 82  KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
                M    GT  YIAPEV     G    K DV+S G+++  +  G
Sbjct: 176 -QNTKMKDRIGTAYYIAPEVLR---GTYDEKCDVWSAGVILYILLSG 218

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 76/185 (41%), Gaps = 23/185 (12%)
Query: 20  RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ 79
           R L    +   A  I++G++YL     + +VH D+   NIL+ E    KISDFGL++   
Sbjct: 145 RALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 80  DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRS 139
           ++ S +     R  + ++A E         + +SDV+S+G+++ E+     N        
Sbjct: 202 EEDSXVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTLGGNP------- 252
Query: 140 SDIYFPNSIYKHIEPGNDFQL--DGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVL 197
                    Y  I P   F L   G            M  + L C +  P  RP   ++ 
Sbjct: 253 ---------YPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADIS 303
Query: 198 EMLES 202
           + LE 
Sbjct: 304 KDLEK 308

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 56/104 (53%), Gaps = 9/104 (8%)
Query: 31  AGGIARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           A  I+ GL +LH RG    I++ D+K  N++LD +   KI+DFG+ K+       ++   
Sbjct: 126 AAEISIGLFFLHKRG----IIYRDLKLDNVMLDSEGHIKIADFGMCKEHM--MDGVTTRE 179
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNAD 133
             GT  YIAPE+      G S   D ++YG+++ EM  G+   D
Sbjct: 180 FCGTPDYIAPEIIAYQPYGKS--VDWWAYGVLLYEMLAGQPPFD 221

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 57/103 (55%), Gaps = 13/103 (12%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
           VYQ+     +GL+Y+H   +  +VH D+KP N+ ++ED   KI DFGLA+ +  + +   
Sbjct: 150 VYQML----KGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYV 202
Query: 87  MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           +     T  Y APEV   S+   +   D++S G ++ EM  G+
Sbjct: 203 V-----TRWYRAPEVIL-SWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 58/103 (56%), Gaps = 13/103 (12%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
           VYQ+     +GL+Y+H      +VH D+KP N+ ++ED   KI DFGLA+ + D + T  
Sbjct: 132 VYQML----KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA-DAEMTGY 183
Query: 87  MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           ++    T  Y APEV   S+   +   D++S G ++ EM  G+
Sbjct: 184 VV----TRWYRAPEVIL-SWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 53/98 (54%), Gaps = 10/98 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H   + R++H D+KP N+L++ +   K++DFGLA+       T +  H   T
Sbjct: 112 LLQGLSFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT--HEVVT 166
Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 167 LWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 201

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 59/121 (48%), Gaps = 14/121 (11%)
Query: 10  TYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKI 69
           T  +E    +R  E RT   I   +A  L Y H   + R++H DIKP N+LL  +   KI
Sbjct: 98  TVYRELQKLSRFDEQRTATYITE-LANALSYCH---SKRVIHRDIKPENLLLGSNGELKI 153
Query: 70  SDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAV 127
           +DFG +  +   + T       GT+ Y+ PE+      G  H  K D++S G++  E  V
Sbjct: 154 ADFGWSVHAPSSRRTTLC----GTLDYLPPEM----IEGRMHDEKVDLWSLGVLCYEFLV 205
Query: 128 G 128
           G
Sbjct: 206 G 206

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 53/98 (54%), Gaps = 10/98 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H   + R++H D+KP N+L++ +   K++DFGLA+       T +  H   T
Sbjct: 112 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT--HEVVT 166
Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 167 LWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 53/98 (54%), Gaps = 10/98 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H   + R++H D+KP N+L++ +   K++DFGLA+       T +  H   T
Sbjct: 111 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT--HEVVT 165
Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 166 LWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 200

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 53/98 (54%), Gaps = 10/98 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H   + R++H D+KP N+L++ +   K++DFGLA+       T +  H   T
Sbjct: 113 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT--HEVVT 167
Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 168 LWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 202

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 53/98 (54%), Gaps = 10/98 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H   + R++H D+KP N+L++ +   K++DFGLA+       T +  H   T
Sbjct: 111 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT--HEVVT 165
Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 166 LWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 200

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 53/98 (54%), Gaps = 10/98 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H   + R++H D+KP N+L++ +   K++DFGLA+       T +  H   T
Sbjct: 112 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT--HEVVT 166
Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 167 LWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 201

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 53/98 (54%), Gaps = 10/98 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H   + R++H D+KP N+L++ +   K++DFGLA+       T +  H   T
Sbjct: 112 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT--HEVVT 166
Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 167 LWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 201

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/107 (34%), Positives = 54/107 (50%), Gaps = 16/107 (14%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD---EDFCPKISDFGLAKQSQDK 81
           R + Q+  GI     Y H+    +IVH D+KP N+LL+   +D   +I DFGL+   +  
Sbjct: 130 RIIRQVLSGIT----YXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182
Query: 82  KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           K     +   GT  YIAPEV     G    K DV+S G+++  +  G
Sbjct: 183 KKXKDKI---GTAYYIAPEVL---HGTYDEKCDVWSTGVILYILLSG 223

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 53/98 (54%), Gaps = 10/98 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H   + R++H D+KP N+L++ +   K++DFGLA+       T +  H   T
Sbjct: 111 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT--HEVVT 165
Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 166 LWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 200

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 53/98 (54%), Gaps = 10/98 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H   + R++H D+KP N+L++ +   K++DFGLA+       T +  H   T
Sbjct: 111 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT--HEVVT 165
Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 166 LWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 200

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 84/207 (40%), Gaps = 19/207 (9%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  G L  +        G + +  +T+ +    IA G+EYL    N   +H D+   N +
Sbjct: 123 MKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCM 179
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           L +D    ++DFGL+K+            A+  + +IA E         + KSDV+++G+
Sbjct: 180 LRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV--YTSKSDVWAFGV 237
Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSL 180
            + E+A  R        ++ ++Y             D+ L G            +  +  
Sbjct: 238 TMWEIAT-RGMTPYPGVQNHEMY-------------DYLLHGHRLKQPEDCLDELYEIMY 283
Query: 181 WCIQTNPSDRPSMHEVLEMLESSTEIL 207
            C +T+P DRP+   +   LE   E L
Sbjct: 284 SCWRTDPLDRPTFSVLRLQLEKLLESL 310

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 52/103 (50%), Gaps = 12/103 (11%)
Query: 29  QIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGLAKQSQDKKSTI 85
           +I   +  G+ Y+H+     IVH D+KP NILL   ++D   KI DFGL+   Q      
Sbjct: 125 RIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ---QNT 178
Query: 86  SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            M    GT  YIAPEV     G    K DV+S G+++  +  G
Sbjct: 179 KMKDRIGTAYYIAPEVL---RGTYDEKCDVWSAGVILYILLSG 218

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 69/145 (47%), Gaps = 14/145 (9%)
Query: 1   MPNGSLDQFTYDQESSNGNR-TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP G L  +  + + + G++  L W         IA+G+ YL    + R+VH D+   N+
Sbjct: 102 MPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNV 152
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L+      KI+DFG AK    ++        +  I ++A E         +H+SDV+SYG
Sbjct: 153 LVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYG 210
Query: 120 MMILE-MAVGRKNAD-VKASRSSDI 142
           + + E M  G K  D + AS  S I
Sbjct: 211 VTVWELMTFGSKPYDGIPASEISSI 235

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 52/99 (52%), Gaps = 11/99 (11%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNIL-LDEDFCP---KISDFGLAKQSQDKKSTISMLH 89
           I + +EYLH      +VH D+KP NIL +DE   P   +I DFG AKQ + +     ++ 
Sbjct: 125 ITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL--LMT 179
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
              T  ++APEV  R   G     D++S G+++  M  G
Sbjct: 180 PCYTANFVAPEVLERQ--GYDAACDIWSLGVLLYTMLTG 216

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 69/145 (47%), Gaps = 14/145 (9%)
Query: 1   MPNGSLDQFTYDQESSNGNR-TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP G L  +  + + + G++  L W         IA+G+ YL    + R+VH D+   N+
Sbjct: 105 MPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNV 155
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L+      KI+DFG AK    ++        +  I ++A E         +H+SDV+SYG
Sbjct: 156 LVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYG 213
Query: 120 MMILE-MAVGRKNAD-VKASRSSDI 142
           + + E M  G K  D + AS  S I
Sbjct: 214 VTVWELMTFGSKPYDGIPASEISSI 238

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 69/145 (47%), Gaps = 14/145 (9%)
Query: 1   MPNGSLDQFTYDQESSNGNR-TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP G L  +  + + + G++  L W         IA+G+ YL    + R+VH D+   N+
Sbjct: 100 MPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNV 150
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L+      KI+DFG AK    ++        +  I ++A E         +H+SDV+SYG
Sbjct: 151 LVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYG 208
Query: 120 MMILE-MAVGRKNAD-VKASRSSDI 142
           + + E M  G K  D + AS  S I
Sbjct: 209 VTVWELMTFGSKPYDGIPASEISSI 233

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 69/145 (47%), Gaps = 14/145 (9%)
Query: 1   MPNGSLDQFTYDQESSNGNR-TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP G L  +  + + + G++  L W         IA+G+ YL    + R+VH D+   N+
Sbjct: 98  MPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNV 148
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L+      KI+DFG AK    ++        +  I ++A E         +H+SDV+SYG
Sbjct: 149 LVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYG 206
Query: 120 MMILE-MAVGRKNAD-VKASRSSDI 142
           + + E M  G K  D + AS  S I
Sbjct: 207 VTVWELMTFGSKPYDGIPASEISSI 231

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 53/98 (54%), Gaps = 10/98 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H   + R++H D+KP N+L++ +   K++DFGLA+       T +  H   T
Sbjct: 116 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT--HEVVT 170
Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 171 LWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 205

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 53/98 (54%), Gaps = 10/98 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H   + R++H D+KP N+L++ +   K++DFGLA+       T +  H   T
Sbjct: 119 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT--HEVVT 173
Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 174 LWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 208

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 52/103 (50%), Gaps = 12/103 (11%)
Query: 29  QIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGLAKQSQDKKSTI 85
           +I   +  G+ Y+H+     IVH D+KP NILL   ++D   KI DFGL+   Q      
Sbjct: 125 RIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ---QNT 178
Query: 86  SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            M    GT  YIAPEV     G    K DV+S G+++  +  G
Sbjct: 179 KMKDRIGTAYYIAPEVL---RGTYDEKCDVWSAGVILYILLSG 218

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 69/145 (47%), Gaps = 14/145 (9%)
Query: 1   MPNGSLDQFTYDQESSNGNR-TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP G L  +  + + + G++  L W         IA+G+ YL    + R+VH D+   N+
Sbjct: 100 MPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNV 150
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L+      KI+DFG AK    ++        +  I ++A E         +H+SDV+SYG
Sbjct: 151 LVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYG 208
Query: 120 MMILE-MAVGRKNAD-VKASRSSDI 142
           + + E M  G K  D + AS  S I
Sbjct: 209 VTVWELMTFGSKPYDGIPASEISSI 233

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 69/145 (47%), Gaps = 14/145 (9%)
Query: 1   MPNGSLDQFTYDQESSNGNR-TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           MP G L  +  + + + G++  L W         IA+G+ YL    + R+VH D+   N+
Sbjct: 100 MPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNV 150
Query: 60  LLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L+      KI+DFG AK    ++        +  I ++A E         +H+SDV+SYG
Sbjct: 151 LVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYG 208
Query: 120 MMILE-MAVGRKNAD-VKASRSSDI 142
           + + E M  G K  D + AS  S I
Sbjct: 209 VTVWELMTFGSKPYDGIPASEISSI 233

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 56/112 (50%), Gaps = 10/112 (8%)
Query: 21  TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD 80
           TL  +   +I   +   +  LH+   + IVH D+KP NILLD+D   K++DFG + Q   
Sbjct: 107 TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 163
Query: 81  KKSTISMLHARGTIGYIAPEVFCRSFG----GASHKSDVYSYGMMILEMAVG 128
            +    +    GT  Y+APE+   S      G   + D++S G+++  +  G
Sbjct: 164 GE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 65/127 (51%), Gaps = 13/127 (10%)
Query: 1   MPNGSLDQFTYDQESS-NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           +P+G L  F     +  + +R L +      +  I +G+EYL    + R VH D+   NI
Sbjct: 108 LPSGCLRDFLQRHRARLDASRLLLY------SSQICKGMEYLG---SRRCVHRDLAARNI 158
Query: 60  LLDEDFCPKISDFGLAK-QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSY 118
           L++ +   KI+DFGLAK    DK   +     +  I + APE    +    S +SDV+S+
Sbjct: 159 LVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI--FSRQSDVWSF 216
Query: 119 GMMILEM 125
           G+++ E+
Sbjct: 217 GVVLYEL 223

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/139 (28%), Positives = 65/139 (46%), Gaps = 19/139 (13%)
Query: 22  LEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDK 81
           +E R ++Q    I   ++Y HR     +VH D+KP N+LLD     KI+DFGL+    D 
Sbjct: 111 MEARRLFQ---QILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164
Query: 82  KSTISMLHARGTIGYIAPEVFC-RSFGGASHKSDVYSYGMMILEMAVGRKNAD------- 133
           +   +   + G+  Y APEV   R + G   + D++S G+++  +  G    D       
Sbjct: 165 EFLRT---SCGSPNYAAPEVISGRLYAGP--EVDIWSCGVILYALLCGTLPFDDEHVPTL 219
Query: 134 VKASRSSDIYFPNSIYKHI 152
            K  R    Y P  + + +
Sbjct: 220 FKKIRGGVFYIPEYLNRSV 238

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 56/112 (50%), Gaps = 10/112 (8%)
Query: 21  TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD 80
           TL  +   +I   +   +  LH+   + IVH D+KP NILLD+D   K++DFG + Q   
Sbjct: 120 TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176
Query: 81  KKSTISMLHARGTIGYIAPEVFCRSFG----GASHKSDVYSYGMMILEMAVG 128
            +    +    GT  Y+APE+   S      G   + D++S G+++  +  G
Sbjct: 177 GE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 12/102 (11%)
Query: 36  RGLEYLHRGCNVR-------IVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISML 88
           R +E +   C          I+H D+KP NIL+      K+ DFG+A+   D  +++   
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQT 176
Query: 89  HAR-GTIGYIAPEVFCRSFGGA-SHKSDVYSYGMMILEMAVG 128
            A  GT  Y++PE   ++ G +   +SDVYS G ++ E+  G
Sbjct: 177 AAVIGTAQYLSPE---QARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 61/127 (48%), Gaps = 6/127 (4%)
Query: 3   NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD 62
           +  L ++   +   N  R LE   V      + +GL + H     +I+H D+KP N+L++
Sbjct: 86  DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLIN 142
Query: 63  EDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMI 122
           +    K+ DFGLA+      +T S      T+ Y AP+V   S    S   D++S G ++
Sbjct: 143 KRGQLKLGDFGLARAFGIPVNTFS--SEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCIL 199
Query: 123 LEMAVGR 129
            EM  G+
Sbjct: 200 AEMITGK 206

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/103 (38%), Positives = 54/103 (52%), Gaps = 14/103 (13%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDED---FCPKISDFGLAK-QSQDKKSTI 85
           I   I  G+ YLH+     IVH DIKP NILL+        KI DFGL+   S+D K   
Sbjct: 151 IMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK--- 204
Query: 86  SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            +    GT  YIAPEV  + +   + K DV+S G+++  +  G
Sbjct: 205 -LRDRLGTAYYIAPEVLKKKY---NEKCDVWSCGVIMYILLCG 243

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 65/127 (51%), Gaps = 13/127 (10%)
Query: 1   MPNGSLDQFTYDQESS-NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           +P+G L  F     +  + +R L +      +  I +G+EYL    + R VH D+   NI
Sbjct: 95  LPSGCLRDFLQRHRARLDASRLLLY------SSQICKGMEYLG---SRRCVHRDLAARNI 145
Query: 60  LLDEDFCPKISDFGLAK-QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSY 118
           L++ +   KI+DFGLAK    DK   +     +  I + APE    +    S +SDV+S+
Sbjct: 146 LVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI--FSRQSDVWSF 203
Query: 119 GMMILEM 125
           G+++ E+
Sbjct: 204 GVVLYEL 210

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/139 (28%), Positives = 65/139 (46%), Gaps = 19/139 (13%)
Query: 22  LEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDK 81
           +E R ++Q    I   ++Y HR     +VH D+KP N+LLD     KI+DFGL+    D 
Sbjct: 111 MEARRLFQ---QILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164
Query: 82  KSTISMLHARGTIGYIAPEVFC-RSFGGASHKSDVYSYGMMILEMAVGRKNAD------- 133
           +    +  + G+  Y APEV   R + G   + D++S G+++  +  G    D       
Sbjct: 165 E---FLRDSCGSPNYAAPEVISGRLYAGP--EVDIWSCGVILYALLCGTLPFDDEHVPTL 219
Query: 134 VKASRSSDIYFPNSIYKHI 152
            K  R    Y P  + + +
Sbjct: 220 FKKIRGGVFYIPEYLNRSV 238

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 65/127 (51%), Gaps = 13/127 (10%)
Query: 1   MPNGSLDQFTYDQESS-NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           +P+G L  F     +  + +R L +      +  I +G+EYL    + R VH D+   NI
Sbjct: 96  LPSGCLRDFLQRHRARLDASRLLLY------SSQICKGMEYLG---SRRCVHRDLAARNI 146
Query: 60  LLDEDFCPKISDFGLAK-QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSY 118
           L++ +   KI+DFGLAK    DK   +     +  I + APE    +    S +SDV+S+
Sbjct: 147 LVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI--FSRQSDVWSF 204
Query: 119 GMMILEM 125
           G+++ E+
Sbjct: 205 GVVLYEL 211

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/112 (27%), Positives = 55/112 (49%), Gaps = 10/112 (8%)
Query: 21  TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD 80
            L  +    I   +   + +LH      IVH D+KP NILLD++   ++SDFG +   + 
Sbjct: 196 ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252
Query: 81  KKSTISMLHARGTIGYIAPEVF-C---RSFGGASHKSDVYSYGMMILEMAVG 128
            +    +    GT GY+APE+  C    +  G   + D+++ G+++  +  G
Sbjct: 253 GEKLRELC---GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 36  RGLEYLHRGCNVR-------IVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISML 88
           R +E +   C          I+H D+KP NI++      K+ DFG+A+   D  ++++  
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 89  HAR-GTIGYIAPEVFCRSFGGA-SHKSDVYSYGMMILEMAVG 128
            A  GT  Y++PE   ++ G +   +SDVYS G ++ E+  G
Sbjct: 177 AAVIGTAQYLSPE---QARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 36  RGLEYLHRGCNVR-------IVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISML 88
           R +E +   C          I+H D+KP NI++      K+ DFG+A+   D  ++++  
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 89  HAR-GTIGYIAPEVFCRSFGGA-SHKSDVYSYGMMILEMAVG 128
            A  GT  Y++PE   ++ G +   +SDVYS G ++ E+  G
Sbjct: 177 AAVIGTAQYLSPE---QARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 36  RGLEYLHRGCNVR-------IVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISML 88
           R +E +   C          I+H D+KP NI++      K+ DFG+A+   D  ++++  
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 89  HAR-GTIGYIAPEVFCRSFGGA-SHKSDVYSYGMMILEMAVG 128
            A  GT  Y++PE   ++ G +   +SDVYS G ++ E+  G
Sbjct: 177 AAVIGTAQYLSPE---QARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 10/98 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H   + R++H D+KP N+L++ +   K++DFGLA+       T    H   T
Sbjct: 112 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HEVVT 166
Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 167 LWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 201

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 36  RGLEYLHRGCNVR-------IVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISML 88
           R +E +   C          I+H D+KP NI++      K+ DFG+A+   D  ++++  
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 89  HAR-GTIGYIAPEVFCRSFGGA-SHKSDVYSYGMMILEMAVG 128
            A  GT  Y++PE   ++ G +   +SDVYS G ++ E+  G
Sbjct: 177 AAVIGTAQYLSPE---QARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 10/98 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H   + R++H D+KP N+L++ +   K++DFGLA+       T    H   T
Sbjct: 112 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HEVVT 166
Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 167 LWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 201

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 10/98 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H   + R++H D+KP N+L++ +   K++DFGLA+       T    H   T
Sbjct: 113 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HEVVT 167
Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 168 LWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 202

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 10/98 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H   + R++H D+KP N+L++ +   K++DFGLA+       T    H   T
Sbjct: 115 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HEVVT 169
Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 170 LWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 204

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 10/98 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H   + R++H D+KP N+L++ +   K++DFGLA+       T    H   T
Sbjct: 112 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HEVVT 166
Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 167 LWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 201

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 10/98 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H   + R++H D+KP N+L++ +   K++DFGLA+       T    H   T
Sbjct: 115 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HEVVT 169
Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 170 LWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 204

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 10/98 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H   + R++H D+KP N+L++ +   K++DFGLA+       T    H   T
Sbjct: 115 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HEVVT 169
Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 170 LWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 10/98 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H   + R++H D+KP N+L++ +   K++DFGLA+       T    H   T
Sbjct: 114 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HEVVT 168
Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 169 LWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 203

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 10/98 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H     R++H D+KP N+L++ +   K++DFGLA+       T    H   T
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HEVVT 165
Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 166 LWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 200

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 10/98 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H     R++H D+KP N+L++ +   K++DFGLA+       T    H   T
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HEVVT 166
Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 167 LWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 10/98 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H   + R++H D+KP N+L++ +   K++DFGLA+       T    H   T
Sbjct: 111 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HEVVT 165
Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 166 LWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 200

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 10/98 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H   + R++H D+KP N+L++ +   K++DFGLA+       T    H   T
Sbjct: 113 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HEVVT 167
Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 168 LWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 202

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 10/98 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H   + R++H D+KP N+L++ +   K++DFGLA+       T    H   T
Sbjct: 114 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HEVVT 168
Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 169 LWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 203

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 10/98 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H   + R++H D+KP N+L++ +   K++DFGLA+       T    H   T
Sbjct: 115 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HEVVT 169
Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 170 LWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 204

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 10/98 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H   + R++H D+KP N+L++ +   K++DFGLA+       T    H   T
Sbjct: 114 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HEVVT 168
Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 169 LWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 203

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 60/126 (47%), Gaps = 11/126 (8%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +P GSL ++    +       ++   + Q    I +G+EYL      R +H D+   NIL
Sbjct: 98  LPYGSLREYLQKHKER-----IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNIL 149
Query: 61  LDEDFCPKISDFGLAK-QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           ++ +   KI DFGL K   QDK+           I + APE    S    S  SDV+S+G
Sbjct: 150 VENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES--KFSVASDVWSFG 207
Query: 120 MMILEM 125
           +++ E+
Sbjct: 208 VVLYEL 213

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 10/98 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H   + R++H D+KP N+L++ +   K++DFGLA+       T    H   T
Sbjct: 115 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HEVVT 169
Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 170 LWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 204

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 10/98 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H   + R++H D+KP N+L++ +   K++DFGLA+       T    H   T
Sbjct: 116 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HEVVT 170
Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 171 LWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 205

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 52/102 (50%), Gaps = 12/102 (11%)
Query: 36  RGLEYLHRGCNVR-------IVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISML 88
           R +E +   C          I+H D+KP NI++      K+ DFG+A+   D  ++++  
Sbjct: 134 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 193
Query: 89  HAR-GTIGYIAPEVFCRSFG-GASHKSDVYSYGMMILEMAVG 128
            A  GT  Y++PE   ++ G     +SDVYS G ++ E+  G
Sbjct: 194 AAVIGTAQYLSPE---QARGDSVDARSDVYSLGCVLYEVLTG 232

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 10/98 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H   + R++H D+KP N+L++ +   K++DFGLA+       T    H   T
Sbjct: 113 LLQGLAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYX--HEVVT 167
Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 168 LWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 202

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 10/98 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H   + R++H D+KP N+L++ +   K++DFGLA+       T    H   T
Sbjct: 115 LLQGLAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYX--HEVVT 169
Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 170 LWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 204

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 10/98 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H   + R++H D+KP N+L++ +   K++DFGLA+       T    H   T
Sbjct: 112 LLQGLAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYX--HEVVT 166
Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 167 LWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 201

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 50/102 (49%), Gaps = 12/102 (11%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD---EDFCPKISDFGLAKQSQDKKSTIS 86
           I   +  G  YLH+     IVH D+KP N+LL+    D   KI DFGL+   +       
Sbjct: 109 IMKQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFE---VGGK 162
Query: 87  MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           M    GT  YIAPEV  + +     K DV+S G+++  +  G
Sbjct: 163 MKERLGTAYYIAPEVLRKKY---DEKCDVWSCGVILYILLCG 201

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 10/98 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H   + R++H D+KP N+L++ +   K++DFGLA+       T    H   T
Sbjct: 114 LLQGLAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYX--HEVVT 168
Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 169 LWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 203

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 10/98 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H   + R++H D+KP N+L++ +   K++DFGLA+       T    H   T
Sbjct: 113 LLQGLAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYX--HEVVT 167
Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+   C+ +  A    D++S G +  EM   R
Sbjct: 168 LWYRAPEILLGCKYYSTA---VDIWSLGCIFAEMVTRR 202

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/98 (39%), Positives = 51/98 (52%), Gaps = 17/98 (17%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCP--KISDFGLAKQS---QDKKSTISMLHAR 91
           G+ Y H   +++I H D+K  N LLD    P  KI DFG +K S      KST+      
Sbjct: 128 GVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV------ 178
Query: 92  GTIGYIAPEVFCRS-FGGASHKSDVYSYGMMILEMAVG 128
           GT  YIAPEV  R  + G    +DV+S G+ +  M VG
Sbjct: 179 GTPAYIAPEVLLRQEYDGKI--ADVWSCGVTLYVMLVG 214

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 61/122 (50%), Gaps = 16/122 (13%)
Query: 10  TYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKI 69
           T  +E    +R  E RT   I   +A  L Y H   + R++H DIKP N+LL  +   KI
Sbjct: 98  TVYRELQKLSRFDEQRTATYITE-LANALSYCH---SKRVIHRDIKPENLLLGSNGELKI 153
Query: 70  SDFGLAKQS-QDKKSTISMLHARGTIGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMA 126
           +DFG +  +   ++ T+      GT+ Y+ PE+      G  H  K D++S G++  E  
Sbjct: 154 ADFGWSVHAPSSRRDTLC-----GTLDYLPPEM----IEGRMHDEKVDLWSLGVLCYEFL 204
Query: 127 VG 128
           VG
Sbjct: 205 VG 206

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 8/108 (7%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST 84
           R + ++   I + L YL     V  +H D+KP NILLDE    K+ DFG++ +  D K+ 
Sbjct: 124 RILGKMTVAIVKALYYLKEKHGV--IHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK 181
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASH---KSDVYSYGMMILEMAVGR 129
                + G   Y+APE              ++DV+S G+ ++E+A G+
Sbjct: 182 D---RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 53/102 (51%), Gaps = 15/102 (14%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK---QSQDKKSTISMLHA 90
           IA  +E+LH      ++H D+KP NI    D   K+ DFGL     Q +++++ ++ + A
Sbjct: 173 IAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 229
Query: 91  R-------GTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
                   GT  Y++PE         SHK D++S G+++ E+
Sbjct: 230 YATHXGQVGTKLYMSPEQI--HGNNYSHKVDIFSLGLILFEL 269

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 50/100 (50%), Gaps = 6/100 (6%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK-QSQDKKSTI 85
           + Q    I +G+EYL      R +H D+   NIL++ +   KI DFGL K   QDK+   
Sbjct: 147 LLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 203
Query: 86  SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
                   I + APE    S    S  SDV+S+G+++ E+
Sbjct: 204 VKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYEL 241

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 50/100 (50%), Gaps = 6/100 (6%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK-QSQDKKSTI 85
           + Q    I +G+EYL      R +H D+   NIL++ +   KI DFGL K   QDK+   
Sbjct: 123 LLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 179
Query: 86  SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
                   I + APE    S    S  SDV+S+G+++ E+
Sbjct: 180 VKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYEL 217

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 50/100 (50%), Gaps = 6/100 (6%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK-QSQDKKSTI 85
           + Q    I +G+EYL      R +H D+   NIL++ +   KI DFGL K   QDK+   
Sbjct: 119 LLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 175
Query: 86  SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
                   I + APE    S    S  SDV+S+G+++ E+
Sbjct: 176 VKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYEL 213

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 50/102 (49%), Gaps = 12/102 (11%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD---EDFCPKISDFGLAKQSQDKKSTIS 86
           I   +  G  YLH+     IVH D+KP N+LL+    D   KI DFGL+   +       
Sbjct: 126 IMKQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFE---VGGK 179
Query: 87  MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           M    GT  YIAPEV  + +     K DV+S G+++  +  G
Sbjct: 180 MKERLGTAYYIAPEVLRKKY---DEKCDVWSCGVILYILLCG 218

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 50/100 (50%), Gaps = 6/100 (6%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK-QSQDKKSTI 85
           + Q    I +G+EYL      R +H D+   NIL++ +   KI DFGL K   QDK+   
Sbjct: 116 LLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 172
Query: 86  SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
                   I + APE    S    S  SDV+S+G+++ E+
Sbjct: 173 VKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYEL 210

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 50/100 (50%), Gaps = 6/100 (6%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK-QSQDKKSTI 85
           + Q    I +G+EYL      R +H D+   NIL++ +   KI DFGL K   QDK+   
Sbjct: 119 LLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 175
Query: 86  SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
                   I + APE    S    S  SDV+S+G+++ E+
Sbjct: 176 VKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYEL 213

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 50/100 (50%), Gaps = 6/100 (6%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK-QSQDKKSTI 85
           + Q    I +G+EYL      R +H D+   NIL++ +   KI DFGL K   QDK+   
Sbjct: 115 LLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 171
Query: 86  SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
                   I + APE    S    S  SDV+S+G+++ E+
Sbjct: 172 VKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYEL 209

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 55/119 (46%), Gaps = 13/119 (10%)
Query: 33  GIARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ-------SQDKKST 84
           GI RGLE +H +G      H D+KP NILL ++  P + D G   Q       S+   + 
Sbjct: 142 GICRGLEAIHAKG----YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 85  ISMLHARGTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDI 142
                 R TI Y APE+F  +S      ++DV+S G ++  M  G    D+   +   +
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 59/126 (46%), Gaps = 11/126 (8%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +P GSL  +    +       ++   + Q    I +G+EYL      R +H D+   NIL
Sbjct: 113 LPYGSLRDYLQKHKER-----IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNIL 164
Query: 61  LDEDFCPKISDFGLAK-QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           ++ +   KI DFGL K   QDK+           I + APE    S    S  SDV+S+G
Sbjct: 165 VENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES--KFSVASDVWSFG 222
Query: 120 MMILEM 125
           +++ E+
Sbjct: 223 VVLYEL 228

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 50/100 (50%), Gaps = 6/100 (6%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK-QSQDKKSTI 85
           + Q    I +G+EYL      R +H D+   NIL++ +   KI DFGL K   QDK+   
Sbjct: 116 LLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 172
Query: 86  SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
                   I + APE    S    S  SDV+S+G+++ E+
Sbjct: 173 VKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYEL 210

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 59/126 (46%), Gaps = 11/126 (8%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +P GSL  +    +       ++   + Q    I +G+EYL      R +H D+   NIL
Sbjct: 113 LPYGSLRDYLQKHKER-----IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNIL 164
Query: 61  LDEDFCPKISDFGLAK-QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           ++ +   KI DFGL K   QDK+           I + APE    S    S  SDV+S+G
Sbjct: 165 VENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES--KFSVASDVWSFG 222
Query: 120 MMILEM 125
           +++ E+
Sbjct: 223 VVLYEL 228

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 50/100 (50%), Gaps = 6/100 (6%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK-QSQDKKSTI 85
           + Q    I +G+EYL      R +H D+   NIL++ +   KI DFGL K   QDK+   
Sbjct: 114 LLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 170
Query: 86  SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
                   I + APE    S    S  SDV+S+G+++ E+
Sbjct: 171 VKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYEL 208

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 50/100 (50%), Gaps = 6/100 (6%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK-QSQDKKSTI 85
           + Q    I +G+EYL      R +H D+   NIL++ +   KI DFGL K   QDK+   
Sbjct: 122 LLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 178
Query: 86  SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
                   I + APE    S    S  SDV+S+G+++ E+
Sbjct: 179 VKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYEL 216

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 78/174 (44%), Gaps = 22/174 (12%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +A  I+  +EYL +      +H D+   N L+ E+   K++DFGL++       T +   
Sbjct: 135 MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYT-AHAG 190
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIY 149
           A+  I + APE    ++   S KSDV+++G+++ E+A       +      D+   + +Y
Sbjct: 191 AKFPIKWTAPESL--AYNTFSIKSDVWAFGVLLWEIA----TYGMSPYPGIDL---SQVY 241
Query: 150 KHIEPGNDF-QLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLEMLES 202
             +E G    Q +G                   C + +P+DRPS  E  +  E+
Sbjct: 242 DLLEKGYRMEQPEGCPPKVYELMRA--------CWKWSPADRPSFAETHQAFET 287

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 55/107 (51%), Gaps = 7/107 (6%)
Query: 26  TVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ-SQDKKST 84
            V ++   ++ G++YL        VH D+   N+LL      KISDFGL+K    D    
Sbjct: 111 NVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 167
Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILE-MAVGRK 130
            +    +  + + APE  C +F   S +SDV+SYG+ + E ++ G+K
Sbjct: 168 TARSAGKWPLKWYAPE--CINFRKFSSRSDVWSYGVTMWEALSYGQK 212

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 50/100 (50%), Gaps = 6/100 (6%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK-QSQDKKSTI 85
           + Q    I +G+EYL      R +H D+   NIL++ +   KI DFGL K   QDK+   
Sbjct: 121 LLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 177
Query: 86  SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
                   I + APE    S    S  SDV+S+G+++ E+
Sbjct: 178 VKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYEL 215

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 50/100 (50%), Gaps = 6/100 (6%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK-QSQDKKSTI 85
           + Q    I +G+EYL      R +H D+   NIL++ +   KI DFGL K   QDK+   
Sbjct: 120 LLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 176
Query: 86  SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
                   I + APE    S    S  SDV+S+G+++ E+
Sbjct: 177 VKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYEL 214

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 13/92 (14%)
Query: 44  GC----NVRIVHFDIKPHNILLDE-DFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIA 98
           GC    +V + H DIKPHN+L++E D   K+ DFG AK+    +  ++ + +R    Y A
Sbjct: 143 GCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR---YYRA 199
Query: 99  PEVFCRSFGGASHKS--DVYSYGMMILEMAVG 128
           PE+    FG   + +  D++S G +  EM +G
Sbjct: 200 PELI---FGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ--SQDKKSTISMLHAR 91
           + RGL+Y+H   + +++H D+KP N+L++E+   KI DFG+A+   +   +    M    
Sbjct: 168 LLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYV 224
Query: 92  GTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRK 130
            T  Y APE+   S    +   D++S G +  EM   R+
Sbjct: 225 ATRWYRAPELML-SLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ--SQDKKSTISMLHAR 91
           + RGL+Y+H   + +++H D+KP N+L++E+   KI DFG+A+   +   +    M    
Sbjct: 167 LLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYV 223
Query: 92  GTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRK 130
            T  Y APE+   S    +   D++S G +  EM   R+
Sbjct: 224 ATRWYRAPELML-SLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 50/92 (54%), Gaps = 11/92 (11%)
Query: 40  YLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           YLHR   + IVH D+KP N+L    DE+    ISDFGL+K   + K  + M  A GT GY
Sbjct: 135 YLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM--EGKGDV-MSTACGTPGY 188
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           +APEV  +     S   D +S G++   +  G
Sbjct: 189 VAPEVLAQK--PYSKAVDCWSIGVIAYILLCG 218

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 8/102 (7%)
Query: 26  TVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ-SQDKKST 84
           T+ + A  +A G+ YL    + R +H D+   N+LL      KI DFGL +   Q+    
Sbjct: 122 TLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHX 178
Query: 85  ISMLHARGTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEM 125
           +   H +    + APE    R+F   SH SD + +G+ + EM
Sbjct: 179 VMQEHRKVPFAWCAPESLKTRTF---SHASDTWMFGVTLWEM 217

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 53/94 (56%), Gaps = 10/94 (10%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGL-AKQSQDKKSTISMLHARGTIG 95
            L YLH     +I+H D+K  NIL   D   K++DFG+ AK ++  +   S +   GT  
Sbjct: 147 ALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI---GTPY 200
Query: 96  YIAPE-VFCRSFGGA--SHKSDVYSYGMMILEMA 126
           ++APE V C +       +K+DV+S G+ ++EMA
Sbjct: 201 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 234

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 8/102 (7%)
Query: 26  TVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ-SQDKKST 84
           T+ + A  +A G+ YL    + R +H D+   N+LL      KI DFGL +   Q+    
Sbjct: 112 TLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHX 168
Query: 85  ISMLHARGTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEM 125
           +   H +    + APE    R+F   SH SD + +G+ + EM
Sbjct: 169 VMQEHRKVPFAWCAPESLKTRTF---SHASDTWMFGVTLWEM 207

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 53/94 (56%), Gaps = 10/94 (10%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGL-AKQSQDKKSTISMLHARGTIG 95
            L YLH     +I+H D+K  NIL   D   K++DFG+ AK ++  +   S +   GT  
Sbjct: 147 ALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI---GTPY 200
Query: 96  YIAPE-VFCRSFGGA--SHKSDVYSYGMMILEMA 126
           ++APE V C +       +K+DV+S G+ ++EMA
Sbjct: 201 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 234

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 8/102 (7%)
Query: 26  TVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ-SQDKKST 84
           T+ + A  +A G+ YL    + R +H D+   N+LL      KI DFGL +   Q+    
Sbjct: 116 TLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 172
Query: 85  ISMLHARGTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEM 125
           +   H +    + APE    R+F   SH SD + +G+ + EM
Sbjct: 173 VMQEHRKVPFAWCAPESLKTRTF---SHASDTWMFGVTLWEM 211

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 82/168 (48%), Gaps = 28/168 (16%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I   L+++H   + +I+H DIK  NI L +D   ++ DFG+A+      ST+ +  AR  
Sbjct: 134 ICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN---STVEL--ARAC 185
Query: 94  IG---YIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYK 150
           IG   Y++PE+ C +    ++KSD+++ G ++ E+   +   +  + ++  +   +  + 
Sbjct: 186 IGTPYYLSPEI-CEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP 243
Query: 151 HIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNPSDRPSMHEVLE 198
            +     + L                LVS    + NP DRPS++ +LE
Sbjct: 244 PVSLHYSYDLRS--------------LVS-QLFKRNPRDRPSVNSILE 276

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 50/100 (50%), Gaps = 6/100 (6%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK-QSQDKKSTI 85
           + Q    I +G+EYL      R +H D+   NIL++ +   KI DFGL K   QDK+   
Sbjct: 116 LLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFK 172
Query: 86  SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
                   I + APE    S    S  SDV+S+G+++ E+
Sbjct: 173 VKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYEL 210

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 8/102 (7%)
Query: 26  TVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ-SQDKKST 84
           T+ + A  +A G+ YL    + R +H D+   N+LL      KI DFGL +   Q+    
Sbjct: 122 TLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 178
Query: 85  ISMLHARGTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEM 125
           +   H +    + APE    R+F   SH SD + +G+ + EM
Sbjct: 179 VMQEHRKVPFAWCAPESLKTRTF---SHASDTWMFGVTLWEM 217

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/124 (25%), Positives = 65/124 (52%), Gaps = 14/124 (11%)
Query: 3   NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD 62
            G+L+Q+   +     ++ L      QI     +G++Y+H   + ++++ D+KP NI L 
Sbjct: 104 KGTLEQWIEKRRGEKLDKVLALELFEQIT----KGVDYIH---SKKLINRDLKPSNIFLV 156
Query: 63  EDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMM 121
           +    KI DFGL       K+      ++GT+ Y++PE +  + +G    + D+Y+ G++
Sbjct: 157 DTKQVKIGDFGLVTSL---KNDGKRXRSKGTLRYMSPEQISSQDYG---KEVDLYALGLI 210
Query: 122 ILEM 125
           + E+
Sbjct: 211 LAEL 214

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/133 (33%), Positives = 60/133 (45%), Gaps = 26/133 (19%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCP--KISDFGLAKQS---QDKKSTISMLHAR 91
           G+ Y H    +++ H D+K  N LLD    P  KI DFG +K S      KST+      
Sbjct: 126 GVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV------ 176
Query: 92  GTIGYIAPEVFCRS-FGGASHKSDVYSYGMMILEMAVGR---------KNADVKASRSSD 141
           GT  YIAPEV  +  + G    +DV+S G+ +  M VG          KN      R  +
Sbjct: 177 GTPAYIAPEVLLKKEYDGKV--ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILN 234
Query: 142 IYFPNSIYKHIEP 154
           + +    Y HI P
Sbjct: 235 VQYAIPDYVHISP 247

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/133 (33%), Positives = 60/133 (45%), Gaps = 26/133 (19%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCP--KISDFGLAKQS---QDKKSTISMLHAR 91
           G+ Y H    +++ H D+K  N LLD    P  KI DFG +K S      KST+      
Sbjct: 127 GVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV------ 177
Query: 92  GTIGYIAPEVFCRS-FGGASHKSDVYSYGMMILEMAVGR---------KNADVKASRSSD 141
           GT  YIAPEV  +  + G    +DV+S G+ +  M VG          KN      R  +
Sbjct: 178 GTPAYIAPEVLLKKEYDGKV--ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILN 235
Query: 142 IYFPNSIYKHIEP 154
           + +    Y HI P
Sbjct: 236 VQYAIPDYVHISP 248

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 6/96 (6%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H   + R++H D+KP N+L++ +   K++DFGLA+       T +  H   T
Sbjct: 112 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT--HEVVT 166
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+        S   D++S G +  EM   R
Sbjct: 167 LWYRAPEILL-GXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 50/99 (50%), Gaps = 11/99 (11%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNIL-LDEDFCP---KISDFGLAKQSQDKKSTISMLH 89
           I + +EYLH      +VH D+KP NIL +DE   P   +I DFG AKQ + +   +    
Sbjct: 125 ITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXT-- 179
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
              T  ++APEV  R   G     D++S G+++     G
Sbjct: 180 PCYTANFVAPEVLERQ--GYDAACDIWSLGVLLYTXLTG 216

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/111 (34%), Positives = 55/111 (49%), Gaps = 12/111 (10%)
Query: 18  GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGL 74
           GN+ L+  T       +   ++YLH      I+H D+KP N+LL   +ED   KI+DFG 
Sbjct: 107 GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG- 162
Query: 75  AKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKS--DVYSYGMMIL 123
              S+    T  M    GT  Y+APEV   S G A +    D +S G+++ 
Sbjct: 163 --HSKILGETSLMRTLCGTPTYLAPEVLV-SVGTAGYNRAVDCWSLGVILF 210

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/111 (34%), Positives = 55/111 (49%), Gaps = 12/111 (10%)
Query: 18  GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGL 74
           GN+ L+  T       +   ++YLH      I+H D+KP N+LL   +ED   KI+DFG 
Sbjct: 106 GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG- 161
Query: 75  AKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKS--DVYSYGMMIL 123
              S+    T  M    GT  Y+APEV   S G A +    D +S G+++ 
Sbjct: 162 --HSKILGETSLMRTLCGTPTYLAPEVLV-SVGTAGYNRAVDCWSLGVILF 209

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/111 (34%), Positives = 55/111 (49%), Gaps = 12/111 (10%)
Query: 18  GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGL 74
           GN+ L+  T       +   ++YLH      I+H D+KP N+LL   +ED   KI+DFG 
Sbjct: 107 GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG- 162
Query: 75  AKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKS--DVYSYGMMIL 123
              S+    T  M    GT  Y+APEV   S G A +    D +S G+++ 
Sbjct: 163 --HSKILGETSLMRTLCGTPTYLAPEVLV-SVGTAGYNRAVDCWSLGVILF 210

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/111 (34%), Positives = 55/111 (49%), Gaps = 12/111 (10%)
Query: 18  GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGL 74
           GN+ L+  T       +   ++YLH      I+H D+KP N+LL   +ED   KI+DFG 
Sbjct: 107 GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG- 162
Query: 75  AKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKS--DVYSYGMMIL 123
              S+    T  M    GT  Y+APEV   S G A +    D +S G+++ 
Sbjct: 163 --HSKILGETSLMRTLCGTPTYLAPEVLV-SVGTAGYNRAVDCWSLGVILF 210

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 8/102 (7%)
Query: 26  TVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ-SQDKKST 84
           T+ + A  +A G+ YL    + R +H D+   N+LL      KI DFGL +   Q+    
Sbjct: 116 TLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 172
Query: 85  ISMLHARGTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEM 125
           +   H +    + APE    R+F   SH SD + +G+ + EM
Sbjct: 173 VMQEHRKVPFAWCAPESLKTRTF---SHASDTWMFGVTLWEM 211

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 6/96 (6%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           + +GL + H   + R++H D+KP N+L++ +   K++DFGLA+       T +  H   T
Sbjct: 119 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT--HEVVT 173
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y APE+        S   D++S G +  EM   R
Sbjct: 174 LWYRAPEILL-GXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 8/102 (7%)
Query: 26  TVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ-SQDKKST 84
           T+ + A  +A G+ YL    + R +H D+   N+LL      KI DFGL +   Q+    
Sbjct: 112 TLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 168
Query: 85  ISMLHARGTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEM 125
           +   H +    + APE    R+F   SH SD + +G+ + EM
Sbjct: 169 VMQEHRKVPFAWCAPESLKTRTF---SHASDTWMFGVTLWEM 207

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 8/102 (7%)
Query: 26  TVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ-SQDKKST 84
           T+ + A  +A G+ YL    + R +H D+   N+LL      KI DFGL +   Q+    
Sbjct: 112 TLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 168
Query: 85  ISMLHARGTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEM 125
           +   H +    + APE    R+F   SH SD + +G+ + EM
Sbjct: 169 VMQEHRKVPFAWCAPESLKTRTF---SHASDTWMFGVTLWEM 207

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 12/92 (13%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP----KISDFGLAKQSQDKKSTISMLH 89
           I  G+ YLH     +I HFD+KP NI+L +   P    K+ DFGLA + +D    +   +
Sbjct: 124 ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---GVEFKN 177
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMM 121
             GT  ++APE+   ++     ++D++S G++
Sbjct: 178 IFGTPEFVAPEIV--NYEPLGLEADMWSIGVI 207

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 51/108 (47%), Gaps = 7/108 (6%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL--DEDFCPKISDFGLAKQ--SQD 80
           + +  I   I   L YLH   N  I H DIKP N L   ++ F  K+ DFGL+K+    +
Sbjct: 168 KLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLN 224
Query: 81  KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
                 M    GT  ++APEV   +      K D +S G+++  + +G
Sbjct: 225 NGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMG 272

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/111 (34%), Positives = 55/111 (49%), Gaps = 12/111 (10%)
Query: 18  GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGL 74
           GN+ L+  T       +   ++YLH      I+H D+KP N+LL   +ED   KI+DFG 
Sbjct: 113 GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG- 168
Query: 75  AKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKS--DVYSYGMMIL 123
              S+    T  M    GT  Y+APEV   S G A +    D +S G+++ 
Sbjct: 169 --HSKILGETSLMRTLCGTPTYLAPEVLV-SVGTAGYNRAVDCWSLGVILF 216

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 12/92 (13%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP----KISDFGLAKQSQDKKSTISMLH 89
           I  G+ YLH     +I HFD+KP NI+L +   P    K+ DFGLA + +D    +   +
Sbjct: 124 ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---GVEFKN 177
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMM 121
             GT  ++APE+   ++     ++D++S G++
Sbjct: 178 IFGTPEFVAPEIV--NYEPLGLEADMWSIGVI 207

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 55/108 (50%), Gaps = 15/108 (13%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP------KISDFGLAKQSQD 80
           V QI+  +  GL+Y+HR C   I+H DIKP N+L++    P      KI+D G A    D
Sbjct: 133 VKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW-YD 189
Query: 81  KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           +  T S+     T  Y +PEV   +  G    +D++S   +I E+  G
Sbjct: 190 EHYTNSI----QTREYRSPEVLLGAPWGCG--ADIWSTACLIFELITG 231

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 55/108 (50%), Gaps = 15/108 (13%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP------KISDFGLAKQSQD 80
           V QI+  +  GL+Y+HR C   I+H DIKP N+L++    P      KI+D G A    D
Sbjct: 133 VKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW-YD 189
Query: 81  KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           +  T S+     T  Y +PEV   +  G    +D++S   +I E+  G
Sbjct: 190 EHYTNSI----QTREYRSPEVLLGAPWGCG--ADIWSTACLIFELITG 231

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 86/194 (44%), Gaps = 27/194 (13%)
Query: 12  DQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISD 71
           + E++ G      + + Q+A  IA G+ YL+     + VH D+   N ++  DF  KI D
Sbjct: 117 EAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGD 173
Query: 72  FGLAKQSQD----KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV 127
           FG+ +   +    +K    +L  R    ++APE      G  +  SD++S+G+++ E+  
Sbjct: 174 FGMTRDIXETDXXRKGGKGLLPVR----WMAPESL--KDGVFTTSSDMWSFGVVLWEI-- 225
Query: 128 GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNP 187
                    S +   Y   S  + ++    F +DG            +  +   C Q NP
Sbjct: 226 --------TSLAEQPYQGLSNEQVLK----FVMDGGYLDQPDNCPERVTDLMRMCWQFNP 273
Query: 188 SDRPSMHEVLEMLE 201
           + RP+  E++ +L+
Sbjct: 274 NMRPTFLEIVNLLK 287

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 55/109 (50%), Gaps = 11/109 (10%)
Query: 29  QIAGGIARGLEYLHR---GCNVR--IVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS 83
           ++A   A GL +LH    G   +  I H D+K  NIL+ ++    I+D GLA +      
Sbjct: 143 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 202
Query: 84  TISML--HARGTIGYIAPEVFCRSFG----GASHKSDVYSYGMMILEMA 126
           TI +   H  GT  Y+APEV   S       +  ++D+Y+ G++  E+A
Sbjct: 203 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/111 (34%), Positives = 55/111 (49%), Gaps = 12/111 (10%)
Query: 18  GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGL 74
           GN+ L+  T       +   ++YLH      I+H D+KP N+LL   +ED   KI+DFG 
Sbjct: 246 GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG- 301
Query: 75  AKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKS--DVYSYGMMIL 123
              S+    T  M    GT  Y+APEV   S G A +    D +S G+++ 
Sbjct: 302 --HSKILGETSLMRTLCGTPTYLAPEVLV-SVGTAGYNRAVDCWSLGVILF 349

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 55/109 (50%), Gaps = 11/109 (10%)
Query: 29  QIAGGIARGLEYLHR---GCNVR--IVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS 83
           ++A   A GL +LH    G   +  I H D+K  NIL+ ++    I+D GLA +      
Sbjct: 130 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 189
Query: 84  TISML--HARGTIGYIAPEVFCRSFG----GASHKSDVYSYGMMILEMA 126
           TI +   H  GT  Y+APEV   S       +  ++D+Y+ G++  E+A
Sbjct: 190 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 12/92 (13%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP----KISDFGLAKQSQDKKSTISMLH 89
           I  G+ YLH     +I HFD+KP NI+L +   P    K+ DFGLA + +D    +   +
Sbjct: 124 ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---GVEFKN 177
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMM 121
             GT  ++APE+   ++     ++D++S G++
Sbjct: 178 IFGTPEFVAPEIV--NYEPLGLEADMWSIGVI 207

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 12/92 (13%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP----KISDFGLAKQSQDKKSTISMLH 89
           I  G+ YLH     +I HFD+KP NI+L +   P    K+ DFGLA + +D    +   +
Sbjct: 124 ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---GVEFKN 177
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMM 121
             GT  ++APE+   ++     ++D++S G++
Sbjct: 178 IFGTPEFVAPEIV--NYEPLGLEADMWSIGVI 207

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 55/109 (50%), Gaps = 11/109 (10%)
Query: 29  QIAGGIARGLEYLHR---GCNVR--IVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS 83
           ++A   A GL +LH    G   +  I H D+K  NIL+ ++    I+D GLA +      
Sbjct: 105 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 164
Query: 84  TISML--HARGTIGYIAPEVFCRSFG----GASHKSDVYSYGMMILEMA 126
           TI +   H  GT  Y+APEV   S       +  ++D+Y+ G++  E+A
Sbjct: 165 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 57/114 (50%), Gaps = 17/114 (14%)
Query: 28  YQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISM 87
           YQ++  +A    YL    + R VH DI   N+L+  + C K+ DFGL++  +D  +    
Sbjct: 118 YQLSTALA----YLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STXXKA 169
Query: 88  LHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-------GRKNADV 134
              +  I ++APE    +F   +  SDV+ +G+ + E+ +       G KN DV
Sbjct: 170 SKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 221

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 55/109 (50%), Gaps = 11/109 (10%)
Query: 29  QIAGGIARGLEYLHR---GCNVR--IVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS 83
           ++A   A GL +LH    G   +  I H D+K  NIL+ ++    I+D GLA +      
Sbjct: 107 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 166
Query: 84  TISML--HARGTIGYIAPEVFCRSFG----GASHKSDVYSYGMMILEMA 126
           TI +   H  GT  Y+APEV   S       +  ++D+Y+ G++  E+A
Sbjct: 167 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 55/109 (50%), Gaps = 11/109 (10%)
Query: 29  QIAGGIARGLEYLHR---GCNVR--IVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS 83
           ++A   A GL +LH    G   +  I H D+K  NIL+ ++    I+D GLA +      
Sbjct: 104 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 163
Query: 84  TISML--HARGTIGYIAPEVFCRSFG----GASHKSDVYSYGMMILEMA 126
           TI +   H  GT  Y+APEV   S       +  ++D+Y+ G++  E+A
Sbjct: 164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 57/113 (50%), Gaps = 9/113 (7%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I   L +LH   +  I++ D+K  N+LLD +   K++DFG+ K+      T +    
Sbjct: 130 AAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC- 185
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIY 143
            GT  YIAPE+      G +   D ++ G+++ EM  G  +A  +A    D++
Sbjct: 186 -GTPDYIAPEILQEMLYGPA--VDWWAMGVLLYEMLCG--HAPFEAENEDDLF 233

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 85/194 (43%), Gaps = 27/194 (13%)
Query: 12  DQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISD 71
           + E++ G      + + Q+A  IA G+ YL+     + VH D+   N ++  DF  KI D
Sbjct: 114 EAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGD 170
Query: 72  FGLAKQSQD----KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV 127
           FG+ +   +    +K    +L  R    ++APE      G  +  SD++S+G+++ E+  
Sbjct: 171 FGMTRDIXETDXXRKGGKGLLPVR----WMAPESL--KDGVFTTSSDMWSFGVVLWEI-- 222
Query: 128 GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNP 187
                    S +   Y   S  + ++    F +DG            +  +   C Q NP
Sbjct: 223 --------TSLAEQPYQGLSNEQVLK----FVMDGGYLDQPDNCPERVTDLMRMCWQFNP 270
Query: 188 SDRPSMHEVLEMLE 201
             RP+  E++ +L+
Sbjct: 271 KMRPTFLEIVNLLK 284

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 12/92 (13%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP----KISDFGLAKQSQDKKSTISMLH 89
           I  G+ YLH     +I HFD+KP NI+L +   P    K+ DFGLA + +D    +   +
Sbjct: 124 ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---GVEFKN 177
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMM 121
             GT  ++APE+   ++     ++D++S G++
Sbjct: 178 IFGTPEFVAPEIV--NYEPLGLEADMWSIGVI 207

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/111 (34%), Positives = 55/111 (49%), Gaps = 12/111 (10%)
Query: 18  GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGL 74
           GN+ L+  T       +   ++YLH      I+H D+KP N+LL   +ED   KI+DFG 
Sbjct: 232 GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG- 287
Query: 75  AKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKS--DVYSYGMMIL 123
              S+    T  M    GT  Y+APEV   S G A +    D +S G+++ 
Sbjct: 288 --HSKILGETSLMRTLCGTPTYLAPEVLV-SVGTAGYNRAVDCWSLGVILF 335

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 12/92 (13%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP----KISDFGLAKQSQDKKSTISMLH 89
           I  G+ YLH     +I HFD+KP NI+L +   P    K+ DFGLA + +D    +   +
Sbjct: 124 ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---GVEFKN 177
Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMM 121
             GT  ++APE+   ++     ++D++S G++
Sbjct: 178 IFGTPEFVAPEIV--NYEPLGLEADMWSIGVI 207

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 60/118 (50%), Gaps = 9/118 (7%)
Query: 12  DQESSNGNRT----LEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP 67
           D  S++ +RT    LE      +   IA G+EYL    +  +VH D+   N+L+ +    
Sbjct: 128 DVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNV 184
Query: 68  KISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
           KISD GL ++         + ++   I ++APE     +G  S  SD++SYG+++ E+
Sbjct: 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM--YGKFSIDSDIWSYGVVLWEV 240

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 66/132 (50%), Gaps = 21/132 (15%)
Query: 2   PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL 61
           P G++D    +      +R L    +  +   +   L +LH   + RI+H D+K  N+L+
Sbjct: 99  PGGAVDAIMLEL-----DRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLM 150
Query: 62  DEDFCPKISDFGLA----KQSQDKKSTISMLHARGTIGYIAPE-VFCRSFGGA--SHKSD 114
             +   +++DFG++    K  Q + S I      GT  ++APE V C +       +K+D
Sbjct: 151 TLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAPEVVMCETMKDTPYDYKAD 204
Query: 115 VYSYGMMILEMA 126
           ++S G+ ++EMA
Sbjct: 205 IWSLGITLIEMA 216

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 55/109 (50%), Gaps = 11/109 (10%)
Query: 29  QIAGGIARGLEYLHR---GCNVR--IVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS 83
           ++A   A GL +LH    G   +  I H D+K  NIL+ ++    I+D GLA +      
Sbjct: 110 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 169
Query: 84  TISML--HARGTIGYIAPEVFCRSFG----GASHKSDVYSYGMMILEMA 126
           TI +   H  GT  Y+APEV   S       +  ++D+Y+ G++  E+A
Sbjct: 170 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 85/194 (43%), Gaps = 27/194 (13%)
Query: 12  DQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISD 71
           + E++ G      + + Q+A  IA G+ YL+     + VH D+   N ++  DF  KI D
Sbjct: 117 EAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGD 173
Query: 72  FGLAKQSQD----KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV 127
           FG+ +   +    +K    +L  R    ++APE      G  +  SD++S+G+++ E+  
Sbjct: 174 FGMTRDIXETDXXRKGGKGLLPVR----WMAPESL--KDGVFTTSSDMWSFGVVLWEI-- 225
Query: 128 GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNP 187
                    S +   Y   S  + ++    F +DG            +  +   C Q NP
Sbjct: 226 --------TSLAEQPYQGLSNEQVLK----FVMDGGYLDQPDNCPERVTDLMRMCWQFNP 273
Query: 188 SDRPSMHEVLEMLE 201
             RP+  E++ +L+
Sbjct: 274 KMRPTFLEIVNLLK 287

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 8/92 (8%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH      I+H D+KP NI++  D   KI DFGLA+ +    ++  M     T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            APEV      G     D++S G+++ EM  G
Sbjct: 192 RAPEVILGM--GYKENVDIWSVGVIMGEMIKG 221

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 60/118 (50%), Gaps = 9/118 (7%)
Query: 12  DQESSNGNRT----LEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP 67
           D  S++ +RT    LE      +   IA G+EYL    +  +VH D+   N+L+ +    
Sbjct: 111 DVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNV 167
Query: 68  KISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
           KISD GL ++         + ++   I ++APE     +G  S  SD++SYG+++ E+
Sbjct: 168 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM--YGKFSIDSDIWSYGVVLWEV 223

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/130 (34%), Positives = 60/130 (46%), Gaps = 15/130 (11%)
Query: 3   NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD 62
            GSL Q   +Q     +R L +       G    GLEYLH   + RI+H D+K  N+LL 
Sbjct: 169 GGSLGQLVKEQGCLPEDRALYY------LGQALEGLEYLH---SRRILHGDVKADNVLLS 219
Query: 63  EDFC-PKISDFGLAKQSQDK---KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSY 118
            D     + DFG A   Q     KS ++  +  GT  ++APEV       A  K DV+S 
Sbjct: 220 SDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDA--KVDVWSS 277
Query: 119 GMMILEMAVG 128
             M+L M  G
Sbjct: 278 CCMMLHMLNG 287

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 59/130 (45%), Gaps = 20/130 (15%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCP--KISDFGLAKQSQDKKSTISMLHARGTI 94
           G+ Y H    +++ H D+K  N LLD    P  KI+DFG +K S       S   A GT 
Sbjct: 127 GVSYAH---AMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKS---AVGTP 180
Query: 95  GYIAPEVFCRS-FGGASHKSDVYSYGMMILEMAVGR---------KNADVKASRSSDIYF 144
            YIAPEV  +  + G    +DV+S G+ +  M VG          KN      R  ++ +
Sbjct: 181 AYIAPEVLLKKEYDGKV--ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY 238
Query: 145 PNSIYKHIEP 154
               Y HI P
Sbjct: 239 AIPDYVHISP 248

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 66/132 (50%), Gaps = 21/132 (15%)
Query: 2   PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL 61
           P G++D    +      +R L    +  +   +   L +LH   + RI+H D+K  N+L+
Sbjct: 91  PGGAVDAIMLEL-----DRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLM 142
Query: 62  DEDFCPKISDFGLA----KQSQDKKSTISMLHARGTIGYIAPE-VFCRSFGGA--SHKSD 114
             +   +++DFG++    K  Q + S I      GT  ++APE V C +       +K+D
Sbjct: 143 TLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAPEVVMCETMKDTPYDYKAD 196
Query: 115 VYSYGMMILEMA 126
           ++S G+ ++EMA
Sbjct: 197 IWSLGITLIEMA 208

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 50/98 (51%), Gaps = 12/98 (12%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           +   ++YLH      IVH D+KP N+L    +E+    I+DFGL+K  Q+      M  A
Sbjct: 115 VLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTA 167
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT GY+APEV  +     S   D +S G++   +  G
Sbjct: 168 CGTPGYVAPEVLAQK--PYSKAVDCWSIGVITYILLCG 203

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 8/92 (8%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH      I+H D+KP NI++  D   KI DFGLA+ +    ++  M     T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            APEV      G     D++S G+++ EM  G
Sbjct: 192 RAPEVILGM--GYKENVDIWSVGVIMGEMIKG 221

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 85/194 (43%), Gaps = 27/194 (13%)
Query: 12  DQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISD 71
           + E++ G      + + Q+A  IA G+ YL+     + VH D+   N ++  DF  KI D
Sbjct: 116 EAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGD 172
Query: 72  FGLAKQSQD----KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV 127
           FG+ +   +    +K    +L  R    ++APE      G  +  SD++S+G+++ E+  
Sbjct: 173 FGMTRDIYETDYYRKGGKGLLPVR----WMAPESL--KDGVFTTSSDMWSFGVVLWEI-- 224
Query: 128 GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNP 187
                    S +   Y   S  + ++    F +DG            +  +   C Q NP
Sbjct: 225 --------TSLAEQPYQGLSNEQVLK----FVMDGGYLDQPDNCPERVTDLMRMCWQFNP 272
Query: 188 SDRPSMHEVLEMLE 201
             RP+  E++ +L+
Sbjct: 273 KMRPTFLEIVNLLK 286

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 66/126 (52%), Gaps = 11/126 (8%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +P+GSL ++       N N+ +  +   + A  I +G++YL    + + VH D+   N+L
Sbjct: 107 LPSGSLKEYL----PKNKNK-INLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVL 158
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGT-IGYIAPEVFCRSFGGASHKSDVYSYG 119
           ++ +   KI DFGL K  +  K   ++   R + + + APE   +S    +  SDV+S+G
Sbjct: 159 VESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIA--SDVWSFG 216
Query: 120 MMILEM 125
           + + E+
Sbjct: 217 VTLHEL 222

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 66/126 (52%), Gaps = 11/126 (8%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +P+GSL ++       N N+ +  +   + A  I +G++YL    + + VH D+   N+L
Sbjct: 95  LPSGSLKEYL----PKNKNK-INLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVL 146
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGT-IGYIAPEVFCRSFGGASHKSDVYSYG 119
           ++ +   KI DFGL K  +  K   ++   R + + + APE   +S    +  SDV+S+G
Sbjct: 147 VESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIA--SDVWSFG 204
Query: 120 MMILEM 125
           + + E+
Sbjct: 205 VTLHEL 210

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 49/105 (46%), Gaps = 11/105 (10%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD---EDFCPKISDFGLAKQSQDKKS 83
           +  +   I+  L YLH     RI+H D+KP NI+L    +    KI D G AK+    + 
Sbjct: 124 IRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 180
Query: 84  TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
               +   GT+ Y+APE+  +     +   D +S+G +  E   G
Sbjct: 181 CTEFV---GTLQYLAPELLEQKKYTVT--VDYWSFGTLAFECITG 220

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 49/105 (46%), Gaps = 11/105 (10%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD---EDFCPKISDFGLAKQSQDKKS 83
           +  +   I+  L YLH     RI+H D+KP NI+L    +    KI D G AK+    + 
Sbjct: 123 IRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179
Query: 84  TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
               +   GT+ Y+APE+  +     +   D +S+G +  E   G
Sbjct: 180 CTEFV---GTLQYLAPELLEQKKYTVT--VDYWSFGTLAFECITG 219

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 85/194 (43%), Gaps = 27/194 (13%)
Query: 12  DQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISD 71
           + E++ G      + + Q+A  IA G+ YL+     + VH D+   N ++  DF  KI D
Sbjct: 117 EAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGD 173
Query: 72  FGLAKQSQD----KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV 127
           FG+ +   +    +K    +L  R    ++APE      G  +  SD++S+G+++ E+  
Sbjct: 174 FGMTRDIYETDYYRKGGKGLLPVR----WMAPESL--KDGVFTTSSDMWSFGVVLWEI-- 225
Query: 128 GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNP 187
                    S +   Y   S  + ++    F +DG            +  +   C Q NP
Sbjct: 226 --------TSLAEQPYQGLSNEQVLK----FVMDGGYLDQPDNCPERVTDLMRMCWQFNP 273
Query: 188 SDRPSMHEVLEMLE 201
             RP+  E++ +L+
Sbjct: 274 KMRPTFLEIVNLLK 287

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 66/125 (52%), Gaps = 11/125 (8%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NG L    Y +E  +  +T   + + ++   +   +EYL    + + +H D+   N L
Sbjct: 101 MANGCL--LNYLREMRHRFQT---QQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCL 152
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           +++    K+SDFGL++   D + T S + ++  + +  PEV    +   S KSD++++G+
Sbjct: 153 VNDQGVVKVSDFGLSRYVLDDEET-SSVGSKFPVRWSPPEVLM--YSKFSSKSDIWAFGV 209
Query: 121 MILEM 125
           ++ E+
Sbjct: 210 LMWEI 214

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 29  QIAG---GIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTI 85
           QIA     + + L  LH      ++H DIK  +ILL  D   K+SDFG   Q   +    
Sbjct: 126 QIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 182
Query: 86  SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
             L   GT  ++APE+  R   G   + D++S G+M++EM  G
Sbjct: 183 KXLV--GTPYWMAPELISRLPYGP--EVDIWSLGIMVIEMVDG 221

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 29  QIAG---GIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTI 85
           QIA     + + L  LH      ++H DIK  +ILL  D   K+SDFG   Q   +    
Sbjct: 128 QIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 184
Query: 86  SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
             L   GT  ++APE+  R   G   + D++S G+M++EM  G
Sbjct: 185 KXL--VGTPYWMAPELISRLPYGP--EVDIWSLGIMVIEMVDG 223

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 81/194 (41%), Gaps = 27/194 (13%)
Query: 12  DQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISD 71
           + E++ G      + + Q+A  IA G+ YL+     + VH D+   N ++  DF  KI D
Sbjct: 117 EAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGD 173
Query: 72  FGLAKQSQD----KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV 127
           FG+ +   +    +K    +L  R    ++APE      G  +  SD++S+G+++ E+  
Sbjct: 174 FGMTRDIYETAYYRKGGKGLLPVR----WMAPESL--KDGVFTTSSDMWSFGVVLWEITS 227
Query: 128 GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNP 187
             +      S    +               F +DG            +  +   C Q NP
Sbjct: 228 LAEQPYQGLSNEQVL--------------KFVMDGGYLDQPDNCPERVTDLMRMCWQFNP 273
Query: 188 SDRPSMHEVLEMLE 201
             RP+  E++ +L+
Sbjct: 274 KMRPTFLEIVNLLK 287

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/114 (28%), Positives = 55/114 (48%), Gaps = 11/114 (9%)
Query: 18  GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE---DFCPKISDFGL 74
           G++    R   +I   I   ++YLH   ++ I H D+KP N+L      +   K++DFG 
Sbjct: 160 GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 216
Query: 75  AKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           AK++    S  +  +   T  Y+APEV        S   D++S G+++  +  G
Sbjct: 217 AKETTSHNSLTTPCY---TPYYVAPEVLGPEKYDKS--CDMWSLGVIMYILLCG 265

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 29  QIAG---GIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTI 85
           QIA     + + L  LH      ++H DIK  +ILL  D   K+SDFG   Q   +    
Sbjct: 117 QIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 173
Query: 86  SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
             L   GT  ++APE+  R   G   + D++S G+M++EM  G
Sbjct: 174 KXL--VGTPYWMAPELISRLPYGP--EVDIWSLGIMVIEMVDG 212

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 29  QIAG---GIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTI 85
           QIA     + + L  LH      ++H DIK  +ILL  D   K+SDFG   Q   +    
Sbjct: 248 QIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 304
Query: 86  SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
             L   GT  ++APE+  R   G   + D++S G+M++EM  G
Sbjct: 305 KXLV--GTPYWMAPELISRLPYGP--EVDIWSLGIMVIEMVDG 343

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 57/115 (49%), Gaps = 17/115 (14%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
            YQ++  +A    YL    + R VH DI   N+L+  + C K+ DFGL++  +D  +   
Sbjct: 120 AYQLSTALA----YLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYK 171
Query: 87  MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-------GRKNADV 134
               +  I ++APE    +F   +  SDV+ +G+ + E+ +       G KN DV
Sbjct: 172 ASKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 224

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 57/114 (50%), Gaps = 17/114 (14%)
Query: 28  YQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISM 87
           YQ++  +A    YL    + R VH DI   N+L+  + C K+ DFGL++  +D  +    
Sbjct: 118 YQLSTALA----YLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKA 169
Query: 88  LHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-------GRKNADV 134
              +  I ++APE    +F   +  SDV+ +G+ + E+ +       G KN DV
Sbjct: 170 SKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 221

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 57/115 (49%), Gaps = 17/115 (14%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
            YQ++  +A    YL    + R VH DI   N+L+  + C K+ DFGL++  +D  +   
Sbjct: 119 AYQLSTALA----YLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYK 170
Query: 87  MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-------GRKNADV 134
               +  I ++APE    +F   +  SDV+ +G+ + E+ +       G KN DV
Sbjct: 171 ASKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 223

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 7/99 (7%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  IA GL +L    +  I++ D+K  N++LD +   KI+DFG+ K++     T      
Sbjct: 127 AAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFC- 182
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
            GT  YIAPE+      G S   D +++G+++ EM  G+
Sbjct: 183 -GTPDYIAPEIIAYQPYGKS--VDWWAFGVLLYEMLAGQ 218

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 57/114 (50%), Gaps = 17/114 (14%)
Query: 28  YQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISM 87
           YQ++  +A    YL    + R VH DI   N+L+  + C K+ DFGL++  +D  +    
Sbjct: 118 YQLSTALA----YLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKA 169
Query: 88  LHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-------GRKNADV 134
              +  I ++APE    +F   +  SDV+ +G+ + E+ +       G KN DV
Sbjct: 170 SKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 221

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/114 (28%), Positives = 55/114 (48%), Gaps = 11/114 (9%)
Query: 18  GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE---DFCPKISDFGL 74
           G++    R   +I   I   ++YLH   ++ I H D+KP N+L      +   K++DFG 
Sbjct: 114 GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 170
Query: 75  AKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           AK++    S  +  +   T  Y+APEV        S   D++S G+++  +  G
Sbjct: 171 AKETTSHNSLTTPCY---TPYYVAPEVLGPEKYDKS--CDMWSLGVIMYILLCG 219

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/114 (28%), Positives = 55/114 (48%), Gaps = 11/114 (9%)
Query: 18  GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE---DFCPKISDFGL 74
           G++    R   +I   I   ++YLH   ++ I H D+KP N+L      +   K++DFG 
Sbjct: 154 GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210
Query: 75  AKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           AK++    S  +  +   T  Y+APEV        S   D++S G+++  +  G
Sbjct: 211 AKETTSHNSLTTPCY---TPYYVAPEVLGPEKYDKS--CDMWSLGVIMYILLCG 259

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/114 (28%), Positives = 55/114 (48%), Gaps = 11/114 (9%)
Query: 18  GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE---DFCPKISDFGL 74
           G++    R   +I   I   ++YLH   ++ I H D+KP N+L      +   K++DFG 
Sbjct: 110 GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
Query: 75  AKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           AK++    S  +  +   T  Y+APEV        S   D++S G+++  +  G
Sbjct: 167 AKETTSHNSLTTPCY---TPYYVAPEVLGPEKYDKS--CDMWSLGVIMYILLCG 215

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/114 (28%), Positives = 55/114 (48%), Gaps = 11/114 (9%)
Query: 18  GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE---DFCPKISDFGL 74
           G++    R   +I   I   ++YLH   ++ I H D+KP N+L      +   K++DFG 
Sbjct: 116 GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 172
Query: 75  AKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           AK++    S  +  +   T  Y+APEV        S   D++S G+++  +  G
Sbjct: 173 AKETTSHNSLTTPCY---TPYYVAPEVLGPEKYDKS--CDMWSLGVIMYILLCG 221

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 41/78 (52%), Gaps = 6/78 (7%)
Query: 49  IVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGG 108
           +VH D+KP NI L      K+ DFGL  +     +        G   Y+APE+   S+G 
Sbjct: 178 LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ---EGDPRYMAPELLQGSYGT 234
Query: 109 ASHKSDVYSYGMMILEMA 126
           A   +DV+S G+ ILE+A
Sbjct: 235 A---ADVFSLGLTILEVA 249

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 66/125 (52%), Gaps = 11/125 (8%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NG L    Y +E  +  +T   + + ++   +   +EYL    + + +H D+   N L
Sbjct: 85  MANGCL--LNYLREMRHRFQT---QQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCL 136
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           +++    K+SDFGL++   D + T S + ++  + +  PEV    +   S KSD++++G+
Sbjct: 137 VNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLM--YSKFSSKSDIWAFGV 193
Query: 121 MILEM 125
           ++ E+
Sbjct: 194 LMWEI 198

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 29  QIAG---GIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTI 85
           QIA     + + L  LH      ++H DIK  +ILL  D   K+SDFG   Q   +    
Sbjct: 121 QIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 177
Query: 86  SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
             L   GT  ++APE+  R   G   + D++S G+M++EM  G
Sbjct: 178 KXL--VGTPYWMAPELISRLPYGP--EVDIWSLGIMVIEMVDG 216

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/114 (28%), Positives = 55/114 (48%), Gaps = 11/114 (9%)
Query: 18  GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE---DFCPKISDFGL 74
           G++    R   +I   I   ++YLH   ++ I H D+KP N+L      +   K++DFG 
Sbjct: 124 GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 180
Query: 75  AKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           AK++    S  +  +   T  Y+APEV        S   D++S G+++  +  G
Sbjct: 181 AKETTSHNSLTTPCY---TPYYVAPEVLGPEKYDKS--CDMWSLGVIMYILLCG 229

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 43/80 (53%), Gaps = 4/80 (5%)
Query: 49  IVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGG 108
           ++H DIK  +ILL  D   K+SDFG   Q   +      L   GT  ++APE+  R   G
Sbjct: 191 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV--GTPYWMAPELISRLPYG 248
Query: 109 ASHKSDVYSYGMMILEMAVG 128
              + D++S G+M++EM  G
Sbjct: 249 P--EVDIWSLGIMVIEMVDG 266

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/114 (28%), Positives = 55/114 (48%), Gaps = 11/114 (9%)
Query: 18  GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE---DFCPKISDFGL 74
           G++    R   +I   I   ++YLH   ++ I H D+KP N+L      +   K++DFG 
Sbjct: 108 GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 164
Query: 75  AKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           AK++    S  +  +   T  Y+APEV        S   D++S G+++  +  G
Sbjct: 165 AKETTSHNSLTTPCY---TPYYVAPEVLGPEKYDKS--CDMWSLGVIMYILLCG 213

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/114 (28%), Positives = 55/114 (48%), Gaps = 11/114 (9%)
Query: 18  GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE---DFCPKISDFGL 74
           G++    R   +I   I   ++YLH   ++ I H D+KP N+L      +   K++DFG 
Sbjct: 115 GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 171
Query: 75  AKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           AK++    S  +  +   T  Y+APEV        S   D++S G+++  +  G
Sbjct: 172 AKETTSHNSLTTPCY---TPYYVAPEVLGPEKYDKS--CDMWSLGVIMYILLCG 220

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 57/114 (50%), Gaps = 17/114 (14%)
Query: 28  YQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISM 87
           YQ++  +A    YL    + R VH DI   N+L+  + C K+ DFGL++  +D  +    
Sbjct: 115 YQLSTALA----YLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKA 166
Query: 88  LHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-------GRKNADV 134
              +  I ++APE    +F   +  SDV+ +G+ + E+ +       G KN DV
Sbjct: 167 SKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 218

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 57/115 (49%), Gaps = 17/115 (14%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
            YQ++  +A    YL    + R VH DI   N+L+  + C K+ DFGL++  +D  +   
Sbjct: 145 AYQLSTALA----YLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYK 196
Query: 87  MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-------GRKNADV 134
               +  I ++APE    +F   +  SDV+ +G+ + E+ +       G KN DV
Sbjct: 197 ASKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 249

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 66/125 (52%), Gaps = 11/125 (8%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NG L    Y +E  +  +T   + + ++   +   +EYL    + + +H D+   N L
Sbjct: 86  MANGCL--LNYLREMRHRFQT---QQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCL 137
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           +++    K+SDFGL++   D + T S + ++  + +  PEV    +   S KSD++++G+
Sbjct: 138 VNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLM--YSKFSSKSDIWAFGV 194
Query: 121 MILEM 125
           ++ E+
Sbjct: 195 LMWEI 199

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 49/98 (50%), Gaps = 6/98 (6%)
Query: 29  QIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK-QSQDKKSTISM 87
           Q    I +G+EYL      R +H ++   NIL++ +   KI DFGL K   QDK+     
Sbjct: 119 QYTSQICKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK 175
Query: 88  LHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
                 I + APE    S    S  SDV+S+G+++ E+
Sbjct: 176 EPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYEL 211

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 7/99 (7%)
Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  IA GL +L    +  I++ D+K  N++LD +   KI+DFG+ K++     T      
Sbjct: 448 AAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFC- 503
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
            GT  YIAPE+      G S   D +++G+++ EM  G+
Sbjct: 504 -GTPDYIAPEIIAYQPYGKS--VDWWAFGVLLYEMLAGQ 539

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 66/125 (52%), Gaps = 11/125 (8%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NG L    Y +E  +  +T   + + ++   +   +EYL    + + +H D+   N L
Sbjct: 81  MANGCL--LNYLREMRHRFQT---QQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCL 132
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           +++    K+SDFGL++   D + T S + ++  + +  PEV    +   S KSD++++G+
Sbjct: 133 VNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLM--YSKFSSKSDIWAFGV 189
Query: 121 MILEM 125
           ++ E+
Sbjct: 190 LMWEI 194

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/114 (28%), Positives = 55/114 (48%), Gaps = 11/114 (9%)
Query: 18  GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE---DFCPKISDFGL 74
           G++    R   +I   I   ++YLH   ++ I H D+KP N+L      +   K++DFG 
Sbjct: 110 GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
Query: 75  AKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           AK++    S  +  +   T  Y+APEV        S   D++S G+++  +  G
Sbjct: 167 AKETTSHNSLTTPCY---TPYYVAPEVLGPEKYDKS--CDMWSLGVIMYILLCG 215

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 57/115 (49%), Gaps = 17/115 (14%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
            YQ++  +A    YL    + R VH DI   N+L+  + C K+ DFGL++  +D  +   
Sbjct: 122 AYQLSTALA----YLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYK 173
Query: 87  MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-------GRKNADV 134
               +  I ++APE    +F   +  SDV+ +G+ + E+ +       G KN DV
Sbjct: 174 ASKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 226

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS--QDKKSTISMLHAR 91
           +  G+ Y H   + R++H D+KP N+L++ +   KI+DFGLA+      +K T    H  
Sbjct: 109 LLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT----HEV 161
Query: 92  GTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            T+ Y AP+V   S    S   D++S G +  EM  G
Sbjct: 162 VTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/114 (28%), Positives = 55/114 (48%), Gaps = 11/114 (9%)
Query: 18  GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE---DFCPKISDFGL 74
           G++    R   +I   I   ++YLH   ++ I H D+KP N+L      +   K++DFG 
Sbjct: 109 GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 165
Query: 75  AKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           AK++    S  +  +   T  Y+APEV        S   D++S G+++  +  G
Sbjct: 166 AKETTSHNSLTTPCY---TPYYVAPEVLGPEKYDKS--CDMWSLGVIMYILLCG 214

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 10/94 (10%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGL-AKQSQDKKSTISMLHARGTIG 95
            L YLH     +I+H D+K  NIL   D   K++DFG+ AK ++  +     +   GT  
Sbjct: 147 ALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFI---GTPY 200
Query: 96  YIAPE-VFCRSFGGA--SHKSDVYSYGMMILEMA 126
           ++APE V C +       +K+DV+S G+ ++EMA
Sbjct: 201 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 234

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 55/106 (51%), Gaps = 7/106 (6%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ-SQDKKSTI 85
           V ++   ++ G++YL        VH ++   N+LL      KISDFGL+K    D     
Sbjct: 438 VAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494
Query: 86  SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILE-MAVGRK 130
           +    +  + + APE  C +F   S +SDV+SYG+ + E ++ G+K
Sbjct: 495 ARSAGKWPLKWYAPE--CINFRKFSSRSDVWSYGVTMWEALSYGQK 538

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS--QDKKSTISMLHAR 91
           +  G+ Y H   + R++H D+KP N+L++ +   KI+DFGLA+      +K T    H  
Sbjct: 109 LLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT----HEV 161
Query: 92  GTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            T+ Y AP+V   S    S   D++S G +  EM  G
Sbjct: 162 VTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 58/116 (50%), Gaps = 19/116 (16%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
            YQ++  +A    YL    + R VH DI   N+L+  + C K+ DFGL++  +D  +   
Sbjct: 497 AYQLSTALA----YLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYK 548
Query: 87  MLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEMAV-------GRKNADV 134
               +  I ++APE +  R F  A   SDV+ +G+ + E+ +       G KN DV
Sbjct: 549 ASKGKLPIKWMAPESINFRRFTSA---SDVWMFGVCMWEILMHGVKPFQGVKNNDV 601

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 48/92 (52%), Gaps = 5/92 (5%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           IA+G+ YL       +VH ++   N+LL      +++DFG+A         +    A+  
Sbjct: 142 IAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 198
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
           I ++A E     FG  +H+SDV+SYG+ + E+
Sbjct: 199 IKWMALESI--HFGKYTHQSDVWSYGVTVWEL 228

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 51/98 (52%), Gaps = 13/98 (13%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ--DKKSTISMLHAR 91
           I   ++Y H+    RIVH D+K  N+LLD D   KI+DFG + +     K  T       
Sbjct: 120 IVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFC----- 171
Query: 92  GTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVG 128
           G+  Y APE+F  + + G   + DV+S G+++  +  G
Sbjct: 172 GSPPYAAPELFQGKKYDGP--EVDVWSLGVILYTLVSG 207

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 8/92 (8%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH   +  I+H D+KP NI++  D   KI DFGLA+ +    ++  M+    T  Y
Sbjct: 140 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMVPFVVTRYY 193
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            APEV      G     D++S G ++ EM  G
Sbjct: 194 RAPEVILGM--GYKENVDIWSVGCIMGEMIKG 223

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 51/102 (50%), Gaps = 12/102 (11%)
Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK--------QSQDKKSTISM 87
           R ++ LH G NV  +H D+KP N+L++ +   K+ DFGLA+         S+       M
Sbjct: 123 RAVKVLH-GSNV--IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 88  LHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           +    T  Y APEV   S    S   DV+S G ++ E+ + R
Sbjct: 180 VEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRR 220

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 66/125 (52%), Gaps = 11/125 (8%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NG L    Y +E  +  +T   + + ++   +   +EYL    + + +H D+   N L
Sbjct: 92  MANGCL--LNYLREMRHRFQT---QQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCL 143
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           +++    K+SDFGL++   D + T S + ++  + +  PEV    +   S KSD++++G+
Sbjct: 144 VNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLM--YSKFSSKSDIWAFGV 200
Query: 121 MILEM 125
           ++ E+
Sbjct: 201 LMWEI 205

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS--QDKKSTISMLHAR 91
           +  G+ Y H   + R++H D+KP N+L++ +   KI+DFGLA+      +K T    H  
Sbjct: 109 LLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT----HEI 161
Query: 92  GTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            T+ Y AP+V   S    S   D++S G +  EM  G
Sbjct: 162 VTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 48/92 (52%), Gaps = 5/92 (5%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           IA+G+ YL       +VH ++   N+LL      +++DFG+A         +    A+  
Sbjct: 124 IAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180
Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
           I ++A E     FG  +H+SDV+SYG+ + E+
Sbjct: 181 IKWMALESI--HFGKYTHQSDVWSYGVTVWEL 210

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 66/125 (52%), Gaps = 11/125 (8%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NG L    Y +E  +  +T   + + ++   +   +EYL    + + +H D+   N L
Sbjct: 101 MANGCL--LNYLREMRHRFQT---QQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCL 152
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           +++    K+SDFGL++   D + T S + ++  + +  PEV    +   S KSD++++G+
Sbjct: 153 VNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLM--YSKFSSKSDIWAFGV 209
Query: 121 MILEM 125
           ++ E+
Sbjct: 210 LMWEI 214

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 9/88 (10%)
Query: 18  GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE---DFCPKISDFGL 74
           G++    R   +I   I   ++YLH   ++ I H D+KP N+L      +   K++DFG 
Sbjct: 154 GDQAFTEREASEIXKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210
Query: 75  AKQSQDKKSTISMLHARGTIGYIAPEVF 102
           AK++    S  +  +   T  Y+APEV 
Sbjct: 211 AKETTSHNSLTTPCY---TPYYVAPEVL 235

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 62/122 (50%), Gaps = 18/122 (14%)
Query: 4   GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE 63
           G L  F  ++ES       E+  + QI  G+     YLH   +++I HFD+KP NI+L +
Sbjct: 99  GELFDFLAEKESLTEEEATEF--LKQILNGVY----YLH---SLQIAHFDLKPENIMLLD 149
Query: 64  DFCP----KISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
              P    KI DFGLA +        ++    GT  ++APE+   ++     ++D++S G
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPAFVAPEIV--NYEPLGLEADMWSIG 204
Query: 120 MM 121
           ++
Sbjct: 205 VI 206

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 51/109 (46%), Gaps = 10/109 (9%)
Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS 78
            + L+   +  +  G  +GL YLH   +  ++H D+K  NILL E    K+ DFG A   
Sbjct: 148 KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 204
Query: 79  QDKKSTISMLHARGTIGYIAPEV-FCRSFGGASHKSDVYSYGMMILEMA 126
                 +      GT  ++APEV      G    K DV+S G+  +E+A
Sbjct: 205 APANXFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 247

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 50/102 (49%), Gaps = 12/102 (11%)
Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK--------QSQDKKSTISM 87
           R ++ LH G NV  +H D+KP N+L++ +   K+ DFGLA+         S+       M
Sbjct: 123 RAVKVLH-GSNV--IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 88  LHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
                T  Y APEV   S    S   DV+S G ++ E+ + R
Sbjct: 180 TEXVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRR 220

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 60/122 (49%), Gaps = 18/122 (14%)
Query: 4   GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE 63
           G L  F  ++ES      L      Q    I  G+ YLH   + RI HFD+KP NI+L +
Sbjct: 93  GELFDFLAEKES------LTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLD 143
Query: 64  DFCP----KISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
              P    K+ DFG+A + +      ++    GT  ++APE+   ++     ++D++S G
Sbjct: 144 KNVPNPRIKLIDFGIAHKIEAGNEFKNIF---GTPEFVAPEIV--NYEPLGLEADMWSIG 198
Query: 120 MM 121
           ++
Sbjct: 199 VI 200

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/114 (28%), Positives = 54/114 (47%), Gaps = 11/114 (9%)
Query: 18  GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE---DFCPKISDFGL 74
           G++    R   +I   I   ++YLH   ++ I H D+KP N+L      +   K++DFG 
Sbjct: 108 GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 164
Query: 75  AKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           AK++    S     +   T  Y+APEV        S   D++S G+++  +  G
Sbjct: 165 AKETTSHNSLTEPCY---TPYYVAPEVLGPEKYDKS--CDMWSLGVIMYILLCG 213

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 60/122 (49%), Gaps = 18/122 (14%)
Query: 4   GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE 63
           G L  F  ++ES      L      Q    I  G+ YLH   + RI HFD+KP NI+L +
Sbjct: 114 GELFDFLAEKES------LTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLD 164
Query: 64  DFCP----KISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
              P    K+ DFG+A + +      ++    GT  ++APE+   ++     ++D++S G
Sbjct: 165 KNVPNPRIKLIDFGIAHKIEAGNEFKNIF---GTPEFVAPEIV--NYEPLGLEADMWSIG 219
Query: 120 MM 121
           ++
Sbjct: 220 VI 221

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 60/122 (49%), Gaps = 18/122 (14%)
Query: 4   GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE 63
           G L  F  ++ES      L      Q    I  G+ YLH   + RI HFD+KP NI+L +
Sbjct: 100 GELFDFLAEKES------LTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLD 150
Query: 64  DFCP----KISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
              P    K+ DFG+A + +      ++    GT  ++APE+   ++     ++D++S G
Sbjct: 151 KNVPNPRIKLIDFGIAHKIEAGNEFKNIF---GTPEFVAPEIV--NYEPLGLEADMWSIG 205
Query: 120 MM 121
           ++
Sbjct: 206 VI 207

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 47/92 (51%), Gaps = 8/92 (8%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH      I+H D+KP NI++  D   KI DFGLA+ +    ++  M     T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            APEV      G     D++S G ++ EM  G
Sbjct: 192 RAPEVILGM--GYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 47/92 (51%), Gaps = 8/92 (8%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH      I+H D+KP NI++  D   KI DFGLA+ +    ++  M     T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            APEV      G     D++S G ++ EM  G
Sbjct: 192 RAPEVILGM--GYKENVDIWSVGCIMGEMIKG 221

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 51/97 (52%), Gaps = 11/97 (11%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHAR-G 92
           I   ++Y H+    RIVH D+K  N+LLD D   KI+DFG + +     +    L A  G
Sbjct: 123 IVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEF----TVGGKLDAFCG 175
Query: 93  TIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVG 128
              Y APE+F  + + G   + DV+S G+++  +  G
Sbjct: 176 APPYAAPELFQGKKYDGP--EVDVWSLGVILYTLVSG 210

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 8/92 (8%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH   +  I+H D+KP NI++  D   KI DFGLA+ +    ++  M     T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPEVVTRYY 191
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            APEV      G     D++S G ++ EM  G
Sbjct: 192 RAPEVILGM--GYKENVDIWSVGCIMGEMIKG 221

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 56/114 (49%), Gaps = 17/114 (14%)
Query: 28  YQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISM 87
           YQ++  +A    YL    + R VH DI   N+L+    C K+ DFGL++  +D  +    
Sbjct: 118 YQLSTALA----YLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMED-STYYKA 169
Query: 88  LHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-------GRKNADV 134
              +  I ++APE    +F   +  SDV+ +G+ + E+ +       G KN DV
Sbjct: 170 SKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 47/92 (51%), Gaps = 8/92 (8%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH      I+H D+KP NI++  D   KI DFGLA+ +    ++  M     T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            APEV      G     D++S G ++ EM  G
Sbjct: 192 RAPEVILGM--GYKENVDIWSVGCIMGEMIKG 221

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/194 (22%), Positives = 82/194 (42%), Gaps = 27/194 (13%)
Query: 12  DQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISD 71
           + E++ G      + + Q+A  IA G+ YL+     + VH ++   N ++  DF  KI D
Sbjct: 118 EAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGD 174
Query: 72  FGLAKQSQD----KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV 127
           FG+ +   +    +K    +L  R    ++APE      G  +  SD++S+G+++ E+  
Sbjct: 175 FGMTRDIYETDYYRKGGKGLLPVR----WMAPESL--KDGVFTTSSDMWSFGVVLWEITS 228
Query: 128 GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNP 187
             +      S    +               F +DG            +  +   C Q NP
Sbjct: 229 LAEQPYQGLSNEQVL--------------KFVMDGGYLDQPDNCPERVTDLMRMCWQFNP 274
Query: 188 SDRPSMHEVLEMLE 201
           + RP+  E++ +L+
Sbjct: 275 NMRPTFLEIVNLLK 288

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 51/109 (46%), Gaps = 10/109 (9%)
Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS 78
            + L+   +  +  G  +GL YLH   +  ++H D+K  NILL E    K+ DFG A   
Sbjct: 109 KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165
Query: 79  QDKKSTISMLHARGTIGYIAPEV-FCRSFGGASHKSDVYSYGMMILEMA 126
                 +      GT  ++APEV      G    K DV+S G+  +E+A
Sbjct: 166 APANXFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 208

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 50/102 (49%), Gaps = 12/102 (11%)
Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK--------QSQDKKSTISM 87
           R ++ LH G NV  +H D+KP N+L++ +   K+ DFGLA+         S+       M
Sbjct: 123 RAVKVLH-GSNV--IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 88  LHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
                T  Y APEV   S    S   DV+S G ++ E+ + R
Sbjct: 180 TEYVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRR 220

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/194 (22%), Positives = 82/194 (42%), Gaps = 27/194 (13%)
Query: 12  DQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISD 71
           + E++ G      + + Q+A  IA G+ YL+     + VH ++   N ++  DF  KI D
Sbjct: 117 EAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGD 173
Query: 72  FGLAKQSQD----KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV 127
           FG+ +   +    +K    +L  R    ++APE      G  +  SD++S+G+++ E+  
Sbjct: 174 FGMTRDIYETDYYRKGGKGLLPVR----WMAPESL--KDGVFTTSSDMWSFGVVLWEITS 227
Query: 128 GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGXXXXXXXXXXXXMILVSLWCIQTNP 187
             +      S    +               F +DG            +  +   C Q NP
Sbjct: 228 LAEQPYQGLSNEQVL--------------KFVMDGGYLDQPDNCPERVTDLMRMCWQFNP 273
Query: 188 SDRPSMHEVLEMLE 201
           + RP+  E++ +L+
Sbjct: 274 NMRPTFLEIVNLLK 287

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 66/128 (51%), Gaps = 17/128 (13%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NG L    Y +E  +  +T   + + ++   +   +EYL    + + +H D+   N L
Sbjct: 86  MANGCL--LNYLREMRHRFQT---QQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCL 137
Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGT---IGYIAPEVFCRSFGGASHKSDVYS 117
           +++    K+SDFGL++   D + T S    RG+   + +  PEV    +   S KSD+++
Sbjct: 138 VNDQGVVKVSDFGLSRYVLDDEYTSS----RGSKFPVRWSPPEVLM--YSKFSSKSDIWA 191
Query: 118 YGMMILEM 125
           +G+++ E+
Sbjct: 192 FGVLMWEI 199

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 57/138 (41%), Gaps = 29/138 (21%)
Query: 10  TYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL-----DED 64
           TYD    NG        + ++A  I + + +LH     ++ H D+KP NIL       E 
Sbjct: 103 TYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEA 159
Query: 65  FCPKIS--------------DFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGAS 110
           + PKI               DFG A    +  ST+       T  Y APEV      G S
Sbjct: 160 YNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLV-----STRHYRAPEVILAL--GWS 212
Query: 111 HKSDVYSYGMMILEMAVG 128
              DV+S G +++E  +G
Sbjct: 213 QPCDVWSIGCILIEYYLG 230

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 45/97 (46%), Gaps = 6/97 (6%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
            A  I  G+ YLH       +H D+   N+LLD D   KI DFGLAK   +      +  
Sbjct: 139 FAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVRE 195
Query: 90  -ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
                + + APE  C       + SDV+S+G+ + E+
Sbjct: 196 DGDSPVFWYAPE--CLKEYKFYYASDVWSFGVTLYEL 230

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 56/115 (48%), Gaps = 17/115 (14%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
            YQ++  +A    YL    + R VH DI   N+L+    C K+ DFGL++  +D  +   
Sbjct: 497 AYQLSTALA----YLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMED-STYYK 548
Query: 87  MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-------GRKNADV 134
               +  I ++APE    +F   +  SDV+ +G+ + E+ +       G KN DV
Sbjct: 549 ASKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 601

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 47/92 (51%), Gaps = 8/92 (8%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH      I+H D+KP NI++  D   KI DFGLA+ +    ++  M     T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            APEV      G     D++S G ++ EM  G
Sbjct: 192 RAPEVILGM--GYKENVDIWSVGCIMGEMIKG 221

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 44/130 (33%), Positives = 59/130 (45%), Gaps = 15/130 (11%)
Query: 3   NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD 62
            GSL Q   +Q     +R L +       G    GLEYLH   + RI+H D+K  N+LL 
Sbjct: 150 GGSLGQLVKEQGCLPEDRALYY------LGQALEGLEYLH---SRRILHGDVKADNVLLS 200
Query: 63  EDFC-PKISDFGLAKQSQDK---KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSY 118
            D     + DFG A   Q     K  ++  +  GT  ++APEV       A  K DV+S 
Sbjct: 201 SDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDA--KVDVWSS 258
Query: 119 GMMILEMAVG 128
             M+L M  G
Sbjct: 259 CCMMLHMLNG 268

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 8/92 (8%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH   +  I+H D+KP NI++  D   KI DFGLA+ +    ++  M     T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            APEV      G     D++S G ++ EM  G
Sbjct: 192 RAPEVILGM--GYKENVDIWSVGCIMGEMIKG 221

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 8/92 (8%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH   +  I+H D+KP NI++  D   KI DFGLA+ +    ++  M     T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            APEV      G     D++S G ++ EM  G
Sbjct: 192 RAPEVILGM--GYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 8/92 (8%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH   +  I+H D+KP NI++  D   KI DFGLA+ +    ++  M     T  Y
Sbjct: 139 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 192
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            APEV      G     D++S G ++ EM  G
Sbjct: 193 RAPEVILGM--GYKENVDIWSVGCIMGEMIKG 222

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 51/98 (52%), Gaps = 13/98 (13%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ--DKKSTISMLHAR 91
           I   ++Y H+     IVH D+K  N+LLD D   KI+DFG + +    +K  T       
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----- 173
Query: 92  GTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVG 128
           G+  Y APE+F  + + G   + DV+S G+++  +  G
Sbjct: 174 GSPPYAAPELFQGKKYDGP--EVDVWSLGVILYTLVSG 209

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 51/98 (52%), Gaps = 13/98 (13%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ--DKKSTISMLHAR 91
           I   ++Y H+     IVH D+K  N+LLD D   KI+DFG + +    +K  T       
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----- 173
Query: 92  GTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVG 128
           G+  Y APE+F  + + G   + DV+S G+++  +  G
Sbjct: 174 GSPPYAAPELFQGKKYDGP--EVDVWSLGVILYTLVSG 209

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 51/98 (52%), Gaps = 13/98 (13%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ--DKKSTISMLHAR 91
           I   ++Y H+     IVH D+K  N+LLD D   KI+DFG + +    +K  T       
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----- 173
Query: 92  GTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVG 128
           G+  Y APE+F  + + G   + DV+S G+++  +  G
Sbjct: 174 GSPPYAAPELFQGKKYDGP--EVDVWSLGVILYTLVSG 209

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 51/98 (52%), Gaps = 13/98 (13%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ--DKKSTISMLHAR 91
           I   ++Y H+     IVH D+K  N+LLD D   KI+DFG + +    +K  T       
Sbjct: 115 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----- 166
Query: 92  GTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVG 128
           G+  Y APE+F  + + G   + DV+S G+++  +  G
Sbjct: 167 GSPPYAAPELFQGKKYDGP--EVDVWSLGVILYTLVSG 202

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 13/99 (13%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP----KISDFGLAKQSQDKK 82
           V ++   I  G+ YLH+     IVH D+KP NILL   + P    KI DFG++++     
Sbjct: 133 VIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIY-PLGDIKIVDFGMSRKI---G 185
Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMM 121
               +    GT  Y+APE+   ++   +  +D+++ G++
Sbjct: 186 HACELREIMGTPEYLAPEIL--NYDPITTATDMWNIGII 222

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 7/100 (7%)
Query: 32  GGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHAR 91
           G +   ++ +H+   +  VH DIKP N+LLD +   +++DFG   +  D  +  S + A 
Sbjct: 198 GEMVLAIDSIHQ---LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSV-AV 253
Query: 92  GTIGYIAPEVFCR---SFGGASHKSDVYSYGMMILEMAVG 128
           GT  YI+PE+        G    + D +S G+ + EM  G
Sbjct: 254 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 293

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 62/122 (50%), Gaps = 18/122 (14%)
Query: 4   GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE 63
           G L  F  ++ES       E+  + QI  G+     YLH   +++I HFD+KP NI+L +
Sbjct: 99  GELFDFLAEKESLTEEEATEF--LKQILNGVY----YLH---SLQIAHFDLKPENIMLLD 149
Query: 64  DFCP----KISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
              P    KI DFGLA +        ++    GT  ++APE+   ++     ++D++S G
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIV--NYEPLGLEADMWSIG 204
Query: 120 MM 121
           ++
Sbjct: 205 VI 206

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 62/122 (50%), Gaps = 18/122 (14%)
Query: 4   GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE 63
           G L  F  ++ES       E+  + QI  G+     YLH   +++I HFD+KP NI+L +
Sbjct: 99  GELFDFLAEKESLTEEEATEF--LKQILNGVY----YLH---SLQIAHFDLKPENIMLLD 149
Query: 64  DFCP----KISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
              P    KI DFGLA +        ++    GT  ++APE+   ++     ++D++S G
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIV--NYEPLGLEADMWSIG 204
Query: 120 MM 121
           ++
Sbjct: 205 VI 206

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 62/122 (50%), Gaps = 18/122 (14%)
Query: 4   GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE 63
           G L  F  ++ES       E+  + QI  G+     YLH   +++I HFD+KP NI+L +
Sbjct: 99  GELFDFLAEKESLTEEEATEF--LKQILNGVY----YLH---SLQIAHFDLKPENIMLLD 149
Query: 64  DFCP----KISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
              P    KI DFGLA +        ++    GT  ++APE+   ++     ++D++S G
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIV--NYEPLGLEADMWSIG 204
Query: 120 MM 121
           ++
Sbjct: 205 VI 206

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 62/122 (50%), Gaps = 18/122 (14%)
Query: 4   GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE 63
           G L  F  ++ES       E+  + QI  G+     YLH   +++I HFD+KP NI+L +
Sbjct: 99  GELFDFLAEKESLTEEEATEF--LKQILNGVY----YLH---SLQIAHFDLKPENIMLLD 149
Query: 64  DFCP----KISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
              P    KI DFGLA +        ++    GT  ++APE+   ++     ++D++S G
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIV--NYEPLGLEADMWSIG 204
Query: 120 MM 121
           ++
Sbjct: 205 VI 206

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 62/122 (50%), Gaps = 18/122 (14%)
Query: 4   GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE 63
           G L  F  ++ES       E+  + QI  G+     YLH   +++I HFD+KP NI+L +
Sbjct: 99  GELFDFLAEKESLTEEEATEF--LKQILNGVY----YLH---SLQIAHFDLKPENIMLLD 149
Query: 64  DFCP----KISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
              P    KI DFGLA +        ++    GT  ++APE+   ++     ++D++S G
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIV--NYEPLGLEADMWSIG 204
Query: 120 MM 121
           ++
Sbjct: 205 VI 206

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 7/100 (7%)
Query: 32  GGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHAR 91
           G +   ++ +H+   +  VH DIKP N+LLD +   +++DFG   +  D  +  S + A 
Sbjct: 182 GEMVLAIDSIHQ---LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSV-AV 237
Query: 92  GTIGYIAPEVFCR---SFGGASHKSDVYSYGMMILEMAVG 128
           GT  YI+PE+        G    + D +S G+ + EM  G
Sbjct: 238 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 277

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH      I+H D+KP NI++  D   KI DFGLA+ +    ++  M     T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMA 126
            APEV      G     D++S G ++ EM 
Sbjct: 192 RAPEVILGM--GYKENVDIWSVGCIMGEMV 219

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 62/122 (50%), Gaps = 18/122 (14%)
Query: 4   GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE 63
           G L  F  ++ES       E+  + QI  G+     YLH   +++I HFD+KP NI+L +
Sbjct: 99  GELFDFLAEKESLTEEEATEF--LKQILNGVY----YLH---SLQIAHFDLKPENIMLLD 149
Query: 64  DFCP----KISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
              P    KI DFGLA +        ++    GT  ++APE+   ++     ++D++S G
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIV--NYEPLGLEADMWSIG 204
Query: 120 MM 121
           ++
Sbjct: 205 VI 206

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 62/122 (50%), Gaps = 18/122 (14%)
Query: 4   GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE 63
           G L  F  ++ES       E+  + QI  G+     YLH   +++I HFD+KP NI+L +
Sbjct: 99  GELFDFLAEKESLTEEEATEF--LKQILNGVY----YLH---SLQIAHFDLKPENIMLLD 149
Query: 64  DFCP----KISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
              P    KI DFGLA +        ++    GT  ++APE+   ++     ++D++S G
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIV--NYEPLGLEADMWSIG 204
Query: 120 MM 121
           ++
Sbjct: 205 VI 206

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 59/133 (44%), Gaps = 26/133 (19%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCP--KISDFGLAKQS---QDKKSTISMLHAR 91
           G+ Y H    +++ H D+K  N LLD    P  KI  FG +K S      KST+      
Sbjct: 127 GVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTV------ 177
Query: 92  GTIGYIAPEVFCRS-FGGASHKSDVYSYGMMILEMAVGR---------KNADVKASRSSD 141
           GT  YIAPEV  +  + G    +DV+S G+ +  M VG          KN      R  +
Sbjct: 178 GTPAYIAPEVLLKKEYDGKV--ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILN 235
Query: 142 IYFPNSIYKHIEP 154
           + +    Y HI P
Sbjct: 236 VQYAIPDYVHISP 248

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 62/122 (50%), Gaps = 18/122 (14%)
Query: 4   GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE 63
           G L  F  ++ES       E+  + QI  G+     YLH   +++I HFD+KP NI+L +
Sbjct: 99  GELFDFLAEKESLTEEEATEF--LKQILNGVY----YLH---SLQIAHFDLKPENIMLLD 149
Query: 64  DFCP----KISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
              P    KI DFGLA +        ++    GT  ++APE+   ++     ++D++S G
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIV--NYEPLGLEADMWSIG 204
Query: 120 MM 121
           ++
Sbjct: 205 VI 206

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 62/122 (50%), Gaps = 18/122 (14%)
Query: 4   GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE 63
           G L  F  ++ES       E+  + QI  G+     YLH   +++I HFD+KP NI+L +
Sbjct: 99  GELFDFLAEKESLTEEEATEF--LKQILNGVY----YLH---SLQIAHFDLKPENIMLLD 149
Query: 64  DFCP----KISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
              P    KI DFGLA +        ++    GT  ++APE+   ++     ++D++S G
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIV--NYEPLGLEADMWSIG 204
Query: 120 MM 121
           ++
Sbjct: 205 VI 206

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 62/122 (50%), Gaps = 18/122 (14%)
Query: 4   GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE 63
           G L  F  ++ES       E+  + QI  G+     YLH   +++I HFD+KP NI+L +
Sbjct: 99  GELFDFLAEKESLTEEEATEF--LKQILNGVY----YLH---SLQIAHFDLKPENIMLLD 149
Query: 64  DFCP----KISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
              P    KI DFGLA +        ++    GT  ++APE+   ++     ++D++S G
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIV--NYEPLGLEADMWSIG 204
Query: 120 MM 121
           ++
Sbjct: 205 VI 206

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH      I+H D+KP NI++  D   KI DFGLA+ +    ++  M     T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMA 126
            APEV      G     D++S G ++ EM 
Sbjct: 192 RAPEVILGM--GYKENVDIWSVGCIMGEMV 219

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH      I+H D+KP NI++  D   KI DFGLA+ +    ++  M     T  Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 184
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMA 126
            APEV      G     D++S G ++ EM 
Sbjct: 185 RAPEVILGM--GYKENVDIWSVGCIMGEMV 212

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 62/122 (50%), Gaps = 18/122 (14%)
Query: 4   GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE 63
           G L  F  ++ES       E+  + QI  G+     YLH   +++I HFD+KP NI+L +
Sbjct: 98  GELFDFLAEKESLTEEEATEF--LKQILNGVY----YLH---SLQIAHFDLKPENIMLLD 148
Query: 64  DFCP----KISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
              P    KI DFGLA +        ++    GT  ++APE+   ++     ++D++S G
Sbjct: 149 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIV--NYEPLGLEADMWSIG 203
Query: 120 MM 121
           ++
Sbjct: 204 VI 205

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH      I+H D+KP NI++  D   KI DFGLA+ +    ++  M     T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMA 126
            APEV      G     D++S G ++ EM 
Sbjct: 192 RAPEVILGM--GYKENVDIWSVGCIMGEMV 219

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 62/122 (50%), Gaps = 18/122 (14%)
Query: 4   GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE 63
           G L  F  ++ES       E+  + QI  G+     YLH   +++I HFD+KP NI+L +
Sbjct: 98  GELFDFLAEKESLTEEEATEF--LKQILNGVY----YLH---SLQIAHFDLKPENIMLLD 148
Query: 64  DFCP----KISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
              P    KI DFGLA +        ++    GT  ++APE+   ++     ++D++S G
Sbjct: 149 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIV--NYEPLGLEADMWSIG 203
Query: 120 MM 121
           ++
Sbjct: 204 VI 205

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH      I+H D+KP NI++  D   KI DFGLA+ +    ++  M     T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMA 126
            APEV      G     D++S G ++ EM 
Sbjct: 192 RAPEVILGM--GYKENVDIWSVGCIMGEMV 219

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 8/92 (8%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH   +  I+H D+KP NI++  D   KI DFGLA+ +    +   M     T  Y
Sbjct: 136 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---STNFMMTPYVVTRYY 189
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            APEV      G     D++S G ++ E+  G
Sbjct: 190 RAPEVILGM--GYKENVDIWSVGCIMGELVKG 219

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 62/122 (50%), Gaps = 18/122 (14%)
Query: 4   GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE 63
           G L  F  ++ES       E+  + QI  G+     YLH   +++I HFD+KP NI+L +
Sbjct: 99  GELFDFLAEKESLTEEEATEF--LKQILNGVY----YLH---SLQIAHFDLKPENIMLLD 149
Query: 64  DFCP----KISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
              P    KI DFGLA +        ++    GT  ++APE+   ++     ++D++S G
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIV--NYEPLGLEADMWSIG 204
Query: 120 MM 121
           ++
Sbjct: 205 VI 206

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/82 (35%), Positives = 44/82 (53%), Gaps = 4/82 (4%)
Query: 50  VHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGA 109
           VH DIKP NIL+D +   +++DFG   +  +  +  S + A GT  YI+PE+     GG 
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGTPDYISPEILQAMEGGK 255
Query: 110 SH---KSDVYSYGMMILEMAVG 128
                + D +S G+ + EM  G
Sbjct: 256 GRYGPECDWWSLGVCMYEMLYG 277

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 64/135 (47%), Gaps = 18/135 (13%)
Query: 3   NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGC-----NVRIVHFDIKPH 57
           NGSL    YD   S    TL+ +++ ++A     GL +LH           I H D+K  
Sbjct: 119 NGSL----YDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSK 171
Query: 58  NILLDEDFCPKISDFGLAKQ--SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKS-- 113
           NIL+ ++    I+D GLA +  S   +  I      GT  Y+ PEV   S      +S  
Sbjct: 172 NILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYI 231
Query: 114 --DVYSYGMMILEMA 126
             D+YS+G+++ E+A
Sbjct: 232 MADMYSFGLILWEVA 246

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 14/95 (14%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDE-----DFCPKISDFGLAKQSQDKKSTISMLH-A 90
           GL +LH   ++ IVH D+KPHNIL+            ISDFGL K+    + + S     
Sbjct: 130 GLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186
Query: 91  RGTIGYIAPEVF---CRSFGGASHKSDVYSYGMMI 122
            GT G+IAPE+    C+     ++  D++S G + 
Sbjct: 187 PGTEGWIAPEMLSEDCKE--NPTYTVDIFSAGCVF 219

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 51/98 (52%), Gaps = 13/98 (13%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ--DKKSTISMLHAR 91
           I   ++Y H+     IVH D+K  N+LLD D   KI+DFG + +    +K  T       
Sbjct: 123 IVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFC----- 174
Query: 92  GTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVG 128
           G+  Y APE+F  + + G   + DV+S G+++  +  G
Sbjct: 175 GSPPYAAPELFQGKKYDGP--EVDVWSLGVILYTLVSG 210

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/83 (33%), Positives = 47/83 (56%), Gaps = 7/83 (8%)
Query: 49  IVHFDIKPHNILLD---EDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRS 105
           IVH D+KP N+LL    +    K++DFGLA + Q ++   +     GT GY++PEV  + 
Sbjct: 151 IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQ--AWFGFAGTPGYLSPEVLRKD 208
Query: 106 FGGASHKSDVYSYGMMILEMAVG 128
             G     D+++ G+++  + VG
Sbjct: 209 PYGKP--VDIWACGVILYILLVG 229

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 49/101 (48%), Gaps = 10/101 (9%)
Query: 38  LEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYI 97
           LE +H      IVH D+KP N L+  D   K+ DFG+A Q Q   +++      GT+ Y+
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 98  APEVF-----CRSFG----GASHKSDVYSYGMMILEMAVGR 129
            PE        R  G      S KSDV+S G ++  M  G+
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 46/97 (47%), Gaps = 6/97 (6%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
            A  I  G+ YLH   +   +H ++   N+LLD D   KI DFGLAK   +      +  
Sbjct: 122 FAQQICEGMAYLH---SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 178
Query: 90  -ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
                + + APE  C       + SDV+S+G+ + E+
Sbjct: 179 DGDSPVFWYAPE--CLKEYKFYYASDVWSFGVTLYEL 213

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 47/90 (52%), Gaps = 8/90 (8%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH   +  I+H D+KP NI++  D   KI DFGLA+ +    ++  M     T  Y
Sbjct: 176 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 229
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMA 126
            APEV      G     D++S G ++ EM 
Sbjct: 230 RAPEVILGM--GYKENVDIWSVGCIMGEMV 257

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 47/90 (52%), Gaps = 8/90 (8%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH   +  I+H D+KP NI++  D   KI DFGLA+ +    ++  M     T  Y
Sbjct: 139 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 192
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMA 126
            APEV      G     D++S G ++ EM 
Sbjct: 193 RAPEVILGM--GYKENVDIWSVGCIMGEMV 220

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH      I+H D+KP NI++  D   KI DFGLA+ +    ++  M     T  Y
Sbjct: 137 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 190
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMA 126
            APEV      G     D++S G ++ EM 
Sbjct: 191 RAPEVILGM--GYKENVDIWSVGCIMGEMV 218

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 47/90 (52%), Gaps = 8/90 (8%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH   +  I+H D+KP NI++  D   KI DFGLA+ +    ++  M     T  Y
Sbjct: 132 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 185
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMA 126
            APEV      G     D++S G ++ EM 
Sbjct: 186 RAPEVILGM--GYKENVDIWSVGCIMGEMV 213

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH      I+H D+KP NI++  D   KI DFGLA+ +    ++  M     T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMA 126
            APEV      G     D++S G ++ EM 
Sbjct: 192 RAPEVILGM--GYKENVDIWSVGCIMGEMV 219

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH      I+H D+KP NI++  D   KI DFGLA+ +    ++  M     T  Y
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 192
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMA 126
            APEV      G     D++S G ++ EM 
Sbjct: 193 RAPEVILGM--GYKENVDIWSVGCIMGEMV 220

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH      I+H D+KP NI++  D   KI DFGLA+ +    ++  M     T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMA 126
            APEV      G     D++S G ++ EM 
Sbjct: 192 RAPEVILGM--GYKENVDIWSVGCIMGEMV 219

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 3/92 (3%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           GLEYLH   +  IVH DIKP N+LL      KIS  G+A+      +  +   ++G+  +
Sbjct: 121 GLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
             PE+       +  K D++S G+ +  +  G
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 47/90 (52%), Gaps = 8/90 (8%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH   +  I+H D+KP NI++  D   KI DFGLA+ +    ++  M     T  Y
Sbjct: 132 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 185
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMA 126
            APEV      G     D++S G ++ EM 
Sbjct: 186 RAPEVILGM--GYKENVDIWSVGCIMGEMV 213

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 10/101 (9%)
Query: 38  LEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYI 97
           LE +H      IVH D+KP N L+ +    K+ DFG+A Q Q   +++      GT+ Y+
Sbjct: 121 LEAVHTIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYM 179
Query: 98  APEVF-----CRSFG----GASHKSDVYSYGMMILEMAVGR 129
            PE        R  G      S KSDV+S G ++  M  G+
Sbjct: 180 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 220

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 47/90 (52%), Gaps = 8/90 (8%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH   +  I+H D+KP NI++  D   KI DFGLA+ +    ++  M     T  Y
Sbjct: 131 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 184
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMA 126
            APEV      G     D++S G ++ EM 
Sbjct: 185 RAPEVILGM--GYKENVDIWSVGCIMGEMV 212

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 47/90 (52%), Gaps = 8/90 (8%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH   +  I+H D+KP NI++  D   KI DFGLA+ +    ++  M     T  Y
Sbjct: 176 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 229
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMA 126
            APEV      G     D++S G ++ EM 
Sbjct: 230 RAPEVILGM--GYKENVDIWSVGCIMGEMV 257

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 49/101 (48%), Gaps = 10/101 (9%)
Query: 38  LEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYI 97
           LE +H      IVH D+KP N L+  D   K+ DFG+A Q Q   +++      GT+ Y+
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 98  APEVF-----CRSFG----GASHKSDVYSYGMMILEMAVGR 129
            PE        R  G      S KSDV+S G ++  M  G+
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 49/101 (48%), Gaps = 10/101 (9%)
Query: 38  LEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYI 97
           LE +H      IVH D+KP N L+  D   K+ DFG+A Q Q   +++      GT+ Y+
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 98  APEVF-----CRSFG----GASHKSDVYSYGMMILEMAVGR 129
            PE        R  G      S KSDV+S G ++  M  G+
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 53/108 (49%), Gaps = 10/108 (9%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFC-PKISDFGLAKQSQDK-- 81
           R +Y + G    GLEYLH     RI+H D+K  N+LL  D     + DFG A   Q    
Sbjct: 165 RALYYL-GQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 220
Query: 82  -KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            KS ++  +  GT  ++APEV       A  K D++S   M+L M  G
Sbjct: 221 GKSLLTGDYIPGTETHMAPEVVMGKPCDA--KVDIWSSCCMMLHMLNG 266

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 53/108 (49%), Gaps = 10/108 (9%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFC-PKISDFGLAKQSQDK-- 81
           R +Y + G    GLEYLH     RI+H D+K  N+LL  D     + DFG A   Q    
Sbjct: 151 RALYYL-GQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206
Query: 82  -KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            KS ++  +  GT  ++APEV       A  K D++S   M+L M  G
Sbjct: 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDA--KVDIWSSCCMMLHMLNG 252

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 53/108 (49%), Gaps = 10/108 (9%)
Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFC-PKISDFGLAKQSQDK-- 81
           R +Y + G    GLEYLH     RI+H D+K  N+LL  D     + DFG A   Q    
Sbjct: 167 RALYYL-GQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 222
Query: 82  -KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            KS ++  +  GT  ++APEV       A  K D++S   M+L M  G
Sbjct: 223 GKSLLTGDYIPGTETHMAPEVVMGKPCDA--KVDIWSSCCMMLHMLNG 268

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/84 (33%), Positives = 48/84 (57%), Gaps = 9/84 (10%)
Query: 49  IVHFDIKPHNILLD---EDFCPKISDFGLAKQSQ-DKKSTISMLHARGTIGYIAPEVFCR 104
           +VH D+KP N+LL    +    K++DFGLA + Q D+++        GT GY++PEV  +
Sbjct: 124 VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFA---GTPGYLSPEVLRK 180
Query: 105 SFGGASHKSDVYSYGMMILEMAVG 128
              G     D+++ G+++  + VG
Sbjct: 181 EAYGKP--VDIWACGVILYILLVG 202

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 49/101 (48%), Gaps = 10/101 (9%)
Query: 38  LEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYI 97
           LE +H      IVH D+KP N L+  D   K+ DFG+A Q Q   +++      GT+ Y+
Sbjct: 118 LEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 98  APEVF-----CRSFG----GASHKSDVYSYGMMILEMAVGR 129
            PE        R  G      S KSDV+S G ++  M  G+
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 8/93 (8%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH   +  I+H D+KP NI++  D   KI DFGLA+ +    ++  M     T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMEPEVVTRYY 191
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
            APEV      G     D++S G ++ EM   +
Sbjct: 192 RAPEVILGM--GYKENVDIWSVGCIMGEMVCHK 222

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 8/92 (8%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH   +  I+H D+KP NI++  D   KI DFGLA+ +    +   M     T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFMMTPYVVTRYY 191
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            APEV      G +   D++S G ++ E+  G
Sbjct: 192 RAPEVILGM--GYAANVDIWSVGCIMGELVKG 221

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 49/101 (48%), Gaps = 10/101 (9%)
Query: 38  LEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYI 97
           LE +H      IVH D+KP N L+  D   K+ DFG+A Q Q   +++      GT+ Y+
Sbjct: 117 LEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 175
Query: 98  APEVF-----CRSFG----GASHKSDVYSYGMMILEMAVGR 129
            PE        R  G      S KSDV+S G ++  M  G+
Sbjct: 176 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 216

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 12/99 (12%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDF-CPKISDFGLAKQSQDKKSTISMLHARG 92
           + R L Y+H   ++ I H DIKP N+LLD      K+ DFG AK     +  +S + +R 
Sbjct: 150 LLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSR- 205
Query: 93  TIGYIAPEVFCRSFGGASHKS--DVYSYGMMILEMAVGR 129
              Y APE+    FG  ++ +  D++S G ++ E+  G+
Sbjct: 206 --YYRAPELI---FGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 64/130 (49%), Gaps = 24/130 (18%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLD-------------EDFCPKISDFGLAKQSQD 80
           IA G+ +LH   +++I+H D+KP NIL+              E+    ISDFGL K+   
Sbjct: 124 IASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 81  KKSTI--SMLHARGTIGYIAPEVFCRSFGGASHKS-----DVYSYGMMILE-MAVGRKNA 132
            +S+   ++ +  GT G+ APE+   S    + +      D++S G +    ++ G+   
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 133 DVKASRSSDI 142
             K SR S+I
Sbjct: 241 GDKYSRESNI 250

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 48/96 (50%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I   ++Y H+     IVH D+K  N+LLD D   KI+DFG + +        +     G 
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFC---GA 175
Query: 94  IGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVG 128
             Y APE+F  + + G   + DV+S G+++  +  G
Sbjct: 176 PPYAAPELFQGKKYDGP--EVDVWSLGVILYTLVSG 209

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 8/93 (8%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH   +  I+H D+KP NI++  D   KI DFGLA+ +    ++  M     T  Y
Sbjct: 143 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 196
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
            APEV      G     D++S G ++ EM   +
Sbjct: 197 RAPEVILGM--GYKENVDLWSVGCIMGEMVCHK 227

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 8/93 (8%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH   +  I+H D+KP NI++  D   KI DFGLA+ +    ++  M     T  Y
Sbjct: 132 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 185
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
            APEV      G     D++S G ++ EM   +
Sbjct: 186 RAPEVILGM--GYKENVDLWSVGCIMGEMVCHK 216

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 48/96 (50%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I   ++Y H+     IVH D+K  N+LLD D   KI+DFG + +              G+
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFC---GS 175
Query: 94  IGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVG 128
             Y APE+F  + + G   + DV+S G+++  +  G
Sbjct: 176 PPYAAPELFQGKKYDGP--EVDVWSLGVILYTLVSG 209

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 56/138 (40%), Gaps = 29/138 (21%)
Query: 10  TYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL-----DED 64
           TYD    NG        + ++A  I + + +LH     ++ H D+KP NIL       E 
Sbjct: 103 TYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEA 159
Query: 65  FCPKIS--------------DFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGAS 110
           + PKI               DFG A    +  ST+          Y APEV      G S
Sbjct: 160 YNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVXXR-----HYRAPEVILAL--GWS 212
Query: 111 HKSDVYSYGMMILEMAVG 128
              DV+S G +++E  +G
Sbjct: 213 QPCDVWSIGCILIEYYLG 230

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 45/97 (46%), Gaps = 6/97 (6%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
            A  I  G+ YLH       +H ++   N+LLD D   KI DFGLAK   +      +  
Sbjct: 122 FAQQICEGMAYLH---AQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 178
Query: 90  -ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
                + + APE  C       + SDV+S+G+ + E+
Sbjct: 179 DGDSPVFWYAPE--CLKEYKFYYASDVWSFGVTLYEL 213

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 40/79 (50%), Gaps = 4/79 (5%)
Query: 49  IVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGG 108
           ++H D+KP N+ LD     K+ DFGLA+      S        GT  Y++PE   R    
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV--GTPYYMSPEQMNRM--S 192
Query: 109 ASHKSDVYSYGMMILEMAV 127
            + KSD++S G ++ E+  
Sbjct: 193 YNEKSDIWSLGCLLYELCA 211

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 58/120 (48%), Gaps = 7/120 (5%)
Query: 7   DQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFC 66
           D  T  + SS G   L       IA  +A G+ YL      + VH D+   N L+ E+  
Sbjct: 156 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMV 212
Query: 67  PKISDFGLAKQSQDKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILEM 125
            KI+DFGL++         +  +    I ++ PE +F   +   + +SDV++YG+++ E+
Sbjct: 213 VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF---YNRYTTESDVWAYGVVLWEI 269

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 46/99 (46%), Gaps = 10/99 (10%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
            A  I  G+ YLH       +H  +   N+LLD D   KI DFGLAK   +      +  
Sbjct: 117 FAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 173
Query: 90  -ARGTIGYIAPEVF--CRSFGGASHKSDVYSYGMMILEM 125
                + + APE    C+ +    + SDV+S+G+ + E+
Sbjct: 174 DGDSPVFWYAPECLKECKFY----YASDVWSFGVTLYEL 208

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 48/84 (57%), Gaps = 9/84 (10%)
Query: 49  IVHFDIKPHNILL---DEDFCPKISDFGLAKQSQ-DKKSTISMLHARGTIGYIAPEVFCR 104
           IVH D+KP N+LL    +    K++DFGLA + Q D+++        GT GY++PEV  +
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA---GTPGYLSPEVLRK 180
Query: 105 SFGGASHKSDVYSYGMMILEMAVG 128
              G     D+++ G+++  + VG
Sbjct: 181 DPYGKP--VDMWACGVILYILLVG 202

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 46/99 (46%), Gaps = 10/99 (10%)
Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH 89
            A  I  G+ YLH       +H  +   N+LLD D   KI DFGLAK   +      +  
Sbjct: 116 FAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 172
Query: 90  -ARGTIGYIAPEVF--CRSFGGASHKSDVYSYGMMILEM 125
                + + APE    C+ +    + SDV+S+G+ + E+
Sbjct: 173 DGDSPVFWYAPECLKECKFY----YASDVWSFGVTLYEL 207

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 40/79 (50%), Gaps = 4/79 (5%)
Query: 49  IVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGG 108
           ++H D+KP N+ LD     K+ DFGLA+      S        GT  Y++PE   R    
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV--GTPYYMSPEQMNRM--S 192
Query: 109 ASHKSDVYSYGMMILEMAV 127
            + KSD++S G ++ E+  
Sbjct: 193 YNEKSDIWSLGCLLYELCA 211

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 48/84 (57%), Gaps = 9/84 (10%)
Query: 49  IVHFDIKPHNILL---DEDFCPKISDFGLAKQSQ-DKKSTISMLHARGTIGYIAPEVFCR 104
           IVH D+KP N+LL    +    K++DFGLA + Q D+++        GT GY++PEV  +
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA---GTPGYLSPEVLRK 180
Query: 105 SFGGASHKSDVYSYGMMILEMAVG 128
              G     D+++ G+++  + VG
Sbjct: 181 DPYGKP--VDMWACGVILYILLVG 202

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 48/96 (50%), Gaps = 9/96 (9%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I   ++Y H+     IVH D+K  N+LLD D   KI+DFG + +        +     G 
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFC---GA 175
Query: 94  IGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVG 128
             Y APE+F  + + G   + DV+S G+++  +  G
Sbjct: 176 PPYAAPELFQGKKYDGP--EVDVWSLGVILYTLVSG 209

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 62/126 (49%), Gaps = 20/126 (15%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLD-------------EDFCPKISDFGLAKQ--S 78
           IA G+ +LH   +++I+H D+KP NIL+              E+    ISDFGL K+  S
Sbjct: 142 IASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 198
Query: 79  QDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKS-DVYSYGMMILE-MAVGRKNADVKA 136
                  ++ +  GT G+ APE+   S      +S D++S G +    ++ G+     K 
Sbjct: 199 GQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 258
Query: 137 SRSSDI 142
           SR S+I
Sbjct: 259 SRESNI 264

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 58/133 (43%), Gaps = 26/133 (19%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCP--KISDFGLAKQS---QDKKSTISMLHAR 91
           G+ Y H    +++ H D+K  N LLD    P  KI  FG +K S      K T+      
Sbjct: 127 GVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTV------ 177
Query: 92  GTIGYIAPEVFCRS-FGGASHKSDVYSYGMMILEMAVGR---------KNADVKASRSSD 141
           GT  YIAPEV  +  + G    +DV+S G+ +  M VG          KN      R  +
Sbjct: 178 GTPAYIAPEVLLKKEYDGKV--ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILN 235
Query: 142 IYFPNSIYKHIEP 154
           + +    Y HI P
Sbjct: 236 VQYAIPDYVHISP 248

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 62/126 (49%), Gaps = 20/126 (15%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLD-------------EDFCPKISDFGLAKQ--S 78
           IA G+ +LH   +++I+H D+KP NIL+              E+    ISDFGL K+  S
Sbjct: 142 IASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 198
Query: 79  QDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKS-DVYSYGMMILE-MAVGRKNADVKA 136
                  ++ +  GT G+ APE+   S      +S D++S G +    ++ G+     K 
Sbjct: 199 GQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 258
Query: 137 SRSSDI 142
           SR S+I
Sbjct: 259 SRESNI 264

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 8/93 (8%)
Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGY 96
           G+++LH   +  I+H D+KP NI++  D   KI DFGLA+ +    ++  M     T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMEPEVVTRYY 191
Query: 97  IAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
            APEV      G     D++S G ++ EM   +
Sbjct: 192 RAPEVILGM--GYKENVDLWSVGCIMGEMVCHK 222

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 53/103 (51%), Gaps = 10/103 (9%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ-SQDKKSTI 85
           + ++   +  GL Y+HR    +I+H D+K  N+L+  D   K++DFGLA+  S  K S  
Sbjct: 127 IKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 86  SMLHAR-GTIGYIAPEVFC--RSFGGASHKSDVYSYGMMILEM 125
           +    R  T+ Y  PE+    R +G      D++  G ++ EM
Sbjct: 184 NRYXNRVVTLWYRPPELLLGERDYGPP---IDLWGAGCIMAEM 223

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/80 (32%), Positives = 43/80 (53%), Gaps = 6/80 (7%)
Query: 49  IVHFDIKPHNILLDEDFCPKISDFGLAK-QSQDKKSTISMLHARGTIGYIAPEVFCRSFG 107
           ++H D+KP N+ LD     K+ DFGLA+  + D+      +   GT  Y++PE   R   
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFV---GTPYYMSPEQMNRM-- 191
Query: 108 GASHKSDVYSYGMMILEMAV 127
             + KSD++S G ++ E+  
Sbjct: 192 SYNEKSDIWSLGCLLYELCA 211

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 51/90 (56%), Gaps = 10/90 (11%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNIL-LDEDFCP-KISDFGLAKQSQDKKSTISMLHAR 91
           I  G+ ++H+   + I+H D+KP NIL ++ D    KI DFGLA++ + ++         
Sbjct: 196 ICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF--- 249
Query: 92  GTIGYIAPEVFCRSFGGASHKSDVYSYGMM 121
           GT  ++APEV    F   S  +D++S G++
Sbjct: 250 GTPEFLAPEVVNYDF--VSFPTDMWSVGVI 277

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 53/103 (51%), Gaps = 10/103 (9%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ-SQDKKSTI 85
           + ++   +  GL Y+HR    +I+H D+K  N+L+  D   K++DFGLA+  S  K S  
Sbjct: 126 IKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182
Query: 86  SMLHAR-GTIGYIAPEVFC--RSFGGASHKSDVYSYGMMILEM 125
           +    R  T+ Y  PE+    R +G      D++  G ++ EM
Sbjct: 183 NRYXNRVVTLWYRPPELLLGERDYGPP---IDLWGAGCIMAEM 222

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 53/103 (51%), Gaps = 10/103 (9%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ-SQDKKSTI 85
           + ++   +  GL Y+HR    +I+H D+K  N+L+  D   K++DFGLA+  S  K S  
Sbjct: 127 IKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 86  SMLHAR-GTIGYIAPEVFC--RSFGGASHKSDVYSYGMMILEM 125
           +    R  T+ Y  PE+    R +G      D++  G ++ EM
Sbjct: 184 NRYXNRVVTLWYRPPELLLGERDYGPP---IDLWGAGCIMAEM 223

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 53/103 (51%), Gaps = 10/103 (9%)
Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ-SQDKKSTI 85
           + ++   +  GL Y+HR    +I+H D+K  N+L+  D   K++DFGLA+  S  K S  
Sbjct: 127 IKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 86  SMLHAR-GTIGYIAPEVFC--RSFGGASHKSDVYSYGMMILEM 125
           +    R  T+ Y  PE+    R +G      D++  G ++ EM
Sbjct: 184 NRYXNRVVTLWYRPPELLLGERDYGPP---IDLWGAGCIMAEM 223

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 57/122 (46%), Gaps = 20/122 (16%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDE--DFCP-KISDFGLA---KQSQDKK--STI 85
           +A  L++LH   N  I H D+KP NIL +      P KI DFGL    K + D    ST 
Sbjct: 120 VASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTP 176
Query: 86  SMLHARGTIGYIAPEV---FCRSFGGASHKSDVYSYGMMILEMA------VGRKNADVKA 136
            +L   G+  Y+APEV   F         + D++S G+++  +       VGR  +D   
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW 236
Query: 137 SR 138
            R
Sbjct: 237 DR 238

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%), Gaps = 7/83 (8%)
Query: 49  IVHFDIKPHNILLDEDF---CPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRS 105
           +VH D+KP N+LL         K++DFGLA + + ++   +     GT GY++PEV  + 
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKD 199
Query: 106 FGGASHKSDVYSYGMMILEMAVG 128
             G     D+++ G+++  + VG
Sbjct: 200 PYGKP--VDLWACGVILYILLVG 220

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 47/101 (46%), Gaps = 10/101 (9%)
Query: 38  LEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYI 97
           LE +H      IVH D+KP N L+  D   K+ DFG+A Q Q     +      GT+ Y+
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYM 195
Query: 98  APEVF-----CRSFG----GASHKSDVYSYGMMILEMAVGR 129
            PE        R  G      S KSDV+S G ++  M  G+
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 34/127 (26%), Positives = 63/127 (49%), Gaps = 17/127 (13%)
Query: 2   PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL 61
           P G L    Y + + N  + L   T+   +  I + + YL    ++  VH DI   NIL+
Sbjct: 91  PYGELGH--YLERNKNSLKVL---TLVLYSLQICKAMAYLE---SINCVHRDIAVRNILV 142
Query: 62  DEDFCPKISDFGLAKQSQDK---KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSY 118
               C K+ DFGL++  +D+   K++++    R  I +++PE    +F   +  SDV+ +
Sbjct: 143 ASPECVKLGDFGLSRYIEDEDYYKASVT----RLPIKWMSPESI--NFRRFTTASDVWMF 196
Query: 119 GMMILEM 125
            + + E+
Sbjct: 197 AVCMWEI 203

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 46/83 (55%), Gaps = 8/83 (9%)
Query: 49  IVHFDIKPHNILL---DEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRS 105
           IVH ++KP N+LL    +    K++DFGLA +  D ++        GT GY++PEV  + 
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTPGYLSPEVLKKD 205
Query: 106 FGGASHKSDVYSYGMMILEMAVG 128
               S   D+++ G+++  + VG
Sbjct: 206 --PYSKPVDIWACGVILYILLVG 226

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 6/98 (6%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLD-EDFCPKISDFGLAKQSQDKKSTISML-HAR 91
           + RGL+Y+H   +  ++H D+KP N+ ++ ED   KI DFGLA+      S    L    
Sbjct: 129 LLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185
Query: 92  GTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
            T  Y +P +   S    +   D+++ G +  EM  G+
Sbjct: 186 VTKWYRSPRLLL-SPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 13/97 (13%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +A  L Y H     +++H DIKP N+L+      KI+DFG +  +     ++      GT
Sbjct: 124 LADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHA----PSLRRRXMCGT 176
Query: 94  IGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVG 128
           + Y+ PE+      G +H  K D++  G++  E  VG
Sbjct: 177 LDYLPPEM----IEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 24/54 (44%), Positives = 30/54 (55%), Gaps = 3/54 (5%)
Query: 49  IVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVF 102
           I+H DIK  NI++ EDF  K+ DFG A   +  K   +     GTI Y APEV 
Sbjct: 151 IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIEYCAPEVL 201

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 34/127 (26%), Positives = 63/127 (49%), Gaps = 17/127 (13%)
Query: 2   PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL 61
           P G L    Y + + N  + L   T+   +  I + + YL    ++  VH DI   NIL+
Sbjct: 107 PYGELGH--YLERNKNSLKVL---TLVLYSLQICKAMAYLE---SINCVHRDIAVRNILV 158
Query: 62  DEDFCPKISDFGLAKQSQDK---KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSY 118
               C K+ DFGL++  +D+   K++++    R  I +++PE    +F   +  SDV+ +
Sbjct: 159 ASPECVKLGDFGLSRYIEDEDYYKASVT----RLPIKWMSPESI--NFRRFTTASDVWMF 212
Query: 119 GMMILEM 125
            + + E+
Sbjct: 213 AVCMWEI 219

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 13/97 (13%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +A  L Y H     +++H DIKP N+L+      KI+DFG +  +     ++      GT
Sbjct: 123 LADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHA----PSLRRRXMCGT 175
Query: 94  IGYIAPEVFCRSFGGASH--KSDVYSYGMMILEMAVG 128
           + Y+ PE+      G +H  K D++  G++  E  VG
Sbjct: 176 LDYLPPEM----IEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 48/98 (48%), Gaps = 11/98 (11%)
Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDE---DFCPKISDFGLAKQSQDKKSTISMLHA 90
           I   + YLH      IVH D+KP N+L      D   KI+DFGL+K  + +   + M   
Sbjct: 157 ILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ---VLMKTV 210
Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
            GT GY APE+      G   + D++S G++   +  G
Sbjct: 211 CGTPGYCAPEILRGCAYGP--EVDMWSVGIITYILLCG 246

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 35/136 (25%), Positives = 59/136 (43%), Gaps = 17/136 (12%)
Query: 1   MPNGSLDQFT----------YDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIV 50
           M +G L++F            D +       L    +  IA  IA G+ YL    +   V
Sbjct: 99  MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFV 155
Query: 51  HFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPE-VFCRSFGGA 109
           H D+   N L+  +   KI DFG+++            H    I ++ PE +  R F   
Sbjct: 156 HRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF--- 212
Query: 110 SHKSDVYSYGMMILEM 125
           + +SDV+S+G+++ E+
Sbjct: 213 TTESDVWSFGVILWEI 228

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 60/131 (45%), Gaps = 16/131 (12%)
Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  G L  F+  QE   G++    R   +I   I   +++LH   +  I H D+KP N+L
Sbjct: 89  MEGGEL--FSRIQE--RGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLL 141
Query: 61  L---DEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYS 117
               ++D   K++DFG AK++              T  Y+APEV        S   D++S
Sbjct: 142 YTSKEKDAVLKLTDFGFAKETTQNALQTPCY----TPYYVAPEVLGPEKYDKS--CDMWS 195
Query: 118 YGMMILEMAVG 128
            G+++  +  G
Sbjct: 196 LGVIMYILLCG 206

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 34/127 (26%), Positives = 63/127 (49%), Gaps = 17/127 (13%)
Query: 2   PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL 61
           P G L    Y + + N  + L   T+   +  I + + YL    ++  VH DI   NIL+
Sbjct: 95  PYGELGH--YLERNKNSLKVL---TLVLYSLQICKAMAYLE---SINCVHRDIAVRNILV 146
Query: 62  DEDFCPKISDFGLAKQSQDK---KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSY 118
               C K+ DFGL++  +D+   K++++    R  I +++PE    +F   +  SDV+ +
Sbjct: 147 ASPECVKLGDFGLSRYIEDEDYYKASVT----RLPIKWMSPESI--NFRRFTTASDVWMF 200
Query: 119 GMMILEM 125
            + + E+
Sbjct: 201 AVCMWEI 207

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 46/83 (55%), Gaps = 8/83 (9%)
Query: 49  IVHFDIKPHNILL---DEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRS 105
           IVH ++KP N+LL    +    K++DFGLA +  D ++        GT GY++PEV  + 
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTPGYLSPEVLKKD 182
Query: 106 FGGASHKSDVYSYGMMILEMAVG 128
               S   D+++ G+++  + VG
Sbjct: 183 --PYSKPVDIWACGVILYILLVG 203

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 48/101 (47%), Gaps = 10/101 (9%)
Query: 38  LEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYI 97
           LE +H      IVH D+KP N L+  D   K+ DFG+A Q Q   +++      G + Y+
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 98  APEVF-----CRSFG----GASHKSDVYSYGMMILEMAVGR 129
            PE        R  G      S KSDV+S G ++  M  G+
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 46/83 (55%), Gaps = 8/83 (9%)
Query: 49  IVHFDIKPHNILL---DEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRS 105
           IVH ++KP N+LL    +    K++DFGLA +  D ++        GT GY++PEV  + 
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTPGYLSPEVLKKD 182
Query: 106 FGGASHKSDVYSYGMMILEMAVG 128
               S   D+++ G+++  + VG
Sbjct: 183 --PYSKPVDIWACGVILYILLVG 203

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 46/83 (55%), Gaps = 8/83 (9%)
Query: 49  IVHFDIKPHNILL---DEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRS 105
           IVH ++KP N+LL    +    K++DFGLA +  D ++        GT GY++PEV  + 
Sbjct: 125 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTPGYLSPEVLKKD 181
Query: 106 FGGASHKSDVYSYGMMILEMAVG 128
               S   D+++ G+++  + VG
Sbjct: 182 --PYSKPVDIWACGVILYILLVG 202

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/114 (27%), Positives = 53/114 (46%), Gaps = 12/114 (10%)
Query: 18  GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGL 74
           G++    R   +I   I   +++LH   +  I H D+KP N+L    ++D   K++DFG 
Sbjct: 121 GDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177
Query: 75  AKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           AK++              T  Y+APEV        S   D++S G+++  +  G
Sbjct: 178 AKETTQNALQTPCY----TPYYVAPEVLGPEKYDKS--CDMWSLGVIMYILLCG 225

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 40.4 bits (93), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 51/109 (46%), Gaps = 10/109 (9%)
Query: 22  LEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDK 81
           L+++ V +    I  G+ + H   +  I+H DIKP NIL+ +    K+ DFG A+     
Sbjct: 121 LDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177
Query: 82  KSTISMLHARGTIGYIAPEVFC--RSFGGASHKSDVYSYGMMILEMAVG 128
                      T  Y APE+      +G A    DV++ G ++ EM +G
Sbjct: 178 GEVYD--DEVATRWYRAPELLVGDVKYGKA---VDVWAIGCLVTEMFMG 221

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	242
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-70
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-58
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-53
3soc_A	322	Activin receptor type-2A; structural genomics cons	7e-47
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-43
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	7e-43
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-42
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-40
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-39
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-38
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-38
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-37
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-37
3q4u_A	301	Activin receptor type-1; structural genomics conso	6e-37
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-37
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-37
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-36
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-35
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-30
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-29
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-27
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-27
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-27
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-27
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-27
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	9e-27
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-26
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-26
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-25
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-25
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-25
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-24
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-24
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-24
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-24
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-24
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-24
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-24
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-24
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	7e-24
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-23
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-23
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-23
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-23
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-23
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-23
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-23
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-23
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-23
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	9e-23
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-22
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-22
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-22
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-22
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	7e-22
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	9e-22
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	9e-22
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-21
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-21
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-21
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	7e-21
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	9e-21
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	9e-21
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-20
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-20
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-20
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-20
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-20
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-20
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	7e-20
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-20
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	9e-20
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-19
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-19
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-19
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-19
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-19
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-19
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-19
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-19
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-19
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-19
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	7e-19
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-19
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	7e-19
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-19
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-18
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-18
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-18
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-18
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-18
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-18
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-18
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-18
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-18
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-18
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-18
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-18
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-18
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-18
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-18
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-18
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	7e-18
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	7e-18
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	9e-18
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-17
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-17
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-17
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-17
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-17
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-17
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-17
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-17
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-17
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-17
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-17
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-17
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-17
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-17
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-17
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-17
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-17
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-17
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-17
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-17
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-17
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-17
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	9e-17
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-16
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-16
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-16
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-16
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-16
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-16
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-16
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-16
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-16
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-16
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-16
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-16
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-16
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-16
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-16
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-16
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-16
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-16
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-16
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-16
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	9e-16
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-15
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-15
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-15
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-15
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-15
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-15
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-15
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-15
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-15
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-15
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-15
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-15
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-15
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-15
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-15
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-15
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-15
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-15
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-15
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	7e-15
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-15
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	8e-15
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-14
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-14
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-14
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-14
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-14
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-14
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-14
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-14
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	7e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	9e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-13
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-13
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-13
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-13
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-12
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-12
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-12
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-12
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-12
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	9e-12
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	9e-12
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-11
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-11
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-11
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-11
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-11
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-11
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-11
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-11
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	6e-11
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	7e-11
3niz_A	311	Rhodanese family protein; structural genomics, str	8e-11
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	9e-11
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-10
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-10
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-10
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-10
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-10
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	8e-10
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-09
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-09
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-09
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-09
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-09
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-09
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-09
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-09
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	6e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-07
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	6e-07
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-06
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-06
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-06
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	6e-05
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  217 bits (555), Expect = 3e-70
 Identities = 77/208 (37%), Positives = 117/208 (56%), Gaps = 14/208 (6%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NGS+     ++        L+W    +IA G ARGL YLH  C+ +I+H D+K  NIL
Sbjct: 109 MANGSVASCLRERP--ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANIL 166

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           LDE+F   + DFGLAK    K + ++    RGTIG+IAPE      G +S K+DV+ YG+
Sbjct: 167 LDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGTIGHIAPEYLST--GKSSEKTDVFGYGV 223

Query: 121 MILEMAVGRKNADV-KASRSSDIYFPNSIYKHIEPGN-----DFQLDGVVTEEEKELVKK 174
           M+LE+  G++  D+ + +   D+   + +   ++        D  L G   +EE   V++
Sbjct: 224 MLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEE---VEQ 280

Query: 175 MILVSLWCIQTNPSDRPSMHEVLEMLES 202
           +I V+L C Q++P +RP M EV+ MLE 
Sbjct: 281 LIQVALLCTQSSPMERPKMSEVVRMLEG 308

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  185 bits (472), Expect = 4e-58
 Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 32/213 (15%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           MPNGSL          +G   L W    +IA G A G+ +LH       +H DIK  NIL
Sbjct: 112 MPNGSLLDRLSC---LDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL 165

Query: 61  LDEDFCPKISDFGLAKQS-QDKKSTIS---MLHARGTIGYIAPEVFCRSFGGASHKSDVY 116
           LDE F  KISDFGLA+ S +  ++ ++   +    GT  Y+APE      G  + KSD+Y
Sbjct: 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIV----GTTAYMAPEA---LRGEITPKSDIY 218

Query: 117 SYGMMILEMAVGRKNADVKASRSSDI-------YFPNSIYKHIEPGNDFQLDGVVTEEEK 169
           S+G+++LE+  G    D    R   +              K IE   D +++   +    
Sbjct: 219 SFGVVLLEIITGLPAVD--EHREPQLLLDIKEEIEDEE--KTIEDYIDKKMNDADSTS-- 272

Query: 170 ELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES 202
             V+ M  V+  C+    + RP + +V ++L+ 
Sbjct: 273 --VEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  173 bits (441), Expect = 3e-53
 Identities = 71/218 (32%), Positives = 105/218 (48%), Gaps = 27/218 (12%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NG+L +  Y   S     ++ W    +I  G ARGL YLH      I+H D+K  NIL
Sbjct: 117 MENGNLKRHLYG--SDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINIL 171

Query: 61  LDEDFCPKISDFGLAKQSQDKK----STISMLHARGTIGYIAPEVFCRSFGGASHKSDVY 116
           LDE+F PKI+DFG++K+  +      ST+      GT+GYI PE F +  G  + KSDVY
Sbjct: 172 LDENFVPKITDFGISKKGTELDQTHLSTVVK----GTLGYIDPEYFIK--GRLTEKSDVY 225

Query: 117 SYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN-----DFQLDGVVTEEEKEL 171
           S+G+++ E+   R        R   +       +    G      D  L   +  E    
Sbjct: 226 SFGVVLFEVLCARSAIVQSLPR-EMVNLAEWAVESHNNGQLEQIVDPNLADKIRPES--- 281

Query: 172 VKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQI 209
           ++K    ++ C+  +  DRPSM +VL  LE     L++
Sbjct: 282 LRKFGDTAVKCLALSSEDRPSMGDVLWKLE---YALRL 316

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  157 bits (398), Expect = 7e-47
 Identities = 57/222 (25%), Positives = 85/222 (38%), Gaps = 30/222 (13%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLH-------RGCNVRIVHFD 53
              GSL  F            + W  +  IA  +ARGL YLH        G    I H D
Sbjct: 104 HEKGSLSDFLK-------ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRD 156

Query: 54  IKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGG---AS 110
           IK  N+LL  +    I+DFGLA + +  KS        GT  Y+APEV   +      A 
Sbjct: 157 IKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAF 216

Query: 111 HKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTE---- 166
            + D+Y+ G+++ E+A     AD        + F   I +H  P  +   + VV +    
Sbjct: 217 LRIDMYAMGLVLWELASRCTAADGPV-DEYMLPFEEEIGQH--PSLEDMQEVVVHKKKRP 273

Query: 167 ------EEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES 202
                 ++   +  +      C   +   R S   V E +  
Sbjct: 274 VLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  146 bits (371), Expect = 5e-43
 Identities = 54/226 (23%), Positives = 86/226 (38%), Gaps = 48/226 (21%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
              GSL    +  E                    ++G+ YLH      ++H D+KP N+L
Sbjct: 81  AEGGSLYNVLHGAEP---LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLL 137

Query: 61  LDEDF-CPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L       KI DFG A   Q       M + +G+  ++APEVF  S    S K DV+S+G
Sbjct: 138 LVAGGTVLKICDFGTACDIQT-----HMTNNKGSAAWMAPEVFEGS--NYSEKCDVFSWG 190

Query: 120 MMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEE----------- 168
           +++ E+   RK              P   +  I  G  F++   V               
Sbjct: 191 IILWEVITRRK--------------P---FDEIG-GPAFRIMWAVHNGTRPPLIKNLPKP 232

Query: 169 -KELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKP 213
            + L+ +       C   +PS RPSM E+++++           +P
Sbjct: 233 IESLMTR-------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  145 bits (369), Expect = 7e-43
 Identities = 45/219 (20%), Positives = 80/219 (36%), Gaps = 52/219 (23%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +P G L     D+        ++W    ++   IA G+EY+    N  IVH D++  NI 
Sbjct: 103 VPCGDLYHRLLDK-----AHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIF 156

Query: 61  LDE-----DFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDV 115
           L         C K++DFGL++QS       S+    G   ++APE         + K+D 
Sbjct: 157 LQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADT 211

Query: 116 YSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEE------- 168
           YS+ M++  +  G                P   +     G    ++ +  E         
Sbjct: 212 YSFAMILYTILTGEG--------------P---FDEYSYGKIKFINMIREEGLRPTIPED 254

Query: 169 -----KELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES 202
                + +++        C   +P  RP    +++ L  
Sbjct: 255 CPPRLRNVIEL-------CWSGDPKKRPHFSYIVKELSE 286

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  145 bits (368), Expect = 2e-42
 Identities = 54/227 (23%), Positives = 98/227 (43%), Gaps = 48/227 (21%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +  GSL +  +   +      L+ R    +A  +A+G+ YLH   N  IVH ++K  N+L
Sbjct: 116 LSRGSLYRLLHKSGA---REQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLL 171

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           +D+ +  K+ DFGL++      + +S   A GT  ++APEV       ++ KSDVYS+G+
Sbjct: 172 VDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGTPEWMAPEVLRDE--PSNEKSDVYSFGV 227

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEE------------ 168
           ++ E+A  ++              P   + ++ P    Q+   V  +             
Sbjct: 228 ILWELATLQQ--------------P---WGNLNP---AQVVAAVGFKCKRLEIPRNLNPQ 267

Query: 169 -KELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPS 214
              +++        C    P  RPS   ++++L    +    PP  S
Sbjct: 268 VAAIIEG-------CWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRS 307

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  140 bits (354), Expect = 3e-40
 Identities = 51/242 (21%), Positives = 82/242 (33%), Gaps = 36/242 (14%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLH------RGCNVRIVHFDI 54
            PNGSL ++           T +W +  ++A  + RGL YLH            I H D+
Sbjct: 94  YPNGSLXKYLSLH-------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDL 146

Query: 55  KPHNILLDEDFCPKISDFGLAK------QSQDKKSTISMLHARGTIGYIAPEVF-----C 103
              N+L+  D    ISDFGL+         +  +   + +   GTI Y+APEV       
Sbjct: 147 NSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNL 206

Query: 104 RSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGV 163
           R    A  + D+Y+ G++  E+ + R           +            P  +     V
Sbjct: 207 RDXESALKQVDMYALGLIYWEIFM-RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLV 265

Query: 164 VTE-----------EEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPK 212
             E           E    V+ +      C   +   R +     E +     I +    
Sbjct: 266 SREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKS 325

Query: 213 PS 214
            S
Sbjct: 326 VS 327

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  135 bits (343), Expect = 3e-39
 Identities = 36/216 (16%), Positives = 74/216 (34%), Gaps = 53/216 (24%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           MP GSL    ++      N  ++     + A  +ARG+ +LH      I    +   +++
Sbjct: 91  MPYGSLYNVLHEGT----NFVVDQSQAVKFALDMARGMAFLH-TLEPLIPRHALNSRSVM 145

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRS-FGGASHKSDVYSYG 119
           +DED   +IS   +    Q                ++APE   +         +D++S+ 
Sbjct: 146 IDEDMTARISMADVKFSFQSPGRM-------YAPAWVAPEALQKKPEDTNRRSADMWSFA 198

Query: 120 MMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEE----------- 168
           +++ E+                   P   +  +      ++   V  E            
Sbjct: 199 VLLWELVTREV--------------P---FADLSN---MEIGMKVALEGLRPTIPPGISP 238

Query: 169 --KELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES 202
              +L+K        C+  +P+ RP    ++ +LE 
Sbjct: 239 HVSKLMKI-------CMNEDPAKRPKFDMIVPILEK 267

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  135 bits (342), Expect = 2e-38
 Identities = 50/223 (22%), Positives = 86/223 (38%), Gaps = 32/223 (14%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLH-----RGCNVRIVHFDIK 55
             NGSL  +         + TL+ +++ ++A     GL +LH           I H D+K
Sbjct: 117 HENGSLYDYLK-------STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLK 169

Query: 56  PHNILLDEDFCPKISDFGLA--KQSQDKKSTISMLHARGTIGYIAPEVFCRSFGG----A 109
             NIL+ ++    I+D GLA    S   +  I      GT  Y+ PEV   S       +
Sbjct: 170 SKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQS 229

Query: 110 SHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTE--- 166
              +D+YS+G+++ E+A       V      +   P       +P  +   + V  +   
Sbjct: 230 YIMADMYSFGLILWEVARR----CVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLR 285

Query: 167 -------EEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES 202
                     E +++M  +   C   NP+ R +   V + L  
Sbjct: 286 PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  134 bits (339), Expect = 2e-38
 Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 37/212 (17%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
               SL    +  E        E + +  IA   ARG++YLH   +  I+H D+K +NI 
Sbjct: 101 CEGSSLYHHLHASE-----TKFEMKKLIDIARQTARGMDYLHA-KS--IIHRDLKSNNIF 152

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGA-SHKSDVYSYG 119
           L ED   KI DFGLA +      +       G+I ++APEV         S +SDVY++G
Sbjct: 153 LHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFG 212

Query: 120 MMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELV------- 172
           +++ E+  G+               P   Y +I   +  Q+  +V               
Sbjct: 213 IVLYELMTGQ--------------LP---YSNINNRD--QIIEMVGRGSLSPDLSKVRSN 253

Query: 173 --KKMILVSLWCIQTNPSDRPSMHEVLEMLES 202
             K+M  +   C++    +RPS   +L  +E 
Sbjct: 254 CPKRMKRLMAECLKKKRDERPSFPRILAEIEE 285

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  130 bits (330), Expect = 6e-37
 Identities = 48/223 (21%), Positives = 81/223 (36%), Gaps = 32/223 (14%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLH-----RGCNVRIVHFDIK 55
              GSL  +           TL+  +  +I   IA GL +LH           I H D+K
Sbjct: 88  HEMGSLYDYLQ-------LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLK 140

Query: 56  PHNILLDEDFCPKISDFGLA--KQSQDKKSTISMLHARGTIGYIAPEVF----CRSFGGA 109
             NIL+ ++    I+D GLA        +  +      GT  Y+APEV           +
Sbjct: 141 SKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDS 200

Query: 110 SHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEE- 168
             + D++++G+++ E+A  R+             F + +     P  +     V  +++ 
Sbjct: 201 YKRVDIWAFGLVLWEVA--RRMVSNGIVEDYKPPFYDVVPND--PSFEDMRKVVCVDQQR 256

Query: 169 ----KELVKKMILVSLW-----CIQTNPSDRPSMHEVLEMLES 202
                       L SL      C   NPS R +   + + L  
Sbjct: 257 PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  129 bits (327), Expect = 7e-37
 Identities = 53/219 (24%), Positives = 86/219 (39%), Gaps = 53/219 (24%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
              G L++           + +    +   A  IARG+ YLH    V I+H D+K  NIL
Sbjct: 88  ARGGPLNRVLS-------GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNIL 140

Query: 61  LDEDFCP--------KISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHK 112
           + +            KI+DFGLA++        + + A G   ++APEV   S    S  
Sbjct: 141 ILQKVENGDLSNKILKITDFGLARE----WHRTTKMSAAGAYAWMAPEVIRAS--MFSKG 194

Query: 113 SDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEK--- 169
           SDV+SYG+++ E+  G                P   ++ I+      +   V   +    
Sbjct: 195 SDVWSYGVLLWELLTGEV--------------P---FRGIDG---LAVAYGVAMNKLALP 234

Query: 170 ------ELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES 202
                 E   K++     C   +P  RPS   +L+ L +
Sbjct: 235 IPSTCPEPFAKLM---EDCWNPDPHSRPSFTNILDQLTT 270

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  130 bits (330), Expect = 7e-37
 Identities = 45/230 (19%), Positives = 82/230 (35%), Gaps = 45/230 (19%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
               +L     D +       L+     QIA  I +G+ YLH      I+H D+K  N+ 
Sbjct: 111 CKGRTLYSVVRDAK-----IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVF 162

Query: 61  LDEDFCPKISDFGLAK---QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGA-------S 110
            D      I+DFGL       Q  +    +    G + ++APE+  +            S
Sbjct: 163 YDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFS 221

Query: 111 HKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKE 170
             SDV++ G +  E+                  +P   +K         +   +    K 
Sbjct: 222 KHSDVFALGTIWYELHARE--------------WP---FKTQPA---EAIIWQMGTGMKP 261

Query: 171 LV------KKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPS 214
            +      K++  + L+C      +RP+  ++++MLE   +  +    P 
Sbjct: 262 NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPG 311

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  130 bits (328), Expect = 2e-36
 Identities = 48/223 (21%), Positives = 81/223 (36%), Gaps = 32/223 (14%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLH-----RGCNVRIVHFDIK 55
             +GSL  +           T+    + ++A   A GL +LH           I H D+K
Sbjct: 122 HEHGSLFDYLN-------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 174

Query: 56  PHNILLDEDFCPKISDFGLA--KQSQDKKSTISMLHARGTIGYIAPEVFCRSFGG----A 109
             NIL+ ++    I+D GLA    S      I+  H  GT  Y+APEV   S       +
Sbjct: 175 SKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFES 234

Query: 110 SHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTE--- 166
             ++D+Y+ G++  E+A              D   P       +P  +     V  +   
Sbjct: 235 FKRADIYAMGLVFWEIARR----CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR 290

Query: 167 -------EEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES 202
                  +  E ++ M  +   C   N + R +   + + L  
Sbjct: 291 PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  127 bits (321), Expect = 1e-35
 Identities = 55/255 (21%), Positives = 89/255 (34%), Gaps = 57/255 (22%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +  G+L       +S        W      A  IA G+ YLH   N  I+H D+  HN L
Sbjct: 89  IKGGTLRGIIKSMDSQ-----YPWSQRVSFAKDIASGMAYLHS-MN--IIHRDLNSHNCL 140

Query: 61  LDEDFCPKISDFGLAKQSQD------------KKSTISMLHARGTIGYIAPEVFCRSFGG 108
           + E+    ++DFGLA+   D            K          G   ++APE+   +   
Sbjct: 141 VRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI--NGRS 198

Query: 109 ASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEE 168
              K DV+S+G+++ E+ +GR NAD                          +D  +    
Sbjct: 199 YDEKVDVFSFGIVLCEI-IGRVNAD-------------------PDYLPRTMDFGLNVRG 238

Query: 169 K----------ELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEIL--QIPPKPSLA 216
                           +    + C   +P  RPS  ++   LE+    L   +P  P L 
Sbjct: 239 FLDRYCPPNCPPSFFPIT---VRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLE 295

Query: 217 LPKKSAIQSSRTSSS 231
              +   ++ R   S
Sbjct: 296 QLDRGFWETYRRGES 310

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  115 bits (289), Expect = 1e-30
 Identities = 28/212 (13%), Positives = 59/212 (27%), Gaps = 19/212 (8%)

Query: 7   DQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFC 66
             F+                ++ +   + R    L       +VH    P N+ +  D  
Sbjct: 176 LLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGR 232

Query: 67  PKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMA 126
             + D     +   +    S       + Y   E    S    +H  + +  G+ I  + 
Sbjct: 233 LMLGDVSALWKVGTRGPASS-----VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287

Query: 127 VGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTN 186
                  +        +   S+         F     + +  K L+ +        +  +
Sbjct: 288 CLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRF-------LNFD 340

Query: 187 PSDRPSMHEVLEMLESSTEILQIPPKPSLALP 218
              R    E +E    + E LQ+  + S +L 
Sbjct: 341 RRRRLLPLEAME----TPEFLQLQNEISSSLS 368

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  111 bits (279), Expect = 1e-29
 Identities = 49/200 (24%), Positives = 85/200 (42%), Gaps = 30/200 (15%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M +G+L  +          + ++ + +      I +GL++LH      I+H D+K  NI 
Sbjct: 111 MTSGTLKTYL------KRFKVMKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIF 163

Query: 61  LD-EDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           +       KI D GLA   +   +  ++    GT  ++APE++           DVY++G
Sbjct: 164 ITGPTGSVKIGDLGLATLKRASFAK-AV---IGTPEFMAPEMYEE---KYDESVDVYAFG 216

Query: 120 MMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN-DFQLDGVVTEEEKELVKKMILV 178
           M +LEMA             S+      IY+ +  G      D V   E KE+++     
Sbjct: 217 MCMLEMATSEYP-------YSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG---- 265

Query: 179 SLWCIQTNPSDRPSMHEVLE 198
              CI+ N  +R S+ ++L 
Sbjct: 266 ---CIRQNKDERYSIKDLLN 282

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  106 bits (266), Expect = 2e-27
 Identities = 36/166 (21%), Positives = 65/166 (39%), Gaps = 26/166 (15%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
               L +LH   +  +VH D+KP NI L      K+ DFGL  +     +        G 
Sbjct: 166 TLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GD 219

Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIE 153
             Y+APE+  +  G     +DV+S G+ ILE+A   +                 + +   
Sbjct: 220 PRYMAPEL-LQ--GSYGTAADVFSLGLTILEVACNMELPHGGEGW-------QQLRQGYL 269

Query: 154 PGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM 199
           P    +    ++ E + ++  M       ++ +P  R +   +L +
Sbjct: 270 PP---EFTAGLSSELRSVLVMM-------LEPDPKLRATAEALLAL 305

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  107 bits (270), Expect = 2e-27
 Identities = 54/217 (24%), Positives = 84/217 (38%), Gaps = 26/217 (11%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDE-----DFCPKISDFGLAKQSQDKKSTISML 88
              GL +LH   ++ IVH D+KPHNIL+            ISDFGL K+    + + S  
Sbjct: 127 TTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183

Query: 89  HAR-GTIGYIAPEVFCRSF-GGASHKSDVYSYGMMILEMAVGRKNA-DVKASRSSDIYFP 145
               GT G+IAPE+         ++  D++S G +   +     +       R ++I   
Sbjct: 184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLG 243

Query: 146 NSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE--MLESS 203
                 + P      +       +EL++KM       I  +P  RPS   VL+     S 
Sbjct: 244 ACSLDCLHP------EKHEDVIARELIEKM-------IAMDPQKRPSAKHVLKHPFFWSL 290

Query: 204 TEILQIPPKPSLALPKKSAIQSSRTSSSAGIEEVMGE 240
            + LQ     S  + K+S           G   V+  
Sbjct: 291 EKQLQFFQDVSDRIEKESLDGPIVKQLERGGRAVVKM 327

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  106 bits (266), Expect = 2e-27
 Identities = 44/211 (20%), Positives = 84/211 (39%), Gaps = 41/211 (19%)

Query: 2   PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL 61
              +L  +             E      I   IA  +E+LH   +  ++H D+KP NI  
Sbjct: 144 RKENLKDW---MNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFF 197

Query: 62  DEDFCPKISDFGLAK---QSQDKKSTISMLHAR-------GTIGYIAPEVFCRSFGGASH 111
             D   K+ DFGL     Q +++++ ++ + A        GT  Y++PE    +    SH
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGN--NYSH 255

Query: 112 KSDVYSYGMMILEMAVGRKNADVKASRSSDI---YFPNSIYKHIEPGNDFQLDGVVTEEE 168
           K D++S G+++ E+         +    +D+    FP    +                +E
Sbjct: 256 KVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKY-------------PQE 302

Query: 169 KELVKKMILVSLWCIQTNPSDRPSMHEVLEM 199
             +V+ M       +  +P++RP   +++E 
Sbjct: 303 HMMVQDM-------LSPSPTERPEATDIIEN 326

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  105 bits (263), Expect = 2e-27
 Identities = 44/199 (22%), Positives = 88/199 (44%), Gaps = 32/199 (16%)

Query: 2   PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL 61
             G+L+Q+   +     ++ L      QI     +G++Y+H   + ++++ D+KP NI L
Sbjct: 103 DKGTLEQWIEKRRGEKLDKVLALELFEQIT----KGVDYIH---SKKLINRDLKPSNIFL 155

Query: 62  DEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMM 121
            +    KI DFGL       K+      ++GT+ Y++PE           + D+Y+ G++
Sbjct: 156 VDTKQVKIGDFGLVTSL---KNDGKRTRSKGTLRYMSPEQISSQ--DYGKEVDLYALGLI 210

Query: 122 ILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLW 181
           + E+      A          +  +  +  +  G    +  +  ++EK L++K+      
Sbjct: 211 LAELLHVCDTA----------FETSKFFTDLRDG---IISDIFDKKEKTLLQKL------ 251

Query: 182 CIQTNPSDRPSMHEVLEML 200
            +   P DRP+  E+L  L
Sbjct: 252 -LSKKPEDRPNTSEILRTL 269

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  105 bits (263), Expect = 4e-27
 Identities = 39/179 (21%), Positives = 76/179 (42%), Gaps = 36/179 (20%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +   +  +H+     IVH D+KP N L+ +    K+ DFG+A Q Q   +++      GT
Sbjct: 136 MLEAVHTIHQH---GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGT 191

Query: 94  IGYIAPEVFCRSFGGA---------SHKSDVYSYGMMILEMAVGR-----KNADVKASRS 139
           + Y+ PE                  S KSDV+S G ++  M  G+         +     
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK--- 248

Query: 140 SDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
                   ++  I+P ++ +   +  ++ ++++K        C++ +P  R S+ E+L 
Sbjct: 249 --------LHAIIDPNHEIEFPDIPEKDLQDVLKC-------CLKRDPKQRISIPELLA 292

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  104 bits (262), Expect = 9e-27
 Identities = 41/180 (22%), Positives = 77/180 (42%), Gaps = 38/180 (21%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +   +  +H+     IVH D+KP N L+ +    K+ DFG+A Q Q   +++      GT
Sbjct: 117 MLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 172

Query: 94  IGYIAPEVFCRSFGGA---------SHKSDVYSYGMMILEMAVGR------KNADVKASR 138
           + Y+ PE                  S KSDV+S G ++  M  G+       N   K   
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK--- 229

Query: 139 SSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
                    ++  I+P ++ +   +  ++ ++++K        C++ +P  R S+ E+L 
Sbjct: 230 ---------LHAIIDPNHEIEFPDIPEKDLQDVLKC-------CLKRDPKQRISIPELLA 273

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  103 bits (258), Expect = 2e-26
 Identities = 44/178 (24%), Positives = 70/178 (39%), Gaps = 32/178 (17%)

Query: 34  IARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHAR- 91
           I   L Y+H +G    I+H D+KP NI +DE    KI DFGLAK        + +     
Sbjct: 125 ILEALSYIHSQG----IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180

Query: 92  -----------GTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSS 140
                      GT  Y+A EV     G  + K D+YS G++  EM         + +   
Sbjct: 181 PGSSDNLTSAIGTAMYVATEV-LDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILK 239

Query: 141 DIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
            +       + +        D    + EK++++ +       I  +P+ RP    +L 
Sbjct: 240 KL-------RSVSIEFPPDFDDNKMKVEKKIIRLL-------IDHDPNKRPGARTLLN 283

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  102 bits (257), Expect = 2e-26
 Identities = 43/207 (20%), Positives = 78/207 (37%), Gaps = 35/207 (16%)

Query: 2   PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL 61
              +L  +             E      I   IA  +E+LH   +  ++H D+KP NI  
Sbjct: 98  RKENLKDWM---NGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFF 151

Query: 62  DEDFCPKISDFGLAK---QSQDKKSTISMLHAR-------GTIGYIAPEVFCRSFGGASH 111
             D   K+ DFGL     Q +++++ ++ + A        GT  Y++PE    +    SH
Sbjct: 152 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN--SYSH 209

Query: 112 KSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKEL 171
           K D++S G+++ E+           S   +          +       L       E  +
Sbjct: 210 KVDIFSLGLILFELL-------YPFSTQME---RVRTLTDVRNLKFPPLFTQKYPCEYVM 259

Query: 172 VKKMILVSLWCIQTNPSDRPSMHEVLE 198
           V+ M       +  +P +RP    ++E
Sbjct: 260 VQDM-------LSPSPMERPEAINIIE 279

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 99.5 bits (249), Expect = 2e-25
 Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 46/206 (22%)

Query: 2   PNGSLDQFTYDQESSNGNRTLEWRT---VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHN 58
            NG +         +      E      ++QI  G    + YLH      I+H D+   N
Sbjct: 94  HNGEM----NRYLKNRVKPFSENEARHFMHQIITG----MLYLHS---HGILHRDLTLSN 142

Query: 59  ILLDEDFCPKISDFGLA---KQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDV 115
           +LL  +   KI+DFGLA   K   +K  T+      GT  YI+PE+  RS      +SDV
Sbjct: 143 LLLTRNMNIKIADFGLATQLKMPHEKHYTLC-----GTPNYISPEIATRS--AHGLESDV 195

Query: 116 YSYGMMILEMAVGR---KNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELV 172
           +S G M   + +GR       VK           +    +    D+++   ++ E K+L+
Sbjct: 196 WSLGCMFYTLLIGRPPFDTDTVK-----------NTLNKVV-LADYEMPSFLSIEAKDLI 243

Query: 173 KKMILVSLWCIQTNPSDRPSMHEVLE 198
            ++       ++ NP+DR S+  VL+
Sbjct: 244 HQL-------LRRNPADRLSLSSVLD 262

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  101 bits (252), Expect = 3e-25
 Identities = 38/179 (21%), Positives = 75/179 (41%), Gaps = 36/179 (20%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +   +  +H+     IVH D+KP N L+ +    K+ DFG+A Q Q   +++      G 
Sbjct: 164 MLEAVHTIHQH---GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGA 219

Query: 94  IGYIAPEVFCRSFGGA---------SHKSDVYSYGMMILEMAVGR-----KNADVKASRS 139
           + Y+ PE                  S KSDV+S G ++  M  G+         +     
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK--- 276

Query: 140 SDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
                   ++  I+P ++ +   +  ++ ++++K        C++ +P  R S+ E+L 
Sbjct: 277 --------LHAIIDPNHEIEFPDIPEKDLQDVLKC-------CLKRDPKQRISIPELLA 320

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 98.4 bits (246), Expect = 7e-25
 Identities = 47/171 (27%), Positives = 74/171 (43%), Gaps = 37/171 (21%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK-STISMLHARG 92
           +A  L Y H     R++H DIKP N+LL      KI+DFG +  +   + + +      G
Sbjct: 118 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-----G 169

Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR-----KNADVKASRSSDIYFPNS 147
           T+ Y+ PE+          K D++S G++  E  VG+                       
Sbjct: 170 TLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANT-------------YQE 214

Query: 148 IYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
            YK I    +F     VTE  ++L+ ++       ++ NPS RP + EVLE
Sbjct: 215 TYKRISRV-EFTFPDFVTEGARDLISRL-------LKHNPSQRPMLREVLE 257

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 98.6 bits (246), Expect = 1e-24
 Identities = 47/214 (21%), Positives = 89/214 (41%), Gaps = 32/214 (14%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIAR----GLEYLHRGCNVRIVHFDIKP 56
           M N S+    +D+     ++        Q+   I +       Y+H   N  I H D+KP
Sbjct: 125 MENDSI--LKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKP 180

Query: 57  HNILLDEDFCPKISDFGLAKQSQDKKSTISMLH-ARGTIGYIAPEVFCRSFGGASHKSDV 115
            NIL+D++   K+SDFG ++   DKK     +  +RGT  ++ PE F         K D+
Sbjct: 181 SNILMDKNGRVKLSDFGESEYMVDKK-----IKGSRGTYEFMPPEFFSNESSYNGAKVDI 235

Query: 116 YSYGMMILEMAVGR------KNADV--KASRSSDIYFPNSIYKHIEPGNDFQLDGV---V 164
           +S G+ +  M           +        R+ +I +P      + P  + +       +
Sbjct: 236 WSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFL 295

Query: 165 TEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
           + E+ + +K         ++ NP++R +  + L+
Sbjct: 296 SNEDIDFLKLF-------LRKNPAERITSEDALK 322

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 98.1 bits (245), Expect = 1e-24
 Identities = 46/226 (20%), Positives = 93/226 (41%), Gaps = 37/226 (16%)

Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS 78
              +  +   ++     + L + H+     I+H D+KP NI++      K+ DFG+A+  
Sbjct: 110 EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAI 166

Query: 79  QDKKSTI----SMLHARGTIGYIAPEVFCRSFGG-ASHKSDVYSYGMMILEMAVGRK--N 131
            D  +++    +++   GT  Y++PE   ++ G     +SDVYS G ++ E+  G     
Sbjct: 167 ADSGNSVTQTAAVI---GTAQYLSPE---QARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220

Query: 132 ADVKASRSSDIYFPNSI-YKHI--EPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPS 188
            D           P S+ Y+H+  +P         ++ +   +V       L  +  NP 
Sbjct: 221 GDS----------PVSVAYQHVREDPIPPSARHEGLSADLDAVV-------LKALAKNPE 263

Query: 189 DRP-SMHEVLEMLESSTEILQIPPKPSLALPKKSAIQSSRTSSSAG 233
           +R  +  E+   L              L   +++++ SS   + +G
Sbjct: 264 NRYQTAAEMRADLVRVHNGEPPEAPKVLTDAERTSLLSSAAGNLSG 309

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 97.3 bits (243), Expect = 2e-24
 Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 31/213 (14%)

Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS 78
           +  L   T       I  G+++ H    +RIVH DIKP NIL+D +   KI DFG+AK  
Sbjct: 105 HGPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161

Query: 79  QDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRK--NADVKA 136
            +   T +  H  GT+ Y +PE   +        +D+YS G+++ EM VG    N +   
Sbjct: 162 SETSLTQTN-HVLGTVQYFSPEQ-AKG-EATDECTDIYSIGIVLYEMLVGEPPFNGET-- 216

Query: 137 SRSSDIYFPNSI-YKHIE---PGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRP- 191
                     SI  KHI+   P     +   + +    ++       L   + + ++R  
Sbjct: 217 --------AVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVI-------LRATEKDKANRYK 261

Query: 192 SMHEVLEMLESSTEILQIP-PKPSLALPKKSAI 223
           ++ E+ + L S     +       L   K  A+
Sbjct: 262 TIQEMKDDLSSVLHENRANEDVYELDKMKTIAV 294

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 97.8 bits (244), Expect = 3e-24
 Identities = 52/171 (30%), Positives = 87/171 (50%), Gaps = 35/171 (20%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ---DKKSTISMLHA 90
           I  G +YLHR    R++H D+K  N+ L+ED   KI DFGLA + +   ++K  +     
Sbjct: 150 IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---- 202

Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR---KNADVKASRSSDIYFPNS 147
            GT  YIAPEV  +   G S + DV+S G ++  + VG+   + + +K            
Sbjct: 203 -GTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----------- 248

Query: 148 IYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
            Y  I+  N++ +   +      L++KM       +QT+P+ RP+++E+L 
Sbjct: 249 TYLRIK-KNEYSIPKHINPVAASLIQKM-------LQTDPTARPTINELLN 291

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 96.9 bits (242), Expect = 3e-24
 Identities = 52/171 (30%), Positives = 87/171 (50%), Gaps = 35/171 (20%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ---DKKSTISMLHA 90
           I  G +YLHR    R++H D+K  N+ L+ED   KI DFGLA + +   ++K  +     
Sbjct: 124 IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---- 176

Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR---KNADVKASRSSDIYFPNS 147
            GT  YIAPEV  +   G S + DV+S G ++  + VG+   + + +K            
Sbjct: 177 -GTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-----------E 222

Query: 148 IYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
            Y  I+  N++ +   +      L++KM       +QT+P+ RP+++E+L 
Sbjct: 223 TYLRIK-KNEYSIPKHINPVAASLIQKM-------LQTDPTARPTINELLN 265

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 97.0 bits (242), Expect = 4e-24
 Identities = 51/230 (22%), Positives = 82/230 (35%), Gaps = 48/230 (20%)

Query: 2   PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL 61
             G+L  +   +   +    L    +  +  GI RGLE +H        H D+KP NILL
Sbjct: 113 KRGTL--WNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILL 167

Query: 62  DEDFCPKISDFGLAKQSQDKKSTISMLHA-------RGTIGYIAPEVF-CRSFGGASHKS 113
            ++  P + D G   Q+                   R TI Y APE+F  +S      ++
Sbjct: 168 GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERT 227

Query: 114 DVYSYGMMILEMAVGR--------KNADVKASRSSDIYFP-NSIYKHIEPGNDFQLDGVV 164
           DV+S G ++  M  G         K   V  +  + +  P +  +               
Sbjct: 228 DVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRH--------------- 272

Query: 165 TEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPS 214
           +    +L+  M       +  +P  RP +  +L  L    E LQ P    
Sbjct: 273 SSALWQLLNSM-------MTVDPHQRPHIPLLLSQL----EALQPPAPGQ 311

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 96.6 bits (241), Expect = 4e-24
 Identities = 50/205 (24%), Positives = 87/205 (42%), Gaps = 38/205 (18%)

Query: 4   GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE 63
            SLD+F Y Q    G    E   + +IA  I + LE+LH    + ++H D+KP N+L++ 
Sbjct: 90  TSLDKF-YKQVIDKGQTIPE-DILGKIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINA 145

Query: 64  DFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGA--SHKSDVYSYGMM 121
               K+ DFG++    D    ++     G   Y+APE           S KSD++S G+ 
Sbjct: 146 LGQVKMCDFGISGYLVD---DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGIT 202

Query: 122 ILEMAVGRKNADVKASRSSDIYFPNSIYKH-------IEPGNDFQL-DGVVTEEEKELVK 173
           ++E+A+ R              FP   +         +      QL     + E  +   
Sbjct: 203 MIELAILR--------------FPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTS 248

Query: 174 KMILVSLWCIQTNPSDRPSMHEVLE 198
           +       C++ N  +RP+  E+++
Sbjct: 249 Q-------CLKKNSKERPTYPELMQ 266

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 98.7 bits (246), Expect = 4e-24
 Identities = 49/186 (26%), Positives = 82/186 (44%), Gaps = 35/186 (18%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLD-------------EDFCPKISDFGLAKQSQD 80
           IA G+ +LH   +++I+H D+KP NIL+              E+    ISDFGL K+   
Sbjct: 124 IASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180

Query: 81  KKSTIS--MLHARGTIGYIAPEVFCRSFGGASHKS-----DVYSYGMMILEM-AVGRKNA 132
            +S+    + +  GT G+ APE+   S    + +      D++S G +   + + G+   
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240

Query: 133 DVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPS 192
             K SR S+I     I+           D  +  E  +L+ +M       I  +P  RP+
Sbjct: 241 GDKYSRESNII--RGIFS--LDEMKCLHDRSLIAEATDLISQM-------IDHDPLKRPT 289

Query: 193 MHEVLE 198
             +VL 
Sbjct: 290 AMKVLR 295

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 97.4 bits (242), Expect = 7e-24
 Identities = 27/192 (14%), Positives = 64/192 (33%), Gaps = 44/192 (22%)

Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS 78
           +++L      Q+   + R L  LH      +VH  ++P +I+LD+     ++ F    + 
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256

Query: 79  QDKKSTISMLHARGTIGYIAPEVFCRSFG---------GASHKSDVYSYGMMILEMAVGR 129
             +  +        + G+  PE+  R              +   D ++ G++I  +    
Sbjct: 257 GARVVS------SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA- 309

Query: 130 KNADVKASRSSDIYFP---NSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTN 186
                          P   ++     E    F+    + +  + L++         ++  
Sbjct: 310 -------------DLPITKDAALGGSEW--IFRSCKNIPQPVRALLEGF-------LRYP 347

Query: 187 PSDRPSMHEVLE 198
             DR    + +E
Sbjct: 348 KEDRLLPLQAME 359

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 95.5 bits (238), Expect = 1e-23
 Identities = 41/216 (18%), Positives = 75/216 (34%), Gaps = 49/216 (22%)

Query: 2   PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL 61
             GSL       E+       +   +  +   + RGL Y+H   ++ +VH DIKP NI +
Sbjct: 94  NGGSLADAI--SENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFI 148

Query: 62  DEDFCP-------------------KISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVF 102
                P                   KI D G   +    +         G   ++A EV 
Sbjct: 149 SRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE------GDSRFLANEV- 201

Query: 103 CRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDG 162
            +       K+D+++  + ++  A               +      +  I  G   ++  
Sbjct: 202 LQENYTHLPKADIFALALTVVCAAGAE-----------PLPRNGDQWHEIRQGRLPRIPQ 250

Query: 163 VVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
           V+++E  EL+K         I  +P  RPS   +++
Sbjct: 251 VLSQEFTELLKV-------MIHPDPERRPSAMALVK 279

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 95.5 bits (238), Expect = 2e-23
 Identities = 45/203 (22%), Positives = 79/203 (38%), Gaps = 31/203 (15%)

Query: 2   PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL 61
             G L +    +      R +  RTV++    +   LE++H     R++H DIKP N+ +
Sbjct: 115 DAGDLSRMI--KHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFI 169

Query: 62  DEDFCPKISDFGLAKQ---SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSY 118
                 K+ D GL +          ++      GT  Y++PE       G + KSD++S 
Sbjct: 170 TATGVVKLGDLGLGRFFSSKTTAAHSLV-----GTPYYMSPER-IHE-NGYNFKSDIWSL 222

Query: 119 GMMILEMAVGRKNADVKASRSSDIYF--PNSIYKHIEPGNDFQLDGVVTEEEKELVKKMI 176
           G ++ EMA  +            +        Y  +   +        +EE ++LV    
Sbjct: 223 GCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDH-------YSEELRQLVN--- 272

Query: 177 LVSLWCIQTNPSDRPSMHEVLEM 199
                CI  +P  RP +  V ++
Sbjct: 273 ----MCINPDPEKRPDVTYVYDV 291

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 96.7 bits (240), Expect = 2e-23
 Identities = 24/186 (12%), Positives = 57/186 (30%), Gaps = 33/186 (17%)

Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS 78
           +++L      Q+   + R L  LH      +VH  ++P +I+LD+     ++ F    + 
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 79  QDKKSTISMLHARGTIGYIAPEVFCRSFGG---ASHKSDVYSYGMMILEMAVGRKNADVK 135
                +             A  +           +   D ++ G+ I  +          
Sbjct: 262 GASAVSPIGR-GFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD------ 314

Query: 136 ASRSSDIYFP---NSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPS 192
                    P   ++     E    F+    + +  + L++         ++    DR  
Sbjct: 315 --------LPNTDDAALGGSEW--IFRSCKNIPQPVRALLEGF-------LRYPKEDRLL 357

Query: 193 MHEVLE 198
             + +E
Sbjct: 358 PLQAME 363

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 95.5 bits (238), Expect = 2e-23
 Identities = 43/201 (21%), Positives = 87/201 (43%), Gaps = 32/201 (15%)

Query: 2   PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL 61
             G L +    Q+        +   +      I   L+++H     +I+H DIK  NI L
Sbjct: 106 EGGDLFKRINAQK----GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFL 158

Query: 62  DEDFCPKISDFGLAKQ---SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSY 118
            +D   ++ DFG+A+    + +           GT  Y++PE+ C +    ++KSD+++ 
Sbjct: 159 TKDGTVQLGDFGIARVLNSTVELARACI-----GTPYYLSPEI-CEN-KPYNNKSDIWAL 211

Query: 119 GMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILV 178
           G ++ E+   +      A  +  +    ++   I  G+   +    + + + LV ++   
Sbjct: 212 GCVLYELCTLK-----HAFEAGSMK---NLVLKIISGSFPPVSLHYSYDLRSLVSQL--- 260

Query: 179 SLWCIQTNPSDRPSMHEVLEM 199
                + NP DRPS++ +LE 
Sbjct: 261 ----FKRNPRDRPSVNSILEK 277

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 94.3 bits (235), Expect = 2e-23
 Identities = 42/200 (21%), Positives = 76/200 (38%), Gaps = 25/200 (12%)

Query: 3   NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLH--RGCNVRIVHFDIKPHNIL 60
            G L       + +   + L+   V ++   +   L+  H        ++H D+KP N+ 
Sbjct: 91  GGDLASVI--TKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVF 148

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHAR-GTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           LD     K+ DFGLA+         S      GT  Y++PE         + KSD++S G
Sbjct: 149 LDGKQNVKLGDFGLARI---LNHDTSFAKTFVGTPYYMSPEQ-MNR-MSYNEKSDIWSLG 203

Query: 120 MMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVS 179
            ++ E+             +        +   I  G   ++    ++E  E++ +M    
Sbjct: 204 CLLYELCALM-----PPFTAFSQK---ELAGKIREGKFRRIPYRYSDELNEIITRM---- 251

Query: 180 LWCIQTNPSDRPSMHEVLEM 199
              +      RPS+ E+LE 
Sbjct: 252 ---LNLKDYHRPSVEEILEN 268

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 94.2 bits (235), Expect = 3e-23
 Identities = 40/190 (21%), Positives = 75/190 (39%), Gaps = 41/190 (21%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHAR-G 92
           +A  L Y H     +++H DIKP N+L+      KI+DFG +  +   +          G
Sbjct: 123 LADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR-----RRTMCG 174

Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR-----KNADVKASRSSDIYFPNS 147
           T+ Y+ PE+          K D++  G++  E  VG       +                
Sbjct: 175 TLDYLPPEMIEGK--THDEKVDLWCAGVLCYEFLVGMPPFDSPS-------------HTE 219

Query: 148 IYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE---MLESST 204
            ++ I    D +    +++  K+L+ K+       ++ +P  R  +  V+E   +  +S 
Sbjct: 220 THRRIVNV-DLKFPPFLSDGSKDLISKL-------LRYHPPQRLPLKGVMEHPWVKANSR 271

Query: 205 EILQIPPKPS 214
            +L  P   S
Sbjct: 272 RVLP-PVYQS 280

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 94.8 bits (236), Expect = 4e-23
 Identities = 44/172 (25%), Positives = 64/172 (37%), Gaps = 28/172 (16%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-KISDFGLAKQSQDKKSTISMLHA-- 90
              GLEYLH     RI+H D+K  N+LL  D     + DFG A   Q      S+L    
Sbjct: 159 ALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215

Query: 91  -RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRK-NADVKASRSSDIYFPNSI 148
             GT  ++APEV          K D++S   M+L M  G               YF   +
Sbjct: 216 IPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHMLNGCHPWTQ---------YFRGPL 264

Query: 149 YKHI--EPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
              I  EP    ++         + +++        ++  P  R S  E+  
Sbjct: 265 CLKIASEPPPIREIPPSCAPLTAQAIQE-------GLRKEPVHRASAMELRR 309

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 94.3 bits (235), Expect = 4e-23
 Identities = 59/210 (28%), Positives = 86/210 (40%), Gaps = 42/210 (20%)

Query: 3   NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD 62
           + S D+F Y    S  +  +    + +I     + L +L    N++I+H DIKP NILLD
Sbjct: 104 STSFDKF-YKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLD 160

Query: 63  EDFCPKISDFGLAKQ---SQDKKSTISMLHARGTIGYIAPEVFCRSFGGA--SHKSDVYS 117
                K+ DFG++ Q   S  K          G   Y+APE    S        +SDV+S
Sbjct: 161 RSGNIKLCDFGISGQLVDSIAKTRDA------GCRPYMAPERIDPSASRQGYDVRSDVWS 214

Query: 118 YGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMIL 177
            G+ + E+A GR              FP   Y       D QL  VV  +  +L      
Sbjct: 215 LGITLYELATGR--------------FP---YPKWNSVFD-QLTQVVKGDPPQLSNSEER 256

Query: 178 ---------VSLWCIQTNPSDRPSMHEVLE 198
                    V+L C+  + S RP   E+L+
Sbjct: 257 EFSPSFINFVNL-CLTKDESKRPKYKELLK 285

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 93.1 bits (232), Expect = 9e-23
 Identities = 52/201 (25%), Positives = 87/201 (43%), Gaps = 26/201 (12%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +P GSL        S  G      +T+      I  GL+YLH   + +IVH DIK  N+L
Sbjct: 101 VPGGSLSALL---RSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVL 154

Query: 61  LD-EDFCPKISDFGLAKQSQDKKS-TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSY 118
           ++      KISDFG +K+       T +     GT+ Y+APE+  +   G    +D++S 
Sbjct: 155 INTYSGVLKISDFGTSKRLAGINPCTETF---TGTLQYMAPEIIDKGPRGYGKAADIWSL 211

Query: 119 GMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDF-QLDGVVTEEEKELVKKMIL 177
           G  I+EMA G+           ++  P +    +       ++   ++ E K  + K   
Sbjct: 212 GCTIIEMATGKPPF-------YELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILK--- 261

Query: 178 VSLWCIQTNPSDRPSMHEVLE 198
               C + +P  R   +++L 
Sbjct: 262 ----CFEPDPDKRACANDLLV 278

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 94.5 bits (235), Expect = 2e-22
 Identities = 38/220 (17%), Positives = 66/220 (30%), Gaps = 47/220 (21%)

Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS 78
            + L           I   L YLH    + +V+ D+KP NI+L E+   K+ D G   + 
Sbjct: 176 GQKLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRI 231

Query: 79  QDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASR 138
                        GT G+ APE+  R   G +  +D+Y+ G  +  + +           
Sbjct: 232 NSFGYLY------GTPGFQAPEI-VR--TGPTVATDIYTVGRTLAALTLDLP-------- 274

Query: 139 SSDIYFPNSIYKHI-----EPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRP-S 192
                        +               ++                  I  +P  R  +
Sbjct: 275 ----TRNGRYVDGLPEDDPVLKTYDSYGRLL---------------RRAIDPDPRQRFTT 315

Query: 193 MHEVLEMLESSTEILQIPPKPSLALPKKSAIQSSRTSSSA 232
             E+   L      + +     +  P  S I S   S+  
Sbjct: 316 AEEMSAQLTGVLREV-VAQDTGVPRPGLSTIFSPSRSTFG 354

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 93.6 bits (233), Expect = 3e-22
 Identities = 57/197 (28%), Positives = 87/197 (44%), Gaps = 45/197 (22%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           +  G+ Y+H      IVH D+KP NILL   ++D   KI DFGL+   Q        +  
Sbjct: 130 VFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-- 184

Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP----- 145
            GT  YIAPEV   ++     K DV+S G+++  +  G                P     
Sbjct: 185 -GTAYYIAPEVLRGTYD---EKCDVWSAGVILYILLSG--------------TPPFYGKN 226

Query: 146 -NSIYKHIEPGN-DFQLD--GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE--- 198
              I K +E G   F L     ++++ K+L++KM       +  +PS R +  + LE   
Sbjct: 227 EYDILKRVETGKYAFDLPQWRTISDDAKDLIRKM-------LTFHPSLRITATQCLEHPW 279

Query: 199 MLESSTEILQIPPKPSL 215
           + + S+E   I   PSL
Sbjct: 280 IQKYSSETPTISDLPSL 296

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 93.6 bits (233), Expect = 3e-22
 Identities = 51/177 (28%), Positives = 78/177 (44%), Gaps = 42/177 (23%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           +  G+ Y+H     +IVH D+KP N+LL    +D   +I DFGL+   +  K     +  
Sbjct: 135 VLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI-- 189

Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP----- 145
            GT  YIAPEV   ++     K DV+S G+++  +  G                P     
Sbjct: 190 -GTAYYIAPEVLHGTYD---EKCDVWSTGVILYILLSG--------------CPPFNGAN 231

Query: 146 -NSIYKHIEPGN-DFQLD--GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
              I K +E G   F+L     V+E  K+L++KM       +   PS R S  + L+
Sbjct: 232 EYDILKKVEKGKYTFELPQWKKVSESAKDLIRKM-------LTYVPSMRISARDALD 281

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 91.7 bits (228), Expect = 5e-22
 Identities = 46/224 (20%), Positives = 82/224 (36%), Gaps = 39/224 (17%)

Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLA--------- 75
            TV +I     R ++++HR     I+H D+K  N+LL      K+ DFG A         
Sbjct: 136 DTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDY 194

Query: 76  KQSQDKKSTISMLHAR-GTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVGR---K 130
             S  +++ +     R  T  Y  PE+    S      K D+++ G ++  +   +   +
Sbjct: 195 SWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254

Query: 131 NADVKASRSSDIYFP-NSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSD 189
           +       +     P +                        L++ M       +Q NP +
Sbjct: 255 DGAKLRIVNGKYSIPPHDTQ---------------YTVFHSLIRAM-------LQVNPEE 292

Query: 190 RPSMHEVLEMLESSTEILQIPPK-PSLALPKKSAIQSSRTSSSA 232
           R S+ EV+  L+       + PK P   L +++    S T S  
Sbjct: 293 RLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGSATLSRG 336

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 91.9 bits (229), Expect = 7e-22
 Identities = 47/209 (22%), Positives = 81/209 (38%), Gaps = 38/209 (18%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +  G    F      + G   L  +T+ Q+ G  A G+EYL        +H D+   N L
Sbjct: 194 VQGGDFLTFL----RTEG-ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCL 245

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + E    KISDFG++++  D     S    +  + + APE    ++G  S +SDV+S+G+
Sbjct: 246 VTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEAL--NYGRYSSESDVWSFGI 303

Query: 121 MILEMAV-------GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVK 173
           ++ E             N                  + +E G       +  +    L++
Sbjct: 304 LLWETFSLGASPYPNLSNQQT--------------REFVEKGGRLPCPELCPDAVFRLME 349

Query: 174 KMILVSLWCIQTNPSDRPSMHEVLEMLES 202
           +       C    P  RPS   + + L+S
Sbjct: 350 Q-------CWAYEPGQRPSFSTIYQELQS 371

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 90.4 bits (225), Expect = 9e-22
 Identities = 32/110 (29%), Positives = 51/110 (46%), Gaps = 10/110 (9%)

Query: 22  LEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDK 81
           L       I   I   L+  H        H D+KP NIL+  D    + DFG+A  + D+
Sbjct: 131 LAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187

Query: 82  KSTI--SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           K T   + +   GT+ Y+APE F      A++++D+Y+   ++ E   G 
Sbjct: 188 KLTQLGNTV---GTLYYMAPERFSE--SHATYRADIYALTCVLYECLTGS 232

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 91.0 bits (226), Expect = 9e-22
 Identities = 40/178 (22%), Positives = 65/178 (36%), Gaps = 37/178 (20%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILL--DEDFCPKISDFGLAK--QSQDKKSTISMLH 89
           I   L YLH   N  I H DIKP N L   ++ F  K+ DFGL+K     +      M  
Sbjct: 177 IFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT 233

Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP---- 145
             GT  ++APEV   +      K D +S G+++  + +G                P    
Sbjct: 234 KAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMG--------------AVPFPGV 279

Query: 146 --NSIYKHIEPGN-DFQLD--GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
                   +      F+     V++   ++L+  +       +  N  +R      L+
Sbjct: 280 NDADTISQVLNKKLCFENPNYNVLSPLARDLLSNL-------LNRNVDERFDAMRALQ 330

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 91.3 bits (227), Expect = 2e-21
 Identities = 53/177 (29%), Positives = 73/177 (41%), Gaps = 42/177 (23%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           I  G+ YLH      IVH DIKP NILL   +     KI DFGL+            L  
Sbjct: 155 ILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL-- 209

Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP----- 145
            GT  YIAPEV  + +     K DV+S G+++  +  G              Y P     
Sbjct: 210 -GTAYYIAPEVLKKKYN---EKCDVWSCGVIMYILLCG--------------YPPFGGQN 251

Query: 146 -NSIYKHIEPGN-DFQLD--GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
              I K +E G   F  +    +++E KEL+K M       +  + + R +  E L 
Sbjct: 252 DQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLM-------LTYDYNKRCTAEEALN 301

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 90.9 bits (226), Expect = 3e-21
 Identities = 53/177 (29%), Positives = 79/177 (44%), Gaps = 42/177 (23%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           +  G+ YLH      IVH D+KP N+LL   ++D   KI DFGL+   +++K     L  
Sbjct: 145 VLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL-- 199

Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP----- 145
            GT  YIAPEV  + +     K DV+S G+++  +  G              Y P     
Sbjct: 200 -GTAYYIAPEVLRKKYD---EKCDVWSIGVILFILLAG--------------YPPFGGQT 241

Query: 146 -NSIYKHIEPGN-DFQLD--GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
              I + +E G   F       V+E  K+L+K+M       +Q +   R S  + LE
Sbjct: 242 DQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQM-------LQFDSQRRISAQQALE 291

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 88.1 bits (219), Expect = 6e-21
 Identities = 43/178 (24%), Positives = 71/178 (39%), Gaps = 40/178 (22%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +   +  LH    + IVH D+KP NILLD+D   K++DFG + Q    +    +    GT
Sbjct: 133 LLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC---GT 186

Query: 94  IGYIAPEVFCRSFGGASH----KSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP---- 145
             Y+APE+   S          + D++S G+++  +  G                P    
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG--------------SPPFWHR 232

Query: 146 --NSIYKHIEPGN-DFQLD--GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
               + + I  GN  F        ++  K+LV + ++V        P  R +  E L 
Sbjct: 233 KQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVV-------QPQKRYTAEEALA 283

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 88.7 bits (220), Expect = 7e-21
 Identities = 54/221 (24%), Positives = 89/221 (40%), Gaps = 39/221 (17%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSLDQ           R  E + + +++  + +GL YL      +I+H D+KP NIL
Sbjct: 113 MDGGSLDQV-----LKKAGRIPE-QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNIL 164

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHAR-GTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           ++     K+ DFG++ Q  D     SM ++  GT  Y++PE    +    S +SD++S G
Sbjct: 165 VNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPERLQGT--HYSVQSDIWSMG 217

Query: 120 MMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVS 179
           + ++EMAVGR              +P       +      + G   E +           
Sbjct: 218 LSLVEMAVGR--------------YP---IPPPDAKELELMFGCQVEGDAAETPPRPRTP 260

Query: 180 LWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSLALPKK 220
              +     D      + E+L+       I  +P   LP  
Sbjct: 261 GRPLNKFGMDSRPPMAIFELLD------YIVNEPPPKLPSG 295

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 88.9 bits (221), Expect = 9e-21
 Identities = 34/97 (35%), Positives = 48/97 (49%), Gaps = 7/97 (7%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +   L+YL      RI+H D+KP NILLDE     I+DF +A     +    +M    GT
Sbjct: 124 LVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GT 177

Query: 94  IGYIAPEVFCRSFGGASHKS-DVYSYGMMILEMAVGR 129
             Y+APE+F    G     + D +S G+   E+  GR
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 89.4 bits (222), Expect = 9e-21
 Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 45/224 (20%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSL  F          + L    +  +A  IA G+ Y+ R   +  VH D++  NIL
Sbjct: 260 MSKGSLLDFLK----GETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANIL 312

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + E+   K++DFGLA+  +D + T     A+  I + APE     +G  + KSDV+S+G+
Sbjct: 313 VGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAA--LYGRFTIKSDVWSFGI 369

Query: 121 MILEMAV-------GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLD--GVVTEEEKEL 171
           ++ E+         G  N +V                 +E G  +++       E   +L
Sbjct: 370 LLTELTTKGRVPYPGMVNREV--------------LDQVERG--YRMPCPPECPESLHDL 413

Query: 172 VKKMILVSLWCIQTNPSDRPSMHEVLEMLES---STEILQIPPK 212
              M      C +  P +RP+   +   LE    STE    P +
Sbjct: 414 ---M----CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 450

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 87.4 bits (217), Expect = 1e-20
 Identities = 47/183 (25%), Positives = 73/183 (39%), Gaps = 42/183 (22%)

Query: 30  IAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ---SQDKKSTIS 86
           +   I + L YL       ++H D+KP NILLDE    K+ DFG++ +    + K  +  
Sbjct: 129 MTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA- 185

Query: 87  MLHARGTIGYIAPEVF-CRSFGGA--SHKSDVYSYGMMILEMAVGRKNADVKASRSSDIY 143
                G   Y+APE              ++DV+S G+ ++E+A G+              
Sbjct: 186 -----GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ-------------- 226

Query: 144 FPNSIYKHIEPGNDF-QLDGVVTEEEKELVKKMI-------LVSLWCIQTNPSDRPSMHE 195
           FP           DF  L  V+ EE   L   M         V   C+  +   RP  ++
Sbjct: 227 FPYK-----NCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKD-CLTKDHRKRPKYNK 280

Query: 196 VLE 198
           +LE
Sbjct: 281 LLE 283

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 88.8 bits (220), Expect = 2e-20
 Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 45/224 (20%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSL  F          + L    +  +A  IA G+ Y+ R   +  VH D++  NIL
Sbjct: 343 MSKGSLLDFLK----GETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANIL 395

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + E+   K++DFGLA+  +D + T     A+  I + APE     +G  + KSDV+S+G+
Sbjct: 396 VGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAAL--YGRFTIKSDVWSFGI 452

Query: 121 MILEMAV-------GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLD--GVVTEEEKEL 171
           ++ E+         G  N +V                 +E G  +++       E   +L
Sbjct: 453 LLTELTTKGRVPYPGMVNREV--------------LDQVERG--YRMPCPPECPESLHDL 496

Query: 172 VKKMILVSLWCIQTNPSDRPSMHEVLEMLES---STEILQIPPK 212
              M      C +  P +RP+   +   LE    STE    P +
Sbjct: 497 ---M----CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 533

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 87.9 bits (218), Expect = 3e-20
 Identities = 50/211 (23%), Positives = 90/211 (42%), Gaps = 42/211 (19%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  G+L  +          + +    +  +A  I+  +EYL +      +H ++   N L
Sbjct: 298 MTYGNLLDYL----RECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCL 350

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + E+   K++DFGL++       T     A+  I + APE    ++   S KSDV+++G+
Sbjct: 351 VGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESL--AYNKFSIKSDVWAFGV 407

Query: 121 MILEMAV-------GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLD--GVVTEEEKEL 171
           ++ E+A        G   + V              Y+ +E    ++++      E+  EL
Sbjct: 408 LLWEIATYGMSPYPGIDLSQV--------------YELLEKD--YRMERPEGCPEKVYEL 451

Query: 172 VKKMILVSLWCIQTNPSDRPSMHEVLEMLES 202
              M      C Q NPSDRPS  E+ +  E+
Sbjct: 452 ---M----RACWQWNPSDRPSFAEIHQAFET 475

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 86.6 bits (215), Expect = 3e-20
 Identities = 44/186 (23%), Positives = 77/186 (41%), Gaps = 31/186 (16%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGLAKQSQDKK-----STI 85
           +A  L++LH   N  I H D+KP NIL    ++    KI DF L    +        ST 
Sbjct: 120 VASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176

Query: 86  SMLHARGTIGYIAPEVFCRSFGGASH---KSDVYSYGMMILEMAVG-------RKNADVK 135
            +L   G+  Y+APEV       AS    + D++S G+++  +  G         +    
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW 236

Query: 136 ASRSSDIYFPNSIYKHIEPGN-DFQLD--GVVTEEEKELVKKMILVSLWCIQTNPSDRPS 192
               +     N +++ I+ G  +F       ++   K+L+ K+       +  +   R S
Sbjct: 237 DRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKL-------LVRDAKQRLS 289

Query: 193 MHEVLE 198
             +VL+
Sbjct: 290 AAQVLQ 295

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 85.3 bits (212), Expect = 5e-20
 Identities = 38/177 (21%), Positives = 70/177 (39%), Gaps = 42/177 (23%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           +   + Y H    + + H D+KP N L      D   K+ DFGLA + +  K   + +  
Sbjct: 115 VLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV-- 169

Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP----- 145
            GT  Y++P+V    +G    + D +S G+M+  +  G              Y P     
Sbjct: 170 -GTPYYVSPQVLEGLYG---PECDEWSAGVMMYVLLCG--------------YPPFSAPT 211

Query: 146 -NSIYKHIEPGN-DFQLD--GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
            + +   I  G   F       V+ + + L++++       +  +P  R +  + LE
Sbjct: 212 DSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRL-------LTKSPKQRITSLQALE 261

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 85.8 bits (213), Expect = 6e-20
 Identities = 40/177 (22%), Positives = 80/177 (45%), Gaps = 33/177 (18%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           +   + ++H   +V +VH D+KP N+L    +++   KI DFG A+          +   
Sbjct: 115 LVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--LKTP 169

Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR-----KNADVKASRSSDIYFP 145
             T+ Y APE+  ++  G     D++S G+++  M  G+      +  +  + + +    
Sbjct: 170 CFTLHYAAPELLNQN--GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE---- 223

Query: 146 NSIYKHIEPGNDFQLDG----VVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
             I K I+ G DF  +G     V++E K+L++ +       +  +P+ R  M  +  
Sbjct: 224 --IMKKIKKG-DFSFEGEAWKNVSQEAKDLIQGL-------LTVDPNKRLKMSGLRY 270

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 85.0 bits (211), Expect = 7e-20
 Identities = 51/177 (28%), Positives = 78/177 (44%), Gaps = 42/177 (23%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           +  G+ Y+H      IVH D+KP NILL   ++D   KI DFGL+   Q        +  
Sbjct: 130 VFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-- 184

Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP----- 145
            GT  YIAPEV   ++     K DV+S G+++  +  G                P     
Sbjct: 185 -GTAYYIAPEVLRGTYD---EKCDVWSAGVILYILLSG--------------TPPFYGKN 226

Query: 146 -NSIYKHIEPGN-DFQLD--GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
              I K +E G   F L     ++++ K+L++KM       +  +PS R +  + LE
Sbjct: 227 EYDILKRVETGKYAFDLPQWRTISDDAKDLIRKM-------LTFHPSLRITATQCLE 276

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 85.7 bits (213), Expect = 7e-20
 Identities = 47/220 (21%), Positives = 86/220 (39%), Gaps = 43/220 (19%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           MP G L  +  + + + G++ L           IA+G+ YL      R+VH D+   N+L
Sbjct: 98  MPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLED---RRLVHRDLAARNVL 149

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFC-RSFGGASHKSDVYSYG 119
           +      KI+DFGLAK    ++        +  I ++A E    R +   +H+SDV+SYG
Sbjct: 150 VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY---THQSDVWSYG 206

Query: 120 MMILEMA-------VGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELV 172
           + + E+         G   +++                 +E G       + T +   + 
Sbjct: 207 VTVWELMTFGSKPYDGIPASEI--------------SSILEKGERLPQPPICTIDVYMI- 251

Query: 173 KKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPK 212
             M      C   +   RP   E++       ++ + P +
Sbjct: 252 --M----RKCWMIDADSRPKFRELIIEFS---KMARDPQR 282

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 84.6 bits (210), Expect = 9e-20
 Identities = 44/176 (25%), Positives = 73/176 (41%), Gaps = 41/176 (23%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           +   L Y H   +  +VH D+KP NIL          KI DFGLA+  +  +      +A
Sbjct: 133 MMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNA 186

Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP----- 145
            GT  Y+APEVF R       K D++S G+++  +  G                P     
Sbjct: 187 AGTALYMAPEVFKRDVT---FKCDIWSAGVVMYFLLTG--------------CLPFTGTS 229

Query: 146 -NSIYKHIEPGN-DFQLD-GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
              + +       ++ ++   +T +  +L+K+M       +  +P  RPS  +VL 
Sbjct: 230 LEEVQQKATYKEPNYAVECRPLTPQAVDLLKQM-------LTKDPERRPSAAQVLH 278

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 84.5 bits (210), Expect = 1e-19
 Identities = 46/177 (25%), Positives = 76/177 (42%), Gaps = 41/177 (23%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           I   + Y H   +  IVH ++KP N+LL    +    K++DFGLA +  D ++       
Sbjct: 114 ILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA-- 168

Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP----- 145
            GT GY++PEV  +         D+++ G+++  + VG              Y P     
Sbjct: 169 -GTPGYLSPEVLKKDPYS--KPVDIWACGVILYILLVG--------------YPPFWDED 211

Query: 146 -NSIYKHIEPGN-DFQLD--GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
            + +Y  I+ G  D+       VT E K L+  M+ V       NP  R +  + L+
Sbjct: 212 QHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTV-------NPKKRITADQALK 261

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 85.1 bits (211), Expect = 1e-19
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 62/245 (25%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NG+LD+F  +++            +  +  GIA G++YL     +  VH D+   NIL
Sbjct: 128 MENGALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNIL 179

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGT---IGYIAPEVFCRSFGGASHKSDVYS 117
           ++ +   K+SDFGL++  +D           G    I + APE    S+   +  SDV+S
Sbjct: 180 VNSNLVCKVSDFGLSRVLEDDPEATY--TTSGGKIPIRWTAPEAI--SYRKFTSASDVWS 235

Query: 118 YGMMILE-MAVGRK------NADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEK- 169
           +G+++ E M  G +      N +V               K I  G  F+L          
Sbjct: 236 FGIVMWEVMTYGERPYWELSNHEV--------------MKAINDG--FRL-------PTP 272

Query: 170 -----ELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE-------SSTEILQIPPKPSLAL 217
                 + + M    + C Q   + RP   +++ +L+       S   +    P+ S+ L
Sbjct: 273 MDCPSAIYQLM----MQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRL 328

Query: 218 PKKSA 222
           P  S 
Sbjct: 329 PSTSG 333

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 85.1 bits (211), Expect = 1e-19
 Identities = 50/252 (19%), Positives = 91/252 (36%), Gaps = 42/252 (16%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           MP G L  +  + + + G++ L           IA+G+ YL    + R+VH D+   N+L
Sbjct: 98  MPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE---DRRLVHRDLAARNVL 149

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           +      KI+DFGLAK    ++        +  I ++A E         +H+SDV+SYG+
Sbjct: 150 VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI--LHRIYTHQSDVWSYGV 207

Query: 121 MILEMA-------VGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVK 173
            + E+         G   +++                 +E G       + T +   +  
Sbjct: 208 TVWELMTFGSKPYDGIPASEI--------------SSILEKGERLPQPPICTIDVYMI-- 251

Query: 174 KMILVSLWCIQTNPSDRPSMHEVLEMLE----SSTEILQIPPKPSLALPKKSAIQSSRTS 229
            M    + C   +   RP   E++             L I     + LP  +     R  
Sbjct: 252 -M----VKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRAL 306

Query: 230 SSAGIEEVMGEM 241
                 + + + 
Sbjct: 307 MDEEDMDDVVDA 318

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 85.9 bits (213), Expect = 1e-19
 Identities = 52/224 (23%), Positives = 96/224 (42%), Gaps = 47/224 (20%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSL  F      S+         +   +  IA G+ ++ +      +H D++  NIL
Sbjct: 264 MAKGSLLDFLK----SDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANIL 316

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           +      KI+DFGLA+  +D + T     A+  I + APE    +FG  + KSDV+S+G+
Sbjct: 317 VSASLVCKIADFGLARVIEDNEYTARE-GAKFPIKWTAPEAI--NFGSFTIKSDVWSFGI 373

Query: 121 MILEMAV-------GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLD--GVVTEEEKEL 171
           +++E+         G  N +V               + +E G  +++       EE   +
Sbjct: 374 LLMEIVTYGRIPYPGMSNPEV--------------IRALERG--YRMPRPENCPEELYNI 417

Query: 172 VKKMILVSLWCIQTNPSDRPSMHEVLEMLE-----SSTEILQIP 210
              M    + C +  P +RP+   +  +L+     + ++  +IP
Sbjct: 418 ---M----MRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEIP 454

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 85.9 bits (213), Expect = 1e-19
 Identities = 46/174 (26%), Positives = 76/174 (43%), Gaps = 31/174 (17%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           +   ++YLH      I+H D+KP N+LL   +ED   KI+DFG +K   +     ++   
Sbjct: 248 MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC-- 302

Query: 91  RGTIGYIAPEVFCRSF-GGASHKSDVYSYGMMILEMAVGRK--NADVKASRSSDIYFPNS 147
            GT  Y+APEV       G +   D +S G+++     G    +               S
Sbjct: 303 -GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH---------RTQVS 352

Query: 148 IYKHIEPGN-DFQLD--GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
           +   I  G  +F  +    V+E+  +LVKK+++V       +P  R +  E L 
Sbjct: 353 LKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVV-------DPKARFTTEEALR 399

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 84.2 bits (209), Expect = 2e-19
 Identities = 46/203 (22%), Positives = 81/203 (39%), Gaps = 43/203 (21%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH-ARG 92
           +  GLEYLH      IVH DIKP N+LL      KIS  G+A+      +       ++G
Sbjct: 118 LIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD-DTCRTSQG 173

Query: 93  TIGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP----- 145
           +  +  PE+     +F G   K D++S G+ +  +  G               +P     
Sbjct: 174 SPAFQPPEIANGLDTFSGF--KVDIWSAGVTLYNITTG--------------LYPFEGDN 217

Query: 146 -NSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM----- 199
              ++++I  G  + + G       +L+K M       ++  P+ R S+ ++ +      
Sbjct: 218 IYKLFENIGKG-SYAIPGDCGPPLSDLLKGM-------LEYEPAKRFSIRQIRQHSWFRK 269

Query: 200 -LESSTEILQIPPKPSLALPKKS 221
               +   + IPP P      +S
Sbjct: 270 KHPPAEAPVPIPPSPDTKDRWRS 292

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 85.0 bits (210), Expect = 2e-19
 Identities = 41/247 (16%), Positives = 77/247 (31%), Gaps = 44/247 (17%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ---SQDKKSTISMLHAR- 91
           + L+Y+H    +  VH  +K  +IL+  D    +S             ++  +       
Sbjct: 139 KALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195

Query: 92  -GTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR----------------KNA-- 132
              + +++PEV  ++  G   KSD+YS G+   E+A G                      
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255

Query: 133 --DVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLW--------- 181
                ++  ++    +        G    L                    +         
Sbjct: 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVE 315

Query: 182 -CIQTNPSDRPSMHEVLE------MLESSTEILQIPPKPSLALPKKSAIQSSRTSSSAGI 234
            C+Q NP  RPS   +L       +   ++E L    +P   +      QS   S   G+
Sbjct: 316 QCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHSGIFGL 375

Query: 235 EEVMGEM 241
              + E+
Sbjct: 376 VTNLEEL 382

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 84.3 bits (209), Expect = 2e-19
 Identities = 51/210 (24%), Positives = 82/210 (39%), Gaps = 26/210 (12%)

Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHAR-GTIG 95
           G+ YLH    + I H DIKP N+LLDE    KISDFGLA   +       +L+   GT+ 
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-RLLNKMCGTLP 172

Query: 96  YIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEP 154
           Y+APE+   R F       DV+S G+++  M  G    D               Y   + 
Sbjct: 173 YVAPELLKRREFHAE--PVDVWSCGIVLTAMLAGELPWD-------QPSDSCQEYSDWKE 223

Query: 155 GNDFQLDGV-VTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE---MLESSTEILQIP 210
              +      +      L+ K+       +  NPS R ++ ++ +     +   +  + P
Sbjct: 224 KKTYLNPWKKIDSAPLALLHKI-------LVENPSARITIPDIKKDRWYNKPLKKGAKRP 276

Query: 211 PKPSLALPKKSAIQSSRTSSSAGIEEVMGE 240
              S  + +  +  S    S+     V   
Sbjct: 277 RVTSGGVSESPSGFSKHIQSNLDFSPVNSA 306

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 83.9 bits (208), Expect = 4e-19
 Identities = 40/176 (22%), Positives = 72/176 (40%), Gaps = 39/176 (22%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           I   L Y H   +  I+H D+KPH +LL   +     K+  FG+A Q  +          
Sbjct: 139 ILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV--AGGR 193

Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP----- 145
            GT  ++APEV  R         DV+  G+++  +  G                P     
Sbjct: 194 VGTPHFMAPEVVKRE--PYGKPVDVWGCGVILFILLSG--------------CLPFYGTK 237

Query: 146 NSIYKHIEPGN-DFQLD--GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
             +++ I  G           ++E  K+LV++M+++       +P++R +++E L 
Sbjct: 238 ERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLML-------DPAERITVYEALN 286

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 83.2 bits (206), Expect = 5e-19
 Identities = 55/246 (22%), Positives = 90/246 (36%), Gaps = 46/246 (18%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +P+G L  F     +      L        +  I +G+EYL      R VH D+   NIL
Sbjct: 108 LPSGCLRDFLQRHRARLDASRL-----LLYSSQICKGMEYLGS---RRCVHRDLAARNIL 159

Query: 61  LDEDFCPKISDFGLAKQSQDKKST-ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           ++ +   KI+DFGLAK     K   +     +  I + APE    S    S +SDV+S+G
Sbjct: 160 VESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE--SLSDNIFSRQSDVWSFG 217

Query: 120 MMILEMA-VGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKK---- 174
           +++ E+     K                S           + D        EL+++    
Sbjct: 218 VVLYELFTYCDK--------------SCSPSAEFLRMMGCERDVPALSRLLELLEEGQRL 263

Query: 175 -----------MILVSLWCIQTNPSDRPS---MHEVLEMLESSTEILQIPPKPSLALPKK 220
                       ++   W    +P DRPS   +   L+ML S +   +     +    K 
Sbjct: 264 PAPPACPAEVHELMKLCW--APSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKH 321

Query: 221 SAIQSS 226
            ++  S
Sbjct: 322 HSLSFS 327

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 83.6 bits (207), Expect = 7e-19
 Identities = 60/258 (23%), Positives = 100/258 (38%), Gaps = 72/258 (27%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NGSLD F    +            +  +  GIA G++YL     +  VH D+   NIL
Sbjct: 128 MENGSLDSFLRKHD-----AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNIL 179

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGT---IGYIAPEVFCRSFGGASHKSDVYS 117
           ++ +   K+SDFGL +  +D          RG    I + +PE    ++   +  SDV+S
Sbjct: 180 INSNLVCKVSDFGLGRVLEDDPEAAYT--TRGGKIPIRWTSPEAI--AYRKFTSASDVWS 235

Query: 118 YGMMILE-MAVGRK------NADVKASRSSDIYFPNSIYKHIE-----------PGNDFQ 159
           YG+++ E M+ G +      N DV               K ++           P   +Q
Sbjct: 236 YGIVLWEVMSYGERPYWEMSNQDV--------------IKAVDEGYRLPPPMDCPAALYQ 281

Query: 160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE-------SSTEILQIPPK 212
           L              M    L C Q + ++RP   +++ +L+       S   I     +
Sbjct: 282 L--------------M----LDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAAR 323

Query: 213 PSLALPKKSAIQSSRTSS 230
           PS  L  +S +  +   +
Sbjct: 324 PSNLLLDQSNVDITTFRT 341

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 83.2 bits (206), Expect = 7e-19
 Identities = 38/178 (21%), Positives = 72/178 (40%), Gaps = 40/178 (22%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +   + +LH      IVH D+KP NILLD++   ++SDFG +   +  +    +    GT
Sbjct: 209 LLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC---GT 262

Query: 94  IGYIAPEVFCRSFGGA----SHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP---- 145
            GY+APE+   S          + D+++ G+++  +  G                P    
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG--------------SPPFWHR 308

Query: 146 --NSIYKHIEPGN-DFQLD--GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
               + + I  G   F        +   K+L+ +++ V       +P  R +  + L+
Sbjct: 309 RQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQV-------DPEARLTAEQALQ 359

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 82.8 bits (205), Expect = 7e-19
 Identities = 37/173 (21%), Positives = 77/173 (44%), Gaps = 30/173 (17%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           I   +++LH   +  I H D+KP N+L    ++D   K++DFG AK++        +   
Sbjct: 137 IGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTP 189

Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRK--NADVKASRSSDIYFPNSI 148
             T  Y+APEV            D++S G+++  +  G     ++      +       +
Sbjct: 190 CYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYSN------TGQAISPGM 241

Query: 149 YKHIEPGN-DFQLD--GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
            + I  G   F       V+E+ K+L++ +       ++T+P++R ++ + + 
Sbjct: 242 KRRIRLGQYGFPNPEWSEVSEDAKQLIRLL-------LKTDPTERLTITQFMN 287

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 82.7 bits (205), Expect = 8e-19
 Identities = 50/178 (28%), Positives = 72/178 (40%), Gaps = 38/178 (21%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCP-KISDFGLAKQSQDKKSTISMLH 89
           I + +EYLH      +VH D+KP NIL      +    +I DFG AKQ + +   +    
Sbjct: 125 ITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC 181

Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG-----RKNADVKASRSSDIYF 144
              T  ++APEV  R   G     D++S G+++  M  G         D           
Sbjct: 182 --YTANFVAPEVLERQ--GYDAACDIWSLGVLLYTMLTGYTPFANGPDD----------T 227

Query: 145 PNSIYKHIEPGNDFQLDG----VVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
           P  I   I  G  F L G     V++  K+LV KM       +  +P  R +   VL 
Sbjct: 228 PEEILARIGSG-KFSLSGGYWNSVSDTAKDLVSKM-------LHVDPHQRLTAALVLR 277

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 82.7 bits (205), Expect = 1e-18
 Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 43/178 (24%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           I   + Y H   +  IVH ++KP N+LL    +    K++DFGLA +  D ++       
Sbjct: 137 ILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA-- 191

Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP----- 145
            GT GY++PEV  +     S   D+++ G+++  + VG               +P     
Sbjct: 192 -GTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVG---------------YPPFWDE 233

Query: 146 --NSIYKHIEPGN-DFQLD--GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
             + +Y  I+ G  D+       VT E K L+  M+ V       NP  R +  + L+
Sbjct: 234 DQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTV-------NPKKRITADQALK 284

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 81.5 bits (202), Expect = 1e-18
 Identities = 46/165 (27%), Positives = 70/165 (42%), Gaps = 23/165 (13%)

Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHAR-GTIG 95
           G+ YLH    + I H DIKP N+LLDE    KISDFGLA   +       +L+   GT+ 
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-RLLNKMCGTLP 172

Query: 96  YIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEP 154
           Y+APE+   R F       DV+S G+++  M  G    D               Y   + 
Sbjct: 173 YVAPELLKRREFHAE--PVDVWSCGIVLTAMLAGELPWD-------QPSDSCQEYSDWKE 223

Query: 155 GNDFQLDGV-VTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
              +      +      L+ K+       +  NPS R ++ ++ +
Sbjct: 224 KKTYLNPWKKIDSAPLALLHKI-------LVENPSARITIPDIKK 261

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 81.8 bits (203), Expect = 1e-18
 Identities = 45/186 (24%), Positives = 80/186 (43%), Gaps = 46/186 (24%)

Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGLAKQSQDK 81
             + Q+   +     YLH      IVH D+KP N+L    +E+    I+DFGL+K  Q+ 
Sbjct: 110 LVIQQVLSAVK----YLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162

Query: 82  KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSD 141
                M  A GT GY+APEV  +     S   D +S G++   +  G             
Sbjct: 163 I----MSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVITYILLCG------------- 203

Query: 142 IYFP------NSIYKHIEPGN-DFQLD--GVVTEEEKELVKKMILVSLWCIQTNPSDRPS 192
            Y P      + +++ I+ G  +F+      ++E  K+ +  +       ++ +P++R +
Sbjct: 204 -YPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHL-------LEKDPNERYT 255

Query: 193 MHEVLE 198
             + L 
Sbjct: 256 CEKALS 261

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 81.1 bits (201), Expect = 1e-18
 Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 50/215 (23%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NGSL  F      +     L    +  +A  IA G+ ++        +H D++  NIL
Sbjct: 89  MENGSLVDFLK----TPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANIL 141

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + +    KI+DFGLA+  +D + T     A+  I + APE    ++G  + KSDV+S+G+
Sbjct: 142 VSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAI--NYGTFTIKSDVWSFGI 198

Query: 121 MILEMAV-------GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEK---- 169
           ++ E+         G  N +V               +++E G  +++        +    
Sbjct: 199 LLTEIVTHGRIPYPGMTNPEV--------------IQNLERG--YRM-------VRPDNC 235

Query: 170 --ELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES 202
             EL + M      C +  P DRP+   +  +LE 
Sbjct: 236 PEELYQLM----RLCWKERPEDRPTFDYLRSVLED 266

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 81.6 bits (202), Expect = 1e-18
 Identities = 43/220 (19%), Positives = 82/220 (37%), Gaps = 45/220 (20%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +P+GSL ++    ++    +        + A  I +G++YL      + VH D+   N+L
Sbjct: 107 LPSGSLKEYLPKNKNKINLKQQ-----LKYAVQICKGMDYLGS---RQYVHRDLAARNVL 158

Query: 61  LDEDFCPKISDFGLAKQ-SQDKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSY 118
           ++ +   KI DFGL K    DK+           + + APE +    F      SDV+S+
Sbjct: 159 VESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKF---YIASDVWSF 215

Query: 119 GMMILE-MAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKK--- 174
           G+ + E +     ++   A     I      +             +        +K+   
Sbjct: 216 GVTLHELLTYCDSDSSPMALFLKMIGPT---H-----------GQMTVTRLVNTLKEGKR 261

Query: 175 ------------MILVSLWCIQTNPSDRPSMHEVLEMLES 202
                        ++   W  +  PS+R S   ++E  E+
Sbjct: 262 LPCPPNCPDEVYQLMRKCW--EFQPSNRTSFQNLIEGFEA 299

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 82.1 bits (203), Expect = 1e-18
 Identities = 37/167 (22%), Positives = 65/167 (38%), Gaps = 33/167 (19%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHAR-G 92
           +   + YL       I+H DIK  NI++ EDF  K+ DFG A   +  K    + +   G
Sbjct: 139 LVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK----LFYTFCG 191

Query: 93  TIGYIAPEVFC-RSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKH 151
           TI Y APEV     + G   + +++S G+ +  +                   P    + 
Sbjct: 192 TIEYCAPEVLMGNPYRGP--ELEMWSLGVTLYTLVFE--------------ENPFCELEE 235

Query: 152 IEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
                      +V++E   LV  +       +Q  P  R ++ +++ 
Sbjct: 236 TVEA-AIHPPYLVSKELMSLVSGL-------LQPVPERRTTLEKLVT 274

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 82.0 bits (203), Expect = 2e-18
 Identities = 48/262 (18%), Positives = 91/262 (34%), Gaps = 57/262 (21%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +P GSL         + G + L           IA+G+ YL       +VH ++   N+L
Sbjct: 96  LPLGSLLDHVRQHRGALGPQLL-----LNWGVQIAKGMYYLEE---HGMVHRNLAARNVL 147

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           L      +++DFG+A         +    A+  I ++A E     FG  +H+SDV+SYG+
Sbjct: 148 LKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI--HFGKYTHQSDVWSYGV 205

Query: 121 MILEMA-------VGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEK---- 169
            + E+         G + A+V                 +E G   +L        +    
Sbjct: 206 TVWELMTFGAEPYAGLRLAEV--------------PDLLEKG--ERL-------AQPQIC 242

Query: 170 --ELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE-------SSTEILQIPPKPSLALPKK 220
             ++   M    + C   + + RP+  E+                I +         P+ 
Sbjct: 243 TIDVYMVM----VKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRESGPGIAPGPEP 298

Query: 221 SAIQSSRTSSSAGIEEVMGEMY 242
             + + +        E+  ++ 
Sbjct: 299 HGLTNKKLEEVELEPELDLDLD 320

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 82.4 bits (204), Expect = 2e-18
 Identities = 48/211 (22%), Positives = 81/211 (38%), Gaps = 46/211 (21%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSL  +      S G   L    + + +  +   +EYL        VH D+   N+L
Sbjct: 269 MAKGSLVDYL----RSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVL 321

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + ED   K+SDFGL K++   + T      +  + + APE         S KSDV+S+G+
Sbjct: 322 VSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALR--EKKFSTKSDVWSFGI 374

Query: 121 MILEMAV-------GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLD--GVVTEEEKEL 171
           ++ E+              DV                 +E G  +++D          ++
Sbjct: 375 LLWEIYSFGRVPYPRIPLKDV--------------VPRVEKG--YKMDAPDGCPPAVYDV 418

Query: 172 VKKMILVSLWCIQTNPSDRPSMHEVLEMLES 202
              M      C   + + RP+  ++ E LE 
Sbjct: 419 ---M----KNCWHLDAATRPTFLQLREQLEH 442

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 81.3 bits (201), Expect = 2e-18
 Identities = 32/193 (16%), Positives = 66/193 (34%), Gaps = 35/193 (18%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILL----DEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +  G+ +L       IVH +IKP NI+     D     K++DFG A++ +D +  +S+  
Sbjct: 121 VVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY- 176

Query: 90  ARGTIGYIAPEVFCRSFGGA------SHKSDVYSYGMMILEMAVGR-------------- 129
             GT  Y+ P+++ R+              D++S G+     A G               
Sbjct: 177 --GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234

Query: 130 --KNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNP 187
                       +      +    I+   D  +   ++   + L+  ++   L   + + 
Sbjct: 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANIL---EADQ 291

Query: 188 SDRPSMHEVLEML 200
                  +     
Sbjct: 292 EKCWGFDQFFAET 304

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 81.2 bits (201), Expect = 3e-18
 Identities = 50/188 (26%), Positives = 79/188 (42%), Gaps = 45/188 (23%)

Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGLAKQSQDK 81
              YQ+   +    +YLH      I+H D+KP N+LL   +ED   KI+DFG +K   + 
Sbjct: 118 LYFYQMLLAV----QYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170

Query: 82  KSTISMLHARGTIGYIAPEVFC-RSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSS 140
               ++    GT  Y+APEV       G +   D +S G+++     G            
Sbjct: 171 SLMRTLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG------------ 215

Query: 141 DIYFP-------NSIYKHIEPGN-DFQLD--GVVTEEEKELVKKMILVSLWCIQTNPSDR 190
             Y P        S+   I  G  +F  +    V+E+  +LVKK+++V       +P  R
Sbjct: 216 --YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVV-------DPKAR 266

Query: 191 PSMHEVLE 198
            +  E L 
Sbjct: 267 FTTEEALR 274

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 82.5 bits (204), Expect = 3e-18
 Identities = 37/96 (38%), Positives = 53/96 (55%), Gaps = 8/96 (8%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I  GLE LHR    RIV+ D+KP NILLD+    +ISD GLA    + ++    +   GT
Sbjct: 295 ICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV---GT 348

Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           +GY+APEV        +   D ++ G ++ EM  G+
Sbjct: 349 VGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQ 382

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 80.4 bits (199), Expect = 4e-18
 Identities = 50/219 (22%), Positives = 83/219 (37%), Gaps = 42/219 (19%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +P GSL  +    +    +  L      Q    I +G+EYL      R +H D+   NIL
Sbjct: 95  LPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLGT---KRYIHRDLATRNIL 146

Query: 61  LDEDFCPKISDFGLAKQ-SQDKKSTISMLHARGTIGYIAPEV-FCRSFGGASHKSDVYSY 118
           ++ +   KI DFGL K   QDK+           I + APE      F   S  SDV+S+
Sbjct: 147 VENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF---SVASDVWSF 203

Query: 119 GMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKK---- 174
           G+++ E+           +       P + +  +   +      ++     EL+K     
Sbjct: 204 GVVLYEL----------FTYIEKSKSPPAEFMRMIGNDKQ--GQMIVFHLIELLKNNGRL 251

Query: 175 -----------MILVSLWCIQTNPSDRPSMHEVLEMLES 202
                      MI+   W    N + RPS  ++   ++ 
Sbjct: 252 PRPDGCPDEIYMIMTECW--NNNVNQRPSFRDLALRVDQ 288

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 81.2 bits (201), Expect = 4e-18
 Identities = 46/187 (24%), Positives = 74/187 (39%), Gaps = 46/187 (24%)

Query: 25  RTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGLAKQSQDK 81
             V QI   +A    YLH      IVH D+KP N+L      D   KI+DFGL+K  + +
Sbjct: 152 DAVKQILEAVA----YLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204

Query: 82  KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSD 141
               ++    GT GY APE+          + D++S G++   +  G             
Sbjct: 205 VLMKTVC---GTPGYCAPEILRGC--AYGPEVDMWSVGIITYILLCG------------- 246

Query: 142 IYFP-------NSIYKHIEPGN-DFQLD--GVVTEEEKELVKKMILVSLWCIQTNPSDRP 191
            + P         +++ I      F       V+   K+LV+K+       I  +P  R 
Sbjct: 247 -FEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKL-------IVLDPKKRL 298

Query: 192 SMHEVLE 198
           +  + L+
Sbjct: 299 TTFQALQ 305

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 81.9 bits (202), Expect = 4e-18
 Identities = 39/99 (39%), Positives = 53/99 (53%), Gaps = 14/99 (14%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHAR-G 92
           I  GLE++H      +V+ D+KP NILLDE    +ISD GLA     KK      HA  G
Sbjct: 301 IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HASVG 352

Query: 93  TIGYIAPEVFCRSFGGASHKSDV--YSYGMMILEMAVGR 129
           T GY+APEV  +   G ++ S    +S G M+ ++  G 
Sbjct: 353 THGYMAPEVLQK---GVAYDSSADWFSLGCMLFKLLRGH 388

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 80.4 bits (199), Expect = 5e-18
 Identities = 49/213 (23%), Positives = 91/213 (42%), Gaps = 43/213 (20%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  G L  +        G + +  +T+ +    IA G+EYL    N   +H D+   N +
Sbjct: 123 MKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCM 179

Query: 61  LDEDFCPKISDFGLAK--QSQD--KKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDV 115
           L +D    ++DFGL+K   S D  ++  I+ +  +      A E +  R +   + KSDV
Sbjct: 180 LRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI----AIESLADRVY---TSKSDV 232

Query: 116 YSYGMMILEMA-------VGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEE 168
           +++G+ + E+A        G +N ++              Y ++  G+  +      +E 
Sbjct: 233 WAFGVTMWEIATRGMTPYPGVQNHEM--------------YDYLLHGHRLKQPEDCLDEL 278

Query: 169 KELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE 201
            E++         C +T+P DRP+   +   LE
Sbjct: 279 YEIMYS-------CWRTDPLDRPTFSVLRLQLE 304

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 79.6 bits (197), Expect = 6e-18
 Identities = 50/215 (23%), Positives = 80/215 (37%), Gaps = 51/215 (23%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
              G L  F   ++      +L+  ++   A  ++  L YL      R VH DI   N+L
Sbjct: 97  CTLGELRSFLQVRK-----YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVL 148

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           +  + C K+ DFGL++  +D     +    +  I ++APE    +F   +  SDV+ +G+
Sbjct: 149 VSSNDCVKLGDFGLSRYMEDSTYYKAS-KGKLPIKWMAPESI--NFRRFTSASDVWMFGV 205

Query: 121 MILEMA-------VGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEK---- 169
            + E+         G KN DV                 IE G   +L             
Sbjct: 206 CMWEILMHGVKPFQGVKNNDV--------------IGRIENG--ERL-------PMPPNC 242

Query: 170 --ELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES 202
              L   M      C   +PS RP   E+   L +
Sbjct: 243 PPTLYSLM----TKCWAYDPSRRPRFTELKAQLST 273

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 79.7 bits (197), Expect = 7e-18
 Identities = 44/168 (26%), Positives = 76/168 (45%), Gaps = 17/168 (10%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT-I 94
            GLEYLH+      +H D+K  NILL ED   +I+DFG++         I+    R T +
Sbjct: 132 EGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLAT-GGDITRNKVRKTFV 187

Query: 95  G---YIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRK-NADVKASRSSDIYFPNSIYK 150
           G   ++APEV  +   G   K+D++S+G+  +E+A G          +   +   N    
Sbjct: 188 GTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246

Query: 151 HIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
                 D ++     +  ++++         C+Q +P  RP+  E+L 
Sbjct: 247 LETGVQDKEMLKKYGKSFRKMISL-------CLQKDPEKRPTAAELLR 287

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 80.1 bits (198), Expect = 7e-18
 Identities = 44/219 (20%), Positives = 78/219 (35%), Gaps = 45/219 (20%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +P GSL  +           ++    +   A  I  G+ YLH       +H D+   N+L
Sbjct: 117 VPLGSLRDYLPR-------HSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVL 166

Query: 61  LDEDFCPKISDFGLAKQ-SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           LD D   KI DFGLAK   +  +           + + APE  C       + SDV+S+G
Sbjct: 167 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE--CLKEYKFYYASDVWSFG 224

Query: 120 MMILEMA-VGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKK---- 174
           + + E+      +          I                    +      EL+++    
Sbjct: 225 VTLYELLTHCDSSQSPPTKFLELIGIAQG--------------QMTVLRLTELLERGERL 270

Query: 175 -----------MILVSLWCIQTNPSDRPSMHEVLEMLES 202
                       ++ + W  +T  S RP+   ++ +L++
Sbjct: 271 PRPDKCPAEVYHLMKNCW--ETEASFRPTFENLIPILKT 307

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 79.7 bits (197), Expect = 9e-18
 Identities = 49/213 (23%), Positives = 85/213 (39%), Gaps = 43/213 (20%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M +G L  F            L  +T+ +    IA G+EYL    +   +H D+   N +
Sbjct: 113 MKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCM 169

Query: 61  LDEDFCPKISDFGLAK--QSQD--KKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDV 115
           L ED    ++DFGL++   S D  ++   S L  +      A E +    +   +  SDV
Sbjct: 170 LAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL----ALESLADNLY---TVHSDV 222

Query: 116 YSYGMMILEMA-------VGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEE 168
           +++G+ + E+         G +NA++              Y ++  GN  +      EE 
Sbjct: 223 WAFGVTMWEIMTRGQTPYAGIENAEI--------------YNYLIGGNRLKQPPECMEEV 268

Query: 169 KELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE 201
            +L+ +       C   +P  RPS   +   LE
Sbjct: 269 YDLMYQ-------CWSADPKQRPSFTCLRMELE 294

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 79.2 bits (196), Expect = 1e-17
 Identities = 42/177 (23%), Positives = 75/177 (42%), Gaps = 42/177 (23%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLH-ARG 92
           + +G+EYLH     +I+H DIKP N+L+ ED   KI+DFG++ + +      ++L    G
Sbjct: 146 LIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD---ALLSNTVG 199

Query: 93  TIGYIAPEVF---CRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP---- 145
           T  ++APE      + F G     DV++ G+ +     G                P    
Sbjct: 200 TPAFMAPESLSETRKIFSGK--ALDVWAMGVTLYCFVFG--------------QCPFMDE 243

Query: 146 --NSIYKHIEPGNDFQL--DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
               ++  I+     +      + E+ K+L+ +M       +  NP  R  + E+  
Sbjct: 244 RIMCLHSKIKSQ-ALEFPDQPDIAEDLKDLITRM-------LDKNPESRIVVPEIKL 292

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 80.4 bits (199), Expect = 1e-17
 Identities = 47/179 (26%), Positives = 80/179 (44%), Gaps = 44/179 (24%)

Query: 34  IARGLEYLH-RGCNVRIVHFDIKPHNILL---DEDFCPKISDFGLAKQSQDKKSTISMLH 89
           I   + + H  G    +VH ++KP N+LL    +    K++DFGLA + + ++       
Sbjct: 119 ILEAVLHCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA--WFG 172

Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP---- 145
             GT GY++PEV  +   G     D+++ G+++  + VG               +P    
Sbjct: 173 FAGTPGYLSPEVLRKDPYG--KPVDLWACGVILYILLVG---------------YPPFWD 215

Query: 146 ---NSIYKHIEPGN-DFQLD--GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
              + +Y+ I+ G  DF       VT E K+L+ KM       +  NPS R +  E L+
Sbjct: 216 EDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKM-------LTINPSKRITAAEALK 267

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 80.8 bits (199), Expect = 1e-17
 Identities = 45/221 (20%), Positives = 72/221 (32%), Gaps = 61/221 (27%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
              G L +F   +        +    V ++   ++ G++YL        VH ++   N+L
Sbjct: 417 AGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVL 468

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISM-LHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L      KISDFGL+K      S  +     +  + + APE    +F   S +SDV+SYG
Sbjct: 469 LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI--NFRKFSSRSDVWSYG 526

Query: 120 MMILEMA-------VGRKNADVKASRSSDIYFPNSIYKHIE-----------PGNDFQLD 161
           + + E            K  +V                 IE           P   + L 
Sbjct: 527 VTMWEALSYGQKPYKKMKGPEV--------------MAFIEQGKRMECPPECPPELYAL- 571

Query: 162 GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES 202
                        M      C      DRP    V + + +
Sbjct: 572 -------------M----SDCWIYKWEDRPDFLTVEQRMRA 595

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 78.8 bits (195), Expect = 1e-17
 Identities = 46/221 (20%), Positives = 72/221 (32%), Gaps = 61/221 (27%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
              G L +F   +        +    V ++   ++ G++YL        VH D+   N+L
Sbjct: 91  AGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVL 142

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISM-LHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L      KISDFGL+K      S  +     +  + + APE    +F   S +SDV+SYG
Sbjct: 143 LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI--NFRKFSSRSDVWSYG 200

Query: 120 MMILEMA-------VGRKNADVKASRSSDIYFPNSIYKHIE-----------PGNDFQLD 161
           + + E            K  +V                 IE           P   + L 
Sbjct: 201 VTMWEALSYGQKPYKKMKGPEV--------------MAFIEQGKRMECPPECPPELYAL- 245

Query: 162 GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES 202
                        M      C      DRP    V + + +
Sbjct: 246 -------------M----SDCWIYKWEDRPDFLTVEQRMRA 269

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 79.8 bits (197), Expect = 1e-17
 Identities = 41/173 (23%), Positives = 75/173 (43%), Gaps = 29/173 (16%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           I   ++YLH   ++ I H D+KP N+L      +   K++DFG AK++       S+   
Sbjct: 170 IGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTP 223

Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRK--NADVKASRSSDIYFPNSI 148
             T  Y+APEV            D++S G+++  +  G     ++   + S        +
Sbjct: 224 CYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG------M 275

Query: 149 YKHIEPGN-DFQLD--GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
              I  G  +F       V+EE K L++ +       ++T P+ R ++ E + 
Sbjct: 276 KTRIRMGQYEFPNPEWSEVSEEVKMLIRNL-------LKTEPTQRMTITEFMN 321

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 79.0 bits (195), Expect = 2e-17
 Identities = 50/219 (22%), Positives = 83/219 (37%), Gaps = 42/219 (19%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +P GSL  +    +    +  L      Q    I +G+EYL      R +H D+   NIL
Sbjct: 126 LPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLGT---KRYIHRDLATRNIL 177

Query: 61  LDEDFCPKISDFGLAKQ-SQDKKSTISMLHARGTIGYIAPEV-FCRSFGGASHKSDVYSY 118
           ++ +   KI DFGL K   QDK+           I + APE      F   S  SDV+S+
Sbjct: 178 VENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF---SVASDVWSF 234

Query: 119 GMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKK---- 174
           G+++ E+           +       P + +  +   +      ++     EL+K     
Sbjct: 235 GVVLYEL----------FTYIEKSKSPPAEFMRMIGNDKQ--GQMIVFHLIELLKNNGRL 282

Query: 175 -----------MILVSLWCIQTNPSDRPSMHEVLEMLES 202
                      MI+   W    N + RPS  ++   ++ 
Sbjct: 283 PRPDGCPDEIYMIMTECW--NNNVNQRPSFRDLALRVDQ 319

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 78.4 bits (194), Expect = 2e-17
 Identities = 47/218 (21%), Positives = 88/218 (40%), Gaps = 56/218 (25%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  G+L  +          + +    +  +A  I+  +EYL +      +H D+   N L
Sbjct: 91  MTYGNLLDYL----RECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCL 143

Query: 61  LDEDFCPKISDFGLAKQSQD---KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYS 117
           + E+   K++DFGL++            +    + T    APE    ++   S KSDV++
Sbjct: 144 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESL--AYNKFSIKSDVWA 197

Query: 118 YGMMILEMAV-------GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEK- 169
           +G+++ E+A        G   + V              Y+ +E    +++       E+ 
Sbjct: 198 FGVLLWEIATYGMSPYPGIDLSQV--------------YELLEKD--YRM-------ERP 234

Query: 170 -----ELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES 202
                ++ + M      C Q NPSDRPS  E+ +  E+
Sbjct: 235 EGCPEKVYELM----RACWQWNPSDRPSFAEIHQAFET 268

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 78.1 bits (193), Expect = 2e-17
 Identities = 46/217 (21%), Positives = 71/217 (32%), Gaps = 52/217 (23%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
            P GSL       +      TL      + A  +A G+ YL      R +H D+   N+L
Sbjct: 102 APLGSLLDRLRKHQGHFLLGTL-----SRYAVQVAEGMGYLES---KRFIHRDLAARNLL 153

Query: 61  LDEDFCPKISDFGLAKQ-SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L      KI DFGL +   Q+    +   H +    + APE         SH SD + +G
Sbjct: 154 LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL--KTRTFSHASDTWMFG 211

Query: 120 MMILEMA-------VGRKNADVKASRSSDIY-------FPNSIYKHIEPGNDFQLDGVVT 165
           + + EM        +G   + +      +          P  IY                
Sbjct: 212 VTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIY---------------- 255

Query: 166 EEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES 202
                     ++V  W     P DRP+   + + L  
Sbjct: 256 ---------NVMVQCW--AHKPEDRPTFVALRDFLLE 281

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 77.6 bits (192), Expect = 3e-17
 Identities = 48/214 (22%), Positives = 81/214 (37%), Gaps = 54/214 (25%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSL  +      S G   L    + + +  +   +EYL        VH D+   N+L
Sbjct: 97  MAKGSLVDYL----RSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVL 149

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + ED   K+SDFGL K++   + T      +  + + APE         S KSDV+S+G+
Sbjct: 150 VSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEAL--REKKFSTKSDVWSFGI 202

Query: 121 MILEMAV-------GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEK---- 169
           ++ E+              DV                 +E G  +++       +     
Sbjct: 203 LLWEIYSFGRVPYPRIPLKDV--------------VPRVEKG--YKM-------DAPDGC 239

Query: 170 --ELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE 201
              + + M      C   + + RPS  ++ E LE
Sbjct: 240 PPAVYEVM----KNCWHLDAAMRPSFLQLREQLE 269

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 78.1 bits (193), Expect = 3e-17
 Identities = 52/238 (21%), Positives = 84/238 (35%), Gaps = 67/238 (28%)

Query: 1   MPNGSLDQF---------TYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVH 51
           M +G L++F                     L    +  +A  +A G+ YL     +  VH
Sbjct: 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVH 181

Query: 52  FDIKPHNILLDEDFCPKISDFGLAK--QSQD--KKSTISMLHARGTIGYIAPEVFC-RSF 106
            D+   N L+ +    KI DFG+++   S D  +    +ML  R       PE    R F
Sbjct: 182 RDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM----PPESILYRKF 237

Query: 107 GGASHKSDVYSYGMMILEMAV-------GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ 159
              + +SDV+S+G+++ E+            N +                  I  G   +
Sbjct: 238 ---TTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA--------------IDCITQGR--E 278

Query: 160 LDGVVTEEEK------ELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPP 211
           L       E+      E+   M      C Q  P  R S+ +V   L+    + Q PP
Sbjct: 279 L-------ERPRACPPEVYAIM----RGCWQREPQQRHSIKDVHARLQ---ALAQAPP 322

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 78.1 bits (193), Expect = 3e-17
 Identities = 37/168 (22%), Positives = 60/168 (35%), Gaps = 35/168 (20%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-KISDFGLAKQSQDKKSTISMLH-AR 91
           +   +++ H      +VH DIK  NIL+D      K+ DFG      D            
Sbjct: 148 VVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD-----EPYTDFD 199

Query: 92  GTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYK 150
           GT  Y  PE      +      + V+S G+++ +M  G                P    +
Sbjct: 200 GTRVYSPPEWISRHQYHAL--PATVWSLGILLYDMVCG--------------DIPFERDQ 243

Query: 151 HIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
            I    +      V+ +   L++        C+   PS RPS+ E+L 
Sbjct: 244 EILEA-ELHFPAHVSPDCCALIR-------RCLAPKPSSRPSLEEILL 283

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 77.7 bits (192), Expect = 3e-17
 Identities = 54/239 (22%), Positives = 87/239 (36%), Gaps = 68/239 (28%)

Query: 1   MPNGSLDQF----------TYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIV 50
           M +G L++F            D +       L    +  IA  IA G+ YL        V
Sbjct: 99  MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFV 155

Query: 51  HFDIKPHNILLDEDFCPKISDFGLAK--QSQD--KKSTISMLHARGTIGYIAPEVFC-RS 105
           H D+   N L+  +   KI DFG+++   S D  +    +ML  R       PE    R 
Sbjct: 156 HRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM----PPESIMYRK 211

Query: 106 FGGASHKSDVYSYGMMILEMAV-------GRKNADVKASRSSDIYFPNSIYKHIEPGNDF 158
           F   + +SDV+S+G+++ E+            N +V               + I  G   
Sbjct: 212 F---TTESDVWSFGVILWEIFTYGKQPWFQLSNTEV--------------IECITQGR-- 252

Query: 159 QLDGVVTEEEK------ELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPP 211
            L       E+      E+   M    L C Q  P  R ++ E+ ++L     + +  P
Sbjct: 253 VL-------ERPRVCPKEVYDVM----LGCWQREPQQRLNIKEIYKILH---ALGKATP 297

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 77.6 bits (192), Expect = 3e-17
 Identities = 52/235 (22%), Positives = 78/235 (33%), Gaps = 75/235 (31%)

Query: 1   MPNGSLDQF----------TYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIV 50
             +G L +F              +       LE      +   IA G+EYL       +V
Sbjct: 94  CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVV 150

Query: 51  HFDIKPHNILLDEDFCPKISDFGLAK--QSQD--KKSTISMLHARGTIGYIAPE-VFCRS 105
           H D+   N+L+ +    KISD GL +   + D  K    S+L  R      APE +    
Sbjct: 151 HKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWM----APEAIMYGK 206

Query: 106 FGGASHKSDVYSYGMMILEMAV-------GRKNADVKASRSSDIYFPNSIYKHIE----- 153
           F   S  SD++SYG+++ E+         G  N DV               + I      
Sbjct: 207 F---SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV--------------VEMIRNRQVL 249

Query: 154 ------PGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES 202
                 P   + L              M    + C    PS RP   ++   L +
Sbjct: 250 PCPDDCPAWVYAL--------------M----IECWNEFPSRRPRFKDIHSRLRA 286

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 78.1 bits (193), Expect = 4e-17
 Identities = 55/227 (24%), Positives = 91/227 (40%), Gaps = 58/227 (25%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NGSLD F    +            +  +  G+  G+ YL     +  VH D+   N+L
Sbjct: 132 MENGSLDTFLRTHD-----GQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVL 183

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGT---IGYIAPEVFCRSFGGASHKSDVYS 117
           +D +   K+SDFGL++  +D           G    I + APE    +F   S  SDV+S
Sbjct: 184 VDSNLVCKVSDFGLSRVLEDDPDAAYT--TTGGKIPIRWTAPEAI--AFRTFSSASDVWS 239

Query: 118 YGMMILE-MAVGRK------NADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEK- 169
           +G+++ E +A G +      N DV                 +E G  ++L          
Sbjct: 240 FGVVMWEVLAYGERPYWNMTNRDV--------------ISSVEEG--YRL-------PAP 276

Query: 170 -----ELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES---STEILQ 208
                 L + M    L C   + + RP   +++ +L++   S E L+
Sbjct: 277 MGCPHALHQLM----LDCWHKDRAQRPRFSQIVSVLDALIRSPESLR 319

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 78.0 bits (193), Expect = 4e-17
 Identities = 41/163 (25%), Positives = 71/163 (43%), Gaps = 33/163 (20%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS---TISMLHA 90
           I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK    +       S +  
Sbjct: 139 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-- 193

Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR---KNADVKASRSSDIYFPNS 147
            GT  Y++PE+       A   SD+++ G +I ++  G    +  +              
Sbjct: 194 -GTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGN-----------EYL 239

Query: 148 IYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDR 190
           I++ I    ++        + ++LV+K+       +  + + R
Sbjct: 240 IFQKIIKL-EYDFPEKFFPKARDLVEKL-------LVLDATKR 274

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 77.7 bits (192), Expect = 4e-17
 Identities = 50/167 (29%), Positives = 87/167 (52%), Gaps = 30/167 (17%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ---SQDKKSTISMLHARG 92
           +GL+YLH   + + +H DIK  N+LL E    K++DFG+A Q   +Q K++T       G
Sbjct: 130 KGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-----G 181

Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRK-NADVKASRSSDIYFPNSIYKH 151
           T  ++APEV  +       K+D++S G+  +E+A G   ++++   +   ++    I K+
Sbjct: 182 TPFWMAPEVIKQ--SAYDSKADIWSLGITAIELARGEPPHSELHPMKV--LFL---IPKN 234

Query: 152 IEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
             P     L+G  ++  KE V+        C+   PS RP+  E+L+
Sbjct: 235 NPP----TLEGNYSKPLKEFVEA-------CLNKEPSFRPTAKELLK 270

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 79.1 bits (195), Expect = 4e-17
 Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 9/97 (9%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHAR-G 92
           I  GLE+LH+     I++ D+KP N+LLD+D   +ISD GLA + +  ++         G
Sbjct: 298 IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT---KGYAG 351

Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T G++APE+            D ++ G+ + EM   R
Sbjct: 352 TPGFMAPELLLGE--EYDFSVDYFALGVTLYEMIAAR 386

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 78.1 bits (193), Expect = 4e-17
 Identities = 39/173 (22%), Positives = 75/173 (43%), Gaps = 39/173 (22%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHAR-G 92
           I   ++Y H+     IVH D+K  N+LLD D   KI+DFG + +          L A  G
Sbjct: 123 IVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG----KLDAFCG 175

Query: 93  TIGYIAPEVFC-RSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP------ 145
              Y APE+F  + + G   + DV+S G+++  +  G                P      
Sbjct: 176 APPYAAPELFQGKKYDGP--EVDVWSLGVILYTLVSG--------------SLPFDGQNL 219

Query: 146 NSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
             + + +  G  +++   ++ + + L+K+        +  NP  R ++ ++++
Sbjct: 220 KELRERVLRG-KYRIPFYMSTDCENLLKRF-------LVLNPIKRGTLEQIMK 264

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 77.7 bits (192), Expect = 5e-17
 Identities = 52/221 (23%), Positives = 84/221 (38%), Gaps = 47/221 (21%)

Query: 1   MPNGSLDQF----TYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKP 56
           M  G L  +         ++          + Q+AG IA G+ YL+     + VH D+  
Sbjct: 110 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAA 166

Query: 57  HNILLDEDFCPKISDFGLAK--QSQD--KKSTISMLHARGTIGYIAPEVFC-RSFGGASH 111
            N ++ EDF  KI DFG+ +     D  +K    +L  R      +PE      F   + 
Sbjct: 167 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM----SPESLKDGVF---TT 219

Query: 112 KSDVYSYGMMILEMAV-------GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVV 164
            SDV+S+G+++ E+A        G  N  V               + +  G         
Sbjct: 220 YSDVWSFGVVLWEIATLAEQPYQGLSNEQV--------------LRFVMEGGLLDKPDNC 265

Query: 165 TEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTE 205
            +   EL++        C Q NP  RPS  E++  ++   E
Sbjct: 266 PDMLFELMRM-------CWQYNPKMRPSFLEIISSIKEEME 299

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 78.4 bits (193), Expect = 5e-17
 Identities = 38/192 (19%), Positives = 73/192 (38%), Gaps = 29/192 (15%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILL----DEDFCPKISDFGLAKQSQDKKSTISMLH 89
           +  G+ +L       IVH +IKP NI+     D     K++DFG A++ +D +  +S+  
Sbjct: 121 VVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY- 176

Query: 90  ARGTIGYIAPEVFCRSFGGASH------KSDVYSYGMMILEMAVG----------RKNAD 133
             GT  Y+ P+++ R+     H        D++S G+     A G          R+N +
Sbjct: 177 --GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234

Query: 134 V--KASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSL-WCIQTNPSDR 190
           V  K          + + K      D+  D  V+      ++ ++   L   ++ +    
Sbjct: 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKC 294

Query: 191 PSMHEVLEMLES 202
               +       
Sbjct: 295 WGFDQFFAETSD 306

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 76.9 bits (190), Expect = 6e-17
 Identities = 46/220 (20%), Positives = 77/220 (35%), Gaps = 61/220 (27%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
            P G L  +    +      +L+  T+   +  I + + YL     +  VH DI   NIL
Sbjct: 94  YPYGELGHYLERNK-----NSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNIL 145

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           +    C K+ DFGL++  +D +        R  I +++PE    +F   +  SDV+ + +
Sbjct: 146 VASPECVKLGDFGLSRYIED-EDYYKASVTRLPIKWMSPESI--NFRRFTTASDVWMFAV 202

Query: 121 MILEMA-------VGRKNADVKASRSSDIYFPNSIYKHIE-----------PGNDFQLDG 162
            + E+           +N DV                 +E           P   + L  
Sbjct: 203 CMWEILSFGKQPFFWLENKDV--------------IGVLEKGDRLPKPDLCPPVLYTL-- 246

Query: 163 VVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES 202
                       M      C   +PSDRP   E++  L  
Sbjct: 247 ------------M----TRCWDYDPSDRPRFTELVCSLSD 270

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 78.7 bits (194), Expect = 6e-17
 Identities = 51/216 (23%), Positives = 79/216 (36%), Gaps = 53/216 (24%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
              G L  F   ++ S     L+  ++   A  ++  L YL      R VH DI   N+L
Sbjct: 472 CTLGELRSFLQVRKFS-----LDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVL 523

Query: 61  LDEDFCPKISDFGLAKQSQDK---KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYS 117
           +  + C K+ DFGL++  +D    K++   L  +      APE    +F   +  SDV+ 
Sbjct: 524 VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESI--NFRRFTSASDVWM 577

Query: 118 YGMMILEMA-------VGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEE--- 167
           +G+ + E+         G KN DV                 IE       +G        
Sbjct: 578 FGVCMWEILMHGVKPFQGVKNNDV--------------IGRIE-------NGERLPMPPN 616

Query: 168 -EKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES 202
               L   M      C   +PS RP   E+   L +
Sbjct: 617 CPPTLYSLM----TKCWAYDPSRRPRFTELKAQLST 648

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 76.1 bits (188), Expect = 9e-17
 Identities = 44/215 (20%), Positives = 84/215 (39%), Gaps = 51/215 (23%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           + NG L  +          + LE   + ++   +  G+ +L      + +H D+   N L
Sbjct: 85  ISNGCLLNYLRSHG-----KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCL 136

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           +D D C K+SDFG+ +   D +   S+   +  + + APEVF   +   S KSDV+++G+
Sbjct: 137 VDRDLCVKVSDFGMTRYVLDDQYVSSV-GTKFPVKWSAPEVF--HYFKYSSKSDVWAFGI 193

Query: 121 MILEMAV-------GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEK---- 169
           ++ E+            N++V                 +  G   +L        +    
Sbjct: 194 LMWEVFSLGKMPYDLYTNSEV--------------VLKVSQG--HRL-------YRPHLA 230

Query: 170 --ELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES 202
              + + M      C    P  RP+  ++L  +E 
Sbjct: 231 SDTIYQIM----YSCWHELPEKRPTFQQLLSSIEP 261

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 76.9 bits (190), Expect = 1e-16
 Identities = 43/227 (18%), Positives = 90/227 (39%), Gaps = 48/227 (21%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILL----DEDFCPKISDFGLAKQSQDKKSTISMLH 89
           I  G+ YLH   +++I HFD+KP NI+L          KI DFGLA +        ++  
Sbjct: 123 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF- 178

Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP---- 145
             GT  ++APE+          ++D++S G++   +  G                P    
Sbjct: 179 --GTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSG--------------ASPFLGD 220

Query: 146 --NSIYKHIEPGN-DFQLD--GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE-- 198
                  ++   N +F+ +     +   K+ ++++++        +P  R ++ + L+  
Sbjct: 221 TKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK-------DPKKRMTIQDSLQHP 273

Query: 199 ---MLESSTEILQIPPKPSLALPKKSAIQS-SRTSSSAGIEEVMGEM 241
                ++   + +     ++   KK A +  S   S  G+ ++    
Sbjct: 274 WIKPKDTQQALSRKASAVNMEKFKKFAARKKSNNGSGGGLNDIFEAQ 320

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 77.4 bits (191), Expect = 1e-16
 Identities = 38/167 (22%), Positives = 65/167 (38%), Gaps = 35/167 (20%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +   L+ +H   ++  +H D+KP N+LLD+    K++DFG   +   +        A GT
Sbjct: 177 VVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGT 232

Query: 94  IGYIAPEVFCRSFGGASHKSDV--YSYGMMILEMAVGR-----KNADVKASRSSDIYFPN 146
             YI+PEV     G   +  +   +S G+ + EM VG       +               
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-------------LV 279

Query: 147 SIYKHIEPGND---FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDR 190
             Y  I    +   F  D  +++E K L+   +        T+   R
Sbjct: 280 GTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL--------TDREVR 318

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 76.5 bits (189), Expect = 1e-16
 Identities = 53/227 (23%), Positives = 93/227 (40%), Gaps = 64/227 (28%)

Query: 1   MPNGSLDQF----------TYDQESSNGNRTLEWRTVYQIAGGIARGLEYL-HRGCNVRI 49
            P+G+L  F               +++   TL  + +   A  +ARG++YL  +      
Sbjct: 108 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF---- 163

Query: 50  VHFDIKPHNILLDEDFCPKISDFGLAKQSQD-KKSTISMLHARGTIGYIAPE-VFCRSFG 107
           +H D+   NIL+ E++  KI+DFGL++  +   K T+  L  R      A E +    + 
Sbjct: 164 IHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM----AIESLNYSVY- 218

Query: 108 GASHKSDVYSYGMMILEMAV-------GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL 160
             +  SDV+SYG+++ E+         G   A++              Y+ +  G  ++L
Sbjct: 219 --TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--------------YEKLPQG--YRL 260

Query: 161 DGVVTEEEK------ELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE 201
                  EK      E+   M      C +  P +RPS  ++L  L 
Sbjct: 261 -------EKPLNCDDEVYDLM----RQCWREKPYERPSFAQILVSLN 296

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 75.7 bits (187), Expect = 1e-16
 Identities = 52/215 (24%), Positives = 85/215 (39%), Gaps = 51/215 (23%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M +G L  +   Q       TL       +   +  G+ YL       ++H D+   N L
Sbjct: 85  MEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYLEE---ACVIHRDLAARNCL 136

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + E+   K+SDFG+ +   D + T S    +  + + +PEVF  SF   S KSDV+S+G+
Sbjct: 137 VGENQVIKVSDFGMTRFVLDDQYTSST-GTKFPVKWASPEVF--SFSRYSSKSDVWSFGV 193

Query: 121 MILEMAV-------GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEK---- 169
           ++ E+          R N++V               + I  G  F+L        K    
Sbjct: 194 LMWEVFSEGKIPYENRSNSEV--------------VEDISTG--FRL-------YKPRLA 230

Query: 170 --ELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES 202
              + + M      C +  P DRP+   +L  L  
Sbjct: 231 STHVYQIM----NHCWRERPEDRPAFSRLLRQLAE 261

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 77.4 bits (190), Expect = 1e-16
 Identities = 35/181 (19%), Positives = 67/181 (37%), Gaps = 29/181 (16%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLD---EDFCPKISDFGLAKQSQDKKSTISMLHA 90
           I+  L YLH     RI+H D+KP NI+L    +    KI D G AK+         +   
Sbjct: 130 ISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG----ELCTE 182

Query: 91  R-GTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVGR-----------KNADVKAS 137
             GT+ Y+APE+   + +       D +S+G +  E   G             +  V+  
Sbjct: 183 FVGTLQYLAPELLEQKKYT---VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREK 239

Query: 138 RSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVL 197
            +  I   + +   ++  +       ++      +++ +   L     +   R +  +  
Sbjct: 240 SNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCML---MWHQRQRGTDPQNP 296

Query: 198 E 198
            
Sbjct: 297 N 297

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 75.8 bits (187), Expect = 2e-16
 Identities = 45/221 (20%), Positives = 81/221 (36%), Gaps = 62/221 (28%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
              G L+++         NR ++ + + ++   ++ G++YL        VH D+   N+L
Sbjct: 99  AELGPLNKYLQQ------NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVL 149

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISM-LHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L      KISDFGL+K  +  ++      H +  + + APE    ++   S KSDV+S+G
Sbjct: 150 LVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--NYYKFSSKSDVWSFG 207

Query: 120 MMILEMA-------VGRKNADVKASRSSDIYFPNSIYKHIE-----------PGNDFQLD 161
           +++ E          G K ++V                 +E           P   + L 
Sbjct: 208 VLMWEAFSYGQKPYRGMKGSEV--------------TAMLEKGERMGCPAGCPREMYDL- 252

Query: 162 GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES 202
                        M      C   +  +RP    V   L +
Sbjct: 253 -------------M----NLCWTYDVENRPGFAAVELRLRN 276

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 76.1 bits (188), Expect = 2e-16
 Identities = 39/177 (22%), Positives = 69/177 (38%), Gaps = 41/177 (23%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           I  G+ YLH      IVH D+KP NILL         KI DFG++++         ++  
Sbjct: 140 ILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM-- 194

Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP----- 145
            GT  Y+APE+        +  +D+++ G++   +                   P     
Sbjct: 195 -GTPEYLAPEILNYD--PITTATDMWNIGIIAYMLLTH--------------TSPFVGED 237

Query: 146 -NSIYKHIEPGN-DFQLD--GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
               Y +I   N D+  +    V++   + ++ +++        NP  RP+    L 
Sbjct: 238 NQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVK-------NPEKRPTAEICLS 287

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 75.8 bits (187), Expect = 2e-16
 Identities = 50/232 (21%), Positives = 88/232 (37%), Gaps = 60/232 (25%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M +G L QF    +     R    + +      +ARG+EYL      + VH D+   N +
Sbjct: 105 MCHGDLLQFIRSPQ-----RNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCM 156

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGT--IGYIAPE-VFCRSFGGASHKSDVYS 117
           LDE F  K++DFGLA+   D++      H      + + A E +    F   + KSDV+S
Sbjct: 157 LDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRF---TTKSDVWS 213

Query: 118 YGMMILEMAV-------GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEK- 169
           +G+++ E+              D+                 +  G   +L        + 
Sbjct: 214 FGVLLWELLTRGAPPYRHIDPFDL--------------THFLAQGR--RL-------PQP 250

Query: 170 -----ELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE------SSTEILQIP 210
                 L + M      C + +P+ RP+   ++  +E           +Q+P
Sbjct: 251 EYCPDSLYQVM----QQCWEADPAVRPTFRVLVGEVEQIVSALLGDHYVQLP 298

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 75.3 bits (186), Expect = 2e-16
 Identities = 40/214 (18%), Positives = 79/214 (36%), Gaps = 49/214 (22%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NG L  +  +          + + + ++   +   +EYL      + +H D+   N L
Sbjct: 101 MANGCLLNYLREMR-----HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCL 152

Query: 61  LDEDFCPKISDFGLAKQSQD---KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYS 117
           +++    K+SDFGL++   D     S  S    R +     PEV    +   S KSD+++
Sbjct: 153 VNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVL--MYSKFSSKSDIWA 206

Query: 118 YGMMILEMAV-------GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEE-- 168
           +G+++ E+            N++                +HI  G   +L          
Sbjct: 207 FGVLMWEIYSLGKMPYERFTNSET--------------AEHIAQG--LRLY---RPHLAS 247

Query: 169 KELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES 202
           +++   M      C      +RP+   +L  +  
Sbjct: 248 EKVYTIM----YSCWHEKADERPTFKILLSNILD 277

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 75.3 bits (186), Expect = 2e-16
 Identities = 40/178 (22%), Positives = 74/178 (41%), Gaps = 42/178 (23%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILL----DEDFCPKISDFGLAKQSQDKKSTISMLH 89
           I  G+ YLH     RI HFD+KP NI+L      +   K+ DFG+A + +      ++  
Sbjct: 117 ILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF- 172

Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP---- 145
             GT  ++APE+          ++D++S G++   +  G                P    
Sbjct: 173 --GTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSG--------------ASPFLGE 214

Query: 146 --NSIYKHIEPGN-DFQLD--GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
                  +I   N DF  +     +E  K+ ++++++        +P  R ++ + LE
Sbjct: 215 TKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVK-------DPKRRMTIAQSLE 265

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 75.5 bits (186), Expect = 3e-16
 Identities = 52/177 (29%), Positives = 90/177 (50%), Gaps = 31/177 (17%)

Query: 29  QIAG---GIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ---SQDKK 82
           +IA       +GLEYLH    +R +H DIK  NILL+ +   K++DFG+A Q   +  K+
Sbjct: 126 EIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR 182

Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRK-NADVKASRSSD 141
           +T+      GT  ++APEV      G +  +D++S G+  +EMA G+   AD+   R+  
Sbjct: 183 NTVI-----GTPFWMAPEVIQEI--GYNCVADIWSLGITAIEMAEGKPPYADIHPMRA-- 233

Query: 142 IYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
           I+    I  +  P   F+   + ++   + VK+       C+  +P  R +  ++L+
Sbjct: 234 IFM---IPTNPPP--TFRKPELWSDNFTDFVKQ-------CLVKSPEQRATATQLLQ 278

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 75.9 bits (187), Expect = 3e-16
 Identities = 44/168 (26%), Positives = 71/168 (42%), Gaps = 27/168 (16%)

Query: 37  GLEYLHRGCNVRIVHFDIKPHNILLDEDFCP--KISDFGLAKQSQDKKSTISMLHAR-GT 93
           G+ Y H    ++I H D+K  N LLD    P  KI DFG +K S       S   +  GT
Sbjct: 128 GVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH----SQPKSTVGT 180

Query: 94  IGYIAPEVFC-RSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHI 152
             YIAPEV   + + G    +DV+S G+ +  M VG    +       +        + I
Sbjct: 181 PAYIAPEVLLRQEYDGK--IADVWSCGVTLYVMLVGAYPFE----DPEEPRDYRKTIQRI 234

Query: 153 EPGNDFQL--DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
                + +  D  ++ E   L+ ++ +        +P+ R S+ E+  
Sbjct: 235 LSV-KYSIPDDIRISPECCHLISRIFVA-------DPATRISIPEIKT 274

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 75.9 bits (187), Expect = 3e-16
 Identities = 50/223 (22%), Positives = 94/223 (42%), Gaps = 53/223 (23%)

Query: 1   MPNGSLDQF----------TYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIV 50
              G+L ++               +      + ++ +      +ARG+EYL    + + +
Sbjct: 169 ASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCI 225

Query: 51  HFDIKPHNILLDEDFCPKISDFGLAK--QSQD--KKSTISMLHARGTIGYIAPE-VFCRS 105
           H D+   N+L+ E+   KI+DFGLA+   + D  KK+T   L  +      APE +F R 
Sbjct: 226 HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM----APEALFDRV 281

Query: 106 FGGASHKSDVYSYGMMILEMAV-------GRKNADVKASRSSDIYFPNSIYKHIEPGNDF 158
           +   +H+SDV+S+G+++ E+         G    ++              +K ++ G+  
Sbjct: 282 Y---THQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL--------------FKLLKEGHRM 324

Query: 159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE 201
                 T E   +   M      C    PS RP+  +++E L+
Sbjct: 325 DKPANCTNELYMM---M----RDCWHAVPSQRPTFKQLVEDLD 360

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 75.4 bits (186), Expect = 4e-16
 Identities = 53/234 (22%), Positives = 81/234 (34%), Gaps = 50/234 (21%)

Query: 1   MPNGSLDQFTYDQESSNGN-RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           M  G L  F  +         +L    +  +A  IA G +YL        +H DI   N 
Sbjct: 115 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNC 171

Query: 60  LLD---EDFCPKISDFGLAK--QSQD--KKSTISMLHARGTIGYIAPEVFC-RSFGGASH 111
           LL         KI DFG+A+        +K   +ML  +       PE F    F   + 
Sbjct: 172 LLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM----PPEAFMEGIF---TS 224

Query: 112 KSDVYSYGMMILEMAV-------GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVV 164
           K+D +S+G+++ E+          + N +V               + +  G         
Sbjct: 225 KTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------LEFVTSGGRMDPPKNC 270

Query: 165 TEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSLALP 218
                 +   M      C Q  P DRP+   +LE +E      Q P   + ALP
Sbjct: 271 PGPVYRI---M----TQCWQHQPEDRPNFAIILERIE---YCTQDPDVINTALP 314

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 75.4 bits (186), Expect = 4e-16
 Identities = 40/178 (22%), Positives = 72/178 (40%), Gaps = 42/178 (23%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCP-KISDFGLAKQSQDKKSTISMLH 89
           I  G+ YLH     +I HFD+KP NI+L   +      K+ DFGLA + +D     ++  
Sbjct: 124 ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF- 179

Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP---- 145
             GT  ++APE+          ++D++S G++   +  G                P    
Sbjct: 180 --GTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSG--------------ASPFLGD 221

Query: 146 --NSIYKHIEPGN-DFQLD--GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
                  +I   + DF  +     +E  K+ ++K+++            R ++ E L 
Sbjct: 222 TKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVK-------ETRKRLTIQEALR 272

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 75.1 bits (185), Expect = 4e-16
 Identities = 38/172 (22%), Positives = 64/172 (37%), Gaps = 43/172 (25%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-KISDFGLAKQSQDKKSTISMLHAR- 91
           +   + + H      ++H DIK  NIL+D +    K+ DFG     +D     ++     
Sbjct: 158 VLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-----TVYTDFD 209

Query: 92  GTIGYIAPEVF-CRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP----N 146
           GT  Y  PE      + G    + V+S G+++ +M  G                P     
Sbjct: 210 GTRVYSPPEWIRYHRYHGR--SAAVWSLGILLYDMVCG--------------DIPFEHDE 253

Query: 147 SIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
            I +             V+ E + L++       WC+   PSDRP+  E+  
Sbjct: 254 EIIRG-----QVFFRQRVSSECQHLIR-------WCLALRPSDRPTFEEIQN 293

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 74.2 bits (183), Expect = 5e-16
 Identities = 44/173 (25%), Positives = 73/173 (42%), Gaps = 39/173 (22%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHAR-G 92
           I   ++Y HR     +VH D+KP N+LLD     KI+DFGL+    D +     L    G
Sbjct: 120 ILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE----FLRTSCG 172

Query: 93  TIGYIAPEVFC-RSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP------ 145
           +  Y APEV   R + G   + D++S G+++  +  G                P      
Sbjct: 173 SPNYAAPEVISGRLYAGP--EVDIWSCGVILYALLCG--------------TLPFDDEHV 216

Query: 146 NSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
            +++K I  G  F +   +      L+  M       +Q +P  R ++ ++ E
Sbjct: 217 PTLFKKIRGG-VFYIPEYLNRSVATLLMHM-------LQVDPLKRATIKDIRE 261

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 75.1 bits (185), Expect = 5e-16
 Identities = 41/178 (23%), Positives = 73/178 (41%), Gaps = 42/178 (23%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP----KISDFGLAKQSQDKKSTISMLH 89
           I  G+ YLH     +I HFD+KP NI+L +   P    K+ DFGLA + +D     ++  
Sbjct: 124 ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF- 179

Query: 90  ARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP---- 145
             GT  ++APE+          ++D++S G++   +  G                P    
Sbjct: 180 --GTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSG--------------ASPFLGD 221

Query: 146 --NSIYKHIEPGN-DFQLD--GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
                  +I   + DF  +     +E  K+ ++K+++            R ++ E L 
Sbjct: 222 TKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVK-------ETRKRLTIQEALR 272

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 75.1 bits (185), Expect = 6e-16
 Identities = 40/167 (23%), Positives = 71/167 (42%), Gaps = 31/167 (18%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I   ++ +H    +  VH DIKP NILLD     +++DFG   + +   +  S++ A GT
Sbjct: 171 IVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV-AVGT 226

Query: 94  IGYIAPEVFCRSFGGASHKS-----DVYSYGMMILEMAVGR-----KNADVKASRSSDIY 143
             Y++PE+     GG    S     D ++ G+   EM  G+      +         + Y
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA-------ETY 279

Query: 144 FPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDR 190
               I  + E  +   +D  V EE ++ +++++          P  R
Sbjct: 280 --GKIVHYKEHLSLPLVDEGVPEEARDFIQRLL--------CPPETR 316

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 74.3 bits (183), Expect = 9e-16
 Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 13/96 (13%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ---SQDKKSTISMLHARG 92
           + L YLH      ++H DIK  +ILL  D   K+SDFG   Q      K+ ++      G
Sbjct: 152 QALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-----G 203

Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T  ++APEV  RS    + + D++S G+M++EM  G
Sbjct: 204 TPYWMAPEVISRS--LYATEVDIWSLGIMVIEMVDG 237

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 73.8 bits (182), Expect = 1e-15
 Identities = 47/221 (21%), Positives = 83/221 (37%), Gaps = 62/221 (28%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M +G L  F  ++           + +      +A+G++YL    + + VH D+   N +
Sbjct: 109 MKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCM 160

Query: 61  LDEDFCPKISDFGLAKQSQDK------KSTISMLHARGTIGYIAPE-VFCRSFGGASHKS 113
           LDE F  K++DFGLA+   DK        T + L  +      A E +  + F   + KS
Sbjct: 161 LDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM----ALESLQTQKF---TTKS 213

Query: 114 DVYSYGMMILEMAV-------GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTE 166
           DV+S+G+++ E+              D+                ++  G   +L      
Sbjct: 214 DVWSFGVLLWELMTRGAPPYPDVNTFDI--------------TVYLLQGR--RL------ 251

Query: 167 EEK------ELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE 201
             +       L + M    L C       RPS  E++  + 
Sbjct: 252 -LQPEYCPDPLYEVM----LKCWHPKAEMRPSFSELVSRIS 287

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 74.2 bits (183), Expect = 1e-15
 Identities = 40/165 (24%), Positives = 74/165 (44%), Gaps = 36/165 (21%)

Query: 31  AGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           A  I    EYLH   ++ +++ D+KP N+L+D+    +++DFG AK+ + +  T+     
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC---- 199

Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR-----KNADVKASRSSDIYFP 145
            GT   +APE+      G +   D ++ G++I EMA G                     P
Sbjct: 200 -GTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQ-------------P 243

Query: 146 NSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDR 190
             IY+ I  G   +     + + K+L++ +       +Q + + R
Sbjct: 244 IQIYEKIVSG-KVRFPSHFSSDLKDLLRNL-------LQVDLTKR 280

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 74.0 bits (182), Expect = 1e-15
 Identities = 43/211 (20%), Positives = 84/211 (39%), Gaps = 42/211 (19%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M +G L  F  ++           + +      +A+G+++L    + + VH D+   N +
Sbjct: 173 MKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCM 224

Query: 61  LDEDFCPKISDFGLAK--QSQDKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYS 117
           LDE F  K++DFGLA+    ++  S  +   A+  + ++A E +  + F   + KSDV+S
Sbjct: 225 LDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF---TTKSDVWS 281

Query: 118 YGMMILEMAV-------GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKE 170
           +G+++ E+              D+                ++  G          +   E
Sbjct: 282 FGVLLWELMTRGAPPYPDVNTFDI--------------TVYLLQGRRLLQPEYCPDPLYE 327

Query: 171 LVKKMILVSLWCIQTNPSDRPSMHEVLEMLE 201
           +   M    L C       RPS  E++  + 
Sbjct: 328 V---M----LKCWHPKAEMRPSFSELVSRIS 351

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 74.0 bits (182), Expect = 1e-15
 Identities = 46/183 (25%), Positives = 85/183 (46%), Gaps = 39/183 (21%)

Query: 29  QIA---GGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ---SQDKK 82
            IA     I RGL +LH     +++H DIK  N+LL E+   K+ DFG++ Q   +  ++
Sbjct: 130 WIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 186

Query: 83  STISMLHARGTIGYIAPEVFCRSFGGAS---HKSDVYSYGMMILEMAVGRK-NADVKASR 138
           +T       GT  ++APEV        +    KSD++S G+  +EMA G     D+   R
Sbjct: 187 NTFI-----GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR 241

Query: 139 SSDIYFPNSIYKHIEP---GNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHE 195
           +  ++    I ++  P      +      +++ +  ++        C+  N S RP+  +
Sbjct: 242 A--LFL---IPRNPAPRLKSKKW------SKKFQSFIES-------CLVKNHSQRPATEQ 283

Query: 196 VLE 198
           +++
Sbjct: 284 LMK 286

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 73.7 bits (182), Expect = 1e-15
 Identities = 47/162 (29%), Positives = 70/162 (43%), Gaps = 36/162 (22%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +   LEYLH   +  I++ D+KP NILLD++   KI+DFG AK   D   T+      GT
Sbjct: 115 VCLALEYLH-SKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GT 166

Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR-----KNADVKASRSSDIYFPNSI 148
             YIAPEV        +   D +S+G++I EM  G       N                 
Sbjct: 167 PDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSN-------------TMKT 211

Query: 149 YKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDR 190
           Y+ I    + +      E+ K+L+ ++       I  + S R
Sbjct: 212 YEKILNA-ELRFPPFFNEDVKDLLSRL-------ITRDLSQR 245

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 73.9 bits (182), Expect = 1e-15
 Identities = 50/223 (22%), Positives = 94/223 (42%), Gaps = 53/223 (23%)

Query: 1   MPNGSLDQF----------TYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIV 50
              G+L ++               +      + ++ +      +ARG+EYL    + + +
Sbjct: 123 ASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCI 179

Query: 51  HFDIKPHNILLDEDFCPKISDFGLAK--QSQD--KKSTISMLHARGTIGYIAPE-VFCRS 105
           H D+   N+L+ E+   KI+DFGLA+   + D  KK+T   L  +      APE +F R 
Sbjct: 180 HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM----APEALFDRV 235

Query: 106 FGGASHKSDVYSYGMMILEMAV-------GRKNADVKASRSSDIYFPNSIYKHIEPGNDF 158
           +   +H+SDV+S+G+++ E+         G    ++              +K ++ G+  
Sbjct: 236 Y---THQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL--------------FKLLKEGHRM 278

Query: 159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE 201
                 T E   +   M      C    PS RP+  +++E L+
Sbjct: 279 DKPANCTNELYMM---M----RDCWHAVPSQRPTFKQLVEDLD 314

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 73.1 bits (180), Expect = 1e-15
 Identities = 37/96 (38%), Positives = 53/96 (55%), Gaps = 13/96 (13%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ---SQDKKSTISMLHARG 92
           + LE+LH   + +++H DIK  NILL  D   K++DFG   Q    Q K+ST+      G
Sbjct: 127 QALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----G 178

Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           T  ++APEV  R       K D++S G+M +EM  G
Sbjct: 179 TPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEG 212

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 74.0 bits (182), Expect = 2e-15
 Identities = 53/234 (22%), Positives = 81/234 (34%), Gaps = 50/234 (21%)

Query: 1   MPNGSLDQFTYDQESSNGN-RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNI 59
           M  G L  F  +         +L    +  +A  IA G +YL        +H DI   N 
Sbjct: 156 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNC 212

Query: 60  LLD---EDFCPKISDFGLAK--QSQD--KKSTISMLHARGTIGYIAPEVFC-RSFGGASH 111
           LL         KI DFG+A+        +K   +ML  +       PE F    F   + 
Sbjct: 213 LLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM----PPEAFMEGIF---TS 265

Query: 112 KSDVYSYGMMILEMAV-------GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVV 164
           K+D +S+G+++ E+          + N +V               + +  G         
Sbjct: 266 KTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------LEFVTSGGRMDPPKNC 311

Query: 165 TEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSLALP 218
                 +   M      C Q  P DRP+   +LE +E      Q P   + ALP
Sbjct: 312 PGPVYRI---M----TQCWQHQPEDRPNFAIILERIE---YCTQDPDVINTALP 355

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 74.0 bits (182), Expect = 2e-15
 Identities = 38/174 (21%), Positives = 69/174 (39%), Gaps = 36/174 (20%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILL--DEDFCPKISDFGLAKQSQDKKSTISMLHAR 91
              GL+++H      IVH DIKP NI+    +    KI DFGLA +    +         
Sbjct: 158 ACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--- 211

Query: 92  GTIGYIAPEVFCRSFGGASHKSDVYSYGMM--ILEMAV----GRKNADV-KASRSSDIYF 144
            T  + APE+  R        +D+++ G++  +L   +    G  + +  +  +  D  F
Sbjct: 212 ATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF 269

Query: 145 PNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
               +  +            + E K+ +K ++          P  R ++H+ LE
Sbjct: 270 DEDAFSSV------------SPEAKDFIKNLLQK-------EPRKRLTVHDALE 304

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 73.2 bits (180), Expect = 2e-15
 Identities = 45/166 (27%), Positives = 73/166 (43%), Gaps = 28/166 (16%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIG 95
           +GL YLH   +  ++H D+K  NILL E    K+ DFG A       S +      GT  
Sbjct: 165 QGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPY 215

Query: 96  YIAPEV-FCRSFGGASHKSDVYSYGMMILEMAVGRK-NADVKASRSSDIYF-PNSIYKHI 152
           ++APEV      G    K DV+S G+  +E+A  +    ++ A  +  +Y    +    +
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQNESPAL 273

Query: 153 EPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
           + G+        +E  +  V         C+Q  P DRP+   +L+
Sbjct: 274 QSGH-------WSEYFRNFVDS-------CLQKIPQDRPTSEVLLK 305

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 72.7 bits (179), Expect = 3e-15
 Identities = 45/173 (26%), Positives = 77/173 (44%), Gaps = 39/173 (22%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHAR-G 92
           I   +EY HR    +IVH D+KP N+LLD++   KI+DFGL+    D       L    G
Sbjct: 117 IICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN----FLKTSCG 169

Query: 93  TIGYIAPEVFC-RSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP------ 145
           +  Y APEV   + + G   + DV+S G+++  M VG                P      
Sbjct: 170 SPNYAAPEVINGKLYAGP--EVDVWSCGIVLYVMLVG--------------RLPFDDEFI 213

Query: 146 NSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
            +++K +     + +   ++   + L+++M       I  +P  R ++ E+  
Sbjct: 214 PNLFKKVNSC-VYVMPDFLSPGAQSLIRRM-------IVADPMQRITIQEIRR 258

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 73.1 bits (179), Expect = 3e-15
 Identities = 22/136 (16%), Positives = 41/136 (30%), Gaps = 16/136 (11%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-----------KISDFGLAKQSQDKK 82
           +   +E +H   +  I+H DIKP N +L   F              + D G +   +   
Sbjct: 181 MLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237

Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDI 142
                     T G+   E+        +++ D +     +  M  G              
Sbjct: 238 KGTIFTAKCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKP 295

Query: 143 YFPNSIYKHIEPGNDF 158
                   H++  N+F
Sbjct: 296 EGLFRRLPHLDMWNEF 311

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 72.7 bits (179), Expect = 3e-15
 Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 8/98 (8%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ--SQDKKSTISMLHAR 91
           I   LE+LH    + I++ DIK  NILLD +    ++DFGL+K+  + + +         
Sbjct: 168 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC--- 221

Query: 92  GTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           GTI Y+AP++      G     D +S G+++ E+  G 
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 72.2 bits (178), Expect = 4e-15
 Identities = 38/97 (39%), Positives = 61/97 (62%), Gaps = 9/97 (9%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS-QDKKSTISMLHARG 92
           +A  L++LH   ++ I++ D+KP NILLDE+   K++DFGL+K+S   +K   S     G
Sbjct: 135 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC---G 188

Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T+ Y+APEV  R   G +  +D +S+G+++ EM  G 
Sbjct: 189 TVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGT 223

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 72.8 bits (179), Expect = 4e-15
 Identities = 43/176 (24%), Positives = 73/176 (41%), Gaps = 40/176 (22%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILL--DEDFCPKISDFGLAKQSQDKKSTISMLHAR 91
           I  G+ ++H    + I+H D+KP NIL    +    KI DFGLA++ + ++         
Sbjct: 196 ICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF--- 249

Query: 92  GTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP------ 145
           GT  ++APEV    F   S  +D++S G++   +  G                P      
Sbjct: 250 GTPEFLAPEVVNYDF--VSFPTDMWSVGVIAYMLLSG--------------LSPFLGDND 293

Query: 146 NSIYKHIEPGN-DFQLDG--VVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
                +I     D + +    ++EE KE + K+++          S R S  E L+
Sbjct: 294 AETLNNILACRWDLEDEEFQDISEEAKEFISKLLIK-------EKSWRISASEALK 342

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 72.3 bits (178), Expect = 4e-15
 Identities = 46/232 (19%), Positives = 84/232 (36%), Gaps = 68/232 (29%)

Query: 1   MPNGSLDQF------------TYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVR 48
              G L  F            T      +    L+   +   +  +A+G+ +L       
Sbjct: 109 CCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KN 165

Query: 49  IVHFDIKPHNILLDEDFCPKISDFGLAKQSQD----KKSTISMLHARGTIGYIAPE-VFC 103
            +H D+   NILL      KI DFGLA+  ++         + L  +      APE +F 
Sbjct: 166 CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWM----APESIFN 221

Query: 104 RSFGGASHKSDVYSYGMMILEMA-VGR-------KNADVKASRSSDIYFPNSIYKHIEPG 155
             +   + +SDV+SYG+ + E+  +G         ++                YK I+ G
Sbjct: 222 CVY---TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF--------------YKMIKEG 264

Query: 156 NDFQLDGVVTEEEK------ELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE 201
             F++               E+   M      C   +P  RP+  ++++++E
Sbjct: 265 --FRM-------LSPEHAPAEMYDIM----KTCWDADPLKRPTFKQIVQLIE 303

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 71.6 bits (176), Expect = 6e-15
 Identities = 36/219 (16%), Positives = 72/219 (32%), Gaps = 57/219 (26%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +  GSLD +    ++      +      ++A  +A  + +L       ++H ++   NIL
Sbjct: 94  VKFGSLDTYLKKNKNC-----INILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNIL 145

Query: 61  LDEDFCP--------KISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVF--CRSFGGAS 110
           L  +           K+SD G++     K         +  I ++ PE     ++    +
Sbjct: 146 LIREEDRKTGNPPFIKLSDPGISITVLPKDIL------QERIPWVPPECIENPKNL---N 196

Query: 111 HKSDVYSYGMMILEMA-------VGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGV 163
             +D +S+G  + E+            +                  +  E     QL   
Sbjct: 197 LATDKWSFGTTLWEICSGGDKPLSALDSQRK--------------LQFYEDR--HQLP-- 238

Query: 164 VTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES 202
              +  EL   +      C+   P  RPS   ++  L S
Sbjct: 239 -APKAAELANLI----NNCMDYEPDHRPSFRAIIRDLNS 272

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 72.5 bits (178), Expect = 6e-15
 Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 8/97 (8%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS-QDKKSTISMLHARG 92
           I   L+YLH   N  +V+ D+K  N++LD+D   KI+DFGL K+  +D  +  +     G
Sbjct: 257 IVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC---G 311

Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T  Y+APEV   +        D +  G+++ EM  GR
Sbjct: 312 TPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 346

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 71.8 bits (177), Expect = 6e-15
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 9/97 (9%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS-QDKKSTISMLHARG 92
           I+  L +LH      I++ D+KP NI+L+     K++DFGL K+S  D   T +     G
Sbjct: 130 ISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC---G 183

Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           TI Y+APE+  RS  G +   D +S G ++ +M  G 
Sbjct: 184 TIEYMAPEILMRS--GHNRAVDWWSLGALMYDMLTGA 218

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 71.9 bits (177), Expect = 7e-15
 Identities = 46/228 (20%), Positives = 82/228 (35%), Gaps = 64/228 (28%)

Query: 1   MPNGSLDQF--------TYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHF 52
              G L  F          D   +  N T   R +   +  +A+G+ +L        +H 
Sbjct: 132 CCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHR 188

Query: 53  DIKPHNILLDEDFCPKISDFGLAK--QSQD--KKSTISMLHARGTIGYIAPE-VFCRSFG 107
           D+   N+LL      KI DFGLA+   +         + L  +      APE +F   + 
Sbjct: 189 DVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWM----APESIFDCVY- 243

Query: 108 GASHKSDVYSYGMMILEMA-VGRK-------NADVKASRSSDIYFPNSIYKHIEPGNDFQ 159
             + +SDV+SYG+++ E+  +G         N+                YK ++ G  +Q
Sbjct: 244 --TVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF--------------YKLVKDG--YQ 285

Query: 160 LDGVVTEEEK------ELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE 201
           +        +       +   M      C    P+ RP+  ++   L+
Sbjct: 286 M-------AQPAFAPKNIYSIM----QACWALEPTHRPTFQQICSFLQ 322

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 71.6 bits (176), Expect = 7e-15
 Identities = 43/180 (23%), Positives = 81/180 (45%), Gaps = 32/180 (17%)

Query: 29  QIAG---GIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ---SQDKK 82
           QI      +   L +LH   + RI+H D+K  N+L+  +   +++DFG++ +   +  K+
Sbjct: 118 QIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR 174

Query: 83  STISMLHARGTIGYIAPEV-FCRSFGGAS--HKSDVYSYGMMILEMAVGRK-NADVKASR 138
            +       GT  ++APEV  C +       +K+D++S G+ ++EMA     + ++   R
Sbjct: 175 DSFI-----GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 229

Query: 139 SSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
              +     I K   P          + E ++ +K         +  NP  RPS  ++LE
Sbjct: 230 V--LLK---IAKSDPPT--LLTPSKWSVEFRDFLKI-------ALDKNPETRPSAAQLLE 275

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 71.6 bits (176), Expect = 8e-15
 Identities = 56/229 (24%), Positives = 95/229 (41%), Gaps = 65/229 (28%)

Query: 1   MPNGSLDQF----------TYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIV 50
              G+L ++               S N    L  + +   A  +ARG+EYL    + + +
Sbjct: 157 ASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCI 213

Query: 51  HFDIKPHNILLDEDFCPKISDFGLAK--QSQD--KKSTISMLHARGTIGYIAPE-VFCRS 105
           H D+   N+L+ ED   KI+DFGLA+     D  KK+T   L  +      APE +F R 
Sbjct: 214 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM----APEALFDRI 269

Query: 106 FGGASHKSDVYSYGMMILEMAV-------GRKNADVKASRSSDIYFPNSIYKHIEPGNDF 158
           +   +H+SDV+S+G+++ E+         G    ++              +K ++ G+  
Sbjct: 270 Y---THQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL--------------FKLLKEGH-- 310

Query: 159 QLDGVVTEEEK------ELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE 201
                    +K      EL   M      C    PS RP+  +++E L+
Sbjct: 311 -------RMDKPSNCTNELYMMM----RDCWHAVPSQRPTFKQLVEDLD 348

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 71.2 bits (175), Expect = 1e-14
 Identities = 55/238 (23%), Positives = 86/238 (36%), Gaps = 73/238 (30%)

Query: 1   MPNGSLDQF------------------TYDQESSNGNRTLEWRTVYQIAGGIARGLEYLH 42
           M  G L++F                  T  + SS G   L       IA  +A G+ YL 
Sbjct: 132 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS 191

Query: 43  RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK--QSQD--KKSTISMLHARGTIGYIA 98
                + VH D+   N L+ E+   KI+DFGL++   S D  K      +  R       
Sbjct: 192 ---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWM----P 244

Query: 99  PE-VFCRSFGGASHKSDVYSYGMMILEMAV-------GRKNADVKASRSSDIYFPNSIYK 150
           PE +F   +   + +SDV++YG+++ E+         G  + +V                
Sbjct: 245 PESIFYNRY---TTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV--------------IY 287

Query: 151 HIEPGNDFQLDGVVTEEEK------ELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES 202
           ++  GN   L               EL   M      C    P+DRPS   +  +L+ 
Sbjct: 288 YVRDGN--IL-------ACPENCPLELYNLM----RLCWSKLPADRPSFCSIHRILQR 332

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 71.7 bits (176), Expect = 1e-14
 Identities = 30/99 (30%), Positives = 49/99 (49%), Gaps = 7/99 (7%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +   ++ +H    +  VH DIKP NIL+D +   +++DFG   +  +  +  S + A GT
Sbjct: 184 MVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGT 239

Query: 94  IGYIAPEVFCRSFGGASH--KS-DVYSYGMMILEMAVGR 129
             YI+PE+     GG        D +S G+ + EM  G 
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 71.1 bits (175), Expect = 1e-14
 Identities = 36/176 (20%), Positives = 65/176 (36%), Gaps = 40/176 (22%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILL--DEDFCPKISDFGLAKQSQDKKSTISMLHAR 91
           +   L++LH   +  I HFDI+P NI+         KI +FG A+Q +   +   +    
Sbjct: 111 VCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--- 164

Query: 92  GTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP------ 145
               Y APEV        S  +D++S G ++  +  G                P      
Sbjct: 165 TAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSG--------------INPFLAETN 208

Query: 146 NSIYKHIEPGN-DFQLD--GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
             I ++I      F  +    ++ E  + V ++++            R +  E L+
Sbjct: 209 QQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVK-------ERKSRMTASEALQ 257

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 70.8 bits (174), Expect = 1e-14
 Identities = 46/230 (20%), Positives = 84/230 (36%), Gaps = 66/230 (28%)

Query: 1   MPNGSLDQF----------TYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIV 50
              G+L  +                      L    +   +  +A+G+E+L      + +
Sbjct: 114 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCI 170

Query: 51  HFDIKPHNILLDEDFCPKISDFGLAK--QSQD--KKSTISMLHARGTIGYIAPE-VFCRS 105
           H D+   NILL E    KI DFGLA+         +   + L  +      APE +F R 
Sbjct: 171 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM----APETIFDRV 226

Query: 106 FGGASHKSDVYSYGMMILEMA-VGR-------KNADVKASRSSDIYFPNSIYKHIEPGND 157
           +   + +SDV+S+G+++ E+  +G         + +                + ++ G  
Sbjct: 227 Y---TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--------------CRRLKEGT- 268

Query: 158 FQLDGVVTEEEK------ELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE 201
            ++               E+ + M    L C    PS RP+  E++E L 
Sbjct: 269 -RM-------RAPDYTTPEMYQTM----LDCWHGEPSQRPTFSELVEHLG 306

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 70.8 bits (174), Expect = 2e-14
 Identities = 34/97 (35%), Positives = 50/97 (51%), Gaps = 9/97 (9%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS-QDKKSTISMLHARG 92
           IA  L YLH   ++ IV+ D+KP NILLD      ++DFGL K++ +   +T +     G
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC---G 201

Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T  Y+APEV  +         D +  G ++ EM  G 
Sbjct: 202 TPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGL 236

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 71.0 bits (174), Expect = 2e-14
 Identities = 48/167 (28%), Positives = 76/167 (45%), Gaps = 27/167 (16%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHAR-G 92
           I  G++Y HR     +VH D+KP N+LLD     KI+DFGL+    D +     L    G
Sbjct: 125 ILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE----FLRTSCG 177

Query: 93  TIGYIAPEVFC-RSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKH 151
           +  Y APEV   R + G   + D++S G+++  +  G    D       D + P  ++K 
Sbjct: 178 SPNYAAPEVISGRLYAGP--EVDIWSSGVILYALLCGTLPFD-------DDHVPT-LFKK 227

Query: 152 IEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
           I  G  F     +      L+K M       +Q +P  R ++ ++ E
Sbjct: 228 ICDG-IFYTPQYLNPSVISLLKHM-------LQVDPMKRATIKDIRE 266

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 70.3 bits (173), Expect = 2e-14
 Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 9/97 (9%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS-QDKKSTISMLHARG 92
           I   LEYLH   +  +V+ DIK  N++LD+D   KI+DFGL K+   D  +  +     G
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC---G 167

Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T  Y+APEV   +        D +  G+++ EM  GR
Sbjct: 168 TPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 202

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 69.6 bits (171), Expect = 3e-14
 Identities = 48/238 (20%), Positives = 88/238 (36%), Gaps = 73/238 (30%)

Query: 1   MPNGSLDQF------------------TYDQESSNGNRTLEWRTVYQIAGGIARGLEYLH 42
              GSL  F                            R L    +   A  I++G++YL 
Sbjct: 108 AKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA 167

Query: 43  RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK--QSQD--KKSTISMLHARGTIGYIA 98
               +++VH D+   NIL+ E    KISDFGL++    +D   K +   +  +      A
Sbjct: 168 ---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWM----A 220

Query: 99  PE-VFCRSFGGASHKSDVYSYGMMILEMAV-------GRKNADVKASRSSDIYFPNSIYK 150
            E +F   +   + +SDV+S+G+++ E+         G     +              + 
Sbjct: 221 IESLFDHIY---TTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL--------------FN 263

Query: 151 HIEPGNDFQLDGVVTEEEK------ELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES 202
            ++ G+  ++       E+      E+ + M    L C +  P  RP   ++ + LE 
Sbjct: 264 LLKTGH--RM-------ERPDNCSEEMYRLM----LQCWKQEPDKRPVFADISKDLEK 308

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 70.3 bits (172), Expect = 3e-14
 Identities = 37/176 (21%), Positives = 74/176 (42%), Gaps = 40/176 (22%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILL--DEDFCPKISDFGLAKQSQDKKSTISMLHAR 91
           + +GL ++H       VH D+KP NI+         K+ DFGL      K+   S+    
Sbjct: 264 VCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTT 317

Query: 92  GTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP------ 145
           GT  + APEV         + +D++S G++   +  G                P      
Sbjct: 318 GTAEFAAPEVA--EGKPVGYYTDMWSVGVLSYILLSG--------------LSPFGGEND 361

Query: 146 NSIYKHIEPGN-DFQLD--GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
           +   ++++  + +        ++E+ K+ ++K++L        +P+ R ++H+ LE
Sbjct: 362 DETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLA-------DPNTRMTIHQALE 410

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 69.9 bits (172), Expect = 3e-14
 Identities = 36/98 (36%), Positives = 56/98 (57%), Gaps = 11/98 (11%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDED-FCPKISDFGLAKQS-QDKKSTISMLHAR 91
           I  GL++LH   +  IV+ D+K  NILLD+D    KI+DFG+ K++      T +     
Sbjct: 127 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFC--- 179

Query: 92  GTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           GT  YIAPE+        +H  D +S+G+++ EM +G+
Sbjct: 180 GTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQ 215

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 70.0 bits (172), Expect = 4e-14
 Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 9/97 (9%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS-QDKKSTISMLHARG 92
           I   L +LH      I++ D+K  N+LLD +   K++DFG+ K+   +  +T +     G
Sbjct: 133 IISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC---G 186

Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T  YIAPE+            D ++ G+++ EM  G 
Sbjct: 187 TPDYIAPEILQEM--LYGPAVDWWAMGVLLYEMLCGH 221

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 68.8 bits (169), Expect = 7e-14
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 9/97 (9%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS-QDKKSTISMLHARG 92
           I+  L YLH      I++ D+K  N+LLD +   K++D+G+ K+  +   +T +     G
Sbjct: 119 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---G 172

Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T  YIAPE+            D ++ G+++ EM  GR
Sbjct: 173 TPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGR 207

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 68.8 bits (169), Expect = 9e-14
 Identities = 31/97 (31%), Positives = 53/97 (54%), Gaps = 9/97 (9%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS-QDKKSTISMLHARG 92
           IA GL +L    +  I++ D+K  N++LD +   KI+DFG+ K++  D  +T +     G
Sbjct: 130 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC---G 183

Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T  YIAPE+            D +++G+++ EM  G+
Sbjct: 184 TPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQ 218

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 68.9 bits (168), Expect = 1e-13
 Identities = 31/97 (31%), Positives = 53/97 (54%), Gaps = 9/97 (9%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS-QDKKSTISMLHARG 92
           IA GL +L    +  I++ D+K  N++LD +   KI+DFG+ K++  D  +T +     G
Sbjct: 451 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC---G 504

Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T  YIAPE+            D +++G+++ EM  G+
Sbjct: 505 TPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQ 539

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 67.8 bits (166), Expect = 2e-13
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 9/97 (9%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS-QDKKSTISMLHARG 92
           I+  L YLH      I++ D+K  N+LLD +   K++D+G+ K+  +   +T +     G
Sbjct: 162 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---G 215

Query: 93  TIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           T  YIAPE+            D ++ G+++ EM  GR
Sbjct: 216 TPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGR 250

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 67.3 bits (165), Expect = 2e-13
 Identities = 47/238 (19%), Positives = 78/238 (32%), Gaps = 73/238 (30%)

Query: 1   MPNGSLDQF-----------------TYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHR 43
              G L  +                     E       L +  +   A  +A+G+E+L  
Sbjct: 131 CCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF 190

Query: 44  GCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD----KKSTISMLHARGTIGYIAP 99
                 VH D+   N+L+      KI DFGLA+             + L  +      AP
Sbjct: 191 K---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWM----AP 243

Query: 100 E-VFCRSFGGASHKSDVYSYGMMILEMA-VGR-------KNADVKASRSSDIYFPNSIYK 150
           E +F   +   + KSDV+SYG+++ E+  +G         +A+               YK
Sbjct: 244 ESLFEGIY---TIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF--------------YK 286

Query: 151 HIEPGNDFQLDGVVTEEEK------ELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES 202
            I+ G          + ++      E+   M      C   +   RPS   +   L  
Sbjct: 287 LIQNGF---------KMDQPFYATEEIYIIM----QSCWAFDSRKRPSFPNLTSFLGC 331

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 66.7 bits (163), Expect = 4e-13
 Identities = 30/113 (26%), Positives = 55/113 (48%), Gaps = 30/113 (26%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-KISDFGLAKQSQDKKSTI 85
           +YQ+     R + ++H   ++ I H DIKP N+L++      K+ DFG AK+    + ++
Sbjct: 147 IYQLF----RAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV 199

Query: 86  SMLHARGTIGYI------APEVFCRSFGGASHKS---DVYSYGMMILEMAVGR 129
           +         YI      APE+      GA+  +   D++S G +  E+ +G+
Sbjct: 200 A---------YICSRFYRAPELML----GATEYTPSIDLWSIGCVFGELILGK 239

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 66.5 bits (163), Expect = 5e-13
 Identities = 33/113 (29%), Positives = 52/113 (46%), Gaps = 28/113 (24%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-KISDFGLAKQSQDKKSTI 85
           ++Q+     R +  LH    V + H DIKPHN+L++E     K+ DFG AK+    +  +
Sbjct: 135 LFQLI----RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV 189

Query: 86  SMLHARGTIGYI------APEVFCRSFGGASHKS---DVYSYGMMILEMAVGR 129
           +         YI      APE+      G  H +   D++S G +  EM +G 
Sbjct: 190 A---------YICSRYYRAPELIF----GNQHYTTAVDIWSVGCIFAEMMLGE 229

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 65.3 bits (159), Expect = 1e-12
 Identities = 50/197 (25%), Positives = 86/197 (43%), Gaps = 28/197 (14%)

Query: 11  YDQESSNGNRTLEWRTVYQIAGGIARGLEYL-HRGCNVRIVHFDIKPHNILLDEDFCPKI 69
            +         L    +   +  +A+G+E+L  R C    +H D+   NILL E    KI
Sbjct: 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKI 234

Query: 70  SDFGLAKQSQDKKSTISMLHARGTIGYIAPE-VFCRSFGGASHKSDVYSYGMMILE-MAV 127
            DFGLA+        +    AR  + ++APE +F R +   + +SDV+S+G+++ E  ++
Sbjct: 235 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEIFSL 291

Query: 128 GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLD--GVVTEEEKELVKKMILVSLWCIQT 185
           G       AS    +       + ++ G   ++      T E  +    M    L C   
Sbjct: 292 G-------ASPYPGVKIDEEFCRRLKEG--TRMRAPDYTTPEMYQT---M----LDCWHG 335

Query: 186 NPSDRPSMHEVLEMLES 202
            PS RP+  E++E L +
Sbjct: 336 EPSQRPTFSELVEHLGN 352

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 65.0 bits (159), Expect = 2e-12
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 13/103 (12%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
           VYQ+     +GL Y+H      I+H D+KP N+ ++ED   KI DFGLA+Q+        
Sbjct: 134 VYQML----KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS-----E 181

Query: 87  MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           M     T  Y APEV   ++   +   D++S G ++ EM  G+
Sbjct: 182 MTGYVVTRWYRAPEVIL-NWMRYTQTVDIWSVGCIMAEMITGK 223

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 65.0 bits (159), Expect = 2e-12
 Identities = 36/104 (34%), Positives = 53/104 (50%), Gaps = 9/104 (8%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK-QSQDKKSTI 85
           +YQI     RGL+Y+H      ++H D+KP N+LL+     KI DFGLA+    D   T 
Sbjct: 134 LYQIL----RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186

Query: 86  SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
            +     T  Y APE+   +  G +   D++S G ++ EM   R
Sbjct: 187 FLTEYVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 229

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 64.2 bits (157), Expect = 3e-12
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 13/103 (12%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
           VYQ+     +GL+Y+H      +VH D+KP N+ ++ED   KI DFGLA+ +        
Sbjct: 132 VYQML----KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADA-----E 179

Query: 87  MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           M     T  Y APEV   S+   +   D++S G ++ EM  G+
Sbjct: 180 MTGYVVTRWYRAPEVIL-SWMHYNQTVDIWSVGCIMAEMLTGK 221

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 63.9 bits (156), Expect = 4e-12
 Identities = 36/114 (31%), Positives = 55/114 (48%), Gaps = 32/114 (28%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-KISDFGLAKQSQDKKSTI 85
           +YQ+     R L Y+H   ++ I H DIKP N+LLD      K+ DFG AK     +  +
Sbjct: 147 MYQLL----RSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV 199

Query: 86  SMLHARGTIGYI------APEV-FCRSFGGASHKS---DVYSYGMMILEMAVGR 129
           S         YI      APE+ F     GA++ +   D++S G ++ E+  G+
Sbjct: 200 S---------YICSRYYRAPELIF-----GATNYTTNIDIWSTGCVMAELMQGQ 239

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 63.5 bits (155), Expect = 5e-12
 Identities = 36/103 (34%), Positives = 55/103 (53%), Gaps = 13/103 (12%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
           +YQI     RGL+Y+H      I+H D+KP N+ ++ED   KI DFGLA+ + D      
Sbjct: 138 IYQIL----RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----E 185

Query: 87  MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           M     T  Y APE+   ++   +   D++S G ++ E+  GR
Sbjct: 186 MTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 227

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 64.0 bits (156), Expect = 5e-12
 Identities = 38/113 (33%), Positives = 55/113 (48%), Gaps = 30/113 (26%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-KISDFGLAKQSQDKKSTI 85
           +YQ+     R L Y+H   +  I H DIKP N+LLD D    K+ DFG AKQ    +  +
Sbjct: 162 MYQLF----RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 214

Query: 86  SMLHARGTIGYI------APEVFCRSFGGASHKS---DVYSYGMMILEMAVGR 129
           S         YI      APE+      GA+  +   DV+S G ++ E+ +G+
Sbjct: 215 S---------YICSRYYRAPELIF----GATDYTSSIDVWSAGCVLAELLLGQ 254

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 62.8 bits (153), Expect = 9e-12
 Identities = 34/126 (26%), Positives = 54/126 (42%), Gaps = 17/126 (13%)

Query: 11  YDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP--- 67
                   +R +    V QI+  +  GL+Y+HR C   I+H DIKP N+L++    P   
Sbjct: 117 LALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENL 174

Query: 68  ---KISDFGLAKQSQDKKST-ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMIL 123
              KI+D G A    +  +  I          Y +PEV   +       +D++S   +I 
Sbjct: 175 IQIKIADLGNACWYDEHYTNSIQTRE------YRSPEVLLGA--PWGCGADIWSTACLIF 226

Query: 124 EMAVGR 129
           E+  G 
Sbjct: 227 ELITGD 232

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 62.7 bits (153), Expect = 9e-12
 Identities = 28/105 (26%), Positives = 49/105 (46%), Gaps = 10/105 (9%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-KISDFGLAK-QSQDKKST 84
           +YQ+     RGL+Y+H      ++H D+KP N+ ++ +    KI DFGLA+         
Sbjct: 126 MYQLL----RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178

Query: 85  ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             +     T  Y +P +   S    +   D+++ G +  EM  G+
Sbjct: 179 GHLSEGLVTKWYRSPRLLL-SPNNYTKAIDMWAAGCIFAEMLTGK 222

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 62.3 bits (152), Expect = 1e-11
 Identities = 34/173 (19%), Positives = 65/173 (37%), Gaps = 50/173 (28%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGLAKQSQDKKSTISMLHA 90
           I   ++YLH   ++ I H D+KP N+L      +   K++DFG A               
Sbjct: 126 IGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA--------------- 167

Query: 91  RGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRK--NADVKASRSSDIYFPNSI 148
                    E     +       D++S G+++  +  G     ++   + S  +      
Sbjct: 168 --------KETTGEKYD---KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK----- 211

Query: 149 YKHIEPGN-DFQLD--GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
              I  G  +F       V+EE K L++ ++       +T P+ R ++ E + 
Sbjct: 212 -TRIRMGQYEFPNPEWSEVSEEVKMLIRNLL-------KTEPTQRMTITEFMN 256

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 61.6 bits (150), Expect = 2e-11
 Identities = 34/103 (33%), Positives = 51/103 (49%), Gaps = 12/103 (11%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
           +YQ+      G+++LH      I+H D+KP NI++  D   KI DFGLA+ +    ++  
Sbjct: 133 LYQML----CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFM 182

Query: 87  MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           M     T  Y APEV      G     D++S G ++ EM  G 
Sbjct: 183 MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGG 223

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 61.6 bits (150), Expect = 2e-11
 Identities = 31/103 (30%), Positives = 47/103 (45%), Gaps = 11/103 (10%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
           +Y I      GL  LH      +VH D+ P NILL ++    I DF LA++     +  +
Sbjct: 140 MYHIL----LGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDT---ADAN 189

Query: 87  MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
             H      Y APE+    F G +   D++S G ++ EM   +
Sbjct: 190 KTHYVTHRWYRAPELVM-QFKGFTKLVDMWSAGCVMAEMFNRK 231

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 61.5 bits (150), Expect = 2e-11
 Identities = 29/111 (26%), Positives = 53/111 (47%), Gaps = 16/111 (14%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
           +YQ      R ++ LH      ++H D+KP N+L++ +   K+ DFGLA+   +  +  S
Sbjct: 118 IYQTL----RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170

Query: 87  MLHARGTI--GYI------APEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
               + +    ++      APEV   +    S   DV+S G ++ E+ + R
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVML-TSAKYSRAMDVWSCGCILAELFLRR 220

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 61.5 bits (149), Expect = 3e-11
 Identities = 53/266 (19%), Positives = 78/266 (29%), Gaps = 96/266 (36%)

Query: 17  NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL--------------- 61
           +  + L    V +I   + +GL+YLH  C   I+H DIKP NILL               
Sbjct: 138 SNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEAT 195

Query: 62  ----------------------------------DEDFCPKISDFGLAKQSQDKKSTISM 87
                                              E    KI+D G A       +    
Sbjct: 196 EWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ 255

Query: 88  LHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR------------KNAD-- 133
                T  Y + EV   S  G +  +D++S   M  E+A G             ++ D  
Sbjct: 256 -----TRQYRSLEVLIGS--GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHI 308

Query: 134 ---------------VKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTE------EEKELV 172
                          V    S + +      KHI     + L  V+ E      EE    
Sbjct: 309 ALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGF 368

Query: 173 KKMILVSLWCIQTNPSDRPSMHEVLE 198
              +   L  ++  P  R +  E L 
Sbjct: 369 TDFL---LPMLELIPEKRATAAECLR 391

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 60.6 bits (148), Expect = 3e-11
 Identities = 27/98 (27%), Positives = 47/98 (47%), Gaps = 12/98 (12%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIG 95
           +GL + H      ++H D+KP N+L++ +   K+++FGLA+         S      T+ 
Sbjct: 112 KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS--AEVVTLW 166

Query: 96  YIAPEVFCRSFGGASHKS---DVYSYGMMILEMAVGRK 130
           Y  P+V      GA   S   D++S G +  E+A   +
Sbjct: 167 YRPPDVLF----GAKLYSTSIDMWSAGCIFAELANAGR 200

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 60.2 bits (147), Expect = 5e-11
 Identities = 31/97 (31%), Positives = 48/97 (49%), Gaps = 12/97 (12%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIG 95
            G+ Y H     R++H D+KP N+L++ +   KI+DFGLA+         +  H   T+ 
Sbjct: 111 NGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT--HEIVTLW 165

Query: 96  YIAPEVFCRSFGGASHKS---DVYSYGMMILEMAVGR 129
           Y AP+V      G+   S   D++S G +  EM  G 
Sbjct: 166 YRAPDVLM----GSKKYSTTIDIWSVGCIFAEMVNGT 198

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 60.3 bits (147), Expect = 6e-11
 Identities = 34/96 (35%), Positives = 53/96 (55%), Gaps = 10/96 (10%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIG 95
           +GLEYLH+     I+H D+KP+N+LLDE+   K++DFGLAK         +  H   T  
Sbjct: 123 QGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT--HQVVTRW 177

Query: 96  YIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           Y APE+    R +G      D+++ G ++ E+ +  
Sbjct: 178 YRAPELLFGARMYGVG---VDMWAVGCILAELLLRV 210

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 60.0 bits (146), Expect = 7e-11
 Identities = 24/105 (22%), Positives = 49/105 (46%), Gaps = 12/105 (11%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-KISDFGLAKQSQDKKSTI 85
           +Y+I     + L+Y H      I+H D+KPHN+++D +    ++ D+GLA+     +   
Sbjct: 136 MYEIL----KALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--- 185

Query: 86  SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRK 130
                  +  +  PE+    +    +  D++S G M+  M   ++
Sbjct: 186 EYNVRVASRYFKGPELLV-DYQMYDYSLDMWSLGCMLASMIFRKE 229

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 59.9 bits (146), Expect = 8e-11
 Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 12/97 (12%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIG 95
           RG+ + H+    RI+H D+KP N+L++ D   K++DFGLA+       + +  H   T+ 
Sbjct: 130 RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYT--HEVVTLW 184

Query: 96  YIAPEVFCRSFGGASHKS---DVYSYGMMILEMAVGR 129
           Y AP+V      G+   S   D++S G +  EM  G+
Sbjct: 185 YRAPDVLM----GSKKYSTSVDIWSIGCIFAEMITGK 217

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 59.5 bits (145), Expect = 9e-11
 Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 12/97 (12%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIG 95
           RGL Y HR    +++H D+KP N+L++E    K++DFGLA+       T    +   T+ 
Sbjct: 111 RGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD--NEVVTLW 165

Query: 96  YIAPEVFCRSFGGASHKS---DVYSYGMMILEMAVGR 129
           Y  P++      G++  S   D++  G +  EMA GR
Sbjct: 166 YRPPDILL----GSTDYSTQIDMWGVGCIFYEMATGR 198

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 59.5 bits (145), Expect = 1e-10
 Identities = 31/97 (31%), Positives = 51/97 (52%), Gaps = 12/97 (12%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIG 95
           +GL + H     +I+H D+KP N+L+++    K+ DFGLA+      +T S      T+ 
Sbjct: 119 QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFS--SEVVTLW 173

Query: 96  YIAPEVFCRSFGGASHKS---DVYSYGMMILEMAVGR 129
           Y AP+V      G+   S   D++S G ++ EM  G+
Sbjct: 174 YRAPDVLM----GSRTYSTSIDIWSCGCILAEMITGK 206

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 58.7 bits (142), Expect = 2e-10
 Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 12/103 (11%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
           +YQ+      G+++LH      I+H D+KP NI++  D   KI DFGLA+ +    ++  
Sbjct: 170 LYQML----CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFM 219

Query: 87  MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR 129
           M     T  Y APEV      G     D++S G ++ EM   +
Sbjct: 220 MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHK 260

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 57.8 bits (140), Expect = 3e-10
 Identities = 20/213 (9%), Positives = 48/213 (22%), Gaps = 66/213 (30%)

Query: 22  LEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDK 81
                  +    +A   +  HR     +      P  + +  D    ++           
Sbjct: 126 PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYP--------- 173

Query: 82  KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSD 141
                          +           A+ + D+   G  +  + V R        RS  
Sbjct: 174 -------------ATMPD---------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL 211

Query: 142 IYFPNSIYKHIE----------PGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRP 191
                   +                 FQ+  V                   +Q +   R 
Sbjct: 212 ----APAERDTAGQPIEPADIDRDIPFQISAVA---------------ARSVQGDGGIRS 252

Query: 192 S--MHEVLEMLESSTEILQIPPKPSLALPKKSA 222
           +  +  +++   +  +  ++   P    P  +A
Sbjct: 253 ASTLLNLMQQATAVADRTEVLG-PIDEAPVSAA 284

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 57.6 bits (140), Expect = 4e-10
 Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 12/96 (12%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIG 95
           RGL++LH      IVH D+KP NIL+      K++DFGLA+        +++     T+ 
Sbjct: 131 RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALTPVVVTLW 184

Query: 96  YIAPEVFCRSFGGASHKS--DVYSYGMMILEMAVGR 129
           Y APEV       +++ +  D++S G +  EM   +
Sbjct: 185 YRAPEVLL----QSTYATPVDMWSVGCIFAEMFRRK 216

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 57.3 bits (139), Expect = 6e-10
 Identities = 29/104 (27%), Positives = 44/104 (42%), Gaps = 17/104 (16%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-----KISDFGLAKQSQDKKSTISML 88
           +  G+ + H     R +H D+KP N+LL           KI DFGLA+         +  
Sbjct: 141 LINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFT-- 195

Query: 89  HARGTIGYIAPEVFCRSFGGASHKS---DVYSYGMMILEMAVGR 129
           H   T+ Y  PE+      G+ H S   D++S   +  EM +  
Sbjct: 196 HEIITLWYRPPEILL----GSRHYSTSVDIWSIACIWAEMLMKT 235

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 56.8 bits (138), Expect = 8e-10
 Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 12/96 (12%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIG 95
           RGL++LH     R+VH D+KP NIL+      K++DFGLA+        +++     T+ 
Sbjct: 131 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLW 184

Query: 96  YIAPEVFCRSFGGASHKS--DVYSYGMMILEMAVGR 129
           Y APEV       +S+ +  D++S G +  EM   +
Sbjct: 185 YRAPEVLL----QSSYATPVDLWSVGCIFAEMFRRK 216

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 56.6 bits (137), Expect = 1e-09
 Identities = 29/122 (23%), Positives = 54/122 (44%), Gaps = 27/122 (22%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
           VYQ+     + ++YLH G    ++H D+KP NILL+ +   K++DFGL++   + +   +
Sbjct: 115 VYQLI----KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167

Query: 87  MLHARGTIG-------------------YIAPEVFCRSFGGASHKSDVYSYGMMILEMAV 127
            +                          Y APE+        +   D++S G ++ E+  
Sbjct: 168 NIPLSINENTENFDDDQPILTDYVATRWYRAPEILL-GSTKYTKGIDMWSLGCILGEILC 226

Query: 128 GR 129
           G+
Sbjct: 227 GK 228

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 56.4 bits (137), Expect = 1e-09
 Identities = 24/105 (22%), Positives = 42/105 (40%), Gaps = 14/105 (13%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
            +Q      + + + H+      +H D+KP NIL+ +    K+ DFG A+          
Sbjct: 108 TWQTL----QAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD 160

Query: 87  MLHARGTIGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
                 T  Y +PE+      +G      DV++ G +  E+  G 
Sbjct: 161 --DEVATRWYRSPELLVGDTQYGPP---VDVWAIGCVFAELLSGV 200

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 56.7 bits (137), Expect = 1e-09
 Identities = 20/80 (25%), Positives = 33/80 (41%), Gaps = 7/80 (8%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTIS 86
           +Y +      G  ++H      I+H D+KP N LL++D   K+ DFGLA+    +K T  
Sbjct: 135 LYNLL----LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI 187

Query: 87  MLHARGTIGYIAPEVFCRSF 106
           +                +  
Sbjct: 188 VNDLEENEEPGPHNKNLKKQ 207

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 56.3 bits (136), Expect = 2e-09
 Identities = 34/122 (27%), Positives = 51/122 (41%), Gaps = 14/122 (11%)

Query: 11  YDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP--K 68
           Y+    N  +      V + A  I + L+ LH+    RI+H D+KP NILL +      K
Sbjct: 186 YELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIK 242

Query: 69  ISDFGLAKQSQDKKST-ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV 127
           + DFG +     +  T I          Y APEV            D++S G ++ E+  
Sbjct: 243 VIDFGSSCYEHQRVYTYIQSRF------YRAPEVILG--ARYGMPIDMWSLGCILAELLT 294

Query: 128 GR 129
           G 
Sbjct: 295 GY 296

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 55.7 bits (135), Expect = 2e-09
 Identities = 30/98 (30%), Positives = 44/98 (44%), Gaps = 10/98 (10%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           I  G+ + H      I+H DIKP NIL+ +    K+ DFG A+                T
Sbjct: 133 IINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD--DEVAT 187

Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
             Y APE+      +G A    DV++ G ++ EM +G 
Sbjct: 188 RWYRAPELLVGDVKYGKA---VDVWAIGCLVTEMFMGE 222

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 56.0 bits (135), Expect = 2e-09
 Identities = 28/102 (27%), Positives = 45/102 (44%), Gaps = 15/102 (14%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDF----CPKISDFGLAKQSQDKKSTISMLHAR 91
            G+ YLH      ++H D+KP NIL+  +       KI+D G A+        ++ L   
Sbjct: 139 DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195

Query: 92  -GTIGYIAPEVFCRSFGGASHKS---DVYSYGMMILEMAVGR 129
             T  Y APE+      GA H +   D+++ G +  E+    
Sbjct: 196 VVTFWYRAPELLL----GARHYTKAIDIWAIGCIFAELLTSE 233

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 55.7 bits (135), Expect = 3e-09
 Identities = 28/98 (28%), Positives = 45/98 (45%), Gaps = 10/98 (10%)

Query: 36  RGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ--SQDKKSTISMLHARGT 93
            GL Y+HR    +I+H D+K  N+L+  D   K++DFGLA+              +   T
Sbjct: 135 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 191

Query: 94  IGYIAPEVF--CRSFGGASHKSDVYSYGMMILEMAVGR 129
           + Y  PE+    R +G      D++  G ++ EM    
Sbjct: 192 LWYRPPELLLGERDYGPP---IDLWGAGCIMAEMWTRS 226

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 55.6 bits (134), Expect = 3e-09
 Identities = 18/49 (36%), Positives = 29/49 (59%), Gaps = 7/49 (14%)

Query: 27  VYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLA 75
           +Y +      G++Y+H      I+H D+KP N L+++D   K+ DFGLA
Sbjct: 162 LYNLL----VGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 54.3 bits (131), Expect = 6e-09
 Identities = 33/123 (26%), Positives = 49/123 (39%), Gaps = 14/123 (11%)

Query: 11  YDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP--K 68
           YD   +   R +      + A  +   L +L     + I+H D+KP NILL        K
Sbjct: 143 YDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIK 201

Query: 69  ISDFGLAKQSQDKKST-ISMLHARGTIGYIAPEVFCRSFG-GASHKSDVYSYGMMILEMA 126
           I DFG + Q   +    I          Y +PEV     G       D++S G +++EM 
Sbjct: 202 IVDFGSSCQLGQRIYQYIQSRF------YRSPEVL---LGMPYDLAIDMWSLGCILVEMH 252

Query: 127 VGR 129
            G 
Sbjct: 253 TGE 255

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 51.3 bits (123), Expect = 6e-08
 Identities = 20/69 (28%), Positives = 32/69 (46%), Gaps = 5/69 (7%)

Query: 17  NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKI--SDFGL 74
             N T +  TV Q+   +   LEY+H       VH DIK  N+LL      ++  +D+GL
Sbjct: 143 GQNGTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGL 199

Query: 75  AKQSQDKKS 83
           + +     +
Sbjct: 200 SYRYCPNGN 208

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 50.5 bits (121), Expect = 1e-07
 Identities = 16/71 (22%), Positives = 31/71 (43%), Gaps = 5/71 (7%)

Query: 17  NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKI--SDFGL 74
           +    L  R+V Q+A  +   LE+LH       VH ++   NI +D +   ++  + +G 
Sbjct: 151 SPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGF 207

Query: 75  AKQSQDKKSTI 85
           A +       +
Sbjct: 208 AFRYCPSGKHV 218

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 49.8 bits (119), Expect = 2e-07
 Identities = 20/67 (29%), Positives = 32/67 (47%), Gaps = 5/67 (7%)

Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKI--SDFGLAK 76
            +    +TV Q++  I   LEY+H       VH DIK  N+LL+     ++   D+GLA 
Sbjct: 146 AKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

Query: 77  QSQDKKS 83
           +   +  
Sbjct: 203 RYCPEGV 209

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 48.9 bits (117), Expect = 4e-07
 Identities = 32/144 (22%), Positives = 53/144 (36%), Gaps = 33/144 (22%)

Query: 6   LDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF 65
           L + T++    N  +      V  +A  +   L +LH     ++ H D+KP NIL     
Sbjct: 104 LGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSE 160

Query: 66  CP-------------------KISDFGLAKQSQDKKST-ISMLHARGTIGYIAPEVFCRS 105
                                +++DFG A    +  +T ++  H      Y  PEV    
Sbjct: 161 FETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRH------YRPPEVI--- 211

Query: 106 FG-GASHKSDVYSYGMMILEMAVG 128
              G +   DV+S G ++ E   G
Sbjct: 212 LELGWAQPCDVWSIGCILFEYYRG 235

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 48.5 bits (116), Expect = 6e-07
 Identities = 48/250 (19%), Positives = 87/250 (34%), Gaps = 69/250 (27%)

Query: 6   LDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF 65
           L    Y+  + N         +      I + L YL +   + + H D+KP NILLD+ +
Sbjct: 118 LGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPY 174

Query: 66  CP-------------------------KISDFGLAKQSQDKKST-ISMLHARGTIGYIAP 99
                                      K+ DFG A    D   + I+         Y AP
Sbjct: 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQ------YRAP 228

Query: 100 EVFCRSFG-GASHKSDVYSYGMMILEMAVG------RKNAD-----------------VK 135
           EV       G    SD++S+G ++ E+  G       ++ +                  +
Sbjct: 229 EVI---LNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYE 285

Query: 136 ASRSSDI-YFPNSIYKHIEPGNDFQLDGV----VTEEEKELVKKMILVSL--WCIQTNPS 188
           A++++   Y      K   P N   ++ +          +++K  +        +Q +P+
Sbjct: 286 ATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPT 345

Query: 189 DRPSMHEVLE 198
            RPS  E+L+
Sbjct: 346 LRPSPAELLK 355

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 46.9 bits (112), Expect = 2e-06
 Identities = 37/139 (26%), Positives = 55/139 (39%), Gaps = 33/139 (23%)

Query: 11  YDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP--- 67
           YD    NG        + ++A  I + + +LH     ++ H D+KP NIL  +       
Sbjct: 104 YDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAY 160

Query: 68  ----------------KISDFGLAKQSQDKKST-ISMLHARGTIGYIAPEVFCRSFG-GA 109
                           K+ DFG A    +  ST +S  H R      APEV       G 
Sbjct: 161 NPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYR------APEVI---LALGW 211

Query: 110 SHKSDVYSYGMMILEMAVG 128
           S   DV+S G +++E  +G
Sbjct: 212 SQPCDVWSIGCILIEYYLG 230

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 46.2 bits (110), Expect = 3e-06
 Identities = 21/70 (30%), Positives = 35/70 (50%), Gaps = 8/70 (11%)

Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPK-----ISDFG 73
           +RT   +TV  IA  +   +EY+H   +  +++ D+KP N L+            I DF 
Sbjct: 99  DRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA 155

Query: 74  LAKQSQDKKS 83
           LAK+  D ++
Sbjct: 156 LAKEYIDPET 165

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 45.8 bits (109), Expect = 4e-06
 Identities = 17/70 (24%), Positives = 29/70 (41%), Gaps = 8/70 (11%)

Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPK-----ISDFG 73
            R    +TV   A  +   ++ +H      +V+ DIKP N L+            + DFG
Sbjct: 100 GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156

Query: 74  LAKQSQDKKS 83
           + K  +D  +
Sbjct: 157 MVKFYRDPVT 166

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 43.1 bits (102), Expect = 3e-05
 Identities = 21/68 (30%), Positives = 35/68 (51%), Gaps = 6/68 (8%)

Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPK---ISDFGLA 75
           +R    +TV  +A  +   +EY+H   +   +H D+KP N L+          I DFGLA
Sbjct: 99  SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155

Query: 76  KQSQDKKS 83
           K+ +D ++
Sbjct: 156 KKYRDART 163

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 42.2 bits (98), Expect = 6e-05
 Identities = 15/85 (17%), Positives = 26/85 (30%), Gaps = 8/85 (9%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
              G +D      + S+        T   I   +   L       ++R  H D+   N+L
Sbjct: 143 FEFGGIDLEQMRTKLSS------LATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTI 85
           L +    K+      K S      +
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIPSCGL 219

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 40.4 bits (94), Expect = 4e-04
 Identities = 22/68 (32%), Positives = 35/68 (51%), Gaps = 6/68 (8%)

Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPK---ISDFGLA 75
           +R L  +TV  +A  +   +E++H   +   +H DIKP N L+          I DFGLA
Sbjct: 97  SRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153

Query: 76  KQSQDKKS 83
           K+ +D  +
Sbjct: 154 KKYRDTST 161

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	242
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.98
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.98
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.98
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.98
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.98
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.98
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.98
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.98
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.98
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.98
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.98
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.98
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.98
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.98
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.98
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.98
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.98
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.98
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.98
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.97
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.97
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.97
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.97
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.97
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.97
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.97
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.97
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.97
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.97
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.97
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.97
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.97
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.97
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.97
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.97
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.97
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.97
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.97
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.97
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.97
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.97
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.97
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.97
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.97
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.97
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.97
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.97
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.97
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.97
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.97
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.97
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.97
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.97
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.97
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.97
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.97
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.97
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.97
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.97
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.97
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.97
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.97
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.97
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.97
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.97
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.97
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.97
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.97
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.97
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.97
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.97
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.97
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.97
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.97
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.97
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.97
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.97
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.97
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.97
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.97
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.97
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.97
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.97
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.97
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.97
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.97
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.97
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.97
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.97
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.97
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.97
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.97
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.97
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.97
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.97
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.97
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.97
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.97
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.97
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.97
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.97
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.97
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.97
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.97
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.97
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.97
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.97
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.97
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.97
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.97
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.97
3niz_A	311	Rhodanese family protein; structural genomics, str	99.97
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.97
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.97
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.97
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.97
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.97
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.97
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.97
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.97
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.97
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.97
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.97
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.97
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.97
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.97
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.97
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.97
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.97
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.97
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.97
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.97
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.97
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.96
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.96
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.96
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.96
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.96
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.96
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.96
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.96
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.96
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.96
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.96
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.96
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.96
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.96
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.96
3bhy_A	283	Death-associated protein kinase 3; death associate	99.96
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.96
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.96
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.96
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.96
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.96
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.96
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.96
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.96
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.96
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.96
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.96
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.96
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.96
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.96
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.96
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.96
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.96
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.96
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.96
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.96
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.96
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.96
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.96
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.96
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.96
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.96
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.96
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.96
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.96
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.96
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.96
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.96
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.96
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.96
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.96
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.96
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.96
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.95
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.95
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.95
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.95
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.95
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.95
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.95
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.95
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.95
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.95
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.95
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.95
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.94
3uqc_A	286	Probable conserved transmembrane protein; structur	99.93
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.9
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.84
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.65
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.34
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.04
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	98.59
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	97.96
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	97.69
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.68
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	97.64
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	97.36
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	96.62
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	96.13
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	95.46
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	95.13
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	93.73
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	93.4
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	93.39
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	93.28
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	93.26
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	93.13
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	93.09
3ats_A	357	Putative uncharacterized protein; hypothetical pro	92.94
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	92.48
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	92.23
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	91.94
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	91.7
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	91.15
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	89.66
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	89.06
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	88.91
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	88.75
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	87.61
3mes_A	424	Choline kinase; malaria, structural genomics, stru	83.68

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=5.8e-42  Score=276.93  Aligned_cols=188  Identities=26%  Similarity=0.365  Sum_probs=137.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||||.++|...+     ..+++.++..++.|+++||.|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       113 ~~gGsL~~~l~~~~-----~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  184 (307)
T 3omv_A          113 CEGSSLYKHLHVQE-----TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR  184 (307)
T ss_dssp             CSSCBHHHHHHTSC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred             CCCCCHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence            78999999997643     4699999999999999999999999   999999999999999999999999999986554


Q ss_pred             Ccccchhcccccccccccchhhhcc-cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRS-FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ...........||+.|+|||++... ...++.++|||||||++|||++|+.||........   ................
T Consensus       185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~---~~~~~~~~~~~p~~~~  261 (307)
T 3omv_A          185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ---IIFMVGRGYASPDLSK  261 (307)
T ss_dssp             ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---HHHHHHTTCCCCCSTT
T ss_pred             CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH---HHHHHhcCCCCCCccc
Confidence            3322223345699999999998653 23578999999999999999999999964332110   0001111111111122


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      .+..+++++.+       ++.+||+.||++|||+.++++.|+.+...
T Consensus       262 ~~~~~~~~l~~-------li~~cl~~dP~~RPs~~ei~~~Le~l~~~  301 (307)
T 3omv_A          262 LYKNCPKAMKR-------LVADCVKKVKEERPLFPQILSSIELLQHS  301 (307)
T ss_dssp             SCTTSCHHHHH-------HHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred             ccccchHHHHH-------HHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence            23345555444       45559999999999999999999987654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=8e-42  Score=275.80  Aligned_cols=186  Identities=25%  Similarity=0.375  Sum_probs=145.4

Q ss_pred             CCCCCcchhccccC-------CCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccc
Q 026160            1 MPNGSLDQFTYDQE-------SSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFG   73 (242)
Q Consensus         1 ~~~GsL~~~l~~~~-------~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg   73 (242)
                      |+||||.++|.++.       ..+....+++.++..++.|+++||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        97 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~DFG  173 (299)
T 4asz_A           97 MKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFG  173 (299)
T ss_dssp             CTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCS
T ss_pred             CCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECCcc
Confidence            78999999997642       123346799999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhcc
Q 026160           74 LAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHI  152 (242)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~  152 (242)
                      +++...............+|+.|+|||.+.+.  .++.++|||||||++|||+| |+.||.....        ......+
T Consensus       174 la~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--------~~~~~~i  243 (299)
T 4asz_A          174 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------NEVIECI  243 (299)
T ss_dssp             CHHHHTGGGCEEETTTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHHHHHH
T ss_pred             cceecCCCCceeecCceecChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHH
Confidence            99865544333222234589999999999764  68999999999999999998 8999975432        1222223


Q ss_pred             CCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          153 EPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      ..+.....+..+++++.+       ++.+||+.||++|||+.++++.|+.+.+.
T Consensus       244 ~~~~~~~~p~~~~~~~~~-------li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          244 TQGRVLQRPRTCPQEVYE-------LMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             HHTCCCCCCTTCCHHHHH-------HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HcCCCCCCCccchHHHHH-------HHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            333333445556665554       45559999999999999999999987764

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.2e-41  Score=276.75  Aligned_cols=186  Identities=22%  Similarity=0.336  Sum_probs=137.6

Q ss_pred             CCCCCcchhccccCCC---------CCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcc
Q 026160            1 MPNGSLDQFTYDQESS---------NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISD   71 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~---------~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~d   71 (242)
                      |+||||.++|.++...         .....+++.+++.++.|+++||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus       125 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~D  201 (329)
T 4aoj_A          125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGD  201 (329)
T ss_dssp             CTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECC
T ss_pred             CCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEcc
Confidence            7899999999865321         1235799999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhh
Q 026160           72 FGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYK  150 (242)
Q Consensus        72 fg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~  150 (242)
                      ||+++...............+|+.|+|||++.+.  .++.++|||||||++|||+| |+.||.....        .....
T Consensus       202 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--------~~~~~  271 (329)
T 4aoj_A          202 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--------TEAID  271 (329)
T ss_dssp             CC----------------CCCCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--------HHHHH
T ss_pred             cccceeccCCCcceecCcccccccccChhhhcCC--CCCccccccchHHHHHHHHcCCCCCCCCCCH--------HHHHH
Confidence            9999866544333223344689999999998764  67999999999999999998 8999974432        11222


Q ss_pred             ccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          151 HIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      .+..+.....+..+++++.+       ++.+||+.||++|||+.++++.|+.+.+.
T Consensus       272 ~i~~g~~~~~p~~~~~~~~~-------li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          272 CITQGRELERPRACPPEVYA-------IMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHHHTCCCCCCTTCCHHHHH-------HHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHcCCCCCCcccccHHHHH-------HHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            22233334445556665554       45559999999999999999999988764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.9e-41  Score=272.88  Aligned_cols=184  Identities=22%  Similarity=0.305  Sum_probs=143.3

Q ss_pred             CCCCCcchhccccCCC----------CCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEc
Q 026160            1 MPNGSLDQFTYDQESS----------NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKIS   70 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~   70 (242)
                      |++|||.++|......          .....+++.+++.++.||++||.|||+.   +|+||||||+|||++.++.+||+
T Consensus       111 ~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~Ki~  187 (308)
T 4gt4_A          111 CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKIS  187 (308)
T ss_dssp             CSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred             CCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCEEEC
Confidence            7899999999754321          1134699999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhh
Q 026160           71 DFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIY  149 (242)
Q Consensus        71 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~  149 (242)
                      |||+++...............||+.|+|||.+.+.  .++.++|||||||++|||+| |..||.....        ....
T Consensus       188 DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~--~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--------~~~~  257 (308)
T 4gt4_A          188 DLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--------QDVV  257 (308)
T ss_dssp             CSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--------HHHH
T ss_pred             CcccceeccCCCceeEecccccCCcccCHHHHhCC--CCCccchhhhHHHHHHHHHhCCCCCCCCCCH--------HHHH
Confidence            99999865443332223344689999999998764  78999999999999999998 8899965432        1222


Q ss_pred             hccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchh
Q 026160          150 KHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESST  204 (242)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~  204 (242)
                      ..+..+.....+..+++++.       +++.+||+.||++|||+.+|++.|++..
T Consensus       258 ~~i~~~~~~~~p~~~~~~~~-------~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          258 EMIRNRQVLPCPDDCPAWVY-------ALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             HHHHTTCCCCCCTTCCHHHH-------HHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             HHHHcCCCCCCcccchHHHH-------HHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence            23333333444555555544       4555699999999999999999998754

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.4e-40  Score=269.16  Aligned_cols=189  Identities=25%  Similarity=0.255  Sum_probs=143.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCC-ceEEcccccccccC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF-CPKISDFGLAKQSQ   79 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~-~~~L~dfg~~~~~~   79 (242)
                      |+||+|.++|.+.      +.+++.++..++.||+.||.|||++   +|+||||||+|||++.+| .+||+|||+++...
T Consensus       132 ~~gg~L~~~l~~~------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~  202 (336)
T 4g3f_A          132 LEGGSLGQLIKQM------GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQ  202 (336)
T ss_dssp             CTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred             cCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence            7899999999875      4599999999999999999999999   999999999999999887 69999999998765


Q ss_pred             CCccc---chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCC
Q 026160           80 DKKST---ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN  156 (242)
Q Consensus        80 ~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  156 (242)
                      .....   .......||+.|+|||++.+.  .++.++|||||||++|||++|..||........    ...+..  ....
T Consensus       203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----~~~i~~--~~~~  274 (336)
T 4g3f_A          203 PDGLGKSLLTGDYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL----CLKIAS--EPPP  274 (336)
T ss_dssp             -----------CCCCCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC----HHHHHH--SCCG
T ss_pred             CCCcccceecCCccccCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH----HHHHHc--CCCC
Confidence            43211   111224699999999999764  678999999999999999999999975432211    111111  1111


Q ss_pred             ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccCCCCC
Q 026160          157 DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKP  213 (242)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~  213 (242)
                      ....+..+++++.+++.+       ||+.||++|||+.|++++|.........-.+|
T Consensus       275 ~~~~~~~~s~~~~~li~~-------~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hP  324 (336)
T 4g3f_A          275 IREIPPSCAPLTAQAIQE-------GLRKEPVHRASAMELRRKVGKALQEVGGLKSP  324 (336)
T ss_dssp             GGGSCTTSCHHHHHHHHH-------HTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSC
T ss_pred             chhcCccCCHHHHHHHHH-------HccCCHhHCcCHHHHHHHHHHHHhhhhhccCC
Confidence            123445567777666666       88999999999999999999888765544444

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=5.5e-41  Score=276.54  Aligned_cols=187  Identities=24%  Similarity=0.363  Sum_probs=146.3

Q ss_pred             CCCCCcchhccccCCC----------CCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEc
Q 026160            1 MPNGSLDQFTYDQESS----------NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKIS   70 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~   70 (242)
                      |++|||.++|.+....          .....+++.+++.++.||++||.|||++   +|+||||||+|||++.++.+||+
T Consensus       151 ~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~vKi~  227 (353)
T 4ase_A          151 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKIC  227 (353)
T ss_dssp             CTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred             CCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeCCCCCEEEC
Confidence            7899999999764321          1234699999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhh
Q 026160           71 DFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIY  149 (242)
Q Consensus        71 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~  149 (242)
                      |||+++...............+|+.|+|||++.+.  .++.++|||||||++|||+| |..||......       ....
T Consensus       228 DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~--~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~-------~~~~  298 (353)
T 4ase_A          228 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------EEFC  298 (353)
T ss_dssp             CCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-------HHHH
T ss_pred             cchhhhhcccCCCceeeccccccccccCHHHHhcC--CCCCcccEeehHHHHHHHHhCCCCCCCCCCHH-------HHHH
Confidence            99999866544333223344689999999999764  78999999999999999998 89999654321       2222


Q ss_pred             hccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          150 KHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      ..+..+.....+..+++++.++       +.+||+.||++|||+.+++++|+.+.+.
T Consensus       299 ~~i~~g~~~~~p~~~~~~~~~l-------i~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          299 RRLKEGTRMRAPDYTTPEMYQT-------MLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHH-------HHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHcCCCCCCCccCCHHHHHH-------HHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            3333334444555566665544       4559999999999999999999987654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-39  Score=261.44  Aligned_cols=169  Identities=28%  Similarity=0.483  Sum_probs=133.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCC--eeecCCCCCceeeCC-CCceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVR--IVHFDIKPHNILLDE-DFCPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~--i~h~dlk~~nil~~~-~~~~~L~dfg~~~~   77 (242)
                      |+||+|.++|.+.      +.+++.++..++.||+.||.|||++   +  |+||||||+|||++. ++.+||+|||+++.
T Consensus       111 ~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~  181 (290)
T 3fpq_A          111 MTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             CCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             CCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence            7899999999875      4699999999999999999999998   7  999999999999985 78999999999975


Q ss_pred             cCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCC-
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN-  156 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  156 (242)
                      ......    ....||+.|+|||++.+   .++.++|||||||++|||++|..||......       ......+..+. 
T Consensus       182 ~~~~~~----~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-------~~~~~~i~~~~~  247 (290)
T 3fpq_A          182 KRASFA----KAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYRRVTSGVK  247 (290)
T ss_dssp             CCTTSB----EESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHHHHTTTCC
T ss_pred             CCCCcc----CCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-------HHHHHHHHcCCC
Confidence            443322    23469999999998854   4789999999999999999999999643221       22222222222 


Q ss_pred             ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          157 DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ....+...++++.+++.+       ||+.||++|||+.+++++
T Consensus       248 ~~~~~~~~~~~~~~li~~-------~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          248 PASFDKVAIPEVKEIIEG-------CIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             CGGGGGCCCHHHHHHHHH-------HSCSSGGGSCCHHHHHTS
T ss_pred             CCCCCccCCHHHHHHHHH-------HccCChhHCcCHHHHhcC
Confidence            223344556666655555       999999999999999874

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.5e-40  Score=270.31  Aligned_cols=173  Identities=24%  Similarity=0.338  Sum_probs=137.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.++|...+.    ..+++.+++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       105 ~~gg~L~~~i~~~~~----~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  177 (350)
T 4b9d_A          105 CEGGDLFKRINAQKG----VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS  177 (350)
T ss_dssp             CTTCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred             CCCCcHHHHHHHcCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence            789999999976532    5689999999999999999999999   999999999999999999999999999987654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....||+.|+|||++.+.  .++.++|||||||++|||++|..||.....        ......+..+.....
T Consensus       178 ~~~~--~~~~~GT~~YmAPE~l~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i~~~~~~~~  245 (350)
T 4b9d_A          178 TVEL--ARACIGTPYYLSPEICENK--PYNNKSDIWALGCVLYELCTLKHAFEAGSM--------KNLVLKIISGSFPPV  245 (350)
T ss_dssp             HHHH--HHHHHSCCTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTCCCCC
T ss_pred             Cccc--ccccCCCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHcCCCCCC
Confidence            3211  1234599999999999764  678899999999999999999999975432        111112222222334


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      +..+++++.+++.+       ||+.||++|||+.|++++
T Consensus       246 ~~~~s~~~~~li~~-------~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          246 SLHYSYDLRSLVSQ-------LFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             CTTSCHHHHHHHHH-------HTCSSGGGSCCHHHHHTS
T ss_pred             CccCCHHHHHHHHH-------HccCChhHCcCHHHHhcC
Confidence            45577777776666       889999999999999864

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.1e-39  Score=261.83  Aligned_cols=199  Identities=23%  Similarity=0.254  Sum_probs=141.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCC-----CCCeeecCCCCCceeeCCCCceEEcccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGC-----NVRIVHFDIKPHNILLDEDFCPKISDFGLA   75 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~-----~~~i~h~dlk~~nil~~~~~~~~L~dfg~~   75 (242)
                      |+||||.++|...       .++++++..++.|+++||.|||++.     ..+|+||||||+|||++.++.+||+|||++
T Consensus        83 ~~~gsL~~~l~~~-------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           83 HEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             CTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CCCCcHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            7899999999753       5999999999999999999999752     348999999999999999999999999999


Q ss_pred             cccCCCcccc--hhcccccccccccchhhhcccC----CCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcC-----
Q 026160           76 KQSQDKKSTI--SMLHARGTIGYIAPEVFCRSFG----GASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYF-----  144 (242)
Q Consensus        76 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~----~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~-----  144 (242)
                      +.........  ......||+.|+|||++.+...    .++.++|||||||++|||++|..|+............     
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~  235 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence            8654432221  1123469999999999865321    2467899999999999999998887644332211100     


Q ss_pred             ---cchhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhcc
Q 026160          145 ---PNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQ  208 (242)
Q Consensus       145 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~  208 (242)
                         .............+.++....  ..+....+.+++.+||+.||++|||+.++++.|+.+.+...
T Consensus       236 ~~~~~~~~~~~~~~~rp~~p~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~  300 (303)
T 3hmm_A          236 PSVEEMRKVVCEQKLRPNIPNRWQ--SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  300 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGG--SSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             chHHHHHHHHhcccCCCCCCcccc--chHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcC
Confidence               001111112222222222111  12345667788999999999999999999999998876543

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=9.3e-40  Score=263.71  Aligned_cols=170  Identities=26%  Similarity=0.408  Sum_probs=136.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.++|.+.      +.+++.++..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       114 ~~gG~L~~~i~~~------~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          114 AKNGELLKYIRKI------GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             CTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            6899999999876      4599999999999999999999999   999999999999999999999999999987654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ..........+||+.|+|||++.+.  .++.++|||||||++|+|++|..||...+.        ......+... ...+
T Consensus       185 ~~~~~~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~~~-~~~~  253 (311)
T 4aw0_A          185 ESKQARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNE--------GLIFAKIIKL-EYDF  253 (311)
T ss_dssp             TTTCCCBCCCCSCGGGCCHHHHHHS--CBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHT-CCCC
T ss_pred             CCCcccccCcccCcccCCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcC-CCCC
Confidence            3332222345699999999999764  678899999999999999999999975432        1111111111 1234


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVL  197 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll  197 (242)
                      +..+++++++++.+       ||+.||++|||+.|++
T Consensus       254 p~~~s~~~~dli~~-------lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          254 PEKFFPKARDLVEK-------LLVLDATKRLGCEEME  283 (311)
T ss_dssp             CTTCCHHHHHHHHH-------HSCSSGGGSTTSGGGT
T ss_pred             CcccCHHHHHHHHH-------HccCCHhHCcChHHHc
Confidence            55677777777766       7799999999999864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.8e-39  Score=263.14  Aligned_cols=170  Identities=24%  Similarity=0.342  Sum_probs=134.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.+++.+       +.+++.++..++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||+++....
T Consensus       153 ~~gg~L~~~l~~-------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  222 (346)
T 4fih_A          153 LEGGALTDIVTH-------TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  222 (346)
T ss_dssp             CTTEEHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             CCCCcHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence            689999999965       3599999999999999999999999   999999999999999999999999999987654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCC--cc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN--DF  158 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~  158 (242)
                      ....  ....+||+.|+|||++.+.  .++.++|||||||++|||++|..||......        .....+....  ..
T Consensus       223 ~~~~--~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--------~~~~~i~~~~~~~~  290 (346)
T 4fih_A          223 EVPR--RKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--------KAMKMIRDNLPPRL  290 (346)
T ss_dssp             SSCC--BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSSCCCC
T ss_pred             CCCc--ccccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------HHHHHHHcCCCCCC
Confidence            3322  1234699999999998654  6789999999999999999999999643321        1111111111  11


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .....+++++.+++.+       ||+.||++|||+.|++++
T Consensus       291 ~~~~~~s~~~~dli~~-------~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          291 KNLHKVSPSLKGFLDR-------LLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             SCGGGSCHHHHHHHHH-------HSCSSTTTSCCHHHHTTC
T ss_pred             CccccCCHHHHHHHHH-------HcCCChhHCcCHHHHhcC
Confidence            2233466777666665       889999999999999875

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.4e-38  Score=253.36  Aligned_cols=168  Identities=30%  Similarity=0.460  Sum_probs=125.5

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      +|+|.++|.+.      +.+++.++..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus        96 ~g~L~~~l~~~------~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  166 (275)
T 3hyh_A           96 GNELFDYIVQR------DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN  166 (275)
T ss_dssp             CEEHHHHHHHS------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             CCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence            68999999765      4699999999999999999999999   99999999999999999999999999998655433


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccccc
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDG  162 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (242)
                      ..   ....||+.|+|||++.+. ...+.++|||||||++|+|++|..||.....        ......+..+ ...++.
T Consensus       167 ~~---~~~~GT~~Y~APE~~~~~-~y~~~~~DiwSlGvily~lltg~~PF~~~~~--------~~~~~~i~~~-~~~~p~  233 (275)
T 3hyh_A          167 FL---KTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYVMLCRRLPFDDESI--------PVLFKNISNG-VYTLPK  233 (275)
T ss_dssp             -----------CTTSCHHHHSSS-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHT-CCCCCT
T ss_pred             cc---CCeeECcccCChhhhcCC-CCCCChhhhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcC-CCCCCC
Confidence            22   234699999999998764 2346799999999999999999999964321        1111111111 123445


Q ss_pred             ccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          163 VVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       163 ~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .+++++.+++.+       ||+.||++|||+.|++++
T Consensus       234 ~~s~~~~~li~~-------~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          234 FLSPGAAGLIKR-------MLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             TSCHHHHHHHHH-------HSCSSGGGSCCHHHHHHC
T ss_pred             CCCHHHHHHHHH-------HccCChhHCcCHHHHHcC
Confidence            577777766666       789999999999999874

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.4e-38  Score=256.58  Aligned_cols=169  Identities=28%  Similarity=0.427  Sum_probs=131.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.++|.+.      +.+++.++..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       108 ~~gg~L~~~l~~~------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          108 LRGGDLFTRLSKE------VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             CTTCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             CCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            6899999999876      4699999999999999999999999   999999999999999999999999999986543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....||+.|+|||++.+.  .++.++|||||||++|+|++|..||...+..        .....+... ...+
T Consensus       179 ~~~~--~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~~--------~~~~~i~~~-~~~~  245 (304)
T 3ubd_A          179 HEKK--AYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGTLPFQGKDRK--------ETMTMILKA-KLGM  245 (304)
T ss_dssp             --CC--CCSCCCCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHC-CCCC
T ss_pred             CCcc--ccccccCcccCCHHHhccC--CCCCCCcccchHHHHHHHHhCCCCCCCcCHH--------HHHHHHHcC-CCCC
Confidence            2221  1234699999999998764  6788999999999999999999999754321        111111111 1234


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSM-----HEVLE  198 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~-----~~ll~  198 (242)
                      +..+++++.+++.+       ||+.||++|||+     +|+++
T Consensus       246 p~~~s~~~~~li~~-------~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          246 PQFLSPEAQSLLRM-------LFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             CTTSCHHHHHHHHH-------HTCSSGGGSTTCSTTTHHHHHT
T ss_pred             CCcCCHHHHHHHHH-------HcccCHHHCCCCCcCCHHHHHc
Confidence            45677777776666       889999999984     67765

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.4e-38  Score=264.19  Aligned_cols=170  Identities=24%  Similarity=0.346  Sum_probs=134.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.+++..       +.+++.++..++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||++.....
T Consensus       230 ~~gG~L~~~i~~-------~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~  299 (423)
T 4fie_A          230 LEGGALTDIVTH-------TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  299 (423)
T ss_dssp             CTTEEHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred             CCCCcHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence            789999999965       3599999999999999999999999   999999999999999999999999999987654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCC--Ccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPG--NDF  158 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~  158 (242)
                      ....  ....+||+.|+|||++.+.  .++.++|||||||++|||++|..||......        .....+...  ...
T Consensus       300 ~~~~--~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--------~~~~~i~~~~~~~~  367 (423)
T 4fie_A          300 EVPR--RKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--------KAMKMIRDNLPPRL  367 (423)
T ss_dssp             SCCC--BCCCEECTTTCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSCCCCC
T ss_pred             CCcc--ccccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------HHHHHHHcCCCCCC
Confidence            3322  1234699999999998664  6789999999999999999999999644321        111111111  111


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .....+++++.+++.+       ||+.||++|||+.|++++
T Consensus       368 ~~~~~~s~~~~dli~~-------~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          368 KNLHKVSPSLKGFLDR-------LLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             SCTTSSCHHHHHHHHH-------HSCSSTTTSCCHHHHTTC
T ss_pred             cccccCCHHHHHHHHH-------HcCCChhHCcCHHHHhcC
Confidence            2234567777776666       889999999999999875

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.8e-35  Score=244.80  Aligned_cols=122  Identities=27%  Similarity=0.402  Sum_probs=101.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCC-CceEEcccccccccC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDED-FCPKISDFGLAKQSQ   79 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~-~~~~L~dfg~~~~~~   79 (242)
                      |+||+|.+++.         .+++.++..++.||+.||.|||++   +|+||||||+|||++.+ +.+||+|||+++...
T Consensus       102 ~~g~~L~~~~~---------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~  169 (361)
T 4f9c_A          102 LEHESFLDILN---------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH  169 (361)
T ss_dssp             CCCCCHHHHHT---------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred             CCcccHHHHHc---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence            68999999983         389999999999999999999999   99999999999999876 789999999997654


Q ss_pred             CCccc--------------------------chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcc
Q 026160           80 DKKST--------------------------ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNAD  133 (242)
Q Consensus        80 ~~~~~--------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~  133 (242)
                      .....                          .......||+.|+|||++.+. ..++.++||||+||++|+|++|+.||.
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~~Pf~  248 (361)
T 4f9c_A          170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGRYPFY  248 (361)
T ss_dssp             TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCCCCCC
Confidence            32111                          011223699999999998764 357889999999999999999999996


Q ss_pred             cc
Q 026160          134 VK  135 (242)
Q Consensus       134 ~~  135 (242)
                      ..
T Consensus       249 ~~  250 (361)
T 4f9c_A          249 KA  250 (361)
T ss_dssp             CC
T ss_pred             CC
Confidence            43

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2e-36  Score=244.50  Aligned_cols=174  Identities=21%  Similarity=0.305  Sum_probs=121.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.....   ....+...++.++.||++||.|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        97 ~~gg~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~  170 (299)
T 4g31_A           97 CRKENLKDWMNGRCT---IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ  170 (299)
T ss_dssp             CCSCCHHHHHHTCCS---GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCCCC-----
T ss_pred             CCCCcHHHHHHhcCC---CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccCccceecCC
Confidence            689999999976532   12345667889999999999999999   999999999999999999999999999986554


Q ss_pred             Ccccc----------hhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhh
Q 026160           81 KKSTI----------SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYK  150 (242)
Q Consensus        81 ~~~~~----------~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~  150 (242)
                      .....          ......||+.|+|||++.+.  .++.++|||||||++|||++   ||......       .....
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyell~---Pf~~~~~~-------~~~~~  238 (299)
T 4g31_A          171 DEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFELLY---PFSTQMER-------VRTLT  238 (299)
T ss_dssp             ---------------------CCCTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHS---CCSSHHHH-------HHHHH
T ss_pred             CccccccccccccccccCCcccCccccCHHHHcCC--CCCCHHHHHHHHHHHHHHcc---CCCCccHH-------HHHHH
Confidence            32111          11223599999999998764  67899999999999999996   66422110       11111


Q ss_pred             ccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          151 HIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .....       ..++..........+++.+||+.||++|||+.+++++
T Consensus       239 ~~~~~-------~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          239 DVRNL-------KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             HHHTT-------CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHhcC-------CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            11111       1223333333444567777999999999999999874

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.3e-35  Score=257.00  Aligned_cols=172  Identities=28%  Similarity=0.367  Sum_probs=136.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.++|.+.      +.+++..+..++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||++.....
T Consensus       274 ~~GGdL~~~l~~~------~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          274 MNGGDLHYHLSQH------GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             CCSCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            6899999999876      4599999999999999999999999   999999999999999999999999999987655


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....    ..+||+.|+|||++... ..++.++|+|||||++|+|++|..||........     ..+..... .....+
T Consensus       345 ~~~~----t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-----~~i~~~i~-~~~~~~  413 (689)
T 3v5w_A          345 KKPH----ASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMTL-TMAVEL  413 (689)
T ss_dssp             CCCC----SCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-----HHHHHHHH-HCCCCC
T ss_pred             CCCC----CccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHhhc-CCCCCC
Confidence            4322    34699999999998542 3578999999999999999999999975443221     11111111 112234


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPS-----MHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps-----~~~ll~~  199 (242)
                      +..+++++++++.+       ||+.||++|++     +.+++++
T Consensus       414 p~~~S~~a~dLI~~-------lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          414 PDSFSPELRSLLEG-------LLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             CTTSCHHHHHHHHH-------HTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             CccCCHHHHHHHHH-------HccCCHhHCCCCCCCCHHHHhcC
Confidence            55678888877777       77999999998     6888753

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.9e-35  Score=244.34  Aligned_cols=124  Identities=28%  Similarity=0.386  Sum_probs=103.1

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      +|+|.++|.+.      +.+++.++..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus       142 ~g~L~~~i~~~------~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~  212 (398)
T 4b99_A          142 ESDLHQIIHSS------QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP  212 (398)
T ss_dssp             SEEHHHHHTSS------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC----
T ss_pred             CCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeecccCc
Confidence            47799998765      5699999999999999999999999   99999999999999999999999999998654321


Q ss_pred             c--cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccc
Q 026160           83 S--TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKA  136 (242)
Q Consensus        83 ~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  136 (242)
                      .  ........||+.|+|||++.+. ..++.++||||+||++|||++|..||...+
T Consensus       213 ~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~  267 (398)
T 4b99_A          213 AEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKN  267 (398)
T ss_dssp             ---CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred             cccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCC
Confidence            1  1112234699999999998764 356889999999999999999999996543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2e-34  Score=235.55  Aligned_cols=193  Identities=23%  Similarity=0.344  Sum_probs=135.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...........+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       113 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~  189 (323)
T 3qup_A          113 MKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYS  189 (323)
T ss_dssp             CTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             ccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEeeccccccccc
Confidence            57899999998765444445799999999999999999999999   999999999999999999999999999986654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ...........++..|.|||.+.+.  .++.++||||||+++|++++ |..||......        .............
T Consensus       190 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--------~~~~~~~~~~~~~  259 (323)
T 3qup_A          190 GDYYRQGCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--------EIYNYLIGGNRLK  259 (323)
T ss_dssp             -----------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------GHHHHHHTTCCCC
T ss_pred             cccccccccccCcccccCchhhcCC--CCCCccchhhHHHHHHHHHhCCCCCccccChH--------HHHHHHhcCCCCC
Confidence            4332222233467789999998664  67899999999999999999 89998754321        1111222222223


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccCCCCC
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKP  213 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~  213 (242)
                      .+..+++++.+       ++.+||+.||++|||+.++++.|+.+.........+
T Consensus       260 ~~~~~~~~l~~-------li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~  306 (323)
T 3qup_A          260 QPPECMEEVYD-------LMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS  306 (323)
T ss_dssp             CCTTCCHHHHH-------HHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred             CCCccCHHHHH-------HHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence            33445555544       445599999999999999999999998876555443

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=5.4e-34  Score=233.39  Aligned_cols=181  Identities=22%  Similarity=0.328  Sum_probs=140.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....     ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        96 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           96 LPLGSLLDHVRQHR-----GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             CTTCBSHHHHHSSG-----GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             CCCCCHHHHHHHcc-----ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            57899999997642     4699999999999999999999999   999999999999999999999999999987655


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ...........++..|+|||.+.+.  .++.++||||||+++|++++ |..||......        .............
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~  237 (325)
T 3kex_A          168 DDKQLLYSEAKTPIKWMALESIHFG--KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--------EVPDLLEKGERLA  237 (325)
T ss_dssp             CTTCCC-----CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--------HHHHHHHTTCBCC
T ss_pred             ccccccccCCCCcccccChHHhccC--CCChhhHhHHhHHHHHHHHhCCCCCccccCHH--------HHHHHHHcCCCCC
Confidence            4333323334577899999998654  57899999999999999999 99999754321        1222222223333


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      .+..++.++.+++.+       ||+.||++|||+.++++.|+.+...
T Consensus       238 ~~~~~~~~~~~li~~-------~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          238 QPQICTIDVYMVMVK-------CWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             CCTTBCTTTTHHHHH-------HTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             CCCcCcHHHHHHHHH-------HcCCChhhCcCHHHHHHHHHHHHhc
Confidence            344456665555554       9999999999999999999988754

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=7.3e-34  Score=236.62  Aligned_cols=187  Identities=23%  Similarity=0.415  Sum_probs=142.3

Q ss_pred             CCCCCcchhccccCCC----------CCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEc
Q 026160            1 MPNGSLDQFTYDQESS----------NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKIS   70 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~   70 (242)
                      |++|+|.+++......          .....+++.+++.++.||+.||.|||+.   +++|+||||+||+++.++.++|+
T Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kl~  245 (370)
T 2psq_A          169 ASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIA  245 (370)
T ss_dssp             CTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEEC
T ss_pred             CCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECCCCCEEEc
Confidence            5789999999865321          1234689999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhh
Q 026160           71 DFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIY  149 (242)
Q Consensus        71 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~  149 (242)
                      |||++................++..|+|||.+.+.  .++.++|||||||++|+|++ |..||.....        ....
T Consensus       246 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~p~~~~~~--------~~~~  315 (370)
T 2psq_A          246 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--------EELF  315 (370)
T ss_dssp             CCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--------GGHH
T ss_pred             cccCCcccCcccceecccCCCcccceECHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHH
Confidence            99999866543322222223467899999998664  67899999999999999999 9999864332        1122


Q ss_pred             hccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhc
Q 026160          150 KHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEIL  207 (242)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~  207 (242)
                      .....+.....+..++.++.++       +.+||+.||++|||+.++++.|+.+....
T Consensus       316 ~~~~~~~~~~~~~~~~~~l~~l-------i~~~l~~dP~~Rpt~~ell~~L~~il~~~  366 (370)
T 2psq_A          316 KLLKEGHRMDKPANCTNELYMM-------MRDCWHAVPSQRPTFKQLVEDLDRILTLT  366 (370)
T ss_dssp             HHHHTTCCCCCCTTSCHHHHHH-------HHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHhcCCCCCCCCCCCHHHHHH-------HHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            2222222333444455555544       44599999999999999999999987653

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.9e-33  Score=229.69  Aligned_cols=195  Identities=34%  Similarity=0.555  Sum_probs=143.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.....  ....+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       117 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  191 (321)
T 2qkw_B          117 MENGNLKRHLYGSDL--PTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTE  191 (321)
T ss_dssp             CTTCBTGGGSSSSCC--CSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred             CCCCcHHHHHhccCC--CccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            578999999976432  334699999999999999999999999   999999999999999999999999999986543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhc-----cCCC
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKH-----IEPG  155 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~  155 (242)
                      ...........++..|+|||.+.+.  .++.++||||||+++|+|++|..||........... ..+....     ....
T Consensus       192 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  268 (321)
T 2qkw_B          192 LDQTHLSTVVKGTLGYIDPEYFIKG--RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL-AEWAVESHNNGQLEQI  268 (321)
T ss_dssp             SSCCCCBCCCEEETTTCCHHHHHHC--BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCH-HHHTHHHHTTTCCCSS
T ss_pred             ccccccccccCCCccccCHHHhcCC--CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHH-HHHhhhccccccHHHh
Confidence            3222222233488999999998654  578899999999999999999999975443221110 0000000     0111


Q ss_pred             CccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          156 NDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      ..........   ......+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       269 ~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          269 VDPNLADKIR---PESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             SSSSCTTCSC---HHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             cChhhccccC---HHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            1111111122   34556677888889999999999999999999987654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=7.4e-34  Score=231.11  Aligned_cols=187  Identities=25%  Similarity=0.429  Sum_probs=131.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCC--eeecCCCCCceeeCCCCceEEccccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVR--IVHFDIKPHNILLDEDFCPKISDFGLAKQS   78 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~--i~h~dlk~~nil~~~~~~~~L~dfg~~~~~   78 (242)
                      |++|+|.+++.....   ...+++..++.++.|++.||.|||+.   +  ++|+||||+||+++.++.++|+|||++...
T Consensus       116 ~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  189 (309)
T 3p86_A          116 LSRGSLYRLLHKSGA---REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK  189 (309)
T ss_dssp             CTTCBHHHHHHSTTH---HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred             CCCCcHHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence            578999999976421   13499999999999999999999998   8  999999999999999999999999998754


Q ss_pred             CCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           79 QDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        79 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      ......  .....++..|+|||.+.+.  ..+.++||||||+++|++++|..||......       .............
T Consensus       190 ~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~-------~~~~~~~~~~~~~  258 (309)
T 3p86_A          190 ASTFLS--SKSAAGTPEWMAPEVLRDE--PSNEKSDVYSFGVILWELATLQQPWGNLNPA-------QVVAAVGFKCKRL  258 (309)
T ss_dssp             --------------CCTTSCHHHHTTC--CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH-------HHHHHHHHSCCCC
T ss_pred             cccccc--cccCCCCccccChhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcCCCC
Confidence            432211  1223589999999998764  5688999999999999999999999744321       1111111112222


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccCCC
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPP  211 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~  211 (242)
                      ..+..+++++.+++.       +||+.||++|||+.++++.|+.+.+....++
T Consensus       259 ~~~~~~~~~l~~li~-------~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~  304 (309)
T 3p86_A          259 EIPRNLNPQVAAIIE-------GCWTNEPWKRPSFATIMDLLRPLIKSAVPPP  304 (309)
T ss_dssp             CCCTTSCHHHHHHHH-------HHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred             CCCccCCHHHHHHHH-------HHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence            334456666555554       4999999999999999999999987654443

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5.1e-34  Score=249.13  Aligned_cols=171  Identities=23%  Similarity=0.368  Sum_probs=133.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCC--CceEEccccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDED--FCPKISDFGLAKQS   78 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~--~~~~L~dfg~~~~~   78 (242)
                      |+||+|.++|.+..     ..+++.++..++.||+.||.|||++   +|+||||||+|||++.+  +.+||+|||+++..
T Consensus       236 ~~gg~L~~~i~~~~-----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          236 MSGGELFEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             CCCCBHHHHHTCTT-----SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred             cCCCcHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence            68999999996542     4699999999999999999999999   99999999999999854  78999999999877


Q ss_pred             CCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCC---C
Q 026160           79 QDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEP---G  155 (242)
Q Consensus        79 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~  155 (242)
                      .......   ...||+.|+|||++.+.  .++.++|||||||++|+|++|..||......        .....+..   .
T Consensus       308 ~~~~~~~---~~~GT~~y~APEv~~~~--~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~--------~~~~~i~~~~~~  374 (573)
T 3uto_A          308 DPKQSVK---VTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGENDD--------ETLRNVKSCDWN  374 (573)
T ss_dssp             CTTSEEE---EECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHTTCCC
T ss_pred             cCCCcee---eeEECccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------HHHHHHHhCCCC
Confidence            6543322   34599999999998764  6788999999999999999999999744321        11111111   1


Q ss_pred             CccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          156 NDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ........+++++.+++.+       ||+.||++|||+.|++++
T Consensus       375 ~~~~~~~~~s~~~~dli~~-------~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          375 MDDSAFSGISEDGKDFIRK-------LLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             CCSGGGTTSCHHHHHHHHT-------TSCSSGGGSCCHHHHHHS
T ss_pred             CCcccccCCCHHHHHHHHH-------HccCChhHCcCHHHHhcC
Confidence            1112223456666665555       889999999999999985

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=7.8e-34  Score=232.69  Aligned_cols=181  Identities=25%  Similarity=0.391  Sum_probs=138.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....     ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        98 ~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           98 MPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             CTTCBHHHHHHHST-----TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             cCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            57899999997643     4699999999999999999999999   999999999999999999999999999987654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ...........++..|+|||.+.+.  .++.++||||||+++|++++ |..||......        ........+....
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~~~~~~~~~~~~  239 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------EISSILEKGERLP  239 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------GHHHHHHTTCCCC
T ss_pred             CcccccccCCCccccccChHHhccC--CCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--------HHHHHHHcCCCCC
Confidence            4333222333467899999998764  67899999999999999999 99999754321        1112222222223


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      .+..++..+.       .++.+||+.||++|||+.++++.|+.+...
T Consensus       240 ~~~~~~~~~~-------~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          240 QPPICTIDVY-------MIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             CCTTBCHHHH-------HHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             CCccCCHHHH-------HHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence            3334555444       455559999999999999999999988754

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.9e-33  Score=228.72  Aligned_cols=187  Identities=25%  Similarity=0.374  Sum_probs=137.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...........+++.+++.++.|+++||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       123 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~  199 (313)
T 3brb_A          123 MKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYS  199 (313)
T ss_dssp             CTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSCSCC-----
T ss_pred             ccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeecCcceeccc
Confidence            57899999997655545567899999999999999999999999   999999999999999999999999999986554


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ...........++..|.|||.+.+.  .++.++||||||+++|+|++ |..||......        .............
T Consensus       200 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~  269 (313)
T 3brb_A          200 GDYYRQGRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--------EMYDYLLHGHRLK  269 (313)
T ss_dssp             -----------CCGGGSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--------GHHHHHHTTCCCC
T ss_pred             ccccCcccccCCCccccCchhhcCC--CccchhhhHHHHHHHHHHHhcCCCCCccCCHH--------HHHHHHHcCCCCC
Confidence            3322222223467889999998653  67889999999999999999 88888644321        1111122222223


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhc
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEIL  207 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~  207 (242)
                      .+..+++.+.++       +.+||+.||++|||+.++++.|+.+.+.+
T Consensus       270 ~~~~~~~~l~~l-------i~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          270 QPEDCLDELYEI-------MYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             CBTTCCHHHHHH-------HHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CCccccHHHHHH-------HHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            334455555444       44599999999999999999999988764

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-33  Score=234.17  Aligned_cols=192  Identities=24%  Similarity=0.418  Sum_probs=145.9

Q ss_pred             CCCCCcchhccccCCC----------CCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEc
Q 026160            1 MPNGSLDQFTYDQESS----------NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKIS   70 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~   70 (242)
                      |++|+|.+++......          .....+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+
T Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~  233 (382)
T 3tt0_A          157 ASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIA  233 (382)
T ss_dssp             CTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEEC
T ss_pred             cCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEcCCCcEEEc
Confidence            5789999999875321          2235699999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhh
Q 026160           71 DFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIY  149 (242)
Q Consensus        71 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~  149 (242)
                      |||++................++..|+|||.+.+.  .++.++||||||+++|++++ |..||.....        ....
T Consensus       234 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~ellt~g~~p~~~~~~--------~~~~  303 (382)
T 3tt0_A          234 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--------EELF  303 (382)
T ss_dssp             SCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHH
T ss_pred             ccCcccccccccccccccCCCCCcceeCHHHhcCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHH
Confidence            99999866543322222233477899999998653  67889999999999999999 9999864332        1222


Q ss_pred             hccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccCCCC
Q 026160          150 KHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPK  212 (242)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~~  212 (242)
                      .....+.....+..+++++.+++.       +||+.||++|||+.++++.|+.+.........
T Consensus       304 ~~~~~~~~~~~~~~~~~~l~~li~-------~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~  359 (382)
T 3tt0_A          304 KLLKEGHRMDKPSNCTNELYMMMR-------DCWHAVPSQRPTFKQLVEDLDRIVALTSNQEM  359 (382)
T ss_dssp             HHHHTTCCCCCCSSCCHHHHHHHH-------HHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC-
T ss_pred             HHHHcCCCCCCCccCCHHHHHHHH-------HHcCCChhhCcCHHHHHHHHHHHHHHHhcCCC
Confidence            222223233334455655555444       49999999999999999999999876554443

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.9e-34  Score=232.67  Aligned_cols=181  Identities=25%  Similarity=0.375  Sum_probs=133.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....     ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        98 ~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           98 MPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             CSSCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             cCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            57899999997643     4699999999999999999999999   999999999999999999999999999987654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ...........++..|+|||.+.+.  .++.++||||||+++|++++ |..||......        .............
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--------~~~~~~~~~~~~~  239 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------EISSILEKGERLP  239 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------GHHHHHHTTCCCC
T ss_pred             ccccccccCCCccccccCHHHHcCC--CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--------HHHHHHHcCCCCC
Confidence            4333222233467789999998764  67889999999999999999 99999754322        1222222222333


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      .+..++.++.++       +.+||+.||++|||+.++++.|+.+...
T Consensus       240 ~~~~~~~~l~~l-------i~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          240 QPPICTIDVYMI-------MRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             CCTTBCHHHHHH-------HHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             CCccCCHHHHHH-------HHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            344455555544       4459999999999999999999998754

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.9e-33  Score=226.99  Aligned_cols=198  Identities=17%  Similarity=0.158  Sum_probs=144.4

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCc-----eEEcccccccc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFC-----PKISDFGLAKQ   77 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~-----~~L~dfg~~~~   77 (242)
                      +|+|.+++....     ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.     ++|+|||++..
T Consensus        89 ~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           89 GPSLEDLLDLCG-----RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             CCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             CCCHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            899999997642     3599999999999999999999999   9999999999999987665     99999999986


Q ss_pred             cCCCccc-----chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhcc
Q 026160           78 SQDKKST-----ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHI  152 (242)
Q Consensus        78 ~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  152 (242)
                      .......     .......++..|.|||.+.+.  .++.++||||||+++|++++|..||............. ......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~-~~~~~~  237 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE-RIGEKK  237 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH-HHHHHH
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHH-HHHhhc
Confidence            6543221     111233589999999998654  57889999999999999999999997543221110000 000000


Q ss_pred             CCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccCCCCCCCCCC
Q 026160          153 EPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSLALP  218 (242)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~~~~~~  218 (242)
                      ...........+++++       .+++.+||+.||++|||+.++++.|+.+.+.+........+|.
T Consensus       238 ~~~~~~~~~~~~~~~l-------~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~  296 (298)
T 1csn_A          238 QSTPLRELCAGFPEEF-------YKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN  296 (298)
T ss_dssp             HHSCHHHHTTTSCHHH-------HHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred             cCccHHHHHhhCcHHH-------HHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccC
Confidence            0000111112334444       4455559999999999999999999999988777666666653

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.3e-33  Score=233.88  Aligned_cols=166  Identities=26%  Similarity=0.406  Sum_probs=128.7

Q ss_pred             ccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccccchh
Q 026160           22 LEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEV  101 (242)
Q Consensus        22 l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~  101 (242)
                      +++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++................++..|+|||.
T Consensus       190 l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~  266 (359)
T 3vhe_A          190 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET  266 (359)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhh
Confidence            99999999999999999999999   999999999999999999999999999986654433333333457889999999


Q ss_pred             hhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccccccccchHHHHHHHHHHHHHH
Q 026160          102 FCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSL  180 (242)
Q Consensus       102 ~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  180 (242)
                      +.+.  .++.++||||||+++|+|++ |..||......       .........+.....+..+++++.+++       .
T Consensus       267 ~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li-------~  330 (359)
T 3vhe_A          267 IFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------EEFCRRLKEGTRMRAPDYTTPEMYQTM-------L  330 (359)
T ss_dssp             HHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-------HHHHHHHHHTCCCCCCTTCCHHHHHHH-------H
T ss_pred             hcCC--CCCchhhhhhHHHHHHHHHhcCCCCCCccchh-------HHHHHHHHcCCCCCCCCCCCHHHHHHH-------H
Confidence            8754  67899999999999999998 99998644321       111122222222333444565555544       4


Q ss_pred             HhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          181 WCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       181 ~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      +||+.||++|||+.+++++|+.+.+.
T Consensus       331 ~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          331 DCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHccCChhhCCCHHHHHHHHHHHHHH
Confidence            59999999999999999999988764

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.6e-33  Score=235.07  Aligned_cols=180  Identities=24%  Similarity=0.377  Sum_probs=137.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....     ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       194 ~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          194 VQGGDFLTFLRTEG-----ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             CTTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             CCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            57999999997642     3599999999999999999999999   999999999999999999999999999986544


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ...........++..|+|||.+...  .++.++||||||+++||+++ |..||.....        .........+....
T Consensus       266 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~  335 (377)
T 3cbl_A          266 GVYAASGGLRQVPVKWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPNLSN--------QQTREFVEKGGRLP  335 (377)
T ss_dssp             SEEECCSSCCEEEGGGSCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--------HHHHHHHHTTCCCC
T ss_pred             CceeecCCCCCCCcCcCCHhHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCC
Confidence            3222111122356789999998653  57889999999999999998 8999864332        11112222233333


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTE  205 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~  205 (242)
                      .+..+++++.+       ++.+||+.||++|||+.++++.|+.+..
T Consensus       336 ~~~~~~~~l~~-------li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          336 CPELCPDAVFR-------LMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             CCTTCCHHHHH-------HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHH-------HHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence            34445555444       5555999999999999999999998765

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.8e-33  Score=229.98  Aligned_cols=198  Identities=26%  Similarity=0.316  Sum_probs=141.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhC-------CCCCeeecCCCCCceeeCCCCceEEcccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRG-------CNVRIVHFDIKPHNILLDEDFCPKISDFG   73 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~-------~~~~i~h~dlk~~nil~~~~~~~~L~dfg   73 (242)
                      |++|+|.+++...       .+++.+++.++.|++.||.|||+.       +..+++|+||||+||+++.++.++|+|||
T Consensus       104 ~~~g~L~~~l~~~-------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg  176 (322)
T 3soc_A          104 HEKGSLSDFLKAN-------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG  176 (322)
T ss_dssp             CTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence            5789999999653       499999999999999999999985       12389999999999999999999999999


Q ss_pred             cccccCCCcccchhcccccccccccchhhhccc---CCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcC------
Q 026160           74 LAKQSQDKKSTISMLHARGTIGYIAPEVFCRSF---GGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYF------  144 (242)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~---~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~------  144 (242)
                      ++................++..|+|||.+.+..   ..++.++|||||||++|+|++|..||............      
T Consensus       177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  256 (322)
T 3soc_A          177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH  256 (322)
T ss_dssp             TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred             cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence            997665443322222345899999999986531   13456889999999999999999999754332211100      


Q ss_pred             ---cchhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhc
Q 026160          145 ---PNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEIL  207 (242)
Q Consensus       145 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~  207 (242)
                         .....................  .......+.+++.+||+.||++|||+.++++.|+.+.+..
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~  320 (322)
T 3soc_A          257 PSLEDMQEVVVHKKKRPVLRDYWQ--KHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT  320 (322)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGG--SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CchhhhhhhhhcccCCCCcccccc--ccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence               000011111111111111111  1123455777888899999999999999999999987653

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5.4e-33  Score=224.05  Aligned_cols=198  Identities=19%  Similarity=0.224  Sum_probs=146.1

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceee---CCCCceEEcccccccccC
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGLAKQSQ   79 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~---~~~~~~~L~dfg~~~~~~   79 (242)
                      +|+|.+++....     +.+++.+++.++.|++.||.|||+.   +++|+||||+||++   +.++.++|+|||++....
T Consensus        88 ~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           88 GPSLEDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CCBHHHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            799999997532     4599999999999999999999999   99999999999999   788899999999998655


Q ss_pred             CCccc-----chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCC
Q 026160           80 DKKST-----ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEP  154 (242)
Q Consensus        80 ~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  154 (242)
                      .....     .......++..|.|||.+.+.  .++.++||||||+++|++++|..||.................... .
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~  236 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-S  236 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH-H
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCC--CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc-c
Confidence            43221     111233589999999998764  578899999999999999999999975443322211111111100 0


Q ss_pred             CCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccCCCCCCCCCC
Q 026160          155 GNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSLALP  218 (242)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~~~~~~  218 (242)
                      .........++++       +.+++..||+.||++|||+.++++.|+.+.+..........+|.
T Consensus       237 ~~~~~~~~~~~~~-------l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~  293 (296)
T 4hgt_A          237 TPIEVLCKGYPSE-------FATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN  293 (296)
T ss_dssp             SCHHHHTTTSCHH-------HHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGG
T ss_pred             chhhhhhccCCHH-------HHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchh
Confidence            0001111223444       44555559999999999999999999999998877766666554

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1e-32  Score=225.66  Aligned_cols=195  Identities=38%  Similarity=0.647  Sum_probs=143.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....  .....+++..+..++.|++.||.|||+.+..+++|+||||+||+++.++.++|+|||++.....
T Consensus       109 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  186 (326)
T 3uim_A          109 MANGSVASCLRERP--ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY  186 (326)
T ss_dssp             CTTCBHHHHHHCCS--TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCS
T ss_pred             ccCCCHHHHHHhcc--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCc
Confidence            57899999997653  2445699999999999999999999997556899999999999999999999999999986654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCC-cCcchhhhccCCC----
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDI-YFPNSIYKHIEPG----  155 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~----  155 (242)
                      ..... .....++..|+|||.+.+.  .++.++||||||+++|+|++|..||.......... ....+........    
T Consensus       187 ~~~~~-~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (326)
T 3uim_A          187 KDTHV-TTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA  263 (326)
T ss_dssp             SSSCE-ECCCCSCGGGCCHHHHHHS--EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTT
T ss_pred             ccccc-cccccCCcCccCHHHhccC--CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhh
Confidence            32221 1223489999999998654  56889999999999999999999997443222111 1111111111111    


Q ss_pred             -CccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          156 -NDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       156 -~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                       .........   .......+.+++.+||+.||++|||+.+++++|++.
T Consensus       264 ~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          264 LVDVDLQGNY---KDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             SSCTTCTTSC---CHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             hcChhhcccc---CHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence             111111112   234456778888889999999999999999999863

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.8e-33  Score=232.55  Aligned_cols=198  Identities=16%  Similarity=0.167  Sum_probs=145.0

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeC--CCCceEEcccccccccCC
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD--EDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~--~~~~~~L~dfg~~~~~~~   80 (242)
                      +|+|.+++....     +.+++.+++.++.||+.||.|||+.   +|+|+||||+|||++  .++.++|+|||++.....
T Consensus       135 g~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~  206 (364)
T 3op5_A          135 GSDLQKIYEANA-----KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP  206 (364)
T ss_dssp             EEEHHHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCTTCEEECCCTTCEESSG
T ss_pred             CCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCCCeEEEEECCcceeccc
Confidence            789999987642     4699999999999999999999999   999999999999998  889999999999976543


Q ss_pred             Ccccch-----hcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCC
Q 026160           81 KKSTIS-----MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPG  155 (242)
Q Consensus        81 ~~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  155 (242)
                      ......     .....+|..|+|||.+.+.  .++.++|||||||++|+|++|..||..........   ..........
T Consensus       207 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~---~~~~~~~~~~  281 (364)
T 3op5_A          207 EGVHKAYAADPKRCHDGTIEFTSIDAHNGV--APSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV---RDSKIRYREN  281 (364)
T ss_dssp             GGCCCCSSCCSSCCCCCCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH---HHHHHHHHHC
T ss_pred             CCcccccccCcccccCCCCCccCHHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH---HHHHHHhhhh
Confidence            322111     1123489999999998764  57899999999999999999999998533211000   0000000000


Q ss_pred             Cc----ccc-ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccCCCCCCCCCCcc
Q 026160          156 ND----FQL-DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSLALPKK  220 (242)
Q Consensus       156 ~~----~~~-~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~~~~~~~~  220 (242)
                      ..    ..+ ...++       ..+..++..||+.||++||++.++++.|+.+.+..........+|...
T Consensus       282 ~~~~~~~~~~~~~~~-------~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~  344 (364)
T 3op5_A          282 IASLMDKCFPAANAP-------GEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVV  344 (364)
T ss_dssp             HHHHHHHHSCTTCCC-------HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC---
T ss_pred             HHHHHHHhcccccCH-------HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEec
Confidence            00    000 01223       345556666999999999999999999999999988888888877654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.5e-32  Score=223.20  Aligned_cols=186  Identities=24%  Similarity=0.348  Sum_probs=139.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....     ..+++.++..++.|+++||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        89 ~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  160 (310)
T 3s95_A           89 IKGGTLRGIIKSMD-----SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVD  160 (310)
T ss_dssp             CTTCBHHHHHHHCC-----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred             cCCCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence            57999999997642     4699999999999999999999999   999999999999999999999999999986644


Q ss_pred             Ccccch------------hcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchh
Q 026160           81 KKSTIS------------MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSI  148 (242)
Q Consensus        81 ~~~~~~------------~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~  148 (242)
                      ......            .....|++.|+|||.+.+.  .++.++||||||+++|++++|..|+................
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~  238 (310)
T 3s95_A          161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR--SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG  238 (310)
T ss_dssp             -------------------CCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHH
T ss_pred             ccccccccccccccccccccccCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhc
Confidence            322110            0123589999999998663  67889999999999999999999886544332221111110


Q ss_pred             hhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccC
Q 026160          149 YKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQI  209 (242)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~  209 (242)
                      ..      ....+..+++.+.+++       .+||+.||++|||+.++++.|+.+...+..
T Consensus       239 ~~------~~~~~~~~~~~l~~li-------~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~  286 (310)
T 3s95_A          239 FL------DRYCPPNCPPSFFPIT-------VRCCDLDPEKRPSFVKLEHWLETLRMHLAG  286 (310)
T ss_dssp             HH------HHTCCTTCCTTHHHHH-------HHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             cc------cccCCCCCCHHHHHHH-------HHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence            00      0111234555555544       459999999999999999999998876543

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=8e-33  Score=223.15  Aligned_cols=199  Identities=19%  Similarity=0.220  Sum_probs=146.7

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeC---CCCceEEcccccccccC
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD---EDFCPKISDFGLAKQSQ   79 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~---~~~~~~L~dfg~~~~~~   79 (242)
                      +|+|.+++....     ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++   .++.++|+|||++....
T Consensus        88 ~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           88 GPSLEDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CCCHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            789999997432     4699999999999999999999999   999999999999994   78899999999998665


Q ss_pred             CCcccc-----hhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCC
Q 026160           80 DKKSTI-----SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEP  154 (242)
Q Consensus        80 ~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  154 (242)
                      ......     ......++..|.|||.+.+.  .++.++||||||+++|++++|..||.................... .
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~  236 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-S  236 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH-H
T ss_pred             ccccccccccccccccccccccCChhhhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc-C
Confidence            432211     11233589999999998764  578899999999999999999999975443322211111111100 0


Q ss_pred             CCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccCCCCCCCCCCc
Q 026160          155 GNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSLALPK  219 (242)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~~~~~~~  219 (242)
                      .........++++       +..++.+||+.||++|||+.++++.|+.+............+|..
T Consensus       237 ~~~~~~~~~~~~~-------l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~  294 (296)
T 3uzp_A          237 TPIEVLCKGYPSE-------FATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM  294 (296)
T ss_dssp             SCHHHHTTTSCHH-------HHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGG
T ss_pred             CchHHHHhhCCHH-------HHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccccc
Confidence            0011111234444       444555599999999999999999999999888777776666643

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1e-32  Score=225.68  Aligned_cols=178  Identities=25%  Similarity=0.256  Sum_probs=132.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        87 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  157 (323)
T 3tki_A           87 CSGGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (323)
T ss_dssp             CTTEEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             CCCCcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence            5789999999764      4599999999999999999999999   999999999999999999999999999976543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ...........+++.|+|||.+.+. ...+.++||||||+++|+|++|..||........      ..............
T Consensus       158 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~~~~~~~~~~~~  230 (323)
T 3tki_A          158 NNRERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------EYSDWKEKKTYLNP  230 (323)
T ss_dssp             TTEECCBCSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH------HHHHHHTTCTTSTT
T ss_pred             CCcccccCCCccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH------HHHHHhcccccCCc
Confidence            3222222234689999999998654 2347789999999999999999999975443211      11111111111111


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      ...+++.+.       +++.+||+.||++|||+.+++++-.
T Consensus       231 ~~~~~~~~~-------~li~~~L~~dP~~R~t~~eil~h~~  264 (323)
T 3tki_A          231 WKKIDSAPL-------ALLHKILVENPSARITIPDIKKDRW  264 (323)
T ss_dssp             GGGSCHHHH-------HHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred             cccCCHHHH-------HHHHHHccCChhhCcCHHHHhhChh
Confidence            223444444       4555588999999999999987643

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-33  Score=234.22  Aligned_cols=190  Identities=24%  Similarity=0.352  Sum_probs=141.2

Q ss_pred             CCCCCcchhccccCC-CCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCC---ceEEccccccc
Q 026160            1 MPNGSLDQFTYDQES-SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF---CPKISDFGLAK   76 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~-~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~---~~~L~dfg~~~   76 (242)
                      |++|+|.+++..... ......+++.+++.++.|++.||.|||+.   +|+|+||||+|||++.++   .++|+|||++.
T Consensus       156 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~  232 (367)
T 3l9p_A          156 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR  232 (367)
T ss_dssp             CTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHHH
T ss_pred             CCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECCCcccc
Confidence            578999999987532 22335699999999999999999999999   999999999999998554   59999999997


Q ss_pred             ccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCC
Q 026160           77 QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPG  155 (242)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  155 (242)
                      ...............+++.|+|||.+.+.  .++.++|||||||++|+|++ |..||.....        .........+
T Consensus       233 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~pf~~~~~--------~~~~~~i~~~  302 (367)
T 3l9p_A          233 DIYRAGYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QEVLEFVTSG  302 (367)
T ss_dssp             HHHHHSSCTTCCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHHHHHTT
T ss_pred             ccccccccccCCCcCCcccEECHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcC
Confidence            54322211112223478899999998664  67889999999999999998 9999864432        1122222222


Q ss_pred             CccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccCC
Q 026160          156 NDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIP  210 (242)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~  210 (242)
                      .....+..++..+.       +++.+||+.||++|||+.++++.|+.+.....+.
T Consensus       303 ~~~~~~~~~~~~l~-------~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~~  350 (367)
T 3l9p_A          303 GRMDPPKNCPGPVY-------RIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI  350 (367)
T ss_dssp             CCCCCCTTCCHHHH-------HHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHH
T ss_pred             CCCCCCccCCHHHH-------HHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhhc
Confidence            22333344555544       4555599999999999999999999988764433

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=6e-33  Score=225.67  Aligned_cols=186  Identities=25%  Similarity=0.409  Sum_probs=141.1

Q ss_pred             CCCCCcchhccccCCCC------------------CCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeC
Q 026160            1 MPNGSLDQFTYDQESSN------------------GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD   62 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~------------------~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~   62 (242)
                      |++|+|.+++.......                  ....+++.+++.++.|++.||.|||+.   +++|+||||+||+++
T Consensus       108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NIli~  184 (314)
T 2ivs_A          108 AKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVA  184 (314)
T ss_dssp             CTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEE
T ss_pred             cCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchheEEEc
Confidence            57899999998653211                  124599999999999999999999999   999999999999999


Q ss_pred             CCCceEEcccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCC
Q 026160           63 EDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSD  141 (242)
Q Consensus        63 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~  141 (242)
                      .++.++|+|||++................++..|+|||.+.+.  .++.++||||||+++|+|++ |..||.....    
T Consensus       185 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~----  258 (314)
T 2ivs_A          185 EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP----  258 (314)
T ss_dssp             TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCG----
T ss_pred             CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC--CcCchhhHHHHHHHHHHHHhCCCCCCCCCCH----
Confidence            9999999999999866544333222233467889999998653  56889999999999999999 9999864432    


Q ss_pred             CcCcchhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          142 IYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                          ...............+..+++.+.+++.+       ||+.||++|||+.++++.|+++...
T Consensus       259 ----~~~~~~~~~~~~~~~~~~~~~~~~~li~~-------~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          259 ----ERLFNLLKTGHRMERPDNCSEEMYRLMLQ-------CWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             ----GGHHHHHHTTCCCCCCTTCCHHHHHHHHH-------HTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ----HHHHHHhhcCCcCCCCccCCHHHHHHHHH-------HccCChhhCcCHHHHHHHHHHHHhh
Confidence                11222222222333344556655555544       8899999999999999999987653

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.5e-33  Score=224.62  Aligned_cols=189  Identities=22%  Similarity=0.256  Sum_probs=134.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhh--------hCCCCCeeecCCCCCceeeCCCCceEEccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLH--------RGCNVRIVHFDIKPHNILLDEDFCPKISDF   72 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH--------~~~~~~i~h~dlk~~nil~~~~~~~~L~df   72 (242)
                      |++|+|.+++..       ..+++..++.++.|++.||.|||        +.   +++|+||||+||+++.++.++|+||
T Consensus        88 ~~~g~L~~~l~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Df  157 (301)
T 3q4u_A           88 HEMGSLYDYLQL-------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADL  157 (301)
T ss_dssp             CTTCBHHHHHTT-------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCC
T ss_pred             ccCCCHHHHHhh-------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeC
Confidence            578999999954       35999999999999999999999        77   9999999999999999999999999


Q ss_pred             ccccccCCCcccc--hhcccccccccccchhhhcccC----CCCCCccchhHHHHHHHHHhc----------CCCccccc
Q 026160           73 GLAKQSQDKKSTI--SMLHARGTIGYIAPEVFCRSFG----GASHKSDVYSYGMMILEMAVG----------RKNADVKA  136 (242)
Q Consensus        73 g~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~----~~~~~~Di~slG~~~~~ll~g----------~~p~~~~~  136 (242)
                      |++..........  ......++..|+|||.+.+...    .++.++||||||+++|+|++|          ..||....
T Consensus       158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence            9997554332221  1112358999999999865422    234689999999999999999          66664333


Q ss_pred             cCCCCCcCcchhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          137 SRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                      ......  ................+...  ........+.+++.+||+.||++|||+.++++.|+++
T Consensus       238 ~~~~~~--~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          238 PNDPSF--EDMRKVVCVDQQRPNIPNRW--FSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CSSCCH--HHHHHHHTTSCCCCCCCGGG--GGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcch--hhhhHHHhccCCCCCCChhh--ccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            222111  01111111111111111111  1123445677778889999999999999999999875

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.5e-33  Score=228.48  Aligned_cols=188  Identities=24%  Similarity=0.334  Sum_probs=138.3

Q ss_pred             CCCCCcchhccccCCC-----------------CCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC
Q 026160            1 MPNGSLDQFTYDQESS-----------------NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE   63 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~-----------------~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~   63 (242)
                      |++|+|.+++......                 .....+++..++.++.|++.||.|||+.   +++|+||||+||+++.
T Consensus       131 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~  207 (344)
T 1rjb_A          131 CCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTH  207 (344)
T ss_dssp             CTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEEET
T ss_pred             CCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEEcC
Confidence            5789999999765321                 1124589999999999999999999999   9999999999999999


Q ss_pred             CCceEEcccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCC
Q 026160           64 DFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDI  142 (242)
Q Consensus        64 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~  142 (242)
                      ++.++|+|||++................++..|+|||.+.+.  .++.++||||||+++|+|++ |..||......    
T Consensus       208 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----  281 (344)
T 1rjb_A          208 GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD----  281 (344)
T ss_dssp             TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS----
T ss_pred             CCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC--CCChhHhHHHHHHHHHHHHcCCCCCcccCCcH----
Confidence            999999999999765443322222233467889999988664  57889999999999999998 99998654321    


Q ss_pred             cCcchhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhc
Q 026160          143 YFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEIL  207 (242)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~  207 (242)
                         ...............+..+++++.+++       .+||+.||++|||+.++++.|+.+....
T Consensus       282 ---~~~~~~~~~~~~~~~~~~~~~~l~~li-------~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          282 ---ANFYKLIQNGFKMDQPFYATEEIYIIM-------QSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             ---HHHHHHHHTTCCCCCCTTCCHHHHHHH-------HHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             ---HHHHHHHhcCCCCCCCCCCCHHHHHHH-------HHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence               111122222222233344555555544       4599999999999999999999877653

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.8e-33  Score=230.14  Aligned_cols=200  Identities=21%  Similarity=0.267  Sum_probs=148.3

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCC--ceEEcccccccccCC
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF--CPKISDFGLAKQSQD   80 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~--~~~L~dfg~~~~~~~   80 (242)
                      +|+|.+++....    ...+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++  .++|+|||++.....
T Consensus       141 ~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~  213 (352)
T 2jii_A          141 GRSLQSALDVSP----KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP  213 (352)
T ss_dssp             CEEHHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSG
T ss_pred             CcCHHHHHHhCC----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcCCCCceEEEecCcceeeccC
Confidence            789999998652    25699999999999999999999999   999999999999999988  899999999976554


Q ss_pred             Ccccc-----hhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCC
Q 026160           81 KKSTI-----SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPG  155 (242)
Q Consensus        81 ~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  155 (242)
                      .....     ......++..|+|||.+.+.  .++.++||||||+++|+|++|..||...........  ..........
T Consensus       214 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~--~~~~~~~~~~  289 (352)
T 2jii_A          214 SGKHVAYVEGSRSPHEGDLEFISMDLHKGC--GPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIM--KQKQKFVDKP  289 (352)
T ss_dssp             GGCCCCCCTTSSCTTCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH--HHHHHHHHSC
T ss_pred             CCccccccccccccccCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHH--HHHHhccCCh
Confidence            32211     11123589999999998764  578899999999999999999999976542211110  0000000000


Q ss_pred             Ccc----ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccCCCCCCCCCCcc
Q 026160          156 NDF----QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSLALPKK  220 (242)
Q Consensus       156 ~~~----~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~~~~~~~~  220 (242)
                      ...    .....+++++.+++.+       ||+.||++|||+.++++.|+.+.+........+..|+..
T Consensus       290 ~~~~~~~~~~~~~~~~l~~li~~-------~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~dw~~~  351 (352)
T 2jii_A          290 GPFVGPCGHWIRPSETLQKYLKV-------VMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGLPMV  351 (352)
T ss_dssp             CCEECTTSCEECCCHHHHHHHHH-------HHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCCCCC-
T ss_pred             hhhhhhccccCCCcHHHHHHHHH-------HHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccccCcCC
Confidence            000    0011245555555554       889999999999999999999999988888888888753

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.6e-33  Score=225.32  Aligned_cols=190  Identities=22%  Similarity=0.345  Sum_probs=135.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....     ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        95 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~  166 (295)
T 3ugc_A           95 LPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ  166 (295)
T ss_dssp             CTTCBHHHHHHHCG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred             CCCCCHHHHHHhcc-----cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence            57999999997653     3599999999999999999999999   999999999999999999999999999986654


Q ss_pred             Cccc-chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccC--------CCCCcCcchhhhc
Q 026160           81 KKST-ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASR--------SSDIYFPNSIYKH  151 (242)
Q Consensus        81 ~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~--------~~~~~~~~~~~~~  151 (242)
                      .... .......++..|+|||.+.+.  .++.++||||||+++|++++|..||......        .............
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (295)
T 3ugc_A          167 DKEFFKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL  244 (295)
T ss_dssp             ---------CTTCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred             CcceeeeccCCCCccceeCcHHhcCC--CCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence            3221 111123467789999998764  6789999999999999999999887543211        0000000011112


Q ss_pred             cCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhc
Q 026160          152 IEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEIL  207 (242)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~  207 (242)
                      .........+..+++++.++       +.+||+.||++|||+.++++.|+.+.+.+
T Consensus       245 ~~~~~~~~~~~~~~~~l~~l-------i~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          245 LKNNGRLPRPDGCPDEIYMI-------MTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             HHTTCCCCCCTTCCHHHHHH-------HHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HhccCcCCCCcCcCHHHHHH-------HHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            22222333344555555554       44599999999999999999999987754

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-33  Score=229.24  Aligned_cols=187  Identities=25%  Similarity=0.360  Sum_probs=139.0

Q ss_pred             CCCCCcchhccccCCC------------------CCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeC
Q 026160            1 MPNGSLDQFTYDQESS------------------NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD   62 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~   62 (242)
                      |++|+|.+++......                  .....+++.+++.++.|+++||.|||+.   +++|+||||+||+++
T Consensus       132 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~  208 (343)
T 1luf_A          132 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVG  208 (343)
T ss_dssp             CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred             CCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEC
Confidence            5789999999764211                  1125799999999999999999999999   999999999999999


Q ss_pred             CCCceEEcccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCC
Q 026160           63 EDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSD  141 (242)
Q Consensus        63 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~  141 (242)
                      .++.++|+|||++................++..|+|||.+.+.  .++.++||||||+++|+|++ |..||.....    
T Consensus       209 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~----  282 (343)
T 1luf_A          209 ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMAH----  282 (343)
T ss_dssp             GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH----
T ss_pred             CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC--CcCcccccHHHHHHHHHHHhcCCCcCCCCCh----
Confidence            9999999999999765443322222233578899999998754  57899999999999999998 9999864332    


Q ss_pred             CcCcchhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhc
Q 026160          142 IYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEIL  207 (242)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~  207 (242)
                          .........+.....+..+++.+.++       +.+||+.||++|||+.++++.|+.+.+..
T Consensus       283 ----~~~~~~~~~~~~~~~~~~~~~~l~~l-------i~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          283 ----EEVIYYVRDGNILACPENCPLELYNL-------MRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             ----HHHHHHHHTTCCCCCCTTCCHHHHHH-------HHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             ----HHHHHHHhCCCcCCCCCCCCHHHHHH-------HHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence                11112222222233344555555544       44599999999999999999999887653

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1e-32  Score=219.64  Aligned_cols=180  Identities=23%  Similarity=0.454  Sum_probs=137.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....     ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        85 ~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  156 (268)
T 3sxs_A           85 ISNGCLLNYLRSHG-----KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD  156 (268)
T ss_dssp             CTTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred             cCCCcHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecch
Confidence            57899999997652     4699999999999999999999999   999999999999999999999999999986654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ..... .....++..|.|||.+.+.  .++.++|+||||+++|++++ |..||......        .............
T Consensus       157 ~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~  225 (268)
T 3sxs_A          157 DQYVS-SVGTKFPVKWSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS--------EVVLKVSQGHRLY  225 (268)
T ss_dssp             TCEEE-CCSCCCCGGGCCHHHHHHS--EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHHHHHHTTCCCC
T ss_pred             hhhhc-ccCCCcCcccCCHHHHhcc--CCchhhhhHHHHHHHHHHHcCCCCCccccChH--------HHHHHHHcCCCCC
Confidence            43221 1223466789999998653  56889999999999999998 99998644321        1111122222222


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      .+...++.+.+       ++.+||+.||++|||+.++++.|+.+.+.
T Consensus       226 ~~~~~~~~l~~-------li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          226 RPHLASDTIYQ-------IMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             CCTTSCHHHHH-------HHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             CCCcChHHHHH-------HHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            33334554444       45559999999999999999999988754

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=7.6e-33  Score=226.64  Aligned_cols=181  Identities=24%  Similarity=0.414  Sum_probs=136.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....     ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       132 ~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          132 MENGSLDTFLRTHD-----GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             CTTCBHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             CCCCcHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            57899999996542     4699999999999999999999999   999999999999999999999999999987654


Q ss_pred             Ccccc-hhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           81 KKSTI-SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        81 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      ..... ......++..|+|||.+.+.  .++.++||||||+++|++++ |..||.....        .............
T Consensus       204 ~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~~~~~~~~~~~~~  273 (325)
T 3kul_A          204 DPDAAYTTTGGKIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNMTN--------RDVISSVEEGYRL  273 (325)
T ss_dssp             ---CCEECC---CCGGGSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------HHHHHHHHTTCCC
T ss_pred             CccceeeccCCCCcccccCHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHHcCCCC
Confidence            32211 11122356789999998654  56889999999999999998 9999864332        1112222222233


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      ..+..+++.+.++       +..||+.||++|||+.++++.|+.+...
T Consensus       274 ~~~~~~~~~l~~l-------i~~~l~~dp~~Rps~~eil~~L~~l~~~  314 (325)
T 3kul_A          274 PAPMGCPHALHQL-------MLDCWHKDRAQRPRFSQIVSVLDALIRS  314 (325)
T ss_dssp             CCCTTCCHHHHHH-------HHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             CCCCCcCHHHHHH-------HHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence            3344455555554       4459999999999999999999998764

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.6e-32  Score=222.67  Aligned_cols=195  Identities=33%  Similarity=0.520  Sum_probs=141.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....   ....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       112 ~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  185 (307)
T 2nru_A          112 MPNGSLLDRLSCLD---GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEK  185 (307)
T ss_dssp             CTTCBHHHHHHTGG---GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             cCCCcHHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcCCCcEEEeeccccccccc
Confidence            57899999997542   235699999999999999999999999   999999999999999999999999999886654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ...........++..|+|||.+.+   .++.++|+||||+++|++++|..||...........+...... .........
T Consensus       186 ~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  261 (307)
T 2nru_A          186 FAQTVMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIED-EEKTIEDYI  261 (307)
T ss_dssp             CSSCEECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHT-TSCCHHHHS
T ss_pred             ccccccccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhh-hhhhhhhhc
Confidence            332222223358999999998864   3678999999999999999999999765433211111010000 000000001


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhh
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTE  205 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~  205 (242)
                      ..............+..++.+||+.||++|||+.++++.|+.+..
T Consensus       262 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          262 DKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             CSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             cccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            111122223445667778888999999999999999999997653

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.98  E-value=8.5e-33  Score=226.71  Aligned_cols=197  Identities=18%  Similarity=0.190  Sum_probs=145.8

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCc-----eEEcccccccc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFC-----PKISDFGLAKQ   77 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~-----~~L~dfg~~~~   77 (242)
                      +|+|.+++....     +.+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.     ++|+|||++..
T Consensus        88 ~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           88 GPSLEDLFDLCD-----RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             CCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             CCCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            799999997642     4699999999999999999999999   9999999999999998876     99999999986


Q ss_pred             cCCCcccc-----hhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhcc
Q 026160           78 SQDKKSTI-----SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHI  152 (242)
Q Consensus        78 ~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  152 (242)
                      ........     ......||..|+|||.+.+.  .++.++||||||+++|+|++|..||.........     .....+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~-----~~~~~i  232 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGK--EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK-----ERYQKI  232 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHH-----HHHHHH
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCC--CCCchhHHHHHHHHHHHHhcCCCCccccccccHH-----HHHHHH
Confidence            54332211     11234589999999998764  5788999999999999999999999754322110     000000


Q ss_pred             CCCCccccccccchHH-HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccCCCCCCCCCCc
Q 026160          153 EPGNDFQLDGVVTEEE-KELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSLALPK  219 (242)
Q Consensus       153 ~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~~~~~~~  219 (242)
                      ...... .+   .... .... .+..++..||+.||.+||++.++++.|+.+.+..........+|..
T Consensus       233 ~~~~~~-~~---~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~  295 (330)
T 2izr_A          233 GDTKRA-TP---IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIG  295 (330)
T ss_dssp             HHHHHH-SC---HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTTT
T ss_pred             Hhhhcc-CC---HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCCC
Confidence            000000 00   0000 0012 5666677799999999999999999999999888777776777764

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.98  E-value=1.4e-32  Score=221.04  Aligned_cols=178  Identities=25%  Similarity=0.399  Sum_probs=135.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCC--eeecCCCCCceeeCCCCc-----eEEcccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVR--IVHFDIKPHNILLDEDFC-----PKISDFG   73 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~--i~h~dlk~~nil~~~~~~-----~~L~dfg   73 (242)
                      |++|+|.+++....     ..+++..++.++.|++.||.|||+.   +  ++|+||||+||+++.++.     ++|+|||
T Consensus       103 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg  174 (287)
T 4f0f_A          103 VPCGDLYHRLLDKA-----HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG  174 (287)
T ss_dssp             CTTCBHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred             cCCCCHHHHHhccc-----CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence            57899999986543     4699999999999999999999998   8  999999999999987776     9999999


Q ss_pred             cccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccC
Q 026160           74 LAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIE  153 (242)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  153 (242)
                      ++........     ...++..|.|||.+......++.++||||||+++|++++|..||........     ........
T Consensus       175 ~~~~~~~~~~-----~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~~~~~  244 (287)
T 4f0f_A          175 LSQQSVHSVS-----GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-----KFINMIRE  244 (287)
T ss_dssp             TCBCCSSCEE-----CCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-----HHHHHHHH
T ss_pred             cccccccccc-----ccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-----HHHHHHhc
Confidence            9975444321     2358999999999854434568899999999999999999999964432211     01111112


Q ss_pred             CCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          154 PGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                      .......+..+++++.+++.+       ||+.||++|||+.++++.|+.+
T Consensus       245 ~~~~~~~~~~~~~~l~~li~~-------~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          245 EGLRPTIPEDCPPRLRNVIEL-------CWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             SCCCCCCCTTSCHHHHHHHHH-------HTCSSGGGSCCHHHHHHHHHTC
T ss_pred             cCCCCCCCcccCHHHHHHHHH-------HhcCChhhCcCHHHHHHHHHhC
Confidence            222233444566665555555       8899999999999999999863

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.98  E-value=6.9e-33  Score=227.15  Aligned_cols=171  Identities=22%  Similarity=0.372  Sum_probs=133.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      +.+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        96 ~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           96 ASGGEVFDYLVAH------GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             CTTCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence            5789999999775      4599999999999999999999999   999999999999999999999999999976654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....   ....+++.|+|||.+.+. ...+.++|||||||++|+|++|..||......        ........+ ....
T Consensus       167 ~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~i~~~-~~~~  233 (328)
T 3fe3_A          167 GGKL---DAFCGAPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK--------ELRERVLRG-KYRI  233 (328)
T ss_dssp             SCGG---GTTSSSGGGCCHHHHHTC-CCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHC-CCCC
T ss_pred             CCcc---ccccCCcceeCcccccCC-CcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhC-CCCC
Confidence            4322   233589999999998764 23357899999999999999999999754321        111111111 1123


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML  200 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l  200 (242)
                      +..+++++.+++.+       ||+.||++|||+.+++++-
T Consensus       234 p~~~s~~~~~li~~-------~L~~dP~~R~t~~eil~h~  266 (328)
T 3fe3_A          234 PFYMSTDCENLLKR-------FLVLNPIKRGTLEQIMKDR  266 (328)
T ss_dssp             CTTSCHHHHHHHHH-------HCCSSTTTSCCHHHHTTCT
T ss_pred             CCCCCHHHHHHHHH-------HCCCChhHCcCHHHHhcCH
Confidence            33456666655555       8899999999999999863

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.98  E-value=1.1e-32  Score=223.04  Aligned_cols=172  Identities=25%  Similarity=0.368  Sum_probs=130.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...       .+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        99 ~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (297)
T 3fxz_A           99 LAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (297)
T ss_dssp             CTTCBHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             CCCCCHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            5799999999753       489999999999999999999999   999999999999999999999999999876654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      .....  ....+++.|+|||.+.+.  .++.++||||||+++|+|++|..||.......      ...............
T Consensus       169 ~~~~~--~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~~~~~~~~~  238 (297)
T 3fxz_A          169 EQSKR--STMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGTPELQN  238 (297)
T ss_dssp             TTCCB--CCCCSCGGGCCHHHHHCS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCSCCCSC
T ss_pred             ccccc--CCccCCcCccChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCCCCCCC
Confidence            33221  123589999999998764  67889999999999999999999996433211      000000001111122


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      +..++..+.+++       .+||+.||++|||+.+++++
T Consensus       239 ~~~~~~~~~~li-------~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          239 PEKLSAIFRDFL-------NRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             GGGSCHHHHHHH-------HHHSCSSTTTSCCHHHHTTC
T ss_pred             ccccCHHHHHHH-------HHHccCChhHCcCHHHHhhC
Confidence            334555555544       45999999999999999874

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.98  E-value=9.6e-33  Score=224.40  Aligned_cols=187  Identities=24%  Similarity=0.399  Sum_probs=139.6

Q ss_pred             CCCCCcchhccccCCC------------CCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceE
Q 026160            1 MPNGSLDQFTYDQESS------------NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPK   68 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~------------~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~   68 (242)
                      |++|+|.+++......            .....+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++
T Consensus       109 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~k  185 (313)
T 1t46_A          109 CCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITK  185 (313)
T ss_dssp             CTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTEEE
T ss_pred             CCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcCCCCEE
Confidence            5789999999865321            1233599999999999999999999999   999999999999999999999


Q ss_pred             EcccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcch
Q 026160           69 ISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNS  147 (242)
Q Consensus        69 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~  147 (242)
                      |+|||++................++..|+|||.+.+.  .++.++||||||+++|+|++ |..||......       ..
T Consensus       186 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~  256 (313)
T 1t46_A          186 ICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-------SK  256 (313)
T ss_dssp             ECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-------HH
T ss_pred             EccccccccccccccceeccCCCCcceeeChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCCCcccch-------hH
Confidence            9999999876554332222233467889999988664  67899999999999999998 99998644321       11


Q ss_pred             hhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          148 IYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      .............+..++..+.++       +.+||+.||++|||+.++++.|+++...
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~l~~l-------i~~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          257 FYKMIKEGFRMLSPEHAPAEMYDI-------MKTCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             HHHHHHHTCCCCCCTTSCHHHHHH-------HHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHhccCCCCCCcccCCHHHHHH-------HHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            111111111122233455555444       4459999999999999999999988765

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.98  E-value=5.5e-33  Score=223.77  Aligned_cols=187  Identities=27%  Similarity=0.407  Sum_probs=126.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....     ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       101 ~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A          101 CEGSSLYHHLHASE-----TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR  172 (289)
T ss_dssp             CCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred             cCCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccc
Confidence            57899999996542     5699999999999999999999999   999999999999999999999999999976543


Q ss_pred             Ccccchhcccccccccccchhhhcc-cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRS-FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ...........++..|+|||.+... ...++.++||||||+++|++++|..||........   ................
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~  249 (289)
T 3og7_A          173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGSLSPDLSK  249 (289)
T ss_dssp             -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH---HHHHHHHTSCCCCTTS
T ss_pred             ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH---HHHHhcccccCcchhh
Confidence            3222222234589999999988522 23567899999999999999999999964332110   0001111111111111


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTE  205 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~  205 (242)
                      ....+++.+.+       ++.+||+.||++|||+.++++.|+.+.+
T Consensus       250 ~~~~~~~~l~~-------li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          250 VRSNCPKRMKR-------LMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             SCTTSCHHHHH-------HHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ccccCCHHHHH-------HHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            22344555544       4445999999999999999999998754

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.98  E-value=9.4e-33  Score=221.47  Aligned_cols=180  Identities=25%  Similarity=0.378  Sum_probs=129.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....     ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        97 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           97 CTLGELRSFLQVRK-----YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             CTTEEHHHHHHHTT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             CCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCc
Confidence            57889999997643     3699999999999999999999999   999999999999999999999999999986654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ..... .....++..|+|||.+...  .++.++||||||+++|++++ |..||......        .....+.......
T Consensus       169 ~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--------~~~~~i~~~~~~~  237 (281)
T 1mp8_A          169 STYYK-ASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--------DVIGRIENGERLP  237 (281)
T ss_dssp             -----------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------GHHHHHHTTCCCC
T ss_pred             ccccc-cccCCCcccccChhhcccC--CCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--------HHHHHHHcCCCCC
Confidence            32211 1122467789999998653  67889999999999999996 88898644321        1111222222233


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      .+..+++.+.+++.       +||+.||++|||+.++++.|+.+.+.
T Consensus       238 ~~~~~~~~l~~li~-------~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          238 MPPNCPPTLYSLMT-------KCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             CCTTCCHHHHHHHH-------HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHH-------HHccCChhhCcCHHHHHHHHHHHHHH
Confidence            44456665555544       48999999999999999999988764

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.98  E-value=8.3e-33  Score=225.04  Aligned_cols=187  Identities=24%  Similarity=0.368  Sum_probs=140.3

Q ss_pred             CCCCCcchhccccCCCC----------CCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEc
Q 026160            1 MPNGSLDQFTYDQESSN----------GNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKIS   70 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~   70 (242)
                      |++|+|.+++.......          ....+++..++.++.|+++||.|||+.   +++|+||||+||+++.++.++|+
T Consensus       114 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~  190 (316)
T 2xir_A          114 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKIC  190 (316)
T ss_dssp             CTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred             CCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEC
Confidence            57899999997653210          022389999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhh
Q 026160           71 DFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIY  149 (242)
Q Consensus        71 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~  149 (242)
                      |||++................++..|+|||.+.+.  .++.++||||||+++|++++ |..||......       ....
T Consensus       191 Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-------~~~~  261 (316)
T 2xir_A          191 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------EEFC  261 (316)
T ss_dssp             CCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-------HHHH
T ss_pred             CCccccccccCccceeccCCCcceeecCchhhccc--cccchhHHHHHHHHHHHHHhCCCCCCcccchh-------HHHH
Confidence            99999866543332222233477899999998664  67889999999999999998 99998644321       1111


Q ss_pred             hccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          150 KHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      .....+.....+..+++++.+++       .+||+.||++|||+.+++++|+.+.+.
T Consensus       262 ~~~~~~~~~~~~~~~~~~l~~li-------~~~l~~dp~~Rps~~ell~~L~~~~~~  311 (316)
T 2xir_A          262 RRLKEGTRMRAPDYTTPEMYQTM-------LDCWHGEPSQRPTFSELVEHLGNLLQA  311 (316)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHH-------HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHhccCccCCCCCCCCHHHHHHH-------HHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            11112222233344555555544       459999999999999999999988765

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.98  E-value=1.5e-32  Score=225.66  Aligned_cols=189  Identities=23%  Similarity=0.403  Sum_probs=140.5

Q ss_pred             CCCCCcchhccccCCC----------CCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEc
Q 026160            1 MPNGSLDQFTYDQESS----------NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKIS   70 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~   70 (242)
                      |++|+|.+++......          .....+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+
T Consensus       123 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~  199 (334)
T 2pvf_A          123 ASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIA  199 (334)
T ss_dssp             CTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred             CCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEcCCCCEEEc
Confidence            5789999999865321          1124589999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhh
Q 026160           71 DFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIY  149 (242)
Q Consensus        71 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~  149 (242)
                      |||++................++..|.|||.+.+.  .++.++||||||+++|+|++ |..||.....        ....
T Consensus       200 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~  269 (334)
T 2pvf_A          200 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--------EELF  269 (334)
T ss_dssp             CCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHH
T ss_pred             cccccccccccccccccCCCCcccceeChHHhcCC--CcChHHHHHHHHHHHHHHHhCCCCCcCcCCH--------HHHH
Confidence            99999876554332222223467889999988653  56889999999999999999 9999864322        1111


Q ss_pred             hccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccC
Q 026160          150 KHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQI  209 (242)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~  209 (242)
                      .....+.....+..++.++.+       ++.+||+.||++|||+.++++.|+.+......
T Consensus       270 ~~~~~~~~~~~~~~~~~~l~~-------li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~  322 (334)
T 2pvf_A          270 KLLKEGHRMDKPANCTNELYM-------MMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN  322 (334)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHH-------HHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             HHHhcCCCCCCCccCCHHHHH-------HHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence            111112222233345555544       44559999999999999999999999876443

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.98  E-value=1.9e-32  Score=233.65  Aligned_cols=177  Identities=24%  Similarity=0.411  Sum_probs=137.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.++|.+...    ..++...++.++.|++.||.|||+.   +++|+||||+|||++.++.++|+|||++.....
T Consensus       269 ~~~g~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          269 MAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             CTTCBHHHHHHHHCT----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             cCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            679999999987532    4589999999999999999999999   999999999999999999999999999975443


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ...     ...++..|+|||.+.+.  .++.++||||||+++|||++ |..||......        ........+....
T Consensus       342 ~~~-----~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--------~~~~~i~~~~~~~  406 (450)
T 1k9a_A          342 TQD-----TGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------DVVPRVEKGYKMD  406 (450)
T ss_dssp             ----------CCCTTTSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT--------THHHHHHTTCCCC
T ss_pred             ccc-----CCCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCC
Confidence            221     12467899999998654  67899999999999999998 99998644321        1112222333333


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      .+..+++++.+++       .+||+.||++|||+.++++.|+.+...
T Consensus       407 ~p~~~~~~l~~li-------~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          407 APDGCPPAVYDVM-------KNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             CCTTCCHHHHHHH-------HHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCcCCHHHHHHH-------HHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence            4445666555544       459999999999999999999987653

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.98  E-value=1.3e-32  Score=234.76  Aligned_cols=185  Identities=27%  Similarity=0.426  Sum_probs=136.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.++|.....    ..+++.+++.++.|++.||.|||+.   +++|+||||+|||++.++.++|+|||++.....
T Consensus       260 ~~~gsL~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  332 (452)
T 1fmk_A          260 MSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED  332 (452)
T ss_dssp             CTTCBHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             hcCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence            578999999975421    4599999999999999999999999   999999999999999999999999999986543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      .... ......++..|+|||.+...  .++.++||||||+++|+|++ |..||.....        .........+....
T Consensus       333 ~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~i~~~~~~~  401 (452)
T 1fmk_A          333 NEYT-ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERGYRMP  401 (452)
T ss_dssp             -----------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTCCCC
T ss_pred             Ccee-cccCCcccccccCHhHHhcC--CCCccccHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCC
Confidence            2211 11123467889999988654  67899999999999999999 8999864332        11122222222333


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccCC
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIP  210 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~  210 (242)
                      .+..+++.+.+       ++.+||+.||++|||+.++++.|+.+.......
T Consensus       402 ~~~~~~~~l~~-------li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~  445 (452)
T 1fmk_A          402 CPPECPESLHD-------LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ  445 (452)
T ss_dssp             CCTTSCHHHHH-------HHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred             CCCCCCHHHHH-------HHHHHccCChhhCcCHHHHHHHHHHHhccCCcc
Confidence            34445555444       555599999999999999999999887654433

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.98  E-value=4.2e-32  Score=220.51  Aligned_cols=189  Identities=27%  Similarity=0.366  Sum_probs=135.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCc-eEEcccccccccC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFC-PKISDFGLAKQSQ   79 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~-~~L~dfg~~~~~~   79 (242)
                      |++|+|.+++.....   ...++...++.++.|+++||.|||+.+..+++|+||||+||+++.++. ++|+|||++....
T Consensus        81 ~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~  157 (307)
T 2eva_A           81 AEGGSLYNVLHGAEP---LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ  157 (307)
T ss_dssp             CTTCBHHHHHHCSSS---EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred             CCCCCHHHHHhccCC---CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence            578999999976421   234789999999999999999999932229999999999999988876 7999999987554


Q ss_pred             CCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           80 DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        80 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ....     ...++..|+|||.+.+.  .++.++||||||+++|+|++|..||.......      ..............
T Consensus       158 ~~~~-----~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~~  224 (307)
T 2eva_A          158 THMT-----NNKGSAAWMAPEVFEGS--NYSEKCDVFSWGIILWEVITRRKPFDEIGGPA------FRIMWAVHNGTRPP  224 (307)
T ss_dssp             ------------CCTTSSCHHHHTCC--CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH------HHHHHHHHTTCCCC
T ss_pred             cccc-----cCCCCCceEChhhhCCC--CCCcHHHHHHHHHHHHHHHHCCCCchhhCccH------HHHHHHHhcCCCCC
Confidence            3221     22489999999998653  67889999999999999999999996433211      11111111222223


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccCCCC
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPK  212 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~~  212 (242)
                      ....++..+.++       +.+||+.||++|||+.++++.|+.+.........
T Consensus       225 ~~~~~~~~l~~l-------i~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~  270 (307)
T 2eva_A          225 LIKNLPKPIESL-------MTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE  270 (307)
T ss_dssp             CBTTCCHHHHHH-------HHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTS
T ss_pred             cccccCHHHHHH-------HHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCC
Confidence            334455555554       4459999999999999999999998877654443

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.98  E-value=1.6e-32  Score=218.80  Aligned_cols=180  Identities=25%  Similarity=0.435  Sum_probs=137.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....     ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        87 ~~~~~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           87 MEHGCLSDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             CTTCBHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             CCCCcHHHHHHhcC-----cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccc
Confidence            57899999997643     4699999999999999999999999   999999999999999999999999999986544


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      .... ......++..|+|||.+.+.  .++.++|+||||+++|++++ |..||.....        ..............
T Consensus       159 ~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~--------~~~~~~~~~~~~~~  227 (269)
T 4hcu_A          159 DQYT-SSTGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDISTGFRLY  227 (269)
T ss_dssp             HHHH-STTSTTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTCCCC
T ss_pred             cccc-cccCcccccccCCHHHhcCC--CCCchhhhHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHhcCccCC
Confidence            3211 11223467789999998654  67889999999999999999 8999864332        11112222222223


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      .+...++.+.++       +.+||+.||++|||+.+++++|+.+.+.
T Consensus       228 ~~~~~~~~~~~l-------i~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          228 KPRLASTHVYQI-------MNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             CCTTSCHHHHHH-------HHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCcCCHHHHHH-------HHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            333445555444       4459999999999999999999987653

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.98  E-value=1e-32  Score=229.79  Aligned_cols=175  Identities=13%  Similarity=0.083  Sum_probs=127.4

Q ss_pred             CCcchhccccCCCCCCccccHHHH------HHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTV------YQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ   77 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~------~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~   77 (242)
                      |+|.+++....     ..++...+      ..++.||+.||.|||+.   +|+|+||||+|||++.++.++|+|||++..
T Consensus       172 ~~L~~~l~~~~-----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~  243 (371)
T 3q60_A          172 VDLELLFSTLD-----FVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWK  243 (371)
T ss_dssp             EEHHHHHHHHH-----HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEECTTSCEEECCGGGEEE
T ss_pred             CCHHHHHHHhc-----cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccCcCCHHHEEECCCCCEEEEecceeee
Confidence            89999998642     23455555      77889999999999999   999999999999999999999999999987


Q ss_pred             cCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      ......     ...+++.|+|||.+.+....++.++|||||||++|+|++|..||.........................
T Consensus       244 ~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  318 (371)
T 3q60_A          244 VGTRGP-----ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLA  318 (371)
T ss_dssp             TTCEEE-----GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCC
T ss_pred             cCCCcc-----CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccc
Confidence            654331     123679999999986532367899999999999999999999997664332221111111111111111


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE  198 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~  198 (242)
                      ......+++.+.+++.+       ||+.||++|||+.++++
T Consensus       319 ~~~~~~~~~~~~~li~~-------~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          319 FGSCTPLPDFVKTLIGR-------FLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             CTTSSCCCHHHHHHHHH-------HTCSSTTTCCCHHHHTT
T ss_pred             hhhccCCCHHHHHHHHH-------HcCCChhhCCCHHHHhc
Confidence            12223456666555555       88999999999999975

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.98  E-value=2e-32  Score=229.36  Aligned_cols=178  Identities=23%  Similarity=0.357  Sum_probs=132.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.+++...      +.+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.++|+|||++.....
T Consensus       135 ~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          135 VNGGDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             CTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            6799999999875      4599999999999999999999999   999999999999999999999999999975332


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcC-cchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYF-PNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  159 (242)
                      ....  .....||+.|+|||++.+.  .++.++|+|||||++|+|++|..||............ .......+. .....
T Consensus       206 ~~~~--~~~~~gt~~Y~aPE~l~~~--~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~-~~~~~  280 (396)
T 4dc2_A          206 PGDT--TSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-EKQIR  280 (396)
T ss_dssp             TTCC--BCCCCBCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHH-HCCCC
T ss_pred             CCCc--cccccCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHh-ccccC
Confidence            2111  1234589999999998764  6789999999999999999999999654322211110 011111111 11223


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSM------HEVLEM  199 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~------~~ll~~  199 (242)
                      ++..+++++.+++.+       ||+.||++||++      .+++++
T Consensus       281 ~p~~~s~~~~~li~~-------lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          281 IPRSLSVKAASVLKS-------FLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             CCTTSCHHHHHHHHH-------HTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             CCCcCCHHHHHHHHH-------HhcCCHhHcCCCCCCCCHHHHhcC
Confidence            444567766666666       789999999985      566653

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=4.3e-32  Score=226.12  Aligned_cols=183  Identities=23%  Similarity=0.361  Sum_probs=129.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....     ..+++.+++.++.|+++||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       173 ~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          173 MKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             CTTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             CCCCCHHHHHhhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccc
Confidence            57899999997543     4689999999999999999999999   999999999999999999999999999976543


Q ss_pred             Cccc--chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           81 KKST--ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        81 ~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      ....  .......++..|+|||.+.+.  .++.++||||||+++|++++ |.+||.......        .......+..
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--------~~~~~~~~~~  314 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--------ITVYLLQGRR  314 (373)
T ss_dssp             -------------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--------HHHHHHTTCC
T ss_pred             cccccccccCCCCCcccccChHHhcCC--CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--------HHHHHHcCCC
Confidence            2211  111123467889999998754  67899999999999999999 666765433211        1111112222


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhcc
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQ  208 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~  208 (242)
                      ...+..++..+.       .++.+||+.||++|||+.++++.|+.+.....
T Consensus       315 ~~~p~~~~~~l~-------~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          315 LLQPEYCPDPLY-------EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             CCCCTTCCHHHH-------HHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             CCCCCCCCHHHH-------HHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence            223334555444       45555999999999999999999999887654

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.98  E-value=5.2e-32  Score=218.76  Aligned_cols=183  Identities=24%  Similarity=0.362  Sum_probs=136.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....     ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       109 ~~~~~L~~~l~~~~-----~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          109 MKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             CTTCBHHHHHHCTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             CCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccc
Confidence            57899999997532     4689999999999999999999999   999999999999999999999999999986654


Q ss_pred             Cccc--chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhc-CCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           81 KKST--ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG-RKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        81 ~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      ....  .......++..|.|||.+.+.  .++.++|+||||+++|++++| .+||.......        ..........
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--------~~~~~~~~~~  250 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--------ITVYLLQGRR  250 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--------HHHHHHTTCC
T ss_pred             cchhccccccCCCCCccccChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--------HHHHHhcCCC
Confidence            3221  111223467889999998664  678899999999999999995 55554332211        1111112222


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhcc
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQ  208 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~  208 (242)
                      ...+..++..+.+       ++.+||+.||++|||+.++++.|+.+.....
T Consensus       251 ~~~~~~~~~~l~~-------li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          251 LLQPEYCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             CCCCTTCCHHHHH-------HHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             CCCCccCCHHHHH-------HHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence            2233345555544       4455999999999999999999999887543

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=6.9e-32  Score=217.87  Aligned_cols=185  Identities=25%  Similarity=0.380  Sum_probs=138.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....     ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       105 ~~~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          105 MCHGDLLQFIRSPQ-----RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             CTTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             ccCCCHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            46899999997632     5689999999999999999999999   999999999999999999999999999976543


Q ss_pred             Cccc--chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           81 KKST--ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        81 ~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      ....  .......++..|.|||.+.+.  .++.++||||||+++|++++|..|+......       .............
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-------~~~~~~~~~~~~~  247 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTY--RFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-------FDLTHFLAQGRRL  247 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-------GGHHHHHHTTCCC
T ss_pred             CcccccccCcCCCCCccccChhhhccC--CCChhhchhhHHHHHHHHhhCCCCCCccCCH-------HHHHHHhhcCCCC
Confidence            3211  111123478899999998653  6788999999999999999966554322211       1111222222223


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccC
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQI  209 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~  209 (242)
                      ..+..+++.+.++       +.+||+.||++|||+.++++.|+.+.+.+..
T Consensus       248 ~~~~~~~~~l~~l-------i~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~  291 (298)
T 3pls_A          248 PQPEYCPDSLYQV-------MQQCWEADPAVRPTFRVLVGEVEQIVSALLG  291 (298)
T ss_dssp             CCCTTCCHHHHHH-------HHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred             CCCccchHHHHHH-------HHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence            3344455555544       4458999999999999999999999887543

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=2.2e-32  Score=219.98  Aligned_cols=187  Identities=25%  Similarity=0.347  Sum_probs=143.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....     ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        91 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           91 AGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             CTTEEHHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             CCCCCHHHHHHhCC-----ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            57889999996532     4699999999999999999999999   999999999999999999999999999987654


Q ss_pred             Ccccc-hhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           81 KKSTI-SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        81 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      ..... ......++..|.|||.+.+.  .++.++||||||+++|++++ |..||.....        ......+..+...
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~~~i~~~~~~  232 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVMAFIEQGKRM  232 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--------HHHHHHHHTTCCC
T ss_pred             CcceeeccccccccccccCHHHhccC--CCCchhhHHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHhcCCcC
Confidence            32221 11122367889999998653  56889999999999999998 9999864332        1111222222233


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccCCCC
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPK  212 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~~  212 (242)
                      ..+..+++++.+++.+       ||+.||++|||+.++++.|+.+......+..
T Consensus       233 ~~~~~~~~~l~~li~~-------~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~  279 (287)
T 1u59_A          233 ECPPECPPELYALMSD-------CWIYKWEDRPDFLTVEQRMRACYYSLASKVE  279 (287)
T ss_dssp             CCCTTCCHHHHHHHHH-------TTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred             CCCCCcCHHHHHHHHH-------HcCCChhhCcCHHHHHHHHHHHHHhcCCccc
Confidence            3444566655555554       9999999999999999999999887666544

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.97  E-value=2.9e-32  Score=218.74  Aligned_cols=180  Identities=22%  Similarity=0.392  Sum_probs=138.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....     ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       101 ~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A          101 MANGCLLNYLREMR-----HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             CTTCBHHHHHHCGG-----GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             cCCCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            57899999997642     4599999999999999999999999   999999999999999999999999999986554


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      .... ......++..|.|||.+.+.  .++.++|+||||+++|++++ |..||......        .............
T Consensus       173 ~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~~~~~~~~~  241 (283)
T 3gen_A          173 DEYT-SSVGSKFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--------ETAEHIAQGLRLY  241 (283)
T ss_dssp             HHHH-STTSTTSCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHHHHHHTTCCCC
T ss_pred             cccc-cccCCccCcccCCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCccccChh--------HHHHHHhcccCCC
Confidence            3221 11123467789999998754  57889999999999999998 99998654321        1111222222222


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      .+..+++.+.       +++.+||+.||++|||+.++++.|+.+.+.
T Consensus       242 ~~~~~~~~l~-------~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          242 RPHLASEKVY-------TIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             CCTTCCHHHH-------HHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCcCCHHHH-------HHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            3334455444       455559999999999999999999988764

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.97  E-value=3.6e-32  Score=228.60  Aligned_cols=181  Identities=23%  Similarity=0.278  Sum_probs=127.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC---CCceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE---DFCPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~---~~~~~L~dfg~~~~   77 (242)
                      |+||+|.++|....    ...+++.++..++.||+.||.|||+.   +|+|+||||+|||++.   ++.++|+|||++..
T Consensus       141 ~~gg~L~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~  213 (400)
T 1nxk_A          141 LDGGELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  213 (400)
T ss_dssp             CCSEEHHHHHHCC-------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             CCCCcHHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccc
Confidence            57899999997642    25699999999999999999999999   9999999999999987   78899999999986


Q ss_pred             cCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      .......   ....+|..|+|||++.+.  .++.++|||||||++|+|++|..||...............+... .....
T Consensus       214 ~~~~~~~---~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~-~~~~~  287 (400)
T 1nxk_A          214 TTSHNSL---TTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG-QYEFP  287 (400)
T ss_dssp             CC--------------CTTCCGGGSCCC--CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT-CCCCC
T ss_pred             cCCCCcc---ccCCCCCCccCHhhcCCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC-cccCC
Confidence            5543222   233589999999998553  67899999999999999999999997544322111111111110 00001


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      ......++.++.+       ++.+||+.||++|||+.+++++-.
T Consensus       288 ~~~~~~~s~~~~~-------li~~~L~~dP~~Rpt~~eil~hp~  324 (400)
T 1nxk_A          288 NPEWSEVSEEVKM-------LIRNLLKTEPTQRMTITEFMNHPW  324 (400)
T ss_dssp             TTTTTTSCHHHHH-------HHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             CcccccCCHHHHH-------HHHHHCCCChhHCcCHHHHhcCcc
Confidence            1111234555544       455599999999999999998643

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.97  E-value=1.3e-32  Score=234.91  Aligned_cols=181  Identities=25%  Similarity=0.428  Sum_probs=137.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.++|.....    ..+++.+++.++.|++.||.|||+.   +++|+||||+|||++.++.++|+|||+++....
T Consensus       264 ~~~g~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          264 MAKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED  336 (454)
T ss_dssp             CTTCBHHHHHHSHHH----HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred             cCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence            579999999976421    3589999999999999999999999   999999999999999999999999999986543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      .... ......++..|+|||.+...  .++.++||||||+++|||++ |..||......        .....+..+....
T Consensus       337 ~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--------~~~~~i~~~~~~~  405 (454)
T 1qcf_A          337 NEYT-AREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--------EVIRALERGYRMP  405 (454)
T ss_dssp             HHHH-TTCSSSSCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------HHHHHHHHTCCCC
T ss_pred             Ccee-ccCCCcccccccCHHHhccC--CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCC
Confidence            2211 11122467789999998653  67899999999999999999 99998643321        1111121222222


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      .+..+++++.       +++.+||+.||++|||+.++++.|+.+...
T Consensus       406 ~~~~~~~~l~-------~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          406 RPENCPEELY-------NIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             CCTTSCHHHH-------HHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             CCCCCCHHHH-------HHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence            3334555544       455559999999999999999999987654

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.97  E-value=1.2e-32  Score=227.22  Aligned_cols=183  Identities=18%  Similarity=0.207  Sum_probs=132.7

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCC--ceEEcccccccccCC
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF--CPKISDFGLAKQSQD   80 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~--~~~L~dfg~~~~~~~   80 (242)
                      +|+|.+++...      +.+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++  .++|+|||++.....
T Consensus       135 ~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~  205 (345)
T 2v62_A          135 GIDLQKISGQN------GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCP  205 (345)
T ss_dssp             EEEHHHHCBGG------GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTSEEECCCTTCEESSG
T ss_pred             CCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCcEEEEeCCCceeccc
Confidence            68999999765      3699999999999999999999999   999999999999998777  999999999976543


Q ss_pred             Ccccc-----hhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCC
Q 026160           81 KKSTI-----SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPG  155 (242)
Q Consensus        81 ~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  155 (242)
                      .....     ......++..|+|||.+.+.  .++.++||||||+++|+|++|..||..........  ...........
T Consensus       206 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~--~~~~~~~~~~~  281 (345)
T 2v62_A          206 NGNHKQYQENPRKGHNGTIEFTSLDAHKGV--ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV--QTAKTNLLDEL  281 (345)
T ss_dssp             GGCCCCCCCCGGGCSCSCTTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH--HHHHHHHHHTT
T ss_pred             ccccccchhccccccCCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCccccccccHHH--HHHHHhhcccc
Confidence            22111     11233589999999998764  67899999999999999999999996432211100  00000000000


Q ss_pred             Ccc--c--cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhh
Q 026160          156 NDF--Q--LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTE  205 (242)
Q Consensus       156 ~~~--~--~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~  205 (242)
                      ...  .  ....++.       .+.+++..||+.||++|||+.++++.|+....
T Consensus       282 ~~~~~~~~~~~~~~~-------~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          282 PQSVLKWAPSGSSCC-------EIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             THHHHHHSCTTSCCH-------HHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             cHHHHhhccccccHH-------HHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            000  0  0002333       44555556999999999999999999998654

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.97  E-value=9.6e-33  Score=226.06  Aligned_cols=193  Identities=26%  Similarity=0.370  Sum_probs=138.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....     ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       108 ~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  179 (327)
T 3lxl_A          108 LPSGCLRDFLQRHR-----ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPL  179 (327)
T ss_dssp             CTTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred             cCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence            57999999997643     3599999999999999999999999   999999999999999999999999999987654


Q ss_pred             Cccc-chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCC-------CCCcCcchhhhcc
Q 026160           81 KKST-ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRS-------SDIYFPNSIYKHI  152 (242)
Q Consensus        81 ~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~-------~~~~~~~~~~~~~  152 (242)
                      .... .......++..|+|||.+.+.  .++.++||||||+++|++++|..||.......       .............
T Consensus       180 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (327)
T 3lxl_A          180 DKDYYVVREPGQSPIFWYAPESLSDN--IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL  257 (327)
T ss_dssp             TCSEEECSSCCCSCGGGSCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred             CCccceeeccCCccccccCHHHhccC--CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence            3322 112223477889999998654  56889999999999999999999986433210       0000001111222


Q ss_pred             CCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccCC
Q 026160          153 EPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIP  210 (242)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~  210 (242)
                      ..+.....+..+++.+.+++.+       ||+.||++|||+.++++.|+.+.......
T Consensus       258 ~~~~~~~~~~~~~~~l~~li~~-------~l~~dP~~Rps~~ell~~L~~~~~~~~~~  308 (327)
T 3lxl_A          258 EEGQRLPAPPACPAEVHELMKL-------CWAPSPQDRPSFSALGPQLDMLWSGSRGC  308 (327)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHH-------HTCSSGGGSCCHHHHHHHHHHC-------
T ss_pred             hcccCCCCCCcccHHHHHHHHH-------HcCCChhhCcCHHHHHHHHHHHHhhhcCc
Confidence            2222333344555555555554       88999999999999999999987754433

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.97  E-value=6e-32  Score=220.61  Aligned_cols=191  Identities=19%  Similarity=0.253  Sum_probs=137.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceee----CCCCceEEccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL----DEDFCPKISDFGLAK   76 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~----~~~~~~~L~dfg~~~   76 (242)
                      |++|+|.+++.....   ...+++.+++.++.|++.||.|||+.   +++|+||||+||++    +.++.++|+|||++.
T Consensus        91 ~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           91 CPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             CTTCBHHHHHHSGGG---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             CCCCCHHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            578999999986532   23499999999999999999999999   99999999999999    777889999999998


Q ss_pred             ccCCCcccchhcccccccccccchhhhcc------cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhh
Q 026160           77 QSQDKKSTISMLHARGTIGYIAPEVFCRS------FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYK  150 (242)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~------~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~  150 (242)
                      .........   ...++..|+|||.+...      ...++.++|||||||++|+|++|..||..................
T Consensus       165 ~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          165 ELEDDEQFV---SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             ECCTTCCBC---CCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             ecCCCCcee---ecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            765543322   23489999999988531      246788999999999999999999999744332211110011110


Q ss_pred             ccCCCC----------------ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          151 HIEPGN----------------DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       151 ~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                      ......                .......++   ..+...+..++.+||+.||++|||+.|++++....
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLS---RGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTTCSSC---HHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             CCCcccchhhhcccCCccccCccCCcccccc---hhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            000000                000011122   33444556677789999999999999999988753

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=4.4e-32  Score=222.79  Aligned_cols=183  Identities=24%  Similarity=0.415  Sum_probs=132.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....     ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       128 ~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          128 MENGALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             CTTEEHHHHHHHTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             CCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            57899999997642     4699999999999999999999999   999999999999999999999999999986554


Q ss_pred             Ccccc-hhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           81 KKSTI-SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        81 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      ..... ......++..|+|||.+...  .++.++||||||+++|++++ |..||.....        .........+...
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~~~~~~~~~~~~  269 (333)
T 1mqb_A          200 DPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSN--------HEVMKAINDGFRL  269 (333)
T ss_dssp             -----------CCCGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTCCC
T ss_pred             ccccccccCCCCccccccCchhcccC--CCCchhhhHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHHCCCcC
Confidence            32211 11112357789999998653  67889999999999999998 9999864332        1111222222222


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhcc
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQ  208 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~  208 (242)
                      ..+..++..+.+       ++.+||+.||++||++.++++.|+.+.....
T Consensus       270 ~~~~~~~~~l~~-------li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          270 PTPMDCPSAIYQ-------LMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             CCCTTCBHHHHH-------HHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             CCcccCCHHHHH-------HHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence            233345555444       4555999999999999999999998876533

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.97  E-value=2.5e-32  Score=227.60  Aligned_cols=181  Identities=25%  Similarity=0.418  Sum_probs=126.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....     ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       128 ~~~~sL~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          128 MENGSLDSFLRKHD-----AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             CTTCBHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             CCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            57999999997642     4699999999999999999999999   999999999999999999999999999986554


Q ss_pred             Ccccc-hhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           81 KKSTI-SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        81 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      ..... ......++..|+|||.+.+.  .++.++||||||+++|++++ |..||.....        .........+...
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--------~~~~~~i~~~~~~  269 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWEMSN--------QDVIKAVDEGYRL  269 (373)
T ss_dssp             --------------CTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--------HHHHHHHHTTEEC
T ss_pred             CCccceeccCCCcCCCccChhhhccC--CcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCC
Confidence            32211 11112356789999998654  67889999999999999997 9999864332        1111112222222


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      ..+..++..+       .+++.+||+.||++|||+.++++.|+.+...
T Consensus       270 ~~~~~~~~~l-------~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          270 PPPMDCPAAL-------YQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             CCCTTCBHHH-------HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCccccHHH-------HHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence            2233344444       4455559999999999999999999998764

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.97  E-value=4e-32  Score=223.01  Aligned_cols=199  Identities=23%  Similarity=0.302  Sum_probs=139.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCC------CCCeeecCCCCCceeeCCCCceEEccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGC------NVRIVHFDIKPHNILLDEDFCPKISDFGL   74 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~------~~~i~h~dlk~~nil~~~~~~~~L~dfg~   74 (242)
                      |++|+|.+++...       .+++..++.++.|+++||.|||+..      ..+++|+||||+||+++.++.++|+|||+
T Consensus        94 ~~~g~L~~~l~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~  166 (336)
T 3g2f_A           94 YPNGSLXKYLSLH-------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL  166 (336)
T ss_dssp             CTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTT
T ss_pred             CCCCcHHHHHhhc-------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccc
Confidence            5799999999654       3689999999999999999999862      22899999999999999999999999999


Q ss_pred             ccccCCCccc------chhcccccccccccchhhhccc-----CCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCc
Q 026160           75 AKQSQDKKST------ISMLHARGTIGYIAPEVFCRSF-----GGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIY  143 (242)
Q Consensus        75 ~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~-----~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~  143 (242)
                      +.........      .......++..|+|||.+.+..     ..++.++|||||||++|+|++|..||...........
T Consensus       167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~  246 (336)
T 3g2f_A          167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM  246 (336)
T ss_dssp             CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred             eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence            9866533211      1111235899999999986521     1345789999999999999999887754443222111


Q ss_pred             Ccc-----------hhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhc
Q 026160          144 FPN-----------SIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEIL  207 (242)
Q Consensus       144 ~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~  207 (242)
                      ...           .............++..... .......+.+++.+||+.||++|||+.++++.|+.+....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~  320 (336)
T 3g2f_A          247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKE-NSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW  320 (336)
T ss_dssp             TTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCC-CSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred             hhhcccCCCchHHHHHhhhcccccCCCCCccccc-ccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence            000           00000111111222221111 1223445677777899999999999999999999988653

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.97  E-value=3.4e-32  Score=217.88  Aligned_cols=185  Identities=28%  Similarity=0.420  Sum_probs=138.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.....    ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        89 ~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  161 (279)
T 1qpc_A           89 MENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (279)
T ss_dssp             CTTCBHHHHTTSHHH----HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             CCCCCHHHHHhcCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence            578999999976421    3599999999999999999999999   999999999999999999999999999987654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ..... .....++..|.|||.+.+.  .++.++||||||+++|++++ |..||......        .............
T Consensus       162 ~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~  230 (279)
T 1qpc_A          162 NEYTA-REGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--------EVIQNLERGYRMV  230 (279)
T ss_dssp             SCEEC-CTTCCCCTTTSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTTCCCC
T ss_pred             ccccc-ccCCCCccCccChhhhccC--CCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--------HHHHHHhcccCCC
Confidence            32221 1122367789999998653  56889999999999999999 88888643321        1111122222222


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccCC
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIP  210 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~  210 (242)
                      .+..++.++.+++       .+||+.||++|||+.++++.|+.+......+
T Consensus       231 ~~~~~~~~l~~li-------~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~  274 (279)
T 1qpc_A          231 RPDNCPEELYQLM-------RLCWKERPEDRPTFDYLRSVLEDFFTATEGQ  274 (279)
T ss_dssp             CCTTCCHHHHHHH-------HHHTCSSGGGSCCHHHHHHHHHHHHHHC---
T ss_pred             CcccccHHHHHHH-------HHHhccChhhCCCHHHHHHHHHHHHHhccCC
Confidence            3334555555544       4589999999999999999999987764443

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.97  E-value=9.3e-33  Score=236.77  Aligned_cols=188  Identities=20%  Similarity=0.217  Sum_probs=138.0

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceee---CCCCceEEcccccccccC
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGLAKQSQ   79 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~---~~~~~~~L~dfg~~~~~~   79 (242)
                      +|+|.+++....     +.+++.+++.++.||+.||.|||+.   +|+|+||||+|||+   +.++.++|+|||++....
T Consensus        86 g~sL~~ll~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           86 GPSLEDLFNFCS-----RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CCCHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            899999997532     4699999999999999999999999   99999999999999   578899999999998665


Q ss_pred             CCccc-----chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCC
Q 026160           80 DKKST-----ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEP  154 (242)
Q Consensus        80 ~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  154 (242)
                      .....     .......++..|++||.+.+.  .++.++|||||||++|+|++|..||...........+......... 
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-  234 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA-  234 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH-
T ss_pred             CCccccccccccccccCCCccccCHHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc-
Confidence            43221     111134589999999998764  5788999999999999999999999754432211100000000000 


Q ss_pred             CCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhcc
Q 026160          155 GNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQ  208 (242)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~  208 (242)
                      .....+...++       ..+..++..||+.||++||++.+|++.|+.+.....
T Consensus       235 ~~~~~l~~~~p-------~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~  281 (483)
T 3sv0_A          235 TSIEALCRGYP-------TEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG  281 (483)
T ss_dssp             SCHHHHHTTSC-------HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             ccHHHHhcCCc-------HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence            00001112233       345566666999999999999999999999876543

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.97  E-value=4.8e-32  Score=216.03  Aligned_cols=176  Identities=29%  Similarity=0.427  Sum_probs=127.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC--------CCceEEccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE--------DFCPKISDF   72 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~--------~~~~~L~df   72 (242)
                      |++|+|.+++..       +.+++..++.++.|++.||.|||+....+++|+||||+||+++.        ++.++|+||
T Consensus        88 ~~~~~L~~~~~~-------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           88 ARGGPLNRVLSG-------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             CTTEEHHHHHTS-------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             CCCCCHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            578999999853       45999999999999999999999982112999999999999985        678999999


Q ss_pred             ccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhcc
Q 026160           73 GLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHI  152 (242)
Q Consensus        73 g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  152 (242)
                      |++.........    ...++..|.|||.+.+.  .++.++||||||+++|++++|..||......       .......
T Consensus       161 g~~~~~~~~~~~----~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~  227 (271)
T 3dtc_A          161 GLAREWHRTTKM----SAAGAYAWMAPEVIRAS--MFSKGSDVWSYGVLLWELLTGEVPFRGIDGL-------AVAYGVA  227 (271)
T ss_dssp             CC-----------------CCGGGSCHHHHHHC--CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH-------HHHHHHH
T ss_pred             Cccccccccccc----CCCCccceeCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHhhh
Confidence            999765443322    23489999999998654  5788999999999999999999999643321       1111112


Q ss_pred             CCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          153 EPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                      ........+..+++.+.+++.       +||+.||++|||+.+++++|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~li~-------~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          228 MNKLALPIPSTCPEPFAKLME-------DCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             TSCCCCCCCTTCCHHHHHHHH-------HHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             cCCCCCCCCcccCHHHHHHHH-------HHhcCCcccCcCHHHHHHHHhcC
Confidence            222222334445555555544       49999999999999999999864

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.97  E-value=4.9e-32  Score=215.71  Aligned_cols=177  Identities=19%  Similarity=0.313  Sum_probs=134.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCC--eeecCCCCCceeeCCCCceEEccccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVR--IVHFDIKPHNILLDEDFCPKISDFGLAKQS   78 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~--i~h~dlk~~nil~~~~~~~~L~dfg~~~~~   78 (242)
                      |++|+|.+++.....    ..+++.+++.++.|++.||.|||+.   +  ++|+||||+||+++.++.++++|||+....
T Consensus        91 ~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           91 MPYGSLYNVLHEGTN----FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             CTTCBHHHHHHSCSS----CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             cCCCcHHHHHhhccc----CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence            578999999976532    4699999999999999999999998   8  999999999999999999999988876543


Q ss_pred             CCCcccchhcccccccccccchhhhccc-CCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           79 QDKKSTISMLHARGTIGYIAPEVFCRSF-GGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        79 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      ...       ...+++.|+|||.+.+.. ...+.++||||||+++|++++|..||......       ............
T Consensus       164 ~~~-------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~  229 (271)
T 3kmu_A          164 QSP-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM-------EIGMKVALEGLR  229 (271)
T ss_dssp             SCT-------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH-------HHHHHHHHSCCC
T ss_pred             ccc-------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH-------HHHHHHHhcCCC
Confidence            322       124789999999986531 12344799999999999999999999643321       111111222222


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhh
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTE  205 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~  205 (242)
                      ...+..+++++.+++.+       ||+.||++|||+.++++.|+.+.+
T Consensus       230 ~~~~~~~~~~~~~li~~-------~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          230 PTIPPGISPHVSKLMKI-------CMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             CCCCTTCCHHHHHHHHH-------HTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             CCCCCCCCHHHHHHHHH-------HcCCChhhCcCHHHHHHHHHHhhc
Confidence            33444566665555555       889999999999999999998754

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.97  E-value=4.9e-32  Score=221.19  Aligned_cols=185  Identities=24%  Similarity=0.392  Sum_probs=138.1

Q ss_pred             CCCCCcchhccccCC----CCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEccccccc
Q 026160            1 MPNGSLDQFTYDQES----SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK   76 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~----~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~   76 (242)
                      |++|+|.+++.....    ......+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.
T Consensus       110 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Dfg~~~  186 (322)
T 1p4o_A          110 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR  186 (322)
T ss_dssp             CTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCCC
T ss_pred             CCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECcCcccc
Confidence            578999999976421    11123579999999999999999999999   99999999999999999999999999997


Q ss_pred             ccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCC
Q 026160           77 QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPG  155 (242)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  155 (242)
                      ...............++..|+|||.+.+.  .++.++||||||+++|++++ |..||.....        ..........
T Consensus       187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~~~~~~  256 (322)
T 1p4o_A          187 DIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------EQVLRFVMEG  256 (322)
T ss_dssp             GGGGGGCEEGGGSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--------HHHHHHHHTT
T ss_pred             ccccccccccccCCCCCCCccChhhhccC--CCCchhhHHHHHHHHHHHHhcCCCccccCCH--------HHHHHHHHcC
Confidence            65443322222233467889999998654  57889999999999999999 8888864332        1111111122


Q ss_pred             CccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhh
Q 026160          156 NDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTE  205 (242)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~  205 (242)
                      .....+..++..+.+++.       +||+.||++|||+.++++.|+.+..
T Consensus       257 ~~~~~~~~~~~~l~~li~-------~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          257 GLLDKPDNCPDMLFELMR-------MCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             CCCCCCTTCCHHHHHHHH-------HHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             CcCCCCCCCCHHHHHHHH-------HHcCCCcccCcCHHHHHHHHHHhhc
Confidence            222233445555555444       4899999999999999999998754

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.97  E-value=2.4e-32  Score=223.01  Aligned_cols=191  Identities=25%  Similarity=0.358  Sum_probs=140.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...       .+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       117 ~~~~~L~~~l~~~-------~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  186 (318)
T 3lxp_A          117 VPLGSLRDYLPRH-------SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  186 (318)
T ss_dssp             CTTCBHHHHGGGS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred             ccCCcHHHHHhhC-------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccc
Confidence            5789999999753       499999999999999999999999   999999999999999999999999999987655


Q ss_pred             Ccccc-hhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCC-------CCcCcchhhhcc
Q 026160           81 KKSTI-SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSS-------DIYFPNSIYKHI  152 (242)
Q Consensus        81 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~-------~~~~~~~~~~~~  152 (242)
                      ..... ......++..|+|||.+.+.  .++.++||||||+++|++++|..||........       ............
T Consensus       187 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (318)
T 3lxp_A          187 GHEYYRVREDGDSPVFWYAPECLKEY--KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL  264 (318)
T ss_dssp             TCSEEEC---CCCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred             cccccccccCCCCCceeeChHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence            43221 12223477889999998654  567899999999999999999999864321100       000000111112


Q ss_pred             CCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccCC
Q 026160          153 EPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIP  210 (242)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~  210 (242)
                      ........+..+++++.+++.       +||+.||++|||+.++++.|+.+.+..+.+
T Consensus       265 ~~~~~~~~~~~~~~~l~~li~-------~~l~~dP~~Rps~~ell~~L~~l~~~~~~~  315 (318)
T 3lxp_A          265 ERGERLPRPDKCPAEVYHLMK-------NCWETEASFRPTFENLIPILKTVHEKYQGQ  315 (318)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHH-------HHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred             hcccCCCCCccccHHHHHHHH-------HHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence            222233334445555555444       599999999999999999999998876544

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.97  E-value=3.6e-32  Score=217.98  Aligned_cols=180  Identities=23%  Similarity=0.363  Sum_probs=134.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....     ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        94 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           94 YPYGELGHYLERNK-----NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             CTTCBHHHHHHHHT-----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             CCCCCHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            57899999997643     4599999999999999999999999   999999999999999999999999999986554


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ..... .....++..|.|||.+.+.  .++.++||||||+++|++++ |..||.......        ............
T Consensus       166 ~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--------~~~~~~~~~~~~  234 (281)
T 3cc6_A          166 EDYYK-ASVTRLPIKWMSPESINFR--RFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--------VIGVLEKGDRLP  234 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--------HHHHHHHTCCCC
T ss_pred             ccccc-cccCCCCcceeCchhhccC--CCCchhccHHHHHHHHHHHhCCCCCcccCChHH--------HHHHHhcCCCCC
Confidence            32211 1123467789999998653  67889999999999999998 999986433211        111111111222


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      .+..+++.+.+++       .+||+.||++|||+.++++.|+.+.+.
T Consensus       235 ~~~~~~~~l~~li-------~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          235 KPDLCPPVLYTLM-------TRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             CCTTCCHHHHHHH-------HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHH-------HHHccCCchhCcCHHHHHHHHHHHHHh
Confidence            3334555555544       459999999999999999999987653

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.97  E-value=3.4e-32  Score=219.78  Aligned_cols=180  Identities=28%  Similarity=0.394  Sum_probs=132.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      +.+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        93 ~~g~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           93 IEGPTLSEYIESH------GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             CCSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             CCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            5789999999765      4599999999999999999999999   999999999999999999999999999986543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCC---c
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN---D  157 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~  157 (242)
                      ..... .....+++.|+|||.+.+.  .++.++||||||+++|++++|..||.......       ..........   .
T Consensus       164 ~~~~~-~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-------~~~~~~~~~~~~~~  233 (294)
T 4eqm_A          164 TSLTQ-TNHVLGTVQYFSPEQAKGE--ATDECTDIYSIGIVLYEMLVGEPPFNGETAVS-------IAIKHIQDSVPNVT  233 (294)
T ss_dssp             ------------CCSSCCHHHHHTC--CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH-------HHHHHHSSCCCCHH
T ss_pred             ccccc-cCccccCccccCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-------HHHHHhhccCCCcc
Confidence            32211 1123589999999998764  56889999999999999999999996543211       1111111111   1


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHhhchhhh
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRP-SMHEVLEMLESSTEI  206 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp-s~~~ll~~l~~~~~~  206 (242)
                      ......+++.+.+       ++.+||+.||++|| ++.++.+.|+.+...
T Consensus       234 ~~~~~~~~~~l~~-------li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          234 TDVRKDIPQSLSN-------VILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             HHSCTTSCHHHHH-------HHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             hhcccCCCHHHHH-------HHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence            1122334444444       44559999999998 999999999987654

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.8e-31  Score=218.95  Aligned_cols=197  Identities=23%  Similarity=0.255  Sum_probs=135.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCC-----CCCeeecCCCCCceeeCCCCceEEcccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGC-----NVRIVHFDIKPHNILLDEDFCPKISDFGLA   75 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~-----~~~i~h~dlk~~nil~~~~~~~~L~dfg~~   75 (242)
                      |++|+|.+++...       .+++.+++.++.|++.||.|||+..     ..+++|+||||+||+++.++.++|+|||++
T Consensus       117 ~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a  189 (337)
T 3mdy_A          117 HENGSLYDYLKST-------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  189 (337)
T ss_dssp             CTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             cCCCcHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCc
Confidence            5789999999653       5999999999999999999999751     238999999999999999999999999999


Q ss_pred             cccCCCcccch--hcccccccccccchhhhcccCCCC----CCccchhHHHHHHHHHhcCC----------CccccccCC
Q 026160           76 KQSQDKKSTIS--MLHARGTIGYIAPEVFCRSFGGAS----HKSDVYSYGMMILEMAVGRK----------NADVKASRS  139 (242)
Q Consensus        76 ~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~----~~~Di~slG~~~~~ll~g~~----------p~~~~~~~~  139 (242)
                      ...........  .....++..|+|||.+.+......    .++|||||||++|+|++|..          ||.......
T Consensus       190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~  269 (337)
T 3mdy_A          190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD  269 (337)
T ss_dssp             EECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC
Confidence            76544332211  112358999999999865422111    24899999999999999944          443222211


Q ss_pred             CCCcCcchhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhcc
Q 026160          140 SDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQ  208 (242)
Q Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~  208 (242)
                      ...  ................+...  ........+.+++.+||+.||++|||+.+++++|+++.+...
T Consensus       270 ~~~--~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  334 (337)
T 3mdy_A          270 PSY--EDMREIVCIKKLRPSFPNRW--SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD  334 (337)
T ss_dssp             CCH--HHHHHHHTTSCCCCCCCGGG--GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred             Cch--hhhHHHHhhhccCccccccc--hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence            110  01111111111111111111  112455667778888999999999999999999999987654

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.97  E-value=2.8e-32  Score=224.84  Aligned_cols=178  Identities=23%  Similarity=0.366  Sum_probs=127.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +.+|+|.+++...      +.+++.++..++.|++.||.|||+.   +|+|+||||+|||++ ++.++|+|||++.....
T Consensus        90 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           90 CGNIDLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             CCSEEHHHHHHHS------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             CCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            4678999999765      4599999999999999999999999   999999999999997 67899999999987654


Q ss_pred             Ccccchhcccccccccccchhhhcc---------cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRS---------FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKH  151 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~---------~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~  151 (242)
                      ...........|++.|+|||.+.+.         ...++.++|||||||++|+|++|..||......      .......
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~  233 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ISKLHAI  233 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH------HHHHHHH
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH------HHHHHHH
Confidence            4333222334689999999998641         135688999999999999999999999632211      0111122


Q ss_pred             cCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          152 IEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      .........+...+.++.++       +.+||+.||++|||+.+++++-.
T Consensus       234 ~~~~~~~~~~~~~~~~l~~l-------i~~~L~~dp~~Rpt~~e~l~hp~  276 (343)
T 3dbq_A          234 IDPNHEIEFPDIPEKDLQDV-------LKCCLKRDPKQRISIPELLAHPY  276 (343)
T ss_dssp             HCTTSCCCCCCCSCHHHHHH-------HHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             hcCCcccCCcccCCHHHHHH-------HHHHcCCChhHCCCHHHHHhCcc
Confidence            22222333344445555544       44599999999999999987643

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.97  E-value=4.8e-32  Score=221.91  Aligned_cols=187  Identities=26%  Similarity=0.438  Sum_probs=139.4

Q ss_pred             CCCCCcchhccccCC----------CCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEc
Q 026160            1 MPNGSLDQFTYDQES----------SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKIS   70 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~   70 (242)
                      |++|+|.+++.....          ......+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+
T Consensus       108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL~  184 (327)
T 1fvr_A          108 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA  184 (327)
T ss_dssp             CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEEC
T ss_pred             CCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEEc
Confidence            578999999976531          01234699999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhh
Q 026160           71 DFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIY  149 (242)
Q Consensus        71 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~  149 (242)
                      |||++.........   ....++..|.|||.+.+.  .++.++||||||+++|+|++ |..||.....        ....
T Consensus       185 Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~~~  251 (327)
T 1fvr_A          185 DFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AELY  251 (327)
T ss_dssp             CTTCEESSCEECCC-------CCTTTCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHH
T ss_pred             ccCcCccccccccc---cCCCCCccccChhhhccc--cCCchhcchHHHHHHHHHHcCCCCCCCCCcH--------HHHH
Confidence            99998743322211   122367889999998653  56889999999999999998 9999964432        1111


Q ss_pred             hccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccCC
Q 026160          150 KHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIP  210 (242)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~  210 (242)
                      .....+.....+..+++.+.+++.       +||+.||++|||+.++++.|+.+.+.....
T Consensus       252 ~~~~~~~~~~~~~~~~~~l~~li~-------~~l~~dp~~Rps~~ell~~L~~~~~~~~~~  305 (327)
T 1fvr_A          252 EKLPQGYRLEKPLNCDDEVYDLMR-------QCWREKPYERPSFAQILVSLNRMLEERKTY  305 (327)
T ss_dssp             HHGGGTCCCCCCTTBCHHHHHHHH-------HHTCSSGGGSCCHHHHHHHHHHHHHSSSCS
T ss_pred             HHhhcCCCCCCCCCCCHHHHHHHH-------HHccCChhhCcCHHHHHHHHHHHHHhhcCc
Confidence            222222222333445555555554       488999999999999999999988764433

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.97  E-value=9.4e-32  Score=237.10  Aligned_cols=186  Identities=24%  Similarity=0.319  Sum_probs=139.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.++|....     ..+++.+++.++.|++.||.|||+.   +|+|+||||+|||++.++.++|+|||++.....
T Consensus       417 ~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          417 AGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             CTTCBHHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             CCCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            68999999996542     4699999999999999999999999   999999999999999999999999999986543


Q ss_pred             Ccccc-hhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           81 KKSTI-SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        81 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      ..... ......++..|+|||.+...  .++.++||||||+++|||++ |..||.....        ......+..+...
T Consensus       489 ~~~~~~~~~~~~~~~~y~APE~~~~~--~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--------~~~~~~i~~~~~~  558 (613)
T 2ozo_A          489 DDSYYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVMAFIEQGKRM  558 (613)
T ss_dssp             -------------CCTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS--------HHHHHHHHTTCCC
T ss_pred             CCceeeeccCCCCccceeCHhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH--------HHHHHHHHcCCCC
Confidence            32211 11122356789999998653  67899999999999999998 9999975432        1222223333333


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccCCC
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPP  211 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~  211 (242)
                      ..+..+++++.+       ++..||+.||++|||+.++++.|+.+........
T Consensus       559 ~~p~~~~~~l~~-------li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~  604 (613)
T 2ozo_A          559 ECPPECPPELYA-------LMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV  604 (613)
T ss_dssp             CCCTTCCHHHHH-------HHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSC
T ss_pred             CCCCcCCHHHHH-------HHHHHcCCChhHCcCHHHHHHHHHHHHHHhcccc
Confidence            444455655554       4455999999999999999999999876654443

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.97  E-value=4e-32  Score=218.85  Aligned_cols=183  Identities=23%  Similarity=0.365  Sum_probs=139.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++...      +.+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        99 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           99 AELGPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             CTTEEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHHhC------cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            5789999999765      4599999999999999999999999   999999999999999999999999999986654


Q ss_pred             Ccccc-hhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           81 KKSTI-SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        81 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      ..... ......++..|.|||.+.+.  .++.++||||||+++|++++ |..||.....        .........+...
T Consensus       170 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~  239 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAMLEKGERM  239 (291)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTCCC
T ss_pred             CCCcccccccCCCCceeeChHHhccC--CCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCC
Confidence            33221 11122366889999998653  56789999999999999999 9999865432        1122222222233


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccC
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQI  209 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~  209 (242)
                      ..+..+++.+.+++.+       ||+.||++|||+.++++.|+.+......
T Consensus       240 ~~~~~~~~~l~~li~~-------~l~~dp~~Rps~~~l~~~L~~~~~~~~~  283 (291)
T 1xbb_A          240 GCPAGCPREMYDLMNL-------CWTYDVENRPGFAAVELRLRNYYYDVVN  283 (291)
T ss_dssp             CCCTTCCHHHHHHHHH-------HTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHH-------HcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence            3344556655555544       9999999999999999999988765443

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.97  E-value=5.3e-32  Score=233.36  Aligned_cols=180  Identities=26%  Similarity=0.395  Sum_probs=138.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.++|.....    ..+++..++.++.|++.||.|||+.   +++|+||||+|||++.++.++|+|||++.....
T Consensus       298 ~~~g~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          298 MTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             CTTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred             cCCCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence            678999999976432    5699999999999999999999999   999999999999999999999999999986543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      .... ......++..|+|||.+...  .++.++||||||+++|+|++ |..||......        .....+.......
T Consensus       371 ~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~  439 (495)
T 1opk_A          371 DTYT-AHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYELLEKDYRME  439 (495)
T ss_dssp             CCEE-CCTTCCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--------GHHHHHHTTCCCC
T ss_pred             Ccee-ecCCCcCCcceeCHhHHhcC--CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCC
Confidence            3211 11123467789999998653  57889999999999999999 88888644321        1112222222233


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTE  205 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~  205 (242)
                      .+..+++++.+       ++.+||+.||++|||+.++++.|+.+..
T Consensus       440 ~~~~~~~~l~~-------li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          440 RPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             CCTTCCHHHHH-------HHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             CCCCCCHHHHH-------HHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence            34445555544       4455999999999999999999998754

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.97  E-value=2.8e-32  Score=220.65  Aligned_cols=187  Identities=22%  Similarity=0.372  Sum_probs=137.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....     ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       107 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  178 (302)
T 4e5w_A          107 LPSGSLKEYLPKNK-----NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  178 (302)
T ss_dssp             CTTCBHHHHHHHHT-----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             CCCCcHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccccC
Confidence            57899999996543     4599999999999999999999999   999999999999999999999999999987654


Q ss_pred             Cccc-chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccccc-------CCCCCcCcchhhhcc
Q 026160           81 KKST-ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKAS-------RSSDIYFPNSIYKHI  152 (242)
Q Consensus        81 ~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~-------~~~~~~~~~~~~~~~  152 (242)
                      .... .......++..|.|||.+.+.  .++.++||||||+++|++++|..|+.....       ...............
T Consensus       179 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (302)
T 4e5w_A          179 DKEYYTVKDDRDSPVFWYAPECLMQS--KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL  256 (302)
T ss_dssp             TCCEEECCCCTTCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred             CCcceeccCCCCCCccccCCeeecCC--CCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence            4322 112223477889999988664  567899999999999999999988643211       000000011111222


Q ss_pred             CCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchh
Q 026160          153 EPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESST  204 (242)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~  204 (242)
                      ........+..+++.+.+++       .+||+.||++|||+.++++.|+.+.
T Consensus       257 ~~~~~~~~~~~~~~~l~~li-------~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          257 KEGKRLPCPPNCPDEVYQLM-------RKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HTTCCCCCCTTCCHHHHHHH-------HHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hccCCCCCCCCCCHHHHHHH-------HHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            22333334445555555544       4599999999999999999999764

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.97  E-value=4e-32  Score=217.41  Aligned_cols=177  Identities=26%  Similarity=0.424  Sum_probs=132.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.....    ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        97 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           97 MAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             CTTEEHHHHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             CCCCCHHHHHHhccc----ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            467899999976421    3489999999999999999999999   999999999999999999999999999875543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ...     ...++..|.|||.+.+.  .++.++|+||||+++|++++ |..||.....        .........+....
T Consensus       170 ~~~-----~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--------~~~~~~~~~~~~~~  234 (278)
T 1byg_A          170 TQD-----TGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPRVEKGYKMD  234 (278)
T ss_dssp             -----------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--------GGHHHHHTTTCCCC
T ss_pred             ccc-----CCCccccccCHHHhCCC--CCCchhcHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHhcCCCCC
Confidence            321     12367889999998653  67889999999999999998 9999864332        11222222333333


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      .+..+++.+.+++.+       ||+.||++|||+.++++.|+.+...
T Consensus       235 ~~~~~~~~l~~li~~-------~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          235 APDGCPPAVYEVMKN-------CWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             CCTTCCHHHHHHHHH-------HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CcccCCHHHHHHHHH-------HhcCChhhCCCHHHHHHHHHHHHhh
Confidence            444566665555554       9999999999999999999987653

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.97  E-value=8.5e-32  Score=223.28  Aligned_cols=170  Identities=25%  Similarity=0.380  Sum_probs=130.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCC----ceEEccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF----CPKISDFGLAK   76 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~----~~~L~dfg~~~   76 (242)
                      |+||+|.+++...      +.+++.++..++.||+.||.|||+.   +++|+||||+||+++.++    .++|+|||++.
T Consensus        97 ~~gg~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~  167 (361)
T 2yab_A           97 VSGGELFDFLAQK------ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (361)
T ss_dssp             CCSCBHHHHHTTC------SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence            5799999999764      4699999999999999999999999   999999999999998776    79999999998


Q ss_pred             ccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCC
Q 026160           77 QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN  156 (242)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  156 (242)
                      ........   ....|++.|+|||++.+.  .++.++|+||||+++|+|++|..||......        .....+....
T Consensus       168 ~~~~~~~~---~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~--------~~~~~i~~~~  234 (361)
T 2yab_A          168 EIEDGVEF---KNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANITAVS  234 (361)
T ss_dssp             ECCTTCCC---CCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHTTC
T ss_pred             EcCCCCcc---ccCCCCccEECchHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhcC
Confidence            76543322   223589999999998653  5788999999999999999999999643321        1111111111


Q ss_pred             ---ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          157 ---DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       157 ---~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                         .......+++++.+++.+       ||..||++|||+.+++++
T Consensus       235 ~~~~~~~~~~~s~~~~~li~~-------~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          235 YDFDEEFFSQTSELAKDFIRK-------LLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHH-------HSCSSTTTSCCHHHHHTS
T ss_pred             CCCCchhccCCCHHHHHHHHH-------HCCCChhHCcCHHHHhcC
Confidence               111123345555555555       889999999999999863

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.97  E-value=1.9e-32  Score=224.67  Aligned_cols=187  Identities=23%  Similarity=0.383  Sum_probs=137.0

Q ss_pred             CCCCCcchhccccCCC--------CCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEccc
Q 026160            1 MPNGSLDQFTYDQESS--------NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDF   72 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~--------~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~df   72 (242)
                      |++|+|.+++......        ..+..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+||
T Consensus       132 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df  208 (333)
T 2i1m_A          132 CCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDF  208 (333)
T ss_dssp             CTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGEEEBCCC
T ss_pred             CCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCeEEECcc
Confidence            5788999999754210        0124689999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhc
Q 026160           73 GLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKH  151 (242)
Q Consensus        73 g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~  151 (242)
                      |++................++..|+|||.+.+.  .++.++||||||+++|+|++ |..||......       ......
T Consensus       209 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-------~~~~~~  279 (333)
T 2i1m_A          209 GLARDIMNDSNYIVKGNARLPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGLNPYPGILVN-------SKFYKL  279 (333)
T ss_dssp             GGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS-------HHHHHH
T ss_pred             ccccccccccceeecCCCCCCccccCHHHhccC--CCChHHHHHHHHHHHHHHHcCCCCCCcccchh-------HHHHHH
Confidence            999765433222222223467789999988764  57899999999999999998 88888643321       111111


Q ss_pred             cCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          152 IEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      .........+..+++.+.       .++..||+.||++|||+.++++.|+.+...
T Consensus       280 ~~~~~~~~~~~~~~~~l~-------~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          280 VKDGYQMAQPAFAPKNIY-------SIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             HHHTCCCCCCTTCCHHHH-------HHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HhcCCCCCCCCCCCHHHH-------HHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence            111112222333444444       455559999999999999999999987654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.97  E-value=6.1e-32  Score=222.96  Aligned_cols=178  Identities=23%  Similarity=0.360  Sum_probs=131.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.+.      +.+++..+..++.||+.||.|||+.   +|+|+||||+||+++.++.++|+|||++.....
T Consensus        92 ~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           92 VNGGDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             CCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            5799999999765      4599999999999999999999999   999999999999999999999999999975332


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCC-cCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDI-YFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  159 (242)
                      ....  .....|++.|+|||.+.+.  .++.++|+|||||++|+|++|..||.......... .........+.. ....
T Consensus       163 ~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~-~~~~  237 (345)
T 3a8x_A          163 PGDT--TSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIR  237 (345)
T ss_dssp             TTCC--BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH-CCCC
T ss_pred             CCCc--ccccCCCccccCccccCCC--CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc-CCCC
Confidence            2111  1223589999999998764  67899999999999999999999996533221110 001111111111 1122


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSM------HEVLEM  199 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~------~~ll~~  199 (242)
                      ++..++.++.+++.+       ||+.||++||++      .+++++
T Consensus       238 ~p~~~s~~~~~li~~-------lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          238 IPRSLSVKAASVLKS-------FLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             CCTTSCHHHHHHHHH-------HTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             CCCCCCHHHHHHHHH-------HhcCCHhHCCCCCCcCCHHHHhcC
Confidence            344566666666665       889999999995      666653

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.97  E-value=5.9e-32  Score=226.59  Aligned_cols=177  Identities=23%  Similarity=0.373  Sum_probs=127.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +.+|+|.+++...      ..+++.++..++.||+.||.|||+.   +|+|+||||+|||++ ++.++|+|||++.....
T Consensus       137 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          137 CGNIDLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             CCSEEHHHHHHHC------SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             cCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            4678999999765      3589999999999999999999999   999999999999995 57899999999987654


Q ss_pred             Ccccchhcccccccccccchhhhcc---------cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRS---------FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKH  151 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~---------~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~  151 (242)
                      ...........|++.|+|||++.+.         ...++.++|||||||++|+|++|..||......      .......
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~~~~  280 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ISKLHAI  280 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHH
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH------HHHHHHH
Confidence            3322222334699999999998641         125688999999999999999999999643211      0111111


Q ss_pred             cCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 026160          152 IEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML  200 (242)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l  200 (242)
                      .........+...+.++.+       ++.+||+.||++|||+.+++++-
T Consensus       281 ~~~~~~~~~~~~~~~~~~~-------li~~~L~~dP~~Rps~~ell~hp  322 (390)
T 2zmd_A          281 IDPNHEIEFPDIPEKDLQD-------VLKCCLKRDPKQRISIPELLAHP  322 (390)
T ss_dssp             HCTTSCCCCCCCSCHHHHH-------HHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             hCccccCCCCccchHHHHH-------HHHHHcccChhhCCCHHHHhhCc
Confidence            2222222333334444444       44559999999999999998753

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.97  E-value=2.8e-31  Score=215.61  Aligned_cols=178  Identities=25%  Similarity=0.300  Sum_probs=128.6

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      +|+|.+++.....    ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus       102 ~~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  174 (308)
T 3g33_A          102 DQDLRTYLDKAPP----PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM  174 (308)
T ss_dssp             CCBHHHHHHTCCT----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCC
T ss_pred             hcCHHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEeeCccccccCCCc
Confidence            4789999876532    4599999999999999999999999   99999999999999999999999999998665433


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCC------------CCcCc-----
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSS------------DIYFP-----  145 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~------------~~~~~-----  145 (242)
                      ...   ...+++.|+|||.+.+.  .++.++|||||||++|+|++|..||........            ...++     
T Consensus       175 ~~~---~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  249 (308)
T 3g33_A          175 ALT---PVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSL  249 (308)
T ss_dssp             CSG---GGGCCCSSCCHHHHHTS--CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSS
T ss_pred             ccC---CccccccccCchHHcCC--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhc
Confidence            322   23589999999998664  578899999999999999999999964332110            00000     


Q ss_pred             -chhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          146 -NSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       146 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                       ..................+++.+       .+++.+||+.||++|||+.+++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~-------~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          250 PRGAFPPRGPRPVQSVVPEMEESG-------AQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             CGGGSCCCCCCCHHHHSCSCCHHH-------HHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccCCCCCCcHHHhCccccHHH-------HHHHHHHhcCCCccCCCHHHHhcC
Confidence             00000000000001112234444       445555889999999999999875

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.97  E-value=9.6e-32  Score=221.04  Aligned_cols=170  Identities=28%  Similarity=0.398  Sum_probs=132.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.+++...      +.+++.++..++.||+.||.|||+.   +|+|+||||+||+++.++.++|+|||++.....
T Consensus        87 ~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           87 ANGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             CTTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            5799999999765      4599999999999999999999999   999999999999999999999999999875432


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....||+.|+|||.+.+.  .++.++|+|||||++|+|++|..||......        .....+.. ....+
T Consensus       158 ~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~i~~-~~~~~  224 (337)
T 1o6l_A          158 DGAT--MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------RLFELILM-EEIRF  224 (337)
T ss_dssp             TTCC--BCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHH-CCCCC
T ss_pred             CCCc--ccccccChhhCChhhhcCC--CCCchhhcccchhHHHHHhcCCCCCCCCCHH--------HHHHHHHc-CCCCC
Confidence            2111  1123589999999998654  6789999999999999999999999643321        11111100 11223


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRP-----SMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp-----s~~~ll~~  199 (242)
                      +..+++++.+++.+       ||+.||++||     ++.+++++
T Consensus       225 p~~~s~~~~~li~~-------lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          225 PRTLSPEAKSLLAG-------LLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             CTTSCHHHHHHHHH-------HTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CCCCCHHHHHHHHH-------HhhcCHHHhcCCCCCCHHHHHcC
Confidence            44567777666666       8899999999     89999875

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.97  E-value=7.3e-32  Score=214.43  Aligned_cols=179  Identities=25%  Similarity=0.441  Sum_probs=136.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....     ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        85 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  156 (267)
T 3t9t_A           85 MEHGCLSDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  156 (267)
T ss_dssp             CTTCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             CCCCcHHHHHhhCc-----ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccc
Confidence            57899999997642     4689999999999999999999999   999999999999999999999999999876543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      .... ......++..|.|||.+.+.  .++.++|+||||+++|++++ |..||.....        .........+....
T Consensus       157 ~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~i~~~~~~~  225 (267)
T 3t9t_A          157 DQYT-SSTGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDISTGFRLY  225 (267)
T ss_dssp             HHHH-STTSTTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTCCCC
T ss_pred             cccc-ccccccccccccChhhhcCC--CccchhchhhhHHHHHHHhccCCCCCCCCCH--------HHHHHHHhcCCcCC
Confidence            2211 11123467789999998654  56889999999999999999 8999864332        11111122222222


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTE  205 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~  205 (242)
                      .+..++..+.+       ++.+||+.||++|||+.++++.|+.+.+
T Consensus       226 ~~~~~~~~l~~-------li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          226 KPRLASTHVYQ-------IMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             CCTTSCHHHHH-------HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCccCcHHHHH-------HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            23334555444       4555999999999999999999998865

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.97  E-value=9.4e-32  Score=221.20  Aligned_cols=194  Identities=23%  Similarity=0.265  Sum_probs=138.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhh--------hCCCCCeeecCCCCCceeeCCCCceEEccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLH--------RGCNVRIVHFDIKPHNILLDEDFCPKISDF   72 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH--------~~~~~~i~h~dlk~~nil~~~~~~~~L~df   72 (242)
                      |++|+|.+++.+.       .+++.+++.++.|++.||.|||        +.   +++|+||||+||+++.++.++|+||
T Consensus       122 ~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~kL~Df  191 (342)
T 1b6c_B          122 HEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCCIADL  191 (342)
T ss_dssp             CTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEEECCC
T ss_pred             cCCCcHHHHHhcc-------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEEEEEC
Confidence            5789999999653       5999999999999999999999        77   9999999999999999999999999


Q ss_pred             ccccccCCCcccc--hhcccccccccccchhhhcccC----CCCCCccchhHHHHHHHHHhc----------CCCccccc
Q 026160           73 GLAKQSQDKKSTI--SMLHARGTIGYIAPEVFCRSFG----GASHKSDVYSYGMMILEMAVG----------RKNADVKA  136 (242)
Q Consensus        73 g~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~----~~~~~~Di~slG~~~~~ll~g----------~~p~~~~~  136 (242)
                      |++..........  ......++..|.|||.+.+...    ..+.++||||||+++|+|++|          ..||....
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~  271 (342)
T 1b6c_B          192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  271 (342)
T ss_dssp             TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence            9997655433211  1123358999999999865321    123689999999999999999          55664332


Q ss_pred             cCCCCCcCcchhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhcc
Q 026160          137 SRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQ  208 (242)
Q Consensus       137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~  208 (242)
                      ......  ................+...  ........+.+++.+||+.||++|||+.+++++|+.+.+...
T Consensus       272 ~~~~~~--~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~  339 (342)
T 1b6c_B          272 PSDPSV--EEMRKVVCEQKLRPNIPNRW--QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  339 (342)
T ss_dssp             CSSCCH--HHHHHHHTTSCCCCCCCGGG--GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred             cCcccH--HHHHHHHHHHHhCCCCcccc--cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence            221110  01111111111111111111  112445567778888999999999999999999999887643

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.97  E-value=8.2e-32  Score=216.49  Aligned_cols=182  Identities=27%  Similarity=0.402  Sum_probs=139.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.....    ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        91 ~~~~~L~~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  163 (288)
T 3kfa_A           91 MTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  163 (288)
T ss_dssp             CTTEEHHHHHHHCCT----TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred             CCCCcHHHHHHhccc----CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence            568999999976432    5699999999999999999999999   999999999999999999999999999986654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ..... .....++..|.|||.+.+.  .++.++||||||+++|++++ |..||......        .............
T Consensus       164 ~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--------~~~~~~~~~~~~~  232 (288)
T 3kfa_A          164 DTYTA-HAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYELLEKDYRME  232 (288)
T ss_dssp             SSSEE-ETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--------GHHHHHHTTCCCC
T ss_pred             Ccccc-ccCCccccCcCChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHhccCCCC
Confidence            33221 1123467789999998654  67889999999999999999 88888644321        1111222222223


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhc
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEIL  207 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~  207 (242)
                      .+..+++.+.+++.       +||+.||++|||+.++++.|+.+....
T Consensus       233 ~~~~~~~~l~~li~-------~~l~~dp~~Rps~~~~~~~l~~~~~~~  273 (288)
T 3kfa_A          233 RPEGCPEKVYELMR-------ACWQWNPSDRPSFAEIHQAFETMFQES  273 (288)
T ss_dssp             CCTTCCHHHHHHHH-------HHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHH-------HHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence            33445655555554       488999999999999999999877653

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.97  E-value=5.8e-32  Score=216.79  Aligned_cols=177  Identities=23%  Similarity=0.441  Sum_probs=135.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.....    ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       102 ~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  174 (284)
T 2a19_B          102 CDKGTLEQWIEKRRG----EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN  174 (284)
T ss_dssp             CCSCBHHHHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEESSC
T ss_pred             cCCCCHHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEEECcchhheeccc
Confidence            578999999976432    4699999999999999999999999   999999999999999999999999999887654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      .....   ...++..|.|||.+.+.  .++.++||||||+++|+|++|..|+......          .......   ..
T Consensus       175 ~~~~~---~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~~~~~----------~~~~~~~---~~  236 (284)
T 2a19_B          175 DGKRT---RSKGTLRYMSPEQISSQ--DYGKEVDLYALGLILAELLHVCDTAFETSKF----------FTDLRDG---II  236 (284)
T ss_dssp             CSCCC---CCCSCCTTSCHHHHHCS--CCCTHHHHHHHHHHHHHHHSCCSSHHHHHHH----------HHHHHTT---CC
T ss_pred             ccccc---ccCCcccccChhhhccC--CCcchhhhHHHHHHHHHHHhcCCcchhHHHH----------HHHhhcc---cc
Confidence            33221   23489999999998653  5688999999999999999999887532210          0001010   12


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccC
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQI  209 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~  209 (242)
                      +..++..+.++       +.+||+.||++|||+.++++.|+.+......
T Consensus       237 ~~~~~~~~~~l-------i~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~  278 (284)
T 2a19_B          237 SDIFDKKEKTL-------LQKLLSKKPEDRPNTSEILRTLTVWKKSPEK  278 (284)
T ss_dssp             CTTSCHHHHHH-------HHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred             cccCCHHHHHH-------HHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence            23345555544       4458899999999999999999988765443

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.97  E-value=1.4e-31  Score=218.16  Aligned_cols=194  Identities=22%  Similarity=0.258  Sum_probs=129.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....     ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++ ++.++|+|||++.....
T Consensus       111 ~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~  181 (319)
T 2y4i_B          111 CKGRTLYSVVRDAK-----IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGV  181 (319)
T ss_dssp             CCSEEHHHHTTSSC-----CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred             ccCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence            57899999997642     4699999999999999999999999   999999999999998 67999999999765432


Q ss_pred             Cccc---chhcccccccccccchhhhcc-------cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhh
Q 026160           81 KKST---ISMLHARGTIGYIAPEVFCRS-------FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYK  150 (242)
Q Consensus        81 ~~~~---~~~~~~~~~~~y~~PE~~~~~-------~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~  150 (242)
                      ....   .......++..|.|||.+...       ...++.++||||||+++|++++|..||......       .....
T Consensus       182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~  254 (319)
T 2y4i_B          182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-------AIIWQ  254 (319)
T ss_dssp             ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-------HHHHH
T ss_pred             ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHH
Confidence            1111   111123488899999998642       124578999999999999999999999643321       11111


Q ss_pred             ccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccCCCCCCCCC
Q 026160          151 HIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSLAL  217 (242)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~~~~~  217 (242)
                      .............++.++.+++.+       ||+.||++|||+.++++.|+.+.........|...|
T Consensus       255 ~~~~~~~~~~~~~~~~~l~~li~~-------~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~  314 (319)
T 2y4i_B          255 MGTGMKPNLSQIGMGKEISDILLF-------CWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFW  314 (319)
T ss_dssp             HHTTCCCCCCCSSCCTTHHHHHHH-------HHCSSTTTSCCHHHHHHHHTTC--------------
T ss_pred             hccCCCCCCCcCCCCHHHHHHHHH-------HhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcccc
Confidence            111111111122355555555555       889999999999999999999887755554444443

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.97  E-value=1.2e-31  Score=219.68  Aligned_cols=173  Identities=22%  Similarity=0.306  Sum_probs=129.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCC----ceEEccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF----CPKISDFGLAK   76 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~----~~~L~dfg~~~   76 (242)
                      |++|+|.+++...      ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++    .++|+|||++.
T Consensus        96 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           96 VAGGELFDFLAEK------ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             CCSCBHHHHHTTS------SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             CCCCCHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            5789999999754      4699999999999999999999999   999999999999998877    79999999998


Q ss_pred             ccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCC
Q 026160           77 QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN  156 (242)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  156 (242)
                      ........   ....+++.|+|||.+...  .++.++||||||+++|+|++|..||........    ..... ......
T Consensus       167 ~~~~~~~~---~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~~~-~~~~~~  236 (326)
T 2y0a_A          167 KIDFGNEF---KNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQET----LANVS-AVNYEF  236 (326)
T ss_dssp             ECCTTSCC---CCCCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH----HHHHH-HTCCCC
T ss_pred             ECCCCCcc---ccccCCcCcCCceeecCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH----HHHHH-hcCCCc
Confidence            76543222   123589999999998653  578899999999999999999999964332100    00000 000001


Q ss_pred             ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          157 DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .......++..+.+       ++.+||+.||++|||+.+++++
T Consensus       237 ~~~~~~~~~~~~~~-------li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          237 EDEYFSNTSALAKD-------FIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             CHHHHTTSCHHHHH-------HHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CccccccCCHHHHH-------HHHHHccCChhhCCCHHHHhcC
Confidence            11111234444444       4555889999999999999975

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.97  E-value=1.2e-31  Score=223.88  Aligned_cols=173  Identities=30%  Similarity=0.422  Sum_probs=131.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.+++...      ..+++..+..++.||+.||.|||+.   +|+|+||||+||+++.++.++|+|||++.....
T Consensus        97 ~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           97 LLGGDLRYHLQQN------VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             CTTEEHHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            5799999999764      4599999999999999999999999   999999999999999999999999999986654


Q ss_pred             Ccccchhcccccccccccchhhhcc-cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRS-FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ....   ....||+.|+|||++... ...++.++|+|||||++|+|++|..||.........     ....... .....
T Consensus       168 ~~~~---~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~-----~~~~~~~-~~~~~  238 (384)
T 4fr4_A          168 ETQI---TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK-----EIVHTFE-TTVVT  238 (384)
T ss_dssp             TCCB---CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH-----HHHHHHH-HCCCC
T ss_pred             CCce---eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH-----HHHHHHh-hcccC
Confidence            3322   233599999999998643 235788999999999999999999999754332211     1111100 11122


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCC-HHHHHH
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPS-MHEVLE  198 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps-~~~ll~  198 (242)
                      .+..++..+.+++.+       ||+.||++||+ +.++++
T Consensus       239 ~p~~~s~~~~~li~~-------lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          239 YPSAWSQEMVSLLKK-------LLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             CCTTSCHHHHHHHHH-------HSCSSGGGSCCSHHHHHT
T ss_pred             CCCcCCHHHHHHHHH-------HhcCCHhHhcccHHHHHc
Confidence            334456665555555       88999999998 777664

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.97  E-value=1.3e-31  Score=219.47  Aligned_cols=176  Identities=20%  Similarity=0.291  Sum_probs=128.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC---CCceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE---DFCPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~---~~~~~L~dfg~~~~   77 (242)
                      |++|+|.+++....    ...+++.+++.++.|++.||.|||+.   +++|+||||+||+++.   ++.++|+|||++..
T Consensus       111 ~~~~~L~~~~~~~~----~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~  183 (327)
T 3lm5_A          111 AAGGEIFSLCLPEL----AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK  183 (327)
T ss_dssp             CTTEEGGGGGSSCC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred             cCCCcHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence            57899999986542    25699999999999999999999999   9999999999999987   78999999999987


Q ss_pred             cCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      ........   ...+++.|+|||.+...  .++.++||||||+++|+|++|..||........     ............
T Consensus       184 ~~~~~~~~---~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-----~~~i~~~~~~~~  253 (327)
T 3lm5_A          184 IGHACELR---EIMGTPEYLAPEILNYD--PITTATDMWNIGIIAYMLLTHTSPFVGEDNQET-----YLNISQVNVDYS  253 (327)
T ss_dssp             C------------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHHTCCCCC
T ss_pred             cCCccccc---cccCCcCccCCeeecCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-----HHHHHhcccccC
Confidence            65433221   23589999999998653  678899999999999999999999964432110     000011111111


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML  200 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l  200 (242)
                      ......+++.+.++       +.+||+.||++|||+.+++++-
T Consensus       254 ~~~~~~~~~~~~~l-------i~~~L~~dP~~Rpt~~~ll~h~  289 (327)
T 3lm5_A          254 EETFSSVSQLATDF-------IQSLLVKNPEKRPTAEICLSHS  289 (327)
T ss_dssp             TTTTTTSCHHHHHH-------HHHHSCSSGGGSCCHHHHTTCG
T ss_pred             chhhcccCHHHHHH-------HHHHcCCChhhCcCHHHHhCCH
Confidence            12223345555544       4458899999999999998763

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.97  E-value=3e-31  Score=211.87  Aligned_cols=176  Identities=25%  Similarity=0.273  Sum_probs=130.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      ..+++.++..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        87 ~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  157 (276)
T 2yex_A           87 CSGGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (276)
T ss_dssp             CTTEEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             cCCCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence            5688999999754      4699999999999999999999999   999999999999999999999999999876543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ...........++..|.|||.+.+. ...+.++|+||||+++|++++|..||........      ..............
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~  230 (276)
T 2yex_A          158 NNRERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------EYSDWKEKKTYLNP  230 (276)
T ss_dssp             TTEECCBCCCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH------HHHHHHTTCTTSTT
T ss_pred             CcchhcccCCccccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH------HHHHhhhcccccCc
Confidence            2221112234588999999998653 2346789999999999999999999975443211      11111111111111


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ...+++.+.+       ++.+||+.||++|||+.+++++
T Consensus       231 ~~~~~~~~~~-------li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          231 WKKIDSAPLA-------LLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             GGGSCHHHHH-------HHHHHSCSSTTTSCCHHHHTTC
T ss_pred             hhhcCHHHHH-------HHHHHCCCCchhCCCHHHHhcC
Confidence            2234555544       4455889999999999999874

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.97  E-value=2.3e-31  Score=215.07  Aligned_cols=173  Identities=23%  Similarity=0.336  Sum_probs=127.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++..       +.+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       120 ~~~~~l~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  189 (298)
T 2zv2_A          120 VNQGPVMEVPTL-------KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG  189 (298)
T ss_dssp             CTTCBSCCSSCS-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             CCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCCEEEecCCCcccccc
Confidence            568888887643       4699999999999999999999999   999999999999999999999999999987654


Q ss_pred             CcccchhcccccccccccchhhhcccCC-CCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGG-ASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      .....  ....++..|+|||.+.+.... .+.++||||||+++|+|++|..||......       ..............
T Consensus       190 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~  260 (298)
T 2zv2_A          190 SDALL--SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM-------CLHSKIKSQALEFP  260 (298)
T ss_dssp             SSCEE--CCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCCCC
T ss_pred             ccccc--cCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH-------HHHHHHhcccCCCC
Confidence            33221  123589999999998654222 367899999999999999999999643211       00000000111111


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ....+++++.+++.+       ||+.||++|||+.+++++
T Consensus       261 ~~~~~~~~l~~li~~-------~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          261 DQPDIAEDLKDLITR-------MLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             SSSCCCHHHHHHHHH-------HTCSCTTTSCCHHHHTTC
T ss_pred             CccccCHHHHHHHHH-------HhhcChhhCCCHHHHhcC
Confidence            123455555555554       889999999999998753

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.97  E-value=7.7e-32  Score=220.69  Aligned_cols=189  Identities=24%  Similarity=0.369  Sum_probs=137.9

Q ss_pred             CCCCCcchhccccCCC-CCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC---CCceEEccccccc
Q 026160            1 MPNGSLDQFTYDQESS-NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE---DFCPKISDFGLAK   76 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~-~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~---~~~~~L~dfg~~~   76 (242)
                      |++|+|.+++...... .....+++.+++.++.|++.||.|||+.   +++|+||||+||+++.   +..++|+|||++.
T Consensus       115 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~  191 (327)
T 2yfx_A          115 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR  191 (327)
T ss_dssp             CTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHHH
T ss_pred             CCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEECcccccc
Confidence            5789999999875422 2235699999999999999999999999   9999999999999984   4469999999987


Q ss_pred             ccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCC
Q 026160           77 QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPG  155 (242)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  155 (242)
                      ...............++..|+|||.+.+.  .++.++||||||+++|+|++ |..||.....        .........+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~~~~~~~  261 (327)
T 2yfx_A          192 DIYRASYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QEVLEFVTSG  261 (327)
T ss_dssp             HHHC------CCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHHHHHTT
T ss_pred             ccccccccccCCCcCCCcceeCHhHhcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--------HHHHHHHhcC
Confidence            54332222222223478899999998654  57889999999999999998 8888864332        1111122222


Q ss_pred             CccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccC
Q 026160          156 NDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQI  209 (242)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~  209 (242)
                      .....+..++..+.++       +.+||+.||++|||+.++++.|+.+.....+
T Consensus       262 ~~~~~~~~~~~~l~~l-------i~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~  308 (327)
T 2yfx_A          262 GRMDPPKNCPGPVYRI-------MTQCWQHQPEDRPNFAIILERIEYCTQDPDV  308 (327)
T ss_dssp             CCCCCCTTCCHHHHHH-------HHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred             CCCCCCCCCCHHHHHH-------HHHHhcCChhhCcCHHHHHHHHHHHhcCHHH
Confidence            2223334455555544       4559999999999999999999988765443

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.97  E-value=5.1e-32  Score=224.01  Aligned_cols=169  Identities=24%  Similarity=0.354  Sum_probs=128.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.+++.+.      +.+++.++..++.||+.||.|||+.   +|+||||||+|||++.++.++|+|||++.....
T Consensus       106 ~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A          106 VNGGDLMFHIQKS------RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             CCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence            6799999999875      4599999999999999999999999   999999999999999999999999999875332


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....||+.|+|||++.+.  .++.++|+|||||++|+|++|..||......        .....+... ....
T Consensus       177 ~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~-~~~~  243 (353)
T 3txo_A          177 NGVT--TATFCGTPDYIAPEILQEM--LYGPAVDWWAMGVLLYEMLCGHAPFEAENED--------DLFEAILND-EVVY  243 (353)
T ss_dssp             -----------CCGGGCCHHHHHHH--HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHC-CCCC
T ss_pred             CCcc--ccccCCCcCeEChhhcCCC--CcCCccCCCcchHHHHHHHhCCCCCCCCCHH--------HHHHHHHcC-CCCC
Confidence            2211  1233589999999998764  5688999999999999999999999754321        111111111 1223


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCH------HHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSM------HEVLE  198 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~------~~ll~  198 (242)
                      +..+++++.+++.+       ||+.||++||++      .++++
T Consensus       244 p~~~~~~~~~li~~-------lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          244 PTWLHEDATGILKS-------FMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             CTTSCHHHHHHHHH-------HTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             CCCCCHHHHHHHHH-------HhhhCHHHccCCcccCCHHHHhh
Confidence            34466666666665       779999999998      77775

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.97  E-value=8.8e-32  Score=218.94  Aligned_cols=181  Identities=22%  Similarity=0.342  Sum_probs=125.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      +.+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        98 ~~g~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  168 (311)
T 3ork_A           98 VDGVTLRDIVHTE------GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD  168 (311)
T ss_dssp             CCEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred             CCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence            5689999999765      4599999999999999999999999   999999999999999999999999999976544


Q ss_pred             Ccccc-hhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCC--Cc
Q 026160           81 KKSTI-SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPG--ND  157 (242)
Q Consensus        81 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~  157 (242)
                      ..... ......++..|+|||.+.+.  .++.++||||||+++|+|++|..||.......       .........  ..
T Consensus       169 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-------~~~~~~~~~~~~~  239 (311)
T 3ork_A          169 SGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-------VAYQHVREDPIPP  239 (311)
T ss_dssp             -------------CCTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHCCCCCH
T ss_pred             cccccccccccCcCcccCCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-------HHHHHhcCCCCCc
Confidence            32211 11223589999999998664  67889999999999999999999996443211       111111111  11


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHH-HHHHHhhchhhh
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMH-EVLEMLESSTEI  206 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~-~ll~~l~~~~~~  206 (242)
                      ......+++++.+       ++.+||+.||++||++. ++.+.+......
T Consensus       240 ~~~~~~~~~~l~~-------li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  282 (311)
T 3ork_A          240 SARHEGLSADLDA-------VVLKALAKNPENRYQTAAEMRADLVRVHNG  282 (311)
T ss_dssp             HHHSTTCCHHHHH-------HHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred             ccccCCCCHHHHH-------HHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence            1112234444444       44559999999999555 455666655443

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.97  E-value=5.8e-32  Score=235.11  Aligned_cols=183  Identities=27%  Similarity=0.418  Sum_probs=139.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.++|.....    ..+++.+++.++.||+.||.|||+.   +++|+||||+|||++.++.++|+|||++.....
T Consensus       343 ~~~gsL~~~l~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  415 (535)
T 2h8h_A          343 MSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED  415 (535)
T ss_dssp             CTTEEHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred             hcCCcHHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence            578999999975421    4589999999999999999999999   999999999999999999999999999986553


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ... .......++..|+|||.+...  .++.++||||||+++|||++ |..||.....        ......+..+....
T Consensus       416 ~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--------~~~~~~i~~~~~~~  484 (535)
T 2h8h_A          416 NEY-TARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERGYRMP  484 (535)
T ss_dssp             HHH-HTTCSTTSCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--------HHHHHHHHTTCCCC
T ss_pred             Cce-ecccCCcCcccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCC
Confidence            211 111122467889999988653  67899999999999999999 8999864332        11112222222223


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhcc
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQ  208 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~  208 (242)
                      .+..++..+.       +++.+||+.||++|||+.+|++.|+.+.....
T Consensus       485 ~~~~~~~~l~-------~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  526 (535)
T 2h8h_A          485 CPPECPESLH-------DLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  526 (535)
T ss_dssp             CCTTCCHHHH-------HHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred             CCCCCCHHHH-------HHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence            3344555544       45555999999999999999999998876543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.97  E-value=8.5e-32  Score=220.40  Aligned_cols=190  Identities=22%  Similarity=0.354  Sum_probs=138.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....     ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       126 ~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~  197 (326)
T 2w1i_A          126 LPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ  197 (326)
T ss_dssp             CTTCBHHHHHHHST-----TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred             CCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence            57899999997653     3599999999999999999999999   999999999999999999999999999987654


Q ss_pred             Ccccch-hcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccccc-------CCCC-CcCcchhhhc
Q 026160           81 KKSTIS-MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKAS-------RSSD-IYFPNSIYKH  151 (242)
Q Consensus        81 ~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~-------~~~~-~~~~~~~~~~  151 (242)
                      ...... .....++..|.|||.+.+.  .++.++||||||+++|++++|..||.....       .... ..........
T Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (326)
T 2w1i_A          198 DKEYYKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL  275 (326)
T ss_dssp             SCSEEECSSCCSCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred             cccccccccCCCCceeEECchhhcCC--CCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence            432211 1123467789999998654  568899999999999999999988763310       0000 0000011111


Q ss_pred             cCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhc
Q 026160          152 IEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEIL  207 (242)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~  207 (242)
                      .........+..+++++.+       ++.+||+.||++|||+.++++.|+.+.+++
T Consensus       276 ~~~~~~~~~~~~~~~~l~~-------li~~cl~~dP~~Rps~~el~~~L~~l~~~l  324 (326)
T 2w1i_A          276 LKNNGRLPRPDGCPDEIYM-------IMTECWNNNVNQRPSFRDLALRVDQIRDQM  324 (326)
T ss_dssp             HHTTCCCCCCTTCCHHHHH-------HHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             hhcCCCCCCCCcccHHHHH-------HHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            1122222233445555444       455599999999999999999999988764

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.97  E-value=3.8e-31  Score=216.20  Aligned_cols=174  Identities=24%  Similarity=0.338  Sum_probs=130.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++..       ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       124 ~~~~~L~~~l~~-------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  193 (321)
T 2c30_A          124 LQGGALTDIVSQ-------VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK  193 (321)
T ss_dssp             CCSCBHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             CCCCCHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeeccc
Confidence            579999999864       3599999999999999999999999   999999999999999999999999999876654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      .....  ....++..|+|||.+.+.  .++.++||||||+++|+|++|..||........    .........  .....
T Consensus       194 ~~~~~--~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~----~~~~~~~~~--~~~~~  263 (321)
T 2c30_A          194 DVPKR--KSLVGTPYWMAPEVISRS--LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA----MKRLRDSPP--PKLKN  263 (321)
T ss_dssp             SSCCB--CCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----HHHHHHSSC--CCCTT
T ss_pred             Ccccc--ccccCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhcCCC--CCcCc
Confidence            32211  123589999999998653  678899999999999999999999964332110    000111100  01111


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      ...+++.+.++       +.+||+.||++|||+.+++++-.
T Consensus       264 ~~~~~~~l~~l-------i~~~l~~dp~~Rps~~ell~hp~  297 (321)
T 2c30_A          264 SHKVSPVLRDF-------LERMLVRDPQERATAQELLDHPF  297 (321)
T ss_dssp             GGGSCHHHHHH-------HHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             cccCCHHHHHH-------HHHHccCChhhCcCHHHHhcChh
Confidence            22345555444       44589999999999999998643

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=8.3e-32  Score=220.13  Aligned_cols=174  Identities=20%  Similarity=0.221  Sum_probs=130.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC--CCceEEccccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE--DFCPKISDFGLAKQS   78 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~--~~~~~L~dfg~~~~~   78 (242)
                      |++|+|.+++....     ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.  ++.++|+|||++...
T Consensus        83 ~~g~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~  154 (321)
T 1tki_A           83 ISGLDIFERINTSA-----FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             CCCCBHHHHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             CCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence            57899999996542     3699999999999999999999999   9999999999999987  789999999999876


Q ss_pred             CCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCC--
Q 026160           79 QDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN--  156 (242)
Q Consensus        79 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  156 (242)
                      .......   ...+++.|+|||.+.+.  .++.++||||||+++|+|++|..||......       ...........  
T Consensus       155 ~~~~~~~---~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~~~  222 (321)
T 1tki_A          155 KPGDNFR---LLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETNQ-------QIIENIMNAEYTF  222 (321)
T ss_dssp             CTTCEEE---EEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTCCCC
T ss_pred             CCCCccc---cccCChhhcCcHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-------HHHHHHHcCCCCC
Confidence            5443322   23589999999998653  4688999999999999999999999643321       11110000000  


Q ss_pred             ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          157 DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      .......++.+       +.+++.+||+.||++|||+.+++++-.
T Consensus       223 ~~~~~~~~s~~-------~~~li~~~L~~dp~~Rpt~~e~l~hp~  260 (321)
T 1tki_A          223 DEEAFKEISIE-------AMDFVDRLLVKERKSRMTASEALQHPW  260 (321)
T ss_dssp             CHHHHTTSCHH-------HHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             ChhhhccCCHH-------HHHHHHHHcCCChhHCcCHHHHhcChh
Confidence            00011123444       445555699999999999999998543

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.97  E-value=3.9e-32  Score=218.49  Aligned_cols=177  Identities=21%  Similarity=0.315  Sum_probs=130.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCc--------eEEccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFC--------PKISDF   72 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~--------~~L~df   72 (242)
                      |++|+|.+++....     ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.        ++|+||
T Consensus        94 ~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df  165 (289)
T 4fvq_A           94 VKFGSLDTYLKKNK-----NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP  165 (289)
T ss_dssp             CTTCBHHHHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred             CCCCCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeeccC
Confidence            57899999997642     3599999999999999999999999   9999999999999988876        999999


Q ss_pred             ccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhcc
Q 026160           73 GLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHI  152 (242)
Q Consensus        73 g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  152 (242)
                      |++........      ..++..|+|||.+.+. ..++.++||||||+++|+|++|..|+......       .......
T Consensus       166 g~~~~~~~~~~------~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-------~~~~~~~  231 (289)
T 4fvq_A          166 GISITVLPKDI------LQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALDS-------QRKLQFY  231 (289)
T ss_dssp             CSCTTTSCHHH------HHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHHHHHH
T ss_pred             cccccccCccc------cCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccch-------HHHHHHh
Confidence            99875543321      2378889999998752 35788999999999999999965444322111       0010100


Q ss_pred             CCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhcc
Q 026160          153 EPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQ  208 (242)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~  208 (242)
                      ..  ....+...++++.+++.+       ||+.||++|||+.++++.|+.+.....
T Consensus       232 ~~--~~~~~~~~~~~l~~li~~-------~l~~dp~~Rps~~~ll~~l~~l~~p~~  278 (289)
T 4fvq_A          232 ED--RHQLPAPKAAELANLINN-------CMDYEPDHRPSFRAIIRDLNSLFTPDL  278 (289)
T ss_dssp             HT--TCCCCCCSSCTTHHHHHH-------HSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred             hc--cCCCCCCCCHHHHHHHHH-------HcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence            00  111223345555555544       999999999999999999998877433

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.97  E-value=9.5e-32  Score=237.75  Aligned_cols=180  Identities=23%  Similarity=0.359  Sum_probs=136.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.++|...      +.+++.+++.++.||+.||.|||+.   +|+|+||||+|||++.++.++|+|||++.....
T Consensus       451 ~~~g~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~  521 (635)
T 4fl3_A          451 AELGPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  521 (635)
T ss_dssp             CTTEEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred             cCCCCHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence            6799999999764      4599999999999999999999999   999999999999999999999999999986654


Q ss_pred             Cccc-chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           81 KKST-ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        81 ~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      .... .......++..|+|||.+...  .++.++||||||+++|+|++ |..||.....        ......+..+...
T Consensus       522 ~~~~~~~~~~~~~t~~y~APE~~~~~--~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--------~~~~~~i~~~~~~  591 (635)
T 4fl3_A          522 DENYYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAMLEKGERM  591 (635)
T ss_dssp             -------------CGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTCCC
T ss_pred             CccccccccCCCCceeeeChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCC
Confidence            3221 111223467889999998653  67899999999999999998 9999965432        1222223333333


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      ..+..+++++.+       ++..||+.||++|||+.++++.|+.+...
T Consensus       592 ~~p~~~~~~l~~-------li~~cl~~dP~~RPs~~~l~~~L~~~~~~  632 (635)
T 4fl3_A          592 GCPAGCPREMYD-------LMNLCWTYDVENRPGFAAVELRLRNYYYD  632 (635)
T ss_dssp             CCCTTCCHHHHH-------HHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHH-------HHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            344455655554       44559999999999999999999987643

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.97  E-value=1e-31  Score=218.84  Aligned_cols=187  Identities=24%  Similarity=0.297  Sum_probs=136.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.....  ....+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       112 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  186 (317)
T 2buj_A          112 FKRGTLWNEIERLKD--KGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI  186 (317)
T ss_dssp             CTTCBHHHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred             CCCCcHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence            578999999976421  235799999999999999999999999   999999999999999999999999998876542


Q ss_pred             Ccccc-------hhcccccccccccchhhhccc-CCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhcc
Q 026160           81 KKSTI-------SMLHARGTIGYIAPEVFCRSF-GGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHI  152 (242)
Q Consensus        81 ~~~~~-------~~~~~~~~~~y~~PE~~~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  152 (242)
                      .....       ......++..|.|||.+.... ..++.++||||||+++|++++|..||..........      ....
T Consensus       187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~~~  260 (317)
T 2buj_A          187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV------ALAV  260 (317)
T ss_dssp             EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH------HHHH
T ss_pred             ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh------hHHh
Confidence            21110       011234789999999885431 135789999999999999999999996533222111      0111


Q ss_pred             CCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhh
Q 026160          153 EPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTE  205 (242)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~  205 (242)
                      ...........++.++.+++       .+||+.||++|||+.++++.|+.+..
T Consensus       261 ~~~~~~~~~~~~~~~l~~li-------~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          261 QNQLSIPQSPRHSSALWQLL-------NSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             HCC--CCCCTTSCHHHHHHH-------HHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             hccCCCCccccCCHHHHHHH-------HHHhhcChhhCCCHHHHHHHhhhcCC
Confidence            11111122233455555444       45889999999999999999998654

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.97  E-value=3.9e-31  Score=224.76  Aligned_cols=174  Identities=24%  Similarity=0.298  Sum_probs=130.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeC---CCCceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD---EDFCPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~---~~~~~~L~dfg~~~~   77 (242)
                      |+||+|.+++...      ..+++.++..++.||+.||.|||+.   +|+|+||||+||+++   .++.++|+|||++..
T Consensus        92 ~~gg~L~~~i~~~------~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           92 VTGGELFEDIVAR------EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             CBCCBHHHHHHHC------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            5789999999875      4599999999999999999999999   999999999999998   457899999999976


Q ss_pred             cCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      .......  .....|++.|+|||++.+.  .++.++|||||||++|+|++|..||........    ...+... .....
T Consensus       163 ~~~~~~~--~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~----~~~i~~~-~~~~~  233 (444)
T 3soa_A          163 VEGEQQA--WFGFAGTPGYLSPEVLRKD--PYGKPVDLWACGVILYILLVGYPPFWDEDQHRL----YQQIKAG-AYDFP  233 (444)
T ss_dssp             CCTTCCB--CCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHT-CCCCC
T ss_pred             ecCCCce--eecccCCcccCCHHHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCccHHHH----HHHHHhC-CCCCC
Confidence            6543222  1223589999999998653  678899999999999999999999964332100    0011110 00111


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ......+++++.+++.+       ||+.||++|||+.+++++
T Consensus       234 ~~~~~~~s~~~~~li~~-------~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          234 SPEWDTVTPEAKDLINK-------MLTINPSKRITAAEALKH  268 (444)
T ss_dssp             TTTTTTSCHHHHHHHHH-------HSCSSTTTSCCHHHHHHS
T ss_pred             ccccccCCHHHHHHHHH-------HcCCChhHCCCHHHHhcC
Confidence            11122456666655555       889999999999999975

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.5e-31  Score=221.42  Aligned_cols=179  Identities=26%  Similarity=0.346  Sum_probs=132.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       141 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  211 (355)
T 1vzo_A          141 INGGELFTHLSQR------ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  211 (355)
T ss_dssp             CCSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence            5789999999765      3599999999999999999999999   999999999999999999999999999986543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ..... .....++..|+|||.+.+....++.++|||||||++|+|++|..||.........    ..+...... .....
T Consensus       212 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~----~~~~~~~~~-~~~~~  285 (355)
T 1vzo_A          212 DETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ----AEISRRILK-SEPPY  285 (355)
T ss_dssp             GGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH----HHHHHHHHH-CCCCC
T ss_pred             CCCCc-ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH----HHHHHHHhc-cCCCC
Confidence            32211 1223589999999998764345688999999999999999999999754332211    111111100 01122


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHHhh
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRP-----SMHEVLEMLE  201 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp-----s~~~ll~~l~  201 (242)
                      +..++..+.+++       .+||+.||++||     |+.+++++..
T Consensus       286 ~~~~~~~~~~li-------~~~L~~dP~~R~~~~~~s~~ell~h~~  324 (355)
T 1vzo_A          286 PQEMSALAKDLI-------QRLLMKDPKKRLGCGPRDADEIKEHLF  324 (355)
T ss_dssp             CTTSCHHHHHHH-------HHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred             CcccCHHHHHHH-------HHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence            334555555444       458899999999     9999998654

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.97  E-value=1.5e-31  Score=219.80  Aligned_cols=170  Identities=27%  Similarity=0.420  Sum_probs=130.9

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      +|+|.+++...      +.+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        92 ~g~l~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           92 GGELFDYIVEK------KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             CEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            68899988765      4599999999999999999999999   99999999999999999999999999998655433


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccccc
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDG  162 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (242)
                      ..   ....|++.|+|||.+.+. ...+.++||||||+++|+|++|..||........        ..... ......+.
T Consensus       163 ~~---~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--------~~~i~-~~~~~~p~  229 (336)
T 3h4j_B          163 FL---KTSCGSPNYAAPEVINGK-LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL--------FKKVN-SCVYVMPD  229 (336)
T ss_dssp             TT---CCCTTSTTTSCGGGSCCS-GGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC--------BCCCC-SSCCCCCT
T ss_pred             cc---ccccCCcCcCCHHHHcCC-CCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH--------HHHHH-cCCCCCcc
Confidence            22   233589999999998654 2236789999999999999999999975432211        01111 11122344


Q ss_pred             ccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          163 VVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       163 ~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      .+++++.+++.+       ||+.||.+|||+.+++++-.
T Consensus       230 ~~s~~~~~li~~-------~L~~dP~~Rpt~~eil~hp~  261 (336)
T 3h4j_B          230 FLSPGAQSLIRR-------MIVADPMQRITIQEIRRDPW  261 (336)
T ss_dssp             TSCHHHHHHHHT-------TSCSSGGGSCCHHHHTTCHH
T ss_pred             cCCHHHHHHHHH-------HcCCChhHCcCHHHHHhChh
Confidence            456666555544       88999999999999987543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.97  E-value=1.8e-31  Score=221.50  Aligned_cols=176  Identities=25%  Similarity=0.299  Sum_probs=121.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCc--eEEccccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFC--PKISDFGLAKQS   78 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~--~~L~dfg~~~~~   78 (242)
                      |++|+|.+++...      +.+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.  ++|+|||++...
T Consensus        98 ~~~~~L~~~l~~~------~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A           98 ASGGELYERICNA------GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             CCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             CCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            5789999999765      3599999999999999999999999   9999999999999987665  999999998743


Q ss_pred             CCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           79 QDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        79 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      ......   ....+++.|+|||.+.+. ...+.++|||||||++|+|++|..||.........   ..............
T Consensus       169 ~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~~~~~~~~~~~~~~  241 (361)
T 3uc3_A          169 VLHSQP---KSTVGTPAYIAPEVLLRQ-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY---RKTIQRILSVKYSI  241 (361)
T ss_dssp             ---------------CTTSCHHHHHCS-SCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH---HHHHHHHHTTCCCC
T ss_pred             cccCCC---CCCcCCCCcCChhhhcCC-CCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH---HHHHHHHhcCCCCC
Confidence            322221   123589999999998654 22344589999999999999999999754432211   11111111111111


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .....+++++.+++.+       ||+.||++|||+.+++++
T Consensus       242 ~~~~~~s~~~~~li~~-------~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          242 PDDIRISPECCHLISR-------IFVADPATRISIPEIKTH  275 (361)
T ss_dssp             CTTSCCCHHHHHHHHH-------HSCSCTTTSCCHHHHHTS
T ss_pred             CCcCCCCHHHHHHHHH-------HccCChhHCcCHHHHHhC
Confidence            2222355666555555       889999999999999976

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.97  E-value=3.6e-31  Score=216.06  Aligned_cols=167  Identities=29%  Similarity=0.408  Sum_probs=131.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.+++...      ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        88 ~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           88 IEGGELFSLLRKS------QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             CCSCBHHHHHHHT------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            5789999999765      4599999999999999999999999   999999999999999999999999999986554


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ...     ...||+.|+|||.+.+.  .++.++|+|||||++|+|++|..||......        .....+... ...+
T Consensus       159 ~~~-----~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~i~~~-~~~~  222 (318)
T 1fot_A          159 VTY-----TLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--------KTYEKILNA-ELRF  222 (318)
T ss_dssp             CBC-----CCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHC-CCCC
T ss_pred             ccc-----cccCCccccCHhHhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhC-CCCC
Confidence            321     23589999999998654  6788999999999999999999999643321        111111111 1223


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRP-----SMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp-----s~~~ll~~  199 (242)
                      +..+++++.+++.+       ||+.||++||     ++.+++++
T Consensus       223 p~~~~~~~~~li~~-------lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          223 PPFFNEDVKDLLSR-------LITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             CTTSCHHHHHHHHH-------HTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CCCCCHHHHHHHHH-------HhccCHHHcCCCcCCCHHHHhcC
Confidence            44566666666666       7799999999     89999854

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.97  E-value=2.7e-31  Score=219.46  Aligned_cols=167  Identities=23%  Similarity=0.369  Sum_probs=132.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.+.      +.+++.++..++.||+.||.|||+.   +|+|+||||+||+++.++.++|+|||++.....
T Consensus       123 ~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          123 VAGGEMFSHLRRI------GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             CTTCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence            5799999999875      3599999999999999999999999   999999999999999999999999999987654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ...     ...|++.|+|||.+.+.  .++.++|+|||||++|+|++|..||.....        ......+..+ ...+
T Consensus       194 ~~~-----~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~-~~~~  257 (350)
T 1rdq_E          194 RTW-----TLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVSG-KVRF  257 (350)
T ss_dssp             CBC-----CCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC-CCCC
T ss_pred             Ccc-----cccCCccccCHHHhcCC--CCCCcCCEecccHhHhHHhhCCCCCCCCCH--------HHHHHHHHcC-CCCC
Confidence            321     23589999999998754  678999999999999999999999964332        1111111111 1223


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPS-----MHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps-----~~~ll~~  199 (242)
                      +..+++++.+++.+       ||+.||++||+     +.+++++
T Consensus       258 p~~~~~~~~~li~~-------lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          258 PSHFSSDLKDLLRN-------LLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             CTTCCHHHHHHHHH-------HSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CCCCCHHHHHHHHH-------HhhcCHHhccCCccCCHHHHHhC
Confidence            44566666666655       88999999998     8888864

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.97  E-value=2e-31  Score=218.60  Aligned_cols=187  Identities=23%  Similarity=0.277  Sum_probs=122.6

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCC--eeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVR--IVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~--i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +|+|.+++....   ....+++.+++.++.||+.||.|||+.   +  ++|+||||+||+++.++.++|+|||++.....
T Consensus       117 ~g~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  190 (337)
T 3ll6_A          117 KGQLVEFLKKME---SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISH  190 (337)
T ss_dssp             SEEHHHHHHHHH---TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSS
T ss_pred             CCCHHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCccceeccc
Confidence            578888886532   124699999999999999999999998   8  99999999999999999999999999986654


Q ss_pred             Ccccc----------hhcccccccccccchhhhc-ccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhh
Q 026160           81 KKSTI----------SMLHARGTIGYIAPEVFCR-SFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIY  149 (242)
Q Consensus        81 ~~~~~----------~~~~~~~~~~y~~PE~~~~-~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~  149 (242)
                      .....          ......++..|+|||.+.. ....++.++||||||+++|+|++|..||........         
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---------  261 (337)
T 3ll6_A          191 YPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI---------  261 (337)
T ss_dssp             CC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------------
T ss_pred             cCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh---------
Confidence            32211          0112348899999998732 223568899999999999999999999964332110         


Q ss_pred             hccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccCCCCC
Q 026160          150 KHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKP  213 (242)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~  213 (242)
                        .............+..+.++       +.+||+.||++|||+.++++.|+.+.........+
T Consensus       262 --~~~~~~~~~~~~~~~~~~~l-------i~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~  316 (337)
T 3ll6_A          262 --VNGKYSIPPHDTQYTVFHSL-------IRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKS  316 (337)
T ss_dssp             ------CCCCTTCCSSGGGHHH-------HHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTS
T ss_pred             --hcCcccCCcccccchHHHHH-------HHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCc
Confidence              00111111122344445444       44589999999999999999999998765555443

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.97  E-value=2.6e-31  Score=222.55  Aligned_cols=129  Identities=22%  Similarity=0.263  Sum_probs=105.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.....    ..+++..+..++.||+.||.|||+.   +|+|+||||+|||++.++.++|+|||.+.....
T Consensus       108 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          108 MAYGSAKDLICTHFM----DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             CTTCBHHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             cCCCCHHHHHhhhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            679999999976532    4699999999999999999999999   999999999999999999999999998764422


Q ss_pred             Cccc-----chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccc
Q 026160           81 KKST-----ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKA  136 (242)
Q Consensus        81 ~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  136 (242)
                      ....     .......++..|+|||.+.+....++.++|||||||++|+|++|..||....
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  241 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP  241 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence            1110     0111235888999999987644467899999999999999999999996543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.97  E-value=2.7e-31  Score=219.67  Aligned_cols=170  Identities=23%  Similarity=0.333  Sum_probs=130.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.+++...      +.+++.++..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++.....
T Consensus       103 ~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A          103 VNGGDLMYHIQQV------GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             CCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            5799999999865      3599999999999999999999999   999999999999999999999999999975332


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....||+.|+|||++.+.  .++.++|+|||||++|+|++|..||......        .....+... ...+
T Consensus       174 ~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~-~~~~  240 (353)
T 2i0e_A          174 DGVT--TKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQSIMEH-NVAY  240 (353)
T ss_dssp             TTCC--BCCCCSCGGGCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHC-CCCC
T ss_pred             CCcc--cccccCCccccChhhhcCC--CcCCcccccchHHHHHHHHcCCCCCCCCCHH--------HHHHHHHhC-CCCC
Confidence            2111  1123589999999998654  6789999999999999999999999743321        111111111 1223


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPS-----MHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps-----~~~ll~~  199 (242)
                      +..+++++.+++.+       ||+.||++||+     +.+++++
T Consensus       241 p~~~s~~~~~li~~-------lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          241 PKSMSKEAVAICKG-------LMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             CTTSCHHHHHHHHH-------HTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             CCCCCHHHHHHHHH-------HhhcCHHHcCCCCCCCHHHHhcC
Confidence            44566666666666       77999999995     5777754

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.97  E-value=3.5e-31  Score=219.83  Aligned_cols=173  Identities=24%  Similarity=0.326  Sum_probs=128.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCC---CceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDED---FCPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~---~~~~L~dfg~~~~   77 (242)
                      |++|+|.+++...      ..+++.++..++.||+.||.|||+.   +|+|+||||+||+++.+   +.++|+|||++..
T Consensus       110 ~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          110 VTGGELFEDIVAR------EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             CCSCBHHHHHTTC------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            5789999999765      4599999999999999999999999   99999999999999764   4599999999987


Q ss_pred             cCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      ........   ...+++.|+|||.+.+.  .++.++|||||||++|+|++|..||.......    ....+... .....
T Consensus       181 ~~~~~~~~---~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~----~~~~i~~~-~~~~~  250 (362)
T 2bdw_A          181 VNDSEAWH---GFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQHR----LYAQIKAG-AYDYP  250 (362)
T ss_dssp             CTTCCSCC---CSCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHT-CCCCC
T ss_pred             ecCCcccc---cCCCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHhC-CCCCC
Confidence            65433221   23589999999998653  57889999999999999999999996433210    00001000 00001


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ......+++++.+++.+       ||+.||++|||+.+++++
T Consensus       251 ~~~~~~~~~~~~~li~~-------~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          251 SPEWDTVTPEAKSLIDS-------MLTVNPKKRITADQALKV  285 (362)
T ss_dssp             TTGGGGSCHHHHHHHHH-------HSCSSGGGSCCHHHHTTS
T ss_pred             cccccCCCHHHHHHHHH-------HcCCChhhCcCHHHHhcC
Confidence            11112345555555544       889999999999998864

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.97  E-value=2.3e-31  Score=214.12  Aligned_cols=181  Identities=23%  Similarity=0.328  Sum_probs=135.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +++|+|.+++....     ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       102 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  173 (291)
T 1u46_A          102 APLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  173 (291)
T ss_dssp             CTTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             ccCCCHHHHHHhcc-----CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccc
Confidence            57899999997642     4699999999999999999999999   999999999999999999999999999987654


Q ss_pred             Ccccc-hhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           81 KKSTI-SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        81 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      ..... ......++..|.|||.+.+.  .++.++||||||+++|++++ |..||......       .............
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~~  244 (291)
T 1u46_A          174 NDDHYVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-------QILHKIDKEGERL  244 (291)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTSCCCC
T ss_pred             cccchhhhccCCCCceeeCchhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-------HHHHHHHccCCCC
Confidence            33221 11223467789999998653  56789999999999999999 99999644321       1111111122222


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhh
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTE  205 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~  205 (242)
                      ..+..++.++.+++.       +||+.||++|||+.++++.|+.+..
T Consensus       245 ~~~~~~~~~l~~li~-------~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          245 PRPEDCPQDIYNVMV-------QCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             CCCTTCCHHHHHHHH-------HHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             CCCcCcCHHHHHHHH-------HHccCCcccCcCHHHHHHHHHHhCc
Confidence            233445555555544       4889999999999999999997654

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.97  E-value=5.7e-31  Score=211.95  Aligned_cols=169  Identities=28%  Similarity=0.458  Sum_probs=129.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCC--eeecCCCCCceeeC-CCCceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVR--IVHFDIKPHNILLD-EDFCPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~--i~h~dlk~~nil~~-~~~~~~L~dfg~~~~   77 (242)
                      |++|+|.+++...      +.+++..++.++.|++.||.|||+.   +  ++|+||||+||+++ .++.++|+|||++..
T Consensus       111 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          111 MTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             CCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             cCCCCHHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            5789999999765      4599999999999999999999998   7  99999999999998 788999999999975


Q ss_pred             cCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCC-C
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPG-N  156 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~  156 (242)
                      .......    ...++..|+|||.+.+   .++.++||||||+++|+|++|..||......       .......... .
T Consensus       182 ~~~~~~~----~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~  247 (290)
T 1t4h_A          182 KRASFAK----AVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYRRVTSGVK  247 (290)
T ss_dssp             CCTTSBE----ESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHHHHTTTCC
T ss_pred             ccccccc----cccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-------HHHHHHHhccCC
Confidence            5443222    2348999999998753   4788999999999999999999999643321       1111111111 1


Q ss_pred             ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          157 DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ....+...++++.       .++.+||+.||++|||+.+++++
T Consensus       248 ~~~~~~~~~~~l~-------~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          248 PASFDKVAIPEVK-------EIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             CGGGGGCCCHHHH-------HHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccccCCCCCHHHH-------HHHHHHccCChhhCCCHHHHhhC
Confidence            2223333444444       45555999999999999999874

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.97  E-value=4e-31  Score=226.31  Aligned_cols=170  Identities=27%  Similarity=0.441  Sum_probs=131.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.+.      +.+++.++..++.||+.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        98 ~~gg~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           98 VSGGELFDYICKN------GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             CSSEEHHHHTTSS------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            5789999999764      4599999999999999999999999   999999999999999999999999999987654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....   ....|++.|.|||.+.+. ...+.++|||||||++|+|++|..||.....        ......+..+ ....
T Consensus       169 ~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--------~~~~~~i~~~-~~~~  235 (476)
T 2y94_A          169 GEFL---RTSCGSPNYAAPEVISGR-LYAGPEVDIWSSGVILYALLCGTLPFDDDHV--------PTLFKKICDG-IFYT  235 (476)
T ss_dssp             TCCB---CCCCSCSTTCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS--------HHHHHHHHTT-CCCC
T ss_pred             cccc---cccCCCcCeEChhhccCC-CCCCCcceehhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHhcC-CcCC
Confidence            3222   123589999999998764 2346789999999999999999999974332        1111111111 1122


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      +..+++++.+++.+       ||+.||++|||+.+++++
T Consensus       236 p~~~s~~~~~Li~~-------~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          236 PQYLNPSVISLLKH-------MLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             CTTCCHHHHHHHHH-------HTCSSTTTSCCHHHHHTC
T ss_pred             CccCCHHHHHHHHH-------HcCCCchhCcCHHHHHhC
Confidence            33456666555555       889999999999999974

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.97  E-value=8.9e-32  Score=221.88  Aligned_cols=169  Identities=27%  Similarity=0.396  Sum_probs=130.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.+++...      +.+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       100 ~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  170 (345)
T 1xjd_A          100 LNGGDLMYHIQSC------HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML  170 (345)
T ss_dssp             CTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence            5799999999865      3599999999999999999999999   999999999999999999999999999975432


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....||+.|+|||.+.+.  .++.++|+|||||++|+|++|..||......        .....+... ....
T Consensus       171 ~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~i~~~-~~~~  237 (345)
T 1xjd_A          171 GDAK--TNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--------ELFHSIRMD-NPFY  237 (345)
T ss_dssp             TTCC--BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHC-CCCC
T ss_pred             CCCc--ccCCCCCcccCChhhhcCC--CCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHhC-CCCC
Confidence            2111  1123589999999998764  6789999999999999999999999644321        111111111 1223


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHH-HHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMH-EVLE  198 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~-~ll~  198 (242)
                      +..+++++.+++.+       ||+.||++||++. ++++
T Consensus       238 p~~~s~~~~~li~~-------lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          238 PRWLEKEAKDLLVK-------LFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             CTTSCHHHHHHHHH-------HSCSSGGGSBTTBSCGGG
T ss_pred             CcccCHHHHHHHHH-------HhcCCHhHcCCChHHHHc
Confidence            34466666666665       8899999999997 6653

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.97  E-value=1.6e-31  Score=224.45  Aligned_cols=197  Identities=19%  Similarity=0.254  Sum_probs=140.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceee----CCCCceEEccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL----DEDFCPKISDFGLAK   76 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~----~~~~~~~L~dfg~~~   76 (242)
                      |++|+|.+++.....   ...+++.+++.++.|++.||.|||+.   +++|+||||+||++    +.++.++|+|||++.
T Consensus        91 ~~~g~L~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           91 CPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             CTTEEHHHHTTSGGG---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             CCCCCHHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            578999999976532   23499999999999999999999999   99999999999999    777789999999998


Q ss_pred             ccCCCcccchhcccccccccccchhhhccc------CCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhh
Q 026160           77 QSQDKKSTISMLHARGTIGYIAPEVFCRSF------GGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYK  150 (242)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~------~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~  150 (242)
                      .........   ...++..|+|||.+....      ..++.++|||||||++|+|++|..||..................
T Consensus       165 ~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          165 ELEDDEQFV---SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             ECCCGGGSS---CSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             EccCCCccc---cccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            765443222   235899999999875421      24577899999999999999999999754432211110000000


Q ss_pred             ccCCC----------C------ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccC
Q 026160          151 HIEPG----------N------DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQI  209 (242)
Q Consensus       151 ~~~~~----------~------~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~  209 (242)
                      .....          .      .......++   ..+...+..++.+||+.||++|||+.++++.++.+.+....
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~---~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~~~  313 (396)
T 4eut_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLS---RGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVI  313 (396)
T ss_dssp             SCCTTCCEEEECSTTCCEEEESSCCTTCSSC---HHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCEEE
T ss_pred             CCCcccchhheeccCCCcccCccCCcccccc---hHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhceEE
Confidence            00000          0      000011122   33445556677889999999999999999999988776433

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.97  E-value=3.7e-31  Score=214.99  Aligned_cols=190  Identities=25%  Similarity=0.352  Sum_probs=129.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.....  ....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       114 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          114 ADAGDLSRMIKHFKK--QKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             CCSCBHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             CCCCCHHHHHHHhcc--cccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            578899999975321  235699999999999999999999999   999999999999999999999999999876544


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccc-
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ-  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  159 (242)
                      .....  ....++..|.|||.+.+.  .++.++|+||||+++|++++|..||.......      .............. 
T Consensus       189 ~~~~~--~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~  258 (310)
T 2wqm_A          189 KTTAA--HSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL------YSLCKKIEQCDYPPL  258 (310)
T ss_dssp             ------------CCSSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTC---CCH------HHHHHHHHTTCSCCC
T ss_pred             CCccc--cccCCCeeEeChHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCCcccchhH------HHHHHHhhcccCCCC
Confidence            32211  123488999999998653  67889999999999999999999986432211      11111111111111 


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccCCCC
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPK  212 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~~  212 (242)
                      ....+++++.++       +.+||+.||++|||+.++++.|+.+......+.+
T Consensus       259 ~~~~~~~~l~~l-------i~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~  304 (310)
T 2wqm_A          259 PSDHYSEELRQL-------VNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE  304 (310)
T ss_dssp             CTTTSCHHHHHH-------HHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred             cccccCHHHHHH-------HHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence            113345555444       4459999999999999999999999887555543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.97  E-value=3e-31  Score=226.03  Aligned_cols=170  Identities=26%  Similarity=0.386  Sum_probs=130.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhh-CCCCCeeecCCCCCceeeCCCCceEEcccccccccC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHR-GCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ   79 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~-~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~   79 (242)
                      |++|+|.+++...      +.+++..+..++.||+.||.|||+ .   +|+|+||||+|||++.++.++|+|||++....
T Consensus       230 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          230 ANGGELFFHLSRE------RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             CSSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            6789999999765      459999999999999999999998 7   99999999999999999999999999987543


Q ss_pred             CCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           80 DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        80 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      .....  .....||+.|+|||++.+.  .++.++|||||||++|+|++|..||......        .....+.. ....
T Consensus       301 ~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~i~~-~~~~  367 (446)
T 4ejn_A          301 KDGAT--MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILM-EEIR  367 (446)
T ss_dssp             C-------CCSSSCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHH-CCCC
T ss_pred             CCCcc--cccccCCccccCHhhcCCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCHH--------HHHHHHHh-CCCC
Confidence            32211  1234589999999998654  6789999999999999999999999643321        11111000 0112


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRP-----SMHEVLEM  199 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp-----s~~~ll~~  199 (242)
                      ++..+++++.+++.+       ||+.||++||     |+.+++++
T Consensus       368 ~p~~~~~~~~~li~~-------~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          368 FPRTLGPEAKSLLSG-------LLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             CCTTSCHHHHHHHHH-------HTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CCccCCHHHHHHHHH-------HcccCHHHhCCCCCCCHHHHHhC
Confidence            334466666665555       8899999999     99999863

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.97  E-value=1.4e-31  Score=219.22  Aligned_cols=179  Identities=21%  Similarity=0.267  Sum_probs=113.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCC---ceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF---CPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~---~~~L~dfg~~~~   77 (242)
                      |++|+|.+++...      +.+++.++..++.|++.||.|||+.   +++|+||||+||+++.++   .++|+|||++..
T Consensus        88 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~  158 (325)
T 3kn6_A           88 LNGGELFERIKKK------KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARL  158 (325)
T ss_dssp             CCSCBHHHHHHHC------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred             cCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence            5789999999775      4599999999999999999999999   999999999999997655   799999999986


Q ss_pred             cCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      .......  .....++..|+|||.+.+.  .++.++||||||+++|+|++|..||............ ......+..+..
T Consensus       159 ~~~~~~~--~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~-~~~~~~i~~~~~  233 (325)
T 3kn6_A          159 KPPDNQP--LKTPCFTLHYAAPELLNQN--GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSA-VEIMKKIKKGDF  233 (325)
T ss_dssp             CCC------------------------C--CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCH-HHHHHHHTTTCC
T ss_pred             cCCCCCc--ccccCCCcCccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccH-HHHHHHHHcCCC
Confidence            5443222  1223578999999998654  5788999999999999999999999755432211111 111122222211


Q ss_pred             cc---cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 026160          158 FQ---LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML  200 (242)
Q Consensus       158 ~~---~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l  200 (242)
                      ..   ....+++++.       +++.+||+.||++|||+.+++++-
T Consensus       234 ~~~~~~~~~~s~~~~-------~li~~~L~~dP~~Rpt~~ell~h~  272 (325)
T 3kn6_A          234 SFEGEAWKNVSQEAK-------DLIQGLLTVDPNKRLKMSGLRYNE  272 (325)
T ss_dssp             CCCSHHHHTSCHHHH-------HHHHHHHCCCTTTCCCTTTSTTCG
T ss_pred             CCCcccccCCCHHHH-------HHHHHHCCCChhHCCCHHHHhcCh
Confidence            10   0112344444       455558899999999999988653

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.97  E-value=3.6e-31  Score=218.72  Aligned_cols=171  Identities=24%  Similarity=0.298  Sum_probs=121.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC---CCceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE---DFCPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~---~~~~~L~dfg~~~~   77 (242)
                      |++|+|.+++...      +.+++.++..++.|++.||.|||+.   +++|+||||+||+++.   ++.++|+|||++..
T Consensus       130 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~  200 (349)
T 2w4o_A          130 VTGGELFDRIVEK------GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI  200 (349)
T ss_dssp             CCSCBHHHHHTTC------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred             CCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence            5789999999764      4599999999999999999999999   9999999999999975   78999999999986


Q ss_pred             cCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCC--
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPG--  155 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--  155 (242)
                      .......   ....++..|+|||.+.+.  .++.++|||||||++|+|++|..||......       ......+...  
T Consensus       201 ~~~~~~~---~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~~i~~~~~  268 (349)
T 2w4o_A          201 VEHQVLM---KTVCGTPGYCAPEILRGC--AYGPEVDMWSVGIITYILLCGFEPFYDERGD-------QFMFRRILNCEY  268 (349)
T ss_dssp             ---------------CGGGSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-------HHHHHHHHTTCC
T ss_pred             cCccccc---ccccCCCCccCHHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCccc-------HHHHHHHHhCCC
Confidence            5443221   123589999999998754  5788999999999999999999999643321       1011111111  


Q ss_pred             -CccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          156 -NDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       156 -~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                       ........++.++.+       ++.+||+.||++|||+.+++++
T Consensus       269 ~~~~~~~~~~~~~~~~-------li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          269 YFISPWWDEVSLNAKD-------LVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             CCCTTTTTTSCHHHHH-------HHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ccCCchhhhCCHHHHH-------HHHHHccCChhhCcCHHHHhcC
Confidence             111112234544444       4555999999999999999975

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.97  E-value=3.7e-31  Score=215.84  Aligned_cols=126  Identities=29%  Similarity=0.399  Sum_probs=105.7

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      |+|.+++...........+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        87 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  163 (317)
T 2pmi_A           87 NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN  163 (317)
T ss_dssp             CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC
T ss_pred             CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc
Confidence            78999987765444556799999999999999999999999   999999999999999999999999999986643322


Q ss_pred             cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           84 TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      .  .....++..|+|||.+.+. ..++.++|||||||++|+|++|..||...
T Consensus       164 ~--~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~  212 (317)
T 2pmi_A          164 T--FSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGT  212 (317)
T ss_dssp             C--CCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             c--CCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            1  1123589999999998653 35688999999999999999999999644

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.97  E-value=5.2e-31  Score=220.46  Aligned_cols=174  Identities=23%  Similarity=0.309  Sum_probs=129.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC--CCceEEccccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE--DFCPKISDFGLAKQS   78 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~--~~~~~L~dfg~~~~~   78 (242)
                      |++|+|.+++....     ..+++.+++.++.||+.||.|||+.   +++|+||||+||+++.  .+.++|+|||++...
T Consensus       130 ~~gg~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~  201 (387)
T 1kob_A          130 LSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL  201 (387)
T ss_dssp             CCCCBHHHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             CCCCcHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceec
Confidence            57899999997542     4699999999999999999999999   9999999999999974  567999999999876


Q ss_pred             CCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           79 QDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        79 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      .......   ...++..|+|||++.+.  .++.++|||||||++|+|++|..||........    ...+.. .......
T Consensus       202 ~~~~~~~---~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~----~~~i~~-~~~~~~~  271 (387)
T 1kob_A          202 NPDEIVK---VTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET----LQNVKR-CDWEFDE  271 (387)
T ss_dssp             CTTSCEE---EECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH----HHHHHH-CCCCCCS
T ss_pred             CCCccee---eeccCCCccCchhccCC--CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH----HHHHHh-CCCCCCc
Confidence            5433221   23589999999998653  578899999999999999999999975432100    000000 0001111


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .....+++++.++       +.+||+.||++|||+.+++++
T Consensus       272 ~~~~~~s~~~~~l-------i~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          272 DAFSSVSPEAKDF-------IKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             STTTTSCHHHHHH-------HHTTSCSSGGGSCCHHHHHTS
T ss_pred             cccccCCHHHHHH-------HHHHcCCChhHCcCHHHHhhC
Confidence            1122345555544       445999999999999999986

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.97  E-value=5.3e-31  Score=214.39  Aligned_cols=166  Identities=23%  Similarity=0.279  Sum_probs=123.7

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      +|+|.+++....     ..+++..++.++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++.......
T Consensus       140 ~~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~  211 (311)
T 3p1a_A          140 GPSLQQHCEAWG-----ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG  211 (311)
T ss_dssp             CCBHHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred             CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence            678888887653     4699999999999999999999999   99999999999999999999999999987665433


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccccc
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDG  162 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (242)
                      ...   ...+++.|+|||.+.+   .++.++||||||+++|+|++|..++.....          .............+.
T Consensus       212 ~~~---~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~~~~~~~~~~  275 (311)
T 3p1a_A          212 AGE---VQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGYLPPEFTA  275 (311)
T ss_dssp             ------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHHTTTCCCHHHHT
T ss_pred             CCc---ccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHhccCCCccccc
Confidence            221   2348999999998864   578899999999999999999765543221          001111111111222


Q ss_pred             ccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          163 VVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       163 ~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .+++++.       +++.+||+.||++|||+.+++++
T Consensus       276 ~~~~~l~-------~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          276 GLSSELR-------SVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             TSCHHHH-------HHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCCHHHH-------HHHHHHcCCChhhCcCHHHHHhC
Confidence            3444444       45555889999999999999864

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.97  E-value=9.2e-31  Score=221.30  Aligned_cols=176  Identities=24%  Similarity=0.282  Sum_probs=123.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCC---ceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF---CPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~---~~~L~dfg~~~~   77 (242)
                      |++|+|.+++...      +.+++.++..++.|++.||.|||+.   +++|+||||+||+++.++   .++|+|||++..
T Consensus       221 ~~~g~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  291 (419)
T 3i6u_A          221 MEGGELFDKVVGN------KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  291 (419)
T ss_dssp             CTTCBGGGGTSSS------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred             CCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeeccccee
Confidence            6799999999765      4599999999999999999999999   999999999999997544   599999999987


Q ss_pred             cCCCcccchhcccccccccccchhhhc-ccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCC
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCR-SFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN  156 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  156 (242)
                      .......   ....+++.|+|||.+.. ....++.++||||||+++|+|++|..||........   ....+.. .....
T Consensus       292 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~---~~~~i~~-~~~~~  364 (419)
T 3i6u_A          292 LGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS---LKDQITS-GKYNF  364 (419)
T ss_dssp             CC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC---HHHHHHT-TCCCC
T ss_pred             cCCCccc---cccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH---HHHHHhc-CCCCC
Confidence            6543222   12358999999998853 224567899999999999999999999974332110   0011111 00000


Q ss_pred             ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          157 DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .......+++.       +.+++.+||+.||++|||+.+++++
T Consensus       365 ~~~~~~~~~~~-------~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          365 IPEVWAEVSEK-------ALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             CHHHHTTSCHH-------HHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CchhhcccCHH-------HHHHHHHHccCChhHCcCHHHHhCC
Confidence            11111223444       4455555899999999999999975

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.97  E-value=1.6e-30  Score=213.71  Aligned_cols=164  Identities=24%  Similarity=0.298  Sum_probs=128.6

Q ss_pred             CCC-CcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            2 PNG-SLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         2 ~~G-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      ++| +|.+++...      +.+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       112 ~~g~~l~~~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  182 (335)
T 3dls_A          112 GSGLDLFAFIDRH------PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER  182 (335)
T ss_dssp             TTSCBHHHHHHTC------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             CCCccHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence            345 899998765      4599999999999999999999999   999999999999999999999999999987654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      .....   ...++..|+|||.+.+. ...+.++||||||+++|+|++|..||.........               ....
T Consensus       183 ~~~~~---~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---------------~~~~  243 (335)
T 3dls_A          183 GKLFY---TFCGTIEYCAPEVLMGN-PYRGPELEMWSLGVTLYTLVFEENPFCELEETVEA---------------AIHP  243 (335)
T ss_dssp             TCCBC---EECSCGGGCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTT---------------CCCC
T ss_pred             CCcee---ccCCCccccChhhhcCC-CCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhh---------------ccCC
Confidence            43322   23589999999998654 23378899999999999999999999643221100               0111


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML  200 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l  200 (242)
                      +..+++++.+++.+       ||+.||++|||+.+++++-
T Consensus       244 ~~~~~~~l~~li~~-------~L~~dP~~Rps~~ell~hp  276 (335)
T 3dls_A          244 PYLVSKELMSLVSG-------LLQPVPERRTTLEKLVTDP  276 (335)
T ss_dssp             SSCCCHHHHHHHHH-------HTCSSGGGSCCHHHHHHCT
T ss_pred             CcccCHHHHHHHHH-------HccCChhhCcCHHHHhcCc
Confidence            22355555555554       8899999999999999873

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.97  E-value=4.7e-31  Score=222.70  Aligned_cols=167  Identities=16%  Similarity=0.164  Sum_probs=122.8

Q ss_pred             CCCCcchhccccC-CCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            2 PNGSLDQFTYDQE-SSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         2 ~~GsL~~~l~~~~-~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      .+|+|.+++.... ....++.+++..++.++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       187 ~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~  263 (413)
T 3dzo_A          187 MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA  263 (413)
T ss_dssp             CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCGGGCEETTE
T ss_pred             hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcccceEEEecCCeEEEEeccceeecCC
Confidence            4578888885211 012346799999999999999999999999   999999999999999999999999999876554


Q ss_pred             Ccccchhcccccccccccchhhhcc--------cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhcc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRS--------FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHI  152 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~--------~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  152 (242)
                      ..     ....| ..|+|||.+...        ...++.++|||||||++|+|++|+.||.........    .....  
T Consensus       264 ~~-----~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~----~~~~~--  331 (413)
T 3dzo_A          264 SA-----VSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS----EWIFR--  331 (413)
T ss_dssp             EE-----CCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCS----GGGGS--
T ss_pred             cc-----ccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhH----HHHHh--
Confidence            31     22347 999999988422        124577999999999999999999999754432110    11100  


Q ss_pred             CCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 026160          153 EPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVL  197 (242)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll  197 (242)
                             ....+++++.+       ++.+||+.||++|||+.+++
T Consensus       332 -------~~~~~~~~~~~-------li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          332 -------SCKNIPQPVRA-------LLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             -------SCCCCCHHHHH-------HHHHHTCSSGGGSCCHHHHT
T ss_pred             -------hcccCCHHHHH-------HHHHHccCChhhCcCHHHHH
Confidence                   11134544444       44559999999999976664

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.97  E-value=7.9e-31  Score=214.19  Aligned_cols=170  Identities=24%  Similarity=0.311  Sum_probs=129.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCC----ceEEccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF----CPKISDFGLAK   76 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~----~~~L~dfg~~~   76 (242)
                      |++|+|.+++...      ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++    .++|+|||++.
T Consensus        97 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A           97 VSGGELFDFLAQK------ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             CCSCBHHHHHHTC------SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence            5789999999764      4699999999999999999999999   999999999999999887    79999999998


Q ss_pred             ccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCC-
Q 026160           77 QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPG-  155 (242)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-  155 (242)
                      ........   ....+++.|+|||.+.+.  .++.++|+||||+++|+|++|..||......        ......... 
T Consensus       168 ~~~~~~~~---~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~i~~~~  234 (321)
T 2a2a_A          168 EIEDGVEF---KNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANITSVS  234 (321)
T ss_dssp             ECCTTCCC---CCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHTTC
T ss_pred             ecCccccc---cccCCCCCccCcccccCC--CCCCccccHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhcc
Confidence            76543322   123489999999998653  5688999999999999999999999643321        111111111 


Q ss_pred             --CccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          156 --NDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       156 --~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                        ........+++.       +.+++.+||+.||++|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~~-------~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          235 YDFDEEFFSHTSEL-------AKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             CCCCHHHHTTCCHH-------HHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             cccChhhhcccCHH-------HHHHHHHHcCCChhhCcCHHHHhcC
Confidence              011111233444       4445556999999999999999974

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.97  E-value=8.7e-31  Score=217.60  Aligned_cols=180  Identities=15%  Similarity=0.126  Sum_probs=134.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC-----------CCceEE
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE-----------DFCPKI   69 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~-----------~~~~~L   69 (242)
                      |++|+|.+++..... .....+++.+++.++.|++.||.|||+.   +|+||||||+|||++.           ++.++|
T Consensus       149 ~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl  224 (365)
T 3e7e_A          149 YSYGTLLNAINLYKN-TPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLAL  224 (365)
T ss_dssp             CCSCBHHHHHHHHHT-STTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------CTTEEE
T ss_pred             cCCCcHHHHHHHhhc-ccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccccCCEEE
Confidence            679999999975321 1235699999999999999999999998   9999999999999988           899999


Q ss_pred             cccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhh
Q 026160           70 SDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIY  149 (242)
Q Consensus        70 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~  149 (242)
                      +|||++................||..|+|||.+.+.  .++.++|||||||++|+|++|..||.........      ..
T Consensus       225 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------~~  296 (365)
T 3e7e_A          225 IDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK------PE  296 (365)
T ss_dssp             CCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE------EC
T ss_pred             eeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC--CCCccccHHHHHHHHHHHHhCCCccccCCCCcee------ec
Confidence            999999754322222222334689999999998764  5789999999999999999999998654332110      00


Q ss_pred             hccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCC-CCHHHHHHHhhchhhh
Q 026160          150 KHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDR-PSMHEVLEMLESSTEI  206 (242)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~R-ps~~~ll~~l~~~~~~  206 (242)
                      ....     ..  ..++.+.+++..       |++.+|.+| |++.++.+.|+...+.
T Consensus       297 ~~~~-----~~--~~~~~~~~~~~~-------~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          297 GLFR-----RL--PHLDMWNEFFHV-------MLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             SCCT-----TC--SSHHHHHHHHHH-------HHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hhcc-----cc--CcHHHHHHHHHH-------HcCCCCCCcchHHHHHHHHHHHHHHH
Confidence            0000     00  123344444444       779999999 5888899998887765

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.97  E-value=8.1e-31  Score=213.08  Aligned_cols=182  Identities=22%  Similarity=0.291  Sum_probs=128.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       116 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          116 INGVDLAAMLRRQ------GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             CCCEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             cCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            5688999999765      3599999999999999999999999   999999999999999999999999999876544


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      .... ......++..|.|||.+.+.  .++.++||||||+++|++++|..||.......    .....  ..........
T Consensus       187 ~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~--~~~~~~~~~~  257 (309)
T 2h34_A          187 EKLT-QLGNTVGTLYYMAPERFSES--HATYRADIYALTCVLYECLTGSPPYQGDQLSV----MGAHI--NQAIPRPSTV  257 (309)
T ss_dssp             -----------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHHHH----HHHHH--HSCCCCGGGT
T ss_pred             cccc-cccccCCCcCccCHHHHcCC--CCCchHhHHHHHHHHHHHHHCCCCCCCchHHH----HHHHh--ccCCCCcccc
Confidence            3211 11223588999999998653  66889999999999999999999997543210    00000  0111111223


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHhhchhhhc
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRP-SMHEVLEMLESSTEIL  207 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp-s~~~ll~~l~~~~~~~  207 (242)
                      ...+++++.+++.+       ||+.||++|| |+.++++.|+......
T Consensus       258 ~~~~~~~l~~li~~-------~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          258 RPGIPVAFDAVIAR-------GMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             STTCCTHHHHHHHH-------HTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             CCCCCHHHHHHHHH-------hccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence            34456666665555       8899999999 9999999999876654

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.97  E-value=4.9e-31  Score=211.19  Aligned_cols=170  Identities=29%  Similarity=0.482  Sum_probs=128.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        91 ~~~~~l~~~l~~~------~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           91 APLGTVYRELQKL------SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             CTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            5688999999765      3599999999999999999999998   999999999999999999999999998865443


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....    ...++..|.|||.+.+.  ..+.++||||||+++|++++|..||......        ........ .....
T Consensus       162 ~~~~----~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~-~~~~~  226 (279)
T 3fdn_A          162 SRRT----DLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--------ETYKRISR-VEFTF  226 (279)
T ss_dssp             ----------CCCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHH-TCCCC
T ss_pred             cccc----ccCCCCCccCHhHhccC--CCCccchhHhHHHHHHHHHHCCCCCCCCcHH--------HHHHHHHh-CCCCC
Confidence            3221    23588999999998654  5688999999999999999999999643321        11111100 11122


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      +..+++.+.+++.+       ||+.||++|||+.+++++-.
T Consensus       227 ~~~~~~~~~~li~~-------~l~~~p~~Rps~~e~l~h~~  260 (279)
T 3fdn_A          227 PDFVTEGARDLISR-------LLKHNPSQRPMLREVLEHPW  260 (279)
T ss_dssp             CTTSCHHHHHHHHH-------HCCSSGGGSCCHHHHHHCHH
T ss_pred             CCcCCHHHHHHHHH-------HhccChhhCCCHHHHhhCcc
Confidence            33455555555554       88999999999999998644

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.97  E-value=1.5e-31  Score=223.16  Aligned_cols=167  Identities=18%  Similarity=0.206  Sum_probs=124.0

Q ss_pred             CCCcchhccccCC-CCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCC
Q 026160            3 NGSLDQFTYDQES-SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDK   81 (242)
Q Consensus         3 ~GsL~~~l~~~~~-~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~   81 (242)
                      +|+|.+++..... ......+++..++.++.|++.||.|||+.   +|+|+||||+|||++.++.++|+|||++......
T Consensus       183 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~  259 (377)
T 3byv_A          183 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR  259 (377)
T ss_dssp             SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCGGGCEETTCE
T ss_pred             CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEechhheecCCc
Confidence            6899999986422 22234566799999999999999999999   9999999999999999999999999999864432


Q ss_pred             cccchhcccccccccccchhhhcc---------cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhcc
Q 026160           82 KSTISMLHARGTIGYIAPEVFCRS---------FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHI  152 (242)
Q Consensus        82 ~~~~~~~~~~~~~~y~~PE~~~~~---------~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  152 (242)
                      .     ....+ ..|+|||.+.+.         ...++.++|||||||++|+|++|..||.........    .....  
T Consensus       260 ~-----~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~----~~~~~--  327 (377)
T 3byv_A          260 V-----VSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGS----EWIFR--  327 (377)
T ss_dssp             E-----ECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCS----GGGGS--
T ss_pred             c-----cCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccch----hhhhh--
Confidence            1     12346 899999998653         014688999999999999999999999654432211    11110  


Q ss_pred             CCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 026160          153 EPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE  198 (242)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~  198 (242)
                             ....+++++.+++.       +||+.||++|||+.++++
T Consensus       328 -------~~~~~~~~~~~li~-------~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          328 -------SCKNIPQPVRALLE-------GFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             -------SCCCCCHHHHHHHH-------HHTCSSGGGCCCHHHHHT
T ss_pred             -------hccCCCHHHHHHHH-------HHcCCCchhCCCHHHHhh
Confidence                   11235555555554       488999999999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.97  E-value=1.4e-31  Score=214.26  Aligned_cols=179  Identities=24%  Similarity=0.328  Sum_probs=133.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCC-----eeecCCCCCceeeCCCCceEEcccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVR-----IVHFDIKPHNILLDEDFCPKISDFGLA   75 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~-----i~h~dlk~~nil~~~~~~~~L~dfg~~   75 (242)
                      |++|+|.+++.....  ....+++..++.++.|++.||.|||+.   +     ++|+||||+||+++.++.++|+|||++
T Consensus        89 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~  163 (279)
T 2w5a_A           89 CEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  163 (279)
T ss_dssp             CTTEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred             CCCCCHHHHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence            568899999976421  224599999999999999999999998   7     999999999999999999999999999


Q ss_pred             cccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCC
Q 026160           76 KQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPG  155 (242)
Q Consensus        76 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  155 (242)
                      ..........  ....++..|.|||.+.+.  .++.++||||||+++|++++|..||.....        ......+..+
T Consensus       164 ~~~~~~~~~~--~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~i~~~  231 (279)
T 2w5a_A          164 RILNHDTSFA--KTFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KELAGKIREG  231 (279)
T ss_dssp             HHC---CHHH--HHHHSCCTTCCHHHHHCC---CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHT
T ss_pred             eeeccccccc--cccCCCccccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCcccCH--------HHHHHHHhhc
Confidence            8665432211  123488999999998654  568899999999999999999999875432        1111111122


Q ss_pred             CccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          156 NDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                      .....+..++.++.+++.+       ||+.||++|||+.++++.+...
T Consensus       232 ~~~~~~~~~~~~l~~li~~-------~l~~~p~~Rps~~~ll~~~~~~  272 (279)
T 2w5a_A          232 KFRRIPYRYSDELNEIITR-------MLNLKDYHRPSVEEILENPLIL  272 (279)
T ss_dssp             CCCCCCTTSCHHHHHHHHH-------HTCSSGGGSCCHHHHHTSTTCC
T ss_pred             ccccCCcccCHHHHHHHHH-------HcCCCcccCCCHHHHHhChhhh
Confidence            2223344456555555554       8899999999999999987653

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=1.2e-30  Score=214.87  Aligned_cols=163  Identities=23%  Similarity=0.285  Sum_probs=117.2

Q ss_pred             ccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCC--ceEEcccccccccCCCcc--cchhcccccccc
Q 026160           20 RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF--CPKISDFGLAKQSQDKKS--TISMLHARGTIG   95 (242)
Q Consensus        20 ~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~--~~~L~dfg~~~~~~~~~~--~~~~~~~~~~~~   95 (242)
                      ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++  .++|+|||++........  ........+++.
T Consensus       163 ~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~  239 (345)
T 3hko_A          163 FVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPY  239 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGG
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCcc
Confidence            3467889999999999999999999   999999999999998766  899999999986533211  111223458999


Q ss_pred             cccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCC--ccccccccchHHHHHHH
Q 026160           96 YIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN--DFQLDGVVTEEEKELVK  173 (242)
Q Consensus        96 y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  173 (242)
                      |+|||.+.+....++.++||||||+++|+|++|..||......       ...........  .......+++.+.+++ 
T Consensus       240 y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~li-  311 (345)
T 3hko_A          240 FVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA-------DTISQVLNKKLCFENPNYNVLSPLARDLL-  311 (345)
T ss_dssp             GCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCCTTSGGGGGSCHHHHHHH-
T ss_pred             ccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChH-------HHHHHHHhcccccCCcccccCCHHHHHHH-
Confidence            9999998764456788999999999999999999999644321       11111111111  1111122455555544 


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          174 KMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       174 ~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                            .+||+.||++|||+.+++++
T Consensus       312 ------~~~l~~~p~~Rps~~~~l~h  331 (345)
T 3hko_A          312 ------SNLLNRNVDERFDAMRALQH  331 (345)
T ss_dssp             ------HHHSCSCTTTSCCHHHHHHS
T ss_pred             ------HHHcCCChhHCCCHHHHhcC
Confidence                  45889999999999999874

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.97  E-value=1.1e-30  Score=209.04  Aligned_cols=171  Identities=29%  Similarity=0.475  Sum_probs=112.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....     ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        93 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           93 CHNGEMNRYLKNRV-----KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             CTTEEHHHHHHTCS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             CCCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            56889999997642     4699999999999999999999999   999999999999999999999999999986543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      .....  ....++..|.|||.+.+.  ..+.++|+||||+++|++++|..||.........       ....  ......
T Consensus       165 ~~~~~--~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~--~~~~~~  231 (278)
T 3cok_A          165 PHEKH--YTLCGTPNYISPEIATRS--AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-------NKVV--LADYEM  231 (278)
T ss_dssp             -------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CC--SSCCCC
T ss_pred             CCCcc--eeccCCCCcCCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-------HHHh--hcccCC
Confidence            22211  123488999999988654  5688999999999999999999999754322110       0000  011123


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      +..++.++.+++.       +||+.||++|||+.+++++
T Consensus       232 ~~~~~~~~~~li~-------~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          232 PSFLSIEAKDLIH-------QLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             CTTSCHHHHHHHH-------HHSCSSGGGSCCHHHHTTS
T ss_pred             ccccCHHHHHHHH-------HHcccCHhhCCCHHHHhcC
Confidence            3345555555544       4889999999999999874

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.97  E-value=6.9e-31  Score=217.18  Aligned_cols=177  Identities=22%  Similarity=0.253  Sum_probs=128.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCc---eEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFC---PKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~---~~L~dfg~~~~   77 (242)
                      |++|+|.+++.+...  ....+++..+..++.||+.||.|||+.   +++|+||||+||+++.++.   ++|+|||++..
T Consensus       108 ~~g~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~  182 (351)
T 3c0i_A          108 MDGADLCFEIVKRAD--AGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ  182 (351)
T ss_dssp             CSSCBHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred             CCCCCHHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence            578999988865421  224589999999999999999999999   9999999999999986554   99999999987


Q ss_pred             cCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      .......  .....+++.|+|||.+.+.  .++.++|||||||++|+|++|..||......    . ...+... .....
T Consensus       183 ~~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~-~~~i~~~-~~~~~  252 (351)
T 3c0i_A          183 LGESGLV--AGGRVGTPHFMAPEVVKRE--PYGKPVDVWGCGVILFILLSGCLPFYGTKER----L-FEGIIKG-KYKMN  252 (351)
T ss_dssp             CCTTSCB--CCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH----H-HHHHHHT-CCCCC
T ss_pred             ecCCCee--ecCCcCCcCccCHHHHcCC--CCCchHhhHHHHHHHHHHHHCCCCCCCcHHH----H-HHHHHcC-CCCCC
Confidence            6543221  1223589999999998654  5789999999999999999999999643210    0 0000000 00000


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ......+++++.+       ++.+||+.||++|||+.+++++
T Consensus       253 ~~~~~~~s~~~~~-------li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          253 PRQWSHISESAKD-------LVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             HHHHTTSCHHHHH-------HHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccCCHHHHH-------HHHHHCCCChhHCcCHHHHhcC
Confidence            1111234444444       4555889999999999999863

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.97  E-value=2.6e-30  Score=211.18  Aligned_cols=175  Identities=25%  Similarity=0.287  Sum_probs=128.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCc---eEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFC---PKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~---~~L~dfg~~~~   77 (242)
                      |++|+|.+++...      ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.   ++|+|||++..
T Consensus        96 ~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  166 (322)
T 2ycf_A           96 MEGGELFDKVVGN------KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  166 (322)
T ss_dssp             CTTEETHHHHSTT------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred             CCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence            5788999998754      4699999999999999999999999   9999999999999987654   99999999987


Q ss_pred             cCCCcccchhcccccccccccchhhhc-ccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCC
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCR-SFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN  156 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  156 (242)
                      ........   ...++..|.|||.+.. ....++.++||||||+++|++++|..||........   ....... .....
T Consensus       167 ~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~-~~~~~  239 (322)
T 2ycf_A          167 LGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS---LKDQITS-GKYNF  239 (322)
T ss_dssp             CCCCHHHH---HHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC---HHHHHHH-TCCCC
T ss_pred             cccccccc---cccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH---HHHHHHh-Ccccc
Confidence            65433221   2348999999998753 224568899999999999999999999974432211   0111111 00000


Q ss_pred             ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 026160          157 DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE  198 (242)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~  198 (242)
                      .......++.       .+.+++.+||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~~-------~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          240 IPEVWAEVSE-------KALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             CHHHHTTSCH-------HHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CchhhhhcCH-------HHHHHHHHHcccCHhhCCCHHHHhh
Confidence            1111122333       4445555699999999999999985

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.97  E-value=5.9e-31  Score=219.09  Aligned_cols=166  Identities=28%  Similarity=0.378  Sum_probs=128.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.+++.+.      +.+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.++|+|||++.....
T Consensus       121 ~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          121 INGGELFYHLQRE------RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             CCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            5799999999875      4599999999999999999999999   999999999999999999999999999975332


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....||+.|+|||++.+.  .++.++|+|||||++|+|++|..||......        .....+... ...+
T Consensus       192 ~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~-~~~~  258 (373)
T 2r5t_A          192 HNST--TSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--------EMYDNILNK-PLQL  258 (373)
T ss_dssp             CCCC--CCSBSCCCCCCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH--------HHHHHHHHS-CCCC
T ss_pred             CCCc--cccccCCccccCHHHhCCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHhc-ccCC
Confidence            2111  1234589999999998754  6788999999999999999999999644321        111111111 1223


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHE  195 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~  195 (242)
                      +..++.++.+++.+       ||+.||++||++.+
T Consensus       259 ~~~~~~~~~~li~~-------lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          259 KPNITNSARHLLEG-------LLQKDRTKRLGAKD  286 (373)
T ss_dssp             CSSSCHHHHHHHHH-------HTCSSGGGSTTTTT
T ss_pred             CCCCCHHHHHHHHH-------HcccCHHhCCCCCC
Confidence            44566666666666       77999999999853

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.97  E-value=1.5e-30  Score=216.22  Aligned_cols=172  Identities=23%  Similarity=0.362  Sum_probs=129.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      ..+++..+..++.|++.||.|||+.   +++|+||||.||+++.++.++|+|||++.....
T Consensus       182 ~~g~~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~  252 (365)
T 2y7j_A          182 MRKGELFDYLTEK------VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP  252 (365)
T ss_dssp             CTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence            5789999999765      4599999999999999999999999   999999999999999999999999999987654


Q ss_pred             Ccccchhcccccccccccchhhhcc----cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCC
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRS----FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN  156 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~----~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  156 (242)
                      .....   ...+++.|+|||.+.+.    ...++.++||||||+++|+|++|..||......        .....+..+.
T Consensus       253 ~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--------~~~~~i~~~~  321 (365)
T 2y7j_A          253 GEKLR---ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI--------LMLRMIMEGQ  321 (365)
T ss_dssp             TCCBC---CCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTC
T ss_pred             Ccccc---cCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhCC
Confidence            33221   23589999999988642    224688999999999999999999999643211        1111110000


Q ss_pred             ---ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          157 ---DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       157 ---~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                         .......++..+       .+++.+||+.||++|||+.+++++
T Consensus       322 ~~~~~~~~~~~~~~~-------~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          322 YQFSSPEWDDRSSTV-------KDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             CCCCHHHHSSSCHHH-------HHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCCCcccccCCHHH-------HHHHHHHcCCChhHCcCHHHHhcC
Confidence               000112234444       445555899999999999999874

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.97  E-value=1.5e-30  Score=208.76  Aligned_cols=173  Identities=24%  Similarity=0.291  Sum_probs=129.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCc---eEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFC---PKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~---~~L~dfg~~~~   77 (242)
                      |++|+|.+++...      ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.   ++|+|||++..
T Consensus        87 ~~~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           87 VTGGELFEDIVAR------EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             CCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             CCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            5789999998765      4599999999999999999999999   9999999999999976554   99999999977


Q ss_pred             cCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      ........   ...+++.|+|||.+.+.  .++.++||||||+++|++++|..||........    ...... ......
T Consensus       158 ~~~~~~~~---~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~-~~~~~~  227 (284)
T 3kk8_A          158 VNDSEAWH---GFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQHRL----YAQIKA-GAYDYP  227 (284)
T ss_dssp             CCSSCBCC---CSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHH-TCCCCC
T ss_pred             cccCcccc---CCCCCcCCcCchhhcCC--CCCcccchHHHHHHHHHHHHCCCCCCCCchhHH----HHHHHh-ccccCC
Confidence            65543322   23489999999998654  578899999999999999999999964332110    000000 011111


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ......+++++.+++       .+||+.||++|||+.+++++
T Consensus       228 ~~~~~~~~~~~~~li-------~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          228 SPEWDTVTPEAKSLI-------DSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             TTTTTTSCHHHHHHH-------HHHSCSSTTTSCCHHHHTTS
T ss_pred             chhhcccCHHHHHHH-------HHHcccChhhCCCHHHHhcC
Confidence            111223455555444       45889999999999999874

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.97  E-value=2.1e-30  Score=214.79  Aligned_cols=119  Identities=29%  Similarity=0.380  Sum_probs=102.7

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC-------------------
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE-------------------   63 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~-------------------   63 (242)
                      +|+|.+++.....    ..+++.++..++.||+.||.|||+.   +|+|+||||+|||++.                   
T Consensus       119 ~~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~  191 (360)
T 3llt_A          119 GPSLYEIITRNNY----NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI  191 (360)
T ss_dssp             CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEE
T ss_pred             CCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhcccccccc
Confidence            7899999976532    4699999999999999999999999   9999999999999975                   


Q ss_pred             ------CCceEEcccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           64 ------DFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        64 ------~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                            ++.++|+|||++........     ...++..|+|||.+.+.  .++.++|||||||++|+|++|..||...
T Consensus       192 ~~~~~~~~~~kl~DFG~a~~~~~~~~-----~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~  262 (360)
T 3llt_A          192 QIYRTKSTGIKLIDFGCATFKSDYHG-----SIINTRQYRAPEVILNL--GWDVSSDMWSFGCVLAELYTGSLLFRTH  262 (360)
T ss_dssp             EEEEESCCCEEECCCTTCEETTSCCC-----SCCSCGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccCCCCEEEEeccCceecCCCCc-----CccCcccccCcHHHcCC--CCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence                  78899999999986544322     23589999999998764  6789999999999999999999999643

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.97  E-value=1.2e-30  Score=212.21  Aligned_cols=178  Identities=23%  Similarity=0.258  Sum_probs=125.7

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      |+|.+++....     ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus       103 ~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  174 (311)
T 3niz_A          103 KDLKKVLDENK-----TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR  174 (311)
T ss_dssp             EEHHHHHHTCT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred             CCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence            57777776532     4599999999999999999999999   999999999999999999999999999987653322


Q ss_pred             cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCC------------cCcchh---
Q 026160           84 TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDI------------YFPNSI---  148 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~------------~~~~~~---  148 (242)
                      .  .....++..|+|||.+.+. ..++.++|||||||++|+|++|..||..........            .++...   
T Consensus       175 ~--~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          175 S--YTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP  251 (311)
T ss_dssp             -----CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred             c--ccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence            2  1223589999999998653 356889999999999999999999996543321100            000000   


Q ss_pred             ---hhc---cCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          149 ---YKH---IEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       149 ---~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                         ...   ............++++       +.+++.+||+.||++|||+.+++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          252 LWKQRTFQVFEKKPWSSIIPGFCQE-------GIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             HHHSCCCCCCCCCCHHHHSTTCCHH-------HHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhhcccccccCCcHHHhCcccCHH-------HHHHHHHHcCCChhHCCCHHHHhcC
Confidence               000   0000000111123333       4455566889999999999999874

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.97  E-value=1.3e-30  Score=209.24  Aligned_cols=168  Identities=24%  Similarity=0.408  Sum_probs=130.3

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      +.+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        96 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           96 APRGELYKELQKH------GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             CTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            4688999999765      3599999999999999999999999   999999999999999999999999999876544


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....    ...++..|.|||.+.+.  .++.++|+||||+++|++++|..||.......        ....... .....
T Consensus       167 ~~~~----~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~~~~-~~~~~  231 (284)
T 2vgo_A          167 LRRR----TMCGTLDYLPPEMIEGK--THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE--------THRRIVN-VDLKF  231 (284)
T ss_dssp             SCBC----CCCSCGGGCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHT-TCCCC
T ss_pred             cccc----cccCCCCcCCHHHhccC--CCCcccchhhHHHHHHHHHHCCCCCCCCCHhH--------HHHHHhc-cccCC
Confidence            3221    23488999999998654  56889999999999999999999996433211        1111111 11123


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      +..++..+.+++.+       ||+.||++|||+.+++++
T Consensus       232 ~~~~~~~~~~li~~-------~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          232 PPFLSDGSKDLISK-------LLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             CTTSCHHHHHHHHH-------HSCSSGGGSCCHHHHHTC
T ss_pred             CCcCCHHHHHHHHH-------HhhcCHhhCCCHHHHhhC
Confidence            34455555555555       889999999999999974

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.97  E-value=1.1e-30  Score=210.14  Aligned_cols=178  Identities=25%  Similarity=0.284  Sum_probs=123.4

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      |+|.+++....     +.+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        84 ~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           84 QDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             EEHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence            57777776532     4699999999999999999999999   999999999999999999999999999976543221


Q ss_pred             cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCC------------CCCcCcchhh-h
Q 026160           84 TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRS------------SDIYFPNSIY-K  150 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~------------~~~~~~~~~~-~  150 (242)
                      .  .....++..|+|||.+.+. ..++.++||||||+++|+|++|..||.......            ....++.... .
T Consensus       156 ~--~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T 1ob3_A          156 K--YTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP  232 (288)
T ss_dssp             --------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             c--cccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc
Confidence            1  1123579999999998653 356889999999999999999999996433110            0000000000 0


Q ss_pred             cc-------CCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          151 HI-------EPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       151 ~~-------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ..       ...........+++++.+       ++.+||+.||++|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          233 KYDPNFTVYEPLPWESFLKGLDESGID-------LLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHH-------HHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccCccHHHHhhhcCHHHHH-------HHHHHcCCCcccCCCHHHHhcC
Confidence            00       000001111234444444       4555889999999999999864

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.97  E-value=1.9e-30  Score=211.27  Aligned_cols=183  Identities=21%  Similarity=0.250  Sum_probs=125.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCc---eEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFC---PKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~---~~L~dfg~~~~   77 (242)
                      |++|+|.+++...      +.+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.   ++|+|||++..
T Consensus        93 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~  163 (316)
T 2ac3_A           93 MRGGSILSHIHKR------RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSG  163 (316)
T ss_dssp             CTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred             CCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence            5789999999875      3599999999999999999999999   9999999999999987765   99999999875


Q ss_pred             cCCCcc-----cchhcccccccccccchhhhcc---cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcc---
Q 026160           78 SQDKKS-----TISMLHARGTIGYIAPEVFCRS---FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPN---  146 (242)
Q Consensus        78 ~~~~~~-----~~~~~~~~~~~~y~~PE~~~~~---~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~---  146 (242)
                      ......     ........++..|+|||.+...   ...++.++|||||||++|+|++|..||..............   
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  243 (316)
T 2ac3_A          164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP  243 (316)
T ss_dssp             ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred             cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence            532211     1111123489999999998641   12457899999999999999999999976543321111000   


Q ss_pred             ----hhhhccCCCCc---cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          147 ----SIYKHIEPGND---FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       147 ----~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                          .....+.....   ......++++       +.+++.+||+.||++|||+.+++++
T Consensus       244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~-------~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          244 ACQNMLFESIQEGKYEFPDKDWAHISCA-------AKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHHHHHHHCCCCCCHHHHTTSCHH-------HHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hHHHHHHHHHhccCcccCchhcccCCHH-------HHHHHHHHhhCChhhCCCHHHHhcC
Confidence                00011100000   0000123333       4455566999999999999999985

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.97  E-value=1e-30  Score=210.08  Aligned_cols=175  Identities=26%  Similarity=0.333  Sum_probs=123.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceee---CCCCceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~---~~~~~~~L~dfg~~~~   77 (242)
                      |++|+|.+++.....  ....+++..++.++.|++.||.|||+.   +++|+||||+||++   +.++.++|+|||++..
T Consensus       102 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A          102 CEGGELLERIVSAQA--RGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             CSCCBHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             CCCCcHHHHHHhhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            578999999865321  125699999999999999999999999   99999999999999   4567899999999976


Q ss_pred             cCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      .......   ....++..|+|||.+..   .++.++||||||+++|+|++|..||.......      ............
T Consensus       177 ~~~~~~~---~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~  244 (285)
T 3is5_A          177 FKSDEHS---TNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE------VQQKATYKEPNY  244 (285)
T ss_dssp             -------------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCCC
T ss_pred             cCCcccC---cCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCHHH------HHhhhccCCccc
Confidence            5443222   12358999999998753   56889999999999999999999996443211      000000111111


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ......+++++.+       ++.+||+.||++|||+.+++++
T Consensus       245 ~~~~~~~~~~~~~-------li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          245 AVECRPLTPQAVD-------LLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             CC--CCCCHHHHH-------HHHHHTCSCTTTSCCHHHHHTS
T ss_pred             ccccCcCCHHHHH-------HHHHHccCChhhCcCHHHHhcC
Confidence            1111224455544       4455889999999999999863

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.97  E-value=8.4e-31  Score=227.82  Aligned_cols=175  Identities=28%  Similarity=0.408  Sum_probs=134.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.+++.....    ..+++..+..++.||+.||.|||+.   +|+|+||||+|||++.++.++|+|||++.....
T Consensus       266 ~~gg~L~~~l~~~~~----~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          266 MNGGDLKFHIYHMGQ----AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             CCSCBHHHHHHSSSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             CCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            679999999976532    4599999999999999999999999   999999999999999999999999999987654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      .....   ...||+.|+|||++.+.  .++.++|+|||||++|+|++|..||.........    ..+...+.. ....+
T Consensus       339 ~~~~~---~~~GT~~Y~APEvl~~~--~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~----~~i~~~i~~-~~~~~  408 (576)
T 2acx_A          339 GQTIK---GRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR----EEVERLVKE-VPEEY  408 (576)
T ss_dssp             TCCEE---CCCSCGGGCCHHHHTTC--EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH----HHHHHHHHH-CCCCC
T ss_pred             Ccccc---ccCCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCcccccchhH----HHHHHHhhc-ccccC
Confidence            33221   23589999999998653  5789999999999999999999999754322111    111111111 11223


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRP-----SMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp-----s~~~ll~~  199 (242)
                      +..+++++.+++.+       ||+.||++||     ++.+++++
T Consensus       409 p~~~s~~~~dLI~~-------lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          409 SERFSPQARSLCSQ-------LLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             CTTSCHHHHHHHHH-------HTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             CccCCHHHHHHHHH-------hccCCHHHcCCCCCCCHHHHHhC
Confidence            34567777666666       7799999999     78998864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.97  E-value=2.1e-30  Score=209.96  Aligned_cols=171  Identities=22%  Similarity=0.319  Sum_probs=127.6

Q ss_pred             cchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccc
Q 026160            6 LDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTI   85 (242)
Q Consensus         6 L~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~   85 (242)
                      |.+++....    ...+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++..........
T Consensus        94 l~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~  166 (305)
T 2wtk_C           94 MQEMLDSVP----EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADD  166 (305)
T ss_dssp             HHHHHHHST----TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSC
T ss_pred             HHHHHHhCc----ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccCcccccc
Confidence            666665432    25699999999999999999999999   99999999999999999999999999998765332222


Q ss_pred             hhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccccccccc
Q 026160           86 SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVT  165 (242)
Q Consensus        86 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (242)
                      ......++..|.|||.+.+.....+.++||||||+++|+|++|..||......        .....+... ....+..++
T Consensus       167 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~i~~~-~~~~~~~~~  237 (305)
T 2wtk_C          167 TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY--------KLFENIGKG-SYAIPGDCG  237 (305)
T ss_dssp             EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHC-CCCCCSSSC
T ss_pred             ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH--------HHHHHHhcC-CCCCCCccC
Confidence            22234589999999998654334477999999999999999999999743211        111111111 112334456


Q ss_pred             hHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          166 EEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       166 ~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      +.+.+++.+       ||+.||++|||+.+++++
T Consensus       238 ~~l~~li~~-------~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          238 PPLSDLLKG-------MLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             HHHHHHHHH-------HTCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHHH-------HccCChhhCCCHHHHhcC
Confidence            666555554       889999999999999975

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.97  E-value=1.2e-30  Score=209.31  Aligned_cols=169  Identities=23%  Similarity=0.347  Sum_probs=127.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCC----------------
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDED----------------   64 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~----------------   64 (242)
                      |++|+|.+++.....  ....+++.+++.++.|++.||.|||+.   +++|+||||+||+++.+                
T Consensus        93 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           93 CNGGSLADAISENYR--IMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             CTTCBHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC------------------
T ss_pred             cCCCcHHHHHHhhcc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence            578999999976421  124589999999999999999999999   99999999999999844                


Q ss_pred             ---CceEEcccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCC
Q 026160           65 ---FCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSD  141 (242)
Q Consensus        65 ---~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~  141 (242)
                         ..++|+|||++........      ..++..|.|||.+.+. ...+.++||||||+++|++++|..++.....    
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~------~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----  236 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISSPQV------EEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGDQ----  236 (289)
T ss_dssp             --CCCEEECCCTTCEETTCSCC------CCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred             CCceEEEEcccccccccCCccc------cCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence               4799999999987654332      2389999999998653 3456799999999999999999876532211    


Q ss_pred             CcCcchhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          142 IYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                             ......+.....+..+++++.+++.+       ||+.||++|||+.+++++
T Consensus       237 -------~~~~~~~~~~~~~~~~~~~~~~li~~-------~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          237 -------WHEIRQGRLPRIPQVLSQEFTELLKV-------MIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             -------HHHHHTTCCCCCSSCCCHHHHHHHHH-------HTCSSGGGSCCHHHHHTC
T ss_pred             -------HHHHHcCCCCCCCcccCHHHHHHHHH-------HhCCCcccCCCHHHHhhC
Confidence                   11112222233444566666655555       889999999999999865

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.97  E-value=1.1e-30  Score=217.60  Aligned_cols=173  Identities=25%  Similarity=0.257  Sum_probs=128.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceee--CCCCceEEccccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL--DEDFCPKISDFGLAKQS   78 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~--~~~~~~~L~dfg~~~~~   78 (242)
                      |++|+|.+++....     ..+++.+++.++.||+.||.|||+.   +++|+||||+|||+  +.++.++|+|||++...
T Consensus       168 ~~~~~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~  239 (373)
T 2x4f_A          168 VDGGELFDRIIDES-----YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRY  239 (373)
T ss_dssp             CTTCEEHHHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred             CCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence            57899999987542     4699999999999999999999999   99999999999999  56778999999999876


Q ss_pred             CCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           79 QDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        79 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      .......   ...+++.|+|||.+...  .++.++|||||||++|+|++|..||........    ...+... ......
T Consensus       240 ~~~~~~~---~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----~~~i~~~-~~~~~~  309 (373)
T 2x4f_A          240 KPREKLK---VNFGTPEFLAPEVVNYD--FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET----LNNILAC-RWDLED  309 (373)
T ss_dssp             CTTCBCC---CCCSSCTTCCHHHHTTC--BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHHT-CCCSCS
T ss_pred             CCccccc---cccCCCcEeChhhccCC--CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhc-cCCCCh
Confidence            5443222   23489999999988653  568899999999999999999999965432110    0001000 000011


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE  198 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~  198 (242)
                      .....+++++.+       ++.+||+.||++|||+.++++
T Consensus       310 ~~~~~~~~~~~~-------li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          310 EEFQDISEEAKE-------FISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             GGGTTSCHHHHH-------HHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhhccCCHHHHH-------HHHHHcCCChhhCCCHHHHhc
Confidence            111234444444       455599999999999999997

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.97  E-value=1.6e-30  Score=207.94  Aligned_cols=169  Identities=22%  Similarity=0.263  Sum_probs=127.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceee---CCCCceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~---~~~~~~~L~dfg~~~~   77 (242)
                      |++|+|.+++...      +.+++.+++.++.|++.||.|||+.   +++|+||||+||++   +.++.++|+|||++..
T Consensus        88 ~~~~~L~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~  158 (277)
T 3f3z_A           88 CTGGELFERVVHK------RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR  158 (277)
T ss_dssp             CCSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             cCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence            5789999998765      4599999999999999999999999   99999999999999   7788999999999986


Q ss_pred             cCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCC-
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN-  156 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  156 (242)
                      ........   ...++..|.|||.+.+   .++.++||||||+++|++++|..||......        .......... 
T Consensus       159 ~~~~~~~~---~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~  224 (277)
T 3f3z_A          159 FKPGKMMR---TKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS--------EVMLKIREGTF  224 (277)
T ss_dssp             CCTTSCBC---CCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCC
T ss_pred             ccCccchh---ccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhCCC
Confidence            65433222   2348999999998854   4788999999999999999999999643321        1111111100 


Q ss_pred             --ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          157 --DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       157 --~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                        .......+++.+       .+++.+||+.||++|||+.+++++
T Consensus       225 ~~~~~~~~~~~~~~-------~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          225 TFPEKDWLNVSPQA-------ESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             CCCHHHHTTSCHHH-------HHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             CCCchhhhcCCHHH-------HHHHHHHccCChhhCcCHHHHhcC
Confidence              000011234444       445555889999999999999864

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.97  E-value=1.5e-30  Score=211.68  Aligned_cols=178  Identities=23%  Similarity=0.368  Sum_probs=125.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +.+|+|.+++...      +.+++.+++.++.|+++||.|||+.   +++|+||||+||+++ ++.++|+|||++.....
T Consensus       109 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~  178 (313)
T 3cek_A          109 CGNIDLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  178 (313)
T ss_dssp             CCSEEHHHHHHHC------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCC---
T ss_pred             cCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE-CCeEEEeeccccccccC
Confidence            4578999999765      4589999999999999999999999   999999999999996 48899999999986654


Q ss_pred             Ccccchhcccccccccccchhhhcc---------cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRS---------FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKH  151 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~---------~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~  151 (242)
                      ...........++..|+|||.+.+.         ...++.++||||||+++|+|++|..||.......      ......
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~------~~~~~~  252 (313)
T 3cek_A          179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------SKLHAI  252 (313)
T ss_dssp             -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH------HHHHHH
T ss_pred             ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH------HHHHHH
Confidence            3322222234589999999998641         1356789999999999999999999996432110      111112


Q ss_pred             cCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          152 IEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      .........+...+.++.++       +.+||+.||++|||+.+++++-.
T Consensus       253 ~~~~~~~~~~~~~~~~l~~l-------i~~~l~~dp~~Rps~~ell~h~~  295 (313)
T 3cek_A          253 IDPNHEIEFPDIPEKDLQDV-------LKCCLKRDPKQRISIPELLAHPY  295 (313)
T ss_dssp             HCTTSCCCCCCCSCHHHHHH-------HHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             HhcccccCCcccchHHHHHH-------HHHHccCCcccCcCHHHHhcCcc
Confidence            22222223333445445444       44599999999999999997543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.97  E-value=1.1e-30  Score=215.83  Aligned_cols=170  Identities=28%  Similarity=0.372  Sum_probs=128.0

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      |+|.+++....     ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++....... 
T Consensus       138 g~l~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~-  208 (348)
T 1u5q_A          138 GSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-  208 (348)
T ss_dssp             EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC-
T ss_pred             CCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCCC-
Confidence            67777775432     4699999999999999999999999   99999999999999999999999999997655432 


Q ss_pred             cchhcccccccccccchhhhc-ccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccccc
Q 026160           84 TISMLHARGTIGYIAPEVFCR-SFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDG  162 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~-~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (242)
                           ...+++.|+|||.+.. ....++.++||||||+++|+|++|..||.......       ................
T Consensus       209 -----~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~  276 (348)
T 1u5q_A          209 -----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQNESPALQSG  276 (348)
T ss_dssp             -----CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSCCCCCCCT
T ss_pred             -----cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-------HHHHHHhcCCCCCCCC
Confidence                 2348999999998853 22467889999999999999999999986443211       1111111111111223


Q ss_pred             ccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          163 VVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       163 ~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      .+++.+.+++.       +||+.||++|||+.+++++..
T Consensus       277 ~~~~~l~~li~-------~~l~~dP~~Rps~~~ll~h~~  308 (348)
T 1u5q_A          277 HWSEYFRNFVD-------SCLQKIPQDRPTSEVLLKHRF  308 (348)
T ss_dssp             TSCHHHHHHHH-------HHTCSSGGGSCCHHHHTTCHH
T ss_pred             CCCHHHHHHHH-------HHcccChhhCcCHHHHhhChh
Confidence            45555555444       499999999999999987544

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.97  E-value=1.1e-30  Score=215.14  Aligned_cols=175  Identities=28%  Similarity=0.414  Sum_probs=129.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCC----CceEEccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDED----FCPKISDFGLAK   76 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~----~~~~L~dfg~~~   76 (242)
                      |+||+|.+++...      +.+++.++..++.||+.||.|||+.   +++|+||||+||++..+    +.++|+|||++.
T Consensus        98 ~~gg~L~~~i~~~------~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~  168 (342)
T 2qr7_A           98 MKGGELLDKILRQ------KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAK  168 (342)
T ss_dssp             CCSCBHHHHHHTC------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence            5789999999765      4599999999999999999999999   99999999999998532    359999999998


Q ss_pred             ccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCC
Q 026160           77 QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN  156 (242)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  156 (242)
                      ........  .....+++.|+|||.+.+.  .++.++|+|||||++|+|++|..||........     ......+..+.
T Consensus       169 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-----~~~~~~i~~~~  239 (342)
T 2qr7_A          169 QLRAENGL--LMTPCYTANFVAPEVLERQ--GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP-----EEILARIGSGK  239 (342)
T ss_dssp             ECBCTTCC--BCCSSCCSSCCCHHHHHHH--HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH-----HHHHHHHHHCC
T ss_pred             cCcCCCCc--eeccCCCccccCHHHhcCC--CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH-----HHHHHHHccCC
Confidence            65443221  1123589999999998654  467899999999999999999999974322111     11111111111


Q ss_pred             ---ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 026160          157 ---DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML  200 (242)
Q Consensus       157 ---~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l  200 (242)
                         .......+++++.+++.+       ||+.||++|||+.+++++-
T Consensus       240 ~~~~~~~~~~~s~~~~~li~~-------~L~~dP~~R~t~~~il~hp  279 (342)
T 2qr7_A          240 FSLSGGYWNSVSDTAKDLVSK-------MLHVDPHQRLTAALVLRHP  279 (342)
T ss_dssp             CCCCSTTTTTSCHHHHHHHHH-------HTCSSTTTSCCHHHHTTSH
T ss_pred             cccCccccccCCHHHHHHHHH-------HCCCChhHCcCHHHHhcCC
Confidence               111123456666666555       8899999999999998753

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.97  E-value=1.2e-30  Score=213.78  Aligned_cols=170  Identities=28%  Similarity=0.394  Sum_probs=126.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      +.+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       103 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  173 (327)
T 3a62_A          103 LSGGELFMQLERE------GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH  173 (327)
T ss_dssp             CTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred             CCCCcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence            5789999999765      4589999999999999999999999   999999999999999999999999999875432


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....|+..|+|||.+.+.  .++.++|+||||+++|+|++|..||......       ... ..+.. ....+
T Consensus       174 ~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~-~~i~~-~~~~~  240 (327)
T 3a62_A          174 DGTV--THTFCGTIEYMAPEILMRS--GHNRAVDWWSLGALMYDMLTGAPPFTGENRK-------KTI-DKILK-CKLNL  240 (327)
T ss_dssp             -------CTTSSCCTTSCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHH-HHHHH-TCCCC
T ss_pred             CCcc--ccccCCCcCccCHhhCcCC--CCCCcccchhHHHHHHHHHHCCCCCCCCCHH-------HHH-HHHHh-CCCCC
Confidence            2211  1123589999999998654  5688999999999999999999999744321       111 11000 01123


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRP-----SMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp-----s~~~ll~~  199 (242)
                      +..++.++.+++.+       ||+.||++||     ++.+++++
T Consensus       241 p~~~~~~~~~li~~-------~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          241 PPYLTQEARDLLKK-------LLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             CTTSCHHHHHHHHH-------HSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             CCCCCHHHHHHHHH-------HHhcCHhhccCCCCCCHHHHHcC
Confidence            34456666665555       8899999999     78888864

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.97  E-value=1.2e-30  Score=231.59  Aligned_cols=180  Identities=25%  Similarity=0.368  Sum_probs=135.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....     ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       472 ~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          472 CTLGELRSFLQVRK-----FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  543 (656)
T ss_dssp             CTTCBHHHHHHHTT-----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred             CCCCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence            57899999997643     3599999999999999999999999   999999999999999999999999999986654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ..... .....++..|+|||.+...  .++.++||||||+++|+|++ |..||......        .....+..+....
T Consensus       544 ~~~~~-~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--------~~~~~i~~~~~~~  612 (656)
T 2j0j_A          544 STYYK-ASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--------DVIGRIENGERLP  612 (656)
T ss_dssp             -----------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHHTCCCC
T ss_pred             Cccee-ccCCCCCcceeCHHHhcCC--CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHcCCCCC
Confidence            32211 1123467899999998654  67889999999999999997 88898643321        1111111222223


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      .+..+++.+.++       +.+||+.||++|||+.++++.|+.+.+.
T Consensus       613 ~~~~~~~~l~~l-------i~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          613 MPPNCPPTLYSL-------MTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             CCTTCCHHHHHH-------HHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCccccHHHHHH-------HHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            344555555554       4459999999999999999999988654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.97  E-value=1.9e-30  Score=230.82  Aligned_cols=169  Identities=23%  Similarity=0.345  Sum_probs=132.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.++|...      +.+++.++..++.||+.||.|||+.   +|+||||||+|||++.++.++|+|||++.....
T Consensus       424 ~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          424 VNGGDLMYHIQQV------GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             CCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             cCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            6799999999875      3599999999999999999999999   999999999999999999999999999985432


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....||+.|+|||++.+.  .++.++|+||||+++|||++|..||.....        ......+... ...+
T Consensus       495 ~~~~--~~~~~GT~~Y~APE~l~~~--~~~~~~DvwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~-~~~~  561 (674)
T 3pfq_A          495 DGVT--TKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEH-NVAY  561 (674)
T ss_dssp             TTCC--BCCCCSCSSSCCHHHHTCC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHSS-CCCC
T ss_pred             CCcc--cccccCCCcccCHhhhcCC--CCCccceEechHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhC-CCCC
Confidence            2211  1234589999999998654  678999999999999999999999975432        1111111111 1234


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSM-----HEVLE  198 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~-----~~ll~  198 (242)
                      +..+++++.+++.+       ||+.||++||++     .++++
T Consensus       562 p~~~s~~~~~li~~-------lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          562 PKSMSKEAVAICKG-------LMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             CTTSCHHHHHHHHH-------HSCSSSTTCTTCSTTHHHHHHS
T ss_pred             CccCCHHHHHHHHH-------HccCCHHHCCCCCCCcHHHHhc
Confidence            44567777776666       779999999997     77765

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=6.9e-31  Score=219.95  Aligned_cols=121  Identities=26%  Similarity=0.357  Sum_probs=99.2

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      |+|.+++..       ..++...+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||+++.......
T Consensus        95 ~~L~~~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  164 (388)
T 3oz6_A           95 TDLHAVIRA-------NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR  164 (388)
T ss_dssp             EEHHHHHHH-------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred             cCHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence            577777764       3589999999999999999999999   999999999999999999999999999976532110


Q ss_pred             -------------------cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           84 -------------------TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        84 -------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                                         ........+|+.|+|||++.+. ..++.++|||||||++|+|++|..||...
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~  234 (388)
T 3oz6_A          165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGS  234 (388)
T ss_dssp             CCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence                               1111234689999999998653 36789999999999999999999999654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.97  E-value=2.6e-30  Score=211.45  Aligned_cols=174  Identities=22%  Similarity=0.323  Sum_probs=128.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.....   ....++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       143 ~~~~~L~~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  216 (332)
T 3qd2_B          143 CRKENLKDWMNRRCS---LEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ  216 (332)
T ss_dssp             CCSSCHHHHHHTCCS---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSC
T ss_pred             cCCCCHHHHHhcccC---ccchhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCccccccc
Confidence            578999999976532   24456778999999999999999999   999999999999999999999999999987654


Q ss_pred             Cccc----------chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhh
Q 026160           81 KKST----------ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYK  150 (242)
Q Consensus        81 ~~~~----------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~  150 (242)
                      ....          .......+++.|+|||.+.+.  .++.++||||||+++|+|++|..|+.....          ...
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~~~~~~~~~~----------~~~  284 (332)
T 3qd2_B          217 DEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGN--NYSHKVDIFSLGLILFELLYSFSTQMERVR----------IIT  284 (332)
T ss_dssp             C--------------CCCSCC-CGGGSCHHHHHCC--CCCTHHHHHHHHHHHHHHHSCCCCHHHHHH----------HHH
T ss_pred             chhhccccccccccccccccCCCcCccChHHhcCC--CCcchhhHHHHHHHHHHHHHcCCChhHHHH----------HHH
Confidence            4211          111223589999999998764  678999999999999999998776532111          011


Q ss_pred             ccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          151 HIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .....       ..+.........+.+++.+||+.||++|||+.+++++
T Consensus       285 ~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          285 DVRNL-------KFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHTT-------CCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             Hhhcc-------CCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence            11111       1222333334445667777999999999999999874

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.97  E-value=2.2e-30  Score=209.81  Aligned_cols=172  Identities=31%  Similarity=0.417  Sum_probs=131.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++..       +.+++.++..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus       102 ~~~~~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A          102 LGGGSALDLLEP-------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  171 (303)
T ss_dssp             CTTEEHHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred             CCCCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCc
Confidence            578899999864       3599999999999999999999999   999999999999999999999999999976654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      .....  ....++..|.|||.+.+.  .++.++|+||||+++|++++|..||......        ..............
T Consensus       172 ~~~~~--~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~  239 (303)
T 3a7i_A          172 TQIKR--NTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELARGEPPHSELHPM--------KVLFLIPKNNPPTL  239 (303)
T ss_dssp             TBCCB--CCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSCCCCC
T ss_pred             ccccc--CccCCCcCccCHHHHhcC--CCCchhhhHHHHHHHHHHccCCCCCCCcCHH--------HHHHHhhcCCCCCC
Confidence            32211  123588999999998653  5688999999999999999999998643221        11111111122233


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      ...++..+.+++.+       ||+.||++|||+.+++++..
T Consensus       240 ~~~~~~~l~~li~~-------~l~~dp~~Rps~~~ll~~~~  273 (303)
T 3a7i_A          240 EGNYSKPLKEFVEA-------CLNKEPSFRPTAKELLKHKF  273 (303)
T ss_dssp             CSSCCHHHHHHHHH-------HCCSSGGGSCCHHHHTTCHH
T ss_pred             ccccCHHHHHHHHH-------HcCCChhhCcCHHHHhhChh
Confidence            44556555555554       99999999999999987543

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.97  E-value=1.1e-30  Score=214.72  Aligned_cols=180  Identities=23%  Similarity=0.322  Sum_probs=111.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC---CCceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE---DFCPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~---~~~~~L~dfg~~~~   77 (242)
                      |++|+|.+++....    ...+++.+++.++.|++.||.|||+.   +++|+||||+||+++.   ++.++|+|||++..
T Consensus       108 ~~gg~L~~~l~~~~----~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~  180 (336)
T 3fhr_A          108 MEGGELFSRIQERG----DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE  180 (336)
T ss_dssp             CTTEEHHHHHHTC-----CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             cCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence            57899999997653    25799999999999999999999999   9999999999999976   45599999999976


Q ss_pred             cCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      .......    ...+++.|+|||.+...  .++.++||||||+++|++++|..||.................. ......
T Consensus       181 ~~~~~~~----~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~  253 (336)
T 3fhr_A          181 TTQNALQ----TPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL-GQYGFP  253 (336)
T ss_dssp             C--------------------------C--HHHHHHHHHHHHHHHHHHHHSSCCC----------------------CCC
T ss_pred             ccccccc----cCCCCcCccChhhhCCC--CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc-cccccC
Confidence            5533221    23478999999988543  5678999999999999999999999654432211100000000 000111


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      ......+++++.+++       .+||+.||++|||+.+++++-.
T Consensus       254 ~~~~~~~~~~~~~li-------~~~L~~dP~~Rpt~~ell~hp~  290 (336)
T 3fhr_A          254 NPEWSEVSEDAKQLI-------RLLLKTDPTERLTITQFMNHPW  290 (336)
T ss_dssp             TTTSTTCCHHHHHHH-------HHHSCSSGGGSCCHHHHHHSHH
T ss_pred             chhhccCCHHHHHHH-------HHHCCCChhHCcCHHHHhcCcc
Confidence            111123455555544       4588999999999999998543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.97  E-value=1.1e-29  Score=207.64  Aligned_cols=178  Identities=26%  Similarity=0.346  Sum_probs=128.8

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      .|+|.+++.....    ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus       102 ~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  174 (326)
T 1blx_A          102 DQDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM  174 (326)
T ss_dssp             SCBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG
T ss_pred             CCCHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCcccccccCCC
Confidence            3789999876532    4599999999999999999999999   99999999999999999999999999987655332


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCC------------------CCcC
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSS------------------DIYF  144 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~------------------~~~~  144 (242)
                      .   .....++..|.|||.+.+.  .++.++||||||+++|++++|..||........                  ....
T Consensus       175 ~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  249 (326)
T 1blx_A          175 A---LTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL  249 (326)
T ss_dssp             G---GCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred             C---ccccccccceeCHHHHhcC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcccccc
Confidence            2   1223588999999998654  578899999999999999999999964432100                  0000


Q ss_pred             cchhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          145 PNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      +..................++..+.++       +.+||+.||++|||+.+++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~l-------i~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          250 PRQAFHSKSAQPIEKFVTDIDELGKDL-------LLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             CGGGSCCCCCCCGGGTCCSCCHHHHHH-------HHHHSCSSTTTSCCHHHHHTS
T ss_pred             chhhhcccCcchhhhccccCCHHHHHH-------HHHHcCCCcccCCCHHHHhcC
Confidence            000000000111111223345444444       445899999999999999964

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.96  E-value=4.9e-30  Score=217.45  Aligned_cols=119  Identities=26%  Similarity=0.329  Sum_probs=102.2

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCc--eEEcccccccccCC
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFC--PKISDFGLAKQSQD   80 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~--~~L~dfg~~~~~~~   80 (242)
                      +|+|.+++.....    ..+++..+..++.||+.||.|||+.   +|+|+||||+|||++.++.  ++|+|||++.....
T Consensus       182 ~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~  254 (429)
T 3kvw_A          182 SMNLYELIKKNKF----QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ  254 (429)
T ss_dssp             CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred             CCCHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceecCC
Confidence            4788898876533    4699999999999999999999999   9999999999999998887  99999999976544


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      ...     ...+++.|+|||.+.+.  .++.++|||||||++|+|++|..||...
T Consensus       255 ~~~-----~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          255 RVY-----TYIQSRFYRAPEVILGA--RYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             CCC-----SSCSCGGGCCHHHHHTB--CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccc-----ccCCCCCccChHHHhCC--CCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            322     23589999999998765  5789999999999999999999998644

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.96  E-value=4.8e-31  Score=214.31  Aligned_cols=187  Identities=18%  Similarity=0.217  Sum_probs=124.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      +.+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        84 ~~~~~l~~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  154 (311)
T 4agu_A           84 CDHTVLHELDRYQ------RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG  154 (311)
T ss_dssp             CSEEHHHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             CCCchHHHHHhhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence            4677888887654      4599999999999999999999999   999999999999999999999999999986653


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcC--------cchhh---
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYF--------PNSIY---  149 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~--------~~~~~---  149 (242)
                      .....  ....++..|.|||.+.+. ..++.++||||||+++|++++|..||............        +....   
T Consensus       155 ~~~~~--~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (311)
T 4agu_A          155 PSDYY--DDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS  231 (311)
T ss_dssp             -------------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred             ccccc--CCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccc
Confidence            32221  123588999999998653 35688999999999999999999999654321100000        00000   


Q ss_pred             --hccCCCC--ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          150 --KHIEPGN--DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       150 --~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                        .......  ..................+.+++.+||+.||++|||+.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence              0000000  0000000000011122334556666999999999999999965

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.96  E-value=4.6e-30  Score=217.82  Aligned_cols=121  Identities=26%  Similarity=0.347  Sum_probs=97.3

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      +|+|.+++...      ..+++..+..++.||+.||.|||+.   +|+|+||||+|||++.++.++|+|||+++......
T Consensus       113 ~~~L~~~~~~~------~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  183 (432)
T 3n9x_A          113 DSDLKKLFKTP------IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK  183 (432)
T ss_dssp             SEEHHHHHHSS------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC----
T ss_pred             CcCHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcccccccc
Confidence            46888888654      4599999999999999999999999   99999999999999999999999999998765332


Q ss_pred             cc--------------------chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcc
Q 026160           83 ST--------------------ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNAD  133 (242)
Q Consensus        83 ~~--------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~  133 (242)
                      ..                    .......+|+.|+|||.+... ..++.++|||||||++|||++|..||.
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             ---------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhcccccc
Confidence            11                    111234689999999987443 367899999999999999998766654

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.96  E-value=1.9e-30  Score=212.17  Aligned_cols=176  Identities=25%  Similarity=0.329  Sum_probs=124.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.....    ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       109 ~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  181 (326)
T 2x7f_A          109 CGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR  181 (326)
T ss_dssp             CTTEEHHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC----
T ss_pred             CCCCcHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecCc
Confidence            468899999976532    5699999999999999999999999   999999999999999999999999999876543


Q ss_pred             Ccccchhcccccccccccchhhhcc---cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRS---FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      ....  .....++..|+|||.+...   ...++.++||||||+++|+|++|..||.......       ...........
T Consensus       182 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~  252 (326)
T 2x7f_A          182 TVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-------ALFLIPRNPAP  252 (326)
T ss_dssp             -----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSCCC
T ss_pred             Cccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-------HHHHhhcCccc
Confidence            2211  1123488999999998531   2356889999999999999999999986433211       11110011111


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ......++..+.+++.       +||+.||++|||+.+++++
T Consensus       253 ~~~~~~~~~~l~~li~-------~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          253 RLKSKKWSKKFQSFIE-------SCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             CCSCSCSCHHHHHHHH-------HHCCSSGGGSCCHHHHHTS
T ss_pred             cCCccccCHHHHHHHH-------HHhccChhhCCCHHHHhhC
Confidence            1122335555555554       4999999999999999873

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.96  E-value=9.9e-30  Score=217.28  Aligned_cols=117  Identities=24%  Similarity=0.330  Sum_probs=94.3

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      +|+|.+++...      ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.++|+|||+++......
T Consensus       140 ~~~L~~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  210 (458)
T 3rp9_A          140 DSDFKKLFRTP------VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE  210 (458)
T ss_dssp             SEEHHHHHHSS------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred             ccchhhhcccC------CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence            57788888654      4599999999999999999999999   99999999999999999999999999998654221


Q ss_pred             cc-------------------------chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcC
Q 026160           83 ST-------------------------ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR  129 (242)
Q Consensus        83 ~~-------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~  129 (242)
                      ..                         .......+|+.|+|||++... ..++.++|||||||++|||++|.
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg~  281 (458)
T 3rp9_A          211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNMI  281 (458)
T ss_dssp             TCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTTS
T ss_pred             ccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHhc
Confidence            10                         011233579999999986443 36789999999999999999943

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.96  E-value=1.6e-30  Score=207.75  Aligned_cols=170  Identities=26%  Similarity=0.432  Sum_probs=122.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      +.+++.++..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        93 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           93 VSGGELFDYICKH------GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             CCSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             cCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            5789999999765      3599999999999999999999999   999999999999999999999999999986654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      .....   ...++..|.|||.+.+. ...+.++|+||||+++|++++|..||......        ......... ....
T Consensus       164 ~~~~~---~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~-~~~~  230 (276)
T 2h6d_A          164 GEFLR---TSCGSPNYAAPEVISGR-LYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--------TLFKKIRGG-VFYI  230 (276)
T ss_dssp             ----------------CCTGGGTTS-CCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHC-CCCC
T ss_pred             Cccee---cccCCccccCHHHHcCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--------HHHHHhhcC-cccC
Confidence            32211   23488999999998654 23367899999999999999999998643211        111111111 1112


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      +..++..+.++       +.+||+.||++|||+.+++++
T Consensus       231 ~~~~~~~l~~l-------i~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          231 PEYLNRSVATL-------LMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             CTTSCHHHHHH-------HHHHTCSSGGGSCCHHHHHHS
T ss_pred             chhcCHHHHHH-------HHHHccCChhhCCCHHHHHhC
Confidence            33345555544       445889999999999999985

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.96  E-value=2.7e-30  Score=208.28  Aligned_cols=178  Identities=20%  Similarity=0.264  Sum_probs=123.2

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      |+|.+++...     ++.+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        85 ~~l~~~~~~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  156 (292)
T 3o0g_A           85 QDLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             EEHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred             CCHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence            4555555432     25699999999999999999999999   999999999999999999999999999986643322


Q ss_pred             cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCC-------------CCcCcchhh-
Q 026160           84 TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSS-------------DIYFPNSIY-  149 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~-------------~~~~~~~~~-  149 (242)
                      .  .....++..|+|||.+.+. ..++.++||||||+++|+|++|..||........             ...+..... 
T Consensus       157 ~--~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  233 (292)
T 3o0g_A          157 C--YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             C--CCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             c--ccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence            2  1223588999999998654 3468999999999999999998888643221100             000000000 


Q ss_pred             hccC-------CCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          150 KHIE-------PGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       150 ~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ....       ..........+++++.+++.       +||+.||++|||+.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~-------~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQ-------NLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHH-------HHSCSSGGGSCCHHHHHTS
T ss_pred             ccccccccccCCcchhhcccccChHHHHHHH-------HHhccChhhCCCHHHHhcC
Confidence            0000       00011112234455555444       4889999999999999874

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.96  E-value=2.4e-30  Score=212.61  Aligned_cols=170  Identities=28%  Similarity=0.446  Sum_probs=130.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       123 ~~~~~L~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          123 CRRRSLLELHKRR------KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             CTTCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             CCCCCHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            5689999998765      4599999999999999999999999   999999999999999999999999999986543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      .....  ....++..|+|||.+.+.  .++.++||||||+++|+|++|..||......       .........  ...+
T Consensus       194 ~~~~~--~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~--~~~~  260 (335)
T 2owb_A          194 DGERK--KVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-------ETYLRIKKN--EYSI  260 (335)
T ss_dssp             TTCCB--CCCCSCCSSCCHHHHHTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHT--CCCC
T ss_pred             Ccccc--cccCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHHHCcCCCCCCCHH-------HHHHHHhcC--CCCC
Confidence            22211  123588999999998654  5688999999999999999999999643321       111000000  1122


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      +..+++++.++       +.+||+.||++|||+.+++++
T Consensus       261 ~~~~~~~~~~l-------i~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          261 PKHINPVAASL-------IQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             CTTSCHHHHHH-------HHHHTCSSGGGSCCGGGGGGS
T ss_pred             CccCCHHHHHH-------HHHHccCChhHCcCHHHHhcC
Confidence            33455555544       445889999999999999974

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.96  E-value=1.9e-30  Score=209.18  Aligned_cols=178  Identities=28%  Similarity=0.415  Sum_probs=129.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC-CCceEEcccccccccC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE-DFCPKISDFGLAKQSQ   79 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~-~~~~~L~dfg~~~~~~   79 (242)
                      |++|+|.+++....   ....+++..+..++.|++.||.|||+.   +++|+||||+||+++. ++.++|+|||++....
T Consensus       101 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~  174 (295)
T 2clq_A          101 VPGGSLSALLRSKW---GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA  174 (295)
T ss_dssp             CSEEEHHHHHHHTT---CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred             CCCCCHHHHHHhhc---cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence            46899999997642   224577899999999999999999999   9999999999999987 8899999999998655


Q ss_pred             CCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           80 DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        80 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      .....  .....++..|.|||.+.+....++.++||||||+++|+|++|..||........      .............
T Consensus       175 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~~~~~~~  246 (295)
T 2clq_A          175 GINPC--TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA------AMFKVGMFKVHPE  246 (295)
T ss_dssp             C-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH------HHHHHHHHCCCCC
T ss_pred             CCCCc--ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH------HHHhhcccccccc
Confidence            43221  112358899999999866433468899999999999999999999964332110      0000000011122


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .+..+++++.+++       .+||+.||++|||+.+++++
T Consensus       247 ~~~~~~~~~~~li-------~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          247 IPESMSAEAKAFI-------LKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             CCTTSCHHHHHHH-------HHTTCSSTTTSCCHHHHHTS
T ss_pred             ccccCCHHHHHHH-------HHHccCChhhCCCHHHHhcC
Confidence            3344555555544       45999999999999999864

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.96  E-value=2.4e-30  Score=222.50  Aligned_cols=171  Identities=29%  Similarity=0.413  Sum_probs=130.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceee---CCCCceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~---~~~~~~~L~dfg~~~~   77 (242)
                      |++|+|.+++...      +.+++.++..++.|++.||.|||+.   +++|+||||+||++   +.++.++|+|||++..
T Consensus       108 ~~~~~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          108 YTGGELFDEIISR------KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             CCSCBHHHHHHTC------SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             CCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            5789999999765      4599999999999999999999999   99999999999999   4678899999999987


Q ss_pred             cCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCC--
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPG--  155 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--  155 (242)
                      ........   ...+++.|+|||.+.+   .++.++|||||||++|+|++|..||......        .....+..+  
T Consensus       179 ~~~~~~~~---~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~~~~  244 (484)
T 3nyv_A          179 FEASKKMK---DKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANEY--------DILKKVEKGKY  244 (484)
T ss_dssp             BCCCCSHH---HHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCC
T ss_pred             cccccccc---cCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHcCCC
Confidence            65443322   2358999999999865   4788999999999999999999999754321        111111111  


Q ss_pred             -CccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          156 -NDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       156 -~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                       ........+++++.+++.+       ||+.||++|||+.+++++-.
T Consensus       245 ~~~~~~~~~~s~~~~~li~~-------~L~~dp~~R~s~~e~l~h~~  284 (484)
T 3nyv_A          245 TFELPQWKKVSESAKDLIRK-------MLTYVPSMRISARDALDHEW  284 (484)
T ss_dssp             CCCSGGGGGSCHHHHHHHHH-------HTCSSGGGSCCHHHHHTSHH
T ss_pred             CCCCcccccCCHHHHHHHHH-------HCCCChhHCcCHHHHhhChh
Confidence             1111123355555555555       88999999999999997533

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.96  E-value=4.6e-30  Score=208.80  Aligned_cols=174  Identities=27%  Similarity=0.375  Sum_probs=129.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....     ..+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus       106 ~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (314)
T 3com_A          106 CGAGSVSDIIRLRN-----KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD  177 (314)
T ss_dssp             CTTEEHHHHHHHHT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred             CCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence            56889999987432     4699999999999999999999999   999999999999999999999999999976554


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      .....  ....++..|.|||.+.+.  .++.++||||||+++|+|++|..||.......      ...............
T Consensus       178 ~~~~~--~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~  247 (314)
T 3com_A          178 TMAKR--NTVIGTPFWMAPEVIQEI--GYNCVADIWSLGITAIEMAEGKPPYADIHPMR------AIFMIPTNPPPTFRK  247 (314)
T ss_dssp             TBSCB--CCCCSCGGGCCHHHHSSS--CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSCCCCCSS
T ss_pred             hcccc--CccCCCCCccChhhcCCC--CCCccccHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCCcccCC
Confidence            32211  123588999999998654  57889999999999999999999996433211      000000011111112


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      +..++..+.+       ++.+||+.||++|||+.+++++
T Consensus       248 ~~~~~~~l~~-------li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          248 PELWSDNFTD-------FVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             GGGSCHHHHH-------HHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccCCHHHHH-------HHHHHccCChhhCcCHHHHHhC
Confidence            2334555544       4455899999999999999863

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.96  E-value=3.7e-30  Score=223.01  Aligned_cols=177  Identities=23%  Similarity=0.388  Sum_probs=133.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.++|....  .....+++..+..++.||+.||.|||+.   +|+|+||||+||+++.++.++|+|||++.....
T Consensus       267 ~~gg~L~~~l~~~~--~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          267 MNGGDIRYHIYNVD--EDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CTTCBHHHHHHTSS--TTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             ccCCCHHHHHHHhh--cccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            67999999997643  1235799999999999999999999999   999999999999999999999999999987654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      .....  ....||+.|+|||++.+.  .++.++|+|||||++|+|++|..||.........    ......+.. .....
T Consensus       342 ~~~~~--~~~~GT~~Y~APE~l~~~--~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~----~~~~~~i~~-~~~~~  412 (543)
T 3c4z_A          342 GQTKT--KGYAGTPGFMAPELLLGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN----KELKQRVLE-QAVTY  412 (543)
T ss_dssp             TCCCB--CCCCSCTTTSCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH----HHHHHHHHH-CCCCC
T ss_pred             CCccc--ccccCCccccChhhhcCC--CCChHHhcCcchHHHHHHHhCCCCCCCCccchhH----HHHHHHHhh-cccCC
Confidence            33221  123589999999998764  6789999999999999999999999754322111    111111111 11223


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSM-----HEVLE  198 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~-----~~ll~  198 (242)
                      +..+++++.+++.+       ||+.||++||++     .++++
T Consensus       413 p~~~s~~~~~li~~-------lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          413 PDKFSPASKDFCEA-------LLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             CTTSCHHHHHHHHH-------HSCSSGGGSCCCBTTBSHHHHT
T ss_pred             CcccCHHHHHHHHH-------hccCCHhHCCCCcccCHHHHHc
Confidence            44566666666665       889999999965     66764

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.96  E-value=2.2e-30  Score=217.93  Aligned_cols=173  Identities=25%  Similarity=0.335  Sum_probs=132.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.+++...       .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.++|+|||++.....
T Consensus       151 ~~gg~L~~~l~~~-------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~  220 (410)
T 3v8s_A          151 MPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK  220 (410)
T ss_dssp             CTTEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             CCCCcHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence            6799999999653       489999999999999999999999   999999999999999999999999999986654


Q ss_pred             CcccchhcccccccccccchhhhcccC--CCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCC---
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFG--GASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPG---  155 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~--~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---  155 (242)
                      ..... .....||+.|+|||++.....  .++.++|+|||||++|+|++|..||......        .....+...   
T Consensus       221 ~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~~~~~~  291 (410)
T 3v8s_A          221 EGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYSKIMNHKNS  291 (410)
T ss_dssp             TSEEE-CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHTHHHH
T ss_pred             CCccc-ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh--------hHHHHHHhcccc
Confidence            33211 123469999999999875422  2678999999999999999999999744321        111111110   


Q ss_pred             CccccccccchHHHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 026160          156 NDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSD--RPSMHEVLEM  199 (242)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~--Rps~~~ll~~  199 (242)
                      ........+++++.+++.+       ||..+|.+  ||++.+++++
T Consensus       292 ~~~p~~~~~s~~~~~li~~-------lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          292 LTFPDDNDISKEAKNLICA-------FLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             CCCCTTCCCCHHHHHHHHH-------HSSCGGGCTTSSCHHHHHTS
T ss_pred             ccCCCcccccHHHHHHHHH-------HccChhhhCCCCCHHHHhcC
Confidence            0111223467777777776       67888888  9999999975

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.96  E-value=5.4e-30  Score=220.47  Aligned_cols=172  Identities=28%  Similarity=0.372  Sum_probs=128.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeC---CCCceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD---EDFCPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~---~~~~~~L~dfg~~~~   77 (242)
                      |++|+|.+++...      +.+++.++..++.||+.||.|||+.   +|+|+||||+||+++   .++.++|+|||++..
T Consensus       103 ~~~~~L~~~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          103 YTGGELFDEIIKR------KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             CCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            5789999999765      4599999999999999999999999   999999999999995   456799999999976


Q ss_pred             cCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      .......   ....+++.|+|||++.+   .++.++|||||||++|+|++|..||........    ...+.. ......
T Consensus       174 ~~~~~~~---~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~i~~-~~~~~~  242 (486)
T 3mwu_A          174 FQQNTKM---KDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI----LKRVET-GKYAFD  242 (486)
T ss_dssp             BCCC-------CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHH-TCCCSC
T ss_pred             CCCCCcc---CCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHh-CCCCCC
Confidence            5543322   22358999999999864   478899999999999999999999964432110    000000 000111


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ......+++++.+++.+       ||+.||++|||+.+++++
T Consensus       243 ~~~~~~~s~~~~~li~~-------~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          243 LPQWRTISDDAKDLIRK-------MLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             SGGGGGSCHHHHHHHHH-------HTCSSTTTSCCHHHHHHC
T ss_pred             CcccCCCCHHHHHHHHH-------HcCCChhhCcCHHHHhcC
Confidence            11123355555555555       889999999999999986

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.96  E-value=1.2e-30  Score=221.18  Aligned_cols=179  Identities=22%  Similarity=0.257  Sum_probs=132.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.++|.+..     ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||++.....
T Consensus       156 ~~gg~L~~~l~~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~  227 (437)
T 4aw2_A          156 YVGGDLLTLLSKFE-----DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  227 (437)
T ss_dssp             CTTCBHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             CCCCcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence            68999999997632     4699999999999999999999999   999999999999999999999999999976544


Q ss_pred             Ccccchhcccccccccccchhhhcc---cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRS---FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      ..... .....||+.|+|||++...   ...++.++|+|||||++|||++|..||........    ...+.........
T Consensus       228 ~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~----~~~i~~~~~~~~~  302 (437)
T 4aw2_A          228 DGTVQ-SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET----YGKIMNHKERFQF  302 (437)
T ss_dssp             TSCEE-CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHTHHHHCCC
T ss_pred             CCCcc-cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH----HHhhhhccccccC
Confidence            32221 1123599999999998631   23568899999999999999999999975432110    0011000000111


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSD--RPSMHEVLEM  199 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~--Rps~~~ll~~  199 (242)
                      +.....+++++.+++.+       ||..+|++  ||++.+++++
T Consensus       303 p~~~~~~s~~~~dLi~~-------lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          303 PTQVTDVSENAKDLIRR-------LICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             CSSCCCSCHHHHHHHHT-------TSSCGGGCTTTTTTHHHHTS
T ss_pred             CcccccCCHHHHHHHHH-------HhcccccccCCCCHHHHhCC
Confidence            11123467777777777       55666766  9999999875

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.96  E-value=4e-30  Score=206.14  Aligned_cols=170  Identities=24%  Similarity=0.326  Sum_probs=126.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCC----ceEEccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF----CPKISDFGLAK   76 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~----~~~L~dfg~~~   76 (242)
                      |++|+|.+++...      ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++    .++|+|||++.
T Consensus        90 ~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           90 VSGGELFDFLAEK------ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             CCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             cCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            5789999999765      4599999999999999999999999   999999999999998776    79999999998


Q ss_pred             ccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhcc---C
Q 026160           77 QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHI---E  153 (242)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~---~  153 (242)
                      .........   ...++..|.|||.+...  .++.++|+||||+++|++++|..||......        ......   .
T Consensus       161 ~~~~~~~~~---~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~  227 (283)
T 3bhy_A          161 KIEAGNEFK---NIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGETKQ--------ETLTNISAVN  227 (283)
T ss_dssp             ECC-----------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHTTC
T ss_pred             eccCCCccc---ccCCCcCccCcceecCC--CCCcchhhhhHHHHHHHHHHCCCCCCCcchH--------HHHHHhHhcc
Confidence            665433221   23488999999988653  5788999999999999999999999643321        111111   0


Q ss_pred             CCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          154 PGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ..........++..       +.+++.+||+.||++|||+.+++++
T Consensus       228 ~~~~~~~~~~~~~~-------~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          228 YDFDEEYFSNTSEL-------AKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             CCCCHHHHTTCCHH-------HHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             cCCcchhcccCCHH-------HHHHHHHHccCCHhHCcCHHHHHhC
Confidence            00011111223333       4455666999999999999999973

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.96  E-value=4.1e-30  Score=210.32  Aligned_cols=185  Identities=23%  Similarity=0.301  Sum_probs=125.4

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      .|+|.+++....     ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        83 ~~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  154 (324)
T 3mtl_A           83 DKDLKQYLDDCG-----NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  154 (324)
T ss_dssp             SEEHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred             ccCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence            367888886542     4699999999999999999999999   99999999999999999999999999987654332


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCC------------CCCcCcchhhh
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRS------------SDIYFPNSIYK  150 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~------------~~~~~~~~~~~  150 (242)
                      ..  .....++..|+|||.+.+. ..++.++||||||+++|+|++|..||.......            ....++.....
T Consensus       155 ~~--~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  231 (324)
T 3mtl_A          155 KT--YDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN  231 (324)
T ss_dssp             ----------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred             cc--cccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence            21  1123579999999998653 356889999999999999999999996543211            00000000000


Q ss_pred             ------ccC---CCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--hhchhh
Q 026160          151 ------HIE---PGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM--LESSTE  205 (242)
Q Consensus       151 ------~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~--l~~~~~  205 (242)
                            ...   ..........+++++       .+++.+||+.||++|||+.+++++  +..+.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          232 EEFKTYNYPKYRAEALLSHAPRLDSDG-------ADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE  290 (324)
T ss_dssp             HHHHHTCCCCCCCCCHHHHCTTSCHHH-------HHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred             hhhcccccccccchhhhhhcCCCCHHH-------HHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence                  000   000001111233444       455555889999999999999974  444443

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.96  E-value=1.1e-30  Score=219.86  Aligned_cols=178  Identities=22%  Similarity=0.271  Sum_probs=130.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.++|.+..     ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||++.....
T Consensus       143 ~~gg~L~~~l~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~  214 (412)
T 2vd5_A          143 YVGGDLLTLLSKFG-----ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA  214 (412)
T ss_dssp             CCSCBHHHHHHHHS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             CCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccC
Confidence            57999999997642     3599999999999999999999999   999999999999999999999999999986654


Q ss_pred             Ccccchhcccccccccccchhhhcc-----cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCC
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRS-----FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPG  155 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  155 (242)
                      ..... .....||+.|+|||++...     ...++.++|+|||||++|||++|..||........    ...+.......
T Consensus       215 ~~~~~-~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~----~~~i~~~~~~~  289 (412)
T 2vd5_A          215 DGTVR-SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET----YGKIVHYKEHL  289 (412)
T ss_dssp             TSCEE-CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHTHHHHC
T ss_pred             CCccc-cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH----HHHHHhcccCc
Confidence            32211 1123589999999998642     23568899999999999999999999965432110    00111000001


Q ss_pred             CccccccccchHHHHHHHHHHHHHHHhccCCCCCC---CCHHHHHHH
Q 026160          156 NDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDR---PSMHEVLEM  199 (242)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~R---ps~~~ll~~  199 (242)
                      ..+..+..+++++.+++.+       ||. +|.+|   |++.+++++
T Consensus       290 ~~p~~~~~~s~~~~dli~~-------lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          290 SLPLVDEGVPEEARDFIQR-------LLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             CCC----CCCHHHHHHHHT-------TSS-CGGGCTTTTTHHHHHTS
T ss_pred             CCCccccCCCHHHHHHHHH-------HcC-ChhhcCCCCCHHHHhcC
Confidence            1111223466666666666       888 99998   599999864

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.96  E-value=7.2e-30  Score=220.09  Aligned_cols=169  Identities=30%  Similarity=0.419  Sum_probs=128.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCC---CceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDED---FCPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~---~~~~L~dfg~~~~   77 (242)
                      |++|+|.+++...      ..+++.++..++.||+.||.|||+.   +|+|+||||+||+++..   +.++|+|||++..
T Consensus       118 ~~~g~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          118 YKGGELFDEIIHR------MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             CCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            6789999998765      4599999999999999999999999   99999999999999764   4599999999987


Q ss_pred             cCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCC--
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPG--  155 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--  155 (242)
                      ........   ...+++.|+|||++.+   .++.++|||||||++|+|++|..||......        .....+..+  
T Consensus       189 ~~~~~~~~---~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~~~~  254 (494)
T 3lij_A          189 FENQKKMK---ERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--------EILRKVEKGKY  254 (494)
T ss_dssp             CBTTBCBC---CCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTCC
T ss_pred             CCCCcccc---ccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCC
Confidence            65443222   2358999999998753   5788999999999999999999999754321        111111111  


Q ss_pred             -CccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          156 -NDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       156 -~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                       ........+++.+.+++.+       ||+.||++|||+.+++++
T Consensus       255 ~~~~~~~~~~s~~~~~li~~-------~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          255 TFDSPEWKNVSEGAKDLIKQ-------MLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             CCCSGGGTTSCHHHHHHHHH-------HTCSSTTTSCCHHHHHTC
T ss_pred             CCCchhcccCCHHHHHHHHH-------HCCCChhhCccHHHHhcC
Confidence             1111122355555555555       889999999999999865

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.96  E-value=6.1e-30  Score=206.52  Aligned_cols=174  Identities=25%  Similarity=0.298  Sum_probs=128.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      ..+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus       106 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  176 (298)
T 1phk_A          106 MKKGELFDYLTEK------VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP  176 (298)
T ss_dssp             CTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             cCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchhhcCC
Confidence            5789999999765      4599999999999999999999999   999999999999999999999999999986654


Q ss_pred             Ccccchhcccccccccccchhhhcc----cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCC
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRS----FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN  156 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~----~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  156 (242)
                      .....   ...++..|.|||.+...    ...++.++||||||+++|+|++|..||........    ....... ....
T Consensus       177 ~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~-~~~~  248 (298)
T 1phk_A          177 GEKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM----LRMIMSG-NYQF  248 (298)
T ss_dssp             TCCBC---CCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHT-CCCC
T ss_pred             Ccccc---cccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH----HHHHhcC-Cccc
Confidence            33221   23488999999988532    23568899999999999999999999864332100    0000000 0000


Q ss_pred             ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 026160          157 DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE  198 (242)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~  198 (242)
                      .......++..+.       +++.+||+.||++|||+.++++
T Consensus       249 ~~~~~~~~~~~l~-------~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          249 GSPEWDDYSDTVK-------DLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             CTTTGGGSCHHHH-------HHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CcccccccCHHHH-------HHHHHHccCCcccCCCHHHHHh
Confidence            0111123444444       4555599999999999999986

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.96  E-value=5.1e-30  Score=206.74  Aligned_cols=171  Identities=28%  Similarity=0.438  Sum_probs=130.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      +.+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        97 ~~~~~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           97 CRRRSLLELHKRR------KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             CTTCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             CCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            5789999998765      4599999999999999999999999   999999999999999999999999999986543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      .....  ....++..|.|||.+.+.  ..+.++|+||||+++|+|++|..||......       .........  ....
T Consensus       168 ~~~~~--~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~--~~~~  234 (294)
T 2rku_A          168 DGERK--KVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-------ETYLRIKKN--EYSI  234 (294)
T ss_dssp             TTCCB--CCCCSCCSSCCHHHHTTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTT--CCCC
T ss_pred             Ccccc--ccccCCCCcCCcchhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhhc--cCCC
Confidence            22211  123488999999998653  5688999999999999999999999643321       111111111  1122


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML  200 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l  200 (242)
                      +..+++.+.++       +.+||+.||++|||+.+++++-
T Consensus       235 ~~~~~~~~~~l-------i~~~l~~~p~~Rps~~~ll~~~  267 (294)
T 2rku_A          235 PKHINPVAASL-------IQKMLQTDPTARPTINELLNDE  267 (294)
T ss_dssp             CTTSCHHHHHH-------HHHHTCSSGGGSCCGGGGGGSH
T ss_pred             ccccCHHHHHH-------HHHHcccChhhCcCHHHHhhCh
Confidence            33455555544       4458899999999999999753

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.96  E-value=1.2e-29  Score=209.25  Aligned_cols=177  Identities=25%  Similarity=0.372  Sum_probs=127.2

Q ss_pred             CCCCCcchhccccCCC--CCCccccHHHHHHHHHHHHHHhHHhhh-CCCCCeeecCCCCCceeeCCCCceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESS--NGNRTLEWRTVYQIAGGIARGLEYLHR-GCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~--~~~~~l~~~~~~~i~~~l~~al~~LH~-~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~   77 (242)
                      |++|+|.+++......  .....+++..++.++.|++.||.|||+ .   +++|+||+|+||+++.++.++|+|||++..
T Consensus       125 ~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  201 (348)
T 2pml_X          125 MENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMDKNGRVKLSDFGESEY  201 (348)
T ss_dssp             CTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             cCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEcCCCcEEEeccccccc
Confidence            5789999993321111  124679999999999999999999999 8   999999999999999999999999999987


Q ss_pred             cCCCcccchhcccccccccccchhhhcccCCCCC-CccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCC
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASH-KSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN  156 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~-~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  156 (242)
                      ......    ....++..|.|||.+.+.. .++. ++||||||+++|++++|..||.......       ..........
T Consensus       202 ~~~~~~----~~~~~~~~y~aPE~~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~i~~~~  269 (348)
T 2pml_X          202 MVDKKI----KGSRGTYEFMPPEFFSNES-SYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV-------ELFNNIRTKN  269 (348)
T ss_dssp             CBTTEE----CSSCSCGGGCCGGGGSSCC-CEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH-------HHHHHHTSCC
T ss_pred             cccccc----cCCCCCcCccCchhhcCCC-CCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH-------HHHHHHhccC
Confidence            544321    2235899999999986542 3334 8999999999999999999997543310       0000110000


Q ss_pred             -c-----------------cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          157 -D-----------------FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       157 -~-----------------~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                       .                 ......++.++.+       ++.+||+.||++|||+.+++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-------li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          270 IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDID-------FLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             CCCCCSSSSSTTTTCC--------CCCHHHHH-------HHHHHCCSSGGGSCCHHHHHTS
T ss_pred             cCCccchhhhhccccccccccchhhcCHHHHH-------HHHHHccCChhhCCCHHHHhcC
Confidence             0                 0001234444444       4555999999999999999874

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=6.4e-30  Score=212.59  Aligned_cols=174  Identities=23%  Similarity=0.270  Sum_probs=126.6

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      +++|.+++..       ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++......
T Consensus       113 ~~~L~~~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  182 (367)
T 1cm8_A          113 GTDLGKLMKH-------EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM  182 (367)
T ss_dssp             SEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSSC
T ss_pred             CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccccccccc
Confidence            5778888765       3589999999999999999999999   99999999999999999999999999998755432


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCC-------cCcchhh------
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDI-------YFPNSIY------  149 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~-------~~~~~~~------  149 (242)
                      .     ...++..|+|||.+.+. ..++.++|||||||++|+|++|+.||..........       ..+....      
T Consensus       183 ~-----~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~  256 (367)
T 1cm8_A          183 T-----GYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD  256 (367)
T ss_dssp             C-----SSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred             C-----cCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhH
Confidence            1     23489999999998653 357899999999999999999999997543211000       0000000      


Q ss_pred             ------hccC---CCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          150 ------KHIE---PGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       150 ------~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                            ....   ...........++.+.+++.       +||+.||++|||+.+++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~-------~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLE-------KMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHH-------HHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHH-------HHccCChhHCCCHHHHhcC
Confidence                  0000   01111112234455555444       4889999999999999985

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.96  E-value=7e-30  Score=206.94  Aligned_cols=172  Identities=24%  Similarity=0.347  Sum_probs=128.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceee---CCCCceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL---DEDFCPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~---~~~~~~~L~dfg~~~~   77 (242)
                      |++|+|.+++...      +.+++.++..++.|++.||.|||+.   +++|+||||+||++   +.++.++|+|||++..
T Consensus        88 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~  158 (304)
T 2jam_A           88 VSGGELFDRILER------GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM  158 (304)
T ss_dssp             CCSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred             CCCccHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence            5789999999765      3599999999999999999999999   99999999999999   6788999999999875


Q ss_pred             cCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      ......    ....++..|.|||.+.+.  .++.++||||||+++|++++|..||........    ...+.... ....
T Consensus       159 ~~~~~~----~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~i~~~~-~~~~  227 (304)
T 2jam_A          159 EQNGIM----STACGTPGYVAPEVLAQK--PYSKAVDCWSIGVITYILLCGYPPFYEETESKL----FEKIKEGY-YEFE  227 (304)
T ss_dssp             CCCBTT----HHHHSCCCBCCTTTBSSC--SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----HHHHHHCC-CCCC
T ss_pred             cCCCcc----ccccCCCCccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHHcCC-CCCC
Confidence            543321    123489999999998653  578899999999999999999999864332100    00010000 0011


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ......+++++.+++.+       ||+.||++|||+.+++++
T Consensus       228 ~~~~~~~~~~~~~li~~-------~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          228 SPFWDDISESAKDFICH-------LLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             TTTTTTSCHHHHHHHHH-------HHCSSTTTSCCHHHHHTS
T ss_pred             ccccccCCHHHHHHHHH-------HcCCChhHCcCHHHHhcC
Confidence            11223455555555555       789999999999999874

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.96  E-value=4.1e-30  Score=210.51  Aligned_cols=118  Identities=23%  Similarity=0.295  Sum_probs=100.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCC-ceEEcccccccccC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF-CPKISDFGLAKQSQ   79 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~-~~~L~dfg~~~~~~   79 (242)
                      |++|+|.+++.         .++..++..++.|++.||.|||+.   +++|+||||+||+++.++ .++|+|||++....
T Consensus       115 ~~~~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          115 VNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             CCCCCHHHHGG---------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             cCchhHHHHHH---------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            56888888883         389999999999999999999999   999999999999999776 89999999998655


Q ss_pred             CCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccc
Q 026160           80 DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADV  134 (242)
Q Consensus        80 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~  134 (242)
                      ......   ...++..|.|||.+.+. ..++.++|||||||++|+|++|..||..
T Consensus       183 ~~~~~~---~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~  233 (330)
T 3nsz_A          183 PGQEYN---VRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFH  233 (330)
T ss_dssp             TTCCCC---SCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             CCCccc---cccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            433221   23588999999998653 3578999999999999999999999953

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.96  E-value=5.2e-30  Score=219.18  Aligned_cols=171  Identities=22%  Similarity=0.245  Sum_probs=117.4

Q ss_pred             cccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccccch
Q 026160           21 TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPE  100 (242)
Q Consensus        21 ~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE  100 (242)
                      .+++.++..++.||+.||.|||+.   +|+||||||+|||++.++.++|+|||+++........   ....+|+.|+|||
T Consensus       160 ~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE  233 (464)
T 3ttj_A          160 ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPE  233 (464)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-----CCCC-------CCCTTCCHH
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCccc---CCCcccccccCHH
Confidence            389999999999999999999999   9999999999999999999999999999866543222   2235899999999


Q ss_pred             hhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCC---------------cCcchhhhccCCC---Ccccccc
Q 026160          101 VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDI---------------YFPNSIYKHIEPG---NDFQLDG  162 (242)
Q Consensus       101 ~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~---------------~~~~~~~~~~~~~---~~~~~~~  162 (242)
                      ++.+.  .++.++|||||||++|+|++|+.||..........               .............   ....++.
T Consensus       234 ~~~~~--~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (464)
T 3ttj_A          234 VILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPK  311 (464)
T ss_dssp             HHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHH
T ss_pred             HHcCC--CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHH
Confidence            98764  67899999999999999999999996543110000               0000000000000   0000000


Q ss_pred             --------ccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          163 --------VVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       163 --------~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                              ............+.+++.+||+.||++|||+.|++++
T Consensus       312 ~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          312 LFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                    0111122234556777888999999999999999975

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.96  E-value=1.8e-30  Score=209.89  Aligned_cols=184  Identities=26%  Similarity=0.363  Sum_probs=127.4

Q ss_pred             CCCCCcchhccccCC--CCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEccccccccc
Q 026160            1 MPNGSLDQFTYDQES--SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS   78 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~--~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~   78 (242)
                      |++|+|.+++.....  ......+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++...
T Consensus        95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  171 (303)
T 2vwi_A           95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFL  171 (303)
T ss_dssp             CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred             ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence            578999999874211  11235699999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCccc---chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCC-
Q 026160           79 QDKKST---ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEP-  154 (242)
Q Consensus        79 ~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-  154 (242)
                      ......   .......++..|.|||.+... ..++.++||||||+++|++++|..||.........    ......... 
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~~~~~~~~  246 (303)
T 2vwi_A          172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL----MLTLQNDPPS  246 (303)
T ss_dssp             C---------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH----HHHHTSSCCC
T ss_pred             ccCCCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH----HHHhccCCCc
Confidence            432211   111123588999999988653 24688999999999999999999999754322100    000000000 


Q ss_pred             ----CCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          155 ----GNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       155 ----~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                          .........++.++.+       ++.+||+.||++|||+.+++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~-------li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          247 LETGVQDKEMLKKYGKSFRK-------MISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             TTC-----CCCCCCCHHHHH-------HHHHHCCSSGGGSCCHHHHHTS
T ss_pred             cccccccchhhhhhhHHHHH-------HHHHHccCChhhCcCHHHHhhC
Confidence                0011112234444444       4555999999999999999874

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.96  E-value=3.7e-30  Score=214.03  Aligned_cols=118  Identities=31%  Similarity=0.417  Sum_probs=89.0

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      +|+|.+++..       ..+++..+..++.||+.||.|||+.   +++|+||||+||+++.++.++|+|||+++......
T Consensus       117 ~~~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~  186 (367)
T 2fst_X          117 GADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM  186 (367)
T ss_dssp             CEECC------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-----------
T ss_pred             CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccccccccC
Confidence            5778887754       3599999999999999999999999   99999999999999999999999999997654321


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccc
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKA  136 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  136 (242)
                           ....++..|+|||.+.+. ..++.++|||||||++|+|++|..||....
T Consensus       187 -----~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~  234 (367)
T 2fst_X          187 -----TGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTD  234 (367)
T ss_dssp             ---------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             -----CCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                 123589999999998653 357889999999999999999999996543

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.96  E-value=3.2e-30  Score=213.71  Aligned_cols=121  Identities=33%  Similarity=0.478  Sum_probs=101.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      +.+++..+..++.+++.||.|||+..  +++|+||||+||+++.++.++|+|||++.....
T Consensus       113 ~~~~~L~~~l~~~------~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          113 MDGGSLDQVLKKA------GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             CTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            5789999999775      35999999999999999999999831  799999999999999999999999999865432


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      ...    ....++..|+|||.+.+.  .++.++||||||+++|+|++|..||...
T Consensus       185 ~~~----~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~  233 (360)
T 3eqc_A          185 SMA----NSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPP  233 (360)
T ss_dssp             HC--------CCCCTTCCHHHHTTC--CCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred             ccc----cCCCCCCCeECHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            211    123589999999998654  6788999999999999999999999643

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.96  E-value=2.3e-29  Score=206.36  Aligned_cols=119  Identities=28%  Similarity=0.392  Sum_probs=101.8

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC-------------------
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE-------------------   63 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~-------------------   63 (242)
                      +|+|.+++.....    ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.                   
T Consensus       100 ~~~l~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~  172 (339)
T 1z57_A          100 GLSTYDFIKENGF----LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI  172 (339)
T ss_dssp             CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEEEES
T ss_pred             CCCHHHHHHhcCC----CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccccccccc
Confidence            7899999976532    4689999999999999999999999   9999999999999987                   


Q ss_pred             CCceEEcccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           64 DFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        64 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      ++.++|+|||++........     ...++..|+|||.+.+.  .++.++||||||+++|++++|..||...
T Consensus       173 ~~~~kl~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~  237 (339)
T 1z57_A          173 NPDIKVVDFGSATYDDEHHS-----TLVSTRHYRAPEVILAL--GWSQPCDVWSIGCILIEYYLGFTVFPTH  237 (339)
T ss_dssp             CCCEEECCCSSCEETTSCCC-----SSCSCGGGCCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCCceEeeCcccccCccccc-----cccCCccccChHHhhCC--CCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            66799999999976544322     23589999999998754  5788999999999999999999999644

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.96  E-value=1.8e-29  Score=210.98  Aligned_cols=121  Identities=25%  Similarity=0.301  Sum_probs=101.1

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeC--CCCceEEcccccccccCC
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD--EDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~--~~~~~~L~dfg~~~~~~~   80 (242)
                      +|+|.+++.....    +.+++..+..++.|++.||.|||+. ..+|+|+||||+|||++  .++.++|+|||++.....
T Consensus       139 ~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~  213 (382)
T 2vx3_A          139 SYNLYDLLRNTNF----RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ  213 (382)
T ss_dssp             CCBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred             CCCHHHHHhhcCc----CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc
Confidence            4799999876532    4699999999999999999999952 12899999999999995  477899999999987654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      ...     ...+++.|+|||.+.+.  .++.++|||||||++|+|++|..||...
T Consensus       214 ~~~-----~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          214 RIY-----QYIQSRFYRSPEVLLGM--PYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             CCC-----SSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccc-----cccCCccccChHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            322     23588999999998764  5789999999999999999999999754

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.96  E-value=8.4e-30  Score=220.20  Aligned_cols=169  Identities=31%  Similarity=0.429  Sum_probs=129.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCC---ceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF---CPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~---~~~L~dfg~~~~   77 (242)
                      |++|+|.+++...      +.+++..+..++.||+.||.|||+.   +++|+||||+||+++.++   .++|+|||++..
T Consensus       128 ~~gg~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  198 (504)
T 3q5i_A          128 YEGGELFEQIINR------HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSF  198 (504)
T ss_dssp             CTTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEECCCTTCEE
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEEECCCCEE
Confidence            6799999999765      4599999999999999999999999   999999999999998765   699999999987


Q ss_pred             cCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCC-
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN-  156 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  156 (242)
                      .......   ....+++.|+|||.+.+   .++.++|||||||++|+|++|..||......        .....+..+. 
T Consensus       199 ~~~~~~~---~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~~~~  264 (504)
T 3q5i_A          199 FSKDYKL---RDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--------DIIKKVEKGKY  264 (504)
T ss_dssp             CCTTSCB---CCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCC
T ss_pred             cCCCCcc---ccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCC
Confidence            6543322   12358999999999863   5788999999999999999999999754321        1111111111 


Q ss_pred             --ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          157 --DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       157 --~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                        .......+++++.+++.       +||+.||.+|||+.+++++
T Consensus       265 ~~~~~~~~~~s~~~~~li~-------~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          265 YFDFNDWKNISDEAKELIK-------LMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             CCCHHHHTTSCHHHHHHHH-------HHTCSSTTTSCCHHHHHTS
T ss_pred             CCCccccCCCCHHHHHHHH-------HHcCCChhHCCCHHHHhcC
Confidence              11111234555555554       4889999999999999875

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.96  E-value=1.1e-29  Score=210.96  Aligned_cols=180  Identities=23%  Similarity=0.265  Sum_probs=127.2

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      +|+|.+++..       ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus       113 ~~~L~~~l~~-------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          113 ETDLYKLLKT-------QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  182 (364)
T ss_dssp             SEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             CcCHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence            4678888754       3599999999999999999999999   99999999999999999999999999998665432


Q ss_pred             ccch-hcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcC-------cchhh-----
Q 026160           83 STIS-MLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYF-------PNSIY-----  149 (242)
Q Consensus        83 ~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~-------~~~~~-----  149 (242)
                      .... .....+++.|+|||.+.+. ..++.++||||||+++|+|++|..||............       .....     
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  261 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN  261 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCC
T ss_pred             CccccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            2211 1233589999999987654 35688999999999999999999999654322110000       00000     


Q ss_pred             -------hccCCCC---ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 026160          150 -------KHIEPGN---DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML  200 (242)
Q Consensus       150 -------~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l  200 (242)
                             .......   .......++++       +.+++.+||+.||++|||+.+++++=
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~li~~~L~~dP~~R~t~~e~l~hp  315 (364)
T 3qyz_A          262 LKARNYLLSLPHKNKVPWNRLFPNADSK-------ALDLLDKMLTFNPHKRIEVEQALAHP  315 (364)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHCTTSCHH-------HHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred             hhHHHHHHhcCCccCCCHHHhCCCCCHH-------HHHHHHHHcCCChhhCCCHHHHhcCc
Confidence                   0000000   00011223344       44555568899999999999999753

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.96  E-value=4.2e-30  Score=207.84  Aligned_cols=175  Identities=23%  Similarity=0.318  Sum_probs=126.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....     ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        98 ~~~~~l~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (302)
T 2j7t_A           98 CPGGAVDAIMLELD-----RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK  169 (302)
T ss_dssp             CTTEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred             CCCCcHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence            57899999987642     4599999999999999999999999   999999999999999999999999998753221


Q ss_pred             Ccccchhcccccccccccchhhhc---ccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhc-cCCCC
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCR---SFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKH-IEPGN  156 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~  156 (242)
                      ....  .....++..|.|||.+..   ....++.++||||||+++|+|++|..||.......       ..... .....
T Consensus       170 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~  240 (302)
T 2j7t_A          170 TLQK--RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-------VLLKIAKSDPP  240 (302)
T ss_dssp             HHHC-------CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSCCC
T ss_pred             cccc--cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-------HHHHHhccCCc
Confidence            1110  112348899999998742   12356889999999999999999999987443211       11000 01111


Q ss_pred             ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          157 DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ....+..++..+.++       +.+||+.||++|||+.+++++
T Consensus       241 ~~~~~~~~~~~l~~l-------i~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          241 TLLTPSKWSVEFRDF-------LKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             CCSSGGGSCHHHHHH-------HHHHSCSCTTTSCCHHHHTTS
T ss_pred             ccCCccccCHHHHHH-------HHHHcccChhhCCCHHHHhcC
Confidence            111223345555444       445899999999999998863

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.96  E-value=5.3e-30  Score=210.07  Aligned_cols=120  Identities=26%  Similarity=0.346  Sum_probs=95.5

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeC-----CCCceEEccccccccc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD-----EDFCPKISDFGLAKQS   78 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~-----~~~~~~L~dfg~~~~~   78 (242)
                      |+|.+++...      +.+++.++..++.||+.||.|||+.   +++|+||||+||+++     ..+.++|+|||++...
T Consensus       117 ~~L~~~~~~~------~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~  187 (329)
T 3gbz_A          117 NDLKKYMDKN------PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF  187 (329)
T ss_dssp             EEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred             CCHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence            6888888765      4599999999999999999999999   999999999999994     4556999999999865


Q ss_pred             CCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           79 QDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        79 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      ......  .....++..|+|||.+.+. ..++.++|||||||++|+|++|..||...
T Consensus       188 ~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~  241 (329)
T 3gbz_A          188 GIPIRQ--FTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGD  241 (329)
T ss_dssp             C-------------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCcccc--cCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence            433221  1223478999999998653 35689999999999999999999999644

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=2.7e-29  Score=207.21  Aligned_cols=180  Identities=23%  Similarity=0.260  Sum_probs=126.0

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      |+|.+++....     ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        96 ~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  167 (346)
T 1ua2_A           96 TDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  167 (346)
T ss_dssp             EEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             CCHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence            47777775532     4689999999999999999999999   999999999999999999999999999986643322


Q ss_pred             cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCC------------CCCcCcchhh--
Q 026160           84 TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRS------------SDIYFPNSIY--  149 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~------------~~~~~~~~~~--  149 (242)
                      .  .....+++.|+|||.+.+. ..++.++|||||||++|+|++|.+||.......            ....++....  
T Consensus       168 ~--~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  244 (346)
T 1ua2_A          168 A--YTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP  244 (346)
T ss_dssp             C--CCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred             c--CCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCc
Confidence            1  1223589999999998653 346889999999999999999999886443110            0000000000  


Q ss_pred             hccCCCCc-----cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          150 KHIEPGND-----FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       150 ~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      ........     ......++.++       .+++.+||+.||++|||+.+++++-.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~-------~~li~~~L~~dP~~Rpt~~ell~h~~  294 (346)
T 1ua2_A          245 DYVTFKSFPGIPLHHIFSAAGDDL-------LDLIQGLFLFNPCARITATQALKMKY  294 (346)
T ss_dssp             TCCCCCCCCCCCHHHHCTTCCHHH-------HHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred             ccccccccCCCChHHhhccCCHHH-------HHHHHHHhccChhhCCCHHHHhcChh
Confidence            00000000     00012233444       44555588999999999999998644

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.96  E-value=6.3e-30  Score=207.89  Aligned_cols=165  Identities=26%  Similarity=0.389  Sum_probs=128.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeC-CCCceEEcccccccccC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD-EDFCPKISDFGLAKQSQ   79 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~-~~~~~~L~dfg~~~~~~   79 (242)
                      +++|+|.+++...      ..+++..++.++.|++.||.|||+.   +++|+||||+||+++ .++.++|+|||++....
T Consensus       121 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~  191 (312)
T 2iwi_A          121 LPAQDLFDYITEK------GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLH  191 (312)
T ss_dssp             SSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEECCCSSCEECC
T ss_pred             CCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEEEcchhhhcc
Confidence            3678999999765      3599999999999999999999999   999999999999998 78899999999998765


Q ss_pred             CCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           80 DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        80 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      .....    ...++..|.|||.+.+. ...+.++||||||+++|++++|..||.....          ....     ...
T Consensus       192 ~~~~~----~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------~~~~-----~~~  251 (312)
T 2iwi_A          192 DEPYT----DFDGTRVYSPPEWISRH-QYHALPATVWSLGILLYDMVCGDIPFERDQE----------ILEA-----ELH  251 (312)
T ss_dssp             SSCBC----CCCSCTTTSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------HHHT-----CCC
T ss_pred             cCccc----ccCCcccccCceeeecC-CCCCccchHHHHHHHHHHHHHCCCCCCChHH----------Hhhh-----ccC
Confidence            43321    23488999999988654 2335689999999999999999999864321          0000     111


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      ++..++..+.++       +.+||+.||++|||+.+++++-.
T Consensus       252 ~~~~~~~~~~~l-------i~~~l~~~p~~Rps~~e~l~~~~  286 (312)
T 2iwi_A          252 FPAHVSPDCCAL-------IRRCLAPKPSSRPSLEEILLDPW  286 (312)
T ss_dssp             CCTTSCHHHHHH-------HHHHTCSSTTTSCCHHHHHHSTT
T ss_pred             CcccCCHHHHHH-------HHHHccCChhhCcCHHHHhcChh
Confidence            223355555544       44589999999999999998533

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.96  E-value=3.8e-30  Score=206.87  Aligned_cols=175  Identities=26%  Similarity=0.372  Sum_probs=117.3

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      |+|.+++....  .....+++..++.++.|++.||.|||+.  .+++|+||||+||+++.++.++|+|||++........
T Consensus        90 ~~l~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  165 (290)
T 3fme_A           90 TSLDKFYKQVI--DKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA  165 (290)
T ss_dssp             EEHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC-----------
T ss_pred             cchHHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCccccccccc
Confidence            57777775421  1235699999999999999999999984  2899999999999999999999999999976554332


Q ss_pred             cchhcccccccccccchhhhc--ccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccccc
Q 026160           84 TISMLHARGTIGYIAPEVFCR--SFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLD  161 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (242)
                      ..   ...++..|.|||.+..  ....++.++||||||+++|++++|..||.......      ................
T Consensus       166 ~~---~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~  236 (290)
T 3fme_A          166 KD---IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF------QQLKQVVEEPSPQLPA  236 (290)
T ss_dssp             -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH------HHHHHHHHSCCCCCCT
T ss_pred             cc---ccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH------HHHHHHhccCCCCccc
Confidence            21   2248899999999732  12356889999999999999999999996432211      1111111111111112


Q ss_pred             cccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 026160          162 GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE  198 (242)
Q Consensus       162 ~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~  198 (242)
                      ..+++++.++       +.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~l-------i~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          237 DKFSAEFVDF-------TSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             TTSCHHHHHH-------HHHHTCSSGGGSCCHHHHTT
T ss_pred             ccCCHHHHHH-------HHHHhhcChhhCcCHHHHHh
Confidence            2345555444       44588999999999999987

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.96  E-value=4.5e-29  Score=205.93  Aligned_cols=120  Identities=24%  Similarity=0.387  Sum_probs=100.8

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceee-------------------CC
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL-------------------DE   63 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~-------------------~~   63 (242)
                      +|+|.+++.....    ..+++.++..++.||+.||.|||+.   +++|+||||+||++                   +.
T Consensus       105 ~~~l~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~  177 (355)
T 2eu9_A          105 GKNTFEFLKENNF----QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK  177 (355)
T ss_dssp             CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCEEEES
T ss_pred             CCChHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccccccccC
Confidence            5777777765432    4699999999999999999999999   99999999999999                   56


Q ss_pred             CCceEEcccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccc
Q 026160           64 DFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKA  136 (242)
Q Consensus        64 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  136 (242)
                      ++.++|+|||++........     ...++..|+|||.+.+.  .++.++||||||+++|+|++|..||....
T Consensus       178 ~~~~kl~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (355)
T 2eu9_A          178 NTSIRVADFGSATFDHEHHT-----TIVATRHYRPPEVILEL--GWAQPCDVWSIGCILFEYYRGFTLFQTHE  243 (355)
T ss_dssp             CCCEEECCCTTCEETTSCCC-----SSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CCcEEEeecCcccccccccc-----CCcCCCcccCCeeeecC--CCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence            78899999999976544322     23589999999998654  67889999999999999999999997543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.96  E-value=7.6e-30  Score=213.30  Aligned_cols=180  Identities=18%  Similarity=0.193  Sum_probs=125.0

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeC-CCCceEEcccccccccCCCc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD-EDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~-~~~~~~L~dfg~~~~~~~~~   82 (242)
                      |+|.+++....  ..+..+++..+..++.||+.||.|||+.   +++|+||||+||+++ .++.++|+|||++.......
T Consensus       122 ~~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~  196 (383)
T 3eb0_A          122 DTLHKVLKSFI--RSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE  196 (383)
T ss_dssp             EEHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS
T ss_pred             ccHHHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC
Confidence            56666665321  1235699999999999999999999999   999999999999997 58899999999998664433


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCc--------CcchhhhccCC
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIY--------FPNSIYKHIEP  154 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~--------~~~~~~~~~~~  154 (242)
                      ...   ...++..|+|||.+.+. ..++.++|||||||++|+|++|..||......+....        ...........
T Consensus       197 ~~~---~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~  272 (383)
T 3eb0_A          197 PSV---AYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPH  272 (383)
T ss_dssp             CCC---CCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTT
T ss_pred             CCc---CcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcc
Confidence            222   23478999999988654 3478899999999999999999999975432110000        00000000000


Q ss_pred             CC------------ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          155 GN------------DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       155 ~~------------~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ..            ...++..+++++.+       ++.+||+.||++|||+.+++++
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------li~~~L~~dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          273 YTEVRFPTLKAKDWRKILPEGTPSLAID-------LLEQILRYEPDLRINPYEAMAH  322 (383)
T ss_dssp             C--CCCCCCCCCCHHHHSCTTCCHHHHH-------HHHHHCCSSGGGSCCHHHHHTS
T ss_pred             cccccCCccCcccHHhhCCCCCCHHHHH-------HHHHHccCChhhCCCHHHHhcC
Confidence            00            00112234444444       4555889999999999999853

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.96  E-value=1.6e-29  Score=208.79  Aligned_cols=189  Identities=19%  Similarity=0.196  Sum_probs=127.1

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      |+|.+++....     ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus       108 ~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  179 (351)
T 3mi9_A          108 HDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN  179 (351)
T ss_dssp             EEHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSS
T ss_pred             CCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhccccccccc
Confidence            45666665432     4599999999999999999999999   999999999999999999999999999986542211


Q ss_pred             --cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCC------------CCcCcchhh
Q 026160           84 --TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSS------------DIYFPNSIY  149 (242)
Q Consensus        84 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~------------~~~~~~~~~  149 (242)
                        ........+++.|+|||.+.+. ..++.++|||||||++|+|++|..||........            ...++....
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  258 (351)
T 3mi9_A          180 SQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN  258 (351)
T ss_dssp             SSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             ccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccc
Confidence              1112234589999999988653 3568899999999999999999999875432100            000000000


Q ss_pred             hcc-CCCC-ccccccccchHHHH--HHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          150 KHI-EPGN-DFQLDGVVTEEEKE--LVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       150 ~~~-~~~~-~~~~~~~~~~~~~~--~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                      ... .... ...........+..  ....+.+++.+||+.||++|||+.+++++=.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  314 (351)
T 3mi9_A          259 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF  314 (351)
T ss_dssp             CGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             chhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCC
Confidence            000 0000 00000001111111  0233566777799999999999999998633

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.96  E-value=4.5e-30  Score=210.58  Aligned_cols=187  Identities=22%  Similarity=0.305  Sum_probs=122.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus       106 ~~~~~l~~~~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          106 VDHTILDDLELFP------NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             CSEEHHHHHHHST------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             CCcchHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            4567777776543      4599999999999999999999999   999999999999999999999999999976543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCc--------Ccchh--h-
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIY--------FPNSI--Y-  149 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~--------~~~~~--~-  149 (242)
                      ....  .....++..|+|||.+.+. ..++.++||||||+++|+|++|..||...........        .+...  . 
T Consensus       177 ~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (331)
T 4aaa_A          177 PGEV--YDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN  253 (331)
T ss_dssp             ---------CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred             Cccc--cCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhh
Confidence            3221  1123588999999998653 3568899999999999999999999865432110000        00000  0 


Q ss_pred             --hccCCCCccccc--cccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          150 --KHIEPGNDFQLD--GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       150 --~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                        ............  .........+...+.+++.+||+.||++|||+.+++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence              000000000000  00000011123345556666999999999999999864

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.96  E-value=9.9e-30  Score=207.67  Aligned_cols=161  Identities=24%  Similarity=0.347  Sum_probs=125.7

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeC-CCCceEEcccccccccCCC
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD-EDFCPKISDFGLAKQSQDK   81 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~-~~~~~~L~dfg~~~~~~~~   81 (242)
                      +|+|.+++...      +.+++..++.++.|+++||.|||+.   +++|+||||+||+++ .++.++|+|||++......
T Consensus       133 ~~~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~  203 (320)
T 3a99_A          133 VQDLFDFITER------GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT  203 (320)
T ss_dssp             EEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCSS
T ss_pred             CccHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCccccccccc
Confidence            37899998765      4599999999999999999999999   999999999999998 6789999999999876543


Q ss_pred             cccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccccc
Q 026160           82 KSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLD  161 (242)
Q Consensus        82 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (242)
                      ...    ...++..|+|||.+.+. ...+.++||||||+++|+|++|..||......          ...     ....+
T Consensus       204 ~~~----~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~----------~~~-----~~~~~  263 (320)
T 3a99_A          204 VYT----DFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI----------IRG-----QVFFR  263 (320)
T ss_dssp             CBC----CCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH----------HHC-----CCCCS
T ss_pred             ccc----CCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCChhhh----------hcc-----ccccc
Confidence            221    23489999999988654 23467899999999999999999999643210          000     01122


Q ss_pred             cccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          162 GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       162 ~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ..+++++.+++       .+||+.||++|||+.+++++
T Consensus       264 ~~~~~~~~~li-------~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          264 QRVSSECQHLI-------RWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             SCCCHHHHHHH-------HHHTCSSGGGSCCHHHHHTS
T ss_pred             ccCCHHHHHHH-------HHHccCChhhCcCHHHHhcC
Confidence            34555555544       45999999999999999874

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.96  E-value=2.1e-29  Score=209.78  Aligned_cols=181  Identities=24%  Similarity=0.222  Sum_probs=118.7

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      |+|.+++..        .+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus       114 ~~l~~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  182 (371)
T 2xrw_A          114 ANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM  182 (371)
T ss_dssp             EEHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC---------
T ss_pred             CCHHHHHhh--------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecccccccccc
Confidence            456666642        389999999999999999999999   999999999999999999999999999986554322


Q ss_pred             cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCC--------CCcCcchh-------
Q 026160           84 TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSS--------DIYFPNSI-------  148 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~--------~~~~~~~~-------  148 (242)
                      .   ....++..|+|||.+.+.  .++.++|||||||++|+|++|..||........        ....+...       
T Consensus       183 ~---~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  257 (371)
T 2xrw_A          183 M---TPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV  257 (371)
T ss_dssp             ----------CTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred             c---CCceecCCccCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence            1   123589999999998764  578899999999999999999999965432100        00000000       


Q ss_pred             hh---ccCCCCccc--------cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 026160          149 YK---HIEPGNDFQ--------LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEML  200 (242)
Q Consensus       149 ~~---~~~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l  200 (242)
                      ..   .........        ...............+.+++.+||+.||++|||+.+++++=
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  320 (371)
T 2xrw_A          258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP  320 (371)
T ss_dssp             HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence            00   000000000        00001111223345677788889999999999999999753

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.96  E-value=1.9e-29  Score=203.68  Aligned_cols=176  Identities=27%  Similarity=0.402  Sum_probs=120.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....     ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        97 ~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  168 (303)
T 1zy4_A           97 CENGTLYDLIHSEN-----LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHR  168 (303)
T ss_dssp             CCSCBHHHHHHHSC-----GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC
T ss_pred             CCCCCHHHhhhccc-----cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCcchhhccc
Confidence            57899999997542     4688999999999999999999999   999999999999999999999999999876543


Q ss_pred             Ccc------------cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchh
Q 026160           81 KKS------------TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSI  148 (242)
Q Consensus        81 ~~~------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~  148 (242)
                      ...            ........++..|.|||.+.+. ..++.++||||||+++|+|++   ||........   . ...
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~---~-~~~  240 (303)
T 1zy4_A          169 SLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN---I-LKK  240 (303)
T ss_dssp             -------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH---H-HHH
T ss_pred             ccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccCCchhHHH---H-HHh
Confidence            211            0111233588999999998653 357889999999999999998   4432111000   0 000


Q ss_pred             hhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          149 YKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ................+..+.+       ++.+||+.||++|||+.+++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~-------li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          241 LRSVSIEFPPDFDDNKMKVEKK-------IIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             HHSTTCCCCTTCCTTTSHHHHH-------HHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ccccccccCccccccchHHHHH-------HHHHHHhcCcccCcCHHHHhCC
Confidence            0011111111122233444444       4555899999999999999974

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.96  E-value=1.4e-29  Score=212.00  Aligned_cols=184  Identities=26%  Similarity=0.301  Sum_probs=128.8

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCC-----------------
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF-----------------   65 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~-----------------   65 (242)
                      +|+|.+++....    ...+++.++..++.||+.||.|||+.+  +|+|+||||+|||++.++                 
T Consensus       128 ~~~l~~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~  201 (397)
T 1wak_A          128 GHHLLKWIIKSN----YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSG  201 (397)
T ss_dssp             CCBHHHHHHHTT----TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHHHHC------
T ss_pred             CccHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcC
Confidence            567777765542    256999999999999999999999952  899999999999998765                 


Q ss_pred             --------------------------------ceEEcccccccccCCCcccchhcccccccccccchhhhcccCCCCCCc
Q 026160           66 --------------------------------CPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKS  113 (242)
Q Consensus        66 --------------------------------~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~  113 (242)
                                                      .++|+|||++........     ...+|..|+|||.+.+.  .++.++
T Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~-----~~~gt~~y~aPE~~~~~--~~~~~~  274 (397)
T 1wak_A          202 APPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFT-----EDIQTRQYRSLEVLIGS--GYNTPA  274 (397)
T ss_dssp             ---------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSC-----SCCSCGGGCCHHHHHTS--CCCTHH
T ss_pred             CCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCc-----cCCCCCcccCChhhcCC--CCCcHH
Confidence                                            799999999986654321     23589999999998764  578899


Q ss_pred             cchhHHHHHHHHHhcCCCccccccCCCCCcCc--chhhhcc-------------------CCCCccccccccc-------
Q 026160          114 DVYSYGMMILEMAVGRKNADVKASRSSDIYFP--NSIYKHI-------------------EPGNDFQLDGVVT-------  165 (242)
Q Consensus       114 Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~--~~~~~~~-------------------~~~~~~~~~~~~~-------  165 (242)
                      |||||||++|+|++|..||.............  ..+....                   ............+       
T Consensus       275 DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (397)
T 1wak_A          275 DIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVL  354 (397)
T ss_dssp             HHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHH
T ss_pred             HHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhh
Confidence            99999999999999999997554322110000  0000000                   0000000000000       


Q ss_pred             ----hHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          166 ----EEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       166 ----~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                          .........+.+++.+||+.||++|||+.+++++
T Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          355 VEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             HHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             hhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence                0012344567788888999999999999999864

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.96  E-value=2.7e-29  Score=210.69  Aligned_cols=166  Identities=22%  Similarity=0.218  Sum_probs=119.2

Q ss_pred             ccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeC-CCCceEEcccccccccCCCcccchhccccccccccc
Q 026160           20 RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD-EDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIA   98 (242)
Q Consensus        20 ~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~-~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~   98 (242)
                      ..+++..+..++.|++.||.|||+.   +|+|+||||+||+++ .++.++|+|||++..........   ...+++.|+|
T Consensus       136 ~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~---~~~~t~~y~a  209 (394)
T 4e7w_A          136 QTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV---SYICSRYYRA  209 (394)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCC---SSCSCGGGCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCc---ccccCcCccC
Confidence            5699999999999999999999999   999999999999998 78999999999998764433222   2348999999


Q ss_pred             chhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcC--------cchhh--------hccCCCCc----c
Q 026160           99 PEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYF--------PNSIY--------KHIEPGND----F  158 (242)
Q Consensus        99 PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~--------~~~~~--------~~~~~~~~----~  158 (242)
                      ||.+.+. ..++.++|||||||++|+|++|..||............        .....        ........    .
T Consensus       210 PE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (394)
T 4e7w_A          210 PELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSK  288 (394)
T ss_dssp             HHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHH
T ss_pred             HHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHH
Confidence            9998654 35789999999999999999999999754321100000        00000        00000000    0


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .+...+++++.       +++.+||++||++|||+.+++++
T Consensus       289 ~~~~~~~~~~~-------~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          289 VFRPRTPPDAI-------DLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HSCTTCCHHHH-------HHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hccccCCHHHH-------HHHHHHhCCChhhCCCHHHHhcC
Confidence            01122444444       45555889999999999999975

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.96  E-value=1.4e-29  Score=209.18  Aligned_cols=122  Identities=26%  Similarity=0.358  Sum_probs=99.0

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      |+|.+++..       +.+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        98 ~~L~~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  167 (353)
T 2b9h_A           98 TDLHRVIST-------QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA  167 (353)
T ss_dssp             EEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred             ccHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccccccccc
Confidence            677777764       3599999999999999999999999   999999999999999999999999999986653221


Q ss_pred             cc--------hhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccc
Q 026160           84 TI--------SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKA  136 (242)
Q Consensus        84 ~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  136 (242)
                      ..        ......++..|+|||.+... ..++.++||||||+++|+|++|..||....
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~  227 (353)
T 2b9h_A          168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRD  227 (353)
T ss_dssp             ------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            11        11123578999999987543 367889999999999999999999997543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.96  E-value=6.2e-29  Score=199.80  Aligned_cols=172  Identities=26%  Similarity=0.331  Sum_probs=126.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCC---CceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDED---FCPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~---~~~~L~dfg~~~~   77 (242)
                      |++|+|.+++...      +.+++.+++.++.|++.||.|||+.   +++|+||||+||+++.+   +.++|+|||++..
T Consensus       103 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A          103 YTGGELFDEIIKR------KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             CCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             cCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            5789999998765      3599999999999999999999999   99999999999999754   4699999999876


Q ss_pred             cCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      ........   ...++..|.|||.+.+   .++.++|+||||+++|++++|..||.......    ....... ......
T Consensus       174 ~~~~~~~~---~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~-~~~~~~  242 (287)
T 2wei_A          174 FQQNTKMK---DRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD----ILKRVET-GKYAFD  242 (287)
T ss_dssp             BCCCSSCS---CHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHH-CCCCCC
T ss_pred             ecCCCccc---cccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH----HHHHHHc-CCCCCC
Confidence            55433221   2237889999998864   46889999999999999999999996543210    0000100 000001


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ......+++++.+       ++.+||+.||++|||+.++++.
T Consensus       243 ~~~~~~~~~~~~~-------li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          243 LPQWRTISDDAKD-------LIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             SGGGTTSCHHHHH-------HHHHHTCSSGGGSCCHHHHHHS
T ss_pred             chhhhhcCHHHHH-------HHHHHcccChhhCcCHHHHhcC
Confidence            1111234444444       4555889999999999999973

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.96  E-value=1.9e-29  Score=209.14  Aligned_cols=120  Identities=28%  Similarity=0.322  Sum_probs=94.1

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      |+|.+++....     ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus       118 ~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  189 (362)
T 3pg1_A          118 TDLAQVIHDQR-----IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADAN  189 (362)
T ss_dssp             EEHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCTTC---------
T ss_pred             CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEEEecCcccccccccc
Confidence            67777776432     4699999999999999999999999   999999999999999999999999999975443322


Q ss_pred             cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           84 TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      ..   ...++..|+|||.+.+. ..++.++|||||||++|++++|..||...
T Consensus       190 ~~---~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~  237 (362)
T 3pg1_A          190 KT---HYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGS  237 (362)
T ss_dssp             ---------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cc---eecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence            21   23488999999988653 35788999999999999999999999653

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.96  E-value=3.9e-29  Score=207.86  Aligned_cols=184  Identities=24%  Similarity=0.298  Sum_probs=125.7

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeC------CCCceEEccccccc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD------EDFCPKISDFGLAK   76 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~------~~~~~~L~dfg~~~   76 (242)
                      +|+|.+++.....    ..+++..+..++.||+.||.|||+..  +++|+||||+||+++      ..+.++|+|||++.
T Consensus       113 ~~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~  186 (373)
T 1q8y_A          113 GENLLALIKKYEH----RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC  186 (373)
T ss_dssp             CEEHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCE
T ss_pred             CCCHHHHHHHhhc----cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCcceEEEccccccc
Confidence            7889999876432    56999999999999999999999942  899999999999994      34479999999998


Q ss_pred             ccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCc--chhhh----
Q 026160           77 QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP--NSIYK----  150 (242)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~--~~~~~----  150 (242)
                      .......     ...++..|+|||.+.+.  .++.++||||||+++|+|++|..||.............  ..+..    
T Consensus       187 ~~~~~~~-----~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  259 (373)
T 1q8y_A          187 WYDEHYT-----NSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE  259 (373)
T ss_dssp             ETTBCCC-----SCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCS
T ss_pred             ccCCCCC-----CCCCCccccCcHHHhCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCC
Confidence            6654321     23589999999998764  57899999999999999999999997544221100000  00000    


Q ss_pred             -----------------------ccCCCCccccccc---cchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          151 -----------------------HIEPGNDFQLDGV---VTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       151 -----------------------~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                                             .............   ...........+.+++.+||+.||++|||+.+++++
T Consensus       260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  334 (373)
T 1q8y_A          260 LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  334 (373)
T ss_dssp             CCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             CCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence                                   0000000000000   000012345566778888999999999999999984

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.95  E-value=9e-29  Score=204.84  Aligned_cols=173  Identities=22%  Similarity=0.241  Sum_probs=119.7

Q ss_pred             ccccHHHHHHHHHHHHHHhHHhh--hCCCCCeeecCCCCCceeeCC-CCceEEcccccccccCCCcccchhccccccccc
Q 026160           20 RTLEWRTVYQIAGGIARGLEYLH--RGCNVRIVHFDIKPHNILLDE-DFCPKISDFGLAKQSQDKKSTISMLHARGTIGY   96 (242)
Q Consensus        20 ~~l~~~~~~~i~~~l~~al~~LH--~~~~~~i~h~dlk~~nil~~~-~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y   96 (242)
                      ..+++..+..++.|++.||.|||  +.   +++|+||||+||+++. ++.++|+|||++..........   ...++..|
T Consensus       124 ~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~gt~~y  197 (360)
T 3e3p_A          124 VAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV---AYICSRYY  197 (360)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCC---STTSCGGG
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcc---cccCCcce
Confidence            56899999999999999999999  87   9999999999999996 8899999999998765443322   23489999


Q ss_pred             ccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcC-------cchhhhccC-CCCccc--------c
Q 026160           97 IAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYF-------PNSIYKHIE-PGNDFQ--------L  160 (242)
Q Consensus        97 ~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~-------~~~~~~~~~-~~~~~~--------~  160 (242)
                      +|||.+.+. ..++.++||||||+++|+|++|..||............       ......... ......        +
T Consensus       198 ~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (360)
T 3e3p_A          198 RAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPW  276 (360)
T ss_dssp             CCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCH
T ss_pred             eCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCc
Confidence            999998653 34789999999999999999999999754321100000       000000000 000000        0


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ....+.........+.+++.+||+.||++|||+.+++++
T Consensus       277 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          277 SNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             ccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            000000000123445666677999999999999999975

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.95  E-value=8.2e-29  Score=206.21  Aligned_cols=106  Identities=30%  Similarity=0.427  Sum_probs=89.4

Q ss_pred             cccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccccch
Q 026160           21 TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPE  100 (242)
Q Consensus        21 ~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE  100 (242)
                      .+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........     ...+++.|+|||
T Consensus       140 ~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~-----~~~~t~~y~aPE  211 (371)
T 4exu_A          140 EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT-----GYVVTRWYRAPE  211 (371)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-------------CTTCCCTTSCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccccccCcC-----CcccCccccCHH
Confidence            499999999999999999999999   999999999999999999999999999976543322     234799999999


Q ss_pred             hhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160          101 VFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus       101 ~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      .+.+. ..++.++||||||+++|+|++|..||...
T Consensus       212 ~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~  245 (371)
T 4exu_A          212 VILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGK  245 (371)
T ss_dssp             HHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             HhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence            98653 35788999999999999999999999754

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.95  E-value=1.2e-28  Score=208.50  Aligned_cols=166  Identities=25%  Similarity=0.265  Sum_probs=117.5

Q ss_pred             ccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCC-CceEEcccccccccCCCcccchhccccccccccc
Q 026160           20 RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDED-FCPKISDFGLAKQSQDKKSTISMLHARGTIGYIA   98 (242)
Q Consensus        20 ~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~-~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~   98 (242)
                      ..+++..+..++.||+.||.|||+.   +|+|+||||+|||++.+ +.+||+|||+++.........   ...+++.|+|
T Consensus       151 ~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~---~~~~t~~y~a  224 (420)
T 1j1b_A          151 QTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSRYYRA  224 (420)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCC---SCCSCTTSCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCce---eeeeCCCcCC
Confidence            5699999999999999999999998   99999999999999965 568999999998654433221   2358999999


Q ss_pred             chhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCc--------CcchhhhccCCCCccc-----------
Q 026160           99 PEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIY--------FPNSIYKHIEPGNDFQ-----------  159 (242)
Q Consensus        99 PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~-----------  159 (242)
                      ||.+.+. ..++.++|||||||++|||++|+.||...........        ....+...........           
T Consensus       225 PE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~  303 (420)
T 1j1b_A          225 PELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTK  303 (420)
T ss_dssp             HHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHH
T ss_pred             HHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHH
Confidence            9998653 3578899999999999999999999965432110000        0000000000000000           


Q ss_pred             -cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          160 -LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       160 -~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                       +...+++++.       +++.+||++||++|||+.+++++
T Consensus       304 ~~~~~~~~~~~-------~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          304 VFRPRTPPEAI-------ALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HSCTTSCHHHH-------HHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hcCCCCCHHHH-------HHHHHhccCChhHCCCHHHHhCC
Confidence             1122344444       45555889999999999999864

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.95  E-value=4.2e-29  Score=210.22  Aligned_cols=130  Identities=22%  Similarity=0.277  Sum_probs=94.7

Q ss_pred             CCCcchhccccCC---CCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceee----CCCCceEEcccccc
Q 026160            3 NGSLDQFTYDQES---SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILL----DEDFCPKISDFGLA   75 (242)
Q Consensus         3 ~GsL~~~l~~~~~---~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~----~~~~~~~L~dfg~~   75 (242)
                      .|+|.+++.....   ......+++..++.++.||+.||.|||+.   +|+|+||||+|||+    +.++.++|+|||++
T Consensus       103 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  179 (405)
T 3rgf_A          103 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  179 (405)
T ss_dssp             SEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred             CCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence            3566666653211   11223599999999999999999999999   99999999999999    66789999999999


Q ss_pred             cccCCCccc-chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccc
Q 026160           76 KQSQDKKST-ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKA  136 (242)
Q Consensus        76 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  136 (242)
                      ......... .......+|+.|+|||++.+. ..++.++|||||||++|+|++|..||....
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             C----------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             eecCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            866543211 112234589999999998653 357889999999999999999999996543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.95  E-value=1.1e-28  Score=204.01  Aligned_cols=172  Identities=23%  Similarity=0.269  Sum_probs=120.3

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      |+|.+++.        ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++....... 
T Consensus       113 ~~l~~~~~--------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-  180 (353)
T 3coi_A          113 TDLQKIMG--------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM-  180 (353)
T ss_dssp             EEGGGTTT--------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC------
T ss_pred             CCHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCCCCc-
Confidence            45666553        2499999999999999999999999   99999999999999999999999999997654322 


Q ss_pred             cchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCc-------Ccc----------
Q 026160           84 TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIY-------FPN----------  146 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~-------~~~----------  146 (242)
                          ....++..|+|||.+.+. ..++.++||||||+++|+|++|..||...........       ...          
T Consensus       181 ----~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  255 (353)
T 3coi_A          181 ----TGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA  255 (353)
T ss_dssp             -------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred             ----cccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence                123588999999988653 3568899999999999999999999975432100000       000          


Q ss_pred             --hhhhccCCCC---ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          147 --SIYKHIEPGN---DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       147 --~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                        ..........   .......+++++.+++.+       ||+.||++|||+.+++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-------~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEK-------MLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             HHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHH-------HSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHH-------HcCCCcccCCCHHHHhcC
Confidence              0000000000   111122345555555544       889999999999999875

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.95  E-value=3.6e-28  Score=196.55  Aligned_cols=158  Identities=22%  Similarity=0.294  Sum_probs=112.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC---CCceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE---DFCPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~---~~~~~L~dfg~~~~   77 (242)
                      |++|+|.+++....    +..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.   ++.++|+|||++..
T Consensus        97 ~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  169 (299)
T 3m2w_A           97 LDGGELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  169 (299)
T ss_dssp             CCSCBHHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             cCCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence            57899999998753    25699999999999999999999999   9999999999999997   78899999998854


Q ss_pred             cCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      ...                          ..++.++||||||+++|+|++|..||.................... ....
T Consensus       170 ~~~--------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~  222 (299)
T 3m2w_A          170 TTG--------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ-YEFP  222 (299)
T ss_dssp             CTT--------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTC-CSSC
T ss_pred             ccc--------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcc-ccCC
Confidence            321                          1346789999999999999999999965443221110000000000 0000


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ......+++++.       .++.+||+.||++|||+.+++++
T Consensus       223 ~~~~~~~~~~~~-------~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          223 NPEWSEVSEEVK-------MLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             HHHHTTSCHHHH-------HHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             chhcccCCHHHH-------HHHHHHcccChhhCCCHHHHhcC
Confidence            000123444444       45555899999999999999975

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.95  E-value=4.8e-29  Score=211.67  Aligned_cols=182  Identities=26%  Similarity=0.390  Sum_probs=118.3

Q ss_pred             CCCcchhccccCCCCCC-ccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCC-------------CceE
Q 026160            3 NGSLDQFTYDQESSNGN-RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDED-------------FCPK   68 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~-------------~~~~   68 (242)
                      +|+|.+++......... ...++..++.++.|++.||.|||+.   +|+|+||||+||+++.+             +.++
T Consensus        92 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           92 NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEE
Confidence            47999999765331111 1124446788999999999999999   99999999999999654             4799


Q ss_pred             EcccccccccCCCcccc--hhcccccccccccchhhhcc-----cCCCCCCccchhHHHHHHHHHh-cCCCccccccCCC
Q 026160           69 ISDFGLAKQSQDKKSTI--SMLHARGTIGYIAPEVFCRS-----FGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSS  140 (242)
Q Consensus        69 L~dfg~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~-----~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~  140 (242)
                      |+|||++..........  ......|+..|+|||++.+.     ...++.++|||||||++|+|++ |..||....... 
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-  247 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-  247 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence            99999998765432211  11233589999999998652     2457899999999999999998 899986432111 


Q ss_pred             CCcCcchhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 026160          141 DIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE  198 (242)
Q Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~  198 (242)
                           ..+........  .... .  ....+...+.+++.+||+.||++|||+.++++
T Consensus       248 -----~~i~~~~~~~~--~~~~-~--~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 -----SNIIRGIFSLD--EMKC-L--HDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             -----HHHHHTCCCCC--CCTT-C--CCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----HHHhcCCCCcc--cccc-c--ccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence                 11111110000  0000 0  11233445666777799999999999999986

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.95  E-value=1.8e-28  Score=199.59  Aligned_cols=178  Identities=21%  Similarity=0.255  Sum_probs=122.0

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeC-CCCceEEcccccccccCCCc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD-EDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~-~~~~~~L~dfg~~~~~~~~~   82 (242)
                      |+|.+++..       +.+++..++.++.|++.||.|||+.   +++|+||||+||+++ .++.++|+|||++.......
T Consensus       106 ~~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~  175 (320)
T 2i6l_A          106 TDLANVLEQ-------GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY  175 (320)
T ss_dssp             EEHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCCTTCBCC----
T ss_pred             CCHHHHhhc-------CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccCccccccCCCc
Confidence            688888854       3589999999999999999999999   999999999999997 56789999999998654321


Q ss_pred             cc-chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCC-------cCcch-------
Q 026160           83 ST-ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDI-------YFPNS-------  147 (242)
Q Consensus        83 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~-------~~~~~-------  147 (242)
                      .. .......++..|.|||.+... ..++.++||||||+++|++++|..||..........       .....       
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (320)
T 2i6l_A          176 SHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLS  254 (320)
T ss_dssp             ----CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHT
T ss_pred             ccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhh
Confidence            11 111223478899999987653 357889999999999999999999997543211000       00000       


Q ss_pred             -----hhhccC--CCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          148 -----IYKHIE--PGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       148 -----~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                           ......  ..........++.       .+.+++.+||+.||++|||+.+++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          255 VIPVYIRNDMTEPHKPLTQLLPGISR-------EAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             TSCHHHHHHTTSCCCCHHHHSTTCCH-------HHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cCcccccccccCCCCChhHhcchhhH-------HHHHHHHHHcCCCccccCCHHHHhCC
Confidence                 000000  0000001112333       44556666999999999999999874

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.95  E-value=1.3e-27  Score=210.24  Aligned_cols=192  Identities=21%  Similarity=0.287  Sum_probs=130.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCc---eEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFC---PKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~---~~L~dfg~~~~   77 (242)
                      |+||+|.+++....   ....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.   ++|+|||++..
T Consensus       100 ~~ggsL~~~L~~~~---~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~  173 (676)
T 3qa8_A          100 CEGGDLRKYLNQFE---NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE  173 (676)
T ss_dssp             CSSCBHHHHHHSSS---CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCCCCB
T ss_pred             CCCCCHHHHHHhcc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccccccc
Confidence            57999999997643   224699999999999999999999999   9999999999999987654   89999999987


Q ss_pred             cCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccC-----------CCCCcCcc
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASR-----------SSDIYFPN  146 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~-----------~~~~~~~~  146 (242)
                      ........   ...++..|+|||.+.+.  .++.++||||||+++|++++|..||......           ........
T Consensus       174 ~~~~~~~~---~~~gt~~Y~APE~l~~~--~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~  248 (676)
T 3qa8_A          174 LDQGELCT---EFVGTLQYLAPELLEQK--KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD  248 (676)
T ss_dssp             TTSCCCCC---CCCSCCTTCSSCSSCCS--CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred             cccccccc---cccCCcccCChHHhccC--CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence            65443222   23589999999998653  6788999999999999999999999643110           00000000


Q ss_pred             hhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHH-----HHHHhhchhhh
Q 026160          147 SIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHE-----VLEMLESSTEI  206 (242)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~-----ll~~l~~~~~~  206 (242)
                      .......-......+..+...   +...+.+++..||+.||++|||+.+     .++.++.+...
T Consensus       249 ~l~g~~~~~~~lp~p~~l~~~---ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~  310 (676)
T 3qa8_A          249 DLTGAVKFSSVLPTPNHLSGI---LAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL  310 (676)
T ss_dssp             CCSSSCCCCSSSCCSCCCCGG---GHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred             hhccccccccccCCchhhchh---hhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence            000000000011111112222   2344555666699999999999988     45666655544

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.95  E-value=2.7e-28  Score=198.54  Aligned_cols=161  Identities=26%  Similarity=0.374  Sum_probs=110.8

Q ss_pred             ccccHHHHHHHHHHHHHHhHHhhh-CCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhccccccccccc
Q 026160           20 RTLEWRTVYQIAGGIARGLEYLHR-GCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIA   98 (242)
Q Consensus        20 ~~l~~~~~~~i~~~l~~al~~LH~-~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~   98 (242)
                      ..+++..++.++.|++.||.|||+ .   +++|+||||+||+++.++.++|+|||++.........   ....++..|.|
T Consensus       119 ~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~a  192 (318)
T 2dyl_A          119 GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAAYMA  192 (318)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-----------------CCTTCC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccc---cccCCCccccC
Confidence            469999999999999999999998 5   8999999999999999999999999998765443222   12348899999


Q ss_pred             chhhhc---ccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhcc-CCCCccccccccchHHHHHHHH
Q 026160           99 PEVFCR---SFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHI-EPGNDFQLDGVVTEEEKELVKK  174 (242)
Q Consensus        99 PE~~~~---~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  174 (242)
                      ||.+..   ....++.++||||||+++|+|++|..||.......      ....... ...........+++++.+++. 
T Consensus       193 PE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~li~-  265 (318)
T 2dyl_A          193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF------EVLTKVLQEEPPLLPGHMGFSGDFQSFVK-  265 (318)
T ss_dssp             HHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH------HHHHHHHHSCCCCCCSSSCCCHHHHHHHH-
T ss_pred             hhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH------HHHHHHhccCCCCCCccCCCCHHHHHHHH-
Confidence            999853   12356889999999999999999999996432110      1111100 011111111235555555554 


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          175 MILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       175 ~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                            +||+.||++|||+.+++++
T Consensus       266 ------~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          266 ------DCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             ------HHTCSCTTTSCCHHHHTTS
T ss_pred             ------HHccCChhHCcCHHHHhhC
Confidence                  4899999999999999864

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.95  E-value=1.9e-28  Score=207.68  Aligned_cols=175  Identities=25%  Similarity=0.289  Sum_probs=117.0

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC-----CCceEEcccccccc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE-----DFCPKISDFGLAKQ   77 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~-----~~~~~L~dfg~~~~   77 (242)
                      +|+|.+++....     ..++..+++.++.|++.||.|||+.   +|+|+||||+||+++.     ...++|+|||++..
T Consensus       101 ~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~  172 (432)
T 3p23_A          101 AATLQEYVEQKD-----FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK  172 (432)
T ss_dssp             SEEHHHHHHSSS-----CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred             CCCHHHHHHhcC-----CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence            478999987653     2355556788999999999999999   9999999999999953     23578999999986


Q ss_pred             cCCCccc-chhcccccccccccchhhhcc-cCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCC
Q 026160           78 SQDKKST-ISMLHARGTIGYIAPEVFCRS-FGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEP  154 (242)
Q Consensus        78 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~~-~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  154 (242)
                      ....... .......||+.|+|||.+.+. ....+.++|||||||++|++++ |..||......        ........
T Consensus       173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~--------~~~~~~~~  244 (432)
T 3p23_A          173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR--------QANILLGA  244 (432)
T ss_dssp             C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH--------HHHHHTTC
T ss_pred             ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH--------HHHHHhcc
Confidence            6533211 112234589999999998642 2356789999999999999999 88888532211        11111111


Q ss_pred             CCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 026160          155 GNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE  198 (242)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~  198 (242)
                      .......   +.  ......+.+++.+||+.||++|||+.++++
T Consensus       245 ~~~~~~~---~~--~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          245 CSLDCLH---PE--KHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CCCTTSC---TT--CHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCccccC---cc--ccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            0000000   00  111223445667799999999999999994

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.95  E-value=2.9e-28  Score=199.39  Aligned_cols=179  Identities=27%  Similarity=0.336  Sum_probs=107.1

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS   83 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~   83 (242)
                      |+|.+++..... .....+++..+..++.|++.||.|||+.  .+++|+||||+||+++.++.++|+|||++........
T Consensus       105 ~~l~~~~~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  181 (327)
T 3aln_A          105 TSFDKFYKYVYS-VLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA  181 (327)
T ss_dssp             EEHHHHHHHHHH-TTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC------
T ss_pred             CChHHHHHHHHh-hhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecccccc
Confidence            466666653110 1125699999999999999999999994  2899999999999999999999999999976544322


Q ss_pred             cchhcccccccccccchhhhc--ccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccccc
Q 026160           84 TISMLHARGTIGYIAPEVFCR--SFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLD  161 (242)
Q Consensus        84 ~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (242)
                      ..   ...++..|.|||.+..  ....++.++||||||+++|+|++|..||...........  . ..............
T Consensus       182 ~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~-~~~~~~~~~~~~~~  255 (327)
T 3aln_A          182 KT---RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT--Q-VVKGDPPQLSNSEE  255 (327)
T ss_dssp             ---------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------C--C-CCCSCCCCCCCCSS
T ss_pred             cc---cCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHH--H-HhcCCCCCCCCccc
Confidence            21   2248899999999842  123568899999999999999999999975432211100  0 00000000011111


Q ss_pred             cccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 026160          162 GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE  198 (242)
Q Consensus       162 ~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~  198 (242)
                      ..+++.+.++       +.+||+.||++|||+.++++
T Consensus       256 ~~~~~~l~~l-------i~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          256 REFSPSFINF-------VNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCCHHHHHH-------HHHHTCSSGGGSCCHHHHTT
T ss_pred             ccCCHHHHHH-------HHHHhhCChhhCcCHHHHHh
Confidence            2345554444       44599999999999999976

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.94  E-value=3.1e-27  Score=210.87  Aligned_cols=162  Identities=20%  Similarity=0.243  Sum_probs=122.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.+++..        .+++.+++.++.||+.||.|||+.   +|+|+||||+||+++.+ .++|+|||++.....
T Consensus       166 ~~g~~L~~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~  233 (681)
T 2pzi_A          166 VGGQSLKRSKGQ--------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS  233 (681)
T ss_dssp             CCCEECC----C--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred             CCCCcHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence            578899887753        499999999999999999999999   99999999999999875 899999999987654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ..      ...||+.|+|||.+.+.   .+.++||||||+++|+|++|..||........            ..      
T Consensus       234 ~~------~~~gt~~y~aPE~~~~~---~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------------~~------  286 (681)
T 2pzi_A          234 FG------YLYGTPGFQAPEIVRTG---PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL------------PE------  286 (681)
T ss_dssp             CS------CCCCCTTTSCTTHHHHC---SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC------------CT------
T ss_pred             CC------ccCCCccccCHHHHcCC---CCCceehhhhHHHHHHHHhCCCCCcccccccc------------cc------
Confidence            32      23589999999998653   38899999999999999999888764221100            00      


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHhhchhh
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRP-SMHEVLEMLESSTE  205 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp-s~~~ll~~l~~~~~  205 (242)
                          ..........+..++.+||+.||++|| +++++.+.|..+..
T Consensus       287 ----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  328 (681)
T 2pzi_A          287 ----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR  328 (681)
T ss_dssp             ----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred             ----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence                001112234456677779999999999 57777777776653

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.93  E-value=4.3e-26  Score=183.34  Aligned_cols=154  Identities=14%  Similarity=0.106  Sum_probs=111.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.+++...        ....++..++.|++.||.|||+.   +++|+||||+||+++.++.++|++++..     
T Consensus       113 ~~g~~L~~~l~~~--------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~~~-----  176 (286)
T 3uqc_A          113 IRGGSLQEVADTS--------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPATM-----  176 (286)
T ss_dssp             CCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCCCC-----
T ss_pred             cCCCCHHHHHhcC--------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecccc-----
Confidence            5789999999532        35567899999999999999999   9999999999999999999999854322     


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                                       +         ..+.++|||||||++|+|++|..||.................  .........
T Consensus       177 -----------------~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~  228 (286)
T 3uqc_A          177 -----------------P---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA--GQPIEPADI  228 (286)
T ss_dssp             -----------------T---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTT--SCBCCHHHH
T ss_pred             -----------------C---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhc--cCCCChhhc
Confidence                             1         257899999999999999999999986544321100000000  000001112


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      ...+++++.+++       .+||+.||++| |+.++++.|+.+...
T Consensus       229 ~~~~~~~l~~li-------~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          229 DRDIPFQISAVA-------ARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             CTTSCHHHHHHH-------HHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             ccCCCHHHHHHH-------HHHcccCCccC-CHHHHHHHHHHHhcc
Confidence            234555555544       45889999999 999999999987764

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.90  E-value=2.7e-24  Score=176.55  Aligned_cols=164  Identities=14%  Similarity=0.040  Sum_probs=116.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhh-hCCCCCeeecCCCCCceeeCCCC--------------
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLH-RGCNVRIVHFDIKPHNILLDEDF--------------   65 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH-~~~~~~i~h~dlk~~nil~~~~~--------------   65 (242)
                      |++|++.+.+.+       +.+++.++..++.||+.||.||| +.   +|+||||||+|||++.++              
T Consensus       144 ~~~g~ll~~~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~  213 (336)
T 2vuw_A          144 EFGGIDLEQMRT-------KLSSLATAKSILHQLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSST  213 (336)
T ss_dssp             ECCCEETGGGTT-------TCCCHHHHHHHHHHHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEE
T ss_pred             cCCCccHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCcccc
Confidence            468877666643       35899999999999999999999 88   999999999999999876              


Q ss_pred             ------ceEEcccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHH-HHHHHhcCCCccccccC
Q 026160           66 ------CPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMM-ILEMAVGRKNADVKASR  138 (242)
Q Consensus        66 ------~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~-~~~ll~g~~p~~~~~~~  138 (242)
                            .+||+|||+++.....       ...||..|+|||.+.+.   .+.++|||||++. .++++.|..||......
T Consensus       214 ~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aPE~~~g~---~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~  283 (336)
T 2vuw_A          214 IPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDEDLFTGD---GDYQFDIYRLMKKENNNRWGEYHPYSNVLWL  283 (336)
T ss_dssp             EECTTEEEEECCCTTCBEEETT-------EEECCCCTTCSGGGCCC---SSHHHHHHHHHHHHHTTCTTSCCTHHHHHHH
T ss_pred             ccCCCceEEEeeccccEecCCC-------cEEEeecccChhhhcCC---CccceehhhhhCCCCcccccccCCCcchhhh
Confidence                  8999999999865542       23589999999998764   2789999998776 77788898888532100


Q ss_pred             CCCCcCcchhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 026160          139 SSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVL  197 (242)
Q Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll  197 (242)
                      ..   .............     .........+...+.+++.+||++|     |+.+++
T Consensus       284 ~~---~~~~~~~~~~~~~-----~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          284 HY---LTDKMLKQMTFKT-----KCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HH---HHHHHHHTCCCSS-----CCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             hH---HHHhhhhhhccCc-----ccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence            00   0000000000000     0112223445556666777799976     999988

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.84  E-value=8.1e-23  Score=178.46  Aligned_cols=114  Identities=18%  Similarity=0.246  Sum_probs=77.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.++|.+.      +.++..   +|+.||+.||.|+|++   ||+||||||+|||++.+|.+||+|||+++....
T Consensus       324 v~G~~L~d~i~~~------~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          324 LPGRLLSDMLAAG------EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             CCSEEHHHHHHTT------CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             CCCCcHHHHHHhC------CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            6899999999765      346654   4789999999999999   999999999999999999999999999986654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCC
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKN  131 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p  131 (242)
                      ....  .....||+.|++||.+.+.   ...++|+|++|++.+++.++..+
T Consensus       392 ~~~~--~~t~vGTp~YmAPE~l~g~---~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          392 DCSW--PTNLVQSFFVFVNELFAEN---KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             --CC--SHHHHHHHHHHHHHHC--------------------CCCCTTHHH
T ss_pred             CCcc--ccCceechhhccHHHhCCC---CCCcccccccccchhhhccccch
Confidence            3222  1234599999999998653   46789999999998877655443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.65  E-value=1.9e-17  Score=143.74  Aligned_cols=113  Identities=20%  Similarity=0.188  Sum_probs=91.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.+++..              +..++.|+++||.|||+.   +|+|+||||+|||++.  .++|+|||+++....
T Consensus       421 ~~ggsL~~~l~~--------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          421 INGKLAKDVIED--------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             CCSEEHHHHSTT--------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             CCCCCHHHHHHH--------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            578999999864              457999999999999999   9999999999999998  999999999987765


Q ss_pred             Ccccc-----hhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCc
Q 026160           81 KKSTI-----SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNA  132 (242)
Q Consensus        81 ~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~  132 (242)
                      .....     ......+|+.|+|||++......++...|+|+..+-..+.+.++.+|
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            42211     11234589999999998764345677889999988888877666544

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.34  E-value=6.7e-13  Score=106.06  Aligned_cols=60  Identities=18%  Similarity=0.139  Sum_probs=51.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~   77 (242)
                      |+||+|.+ +..            .+...++.|++.||.|||+.   +++|+||||.||+++ ++.++|+|||++..
T Consensus       182 ~~g~~L~~-l~~------------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~DFG~a~~  241 (282)
T 1zar_A          182 IDAKELYR-VRV------------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVE  241 (282)
T ss_dssp             CCCEEGGG-CCC------------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECCCTTCEE
T ss_pred             cCCCcHHH-cch------------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEECCCCeE
Confidence            57888888 521            23446999999999999999   999999999999999 99999999999863

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.04  E-value=2.2e-10  Score=90.19  Aligned_cols=52  Identities=21%  Similarity=0.214  Sum_probs=46.7

Q ss_pred             cHHHHHHHHHHHHHHhHHhh-hCCCCCeeecCCCCCceeeCCCCceEEcccccccccC
Q 026160           23 EWRTVYQIAGGIARGLEYLH-RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ   79 (242)
Q Consensus        23 ~~~~~~~i~~~l~~al~~LH-~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~   79 (242)
                      ++.++..++.|++.+|.||| +.   +++|+||||.|||++.  .++|+|||++....
T Consensus       168 ~~~~~~~i~~qi~~~l~~lH~~~---givHrDlkp~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          168 KELDVEGIFNDVVENVKRLYQEA---ELVHADLSEYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             GGSCHHHHHHHHHHHHHHHHHTS---CEECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred             ChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence            35578899999999999999 88   9999999999999988  89999999997543

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=98.59  E-value=3e-08  Score=82.04  Aligned_cols=51  Identities=20%  Similarity=0.229  Sum_probs=43.6

Q ss_pred             HHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCC----------ceEEcccccccccC
Q 026160           26 TVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF----------CPKISDFGLAKQSQ   79 (242)
Q Consensus        26 ~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~----------~~~L~dfg~~~~~~   79 (242)
                      ....++.|++.+|.+||..   +++||||||.|||++.++          .+.++||+-+....
T Consensus       206 ~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          206 DPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             CHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             HHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence            4456889999999999998   999999999999998766          37899999776543

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=97.96  E-value=4e-06  Score=67.19  Aligned_cols=84  Identities=21%  Similarity=0.236  Sum_probs=49.1

Q ss_pred             CCeeecCCCCCceeeCC--CCceEEcccccccccCCCcccchhcccccccccccchhh---hcccCCC---------CCC
Q 026160           47 VRIVHFDIKPHNILLDE--DFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVF---CRSFGGA---------SHK  112 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~--~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~---~~~~~~~---------~~~  112 (242)
                      ..++|+|+++.||+++.  .+.+.++||+.+.............   ....-..++..   ...++..         ...
T Consensus       191 ~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~---~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~  267 (304)
T 3sg8_A          191 PCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLM---EDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMK  267 (304)
T ss_dssp             CEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTC---CTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHH
T ss_pred             ceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHH---hhccccCHHHHHHHHHHcCCCCcHHHHHHHHHH
Confidence            36899999999999987  4567899999876533211110000   00000122211   1111110         122


Q ss_pred             ccchhHHHHHHHHHhcCCCcc
Q 026160          113 SDVYSYGMMILEMAVGRKNAD  133 (242)
Q Consensus       113 ~Di~slG~~~~~ll~g~~p~~  133 (242)
                      .+.|+++.++|.+.+|..+|.
T Consensus       268 ~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          268 EKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHHHHHHHHHHHHHcCCHHHH
Confidence            578999999999999987664

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=97.69  E-value=2e-05  Score=61.60  Aligned_cols=29  Identities=21%  Similarity=0.295  Sum_probs=24.7

Q ss_pred             CeeecCCCCCceeeCCCCceEEccccccc
Q 026160           48 RIVHFDIKPHNILLDEDFCPKISDFGLAK   76 (242)
Q Consensus        48 ~i~h~dlk~~nil~~~~~~~~L~dfg~~~   76 (242)
                      +++|+|+++.||+++.++.+.|+||+.+.
T Consensus       184 ~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             EEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             eEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence            69999999999999876556799998764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.68  E-value=0.00039  Score=52.46  Aligned_cols=99  Identities=12%  Similarity=0.034  Sum_probs=61.0

Q ss_pred             CcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCccc
Q 026160            5 SLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST   84 (242)
Q Consensus         5 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~   84 (242)
                      ||.+.|....     .+|+++++|.++.|.+.+|.-+-.+.  .-...=+.+..|++..+|.|.+.+ ..+.        
T Consensus        34 SL~eIL~~~~-----~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------   97 (229)
T 2yle_A           34 SLEEILRLYN-----QPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD--------   97 (229)
T ss_dssp             EHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred             cHHHHHHHcC-----CCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc--------
Confidence            5667776654     57999999999999999987762210  111222345788888888887764 1110        


Q ss_pred             chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhc
Q 026160           85 ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG  128 (242)
Q Consensus        85 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g  128 (242)
                            .....+.|||...   ...+.+.-|||||+++|.-+-.
T Consensus        98 ------~~~~~~~~pe~~~---~~~te~~~IysLG~tLY~ALDy  132 (229)
T 2yle_A           98 ------AGEPPPVAGKLGY---SQCMETEVIESLGIIIYKALDY  132 (229)
T ss_dssp             ---------------CCSS---SSSCHHHHHHHHHHHHHHHHTT
T ss_pred             ------ccccCCCChhhcc---ccchHHHHHHHHHHHHHHHhhc
Confidence                  0223456787652   2446777899999999998853

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=97.64  E-value=8.8e-05  Score=60.73  Aligned_cols=57  Identities=18%  Similarity=0.137  Sum_probs=47.4

Q ss_pred             cccHHHHHHHHHHHHHHhHHhhhCC-------------------------------------------------------
Q 026160           21 TLEWRTVYQIAGGIARGLEYLHRGC-------------------------------------------------------   45 (242)
Q Consensus        21 ~l~~~~~~~i~~~l~~al~~LH~~~-------------------------------------------------------   45 (242)
                      .++..++..++.++++.|..||+..                                                       
T Consensus       135 ~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  214 (359)
T 3dxp_A          135 GMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDAD  214 (359)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSS
T ss_pred             cCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCC
Confidence            4678888999999999999999731                                                       


Q ss_pred             CCCeeecCCCCCceeeCCCCc--eEEcccccccc
Q 026160           46 NVRIVHFDIKPHNILLDEDFC--PKISDFGLAKQ   77 (242)
Q Consensus        46 ~~~i~h~dlk~~nil~~~~~~--~~L~dfg~~~~   77 (242)
                      ...++|+|+++.||+++.++.  +.++||+.+..
T Consensus       215 ~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          215 LTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence            147999999999999987653  68999998864

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=97.36  E-value=0.00014  Score=56.37  Aligned_cols=29  Identities=21%  Similarity=0.188  Sum_probs=25.0

Q ss_pred             CeeecCCCCCceeeCCCCceEEccccccc
Q 026160           48 RIVHFDIKPHNILLDEDFCPKISDFGLAK   76 (242)
Q Consensus        48 ~i~h~dlk~~nil~~~~~~~~L~dfg~~~   76 (242)
                      +++|+|+++.||+++.++.+.|+||+.+.
T Consensus       185 ~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          185 VVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             EEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             EEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence            39999999999999876666799999864

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=96.13  E-value=0.0079  Score=48.37  Aligned_cols=31  Identities=23%  Similarity=0.168  Sum_probs=27.4

Q ss_pred             CCeeecCCCCCceeeCCCCceEEcccccccc
Q 026160           47 VRIVHFDIKPHNILLDEDFCPKISDFGLAKQ   77 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~   77 (242)
                      .+++|+|+.+.||+++.++.+.++||+.+..
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            4899999999999998778899999997753

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=95.46  E-value=0.021  Score=45.54  Aligned_cols=30  Identities=33%  Similarity=0.473  Sum_probs=25.2

Q ss_pred             CeeecCCCCCceeeCC---CCc-eEEcccccccc
Q 026160           48 RIVHFDIKPHNILLDE---DFC-PKISDFGLAKQ   77 (242)
Q Consensus        48 ~i~h~dlk~~nil~~~---~~~-~~L~dfg~~~~   77 (242)
                      .++|+|+++.|++++.   ++. +.|+||+.+..
T Consensus       191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             eeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence            6799999999999987   355 48999997764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=95.13  E-value=0.024  Score=47.33  Aligned_cols=31  Identities=13%  Similarity=0.271  Sum_probs=27.1

Q ss_pred             CCeeecCCCCCceeeCCCCceEEccccccccc
Q 026160           47 VRIVHFDIKPHNILLDEDFCPKISDFGLAKQS   78 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~   78 (242)
                      ..++|+|+++.||+++.++ +.++||+.+..-
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            3999999999999998776 999999988643

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=93.73  E-value=0.099  Score=41.90  Aligned_cols=32  Identities=28%  Similarity=0.290  Sum_probs=27.4

Q ss_pred             CCeeecCCCCCceeeCCC----CceEEccccccccc
Q 026160           47 VRIVHFDIKPHNILLDED----FCPKISDFGLAKQS   78 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~~----~~~~L~dfg~~~~~   78 (242)
                      ..++|+|+.+.||+++.+    +.+.++||+.+..-
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            489999999999999874    67899999987643

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=93.39  E-value=0.079  Score=41.87  Aligned_cols=31  Identities=23%  Similarity=0.161  Sum_probs=25.9

Q ss_pred             CCeeecCCCCCceeeCCCCceEEccccccccc
Q 026160           47 VRIVHFDIKPHNILLDEDFCPKISDFGLAKQS   78 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~   78 (242)
                      ..++|+|+.+.||+ ..++.+.++||..+..-
T Consensus       173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          173 LAACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             CEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             ceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            47999999999999 55667899999987643

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=93.28  E-value=0.028  Score=44.85  Aligned_cols=30  Identities=23%  Similarity=0.317  Sum_probs=25.8

Q ss_pred             CCeeecCCCCCceeeCCCCceEEccccccc
Q 026160           47 VRIVHFDIKPHNILLDEDFCPKISDFGLAK   76 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~~~~~~L~dfg~~~   76 (242)
                      .+++|+|+.+.||+++.++.+.++||+.+.
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            389999999999999877666899998765

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=93.26  E-value=0.037  Score=42.86  Aligned_cols=30  Identities=23%  Similarity=0.230  Sum_probs=25.9

Q ss_pred             CeeecCCCCCceeeCCCCceEEcccccccc
Q 026160           48 RIVHFDIKPHNILLDEDFCPKISDFGLAKQ   77 (242)
Q Consensus        48 ~i~h~dlk~~nil~~~~~~~~L~dfg~~~~   77 (242)
                      .++|+|+.+.||+++.++.+-|+||+.+..
T Consensus       194 ~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          194 VVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             EEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             EEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence            589999999999999877778999987753

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=93.13  E-value=0.1  Score=44.04  Aligned_cols=16  Identities=25%  Similarity=0.466  Sum_probs=14.9

Q ss_pred             CCeeecCCCCCceeeC
Q 026160           47 VRIVHFDIKPHNILLD   62 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~   62 (242)
                      ..++|+|+.+.||+++
T Consensus       290 ~v~cHnDl~~gNIL~~  305 (458)
T 2qg7_A          290 IVLCHCDLLSSNIINT  305 (458)
T ss_dssp             EEEECSCCCGGGEEEC
T ss_pred             eeEEecCCCCCcEEee
Confidence            4899999999999998

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=93.09  E-value=0.12  Score=41.11  Aligned_cols=29  Identities=34%  Similarity=0.378  Sum_probs=25.0

Q ss_pred             CCeeecCCCCCceeeCCCCceEEcccccccc
Q 026160           47 VRIVHFDIKPHNILLDEDFCPKISDFGLAKQ   77 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~   77 (242)
                      ..++|+|+++.||+++ + .+.++||+.+..
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            3789999999999998 4 889999987653

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=92.94  E-value=0.065  Score=43.38  Aligned_cols=31  Identities=13%  Similarity=0.094  Sum_probs=26.1

Q ss_pred             CCeeecCCCCCceeeCCCCceEEcccccccc
Q 026160           47 VRIVHFDIKPHNILLDEDFCPKISDFGLAKQ   77 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~   77 (242)
                      ..++|+|+.+.||+++.+..+.|+||+.+..
T Consensus       222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence            4899999999999998644578999998764

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=92.48  E-value=0.087  Score=42.57  Aligned_cols=31  Identities=23%  Similarity=0.261  Sum_probs=27.3

Q ss_pred             CCeeecCCCCCceeeCCCCceEEcccccccc
Q 026160           47 VRIVHFDIKPHNILLDEDFCPKISDFGLAKQ   77 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~   77 (242)
                      ..++|+|+.+.||+++.++.+.++||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4899999999999998778899999987654

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=92.23  E-value=0.19  Score=37.84  Aligned_cols=50  Identities=14%  Similarity=0.205  Sum_probs=43.2

Q ss_pred             cccHHHHHHHHHHHHHHhH-HhhhCCCCCeeecCCCCCceeeCCCCceEEcccccc
Q 026160           21 TLEWRTVYQIAGGIARGLE-YLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLA   75 (242)
Q Consensus        21 ~l~~~~~~~i~~~l~~al~-~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~   75 (242)
                      .++..++++++.+|+.... ++++.     +|.-+.|.|++++.++.+++.-.|+-
T Consensus        81 ~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~NL~f~~~~~p~i~hRGi~  131 (219)
T 4ano_A           81 KTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPENLMFNRALEPFFLHVGVK  131 (219)
T ss_dssp             TSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGGGEEECTTCCEEESCCEET
T ss_pred             hcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCceEEEeCCCcEEEEEcCCc
Confidence            4778899999999999888 77654     78899999999999999999987754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=91.94  E-value=0.11  Score=43.54  Aligned_cols=31  Identities=32%  Similarity=0.355  Sum_probs=25.3

Q ss_pred             CCeeecCCCCCceeeCCC----------------------------CceEEcccccccc
Q 026160           47 VRIVHFDIKPHNILLDED----------------------------FCPKISDFGLAKQ   77 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~~----------------------------~~~~L~dfg~~~~   77 (242)
                      .+++|+|+.+.||+++.+                            +.+.|+||+++..
T Consensus       249 ~v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~  307 (429)
T 1nw1_A          249 VTFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY  307 (429)
T ss_dssp             EEEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred             eEEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence            479999999999999875                            6789999987753

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=91.70  E-value=0.081  Score=43.15  Aligned_cols=29  Identities=21%  Similarity=0.406  Sum_probs=24.6

Q ss_pred             CCeeecCCCCCceeeCCCCceEEccccccc
Q 026160           47 VRIVHFDIKPHNILLDEDFCPKISDFGLAK   76 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~~~~~~L~dfg~~~   76 (242)
                      .+++|+|+.+.||+++.++ +.|+||+.+.
T Consensus       212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          212 IVFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             EEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             eEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            3799999999999998654 8999998775

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=91.15  E-value=0.27  Score=36.91  Aligned_cols=51  Identities=16%  Similarity=0.156  Sum_probs=44.0

Q ss_pred             ccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccc
Q 026160           20 RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLA   75 (242)
Q Consensus        20 ~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~   75 (242)
                      +.++..+++.++.+|+....++++.     +|.-+.|.|++++.++.+++.-.|+.
T Consensus        76 k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL~f~~~~~p~i~~RGik  126 (215)
T 4ann_A           76 KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDELFFTRDGLPIAKTRGLQ  126 (215)
T ss_dssp             GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGEEECTTSCEEESCCEET
T ss_pred             HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceEEEcCCCCEEEEEccCc
Confidence            4588899999999999988777755     78899999999999999999977754

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=89.66  E-value=0.17  Score=41.60  Aligned_cols=30  Identities=23%  Similarity=0.254  Sum_probs=25.6

Q ss_pred             CCeeecCCCCCceeeCCCCceEEcccccccc
Q 026160           47 VRIVHFDIKPHNILLDEDFCPKISDFGLAKQ   77 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~   77 (242)
                      ..++|||+.+.||+++.+ .+.++||..+..
T Consensus       227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~  256 (397)
T 2olc_A          227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFY  256 (397)
T ss_dssp             CEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             CceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence            389999999999999865 489999987764

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=89.06  E-value=0.18  Score=41.45  Aligned_cols=31  Identities=32%  Similarity=0.350  Sum_probs=27.0

Q ss_pred             CCeeecCCCCCceeeCCC----CceEEcccccccc
Q 026160           47 VRIVHFDIKPHNILLDED----FCPKISDFGLAKQ   77 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~~----~~~~L~dfg~~~~   77 (242)
                      ..++|+|+.+.||+++.+    +.+.++||.++..
T Consensus       220 ~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          220 VVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             EEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             cEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            489999999999999876    6899999998753

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=87.61  E-value=0.3  Score=40.39  Aligned_cols=30  Identities=30%  Similarity=0.310  Sum_probs=25.3

Q ss_pred             CeeecCCCCCceee------CCCCceEEcccccccc
Q 026160           48 RIVHFDIKPHNILL------DEDFCPKISDFGLAKQ   77 (242)
Q Consensus        48 ~i~h~dlk~~nil~------~~~~~~~L~dfg~~~~   77 (242)
                      .++|+|+.+.||++      +....+.++||.++..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            57899999999999      4456799999998863

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=83.68  E-value=0.47  Score=39.59  Aligned_cols=30  Identities=17%  Similarity=0.329  Sum_probs=26.4

Q ss_pred             CCeeecCCCCCceeeCCCCceEEcccccccc
Q 026160           47 VRIVHFDIKPHNILLDEDFCPKISDFGLAKQ   77 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~   77 (242)
                      ..++|+|+.+.|++ +.++.+.++||.++..
T Consensus       262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             ceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            37999999999999 7778899999998863

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	242
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-46
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-39
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	9e-39
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-38
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-38
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-38
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-38
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	9e-38
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-37
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-37
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-36
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-36
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-36
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-36
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-35
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-35
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-35
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-35
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-35
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-35
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	7e-35
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-34
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-34
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-34
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-34
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-33
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-33
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-32
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-32
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	6e-31
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-29
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-28
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-28
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	7e-28
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	7e-27
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-26
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-26
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-25
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-25
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-24
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-24
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-23
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-23
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-23
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-23
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-23
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	7e-23
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-22
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-21
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-21
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-21
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	9e-21
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-20
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-20
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-19
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-18
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-18
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	8e-18
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-17
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-16
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-14
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-14
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	7e-10

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 2e-46
 Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 22/213 (10%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
               SL    +  E+       E   +  IA   A+G++YLH      I+H D+K +NI 
Sbjct: 85  CEGSSLYHHLHIIETK-----FEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIF 136

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVF-CRSFGGASHKSDVYSYG 119
           L ED   KI DFGLA        +       G+I ++APEV   +     S +SDVY++G
Sbjct: 137 LHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 196

Query: 120 MMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVS 179
           +++ E+  G+           +I   + I   +  G        V     + +K+++   
Sbjct: 197 IVLYELMTGQLPYS-------NINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLM--- 246

Query: 180 LWCIQTNPSDRPSMHEVLEMLESSTEILQIPPK 212
             C++    +RP   ++L  +E    + +  PK
Sbjct: 247 AECLKKKRDERPLFPQILASIE---LLARSLPK 276

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (342), Expect = 1e-39
 Identities = 51/214 (23%), Positives = 88/214 (41%), Gaps = 24/214 (11%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSL  F   +      + L    +  +A  IA G+ Y+ R      VH D++  NIL
Sbjct: 93  MSKGSLLDFLKGE----TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANIL 145

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + E+   K++DFGLA+  +D + T +   A+  I + APE      G  + KSDV+S+G+
Sbjct: 146 VGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGI 202

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSL 180
           ++ E+    +                 +   +E G          E   +L+ +      
Sbjct: 203 LLTELTTKGRVPYPGMV-------NREVLDQVERGYRMPCPPECPESLHDLMCQ------ 249

Query: 181 WCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPS 214
            C +  P +RP+   +   LE      +   +P 
Sbjct: 250 -CWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 9e-39
 Identities = 43/200 (21%), Positives = 74/200 (37%), Gaps = 23/200 (11%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHR--GCNVRIVHFDIKPHN 58
              G L               L+   V ++   +   L+  HR       ++H D+KP N
Sbjct: 87  CEGGDLASVITKGTKERQ--YLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPAN 144

Query: 59  ILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSY 118
           + LD     K+ DFGLA+      S        GT  Y++PE   R     + KSD++S 
Sbjct: 145 VFLDGKQNVKLGDFGLARILNHDTSFAKAFV--GTPYYMSPEQMNR--MSYNEKSDIWSL 200

Query: 119 GMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILV 178
           G ++ E+                 +    +   I  G   ++    ++E  E++ +    
Sbjct: 201 GCLLYELCALM--------PPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITR---- 248

Query: 179 SLWCIQTNPSDRPSMHEVLE 198
               +      RPS+ E+LE
Sbjct: 249 ---MLNLKDYHRPSVEEILE 265

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 2e-38
 Identities = 49/200 (24%), Positives = 83/200 (41%), Gaps = 30/200 (15%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M +G+L  +          + ++ + +      I +GL++LH      I+H D+K  NI 
Sbjct: 94  MTSGTLKTYLKR------FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIF 146

Query: 61  L-DEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           +       KI D GLA   +   +        GT  ++APE++           DVY++G
Sbjct: 147 ITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFMAPEMYE---EKYDESVDVYAFG 199

Query: 120 MMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND-FQLDGVVTEEEKELVKKMILV 178
           M +LEMA             S+      IY+ +  G      D V   E KE+++     
Sbjct: 200 MCMLEMATSEYP-------YSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG---- 248

Query: 179 SLWCIQTNPSDRPSMHEVLE 198
              CI+ N  +R S+ ++L 
Sbjct: 249 ---CIRQNKDERYSIKDLLN 265

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 2e-38
 Identities = 46/219 (21%), Positives = 81/219 (36%), Gaps = 24/219 (10%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGC-----NVRIVHFDIK 55
             +GSL  +           T+    + ++A   A GL +LH           I H D+K
Sbjct: 83  HEHGSLFDYLN-------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 135

Query: 56  PHNILLDEDFCPKISDFGLAKQSQDKKSTISML--HARGTIGYIAPEVFCRSF----GGA 109
             NIL+ ++    I+D GLA +      TI +   H  GT  Y+APEV   S       +
Sbjct: 136 SKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFES 195

Query: 110 SHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVV----- 164
             ++D+Y+ G++  E+A       +        Y        +E       +  +     
Sbjct: 196 FKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP 255

Query: 165 -TEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES 202
              +  E ++ M  +   C   N + R +   + + L  
Sbjct: 256 NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 4e-38
 Identities = 51/208 (24%), Positives = 92/208 (44%), Gaps = 27/208 (12%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NGSL  F            L    +  +A  IA G+ ++        +H D++  NIL
Sbjct: 89  MENGSLVDFLKT----PSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANIL 141

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + +    KI+DFGLA+  +D +   +   A+  I + APE    ++G  + KSDV+S+G+
Sbjct: 142 VSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGI 198

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSL 180
           ++ E+    +      +          + +++E G          EE  +L++       
Sbjct: 199 LLTEIVTHGRIPYPGMT-------NPEVIQNLERGYRMVRPDNCPEELYQLMR------- 244

Query: 181 WCIQTNPSDRPSMHEVLEMLE---SSTE 205
            C +  P DRP+   +  +LE   ++TE
Sbjct: 245 LCWKERPEDRPTFDYLRSVLEDFFTATE 272

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  132 bits (333), Expect = 5e-38
 Identities = 47/219 (21%), Positives = 81/219 (36%), Gaps = 37/219 (16%)

Query: 1   MPNGSLDQF------------------TYDQESSNGNRTLEWRTVYQIAGGIARGLEYLH 42
           M  G L++F                  T  + SS G   L       IA  +A G+ YL 
Sbjct: 98  MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS 157

Query: 43  RGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVF 102
                + VH D+   N L+ E+   KI+DFGL++         +  +    I ++ PE  
Sbjct: 158 E---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI 214

Query: 103 CRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDG 162
             +    + +SDV++YG+++ E+           +          +  ++  GN      
Sbjct: 215 FYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMA-------HEEVIYYVRDGNILACPE 265

Query: 163 VVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE 201
               E   L+         C    P+DRPS   +  +L+
Sbjct: 266 NCPLELYNLM-------RLCWSKLPADRPSFCSIHRILQ 297

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (329), Expect = 9e-38
 Identities = 48/208 (23%), Positives = 86/208 (41%), Gaps = 28/208 (13%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M +G L  +   Q            T+  +   +  G+ YL   C   ++H D+   N L
Sbjct: 82  MEHGCLSDYLRTQ-----RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCL 133

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + E+   K+SDFG+ +   D + T S    +  + + +PEVF  SF   S KSDV+S+G+
Sbjct: 134 VGENQVIKVSDFGMTRFVLDDQYTSST-GTKFPVKWASPEVF--SFSRYSSKSDVWSFGV 190

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSL 180
           ++ E+    K          +    + + + I  G       + +    +++        
Sbjct: 191 LMWEVFSEGK-------IPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM-------N 236

Query: 181 WCIQTNPSDRPSMHEVLEMLESSTEILQ 208
            C +  P DRP+   +L  L    EI +
Sbjct: 237 HCWKERPEDRPAFSRLLRQLA---EIAE 261

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (324), Expect = 5e-37
 Identities = 46/201 (22%), Positives = 79/201 (39%), Gaps = 28/201 (13%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSL  +   +    G   L    + + +  +   +EYL        VH D+   N+L
Sbjct: 83  MAKGSLVDYLRSR----GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVL 135

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + ED   K+SDFGL K++   + T      +  + + APE         S KSDV+S+G+
Sbjct: 136 VSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALRE--KKFSTKSDVWSFGI 188

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSL 180
           ++ E+    +    +            +   +E G              E++K       
Sbjct: 189 LLWEIYSFGRVPYPRIP-------LKDVVPRVEKGYKMDAPDGCPPAVYEVMKN------ 235

Query: 181 WCIQTNPSDRPSMHEVLEMLE 201
            C   + + RPS  ++ E LE
Sbjct: 236 -CWHLDAAMRPSFLQLREQLE 255

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (324), Expect = 5e-37
 Identities = 49/198 (24%), Positives = 79/198 (39%), Gaps = 31/198 (15%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
            P G++ +              + +        +A  L Y H     R++H DIKP N+L
Sbjct: 88  APLGTVYRELQKL------SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLL 138

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           L      KI+DFG +  +   +         GT+ Y+ PE+          K D++S G+
Sbjct: 139 LGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEG--RMHDEKVDLWSLGV 192

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSL 180
           +  E  VG+   +               YK I    +F     VTE  ++L+ +      
Sbjct: 193 LCYEFLVGKPPFEANT--------YQETYKRISRV-EFTFPDFVTEGARDLISR------ 237

Query: 181 WCIQTNPSDRPSMHEVLE 198
             ++ NPS RP + EVLE
Sbjct: 238 -LLKHNPSQRPMLREVLE 254

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  129 bits (325), Expect = 1e-36
 Identities = 47/199 (23%), Positives = 78/199 (39%), Gaps = 30/199 (15%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
               + D            + L+   +  +  G  +GL YLH      ++H D+K  NIL
Sbjct: 97  CLGSASDLLEVH------KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNIL 147

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVF-CRSFGGASHKSDVYSYG 119
           L E    K+ DFG A       S +      GT  ++APEV      G    K DV+S G
Sbjct: 148 LSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLG 201

Query: 120 MMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVS 179
           +  +E+A  +           ++   +++Y   +  +     G  +E  +  V       
Sbjct: 202 ITCIELAERKPPLF-------NMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS----- 249

Query: 180 LWCIQTNPSDRPSMHEVLE 198
             C+Q  P DRP+   +L+
Sbjct: 250 --CLQKIPQDRPTSEVLLK 266

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 2e-36
 Identities = 38/201 (18%), Positives = 82/201 (40%), Gaps = 25/201 (12%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NG L  +  +          + + + ++   +   +EYL        +H D+   N L
Sbjct: 81  MANGCLLNYLREM-----RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCL 132

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           +++    K+SDFGL++   D + T S + ++  + +  PEV        S KSD++++G+
Sbjct: 133 VNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGV 189

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSL 180
           ++ E+    K          + +  +   +HI  G       + +E+   ++        
Sbjct: 190 LMWEIYSLGK-------MPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIM-------Y 235

Query: 181 WCIQTNPSDRPSMHEVLEMLE 201
            C      +RP+   +L  + 
Sbjct: 236 SCWHEKADERPTFKILLSNIL 256

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  128 bits (322), Expect = 2e-36
 Identities = 51/213 (23%), Positives = 87/213 (40%), Gaps = 30/213 (14%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M NGSLD F         +       +  +  GIA G++YL        VH D+   NIL
Sbjct: 109 MENGSLDSFLRQN-----DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNIL 160

Query: 61  LDEDFCPKISDFGLAKQSQDKKS---TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYS 117
           ++ +   K+SDFGL++  +D  S     S L  +  I + APE     +   +  SDV+S
Sbjct: 161 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI--QYRKFTSASDVWS 218

Query: 118 YGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMIL 177
           YG+++ E+    +       R         +   IE                +L+     
Sbjct: 219 YGIVMWEVMSYGE-------RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLM----- 266

Query: 178 VSLWCIQTNPSDRPSMHEVLEMLESSTEILQIP 210
             L C Q + + RP   +++  L+   ++++ P
Sbjct: 267 --LDCWQKDRNHRPKFGQIVNTLD---KMIRNP 294

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 3e-36
 Identities = 49/219 (22%), Positives = 80/219 (36%), Gaps = 35/219 (15%)

Query: 1   MPNGSLDQFTYDQ-----------------ESSNGNRTLEWRTVYQIAGGIARGLEYLHR 43
              G L  +   +                 E       L +  +   A  +A+G+E+L  
Sbjct: 123 CCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF 182

Query: 44  GCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFC 103
                 VH D+   N+L+      KI DFGLA+      + +   +AR  + ++APE   
Sbjct: 183 K---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF 239

Query: 104 RSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGV 163
              G  + KSDV+SYG+++ E+     N          I    + YK I+ G        
Sbjct: 240 E--GIYTIKSDVWSYGILLWEIFSLGVNPY------PGIPVDANFYKLIQNGFKMDQPFY 291

Query: 164 VTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES 202
            TEE   +++        C   +   RPS   +   L  
Sbjct: 292 ATEEIYIIMQS-------CWAFDSRKRPSFPNLTSFLGC 323

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 1e-35
 Identities = 44/214 (20%), Positives = 84/214 (39%), Gaps = 30/214 (14%)

Query: 1   MPNGSLDQF------------TYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVR 48
              G L  F            T      +    L+   +   +  +A+G+ +L       
Sbjct: 109 CCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---N 165

Query: 49  IVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGG 108
            +H D+   NILL      KI DFGLA+  ++  + +   +AR  + ++APE        
Sbjct: 166 CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--CV 223

Query: 109 ASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEE 168
            + +SDV+SYG+ + E+     +          +   +  YK I+ G           E 
Sbjct: 224 YTFESDVWSYGIFLWELFSLGSSPY------PGMPVDSKFYKMIKEGFRMLSPEHAPAEM 277

Query: 169 KELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES 202
            +++K        C   +P  RP+  ++++++E 
Sbjct: 278 YDIMKT-------CWDADPLKRPTFKQIVQLIEK 304

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (316), Expect = 2e-35
 Identities = 53/233 (22%), Positives = 91/233 (39%), Gaps = 56/233 (24%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  GSLDQ             +  + + +++  + +GL YL      +I+H D+KP NIL
Sbjct: 86  MDGGSLDQVLKK------AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNIL 137

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           ++     K+ DFG++ Q  D  +        GT  Y++PE         S +SD++S G+
Sbjct: 138 VNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERL--QGTHYSVQSDIWSMGL 191

Query: 121 MILEMAVGRK----------------------NADVKASRSSDIYFPNSIYKHIEPGNDF 158
            ++EMAVGR                              R+      +       P   F
Sbjct: 192 SLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIF 251

Query: 159 QL-------------DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
           +L              GV + E ++ V K       C+  NP++R  + +++ 
Sbjct: 252 ELLDYIVNEPPPKLPSGVFSLEFQDFVNK-------CLIKNPAERADLKQLMV 297

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 3e-35
 Identities = 44/180 (24%), Positives = 71/180 (39%), Gaps = 17/180 (9%)

Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS 78
           +  +      +    +  G+ YLH    + I H DIKP N+LLDE    KISDFGLA   
Sbjct: 97  DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF 153

Query: 79  QDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASR 138
           +       +    GT+ Y+APE+  R     +   DV+S G+++  M  G    D  +  
Sbjct: 154 RYNNRERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 212

Query: 139 SSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
             +           E          +      L+ K        +  NPS R ++ ++ +
Sbjct: 213 CQE------YSDWKEKKTYLNPWKKIDSAPLALLHK-------ILVENPSARITIPDIKK 259

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 3e-35
 Identities = 43/206 (20%), Positives = 85/206 (41%), Gaps = 23/206 (11%)

Query: 10  TYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKI 69
             D+     +       +  +  GIA G++YL        VH D+   NIL++ +   K+
Sbjct: 95  ALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKV 151

Query: 70  SDFGLAKQ-SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           SDFGL++    D ++T +    +  I + APE    S+   +  SDV+S+G+++ E+   
Sbjct: 152 SDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI--SYRKFTSASDVWSFGIVMWEVMTY 209

Query: 129 RKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPS 188
            +       R       + + K I  G              +L+       + C Q   +
Sbjct: 210 GE-------RPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLM-------MQCWQQERA 255

Query: 189 DRPSMHEVLEMLESSTEILQIPPKPS 214
            RP   +++ +L+   ++++ P    
Sbjct: 256 RRPKFADIVSILD---KLIRAPDSLK 278

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 4e-35
 Identities = 42/203 (20%), Positives = 80/203 (39%), Gaps = 26/203 (12%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
              G L+++         NR ++ + + ++   ++ G++YL        VH D+   N+L
Sbjct: 89  AELGPLNKYLQQ------NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVL 139

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTI-SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L      KISDFGL+K  +  ++   +  H +  + + APE         S KSDV+S+G
Sbjct: 140 LVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFG 197

Query: 120 MMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVS 179
           +++ E     +       +       + +   +E G           E  +L+       
Sbjct: 198 VLMWEAFSYGQ-------KPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL----- 245

Query: 180 LWCIQTNPSDRPSMHEVLEMLES 202
             C   +  +RP    V   L +
Sbjct: 246 --CWTYDVENRPGFAAVELRLRN 266

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 6e-35
 Identities = 46/203 (22%), Positives = 74/203 (36%), Gaps = 25/203 (12%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
              G L +F   +        +    V ++   ++ G++YL        VH D+   N+L
Sbjct: 90  AGGGPLHKFLVGK-----REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVL 141

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHA-RGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L      KISDFGL+K      S  +   A +  + + APE    +F   S +SDV+SYG
Sbjct: 142 LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI--NFRKFSSRSDVWSYG 199

Query: 120 MMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVS 179
           + + E     +    K            +   IE G   +       E   L+       
Sbjct: 200 VTMWEALSYGQKPYKKMK-------GPEVMAFIEQGKRMECPPECPPELYALMSD----- 247

Query: 180 LWCIQTNPSDRPSMHEVLEMLES 202
             C      DRP    V + + +
Sbjct: 248 --CWIYKWEDRPDFLTVEQRMRA 268

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 7e-35
 Identities = 46/218 (21%), Positives = 84/218 (38%), Gaps = 31/218 (14%)

Query: 1   MPNGSLDQFTYDQ----------ESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIV 50
              G+L  +   +                  L    +   +  +A+G+E+L    + + +
Sbjct: 100 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCI 156

Query: 51  HFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGAS 110
           H D+   NILL E    KI DFGLA+        +    AR  + ++APE         +
Sbjct: 157 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--RVYT 214

Query: 111 HKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKE 170
            +SDV+S+G+++ E+     +          +       + ++ G   +     T E  +
Sbjct: 215 IQSDVWSFGVLLWEIFSLGASPY------PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ 268

Query: 171 LVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQ 208
            +       L C    PS RP+  E++E L     +LQ
Sbjct: 269 TM-------LDCWHGEPSQRPTFSELVEHLG---NLLQ 296

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 1e-34
 Identities = 49/242 (20%), Positives = 96/242 (39%), Gaps = 36/242 (14%)

Query: 1   MPNGSLDQFTYDQE----------SSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIV 50
            P+G+L  F               +++   TL  + +   A  +ARG++YL      + +
Sbjct: 93  APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFI 149

Query: 51  HFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGAS 110
           H D+   NIL+ E++  KI+DFGL++  +           R  + ++A E         +
Sbjct: 150 HRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG---RLPVRWMAIESLNY--SVYT 204

Query: 111 HKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKE 170
             SDV+SYG+++ E+           +          +Y+ +  G   +      +E  +
Sbjct: 205 TNSDVWSYGVLLWEIVSLGGTPYCGMT-------CAELYEKLPQGYRLEKPLNCDDEVYD 257

Query: 171 LVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSLALPKKSAIQSSRTSS 230
           L+++       C +  P +RPS  ++L  L     +L+   K  +          +    
Sbjct: 258 LMRQ-------CWREKPYERPSFAQILVSLN---RMLE-ERKTYVNTTLYEKFTYAGIDC 306

Query: 231 SA 232
           SA
Sbjct: 307 SA 308

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 2e-34
 Identities = 49/231 (21%), Positives = 91/231 (39%), Gaps = 27/231 (11%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           MP G L  +  + + + G      + +      IA+G+ YL    + R+VH D+   N+L
Sbjct: 92  MPFGCLLDYVREHKDNIG-----SQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVL 143

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           +      KI+DFGLAK    ++        +  I ++A E         +H+SDV+SYG+
Sbjct: 144 VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGV 201

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSL 180
            + E+            +  D    + I   +E G       + T +   ++ K      
Sbjct: 202 TVWELMTFGS-------KPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVK------ 248

Query: 181 WCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSLALPKKSAIQSSRTSSS 231
            C   +   RP   E++       ++ + P +  +    +     S T S+
Sbjct: 249 -CWMIDADSRPKFRELIIEFS---KMARDPQRYLVIQGDERMHLPSPTDSN 295

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  122 bits (307), Expect = 3e-34
 Identities = 48/202 (23%), Positives = 87/202 (43%), Gaps = 24/202 (11%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  G+L  +  +       + +    +  +A  I+  +EYL +      +H D+   N L
Sbjct: 95  MTYGNLLDYLRE----CNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCL 147

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           + E+   K++DFGL++       T +   A+  I + APE         S KSDV+++G+
Sbjct: 148 VGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGV 204

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSL 180
           ++ E+A    +              + +Y+ +E     +      E+  EL+        
Sbjct: 205 LLWEIATYGMSPYPGID-------LSQVYELLEKDYRMERPEGCPEKVYELM-------R 250

Query: 181 WCIQTNPSDRPSMHEVLEMLES 202
            C Q NPSDRPS  E+ +  E+
Sbjct: 251 ACWQWNPSDRPSFAEIHQAFET 272

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 5e-34
 Identities = 44/203 (21%), Positives = 76/203 (37%), Gaps = 30/203 (14%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
              G++D    + E     R L    +  +       L YLH     +I+H D+K  NIL
Sbjct: 91  CAGGAVDAVMLELE-----RPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNIL 142

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVF---CRSFGGASHKSDVYS 117
              D   K++DFG++ ++             GT  ++APEV            +K+DV+S
Sbjct: 143 FTLDGDIKLADFGVSAKNTRTIQRRDSF--IGTPYWMAPEVVMCETSKDRPYDYKADVWS 200

Query: 118 YGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHI--EPGNDFQLDGVVTEEEKELVKKM 175
            G+ ++EMA                  P  +   I              +   K+ +KK 
Sbjct: 201 LGITLIEMAEIE--------PPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKK- 251

Query: 176 ILVSLWCIQTNPSDRPSMHEVLE 198
                 C++ N   R +  ++L+
Sbjct: 252 ------CLEKNVDARWTTSQLLQ 268

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 1e-33
 Identities = 40/204 (19%), Positives = 79/204 (38%), Gaps = 26/204 (12%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M +G L  F  ++           + +      +A+G+       + + VH D+   N +
Sbjct: 111 MKHGDLRNFIRNE-----THNPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCM 162

Query: 61  LDEDFCPKISDFGLAKQ--SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSY 118
           LDE F  K++DFGLA+    ++  S  +   A+  + ++A E         + KSDV+S+
Sbjct: 163 LDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSF 220

Query: 119 GMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILV 178
           G+++ E+           +          I  ++  G          +   E++      
Sbjct: 221 GVLLWELMTRGAPPYPDVN-------TFDITVYLLQGRRLLQPEYCPDPLYEVM------ 267

Query: 179 SLWCIQTNPSDRPSMHEVLEMLES 202
            L C       RPS  E++  + +
Sbjct: 268 -LKCWHPKAEMRPSFSELVSRISA 290

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 2e-33
 Identities = 45/202 (22%), Positives = 78/202 (38%), Gaps = 25/202 (12%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
              G L  F   +       +L+  ++   A  ++  L YL      R VH DI   N+L
Sbjct: 89  CTLGELRSFLQVR-----KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVL 140

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           +  + C K+ DFGL++  +D     +    +  I ++APE    +F   +  SDV+ +G+
Sbjct: 141 VSSNDCVKLGDFGLSRYMEDSTYYKAS-KGKLPIKWMAPESI--NFRRFTSASDVWMFGV 197

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSL 180
            + E+ +          +       N +   IE G    +          L+ K      
Sbjct: 198 CMWEILMHGV-------KPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK------ 244

Query: 181 WCIQTNPSDRPSMHEVLEMLES 202
            C   +PS RP   E+   L +
Sbjct: 245 -CWAYDPSRRPRFTELKAQLST 265

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 3e-32
 Identities = 47/211 (22%), Positives = 88/211 (41%), Gaps = 29/211 (13%)

Query: 1   MPNGSLDQF----------TYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIV 50
              G+L ++               S N    L  + +   A  +ARG+EYL    + + +
Sbjct: 101 ASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCI 157

Query: 51  HFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGAS 110
           H D+   N+L+ ED   KI+DFGLA+            + R  + ++APE         +
Sbjct: 158 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--RIYT 215

Query: 111 HKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKE 170
           H+SDV+S+G+++ E+     +                ++K ++ G+        T E   
Sbjct: 216 HQSDVWSFGVLLWEIFTLGGSPYPGVP-------VEELFKLLKEGHRMDKPSNCTNELYM 268

Query: 171 LVKKMILVSLWCIQTNPSDRPSMHEVLEMLE 201
           +++        C    PS RP+  +++E L+
Sbjct: 269 MMRD-------CWHAVPSQRPTFKQLVEDLD 292

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 6e-32
 Identities = 47/209 (22%), Positives = 81/209 (38%), Gaps = 23/209 (11%)

Query: 1   MPNGSLDQFTYDQESSNGNR----TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKP 56
           M  G L  +      +  N           + Q+AG IA G+ YL      + VH D+  
Sbjct: 105 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAA 161

Query: 57  HNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVY 116
            N ++ EDF  KI DFG+ +   +             + +++PE      G  +  SDV+
Sbjct: 162 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL--KDGVFTTYSDVW 219

Query: 117 SYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMI 176
           S+G+++ E+A   +      S          + + +  G          +   EL++   
Sbjct: 220 SFGVVLWEIATLAEQPYQGLS-------NEQVLRFVMEGGLLDKPDNCPDMLFELMR--- 269

Query: 177 LVSLWCIQTNPSDRPSMHEVLEMLESSTE 205
                C Q NP  RPS  E++  ++   E
Sbjct: 270 ----MCWQYNPKMRPSFLEIISSIKEEME 294

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 6e-31
 Identities = 41/202 (20%), Positives = 69/202 (34%), Gaps = 24/202 (11%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
            P GSL       +           T+ + A  +A G+ YL        +H D+   N+L
Sbjct: 92  APLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLL 143

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISML-HARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           L      KI DFGL +          M  H +    + APE         SH SD + +G
Sbjct: 144 LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFG 201

Query: 120 MMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVS 179
           + + EM    +           +     ++K  + G          ++   ++       
Sbjct: 202 VTLWEMFTYGQEPW------IGLNGSQILHKIDKEGERLPRPEDCPQDIYNVM------- 248

Query: 180 LWCIQTNPSDRPSMHEVLEMLE 201
           + C    P DRP+   + + L 
Sbjct: 249 VQCWAHKPEDRPTFVALRDFLL 270

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  108 bits (270), Expect = 5e-29
 Identities = 46/209 (22%), Positives = 82/209 (39%), Gaps = 42/209 (20%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  G L  +  +        TL  +   +I   +   +  LH+   + IVH D+KP NIL
Sbjct: 92  MKKGELFDYLTE------KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENIL 142

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRS----FGGASHKSDVY 116
           LD+D   K++DFG + Q    +    +    GT  Y+APE+   S      G   + D++
Sbjct: 143 LDDDMNIKLTDFGFSCQLDPGEKLREV---CGTPSYLAPEIIECSMNDNHPGYGKEVDMW 199

Query: 117 SYGMMILEMAVGR-------KNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEK 169
           S G+++  +  G        +   ++   S +  F +  +               ++  K
Sbjct: 200 STGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY------------SDTVK 247

Query: 170 ELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
           +LV +        +   P  R +  E L 
Sbjct: 248 DLVSR-------FLVVQPQKRYTAEEALA 269

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (269), Expect = 1e-28
 Identities = 46/199 (23%), Positives = 80/199 (40%), Gaps = 29/199 (14%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +  GSL     +              +  +     + LE+LH     +++H DIK  NIL
Sbjct: 99  LAGGSLTDVVTETCMD-------EGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNIL 148

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           L  D   K++DFG   Q   ++S  S +   GT  ++APEV  R       K D++S G+
Sbjct: 149 LGMDGSVKLTDFGFCAQITPEQSKRSTMV--GTPYWMAPEVVTR--KAYGPKVDIWSLGI 204

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN-DFQLDGVVTEEEKELVKKMILVS 179
           M +EM  G      +           ++Y     G  + Q    ++   ++ + +     
Sbjct: 205 MAIEMIEGEPPYLNENPL-------RALYLIATNGTPELQNPEKLSAIFRDFLNR----- 252

Query: 180 LWCIQTNPSDRPSMHEVLE 198
             C+  +   R S  E+L+
Sbjct: 253 --CLDMDVEKRGSAKELLQ 269

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  106 bits (266), Expect = 6e-28
 Identities = 43/207 (20%), Positives = 81/207 (39%), Gaps = 41/207 (19%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  G L +   D+     +  +      +    + +GL ++H       VH D+KP NI+
Sbjct: 105 MSGGELFEKVADE-----HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIM 156

Query: 61  LDEDFCP--KISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSY 118
                    K+ DFGL      K+S        GT  + APEV         + +D++S 
Sbjct: 157 FTTKRSNELKLIDFGLTAHLDPKQSVKVT---TGTAEFAAPEVAEG--KPVGYYTDMWSV 211

Query: 119 GMMILEMAVGR-------KNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKEL 171
           G++   +  G         +  ++  +S D    +S +  I            +E+ K+ 
Sbjct: 212 GVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI------------SEDGKDF 259

Query: 172 VKKMILVSLWCIQTNPSDRPSMHEVLE 198
           ++K        +  +P+ R ++H+ LE
Sbjct: 260 IRK-------LLLADPNTRMTIHQALE 279

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 7e-28
 Identities = 45/201 (22%), Positives = 79/201 (39%), Gaps = 27/201 (13%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
             NG L ++           + +          I   LEYLH      I+H D+KP NIL
Sbjct: 90  AKNGELLKYIRKI------GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENIL 140

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           L+ED   +I+DFG AK    +          GT  Y++PE+   +   A   SD+++ G 
Sbjct: 141 LNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL--TEKSACKSSDLWALGC 198

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSL 180
           +I ++  G         R+ +      I++ I    ++        + ++LV+K      
Sbjct: 199 IIYQLVAGL-----PPFRAGN---EYLIFQKIIKL-EYDFPEKFFPKARDLVEK------ 243

Query: 181 WCIQTNPSDRPSMHEVLEMLE 201
             +  + + R    E+     
Sbjct: 244 -LLVLDATKRLGCEEMEGYGP 263

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 7e-27
 Identities = 47/225 (20%), Positives = 83/225 (36%), Gaps = 25/225 (11%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +  G L     D     G++    R   +I   I   ++YLH    + I H D+KP N+L
Sbjct: 91  LDGGELFSRIQD----RGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLL 143

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
                   I        +++  S  S+     T  Y+APEV            D++S G+
Sbjct: 144 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGV 201

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN---DFQLDGVVTEEEKELVKKMIL 177
           ++  +  G          +  +     +   I  G           V+EE K L++    
Sbjct: 202 IMYILLCGY----PPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN--- 254

Query: 178 VSLWCIQTNPSDRPSMHEVLEM--LESSTEILQIPPKPSLALPKK 220
                ++T P+ R ++ E +    +  ST++ Q P   S  L + 
Sbjct: 255 ----LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKED 295

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  101 bits (251), Expect = 4e-26
 Identities = 31/203 (15%), Positives = 63/203 (31%), Gaps = 23/203 (11%)

Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCP-----KISDFG 73
            R    +TV   A  +   ++ +H      +V+ DIKP N L+            + DFG
Sbjct: 95  GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 151

Query: 74  LAKQSQDKKSTISMLHAR-----GTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVG 128
           + K  +D  +   + +       GT  Y++           S + D+ + G + +    G
Sbjct: 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRG 209

Query: 129 RKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPS 188
                   + ++   +   I +  +     +L     EE  + +                
Sbjct: 210 SLPWQGLKAATNKQKY-ERIGEKKQSTPLRELCAGFPEEFYKYMHY-------ARNLAFD 261

Query: 189 DRPSMHEVLEMLESSTEILQIPP 211
             P    +  +     E L    
Sbjct: 262 ATPDYDYLQGLFSKVLERLNTTE 284

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (251), Expect = 4e-26
 Identities = 46/216 (21%), Positives = 80/216 (37%), Gaps = 33/216 (15%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +    +DQ             +   T+  +   + RGL++LH      +VH D+KP NIL
Sbjct: 92  LVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNIL 148

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           +      K++DFGLA+    + +  S+     T+ Y APEV  +     +   D++S G 
Sbjct: 149 VTSSGQIKLADFGLARIYSFQMALTSV---VVTLWYRAPEVLLQ--SSYATPVDLWSVGC 203

Query: 121 MILEMAVGR------------------KNADVKASRSSDIYFPNSIYKHIEPGNDFQLDG 162
           +  EM   +                       +     D+  P   +         +   
Sbjct: 204 IFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVT 263

Query: 163 VVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
            + E  K+L+ K       C+  NP+ R S +  L 
Sbjct: 264 DIDELGKDLLLK-------CLTFNPAKRISAYSALS 292

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 1e-25
 Identities = 43/260 (16%), Positives = 84/260 (32%), Gaps = 53/260 (20%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +    + +             L  R +      +   L++LH      I HFDI+P NI+
Sbjct: 83  ISGLDIFERINTS-----AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENII 134

Query: 61  LDEDFCP--KISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSY 118
                    KI +FG A+Q +   +   +        Y APEV        S  +D++S 
Sbjct: 135 YQTRRSSTIKIIEFGQARQLKPGDNFRLL---FTAPEYYAPEVHQH--DVVSTATDMWSL 189

Query: 119 GMMILEMAVGRK-------NADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKEL 171
           G ++  +  G            ++   +++  F    +K I            + E  + 
Sbjct: 190 GTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI------------SIEAMDF 237

Query: 172 VKKMILVSLWCIQTNPSDRPSMHEVLE-------MLESSTEILQIPPK-----PSLALPK 219
           V +        +      R +  E L+       +   ST++++           +    
Sbjct: 238 VDR-------LLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDL 290

Query: 220 KSAIQSSRTSSSAGIEEVMG 239
              + ++R S    I    G
Sbjct: 291 NMVVSAARISCGGAIRSQKG 310

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 99.1 bits (246), Expect = 2e-25
 Identities = 35/192 (18%), Positives = 68/192 (35%), Gaps = 21/192 (10%)

Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL---LDEDFCPKISDFGLA 75
           +R    +TV  +A  +   +EY+H       +H D+KP N L     +     I DFGLA
Sbjct: 97  SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153

Query: 76  KQSQDKKSTISMLHAR-----GTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRK 130
           K+ +D ++   + +       GT  Y +           S + D+ S G +++   +G  
Sbjct: 154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSL 211

Query: 131 NADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDR 190
                 + +    +     K +    +    G    E    +         C      D+
Sbjct: 212 PWQGLKAATKRQKYERISEKKMSTPIEVLCKGY-PSEFATYLNF-------CRSLRFDDK 263

Query: 191 PSMHEVLEMLES 202
           P    + ++  +
Sbjct: 264 PDYSYLRQLFRN 275

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 98.3 bits (244), Expect = 1e-24
 Identities = 48/210 (22%), Positives = 79/210 (37%), Gaps = 32/210 (15%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M  G L          +         +   A  I  GLE++H      +V+ D+KP NIL
Sbjct: 89  MNGGDLHYHLSQHGVFS------EADMRFYAAEIILGLEHMHNRF---VVYRDLKPANIL 139

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           LDE    +ISD GLA     KK   S+    GT GY+APEV  +        +D +S G 
Sbjct: 140 LDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKG-VAYDSSADWFSLGC 194

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSL 180
           M+ ++  G        ++             +      +L    + E + L++       
Sbjct: 195 MLFKLLRGHSPFRQHKTKDKHEID------RMTLTMAVELPDSFSPELRSLLEG------ 242

Query: 181 WCIQTNPSDRPSMHEVLEMLESSTEILQIP 210
             +Q + + R        +   + E+ + P
Sbjct: 243 -LLQRDVNRRLGC-----LGRGAQEVKESP 266

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 97.1 bits (241), Expect = 3e-24
 Identities = 42/207 (20%), Positives = 73/207 (35%), Gaps = 41/207 (19%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +  G L      +     +  +    V         GL+++H      IVH DIKP NI+
Sbjct: 108 LSGGELFDRIAAE-----DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIM 159

Query: 61  LDEDFCP--KISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSY 118
            +       KI DFGLA +    +          T  + APE+  R        +D+++ 
Sbjct: 160 CETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEFAAPEIVDR--EPVGFYTDMWAI 214

Query: 119 GMMILEMAVGR-------KNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKEL 171
           G++   +  G            ++  +  D  F    +  + P            E K+ 
Sbjct: 215 GVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP------------EAKDF 262

Query: 172 VKKMILVSLWCIQTNPSDRPSMHEVLE 198
           +K         +Q  P  R ++H+ LE
Sbjct: 263 IKN-------LLQKEPRKRLTVHDALE 282

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 94.3 bits (234), Expect = 1e-23
 Identities = 40/198 (20%), Positives = 68/198 (34%), Gaps = 23/198 (11%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +  G L     +            R   ++   +   ++YLH    V             
Sbjct: 89  VSGGELFDRIVE------KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYS 142

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           LDED    ISDFGL+K         +     GT GY+APEV  +     S   D +S G+
Sbjct: 143 LDEDSKIMISDFGLSKMEDPGSVLSTAC---GTPGYVAPEVLAQ--KPYSKAVDCWSIGV 197

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSL 180
           +   +  G           +D      I K  E   D      +++  K+ ++       
Sbjct: 198 IAYILLCGYPPFY----DENDAKLFEQILKA-EYEFDSPYWDDISDSAKDFIRH------ 246

Query: 181 WCIQTNPSDRPSMHEVLE 198
             ++ +P  R +  + L+
Sbjct: 247 -LMEKDPEKRFTCEQALQ 263

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.6 bits (232), Expect = 1e-23
 Identities = 44/199 (22%), Positives = 69/199 (34%), Gaps = 35/199 (17%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
            P    D F +  E       L+          +   + +     N  ++H DIK  NIL
Sbjct: 90  RPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHC---HNCGVLHRDIKDENIL 142

Query: 61  LDED-FCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           +D +    K+ DFG     +D   T       GT  Y  PE   R        + V+S G
Sbjct: 143 IDLNRGELKLIDFGSGALLKDTVYT----DFDGTRVYSPPEWI-RYHRYHGRSAAVWSLG 197

Query: 120 MMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVS 179
           +++ +M  G                P    + I  G        V+ E + L++      
Sbjct: 198 ILLYDMVCGD--------------IPFEHDEEIIRG-QVFFRQRVSSECQHLIRW----- 237

Query: 180 LWCIQTNPSDRPSMHEVLE 198
             C+   PSDRP+  E+  
Sbjct: 238 --CLALRPSDRPTFEEIQN 254

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.5 bits (234), Expect = 2e-23
 Identities = 44/203 (21%), Positives = 70/203 (34%), Gaps = 34/203 (16%)

Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS 78
            + L    +      I RGL+Y+H      ++H D+KP N+LL+     KI DFGLA+ +
Sbjct: 103 TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159

Query: 79  QDKKSTISMLHAR-GTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR-------- 129
                    L     T  Y APE+   S G  +   D++S G ++ EM   R        
Sbjct: 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGY-TKSIDIWSVGCILAEMLSNRPIFPGKHY 218

Query: 130 --------------KNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKM 175
                            D+    +           H       +L      +  +L+ K 
Sbjct: 219 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDK- 277

Query: 176 ILVSLWCIQTNPSDRPSMHEVLE 198
                  +  NP  R  + + L 
Sbjct: 278 ------MLTFNPHKRIEVEQALA 294

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.0 bits (233), Expect = 2e-23
 Identities = 47/197 (23%), Positives = 78/197 (39%), Gaps = 29/197 (14%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +  G L                +       A  I  GL++LH      IV+ D+K  NIL
Sbjct: 85  LNGGDLMYHIQS------CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNIL 135

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGM 120
           LD+D   KI+DFG+ K++    +  +     GT  YIAPE+        +H  D +S+G+
Sbjct: 136 LDKDGHIKIADFGMCKENMLGDAKTNTF--CGTPDYIAPEILLG--QKYNHSVDWWSFGV 191

Query: 121 MILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSL 180
           ++ EM +G+     +            ++  I   N F     + +E K+L+ K      
Sbjct: 192 LLYEMLIGQSPFHGQD--------EEELFHSIRMDNPFYPRW-LEKEAKDLLVK------ 236

Query: 181 WCIQTNPSDRPSMHEVL 197
                 P  R  +   +
Sbjct: 237 -LFVREPEKRLGVRGDI 252

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.3 bits (231), Expect = 6e-23
 Identities = 51/254 (20%), Positives = 97/254 (38%), Gaps = 30/254 (11%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +P          +  S   +TL    V      + R L Y+H      I H DIKP N+L
Sbjct: 101 VPETVYRVA---RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLL 154

Query: 61  LDED-FCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           LD D    K+ DFG AKQ    +  +S + +R    Y APE+   +    +   DV+S G
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPELIFGAT-DYTSSIDVWSAG 210

Query: 120 MMILEMAVGR--------KNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKEL 171
            ++ E+ +G+         +  V+  +         I +      +F+   +      ++
Sbjct: 211 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKV 270

Query: 172 VKKMI---LVSL--WCIQTNPSDRPSMHEVL------EMLESSTEILQIPPKPSLALPKK 220
            +       ++L    ++  P+ R +  E        E+ + + ++      P+L     
Sbjct: 271 FRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTT 330

Query: 221 SAIQSSRTSSSAGI 234
             + S+   ++  I
Sbjct: 331 QELSSNPPLATILI 344

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.2 bits (228), Expect = 7e-23
 Identities = 47/228 (20%), Positives = 81/228 (35%), Gaps = 35/228 (15%)

Query: 11  YDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKIS 70
            +    + +  L    +        +GLEYLH+     I+H D+KP+N+LLDE+   K++
Sbjct: 86  LEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLA 142

Query: 71  DFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR- 129
           DFGLAK            H   T  Y APE+            D+++ G ++ E+ +   
Sbjct: 143 DFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFG-ARMYGVGVDMWAVGCILAELLLRVP 199

Query: 130 -----KNADVKASRSSDIYFPNS-------------IYKHIEPGNDFQLDGVVTEEEKEL 171
                 + D        +  P                +K         +     ++  +L
Sbjct: 200 FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDL 259

Query: 172 VKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSLALPK 219
           ++            NP  R +  + L+M   S       P P   LP+
Sbjct: 260 IQG-------LFLFNPCARITATQALKMKYFSNRPG---PTPGCQLPR 297

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 90.6 bits (224), Expect = 2e-22
 Identities = 40/205 (19%), Positives = 80/205 (39%), Gaps = 29/205 (14%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +   +L    + +        +  +   ++     + L + H+     I+H D+KP NI+
Sbjct: 93  VDGVTLRDIVHTE------GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIM 143

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHAR-GTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           +      K+ DFG+A+   D  ++++   A  GT  Y++PE           +SDVYS G
Sbjct: 144 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLG 201

Query: 120 MMILEMAVGRKNADVKASRSSDIYFPNSIYKHI--EPGNDFQLDGVVTEEEKELVKKMIL 177
            ++ E+  G                 +  Y+H+  +P         ++ +   +V K   
Sbjct: 202 CVLYEVLTGEPPFT-------GDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLK--- 251

Query: 178 VSLWCIQTNPSDRP-SMHEVLEMLE 201
                +  NP +R  +  E+   L 
Sbjct: 252 ----ALAKNPENRYQTAAEMRADLV 272

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 87.6 bits (216), Expect = 3e-21
 Identities = 47/200 (23%), Positives = 74/200 (37%), Gaps = 33/200 (16%)

Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS 78
              LE  T       +  G+ Y H     R++H D+KP N+L++ +   KI+DFGLA+  
Sbjct: 94  EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAF 150

Query: 79  QDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR------KNA 132
                     H   T+ Y AP+V        S   D++S G +  EM  G         A
Sbjct: 151 GIPVRK--YTHEIVTLWYRAPDVL-MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA 207

Query: 133 DVKASRSSDIYFPNS--------------IYKHIEPGNDFQLDGVVTEEEKELVKKMILV 178
           D        +  PNS               +   EP         + E   +L+ K    
Sbjct: 208 DQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSK---- 263

Query: 179 SLWCIQTNPSDRPSMHEVLE 198
               ++ +P+ R +  + LE
Sbjct: 264 ---MLKLDPNQRITAKQALE 280

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 87.8 bits (217), Expect = 3e-21
 Identities = 49/188 (26%), Positives = 74/188 (39%), Gaps = 31/188 (16%)

Query: 23  EWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK 82
                   A  +   LEYLH      I++ D+KP NILLD++   KI+DFG AK   D  
Sbjct: 102 PNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 158

Query: 83  STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDI 142
            T+      GT  YIAPEV   S    +   D +S+G++I EM  G              
Sbjct: 159 YTL-----CGTPDYIAPEVV--STKPYNKSIDWWSFGILIYEMLAGYTPFYDSN------ 205

Query: 143 YFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES 202
                 Y+ I    + +      E+ K+L+ +        I  + S R        +   
Sbjct: 206 --TMKTYEKILNA-ELRFPPFFNEDVKDLLSR-------LITRDLSQRLGN-----LQNG 250

Query: 203 STEILQIP 210
           + ++   P
Sbjct: 251 TEDVKNHP 258

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.0 bits (217), Expect = 4e-21
 Identities = 34/216 (15%), Positives = 79/216 (36%), Gaps = 28/216 (12%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
             +            SN         + ++   +  GL Y+HR    +I+H D+K  N+L
Sbjct: 99  CEHDLAGLL------SNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVL 149

Query: 61  LDEDFCPKISDFGLAKQSQDKKSTISMLHAR--GTIGYIAPEVFCRSFGGASHKSDVYSY 118
           +  D   K++DFGLA+     K++    +     T+ Y  PE+            D++  
Sbjct: 150 ITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL-LGERDYGPPIDLWGA 208

Query: 119 GMMILEMAVGR-----KNADVKASRSSDIY--FPNSIYKHIEPGNDFQLDGVVTEEEKEL 171
           G ++ EM              + +  S +       ++ +++    ++   +V  +++++
Sbjct: 209 GCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKV 268

Query: 172 VKKMILVSL---------WCIQTNPSDRPSMHEVLE 198
             ++                +  +P+ R    + L 
Sbjct: 269 KDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.5 bits (213), Expect = 9e-21
 Identities = 38/213 (17%), Positives = 76/213 (35%), Gaps = 33/213 (15%)

Query: 6   LDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF 65
           L Q       ++    +    +      + +GL + H      ++H D+KP N+L++ + 
Sbjct: 83  LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEG 139

Query: 66  CPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEM 125
             K++DFGLA+       T +      T+ Y APE+        S   D++S G +  EM
Sbjct: 140 AIKLADFGLARAFGVPVRTYTHEV--VTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEM 196

Query: 126 AVGRK------NADVKASRSSDIYFPNSI--------------YKHIEPGNDFQLDGVVT 165
              R         D        +  P+ +              +      +  ++   + 
Sbjct: 197 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 256

Query: 166 EEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
           E+ + L+ +        +  +P+ R S    L 
Sbjct: 257 EDGRSLLSQ-------MLHYDPNKRISAKAALA 282

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.0 bits (212), Expect = 3e-20
 Identities = 40/187 (21%), Positives = 72/187 (38%), Gaps = 25/187 (13%)

Query: 24  WRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKS 83
             T  +     A  +  L    +  +V+ DIK  N++LD+D   KI+DFGL K+     +
Sbjct: 101 VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160

Query: 84  TISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIY 143
           T  M    GT  Y+APEV            D +  G+++ EM  GR     +        
Sbjct: 161 T--MKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------- 209

Query: 144 FPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS 203
               +++ I    + +    ++ E K L+          ++ +P  R            +
Sbjct: 210 -HERLFELILME-EIRFPRTLSPEAKSLLAG-------LLKKDPKQRLGGGP-----SDA 255

Query: 204 TEILQIP 210
            E+++  
Sbjct: 256 KEVMEHR 262

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.8 bits (209), Expect = 4e-20
 Identities = 39/202 (19%), Positives = 76/202 (37%), Gaps = 30/202 (14%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           +  G L  F  +        +L      +    I  G+ YLH      I HFD+KP NI+
Sbjct: 95  VAGGELFDFLAE------KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIM 145

Query: 61  LDEDFCP----KISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVY 116
           L +   P    KI DFGLA +           +  GT  ++APE+   ++     ++D++
Sbjct: 146 LLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIV--NYEPLGLEADMW 200

Query: 117 SYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMI 176
           S G++   +  G            +          +    + +     +   K+ +++  
Sbjct: 201 SIGVITYILLSGASP--FLGDTKQETLA---NVSAVNYEFEDEYFSNTSALAKDFIRR-- 253

Query: 177 LVSLWCIQTNPSDRPSMHEVLE 198
                 +  +P  R ++ + L+
Sbjct: 254 -----LLVKDPKKRMTIQDSLQ 270

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.5 bits (205), Expect = 1e-19
 Identities = 36/194 (18%), Positives = 74/194 (38%), Gaps = 20/194 (10%)

Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS 78
           N  L+   V      + +GL + H   +  ++H D+KP N+L++ +   K+++FGLA+  
Sbjct: 95  NGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAF 151

Query: 79  QDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR--------- 129
                  S      T+ Y  P+V   +    S   D++S G +  E+A            
Sbjct: 152 GIPVRCYSAEV--VTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208

Query: 130 -----KNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQ 184
                +   +  + + + +   +     +P   +     +     +L      +    ++
Sbjct: 209 DDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLK 268

Query: 185 TNPSDRPSMHEVLE 198
            NP  R S  E L+
Sbjct: 269 CNPVQRISAEEALQ 282

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.0 bits (199), Expect = 1e-18
 Identities = 35/177 (19%), Positives = 70/177 (39%), Gaps = 18/177 (10%)

Query: 34  IARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGT 93
           +   +  L     + I++ DIK  NILLD +    ++DFGL+K+    ++  +     GT
Sbjct: 135 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY-DFCGT 193

Query: 94  IGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIE 153
           I Y+AP++      G     D +S G+++ E+  G        +   +      I + I 
Sbjct: 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA----SPFTVDGEKNSQAEISRRIL 249

Query: 154 PGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIP 210
              +      ++   K+L+++        +  +P  R            + EI +  
Sbjct: 250 KS-EPPYPQEMSALAKDLIQR-------LLMKDPKKRLGCGP-----RDADEIKEHL 293

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 80.7 bits (198), Expect = 2e-18
 Identities = 35/228 (15%), Positives = 75/228 (32%), Gaps = 53/228 (23%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           + N    Q           +TL    +      I + L+Y H      I+H D+KPHN++
Sbjct: 114 VNNTDFKQL---------YQTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVM 161

Query: 61  LDEDFCP-KISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           +D +    ++ D+GLA+     +          +  +  PE+    +    +  D++S G
Sbjct: 162 IDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPEL-LVDYQMYDYSLDMWSLG 217

Query: 120 MMILEMAVGR-----------------------------KNADVKASRSSDIYFPNSIYK 150
            M+  M   +                                +++     +        K
Sbjct: 218 CMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRK 277

Query: 151 HIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
             E     +   +V+ E  + + K+       ++ +   R +  E +E
Sbjct: 278 RWERFVHSENQHLVSPEALDFLDKL-------LRYDHQSRLTAREAME 318

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 79.1 bits (194), Expect = 8e-18
 Identities = 40/185 (21%), Positives = 76/185 (41%), Gaps = 31/185 (16%)

Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS 78
                       A  I    EYLH    + +++ D+KP N+L+D+    +++DFG AK+ 
Sbjct: 135 IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191

Query: 79  QDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASR 138
           + +  T+      GT   +APE+      G +   D ++ G++I EMA G          
Sbjct: 192 KGRTWTL-----CGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGY--------P 236

Query: 139 SSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDR-----PSM 193
                 P  IY+ I  G   +     + + K+L++         +Q + + R       +
Sbjct: 237 PFFADQPIQIYEKIVSG-KVRFPSHFSSDLKDLLRN-------LLQVDLTKRFGNLKNGV 288

Query: 194 HEVLE 198
           +++  
Sbjct: 289 NDIKN 293

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.3 bits (192), Expect = 1e-17
 Identities = 39/195 (20%), Positives = 76/195 (38%), Gaps = 24/195 (12%)

Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS 78
           +  L    +  +   + +GL Y+H    +   H D+KP N+ ++ED   KI DFGLA+Q+
Sbjct: 115 HEKLGEDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQA 171

Query: 79  QDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR--------K 130
             + +         T  Y APEV   ++   +   D++S G ++ EM  G+         
Sbjct: 172 DSEMTGY-----VVTRWYRAPEVI-LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 225

Query: 131 NADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVS-------LWCI 183
           +   +  + +       + +         + G+   E+K+    +   S          +
Sbjct: 226 DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKML 285

Query: 184 QTNPSDRPSMHEVLE 198
             +   R +  E L 
Sbjct: 286 VLDAEQRVTAGEALA 300

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 75.8 bits (185), Expect = 1e-16
 Identities = 43/231 (18%), Positives = 84/231 (36%), Gaps = 37/231 (16%)

Query: 1   MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNIL 60
           M    L +          +R +    V QI+  +  GL+Y+HR C   I+H DIKP N+L
Sbjct: 101 MVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVL 158

Query: 61  LD-EDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYG 119
           ++  D    +    +A             ++  T  Y +PEV           +D++S  
Sbjct: 159 MEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLG--APWGCGADIWSTA 216

Query: 120 MMILEMAVGR----------------------------KNADVKASRSSDIYFP-NSIYK 150
            +I E+  G                              +  ++  + +  +F    + +
Sbjct: 217 CLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLR 276

Query: 151 HIEPGNDFQLDGVVTEEEK---ELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
           +I     + L+ V+TE+ K   +  K++       +Q +P  R     ++ 
Sbjct: 277 NISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.8 bits (167), Expect = 3e-14
 Identities = 42/202 (20%), Positives = 72/202 (35%), Gaps = 38/202 (18%)

Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS 78
            + L    V  +   I RGL+Y+H    +   H D+KP N+ ++ED   KI DFGLA+ +
Sbjct: 115 CQKLTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHT 171

Query: 79  QDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR--------- 129
            D+ +         T  Y APE+        +   D++S G ++ E+  GR         
Sbjct: 172 DDEMTGYVA-----TRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 225

Query: 130 -------------KNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMI 176
                            +K   S            +   N   +         +L++KM 
Sbjct: 226 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKM- 284

Query: 177 LVSLWCIQTNPSDRPSMHEVLE 198
                 +  +   R +  + L 
Sbjct: 285 ------LVLDSDKRITAAQALA 300

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.4 bits (166), Expect = 5e-14
 Identities = 43/214 (20%), Positives = 79/214 (36%), Gaps = 50/214 (23%)

Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS 78
              L+   +  +   +  G+++LH    +   H D+KP NI++  D   KI DFGLA+ +
Sbjct: 113 QMELDHERMSYLLYQMLCGIKHLHSAGII---HRDLKPSNIVVKSDCTLKILDFGLARTA 169

Query: 79  QDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR--------- 129
                   M     T  Y APEV      G     D++S G ++ EM   +         
Sbjct: 170 GTSF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYI 224

Query: 130 -------------------------KNADVKASRSSDIYFPNSIYKHIEPGNDFQLDGVV 164
                                    +N      + + + FP      + P  D + + + 
Sbjct: 225 DQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFP-ADSEHNKLK 283

Query: 165 TEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE 198
             + ++L+ KM       +  +P+ R S+ + L+
Sbjct: 284 ASQARDLLSKM-------LVIDPAKRISVDDALQ 310

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 54.8 bits (131), Expect = 7e-10
 Identities = 18/106 (16%), Positives = 38/106 (35%), Gaps = 11/106 (10%)

Query: 19  NRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS 78
              +      ++   I   +   +      IVH D+  +N+L+  +    I DF  +   
Sbjct: 97  LYRVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSV-E 151

Query: 79  QDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILE 124
             ++    +L     +  I    F R++     + D+ S    IL+
Sbjct: 152 VGEEGWREIL--ERDVRNII-TYFSRTYR---TEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	242
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.98
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.98
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.97
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.97
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.97
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.97
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.97
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.97
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.96
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.95
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.35
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.9
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	93.52
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	93.4
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	90.53
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	90.21
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	86.28

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-41  Score=266.24  Aligned_cols=188  Identities=26%  Similarity=0.365  Sum_probs=137.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|||.++|...+     ..+++.++..++.||++||.|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        85 ~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~  156 (276)
T d1uwha_          85 CEGSSLYHHLHIIE-----TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR  156 (276)
T ss_dssp             CCEEEHHHHHHTSC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred             CCCCCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence            68999999997543     4599999999999999999999999   999999999999999999999999999986654


Q ss_pred             Ccccchhcccccccccccchhhhcc-cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRS-FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ...........||+.|+|||++... ...++.++|||||||++|||++|+.||........   ................
T Consensus       157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~---~~~~~~~~~~~p~~~~  233 (276)
T d1uwha_         157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGYLSPDLSK  233 (276)
T ss_dssp             ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---HHHHHHHTSCCCCGGG
T ss_pred             cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH---HHHHHhcCCCCCcchh
Confidence            4333333345689999999998653 23568899999999999999999999974432110   0011111111111122


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      .+..+++++.+       ++.+||+.||++|||+.++++.|+.+.+.
T Consensus       234 ~~~~~~~~l~~-------li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         234 VRSNCPKAMKR-------LMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             SCTTCCHHHHH-------HHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ccccchHHHHH-------HHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            33345555544       44559999999999999999999988764

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-39  Score=257.59  Aligned_cols=176  Identities=26%  Similarity=0.303  Sum_probs=134.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.++|.+.      +.+++.++..++.|+++||.|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        85 ~~gg~L~~~l~~~------~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~  155 (271)
T d1nvra_          85 CSGGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY  155 (271)
T ss_dssp             CTTEEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             cCCCcHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence            6899999999764      4699999999999999999999999   999999999999999999999999999987654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ...........||+.|+|||++.+. ...+.++|||||||++|+|++|+.||.......      ...............
T Consensus       156 ~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~------~~~~~~~~~~~~~~~  228 (271)
T d1nvra_         156 NNRERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------QEYSDWKEKKTYLNP  228 (271)
T ss_dssp             TTEECCBCCCCSCGGGSCTHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS------HHHHHHHTTCTTSTT
T ss_pred             CCccccccceeeCcCccCHhHhcCC-CCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH------HHHHHHhcCCCCCCc
Confidence            3332223345699999999998664 234678999999999999999999997544321      111111111111222


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ...+++++.+++.+       ||+.||++|||++|++++
T Consensus       229 ~~~~s~~~~~li~~-------~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         229 WKKIDSAPLALLHK-------ILVENPSARITIPDIKKD  260 (271)
T ss_dssp             GGGSCHHHHHHHHH-------HSCSSTTTSCCHHHHTTC
T ss_pred             cccCCHHHHHHHHH-------HcCCChhHCcCHHHHhcC
Confidence            23456655555554       889999999999999764

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-39  Score=262.51  Aligned_cols=182  Identities=25%  Similarity=0.368  Sum_probs=139.8

Q ss_pred             CCCCCcchhccccCCC-----------------CCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC
Q 026160            1 MPNGSLDQFTYDQESS-----------------NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE   63 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~-----------------~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~   63 (242)
                      |++|+|.++|.+.+..                 .....+++.+++.++.|+++||.|||++   +|+||||||+||+++.
T Consensus       123 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~Nill~~  199 (325)
T d1rjba_         123 CCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTH  199 (325)
T ss_dssp             CTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEEET
T ss_pred             CCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhcccccc
Confidence            6899999999765321                 1234689999999999999999999999   9999999999999999


Q ss_pred             CCceEEcccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCC
Q 026160           64 DFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDI  142 (242)
Q Consensus        64 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~  142 (242)
                      ++.+||+|||+++...............+|+.|+|||.+.+.  .++.++|||||||++|||++ |..||......    
T Consensus       200 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~----  273 (325)
T d1rjba_         200 GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD----  273 (325)
T ss_dssp             TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS----
T ss_pred             CCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC--CCCcceeccchhHHHHHHHhCCCCCCCCCCHH----
Confidence            999999999999865544433333334579999999998764  67899999999999999997 89998643321    


Q ss_pred             cCcchhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhh
Q 026160          143 YFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLE  201 (242)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~  201 (242)
                         .........+.....+..+++++.+++.+       ||+.||++|||+++|+++|.
T Consensus       274 ---~~~~~~~~~~~~~~~p~~~~~~l~~li~~-------cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         274 ---ANFYKLIQNGFKMDQPFYATEEIYIIMQS-------CWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             ---HHHHHHHHTTCCCCCCTTCCHHHHHHHHH-------HTCSSGGGSCCHHHHHHHHH
T ss_pred             ---HHHHHHHhcCCCCCCCCcCCHHHHHHHHH-------HcCCChhHCcCHHHHHHHHh
Confidence               12222233333344455566666555554       99999999999999999985

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-39  Score=259.71  Aligned_cols=187  Identities=24%  Similarity=0.348  Sum_probs=136.7

Q ss_pred             CCCCCcchhccccCCC----------CCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEc
Q 026160            1 MPNGSLDQFTYDQESS----------NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKIS   70 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~   70 (242)
                      |++|+|.++|......          .....+++.++..++.|+++||.|||++   +|+||||||+|||++.++.+||+
T Consensus       100 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~~~~~Kl~  176 (299)
T d1ywna1         100 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKIC  176 (299)
T ss_dssp             CTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEEC
T ss_pred             cCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECCCCcEEEc
Confidence            6899999999764321          1124589999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcC-CCccccccCCCCCcCcchhh
Q 026160           71 DFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR-KNADVKASRSSDIYFPNSIY  149 (242)
Q Consensus        71 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~-~p~~~~~~~~~~~~~~~~~~  149 (242)
                      |||+++...............||+.|+|||.+.+.  .++.++|||||||++|||++|. .||......       ....
T Consensus       177 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~-------~~~~  247 (299)
T d1ywna1         177 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------EEFC  247 (299)
T ss_dssp             C------CCSCTTSCCTTSCCCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-------HHHH
T ss_pred             cCcchhhccccccccccCceeeCccccchhHhhcC--CCCcccceeehHHHHHHHHhCCCCCCCCCCHH-------HHHH
Confidence            99999866544433333344689999999998764  6789999999999999999875 566533221       2222


Q ss_pred             hccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          150 KHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      .....+.....+..+++++.+++       .+||+.||++|||+.+++++|+.+.+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~l~~li-------~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         248 RRLKEGTRMRAPDYTTPEMYQTM-------LDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHH-------HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHhcCCCCCCCccCCHHHHHHH-------HHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            22223333344455666655544       459999999999999999999987654

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-39  Score=251.87  Aligned_cols=167  Identities=30%  Similarity=0.502  Sum_probs=134.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.++|.+.      +.+++.++..++.||++||.|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        88 ~~~g~L~~~l~~~------~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          88 APLGTVYRELQKL------SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             CTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             cCCCcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence            6899999999875      4599999999999999999999999   999999999999999999999999999976654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....    ...||+.|+|||++.+.  .++.++|||||||++|+|++|+.||.....        ......+... ...+
T Consensus       159 ~~~~----~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~-~~~~  223 (263)
T d2j4za1         159 SRRT----TLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRISRV-EFTF  223 (263)
T ss_dssp             CCCE----ETTEEGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTT-CCCC
T ss_pred             Cccc----ccCCCCcccCHHHHcCC--CCCchhhhhhHhHHHHHHhcCCCCCCCCCH--------HHHHHHHHcC-CCCC
Confidence            3322    23589999999999764  568999999999999999999999964332        1111111111 1234


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE  198 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~  198 (242)
                      +..+++++.+++.+       ||+.||++|||+.|+++
T Consensus       224 p~~~s~~~~~li~~-------~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         224 PDFVTEGARDLISR-------LLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             CTTSCHHHHHHHHH-------HTCSSGGGSCCHHHHHT
T ss_pred             CccCCHHHHHHHHH-------HccCCHhHCcCHHHHHc
Confidence            44567766666665       88999999999999986

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-38  Score=255.74  Aligned_cols=180  Identities=27%  Similarity=0.415  Sum_probs=130.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|++++....     +.+++.++..++.||++||.|||++   +++||||||+|||++.++.+||+|||+++....
T Consensus       109 ~~~g~L~~~~~~~~-----~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         109 MENGSLDSFLRQND-----GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             CTTEEHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             cCCCcceeeecccc-----CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccC
Confidence            68999999987643     4699999999999999999999999   999999999999999999999999999986654


Q ss_pred             Ccccchh---cccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCC
Q 026160           81 KKSTISM---LHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGN  156 (242)
Q Consensus        81 ~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  156 (242)
                      .......   ....+++.|+|||.+.+.  .++.++|||||||++|||++ |..||.....        ......+..+.
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--------~~~~~~i~~~~  250 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYR--KFTSASDVWSYGIVMWEVMSYGERPYWDMTN--------QDVINAIEQDY  250 (299)
T ss_dssp             ---------------CGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTC
T ss_pred             CCCcceeeecccccCCccccCHHHHhcC--CCCcccccccchHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCC
Confidence            3222111   112478899999998653  67889999999999999998 8999864432        12222233333


Q ss_pred             ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhh
Q 026160          157 DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTE  205 (242)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~  205 (242)
                      ....+..++.++.+       ++.+||+.||++|||+.++++.|+.+.+
T Consensus       251 ~~~~~~~~~~~l~~-------li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         251 RLPPPMDCPSALHQ-------LMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             CCCCCTTCCHHHHH-------HHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCCCccchHHHHH-------HHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            33344455555544       4555999999999999999999987754

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-39  Score=252.76  Aligned_cols=180  Identities=25%  Similarity=0.402  Sum_probs=128.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....     ..+++..++.++.|+++||.|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        82 ~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  153 (263)
T d1sm2a_          82 MEHGCLSDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  153 (263)
T ss_dssp             CTTCBHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred             cCCCcHHHHhhccc-----cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccC
Confidence            68999999987643     4699999999999999999999999   999999999999999999999999999986654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ..... .....+|..|+|||.+.+.  .++.++|||||||++|||+++..|+......       ......+..+.....
T Consensus       154 ~~~~~-~~~~~gt~~y~aPE~l~~~--~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-------~~~~~~i~~~~~~~~  223 (263)
T d1sm2a_         154 DQYTS-STGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------SEVVEDISTGFRLYK  223 (263)
T ss_dssp             ------------CTTSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-------HHHHHHHHHTCCCCC
T ss_pred             CCcee-ecceecCcccCChHHhcCC--CCCchhhhcchHHHHHHHHHCCCCCCCCCCH-------HHHHHHHHhcCCCCC
Confidence            33221 1123588999999998764  6789999999999999999964444322111       122222222333333


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhh
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTE  205 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~  205 (242)
                      +..+++++.       +++.+||+.||++|||+++++++|+.+.+
T Consensus       224 p~~~~~~l~-------~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         224 PRLASTHVY-------QIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             CTTSCHHHH-------HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccccCHHHH-------HHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            444555544       45555999999999999999999998765

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-38  Score=253.11  Aligned_cols=181  Identities=25%  Similarity=0.342  Sum_probs=143.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...+     ..+++.++..++.|+++||.|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        90 ~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          90 AGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             CTTEEHHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             CCCCcHHHHhhccc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccc
Confidence            68999999986543     4699999999999999999999999   999999999999999999999999999987654


Q ss_pred             Ccccc-hhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           81 KKSTI-SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        81 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      ..... ......+|+.|+|||.+...  .++.++|||||||++|||++ |..||.....        ......+..+...
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--------~~~~~~i~~~~~~  231 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVMAFIEQGKRM  231 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--------HHHHHHHHTTCCC
T ss_pred             cccccccccccccCccccChHHHhCC--CCCccchhhcchHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCC
Confidence            43221 11233588999999998654  67899999999999999998 8999974332        1222333344444


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      ..+..+++++.+++       .+||+.||++|||+.++++.|+.+...
T Consensus       232 ~~p~~~~~~l~~li-------~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         232 ECPPECPPELYALM-------SDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             CCCTTCCHHHHHHH-------HHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHH-------HHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            55566666665544       459999999999999999999876544

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-38  Score=252.48  Aligned_cols=177  Identities=24%  Similarity=0.391  Sum_probs=139.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.+.      ..+++.++..++.||+.||.|||+.   +|+||||||+|||++.++.++|+|||+++....
T Consensus        89 ~~~g~L~~~l~~~------~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~  159 (277)
T d1xbba_          89 AELGPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  159 (277)
T ss_dssp             CTTEEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             CCCCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccc
Confidence            6899999999865      4599999999999999999999999   999999999999999999999999999986654


Q ss_pred             Cccc-chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           81 KKST-ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        81 ~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      .... .......+|+.|+|||.+.+.  .++.++|||||||++|||++ |..||.....        ......+..+...
T Consensus       160 ~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--------~~~~~~i~~~~~~  229 (277)
T d1xbba_         160 DENYYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAMLEKGERM  229 (277)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTCCC
T ss_pred             cccccccccccCCCceecCchhhcCC--CCCchhhhccchhhhhHHhhCCCCCCCCCCH--------HHHHHHHHcCCCC
Confidence            3222 122234588999999998764  57889999999999999997 8999974432        2222233334444


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                      ..+..+++++.+++       .+||+.||++|||+.++++.|+..
T Consensus       230 ~~p~~~~~~~~~li-------~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         230 GCPAGCPREMYDLM-------NLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             CCCTTCCHHHHHHH-------HHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCcccCHHHHHHH-------HHHcCCCHhHCcCHHHHHHHhhCH
Confidence            45556666665554       459999999999999999888764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-38  Score=251.01  Aligned_cols=180  Identities=27%  Similarity=0.419  Sum_probs=138.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.....    ..+++.++..++.||++||.|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        89 ~~~g~L~~~~~~~~~----~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          89 MENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (272)
T ss_dssp             CTTCBHHHHTTSHHH----HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             CCCCcHHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccC
Confidence            689999998866432    4699999999999999999999999   999999999999999999999999999987654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ..... .....++..|+|||.+...  .++.++|||||||++|||++|..|+......       ......+..+.....
T Consensus       162 ~~~~~-~~~~~gt~~y~APE~~~~~--~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-------~~~~~~i~~~~~~~~  231 (272)
T d1qpca_         162 NEYTA-REGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------PEVIQNLERGYRMVR  231 (272)
T ss_dssp             SCEEC-CTTCCCCTTTSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCCCCC
T ss_pred             Ccccc-ccccCCcccccChHHHhCC--CCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhcCCCCC
Confidence            43221 1223588899999998654  5789999999999999999976655432211       222233333444444


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchh
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESST  204 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~  204 (242)
                      +..+++++.++       +.+||+.||++|||++++++.|+.+-
T Consensus       232 p~~~~~~l~~l-------i~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         232 PDNCPEELYQL-------MRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             CTTCCHHHHHH-------HHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccChHHHHHH-------HHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence            55566655544       45599999999999999999988654

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3e-38  Score=252.23  Aligned_cols=182  Identities=26%  Similarity=0.395  Sum_probs=141.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.++|.....    ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        95 ~~~g~l~~~l~~~~~----~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (287)
T d1opja_          95 MTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  167 (287)
T ss_dssp             CTTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred             ccCcchHHHhhhccc----cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCC
Confidence            689999999976432    6799999999999999999999999   999999999999999999999999999987654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ..... .....++..|+|||.+.+.  .++.++|||||||++|||++|..|+......       ......+..+.....
T Consensus       168 ~~~~~-~~~~~g~~~y~aPE~~~~~--~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-------~~~~~~i~~~~~~~~  237 (287)
T d1opja_         168 DTYTA-HAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQVYELLEKDYRMER  237 (287)
T ss_dssp             SSSEE-ETTEEECGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHHHHTTCCCCC
T ss_pred             CCcee-eccccccccccChHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCcchH-------HHHHHHHhcCCCCCC
Confidence            33221 1223478899999998764  6789999999999999999987766433221       222222333333444


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      +..+++++.+++.       +||+.||++|||+.++++.|+.+.+.
T Consensus       238 ~~~~~~~l~~li~-------~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         238 PEGCPEKVYELMR-------ACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             CTTCCHHHHHHHH-------HHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             CccchHHHHHHHH-------HHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            5556666555544       49999999999999999999876543

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-38  Score=248.31  Aligned_cols=169  Identities=28%  Similarity=0.482  Sum_probs=131.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCC--eeecCCCCCceeeC-CCCceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVR--IVHFDIKPHNILLD-EDFCPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~--i~h~dlk~~nil~~-~~~~~~L~dfg~~~~   77 (242)
                      |++|+|.+++.+.      ..+++.++..++.||++||.|||++   +  |+||||||+|||++ .++.+||+|||++..
T Consensus        94 ~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          94 MTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             CCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             CCCCcHHHHHhcc------ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            6899999999875      4599999999999999999999998   7  99999999999997 478999999999976


Q ss_pred             cCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCC-
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN-  156 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  156 (242)
                      .......    ...||+.|+|||.+.+   .++.++|||||||++|+|++|+.||......       ......+..+. 
T Consensus       165 ~~~~~~~----~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-------~~~~~~i~~~~~  230 (270)
T d1t4ha_         165 KRASFAK----AVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYRRVTSGVK  230 (270)
T ss_dssp             CCTTSBE----ESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHHHHTTTCC
T ss_pred             ccCCccC----CcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-------HHHHHHHHcCCC
Confidence            4443222    2359999999998864   4789999999999999999999999633221       22222222222 


Q ss_pred             ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          157 DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ...++...++++.+++.       +||+.||++|||+.|++++
T Consensus       231 ~~~~~~~~~~~~~~li~-------~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         231 PASFDKVAIPEVKEIIE-------GCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             CGGGGGCCCHHHHHHHH-------HHSCSSGGGSCCHHHHHTS
T ss_pred             CcccCccCCHHHHHHHH-------HHccCCHhHCcCHHHHhCC
Confidence            22334445666555554       4999999999999999863

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-39  Score=253.95  Aligned_cols=178  Identities=24%  Similarity=0.343  Sum_probs=126.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCC--CCCeeecCCCCCceeeCCCCceEEccccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGC--NVRIVHFDIKPHNILLDEDFCPKISDFGLAKQS   78 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~--~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~   78 (242)
                      |++|+|.+++.+...  .+..+++.+++.++.|++.||.|||+..  ..+|+||||||+|||++.++.+||+|||++...
T Consensus        87 ~~~g~L~~~i~~~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~  164 (269)
T d2java1          87 CEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL  164 (269)
T ss_dssp             CTTEEHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred             CCCCcHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeec
Confidence            689999999975321  2256999999999999999999999861  013999999999999999999999999999876


Q ss_pred             CCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           79 QDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        79 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      ......  .....||+.|+|||++.+.  .++.++|||||||++|+|++|..||.....        ......+..+...
T Consensus       165 ~~~~~~--~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--------~~~~~~i~~~~~~  232 (269)
T d2java1         165 NHDTSF--AKAFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KELAGKIREGKFR  232 (269)
T ss_dssp             -------------CCCSCCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTCCC
T ss_pred             ccCCCc--cccCCCCcccCCHHHHcCC--CCChHHHHHhhCHHHHHHhhCCCCCCCCCH--------HHHHHHHHcCCCC
Confidence            543222  1224589999999998654  678999999999999999999999964332        1122222222233


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ..+..+++++.+++.+       ||+.||++|||+.|++++
T Consensus       233 ~~~~~~s~~l~~li~~-------~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         233 RIPYRYSDELNEIITR-------MLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             CCCTTSCHHHHHHHHH-------HTCSSGGGSCCHHHHHTS
T ss_pred             CCCcccCHHHHHHHHH-------HcCCChhHCcCHHHHHhC
Confidence            3455567766666555       889999999999999863

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-38  Score=250.82  Aligned_cols=171  Identities=26%  Similarity=0.410  Sum_probs=133.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.+++.+       +.+++.++..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        99 ~~gg~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~  168 (293)
T d1yhwa1          99 LAGGSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (293)
T ss_dssp             CTTCBHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             cCCCcHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence            689999998865       3599999999999999999999999   999999999999999999999999999987654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhcc-CCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHI-EPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  159 (242)
                      .....  ....||+.|+|||++.+.  .++.++|||||||++|+|++|..||......       ....... .......
T Consensus       169 ~~~~~--~~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-------~~~~~~~~~~~~~~~  237 (293)
T d1yhwa1         169 EQSKR--STMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYLIATNGTPELQ  237 (293)
T ss_dssp             TTCCB--CCCCSCGGGCCHHHHSSS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHHCSCCCS
T ss_pred             ccccc--cccccCCCccChhhhcCC--CCCchhceehHhHHHHHHhhCCCCCCCCCHH-------HHHHHHHhCCCCCCC
Confidence            32221  233599999999998764  6788999999999999999999999643321       1111111 1111222


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .+..+++++.+++.+       ||+.||++|||+.|++++
T Consensus       238 ~~~~~s~~~~~li~~-------~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         238 NPEKLSAIFRDFLNR-------CLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             SGGGSCHHHHHHHHH-------HTCSSTTTSCCHHHHTTC
T ss_pred             CcccCCHHHHHHHHH-------HccCChhHCcCHHHHhcC
Confidence            344566676666665       889999999999999864

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.6e-38  Score=251.14  Aligned_cols=185  Identities=25%  Similarity=0.349  Sum_probs=139.3

Q ss_pred             CCCCCcchhccccCC------------------CCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeC
Q 026160            1 MPNGSLDQFTYDQES------------------SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD   62 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~------------------~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~   62 (242)
                      |++|+|.++|.....                  ......+++.+++.++.|++.||+|||+.   +++||||||+|||++
T Consensus        98 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NILld  174 (301)
T d1lufa_          98 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVG  174 (301)
T ss_dssp             CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred             cCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccceEEC
Confidence            679999999975321                  22334689999999999999999999999   999999999999999


Q ss_pred             CCCceEEcccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcC-CCccccccCCCC
Q 026160           63 EDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR-KNADVKASRSSD  141 (242)
Q Consensus        63 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~-~p~~~~~~~~~~  141 (242)
                      .++.+||+|||++................++..|+|||.+.+.  .++.++|||||||++|||++|. +||.....    
T Consensus       175 ~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~----  248 (301)
T d1lufa_         175 ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMAH----  248 (301)
T ss_dssp             GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH----
T ss_pred             CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC--CCChhhhhccchhhHHHHHccCCCCCCCCCH----
Confidence            9999999999999865544333333344588899999998764  6789999999999999999986 45653322    


Q ss_pred             CcCcchhhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhh
Q 026160          142 IYFPNSIYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTE  205 (242)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~  205 (242)
                          ......+..+.....+..+++++       ..++.+||+.||++|||+.+|++.|+.+.+
T Consensus       249 ----~e~~~~v~~~~~~~~p~~~~~~~-------~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         249 ----EEVIYYVRDGNILACPENCPLEL-------YNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             ----HHHHHHHHTTCCCCCCTTCCHHH-------HHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ----HHHHHHHHcCCCCCCCccchHHH-------HHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence                22222333333444455556554       445666999999999999999999998653

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-37  Score=247.60  Aligned_cols=186  Identities=25%  Similarity=0.441  Sum_probs=145.8

Q ss_pred             CCCCCcchhccccCC----------CCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEc
Q 026160            1 MPNGSLDQFTYDQES----------SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKIS   70 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~   70 (242)
                      |++|+|+++|.....          ......+++.+++.++.|++.||.|||+.   +++||||||+|||++.++.+||+
T Consensus       101 ~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~~~~~kl~  177 (299)
T d1fgka_         101 ASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIA  177 (299)
T ss_dssp             CTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEEC
T ss_pred             cCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecCCCCeEec
Confidence            689999999976532          22346799999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhh
Q 026160           71 DFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIY  149 (242)
Q Consensus        71 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~  149 (242)
                      |||++................+++.|+|||.+.+.  .++.++||||||+++|||++ |..||.....        ....
T Consensus       178 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~--~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~--------~~~~  247 (299)
T d1fgka_         178 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--------EELF  247 (299)
T ss_dssp             STTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHH
T ss_pred             cchhhccccccccccccccCCCChhhhhhhHhcCC--CCCchhhhHHhHHHHHHhccCCCCCCCCCCH--------HHHH
Confidence            99999866554333323334588999999998764  78899999999999999998 6777753332        2233


Q ss_pred             hccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          150 KHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      ..+..+.....+..+++++.+++.       +||+.||++|||+.++++.|+++...
T Consensus       248 ~~i~~~~~~~~p~~~~~~l~~li~-------~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         248 KLLKEGHRMDKPSNCTNELYMMMR-------DCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             HHHHTTCCCCCCSSCCHHHHHHHH-------HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHcCCCCCCCccchHHHHHHHH-------HHccCCHhHCcCHHHHHHHHHHHhhc
Confidence            334444555556666766655554       49999999999999999999987653

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-37  Score=251.83  Aligned_cols=180  Identities=25%  Similarity=0.392  Sum_probs=138.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....     ..+++..++.++.||+.||.|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        92 ~~~~~l~~~~~~~~-----~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          92 MPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             CTTCBHHHHHHHTS-----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             ccCCcccccccccc-----cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            57899999887653     5699999999999999999999999   999999999999999999999999999987655


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ...........+|..|+|||.+.+.  .++.++|||||||++|||+| |..||.....        ......+..+....
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--------~~~~~~i~~~~~~~  233 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEISSILEKGERLP  233 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--------GGHHHHHHHTCCCC
T ss_pred             ccccccccccccCccccChHHHhcC--CCChhhhhhhHHHHHHHHHHCCCCCCCCCCH--------HHHHHHHHcCCCCC
Confidence            4333322334589999999998764  67899999999999999998 7888864432        11222222333334


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTE  205 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~  205 (242)
                      .+..+++++.+++.       +||+.||++|||+.++++.|+.+..
T Consensus       234 ~p~~~~~~~~~li~-------~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         234 QPPICTIDVYMIMV-------KCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             CCTTBCHHHHHHHH-------HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCcccCHHHHHHHH-------HhCCCChhhCcCHHHHHHHHHHHHh
Confidence            44556666555444       5999999999999999999988754

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-38  Score=250.67  Aligned_cols=171  Identities=26%  Similarity=0.404  Sum_probs=131.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.+++...      +.+++.++..++.|++.||.|||++   +|+||||||+||+++.++.++|+|||++.....
T Consensus        90 ~~gg~L~~~~~~~------~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          90 AKNGELLKYIRKI------GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             CTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             cCCCCHHHhhhcc------CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence            6899999999876      4599999999999999999999999   999999999999999999999999999987654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ...........||+.|+|||++.+.  .++.++|||||||++|+|++|..||...+.        ......+... ...+
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~~~-~~~~  229 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNE--------YLIFQKIIKL-EYDF  229 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHTT-CCCC
T ss_pred             CCcccccccccCCccccCceeeccC--CCCcccceehhhHHHHHHhhCCCCCCCcCH--------HHHHHHHHcC-CCCC
Confidence            4333223334699999999998764  678899999999999999999999975432        1111111111 1234


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLE  198 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~  198 (242)
                      +..+++++.+++.+       ||+.||++|||++|+++
T Consensus       230 p~~~s~~~~~li~~-------~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         230 PEKFFPKARDLVEK-------LLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             CTTCCHHHHHHHHT-------TSCSSGGGSTTSGGGTC
T ss_pred             CccCCHHHHHHHHH-------HccCCHhHCcCHHHHcC
Confidence            45567766665555       88999999999998754

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-37  Score=246.14  Aligned_cols=182  Identities=24%  Similarity=0.409  Sum_probs=132.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....     +.+++.+++.++.|++.|+.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        91 ~~~~~l~~~~~~~~-----~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          91 MENGALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             CTTEEHHHHHHHTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             cccCcchhhhhccc-----ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccC
Confidence            57888888876543     4699999999999999999999999   999999999999999999999999999986544


Q ss_pred             Cccc-chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKST-ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      .... .......+|..|+|||.+.+.  .++.++|||||||++|||+++..|+......       ......+..+....
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-------~~~~~~i~~~~~~~  233 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSN-------HEVMKAINDGFRLP  233 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTCCCC
T ss_pred             CCccceEeccCCCCccccCHHHHccC--CCCCcccccccHHHHHHHHhCCCCccccCCH-------HHHHHHHhccCCCC
Confidence            3221 111223478999999998654  6788999999999999999976665432211       22233333444444


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      .+..++.++.+       ++.+||+.||++|||+.++++.|+++.+.
T Consensus       234 ~~~~~~~~l~~-------li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         234 TPMDCPSAIYQ-------LMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             CCTTCBHHHHH-------HHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CchhhHHHHHH-------HHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            44455555544       55559999999999999999999987653

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-37  Score=247.92  Aligned_cols=175  Identities=25%  Similarity=0.316  Sum_probs=132.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.+..     +.+++.++..++.||++||.|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        91 ~~~g~L~~~~~~~~-----~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~  162 (288)
T d2jfla1          91 CAGGAVDAVMLELE-----RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  162 (288)
T ss_dssp             CTTEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred             CCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence            68999999986542     4699999999999999999999999   999999999999999999999999999875443


Q ss_pred             Ccccchhcccccccccccchhhhcc---cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhc-cCCCC
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRS---FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKH-IEPGN  156 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~  156 (242)
                      ...  ......||+.|+|||++...   ...++.++|||||||++|+|++|..||.......       ..... .....
T Consensus       163 ~~~--~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-------~~~~i~~~~~~  233 (288)
T d2jfla1         163 TIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-------VLLKIAKSEPP  233 (288)
T ss_dssp             HHH--HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-------HHHHHHHSCCC
T ss_pred             Ccc--cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCCCC
Confidence            211  11234599999999998532   2346889999999999999999999996543211       11111 11111


Q ss_pred             ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          157 DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ....+..+++++.+++.+       ||+.||++|||+.|++++
T Consensus       234 ~~~~~~~~s~~~~~li~~-------~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         234 TLAQPSRWSSNFKDFLKK-------CLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             CCSSGGGSCHHHHHHHHH-------HSCSSTTTSCCHHHHTTS
T ss_pred             CCCccccCCHHHHHHHHH-------HccCChhHCcCHHHHhcC
Confidence            222334566666665555       889999999999999874

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-37  Score=246.10  Aligned_cols=180  Identities=26%  Similarity=0.395  Sum_probs=132.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....     ..+++.+++.++.||++||.|||++   +++||||||+||+++.++.+||+|||+++....
T Consensus        89 ~~~g~l~~~~~~~~-----~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          89 CTLGELRSFLQVRK-----YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             CTTEEHHHHHHHTT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             ccCCcHHhhhhccC-----CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccC
Confidence            68999999876543     4699999999999999999999999   999999999999999999999999999986544


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      .... ......+|+.|+|||.+...  .++.++|||||||++|||++ |.+||......        .....+..+....
T Consensus       161 ~~~~-~~~~~~gt~~y~apE~l~~~--~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--------~~~~~i~~~~~~~  229 (273)
T d1mp8a_         161 STYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--------DVIGRIENGERLP  229 (273)
T ss_dssp             -----------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------GHHHHHHTTCCCC
T ss_pred             Ccce-eccceecCcccchhhHhccC--CCCCccccccchHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCCCC
Confidence            3222 11223578999999998764  67889999999999999998 88888654432        2222233333444


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      .+..+++++.+++.+       ||+.||++|||+.++++.|+++.+.
T Consensus       230 ~~~~~~~~~~~li~~-------cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         230 MPPNCPPTLYSLMTK-------CWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             CCTTCCHHHHHHHHH-------HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHH-------HcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            555677666665555       9999999999999999999987654

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-37  Score=245.77  Aligned_cols=183  Identities=27%  Similarity=0.423  Sum_probs=135.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|..++.....    +.+++.++..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~~~g~l~~~~~~~~~----~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~  165 (285)
T d1fmka3          93 MSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED  165 (285)
T ss_dssp             CTTCBHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             cCCCchhhhhhhccc----ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccC
Confidence            689999999876432    4699999999999999999999999   999999999999999999999999999976543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      .... ......++..|+|||.+...  .++.++|||||||++|||++|..|+......       ......+..+.....
T Consensus       166 ~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-------~~~~~~i~~~~~~~~  235 (285)
T d1fmka3         166 NEYT-ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQVERGYRMPC  235 (285)
T ss_dssp             -----------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCCCCC
T ss_pred             CCce-eeccccccccccChHHHhCC--CCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhcCCCCC
Confidence            3221 12224589999999998764  6789999999999999999976665433221       222222223333344


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhc
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEIL  207 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~  207 (242)
                      +..+++++.+++       .+||+.||++|||+++|++.|+......
T Consensus       236 ~~~~~~~l~~li-------~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         236 PPECPESLHDLM-------CQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             CTTSCHHHHHHH-------HHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             CcccCHHHHHHH-------HHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            555666555544       4599999999999999999998866543

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-37  Score=240.56  Aligned_cols=176  Identities=22%  Similarity=0.409  Sum_probs=138.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....     ..+++..+..++.|+++||.|||+.   +|+|+||||+||+++.++.+||+|||+++....
T Consensus        81 ~~~g~l~~~~~~~~-----~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  152 (258)
T d1k2pa_          81 MANGCLLNYLREMR-----HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  152 (258)
T ss_dssp             CTTEEHHHHHHSGG-----GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred             cCCCcHHHhhhccc-----cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccC
Confidence            57899999976653     4699999999999999999999999   999999999999999999999999999976554


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      .... ......++..|+|||.+.+.  .++.++||||||+++|||++ |+.||.....        ......+..+....
T Consensus       153 ~~~~-~~~~~~~t~~y~aPE~~~~~--~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~--------~~~~~~i~~~~~~~  221 (258)
T d1k2pa_         153 DEYT-SSVGSKFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--------SETAEHIAQGLRLY  221 (258)
T ss_dssp             SSCC-CCCCSCCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------HHHHHHHHTTCCCC
T ss_pred             CCce-eecccCCCCCcCCcHHhcCC--CCCcceeecccchhhHhHHhcCCCCCCCCCH--------HHHHHHHHhCCCCC
Confidence            3222 22234588999999998764  67899999999999999998 7889865442        22223333344444


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhc
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLES  202 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~  202 (242)
                      .+...++++.+++.       +||+.||++|||+.+++++|..
T Consensus       222 ~p~~~~~~l~~li~-------~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         222 RPHLASEKVYTIMY-------SCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CCTTCCHHHHHHHH-------HTTCSSGGGSCCHHHHHHHHHC
T ss_pred             CcccccHHHHHHHH-------HHccCCHhHCcCHHHHHHHhhC
Confidence            45556665555554       4999999999999999999864

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-37  Score=249.63  Aligned_cols=170  Identities=27%  Similarity=0.376  Sum_probs=131.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|+.++...      +.+++.++..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        97 ~~~g~l~~~~~~~------~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          97 CLGSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             CSEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             cCCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            5788888776554      4699999999999999999999999   999999999999999999999999999986554


Q ss_pred             Ccccchhcccccccccccchhhhcc-cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRS-FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ..      ...||+.|+|||++.+. ...++.++|||||||++|+|++|..||......       ..............
T Consensus       168 ~~------~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-------~~~~~i~~~~~~~~  234 (309)
T d1u5ra_         168 AN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNESPAL  234 (309)
T ss_dssp             BC------CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSCCCCC
T ss_pred             CC------ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhCCCCCC
Confidence            32      23599999999998643 235788999999999999999999999643321       11111111111222


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .+..+++++.+++.+       ||+.||++|||+.+++++
T Consensus       235 ~~~~~s~~~~~li~~-------~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         235 QSGHWSEYFRNFVDS-------CLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             SCTTSCHHHHHHHHH-------HTCSSGGGSCCHHHHTTC
T ss_pred             CCCCCCHHHHHHHHH-------HCcCChhHCcCHHHHHhC
Confidence            233466666666555       889999999999999863

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-37  Score=242.45  Aligned_cols=176  Identities=26%  Similarity=0.430  Sum_probs=136.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.++|.+...    ..+++..++.++.||+.||.|||+.   +++|+||||+||+++.++.++++|||++.....
T Consensus        83 ~~~g~L~~~l~~~~~----~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~  155 (262)
T d1byga_          83 MAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  155 (262)
T ss_dssp             CTTEEHHHHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             cCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCC
Confidence            689999999976532    4589999999999999999999999   999999999999999999999999999986544


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDFQ  159 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (242)
                      ...     ...++..|+|||.+.+.  .++.++|||||||++|||++ |..||.....        ......+..+....
T Consensus       156 ~~~-----~~~~~~~y~aPE~l~~~--~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--------~~~~~~i~~~~~~~  220 (262)
T d1byga_         156 TQD-----TGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPRVEKGYKMD  220 (262)
T ss_dssp             -----------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--------GGHHHHHTTTCCCC
T ss_pred             CCc-----cccccccCCChHHHhCC--CCChHHHHHhHHHHHHHHHHCCCCCCCCCCH--------HHHHHHHHcCCCCC
Confidence            322     22478899999998764  67899999999999999998 6777654322        23334444555555


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhh
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTE  205 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~  205 (242)
                      .+..+++++.+++.+       ||+.||++|||+.++++.|+.+..
T Consensus       221 ~~~~~~~~~~~li~~-------cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         221 APDGCPPAVYEVMKN-------CWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             CCTTCCHHHHHHHHH-------HTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCccCCHHHHHHHHH-------HcccCHhHCcCHHHHHHHHHHHHh
Confidence            666677666655554       999999999999999999987754

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-37  Score=250.58  Aligned_cols=121  Identities=33%  Similarity=0.480  Sum_probs=104.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhh-CCCCCeeecCCCCCceeeCCCCceEEcccccccccC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHR-GCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQ   79 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~-~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~   79 (242)
                      |+||+|.+++.+.      +.+++..+..++.|++.||.|||+ +   +|+||||||+|||++.++.+||+|||++....
T Consensus        86 ~~gg~L~~~l~~~------~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  156 (322)
T d1s9ja_          86 MDGGSLDQVLKKA------GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  156 (322)
T ss_dssp             CTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             CCCCcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence            6899999999875      459999999999999999999997 5   89999999999999999999999999998654


Q ss_pred             CCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccc
Q 026160           80 DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKA  136 (242)
Q Consensus        80 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  136 (242)
                      ....    ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||....
T Consensus       157 ~~~~----~~~~GT~~Y~APEvl~~~--~y~~~~DiWSlGvil~ell~G~~Pf~~~~  207 (322)
T d1s9ja_         157 DSMA----NSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPD  207 (322)
T ss_dssp             HHTC-------CCSSCCCCHHHHHCS--CCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred             CCcc----ccccCCccccCchHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            3221    124699999999999764  68899999999999999999999997543

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.8e-36  Score=249.32  Aligned_cols=172  Identities=28%  Similarity=0.376  Sum_probs=136.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.++|.+.      ..+++.++..++.||+.||.|||+.   +++||||||+|||++.++.+||+|||+++....
T Consensus        89 ~~gg~L~~~l~~~------~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          89 MNGGDLHYHLSQH------GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             CCSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred             cCCCcHHHHHHhc------ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence            6899999999876      4589999999999999999999999   999999999999999999999999999987665


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....    ...||+.|+|||++... ..++.++|||||||++|+|++|..||........     ..... .........
T Consensus       160 ~~~~----~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----~~~~~-~~~~~~~~~  228 (364)
T d1omwa3         160 KKPH----ASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDR-MTLTMAVEL  228 (364)
T ss_dssp             SCCC----SCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-----HHHHH-HSSSCCCCC
T ss_pred             Cccc----ccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHH-hcccCCCCC
Confidence            4332    23599999999998643 3568899999999999999999999975443211     11111 122223334


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPS-----MHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps-----~~~ll~~  199 (242)
                      +..+++++.+++.+       ||+.||++|||     +++++++
T Consensus       229 ~~~~s~~~~~li~~-------~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         229 PDSFSPELRSLLEG-------LLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             CSSSCHHHHHHHHH-------HTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             CCCCCHHHHHHHHH-------HcccCHHHhCCCcccCHHHHHcC
Confidence            55677777777666       88999999999     6888864

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.9e-37  Score=246.34  Aligned_cols=173  Identities=25%  Similarity=0.339  Sum_probs=122.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeC---CCCceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD---EDFCPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~---~~~~~~L~dfg~~~~   77 (242)
                      |+||+|.++|...      +.+++.++..++.||+.||.|||+.   +|+||||||+||++.   .++.+||+|||++..
T Consensus        89 ~~gg~L~~~l~~~------~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~  159 (307)
T d1a06a_          89 VSGGELFDRIVEK------GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM  159 (307)
T ss_dssp             CCSCBHHHHHHTC------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred             cCCCcHHHhhhcc------cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEE
Confidence            6899999999765      4699999999999999999999999   999999999999995   478899999999986


Q ss_pred             cCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      .......   ....||+.|+|||++.+.  .++.++|||||||++|+|++|..||.......    ....+. .......
T Consensus       160 ~~~~~~~---~~~~GT~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----~~~~i~-~~~~~~~  229 (307)
T d1a06a_         160 EDPGSVL---STACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPFYDENDAK----LFEQIL-KAEYEFD  229 (307)
T ss_dssp             ----------------CTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHH-TTCCCCC
T ss_pred             ccCCCee---eeeeeCccccCcHHHcCC--CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH----HHHHHh-ccCCCCC
Confidence            5543322   123599999999998764  57899999999999999999999996433211    000111 1111111


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ......+++++.+++.+       ||+.||++|||+.|++++
T Consensus       230 ~~~~~~~s~~~~~li~~-------~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         230 SPYWDDISDSAKDFIRH-------LMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             TTTTTTSCHHHHHHHHH-------HSCSSGGGSCCHHHHHHS
T ss_pred             CccccCCCHHHHHHHHH-------HccCCHhHCcCHHHHhcC
Confidence            22234566666666655       889999999999999985

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-36  Score=247.52  Aligned_cols=176  Identities=24%  Similarity=0.341  Sum_probs=130.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC---CCceEEcccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE---DFCPKISDFGLAKQ   77 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~---~~~~~L~dfg~~~~   77 (242)
                      |+||+|.++|.+..    ...+++.++..++.||+.||.|||+.   +|+||||||+|||++.   .+.+||+|||++..
T Consensus        91 ~~gg~L~~~i~~~~----~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~  163 (335)
T d2ozaa1          91 LDGGELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  163 (335)
T ss_dssp             CCSEEHHHHHHSCS----CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             CCCCcHHHHHHhcC----CCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeee
Confidence            68999999997642    25799999999999999999999999   9999999999999975   45799999999987


Q ss_pred             cCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCc
Q 026160           78 SQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGND  157 (242)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (242)
                      ........   ...||+.|+|||++.+.  .++.++|||||||++|+|++|..||..........    ...........
T Consensus       164 ~~~~~~~~---~~~gt~~y~aPE~~~~~--~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~----~~~~~i~~~~~  234 (335)
T d2ozaa1         164 TTSHNSLT---TPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP----GMKTRIRMGQY  234 (335)
T ss_dssp             CCCCCCCC---CCSCCCSSCCCCCCCGG--GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCSCSS
T ss_pred             ccCCCccc---cccCCcccCCcHHHcCC--CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH----HHHHHHhcCCC
Confidence            65543322   33599999999998664  57889999999999999999999997554322111    11111111110


Q ss_pred             ---cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          158 ---FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       158 ---~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                         ......+++++.       +++.+||+.||++|||+.|++++
T Consensus       235 ~~~~~~~~~~s~~~~-------~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         235 EFPNPEWSEVSEEVK-------MLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             SCCTTHHHHSCHHHH-------HHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCCcccccCCHHHH-------HHHHHHccCChhHCcCHHHHHcC
Confidence               001112344444       44555889999999999999885

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.3e-36  Score=246.32  Aligned_cols=174  Identities=24%  Similarity=0.353  Sum_probs=132.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC--CCceEEccccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE--DFCPKISDFGLAKQS   78 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~--~~~~~L~dfg~~~~~   78 (242)
                      |+||+|.++|.+..     +.+++.++..++.||+.||.|||++   +++||||||+|||++.  ++.+||+|||++...
T Consensus       105 ~~gg~L~~~l~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~  176 (350)
T d1koaa2         105 MSGGELFEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  176 (350)
T ss_dssp             CCSCBHHHHHTCTT-----SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred             CCCCCHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence            68999999996532     4699999999999999999999999   9999999999999964  678999999999876


Q ss_pred             CCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           79 QDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        79 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      .......   ...||+.|+|||++.+.  .++.++|||||||++|+|++|..||........    ...+ .........
T Consensus       177 ~~~~~~~---~~~gT~~Y~aPEv~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~----~~~i-~~~~~~~~~  246 (350)
T d1koaa2         177 DPKQSVK---VTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGENDDET----LRNV-KSCDWNMDD  246 (350)
T ss_dssp             CTTSCEE---EECSCTTTCCHHHHHTC--CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHH-HHTCCCSCC
T ss_pred             ccccccc---eecCcccccCHHHHcCC--CCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH----HHHH-HhCCCCCCc
Confidence            6544332   23589999999998764  568899999999999999999999964432100    0011 011111112


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .....+++++.+++.+       ||+.||++|||+.|++++
T Consensus       247 ~~~~~~s~~~~~li~~-------~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         247 SAFSGISEDGKDFIRK-------LLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             GGGGGCCHHHHHHHHH-------HCCSSGGGSCCHHHHHHS
T ss_pred             ccccCCCHHHHHHHHH-------HccCChhHCcCHHHHhcC
Confidence            2223456666665555       889999999999999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-36  Score=243.43  Aligned_cols=184  Identities=26%  Similarity=0.436  Sum_probs=141.8

Q ss_pred             CCCCCcchhccccCC----------CCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEc
Q 026160            1 MPNGSLDQFTYDQES----------SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKIS   70 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~   70 (242)
                      |+||+|.++|.....          ......+++.++..++.||+.||.|||+.   +++||||||+|||++.++.+||+
T Consensus        93 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~  169 (309)
T d1fvra_          93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA  169 (309)
T ss_dssp             CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEEC
T ss_pred             cCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEc
Confidence            689999999975421          12346799999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCC-CccccccCCCCCcCcchhh
Q 026160           71 DFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRK-NADVKASRSSDIYFPNSIY  149 (242)
Q Consensus        71 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~-p~~~~~~~~~~~~~~~~~~  149 (242)
                      |||+++.........   ...+|..|+|||.+.+.  .++.++||||||+++|||++|.. ||.....        ....
T Consensus       170 DfG~a~~~~~~~~~~---~~~gt~~y~aPE~l~~~--~~~~~sDvwSfGvil~ell~~~~~p~~~~~~--------~~~~  236 (309)
T d1fvra_         170 DFGLSRGQEVYVKKT---MGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AELY  236 (309)
T ss_dssp             CTTCEESSCEECCC-------CCTTTCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHH
T ss_pred             ccccccccccccccc---ceecCCcccchHHhccC--CCCccceeehhHHHHHHHHhcCCCCCCCCCH--------HHHH
Confidence            999997554332221   23488999999998664  67899999999999999999765 5543321        2222


Q ss_pred             hccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhc
Q 026160          150 KHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEIL  207 (242)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~  207 (242)
                      ..+..+.....+..+++++.+++.+       ||+.||++|||+.++++.|+++.+..
T Consensus       237 ~~i~~~~~~~~~~~~~~~~~~li~~-------cl~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         237 EKLPQGYRLEKPLNCDDEVYDLMRQ-------CWREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             HHGGGTCCCCCCTTBCHHHHHHHHH-------HTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             HHHHhcCCCCCCccCCHHHHHHHHH-------HcCCChhHCcCHHHHHHHHHHHHhcC
Confidence            3333344444555666666665555       99999999999999999999987653

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-36  Score=241.13  Aligned_cols=200  Identities=24%  Similarity=0.270  Sum_probs=142.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCC-----CCCeeecCCCCCceeeCCCCceEEcccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGC-----NVRIVHFDIKPHNILLDEDFCPKISDFGLA   75 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~-----~~~i~h~dlk~~nil~~~~~~~~L~dfg~~   75 (242)
                      |++|+|.++|++.       .+++.+++.++.+++.||.|||+..     ..+|+||||||+|||++.++.+||+|||++
T Consensus        83 ~~~g~L~~~l~~~-------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          83 HEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             CTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ccCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            6899999999763       5999999999999999999999731     239999999999999999999999999999


Q ss_pred             cccCCCccc--chhcccccccccccchhhhcccC----CCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCc----
Q 026160           76 KQSQDKKST--ISMLHARGTIGYIAPEVFCRSFG----GASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFP----  145 (242)
Q Consensus        76 ~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~----~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~----  145 (242)
                      .........  .......||+.|+|||.+.+...    .++.++|||||||++|||++|..||.............    
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence            866443221  11223468999999999865321    24678999999999999999988876544322211100    


Q ss_pred             ---chhh-hccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccC
Q 026160          146 ---NSIY-KHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQI  209 (242)
Q Consensus       146 ---~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~  209 (242)
                         .... ........+.++...  ........+.+++.+||+.||++|||+.|+++.|+.+.++...
T Consensus       236 ~~~~~~~~~~~~~~~~p~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~  301 (303)
T d1vjya_         236 PSVEEMRKVVCEQKLRPNIPNRW--QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI  301 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGG--GGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCC
T ss_pred             chHHHHHHHHhccccCCCCCccc--CChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCC
Confidence               0001 111111112222111  1223456677889999999999999999999999998876443

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-36  Score=239.92  Aligned_cols=179  Identities=23%  Similarity=0.332  Sum_probs=136.4

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++..+.     +.+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        92 ~~~~~l~~~~~~~~-----~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          92 APLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             CTTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             ecCcchhhhhhccc-----CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            67899999887653     4699999999999999999999999   999999999999999999999999999987654


Q ss_pred             Ccccc-hhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHh-cCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           81 KKSTI-SMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAV-GRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        81 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      ..... ......++..|+|||.+.+.  .++.++||||||+++|||++ |..||......       .........+...
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~-------~~~~~i~~~~~~~  234 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-------QILHKIDKEGERL  234 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTSCCCC
T ss_pred             CCCcceecCccccCcccCCHHHHhCC--CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH-------HHHHHHHhCCCCC
Confidence            43221 11223477899999998764  67889999999999999998 89998643321       1112222233333


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhch
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESS  203 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~  203 (242)
                      ..+..+++++.+++.       +||+.||++|||+.++++.|+..
T Consensus       235 ~~~~~~~~~l~~li~-------~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         235 PRPEDCPQDIYNVMV-------QCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             CCCTTCCHHHHHHHH-------HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCcccccHHHHHHHH-------HHcCCChhHCcCHHHHHHHHHhc
Confidence            344456666555444       49999999999999999998754

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-36  Score=243.44  Aligned_cols=170  Identities=28%  Similarity=0.394  Sum_probs=135.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.+++.+.      +.+++..+..++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||+++....
T Consensus        87 ~~gg~L~~~~~~~------~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          87 ANGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             CTTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             cCCCchhhhhhcc------cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            7899999999876      4599999999999999999999999   999999999999999999999999999986543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ....  .....||+.|+|||++.+.  .++.++|+|||||++|+|++|..||...+..        ......... ...+
T Consensus       158 ~~~~--~~~~~GT~~Y~aPE~~~~~--~y~~~~DiwSlGvilyeml~G~~pf~~~~~~--------~~~~~i~~~-~~~~  224 (337)
T d1o6la_         158 DGAT--MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------RLFELILME-EIRF  224 (337)
T ss_dssp             TTCC--BCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHC-CCCC
T ss_pred             CCcc--cccceeCHHHhhhhhccCC--CCChhhcccchhhHHHHHHHCCCCCCCcCHH--------HHHHHHhcC-CCCC
Confidence            3221  1234599999999998764  6789999999999999999999999754421        111111111 1234


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPS-----MHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps-----~~~ll~~  199 (242)
                      +..+++++.+++.+       ||+.||++|++     +.+++++
T Consensus       225 p~~~s~~~~dli~~-------~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         225 PRTLSPEAKSLLAG-------LLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             CTTSCHHHHHHHHH-------HTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CccCCHHHHHHHHh-------hccCCchhhcccccccHHHHHcC
Confidence            55677777777666       77999999995     8888874

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-35  Score=239.55  Aligned_cols=182  Identities=24%  Similarity=0.367  Sum_probs=139.0

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++....     ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       111 ~~~g~l~~~~~~~~-----~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~  182 (311)
T d1r0pa_         111 MKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  182 (311)
T ss_dssp             CTTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred             eecCchhhhhcccc-----ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccc
Confidence            68999999987643     4688899999999999999999999   999999999999999999999999999986654


Q ss_pred             Cccc--chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           81 KKST--ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        81 ~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      ....  .......++..|+|||.+...  .++.++||||||+++|||++|..||.......       .....+..+...
T Consensus       183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-------~~~~~i~~g~~~  253 (311)
T d1r0pa_         183 KEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-------DITVYLLQGRRL  253 (311)
T ss_dssp             TTCCCTTCTTCSSCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHHTTCCC
T ss_pred             cccccceecccccccccccChHHHhcC--CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-------HHHHHHHcCCCC
Confidence            3222  112223588999999998764  67899999999999999999888776433221       111122222333


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      ..+..+++++.+       ++.+||+.||++|||+.|+++.|+++...
T Consensus       254 ~~p~~~~~~l~~-------li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         254 LQPEYCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             CCCTTCCHHHHH-------HHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCcccCcHHHHH-------HHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            344445555544       55559999999999999999999998765

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=7.9e-36  Score=244.25  Aligned_cols=174  Identities=24%  Similarity=0.335  Sum_probs=133.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeC--CCCceEEccccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLD--EDFCPKISDFGLAKQS   78 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~--~~~~~~L~dfg~~~~~   78 (242)
                      |+||+|.+++.+..     ..+++.++..++.||+.||.|||+.   +|+||||||+|||++  .++.++|+|||++...
T Consensus       108 ~~gg~L~~~~~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~  179 (352)
T d1koba_         108 LSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL  179 (352)
T ss_dssp             CCCCBHHHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             CCCChHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceec
Confidence            68999999886542     4699999999999999999999999   999999999999997  5789999999999877


Q ss_pred             CCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           79 QDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        79 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      .......   ...+++.|+|||++.+.  .++.++|||||||++|+|++|..||........    ...+. ........
T Consensus       180 ~~~~~~~---~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~----~~~i~-~~~~~~~~  249 (352)
T d1koba_         180 NPDEIVK---VTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET----LQNVK-RCDWEFDE  249 (352)
T ss_dssp             CTTSCEE---EECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH----HHHHH-HCCCCCCS
T ss_pred             CCCCcee---eccCcccccCHHHHcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHH-hCCCCCCc
Confidence            6543322   23589999999998764  678999999999999999999999964432110    00111 11111112


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .....+++++.+++.+       ||+.||++|||+.|++++
T Consensus       250 ~~~~~~s~~~~~li~~-------~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         250 DAFSSVSPEAKDFIKN-------LLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             STTTTSCHHHHHHHHT-------TSCSSGGGSCCHHHHHTS
T ss_pred             ccccCCCHHHHHHHHH-------HccCChhHCcCHHHHhcC
Confidence            2234466666665555       889999999999999885

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=8.1e-36  Score=236.74  Aligned_cols=175  Identities=26%  Similarity=0.325  Sum_probs=134.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.++|..+      +.+++.++..++.||+.||.|||++   +++||||||+||+++.++.+||+|||+++....
T Consensus        92 ~~~g~L~~~l~~~------~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  162 (277)
T d1phka_          92 MKKGELFDYLTEK------VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP  162 (277)
T ss_dssp             CTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             CCCchHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeEccC
Confidence            6899999999765      4699999999999999999999999   999999999999999999999999999987665


Q ss_pred             Ccccchhcccccccccccchhhhcc----cCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCC
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRS----FGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGN  156 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~----~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  156 (242)
                      .....   ...||..|.+||.+.+.    ...++.++||||+||++|+|++|..||........    ...+. ......
T Consensus       163 ~~~~~---~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~----~~~i~-~~~~~~  234 (277)
T d1phka_         163 GEKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM----LRMIM-SGNYQF  234 (277)
T ss_dssp             TCCBC---CCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHH-HTCCCC
T ss_pred             CCcee---eeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH----HHHHH-hCCCCC
Confidence            43322   23589999999988542    23457899999999999999999999975432110    00111 111111


Q ss_pred             ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          157 DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .......+++++.+++.+       ||+.||++|||+.|++++
T Consensus       235 ~~~~~~~~s~~~~~li~~-------~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         235 GSPEWDDYSDTVKDLVSR-------FLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             CTTTGGGSCHHHHHHHHH-------HCCSSGGGSCCHHHHTTS
T ss_pred             CCcccccCCHHHHHHHHH-------HccCChhHCcCHHHHHcC
Confidence            122233566666666665       889999999999999864

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-36  Score=241.19  Aligned_cols=187  Identities=23%  Similarity=0.382  Sum_probs=140.6

Q ss_pred             CCCCCcchhccccCCC------------CCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceE
Q 026160            1 MPNGSLDQFTYDQESS------------NGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPK   68 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~------------~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~   68 (242)
                      |++|+|.++|......            .....+++..+..++.||++||.|||++   +++||||||+||+++.++.++
T Consensus       109 ~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~~~~~~k  185 (311)
T d1t46a_         109 CCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITK  185 (311)
T ss_dssp             CTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTEEE
T ss_pred             CCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccccccccccccCccc
Confidence            6899999999765321            2334699999999999999999999999   999999999999999999999


Q ss_pred             EcccccccccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCC-ccccccCCCCCcCcch
Q 026160           69 ISDFGLAKQSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKN-ADVKASRSSDIYFPNS  147 (242)
Q Consensus        69 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p-~~~~~~~~~~~~~~~~  147 (242)
                      ++|||+++...............+++.|+|||.+...  .++.++||||||+++|||+++..| |......       ..
T Consensus       186 i~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-------~~  256 (311)
T d1t46a_         186 ICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-------SK  256 (311)
T ss_dssp             ECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-------HH
T ss_pred             ccccchheeccCCCcceEeeecccChHHcCHHHhcCC--CCCCcccccchHHHHHHHHhCCCCCCCCCCHH-------HH
Confidence            9999999877655444333445689999999998764  678999999999999999995544 4333221       11


Q ss_pred             hhhccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhh
Q 026160          148 IYKHIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEI  206 (242)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~  206 (242)
                      .......+.....+...++++.++       +.+||+.||++|||+.++++.|++....
T Consensus       257 ~~~~i~~~~~~~~~~~~~~~l~~L-------i~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         257 FYKMIKEGFRMLSPEHAPAEMYDI-------MKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             HHHHHHHTCCCCCCTTSCHHHHHH-------HHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHhcCCCCCCcccccHHHHHH-------HHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            112222222233334455555444       4559999999999999999999876543

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-35  Score=238.11  Aligned_cols=170  Identities=22%  Similarity=0.316  Sum_probs=131.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCC----ceEEccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF----CPKISDFGLAK   76 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~----~~~L~dfg~~~   76 (242)
                      |++|+|.++|...      +.+++.++..++.|++.||.|||+.   +++||||||+||+++.++    .+|++|||++.
T Consensus        95 ~~gg~L~~~i~~~------~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~  165 (293)
T d1jksa_          95 VAGGELFDFLAEK------ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  165 (293)
T ss_dssp             CCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             CCCccccchhccc------cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhh
Confidence            6899999999875      4599999999999999999999999   999999999999998766    49999999998


Q ss_pred             ccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCC-
Q 026160           77 QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPG-  155 (242)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-  155 (242)
                      .........   ...+++.|+|||++.+.  .++.++|||||||++|+|++|..||......        .....+... 
T Consensus       166 ~~~~~~~~~---~~~~t~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------~~~~~i~~~~  232 (293)
T d1jksa_         166 KIDFGNEFK---NIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANVSAVN  232 (293)
T ss_dssp             ECTTSCBCS---CCCCCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHTTC
T ss_pred             hcCCCcccc---ccCCCCcccCHHHHcCC--CCCCcccchhhhHHHHHHHcCCCCCCCCCHH--------HHHHHHHhcC
Confidence            765443322   23589999999998753  6789999999999999999999999744321        111111111 


Q ss_pred             --CccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          156 --NDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       156 --~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                        ........+++++.++       +.+||+.||++|||+.+++++
T Consensus       233 ~~~~~~~~~~~s~~~~~l-------i~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         233 YEFEDEYFSNTSALAKDF-------IRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             CCCCHHHHTTSCHHHHHH-------HHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCCCchhcCCCCHHHHHH-------HHHHccCChhHCcCHHHHhcC
Confidence              1111223345555544       455999999999999999874

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.8e-35  Score=242.05  Aligned_cols=167  Identities=23%  Similarity=0.369  Sum_probs=133.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++.+.      +.+++.++..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       123 ~~~g~l~~~l~~~------~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         123 VAGGEMFSHLRRI------GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             CTTCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ccccchhhhHhhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            5799999999876      4599999999999999999999999   999999999999999999999999999987654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ...     ...||+.|+|||++.+.  .++.++|||||||++|+|++|..||.....        ......+... ....
T Consensus       194 ~~~-----~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~~~-~~~~  257 (350)
T d1rdqe_         194 RTW-----TLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVSG-KVRF  257 (350)
T ss_dssp             CBC-----CCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC-CCCC
T ss_pred             ccc-----cccCccccCCHHHHcCC--CCCccccccchhHHHHHHHhCCCCCCCcCH--------HHHHHHHhcC-CCCC
Confidence            332     23589999999998764  678999999999999999999999964332        1111111111 1223


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRP-----SMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp-----s~~~ll~~  199 (242)
                      +..+++++.+++.+       ||+.||.+|+     |+.+++++
T Consensus       258 p~~~s~~~~~li~~-------~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         258 PSHFSSDLKDLLRN-------LLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             CTTCCHHHHHHHHH-------HSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CccCCHHHHHHHHH-------HhhhCHHhccccccccHHHHHcC
Confidence            44577777776666       8899999994     89999873

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-35  Score=236.63  Aligned_cols=185  Identities=23%  Similarity=0.363  Sum_probs=140.6

Q ss_pred             CCCCCcchhccccCC----CCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEccccccc
Q 026160            1 MPNGSLDQFTYDQES----SNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAK   76 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~----~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~   76 (242)
                      |++|+|.+++.....    ......+++..+..++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       105 ~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFGla~  181 (308)
T d1p4oa_         105 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR  181 (308)
T ss_dssp             CTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCCC
T ss_pred             cCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeecccce
Confidence            689999999875321    11223478999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcC-CCccccccCCCCCcCcchhhhccCCC
Q 026160           77 QSQDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGR-KNADVKASRSSDIYFPNSIYKHIEPG  155 (242)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~  155 (242)
                      ...............+++.|++||.+.+.  .++.++||||||+++|||++|. .||.....        ......+.++
T Consensus       182 ~~~~~~~~~~~~~~~~t~~y~aPe~l~~~--~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~--------~~~~~~i~~~  251 (308)
T d1p4oa_         182 DIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------EQVLRFVMEG  251 (308)
T ss_dssp             GGGGGGCEEGGGSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--------HHHHHHHHTT
T ss_pred             eccCCcceeeccceecccccCCHHHHccC--CCCcccccccHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHhC
Confidence            76555444334444689999999998764  6788999999999999999985 56643221        2222223333


Q ss_pred             CccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhh
Q 026160          156 NDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTE  205 (242)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~  205 (242)
                      .....+..+++.+.+       ++.+||+.||++|||+.++++.|++..+
T Consensus       252 ~~~~~p~~~~~~l~~-------li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         252 GLLDKPDNCPDMLFE-------LMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             CCCCCCTTCCHHHHH-------HHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             CCCCCcccchHHHHH-------HHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            333344455555444       4555999999999999999999988654

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-35  Score=235.23  Aligned_cols=180  Identities=22%  Similarity=0.224  Sum_probs=125.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|++..++...      ..+++.++..++.||+.||.|||++   +++||||||+|||++.++.+||+|||++.....
T Consensus        82 ~~~~~~~~~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~  152 (299)
T d1ua2a_          82 METDLEVIIKDNS------LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS  152 (299)
T ss_dssp             CSEEHHHHHTTCC------SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred             hcchHHhhhhhcc------cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCC
Confidence            3455555554332      5699999999999999999999999   999999999999999999999999999976654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCC------------CCCcCcchh
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRS------------SDIYFPNSI  148 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~------------~~~~~~~~~  148 (242)
                      .....  ....+|+.|+|||.+... ..++.++|||||||++|+|++|..||......+            ....+....
T Consensus       153 ~~~~~--~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~  229 (299)
T d1ua2a_         153 PNRAY--THQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC  229 (299)
T ss_dssp             CCCCC--CCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred             Ccccc--cceecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchh
Confidence            33221  123589999999988653 356889999999999999999999986433110            000000000


Q ss_pred             hh-------ccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          149 YK-------HIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       149 ~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ..       ..............++++.       +++.+||+.||++|||+.|++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~-------dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         230 SLPDYVTFKSFPGIPLHHIFSAAGDDLL-------DLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHH-------HHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ccchhhhhccCCCCChHHhcccCCHHHH-------HHHHHHccCChhhCcCHHHHhCC
Confidence            00       0000000011122344444       45555889999999999999874

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.7e-35  Score=234.08  Aligned_cols=179  Identities=21%  Similarity=0.352  Sum_probs=131.6

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|.+++...      +.+++.++..++.||+.||.|||++   +++||||||+||+++.++..+++|||.+.....
T Consensus        93 ~~g~~L~~~~~~~------~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~  163 (277)
T d1o6ya_          93 VDGVTLRDIVHTE------GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD  163 (277)
T ss_dssp             CCEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred             CCCCEehhhhccc------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhcc
Confidence            6789999998776      4599999999999999999999999   999999999999999999999999998875443


Q ss_pred             Cccc-chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCC--Cc
Q 026160           81 KKST-ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPG--ND  157 (242)
Q Consensus        81 ~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~  157 (242)
                      .... .......||+.|+|||++.+.  .++.++|||||||++|+|++|..||......       ..........  ..
T Consensus       164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~~~~~~~~~~  234 (277)
T d1o6ya_         164 SGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-------SVAYQHVREDPIPP  234 (277)
T ss_dssp             ---------------TTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCCCCCG
T ss_pred             ccccccccccccCcccccCHHHHcCC--CCCcceecccchHHHHHHHhCCCCCCCcCHH-------HHHHHHHhcCCCCC
Confidence            3221 122234589999999998654  6788999999999999999999999643321       1111111111  11


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHhhchh
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRP-SMHEVLEMLESST  204 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp-s~~~ll~~l~~~~  204 (242)
                      ......+++++.+++.+       ||+.||++|| |++++++.|.++.
T Consensus       235 ~~~~~~~s~~l~~li~~-------~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         235 SARHEGLSADLDAVVLK-------ALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             GGTSSSCCHHHHHHHHH-------HTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             chhccCCCHHHHHHHHH-------HccCCHhHCHhHHHHHHHHHHHHh
Confidence            22234566666666655       8899999999 8999999998764

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.1e-35  Score=235.07  Aligned_cols=167  Identities=29%  Similarity=0.408  Sum_probs=133.8

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |+||+|..++...      ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        86 ~~gg~l~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          86 IEGGELFSLLRKS------QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             CCSCBHHHHHHHT------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             cCCcccccccccc------ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence            6899999999876      4589999999999999999999999   999999999999999999999999999987655


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ...     ...||+.|+|||++.+.  .++.++|||||||++|+|++|..||......        .....+... ....
T Consensus       157 ~~~-----~~~Gt~~Y~APE~l~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~~~~i~~~-~~~~  220 (316)
T d1fota_         157 VTY-----TLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--------KTYEKILNA-ELRF  220 (316)
T ss_dssp             CBC-----CCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHC-CCCC
T ss_pred             ccc-----cccCcccccCHHHHcCC--CCCchhhccccchhHHHHHhCCCCCCCcCHH--------HHHHHHHcC-CCCC
Confidence            432     24599999999998664  5788999999999999999999999754321        111111111 1233


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRP-----SMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp-----s~~~ll~~  199 (242)
                      +..+++++.+++.+       ||+.||.+|+     |+++++++
T Consensus       221 p~~~s~~~~~li~~-------~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         221 PPFFNEDVKDLLSR-------LITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             CTTSCHHHHHHHHH-------HTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CCCCCHHHHHHHHH-------HhhhCHHhccccchhhHHHHHcC
Confidence            44567777766666       7799999996     89999875

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-34  Score=231.73  Aligned_cols=165  Identities=27%  Similarity=0.362  Sum_probs=122.9

Q ss_pred             ccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccccc
Q 026160           20 RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAP   99 (242)
Q Consensus        20 ~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~P   99 (242)
                      ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||++.........   ....||+.|+||
T Consensus       111 ~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~~~---~~~~gT~~Y~AP  184 (305)
T d1blxa_         111 PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWYRAP  184 (305)
T ss_dssp             TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGG---CCCCCCCTTCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhhhhhcccccC---CCcccChhhcCc
Confidence            5799999999999999999999999   9999999999999999999999999998765443322   234599999999


Q ss_pred             hhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCC------------------CCCcCcchhhhccCCCCccccc
Q 026160          100 EVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRS------------------SDIYFPNSIYKHIEPGNDFQLD  161 (242)
Q Consensus       100 E~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~  161 (242)
                      |++.+.  .++.++|||||||++|||++|..||.......                  ....................+.
T Consensus       185 E~~~~~--~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (305)
T d1blxa_         185 EVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFV  262 (305)
T ss_dssp             HHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTC
T ss_pred             chhcCC--CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhcc
Confidence            998764  67899999999999999999999996443110                  0000011111111111122233


Q ss_pred             cccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          162 GVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       162 ~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ..+++.+.+++.+       ||++||++|||+.|++++
T Consensus       263 ~~~s~~~~dli~~-------mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         263 TDIDELGKDLLLK-------CLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             CSCCHHHHHHHHH-------HSCSSTTTSCCHHHHHTS
T ss_pred             ccCCHHHHHHHHH-------HCcCChhHCcCHHHHhcC
Confidence            3455555555555       889999999999999875

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-35  Score=238.55  Aligned_cols=169  Identities=27%  Similarity=0.396  Sum_probs=133.7

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.++|...      ..+++.++..++.||+.||.|||++   +++||||||+|||++.++.++|+|||++.....
T Consensus        85 ~~~g~L~~~i~~~------~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          85 LNGGDLMYHIQSC------HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             CTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             cCCCcHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccc
Confidence            6899999999876      4599999999999999999999999   999999999999999999999999999986544


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      .....  ....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||......        .....+... ....
T Consensus       156 ~~~~~--~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~PF~~~~~~--------~~~~~i~~~-~~~~  222 (320)
T d1xjda_         156 GDAKT--NTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--------ELFHSIRMD-NPFY  222 (320)
T ss_dssp             TTCCB--CCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHC-CCCC
T ss_pred             ccccc--cccCCCCCcCCHHHHcCC--CCCchhhhhhhhHHHHHHHhCCCCCCCCCHH--------HHHHHHHcC-CCCC
Confidence            32221  223589999999999764  6788999999999999999999999754321        111111111 1234


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCCCHH-HHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMH-EVLE  198 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~-~ll~  198 (242)
                      +..+++++.+++.+       ||+.||++|||+. ++++
T Consensus       223 p~~~s~~~~dli~~-------~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         223 PRWLEKEAKDLLVK-------LFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CTTSCHHHHHHHHH-------HSCSSGGGSBTTBSCGGG
T ss_pred             CccCCHHHHHHHHH-------hcccCCCCCcCHHHHHHh
Confidence            44567777666666       8899999999995 6764

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-35  Score=230.60  Aligned_cols=160  Identities=24%  Similarity=0.330  Sum_probs=126.4

Q ss_pred             CCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCC-CceEEcccccccccCCCc
Q 026160            4 GSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDED-FCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         4 GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~-~~~~L~dfg~~~~~~~~~   82 (242)
                      |++.+++...      ..+++.++..++.||+.||.|||++   +|+||||||+||+++.+ +.++|+|||++.......
T Consensus        95 ~~l~~~~~~~------~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~  165 (273)
T d1xwsa_          95 QDLFDFITER------GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV  165 (273)
T ss_dssp             EEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCSSC
T ss_pred             chHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccceeccccc
Confidence            5777777665      4599999999999999999999999   99999999999999854 789999999998655433


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccccc
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQLDG  162 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (242)
                      .    ....||+.|+|||.+.+. ..++.++|||||||++|+|++|..||.....          +...     ...++.
T Consensus       166 ~----~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----------i~~~-----~~~~~~  225 (273)
T d1xwsa_         166 Y----TDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRG-----QVFFRQ  225 (273)
T ss_dssp             B----CCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------HHHC-----CCCCSS
T ss_pred             c----cccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCCchH----------Hhhc-----ccCCCC
Confidence            2    234599999999998754 2346789999999999999999999964321          1111     112334


Q ss_pred             ccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          163 VVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       163 ~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .+++++.+++.+       ||+.||++|||++|++++
T Consensus       226 ~~s~~~~~li~~-------~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         226 RVSSECQHLIRW-------CLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             CCCHHHHHHHHH-------HTCSSGGGSCCHHHHHTS
T ss_pred             CCCHHHHHHHHH-------HccCCHhHCcCHHHHhcC
Confidence            567777666665       889999999999999874

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-34  Score=227.73  Aligned_cols=184  Identities=21%  Similarity=0.293  Sum_probs=127.9

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCc
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKK   82 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~   82 (242)
                      +|++.+++....    .+.+++.++..++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||++.......
T Consensus        84 ~~~~~~~~~~~~----~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          84 HQDLKKFMDASA----LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             SEEHHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             CCchhhhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc
Confidence            345555554432    26799999999999999999999999   99999999999999999999999999998665433


Q ss_pred             ccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccC------------CCCCcCcchhhh
Q 026160           83 STISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASR------------SSDIYFPNSIYK  150 (242)
Q Consensus        83 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~------------~~~~~~~~~~~~  150 (242)
                      ...  ....+++.|+|||.+... ...+.++|||||||++|+|++|+.||...+..            .....+......
T Consensus       157 ~~~--~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  233 (298)
T d1gz8a_         157 RTY--THEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM  233 (298)
T ss_dssp             BCT--TCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             ccc--eeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence            221  223589999999987654 34578999999999999999999999644311            111111110000


Q ss_pred             -ccCCCCc-------cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--hhch
Q 026160          151 -HIEPGND-------FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM--LESS  203 (242)
Q Consensus       151 -~~~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~--l~~~  203 (242)
                       .......       ......+++++       .+++.+||+.||++|||+.|++++  ++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~-------~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         234 PDYKPSFPKWARQDFSKVVPPLDEDG-------RSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             TTCCTTSCCCCCCCHHHHSTTCCHHH-------HHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccccccccccccchhhhccCCCHHH-------HHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence             0000000       00111233334       445555889999999999999986  5433

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-34  Score=231.57  Aligned_cols=174  Identities=21%  Similarity=0.239  Sum_probs=129.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC--CCceEEccccccccc
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE--DFCPKISDFGLAKQS   78 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~--~~~~~L~dfg~~~~~   78 (242)
                      |+||+|.++|.+..     ..+++.++..++.||+.||.|||+.   +|+||||||+|||++.  ...++|+|||++...
T Consensus        83 ~~gg~L~~~i~~~~-----~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          83 ISGLDIFERINTSA-----FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             CCCCBHHHHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             CCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcc
Confidence            68999999997642     3699999999999999999999999   9999999999999985  457999999999876


Q ss_pred             CCCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcc
Q 026160           79 QDKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDF  158 (242)
Q Consensus        79 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (242)
                      .......   ...+++.|++||...+.  .++.++|||||||++|+|++|..||........    ...+.. .......
T Consensus       155 ~~~~~~~---~~~~t~~y~ape~~~~~--~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~----~~~i~~-~~~~~~~  224 (321)
T d1tkia_         155 KPGDNFR---LLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETNQQI----IENIMN-AEYTFDE  224 (321)
T ss_dssp             CTTCEEE---EEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHH-TCCCCCH
T ss_pred             ccCCccc---ccccccccccchhccCC--CCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH----HHHHHh-CCCCCCh
Confidence            5443322   23589999999988654  568899999999999999999999975432110    001111 1111111


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      .....+++++.++       +.+||..||++|||+.|++++
T Consensus       225 ~~~~~~s~~~~~l-------i~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         225 EAFKEISIEAMDF-------VDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HHHTTSCHHHHHH-------HHTTSCSSGGGSCCHHHHHHS
T ss_pred             hhccCCCHHHHHH-------HHHHccCChhHCcCHHHHhcC
Confidence            1112345555554       445999999999999999974

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.5e-34  Score=228.12  Aligned_cols=199  Identities=19%  Similarity=0.204  Sum_probs=138.6

Q ss_pred             CCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC---CCceEEcccccccccC
Q 026160            3 NGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE---DFCPKISDFGLAKQSQ   79 (242)
Q Consensus         3 ~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~---~~~~~L~dfg~~~~~~   79 (242)
                      +|+|.+.+....     +.+++.++..++.|++.||+|||++   +|+||||||+||++..   +..++++|||+++...
T Consensus        86 ~~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          86 GPSLEDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             CCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             CCchhhhhhhcc-----CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            677777765432     4699999999999999999999999   9999999999999853   4579999999998765


Q ss_pred             CCccc-----chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCC
Q 026160           80 DKKST-----ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEP  154 (242)
Q Consensus        80 ~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  154 (242)
                      .....     .......||+.|+|||.+.+.  .++.++|||||||++|||++|..||.................... .
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~-~  234 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-S  234 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTB--CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH-H
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCC--CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC-C
Confidence            43221     111234699999999998764  578999999999999999999999975544332221111111100 0


Q ss_pred             CCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccCCCCCCCCCCc
Q 026160          155 GNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSLALPK  219 (242)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~~~~~~~  219 (242)
                      .........+++++.       +++..||+.||++||++.++.+.|+.+..........+.+|..
T Consensus       235 ~~~~~~~~~~p~~~~-------~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~~  292 (299)
T d1ckia_         235 TPIEVLCKGYPSEFA-------TYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM  292 (299)
T ss_dssp             SCHHHHTTTSCHHHH-------HHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHHH
T ss_pred             CChhHhccCCCHHHH-------HHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCchh
Confidence            011112223444444       4455599999999999999999999876654444444455433

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.6e-33  Score=224.20  Aligned_cols=199  Identities=17%  Similarity=0.163  Sum_probs=143.7

Q ss_pred             CCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCC-----CCceEEccccccc
Q 026160            2 PNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDE-----DFCPKISDFGLAK   76 (242)
Q Consensus         2 ~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~-----~~~~~L~dfg~~~   76 (242)
                      .+|+|.+++....     ..++..++..++.|++.||.|||+.   +|+||||||+||+++.     ++.++|+|||+++
T Consensus        83 ~~~~l~~~~~~~~-----~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          83 LGPSLEDLLDLCG-----RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             CCCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             cCCCHHHHHHhhc-----cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeE
Confidence            4789999986643     4699999999999999999999999   9999999999999964     5679999999998


Q ss_pred             ccCCCccc-----chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhc
Q 026160           77 QSQDKKST-----ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKH  151 (242)
Q Consensus        77 ~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~  151 (242)
                      ........     .......||+.|+|||.+.+.  .++.++||||||+++|+|++|..||.............. +...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~--~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~-i~~~  231 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER-IGEK  231 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH-HHHH
T ss_pred             EcccCccccceeecccCceEEchhhcCHHHhcCC--CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH-HHhc
Confidence            75433211     112234699999999998764  678999999999999999999999975443321110000 0000


Q ss_pred             cCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhhchhhhccCCCCCCCCCC
Q 026160          152 IEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEMLESSTEILQIPPKPSLALP  218 (242)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~~~~~~  218 (242)
                      ........+...++++       +.+++..||+.+|++||+++.+.+.|+.+.+..........+|.
T Consensus       232 ~~~~~~~~l~~~~p~~-------l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~  291 (293)
T d1csna_         232 KQSTPLRELCAGFPEE-------FYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN  291 (293)
T ss_dssp             HHHSCHHHHTTTSCHH-------HHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred             cCCCChHHhcCCCCHH-------HHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCC
Confidence            0000111112234444       45555569999999999999999999998877666655555553

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-33  Score=227.63  Aligned_cols=177  Identities=25%  Similarity=0.364  Sum_probs=134.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |++|+|.+++...      +.+++..+..++.||+.||.|||+.   +++||||||+||+++.++.++|+|||++.....
T Consensus       111 ~~~~~L~~~i~~~------~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~  181 (322)
T d1vzoa_         111 INGGELFTHLSQR------ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  181 (322)
T ss_dssp             CCSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             ccccHHHHHHHhc------ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence            6799999999876      3588999999999999999999999   999999999999999999999999999987654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcCcchhhhccCCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYFPNSIYKHIEPGNDFQL  160 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (242)
                      ..... .....+++.|.+||.+......++.++|||||||++|+|++|..||.........    ..+.... .......
T Consensus       182 ~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~----~~i~~~~-~~~~~~~  255 (322)
T d1vzoa_         182 DETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ----AEISRRI-LKSEPPY  255 (322)
T ss_dssp             GGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH----HHHHHHH-HHCCCCC
T ss_pred             ccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHHhc-ccCCCCC
Confidence            43322 2234689999999998766556788999999999999999999999755433211    1111111 0111223


Q ss_pred             ccccchHHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 026160          161 DGVVTEEEKELVKKMILVSLWCIQTNPSDRP-----SMHEVLEM  199 (242)
Q Consensus       161 ~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rp-----s~~~ll~~  199 (242)
                      +..+++++.+++.+       ||++||++||     |++|++++
T Consensus       256 ~~~~s~~~~~li~~-------~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         256 PQEMSALAKDLIQR-------LLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             CTTSCHHHHHHHHH-------HTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             cccCCHHHHHHHHH-------HcccCHHHcCCCCcccHHHHHcC
Confidence            34567777776666       8899999999     48899873

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=2.4e-33  Score=229.40  Aligned_cols=181  Identities=24%  Similarity=0.283  Sum_probs=130.2

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +.+|+|.+++...       .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        92 ~~~g~L~~~l~~~-------~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          92 LMGADLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             CCCEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             ecCCchhhhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            4689999999653       599999999999999999999999   999999999999999999999999999986544


Q ss_pred             Cccc-chhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCc------Ccc-h-----
Q 026160           81 KKST-ISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIY------FPN-S-----  147 (242)
Q Consensus        81 ~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~------~~~-~-----  147 (242)
                      .... .......+++.|+|||.+... ..++.++||||+||++|+|++|..||......+....      .+. .     
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  240 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCccceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence            3222 112334689999999998554 3568899999999999999999999965432110000      000 0     


Q ss_pred             ----h---hhccCCCCc---cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          148 ----I---YKHIEPGND---FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       148 ----~---~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                          .   .........   ......+++++       .+++.+||+.||++|||+.+++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~-------~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         241 INLKARNYLLSLPHKNKVPWNRLFPNADSKA-------LDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHH-------HHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhcccccCCccCCCCHHHhCCCCCHHH-------HHHHHHHccCChhHCcCHHHHhcC
Confidence                0   000000000   01112233344       445555889999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.98  E-value=7.2e-33  Score=221.00  Aligned_cols=167  Identities=26%  Similarity=0.311  Sum_probs=117.7

Q ss_pred             ccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccccc
Q 026160           20 RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAP   99 (242)
Q Consensus        20 ~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~P   99 (242)
                      +.+++.++..++.||+.||+|||+.   +|+||||||+|||++.++.++++|||.+..........  ....+++.|.+|
T Consensus        95 ~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~--~~~~~~~~y~~p  169 (286)
T d1ob3a_          95 GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAP  169 (286)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCH
T ss_pred             CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcccc--ceecccchhhhH
Confidence            5699999999999999999999998   99999999999999999999999999998765432221  122488999999


Q ss_pred             hhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCC------------CCCcCcchhh--------hccCCCCccc
Q 026160          100 EVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRS------------SDIYFPNSIY--------KHIEPGNDFQ  159 (242)
Q Consensus       100 E~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~------------~~~~~~~~~~--------~~~~~~~~~~  159 (242)
                      |.+.+. ..++.++|||||||++|||++|+.||......+            ....++....        ..........
T Consensus       170 E~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (286)
T d1ob3a_         170 DVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWES  248 (286)
T ss_dssp             HHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGG
T ss_pred             HHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhh
Confidence            998654 356899999999999999999999996432110            0000000000        0000011111


Q ss_pred             cccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          160 LDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ....+++.+.+++.       +||+.||++|||++|++++
T Consensus       249 ~~~~~s~~~~dli~-------~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         249 FLKGLDESGIDLLS-------KMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             TCCSCCHHHHHHHH-------HHTCSSTTTSCCHHHHHTS
T ss_pred             hcccCCHHHHHHHH-------HHccCChhHCcCHHHHhcC
Confidence            22334455555544       4889999999999999853

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.2e-32  Score=219.67  Aligned_cols=174  Identities=21%  Similarity=0.281  Sum_probs=119.1

Q ss_pred             ccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCccc--chhcccccccccc
Q 026160           20 RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKST--ISMLHARGTIGYI   97 (242)
Q Consensus        20 ~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~--~~~~~~~~~~~y~   97 (242)
                      ..+++.++..++.|++.||.|||++   +|+||||||+|||++.++.++++|||++.........  .......+|+.|+
T Consensus       112 ~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~  188 (318)
T d3blha1         112 VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR  188 (318)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGC
T ss_pred             cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHh
Confidence            5699999999999999999999999   9999999999999999999999999999765533221  1112235899999


Q ss_pred             cchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCC------------CCcCcc----hhhhccCCCCccccc
Q 026160           98 APEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSS------------DIYFPN----SIYKHIEPGNDFQLD  161 (242)
Q Consensus        98 ~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~------------~~~~~~----~~~~~~~~~~~~~~~  161 (242)
                      |||.+.+. ..++.++|||||||++|+|++|+.||........            ......    ...........  ..
T Consensus       189 aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  265 (318)
T d3blha1         189 PPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKG--QK  265 (318)
T ss_dssp             CHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSS--CC
T ss_pred             hHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhccccc--cc
Confidence            99998654 3568899999999999999999999964321100            000000    00000000000  00


Q ss_pred             cccchHHH--HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          162 GVVTEEEK--ELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       162 ~~~~~~~~--~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ......+.  .....+.+++.+||++||++|||++|++++
T Consensus       266 ~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         266 RKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             BCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            00111111  112244567778999999999999999976

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.6e-32  Score=224.88  Aligned_cols=171  Identities=24%  Similarity=0.234  Sum_probs=121.5

Q ss_pred             ccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCC-ceEEcccccccccCCCcccchhccccccccccc
Q 026160           20 RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF-CPKISDFGLAKQSQDKKSTISMLHARGTIGYIA   98 (242)
Q Consensus        20 ~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~   98 (242)
                      ..+++.++..++.||+.||.|||++   +|+||||||+|||++.++ .+||+|||++..........   ...++..|.|
T Consensus       117 ~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~---~~~gt~~y~a  190 (350)
T d1q5ka_         117 QTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSRYYRA  190 (350)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCC---SCCSCTTSCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhccCCcccc---cccccccccC
Confidence            5799999999999999999999999   999999999999999775 79999999998765443322   2358999999


Q ss_pred             chhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCC--------CcCcchhhhccCCCC------------cc
Q 026160           99 PEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSD--------IYFPNSIYKHIEPGN------------DF  158 (242)
Q Consensus        99 PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~------------~~  158 (242)
                      ||.+.+. ..++.++|||||||++|||++|..||.........        ...............            ..
T Consensus       191 PE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (350)
T d1q5ka_         191 PELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTK  269 (350)
T ss_dssp             HHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGG
T ss_pred             hHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhh
Confidence            9987654 36789999999999999999999999644321100        000000000000000            00


Q ss_pred             ccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--hhchh
Q 026160          159 QLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM--LESST  204 (242)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~--l~~~~  204 (242)
                      ......++++.+++.       +||.+||++|||+.|++++  ++.+.
T Consensus       270 ~~~~~~s~~~~dLl~-------~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         270 VFRPRTPPEAIALCS-------RLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             TSCTTSCHHHHHHHH-------HHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hcccCCCHHHHHHHH-------HHccCChhHCcCHHHHhcCHhhcccc
Confidence            111234555555554       4889999999999999974  44443

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.97  E-value=5.5e-32  Score=219.87  Aligned_cols=119  Identities=23%  Similarity=0.299  Sum_probs=99.5

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCC-ceEEcccccccccC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDF-CPKISDFGLAKQSQ   79 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~-~~~L~dfg~~~~~~   79 (242)
                      |++|+|.++.         +.+++.++..++.||+.||.|||++   +|+||||||+|||++.++ .++|+|||++....
T Consensus       114 ~~~~~L~~~~---------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         114 VNNTDFKQLY---------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             CCSCBGGGTT---------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             cCCCcHHHHh---------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceecc
Confidence            5677876654         3599999999999999999999999   999999999999998655 68999999998765


Q ss_pred             CCcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           80 DKKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        80 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      ......   ...+|..|+|||.+.+. ..++.++||||+||++|++++|..||...
T Consensus       182 ~~~~~~---~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~  233 (328)
T d3bqca1         182 PGQEYN---VRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHG  233 (328)
T ss_dssp             TTCCCC---SCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             CCCccc---ccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence            443222   23589999999998664 35688999999999999999999998643

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.5e-31  Score=218.84  Aligned_cols=169  Identities=24%  Similarity=0.265  Sum_probs=123.6

Q ss_pred             ccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccccc
Q 026160           20 RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAP   99 (242)
Q Consensus        20 ~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~P   99 (242)
                      ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.++++|||++........     ...+++.|+||
T Consensus       116 ~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~t~~y~aP  187 (346)
T d1cm8a_         116 EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT-----GYVVTRWYRAP  187 (346)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSSCC-----SSCSCGGGCCT
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceeccCCccc-----cccccccccCH
Confidence            4599999999999999999999999   999999999999999999999999999987655432     23589999999


Q ss_pred             hhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCC-------------------CcCcchhhhcc---CCCCc
Q 026160          100 EVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSD-------------------IYFPNSIYKHI---EPGND  157 (242)
Q Consensus       100 E~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~-------------------~~~~~~~~~~~---~~~~~  157 (242)
                      |.+.+. ...+.++||||+||++|+|++|..||.........                   ...........   .....
T Consensus       188 E~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (346)
T d1cm8a_         188 EVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF  266 (346)
T ss_dssp             HHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG
T ss_pred             HHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccch
Confidence            998654 35689999999999999999999999654321100                   00000000001   11111


Q ss_pred             cccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--hhchh
Q 026160          158 FQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM--LESST  204 (242)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~--l~~~~  204 (242)
                      .......++.+.+++       .+||..||++|||+.|++++  ++.+.
T Consensus       267 ~~~~~~~s~~~~dli-------~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         267 ASILTNASPLAVNLL-------EKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             GGTCTTCCHHHHHHH-------HHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHhccCCCHHHHHHH-------HHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            112223455555544       45889999999999999986  65543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.4e-31  Score=213.94  Aligned_cols=180  Identities=20%  Similarity=0.234  Sum_probs=126.9

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      +.+|+|..++...      +.+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++|+|||.+.....
T Consensus        83 ~~~~~l~~~~~~~------~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~  153 (292)
T d1unla_          83 CDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             CSEEHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ccccccccccccc------cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccC
Confidence            3566777766554      5699999999999999999999999   999999999999999999999999999987654


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCC-------------CCcCcch
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSS-------------DIYFPNS  147 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~-------------~~~~~~~  147 (242)
                      ......  ...++..|.|||.+... ...+.++|||||||++|+|++|..||........             ...++..
T Consensus       154 ~~~~~~--~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (292)
T d1unla_         154 PVRCYS--AEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM  230 (292)
T ss_dssp             CCSCCC--SCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTG
T ss_pred             CCccce--eeccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhh
Confidence            432221  22467889999988654 3468899999999999999999998743221110             0000000


Q ss_pred             hhh--------ccCCCCccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          148 IYK--------HIEPGNDFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       148 ~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                      ...        .............+++.+.+++.       +||+.||.+|||++|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~-------~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQ-------NLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHH-------HHSCSSGGGSCCHHHHTTS
T ss_pred             hhcccccccccccccchhhhccccCCHHHHHHHH-------HHccCChhHCcCHHHHhcC
Confidence            000        00011111222334555555544       4889999999999999874

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.1e-31  Score=219.87  Aligned_cols=119  Identities=30%  Similarity=0.427  Sum_probs=99.1

Q ss_pred             CCCCCcchhccccCCCCCCccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCC
Q 026160            1 MPNGSLDQFTYDQESSNGNRTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQD   80 (242)
Q Consensus         1 ~~~GsL~~~l~~~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~   80 (242)
                      |.+|+|.+++..       +.+++.++..++.||+.||.|||++   +|+||||||+|||++.++.++++|||++.....
T Consensus       104 ~~gg~L~~~~~~-------~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~  173 (348)
T d2gfsa1         104 LMGADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  173 (348)
T ss_dssp             CCSEEHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred             ecCCchhhhccc-------ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccCc
Confidence            468999999854       3599999999999999999999999   999999999999999999999999999876543


Q ss_pred             CcccchhcccccccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCcccc
Q 026160           81 KKSTISMLHARGTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVK  135 (242)
Q Consensus        81 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  135 (242)
                      ...     ...++..|+|||...+. ...+.++|||||||++|+|++|..||...
T Consensus       174 ~~~-----~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~  222 (348)
T d2gfsa1         174 EMT-----GYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGT  222 (348)
T ss_dssp             GGS-----SSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccc-----cccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence            322     23588999999987654 35688999999999999999999999643

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.5e-29  Score=207.44  Aligned_cols=172  Identities=23%  Similarity=0.219  Sum_probs=115.8

Q ss_pred             ccccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccccc
Q 026160           20 RTLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAP   99 (242)
Q Consensus        20 ~~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~P   99 (242)
                      ..+++.++..++.||+.||.|||+.   +|+|+||||+|||++.++.++++|||++..........   ...+|+.|+||
T Consensus       114 ~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~~---~~~~t~~y~aP  187 (355)
T d2b1pa1         114 MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT---PYVVTRYYRAP  187 (355)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------------------CCTTCCH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhccccccccc---cccccccccCh
Confidence            3589999999999999999999999   99999999999999999999999999987655443322   23589999999


Q ss_pred             hhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCC--------CcCc-------chhh---hccCCCC-----
Q 026160          100 EVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSD--------IYFP-------NSIY---KHIEPGN-----  156 (242)
Q Consensus       100 E~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~--------~~~~-------~~~~---~~~~~~~-----  156 (242)
                      |.+.+.  .++.++||||+||++|+|++|+.||.........        ...+       ....   .......     
T Consensus       188 E~l~~~--~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (355)
T d2b1pa1         188 EVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFP  265 (355)
T ss_dssp             HHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHH
T ss_pred             hhhcCC--CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccc
Confidence            998764  6788999999999999999999998543211000        0000       0000   0000000     


Q ss_pred             ---ccccccccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          157 ---DFQLDGVVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       157 ---~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                         ..................+.+++.+||+.||++|||++|++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         266 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence               0000111222233445567778888999999999999999965

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.95  E-value=2.5e-28  Score=200.55  Aligned_cols=171  Identities=24%  Similarity=0.286  Sum_probs=117.1

Q ss_pred             CccccHHHHHHHHHHHHHHhHHhhh-CCCCCeeecCCCCCceeeCCCC------ceEEcccccccccCCCcccchhcccc
Q 026160           19 NRTLEWRTVYQIAGGIARGLEYLHR-GCNVRIVHFDIKPHNILLDEDF------CPKISDFGLAKQSQDKKSTISMLHAR   91 (242)
Q Consensus        19 ~~~l~~~~~~~i~~~l~~al~~LH~-~~~~~i~h~dlk~~nil~~~~~------~~~L~dfg~~~~~~~~~~~~~~~~~~   91 (242)
                      ...+++..+..++.|++.|+.|||+ .   +|+||||||+|||++.++      .++++|||.+........     ...
T Consensus       119 ~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~~-----~~~  190 (362)
T d1q8ya_         119 HRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT-----NSI  190 (362)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCCC-----SCC
T ss_pred             ccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccccceeeEeecccccccccccc-----ccc
Confidence            3678999999999999999999998 5   999999999999997654      389999999876544322     235


Q ss_pred             cccccccchhhhcccCCCCCCccchhHHHHHHHHHhcCCCccccccCCCCCcC-------------cchhhh--------
Q 026160           92 GTIGYIAPEVFCRSFGGASHKSDVYSYGMMILEMAVGRKNADVKASRSSDIYF-------------PNSIYK--------  150 (242)
Q Consensus        92 ~~~~y~~PE~~~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~~-------------~~~~~~--------  150 (242)
                      +++.|+|||.+...  .++.++|+||+||++++|++|+.||............             +.....        
T Consensus       191 gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  268 (362)
T d1q8ya_         191 QTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTF  268 (362)
T ss_dssp             SCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHH
T ss_pred             ccccccChhhcccc--CCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccc
Confidence            89999999988754  5688999999999999999999999754332111000             000000        


Q ss_pred             --------ccCCCCcccccc---ccchHHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 026160          151 --------HIEPGNDFQLDG---VVTEEEKELVKKMILVSLWCIQTNPSDRPSMHEVLEM  199 (242)
Q Consensus       151 --------~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~~cl~~dp~~Rps~~~ll~~  199 (242)
                              ............   ............+.+++.+||.+||.+|||++|++++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H  328 (362)
T d1q8ya_         269 FNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  328 (362)
T ss_dssp             BCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             cccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                    000000000000   0000113445667778888999999999999999975

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.35  E-value=1.2e-13  Score=102.32  Aligned_cols=90  Identities=16%  Similarity=0.063  Sum_probs=62.5

Q ss_pred             cccHHHHHHHHHHHHHHhHHhhhCCCCCeeecCCCCCceeeCCCCceEEcccccccccCCCcccchhcccccccccccch
Q 026160           21 TLEWRTVYQIAGGIARGLEYLHRGCNVRIVHFDIKPHNILLDEDFCPKISDFGLAKQSQDKKSTISMLHARGTIGYIAPE  100 (242)
Q Consensus        21 ~l~~~~~~~i~~~l~~al~~LH~~~~~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE  100 (242)
                      .++...+..++.|++.++.|||+.   +++|+||||+|||++.+ .++|+|||.+.............+-..    .-.+
T Consensus        99 ~l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~~~l~rd~~----~~~~  170 (191)
T d1zara2          99 RVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVR----NIIT  170 (191)
T ss_dssp             GCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHHHHHHHHHH----HHHH
T ss_pred             chhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEECCCcccCCCCCcHHHHHHHHH----HHHH
Confidence            366677888999999999999999   99999999999999865 489999999876554322211110000    0012


Q ss_pred             hhhcccCCCCCCccchhHHHH
Q 026160          101 VFCRSFGGASHKSDVYSYGMM  121 (242)
Q Consensus       101 ~~~~~~~~~~~~~Di~slG~~  121 (242)
                      .+.   ..++.++|+||+.--
T Consensus       171 ~f~---r~y~~~~d~~s~~~~  188 (191)
T d1zara2         171 YFS---RTYRTEKDINSAIDR  188 (191)
T ss_dssp             HHH---HHHCCCCCHHHHHHH
T ss_pred             HHc---CCCCCcccHHHHHHH
Confidence            222   145788899997543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.90  E-value=0.0039  Score=47.90  Aligned_cols=30  Identities=23%  Similarity=0.317  Sum_probs=27.0

Q ss_pred             CCeeecCCCCCceeeCCCCceEEccccccc
Q 026160           47 VRIVHFDIKPHNILLDEDFCPKISDFGLAK   76 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~~~~~~L~dfg~~~   76 (242)
                      .+++|+|+.+.|++++++...-++||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            389999999999999988777899999875

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=93.52  E-value=0.014  Score=43.17  Aligned_cols=29  Identities=21%  Similarity=0.295  Sum_probs=25.2

Q ss_pred             CeeecCCCCCceeeCCCCceEEccccccc
Q 026160           48 RIVHFDIKPHNILLDEDFCPKISDFGLAK   76 (242)
Q Consensus        48 ~i~h~dlk~~nil~~~~~~~~L~dfg~~~   76 (242)
                      .++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       184 ~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             EEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             EEEEeeccCcceeecCCceEEEeechhcc
Confidence            58999999999999877666799998775

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=93.40  E-value=0.013  Score=43.19  Aligned_cols=30  Identities=20%  Similarity=0.165  Sum_probs=25.7

Q ss_pred             CeeecCCCCCceeeCCCCceEEcccccccc
Q 026160           48 RIVHFDIKPHNILLDEDFCPKISDFGLAKQ   77 (242)
Q Consensus        48 ~i~h~dlk~~nil~~~~~~~~L~dfg~~~~   77 (242)
                      .++|+|+.+.||+++.+..+.|+||+.+..
T Consensus       176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         176 VVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             EEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             eEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            689999999999998876678999987653

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=90.53  E-value=0.15  Score=38.94  Aligned_cols=29  Identities=31%  Similarity=0.379  Sum_probs=23.7

Q ss_pred             CCeeecCCCCCceeeCCCCceEEcccccccc
Q 026160           47 VRIVHFDIKPHNILLDEDFCPKISDFGLAKQ   77 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~   77 (242)
                      .+++|+|+.+.||+++.+  ..++||+-++.
T Consensus       192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            489999999999999743  45899997763

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=90.21  E-value=0.069  Score=42.16  Aligned_cols=30  Identities=23%  Similarity=0.254  Sum_probs=25.9

Q ss_pred             CCeeecCCCCCceeeCCCCceEEcccccccc
Q 026160           47 VRIVHFDIKPHNILLDEDFCPKISDFGLAKQ   77 (242)
Q Consensus        47 ~~i~h~dlk~~nil~~~~~~~~L~dfg~~~~   77 (242)
                      ..++|||+.+.||+++.+ .++++||.++..
T Consensus       223 ~~LiHGDl~~gNIlv~~~-~~~vID~E~a~~  252 (392)
T d2pula1         223 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFY  252 (392)
T ss_dssp             CEEECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred             cceeccCCcCCceeEcCC-ceEEechhhccc
Confidence            379999999999999876 489999988764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=86.28  E-value=0.25  Score=38.77  Aligned_cols=29  Identities=34%  Similarity=0.417  Sum_probs=22.2

Q ss_pred             CeeecCCCCCceeeCC----------------------------CCceEEccccccc
Q 026160           48 RIVHFDIKPHNILLDE----------------------------DFCPKISDFGLAK   76 (242)
Q Consensus        48 ~i~h~dlk~~nil~~~----------------------------~~~~~L~dfg~~~   76 (242)
                      .++|+|+.+.||++..                            ++.++++||.++.
T Consensus       219 v~CHnDL~~~NiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~lID~EYa~  275 (395)
T d1nw1a_         219 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYAS  275 (395)
T ss_dssp             EEECSCCCGGGEEEEC------------------------------CCEECCCTTCE
T ss_pred             eEEecCCCcccEeeccccccccccccccccccccccccccccCCCCcEEEEeecccC
Confidence            5789999999999843                            4568888887775